Serum	B-ANAT
TNF	O
-	O
alpha	O
levels	O
were	O
higher	O
in	O
patients	O
with	O
ARDS	O
than	O
in	O
those	O
with	O
severe	O
pneumonia	O
or	O
in	O
control	O
subjects	O
.	O

Ultrasonic	O
deposition	O
of	O
8	O
.	O
8	O
mg	O
surfactant	O
/	O
kg	O
bw	O
in	O
the	O
injured	O
lungs	B-ANAT
reduced	O
the	O
shunt	O
flow	O
to	O
approximately	O
7	O
%	O
and	O
the	O
perfusion	O
of	O
low	O
V	O
A	O
/	O
Q	O
areas	O
to	O
<	O
2	O
%,	O
coincident	O
with	O
improvement	O
of	O
V	O
A	O
/	O
Q	O
matching	O
in	O
the	O
midrange	O
V	O
A	O
/	O
Q	O
areas	O
.	O

The	O
frameshift	O
takes	O
place	O
at	O
the	O
slippery	O
sequence	O
with	O
the	O
two	O
ribosome	B-ANAT
-	O
bound	O
tRNAs	O
slipping	O
back	B-ANAT
simultaneously	O
by	O
one	O
nucleotide	O
from	O
the	O
zero	O
phase	O
(	O
U	O
UUA	O
AAC	O
)	O
to	O
the	O
-	O
1	O
phase	O
(	O
UUU	O
AAA	O
).	O

TITLE	O
:	O
Retargeting	O
of	O
coronavirus	O
by	O
substitution	O
of	O
the	O
spike	O
glycoprotein	O
ectodomain	O
:	O
crossing	O
the	O
host	B-ANAT
cell	I-ANAT
species	O
barrier	O
.	O

The	O
resulting	O
chimeric	O
virus	O
,	O
designated	O
fMHV	O
,	O
acquired	O
the	O
ability	O
to	O
infect	O
feline	O
cells	B-ANAT
and	O
simultaneously	O
lost	O
the	O
ability	O
to	O
infect	O
murine	O
cells	B-ANAT
in	O
tissue	B-ANAT
culture	O
.	O

This	O
reciprocal	O
switch	O
of	O
species	O
specificity	O
strongly	O
supports	O
the	O
notion	O
that	O
coronavirus	O
host	B-ANAT
cell	I-ANAT
range	O
is	O
determined	O
primarily	O
at	O
the	O
level	O
of	O
interactions	O
between	O
the	O
S	O
protein	O
and	O
the	O
virus	O
receptor	O
.	O

ABSTRACT	O
:	O
The	O
type	O
I	O
glycoprotein	O
S	O
of	O
coronavirus	O
,	O
trimers	O
of	O
which	O
constitute	O
the	O
typical	O
viral	O
spikes	O
,	O
is	O
assembled	O
into	O
virions	B-ANAT
through	O
noncovalent	O
interactions	O
with	O
the	O
M	O
protein	O
.	O

These	O
proteins	O
were	O
tested	O
for	O
their	O
incorporation	O
into	O
VLPs	B-ANAT
of	O
either	O
species	O
.	O

They	O
were	O
found	O
to	O
assemble	O
only	O
into	O
viral	B-ANAT
particles	I-ANAT
of	O
the	O
species	O
from	O
which	O
their	O
carboxy	O
-	O
terminal	O
domain	O
originated	O
.	O

Thus	O
,	O
the	O
64	O
-	O
terminal	O
-	O
residue	O
sequence	O
suffices	O
to	O
draw	O
the	O
1308	O
(	O
MHV	O
)-	O
or	O
1433	O
(	O
FIPV	O
)-	O
amino	O
-	O
acid	O
-	O
long	O
mature	O
S	O
protein	O
into	O
VLPs	B-ANAT
.	O

Both	O
chimeric	O
S	O
proteins	O
appeared	O
to	O
cause	O
cell	B-ANAT
fusion	O
when	O
expressed	O
individually	O
,	O
suggesting	O
that	O
they	O
were	O
biologically	O
fully	O
active	O
.	O

Because	O
there	O
exist	O
normal	O
regions	O
in	O
the	O
lung	B-ANAT
with	O
ARDS	O
and	O
because	O
PLV	O
in	O
the	O
normal	O
lung	B-ANAT
results	O
in	O
worsened	O
gas	O
exchange	O
,	O
we	O
postulated	O
that	O
the	O
optimal	O
dose	O
of	O
PFC	O
for	O
PLV	O
may	O
be	O
less	O
than	O
the	O
functional	O
residual	O
capacity	O
(	O
FRC	O
)	O
dose	O
in	O
the	O
lung	B-ANAT
with	O
limited	O
disease	O
.	O

CONCLUSIONS	O
:	O
Respiratory	O
mechanics	O
during	O
PLV	O
for	O
dependent	O
lung	B-ANAT
-	O
dominant	O
lung	B-ANAT
injury	O
were	O
optimal	O
at	O
a	O
PFC	O
dose	O
less	O
than	O
the	O
FRC	O
.	O

In	O
conclusion	O
,	O
MV	O
will	O
produce	O
AL	O
,	O
particularly	O
when	O
high	O
peak	O
airway	B-ANAT
pressures	O
(	O
barotrauma	O
)	O
or	O
large	O
tidal	O
volumes	O
(	O
volotrauma	O
)	O
are	O
delivered	O
by	O
the	O
ventilator	O
.	O

The	O
study	O
was	O
carried	O
out	O
on	O
71	O
faecal	B-ANAT
samples	O
of	O
pups	O
with	O
enteritis	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	O
(	O
TGEV	O
)	O
agglutinates	O
erythrocytes	B-ANAT
of	O
several	O
species	O
by	O
virtue	O
of	O
sialic	O
acid	O
binding	O
activity	O
of	O
the	O
surface	O
protein	O
S	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
five	O
haemagglutination	O
-	O
defective	O
(	O
HAD	O
)	O
mutants	O
.	O

However	O
,	O
MAb	O
FK50	O
-	O
4	O
did	O
not	O
exhibit	O
neutralizing	O
activity	O
in	O
CrFK	O
cells	B-ANAT
or	O
fcwf	O
-	O
4	O
cells	B-ANAT
,	O
thus	O
showing	O
a	O
very	O
unusual	O
property	O
.	O

Expression	O
studies	O
revealed	O
that	O
for	O
formation	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
,	O
actually	O
only	O
the	O
E	O
protein	O
and	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
are	O
required	O
.	O

A	O
total	O
of	O
93	O
%	O
of	O
the	O
trauma	O
patients	O
who	O
developed	O
acute	O
lung	B-ANAT
injury	O
during	O
the	O
17	O
-	O
month	O
study	O
period	O
were	O
included	O
in	O
the	O
study	O
.	O

In	O
addition	O
,	O
the	O
volume	O
of	O
crystalloid	B-ANAT
solution	O
administered	O
during	O
the	O
first	O
24	O
hrs	O
was	O
significantly	O
greater	O
in	O
patients	O
who	O
later	O
developed	O
acute	O
lung	B-ANAT
injury	O
.	O

Both	O
fluids	B-ANAT
were	O
analyzed	O
for	O
protein	O
carbonyl	O
concentrations	O
as	O
a	O
measure	O
of	O
protein	O
oxidation	O
and	O
thiobarbituric	O
acid	O
-	O
reactive	O
substances	O
as	O
a	O
measure	O
of	O
lipid	O
peroxidation	O
.	O

High	O
protein	O
carbonyl	O
concentrations	O
in	O
plasma	B-ANAT
as	O
well	O
as	O
bronchial	B-ANAT
aspirates	B-ANAT
indicate	O
that	O
oxidation	O
is	O
not	O
restricted	O
to	O
the	O
lungs	B-ANAT
.	O

Analysis	O
was	O
performed	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluids	I-ANAT
(	O
BALF	O
)	O
of	O
patients	O
with	O
ARDS	O
triggered	O
by	O
nonpulmonary	O
underlying	O
events	O
in	O
the	O
absence	O
of	O
lung	B-ANAT
infection	O
(	O
ARDS	O
;	O
n	O
=	O
25	O
),	O
pneumonia	O
demanding	O
mechanical	O
ventilation	O
(	O
PNEU	O
-	O
vent	O
;	O
n	O
=	O
114	O
),	O
spontaneously	O
breathing	O
patients	O
with	O
pneumonia	O
(	O
PNEU	O
-	O
spon	O
;	O
n	O
=	O
40	O
),	O
and	O
ARDS	O
in	O
combination	O
with	O
lung	B-ANAT
infection	O
(	O
ARDS	O
+	O
PNEU	O
;	O
n	O
=	O
43	O
);	O
comparison	O
with	O
healthy	O
control	O
subjects	O
(	O
n	O
=	O
35	O
)	O
was	O
performed	O
.	O

Within	O
the	O
overall	O
number	O
of	O
patients	O
with	O
pneumonia	O
,	O
changes	O
in	O
the	O
alveolar	B-ANAT
hemostatic	O
balance	O
were	O
more	O
prominent	O
in	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
pneumonia	O
than	O
in	O
bronchopneumonia	O
.	O

High	O
serum	B-ANAT
concentrations	O
are	O
associated	O
with	O
severe	O
systemic	O
bacterial	O
,	O
parasitic	O
or	O
fungal	O
infections	O
.	O

PCT	O
is	O
a	O
very	O
stable	O
molecule	O
in	O
vitro	O
,	O
and	O
its	O
measurement	O
requires	O
only	O
20	O
ml	O
of	O
plasma	B-ANAT
or	O
serum	B-ANAT
and	O
can	O
be	O
done	O
within	O
2	O
hours	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
in	O
the	O
form	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
continues	O
to	O
carry	O
a	O
high	O
mortality	O
.	O

The	O
fourth	O
patient	O
sustained	O
a	O
cardiac	B-ANAT
arrest	O
immediately	O
after	O
prone	O
positioning	O
.	O

The	O
increase	O
in	O
IFN	O
secretion	B-ANAT
was	O
most	O
pronounced	O
when	O
cells	B-ANAT
were	O
cultured	O
in	O
the	O
presence	O
of	O
the	O
IFN	O
inducer	O
poly	O
(	O
I	O
.	O
C	O
).	O

Observe	O
symptoms	O
exhibited	O
by	O
pigs	O
,	O
i	O
.	O
e	O
.,	O
huddling	O
,	O
fecal	B-ANAT
material	O
around	O
perineum	B-ANAT
,	O
extreme	O
thirst	O
,	O
etc	O
.	O

Immediately	O
before	O
induction	O
of	O
the	O
acute	O
lung	B-ANAT
injury	O
,	O
the	O
lidocaine	O
treatment	O
group	O
received	O
intravenous	O
lidocaine	O
(	O
2	O
mg	O
/	O
kg	O
bolus	O
followed	O
by	O
2	O
mg	O
/	O
kg	O
/	O
hr	O
)	O
until	O
they	O
were	O
killed	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
is	O
frequent	O
after	O
severe	O
peritonitis	O
.	O

Lung	B-ANAT
tissue	I-ANAT
of	O
anti	O
-	O
CD18	O
-	O
treated	O
rabbits	O
contained	O
less	O
malonyldialdehyde	O
,	O
a	O
by	O
-	O
product	O
of	O
membrane	B-ANAT
lipid	I-ANAT
peroxidation	O
by	O
PMN	B-ANAT
oxygen	O
radicals	O
(	O
950	O
+/-	O
120	O
versus	O
1	O
,	O
710	O
+/-	O

Electrophysiologic	O
sleep	O
was	O
not	O
identifiable	O
in	O
the	O
PSG	B-ANAT
recordings	O
of	O
the	O
remaining	O
patients	O
.	O

TITLE	O
:	O
Immunopathogenesis	O
of	O
haemorrhagic	O
enteritis	O
virus	O
(	O
HEV	B-ANAT
)	O
in	O
turkeys	O
.	O

These	O
results	O
suggested	O
that	O
the	O
tracheal	O
epithelial	B-ANAT
cells	I-ANAT
infected	O
with	O
IBV	O
degenerated	O
within	O
24	O
hours	O
and	O
proliferating	O
activity	O
of	O
basal	B-ANAT
cells	I-ANAT
functioned	O
immediately	O
,	O
and	O
3	O
to	O
4	O
days	O
later	O
,	O
these	O
basal	B-ANAT
cells	I-ANAT
were	O
differentiated	O
to	O
the	O
ciliated	O
epithelia	O
.	O

TITLE	O
:	O
Downstream	O
ribosomal	B-ANAT
entry	O
for	O
translation	O
of	O
coronavirus	O
TGEV	O
gene	O
3b	O
.	O

TITLE	O
:	O
Adoptive	O
transfer	O
of	O
infectious	O
bronchitis	O
virus	O
primed	O
alphabeta	O
T	B-ANAT
cells	I-ANAT
bearing	O
CD8	O
antigen	O
protects	O
chicks	O
from	O
acute	O
infection	O
.	O

In	O
contrast	O
,	O
removal	O
of	O
gammadelta	O
T	B-ANAT
lymphocytes	I-ANAT
had	O
only	O
a	O
small	O
effect	O
on	O
their	O
potential	O
to	O
protect	O
chicks	O
.	O

TITLE	O
:	O
Capture	O
ELISA	O
systems	O
for	O
the	O
detection	O
of	O
bovine	O
coronavirus	O
-	O
specific	O
IgA	O
and	O
IgM	O
antibodies	O
in	O
milk	O
and	O
serum	B-ANAT
.	O

ABSTRACT	O
:	O
Isotype	O
-	O
capture	O
ELISAs	O
for	O
BCV	O
-	O
specific	O
IgA	O
and	O
IgM	O
were	O
developed	O
and	O
tested	O
on	O
milk	O
and	O
serum	B-ANAT
samples	O
from	O
Swedish	O
cattle	O
.	O

None	O
of	O
the	O
aforementioned	O
antisera	O
neutralized	O
SSA	O
infectivity	O
in	O
embryos	B-ANAT
except	O
for	O
the	O
homologous	O
anti	O
-	O
SSA	O
antiserum	O
.	O

ABSTRACT	O
:	O
A	O
rapid	O
-	O
plate	O
hemagglutination	O
(	O
HA	O
)	O
test	O
to	O
detect	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
allantoic	B-ANAT
fluid	I-ANAT
of	O
embryonated	O
eggs	O
was	O
introduced	O
into	O
routine	O
procedures	O
for	O
IBV	O
identification	O
.	O

TITLE	O
:	O
Right	O
atrial	B-ANAT
pressure	O
predicts	O
hemodynamic	O
response	O
to	O
apneic	O
positive	O
airway	B-ANAT
pressure	O
.	O

Twenty	O
-	O
two	O
consecutive	O
ventilator	O
-	O
dependent	O
patients	O
with	O
mild	O
to	O
severe	O
acute	O
lung	B-ANAT
injury	O
with	O
Murray	O
scores	O
(	O
scoring	O
infiltrates	O
on	O
chest	B-ANAT
radiograph	O
,	O
oxygenation	O
index	O
,	O
lung	B-ANAT
compliance	O
,	O
and	O
the	O
level	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
)	O
ranging	O
from	O
0	O
.	O
5	O
to	O
3	O
.	O
0	O
without	O
history	O
of	O
preexisting	O
cardiopulmonary	B-ANAT
disease	O
.	O

ABSTRACT	O
:	O
The	O
acute	O
disappearance	O
of	O
neutrophils	B-ANAT
from	O
the	O
circulation	O
can	O
be	O
associated	O
with	O
pulmonary	B-ANAT
leukostasis	O
,	O
lung	B-ANAT
injury	O
,	O
and	O
respiratory	O
distress	O
.	O

As	O
revealed	O
by	O
class	O
I	O
tetramer	O
technology	O
the	O
paralytic	O
variant	O
was	O
superior	O
in	O
inducing	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
during	O
the	O
acute	O
disease	O
.	O

The	O
present	O
data	O
thus	O
indicate	O
that	O
in	O
immunocompetent	O
mice	O
,	O
effector	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
control	O
infection	O
without	O
mediating	O
either	O
clinical	O
disease	O
or	O
demyelination	O
.	O

We	O
have	O
explored	O
the	O
caspase	O
activation	O
events	O
that	O
are	O
initiated	O
upon	O
infection	O
of	O
the	O
human	O
rectal	O
tumor	B-ANAT
cell	I-ANAT
line	I-ANAT
HRT18	O
with	O
TGEV	O
.	O

In	O
this	O
report	O
we	O
demonstrate	O
that	O
the	O
synthesis	O
and	O
molar	B-ANAT
ratios	O
of	O
subgenomic	O
negative	O
strands	O
are	O
similar	O
in	O
alternative	O
host	O
cells	B-ANAT
,	O
suggesting	O
that	O
these	O
RNAs	O
function	O
as	O
important	O
mediators	O
of	O
positive	O
-	O
strand	O
synthesis	O
.	O

Liver	B-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
were	O
freeze	O
-	O
clamped	O
for	O
measurement	O
of	O
NF	O
-	O
kappaB	O
activation	O
,	O
which	O
was	O
detected	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

Lung	B-ANAT
inflammation	O
is	O
associated	O
with	O
the	O
thawing	O
phase	O
of	O
cryoablation	O
and	O
may	O
be	O
related	O
to	O
soluble	O
mediator	O
(	O
s	O
)	O
released	O
from	O
the	O
cryoablated	O
tissue	B-ANAT
.	O

Lung	B-ANAT
injury	O
is	O
most	O
often	O
the	O
first	O
manifestation	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

The	O
severity	O
of	O
burn	O
shock	O
,	O
preclinical	O
diagnosis	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
disseminated	O
intravascular	O
blood	B-ANAT
coagulation	O
,	O
depth	O
of	O
hemodynamic	O
disorders	O
and	O
disorders	O
in	O
the	O
oxygen	O
transporting	O
system	O
can	O
serve	O
as	O
a	O
criterion	O
of	O
the	O
compensatory	O
stress	O
and	O
be	O
an	O
indication	O
for	O
active	O
respiratory	O
therapy	O
.	O

Cache	O
Valley	O
virus	O
N	O
expressed	O
with	O
a	O
histidine	O
tag	O
,	O
bovine	O
serum	B-ANAT
albumin	O
,	O
and	O
the	O
basic	O
lysozyme	O
protein	O
did	O
not	O
shift	O
the	O
IBV	O
RNA	O
.	O

TITLE	O
:	O
Oligohydramnion	O
,	O
renal	B-ANAT
failure	O
and	O
no	O
pulmonary	B-ANAT
hypoplasia	O
in	O
glomerulocystic	O
kidney	B-ANAT
disease	O
.	O

Both	O
infants	O
'	O
parents	O
were	O
first	O
degree	O
cousins	O
and	O
belonged	O
to	O
the	O
same	O
small	O
Bedouin	O
tribe	O
,	O
and	O
neither	O
they	O
nor	O
the	O
infants	O
'	O
siblings	O
had	O
polycystic	B-ANAT
kidneys	I-ANAT
or	O
renal	B-ANAT
insufficiency	O
,	O
pointing	O
to	O
either	O
a	O
possible	O
genetic	O
etiology	O
or	O
a	O
common	O
external	O
toxic	O
exposure	O
.	O

In	O
an	O
effort	O
to	O
maximize	O
IFN	O
-	O
alpha	O
antiviral	O
efficacy	O
,	O
we	O
have	O
explored	O
the	O
therapeutic	O
potential	O
of	O
murine	O
IFN	O
-	O
alpha2	O
(	O
mIFNalpha2	O
)	O
selectively	O
expressed	O
in	O
the	O
liver	B-ANAT
.	O

We	O
describe	O
the	O
case	O
of	O
a	O
35	O
year	O
old	O
woman	O
who	O
presented	O
with	O
dysarthria	O
,	O
weakness	O
and	O
paraesthesia	O
of	O
her	O
left	O
limbs	B-ANAT
and	O
left	O
central	O
facial	B-ANAT
paralysis	O
of	O
sudden	O
onset	O
.	O

Concerning	O
secretions	B-ANAT
,	O
we	O
collected	O
3	O
.	O
0	O
+/-	O

As	O
a	O
group	O
,	O
patients	O
with	O
cardiopulmonary	B-ANAT
complications	O
were	O
more	O
likely	O
to	O
have	O
cesareans	O
(	O
11	O
%	O
vs	O
6	O
%,	O
p	O
=	O
0	O
.	O
019	O
)	O
earlier	O
in	O
gestation	O
(	O
1366	O
+/-	O

The	O
patient	O
under	O
investigation	O
had	O
carbon	O
monoxide	O
poisoning	O
,	O
and	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
cardiovascular	B-ANAT
collapse	O
following	O
smoke	O
inhalation	O
.	O

Both	O
types	O
of	O
liver	B-ANAT
injury	O
resulted	O
in	O
near	O
identical	O
elevations	O
in	O
serum	B-ANAT
TNF	O
protein	O
and	O
hepatic	B-ANAT
TNF	O
mRNA	O
.	O

TITLE	O
:	O
Elective	O
high	O
frequency	O
oscillatory	O
ventilation	O
versus	O
conventional	O
ventilation	O
for	O
acute	O
pulmonary	B-ANAT
dysfunction	O
in	O
preterm	O
infants	O
.	O

ABSTRACT	O
:	O
Respiratory	O
failure	O
due	O
to	O
lung	B-ANAT
immaturity	O
is	O
a	O
major	O
cause	O
of	O
mortality	O
in	O
preterm	O
infants	O
.	O

Although	O
intermittent	O
positive	O
pressure	O
ventilation	O
(	O
IPPV	O
)	O
saves	O
lives	O
,	O
lung	B-ANAT
distortion	O
during	O
its	O
use	O
is	O
associated	O
with	O
lung	B-ANAT
injury	O
and	O
chronic	O
lung	B-ANAT
disease	O
(	O
CLD	O
).	O

In	O
the	O
subgroup	O
of	O
four	O
trials	O
where	O
a	O
high	O
volume	O
strategy	O
(	O
HVS	O
)	O
was	O
used	O
,	O
HFOV	O
results	O
in	O
more	O
favourable	O
pulmonary	B-ANAT
outcomes	O
.	O

Trials	O
which	O
used	O
HFJV	O
to	O
'	O
rescue	O
'	O
preterm	O
infants	O
due	O
to	O
severe	O
respiratory	O
distress	O
usually	O
beyond	O
24	O
hours	O
,	O
and	O
trials	O
that	O
used	O
HFJV	O
for	O
a	O
mandatory	O
time	O
period	O
and	O
then	O
switched	O
back	B-ANAT
to	O
CV	O
,	O
were	O
not	O
included	O
in	O
this	O
review	O
.	O

The	O
meta	O
-	O
analyses	O
demonstrated	O
significant	O
reductions	O
in	O
risk	O
of	O
pneumothorax	O
(	O
Typical	O
RR	O
0	O
.	O
70	O
,	O
95	O
%	O
CI	O
0	O
.	O
59	O
,	O
0	O
.	O
82	O
;	O
Typical	O
RD	O
-	O
0	O
.	O
05	O
,	O
95	O
%	O
CI	O
-	O
0	O
.	O
08	O
,	O
-	O
0	O
.	O
03	O
),	O
and	O
pulmonary	B-ANAT
interstitial	B-ANAT
emphysema	O
(	O
Typical	O
RR	O
0	O
.	O
63	O
,	O
95	O
%	O
CI	O
0	O
.	O
43	O
,	O
0	O
.	O
93	O
;	O
Typical	O
RD	O
-	O
0	O
.	O
06	O
,	O
95	O
%	O
CI	O
-	O
0	O
.	O
10	O
,	O
-	O
0	O
.	O
01	O
)	O
in	O
infants	O
randomized	O
to	O
early	O
selective	O
surfactant	O
administration	O
.	O

Infants	O
randomized	O
to	O
early	O
selective	O
surfactant	O
administration	O
also	O
demonstrated	O
a	O
decreased	O
risk	O
of	O
neonatal	O
mortality	O
(	O
Typical	O
RR	O
0	O
.	O
87	O
,	O
95	O
%	O
CI	O
0	O
.	O
77	O
,	O
0	O
.	O
99	O
;	O
Typical	O
RD	O
-	O
0	O
.	O
03	O
,	O
95	O
%	O
CI	O
-	O
0	O
.	O
06	O
,	O
-	O
0	O
.	O
00	O
),	O
chronic	O
lung	B-ANAT
disease	O
(	O
Typical	O
RR	O
0	O
.	O
70	O
,	O
95	O
%	O
CI	O
0	O
.	O

55	O
,	O
0	O
.	O
88	O
;	O
Typical	O
RD	O
-	O
0	O
.	O
03	O
,	O
95	O
%	O
CI	O
-	O
0	O
.	O
05	O
,	O
-	O
0	O
.	O
01	O
),	O
and	O
chronic	O
lung	B-ANAT
disease	O
or	O
death	O
at	O
36	O
weeks	O
(	O
Typical	O
RR	O
0	O
.	O
84	O
,	O
95	O
%	O
CI	O
0	O
.	O
75	O
,	O
0	O
.	O
93	O
;	O
Typical	O
RD	O
-	O
0	O
.	O
06	O
,	O
95	O
%	O
CI	O
-	O
0	O
.	O
09	O
,	O
-	O
0	O
.	O
03	O
).	O

Since	O
the	O
E	O
protein	O
occurs	O
in	O
particles	O
only	O
in	O
trace	O
amounts	O
,	O
the	O
lateral	O
interactions	O
between	O
the	O
M	O
proteins	O
apparently	O
generate	O
the	O
major	O
driving	O
force	O
for	O
envelope	B-ANAT
formation	O
.	O

The	O
results	O
indicate	O
that	O
M	O
protein	O
molecules	O
interact	O
with	O
each	O
other	O
through	O
multiple	O
contact	O
sites	O
,	O
particularly	O
at	O
the	O
transmembrane	B-ANAT
level	O
.	O

Immunoprecipitation	O
of	O
UV	O
-	O
cross	O
-	O
linked	O
proteins	O
identified	O
the	O
73	O
-	O
kDa	O
protein	O
as	O
the	O
cytoplasmic	B-ANAT
poly	O
(	O
A	O
)-	O
binding	O
protein	O
(	O
PABP	O
).	O

ABSTRACT	O
:	O
We	O
have	O
isolated	O
the	O
virus	O
from	O
a	O
fecal	B-ANAT
pellet	O
in	O
the	O
colon	B-ANAT
of	O
a	O
BALB	O
/	O
c	O
mouse	O
with	O
X	O
-	O
linked	O
immunodeficiency	O
(	O
xid	O
)	O
housed	O
in	O
a	O
room	O
in	O
which	O
there	O
has	O
recently	O
been	O
an	O
epidemic	O
due	O
to	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
and	O
designated	O
it	O
as	O
the	O
MHV	O
-	O
TY	O
strain	O
.	O

The	O
RT	O
-	O
PCR	O
used	O
for	O
detecting	O
the	O
hemagglutinin	O
gene	O
demonstrated	O
positive	O
bands	O
in	O
all	O
frozen	O
tissues	B-ANAT
and	O
cerebrospinal	B-ANAT
fluid	I-ANAT
taken	O
at	O
autopsy	O
and	O
not	O
in	O
samples	O
obtained	O
on	O
admission	O
.	O

Approximately	O
85	O
participants	O
were	O
selected	O
for	O
their	O
collective	O
expertise	O
in	O
critical	O
care	O
,	O
pulmonary	B-ANAT
medicine	O
,	O
cardiovascular	B-ANAT
medicine	O
and	O
surgery	O
,	O
pediatrics	O
,	O
nursing	O
,	O
biostatistics	O
,	O
and	O
medical	O
economics	O
.	O

Areas	O
given	O
high	O
priority	O
for	O
clinical	O
trials	O
were	O
pulmonary	B-ANAT
artery	I-ANAT
catheter	O
use	O
in	O
persistent	O
/	O
refractory	O
congestive	O
heart	B-ANAT
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
severe	O
sepsis	O
and	O
septic	O
shock	O
,	O
and	O
low	O
-	O
risk	O
coronary	B-ANAT
artery	I-ANAT
bypass	O
graft	B-ANAT
surgery	O
.	O

TITLE	O
:	O
Mucosal	B-ANAT
and	O
systemic	O
immune	O
responses	O
to	O
chimeric	O
fimbriae	B-ANAT
expressed	O
by	O
Salmonella	O
enterica	O
serovar	O
typhimurium	O
vaccine	O
strains	O
.	O

Moreover	O
,	O
mucosal	B-ANAT
IgA	O
against	O
the	O
TGEV	O
C	O
epitope	O
was	O
only	O
detected	O
with	O
serovar	O
Typhimurium	O
chi4550	O
/	O
pCS155	O
.	O

ABSTRACT	O
:	O
The	O
kinetics	O
of	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
(	O
CD3	O
positive	O
(+),	O
CD4	O
+	O
and	O
CD8	O
+	O
cells	B-ANAT
)	O
and	O
B	B-ANAT
-	I-ANAT
cells	I-ANAT
(	O
IgG	O
+,	O
IgM	O
+	O
and	O
IgA	O
+	O
cells	B-ANAT
)	O
in	O
chicken	O
trachea	B-ANAT
were	O
studied	O
immunohistochemically	O
and	O
histopathologically	O
following	O
an	O
intratracheal	O
inoculation	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Thereafter	O
IgG	O
+	O
and	O
IgM	O
+	O
cells	B-ANAT
were	O
gradually	O
increased	O
in	O
number	O
,	O
and	O
dramatically	O
increased	O
from	O
3	O
days	O
p	O
.	O
i	O
.,	O
peaked	O
on	O
4	O
days	O
p	O
.	O
i	O
.,	O
and	O
gradually	O
decreased	O
after	O
5	O
days	O
p	O
.	O
i	O
.	O

Viral	O
RNA	O
was	O
detected	O
in	O
membrane	B-ANAT
fractions	O
containing	O
helicase	O
,	O
p28	B-ANAT
,	O
and	O
N	O
but	O
not	O
in	O
the	O
fractions	O
containing	O
p65	O
and	O
p1a	O
-	O
22	O
.	O

If	O
FiO2	O
remained	O
above	O
0	O
.	O
6	O
and	O
mean	O
airway	B-ANAT
pressure	O
(	O
Paw	B-ANAT
)	O
exceeded	O
15	O
cmH2O	O
in	O
order	O
to	O
maintain	O
arterial	B-ANAT
saturation	O
above	O
89	O
%	O
or	O
if	O
hypercapnia	O
and	O
/	O
or	O
acidosis	O
on	O
CMV	O
with	O
TGI	O
persisted	O
,	O
the	O
patients	O
were	O
switched	O
to	O
HFOV	O
.	O

RESULTS	O
:	O
93	O
of	O
105	O
cattle	O
and	O
106	O
of	O
120	O
cattle	O
developed	O
signs	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
during	O
1997	O
and	O
1998	O
,	O
respectively	O
,	O
and	O
RBCV	O
was	O
isolated	O
from	O
81	O
and	O
89	O
sick	O
cattle	O
,	O
respectively	O
,	O
while	O
at	O
the	O
order	O
-	O
buyer	O
'	O
s	O
barn	O
or	O
the	O
day	O
after	O
arrival	O
at	O
the	O
feedlot	O
.	O

Findings	O
on	O
periodic	O
leg	B-ANAT
movements	O
,	O
arousals	O
and	O
respiratory	O
variables	O
.	O

ABSTRACT	O
:	O
To	O
compare	O
acute	O
pulmonary	B-ANAT
changes	O
secondary	O
to	O
sodium	O
taurocholate	O
hemorrhagic	O
pancreatitis	O
with	O
those	O
changes	O
secondary	O
to	O
a	O
less	O
severe	O
pancreatitis	O
induced	O
by	O
saline	O
infusion	O
into	O
the	O
biliopancreatic	O
duct	B-ANAT
.	O

Since	O
mammal	O
lungs	B-ANAT
are	O
evolutionary	O
specialised	O
to	O
gas	O
exchange	O
using	O
atmospheric	O
oxygen	O
,	O
the	O
application	O
of	O
liquids	O
,	O
even	O
if	O
they	O
transport	O
respiratory	O
gases	O
very	O
well	O
is	O
not	O
physiologic	O
.	O

Heparin	O
has	O
the	O
potential	O
to	O
induce	O
hyperkalemia	O
by	O
several	O
mechanisms	O
,	O
including	O
decreased	O
aldosterone	O
synthesis	O
,	O
reduction	O
in	O
number	O
and	O
affinity	O
of	O
aldosterone	O
II	O
receptors	O
,	O
and	O
atrophy	O
of	O
the	O
renal	B-ANAT
zona	B-ANAT
glomerulosa	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
acute	O
chest	B-ANAT
syndrome	O
is	O
the	O
leading	O
cause	O
of	O
death	O
among	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

In	O
a	O
30	O
-	O
center	O
study	O
,	O
we	O
analyzed	O
671	O
episodes	O
of	O
the	O
acute	O
chest	B-ANAT
syndrome	O
in	O
538	O
patients	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
to	O
determine	O
the	O
cause	O
,	O
outcome	O
,	O
and	O
response	O
to	O
therapy	O
.	O

Samples	O
of	O
blood	B-ANAT
and	O
respiratory	B-ANAT
tract	I-ANAT
secretions	B-ANAT
were	O
sent	O
to	O
central	O
laboratories	O
for	O
antibody	O
testing	O
,	O
culture	O
,	O
DNA	O
testing	O
,	O
and	O
histopathological	O
analyses	O
.	O

TITLE	O
:	O
Effect	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
on	O
splanchnic	O
perfusion	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

PEEP	O
by	O
itself	O
does	O
not	O
have	O
a	O
consistent	O
effect	O
on	O
splanchnic	O
blood	B-ANAT
flow	O
and	O
metabolism	O
when	O
cardiac	B-ANAT
index	O
is	O
stable	O
and	O
patients	O
are	O
ventilated	O
within	O
the	O
linear	O
part	O
of	O
the	O
pv	O
curve	O
.	O

The	O
membrane	B-ANAT
gene	O
of	O
PEDV	O
and	O
the	O
nucleocapsid	B-ANAT
gene	O
of	O
TGEV	O
were	O
chosen	O
as	O
targets	O
.	O

The	O
RNAS	O
of	O
PEDV	O
and	O
TGEV	O
were	O
detected	O
directly	O
in	O
intestinal	B-ANAT
and	O
faecal	B-ANAT
samples	O
from	O
pigs	O
infected	O
experimentally	O
with	O
either	O
virus	O
.	O

TITLE	O
:	O
Abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
in	O
children	O
:	O
experience	O
with	O
three	O
cases	O
.	O

The	O
infection	O
remained	O
subclinical	O
,	O
but	O
the	O
majority	O
of	O
the	O
animals	O
shed	O
the	O
virus	O
via	O
faeces	B-ANAT
throughout	O
the	O
experiment	O
.	O

Previous	O
reports	O
suggest	O
that	O
extraintestinal	O
tissues	B-ANAT
fail	O
to	O
reproduce	O
the	O
disease	O
.	O

On	O
the	O
basis	O
of	O
these	O
observations	O
,	O
we	O
hypothesized	O
that	O
the	O
thymus	B-ANAT
harbors	O
an	O
agent	O
(	O
s	O
)	O
involved	O
in	O
PEMS	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
an	O
unusual	O
case	O
of	O
fulminant	O
tracheobronchial	O
and	O
pulmonary	B-ANAT
aspergillosis	O
presenting	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

As	O
with	O
mouse	O
hepatitis	O
coronaviruses	O
(	O
MHVs	O
),	O
the	O
SDAV	O
genome	O
was	O
able	O
to	O
code	O
for	O
a	O
spike	O
protein	O
,	O
a	O
small	O
membrane	B-ANAT
protein	O
,	O
a	O
membrane	B-ANAT
-	O
associated	O
protein	O
,	O
and	O
a	O
nucleocapsid	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
This	O
study	O
describes	O
the	O
clinicopathologic	O
features	O
of	O
5	O
patients	O
who	O
developed	O
a	O
fulminant	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)-	O
positive	O
clonal	B-ANAT
T	B-ANAT
-	I-ANAT
cell	I-ANAT
lymphoproliferative	O
disorder	O
(	O
LPD	O
)	O
after	O
acute	O
EBV	O
infection	O
.	O

Only	O
rare	O
B	B-ANAT
cells	I-ANAT
were	O
noted	O
.	O

This	O
fulminant	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
LPD	O
after	O
acute	O
/	O
chronic	O
EBV	O
infection	O
is	O
characterized	O
by	O
hepatosplenomegaly	O
,	O
often	O
without	O
significant	O
lymphadenopathy	O
,	O
fever	O
,	O
liver	B-ANAT
failure	O
,	O
pancytopenia	O
,	O
and	O
erythrophagocytosis	O
indicative	O
of	O
a	O
hemophagocytic	O
syndrome	O
.	O

Further	O
,	O
our	O
results	O
suggest	O
that	O
the	O
stem	B-ANAT
segment	O
at	O
the	O
base	O
of	O
the	O
stem	B-ANAT
-	O
loop	O
is	O
an	O
alternative	O
base	O
-	O
pairing	O
structure	O
for	O
part	O
of	O
a	O
downstream	O
,	O
and	O
partially	O
overlapping	O
,	O
RNA	O
pseudoknot	O
that	O
has	O
recently	O
been	O
shown	O
to	O
be	O
necessary	O
for	O
bovine	O
coronavirus	O
replication	O
.	O

Two	O
patients	O
died	O
of	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

The	O
fusion	O
activity	O
of	O
srr	O
S	O
proteins	O
as	O
examined	O
by	O
the	O
expression	O
with	O
recombinant	O
vaccinia	O
virus	O
was	O
apparently	O
lower	O
than	O
that	O
of	O
the	O
wt	O
S	O
protein	O
in	O
BHK	O
-	O
R2	O
cells	B-ANAT
,	O
while	O
there	O
was	O
not	O
such	O
a	O
remarkable	O
difference	O
in	O
BHK	O
-	O
R1	O
cells	B-ANAT
.	O

Thus	O
,	O
a	O
coronaviral	O
infection	O
of	O
glial	B-ANAT
cells	I-ANAT
could	O
lead	O
to	O
the	O
production	O
of	O
inflammatory	O
molecules	O
that	O
have	O
been	O
associated	O
with	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
pathologies	O
such	O
as	O
MS	O
.	O

TITLE	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
induces	O
apoptosis	O
in	O
swine	O
testicular	O
cell	B-ANAT
lines	I-ANAT
but	O
not	O
in	O
intestinal	B-ANAT
enterocytes	B-ANAT
.	O

This	O
is	O
primarily	O
an	O
autoimmune	O
,	O
post	O
-	O
infectious	O
,	O
demyelinating	O
,	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
process	O
.	O

ABSTRACT	O
:	O
The	O
human	O
coronavirus	O
229E	O
replicase	O
gene	O
encodes	O
a	O
protein	O
,	O
p66HEL	O
,	O
that	O
contains	O
a	O
putative	O
zinc	O
finger	B-ANAT
structure	I-ANAT
linked	O
to	O
a	O
putative	O
superfamily	O
(	O
SF	O
)	O
1	O
helicase	O
.	O

ARDS	O
was	O
successfully	O
treated	O
by	O
extracorporeal	O
lung	B-ANAT
assist	O
.	O

CONCLUSIONS	O
:	O
We	O
conclude	O
that	O
each	O
lung	B-ANAT
recruitment	O
strategy	O
improved	O
oxygenation	O
in	O
premature	O
lambs	O
with	O
established	O
lung	B-ANAT
injury	O
.	O

To	O
determine	O
whether	O
a	O
patient	O
has	O
a	O
transudative	O
or	O
exudative	O
pleural	B-ANAT
effusion	I-ANAT
,	O
Light	O
'	O
s	O
criteria	O
should	O
be	O
applied	O
to	O
measure	O
the	O
concentrations	O
of	O
protein	O
and	O
lactate	O
dehydrogenase	O
(	O
LDH	O
)	O
in	O
the	O
pleural	B-ANAT
fluid	I-ANAT
and	O
serum	B-ANAT
.	O

Indicators	O
of	O
a	O
poor	O
prognosis	O
include	O
the	O
presence	O
of	O
frank	O
pus	B-ANAT
,	O
a	O
positive	O
Gram	O
-	O
stain	O
,	O
a	O
pleural	O
glucose	O
concentration	O
of	O
less	O
than	O
2	O
.	O
2	O
mmol	O
/	O
L	O
,	O
a	O
pH	O
less	O
than	O
7	O
.	O
00	O
,	O
the	O
presence	O
of	O
pleural	O
loculations	O
,	O
and	O
an	O
LDH	O
concentration	O
greater	O
than	O
three	O
times	O
the	O
upper	O
limit	O
of	O
normal	O
in	O
serum	B-ANAT
.	O

Two	O
pharmacological	O
approaches	O
exist	O
to	O
reduce	O
the	O
vascular	B-ANAT
resistance	O
:	O
Reduction	O
of	O
the	O
increased	O
vascular	B-ANAT
tone	O
by	O
relaxation	O
of	O
vascular	B-ANAT
smooth	I-ANAT
muscle	I-ANAT
cells	B-ANAT
(	O
effect	O
of	O
vasodilators	O
).	O

The	O
replicase	O
polyprotein	O
is	O
extensively	O
processed	O
by	O
viral	O
and	O
perhaps	O
cellular	B-ANAT
proteinases	O
to	O
give	O
rise	O
to	O
a	O
functional	O
replicase	O
complex	O
.	O

We	O
show	O
that	O
PLP2	O
cleaves	O
a	O
substrate	O
encoding	O
the	O
first	O
predicted	O
membrane	B-ANAT
-	O
spanning	O
domain	O
(	O
MP1	O
)	O
of	O
the	O
replicase	O
polyprotein	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
coronavirus	O
M	O
protein	O
and	O
nucleocapsid	B-ANAT
interaction	O
in	O
infected	O
cells	B-ANAT
.	O

Intracellular	B-ANAT
M	O
protein	O
-	O
N	O
protein	O
interaction	O
was	O
maintained	O
after	O
removal	O
of	O
viral	O
RNAs	O
by	O
RNase	O
treatment	O
.	O

These	O
data	O
indicated	O
that	O
while	O
the	O
M	O
protein	O
-	O
N	O
protein	O
interaction	O
,	O
which	O
is	O
independent	O
of	O
viral	O
RNA	O
,	O
occurred	O
in	O
the	O
M	O
protein	O
-	O
nucleocapsid	B-ANAT
complex	O
,	O
some	O
MHV	O
function	O
(	O
s	O
)	O
was	O
necessary	O
for	O
the	O
initiation	O
of	O
M	O
protein	O
-	O
nucleocapsid	B-ANAT
interaction	O
.	O

ABSTRACT	O
:	O
A	O
65	O
-	O
year	O
-	O
old	O
man	O
,	O
known	O
to	O
have	O
had	O
a	O
gastric	B-ANAT
ulcer	O
and	O
chronic	O
rheumatoid	O
arthritis	O
as	O
well	O
as	O
alcohol	O
and	O
nicotine	O
abuse	O
,	O
was	O
admitted	O
because	O
of	O
suspected	O
endocarditis	O
.	O

Oral	B-ANAT
contraceptives	O
may	O
produce	O
asthma	O
exacerbation	O
,	O
while	O
long	O
term	O
use	O
and	O
/	O
or	O
high	O
doses	O
of	O
postmenopausal	O
hormone	O
replacement	O
therapy	O
increase	O
the	O
risk	O
of	O
asthma	O
.	O

Whereas	O
myalgias	O
are	O
ubiquitous	O
in	O
leptospiral	O
infection	O
,	O
and	O
most	O
patients	O
show	O
mildly	O
elevated	O
muscle	B-ANAT
enzymes	O
,	O
life	O
-	O
threatening	O
rhabdomyolysis	O
is	O
rare	O
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
the	O
T	B-ANAT
cell	I-ANAT
chemoattractant	O
chemokine	O
IFN	O
-	O
inducible	O
protein	O
10	O
(	O
IP	O
-	O
10	O
)	O
in	O
host	O
defense	O
following	O
viral	O
infection	O
of	O
the	O
CNS	B-ANAT
was	O
examined	O
.	O

ABSTRACT	O
:	O
TGEV	O
replicates	O
in	O
intestinal	B-ANAT
enterocytes	B-ANAT
and	O
causes	O
diarrhea	O
in	O
young	O
pigs	O
.	O

Immunohistochemical	O
staining	O
of	O
jejunal	B-ANAT
sections	O
revealed	O
coronavirus	O
antigens	O
.	O

By	O
ELISA	O
,	O
237	O
out	O
of	O
446	O
sera	B-ANAT
tested	O
(	O
53	O
.	O
1	O
%)	O
and	O
54	O
out	O
of	O
88	O
sampled	O
herds	O
(	O
61	O
.	O
3	O
%)	O
were	O
positive	O
against	O
PRCV	O
.	O

ABSTRACT	O
:	O
Formaldehyde	O
is	O
a	O
physiological	O
intermediary	O
metabolite	O
taking	O
part	O
in	O
many	O
biological	O
process	O
in	O
the	O
body	B-ANAT
.	O

Treatment	O
of	O
toxicity	O
is	O
supportive	O
care	O
of	O
the	O
various	O
organ	B-ANAT
systems	I-ANAT
.	O

ABSTRACT	O
:	O
We	O
report	O
use	O
of	O
a	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
-	O
a	O
safe	O
and	O
effective	O
method	O
in	O
the	O
management	O
of	O
severe	O
acute	O
respiratory	O
failure	O
that	O
allows	O
an	O
extracorporal	O
gas	O
-	O
exchange	O
without	O
the	O
use	O
of	O
a	O
pump	O
.	O

Pulmonary	B-ANAT
insufficiency	O
was	O
treated	O
non	O
-	O
invasively	O
with	O
CPAP	O
and	O
the	O
patient	O
recovered	O
from	O
pulmonary	B-ANAT
distress	O
one	O
week	O
later	O
.	O

The	O
number	O
of	O
apoptotic	O
events	O
was	O
significantly	O
elevated	O
in	O
infected	O
eyes	B-ANAT
from	O
BALB	O
/	O
c	O
and	O
CD	O
-	O
1	O
mouse	O
strains	O
,	O
reaching	O
a	O
maximum	O
at	O
days	O
6	O
through	O
10	O
,	O
and	O
returning	O
to	O
normal	O
levels	O
at	O
day	O
20	O
.	O

In	O
contrast	O
,	O
few	O
apoptotic	O
cells	B-ANAT
were	O
observed	O
in	O
normal	O
or	O
mock	O
-	O
injected	O
mouse	O
eyes	B-ANAT
.	O

Reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analysis	O
identified	O
the	O
upregulation	O
of	O
Fas	O
ligand	O
(	O
FasL	O
)	O
and	O
granzyme	O
B	O
mRNAs	O
within	O
the	O
infected	O
retinas	B-ANAT
.	O

The	O
development	O
of	O
apoptosis	O
,	O
regulative	O
gene	O
expression	O
,	O
and	O
viral	O
clearance	O
were	O
similar	O
in	O
both	O
retinal	B-ANAT
degeneration	O
-	O
susceptible	O
(	O
BALB	O
/	O
c	O
)	O
and	O
-	O
resistant	O
(	O
CD	O
-	O
1	O
)	O
mice	O
.	O

Twenty	O
-	O
five	O
of	O
the	O
26	O
lung	B-ANAT
samples	O
were	O
positive	O
for	O
Pasteurella	O
spp	O
.,	O
and	O
their	O
CFU	O
ranged	O
between	O
4	O
.	O
0	O
x	O
10	O
(	O
5	O
)	O
and	O
2	O
.	O
3	O
x	O
10	O
(	O
9	O
)	O
per	O
g	O
.	O
Acute	O
and	O
subacute	O
exudative	O
,	O
necrotizing	O
lobar	O
pneumonia	O
characterized	O
the	O
lung	B-ANAT
lesions	O
of	O
these	O
cattle	O
with	O
a	O
majority	O
of	O
pneumonic	O
lung	B-ANAT
lobes	B-ANAT
exhibiting	O
fibronecrotic	O
and	O
exudative	O
changes	O
typical	O
of	O
pneumonic	O
pasteurellosis	O
,	O
but	O
other	O
lung	B-ANAT
lobules	B-ANAT
had	O
histological	O
changes	O
consisting	O
of	O
bronchiolitis	O
and	O
alveolitis	O
typical	O
of	O
virus	O
-	O
induced	O
changes	O
.	O

TITLE	O
:	O
Association	O
between	O
infection	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
attributable	O
to	O
bovine	O
coronavirus	O
and	O
health	O
and	O
growth	O
performance	O
of	O
cattle	O
in	O
feedlots	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
association	O
between	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
with	O
bovine	O
coronavirus	O
(	O
BCV	O
),	O
treatment	O
for	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
,	O
pulmonary	B-ANAT
lesions	O
at	O
slaughter	O
,	O
and	O
average	O
daily	O
gain	O
in	O
cattle	O
in	O
feedlots	O
.	O

ABSTRACT	O
:	O
Blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
64	O
wild	O
North	O
American	O
river	O
otters	O
(	O
Lontra	O
[	O
Lutra	O
]	O
canadensis	O
)	O
from	O
northern	O
and	O
eastern	O
New	O
York	O
State	O
and	O
analyzed	O
for	O
serologic	O
evidence	O
of	O
exposure	O
to	O
selected	O
viral	O
agents	O
during	O
a	O
1995	O
1996	O
translocation	O
program	O
.	O

Addition	O
of	O
anti	O
-	O
interferon	O
antibody	O
to	O
MHV	O
-	O
infected	O
cells	B-ANAT
did	O
not	O
inhibit	O
28S	O
rRNA	O
cleavage	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
229E	O
infects	O
polarized	O
airway	B-ANAT
epithelia	O
from	O
the	O
apical	O
surface	O
.	O

Of	O
the	O
evaluations	O
performed	O
at	O
slaughter	O
,	O
only	O
detection	O
of	O
lung	B-ANAT
lesions	O
was	O
consistently	O
associated	O
with	O
a	O
decrease	O
in	O
ADG	O
.	O

Of	O
the	O
evaluations	O
performed	O
at	O
slaughter	O
,	O
only	O
detection	O
of	O
lung	B-ANAT
lesions	O
was	O
consistently	O
associated	O
with	O
a	O
decrease	O
in	O
ADG	O
.	O

Genome	O
-	O
length	O
replicative	O
intermediate	O
(	O
RI	O
)	O
RNA	O
was	O
purified	O
by	O
two	O
-	O
dimensional	O
gel	O
electrophoresis	O
of	O
intracellular	B-ANAT
RNAs	O
from	O
cells	B-ANAT
infected	O
with	O
mouse	O
hepatitis	O
virus	O
.	O

All	O
of	O
them	O
had	O
the	O
classical	O
phenotype	O
of	O
early	O
severe	O
encefalopathy	O
,	O
associated	O
with	O
dismorphic	O
features	O
,	O
hypotomÃ­a	O
,	O
neurosensorial	O
defects	O
,	O
brain	B-ANAT
dysgenesis	O
and	O
atrophy	O
,	O
anomalies	O
in	O
the	O
EEG	O
and	O
in	O
5	O
of	O
them	O
there	O
were	O
also	O
systemic	O
anomalies	O
,	O
mainly	O
cardiopathy	O
.	O

Oxidatic	O
phosporilation	O
deficit	O
are	O
frequent	O
and	O
severe	O
diseases	O
of	O
prenatal	O
onset	O
with	O
limited	O
fetal	B-ANAT
effects	O
,	O
homogeneous	O
clinical	O
phenotype	O
with	O
frequent	O
damage	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
and	O
variable	O
extraneurological	O
alteration	O
and	O
inconsistent	O
biochemical	O
pattern	O
.	O

Only	O
one	O
patient	O
had	O
multiple	O
deletions	O
in	O
the	O
mtDNA	B-ANAT
.	O

Of	O
the	O
325	O
sera	B-ANAT
from	O
the	O
field	O
,	O
175	O
were	O
positive	O
for	O
TCV	O
by	O
immunofluorescent	O
antibody	O
(	O
IFA	O
)	O
assay	O
.	O

Protection	O
was	O
assessed	O
5	O
days	O
post	O
-	O
IBV	O
challenged	O
by	O
virus	O
isolation	O
from	O
the	O
trachea	B-ANAT
.	O

TITLE	O
:	O
Reactive	O
hemophagocytic	O
syndrome	O
presenting	O
as	O
a	O
component	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

The	O
pancytopenia	O
was	O
severe	O
(	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
,	O
1	O
.	O
92	O
x	O
10	O
(	O
9	O
)/	O
L	O
;	O
hemoglobin	O
,	O
65	O
g	O
/	O
L	O
;	O
platelets	B-ANAT
,	O
58	O
x	O
10	O
(	O
9	O
)/	O
L	O
)	O
and	O
necessitated	O
transfusional	O
support	O
.	O

In	O
diabetics	O
platelet	B-ANAT
aggregation	O
improved	O
but	O
sludge	B-ANAT
phenomenon	O
and	O
slow	O
blood	B-ANAT
flow	O
persisted	O
.	O

It	O
is	O
possible	O
that	O
therapy	O
with	O
beta	O
-	O
adrenergic	O
agonists	O
might	O
be	O
useful	O
to	O
accelerate	O
the	O
resolution	O
of	O
alveolar	B-ANAT
edema	O
in	O
some	O
patients	O
.	O

In	O
this	O
situation	O
,	O
the	O
abnormal	O
ventilation	O
-	O
perfusion	O
ratio	O
is	O
improved	O
by	O
inhaled	O
NO	O
,	O
limiting	O
arterial	B-ANAT
hypoxia	O
.	O

ABSTRACT	O
:	O
Strains	O
OC43	O
and	O
229E	O
of	O
human	O
coronaviruses	O
(	O
HCoV	O
)	O
cause	O
one	O
-	O
third	O
of	O
common	O
colds	O
and	O
hospital	O
-	O
acquired	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
HCoV	O
infections	O
have	O
been	O
reported	O
in	O
premature	O
newborns	O
.	O

TITLE	O
:	O
Disturbances	O
in	O
leptin	O
metabolism	O
are	O
related	O
to	O
energy	O
imbalance	O
during	O
acute	O
exacerbations	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
.	O

On	O
Day	O
7	O
,	O
sTNF	O
-	O
R55	O
was	O
,	O
independently	O
of	O
%	O
FM	O
,	O
correlated	O
with	O
the	O
natural	O
logarithm	O
(	O
LN	O
)	O
of	O
leptin	O
(	O
r	O
=	O
0	O
.	O
65	O
,	O
p	O
=	O
0	O
.	O
041	O
)	O
and	O
with	O
plasma	B-ANAT
glucose	O
(	O
r	O
=	O
0	O
.	O
81	O
,	O
p	O
=	O
0	O
.	O
015	O
).	O

The	O
bedside	O
chest	B-ANAT
radiograph	O
accurately	O
assessed	O
lung	B-ANAT
morphology	O
in	O
only	O
42	O
%	O
of	O
the	O
patients	O
.	O

A	O
new	O
ARDS	O
Severity	O
Score	O
based	O
on	O
CT	O
lung	B-ANAT
morphology	O
and	O
cardiorespiratory	O
parameters	O
accurately	O
identified	O
patients	O
with	O
the	O
most	O
severe	O
forms	O
of	O
ARDS	O
and	O
a	O
mortality	O
rate	O
above	O
60	O
%.	O

TITLE	O
:	O
Pulmonary	O
capillary	B-ANAT
endothelium	I-ANAT
-	O
bound	O
angiotensin	O
-	O
converting	O
enzyme	O
activity	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Host	O
range	O
phenotypes	O
of	O
the	O
molecularly	O
cloned	O
and	O
wild	O
-	O
type	O
viruses	O
were	O
similar	O
in	O
cells	B-ANAT
of	O
swine	O
and	O
feline	O
origin	O
.	O

Morbidity	O
rates	O
including	O
hyperbilirubinemia	O
,	O
anastomotic	O
leakage	O
,	O
and	O
liver	B-ANAT
dysfunction	O
were	O
significantly	O
lower	O
in	O
the	O
steroid	O
group	O
than	O
in	O
the	O
control	O
group	O
.	O

Thereafter	O
the	O
calves	O
received	O
one	O
test	O
meal	O
of	O
whole	O
fresh	B-ANAT
cow	O
'	O
s	O
milk	O
whose	O
lactose	O
had	O
been	O
hydrolysed	O
by	O
added	O
lactase	O
and	O
one	O
test	O
meal	O
of	O
unprocessed	O
cow	O
'	O
s	O
milk	O
at	O
an	O
interval	O
of	O
24	O
h	O
in	O
a	O
cross	O
-	O
over	O
design	O
trial	O
.	O

There	O
was	O
no	O
treatment	O
effect	O
on	O
mean	O
plasma	B-ANAT
glucose	O
concentration	O
.	O

An	O
HFOV	O
protocol	O
was	O
established	O
with	O
the	O
following	O
inclusion	O
criteria	O
:	O
severe	O
respiratory	O
insufficiency	O
of	O
any	O
origin	O
(	O
infectious	O
,	O
inhalatory	O
,	O
etc	O
.)	O
with	O
an	O
oxygenation	O
index	O
(	O
OI	O
)	O
>	O
13	O
in	O
two	O
arterial	B-ANAT
blood	I-ANAT
gases	O
within	O
a	O
6	O
-	O
hour	O
interval	O
,	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
severe	O
respiratory	O
syncytial	O
virus	O
pneumonia	O
,	O
and	O
gross	O
airleak	O
syndromes	O
(	O
pneumothorax	O
,	O
pneumoperitoneum	O
,	O
pneumomediastinum	O
,	O
etc	O
.).	O

In	O
all	O
patients	O
,	O
normal	O
arterial	B-ANAT
PO2	O
and	O
PCO2	O
were	O
obtained	O
and	O
FiO2	O
could	O
be	O
set	O
below	O
0	O
.	O
6	O
within	O
the	O
first	O
3	O
hours	O
of	O
HFOV	O
.	O

This	O
suggests	O
that	O
the	O
S2A	O
epitope	O
may	O
be	O
involved	O
in	O
binding	O
the	O
virus	O
to	O
the	O
MHV	O
receptor	O
and	O
/	O
or	O
in	O
virus	O
-	O
cell	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
a	O
technique	O
for	O
providing	O
life	O
support	O
,	O
in	O
case	O
the	O
natural	O
lungs	B-ANAT
are	O
failing	O
and	O
are	O
not	O
able	O
to	O
maintain	O
a	O
sufficient	O
oxygenation	O
of	O
the	O
body	B-ANAT
'	O
s	O
organ	B-ANAT
systems	I-ANAT
.	O

In	O
conventional	O
treatment	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategies	O
were	O
introduced	O
and	O
ECMO	O
was	O
made	O
safer	O
by	O
applying	O
heparin	O
-	O
coated	O
equipment	O
,	O
membranes	B-ANAT
and	O
tubings	O
.	O

However	O
,	O
eighteen	O
months	O
ago	O
,	O
he	O
complained	O
about	O
a	O
transient	O
weakness	O
of	O
his	O
left	O
arm	B-ANAT
and	I-ANAT
leg	I-ANAT
.	O

Duplex	O
-	O
sonography	O
as	O
well	O
as	O
MR	O
-	O
angiography	O
documented	O
a	O
complete	O
reopening	O
of	O
the	O
primarily	O
occluded	O
middle	B-ANAT
cerebral	I-ANAT
artery	I-ANAT
.	O

Lactic	O
acidosis	O
with	O
hemolytic	O
-	O
uremic	O
syndrome	O
appeared	O
,	O
and	O
he	O
died	O
as	O
the	O
result	O
of	O
a	O
multivisceral	O
(	O
respiratory	O
,	O
renal	B-ANAT
,	O
hepatic	B-ANAT
)	O
deficiency	O
.	O

BCG	O
instillation	O
is	O
a	O
valuable	O
tool	O
in	O
the	O
therapy	O
of	O
bladder	B-ANAT
carcinoma	O
,	O
but	O
increasing	O
reports	O
of	O
severe	O
adverse	O
reactions	O
should	O
continue	O
to	O
remind	O
practicing	O
urologists	O
to	O
be	O
alert	O
to	O
the	O
possibility	O
of	O
common	O
and	O
uncommon	O
reactions	O
after	O
its	O
use	O
.	O

Antigenic	O
and	O
genomic	O
characterizations	O
of	O
the	O
virus	O
(	O
isolate	O
NC99	O
)	O
were	O
based	O
on	O
serological	O
comparison	O
with	O
other	O
avian	O
and	O
mammalian	O
coronaviruses	O
and	O
sequence	O
analysis	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
gene	O
.	O

ABSTRACT	O
:	O
In	O
total	O
1309	O
patients	O
were	O
entered	O
in	O
the	O
study	O
:	O
699	O
(	O
53	O
.	O
4	O
%)	O
were	O
treated	O
by	O
paramedics	O
operating	O
protocol	O
A	O
and	O
610	O
(	O
46	O
.	O
6	O
%)	O
were	O
treated	O
by	O
paramedics	O
operating	O
protocol	O
B	O
.	O
The	O
randomisation	O
worked	O
well	O
and	O
there	O
were	O
no	O
significant	O
differences	O
between	O
treatment	O
groups	O
in	O
incident	O
characteristics	O
,	O
ambulance	O
performance	O
times	O
,	O
or	O
patient	O
or	O
injury	O
characteristics	O
,	O
apart	O
from	O
slightly	O
more	O
moderate	O
or	O
severe	O
head	B-ANAT
injuries	O
in	O
the	O
protocol	O
A	O
group	O
(	O
25	O
.	O
3	O
%	O
versus	O
20	O
.	O
3	O
%).	O

The	O
estimated	O
odds	O
ratio	O
for	O
being	O
given	O
prehospital	O
fluids	B-ANAT
when	O
treated	O
by	O
protocol	O
A	O
compared	O
to	O
protocol	O
B	O
was	O
2	O
.	O
09	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
53	O
to	O
2	O
.	O
81	O
).	O

Although	O
most	O
virus	O
-	O
infected	O
cells	B-ANAT
,	O
except	O
KQ3E	O
-	O
infected	O
A3	O
-	O
1M	O
,	O
CMT	O
-	O
93	O
and	O
J774A	O
.	O
1	O
cells	B-ANAT
,	O
produced	O
progeny	O
viruses	O
in	O
the	O
supernatants	O
when	O
assayed	O
by	O
plaque	O
formation	O
on	O
DBT	O
cells	B-ANAT
,	O
the	O
kinetics	O
of	O
viral	O
replication	O
were	O
dependent	O
on	O
both	O
the	O
cell	B-ANAT
line	I-ANAT
and	O
virus	O
strain	O
;	O
replication	O
of	O
prototype	O
strains	O
was	O
higher	O
than	O
that	O
of	O
new	O
isolates	O
.	O

Our	O
findings	O
thus	O
support	O
the	O
notion	O
that	O
base	O
-	O
pairing	O
between	O
the	O
leader	O
(	O
or	O
antileader	O
)	O
and	O
the	O
IG	O
is	O
not	O
the	O
sole	B-ANAT
mechanism	O
in	O
subgenomic	O
RNA	O
transcription	O
.	O

Hepatic	B-ANAT
resection	O
(	O
n	O
=	O
21	O
)	O
resulted	O
in	O
slight	O
perivascular	O
edema	O
at	O
1	O
,	O
2	O
,	O
6	O
,	O
and	O
24	O
h	O
post	O
-	O
resection	O
,	O
but	O
there	O
were	O
no	O
other	O
significant	O
changes	O
.	O

Of	O
decisive	O
importance	O
for	O
the	O
outcome	O
in	O
such	O
cases	O
are	O
,	O
besides	O
the	O
use	O
of	O
antibiotics	O
,	O
such	O
as	O
treatment	O
of	O
the	O
cardiac	B-ANAT
insufficiency	O
or	O
long	O
-	O
term	O
oxygen	O
therapy	O
.	O

Transplantation	O
improves	O
exercise	O
capacity	O
,	O
quality	O
of	O
life	O
and	O
lung	B-ANAT
function	O
.	O

ABSTRACT	O
:	O
The	O
effects	O
of	O
kinetic	O
therapy	O
on	O
the	O
oxygenation	O
in	O
the	O
injured	O
lung	B-ANAT
of	O
111	O
polytrauma	O
patients	O
were	O
analysed	O
in	O
an	O
open	O
prospective	O
study	O
.	O

The	O
data	O
of	O
3	O
treatment	O
groups	O
were	O
evaluated	O
:	O
1	O
,	O
acute	O
respiratory	O
disease	O
(	O
ARDS	O
,	O
n	O
=	O
42	O
);	O
2	O
,	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
,	O
n	O
=	O
36	O
);	O
and	O
3	O
,	O
prophylaxis	O
(	O
n	O
=	O
33	O
,	O
a	O
group	O
of	O
prophylactically	O
treated	O
patients	O
with	O
a	O
PaO2	O
/	O
FiO2	O
ratio	O
>	O
or	O
=	O
300	O
and	O
an	O
ISS	O
>	O
or	O
=	O
15	O
).	O

Positioning	O
therapy	O
was	O
administered	O
in	O
group	O
3	O
in	O
order	O
to	O
prevent	O
atelectases	O
,	O
and	O
respirator	O
-	O
induced	O
lung	B-ANAT
injuries	O
during	O
a	O
foreseeable	O
,	O
relatively	O
long	O
period	O
in	O
the	O
intensive	O
care	O
unit	O
in	O
view	O
of	O
the	O
severity	O
of	O
the	O
trauma	O
.	O

1	O
.	O
0	O
),	O
the	O
SOFA	O
score	O
lung	B-ANAT
3	O
.	O
0	O
(+/-	O
0	O
.	O
9	O
).	O

ABSTRACT	O
:	O
The	O
architecture	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	O
includes	O
three	O
different	O
structural	O
levels	O
,	O
the	O
envelope	B-ANAT
,	O
an	O
internal	O
core	O
,	O
and	O
the	O
nucleocapsid	B-ANAT
that	O
is	O
released	O
when	O
the	O
core	O
is	O
disrupted	O
.	O

A	O
specific	O
ionic	O
interaction	O
between	O
the	O
M	O
protein	O
carboxy	O
terminus	O
and	O
the	O
nucleocapsid	B-ANAT
was	O
demonstrated	O
using	O
three	O
complementary	O
approaches	O
:	O
(	O
i	O
)	O
a	O
binding	O
assay	O
performed	O
between	O
a	O
collection	O
of	O
M	O
protein	O
amino	O
acid	O
substitution	O
or	O
deletion	O
mutants	O
and	O
purified	O
nucleocapsids	O
that	O
led	O
to	O
the	O
identification	O
of	O
a	O
16	O
-	O
amino	O
-	O
acid	O
(	O
aa	O
)	O
domain	O
(	O
aa	O
237	O
to	O
252	O
)	O
as	O
being	O
responsible	O
for	O
binding	O
the	O
M	O
protein	O
to	O
the	O
nucleocapsid	B-ANAT
;	O
(	O
ii	O
)	O
the	O
specific	O
inhibition	O
of	O
this	O
binding	O
by	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
binding	O
to	O
a	O
carboxy	O
-	O
terminal	O
M	O
protein	O
domain	O
close	O
to	O
the	O
indicated	O
peptide	O
but	O
not	O
by	O
MAbs	O
specific	O
for	O
the	O
M	O
protein	O
amino	O
terminus	O
;	O
and	O
(	O
iii	O
)	O
a	O
26	O
-	O
residue	O
peptide	O
,	O
including	O
the	O
predicted	O
sequence	O
(	O
aa	O
237	O
to	O
252	O
),	O
which	O
specifically	O
inhibited	O
the	O
binding	O
.	O

It	O
is	O
proposed	O
that	O
the	O
M	O
protein	O
is	O
embedded	O
within	O
the	O
virus	O
membrane	B-ANAT
and	O
that	O
the	O
C	O
region	O
,	O
exposed	O
to	O
the	O
interior	O
face	B-ANAT
of	O
the	O
virion	B-ANAT
in	O
a	O
population	O
of	O
these	O
molecules	O
,	O
interacts	O
with	O
the	O
nucleocapsid	B-ANAT
to	O
which	O
it	O
is	O
anchored	O
,	O
forming	O
the	O
core	O
.	O

TITLE	O
:	O
von	O
Willebrand	O
factor	O
antigen	O
as	O
a	O
prognostic	O
marker	O
in	O
posttraumatic	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
The	O
specific	O
endothelial	B-ANAT
cell	I-ANAT
product	O
von	O
Willebrand	O
factor	O
antigen	O
(	O
vWf	O
:	O
Ag	O
)	O
was	O
measured	O
in	O
plasma	B-ANAT
and	O
lung	B-ANAT
function	O
tests	O
were	O
carried	O
out	O
and	O
the	O
following	O
lung	B-ANAT
injury	O
parameters	O
measured	O
:	O
P	O
(	O
a	O
)	O
O2	O
/	O
F	O
(	O
i	O
)	O
O2	O
ratio	O
,	O
static	O
respiratory	O
compliance	O
and	O
Murray	O
'	O
s	O
lung	B-ANAT
injury	O
score	O
(	O
LIS	O
)	O
in	O
a	O
follow	O
-	O
up	O
study	O
of	O
36	O
severely	O
traumatized	O
patients	O
.	O

ABSTRACT	O
:	O
Recombinant	O
mouse	O
hepatitis	O
viruses	O
(	O
MHV	O
)	O
differing	O
only	O
in	O
the	O
spike	O
gene	O
,	O
containing	O
A59	O
,	O
MHV	O
-	O
4	O
,	O
and	O
MHV	O
-	O
2	O
spike	O
genes	O
in	O
the	O
background	O
of	O
the	O
A59	O
genome	O
,	O
were	O
compared	O
for	O
their	O
ability	O
to	O
replicate	O
in	O
the	O
liver	B-ANAT
and	O
induce	O
hepatitis	O
in	O
weanling	O
C57BL	O
/	O
6	O
mice	O
infected	O
with	O
500	O
PFU	O
of	O
each	O
virus	O
by	O
intrahepatic	O
injection	O
.	O

Based	O
on	O
solubility	O
in	O
high	O
salt	O
solutions	O
,	O
approximately	O
70	O
%	O
of	O
the	O
replicating	O
and	O
transcribing	O
structures	O
that	O
accumulated	O
in	O
infected	O
cells	B-ANAT
by	O
5	O
-	O
6	O
h	O
post	O
-	O
infection	O
were	O
multi	O
-	O
stranded	O
intermediates	O
,	O
the	O
RI	O
/	O
TIs	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
hypothesis	O
that	O
the	O
response	O
to	O
inhaled	O
prostacyclin	O
(	O
PGI2	O
on	O
oxygenation	O
and	O
pulmonary	B-ANAT
hemodynamics	O
may	O
be	O
related	O
to	O
different	O
morphologic	O
features	O
that	O
are	O
supposed	O
to	O
be	O
present	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
originating	O
from	O
pulmonary	B-ANAT
(	O
primary	O
ARDS	O
[	O
ARDS	O
(	O
PR	O
)])	O
and	O
from	O
extrapulmonary	O
disease	O
(	O
secondary	O
ARDS	O
[	O
ARDS	O
(	O
SEC	O
)]).	O

This	O
patient	O
was	O
treated	O
with	O
high	O
doses	O
of	O
methylprednisolone	O
,	O
antibiotics	O
,	O
globulins	O
,	O
urinastatin	O
,	O
neutrophilic	O
elastase	O
inhibitor	O
,	O
nitric	O
oxide	O
inhalation	O
,	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
but	O
died	O
on	O
the	O
thirteenth	O
hospital	O
day	O
.	O

The	O
survivors	O
and	O
nonsurvivors	O
did	O
not	O
differ	O
with	O
respect	O
to	O
age	O
,	O
burn	O
size	O
,	O
pre	O
-	O
NO	O
ventilator	O
settings	O
,	O
or	O
indices	O
of	O
oxygenation	O
including	O
PaO2	O
,	O
oxygen	O
saturation	O
in	O
arterial	B-ANAT
blood	I-ANAT
,	O
PaO2	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FIO2	O
)	O
ratio	O
,	O
and	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
tension	O
difference	O
.	O

PaO2	O
,	O
oxygen	O
saturation	O
in	O
arterial	B-ANAT
blood	I-ANAT
,	O
and	O
the	O
PaO2	O
/	O
FIO2	O
ratio	O
increased	O
in	O
all	O
patients	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
residual	O
pulmonary	B-ANAT
hypertension	O
,	O
cardiopulmonary	B-ANAT
or	O
neurological	O
symptoms	O
in	O
children	O
after	O
treatment	O
with	O
inhaled	O
nitric	O
oxide	O
in	O
severely	O
hypoxaemic	O
and	O
/	O
or	O
pulmonary	B-ANAT
hypertensive	O
mechanically	O
ventilated	O
children	O
.	O

Thus	O
36	O
paediatric	O
or	O
neonatal	O
patients	O
were	O
examined	O
for	O
circulatory	O
,	O
respiratory	O
or	O
neurological	O
disorders	O
with	O
clinical	O
examination	O
,	O
echocardiography	O
,	O
chest	B-ANAT
X	O
-	O
ray	O
and	O
a	O
capillary	B-ANAT
blood	I-ANAT
sample	I-ANAT
.	O

ABSTRACT	O
:	O
An	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
strain	O
CT	O
/	O
7852	O
/	O
97	O
was	O
isolated	O
from	O
a	O
commercial	O
layer	B-ANAT
flock	O
experiencing	O
decreased	O
egg	B-ANAT
production	O
and	O
poor	O
egg	B-ANAT
quality	O
.	O

Six	O
perinatal	O
deaths	O
were	O
related	O
to	O
abruptio	O
placenta	B-ANAT
,	O
intrauterine	B-ANAT
asphyxia	O
and	O
extreme	O
prematurity	O
.	O

Necropsy	O
revealed	O
vasculitis	O
with	O
multifocal	O
areas	O
of	O
necrosis	O
and	O
lymphocytic	O
-	O
plasmacytic	B-ANAT
inflammation	O
in	O
multiple	O
solid	O
organs	B-ANAT
,	O
most	O
likely	O
due	O
to	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Viral	O
inactivation	O
is	O
all	O
the	O
more	O
easy	O
when	O
there	O
is	O
an	O
envelope	B-ANAT
.	O

The	O
membrane	B-ANAT
(	O
M	O
)	O
glycoprotein	O
was	O
the	O
least	O
immunogenic	O
of	O
the	O
major	O
viral	O
structural	O
proteins	O
.	O

TITLE	O
:	O
Airway	B-ANAT
pressure	O
release	O
ventilation	O
and	O
prone	O
positioning	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
absence	O
of	O
PMN	B-ANAT
in	O
the	O
peritoneum	B-ANAT
was	O
due	O
in	O
part	O
to	O
lysis	O
of	O
intraperitoneal	O
PMN	B-ANAT
,	O
because	O
the	O
peritoneal	B-ANAT
fluids	I-ANAT
contained	O
free	O
myeloperoxidase	O
and	O
induced	O
rapid	O
death	O
of	O
normal	O
rabbit	O
PMN	B-ANAT
in	O
vitro	O
.	O

Because	O
the	O
lungs	B-ANAT
of	O
brain	B-ANAT
-	O
dead	O
organ	B-ANAT
donors	O
can	O
contain	O
high	O
levels	O
of	O
IL	O
-	O
8	O
,	O
we	O
hypothesized	O
that	O
this	O
may	O
predispose	O
to	O
early	O
graft	B-ANAT
failure	O
in	O
the	O
recipient	O
after	O
lung	B-ANAT
transplantation	O
.	O

Pulmonary	B-ANAT
consequences	O
of	O
inhaled	O
amyl	O
and	O
butyl	O
nitrites	O
,	O
crystalline	O
methamphetamine	O
(	O
ice	O
),	O
and	O
phencyclidine	O
have	O
been	O
less	O
well	O
documented	O
.	O

The	O
following	O
laboratory	O
parameters	O
were	O
abnormal	O
:	O
sedimentation	O
rate	O
64	O
/	O
70	O
mmHg	O
,	O
CD4	O
+	O
cells	B-ANAT
462	O
/	O
ml	O
,	O
CD4	O
/	O
CD8	O
ratio	O
0	O
.	O
3	O
,	O
serum	B-ANAT
CRP	O
16	O
mg	O
/	O
l	O
,	O
antistreptolysin	O
titre	O
542	O
kU	O
/	O
l	O
,	O
complement	O
C3	O
<	O
0	O
.	O
1	O
g	O
/	O
l	O
,	O
GPT	O
37	O
U	O
/	O
l	O
,	O
albumin	O
49	O
.	O
5	O
%	O
and	O
gamma	O
-	O
globulin	O
28	O
.	O
5	O
%,	O
in	O
urine	B-ANAT
,	O
leukocytes	B-ANAT
25	O
/	O
microliter	O
and	O
protein	O
0	O
.	O
25	O
g	O
/	O
l	O
.	O

Abdominal	B-ANAT
sonography	O
showed	O
minor	O
hepatomegaly	O
,	O
splenomegaly	O
and	O
two	O
0	O
.	O
8	O
cm	O
-	O
large	O
lymph	B-ANAT
nodes	I-ANAT
near	O
the	O
liver	B-ANAT
entrance	O
.	O

This	O
inserted	O
hnRNP	B-ANAT
A1	O
binding	O
site	O
was	O
not	O
able	O
to	O
functionally	O
replace	O
,	O
or	O
enhance	O
transcription	O
from	O
,	O
the	O
intergenic	O
sequence	O
.	O

ABSTRACT	O
:	O
Archived	O
formalin	O
-	O
fixed	B-ANAT
,	O
paraffin	O
-	O
embedded	O
tissues	B-ANAT
from	O
25	O
pigs	O
naturally	O
infected	O
with	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
were	O
examined	O
by	O
in	O
situ	O
hybridization	O
for	O
TGEV	O
nucleic	B-ANAT
acid	O
using	O
a	O
nonradioactive	O
digoxigenin	O
-	O
labeled	O
cDNA	O
probe	O
that	O
targeted	O
the	O
nucleocapsid	B-ANAT
sequence	O
of	O
TGEV	O
strains	O
.	O

A	O
clinical	O
trial	O
using	O
dogs	O
challenged	O
orally	B-ANAT
with	O
CCV	O
SA4	O
and	O
CCV	O
NVSL	O
was	O
used	O
to	O
compare	O
viral	O
isolation	O
and	O
the	O
nPCR	O
assay	O
as	O
detection	O
techniques	O
over	O
a	O
2	O
-	O
week	O
period	O
of	O
infection	O
.	O

Echovirus	O
type	O
6	O
was	O
isolated	O
from	O
blood	B-ANAT
,	O
liver	B-ANAT
,	O
and	O
lungs	B-ANAT
.	O

Infectivity	O
-	O
neutralizing	O
(	O
IN	O
)	O
and	O
hemagglutinin	O
-	O
inhibiting	O
(	O
HAI	O
)	O
antibodies	O
induced	O
by	O
RBCV	O
infections	O
were	O
monitored	O
in	O
sequential	O
serum	B-ANAT
samples	O
collected	O
from	O
cattle	O
during	O
a	O
naturally	O
evolving	O
and	O
experimentally	O
monitored	O
epizootic	O
of	O
shipping	O
fever	O
pneumonia	O
(	O
SFP	O
).	O

An	O
increase	O
in	O
serum	B-ANAT
IN	O
antibody	O
after	O
day	O
7	O
led	O
to	O
reduction	O
of	O
virus	O
shedding	O
in	O
nasal	B-ANAT
secretions	B-ANAT
by	O
the	O
majority	O
of	O
the	O
cattle	O
between	O
days	O
7	O
and	O
14	O
.	O

Protein	O
microsequencing	O
identified	O
the	O
90	O
-	O
kDa	O
protein	O
as	O
mitochondrial	B-ANAT
aconitase	O
.	O

These	O
results	O
are	O
particularly	O
interesting	O
in	O
terms	O
of	O
identification	O
of	O
an	O
RNA	O
target	O
for	O
mitochondrial	B-ANAT
aconitase	O
,	O
which	O
has	O
a	O
cytoplasmic	B-ANAT
homolog	O
,	O
cytoplasmic	B-ANAT
aconitase	O
,	O
also	O
known	O
as	O
iron	O
regulatory	O
protein	O
1	O
,	O
a	O
well	O
-	O
recognized	O
RNA	O
-	O
binding	O
protein	O
.	O

The	O
binding	O
properties	O
of	O
mitochondrial	B-ANAT
aconitase	O
and	O
the	O
functional	O
relevance	O
of	O
RNA	O
binding	O
appear	O
to	O
parallel	O
those	O
of	O
cytoplasmic	B-ANAT
aconitase	O
.	O

Histologic	O
evaluation	O
lungs	B-ANAT
demonstrated	O
that	O
the	O
most	O
severe	O
lung	B-ANAT
injury	O
was	O
seen	O
in	O
the	O
EL	O
mice	O
.	O

The	O
ability	O
of	O
administered	O
colloids	O
to	O
increase	O
colloid	B-ANAT
osmotic	O
pressure	O
(	O
COP	O
)	O
constitutes	O
one	O
mechanism	O
by	O
which	O
colloids	O
might	O
reduce	O
interstitial	B-ANAT
oedema	O
and	O
promote	O
favourable	O
patient	O
outcomes	O
.	O

RESULTS	O
:	O
Serum	B-ANAT
samples	O
(	O
1396	O
)	O
collected	O
from	O
1984	O
to	O
1998	O
were	O
tested	O
for	O
the	O
presence	O
of	O
IgG	O
antibodies	O
to	O
CCV	O
.	O

The	O
most	O
common	O
complication	O
is	O
anaemia	O
accounting	O
for	O
76	O
.	O
56	O
%	O
followed	O
by	O
cerebral	B-ANAT
malaria	O
(	O
59	O
.	O
38	O
%).	O

He	O
was	O
found	O
to	O
be	O
hypercalcemic	O
(	O
11	O
.	O
8	O
mg	O
/	O
dL	O
)	O
and	O
dehydrated	O
,	O
and	O
his	O
hypercalcemia	O
improved	O
with	O
intravenous	O
fluids	B-ANAT
.	O

Clearance	O
of	O
infectious	O
virus	O
is	O
associated	O
with	O
a	O
gradual	O
decline	O
of	O
CNS	B-ANAT
T	B-ANAT
cells	I-ANAT
;	O
nevertheless	O
,	O
activated	O
T	B-ANAT
cells	I-ANAT
are	O
retained	O
within	O
the	O
CNS	B-ANAT
.	O

Immunofluorescent	O
analyses	O
of	O
cells	B-ANAT
expressing	O
biologically	O
active	O
murine	O
coronavirus	O
E	O
protein	O
with	O
a	O
hydrophilic	O
short	O
epitope	O
tag	O
at	O
the	O
N	O
-	O
terminus	O
showed	O
that	O
the	O
epitope	O
tag	O
was	O
exposed	O
cytoplasmically	O
.	O

Immunoprecipitation	O
analyses	O
of	O
the	O
purified	O
microsomal	B-ANAT
membrane	I-ANAT
vesicles	B-ANAT
that	O
contain	O
the	O
same	O
tagged	O
E	O
protein	O
revealed	O
the	O
N	O
-	O
terminal	O
epitope	O
tag	O
outside	O
the	O
microsomal	B-ANAT
membrane	I-ANAT
vesicles	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
the	O
immunogenicity	O
of	O
chimeric	O
987P	O
fimbriae	B-ANAT
on	O
a	O
Salmonella	O
vaccine	O
strain	O
was	O
improved	O
by	O
optimizing	O
fimbrial	O
expression	O
.	O

The	O
constitutive	O
tetA	O
promoter	O
and	O
the	O
in	O
vivo	O
activated	O
nirB	O
and	O
pagC	O
promoters	O
were	O
evaluated	O
for	O
their	O
use	O
to	O
express	O
two	O
epitopes	O
of	O
the	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
spike	O
protein	O
carried	O
by	O
fimbriae	B-ANAT
which	O
were	O
displayed	O
on	O
a	O
Salmonella	O
vaccine	O
strain	O
.	O

Exogeous	O
NO	O
may	O
lead	O
to	O
down	O
regulation	O
of	O
endogenous	O
NO	O
production	O
,	O
and	O
further	O
lead	O
to	O
rapid	O
hydrolization	O
of	O
cyclic	O
guanosine	O
3	O
',	O
5	O
'	O
monophosphate	O
(	O
cGMP	O
),	O
the	O
smooth	B-ANAT
muscle	I-ANAT
relaxant	O
,	O
by	O
the	O
enzyme	O
phosphodiesterase	O
.	O

Laparoscopic	O
exploration	O
,	O
irrigation	O
,	O
drainage	B-ANAT
,	O
and	O
decompression	O
of	O
the	O
pancreas	B-ANAT
were	O
performed	O
.	O

The	O
technique	O
can	O
be	O
used	O
to	O
determine	O
the	O
pathologic	O
extent	O
of	O
the	O
disease	O
,	O
to	O
irrigate	O
and	O
drain	O
the	O
abdominal	B-ANAT
cavity	I-ANAT
,	O
and	O
to	O
decompress	O
the	O
pancreas	B-ANAT
.	O

A	O
chronic	O
(	O
2	O
-	O
year	O
)	O
inhalation	O
toxicity	O
/	O
oncogenicity	O
study	O
showed	O
inflammatory	O
changes	O
in	O
the	O
anterior	O
nasal	B-ANAT
cavity	I-ANAT
but	O
no	O
neoplasms	O
or	O
systemic	O
toxicity	O
.	O

Intestinal	B-ANAT
mucins	O
from	O
piglets	O
(	O
12	O
-	O
14	O
days	O
old	O
)	O
and	O
adult	O
animals	O
were	O
shown	O
to	O
inhibit	O
TGEV	O
to	O
the	O
same	O
extent	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
film	O
showed	O
bilateral	O
alveolar	B-ANAT
infiltrates	O
.	O

Hemosiderin	O
deposition	O
occurred	O
within	O
macrophages	B-ANAT
in	O
the	O
spleen	B-ANAT
and	O
hematopoietic	B-ANAT
tissue	I-ANAT
,	O
and	O
within	O
hepatocytes	B-ANAT
.	O

These	O
changes	O
appeared	O
to	O
be	O
induced	O
by	O
bacterial	O
toxins	O
because	O
bacterial	O
cells	B-ANAT
did	O
not	O
directly	O
invade	O
these	O
affected	O
tissues	B-ANAT
.	O

The	O
5	O
'	O
region	O
of	O
the	O
S1	O
genes	O
,	O
containing	O
hypervariable	O
regions	O
I	O
and	O
II	O
,	O
and	O
3	O
'	O
region	O
of	O
the	O
nucleocapsid	B-ANAT
genes	O
,	O
containing	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocyte	I-ANAT
epitopes	O
,	O
were	O
used	O
to	O
construct	O
phylogenetic	O
trees	O
for	O
analysis	O
.	O

ABSTRACT	O
:	O
Chickens	O
infected	O
with	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
and	O
infectious	O
bursal	O
disease	O
virus	O
(	O
IBDV	O
)	O
commonly	O
develop	O
secondary	O
infection	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
with	O
Escherichia	O
coli	O
,	O
resulting	O
in	O
significant	O
economic	O
losses	O
.	O

ABSTRACT	O
:	O
The	O
pathophysiology	O
of	O
neonatal	O
meconium	B-ANAT
aspiration	O
syndrome	O
(	O
MAS	B-ANAT
),	O
often	O
resulting	O
in	O
severe	O
respiratory	O
failure	O
,	O
is	O
complex	O
and	O
still	O
largely	O
unclear	O
.	O

Although	O
the	O
early	O
pulmonary	B-ANAT
inflammatory	O
response	O
is	O
believed	O
to	O
play	O
a	O
central	O
pathogenetic	O
role	O
in	O
the	O
meconium	B-ANAT
-	O
induced	O
acute	O
lung	B-ANAT
damage	O
,	O
its	O
initiating	O
mechanisms	O
are	O
still	O
poorly	O
defined	O
.	O

ABSTRACT	O
:	O
Matrix	O
metalloproteinases	O
(	O
MMPs	O
)	O
are	O
upregulated	O
locally	O
in	O
sites	O
of	O
inflammation	O
,	O
including	O
the	O
lung	B-ANAT
.	O

The	O
gelatinase	O
B	O
-	O
and	O
the	O
stromelysin	O
1	O
-	O
deficient	O
mice	O
had	O
less	O
severe	O
lung	B-ANAT
injury	O
than	O
did	O
the	O
WT	O
controls	O
,	O
suggesting	O
that	O
both	O
MMPs	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
the	O
lung	B-ANAT
injury	O
.	O

These	O
studies	O
indicate	O
,	O
first	O
,	O
that	O
both	O
gelatinase	O
B	O
and	O
stromelysin	O
1	O
are	O
involved	O
in	O
the	O
development	O
of	O
experimental	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
second	O
,	O
that	O
the	O
mechanisms	O
by	O
which	O
these	O
individual	O
MMPs	O
function	O
appear	O
to	O
differ	O
.	O

CONCLUSIONS	O
:	O
This	O
study	O
shows	O
that	O
,	O
in	O
contrast	O
to	O
NO	O
inhalation	O
,	O
infusion	O
of	O
ANP	O
neither	O
improves	O
oxygenation	O
nor	O
attenuates	O
pulmonary	B-ANAT
hypertension	O
or	O
pulmonary	B-ANAT
edema	O
in	O
patients	O
with	O
severe	O
ARDS	O
.	O

Delayed	O
clinical	O
suspicion	O
and	O
treatment	O
of	O
active	O
pulmonary	B-ANAT
TB	O
with	O
respiratory	O
failure	O
may	O
contribute	O
to	O
the	O
persistently	O
high	O
mortality	O
rates	O
in	O
ICU	O
patients	O
with	O
these	O
diseases	O
.	O

ABSTRACT	O
:	O
Severe	O
cutaneous	O
hemorrhages	O
with	O
dermal	O
and	O
subcutaneous	O
capillary	B-ANAT
angioplasia	O
were	O
seen	O
in	O
aborted	O
and	O
stillborn	O
piglets	O
,	O
concurrently	O
with	O
an	O
acute	O
outbreak	O
of	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
(	O
PRRSV	O
)	O
abortions	O
.	O

Proliferating	O
capillaries	B-ANAT
often	O
were	O
surrounded	O
by	O
large	O
and	O
foamy	O
macrophages	B-ANAT
that	O
stained	O
positively	O
for	O
PRRSV	O
by	O
immunohistochemistry	O
.	O

A	O
high	O
percentage	O
of	O
both	O
maternal	O
antibody	O
-	O
positive	O
(	O
Mab	O
+)	O
and	O
maternal	O
antibody	O
-	O
negative	O
(	O
Mab	O
-)	O
chicks	O
failed	O
to	O
produce	O
IBV	O
antibody	O
when	O
vaccinated	O
at	O
1	O
day	O
of	O
age	O
by	O
the	O
intraocular	B-ANAT
route	O
.	O

A	O
density	O
index	O
was	O
calculated	O
for	O
a	O
2	O
-	O
cm2	O
window	O
in	O
three	O
dorsal	O
and	O
three	O
ventral	O
lung	B-ANAT
regions	O
.	O

A	O
review	O
of	O
the	O
literature	O
shows	O
that	O
pulmonary	B-ANAT
complications	O
of	O
P	O
.	O
vivax	O
are	O
rare	O
but	O
occur	O
more	O
frequently	O
than	O
generally	O
acknowledged	O
.	O

In	O
respect	O
to	O
their	O
hemagglutinating	O
properties	O
and	O
their	O
higher	O
RDE	O
activities	O
with	O
rat	O
erythrocytes	B-ANAT
,	O
WDBCoV	O
strains	O
differed	O
from	O
NCDBCoV	O
strains	O
and	O
respiratory	O
bovine	O
coronaviruses	O
RBCoV	O
strains	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
an	O
acute	O
form	O
of	O
severe	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
injury	O
that	O
evolves	O
after	O
a	O
direct	O
or	O
indirect	O
lung	B-ANAT
insult	O
.	O

Mortality	O
remains	O
high	O
among	O
children	O
with	O
ARDS	O
,	O
particularly	O
when	O
serious	O
underlying	O
conditions	O
co	O
-	O
exist	O
,	O
sepsis	O
occurs	O
,	O
and	O
when	O
there	O
is	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
Axonal	O
damage	O
is	O
T	B-ANAT
cell	I-ANAT
mediated	O
and	O
occurs	O
concomitantly	O
with	O
demyelination	O
in	O
mice	O
infected	O
with	O
a	O
neurotropic	O
coronavirus	O
.	O

RESULTS	O
:	O
Venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
successful	O
in	O
75	O
%	O
patients	O
who	O
survived	O
.	O

TITLE	O
:	O
Echinococcal	O
hydatid	O
cyst	O
at	O
the	O
right	B-ANAT
ventricle	I-ANAT
outlet	O
with	O
leakage	O
to	O
the	O
pulmonary	B-ANAT
artery	I-ANAT
outflow	O
causing	O
follicular	B-ANAT
airway	B-ANAT
disease	O
and	O
sudden	O
death	O
.	O

ABSTRACT	O
:	O
Postmortem	O
examination	O
of	O
a	O
35	O
-	O
year	O
-	O
old	O
parous	O
woman	O
who	O
died	O
suddenly	O
revealed	O
a	O
hydatid	O
cyst	O
mass	O
located	O
at	O
the	O
right	O
ventricular	B-ANAT
outlet	O
,	O
with	O
a	O
grossly	O
discernible	O
defect	O
opening	O
to	O
the	O
pulmonary	B-ANAT
outflow	O
tract	O
.	O

Six	O
patients	O
with	O
severe	O
acute	O
lung	B-ANAT
injury	O
requiring	O
mechanical	O
ventilation	O
.	O

All	O
patients	O
had	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
radiography	O
,	O
a	O
PaO2	O
/	O
FIO2	O
ratio	O
less	O
than	O
200	O
mmHg	O
,	O
and	O
stable	O
hemodynamics	O
without	O
vasoactive	O
drugs	O
.	O

Viral	O
RNA	O
was	O
detected	O
in	O
faeces	B-ANAT
by	O
reverse	O
-	O
transcriptase	O
PCR	O
(	O
RT	O
-	O
PCR	O
),	O
and	O
plasma	B-ANAT
antiviral	O
antibodies	O
by	O
immunofluorescence	O
.	O

Most	O
frequently	O
detected	O
in	O
both	O
diarrheal	O
and	O
normal	O
feces	B-ANAT
were	O
canine	O
coronavirus	O
(	O
55	O
.	O
4	O
%)	O
and	O
G	O
.	O
lamblia	O
(	O
48	O
.	O
2	O
%).	O

Screening	O
of	O
11	O
IBV	O
-	O
encoded	O
proteins	O
suggested	O
that	O
a	O
58	O
-	O
kDa	O
mature	O
cleavage	O
product	O
could	O
induce	O
apoptotic	O
changes	O
in	O
cells	B-ANAT
transiently	O
expressing	O
the	O
protein	O
.	O

Specifically	O
,	O
one	O
membrane	B-ANAT
population	O
contains	O
the	O
gene	O
1	O
proteins	O
p65	O
and	O
p1a	O
-	O
22	O
,	O
while	O
the	O
other	O
contains	O
the	O
gene	O
1	O
proteins	O
p28	B-ANAT
and	O
helicase	O
,	O
as	O
well	O
as	O
the	O
structural	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
and	O
newly	O
synthesized	O
viral	O
RNA	O
.	O

TITLE	O
:	O
Study	O
of	O
protection	O
by	O
recombinant	O
fowl	O
poxvirus	O
expressing	O
C	O
-	O
terminal	O
nucleocapsid	B-ANAT
protein	O
of	O
infectious	O
bronchitis	O
virus	O
against	O
challenge	O
.	O

Thus	O
,	O
the	O
number	O
of	O
basic	O
residues	O
around	O
the	O
cleavage	O
recognition	O
site	O
does	O
not	O
appear	O
to	O
correlate	O
with	O
increased	O
cleavability	O
,	O
host	B-ANAT
cell	I-ANAT
range	O
,	O
and	O
increased	O
virulence	O
as	O
it	O
does	O
with	O
envelope	B-ANAT
glycoproteins	O
in	O
orthomyxoviruses	O
and	O
paramyxoviruses	O
.	O

Dialytic	O
treatment	O
is	O
necessary	O
to	O
correct	O
hydroelectrolytic	O
imbalance	O
and	O
renal	B-ANAT
function	O
alterations	O
and	O
it	O
may	O
be	O
a	O
pathogenetic	O
therapy	O
by	O
myoglobin	O
removal	O
.	O

10	O
yrs	O
,	O
and	O
were	O
suffering	O
from	O
MODS	O
and	O
typical	O
elderly	O
diseases	O
,	O
such	O
as	O
cardiac	B-ANAT
and	O
respiratory	O
chronic	O
failure	O
,	O
except	O
from	O
3	O
patients	O
with	O
acute	O
liver	B-ANAT
failure	O
resulting	O
from	O
poisoning	O
,	O
who	O
were	O
relatively	O
younger	O
.	O

CONCLUSIONS	O
:	O
Early	O
identification	O
of	O
limb	B-ANAT
vascular	B-ANAT
thrombosis	O
through	O
external	O
symptoms	O
is	O
very	O
important	O
,	O
as	O
it	O
can	O
avoid	O
invasive	O
surgical	O
procedures	O
.	O

It	O
is	O
autocatalytically	O
released	O
from	O
the	O
precursors	O
pp1a	O
and	O
pp1ab	O
by	O
one	O
zinc	O
finger	B-ANAT
-	O
containing	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
in	O
IBV	O
and	O
by	O
two	O
paralogous	O
PLpros	O
,	O
PL1pro	O
and	O
PL2pro	O
,	O
in	O
mouse	O
hepatitis	O
virus	O
.	O

Surprisingly	O
,	O
both	O
PL1pro	O
and	O
PL2pro	O
cleaved	B-ANAT
between	O
p87	O
and	O
p195	O
/	O
p210	O
.	O

The	O
IP	O
test	O
did	O
not	O
react	O
with	O
sera	B-ANAT
from	O
either	O
15	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
dogs	O
or	O
7	O
SPF	O
dogs	O
immunized	O
with	O
a	O
multivalent	O
vaccine	O
,	O
including	O
canine	O
parvovirus	O
type	O
2	O
,	O
canine	O
distemper	O
virus	O
,	O
canine	O
adenovirus	O
type	O
2	O
,	O
and	O
canine	O
parainfluenza	O
virus	O
.	O

By	O
immunohistochemical	O
analysis	O
,	O
virus	O
-	O
specific	O
antigen	O
was	O
found	O
first	O
in	O
the	O
pyramidal	B-ANAT
cells	I-ANAT
of	O
the	O
hippocampus	B-ANAT
and	O
cerebral	B-ANAT
cortex	I-ANAT
,	O
and	O
later	O
in	O
the	O
large	O
-	O
sized	O
neurons	B-ANAT
of	O
the	O
pons	B-ANAT
and	O
spinal	B-ANAT
cord	I-ANAT
.	O

To	O
infect	O
enterocytes	B-ANAT
,	O
both	O
S	O
glycoproteins	O
and	O
the	O
viral	B-ANAT
envelope	I-ANAT
must	O
resist	O
degradation	O
by	O
proteases	O
,	O
low	O
and	O
high	O
pH	O
,	O
and	O
bile	B-ANAT
salts	O
.	O

Cytolysis	O
requires	O
interaction	O
of	O
the	O
virus	O
receptor	O
and	O
the	O
viral	O
S	O
glycoprotein	O
,	O
is	O
independent	O
of	O
other	O
viral	O
-	O
induced	O
components	O
,	O
and	O
is	O
not	O
a	O
unique	O
property	O
of	O
B	B-ANAT
cells	I-ANAT
.	O

However	O
,	O
cells	B-ANAT
infected	O
with	O
an	O
MHV	O
strain	O
unable	O
to	O
induce	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
are	O
resistant	O
to	O
lysis	O
and	O
lysis	O
of	O
JHMV	O
-	O
infected	O
cells	B-ANAT
is	O
inhibited	O
by	O
an	O
anti	O
-	O
S	O
-	O
protein	O
nonneutralizing	O
mAb	O
which	O
prevents	O
S	O
-	O
protein	O
-	O
mediated	O
cell	B-ANAT
fusion	O
.	O

TITLE	O
:	O
Analysis	O
of	O
early	O
deaths	O
after	O
isolated	O
lung	B-ANAT
transplantation	O
.	O

Persistent	O
pneumonia	O
confirmed	O
by	O
biopsy	B-ANAT
specimen	I-ANAT
was	O
usually	O
accompanied	O
by	O
histologic	O
manifestations	O
of	O
acute	O
cellular	B-ANAT
rejection	O
and	O
was	O
associated	O
with	O
poor	O
patient	O
outcome	O
(	O
ie	O
,	O
death	O
or	O
subsequent	O
development	O
of	O
bronchiolitis	O
obliterans	O
syndrome	O
).	O

No	O
reaction	O
was	O
observed	O
with	O
extracts	O
of	O
the	O
heart	B-ANAT
,	O
muscles	B-ANAT
,	O
spleen	B-ANAT
,	O
brain	B-ANAT
and	O
lung	B-ANAT
.	O

Reduced	O
virus	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
in	O
the	O
CNS	B-ANAT
coincided	O
with	O
poor	O
peripheral	O
expansion	O
and	O
diminished	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
help	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
the	O
lack	O
of	O
Ab	O
,	O
limited	O
CD8	O
(+)	O
and	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
responses	O
in	O
muMT	O
mice	O
contribute	O
to	O
the	O
ultimate	O
loss	O
of	O
control	O
of	O
CNS	B-ANAT
infection	O
.	O

Using	O
a	O
model	O
of	O
virus	O
infection	O
restricted	O
to	O
the	O
CNS	B-ANAT
,	O
the	O
results	O
provide	O
novel	O
evidence	O
for	O
a	O
role	O
of	O
B	B-ANAT
cells	I-ANAT
in	O
regulating	O
T	B-ANAT
cell	I-ANAT
expansion	O
and	O
differentiation	O
into	O
effector	O
cells	B-ANAT
.	O

Amount	O
and	O
types	O
of	O
infiltrating	O
leukocytes	B-ANAT
in	O
the	O
jejunum	B-ANAT
and	O
activity	O
and	O
cellular	B-ANAT
constituents	O
of	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
,	O
spleen	B-ANAT
,	O
and	O
bone	B-ANAT
marrow	I-ANAT
were	O
determined	O
.	O

Lymphoid	B-ANAT
tissues	I-ANAT
were	O
depleted	O
in	O
cats	O
with	O
PV	O
enteritis	O
and	O
with	O
EUE	O
but	O
were	O
normal	O
or	O
hyperplastic	O
in	O
cats	O
with	O
FAE	O
.	O

TITLE	O
:	O
[	O
Liver	B-ANAT
transplantation	O
for	O
alcoholic	O
liver	B-ANAT
disease	O
].	O

Both	O
CAV	O
-	O
1	O
and	O
CCV	O
were	O
isolated	O
from	O
tissue	B-ANAT
or	O
swab	O
samples	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
pressure	O
ventilation	O
is	O
the	O
keystone	O
in	O
the	O
management	O
of	O
pulmonary	B-ANAT
dysfunction	O
in	O
the	O
critically	O
ill	O
.	O

ABSTRACT	O
:	O
The	O
pathophysiology	O
of	O
pulmonary	B-ANAT
contusion	O
(	O
PC	O
)	O
is	O
poorly	O
understood	O
,	O
and	O
only	O
minimal	O
advances	O
have	O
been	O
made	O
in	O
management	O
of	O
this	O
entity	O
over	O
the	O
past	O
20	O
years	O
.	O

Improvement	O
in	O
understanding	O
of	O
PC	O
has	O
been	O
hindered	O
by	O
the	O
fact	O
that	O
there	O
has	O
been	O
no	O
accurate	O
way	O
to	O
quantitate	O
the	O
amount	O
of	O
pulmonary	B-ANAT
injury	O
.	O

Admission	O
pulmonary	B-ANAT
function	O
variables	O
(	O
Pao2	O
/	O
FiO2	O
,	O
static	O
compliance	O
),	O
injury	O
descriptors	O
(	O
chest	B-ANAT
Abbreviated	O
Injury	O
Score	O
,	O
Injury	O
Severity	O
Score	O
,	O
injury	O
distribution	O
),	O
and	O
indicators	O
of	O
degree	O
of	O
shock	O
(	O
admission	O
systolic	O
blood	B-ANAT
pressure	O
,	O
admission	O
base	O
deficit	O
)	O
were	O
documented	O
.	O

TITLE	O
:	O
Fas	O
/	O
Fas	O
ligand	O
system	O
mediates	O
epithelial	O
injury	O
,	O
but	O
not	O
pulmonary	B-ANAT
host	O
defenses	O
,	O
in	O
response	O
to	O
inhaled	O
bacteria	O
.	O

We	O
conclude	O
that	O
the	O
Fas	O
/	O
FasL	O
system	O
contributes	O
to	O
the	O
development	O
of	O
permeability	O
changes	O
and	O
tissue	B-ANAT
injury	O
during	O
-	O
gram	O
negative	O
bacterial	O
pneumonia	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
attempted	O
to	O
define	O
differences	O
in	O
the	O
hemagglutinin	O
-	O
esterase	O
(	O
HE	O
)	O
glycoprotein	O
between	O
11	O
bovine	O
coronaviruses	O
(	O
BCV	O
)	O
recent	O
(	O
post	O
-	O
1991	O
)	O
and	O
past	O
(	O
pre	O
-	O
1991	O
)	O
isolates	O
from	O
neonatal	O
calf	B-ANAT
diarrhoea	O
(	O
NCD	O
)	O
and	O
winter	O
dysentery	O
(	O
WD	O
)	O
syndromes	O
as	O
a	O
basis	O
for	O
strain	O
differentiation	O
related	O
to	O
the	O
clinical	O
source	O
of	O
the	O
isolates	O
.	O

ABSTRACT	O
:	O
The	O
incidence	O
of	O
acute	O
cor	B-ANAT
pulmonale	O
(	O
ACP	O
),	O
a	O
frequent	O
and	O
usually	O
lethal	O
complication	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
during	O
traditional	O
respiratory	O
support	O
,	O
has	O
never	O
been	O
re	O
-	O
evaluated	O
since	O
protective	O
ventilation	O
gained	O
acceptance	O
.	O

RESULTS	O
:	O
Normal	O
right	O
ventricular	B-ANAT
function	O
was	O
present	O
in	O
56	O
patients	O
,	O
whereas	O
right	O
ventricular	B-ANAT
dysfunction	O
was	O
observed	O
in	O
19	O
patients	O
after	O
2	O
days	O
of	O
respiratory	O
support	O
.	O

A	O
multivariate	O
analysis	O
individualized	O
Paco2	O
level	O
as	O
the	O
sole	B-ANAT
factor	O
independently	O
associated	O
with	O
ACP	O
,	O
suggesting	O
that	O
ACP	O
development	O
in	O
ARDS	O
is	O
influenced	O
by	O
the	O
severity	O
of	O
lung	B-ANAT
damage	O
and	O
/	O
or	O
the	O
respiratory	O
strategy	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
whether	O
rapid	O
or	O
slowly	O
infused	O
intravenous	O
fat	O
emulsions	O
affect	O
the	O
ratio	O
of	O
prostaglandin	O
I2	O
/	O
thromboxane	O
A2	O
in	O
arterial	B-ANAT
blood	I-ANAT
,	O
pulmonary	B-ANAT
hemodynamics	O
,	O
and	O
gas	O
exchange	O
.	O

Arterial	B-ANAT
thromboxane	O
B2	O
and	O
6	O
-	O
keto	O
-	O
prostaglandin	O
-	O
F1alpha	O
plasma	B-ANAT
concentrations	O
were	O
obtained	O
by	O
radioimmunoassay	O
,	O
and	O
6	O
-	O
keto	O
-	O
prostaglandin	O
-	O
F1alpha	O
/	O
thromboxane	O
B2	O
ratios	O
(	O
P	O
/	O
T	O
ratios	O
)	O
were	O
calculated	O
.	O

The	O
inhibition	O
of	O
acetylcholinesterase	O
causes	O
accumulation	O
of	O
acetylcholine	O
at	O
synapses	B-ANAT
,	O
and	O
overstimulation	O
of	O
neurotransmission	O
occurs	O
as	O
a	O
result	O
of	O
this	O
accumulation	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
is	O
to	O
determine	O
whether	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
APRV	O
)	O
can	O
safely	O
enhance	O
hemodynamics	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
/	O
or	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
relative	O
to	O
pressure	O
control	O
ventilation	O
(	O
PCV	O
).	O

9	O
years	O
(	O
n	O
=	O
12	O
)	O
and	O
mean	O
Lung	B-ANAT
Injury	O
Score	O
was	O
7	O
.	O
6	O
+/-	O

Temperature	O
and	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
fractional	O
inspired	O
oxygen	O
(	O
FiO2	O
)	O
were	O
similar	O
among	O
the	O
patients	O
.	O

Urine	B-ANAT
output	O
increased	O
from	O
0	O
.	O
83	O
+/-	O

TITLE	O
:	O
Variation	O
of	O
the	O
sequence	O
in	O
the	O
gene	O
encoding	O
for	O
transmembrane	B-ANAT
protein	O
M	O
of	O
canine	O
coronavirus	O
(	O
CCV	O
).	O

Vuip	O
and	O
Crs	O
changes	O
were	O
proportional	O
,	O
reflecting	O
compression	O
of	O
the	O
PV	O
curve	O
on	O
the	O
volume	O
axis	B-ANAT
and	O
suggesting	O
reduction	O
of	O
the	O
amount	O
of	O
ventilatable	O
lung	B-ANAT
at	O
low	O
airway	B-ANAT
pressure	O
.	O

ABSTRACT	O
:	O
Expression	O
of	O
negative	O
-	O
strand	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
transcripts	O
in	O
MHV	O
-	O
infected	O
cells	B-ANAT
results	O
in	O
the	O
accumulation	O
of	O
positive	O
-	O
strand	O
DI	O
RNAs	O
(	O
M	O
.	O
Joo	O
et	O
al	O
.,	O
1996	O
,	O
J	O
.	O
Virol	O
.	O

The	O
most	O
likely	O
explanation	O
for	O
this	O
is	O
that	O
the	O
N	O
protein	O
induced	O
a	O
cell	B-ANAT
cycle	O
delay	O
or	O
arrest	O
,	O
most	O
likely	O
in	O
the	O
G	O
(	O
2	O
)/	O
M	O
phase	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
possible	O
inhibition	O
of	O
cytokinesis	O
in	O
these	O
cells	B-ANAT
.	O

Surfactant	O
replacement	O
combined	O
with	O
early	O
HFOV	O
using	O
a	O
lung	B-ANAT
recruitment	O
strategy	O
ameliorates	O
the	O
acute	O
lung	B-ANAT
injury	O
in	O
respiratory	O
distress	O
syndrome	O
that	O
predisposes	O
some	O
preterm	O
infants	O
to	O
develop	O
chronic	O
lung	B-ANAT
disease	O
.	O

To	O
explore	O
the	O
events	O
which	O
couple	O
acute	O
pancreatitis	O
to	O
lung	B-ANAT
injury	O
,	O
a	O
number	O
of	O
recent	O
studies	O
have	O
been	O
performed	O
in	O
the	O
author	O
'	O
s	O
laboratory	O
using	O
a	O
variety	O
of	O
experimental	O
models	O
and	O
interventions	O
including	O
gene	O
-	O
targeted	O
deletion	O
of	O
chemokines	O
,	O
cytokines	O
,	O
specific	O
receptors	O
,	O
and	O
adhesion	O
molecules	O
.	O

ABSTRACT	O
:	O
Tissue	B-ANAT
of	O
amputated	O
or	O
nonsalvageable	O
limbs	B-ANAT
may	O
be	O
used	O
for	O
reconstruction	O
of	O
complex	O
defects	O
resulting	O
from	O
tumor	O
and	O
trauma	O
.	O

They	O
can	O
be	O
used	O
as	O
pedicled	O
or	O
free	B-ANAT
flaps	I-ANAT
and	O
are	O
a	O
beneficial	O
reconstruction	O
strategy	O
for	O
major	O
defects	O
,	O
provided	O
there	O
is	O
tissue	B-ANAT
available	O
adjacent	O
to	O
these	O
defects	O
.	O

Eleven	O
ray	O
amputations	O
,	O
two	O
extended	O
procedures	O
for	O
coverage	O
of	O
the	O
hand	O
,	O
and	O
nine	O
forefoot	B-ANAT
amputations	O
were	O
prevented	O
.	O

Overall	O
complication	O
rate	O
,	O
including	O
wound	O
dehiscence	O
and	O
secondary	O
grafting	B-ANAT
,	O
was	O
18	O
percent	O
.	O

Fillet	O
flaps	B-ANAT
facilitate	O
reconstruction	O
in	O
difficult	O
and	O
complex	O
cases	O
.	O

ABSTRACT	O
:	O
Toxic	O
epidermal	B-ANAT
necrolysis	O
(	O
TEN	O
)	O
is	O
a	O
rare	O
severe	O
acute	O
exfoliative	O
drug	O
-	O
induced	O
skin	B-ANAT
disorder	O
which	O
has	O
recently	O
been	O
ascribed	O
to	O
alterations	O
in	O
the	O
control	O
of	O
keratinocyte	B-ANAT
apoptosis	O
,	O
mediated	O
by	O
an	O
interaction	O
between	O
the	O
cell	B-ANAT
surface	I-ANAT
death	O
receptor	O
Fas	O
and	O
its	O
respective	O
ligand	O
.	O

A	O
therapeutic	O
approach	O
with	O
intravenous	O
immunoglobulins	O
(	O
IVIG	O
)	O
associated	O
with	O
pulse	O
methylprednisolone	O
,	O
based	O
on	O
the	O
inhibition	O
of	O
Fas	O
-	O
mediated	O
keratinocyte	B-ANAT
death	O
by	O
naturally	O
occurring	O
Fas	O
-	O
blocking	O
antibodies	O
included	O
in	O
human	O
immunoglobulin	O
preparations	O
,	O
has	O
produced	O
good	O
preliminary	O
results	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
relationship	O
between	O
shedding	O
of	O
bovine	O
coronavirus	O
(	O
BCV	O
)	O
via	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
enteric	O
routes	O
and	O
the	O
association	O
with	O
weight	O
gain	O
in	O
feedlot	O
cattle	O
.	O

Paired	O
fecal	B-ANAT
samples	O
and	O
nasal	B-ANAT
swab	O
specimens	O
were	O
obtained	O
and	O
were	O
tested	O
for	O
BCV	O
,	O
using	O
antigen	O
-	O
capture	O
ELISA	O
.	O

Fecal	B-ANAT
shedding	O
of	O
BCV	O
was	O
associated	O
with	O
significantly	O
reduced	O
weight	O
gain	O
.	O

Six	O
months	O
before	O
,	O
bronchogenic	O
carcinoma	O
had	O
been	O
diagnosed	O
in	O
the	O
lower	O
right	B-ANAT
lung	I-ANAT
.	O

The	O
streptococcal	O
strains	O
involved	O
in	O
north	O
america	O
use	O
to	O
produce	O
the	O
toxin	O
erythrogenic	O
A	O
,	O
the	O
european	O
cases	O
seem	O
to	O
be	O
more	O
related	O
to	O
strains	O
secreting	O
the	O
B	O
toxin	O
with	O
a	O
dysregulation	O
of	O
the	O
mechanisms	O
which	O
control	O
the	O
secretion	B-ANAT
of	O
the	O
toxin	O
.	O

Using	O
double	O
immunofluorescence	O
labeling	O
,	O
we	O
show	O
that	O
during	O
acute	O
infection	O
with	O
murine	O
hepatitis	O
virus	O
,	O
MHC	B-ANAT
class	O
I	O
is	O
expressed	O
in	O
vivo	O
by	O
oligodendrocytes	B-ANAT
,	O
neurons	B-ANAT
,	O
microglia	B-ANAT
,	O
and	O
endothelia	O
,	O
and	O
MHC	B-ANAT
class	O
II	O
is	O
expressed	O
only	O
by	O
microglia	B-ANAT
.	O

Vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
upregulated	O
only	O
in	O
susceptible	O
mice	O
during	O
the	O
secondary	O
(	O
retinal	B-ANAT
degeneration	O
)	O
phase	O
.	O

TITLE	O
:	O
Lack	O
of	O
CCR2	O
results	O
in	O
increased	O
mortality	O
and	O
impaired	O
leukocyte	B-ANAT
activation	O
and	O
trafficking	O
following	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
with	O
a	O
neurotropic	O
coronavirus	O
.	O

An	O
acute	O
respiratory	O
failure	O
occurred	O
36	O
hours	O
after	O
from	O
admission	O
due	O
to	O
an	O
obstructive	O
and	O
desquamative	O
necrosis	O
of	O
the	O
tracheobronchial	O
epithelium	B-ANAT
.	O

RESULTS	O
:	O
Echovirus	O
7	O
was	O
the	O
sole	B-ANAT
pathogen	O
isolated	O
from	O
three	O
cases	O
of	O
acute	O
encephalomyelitis	O
,	O
two	O
of	O
which	O
were	O
fatal	O
due	O
to	O
severe	O
left	O
ventricular	B-ANAT
dysfunction	O
resistant	O
to	O
inotropic	O
support	O
.	O

Biopsies	O
of	O
the	O
olfactory	B-ANAT
mucosa	I-ANAT
in	O
patients	O
that	O
complain	O
of	O
dysosmia	O
after	O
viral	O
infection	O
fall	O
into	O
two	O
categories	O
:	O
one	O
in	O
which	O
no	O
olfactory	B-ANAT
epithelium	I-ANAT
is	O
seen	O
and	O
another	O
in	O
which	O
the	O
epithelium	B-ANAT
is	O
disordered	O
and	O
populated	O
mainly	O
by	O
immature	O
neurons	B-ANAT
.	O

Moreover	O
,	O
surviving	O
mitral	O
cells	B-ANAT
apparently	O
remain	O
disconnected	O
from	O
the	O
sensory	B-ANAT
neuron	I-ANAT
input	O
to	O
the	O
glomerular	B-ANAT
layer	B-ANAT
,	O
judging	O
from	O
retrograde	O
labeling	O
studies	O
using	O
Dil	O
.	O

The	O
results	O
indicate	O
that	O
humoral	O
and	O
cellular	B-ANAT
immunities	O
to	O
TCV	O
are	O
elicited	O
in	O
turkeys	O
following	O
infection	O
with	O
TCV	O
.	O

TITLE	O
:	O
Antibody	O
is	O
required	O
for	O
clearance	O
of	O
infectious	O
murine	O
hepatitis	O
virus	O
A59	O
from	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
,	O
but	O
not	O
the	O
liver	B-ANAT
.	O

To	O
determine	O
how	O
B	B-ANAT
cells	I-ANAT
mediate	O
viral	O
clearance	O
,	O
we	O
first	O
assessed	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
activation	O
in	O
the	O
absence	O
of	O
B	B-ANAT
cells	I-ANAT
as	O
APC	B-ANAT
.	O

The	O
muMT	O
mice	O
that	O
received	O
A59	O
-	O
specific	O
Ab	O
had	O
decreased	O
virus	O
,	O
while	O
mice	O
with	O
B	B-ANAT
cells	I-ANAT
deficient	O
in	O
Ab	O
secretion	B-ANAT
did	O
not	O
clear	O
virus	O
from	O
the	O
CNS	B-ANAT
.	O

These	O
data	O
suggest	O
that	O
clearance	O
of	O
infectious	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
from	O
the	O
CNS	B-ANAT
requires	O
Ab	O
production	O
and	O
perhaps	O
B	B-ANAT
cell	I-ANAT
support	O
of	O
T	B-ANAT
cells	I-ANAT
;	O
however	O
,	O
virus	O
is	O
cleared	O
from	O
the	O
liver	B-ANAT
without	O
the	O
involvement	O
of	O
Abs	O
or	O
B	B-ANAT
cells	I-ANAT
.	O

We	O
measured	O
VO2wb	O
by	O
indirect	O
calorimetry	O
and	O
simultaneously	O
determined	O
systemic	O
oxygen	O
uptake	O
(	O
VO2Fick	O
)	O
as	O
the	O
product	O
of	O
cardiac	B-ANAT
output	O
(	O
echocardiography	O
)	O
and	O
the	O
arterial	B-ANAT
-	O
mixed	O
venous	B-ANAT
oxygen	O
content	O
difference	O
(	O
cooximetry	O
)	O
assuming	O
that	O
VO2wb	O
-	O
VO2Fick	O
accounts	O
for	O
VO2lung	O
.	O

VO2lung	O
can	O
account	O
for	O
the	O
elevated	O
metabolic	O
rate	O
in	O
low	O
-	O
birthweight	O
infants	O
with	O
lung	B-ANAT
injury	O
.	O

Hyaline	B-ANAT
membrane	B-ANAT
formation	O
,	O
intra	O
-	O
alveolar	B-ANAT
neutrophil	B-ANAT
(	O
PMN	B-ANAT
)	O
accumulation	O
and	O
intra	O
-	O
alveolar	B-ANAT
/	O
perivascular	O
haemorrhage	O
were	O
graded	O
semiquantitatively	O
(	O
0	O
-	O
4	O
).	O

In	O
the	O
subgroup	O
of	O
six	O
trials	O
where	O
a	O
high	O
volume	O
strategy	O
(	O
HVS	O
)	O
was	O
used	O
for	O
HFOV	O
,	O
this	O
is	O
associated	O
with	O
significantly	O
lower	O
rates	O
of	O
CLD	O
in	O
survivors	O
at	O
28	O
-	O
30	O
days	O
[	O
three	O
trials	O
,	O
summary	O
RR	O
0	O
.	O
53	O
(	O
0	O
.	O
36	O
,	O
0	O
.	O
76	O
)],	O
of	O
'	O
death	O
or	O
CLD	O
at	O
28	O
-	O
30	O
days	O
'	O
[	O
three	O
trials	O
,	O
summary	O
RR	O
0	O
.	O
56	O
(	O
0	O
.	O
40	O
,	O
0	O
.	O
77	O
)	O
and	O
oxygen	O
use	O
at	O
36	O
-	O
37	O
weeks	O
postmenstrual	O
age	O
or	O
discharge	B-ANAT
[	O
five	O
trials	O
,	O
summary	O
RR	O
0	O
.	O
72	O
(	O
0	O
.	O
56	O
,	O
0	O
.	O
93	O
)].	O

The	O
purpose	O
of	O
the	O
ventilatory	O
management	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
to	O
avoid	O
any	O
barotrauma	O
to	O
the	O
lungs	B-ANAT
by	O
decreasing	O
the	O
tidal	O
volume	O
at	O
the	O
expense	O
of	O
permissive	O
hypercapnia	O
.	O

This	O
hypercapnia	O
is	O
extremely	O
dangerous	O
for	O
severe	O
head	B-ANAT
trauma	O
patients	O
because	O
it	O
increases	O
intracranial	B-ANAT
pressure	O
.	O

We	O
report	O
the	O
cases	O
of	O
two	O
patients	O
with	O
ARDS	O
and	O
severe	O
head	B-ANAT
trauma	O
.	O

Military	O
research	O
altitude	O
chamber	B-ANAT
.	O

We	O
also	O
identified	O
a	O
conserved	O
23	O
-	O
nucleotide	O
stem	B-ANAT
-	O
loop	O
structure	O
involving	O
nucleotides	O
142	O
to	O
132	O
and	O
nucleotides	O
68	O
to	O
79	O
.	O

TITLE	O
:	O
Effect	O
of	O
intravenous	O
taurine	O
on	O
endotoxin	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
sheep	O
.	O

RESULTS	O
:	O
Endotoxin	O
induced	O
a	O
severe	O
lung	B-ANAT
injury	O
characterised	O
by	O
a	O
decrease	O
in	O
mean	O
systemic	O
blood	B-ANAT
pressure	O
and	O
an	O
increase	O
in	O
pulmonary	B-ANAT
artery	I-ANAT
pressure	O
,	O
hypoxia	O
,	O
and	O
an	O
increase	O
in	O
pulmonary	B-ANAT
myeloperoxidase	O
activity	O
.	O

In	O
animals	O
,	O
urea	O
treatment	O
has	O
been	O
clearly	O
shown	O
to	O
protect	O
again	O
ODS	O
,	O
this	O
protective	O
effect	O
could	O
be	O
due	O
to	O
its	O
ability	O
to	O
induce	O
quickly	O
brain	B-ANAT
""""	O
organic	O
osmolytes	O
""""	O
reaccumulation	O
.	O

Intrahepatic	O
NK1	O
.	O
1	O
(+)	O
alphabeta	O
-	O
TCR	B-ANAT
(	O
inter	O
)	O
cells	B-ANAT
decreased	O
in	O
both	O
virally	O
infected	O
groups	O
of	O
mice	O
,	O
while	O
CD4	O
(+)	O
alphabeta	O
-	O
TCR	B-ANAT
(	O
inter	O
)	O
LFA	O
-	O
1	O
(	O
high	O
)	O
cells	B-ANAT
increased	O
in	O
L2	O
-	O
MHV3	O
-	O
infected	O
mice	O
,	O
in	O
contrast	O
with	O
what	O
was	O
seen	O
in	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	O
.	O

Intestinal	B-ANAT
contents	I-ANAT
or	O
intestines	B-ANAT
from	O
affected	O
turkey	O
poults	O
and	O
inoculated	O
turkey	O
embryos	B-ANAT
contained	O
coronaviruses	O
as	O
revealed	O
by	O
electron	O
microscopy	O
or	O
were	O
positive	O
for	O
turkey	O
coronavirus	O
by	O
immunofluorescent	O
antibody	O
assay	O
.	O

Purified	O
viruses	O
hemagglutinated	O
rabbit	O
erythrocytes	B-ANAT
with	O
a	O
titer	O
of	O
16	O
.	O

The	O
lower	O
pulmonary	B-ANAT
VEGF	O
in	O
preterm	O
infants	O
with	O
more	O
severe	O
RDS	O
may	O
contribute	O
to	O
the	O
pathophysiology	O
of	O
the	O
acute	O
lung	B-ANAT
injury	O
.	O

However	O
,	O
experimental	O
evidence	O
suggests	O
that	O
repeated	O
end	O
-	O
expiratory	O
collapse	O
and	O
reexpansion	O
contributes	O
to	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

To	O
address	O
the	O
role	O
of	O
Ron	O
in	O
ALI	O
,	O
the	O
response	O
of	O
mice	O
deficient	O
in	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
of	O
Ron	O
(	O
Ron	O
tk	O
-/-)	O
were	O
assessed	O
in	O
response	O
to	O
nickel	O
exposure	O
.	O

The	O
Oligo	O
data	O
table	O
contains	O
PCR	O
primers	O
and	O
hybridization	O
probes	O
used	O
for	O
detection	O
of	O
viral	O
nucleic	B-ANAT
acids	O
and	O
the	O
Common	O
data	O
table	O
contains	O
the	O
experimental	O
conditions	O
used	O
in	O
their	O
detection	O
.	O

ABSTRACT	O
:	O
A	O
74	O
-	O
year	O
-	O
old	O
woman	O
was	O
admitted	O
to	O
our	O
hospital	O
because	O
of	O
interstitial	B-ANAT
pneumonia	O
.	O

In	O
conclusion	O
,	O
LD	O
systemic	O
heparin	O
(	O
ACT	O
<	O
200s	O
)	O
with	O
a	O
heparin	O
-	O
coated	O
oxygenator	O
does	O
not	O
increase	O
thrombogenicity	O
during	O
AVCO2R	O
for	O
smoke	O
/	O
burn	O
-	O
induced	O
severe	O
lung	B-ANAT
injury	O
in	O
sheep	O
.	O

Histopathology	O
reveals	O
surfactant	O
disruption	O
,	O
epithelial	O
perturbation	O
and	O
sepsis	O
,	O
either	O
as	O
initiating	O
factors	O
or	O
as	O
secondary	O
complications	O
,	O
which	O
in	O
turn	O
increase	O
the	O
expression	O
of	O
cytokines	O
that	O
sequester	O
and	O
activate	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
most	O
notably	O
,	O
neutrophils	B-ANAT
.	O

Stool	B-ANAT
and	O
serum	B-ANAT
samples	O
were	O
analysed	O
for	O
RV	O
and	O
bovine	O
CV	O
antigen	O
and	O
antibody	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

TITLE	O
:	O
[	O
Effect	O
of	O
severe	O
multiple	O
trauma	O
complicated	O
by	O
acute	O
lung	B-ANAT
injury	O
on	O
endothelial	B-ANAT
cell	I-ANAT
activity	O
].	O

At	O
the	O
admission	O
,	O
significant	O
correlation	O
between	O
plasma	B-ANAT
vWF	O
:	O
Ag	O
and	O
ISS	O
was	O
found	O
(	O
Rs	O
=	O
0	O
.	O
568	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Among	O
these	O
,	O
neutrophil	B-ANAT
elastase	O
inhibitors	O
have	O
shown	O
the	O
most	O
promise	O
and	O
are	O
currently	O
undergoing	O
Phase	O
III	O
trials	O
.	O

These	O
results	O
indicated	O
that	O
the	O
binding	O
of	O
soMHVR	O
to	O
the	O
S	O
protein	O
expressed	O
on	O
the	O
DBT	O
cell	B-ANAT
surface	I-ANAT
potentiates	O
the	O
fusion	O
of	O
MHV	O
-	O
infected	O
DBT	O
cells	B-ANAT
with	O
nonpermissive	O
BHK	O
cells	B-ANAT
.	O

We	O
conclude	O
that	O
the	O
binding	O
of	O
soMHVR	O
to	O
the	O
S	O
protein	O
converts	O
the	O
S	O
protein	O
to	O
a	O
fusion	O
-	O
active	O
form	O
competent	O
to	O
mediate	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
,	O
in	O
a	O
fashion	O
similar	O
to	O
the	O
fusion	O
of	O
virus	O
and	O
cell	B-ANAT
membranes	I-ANAT
.	O

However	O
,	O
an	O
N	O
-	O
terminal	O
truncation	O
containing	O
only	O
the	O
cytoplasmic	B-ANAT
domain	I-ANAT
(	O
CTE	O
)	O
was	O
efficiently	O
localized	O
to	O
the	O
Golgi	B-ANAT
complex	I-ANAT
,	O
and	O
this	O
domain	O
could	O
retain	O
a	O
reporter	O
protein	O
in	O
the	O
Golgi	B-ANAT
.	O

This	O
suggests	O
that	O
IBV	O
E	O
is	O
associated	O
with	O
the	O
Golgi	B-ANAT
matrix	O
through	O
interactions	O
of	O
its	O
cytoplasmic	B-ANAT
tail	I-ANAT
and	O
may	O
have	O
interesting	O
implications	O
for	O
coronavirus	O
assembly	O
in	O
early	O
Golgi	B-ANAT
compartments	B-ANAT
.	O

Following	O
transfection	O
of	O
baby	O
hamster	O
kidney	B-ANAT
(	O
BHK	O
)	O
cells	B-ANAT
,	O
a	O
recombinant	O
TGEV	O
(	O
TGEV	O
-	O
GFP2	O
)	O
was	O
isolated	O
that	O
replicated	O
efficiently	O
and	O
expressed	O
GFP	O
.	O

Under	O
identical	O
conditions	O
,	O
TGEV	O
-	O
GFP2	O
spread	O
throughout	O
ST	O
cell	B-ANAT
cultures	O
,	O
expressed	O
GFP	O
,	O
and	O
formed	O
viral	O
plaques	O
.	O

TITLE	O
:	O
The	O
cell	B-ANAT
biology	O
of	O
coronavirus	O
infection	O
.	O

By	O
combining	O
these	O
approaches	O
with	O
available	O
biochemical	O
and	O
molecular	O
biological	O
approaches	O
and	O
the	O
emerging	O
reverse	O
genetic	O
and	O
recombinant	O
genetic	O
approaches	O
,	O
rapid	O
progress	O
in	O
understanding	O
the	O
details	O
of	O
coronavirus	O
-	O
cell	B-ANAT
interactions	O
should	O
be	O
possible	O
.	O

Proliferation	O
of	O
lung	B-ANAT
macrophages	B-ANAT
was	O
associated	O
with	O
systemic	O
proliferation	O
of	O
macrophages	B-ANAT
.	O

A	O
one	O
-	O
step	O
reverse	O
transcription	O
(	O
RT	O
)-	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
targeting	O
a	O
730	O
-	O
base	O
pair	O
fragment	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
of	O
BCV	O
and	O
a	O
nested	O
PCR	O
targeting	O
a	O
407	O
-	O
base	O
pair	O
fragment	O
of	O
the	O
N	O
gene	O
were	O
used	O
in	O
an	O
attempt	O
to	O
detect	O
TOCV	O
from	O
North	O
Carolina	O
,	O
Indiana	O
,	O
and	O
a	O
prototype	O
turkey	O
coronavirus	O
(	O
TCV	O
)	O
obtained	O
from	O
the	O
American	O
Type	O
Culture	O
Collection	O
.	O

These	O
primers	O
amplified	O
a	O
1082	O
-	O
base	O
pair	O
region	O
spanning	O
portions	O
of	O
the	O
membrane	B-ANAT
glycoprotein	O
(	O
M	O
)	O
and	O
N	O
protein	O
genes	O
of	O
IBV	O
and	O
TCV	O
.	O

ABSTRACT	O
:	O
Patient	O
A	O
who	O
was	O
exposed	O
to	O
a	O
critical	O
dose	O
of	O
radiation	O
developed	O
skin	B-ANAT
lesions	O
throughout	O
the	O
body	B-ANAT
surface	O
,	O
gastrointestinal	O
disorder	O
with	O
massive	O
diarrhea	O
and	O
prominent	O
bleeding	O
,	O
which	O
caused	O
severe	O
loss	O
in	O
body	B-ANAT
fluids	I-ANAT
.	O

However	O
,	O
a	O
very	O
recent	O
calculation	O
showed	O
that	O
the	O
absorbed	O
skin	B-ANAT
dose	O
was	O
highest	O
at	O
the	O
upper	O
-	O
right	O
abdomen	B-ANAT
reaching	O
61	O
.	O
8	O
Gy	O
(	O
27	O
.	O
0	O
as	O
neutron	O
plus	O
34	O
.	O
8	O
Gy	O
as	O
y	O
-	O
ray	O
).	O

RESULTS	O
:	O
After	O
2	O
or	O
6	O
hours	O
of	O
LPS	O
intravenous	O
administration	O
,	O
severe	O
lung	B-ANAT
injury	O
and	O
positive	O
signals	O
of	O
NT	O
occurred	O
with	O
the	O
latter	O
located	O
in	O
the	O
pulmonary	B-ANAT
macrophages	I-ANAT
,	O
endothelia	O
,	O
subendothelial	O
and	O
muscular	B-ANAT
layers	B-ANAT
of	O
the	O
pulmonary	B-ANAT
artery	I-ANAT
.	O

Administration	O
of	O
exogenous	O
ONOO	O
(-)	O
caused	O
dose	O
-	O
dependent	O
increase	O
in	O
LC	O
,	O
W	O
/	O
D	O
,	O
ater	O
and	O
EB	O
contents	O
and	O
in	O
the	O
number	O
of	O
MB	O
-	O
labelled	O
blood	B-ANAT
vessels	I-ANAT
in	O
rat	O
lungs	B-ANAT
,	O
together	O
with	O
significant	O
pathological	O
alterations	O
such	O
as	O
diffuse	O
alveolar	B-ANAT
collapse	O
,	O
capillary	B-ANAT
congestion	O
in	O
the	O
septa	O
and	O
focal	O
hemorrhage	O
.	O

Instead	O
,	O
we	O
find	O
the	O
evidence	O
far	O
from	O
compelling	O
,	O
and	O
would	O
advise	O
withholding	O
thyroid	B-ANAT
hormone	O
therapy	O
in	O
the	O
critical	O
care	O
setting	O
in	O
the	O
absence	O
of	O
clear	O
clinical	O
or	O
laboratory	O
evidence	O
for	O
hypothyroidism	O
.	O

There	O
is	O
consensus	O
that	O
severe	O
maternal	O
hypertension	O
(	O
blood	B-ANAT
pressure	O
>	O
or	O
=	O
170	O
/	O
110	O
mmHg	O
)	O
should	O
be	O
treated	O
to	O
minimize	O
the	O
risk	O
of	O
acute	O
cerebrovascular	O
complications	O
.	O

The	O
disease	O
progressed	O
rapidly	O
and	O
all	O
patients	O
died	O
within	O
24	O
-	O
48	O
hours	O
after	O
admission	O
from	O
complications	O
such	O
as	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
),	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

In	O
late	O
convalescence	O
one	O
could	O
observe	O
affections	O
of	O
the	O
heart	B-ANAT
,	O
liver	B-ANAT
,	O
kidneys	B-ANAT
,	O
bones	B-ANAT
,	O
nervous	B-ANAT
system	I-ANAT
,	O
eyes	B-ANAT
.	O

Because	O
anti	O
-	O
JO1	O
antibody	O
is	O
considered	O
to	O
be	O
a	O
marker	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
in	O
polymyositis	O
/	O
dermatomyositis	O
,	O
close	O
pulmonary	B-ANAT
follow	O
-	O
up	O
of	O
anti	O
-	O
JO1	O
-	O
positive	O
patients	O
with	O
polymyositis	O
is	O
therefore	O
required	O
for	O
early	O
detection	O
of	O
subclinical	O
impairment	O
.	O

ABSTRACT	O
:	O
A	O
major	O
goal	O
in	O
gene	O
therapy	O
is	O
to	O
develop	O
efficient	O
gene	O
transfer	O
protocols	O
that	O
allow	O
tissue	B-ANAT
-	O
specific	O
,	O
long	O
-	O
term	O
and	O
tightly	O
regulated	O
expression	O
of	O
the	O
desired	O
transgene	O
.	O

Mice	O
injected	O
with	O
HD	O
-	O
TET	O
-	O
IFN	O
showed	O
high	O
levels	O
of	O
serum	B-ANAT
mIFN	O
(	O
alpha	O
)	O
only	O
upon	O
transcriptional	O
activation	O
.	O

IgA	O
and	O
IgG	O
ASC	O
responses	O
were	O
evident	O
in	O
the	O
intestinal	B-ANAT
lymphoid	B-ANAT
tissues	I-ANAT
from	O
PID	O
21	O
,	O
the	O
highest	O
number	O
of	O
specific	O
ASC	O
corresponded	O
to	O
the	O
duodenum	B-ANAT
lamina	B-ANAT
propria	I-ANAT
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
(	O
HCoV	O
)	O
accounts	O
for	O
15	O
-	O
30	O
%	O
of	O
common	O
colds	O
,	O
but	O
only	O
one	O
case	O
report	O
has	O
described	O
the	O
effect	O
of	O
a	O
coronavirus	O
infection	O
,	O
that	O
was	O
asymptomatic	O
,	O
on	O
human	O
respiratory	B-ANAT
epithelium	I-ANAT
.	O

All	O
subjects	O
inoculated	O
with	O
HCoV	O
,	O
including	O
the	O
three	O
who	O
did	O
not	O
develop	O
symptoms	O
of	O
an	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
had	O
disruption	O
of	O
their	O
respiratory	B-ANAT
epithelium	I-ANAT
on	O
day	O
3	O
.	O

TITLE	O
:	O
Acute	O
hyperoxic	O
lung	B-ANAT
injury	O
does	O
not	O
impede	O
adenoviral	O
-	O
mediated	O
alveolar	B-ANAT
gene	O
transfer	O
.	O

X	O
-	O
gal	O
staining	O
72	O
h	O
postinfection	O
revealed	O
transgene	O
expression	O
in	O
all	O
segments	O
of	O
room	O
air	O
control	O
and	O
hyperoxic	O
lungs	B-ANAT
infected	O
with	O
either	O
dose	O
of	O
adbeta	O
-	O
gal	O
.	O

However	O
,	O
hyperoxia	O
causes	O
lung	B-ANAT
damage	O
in	O
experimental	O
animals	O
and	O
may	O
do	O
so	O
in	O
humans	O
.	O

Cytochrome	O
P4501A	O
enzymes	O
have	O
been	O
implicated	O
in	O
hyperoxic	O
lung	B-ANAT
injury	O
.	O

Furthermore	O
,	O
the	O
whole	O
viral	O
antigen	O
detects	O
all	O
antibodies	O
against	O
the	O
viral	O
structural	O
proteins	O
,	O
including	O
spike	O
(	O
S	O
),	O
nucleocapsid	B-ANAT
,	O
matrix	O
,	O
and	O
other	O
proteins	O
.	O

1143	O
-	O
1665	O
)	O
was	O
cloned	O
into	O
pRSET	O
vectors	O
and	O
transformed	O
into	O
competent	O
Escherichia	O
coli	O
(	O
E	O
.	O
coli	O
)	O
BL21	B-ANAT
(	O
DE3	O
).	O

ABSTRACT	O
:	O
To	O
study	O
the	O
effect	O
of	O
premature	O
rupture	O
of	O
membranes	B-ANAT
and	O
oligohydramnios	O
before	O
20	O
weeks	O
of	O
gestation	O
(	O
PROM20	O
)	O
on	O
acute	O
respiratory	O
morbidity	O
and	O
on	O
short	O
-	O
term	O
outcome	O
in	O
infants	O
with	O
a	O
gestational	O
age	O
>	O
or	O
=	O
24	O
weeks	O
.	O

All	O
the	O
pigs	O
from	O
a	O
control	O
group	O
,	O
not	O
previously	O
exposed	O
to	O
the	O
virus	O
,	O
excreted	O
the	O
virus	O
in	O
faeces	B-ANAT
.	O

In	O
addition	O
,	O
the	O
IgA	O
and	O
IgG	O
ASC	O
responses	O
detected	O
in	O
the	O
blood	B-ANAT
on	O
PID	O
21	O
also	O
correlated	O
with	O
the	O
responses	O
found	O
in	O
the	O
gut	B-ANAT
associated	O
lymphoid	B-ANAT
tissues	I-ANAT
.	O

Stated	O
another	O
way	O
,	O
there	O
is	O
probably	O
no	O
single	O
value	O
for	O
arterial	B-ANAT
P	O
(	O
CO2	O
),	O
pH	O
,	O
or	O
P	O
(	O
O2	O
)	O
that	O
by	O
itself	O
constitutes	O
an	O
indication	O
for	O
IPPV	O
.	O

However	O
,	O
IPPV	O
has	O
not	O
proven	O
to	O
be	O
beneficial	O
in	O
traumatic	O
brain	B-ANAT
injury	O
and	O
flail	O
chest	B-ANAT
,	O
in	O
the	O
absence	O
of	O
other	O
indications	O
.	O

It	O
appears	O
that	O
lead	O
exposure	O
during	O
different	O
stages	O
of	O
embryonic	B-ANAT
development	O
is	O
likely	O
to	O
result	O
in	O
different	O
immunotoxic	O
outcomes	O
in	O
juveniles	O
.	O

While	O
cellular	B-ANAT
immunity	O
initially	O
eliminates	O
infectious	O
virus	O
,	O
CNS	B-ANAT
viral	O
persistence	O
is	O
predominantly	O
controlled	O
by	O
humoral	O
immunity	O
.	O

Serum	B-ANAT
antiviral	O
Ab	O
and	O
CNS	B-ANAT
virus	O
-	O
specific	O
ASC	O
became	O
prominent	O
only	O
during	O
final	O
elimination	O
of	O
infectious	O
virus	O
.	O

Following	O
elimination	O
of	O
infectious	O
virus	O
,	O
virus	O
-	O
specific	O
ASC	O
continued	O
to	O
increase	O
within	O
the	O
CNS	B-ANAT
and	O
then	O
remained	O
stable	O
during	O
persistence	O
,	O
in	O
contrast	O
to	O
declining	O
T	B-ANAT
cell	I-ANAT
numbers	O
.	O

Rapid	O
recruitment	O
of	O
B	B-ANAT
cells	I-ANAT
in	O
the	O
absence	O
of	O
specific	O
Ab	O
secretion	B-ANAT
supports	O
a	O
potential	O
Ab	O
-	O
independent	O
effector	O
function	O
involving	O
lysis	O
of	O
virus	O
-	O
infected	O
cells	B-ANAT
.	O

Lastly	O
,	O
altered	O
antiviral	O
ASC	O
specificities	O
following	O
clearance	O
of	O
infectious	O
virus	O
suggest	O
ongoing	O
recruitment	O
of	O
peripheral	O
memory	B-ANAT
cells	I-ANAT
and	O
/	O
or	O
local	O
B	B-ANAT
cell	I-ANAT
differentiation	O
.	O

Historically	O
this	O
clinical	O
entity	O
has	O
stimulated	O
the	O
production	O
of	O
numerous	O
valuable	O
contributions	O
with	O
one	O
purpose	O
in	O
mind	O
:	O
the	O
improvement	O
of	O
airway	B-ANAT
permeability	O
.	O

Severe	O
pneumonia	O
was	O
induced	O
by	O
alveolar	B-ANAT
instillation	O
of	O
live	O
Pseudomonas	O
aeruginosa	O
(	O
1	O
.	O
5	O
x	O
10	O
(	O
8	O
)	O
colony	O
-	O
forming	O
units	O
/	O
kg	O
)	O
in	O
rats	O
.	O

However	O
,	O
neither	O
protein	O
concentration	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
nor	O
mortality	O
rates	O
were	O
modified	O
by	O
nitric	O
oxide	O
inhalation	O
.	O

ABSTRACT	O
:	O
Transfusion	O
Related	O
Acute	O
Lung	B-ANAT
Injury	O
(	O
TRALI	O
)	O
is	O
the	O
most	O
serious	O
,	O
potentially	O
lethal	O
,	O
transfusion	O
reaction	O
caused	O
by	O
anti	O
leukocyte	B-ANAT
antibodies	O
carried	O
passively	O
into	O
recipient	O
'	O
s	O
circulation	O
by	O
transfused	O
haemoproduct	O
.	O

These	O
results	O
indicate	O
that	O
blocking	O
of	O
specific	O
endothelial	B-ANAT
antigens	O
by	O
GOX	O
immunotargeting	O
modulates	O
important	O
pathological	O
features	O
of	O
the	O
lung	B-ANAT
injury	O
initiated	O
by	O
local	O
generation	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
and	O
that	O
this	O
approach	O
provides	O
specific	O
and	O
robust	O
models	O
of	O
diverse	O
variants	O
of	O
human	O
ALI	O
/	O
ARDS	O
in	O
mice	O
.	O

These	O
integral	O
membrane	B-ANAT
proteins	O
assemble	O
within	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
of	O
infected	O
cells	B-ANAT
and	O
are	O
subsequently	O
endoproteolyzed	O
in	O
the	O
Golgi	B-ANAT
,	O
generating	O
noncovalently	O
associated	O
S1	O
and	O
S2	O
fragments	O
.	O

Pharmacodynamics	O
of	O
iNO	O
in	O
this	O
model	O
was	O
related	O
to	O
improvement	O
in	O
gas	O
exchange	O
,	O
Cdyn	O
,	O
PVRI	O
,	O
and	O
suppression	O
of	O
proinflammatory	O
cytokine	O
expression	O
in	O
the	O
lungs	B-ANAT
,	O
and	O
its	O
adverse	O
effect	O
was	O
mainly	O
confined	O
to	O
MetHb	O
at	O
higher	O
NO	O
dose	O
.	O

Nucleotide	O
sequencing	O
was	O
performed	O
directly	O
on	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
products	O
amplified	O
by	O
reverse	O
transcription	O
(	O
RT	O
)	O
and	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analysis	O
from	O
fecal	B-ANAT
samples	O
or	O
isolated	O
viruses	O
.	O

TITLE	O
:	O
Extracorporeal	B-ANAT
blood	I-ANAT
detoxification	O
by	O
sorbents	O
in	O
treatment	O
of	O
hepatic	B-ANAT
encephalopathy	O
.	O

ABSTRACT	O
:	O
Extracorporeal	B-ANAT
blood	I-ANAT
detoxification	O
by	O
sorbent	O
therapy	O
long	O
has	O
been	O
applied	O
in	O
treatment	O
of	O
hepatic	B-ANAT
failure	O
and	O
encephalopathy	O
,	O
starting	O
with	O
hemoperfusion	O
columns	O
and	O
more	O
recently	O
with	O
the	O
currently	O
marketed	O
Liver	B-ANAT
Dialysis	O
Unit	O
.	O

Clinical	O
results	O
of	O
daily	O
MARS	O
treatments	O
of	O
patients	O
with	O
hepatic	B-ANAT
failure	O
are	O
similar	O
to	O
that	O
of	O
Liver	B-ANAT
Dialysis	O
,	O
with	O
neurologic	O
and	O
physical	O
improvement	O
occurs	O
in	O
most	O
patients	O
with	O
AHE	O
,	O
and	O
improved	O
outcome	O
for	O
patients	O
with	O
A	O
-	O
on	O
-	O
C	O
.	O
The	O
system	O
extends	O
the	O
life	O
of	O
patients	O
with	O
hepatorenal	O
syndrome	O
.	O

Treatments	O
appeared	O
to	O
be	O
safe	O
and	O
resulted	O
in	O
marked	O
decreases	O
in	O
plasma	B-ANAT
levels	O
of	O
bilirubin	O
,	O
aromatic	O
amino	O
acids	O
,	O
ammonium	O
,	O
creatinine	O
,	O
and	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
).	O

ABSTRACT	O
:	O
Most	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
strains	O
,	O
as	O
their	O
name	O
suggests	O
,	O
infect	O
the	O
liver	B-ANAT
.	O

The	O
CNS	B-ANAT
demyelination	O
shares	O
pathological	O
similarities	O
with	O
human	O
CNS	B-ANAT
demyelinating	O
diseases	O
such	O
as	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

These	O
viruses	O
are	O
,	O
therefore	O
,	O
used	O
to	O
study	O
the	O
role	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
in	O
viral	O
clearance	O
from	O
the	O
CNS	B-ANAT
,	O
in	O
CNS	B-ANAT
demyelination	O
,	O
and	O
in	O
remyelination	O
.	O

Mutagenesis	O
was	O
also	O
used	O
to	O
investigate	O
cleavage	O
between	O
Gly	O
-	O
904	O
and	O
Val	O
-	O
905	O
,	O
a	O
cleavage	O
site	O
predicted	O
to	O
produce	O
a	O
precursor	O
of	O
p65	O
,	O
p72	O
,	O
that	O
was	O
detected	O
in	O
cells	B-ANAT
infected	O
with	O
MHV	O
strain	O
JHM	O
,	O
but	O
not	O
with	O
MHV	O
-	O
A59	O
.	O

Ischemia	O
of	O
central	O
chemoreceptors	B-ANAT
or	O
integration	O
of	O
their	O
informations	O
could	O
be	O
one	O
of	O
mechanism	O
.	O

ABSTRACT	O
:	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
is	O
a	O
syndrome	O
that	O
includes	O
dyspnea	O
,	O
hypotension	O
,	O
bilateral	O
pulmonary	B-ANAT
edema	O
,	O
and	O
fever	O
.	O

The	O
M	O
protein	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
is	O
an	O
integral	O
membrane	B-ANAT
protein	O
with	O
a	O
short	O
ectodomain	O
,	O
three	O
transmembrane	B-ANAT
segments	O
,	O
and	O
a	O
large	O
carboxy	O
-	O
terminal	O
endodomain	O
facing	O
the	O
interior	O
of	O
the	O
viral	B-ANAT
envelope	I-ANAT
.	O

It	O
concerns	O
patients	O
presenting	O
with	O
a	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
and	O
often	O
sepsis	O
.	O

Here	O
we	O
report	O
the	O
crystal	B-ANAT
structure	O
of	O
soluble	O
murine	O
sCEACAM1a	O
[	O
1	O
,	O
4	O
],	O
which	O
is	O
composed	O
of	O
two	O
Ig	O
-	O
like	O
domains	O
and	O
has	O
MHV	O
neutralizing	O
activity	O
.	O

Antigen	O
and	O
nucleic	B-ANAT
acid	O
of	O
PEDV	O
were	O
detected	O
in	O
15	O
/	O
15	O
,	O
13	O
/	O
15	O
,	O
and	O
14	O
/	O
15	O
of	O
the	O
intestinal	B-ANAT
and	O
fecal	B-ANAT
samples	O
from	O
the	O
PEDV	O
-	O
inoculated	O
pigs	O
by	O
RT	O
-	O
PCR	O
,	O
immunohistochemistry	O
,	O
and	O
in	O
situ	O
hybridization	O
,	O
respectively	O
.	O

Purified	O
fgl2	O
protein	O
generated	O
in	O
a	O
baculovirus	O
expression	O
system	O
had	O
no	O
measurable	O
prothrombinase	O
activity	O
,	O
whereas	O
the	O
activity	O
was	O
restored	O
when	O
the	O
purified	O
protein	O
was	O
reconstituted	O
into	O
phosphatidyl	O
-	O
L	O
-	O
serine	O
-	O
containing	O
vesicles	B-ANAT
.	O

The	O
relationship	O
between	O
inflammatory	O
bowel	B-ANAT
syndrome	O
and	O
inflammatory	O
demyelinating	O
polyneuropathy	O
is	O
discussed	O
.	O

TITLE	O
:	O
Five	O
-	O
year	O
experience	O
in	O
aortic	B-ANAT
root	I-ANAT
replacement	O
with	O
the	O
flanged	O
composite	O
graft	B-ANAT
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
5	O
-	O
year	O
experience	O
with	O
the	O
composite	O
root	B-ANAT
replacement	O
using	O
our	O
new	O
modification	O
of	O
the	O
Bentall	O
technique	O
.	O

The	O
causes	O
of	O
hospital	O
mortality	O
were	O
severe	O
bleeding	O
(	O
3	O
patients	O
),	O
low	O
cardiac	B-ANAT
output	O
syndrome	O
(	O
2	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
2	O
)	O
and	O
cerebrovascular	O
event	O
(	O
1	O
).	O

Nasal	B-ANAT
samples	O
were	O
obtained	O
by	O
cytological	O
brush	O
at	O
admission	O
and	O
weekly	O
thereafter	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
occurs	O
most	O
frequently	O
in	O
the	O
setting	O
of	O
sepsis	O
,	O
aspiration	O
of	O
gastric	B-ANAT
contents	I-ANAT
,	O
trauma	O
,	O
or	O
multiple	O
transfusions	O
.	O

ABSTRACT	O
:	O
Analyses	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
(	O
MAPKs	O
)	O
in	O
a	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)-	O
infected	O
macrophage	B-ANAT
-	O
derived	O
J774	O
.	O
1	O
cell	B-ANAT
line	I-ANAT
showed	O
activation	O
of	O
two	O
MAPKs	O
,	O
p38	O
MAPK	O
and	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
),	O
but	O
not	O
of	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
).	O

TITLE	O
:	O
Binding	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	O
to	O
cell	B-ANAT
surface	I-ANAT
sialoglycoproteins	O
.	O

On	O
the	O
other	O
hand	O
,	O
binding	O
to	O
the	O
sialic	O
acid	O
residues	O
of	O
the	O
high	O
-	O
molecular	O
-	O
mass	O
glycoprotein	O
was	O
observed	O
regardless	O
of	O
whether	O
the	O
cellular	B-ANAT
proteins	O
had	O
been	O
separated	O
under	O
reducing	O
or	O
nonreducing	O
conditions	O
.	O

TITLE	O
:	O
Membrane	B-ANAT
association	O
and	O
dimerization	O
of	O
a	O
cysteine	O
-	O
rich	O
,	O
16	O
-	O
kilodalton	O
polypeptide	O
released	O
from	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
1a	O
polyprotein	O
.	O

Indirect	O
immunofluorescence	O
demonstrated	O
that	O
the	O
protein	O
exhibits	O
a	O
distinct	O
perinuclear	O
punctate	O
staining	O
pattern	O
,	O
suggesting	O
that	O
it	O
is	O
associated	O
with	O
cellular	B-ANAT
membranes	B-ANAT
.	O

Surfactant	O
treatment	O
resulted	O
in	O
a	O
marked	O
increase	O
in	O
the	O
lavagable	O
phospholipid	O
(	O
PL	O
)	O
pool	O
,	O
but	O
predominance	O
of	O
the	O
alveolar	B-ANAT
surfactant	O
-	O
inhibitory	O
protein	O
load	O
was	O
still	O
encountered	O
.	O

TITLE	O
:	O
A	O
pilot	O
study	O
comparing	O
percutaneous	O
decompression	O
with	O
decompressive	O
laparotomy	O
for	O
acute	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
in	O
thermal	O
injury	O
.	O

Direct	O
laryngoscopic	O
findings	O
included	O
arytenoid	B-ANAT
edema	O
,	O
postcricoid	B-ANAT
ulceration	O
and	O
bilateral	O
vocal	B-ANAT
cord	I-ANAT
paralysis	O
in	O
adduction	O
.	O

Following	O
the	O
repeated	O
passage	O
of	O
these	O
mutants	O
through	O
BHK	O
-	O
R2	O
cells	B-ANAT
,	O
viruses	O
were	O
no	O
longer	O
isolated	O
from	O
srr11	O
-	O
infected	O
cells	B-ANAT
,	O
while	O
two	O
distinct	O
mutants	O
,	O
srr7A	O
and	O
srr7B	O
,	O
were	O
obtained	O
from	O
srr7	O
-	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
[	O
Atypical	O
presentation	O
of	O
acute	O
myeloblastic	B-ANAT
leukemia	O
in	O
two	O
pediatric	O
patients	O
].	O

3	O
.	O
7	O
and	O
the	O
Murray	O
lung	B-ANAT
injury	O
score	O
was	O
2	O
.	O
65	O
+/-	O
0	O
.	O
9	O
.	O

The	O
only	O
complications	O
of	O
IPP	O
were	O
one	O
case	O
of	O
partial	O
-	O
thickness	O
skin	B-ANAT
loss	O
from	O
a	O
malpositioned	O
nasogastric	B-ANAT
tube	O
and	O
a	O
case	O
of	O
transient	O
lingual	B-ANAT
edema	O
.	O

However	O
,	O
even	O
severe	O
cases	O
can	O
recover	O
from	O
hypoxia	O
after	O
liver	B-ANAT
transplantation	O
,	O
and	O
improved	O
survival	O
data	O
were	O
reported	O
in	O
the	O
1990s	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
following	O
epididymitis	O
.	O

Blood	B-ANAT
chemistry	O
data	O
showed	O
severe	O
inflammatory	O
findings	O
.	O

In	O
conclusion	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
patients	O
with	O
SIRS	O
should	O
undergo	O
further	O
examinations	O
of	O
septic	O
shock	O
immediately	O
and	O
resection	O
of	O
the	O
causative	O
tissue	B-ANAT
should	O
be	O
performed	O
as	O
soon	O
as	O
possible	O
.	O

The	O
individual	O
SNAP	O
items	O
that	O
contributed	O
most	O
to	O
SNAP	O
moderate	O
and	O
severe	O
categories	O
were	O
blood	B-ANAT
gas	O
items	O
,	O
creatinine	O
,	O
urine	B-ANAT
output	O
,	O
blood	B-ANAT
glucose	O
,	O
and	O
seizures	O
.	O

AE	O
lesions	O
were	O
identified	O
by	O
light	O
microscopy	O
in	O
Giemsa	O
-	O
stained	O
intestines	B-ANAT
from	O
7	O
of	O
12	O
PEMS	O
-	O
affected	O
turkey	O
flocks	O
.	O

The	O
remaining	O
two	O
isolates	O
,	O
N	O
-	O
M24	O
and	O
N	O
-	O
M39	O
,	O
that	O
did	O
not	O
react	O
with	O
Mass	O
-	O
specific	O
Mab	O
,	O
resisted	O
neutralization	O
by	O
Mass	O
-	O
specific	O
chicken	O
serum	B-ANAT
,	O
and	O
were	O
neutralized	O
only	O
by	O
homologous	O
chicken	O
antibody	O
were	O
identified	O
as	O
non	O
-	O
Mass	O
IBV	O
.	O

The	O
second	O
patient	O
was	O
a	O
64	O
-	O
year	O
-	O
old	O
ASA	O
II	O
man	O
scheduled	O
for	O
abdominal	B-ANAT
surgery	O
.	O

TITLE	O
:	O
Dietary	O
arginine	O
intake	O
alters	O
avian	O
leukocyte	B-ANAT
population	O
distribution	O
during	O
infectious	O
bronchitis	O
challenge	O
.	O

In	O
this	O
study	O
,	O
the	O
effects	O
of	O
dietary	O
arginine	O
on	O
leukocyte	B-ANAT
population	O
changes	O
were	O
examined	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
and	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
chickens	O
inoculated	O
with	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
strain	O
M41	O
.	O

This	O
article	O
will	O
provide	O
an	O
overview	O
on	O
how	O
these	O
molecules	O
regulate	O
T	B-ANAT
cell	I-ANAT
and	O
macrophage	B-ANAT
trafficking	O
into	O
the	O
CNS	B-ANAT
of	O
MHV	O
-	O
infected	O
mice	O
and	O
illustrate	O
the	O
delicate	O
balance	O
that	O
exists	O
with	O
regards	O
to	O
expression	O
of	O
chemokines	O
and	O
their	O
receptors	O
as	O
it	O
relates	O
to	O
both	O
host	O
defense	O
and	O
disease	O
development	O
.	O

ABSTRACT	O
:	O
The	O
obesity	O
-	O
hypoventilation	O
syndrome	O
(	O
or	O
alveolar	B-ANAT
hypoventilation	O
in	O
the	O
obese	O
)	O
is	O
a	O
new	O
name	O
for	O
an	O
old	O
syndrome	O
,	O
Pickwickian	O
syndrome	O
.	O

It	O
is	O
defined	O
as	O
chronic	O
alveolar	B-ANAT
hypoventilation	O
(	O
PaO	O
(	O
2	O
)<	O
70	O
mmHg	O
,	O
PaCO	O
(	O
2	O
)	O
>	O
45	O
mmHg	O
)	O
in	O
obese	O
patient	O
with	O
a	O
body	B-ANAT
mass	O
index	O
>	O
30	O
kg	O
/	O
m	O
(	O
2	O
)	O
who	O
have	O
no	O
other	O
respiratory	O
disease	O
explaining	O
the	O
gas	O
anomalies	O
.	O

There	O
are	O
three	O
principal	O
causes	O
explaining	O
alveolar	B-ANAT
hypoventilation	O
in	O
obese	O
subjects	O
:	O
high	O
cost	O
of	O
the	O
work	O
of	O
respiration	O
,	O
dysfunction	O
of	O
the	O
respiratory	B-ANAT
centers	I-ANAT
,	O
repeated	O
episodes	O
of	O
nocturnal	O
obstructive	O
apnea	O
.	O

Associated	O
diseases	O
favored	O
by	O
obesity	O
are	O
frequent	O
:	O
diabetes	O
,	O
high	O
blood	B-ANAT
pressure	O
,	O
heart	B-ANAT
disease	O
.	O

The	O
kinetics	O
of	O
virus	O
-	O
specific	O
IgA	B-ANAT
antibody	I-ANAT
responses	O
in	O
duodenum	B-ANAT
,	O
jejunum	B-ANAT
,	O
and	O
ileum	B-ANAT
were	O
similar	O
:	O
gradually	O
increased	O
from	O
1	O
week	O
PI	O
,	O
reached	O
the	O
peak	O
at	O
3	O
or	O
4	O
weeks	O
PI	O
,	O
and	O
declined	O
afterward	O
.	O

The	O
results	O
indicate	O
that	O
intestinal	B-ANAT
mucosal	B-ANAT
IgA	O
antibodies	O
to	O
TCV	O
are	O
elicited	O
in	O
turkeys	O
following	O
infection	O
with	O
TCV	O
.	O

Differentiation	O
of	O
turkey	O
anti	O
-	O
TCoV	O
antiserum	O
from	O
normal	O
turkey	O
serum	B-ANAT
was	O
better	O
achieved	O
by	O
ELISA	O
plates	O
coated	O
with	O
TCoV	O
preparation	O
purified	O
by	O
size	O
-	O
exclusion	O
chromatography	O
than	O
that	O
purified	O
by	O
sucrose	O
density	O
gradient	O
.	O

Here	O
,	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
33	O
.	O
1	O
kDa	O
transmissible	O
gastroenteritis	O
(	O
corona	O
)	O
virus	O
M	O
(	O
pro	O
)	O
is	O
reported	O
.	O

Increased	O
induction	O
of	O
MMP	O
,	O
TIMP	O
,	O
and	O
chemokine	O
expression	O
correlated	O
with	O
increased	O
virus	O
replication	O
but	O
not	O
with	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
.	O

We	O
fitted	O
one	O
side	O
of	O
a	O
double	O
-	O
sided	O
72	O
-	O
cage	O
rack	O
with	O
valves	B-ANAT
external	O
to	O
each	O
cage	O
;	O
cages	O
on	O
the	O
other	O
side	O
were	O
fitted	O
with	O
shielded	O
internal	O
valves	B-ANAT
.	O

At	O
8	O
weeks	O
post	O
-	O
infection	O
,	O
mice	O
in	O
one	O
uninoculated	O
cage	O
(	O
which	O
had	O
a	O
filter	O
top	O
and	O
an	O
internal	O
valve	B-ANAT
and	O
was	O
adjacent	O
to	O
a	O
cage	O
of	O
inoculated	O
mice	O
)	O
was	O
seropositive	O
.	O

Cytoalbuminous	O
dissociation	O
was	O
seen	O
in	O
the	O
cerebrospinal	B-ANAT
fluid	I-ANAT
.	O

Peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cell	I-ANAT
(	O
PBMC	O
)	O
MIF	O
expression	O
was	O
determined	O
by	O
flow	O
-	O
cytometry	O
.	O

Notwithstanding	O
the	O
patient	O
received	O
support	O
from	O
cardiovascular	B-ANAT
drugs	O
and	O
pulmonary	B-ANAT
vasodilators	O
cardiopulmonary	B-ANAT
by	O
-	O
pass	O
was	O
necessary	O
.	O

The	O
patient	O
is	O
well	O
at	O
follow	O
-	O
up	O
1	O
year	O
post	O
-	O
transplant	B-ANAT
.	O

ABSTRACT	O
:	O
Multiple	O
sclerosis	O
,	O
a	O
chronic	O
inflammatory	O
disease	O
of	O
the	O
CNS	B-ANAT
,	O
is	O
characterized	O
by	O
immune	O
-	O
mediated	O
demyelination	O
.	O

One	O
possibility	O
is	O
that	O
T	B-ANAT
cells	I-ANAT
specific	O
for	O
the	O
inciting	O
microbial	O
pathogen	O
are	O
able	O
to	O
effect	O
demyelination	O
at	O
a	O
site	O
of	O
ongoing	O
inflammation	O
within	O
the	O
CNS	B-ANAT
.	O

ABSTRACT	O
:	O
Cardiopulmonary	B-ANAT
extracorporeal	O
assistance	O
is	O
a	O
high	O
complexity	O
procedure	O
for	O
patients	O
with	O
acute	O
respiratory	O
failure	O
,	O
who	O
have	O
failed	O
conventional	O
ventilatory	O
support	O
.	O

A	O
30	O
years	O
old	O
female	O
patient	O
with	O
bacterial	O
endocarditis	O
and	O
congestive	O
cardiac	B-ANAT
failure	O
subjected	O
to	O
cardiac	B-ANAT
surgery	O
presented	O
severe	O
hypoxemia	O
,	O
right	B-ANAT
heart	I-ANAT
failure	O
and	O
pulmonary	B-ANAT
hypertension	O
,	O
and	O
failed	O
conventional	O
treatment	O
.	O

Paired	O
sera	B-ANAT
were	O
collected	O
at	O
arrival	O
and	O
21	O
DPA	O
and	O
tested	O
for	O
antibodies	O
to	O
BCV	O
using	O
an	O
indirect	O
ELISA	O
.	O

Thirty	O
-	O
two	O
cattle	O
(	O
38	O
%)	O
showed	O
concurrent	O
enteric	O
and	O
nasal	B-ANAT
shedding	O
detected	O
by	O
both	O
tests	O
.	O

The	O
amount	O
of	O
abnormal	O
parenchyma	B-ANAT
correlated	O
with	O
duration	O
of	O
mechanical	O
ventilation	O
on	O
high	O
end	O
-	O
inspiratory	O
pressure	O
but	O
not	O
with	O
tidal	O
volume	O
or	O
minute	O
ventilation	O
.	O

ABSTRACT	O
:	O
Coccidioides	O
immitis	O
causes	O
a	O
benign	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
endemic	O
areas	O
.	O

It	O
can	O
cause	O
life	O
-	O
threatening	O
morbidities	O
,	O
including	O
cardiac	B-ANAT
arrhythmia	O
and	O
ischemia	O
,	O
hypertension	O
,	O
and	O
respiratory	O
arrest	O
,	O
and	O
even	O
death	O
.	O

ABSTRACT	O
:	O
Severe	O
pancreatitis	O
is	O
frequently	O
associated	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
the	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
resulting	O
pancreatitis	O
was	O
similar	O
in	O
GM	O
-	O
CSF	B-ANAT
-	O
sufficient	O
(	O
GM	O
-	O
CSF	B-ANAT
+/+)	O
control	O
animals	O
and	O
GM	O
-	O
CSF	B-ANAT
-/-	O
mice	O
.	O

Lung	B-ANAT
injury	O
,	O
quantitated	O
by	O
measuring	O
lung	B-ANAT
myeloperoxidase	O
activity	O
(	O
an	O
indicator	O
of	O
neutrophil	B-ANAT
sequestration	O
),	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
permeability	O
,	O
and	O
alveolar	B-ANAT
membrane	B-ANAT
thickness	O
was	O
less	O
severe	O
in	O
GM	O
-	O
CSF	B-ANAT
-/-	O
than	O
in	O
GM	O
-	O
CSF	B-ANAT
+/+	O
mice	O
.	O

ABSTRACT	O
:	O
Lymphocyte	B-ANAT
proliferative	O
responses	O
were	O
evaluated	O
in	O
mucosal	B-ANAT
(	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
)	O
and	O
systemic	O
(	O
spleen	B-ANAT
and	O
blood	B-ANAT
)	O
lymphoid	B-ANAT
tissues	I-ANAT
of	O
conventional	O
piglets	O
inoculated	O
with	O
the	O
virulent	O
or	O
attenuated	O
isolates	O
of	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
(	O
PEDV	O
)	O
strain	O
CV	O
-	O
777	O
and	O
challenged	O
21	O
days	O
later	O
with	O
the	O
virulent	O
isolate	O
of	O
the	O
same	O
virus	O
.	O

A	O
lymphoproliferative	O
assay	O
was	O
developed	O
in	O
which	O
mononuclear	B-ANAT
cells	I-ANAT
isolated	O
from	O
lymphoid	B-ANAT
tissues	I-ANAT
at	O
different	O
postinoculation	O
and	O
postchallenge	O
days	O
underwent	O
a	O
secondary	O
in	O
vitro	O
stimulation	O
with	O
semipurified	O
antigen	O
obtained	O
from	O
PEDV	O
-	O
infected	O
cell	B-ANAT
cultures	O
.	O

Vigorous	O
lymphocyte	B-ANAT
proliferative	O
responses	O
were	O
detected	O
in	O
the	O
pigs	O
inoculated	O
with	O
the	O
virulent	O
PEDV	O
at	O
postinoculation	O
days	O
4	O
-	O
21	O
,	O
especially	O
in	O
the	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
and	O
the	O
blood	B-ANAT
;	O
however	O
,	O
in	O
the	O
spleen	B-ANAT
this	O
response	O
was	O
lower	O
and	O
less	O
regular	O
.	O

The	O
results	O
confirm	O
that	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
helper	O
function	O
,	O
assessed	O
by	O
lymphocyte	B-ANAT
proliferation	O
responses	O
,	O
contributes	O
to	O
establishing	O
a	O
protective	O
immune	O
response	O
against	O
PEDV	O
infections	O
.	O

The	O
lung	B-ANAT
volume	O
retained	O
by	O
PEEPi	O
was	O
then	O
measured	O
.	O

Drugs	O
for	O
cardiovascular	B-ANAT
support	O
were	O
infused	O
in	O
59	O
patients	O
(	O
89	O
%)	O
during	O
transfer	O
.	O

The	O
use	O
of	O
VA	O
ECMO	O
in	O
cardiac	B-ANAT
patients	O
has	O
expanded	O
from	O
an	O
extension	O
of	O
intraoperative	O
cardiopulmonary	B-ANAT
bypass	O
and	O
now	O
includes	O
rescue	O
therapy	O
during	O
cardiopulmonary	B-ANAT
resuscitation	O
,	O
temporary	O
circulatory	O
support	O
for	O
reversible	O
heart	B-ANAT
failure	O
,	O
and	O
bridge	O
support	O
preceding	O
heart	B-ANAT
or	O
heart	B-ANAT
/	O
lung	B-ANAT
transplantation	O
.	O

A	O
2	O
.	O
5	O
kg	O
neonate	O
with	O
severe	O
Ebstein	O
'	O
s	O
anomaly	O
of	O
the	O
tricuspid	B-ANAT
valve	I-ANAT
and	O
recurrent	O
episodes	O
of	O
life	O
-	O
threatening	O
supraventricular	O
tachycardia	O
was	O
electively	O
cannulated	O
for	O
VA	O
ECMO	O
in	O
the	O
cardiac	B-ANAT
intensive	O
care	O
unit	O
.	O

The	O
use	O
of	O
inhaled	O
NO	O
has	O
also	O
been	O
extended	O
to	O
adults	O
with	O
pulmonary	B-ANAT
hypertension	O
and	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Hypercapnic	O
respiratory	O
failure	O
and	O
partial	O
upper	O
airway	B-ANAT
obstruction	O
during	O
high	O
frequency	O
oscillatory	O
ventilation	O
in	O
an	O
adult	O
burn	O
patient	O
.	O

A	O
19	O
-	O
yr	O
-	O
old	O
male	O
with	O
smoke	O
inhalation	O
and	O
flame	O
burns	O
to	O
50	O
%	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
was	O
admitted	O
to	O
the	O
Ross	O
Tilley	O
Burn	O
Centre	O
.	O

A	O
6	O
.	O
0	O
-	O
mm	O
nasotracheal	O
tube	O
was	O
inserted	O
into	O
the	O
supraglottic	B-ANAT
hypopharynx	B-ANAT
to	O
palliate	O
presumed	O
expiratory	O
upper	O
airway	B-ANAT
obstruction	O
.	O

ABSTRACT	O
:	O
The	O
serum	B-ANAT
antibody	O
responses	O
of	O
cattle	O
with	O
respiratory	O
coronavirus	O
infections	O
during	O
the	O
pathogenesis	O
of	O
shipping	O
fever	O
pneumonia	O
were	O
analyzed	O
with	O
different	O
bovine	O
coronavirus	O
antigens	O
,	O
including	O
those	O
from	O
a	O
wild	O
-	O
type	O
respiratory	O
bovine	O
coronavirus	O
(	O
RBCV	O
)	O
strain	O
(	O
97TXSF	O
-	O
Lu	O
15	O
-	O
2	O
)	O
directly	O
isolated	O
from	O
lung	B-ANAT
tissue	I-ANAT
from	O
a	O
fatally	O
infected	O
bovine	O
,	O
a	O
wild	O
-	O
type	O
enteropathogenic	O
bovine	O
coronavirus	O
(	O
EBCV	O
)	O
strain	O
(	O
Ly	O
138	O
-	O
3	O
),	O
and	O
the	O
highly	O
cell	B-ANAT
culture	O
-	O
adapted	O
,	O
enteric	O
prototype	O
strain	O
(	O
EBCV	O
L9	O
-	O
81	O
).	O

We	O
describe	O
a	O
mild	O
case	O
of	O
TRALI	O
during	O
plasma	B-ANAT
exchange	O
for	O
thrombotic	O
thrombocytopenic	O
purpura	O
in	O
a	O
56	O
-	O
year	O
-	O
old	O
woman	O
,	O
status	O
post	O
autologous	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
for	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
.	O

The	O
major	O
complications	O
were	O
severe	O
infection	O
,	O
hypotension	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
multiple	O
organ	B-ANAT
disfunction	O
syndrome	O
(	O
MODS	O
).	O

CONCLUSIONS	O
:	O
Active	O
monitor	O
and	O
support	O
of	O
organ	B-ANAT
function	O
can	O
lower	O
the	O
rate	O
of	O
missed	O
or	O
delayed	O
diagnoses	O
and	O
also	O
decrease	O
complications	O
.	O

Here	O
,	O
a	O
case	O
of	O
bilateral	O
paralysis	O
of	O
the	O
vocal	B-ANAT
cords	I-ANAT
,	O
which	O
was	O
associated	O
with	O
asthma	O
,	O
is	O
described	O
.	O

For	O
the	O
treatment	O
of	O
ARS	O
,	O
we	O
performed	O
HLA	B-ANAT
-	O
DRB1	O
-	O
mismatched	O
unrelated	O
umbilical	B-ANAT
cord	I-ANAT
blood	I-ANAT
transplantation	O
(	O
CBT	O
)	O
for	O
a	O
nuclear	O
accident	O
victim	O
who	O
received	O
8	O
to	O
10	O
GyEq	O
mixed	O
neutron	O
and	O
gamma	O
-	O
ray	O
irradiation	O
at	O
the	O
JCO	O
Co	O
.	O
Ltd	O
.	O
nuclear	O
processing	O
facility	O
in	O
Tokaimura	O
,	O
Japan	O
.	O

These	O
results	O
suggest	O
that	O
fast	O
neutrons	O
in	O
doses	O
higher	O
than	O
8	O
to	O
10	O
Gy	O
cause	O
complete	O
abrogation	O
of	O
the	O
human	O
immune	B-ANAT
system	I-ANAT
,	O
which	O
may	O
lead	O
to	O
fatal	O
outcome	O
even	O
if	O
autologous	O
hematopoiesis	O
recovers	O
.	O

In	O
addition	O
,	O
as	O
skeletal	B-ANAT
muscle	I-ANAT
,	O
lung	B-ANAT
tissue	I-ANAT
may	O
show	O
metabolic	O
adaptations	O
in	O
response	O
to	O
systemic	O
mediators	O
and	O
may	O
contribute	O
to	O
the	O
systemic	O
metabolic	O
response	O
to	O
severe	O
illness	O
even	O
in	O
the	O
absence	O
of	O
direct	O
tissue	B-ANAT
abnormalities	O
.	O

TITLE	O
:	O
Alveolar	B-ANAT
macrophage	I-ANAT
activation	O
after	O
trauma	O
-	O
hemorrhage	O
and	O
sepsis	O
is	O
dependent	O
on	O
NF	O
-	O
kappaB	O
and	O
MAPK	O
/	O
ERK	O
mechanisms	O
.	O

Activation	O
of	O
NF	O
-	O
kappaB	O
increased	O
in	O
lungs	B-ANAT
from	O
the	O
hemorrhage	O
and	O
CLP	O
group	O
compared	O
with	O
shams	O
.	O

Prospective	O
randomized	O
trials	O
show	O
that	O
maintaining	O
gut	B-ANAT
integrity	O
is	O
equally	O
as	O
important	O
as	O
placing	O
the	O
pancreas	B-ANAT
at	O
rest	O
while	O
inflammation	O
within	O
the	O
gland	B-ANAT
resolves	O
.	O

In	O
comparison	O
to	O
total	O
parenteral	O
nutrition	O
and	O
gut	B-ANAT
disuse	O
,	O
enteral	O
feeding	O
attenuates	O
disease	O
severity	O
,	O
reduces	O
oxidative	O
stress	O
,	O
and	O
improves	O
patient	O
outcome	O
.	O

Only	O
four	O
recurrent	O
ONM	O
white	O
patients	O
had	O
brain	B-ANAT
and	I-ANAT
spinal	I-ANAT
cord	I-ANAT
magnetic	O
resonance	O
imaging	O
and	O
cerebrospinal	B-ANAT
fluid	I-ANAT
findings	O
compatible	O
with	O
the	O
diagnosis	O
of	O
multiple	O
sclerosis	O
.	O

The	O
3	O
'-	O
terminal	O
end	O
of	O
the	O
genome	O
of	O
the	O
prototype	O
HEV	B-ANAT
-	O
67N	O
strain	O
and	O
that	O
of	O
the	O
recent	O
QuÃ©bec	O
IAF	O
-	O
404	O
field	O
isolate	O
,	O
both	O
propagated	O
in	O
HRT	O
-	O
18	O
cells	B-ANAT
,	O
were	O
sequenced	O
.	O

Overall	O
,	O
sequencing	O
data	O
indicated	O
that	O
HEV	B-ANAT
has	O
remained	O
antigenically	O
and	O
genetically	O
stable	O
since	O
its	O
first	O
isolation	O
in	O
North	O
America	O
in	O
1962	O
.	O

In	O
addition	O
,	O
a	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
of	O
the	O
S2	O
glycoprotein	O
of	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
was	O
inserted	O
in	O
-	O
frame	O
to	O
replace	O
the	O
NP	O
-	O
IDE	O
.	O

Viral	O
mRNA	O
was	O
detected	O
in	O
bursa	B-ANAT
samples	O
collected	O
at	O
48	O
hr	O
.	O

Extensive	O
antigen	O
staining	O
in	O
the	O
cytoplasm	B-ANAT
of	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
trachea	B-ANAT
,	O
lung	B-ANAT
,	O
bursa	B-ANAT
,	O
and	O
intestine	B-ANAT
was	O
detected	O
at	O
2	O
dpi	O
with	O
all	O
8	O
strains	O
of	O
IBV	O
.	O

In	O
situ	O
hybridization	O
with	O
this	O
probe	O
will	O
be	O
useful	O
for	O
understanding	O
the	O
tissue	B-ANAT
tropism	O
and	O
the	O
pathogenesis	O
of	O
IBV	O
in	O
vivo	O
.	O

TITLE	O
:	O
Neutrophil	B-ANAT
metabolic	O
activity	O
but	O
not	O
neutrophil	B-ANAT
sequestration	O
reflects	O
the	O
development	O
of	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
.	O

However	O
,	O
18FDG	O
uptake	O
uniquely	O
showed	O
that	O
interstitial	B-ANAT
and	O
intra	O
-	O
alveolar	B-ANAT
neutrophil	B-ANAT
migration	O
and	O
activation	O
occurred	O
in	O
severe	O
but	O
not	O
in	O
mild	O
pancreatitis	O
,	O
consistent	O
with	O
clinical	O
correlations	O
between	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
severity	O
of	O
underlying	O
systemic	O
disease	O
.	O

18FDG	O
uptake	O
,	O
which	O
is	O
also	O
accessible	O
by	O
positron	O
emission	B-ANAT
tomography	O
scanning	O
,	O
better	O
quantitates	O
the	O
contribution	O
of	O
activated	O
neutrophils	B-ANAT
to	O
tissue	B-ANAT
injury	O
than	O
other	O
measurements	O
of	O
neutrophil	B-ANAT
accumulation	O
or	O
sequestration	O
.	O

TITLE	O
:	O
A	O
novel	O
animal	O
model	O
of	O
sepsis	O
after	O
acute	O
lung	B-ANAT
injury	O
in	O
sheep	O
.	O

TITLE	O
:	O
Posterior	O
ischemic	O
optic	B-ANAT
neuropathy	O
related	O
to	O
profound	O
shock	O
after	O
penetrating	O
thoracoabdominal	O
trauma	O
.	O

ABSTRACT	O
:	O
Ischemic	O
optic	B-ANAT
neuropathy	O
is	O
a	O
rare	O
cause	O
of	O
blindness	O
reported	O
most	O
commonly	O
in	O
association	O
with	O
collagen	B-ANAT
-	O
vascular	B-ANAT
diseases	O
,	O
infectious	O
processes	O
,	O
and	O
systemic	O
hypotension	O
related	O
to	O
massive	O
exsanguinating	O
hemorrhage	O
.	O

TITLE	O
:	O
Virus	O
-	O
induced	O
demyelination	O
in	O
nude	O
mice	O
is	O
mediated	O
by	O
gamma	O
delta	O
T	B-ANAT
cells	I-ANAT
.	O

Herein	O
,	O
we	O
show	O
that	O
demyelination	O
in	O
nude	O
mice	O
was	O
mediated	O
by	O
gamma	O
delta	O
T	B-ANAT
cells	I-ANAT
.	O

The	O
pathognomonic	O
ELS	O
presented	O
as	O
ordered	O
molecular	O
aggregates	O
when	O
stained	O
using	O
the	O
Verhoeff	O
-	O
van	O
Gieson	O
technique	O
for	O
elastic	B-ANAT
fibers	I-ANAT
.	O

Remarkably	O
,	O
most	O
of	O
the	O
postmortem	O
lungs	B-ANAT
with	O
ELS	O
exhibited	O
no	O
significant	O
acute	O
inflammatory	O
cellular	B-ANAT
response	O
such	O
as	O
neutrophilic	O
reaction	O
,	O
and	O
little	O
evidence	O
of	O
widespread	O
edema	O
except	O
for	O
focal	O
intra	O
-	O
alveolar	B-ANAT
hemorrhage	O
.	O

However	O
,	O
since	O
antibodies	O
against	O
these	O
viruses	O
,	O
HAV	O
and	O
B19	O
,	O
are	O
constantly	O
present	O
in	O
large	O
plasma	B-ANAT
pools	O
,	O
it	O
is	O
conceivable	O
that	O
antibody	O
binding	O
will	O
lead	O
to	O
an	O
increase	O
in	O
size	O
of	O
the	O
viruses	O
due	O
to	O
a	O
corona	O
of	O
antibodies	O
on	O
the	O
virus	O
surfaces	O
.	O

ABSTRACT	O
:	O
Critical	O
illness	O
is	O
a	O
severe	O
and	O
generalized	O
monophasic	O
event	O
,	O
and	O
it	O
is	O
likely	O
that	O
there	O
will	O
be	O
evidence	O
of	O
compromised	O
reserve	O
in	O
all	O
end	O
organs	B-ANAT
if	O
one	O
looks	O
hard	O
enough	O
for	O
it	O
.	O

ABSTRACT	O
:	O
A	O
segment	O
of	O
genomic	O
RNA	O
extending	O
from	O
the	O
3	O
'-	O
end	O
of	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
gene	O
to	O
the	O
5	O
'-	O
end	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
gene	O
of	O
Turkey	O
coronavirus	O
(	O
TCV	O
)	O
was	O
amplified	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

ABSTRACT	O
:	O
Replication	O
-	O
competent	O
propagation	O
-	O
deficient	O
virus	O
vectors	O
based	O
on	O
the	O
transmissible	O
gastroenteritis	O
coronavirus	O
(	O
TGEV	O
)	O
genome	O
that	O
are	O
deficient	O
in	O
the	O
essential	O
E	O
gene	O
have	O
been	O
developed	O
by	O
complementation	O
within	O
E	O
(+)	O
packaging	O
cell	B-ANAT
lines	I-ANAT
.	O

The	O
availability	O
of	O
packaging	O
cell	B-ANAT
lines	I-ANAT
will	O
significantly	O
facilitate	O
the	O
production	O
of	O
safe	O
TGEV	O
-	O
derived	O
vectors	O
for	O
vaccination	O
and	O
possibly	O
gene	O
therapy	O
.	O

A	O
total	O
of	O
177	O
faecal	B-ANAT
samples	O
from	O
dogs	O
CCoV	O
positive	O
previously	O
with	O
the	O
PCR	O
assay	O
were	O
analysed	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
severe	O
acute	O
chest	B-ANAT
syndrome	O
(	O
ACS	O
)	O
requiring	O
endotracheal	O
intubation	O
and	O
erythrocytopheresis	O
are	O
at	O
increased	O
risk	O
for	O
neurologic	O
morbidity	O
.	O

We	O
have	O
developed	O
methods	O
to	O
quantify	O
bone	B-ANAT
-	O
marrow	O
stimulation	O
and	O
showed	O
in	O
animals	O
that	O
acute	O
exposure	O
to	O
ambient	O
particles	O
accelerates	O
the	O
transit	O
of	O
polymorphonuclear	B-ANAT
leukocytes	I-ANAT
(	O
PMN	B-ANAT
)	O
through	O
the	O
marrow	O
whereas	O
chronic	O
exposure	O
expands	O
the	O
size	O
of	O
the	O
bone	B-ANAT
marrow	I-ANAT
pool	O
of	O
PMN	B-ANAT
.	O

Human	O
studies	O
showed	O
that	O
an	O
episode	O
of	O
severe	O
air	O
pollution	O
stimulates	O
the	O
bone	B-ANAT
marrow	I-ANAT
in	O
a	O
manner	O
similar	O
to	O
that	O
observed	O
in	O
animals	O
.	O

Expression	O
of	O
EGFP	O
remained	O
stable	O
through	O
at	O
least	O
six	O
passages	O
in	O
tissue	B-ANAT
culture	O
and	O
during	O
acute	O
infection	O
in	O
the	O
mouse	B-ANAT
central	I-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

TITLE	O
:	O
[	O
Variation	O
in	O
manifestations	O
of	O
heteroplasmic	O
mtDNA	B-ANAT
mutation	O
8993	O
T	O
>	O
G	O
in	O
two	O
families	O
].	O

The	O
surfactant	O
preparation	O
used	O
reduced	O
baseline	O
TNF	O
production	O
by	O
murine	O
alveolar	B-ANAT
macrophages	I-ANAT
,	O
indicating	O
that	O
the	O
exaggeration	O
of	O
ventilation	O
-	O
induced	O
TNF	O
release	O
cannot	O
be	O
explained	O
by	O
a	O
direct	O
effect	O
of	O
surfactant	O
on	O
these	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Although	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
enters	O
cells	B-ANAT
by	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
triggered	O
by	O
its	O
spike	O
(	O
S	O
)	O
protein	O
,	O
it	O
is	O
not	O
well	O
known	O
how	O
the	O
S	O
protein	O
participates	O
in	O
fusion	O
events	O
.	O

Seventy	O
-	O
five	O
biologic	O
samples	O
,	O
primarily	O
feces	B-ANAT
,	O
from	O
captive	O
felids	O
from	O
11	O
institutions	O
were	O
tested	O
using	O
PCR	O
.	O

The	O
best	O
cutoff	O
point	O
for	O
urinary	O
PROP	O
to	O
predict	O
overall	O
severity	O
was	O
>	O
1	O
nmol	O
/	O
l	O
<	O
or	O
=	O
48	O
h	O
after	O
symptom	O
onset	O
(	O
negative	O
predictive	O
value	O
=	O
88	O
%),	O
but	O
the	O
PROP	O
levels	O
failed	O
to	O
predict	O
the	O
development	O
of	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
.	O

ABSTRACT	O
:	O
A	O
profibrinolytic	O
state	O
is	O
normal	O
in	O
the	O
alveoli	B-ANAT
,	O
but	O
this	O
may	O
change	O
as	O
a	O
result	O
of	O
trauma	O
,	O
possibly	O
leading	O
to	O
fibrin	O
deposition	O
,	O
a	O
characteristic	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
study	O
shows	O
an	O
increased	O
concentration	O
of	O
scu	O
-	O
PA	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
of	O
the	O
treated	O
animals	O
in	O
association	O
with	O
an	O
increased	O
plasmin	O
-	O
dependent	O
fibrinolytic	O
activity	O
without	O
increased	O
systemic	O
fibrinolytic	O
activity	O
,	O
the	O
transient	O
increase	O
in	O
the	O
concentration	O
of	O
scu	O
-	O
PA	O
in	O
the	O
plasma	B-ANAT
being	O
minimal	O
.	O

TITLE	O
:	O
Murine	O
coronavirus	O
-	O
induced	O
apoptosis	O
in	O
17Cl	O
-	O
1	O
cells	B-ANAT
involves	O
a	O
mitochondria	B-ANAT
-	O
mediated	O
pathway	O
and	O
its	O
downstream	O
caspase	O
-	O
8	O
activation	O
and	O
bid	O
cleavage	O
.	O

Analyses	O
of	O
the	O
subcellular	O
distribution	O
of	O
cytochrome	O
c	O
,	O
procaspase	O
-	O
9	O
,	O
and	O
Apaf	O
-	O
1	O
suggested	O
an	O
aberrant	O
apoptosome	B-ANAT
formation	O
in	O
the	O
vicinity	O
of	O
the	O
mitochondria	B-ANAT
,	O
which	O
could	O
be	O
a	O
cell	B-ANAT
type	I-ANAT
-	O
specific	O
event	O
.	O

Embryos	B-ANAT
were	O
divided	O
into	O
three	O
groups	O
and	O
were	O
inoculated	O
in	O
the	O
chorioallantoic	O
sac	B-ANAT
with	O
0	O
.	O
2	O
mL	O
of	O
UNAM	O
-	O
97	O
,	O
Mass	O
41	O
IBV	O
(	O
positive	O
control	O
),	O
or	O
sterile	O
PBS	O
(	O
negative	O
control	O
).	O

The	O
UNAM	O
-	O
97	O
IBV	O
variant	O
strain	O
caused	O
two	O
macroscopic	O
lesions	O
uncommon	O
for	O
Mexican	O
strains	O
:	O
thin	O
-	O
walled	O
proventriculus	B-ANAT
and	O
gizzard	B-ANAT
,	O
as	O
well	O
as	O
urate	O
accumulation	O
within	O
an	O
extra	O
-	O
embryonic	B-ANAT
peritoneal	B-ANAT
sac	I-ANAT
,	O
leaving	O
the	O
body	B-ANAT
through	O
the	O
umbilical	O
duct	B-ANAT
and	O
accompanied	O
by	O
the	O
yolk	B-ANAT
sac	I-ANAT
.	O

The	O
joining	O
of	O
the	O
non	O
-	O
contiguous	O
'	O
leader	O
'	O
and	O
'	B-ANAT
body	I-ANAT
'	O
sequences	O
presumably	O
occurs	O
during	O
minus	O
-	O
strand	O
synthesis	O
.	O

TITLE	O
:	O
Functional	O
expression	O
of	O
chemokine	O
receptor	O
CCR5	O
on	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
during	O
virus	O
-	O
induced	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Intracranial	B-ANAT
infection	O
of	O
C57BL	O
/	O
6	O
mice	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
results	O
in	O
an	O
acute	O
encephalomyelitis	O
followed	O
by	O
a	O
demyelinating	O
disease	O
similar	O
in	O
pathology	O
to	O
the	O
human	O
disease	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

Collectively	O
these	O
results	O
demonstrate	O
that	O
CCR5	O
signaling	O
is	O
important	O
to	O
migration	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
to	O
the	O
CNS	B-ANAT
following	O
MHV	O
infection	O
.	O

To	O
clarify	O
the	O
precise	O
function	O
of	O
PTB	O
in	O
MHV	O
replication	O
,	O
we	O
dissociated	O
the	O
processes	O
of	O
viral	O
transcription	O
from	O
translation	O
by	O
transfecting	O
different	O
types	O
of	O
MHV	O
defective	O
-	O
interfering	O
(	O
DI	O
)	O
RNA	O
that	O
contain	O
various	O
reporter	O
genes	O
into	O
these	O
stable	O
cell	B-ANAT
lines	I-ANAT
.	O

A	O
vital	O
role	O
for	O
humoral	O
immunity	O
during	O
persistence	O
is	O
supported	O
by	O
the	O
accumulation	O
and	O
retention	O
of	O
virus	O
-	O
specific	O
antibody	B-ANAT
secreting	I-ANAT
cells	I-ANAT
following	O
clearance	O
of	O
infectious	O
virus	O
.	O

The	O
low	O
turnover	O
of	O
virus	O
,	O
T	B-ANAT
cells	I-ANAT
,	O
and	O
B	B-ANAT
cells	I-ANAT
constitute	O
a	O
unifying	O
feature	O
of	O
persistent	O
infection	O
,	O
illustrating	O
the	O
dichotomy	O
between	O
distinct	O
immune	O
effectors	O
in	O
regulating	O
acute	O
and	O
persistent	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infection	O
.	O

Histopathologic	O
changes	O
included	O
characteristic	O
tubular	O
epithelial	O
degeneration	O
and	O
sloughing	B-ANAT
with	O
lymphoplasmacytic	O
interstitial	B-ANAT
nephritis	O
.	O

Assessment	O
of	O
protection	O
following	O
NIBV	O
challenge	O
was	O
based	O
on	O
several	O
criteria	O
virus	O
reisolation	O
from	O
trachea	B-ANAT
and	O
kidney	B-ANAT
and	O
renal	B-ANAT
microscopic	O
pathology	O
and	O
IBV	O
-	O
specific	O
antigen	O
immunohistochemistry	O
(	O
IHC	O
).	O

TITLE	O
:	O
Chicken	O
egg	B-ANAT
yolk	B-ANAT
antibodies	O
as	O
therapeutics	O
in	O
enteric	O
infectious	O
disease	O
:	O
a	O
review	O
.	O

TITLE	O
:	O
Efficient	O
induction	O
of	O
primary	O
and	O
secondary	O
T	B-ANAT
cell	I-ANAT
-	O
dependent	O
immune	O
responses	O
in	O
vivo	O
in	O
the	O
absence	O
of	O
functional	O
IL	O
-	O
2	O
and	O
IL	O
-	O
15	O
receptors	O
.	O

We	O
have	O
previously	O
characterized	O
a	O
novel	O
transgenic	O
(	O
Tg	O
)	O
mouse	O
on	O
the	O
IL	O
-	O
2Rbeta	O
-/-	O
genetic	O
background	O
(	O
Tg	O
-/-	O
mice	O
)	O
that	O
lacks	O
autoimmune	O
disease	O
but	O
still	O
contains	O
peripheral	O
T	B-ANAT
cells	I-ANAT
that	O
are	O
nonresponsive	O
to	O
IL	O
-	O
2	O
and	O
IL	O
-	O
15	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
glycoprotein	O
(	O
S	O
)	O
of	O
the	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
binds	O
to	O
viral	O
murine	O
CEACAM	O
receptor	O
glycoproteins	O
and	O
causes	O
membrane	B-ANAT
fusion	O
.	O

Increased	O
hydrophobicity	O
of	O
virions	B-ANAT
and	O
conformational	O
change	O
in	O
S2	O
of	O
MHV	O
-	O
A59	O
could	O
also	O
be	O
induced	O
by	O
incubating	O
virions	B-ANAT
at	O
pH	O
8	O
and	O
37	O
degrees	O
C	O
,	O
without	O
soluble	O
receptor	O
.	O

ABSTRACT	O
:	O
The	O
primary	O
target	O
in	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
believed	O
to	O
be	O
either	O
myelin	B-ANAT
itself	O
(	O
myelinopathy	O
)	O
or	O
the	O
myelin	B-ANAT
-	O
forming	O
cell	B-ANAT
,	O
the	O
oligodendrocyte	B-ANAT
(	O
oligodendrogliopathy	O
).	O

The	O
latter	O
possibility	O
where	O
axonal	O
injury	O
leads	O
to	O
other	O
changes	O
is	O
raised	O
from	O
the	O
rather	O
unexpected	O
similarity	O
between	O
spinal	B-ANAT
cord	I-ANAT
injury	O
(	O
SCI	O
)	O
and	O
MS	O
where	O
axonal	O
injury	O
,	O
oligodendrocyte	B-ANAT
apoptosis	O
and	O
demyelination	O
are	O
all	O
present	O
.	O

Subcutaneous	O
insulin	O
and	O
diet	O
are	O
continued	O
but	O
from	O
the	O
first	O
dexamethasone	O
dose	O
until	O
12	O
h	O
after	O
the	O
second	O
,	O
supplementary	O
intravenous	O
insulin	O
is	O
infused	O
according	O
to	O
hourly	O
blood	B-ANAT
glucose	O
measurements	O
.	O

STAT1	O
and	O
STAT3	O
activation	O
in	O
spleen	B-ANAT
increased	O
24	O
to	O
72	O
hr	O
following	O
MHV	O
-	O
3	O
infections	O
in	O
both	O
sensitive	O
and	O
resistant	O
mouse	O
strains	O
.	O

Treatment	O
of	O
sensitive	O
Balb	O
/	O
cJ	O
mice	O
with	O
neutralizing	O
anti	O
-	O
TGF	O
-	O
beta	O
antibody	O
could	O
increase	O
the	O
STAT1	O
alpha	O
/	O
beta	O
ratio	O
to	O
<	O
1	O
.	O
0	O
in	O
spleens	B-ANAT
,	O
predicting	O
enhanced	O
rates	O
of	O
survival	O
.	O

Surprisingly	O
few	O
studies	O
have	O
addressed	O
wild	O
turkeys	O
in	O
this	O
region	O
,	O
perhaps	O
reflecting	O
its	O
status	O
as	O
the	O
heart	B-ANAT
of	O
Rio	O
Grande	O
turkey	O
range	O
.	O

Of	O
these	O
,	O
80	O
%	O
(	O
56	O
)	O
were	O
seropositive	O
for	O
both	O
M	O
.	O
gallisepticum	O
and	O
M	O
.	O
synoviae	O
on	O
the	O
serum	B-ANAT
plate	O
antigen	O
test	O
.	O

TITLE	O
:	O
Combined	O
activation	O
of	O
coagulation	O
and	O
inflammation	O
has	O
an	O
important	O
role	O
in	O
multiple	O
organ	B-ANAT
dysfunction	O
and	O
poor	O
outcome	O
after	O
severe	O
trauma	O
.	O

Maximum	O
DIC	O
scores	O
in	O
the	O
DIC	O
group	O
showed	O
good	O
correlations	O
with	O
peak	O
levels	O
of	O
sICAM	O
-	O
1	O
,	O
sVCAM	O
-	O
1	O
,	O
neutrophil	B-ANAT
elastase	O
,	O
sThrombomodulin	O
,	O
and	O
the	O
number	O
of	O
dysfunctioning	O
organs	B-ANAT
.	O

Highly	O
activated	O
and	O
sustained	O
inflammation	O
caused	O
by	O
neutrophil	B-ANAT
-	O
endothelium	B-ANAT
interaction	O
in	O
DIC	O
gives	O
rise	O
to	O
MODS	O
and	O
poor	O
outcome	O
in	O
patients	O
with	O
severe	O
trauma	O
.	O

A	O
universal	O
feature	O
of	O
this	O
repair	O
process	O
is	O
extensive	O
proliferation	O
of	O
oligodendrocyte	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
(	O
OPs	O
)	O
in	O
response	O
to	O
demyelination	O
.	O

ABSTRACT	O
:	O
Previous	O
work	O
has	O
shown	O
that	O
in	O
vitro	O
thymulin	O
treatments	O
have	O
the	O
ability	O
to	O
enhance	O
natural	O
killer	O
(	O
NK	O
)	O
cell	B-ANAT
cytotoxicity	O
.	O

ABSTRACT	O
:	O
Bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
(	O
BOOP	O
)	O
and	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
(	O
ARDS	O
)	O
are	O
two	O
pulmonary	B-ANAT
diseases	O
with	O
fibrotic	O
components	O
.	O

CBA	O
/	O
J	O
mice	O
infected	O
with	O
1	O
x	O
10	O
(	O
6	O
)	O
plaque	O
-	O
forming	O
units	O
(	O
pfu	O
)	O
reovirus	O
1	O
/	O
L	O
develop	O
follicular	B-ANAT
bronchiolitis	O
and	O
intra	O
-	O
alveolar	B-ANAT
fibrosis	O
similar	O
to	O
BOOP	O
.	O

In	O
contrast	O
,	O
neonatally	O
thymectomized	O
CBA	O
/	O
J	O
mice	O
infected	O
with	O
1	O
x	O
10	O
(	O
6	O
)	O
pfu	O
(	O
BOOP	O
)	O
reovirus	O
1	O
/	O
L	O
do	O
not	O
develop	O
intra	O
-	O
alveolar	B-ANAT
fibrosis	O
associated	O
with	O
BOOP	O
.	O

The	O
primary	O
objective	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
hypothesis	O
that	O
in	O
patients	O
intubated	O
for	O
acute	O
lung	B-ANAT
injury	O
,	O
lower	O
concentrations	O
of	O
surfactant	O
proteins	O
A	O
and	O
D	O
in	O
the	O
pulmonary	B-ANAT
edema	O
fluid	O
and	O
higher	O
concentrations	O
in	O
the	O
plasma	B-ANAT
are	O
associated	O
with	O
more	O
severe	O
lung	B-ANAT
injury	O
and	O
worse	O
clinical	O
outcomes	O
.	O

The	O
use	O
of	O
a	O
low	O
tidal	O
volume	O
with	O
moderate	O
to	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
improves	O
the	O
survival	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Positioning	O
the	O
patient	O
with	O
the	O
""""	O
good	O
lung	B-ANAT
down	O
""""	O
and	O
using	O
differential	O
ventilation	O
with	O
selective	O
positive	O
end	O
-	O
expiratory	O
pressure	O
are	O
the	O
two	O
currently	O
accepted	O
ventilatory	O
strategies	O
to	O
be	O
applied	O
in	O
patients	O
with	O
severe	O
unilateral	O
lung	B-ANAT
injury	O
.	O

Lung	B-ANAT
injury	O
may	O
be	O
rather	O
inhomogeneous	O
-	O
confined	O
to	O
one	O
lung	B-ANAT
or	O
preferentially	O
distributed	O
toward	O
the	O
dependent	O
lung	B-ANAT
areas	O
.	O

TITLE	O
:	O
The	O
pulmonary	B-ANAT
physician	O
in	O
critical	O
care	O
.	O

13	O
:	O
the	O
pulmonary	B-ANAT
circulation	O
and	O
right	O
ventricular	B-ANAT
failure	O
in	O
the	O
ITU	O
.	O

Interstitial	B-ANAT
nephritis	O
is	O
the	O
basic	O
renal	B-ANAT
lesion	O
.	O

Tubular	O
necrosis	O
and	O
interstitial	B-ANAT
nephritis	O
are	O
responsible	O
for	O
renal	B-ANAT
failure	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gases	O
and	O
ventilator	O
settings	O
were	O
recorded	O
at	O
four	O
time	O
points	O
:	O
during	O
conventional	O
ventilation	O
just	O
before	O
initiating	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
,	O
during	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
just	O
before	O
initiating	O
INO	O
,	O
after	O
30	O
mins	O
on	O
the	O
optimal	O
dose	O
of	O
INO	O
,	O
and	O
8	O
-	O
12	O
hrs	O
after	O
starting	O
INO	O
.	O

Oxygenation	O
index	O
([	O
Fio2	O
x	O
mean	O
airway	B-ANAT
pressure	O
x	O
100	O
]/	O
Pao2	O
)	O
and	O
Pao2	O
/	O
Fio2	O
ratios	O
were	O
calculated	O
at	O
the	O
same	O
time	O
intervals	O
.	O

At	O
30	O
mins	O
after	O
INO	O
initiation	O
,	O
83	O
%	O
of	O
patients	O
had	O
a	O
significant	O
increase	O
in	O
blood	B-ANAT
oxygen	O
tension	O
,	O
defined	O
as	O
>	O
or	O
=	O
20	O
%	O
increase	O
in	O
Pao2	O
/	O
Fio2	O
.	O

Ultimately	O
,	O
studies	O
of	O
lung	B-ANAT
injury	O
markers	O
may	O
help	O
define	O
interventions	O
that	O
prevent	O
or	O
moderate	O
ARDS	O
.	O

The	O
assay	O
detected	O
all	O
tested	O
IBV	O
strains	O
and	O
field	O
isolates	O
propagated	O
in	O
chicken	O
embryos	B-ANAT
.	O

We	O
report	O
a	O
patient	O
suffering	O
from	O
multiple	O
injuries	O
including	O
severe	O
pulmonary	B-ANAT
contusion	O
and	O
traumatic	O
parasternal	O
lung	B-ANAT
herniation	O
,	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
have	O
reported	O
recently	O
that	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
from	O
strains	O
of	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
-	O
3	O
,	O
MHV	O
-	O
A59	O
),	O
which	O
cause	O
massive	O
hepatocellular	O
necrosis	O
but	O
not	O
from	O
strains	O
(	O
MHV	O
-	O
JHM	O
,	O
MHV	O
-	O
2	O
)	O
which	O
do	O
not	O
produce	O
serious	O
liver	B-ANAT
disease	O
,	O
induces	O
transcription	O
of	O
fgl2	O
.	O

ABSTRACT	O
:	O
To	O
report	O
two	O
children	O
admitted	O
to	O
our	O
emergency	O
department	O
with	O
respiratory	O
failure	O
,	O
one	O
for	O
status	O
asthmaticus	O
with	O
pneumomediastinum	O
and	O
requiring	O
mechanical	O
ventilation	O
and	O
the	O
other	O
for	O
high	O
suspicion	O
of	O
foreign	O
body	B-ANAT
aspiration	O
.	O

Bronchoscopy	O
revealed	O
obstructive	O
plugs	O
and	O
permitted	O
their	O
extraction	O
and	O
their	O
identification	O
as	O
bronchial	B-ANAT
casts	B-ANAT
after	O
the	O
immersion	O
in	O
normal	O
saline	O
.	O

We	O
recommend	O
the	O
immersion	O
in	O
normal	O
saline	O
of	O
all	O
plugs	O
discovered	O
in	O
children	O
with	O
predisposing	O
diseases	O
mainly	O
represented	O
by	O
infections	O
,	O
allergy	O
,	O
acute	O
chest	B-ANAT
syndrome	O
,	O
and	O
congenital	O
cardiopathies	O
.	O

In	O
this	O
study	O
,	O
108	O
episodes	O
of	O
severe	O
anemia	O
were	O
prospectively	O
evaluated	O
in	O
108	O
patients	O
with	O
hemoglobin	O
SS	O
disease	O
attending	O
the	O
pediatric	O
sickle	B-ANAT
cell	I-ANAT
clinic	O
of	O
the	O
University	O
of	O
Nigeria	O
Teaching	O
Hospital	O
,	O
Enugu	O
,	O
Nigeria	O
.	O

Nowadays	O
,	O
it	O
is	O
well	O
known	O
that	O
inappropriate	O
mechanical	O
ventilation	O
enhances	O
lung	B-ANAT
damage	O
caused	O
by	O
the	O
underlying	O
disease	O
.	O

This	O
paper	O
reviews	O
the	O
interactions	O
between	O
heart	B-ANAT
and	I-ANAT
lung	I-ANAT
.	O

Of	O
the	O
proinflammatory	O
cytokines	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
was	O
present	O
in	O
PF	O
but	O
not	O
in	O
plasma	B-ANAT
,	O
interleukin	O
(	O
IL	O
)-	O
1beta	O
and	O
interferon	O
-	O
gamma	O
were	O
found	O
in	O
low	O
concentrations	O
in	O
both	O
PF	O
and	O
plasma	B-ANAT
,	O
and	O
IL	O
-	O
12	O
(	O
p70	O
)	O
was	O
detectable	O
in	O
plasma	B-ANAT
but	O
not	O
PF	O
.	O

Patients	O
with	O
more	O
severe	O
appendicitis	O
had	O
higher	O
plasma	B-ANAT
levels	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
10	O
and	O
lower	O
plasma	B-ANAT
levels	O
of	O
IL	O
-	O
12	O
and	O
interferon	O
-	O
gamma	O
than	O
did	O
those	O
with	O
uncomplicated	O
disease	O
.	O

Patient	O
plasma	B-ANAT
inhibited	O
LPS	O
-	O
induced	O
stimulation	O
of	O
a	O
monocyte	B-ANAT
cell	B-ANAT
line	I-ANAT
,	O
and	O
this	O
inhibition	O
was	O
accentuated	O
by	O
complicated	O
disease	O
.	O

Uncontrolled	O
infection	O
was	O
associated	O
with	O
limited	O
MHC	B-ANAT
class	O
I	O
up	O
-	O
regulation	O
and	O
an	O
absence	O
of	O
class	O
II	O
expression	O
on	O
microglia	B-ANAT
,	O
coinciding	O
with	O
decreased	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
CNS	B-ANAT
infiltrates	O
.	O

Furthermore	O
,	O
neutropenia	O
resulted	O
in	O
significantly	O
reduced	O
mononuclear	B-ANAT
leukocyte	I-ANAT
infiltration	O
possibly	O
due	O
to	O
reduced	O
loss	O
of	O
blood	B-ANAT
brain	I-ANAT
barrier	I-ANAT
integrity	O
during	O
acute	O
JHMV	O
infection	O
.	O

TITLE	O
:	O
Chronic	O
alcohol	O
abuse	O
is	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
severity	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
in	O
patients	O
with	O
septic	O
shock	O
.	O

Cardiovascular	B-ANAT
changes	O
and	O
profound	O
hemoconcentration	O
developed	O
within	O
6	O
hrs	O
from	O
the	O
start	O
of	O
mechanical	O
ventilation	O
,	O
along	O
with	O
a	O
major	O
decline	O
in	O
pulmonary	B-ANAT
compliance	O
and	O
deterioration	O
in	O
arterial	B-ANAT
blood	I-ANAT
gases	O
.	O

This	O
model	O
of	O
lethal	O
systemic	B-ANAT
capillary	I-ANAT
leak	O
syndrome	O
with	O
multiple	O
system	B-ANAT
organ	I-ANAT
failure	O
differs	O
greatly	O
from	O
our	O
previous	O
sheep	O
model	O
of	O
acute	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
which	O
sheep	O
were	O
ventilated	O
with	O
a	O
peak	O
inspiratory	O
pressure	O
of	O
50	O
cm	O
H2O	O
,	O
a	O
respiratory	O
rate	O
of	O
4	O
breaths	O
x	O
min	O
(-	O
1	O
),	O
and	O
an	O
inspiratory	O
time	O
of	O
1	O
.	O
35	O
secs	O
,	O
without	O
inducing	O
capillary	B-ANAT
leak	O
syndrome	O
.	O

We	O
report	O
here	O
a	O
29	O
-	O
year	O
-	O
old	O
man	O
with	O
chronic	O
pulmonary	B-ANAT
thromboembolism	O
(	O
CPTE	O
).	O

TITLE	O
:	O
CC	O
chemokine	O
ligand	O
3	O
(	O
CCL3	O
)	O
regulates	O
CD8	O
(+)-	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
effector	O
function	O
and	O
migration	O
following	O
viral	O
infection	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
contributions	O
of	O
the	O
CC	O
chemokine	O
ligand	O
3	O
(	O
CCL3	O
)	O
to	O
the	O
differentiation	O
and	O
migration	O
of	O
effector	O
T	B-ANAT
cells	I-ANAT
in	O
response	O
to	O
viral	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
were	O
analyzed	O
.	O

Decreased	O
infiltration	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
into	O
infected	O
CCL3	O
(-/-)	O
mice	O
was	O
associated	O
with	O
enhanced	O
accumulation	O
of	O
primed	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
.	O

ABSTRACT	O
:	O
It	O
has	O
been	O
suspected	O
that	O
embryos	B-ANAT
stored	O
in	O
liquid	O
nitrogen	O
tanks	O
may	O
become	O
contaminated	O
with	O
murine	O
pathogens	O
,	O
if	O
some	O
pathogens	O
had	O
been	O
introduced	O
to	O
the	O
tanks	O
accidentally	O
.	O

These	O
results	O
demonstrated	O
that	O
IBV	O
specific	O
CD8	O
(+)	O
memory	O
T	B-ANAT
cells	I-ANAT
generated	O
at	O
3	O
to	O
6	O
weeks	O
p	O
.	O
i	O
.	O

To	O
investigate	O
the	O
role	O
of	O
VEGF	O
in	O
progressively	O
impaired	O
lung	B-ANAT
function	O
as	O
the	O
major	O
complication	O
and	O
cause	O
of	O
death	O
in	O
septic	O
patients	O
.	O

Compared	O
with	O
expression	O
in	O
nonseptic	O
control	O
individuals	O
(	O
n	O
=	O
10	O
),	O
pulmonary	B-ANAT
VEGF	O
expression	O
as	O
determined	O
by	O
ELISA	O
was	O
significantly	O
(	O
P	O
<.	O
001	O
)	O
decreased	O
in	O
septic	O
patients	O
(	O
n	O
=	O
8	O
).	O

TITLE	O
:	O
Study	O
of	O
direct	O
lung	B-ANAT
injury	O
by	O
seawater	O
in	O
canine	O
models	O
.	O

Within	O
4	O
h	O
after	O
seawater	O
perfusion	O
,	O
no	O
pathological	O
changes	O
were	O
seen	O
in	O
the	O
lung	B-ANAT
tissues	I-ANAT
without	O
direct	O
contact	O
with	O
seawater	O
.	O

TITLE	O
:	O
Future	O
research	O
directions	O
in	O
acute	O
lung	B-ANAT
injury	O
:	O
summary	O
of	O
a	O
National	O
Heart	B-ANAT
,	O
Lung	B-ANAT
,	O
and	O
Blood	B-ANAT
Institute	O
working	O
group	O
.	O

The	O
development	O
of	O
ALI	O
/	O
ARDS	O
is	O
associated	O
with	O
several	O
clinical	O
disorders	O
including	O
direct	O
pulmonary	B-ANAT
injury	O
from	O
pneumonia	O
and	O
aspiration	O
as	O
well	O
as	O
indirect	O
pulmonary	B-ANAT
injury	O
from	O
trauma	O
,	O
sepsis	O
,	O
and	O
other	O
disorders	O
such	O
as	O
acute	O
pancreatitis	O
and	O
drug	O
overdose	O
.	O

Cellular	B-ANAT
and	O
molecular	O
methods	O
combined	O
with	O
animal	O
and	O
clinical	O
studies	O
should	O
lead	O
to	O
further	O
progress	O
in	O
the	O
detection	O
and	O
treatment	O
of	O
this	O
complex	O
disease	O
.	O

FIPV	O
Delta	O
7b	O
had	O
lost	O
the	O
expression	O
of	O
its	O
7b	O
gene	O
but	O
grew	O
unimpaired	O
in	O
cell	B-ANAT
culture	O
,	O
confirming	O
that	O
the	O
7b	O
glycoprotein	O
is	O
not	O
required	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Replication	O
of	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
within	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
is	O
controlled	O
by	O
cellular	B-ANAT
immunity	O
.	O

The	O
most	O
common	O
presenting	O
symptoms	O
were	O
fever	O
(	O
in	O
100	O
percent	O
of	O
cases	O
)	O
and	O
malaise	O
(	O
in	O
70	O
percent	O
),	O
followed	O
by	O
nonproductive	O
cough	O
(	O
in	O
100	O
percent	O
)	O
and	O
dyspnea	O
(	O
in	O
80	O
percent	O
)	O
associated	O
with	O
infiltrates	O
on	O
chest	B-ANAT
radiography	O
(	O
in	O
100	O
percent	O
).	O

When	O
colonic	B-ANAT
obstruction	O
is	O
suspected	O
,	O
one	O
should	O
always	O
consider	O
the	O
possibility	O
of	O
the	O
occurrence	O
of	O
Ogilvie	O
'	O
s	O
syndrome	O

The	O
platelet	B-ANAT
count	O
was	O
10	O
x	O
10	O
(	O
4	O
)/	O
microl	O
or	O
lower	O
in	O
8	O
(	O
28	O
%)	O
patients	O
.	O

In	O
a	O
multivariate	O
analysis	O
,	O
the	O
independent	O
predictors	O
of	O
an	O
adverse	O
outcome	O
were	O
advanced	O
age	O
(	O
odds	O
ratio	O
per	O
decade	O
of	O
life	O
,	O
1	O
.	O
80	O
;	O
95	O
percent	O
confidence	O
interval	O
,	O
1	O
.	O
16	O
to	O
2	O
.	O
81	O
;	O
P	O
=	O
0	O
.	O
009	O
),	O
a	O
high	O
peak	O
lactate	O
dehydrogenase	O
level	O
(	O
odds	O
ratio	O
per	O
100	O
U	O
per	O
liter	O
,	O
2	O
.	O
09	O
;	O
95	O
percent	O
confidence	O
interval	O
,	O
1	O
.	O
28	O
to	O
3	O
.	O
42	O
;	O
P	O
=	O
0	O
.	O
003	O
),	O
and	O
an	O
absolute	O
neutrophil	B-ANAT
count	O
that	O
exceeded	O
the	O
upper	O
limit	O
of	O
the	O
normal	O
range	O
on	O
presentation	O
(	O
odds	O
ratio	O
,	O
1	O
.	O
60	O
;	O
95	O
percent	O
confidence	O
interval	O
,	O
1	O
.	O
03	O
to	O
2	O
.	O
50	O
;	O
P	O
=	O
0	O
.	O
04	O
).	O

This	O
article	O
reviews	O
some	O
of	O
the	O
physiologic	O
actions	O
of	O
proteases	O
,	O
specifically	O
elastase	O
,	O
the	O
evidence	O
for	O
neutrophil	B-ANAT
elastase	O
involvement	O
in	O
ARDS	O
,	O
and	O
the	O
potential	O
therapeutic	O
use	O
of	O
neutrophil	B-ANAT
elastase	O
inhibitors	O
in	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Chronic	O
alcohol	O
abuse	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

Fibrin	O
deposition	O
is	O
an	O
important	O
feature	O
of	O
pulmonary	B-ANAT
infection	O
or	O
severe	O
inflammation	O
.	O

The	O
mechanisms	O
that	O
contribute	O
to	O
this	O
fibrin	O
deposition	O
are	O
bronchoalveolar	O
tissue	B-ANAT
factor	O
-	O
mediated	O
thrombin	O
generation	O
and	O
localized	O
depression	O
of	O
urokinase	O
plasminogen	O
activator	O
-	O
mediated	O
fibrinolysis	O
,	O
caused	O
by	O
the	O
increase	O
of	O
plasminogen	O
activator	O
inhibitors	O
.	O

Coagulation	O
and	O
fibrinolytic	O
proteins	O
may	O
have	O
an	O
additional	O
role	O
beyond	O
fibrin	O
turnover	O
and	O
inflammation	O
,	O
e	O
.	O
g	O
.,	O
in	O
mechanisms	O
mediating	O
cell	B-ANAT
recruitment	O
and	O
migration	O
.	O

During	O
critical	O
illness	O
,	O
neurohumoral	O
factors	O
,	O
cytokines	O
,	O
endothelin	O
,	O
and	O
atrial	B-ANAT
natriuretic	O
peptide	O
all	O
may	O
participate	O
in	O
HPA	B-ANAT
axis	B-ANAT
activation	O
,	O
resulting	O
in	O
elevated	O
plasma	B-ANAT
cortisol	O
production	O
and	O
plasma	B-ANAT
concentrations	O
.	O

For	O
clinical	O
use	O
in	O
adults	O
,	O
a	O
trial	O
of	O
HFOV	O
may	O
be	O
considered	O
when	O
Fio	O
(	O
2	O
)	O
requirements	O
exceed	O
60	O
%	O
and	O
mean	O
airway	B-ANAT
pressure	O
is	O
approaching	O
20	O
cm	O
H	O
(	O
2	O
)	O
O	O
or	O
higher	O
(	O
or	O
,	O
alternatively	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
of	O
>	O
15	O
cm	O
H	O
(	O
2	O
)	O
O	O
).	O

TITLE	O
:	O
Anticoagulant	O
therapy	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Heparin	O
,	O
despite	O
effectively	O
inhibiting	O
thrombin	O
formation	O
,	O
has	O
not	O
shown	O
consistent	O
benefits	O
in	O
reducing	O
lung	B-ANAT
injury	O
,	O
and	O
its	O
efficacy	O
has	O
not	O
yet	O
been	O
evaluated	O
in	O
a	O
controlled	O
study	O
.	O

Activated	O
protein	O
C	O
administration	O
has	O
been	O
shown	O
to	O
improve	O
survival	O
and	O
lung	B-ANAT
function	O
in	O
both	O
animal	O
and	O
clinical	O
studies	O
.	O

Consequently	O
,	O
several	O
alternative	O
ways	O
to	O
selectively	O
modulate	O
pulmonary	B-ANAT
vascular	B-ANAT
tone	O
in	O
patients	O
with	O
ARDS	O
may	O
be	O
available	O
in	O
the	O
near	O
future	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gases	O
,	O
cardiovascular	B-ANAT
hemodynamics	O
,	O
dynamic	O
lung	B-ANAT
compliance	O
,	O
and	O
total	O
lung	B-ANAT
injury	O
scores	O
were	O
measured	O
.	O

In	O
the	O
CMV	O
group	O
,	O
these	O
deleterious	O
conditions	O
remained	O
during	O
the	O
4	O
-	O
hr	O
observation	O
period	O
,	O
and	O
severe	O
lung	B-ANAT
injury	O
was	O
noted	O
histologically	O
.	O

ABSTRACT	O
:	O
In	O
1914	O
,	O
Schottmueller	O
wrote	O
""""	O
Septicemia	O
is	O
a	O
state	O
of	O
microbial	O
invasion	O
from	O
a	O
portal	B-ANAT
of	O
entry	O
into	O
the	O
blood	B-ANAT
stream	O
which	O
causes	O
signs	O
of	O
illness	O
.	O

Establishment	O
of	O
coronavirus	O
NS2	O
-	O
specific	O
,	O
HLA	B-ANAT
-	O
A2	O
-	O
restricted	O
CD8	O
(+)-	O
T	O
-	O
cell	B-ANAT
clones	I-ANAT
and	O
ex	O
vivo	O
analysis	O
of	O
HPV16	O
E7	O
specific	O
T	B-ANAT
cells	I-ANAT
obtained	O
by	O
HLA	B-ANAT
-	O
A2	O
tetramer	O
-	O
guided	O
sorting	O
from	O
PBL	O
or	O
tumor	B-ANAT
-	I-ANAT
infiltrating	I-ANAT
lymphocytes	I-ANAT
obtained	O
from	O
patients	O
with	O
cervical	B-ANAT
cancer	O
showed	O
that	O
cross	O
-	O
reactivity	O
with	O
HPV16	O
E7	O
(	O
11	O
-	O
19	O
(	O
20	O
))	O
and	O
coronavirus	O
NS2	O
(	O
52	O
-	O
60	O
)	O
represents	O
a	O
common	O
feature	O
of	O
this	O
antiviral	O
immune	O
response	O
defined	O
by	O
cytokine	O
production	O
.	O

Fecal	B-ANAT
shedding	O
of	O
BoTV	O
was	O
detected	O
in	O
15	O
of	O
62	O
(	O
24	O
%)	O
calves	O
by	O
use	O
of	O
ELISA	O
and	O
RT	O
-	O
PCR	O
assay	O
,	O
with	O
peak	O
shedding	O
on	O
day	O
4	O
.	O

To	O
assess	O
potential	O
gender	O
effects	O
,	O
we	O
performed	O
a	O
retrospective	O
case	O
-	O
controlled	O
study	O
matching	O
female	O
patients	O
to	O
male	O
counterparts	O
for	O
overall	O
injury	O
severity	O
;	O
hemodynamic	O
status	O
at	O
admission	O
;	O
and	O
head	B-ANAT
,	O
chest	B-ANAT
,	O
and	O
abdomen	B-ANAT
Abbreviated	O
Injury	O
Scale	O
score	O
.	O

Surface	O
marker	O
analysis	O
of	O
these	O
blasts	B-ANAT
showed	O
the	O
following	O
:	O
CD3	O
(-),	O
CD5	O
(-),	O
CD7	O
(-),	O
CD10	O
(+),	O
CD19	O
(+),	O
CD13	O
(+),	O
CD14	O
(-),	O
CD33	O
(+),	O
CD34	O
(+),	O
CD41a	O
(-),	O
and	O
CD56	O
(-).	O

ABSTRACT	O
:	O
The	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
of	O
canine	O
coronavirus	O
(	O
CCoV	O
)	O
was	O
cloned	O
and	O
expressed	O
in	O
E	O
.	O
coli	O
.	O

Fifty	O
serum	B-ANAT
samples	O
,	O
screened	O
previously	O
by	O
whole	O
virus	O
ELISA	O
and	O
Western	O
blotting	O
,	O
were	O
tested	O
.	O

We	O
defined	O
the	O
clinical	O
presentation	O
and	O
risk	O
factors	O
associated	O
with	O
severe	O
disease	O
and	O
investigated	O
the	O
causal	O
agents	O
by	O
chest	B-ANAT
radiography	O
and	O
laboratory	O
testing	O
of	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
and	O
sera	B-ANAT
samples	O
.	O

Laboratory	O
-	O
reared	O
flies	O
were	O
experimentally	O
exposed	O
to	O
TCV	O
by	O
allowing	O
flies	O
to	O
imbibe	O
an	O
inoculum	O
comprised	O
of	O
turkey	O
embryo	B-ANAT
-	O
propagated	O
virus	O
(	O
NC95	O
strain	O
).	O

Six	O
animals	O
were	O
treated	O
2	O
hours	O
after	O
the	O
live	O
bacteria	O
with	O
site	O
-	O
inactivated	O
Factor	O
VIIa	O
,	O
a	O
competitive	O
tissue	B-ANAT
factor	O
inhibitor	O
,	O
and	O
six	O
animals	O
were	O
vehicle	O
-	O
treated	O
sepsis	O
control	O
subjects	O
.	O

TITLE	O
:	O
Coronary	B-ANAT
thrombosis	O
and	O
sudden	O
death	O
after	O
an	O
enteroviral	O
infection	O
.	O

Multiple	O
organ	B-ANAT
distress	O
syndrome	O
(	O
MODS	O
)	O
and	O
renal	B-ANAT
impairment	O
are	O
relatively	O
rare	O
but	O
correlated	O
with	O
death	O
.	O

In	O
previous	O
publications	O
,	O
in	O
patients	O
who	O
did	O
not	O
survive	O
OPP	O
,	O
their	O
deaths	O
were	O
due	O
to	O
MODS	O
or	O
acute	O
renal	B-ANAT
failure	O
.	O

Just	O
as	O
in	O
compartment	B-ANAT
syndrome	O
in	O
the	O
extremities	B-ANAT
,	O
gut	B-ANAT
mucosal	B-ANAT
ischemia	O
begins	O
long	O
before	O
clinical	O
signs	O
are	O
evident	O
,	O
explaining	O
the	O
name	O
of	O
""""	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
""""	O
given	O
to	O
the	O
acute	O
,	O
markedly	O
increased	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
.	O

The	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
was	O
initially	O
described	O
in	O
patients	O
with	O
severe	O
abdominal	B-ANAT
injuries	O
and	O
massive	O
transfusions	O
and	O
crystalloid	B-ANAT
infusions	O
,	O
caused	O
by	O
the	O
closure	O
of	O
fascia	B-ANAT
or	O
skin	B-ANAT
under	O
tension	O
,	O
the	O
use	O
of	O
bulky	O
abdominal	B-ANAT
packs	O
to	O
control	O
diffuse	O
bleeding	O
,	O
the	O
massive	O
bowel	B-ANAT
distension	O
and	O
edema	O
,	O
and	O
the	O
continued	O
bleeding	O
into	O
the	O
abdominal	B-ANAT
cavity	I-ANAT
.	O

ABSTRACT	O
:	O
A	O
33	O
-	O
year	O
-	O
old	O
doctor	O
contracted	O
severe	O
acute	O
respiratory	O
syndrome	O
presenting	O
with	O
features	O
of	O
disseminated	O
intravascular	O
coagulopathy	O
without	O
changes	O
in	O
the	O
chest	B-ANAT
radiograph	O
initially	O
.	O

The	O
following	O
complications	O
were	O
found	O
:	O
acute	O
oliguric	O
renal	B-ANAT
failure	O
(	O
9	O
),	O
HELLP	O
-	O
syndrome	O
(	O
4	O
),	O
cerebral	B-ANAT
haemorrhage	O
(	O
4	O
),	O
acute	O
lung	B-ANAT
oedema	O
(	O
3	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
1	O
).	O

Preoperative	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
and	O
bronchoscopy	O
showed	O
that	O
from	O
the	O
level	O
of	O
12	O
mm	O
beneath	O
the	O
coricoid	O
cartilage	B-ANAT
,	O
the	O
trachea	B-ANAT
tapered	O
and	O
continuing	O
to	O
the	O
tracheal	B-ANAT
carina	I-ANAT
and	O
that	O
the	O
smallest	O
tracheal	O
level	O
was	O
located	O
18	O
mm	O
distal	O
from	O
the	O
coricoid	O
cartilage	B-ANAT
,	O
the	O
area	O
of	O
which	O
was	O
4	O
mm2	O
.	O

We	O
report	O
a	O
postoperative	O
pulmonary	B-ANAT
edema	O
,	O
which	O
was	O
temporally	O
and	O
clinically	O
compatible	O
with	O
TRALI	O
.	O

SARS	O
is	O
a	O
new	O
and	O
highly	O
contagious	O
lung	B-ANAT
disease	O
.	O

CONCLUSIONS	O
:	O
SARS	O
is	O
a	O
new	O
and	O
highly	O
contagious	O
lung	B-ANAT
disease	O
.	O

Following	O
RCV	O
infection	O
,	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	B-ANAT
)	O
pools	O
of	O
different	O
dimensions	O
were	O
observed	O
in	O
the	O
cytoplasm	B-ANAT
of	O
the	O
thymic	O
epithelial	B-ANAT
reticular	I-ANAT
cells	I-ANAT
,	O
merging	O
subsequently	O
with	O
each	O
other	O
into	O
larger	O
ER	B-ANAT
lakes	O
filled	O
with	O
particles	O
of	O
mature	O
RCV	O
,	O
or	O
viral	B-ANAT
inclusion	I-ANAT
bodies	I-ANAT
.	O

The	O
ER	O
lakes	O
are	O
involved	O
in	O
the	O
maturation	O
of	O
the	O
viruses	O
,	O
and	O
the	O
envelop	O
and	O
nuclear	O
capsid	B-ANAT
of	O
the	O
virus	O
entering	O
the	O
cells	B-ANAT
from	O
extracellular	B-ANAT
space	I-ANAT
are	O
removed	O
and	O
degraded	O
in	O
the	O
endosome	B-ANAT
/	O
lysosome	B-ANAT
.	O

Mature	O
RCV	O
particles	O
were	O
distributed	O
around	O
the	O
ER	O
pools	O
,	O
cytoplasm	B-ANAT
,	O
and	O
intercellular	B-ANAT
space	I-ANAT
,	O
and	O
the	O
RCVs	O
in	O
the	O
endosome	B-ANAT
/	O
lysosome	B-ANAT
were	O
devoid	O
of	O
the	O
envelop	O
and	O
nuclear	O
capsid	B-ANAT
.	O

Radiographic	O
appearances	O
of	O
pulmonary	B-ANAT
parenchymal	O
abnormality	O
,	O
distribution	O
,	O
and	O
extent	O
of	O
involvement	O
on	O
initial	O
chest	B-ANAT
radiographs	O
were	O
documented	O
.	O

In	O
most	O
patients	O
,	O
peripheral	O
lung	B-ANAT
involvement	O
was	O
more	O
common	O
(	O
81	O
of	O
108	O
,	O
75	O
.	O
0	O
%).	O

Ask	O
security	O
to	O
screen	O
all	O
patients	O
arriving	O
by	O
car	B-ANAT
before	O
they	O
enter	O
the	O
ED	O
.	O

Granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
increased	O
alveolar	B-ANAT
neutrophil	B-ANAT
recruitment	O
,	O
pulmonary	B-ANAT
edema	O
,	O
and	O
lung	B-ANAT
myeloperoxidase	O
activity	O
on	O
day	O
4	O
.	O

0	O
.	O
06	O
mL	O
/	O
kPa	O
;	O
and	O
bleomycin	O
+	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
,	O
0	O
.	O
65	O
+/-	O

Lidocaine	O
,	O
which	O
prevents	O
neutrophil	B-ANAT
adhesion	O
to	O
endothelial	B-ANAT
cells	I-ANAT
,	O
inhibited	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
-	O
related	O
exacerbation	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
cells	B-ANAT
and	O
pulmonary	B-ANAT
edema	O
)	O
and	O
pulmonary	B-ANAT
fibrosis	O
(	O
lung	B-ANAT
static	O
compliance	O
and	O
morphologic	O
changes	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
is	O
a	O
frequent	O
complication	O
of	O
severe	O
sepsis	O
or	O
blood	B-ANAT
loss	O
and	O
is	O
often	O
associated	O
with	O
an	O
excessive	O
inflammatory	O
response	O
requiring	O
mechanical	O
ventilation	O
.	O

The	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
and	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
2	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
were	O
lower	O
and	O
interleukin	O
-	O
10	O
was	O
higher	O
in	O
the	O
albumin	O
-	O
treated	O
groups	O
than	O
in	O
the	O
Ringer	O
'	O
s	O
lactate	O
group	O
.	O

TITLE	O
:	O
Treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
with	O
convalescent	O
plasma	B-ANAT
.	O

He	O
developed	O
progressive	O
respiratory	O
symptoms	O
and	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
during	O
the	O
second	O
week	O
of	O
his	O
illness	O
.	O

TITLE	O
:	O
Extracorporeal	O
gas	O
exchange	O
with	O
the	O
DeltaStream	O
rotary	O
blood	B-ANAT
pump	O
in	O
experimental	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
In	O
most	O
severe	O
cases	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
used	O
to	O
facilitate	O
gas	O
exchange	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
test	O
the	O
safety	O
and	O
efficacy	O
of	O
the	O
DeltaStream	O
pump	O
for	O
ECMO	O
in	O
animals	O
with	O
normal	O
lung	B-ANAT
function	O
and	O
experimental	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

We	O
concluded	O
that	O
the	O
DeltaStream	O
blood	B-ANAT
pump	O
may	O
be	O
used	O
for	O
veno	O
-	O
venous	B-ANAT
ECMO	O
without	O
major	O
blood	B-ANAT
damage	O
or	O
hemodynamic	O
impairment	O
.	O

TITLE	O
:	O
Lung	B-ANAT
pathology	O
of	O
fatal	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Electron	O
microscopy	O
revealed	O
viral	B-ANAT
particles	I-ANAT
in	O
the	O
cytoplasm	B-ANAT
of	O
epithelial	B-ANAT
cells	I-ANAT
corresponding	O
to	O
coronavirus	O
.	O

In	O
a	O
patient	O
with	O
severe	O
ARDS	O
,	O
oxygenation	O
failure	O
under	O
maximized	O
ventilatory	O
settings	O
,	O
and	O
subsequent	O
five	O
-	O
organ	B-ANAT
system	I-ANAT
failure	O
,	O
an	O
integrated	O
therapeutical	O
approach	O
comprising	O
ECMO	O
,	O
NO	O
,	O
kinetic	O
therapy	O
,	O
surfactant	O
,	O
and	O
urodilatin	O
did	O
cross	O
-	O
bridge	O
respiratory	O
and	O
vital	O
functions	O
,	O
enabling	O
overall	O
survival	O
.	O

The	O
clinical	O
course	O
was	O
complicated	O
by	O
hypotension	O
requiring	O
multiple	O
vasopressors	O
;	O
coagulopathy	O
requiring	O
more	O
than	O
35	O
U	O
of	O
packed	O
red	O
cells	B-ANAT
,	O
more	O
than	O
50	O
U	O
of	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
,	O
and	O
more	O
than	O
80	O
U	O
of	O
platelets	B-ANAT
;	O
acute	O
renal	B-ANAT
failure	O
requiring	O
dialysis	O
;	O
and	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
requiring	O
intricate	O
ventilator	O
management	O
.	O

Nutrition	O
intervention	O
began	O
on	O
post	O
-	O
trauma	O
day	O
4	O
with	O
total	O
parenteral	O
nutrition	O
due	O
to	O
hypotension	O
,	O
resuscitation	O
,	O
and	O
massive	O
bowel	B-ANAT
edema	O
;	O
by	O
post	O
-	O
trauma	O
day	O
8	O
.	O

On	O
post	O
-	O
trauma	O
day	O
27	O
,	O
bowel	B-ANAT
edema	O
was	O
significantly	O
less	O
,	O
and	O
a	O
nasoenteric	O
feeding	O
tube	O
was	O
placed	O
and	O
enteral	O
feeding	O
initiated	O
.	O

Nutrient	O
provision	O
was	O
adjusted	O
daily	O
to	O
account	O
for	O
organ	B-ANAT
and	O
metabolic	O
changes	O
including	O
hepatic	B-ANAT
,	O
pulmonary	B-ANAT
,	O
and	O
renal	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
after	O
chemotherapy	O
for	O
lung	B-ANAT
metastases	O
from	O
non	O
-	O
seminomatous	O
germ	O
-	O
cell	B-ANAT
tumors	O
.	O

Pneumonia	O
virus	O
of	O
mice	O
(	O
PVM	O
)	O
also	O
infects	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
,	O
like	O
Sendai	O
virus	O
,	O
may	O
induce	O
a	O
persistent	O
wasting	O
disease	O
syndrome	O
in	O
immunodeficient	O
mice	O
.	O

The	O
harmful	O
effects	O
on	O
the	O
lung	B-ANAT
tissues	I-ANAT
and	O
resident	O
leucocytes	B-ANAT
of	O
these	O
malignant	O
factors	O
are	O
suspected	O
to	O
be	O
profoundly	O
involved	O
in	O
TRALI	O
reactions	O
.	O

Moreover	O
,	O
MHC	B-ANAT
class	O
II	O
DR	O
-	O
expressing	O
PMNs	O
were	O
also	O
proved	O
to	O
express	O
a	O
high	O
-	O
affinity	O
receptor	O
for	O
immunoglobulin	O
E	O
(	O
IgE	O
)	O
(	O
FcepsilonRI	O
)	O
and	O
to	O
produce	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
,	O
interferon	O
-	O
gamma	O
and	O
interleukin	O
-	O
18	O
following	O
a	O
challenge	O
with	O
an	O
anti	O
-	O
MHC	B-ANAT
class	O
II	O
DR	O
monoclonal	O
Ab	O
(	O
MoAb	O
)	O
or	O
anti	O
-	O
DR	O
antiserum	O
.	O

Furthermore	O
,	O
FcepsilonRI	O
expression	O
,	O
in	O
GM	O
-	O
CSF	B-ANAT
-	O
treated	O
PMNs	O
,	O
suggests	O
the	O
involvement	O
of	O
PMNs	O
in	O
IgE	O
-	O
mediated	O
immune	O
reactions	O
.	O

Accordingly	O
,	O
a	O
3D	O
model	O
for	O
the	O
SARS	O
-	O
CoV	O
3CL	O
proteinase	O
was	O
constructed	O
based	O
on	O
the	O
crystal	B-ANAT
structure	O
of	O
TGEV	O
Mpro	O
.	O

TITLE	O
:	O
Takayasu	O
arteritis	O
presenting	O
as	O
a	O
pulmonary	B-ANAT
-	O
renal	B-ANAT
syndrome	O
.	O

Percutaneous	O
transluminal	O
angioplasty	O
of	O
the	O
left	B-ANAT
renal	I-ANAT
artery	I-ANAT
normalized	O
kidney	B-ANAT
function	O
.	O

TITLE	O
:	O
Recombinant	O
platelet	B-ANAT
-	O
activating	O
factor	O
acetylhydrolase	O
to	O
prevent	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
mortality	O
in	O
severe	O
sepsis	O
:	O
Phase	O
IIb	O
,	O
multicenter	O
,	O
randomized	O
,	O
placebo	O
-	O
controlled	O
,	O
clinical	O
trial	O
.	O

We	O
report	O
the	O
3	O
cases	O
of	O
acute	O
aortic	B-ANAT
dissection	O
,	O
involving	O
both	O
parents	O
and	O
their	O
son	O
.	O

We	O
attempted	O
to	O
perform	O
cardiac	B-ANAT
massage	O
,	O
but	O
we	O
could	O
not	O
bring	O
her	O
back	B-ANAT
to	O
life	O
.	O

ABSTRACT	O
:	O
After	O
infecting	O
the	O
Vero	O
E6	O
cells	B-ANAT
by	O
nasal	B-ANAT
/	O
throat	B-ANAT
swabs	O
collected	O
from	O
SARS	O
patients	O
,	O
we	O
studied	O
the	O
SARS	O
-	O
associated	O
virus	O
by	O
electron	O
microscopy	O
and	O
molecular	O
biological	O
technique	O
.	O

The	O
tracheas	B-ANAT
of	O
challenged	O
birds	O
were	O
analyzed	O
by	O
RT	O
-	O
PCR	O
and	O
re	O
-	O
isolation	O
of	O
virus	O
.	O

TITLE	O
:	O
Novel	O
neutrophil	B-ANAT
elastase	O
inhibitors	O
as	O
a	O
treatment	O
for	O
neutrophil	B-ANAT
-	O
predominant	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

Although	O
precise	O
pathogenic	O
mechanisms	O
have	O
been	O
under	O
debate	O
,	O
the	O
NE	O
-	O
mediated	O
severe	O
pulmonary	B-ANAT
tissue	B-ANAT
damage	O
,	O
based	O
upon	O
the	O
protease	O
-	O
antiprotease	O
imbalance	O
hypothesis	O
,	O
may	O
be	O
a	O
major	O
pathogenic	O
determinant	O
of	O
these	O
diseases	O
,	O
in	O
particular	O
COPD	O
.	O

Novel	O
aggressive	O
therapeutic	O
approaches	O
to	O
these	O
lung	B-ANAT
disorders	O
are	O
required	O
,	O
and	O
prevention	O
of	O
NE	O
release	O
may	O
be	O
considered	O
as	O
a	O
promising	O
strategy	O
for	O
disease	O
outcome	O
.	O

Twenty	O
-	O
four	O
patients	O
(	O
10	O
men	O
,	O
14	O
women	O
;	O
mean	O
age	O
,	O
39	O
years	O
;	O
age	O
range	O
,	O
23	O
-	O
70	O
years	O
)	O
with	O
confirmed	O
SARS	O
underwent	O
follow	O
-	O
up	O
thin	O
-	O
section	O
CT	O
of	O
the	O
thorax	B-ANAT
.	O

Patients	O
in	O
group	O
1	O
were	O
older	O
(	O
mean	O
age	O
,	O
45	O
vs	O
30	O
.	O
3	O
years	O
),	O
had	O
a	O
higher	O
rate	O
of	O
intensive	O
care	O
unit	O
admission	O
(	O
27	O
%	O
[	O
four	O
of	O
15	O
]	O
vs	O
11	O
%	O
[	O
one	O
of	O
nine	O
]),	O
more	O
requirement	O
for	O
pulsed	O
intravenous	O
methylprednisolone	O
(	O
87	O
%,	O
[	O
13	O
of	O
15	O
]	O
vs	O
67	O
%	O
[	O
six	O
of	O
nine	O
]),	O
higher	O
peak	O
lactate	O
dehydrogenase	O
level	O
(	O
438	O
.	O
9	O
vs	O
355	O
.	O
6	O
U	O
/	O
L	O
),	O
and	O
higher	O
peak	O
opacification	O
on	O
chest	B-ANAT
radiographs	O
(	O
estimated	O
area	O
,	O
14	O
%	O
vs	O
11	O
%)	O
than	O
patients	O
in	O
group	O
2	O
.	O

CONCLUSIONS	O
:	O
Pulmonary	B-ANAT
fibrosis	O
may	O
develop	O
early	O
in	O
patients	O
with	O
SARS	O
who	O
have	O
been	O
discharged	O
after	O
treatment	O
.	O

Recommended	O
infection	O
-	O
control	O
precautions	O
include	O
the	O
use	O
of	O
negative	O
-	O
pressure	O
isolation	O
rooms	O
where	O
available	O
;	O
N95	O
or	O
higher	O
level	O
of	O
respiratory	O
protection	O
;	O
gloves	O
,	O
gowns	O
,	O
and	O
eye	B-ANAT
protection	O
;	O
and	O
careful	O
hand	O
hygiene	O
.	O

As	O
an	O
infectious	O
disease	O
spreading	O
through	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
SARS	O
is	O
featured	O
by	O
the	O
inconsistency	O
between	O
its	O
clinical	O
representations	O
,	O
physical	O
signs	O
of	O
the	O
lungs	B-ANAT
and	O
chest	B-ANAT
imaging	O
findings	O
.	O

Of	O
the	O
11	O
patients	O
,	O
six	O
had	O
cardiovascular	B-ANAT
involvement	O
that	O
manifested	O
as	O
shock	O
in	O
three	O
and	O
as	O
capillary	B-ANAT
leak	O
syndrome	O
in	O
three	O
.	O

Liver	B-ANAT
failure	O
occurred	O
in	O
three	O
and	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
involvement	O
and	O
coma	O
in	O
three	O
.	O

The	O
clinical	O
presentation	O
is	O
unspecific	O
and	O
includes	O
fever	O
,	O
respiratory	O
symptoms	O
,	O
lymphopenia	O
and	O
pulmonary	B-ANAT
infiltrates	O
on	O
X	O
-	O
ray	O
.	O

In	O
this	O
study	O
,	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
the	O
amino	O
terminal	O
half	O
of	O
the	O
S	O
glycoprotein	O
gene	O
of	O
one	O
Korean	O
field	O
TGEV	O
strain	O
(	O
133	O
)	O
isolated	O
in	O
1997	O
and	O
three	O
Korean	O
field	O
TGEV	O
strains	O
(	O
KT2	O
,	O
KT3	O
and	O
KT4	O
)	O
isolated	O
in	O
2000	O
and	O
HKT2	O
strain	O
,	O
KT2	O
passaged	O
104	O
times	O
in	O
ST	O
cells	B-ANAT
,	O
were	O
determined	O
.	O

Within	O
1	O
h	O
of	O
CEES	O
infusion	O
at	O
4	O
mg	O
/	O
kg	O
,	O
high	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
alpha	O
),	O
ceramides	O
,	O
and	O
nuclear	O
factor	O
kappaB	O
accumulated	O
in	O
lung	B-ANAT
and	O
alveolar	B-ANAT
macrophages	I-ANAT
.	O

Subsets	O
of	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
were	O
analysed	O
in	O
31	O
patients	O
.	O

Low	O
concentrations	O
of	O
viral	B-ANAT
genome	I-ANAT
are	O
also	O
detectable	O
in	O
feces	B-ANAT
.	O

Detection	O
of	O
sgmRNAs	O
in	O
virions	B-ANAT
by	O
specific	O
reverse	O
transcription	O
-	O
PCRs	O
(	O
RT	O
-	O
PCRs	O
)	O
was	O
related	O
to	O
the	O
purity	O
of	O
virus	O
preparations	O
.	O

The	O
presence	O
of	O
this	O
packaging	O
signal	O
was	O
further	O
confirmed	O
by	O
showing	O
the	O
expression	O
and	O
rescue	O
of	O
the	O
mRNA	O
including	O
the	O
first	O
649	O
nt	O
of	O
the	O
TGEV	O
genome	O
under	O
control	O
of	O
the	O
cytomegalovirus	O
promoter	O
in	O
TGEV	O
-	O
infected	O
cells	B-ANAT
.	O

High	O
-	O
resolution	O
computerized	O
tomography	O
of	O
the	O
thorax	B-ANAT
was	O
an	O
early	O
diagnostic	O
tool	O
if	O
the	O
chest	B-ANAT
radiograph	O
was	O
negative	O
.	O

Additional	O
cannulae	O
placed	O
at	O
the	O
initiation	O
of	O
venovenous	O
ECMO	O
could	O
be	O
beneficial	O
in	O
achieving	O
flow	O
rates	O
necessary	O
for	O
adequate	O
oxygenation	O
and	O
lung	B-ANAT
rest	O
.	O

Immunofluorescent	O
studies	O
revealed	O
that	O
the	O
normal	O
3b	O
protein	O
was	O
localized	O
to	O
the	O
nucleus	B-ANAT
and	O
the	O
truncated	O
product	O
showed	O
a	O
""""	O
free	O
""""	O
distribution	O
pattern	O
,	O
indicating	O
that	O
the	O
C	O
-	O
terminal	O
portion	O
of	O
3b	O
was	O
responsible	O
for	O
its	O
nuclear	O
localization	O
.	O

ABSTRACT	O
:	O
Chemical	O
modification	O
of	O
the	O
proteins	O
bovine	O
serum	B-ANAT
albumin	O
,	O
alpha	O
-	O
lactalbumin	O
,	O
beta	O
-	O
lactoglobulin	O
and	O
chicken	O
lysozyme	O
by	O
3	O
-	O
hydroxyphthalic	O
anhydride	O
(	O
3	O
-	O
HP	O
)	O
yielded	O
compounds	O
which	O
exerted	O
antiviral	O
activity	O
in	O
vitro	O
as	O
compared	O
with	O
the	O
native	O
unmodified	O
proteins	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
177	O
free	O
-	O
ranging	O
chickens	O
from	O
19	O
Qwa	O
-	O
Qwa	O
villages	O
were	O
bled	O
from	O
wing	B-ANAT
veins	B-ANAT
over	O
a	O
period	O
of	O
6	O
months	O
(	O
June	O
-	O
November	O
2000	O
).	O

The	O
appearing	O
time	O
,	O
site	O
,	O
range	O
and	O
imaging	O
features	O
of	O
pulmonary	B-ANAT
lesions	O
in	O
chest	B-ANAT
radiograms	O
were	O
observed	O
in	O
118	O
patients	O
with	O
clinically	O
confirmed	O
SARS	O
treated	O
in	O
our	O
hospital	O
.	O

In	O
seven	O
non	O
-	O
survivors	O
,	O
the	O
lesions	O
were	O
included	O
multi	O
-	O
lung	B-ANAT
lobes	B-ANAT
,	O
revealing	O
earlier	O
appearance	O
and	O
faster	O
progression	O
compared	O
with	O
the	O
others	O
.	O

SARS	O
clinically	O
presents	O
with	O
high	O
-	O
grade	O
fever	O
,	O
chills	O
and	O
rigors	O
,	O
myalgia	O
,	O
headache	O
,	O
cough	O
with	O
or	O
without	O
sputum	B-ANAT
production	O
,	O
dyspnea	O
,	O
and	O
dizziness	O
.	O

Chest	B-ANAT
radiographs	O
reveal	O
unilateral	O
or	O
bilateral	O
,	O
predominantly	O
peripheral	O
,	O
areas	O
of	O
consolidation	O
progressing	O
with	O
in	O
a	O
short	O
time	O
of	O
bilateral	O
patchy	O
consolidation	O
.	O

Collagen	B-ANAT
increment	O
was	O
dose	O
and	O
time	O
dependent	O
.	O

We	O
postulate	O
that	O
hematopoietic	O
growth	O
factors	O
such	O
as	O
G	O
-	O
CSF	B-ANAT
,	O
by	O
mobilizing	O
endogenous	O
blood	B-ANAT
stem	B-ANAT
cells	I-ANAT
and	O
endogenous	O
cytokines	O
,	O
could	O
become	O
a	O
hematological	O
treatment	O
for	O
SARS	O
patients	O
,	O
which	O
may	O
enhance	O
the	O
immune	B-ANAT
system	I-ANAT
against	O
these	O
virus	O
.	O

There	O
was	O
also	O
massive	O
necrosis	O
of	O
splenic	B-ANAT
lymphoid	B-ANAT
tissue	I-ANAT
and	O
localized	O
necrosis	O
in	O
lymph	B-ANAT
nodes	I-ANAT
.	O

Systemic	O
vasculitis	O
included	O
oedema	O
,	O
localized	O
fibrinoid	O
necrosis	O
,	O
and	O
infiltration	O
of	O
monocytes	B-ANAT
,	O
lymphocytes	B-ANAT
,	O
and	O
plasma	B-ANAT
cells	I-ANAT
into	O
vessel	B-ANAT
walls	O
in	O
the	O
heart	B-ANAT
,	O
lung	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
adrenal	B-ANAT
gland	I-ANAT
,	O
and	O
the	O
stroma	B-ANAT
of	O
striated	B-ANAT
muscles	I-ANAT
.	O

The	O
main	O
symptoms	O
and	O
signs	O
of	O
the	O
SARS	O
patients	O
would	O
include	O
fever	O
,	O
cough	O
and	O
chest	B-ANAT
X	O
-	O
ray	O
changes	O
.	O

Head	B-ANAT
trauma	O
patients	O
with	O
ALI	O
had	O
a	O
significantly	O
higher	O
ISS	O
,	O
a	O
greater	O
number	O
of	O
days	O
on	O
the	O
ventilator	O
,	O
and	O
a	O
worse	O
neurologic	O
outcome	O
for	O
those	O
who	O
survived	O
their	O
hospitalization	O
.	O

No	O
correlation	O
was	O
found	O
between	O
the	O
severity	O
of	O
head	B-ANAT
injury	O
(	O
GCS	O
score	O
,	O
Marshall	O
score	O
,	O
or	O
intracranial	B-ANAT
abnormality	O
)	O
and	O
development	O
of	O
ALI	O
.	O

The	O
risk	O
of	O
developing	O
ALI	O
is	O
not	O
associated	O
with	O
specific	O
anatomic	O
lesions	O
diagnosed	O
by	O
cranial	B-ANAT
CT	O
scanning	O
.	O

Physical	O
examination	O
of	O
the	O
chest	B-ANAT
revealed	O
bubbling	O
rales	O
and	O
dullness	O
on	O
percussion	O
.	O

Serial	O
chest	B-ANAT
radiographs	O
showed	O
progressive	O
inflammatory	O
changes	O
.	O

One	O
patient	O
died	O
of	O
progressive	O
respiratory	O
failure	O
;	O
pathological	O
examination	O
of	O
the	O
lung	B-ANAT
showed	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
reported	O
an	O
experimental	O
infection	O
of	O
young	O
adults	O
with	O
a	O
history	O
of	O
episodic	O
and	O
exclusive	O
viral	O
wheeze	O
(	O
EVW	O
)	O
using	O
human	O
coronavirus	O
,	O
in	O
which	O
16	O
of	O
24	O
with	O
EVW	O
(	O
15	O
atopic	O
)	O
and	O
11	O
of	O
19	O
healthy	O
controls	O
(	O
seven	O
atopic	O
)	O
developed	O
a	O
symptomatic	O
cold	O
with	O
evidence	O
of	O
infection	O
,	O
but	O
only	O
those	O
with	O
EVW	O
developed	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
and	O
increased	O
airway	B-ANAT
responsiveness	O
.	O

Symptoms	O
and	O
airway	B-ANAT
responsiveness	O
were	O
correlated	O
with	O
change	O
in	O
neutrophils	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
major	O
virion	B-ANAT
structural	O
protein	O
.	O

RESULTS	O
:	O
The	O
IgM	O
positive	O
critical	O
value	O
of	O
0	O
.	O
233	O
and	O
IgG	O
of	O
0	O
.	O
239	O
were	O
selected	O
as	O
the	O
threshold	O
value	O
for	O
positive	O
results	O
that	O
equals	O
the	O
product	O
of	O
2	O
.	O
1	O
and	O
the	O
mean	O
IgM	O
and	O
IgG	O
levels	O
of	O
200	O
healthy	O
blood	B-ANAT
donors	O
.	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
rapid	O
and	O
efficient	O
method	O
for	O
preparing	O
monoclonal	O
antibodies	O
(	O
mAb	O
)	O
against	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
Cov	O
)	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
.	O

BALB	O
/	O
c	O
mice	O
were	O
injected	O
with	O
the	O
recombinant	O
N	O
protein	O
of	O
SARS	O
-	O
Cov	O
into	O
the	O
foot	B-ANAT
-	O
pads	O
for	O
the	O
immunization	O
,	O
and	O
the	O
popliteal	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
were	O
isolated	O
15	O
d	O
later	O
for	O
mAb	O
-	O
producing	O
hybridomas	B-ANAT
,	O
from	O
which	O
the	O
mAbs	O
against	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
Cov	O
were	O
screened	O
.	O

This	O
is	O
the	O
first	O
report	O
on	O
the	O
preparation	O
of	O
mAb	O
that	O
is	O
specific	O
to	O
the	O
SARS	O
-	O
Cov	O
,	O
and	O
the	O
high	O
-	O
specificity	O
and	O
high	O
-	O
affinity	O
mAb	O
produced	O
by	O
the	O
4	O
strains	O
of	O
hybridomas	B-ANAT
provide	O
a	O
basis	O
for	O
further	O
researches	O
on	O
the	O
pathogenesis	O
and	O
early	O
diagnosis	O
of	O
SARS	O
.	O

Most	O
cases	O
of	O
SARS	O
to	O
date	O
have	O
occurred	O
in	O
young	O
adults	O
and	O
this	O
disease	O
appears	O
to	O
spread	O
most	O
commonly	O
by	O
close	O
person	O
-	O
to	O
-	O
person	O
contact	O
,	O
involving	O
exposure	O
to	O
infectious	O
droplets	O
and	O
body	B-ANAT
fluids	I-ANAT
.	O

8	O
.	O
99	O
days	O
,	O
2	O
of	O
whom	O
showed	O
fibroid	O
cord	B-ANAT
-	O
like	O
changes	O
.	O

ABSTRACT	O
:	O
Detection	O
of	O
antiphospholipid	O
(	O
aPL	O
)	O
antibodies	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
of	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
suggests	O
involvement	O
of	O
autoimmune	O
mechanisms	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
.	O

0	O
.	O
14	O
(	O
neutrophil	B-ANAT
)	O
and	O
0	O
.	O
18	O
+/-	O

(	O
3	O
)	O
Other	O
most	O
common	O
symptoms	O
included	O
fatigue	O
(	O
93	O
.	O
8	O
%),	O
cough	O
(	O
85	O
.	O
4	O
%),	O
mild	O
sputum	B-ANAT
production	O
(	O
66	O
.	O
7	O
%),	O
chills	O
(	O
55	O
.	O
2	O
%),	O
headache	O
(	O
39	O
.	O
6	O
%),	O
general	O
malaise	O
(	O
35	O
.	O
4	O
%)	O
and	O
myalgia	O
(	O
21	O
.	O
9	O
%).	O

SARS	O
appears	O
to	O
be	O
quickly	O
infectious	O
and	O
potentially	O
lethal	O
among	O
health	O
care	O
workers	O
,	O
characterized	O
by	O
acute	O
onset	O
and	O
rapid	O
progression	O
,	O
and	O
mostly	O
bilateral	O
lung	B-ANAT
involvement	O
on	O
chest	B-ANAT
radiographs	O
.	O

TITLE	O
:	O
Measurement	O
of	O
subgroups	O
of	O
peripheral	B-ANAT
blood	I-ANAT
T	B-ANAT
lymphocytes	I-ANAT
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
its	O
clinical	O
significance	O
.	O

Subgroups	O
of	O
blood	B-ANAT
T	B-ANAT
lymphocytes	I-ANAT
in	O
93	O
patients	O
with	O
SARS	O
were	O
detected	O
by	O
flow	O
cytometer	O
.	O

The	O
counts	O
of	O
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+),	O
and	O
CD	O
(	O
8	O
)(+)	O
lymphocytes	B-ANAT
decreased	O
more	O
apparently	O
in	O
patients	O
with	O
severe	O
SARS	O
.	O

The	O
damage	O
of	O
cellular	B-ANAT
immunity	O
is	O
probably	O
an	O
important	O
mechanism	O
of	O
pathogenesis	O
of	O
SARS	O
.	O

SARS	O
is	O
pathologically	O
characterized	O
by	O
interstitial	B-ANAT
exudative	O
inflammation	O
of	O
lung	B-ANAT
with	O
the	O
formation	O
of	O
hyaline	B-ANAT
membrane	B-ANAT
in	O
acute	O
phase	O
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
as	O
a	O
possible	O
adverse	O
drug	O
reaction	O
related	O
to	O
gefitinib	O
.	O

Pulmonary	B-ANAT
lesions	O
included	O
:	O
bilateral	O
and	O
extensive	O
consolidation	O
,	O
localized	O
hemorrhage	O
and	O
necrosis	O
,	O
desquamative	O
alveolitis	O
and	O
bronchitis	O
,	O
alveolar	B-ANAT
proliferation	O
and	O
desquamation	O
,	O
accumulation	O
of	O
protein	O
exudates	B-ANAT
,	O
mononuclear	B-ANAT
cells	I-ANAT
,	O
lymphocytes	B-ANAT
,	O
and	O
plasma	B-ANAT
cells	I-ANAT
as	O
well	O
as	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
in	O
alveoli	B-ANAT
and	O
viral	B-ANAT
inclusion	I-ANAT
bodies	I-ANAT
were	O
seen	O
in	O
the	O
alveolus	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

There	O
were	O
lesions	O
of	O
systemic	O
small	O
vasculitis	O
including	O
edema	O
of	O
the	O
perivascular	O
tissue	B-ANAT
and	O
vascular	B-ANAT
wall	O
of	O
the	O
small	O
veins	B-ANAT
with	O
localized	O
fibrinoid	O
necrosis	O
distributing	O
in	O
the	O
heart	B-ANAT
,	O
lungs	B-ANAT
,	O
kidneys	B-ANAT
,	O
adrenal	B-ANAT
glands	I-ANAT
and	O
the	O
striated	B-ANAT
muscles	I-ANAT
accompanying	O
with	O
mononuclear	B-ANAT
cells	I-ANAT
and	O
lymphocytes	B-ANAT
infiltration	O
.	O

A	O
mixture	O
features	O
of	O
serous	O
,	O
fibrinous	O
and	O
hemorrhagic	O
inflammation	O
were	O
seen	O
in	O
most	O
pulmonary	B-ANAT
alveoli	I-ANAT
with	O
engorgement	O
of	O
capillary	B-ANAT
and	O
there	O
were	O
microthrombosis	O
in	O
some	O
capillary	B-ANAT
.	O

There	O
were	O
thrombo	O
-	O
embolisms	O
in	O
some	O
bronchial	B-ANAT
artery	I-ANAT
.	O

TITLE	O
:	O
[	O
Pathological	O
and	O
ultramicrostructural	O
changes	O
of	O
tissues	B-ANAT
in	O
a	O
patient	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

The	O
structures	O
of	O
lymph	B-ANAT
nodes	I-ANAT
and	O
spleen	B-ANAT
were	O
damaged	O
with	O
lymph	B-ANAT
follicles	B-ANAT
depletion	O
and	O
splenic	B-ANAT
nodules	B-ANAT
atrophy	O
.	O

Infectious	O
virons	O
entered	O
cells	B-ANAT
by	O
endocytosis	O
or	O
membrane	B-ANAT
fusion	O
and	O
released	O
through	O
a	O
budding	O
process	O
.	O

In	O
the	O
present	O
study	O
,	O
interferon	O
(	O
IFN	O
)-	O
gamma	O
production	O
during	O
ECOR	O
was	O
studied	O
and	O
its	O
role	O
evaluated	O
in	O
the	O
clearance	O
of	O
infectious	O
virus	O
from	O
the	O
retina	B-ANAT
.	O

BeauR	O
-	O
M41	O
(	O
S	O
)	O
acquired	O
the	O
same	O
cell	B-ANAT
tropism	O
phenotype	O
as	O
IBV	O
M41	O
-	O
CK	O
in	O
four	O
different	O
cell	B-ANAT
types	O
,	O
demonstrating	O
that	O
the	O
IBV	O
spike	O
glycoprotein	O
is	O
a	O
determinant	O
of	O
cell	B-ANAT
tropism	O
.	O

However	O
,	O
only	O
the	O
presence	O
of	O
diabetes	O
mellitus	O
and	O
/	O
or	O
cardiac	B-ANAT
disease	O
(	O
HR	O
7	O
.	O
3	O
,	O
95	O
%	O
CI	O
3	O
.	O
1	O
to	O
17	O
.	O
4	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
was	O
associated	O
with	O
adverse	O
outcomes	O
as	O
a	O
whole	O
.	O

ABSTRACT	O
:	O
To	O
identify	O
the	O
transcription	O
factor	O
(	O
s	O
)	O
that	O
is	O
essential	O
for	O
activation	O
of	O
mfgl2	O
prothrombinase	O
/	O
fibroleukin	O
gene	O
in	O
response	O
to	O
nucleocapsid	B-ANAT
protein	O
of	O
murine	O
hepatitis	O
virus	O
type	O
3	O
(	O
MHV	O
-	O
3	O
).	O

The	O
chest	B-ANAT
radiograph	O
of	O
these	O
fatal	O
cases	O
consistently	O
showed	O
multifocal	O
infiltration	O
over	O
the	O
unilateral	O
or	O
bilateral	O
lobe	B-ANAT
of	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
during	O
basiliximab	O
induction	O
in	O
three	O
adolescent	O
renal	B-ANAT
transplant	B-ANAT
patients	O
.	O

Patient	O
3	O
was	O
a	O
19	O
-	O
yr	O
-	O
old	O
male	O
with	O
pretransplant	O
Hct	O
of	O
43	O
%	O
who	O
received	O
a	O
cadaveric	O
renal	B-ANAT
transplant	B-ANAT
after	O
23	O
.	O
5	O
-	O
h	O
cold	O
-	O
ischemia	O
;	O
3	O
.	O
5	O
L	O
normal	O
saline	O
was	O
given	O
during	O
surgery	O
.	O

Improved	O
awareness	O
of	O
this	O
potential	O
complication	O
,	O
prudent	O
fluid	O
management	O
,	O
and	O
efforts	O
to	O
minimize	O
graft	B-ANAT
-	O
ischemia	O
are	O
recommended	O
to	O
prevent	O
further	O
cases	O
.	O

There	O
was	O
no	O
difference	O
in	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
mean	O
airway	B-ANAT
pressure	O
,	O
or	O
F	O
(	O
IO	O
)(	O
2	O
),	O
before	O
and	O
after	O
aerosolized	O
PGI	O
(	O
2	O
)	O
(	O
p	O
>	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
The	O
chest	B-ANAT
X	O
-	O
ray	O
image	O
features	O
of	O
patients	O
with	O
severe	O
SRAS	O
:	O
a	O
preliminary	O
study	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
image	O
features	O
in	O
36	O
patients	O
with	O
severe	O
SARS	O
were	O
retrospectively	O
analyzed	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
chest	B-ANAT
X	O
-	O
ray	O
manifestations	O
of	O
SARS	O
cases	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
scanning	O
was	O
performed	O
at	O
a	O
interval	O
of	O
1	O
-	O
3	O
days	O
according	O
to	O
the	O
requirements	O
.	O

A	O
combination	O
of	O
serous	O
,	O
fibrinous	O
and	O
hemorrhagic	O
inflammation	O
was	O
seen	O
in	O
most	O
of	O
the	O
pulmonary	B-ANAT
alveoli	I-ANAT
with	O
the	O
engorgement	O
of	O
capillaries	B-ANAT
and	O
detection	O
of	O
micro	O
-	O
thrombosis	O
in	O
some	O
of	O
these	O
capillaries	B-ANAT
.	O

The	O
peripheral	B-ANAT
blood	I-ANAT
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+)	O
and	O
CD	O
(	O
8	O
)(+)	O
counts	O
were	O
lower	O
than	O
normal	O
in	O
23	O
patients	O
(	O
67	O
.	O
7	O
%),	O
26	O
patients	O
(	O
74	O
.	O
3	O
%)	O
and	O
15	O
patients	O
(	O
42	O
.	O
9	O
%),	O
respectively	O
.	O

The	O
peripheral	B-ANAT
blood	I-ANAT
WBC	B-ANAT
counts	O
were	O
(	O
4	O
.	O
0	O
-	O
10	O
.	O
0	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
in	O
20	O
patients	O
,	O
and	O
their	O
CD	O
(	O
3	O
)(+),	O
CD	O
(	O
4	O
)(+)	O
and	O
CD	O
(	O
8	O
)(+)	O
counts	O
were	O
700	O
.	O
00	O
(	O
502	O
.	O
96	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
347	O
.	O
00	O
(	O
247	O
.	O
58	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
and	O
322	O
.	O
05	O
(	O
228	O
.	O
47	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
respectively	O
.	O

The	O
level	O
of	O
serum	B-ANAT
IL	O
is	O
closely	O
related	O
to	O
cell	B-ANAT
immunity	O
in	O
SARS	O
patients	O
.	O

All	O
patients	O
infected	O
with	O
HIV	O
,	O
CMV	O
and	O
EBV	O
had	O
significantly	O
higher	O
CD8	O
(+)	O
T	B-ANAT
lymphocyte	I-ANAT
counts	O
in	O
comparison	O
with	O
normal	O
controls	O
.	O

After	O
treatment	O
,	O
most	O
lesions	O
were	O
absorbed	O
completely	O
,	O
but	O
slowly	O
in	O
patients	O
with	O
multi	O
-	O
lobe	B-ANAT
consolidation	O
and	O
/	O
or	O
extensive	O
interstitial	B-ANAT
infiltration	O
.	O

We	O
also	O
examined	O
the	O
ability	O
of	O
the	O
mutant	O
and	O
chimeric	O
E	O
and	O
M	O
proteins	O
to	O
form	O
VLPs	B-ANAT
.	O

Seven	O
patients	O
were	O
injured	O
in	O
motor	O
vehicle	O
collisions	O
;	O
one	O
patient	O
suffered	O
a	O
gunshot	O
wound	O
to	O
the	O
chest	B-ANAT
.	O

Four	O
patients	O
had	O
liver	B-ANAT
lacerations	O
,	O
3	O
had	O
pulmonary	B-ANAT
contusions	O
,	O
and	O
1	O
had	O
a	O
renal	B-ANAT
contusion	O
.	O

We	O
assessed	O
the	O
antiviral	O
potential	O
of	O
recombinant	O
interferons	O
against	O
two	O
clinical	O
isolates	O
of	O
SARS	O
-	O
CoV	O
--	O
FFM	O
-	O
1	O
,	O
from	O
Frankfurt	O
patients	O
,	O
and	O
Hong	O
Kong	O
--	O
replicated	O
in	O
Vero	O
and	O
Caco2	O
cells	B-ANAT
.	O

Chest	B-ANAT
radiographs	O
showed	O
that	O
unilateral	O
focal	O
patchy	O
involvement	O
in	O
34	O
.	O
0	O
%	O
of	O
the	O
patients	O
,	O
and	O
unilateral	O
multifocal	O
or	O
bilateral	O
involvement	O
were	O
11	O
.	O
3	O
%	O
and	O
46	O
.	O
2	O
%	O
respectively	O
.	O

The	O
spike	O
protein	O
is	O
the	O
main	O
surface	O
antigen	O
of	O
the	O
coronavirus	O
and	O
there	O
should	O
be	O
antibodies	O
against	O
spike	O
protein	O
in	O
patients	O
serum	B-ANAT
.	O

Partial	O
spike	O
gene	O
fragments	O
(	O
751	O
-	O
1925	O
bp	O
,	O
2005	O
-	O
3410	O
bp	O
,	O
1	O
-	O
1925	O
bp	O
and	O
32	O
-	O
3659	O
bp	O
)	O
and	O
its	O
intact	O
gene	O
were	O
cloned	O
into	O
pET32	O
or	O
pGEX	O
vectors	O
,	O
and	O
transformed	O
into	O
competent	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
)	O
(	O
pLysS	O
),	O
respectively	O
.	O

Continual	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
and	O
glucocorticoid	O
are	O
effective	O
for	O
control	O
of	O
the	O
disease	O
.	O

A	O
history	O
of	O
close	O
contact	O
,	O
fever	O
,	O
X	O
-	O
ray	O
signs	O
of	O
pneumonia	O
and	O
normal	O
or	O
lowered	O
WBC	B-ANAT
counts	O
are	O
favorable	O
for	O
the	O
diagnosis	O
of	O
SARS	O
.	O

TITLE	O
:	O
[	O
Dynamic	O
changes	O
of	O
T	B-ANAT
-	I-ANAT
lymphocytes	I-ANAT
and	O
immunoglobulins	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

The	O
levels	O
of	O
CD3	O
(+),	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
in	O
peripheral	B-ANAT
blood	I-ANAT
of	O
SARS	O
patients	O
decrease	O
significantly	O
and	O
go	O
down	O
to	O
the	O
lowest	O
point	O
at	O
days	O
10	O
approximately	O
12	O
after	O
onset	O
of	O
the	O
disease	O
.	O

The	O
oldest	O
patient	O
(	O
74	O
year	O
old	O
,	O
male	O
)	O
received	O
the	O
healthy	O
convalescent	O
plasma	B-ANAT
infusion	O
(	O
50	O
ml	O
)	O
from	O
recovered	O
SARS	O
subject	O
and	O
completely	O
recovered	O
within	O
21	O
days	O
,	O
having	O
a	O
shorter	O
disease	O
course	O
.	O

The	O
chest	B-ANAT
X	O
-	O
ray	O
show	O
pulmonary	B-ANAT
lesion	O
in	O
the	O
2nd	O
day	O
after	O
onset	O
of	O
the	O
illness	O
,	O
but	O
40	O
.	O
7	O
%	O
cases	O
show	O
positive	O
change	O
after	O
6	O
days	O
onset	O
.	O

TITLE	O
:	O
Protection	O
against	O
CTL	B-ANAT
escape	O
and	O
clinical	O
disease	O
in	O
a	O
murine	O
model	O
of	O
virus	O
persistence	O
.	O

TITLE	O
:	O
[	O
Lung	B-ANAT
pathology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

All	O
lungs	B-ANAT
from	O
these	O
cases	O
were	O
extremely	O
expanded	O
and	O
became	O
solid	O
.	O

Insulin	O
was	O
started	O
to	O
pump	O
in	O
to	O
maintain	O
the	O
blood	B-ANAT
glucose	O
levels	O
between	O
4	O
.	O
44	O
-	O
7	O
.	O
78	O
mmol	O
/	O
L	O
(	O
80	O
-	O
140	O
mg	O
/	O
dl	O
)	O
when	O
the	O
levels	O
exceeded	O
normal	O
range	O
.	O

The	O
longest	O
stool	B-ANAT
shedding	O
case	O
in	O
this	O
study	O
lasted	O
64	O
days	O
.	O

The	O
average	O
stool	B-ANAT
shedding	O
was	O
32	O
days	O
.	O

RESULTS	O
:	O
The	O
characteristics	O
of	O
gender	O
,	O
age	O
,	O
occupation	O
,	O
contagious	O
history	O
and	O
previous	O
therapy	O
were	O
described	O
in	O
SARS	O
inpatients	O
when	O
they	O
visited	O
the	O
outpatient	O
department	O
for	O
SARS	O
in	O
the	O
first	O
time	O
;	O
the	O
clinical	O
symptoms	O
,	O
physical	O
signs	O
,	O
blood	B-ANAT
WBC	B-ANAT
counts	O
and	O
X	O
-	O
ray	O
in	O
lungs	B-ANAT
were	O
also	O
analyzed	O
.	O

There	O
were	O
lung	B-ANAT
infiltrates	O
1	O
to	O
6	O
days	O
after	O
fever	O
and	O
then	O
methylprednisolone	O
was	O
given	O
to	O
them	O
.	O

CONCLUSIONS	O
:	O
Thoracic	B-ANAT
plain	O
film	O
was	O
necessary	O
for	O
diagnosis	O
of	O
SARS	O
,	O
CT	O
could	O
detect	O
the	O
pulmonary	B-ANAT
abnormality	O
of	O
SARS	O
early	O
.	O

(	O
4	O
)	O
Collection	O
,	O
transportation	O
,	O
pre	O
-	O
disposal	O
and	O
storage	B-ANAT
of	O
specimen	O
from	O
patients	O
with	O
SARS	O
for	O
testing	O
should	O
be	O
done	O
in	O
leak	O
-	O
resistant	O
environment	O
.	O

In	O
IRF	O
-	O
1	O
-	O
deficient	O
fibroblasts	B-ANAT
,	O
a	O
higher	O
concentration	O
of	O
limitin	O
than	O
of	O
IFN	O
-	O
alpha	O
was	O
required	O
for	O
the	O
induction	O
of	O
antiviral	O
activity	O
and	O
the	O
transcription	O
of	O
proteins	O
from	O
IFN	O
-	O
stimulated	O
response	O
element	O
.	O

The	O
clinical	O
presentation	O
,	O
chest	B-ANAT
radiographs	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
,	O
response	O
to	O
initial	O
antimicrobial	O
therapy	O
,	O
and	O
outcome	O
in	O
SARS	O
is	O
much	O
different	O
from	O
CAP	O
,	O
differentiate	O
them	O
will	O
be	O
helpful	O
to	O
early	O
recognition	O
,	O
prompt	O
isolation	O
,	O
and	O
prevention	O
of	O
its	O
spread	O
.	O

Consecutive	O
blood	B-ANAT
samples	I-ANAT
from	O
13	O
patients	O
with	O
SARS	O
and	O
10	O
healthy	O
volunteers	O
were	O
collected	O
.	O

TITLE	O
:	O
The	O
glycosylation	O
status	O
of	O
the	O
murine	O
hepatitis	O
coronavirus	O
M	O
protein	O
affects	O
the	O
interferogenic	O
capacity	O
of	O
the	O
virus	O
in	O
vitro	O
and	O
its	O
ability	O
to	O
replicate	O
in	O
the	O
liver	B-ANAT
but	O
not	O
the	O
brain	B-ANAT
.	O

In	O
the	O
lung	B-ANAT
tissue	I-ANAT
of	O
the	O
patients	O
,	O
few	O
CD20	O
+/	O
CD45RA	O
+	O
B	B-ANAT
cells	I-ANAT
and	O
CD4	O
+/	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
spotted	O
,	O
and	O
CD20	O
+/	O
CD45RA	O
+	O
B	B-ANAT
cells	I-ANAT
along	O
with	O
CD4	O
+/	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
also	O
significantly	O
decreased	O
in	O
the	O
spleen	B-ANAT
and	O
lymph	B-ANAT
nodes	I-ANAT
,	O
where	O
few	O
conserved	O
B	O
and	O
T	B-ANAT
cells	I-ANAT
underwent	O
apoptosis	O
.	O

In	O
the	O
lung	B-ANAT
tissue	I-ANAT
of	O
the	O
patients	O
,	O
few	O
CD20	O
+/	O
CD45RA	O
+	O
B	B-ANAT
cells	I-ANAT
and	O
CD4	O
+/	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
spotted	O
,	O
and	O
CD20	O
+/	O
CD45RA	O
+	O
B	B-ANAT
cells	I-ANAT
along	O
with	O
CD4	O
+/	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
also	O
significantly	O
decreased	O
in	O
the	O
spleen	B-ANAT
and	O
lymph	B-ANAT
nodes	I-ANAT
,	O
where	O
few	O
conserved	O
B	O
and	O
T	B-ANAT
cells	I-ANAT
underwent	O
apoptosis	O
.	O

RESULTS	O
:	O
A	O
large	O
quantity	O
of	O
proliferated	O
macrophages	B-ANAT
could	O
be	O
observed	O
in	O
the	O
lungs	B-ANAT
,	O
spleens	B-ANAT
and	O
lymph	B-ANAT
nodes	I-ANAT
of	O
the	O
SARS	O
patients	O
,	O
some	O
of	O
which	O
were	O
positive	O
for	O
CD25	O
marker	O
(	O
active	O
macrophages	B-ANAT
).	O

TITLE	O
:	O
Inducible	O
nitric	O
oxide	O
synthase	O
dimerization	O
inhibitor	O
prevents	O
cardiovascular	B-ANAT
and	O
renal	B-ANAT
morbidity	O
in	O
sheep	O
with	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
.	O

Finally	O
,	O
severely	O
impaired	O
renal	B-ANAT
function	O
(	O
urinary	O
output	O
)	O
was	O
associated	O
with	O
adverse	O
net	O
fluid	O
balance	O
.	O

After	O
CVVH	O
,	O
the	O
symptoms	O
of	O
patients	O
such	O
as	O
tachycardia	O
,	O
respiratory	O
distress	O
,	O
and	O
abdominal	B-ANAT
pain	O
were	O
remitted	O
.	O

Nsp9	O
crystals	B-ANAT
diffract	O
to	O
2	O
.	O
8	O
A	O
resolution	O
and	O
belong	O
to	O
space	O
group	O
P6	O
(	O
1	O
/	O
5	O
)	O
22	O
,	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
b	O
=	O
89	O
.	O
7	O
,	O
c	O
=	O
136	O
.	O
7	O
A	O
.	O
With	O
two	O
molecules	O
in	O
the	O
asymmetric	O
unit	O
,	O
the	O
solvent	O
content	O
is	O
60	O
%	O
(	O
V	O
(	O
M	O
)	O
=	O
3	O
.	O
1	O
A	O
(	O
3	O
)	O
Da	O
(-	O
1	O
)).	O

At	O
the	O
first	O
week	O
,	O
the	O
counts	O
of	O
white	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
WBCs	O
),	O
lymphocyte	B-ANAT
and	O
platelets	B-ANAT
were	O
(	O
4	O
.	O
4	O
+/-	O
1	O
.	O
5	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
0	O
.	O
22	O
+/-	O
0	O
.	O
12	O
and	O
(	O
143	O
+/-	O
37	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
which	O
were	O
significantly	O
lower	O
when	O
compared	O
with	O
those	O
at	O
the	O
2nd	O
to	O
4th	O
week	O
.	O

The	O
medicine	O
associated	O
toxicities	O
may	O
be	O
the	O
main	O
reason	O
of	O
liver	B-ANAT
lesions	O
.	O

TITLE	O
:	O
Activation	O
of	O
site	O
-	O
specific	O
DNA	O
integration	O
in	O
human	O
cells	B-ANAT
by	O
a	O
single	O
chain	O
integration	O
host	O
factor	O
.	O

We	O
have	O
also	O
presented	O
information	O
on	O
porcine	O
parvovirus	O
,	O
Japanese	O
encephalitis	O
virus	O
,	O
encephalomyocarditis	O
virus	O
,	O
herpesviruses	O
(	O
pseudorabies	O
virus	O
,	O
porcine	O
lymphotropic	O
herpesvirus	O
,	O
porcine	O
cytomegalovirus	O
),	O
coronaviruses	O
(	O
TGEV	O
,	O
PRCV	O
,	O
HEV	B-ANAT
,	O
PEDV	O
)	O
and	O
adenovirus	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
clarify	O
the	O
immunohistochemical	O
distribution	O
of	O
surfactant	O
-	O
associated	O
protein	O
A	O
(	O
SP	O
-	O
A	O
)	O
for	O
early	O
diagnosis	O
of	O
ARDS	O
with	O
special	O
regard	O
to	O
hyaline	B-ANAT
membrane	B-ANAT
(	O
HM	O
)	O
formation	O
.	O

The	O
cerebral	B-ANAT
cortexes	O
of	O
18	O
infants	O
were	O
used	O
for	O
this	O
study	O
.	O

ABSTRACT	O
:	O
Establishing	O
immunological	O
memory	O
in	O
female	O
piglets	O
at	O
a	O
young	O
age	O
with	O
PRCV	O
was	O
effective	O
in	O
inducing	O
a	O
secondary	O
immune	O
response	O
to	O
a	O
limiting	O
dose	O
of	O
virulent	O
TGEV	O
given	O
orally	B-ANAT
13	O
-	O
18	O
days	O
prior	O
to	O
farrowing	O
.	O

Over	O
the	O
years	O
a	O
variety	O
of	O
""""	O
lung	B-ANAT
protective	O
""""	O
treatment	O
modalities	O
have	O
been	O
introduced	O
and	O
proved	O
as	O
effective	O
and	O
safe	O
in	O
the	O
treatment	O
of	O
this	O
syndrome	O

The	O
effectiveness	O
of	O
MARS	O
is	O
correlated	O
with	O
reducing	O
the	O
levels	O
of	O
NO	O
and	O
cytokines	O
,	O
except	O
for	O
completely	O
removing	O
of	O
accumulated	O
toxins	O
in	O
liver	B-ANAT
failure	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
summarize	O
the	O
clinical	O
features	O
of	O
liver	B-ANAT
injury	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
providing	O
information	O
for	O
further	O
mechanism	O
and	O
clinical	O
study	O
.	O

All	O
the	O
results	O
suggest	O
strongly	O
that	O
there	O
may	O
be	O
a	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
in	O
most	O
SARS	O
patients	O
in	O
early	O
stage	O
,	O
and	O
the	O
liver	B-ANAT
damage	O
is	O
only	O
its	O
partial	O
signs	O
.	O

Infiltration	O
of	O
pancreatic	B-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
with	O
neutrophils	B-ANAT
(	O
measured	O
as	O
increase	O
in	O
myeloperoxidase	O
activity	O
)	O
was	O
associated	O
with	O
enhanced	O
lipid	O
peroxidation	O
(	O
increased	O
tissue	B-ANAT
levels	O
of	O
malondialdehyde	O
).	O

In	O
contrast	O
,	O
the	O
degree	O
of	O
(	O
1	O
)	O
pancreatic	B-ANAT
inflammation	O
and	O
tissue	B-ANAT
injury	O
(	O
histological	O
score	O
),	O
(	O
2	O
)	O
up	O
-	O
regulation	O
/	O
expression	O
of	O
P	O
-	O
selectin	O
,	O
E	O
-	O
selectin	O
and	O
ICAM	O
-	O
1	O
,	O
and	O
(	O
3	O
)	O
neutrophil	B-ANAT
infiltration	O
was	O
markedly	O
reduced	O
in	O
pancreatic	B-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
obtained	O
from	O
cerulein	O
-	O
treated	O
5	O
-	O
LO	O
-	O
deficient	O
mice	O
.	O

Heme	O
oxygenase	O
-	O
1	O
(	O
HO	O
-	O
1	O
)	O
(	O
EC	O
1	O
.	O
14	O
.	O
99	O
.	O
3	O
),	O
the	O
rate	O
-	O
limiting	O
enzyme	O
in	O
heme	O
catabolism	O
,	O
is	O
known	O
to	O
be	O
induced	O
by	O
oxidative	O
stress	O
and	O
to	O
confer	O
protection	O
against	O
oxidative	O
tissue	B-ANAT
injuries	O
.	O

Following	O
CCl	O
(	O
4	O
)	O
treatment	O
,	O
hepatic	B-ANAT
HO	O
-	O
1	O
expression	O
was	O
markedly	O
increased	O
both	O
at	O
transcriptional	O
and	O
protein	O
levels	O
in	O
hepatocytes	B-ANAT
,	O
especially	O
around	O
the	O
central	B-ANAT
vein	I-ANAT
.	O

The	O
induction	O
of	O
myelin	B-ANAT
-	O
like	O
membrane	B-ANAT
whorls	O
was	O
obvious	O
within	O
the	O
same	O
vacuoles	B-ANAT
as	O
the	O
core	O
particles	O
.	O

During	O
his	O
illness	O
,	O
serial	O
chest	B-ANAT
radiographs	O
showed	O
increasingly	O
severe	O
air	O
-	O
space	O
shadowing	O
in	O
both	O
lungs	B-ANAT
.	O

RESULTS	O
:	O
Woolf	O
and	O
Haldane	O
Odds	O
ratio	O
(	O
OR	O
)	O
and	O
corrected	O
P	O
-	O
value	O
(	O
Pc	O
)	O
obtained	O
from	O
two	O
tails	B-ANAT
Fisher	O
exact	O
test	O
were	O
used	O
to	O
show	O
susceptibility	O
of	O
HLA	B-ANAT
class	O
I	O
or	O
class	O
II	O
alleles	O
with	O
coronavirus	O
infection	O
.	O

By	O
immunofluorescence	O
confocal	O
microscopy	O
,	O
Pol	O
colocalized	O
with	O
viral	O
proteins	O
at	O
replication	O
complexes	O
,	O
distinct	O
from	O
sites	O
of	O
virion	B-ANAT
assembly	O
,	O
over	O
the	O
entire	O
course	O
of	O
infection	O
.	O

All	O
of	O
these	O
proteins	O
contain	O
amino	O
acid	O
sequences	O
with	O
strong	O
similarity	O
to	O
the	O
RNA	O
-	O
binding	O
domains	O
of	O
hnRNP	B-ANAT
A1	O
.	O

Some	O
of	O
these	O
hnRNPs	O
have	O
previously	O
been	O
shown	O
to	O
replace	O
hnRNP	B-ANAT
A1	O
in	O
regulating	O
RNA	O
splicing	O
.	O

The	O
following	O
interventions	O
were	O
systematically	O
reviewed	O
for	O
inclusion	O
in	O
the	O
guidelines	O
:	O
enteral	O
nutrition	O
(	O
EN	O
)	O
versus	O
parenteral	O
nutrition	O
(	O
PN	O
),	O
early	O
versus	O
late	O
EN	O
,	O
dose	O
of	O
EN	O
,	O
composition	O
of	O
EN	O
(	O
protein	O
,	O
carbohydrates	O
,	O
lipids	O
,	O
immune	O
-	O
enhancing	O
additives	O
),	O
strategies	O
to	O
optimize	O
delivery	O
of	O
EN	O
and	O
minimize	O
risks	O
(	O
ie	O
,	O
rate	O
of	O
advancement	O
,	O
checking	O
residuals	O
,	O
use	O
of	O
bedside	O
algorithms	O
,	O
motility	O
agents	O
,	O
small	B-ANAT
bowel	I-ANAT
versus	O
gastric	B-ANAT
feedings	O
,	O
elevation	O
of	O
the	O
head	B-ANAT
of	O
the	O
bed	O
,	O
closed	O
delivery	O
systems	O
,	O
probiotics	O
,	O
bolus	O
administration	O
),	O
enteral	O
nutrition	O
in	O
combination	O
with	O
supplemental	O
PN	O
,	O
use	O
of	O
PN	O
versus	O
standard	O
care	O
in	O
patients	O
with	O
an	O
intact	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
dose	O
of	O
PN	O
and	O
composition	O
of	O
PN	O
(	O
protein	O
,	O
carbohydrates	O
,	O
IV	O
lipids	O
,	O
additives	O
,	O
vitamins	O
,	O
trace	O
elements	O
,	O
immune	O
enhancing	O
substances	O
),	O
and	O
the	O
use	O
of	O
intensive	O
insulin	O
therapy	O
.	O

TITLE	O
:	O
Lung	B-ANAT
pathology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
):	O
a	O
study	O
of	O
8	O
autopsy	O
cases	O
from	O
Singapore	O
.	O

Multinucleated	O
cells	B-ANAT
were	O
shown	O
to	O
be	O
both	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
and	O
macrophages	B-ANAT
by	O
pancytokeratin	O
,	O
thyroid	B-ANAT
transcription	O
factor	O
-	O
1	O
,	O
and	O
CD68	O
staining	O
.	O

These	O
effects	O
were	O
accompanied	O
with	O
a	O
rapid	O
induction	O
of	O
proinflammatory	O
mediators	O
:	O
cytokine	O
granulocyte	B-ANAT
-	O
macrophage	B-ANAT
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	B-ANAT
)	O
and	O
the	O
chemokines	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
2	O
(	O
MIP	O
-	O
2	O
)	O
and	O
KC	O
.	O

12	O
healthy	O
blood	B-ANAT
donors	O
were	O
used	O
as	O
normal	O
controls	O
.	O

RESULTS	O
:	O
All	O
SARS	O
patients	O
had	O
remarkably	O
increased	O
plasma	B-ANAT
IL	O
-	O
8	O
concentrations	O
(	O
median	O
31	O
.	O
23	O
ng	O
/	O
L	O
)	O
at	O
the	O
onset	O
of	O
disease	O
compared	O
with	O
those	O
of	O
normal	O
controls	O
(	O
6	O
.	O
28	O
ng	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
intestinal	B-ANAT
tropism	O
of	O
the	O
SARS	O
-	O
CoV	O
has	O
major	O
implications	O
on	O
clinical	O
presentation	O
and	O
viral	O
transmission	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	O
replicates	O
in	O
mononuclear	B-ANAT
cells	I-ANAT
of	O
peripheral	B-ANAT
blood	I-ANAT
(	O
PBMCs	O
)	O
from	O
SARS	O
patients	O
.	O

In	O
four	O
experiments	O
,	O
29	O
-	O
day	O
-	O
old	O
female	O
commercial	O
broilers	O
housed	O
in	O
isolators	O
,	O
were	O
infected	O
intratracheally	O
and	O
oculonasally	O
with	O
IB	O
vaccine	O
strains	O
(	O
H120	O
and	O
H52	O
)	O
or	O
virulent	O
IB	O
field	O
strains	O
(	O
D387	O
and	O
M41	O
)	O
(	O
4	O
.	O
8	O
or	O
6	O
.	O
8	O
log	O
(	O
10	O
)	O
median	O
embryo	B-ANAT
infective	O
dose	O
,	O
per	O
broiler	O
).	O

The	O
incidence	O
of	O
nasal	B-ANAT
discharge	B-ANAT
at	O
3	O
and	O
5	O
days	O
after	O
IB	O
virus	O
infection	O
was	O
used	O
to	O
assess	O
the	O
clinical	O
effect	O
of	O
the	O
IB	O
infection	O
,	O
while	O
mortality	O
,	O
body	B-ANAT
weight	O
uniformity	O
and	O
E	O
.	O
coli	O
lesions	O
at	O
7	O
days	O
following	O
E	O
.	O
coli	O
inoculation	O
were	O
used	O
as	O
parameters	O
for	O
colibacillosis	O
.	O

Heart	B-ANAT
rate	O
,	O
oxygen	O
saturation	O
,	O
temperature	O
,	O
and	O
alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
aspartate	O
aminotransferase	O
(	O
AST	O
)	O
levels	O
were	O
recorded	O
daily	O
.	O

TITLE	O
:	O
Dynamic	O
changes	O
in	O
blood	B-ANAT
cytokine	O
levels	O
as	O
clinical	O
indicators	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
dynamic	O
changes	O
observed	O
in	O
serum	B-ANAT
levels	O
of	O
interleukins	O
(	O
ILs	O
),	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
and	O
transforming	O
growth	O
factor	O
-	O
beta1	O
(	O
TGF	O
-	O
beta1	O
)	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
.	O

Serum	B-ANAT
levels	O
of	O
ILs	O
,	O
TNF	O
-	O
alpha	O
and	O
TGF	O
-	O
beta	O
1	O
were	O
measured	O
in	O
all	O
subjects	O
.	O

The	O
mean	O
concentration	O
of	O
serum	B-ANAT
IL	O
-	O
6	O
in	O
SARS	O
patients	O
did	O
not	O
differ	O
from	O
that	O
in	O
the	O
control	O
group	O
in	O
initial	O
and	O
peak	O
stages	O
,	O
but	O
became	O
significantly	O
higher	O
in	O
remission	O
and	O
recovery	O
stage	O
compared	O
with	O
the	O
control	O
group	O
,	O
initial	O
and	O
peak	O
stages	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
mean	O
concentration	O
of	O
serum	B-ANAT
IL	O
-	O
8	O
in	O
SARS	O
patients	O
did	O
not	O
differ	O
from	O
that	O
of	O
the	O
control	O
group	O
in	O
initial	O
stage	O
,	O
but	O
was	O
significantly	O
higher	O
than	O
control	O
group	O
in	O
peak	O
stage	O
and	O
remission	O
and	O
recovery	O
stage	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Concurrently	O
,	O
the	O
mean	O
concentration	O
of	O
serum	B-ANAT
IL	O
-	O
13	O
decreased	O
gradually	O
,	O
and	O
the	O
mean	O
concentration	O
of	O
serum	B-ANAT
IL	O
-	O
18	O
level	O
in	O
SARS	O
patients	O
was	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
during	O
all	O
the	O
courses	O
of	O
SARS	O
,	O
suggesting	O
that	O
the	O
immune	O
state	O
of	O
the	O
patients	O
with	O
SARS	O
was	O
obviously	O
abnormal	O
.	O

A	O
SARS	O
-	O
associated	O
coronavirus	O
isolate	O
named	O
ZJ01	O
was	O
obtained	O
from	O
throat	B-ANAT
swab	I-ANAT
samples	O
taken	O
from	O
a	O
patient	O
in	O
Hangzhou	O
,	O
Zhejing	O
province	O
.	O

Pancreatitis	O
was	O
induced	O
by	O
retrograde	O
intraductal	O
infusion	O
of	O
4	O
%	O
sodium	O
taurocholate	O
(	O
100	O
microL	O
/	O
100	O
g	O
of	O
body	B-ANAT
weight	O
).	O

The	O
end	O
point	O
of	O
both	O
WHO	O
-	O
HKU	O
and	O
WHO	O
-	O
Hamburg	O
RT	O
-	O
PCR	O
assays	O
was	O
determined	O
to	O
be	O
0	O
.	O
1	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
dose	O
.	O

Eight	O
months	O
after	O
her	O
original	O
presentation	O
,	O
she	O
developed	O
urticarial	O
lesions	O
on	O
her	O
abdomen	B-ANAT
and	O
legs	B-ANAT
,	O
with	O
muscle	B-ANAT
soreness	O
but	O
no	O
other	O
associated	O
symptoms	O
.	O

ABSTRACT	O
:	O
Sixty	O
-	O
nine	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
discharged	O
from	O
Guangdong	O
Provincial	O
TCM	O
Hospital	O
were	O
followed	O
up	O
from	O
January	O
to	O
April	O
2003	O
during	O
which	O
the	O
patients	O
were	O
asked	O
to	O
fill	O
the	O
questionnaire	O
form	O
and	O
at	O
the	O
same	O
time	O
received	O
blood	B-ANAT
routine	O
examination	O
,	O
hepatic	B-ANAT
,	O
renal	B-ANAT
,	O
pulmonary	B-ANAT
and	O
immune	O
function	O
tests	O
,	O
and	O
spiral	O
computerized	O
tomography	O
(	O
CT	O
)	O
of	O
the	O
chest	B-ANAT
,	O
color	O
B	O
-	O
ultrasonography	O
of	O
the	O
heart	B-ANAT
with	O
the	O
collected	O
data	O
treated	O
by	O
descriptive	O
analysis	O
and	O
deductive	O
analysis	O
.	O

TITLE	O
:	O
[	O
Detection	O
and	O
analysis	O
of	O
SARS	O
coronavirus	O
-	O
specific	O
antibodies	O
in	O
sera	B-ANAT
from	O
non	O
-	O
SARS	O
children	O
].	O

No	O
SARS	O
coronavirus	O
-	O
specific	O
antibody	O
are	O
present	O
in	O
the	O
sera	B-ANAT
of	O
non	O
-	O
SARS	O
children	O
.	O

RESULTS	O
:	O
All	O
the	O
serum	B-ANAT
samples	O
from	O
the	O
1	O
,	O
060	O
non	O
-	O
SARS	O
children	O
were	O
negative	O
for	O
both	O
IgG	O
and	O
IgM	O
antibodies	O
against	O
SARS	O
coronavirus	O
as	O
determined	O
by	O
indirect	O
immunofluorescent	O
assay	O
,	O
with	O
only	O
two	O
serum	B-ANAT
samples	O
showing	O
weak	O
positivity	O
for	O
SARS	O
coronavirus	O
-	O
specific	O
antibodies	O
identified	O
by	O
double	O
-	O
antigen	O
sandwich	O
ELISA	O
.	O

The	O
results	O
indicated	O
that	O
13	O
%	O
of	O
the	O
animal	O
traders	O
,	O
none	O
of	O
whom	O
had	O
SARS	O
diagnosed	O
,	O
had	O
IgG	B-ANAT
antibody	I-ANAT
to	O
SARS	O
-	O
CoV	O
,	O
compared	O
with	O
1	O
%-	O
3	O
%	O
of	O
persons	O
in	O
three	O
control	O
groups	O
.	O

Media	B-ANAT
articles	O
were	O
sorted	O
and	O
classified	O
by	O
topic	O
,	O
and	O
themes	O
were	O
identified	O
.	O

Poults	O
euthanatized	O
at	O
3	O
,	O
5	O
,	O
and	O
7	O
days	O
postinoculation	O
had	O
flaccid	O
,	O
pale	O
,	O
and	O
thin	O
-	O
walled	O
intestines	B-ANAT
with	O
watery	O
contents	O
.	O

When	O
the	O
lung	B-ANAT
and	O
kidney	B-ANAT
isolates	O
of	O
IBV	O
from	O
the	O
latter	O
experiment	O
were	O
compared	O
with	O
the	O
parent	O
-	O
vaccine	O
virus	O
,	O
no	O
changes	O
in	O
their	O
antigenicity	O
,	O
tissue	B-ANAT
tropism	O
,	O
or	O
the	O
nucleotide	O
sequence	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
were	O
observed	O
.	O

Following	O
the	O
introduction	O
of	O
nucleic	B-ANAT
acid	O
testing	O
for	O
human	O
immunodeficiency	O
virus	O
and	O
hepatitis	O
C	O
virus	O
,	O
the	O
American	O
Red	O
Cross	O
estimates	O
the	O
risk	O
of	O
transfusion	O
-	O
transmitted	O
human	O
immunodeficiency	O
virus	O
to	O
be	O
1	O
:	O
1	O
,	O
215	O
,	O
000	O
(	O
per	O
unit	O
transfused	O
)	O
and	O
1	O
:	O
1	O
,	O
935	O
,	O
000	O
for	O
transfusion	O
-	O
transmitted	O
hepatitis	O
C	O
virus	O
.	O

The	O
risk	O
of	O
transfusion	O
-	O
transmitted	O
human	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
leukemia	O
virus	O
I	O
/	O
II	O
is	O
1	O
:	O
2	O
,	O
993	O
,	O
000	O
,	O
based	O
on	O
Red	O
Cross	O
estimates	O
.	O

In	O
addition	O
,	O
subgenomic	O
transcripts	O
were	O
initiated	O
from	O
the	O
consensus	O
sequence	O
ACGAAC	O
in	O
both	O
the	O
WT	O
and	O
infectious	O
clone	O
SARS	O
-	O
CoV	O
.	O
Availability	O
of	O
a	O
SARS	O
-	O
CoV	O
full	O
-	O
length	O
cDNA	O
provides	O
a	O
template	O
for	O
manipulation	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
,	O
allowing	O
for	O
the	O
rapid	O
and	O
rational	O
development	O
and	O
testing	O
of	O
candidate	O
vaccines	O
and	O
therapeutics	O
against	O
this	O
important	O
human	O
pathogen	O
.	O

Less	O
common	O
symptoms	O
included	O
headache	O
(	O
38	O
.	O
9	O
%),	O
diarrhea	O
(	O
38	O
.	O
9	O
%),	O
dizziness	O
(	O
30	O
.	O
6	O
%),	O
myalgia	O
(	O
25	O
%),	O
chills	O
(	O
19	O
.	O
4	O
%),	O
nausea	O
and	O
vomiting	O
(	O
19	O
.	O
4	O
%)	O
and	O
rigor	O
(	O
the	O
occurrence	O
of	O
a	O
sensation	O
of	O
hot	O
-	O
and	O
-	O
cold	O
and	O
shivering	O
in	O
addition	O
to	O
teeth	B-ANAT
chattering	O
and	O
bed	O
shaking	O
)	O
(	O
8	O
.	O
3	O
%).	O

The	O
clinical	O
data	O
and	O
the	O
diagnostic	O
results	O
of	O
108	O
cases	O
of	O
SARS	O
were	O
retrospectively	O
reviewed	O
according	O
to	O
the	O
MHC	B-ANAT
criteria	O
.	O

CR	O
has	O
good	O
preventive	O
and	O
treatment	O
effect	O
in	O
treating	O
complicated	O
acute	O
lung	B-ANAT
injury	O
during	O
extracorporeal	O
circulation	O
(	O
cardiopulmonary	B-ANAT
bypass	O
)	O
in	O
patients	O
with	O
pulmonary	B-ANAT
hypertension	O
.	O

CONCLUSIONS	O
:	O
CR	O
has	O
good	O
preventive	O
and	O
treatment	O
effect	O
in	O
treating	O
complicated	O
acute	O
lung	B-ANAT
injury	O
during	O
extracorporeal	O
circulation	O
(	O
cardiopulmonary	B-ANAT
bypass	O
)	O
in	O
patients	O
with	O
pulmonary	B-ANAT
hypertension	O
.	O

CONCLUSIONS	O
:	O
In	O
treating	O
SARS	O
,	O
ICWM	O
was	O
superior	O
to	O
the	O
treatment	O
with	O
western	O
medicine	O
alone	O
in	O
aspects	O
of	O
improving	O
clinical	O
symptom	O
,	O
promoting	O
recovery	O
of	O
immune	O
function	O
and	O
absorption	O
of	O
lung	B-ANAT
inflammation	O
,	O
decreasing	O
the	O
dosage	O
of	O
hormone	O
used	O
and	O
shortening	O
the	O
therapeutic	O
course	O
.	O

All	O
samples	O
of	O
positive	O
SARS	O
-	O
CoV	O
-	O
IgG	O
and	O
IgM	B-ANAT
antibody	I-ANAT
were	O
negative	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
explore	O
the	O
development	O
of	O
IgG	O
and	O
IgM	O
against	O
SARS	O
CoV	O
and	O
characteristics	O
of	O
changes	O
of	O
antibody	O
titers	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
to	O
search	O
the	O
opportunity	O
for	O
collecting	O
specific	O
anti	O
-	O
serum	B-ANAT
from	O
convalescent	O
patients	O
with	O
SARS	O
.	O

In	O
order	O
to	O
obtain	O
effective	O
anti	O
-	O
serum	B-ANAT
,	O
the	O
titers	O
of	O
antibody	O
must	O
be	O
tested	O
just	O
before	O
collection	O
of	O
convalescent	O
serum	B-ANAT
,	O
and	O
it	O
ensures	O
the	O
therapeutic	O
effect	O
and	O
provides	O
a	O
measurable	O
index	O
for	O
clinical	O
transfusion	O
.	O

Although	O
NO	O
is	O
important	O
in	O
maintaining	O
vasodilator	O
tone	O
,	O
hypoxia	O
-	O
induced	O
pulmonary	B-ANAT
vasoconstriction	O
is	O
accompanied	O
by	O
an	O
increase	O
instead	O
of	O
a	O
decrease	O
in	O
NO	O
release	O
.	O

Recently	O
,	O
we	O
reported	O
several	O
rare	O
cases	O
that	O
indicate	O
that	O
ARDS	O
in	O
patients	O
with	O
Japanese	O
B	O
encephalitis	O
,	O
lymphangitis	O
with	O
breast	B-ANAT
cancer	O
and	O
fat	O
embolism	O
is	O
caused	O
by	O
different	O
mechanisms	O
.	O

In	O
this	O
report	O
we	O
present	O
results	O
of	O
comparative	O
sequence	O
analysis	O
of	O
the	O
spike	O
(	O
S	O
),	O
envelope	B-ANAT
(	O
E	O
),	O
membrane	B-ANAT
(	O
M	O
),	O
and	O
nucleoprotein	O
(	O
N	O
)	O
structural	O
proteins	O
,	O
and	O
the	O
two	O
most	O
conserved	O
replicase	O
domains	O
,	O
putative	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
and	O
RNA	O
helicase	O
(	O
HEL	O
),	O
aimed	O
at	O
a	O
revision	O
of	O
the	O
Coronaviridae	O
taxonomy	O
.	O

There	O
is	O
no	O
antidote	O
and	O
no	O
adequate	O
data	O
to	O
support	O
the	O
use	O
of	O
repeat	O
-	O
dose	O
oral	B-ANAT
cholestyramine	O
,	O
forced	O
diuresis	O
or	O
urine	B-ANAT
alkalinisation	O
as	O
effective	O
methods	O
of	O
enhancing	O
PCP	O
elimination	O
in	O
poisoned	O
humans	O
.	O

Additionally	O
,	O
administration	O
of	O
anti	O
-	O
MHV	O
neutralizing	O
antibody	O
to	O
infected	O
B6	O
mice	O
suppressed	O
the	O
development	O
of	O
CTL	B-ANAT
escape	O
mutants	O
.	O

TITLE	O
:	O
Induction	O
of	O
caspase	O
-	O
dependent	O
apoptosis	O
in	O
cultured	O
rat	O
oligodendrocytes	B-ANAT
by	O
murine	O
coronavirus	O
is	O
mediated	O
during	O
cell	B-ANAT
entry	O
and	O
does	O
not	O
require	O
virus	O
replication	O
.	O

ABSTRACT	O
:	O
Murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
causes	O
demyelination	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
in	O
rats	O
and	O
mice	O
.	O

Apoptotic	O
oligodendrocytes	B-ANAT
have	O
been	O
detected	O
in	O
the	O
vicinity	O
of	O
the	O
CNS	B-ANAT
demyelinating	O
lesions	O
in	O
these	O
animals	O
.	O

However	O
,	O
whether	O
MHV	O
can	O
directly	O
induce	O
oligodendrocyte	B-ANAT
apoptosis	O
has	O
not	O
been	O
documented	O
.	O

All	O
were	O
having	O
positive	O
results	O
for	O
SARS	O
-	O
associated	O
coronavirus	O
ribonucleic	O
acid	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
performed	O
on	O
their	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
or	O
stool	B-ANAT
samples	O
.	O

In	O
particular	O
,	O
the	O
number	O
of	O
CD4	O
+	O
lymphocytes	B-ANAT
in	O
tissues	B-ANAT
decreases	O
during	O
the	O
evolution	O
of	O
FIP	O
lesions	O
.	O

Blood	B-ANAT
from	O
cats	O
with	O
diseases	O
other	O
than	O
FIP	O
was	O
also	O
examined	O
in	O
order	O
to	O
define	O
the	O
diagnostic	O
relevance	O
of	O
the	O
changes	O
.	O

The	O
results	O
of	O
the	O
current	O
study	O
suggest	O
that	O
cats	O
recently	O
infected	O
with	O
FCoV	O
that	O
do	O
not	O
develop	O
the	O
disease	O
have	O
a	O
transient	O
increase	O
in	O
T	B-ANAT
cells	I-ANAT
;	O
cats	O
from	O
groups	O
with	O
high	O
prevalence	O
of	O
FIP	O
have	O
a	O
moderate	O
but	O
persistent	O
decrease	O
in	O
T	B-ANAT
cell	I-ANAT
subsets	I-ANAT
;	O
cats	O
with	O
FIP	O
have	O
a	O
very	O
severe	O
decrease	O
in	O
all	O
the	O
subsets	O
of	O
lymphocytes	B-ANAT
.	O

Virus	O
inoculation	O
of	O
21	O
-	O
day	O
postnatal	O
C57BL	O
/	O
6	O
and	O
BALB	O
/	O
c	O
mice	O
led	O
to	O
a	O
generalized	O
infection	O
of	O
the	O
whole	O
CNS	B-ANAT
,	O
demonstrating	O
HCoV	O
-	O
OC43	O
neuroinvasiveness	O
and	O
neurovirulence	O
.	O

During	O
hospitalization	O
,	O
incidence	O
of	O
diarrhea	O
(	O
53	O
%),	O
anemia	O
(	O
53	O
%),	O
and	O
acute	O
renal	B-ANAT
failure	O
(	O
6	O
%)	O
increased	O
.	O

For	O
members	O
of	O
the	O
Princess	O
Margaret	O
Hospital	O
SARS	O
Study	O
Group	O
,	O
see	O
the	O
Appendix	B-ANAT
.	O

In	O
parallel	O
,	O
use	O
of	O
the	O
three	O
hygiene	O
measures	O
increased	O
significantly	O
in	O
the	O
first	O
phase	O
and	O
remained	O
high	O
for	O
wearing	O
a	O
mask	O
and	O
washing	O
hands	B-ANAT
in	O
the	O
second	O
phase	O
.	O

Pulmonary	B-ANAT
fibrosis	O
were	O
left	O
in	O
2	O
patients	O
and	O
another	O
2	O
patients	O
died	O
.	O

RESULTS	O
:	O
In	O
recovery	O
phase	O
,	O
the	O
rest	O
heart	B-ANAT
rates	O
in	O
64	O
%	O
of	O
patients	O
with	O
SARS	O
exceeded	O
90	O
bpm	O
,	O
and	O
the	O
heart	B-ANAT
rates	O
after	O
mild	O
exercises	O
in	O
72	O
.	O
1	O
%	O
of	O
patients	O
with	O
SARS	O
exceeded	O
100	O
bpm	O
.	O

Because	O
the	O
ELISA	O
titer	O
correlated	O
well	O
with	O
the	O
protection	O
results	O
,	O
the	O
specificity	O
and	O
sensitivity	O
of	O
the	O
ELISA	O
were	O
further	O
evaluated	O
with	O
sera	B-ANAT
collected	O
from	O
pigs	O
reared	O
on	O
1	O
farm	O
on	O
which	O
animals	O
had	O
acute	O
septicemia	O
,	O
2	O
farms	O
on	O
which	O
the	O
animals	O
were	O
infected	O
or	O
free	O
from	O
infection	O
,	O
and	O
10	O
farms	O
on	O
which	O
the	O
animals	O
were	O
vaccinated	O
with	O
live	O
vaccine	O
,	O
among	O
others	O
.	O

RESULTS	O
:	O
The	O
95	O
%	O
confidence	O
interval	O
of	O
total	O
average	O
for	O
the	O
complications	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
shock	O
and	O
kidney	B-ANAT
failure	O
was	O
between	O
2	O
to	O
4	O
days	O
,	O
and	O
for	O
encephalopathy	O
,	O
hemorrhage	O
of	O
the	O
digestive	B-ANAT
tract	I-ANAT
,	O
bacterial	O
infection	O
,	O
fungous	O
infection	O
and	O
abscess	O
between	O
3	O
to	O
6	O
days	O
,	O
3	O
to	O
5	O
days	O
,	O
13	O
to	O
16	O
days	O
,	O
13	O
to	O
16	O
days	O
,	O
and	O
14	O
to	O
23	O
days	O
respectively	O
.	O

Acute	O
respiratory	O
viruses	O
commonly	O
induce	O
inflammatory	O
chemokines	O
such	O
as	O
CCL3	O
(	O
also	O
known	O
as	O
macrophage	B-ANAT
inflammatory	O
protein	O
-	O
1alpha	O
)	O
and	O
CCL5	O
(	O
RANTES	O
),	O
which	O
can	O
amplify	O
inflammatory	O
responses	O
leading	O
to	O
immunopathology	O
.	O

Virus	O
neutralization	O
(	O
VN	O
)	O
antibodies	O
were	O
detected	O
by	O
tracheal	O
organ	B-ANAT
cultures	O
,	O
and	O
the	O
results	O
showed	O
that	O
VN	O
titers	O
reached	O
respectively	O
1	O
:	O
160	O
to	O
1	O
:	O
320	O
and	O
1	O
:	O
320	O
to	O
1	O
:	O
2048	O
with	O
doses	O
of	O
0	O
.	O
5	O
g	O
and	O
1	O
g	O
.	O

TITLE	O
:	O
Herpes	O
simplex	B-ANAT
virus	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
critical	O
care	O
patients	O
:	O
a	O
prospective	O
study	O
.	O

IL	O
-	O
1	O
beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
12	O
,	O
IL	O
-	O
18	O
,	O
TNF	O
-	O
alpha	O
,	O
macrophage	B-ANAT
inhibitory	O
protein	O
(	O
MIP	O
)-	O
1	O
alpha	O
,	O
and	O
RANTES	O
showed	O
no	O
upregulation	O
in	O
the	O
brains	B-ANAT
of	O
control	O
cats	O
,	O
moderate	O
upregulation	O
in	O
neurological	O
FIP	O
cats	O
,	O
and	O
very	O
high	O
upregulation	O
in	O
generalized	O
FIP	O
cats	O
.	O

To	O
determine	O
if	O
the	O
N	O
protein	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
cellular	B-ANAT
signal	O
transduction	O
,	O
an	O
ELISA	O
-	O
based	O
assay	O
on	O
transcription	O
factors	O
was	O
used	O
.	O

Analyses	O
of	O
throat	B-ANAT
swab	I-ANAT
samples	O
using	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
were	O
conducted	O
.	O

Clinical	O
manifestations	O
included	O
fever	O
in	O
31	O
patients	O
(	O
97	O
%),	O
followed	O
by	O
cough	O
,	O
dyspnea	O
,	O
chill	O
,	O
headache	O
,	O
sore	O
throat	B-ANAT
,	O
diarrhea	O
,	O
rhinorrhea	O
,	O
and	O
otalgia	O
.	O

Central	O
to	O
this	O
approach	O
was	O
a	O
DNA	O
microarray	O
designed	O
to	O
detect	O
a	O
wide	O
range	O
of	O
known	O
viruses	O
as	O
well	O
as	O
novel	O
members	O
of	O
existing	O
viral	O
families	O
;	O
this	O
microarray	O
contained	O
the	O
most	O
highly	O
conserved	O
70mer	O
sequences	O
from	O
every	O
fully	O
sequenced	O
reference	O
viral	B-ANAT
genome	I-ANAT
in	O
GenBank	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
was	O
observed	O
only	O
in	O
one	O
patient	O
(	O
age	O
17	O
years	O
and	O
11	O
.	O
5	O
months	O
),	O
whereas	O
interstitial	B-ANAT
disease	O
was	O
not	O
observed	O
in	O
any	O
patient	O
.	O

In	O
situ	O
hybridization	O
was	O
used	O
to	O
detect	O
the	O
expression	O
and	O
location	O
of	O
SARS	O
-	O
CoV	O
RNA	O
polymerase	O
gene	O
in	O
autopsy	O
tissues	B-ANAT
from	O
SARS	O
-	O
Cov	O
-	O
infected	O
subjects	O
,	O
including	O
the	O
lung	B-ANAT
,	O
spleen	B-ANAT
,	O
lymph	B-ANAT
nodes	I-ANAT
,	O
pituitary	B-ANAT
,	O
pancreas	B-ANAT
,	O
parathyroid	B-ANAT
,	O
adrenal	B-ANAT
glands	I-ANAT
,	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
skin	B-ANAT
,	O
brain	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
blood	B-ANAT
vessels	I-ANAT
,	O
striated	B-ANAT
muscles	I-ANAT
of	O
the	O
limbs	B-ANAT
,	O
bone	B-ANAT
marrow	I-ANAT
,	O
heart	B-ANAT
,	O
ovary	B-ANAT
,	O
uterus	B-ANAT
and	O
testicles	B-ANAT
.	O

Tongue	B-ANAT
picture	O
was	O
taken	O
by	O
digital	B-ANAT
camera	O
and	O
colors	O
(	O
red	O
,	O
green	O
and	O
blue	O
)	O
of	O
tongue	B-ANAT
proper	O
and	O
coating	O
were	O
analyzed	O
quantitatively	O
with	O
image	O
processing	O
software	O
.	O

The	O
color	O
of	O
tongue	B-ANAT
coating	O
was	O
mostly	O
thin	O
yellow	O
(	O
32	O
patients	O
,	O
46	O
.	O
4	O
%),	O
and	O
thin	O
white	O
was	O
the	O
second	O
(	O
29	O
patients	O
,	O
42	O
.	O
0	O
%).	O

Swollen	O
tongue	B-ANAT
body	I-ANAT
was	O
found	O
in	O
23	O
patients	O
(	O
14	O
.	O
8	O
%)	O
and	O
teeth	B-ANAT
print	O
on	O
margin	B-ANAT
was	O
found	O
in	O
19	O
patients	O
(	O
12	O
.	O
3	O
%).	O

The	O
colors	O
detected	O
quantitatively	O
by	O
the	O
method	O
described	O
above	O
could	O
comparatively	O
reflect	O
the	O
difference	O
of	O
tongue	B-ANAT
proper	O
and	O
coating	O
sensitively	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
serum	B-ANAT
anti	O
-	O
coronavirus	O
antibody	O
titer	O
in	O
medical	O
personnel	O
who	O
had	O
closely	O
contacted	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
.	O

The	O
serum	B-ANAT
anti	O
-	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
titer	O
in	O
medical	O
personnel	O
who	O
had	O
closely	O
contacted	O
with	O
SARS	O
patients	O
,	O
healthy	O
individuals	O
,	O
patients	O
with	O
community	O
acquired	O
pneumonia	O
and	O
patients	O
recovered	O
from	O
SARS	O
was	O
detected	O
by	O
using	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
method	O
.	O

RESULTS	O
:	O
The	O
serum	B-ANAT
anti	O
-	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
titer	O
in	O
patients	O
recovered	O
from	O
SARS	O
was	O
0	O
.	O
07	O
+/-	O
0	O
.	O
13	O
,	O
which	O
was	O
significantly	O
higher	O
as	O
compared	O
with	O
those	O
in	O
other	O
groups	O
.	O

Proinflammatory	O
cytokines	O
and	O
TGF	O
-	O
beta1	O
were	O
elevated	O
during	O
the	O
early	O
phase	O
of	O
SARS	O
,	O
a	O
phenomenon	O
which	O
may	O
be	O
associated	O
with	O
lung	B-ANAT
infiltration	O
and	O
proliferation	O
.	O

Observing	O
the	O
dynamic	O
changes	O
in	O
blood	B-ANAT
cytokine	O
levels	O
can	O
provide	O
us	O
with	O
a	O
scientific	O
basis	O
to	O
assess	O
pathogenesis	O
and	O
efficacy	O
of	O
clinical	O
treatment	O
of	O
SARS	O
.	O

TITLE	O
:	O
[	O
B	B-ANAT
cell	I-ANAT
subsets	O
and	O
the	O
expression	O
of	O
CD40	O
in	O
peripheral	B-ANAT
blood	I-ANAT
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

The	O
monitoring	O
of	O
B	B-ANAT
cells	I-ANAT
,	O
B1	O
cells	B-ANAT
and	O
the	O
expression	O
of	O
CD40	O
on	O
B	B-ANAT
cells	I-ANAT
is	O
useful	O
in	O
the	O
differential	O
diagnosis	O
of	O
SARS	O
.	O

This	O
case	O
had	O
the	O
following	O
features	O
:	O
(	O
1	O
)	O
a	O
history	O
of	O
contact	O
with	O
mild	O
cats	O
and	O
eating	O
the	O
animal	O
'	O
s	O
meat	O
;	O
(	O
2	O
)	O
high	O
fever	O
(	O
temperature	O
,	O
>	O
38	O
degrees	O
C	O
),	O
followed	O
by	O
dry	O
cough	O
,	O
rapid	O
progression	O
to	O
respiratory	O
failure	O
,	O
followed	O
by	O
radiographic	O
evidence	O
of	O
bilateral	O
air	O
-	O
space	O
lesions	O
;	O
(	O
3	O
)	O
no	O
leukocytosis	O
;	O
(	O
4	O
)	O
spread	O
to	O
4	O
family	O
members	O
who	O
had	O
had	O
direct	O
contact	O
with	O
this	O
patient	O
;	O
(	O
5	O
)	O
the	O
patient	O
'	O
s	O
serum	B-ANAT
SARS	O
virus	O
IgG	O
was	O
confirmed	O
to	O
be	O
positive	O
;	O
(	O
6	O
)	O
the	O
patient	O
was	O
treated	O
with	O
anti	O
-	O
viral	O
agents	O
,	O
antibiotics	O
and	O
mechanical	O
ventilation	O
and	O
molecular	O
adsorbent	O
re	O
-	O
circulating	O
system	O
(	O
MARS	O
).	O

It	O
was	O
suggested	O
that	O
the	O
causes	O
for	O
cardiac	B-ANAT
arrest	O
in	O
SARS	O
patients	O
may	O
include	O
:	O
(	O
1	O
)	O
the	O
lung	B-ANAT
injury	O
caused	O
by	O
the	O
SARS	O
virus	O
leads	O
to	O
hypoxemia	O
and	O
thus	O
an	O
unsteady	O
state	O
of	O
the	O
myocardial	O
electricity	O
;	O
(	O
2	O
)	O
SARS	O
virus	O
directly	O
causes	O
injury	O
to	O
the	O
myocardial	O
cells	B-ANAT
and	O
/	O
or	O
the	O
conduct	O
system	O
;	O
(	O
3	O
)	O
SARS	O
infection	O
aggravates	O
the	O
original	O
myocardial	O
pathological	O
change	O
,	O
worsening	O
the	O
conduct	O
block	O
;	O
(	O
4	O
)	O
extreme	O
anxiety	O
leads	O
to	O
extra	O
secretion	B-ANAT
of	O
catecholamine	O
,	O
which	O
causes	O
instability	O
of	O
myocardial	O
electricity	O
;	O
(	O
5	O
)	O
defecation	O
worsens	O
hypoxemia	O
,	O
which	O
induces	O
arrhythmia	O
(	O
ventricular	B-ANAT
fibrillation	O
)	O
and	O
causes	O
cardiac	B-ANAT
arrest	O
.	O

The	O
median	O
serum	B-ANAT
SARS	O
-	O
CoV	O
concentrations	O
in	O
patients	O
who	O
required	O
and	O
did	O
not	O
require	O
intensive	O
care	O
unit	O
admission	O
during	O
the	O
course	O
of	O
hospitalization	O
were	O
5800	O
and	O
140	O
copies	O
/	O
mL	O
,	O
respectively	O
(	O
Mann	O
-	O
Whitney	O
test	O
,	O
P	O
<	O
0	O
.	O
005	O
).	O

We	O
used	O
experimental	O
infection	O
of	O
cats	O
with	O
a	O
highly	O
pathogenic	O
FIPV	O
isolate	O
,	O
UCD8	O
,	O
to	O
study	O
histologic	O
lesions	O
,	O
virus	O
replication	O
,	O
and	O
cytokine	O
expression	O
in	O
multiple	O
lymphoid	B-ANAT
tissues	I-ANAT
during	O
the	O
effusive	O
phase	O
of	O
disease	O
.	O

All	O
tissues	B-ANAT
positive	O
for	O
virus	O
replication	O
also	O
demonstrated	O
lymphoid	O
depletion	O
.	O

Although	O
no	O
differences	O
in	O
IFN	O
-	O
gamma	O
or	O
TNF	O
-	O
alpha	O
mRNA	O
were	O
measured	O
,	O
TNF	O
-	O
alpha	O
protein	O
expression	O
was	O
greater	O
in	O
affected	O
tissues	B-ANAT
and	O
demonstrated	O
a	O
shift	O
in	O
the	O
source	O
of	O
TNF	O
-	O
alpha	O
from	O
macrophages	B-ANAT
to	O
lymphocytes	B-ANAT
.	O

In	O
this	O
study	O
,	O
we	O
immunized	O
cats	O
with	O
cell	B-ANAT
lysate	O
with	O
recombinant	O
baculovirus	O
-	O
expressed	O
N	O
protein	O
of	O
the	O
Type	O
I	O
FIPV	O
strain	O
KU	O
-	O
2	O
with	O
an	O
adjuvant	O
and	O
investigated	O
its	O
preventive	O
effect	O
on	O
the	O
progression	O
of	O
FIP	O
.	O

Surprisingly	O
,	O
in	O
20	O
%	O
of	O
infants	O
who	O
did	O
not	O
present	O
with	O
nasal	B-ANAT
symptoms	O
,	O
rhinovirus	O
infections	O
were	O
also	O
detected	O
.	O

We	O
found	O
that	O
a	O
soluble	O
form	O
of	O
ACE2	O
,	O
but	O
not	O
of	O
the	O
related	O
enzyme	O
ACE1	O
,	O
blocked	O
association	O
of	O
the	O
S1	O
domain	O
with	O
Vero	O
E6	O
cells	B-ANAT
.	O

The	O
recombinant	O
N	O
protein	O
was	O
expressed	O
in	O
E	O
.	O
coli	O
BL21	B-ANAT
(	O
DE3	O
),	O
and	O
purified	O
by	O
Ni	O
(	O
2	O
+)-	O
NTA	O
.	O

The	O
monoclonal	O
antibodies	O
of	O
CD8	O
,	O
CD20	O
,	O
CD34	O
,	O
LCA	O
,	O
CD56	O
,	O
CD68	O
,	O
and	O
AE1	O
/	O
AE3	O
are	O
used	O
to	O
demonstrate	O
the	O
different	O
cells	B-ANAT
in	O
the	O
lung	B-ANAT
specimens	O
of	O
SARS	O
patients	O
in	O
order	O
to	O
study	O
the	O
patterns	O
of	O
cell	B-ANAT
responses	O
in	O
this	O
new	O
disease	O
.	O

The	O
number	O
of	O
capillaries	B-ANAT
increased	O
and	O
the	O
capillaries	B-ANAT
clearly	O
outlined	O
the	O
contour	O
of	O
alveolar	B-ANAT
wall	I-ANAT
from	O
beginning	O
to	O
early	O
stage	O
of	O
organization	O
,	O
the	O
number	O
of	O
lymphocytes	B-ANAT
decreased	O
sharply	O
while	O
the	O
number	O
of	O
macrophage	B-ANAT
remarkably	O
increased	O
,	O
together	O
with	O
proliferation	O
of	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
.	O

The	O
lesions	O
in	O
the	O
lung	B-ANAT
from	O
SARS	O
patients	O
are	O
consisted	O
of	O
the	O
tissue	B-ANAT
reaction	O
to	O
the	O
inflammatory	O
injury	O
,	O
including	O
extensive	O
exudation	O
,	O
capillary	B-ANAT
proliferation	O
,	O
fibrosis	O
,	O
and	O
obvious	O
infiltration	O
of	O
macrophages	B-ANAT
which	O
may	O
play	O
a	O
key	O
role	O
in	O
the	O
pathogenesis	O
of	O
pulmonary	B-ANAT
lesions	O
of	O
SARS	O
.	O

The	O
numbers	O
of	O
blood	B-ANAT
vessels	I-ANAT
decreased	O
in	O
the	O
fibrotic	O
and	O
consolidated	O
lung	B-ANAT
tissue	I-ANAT
,	O
and	O
the	O
vessel	B-ANAT
cavities	B-ANAT
enlarged	O
,	O
losing	O
the	O
normal	O
contour	O
of	O
alveolar	B-ANAT
septa	O
.	O

Among	O
them	O
,	O
65	O
also	O
had	O
laboratory	O
results	O
and	O
91	O
underwent	O
examinations	O
of	O
pulmonary	B-ANAT
function	O
.	O

One	O
hundred	O
and	O
fifty	O
-	O
eight	O
nasal	B-ANAT
and	O
throat	B-ANAT
swabs	O
specimens	O
from	O
79	O
SARS	O
patients	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
between	O
April	O
and	O
May	O
,	O
2003	O
were	O
cultured	O
for	O
SARS	O
-	O
coronavirus	O
.	O

Acute	O
and	O
convalescent	O
phase	O
serum	B-ANAT
specimens	O
collected	O
from	O
SARS	O
patients	O
were	O
found	O
with	O
seroconversions	O
and	O
/	O
or	O
a	O
fourfold	O
or	O
greater	O
rises	O
in	O
indirect	O
fluorescence	O
antibodies	O
(	O
IgG	O
and	O
IgM	O
)	O
titers	O
when	O
the	O
3	O
isolates	O
(	O
infected	O
Vero	B-ANAT
cells	I-ANAT
)	O
were	O
used	O
as	O
antigen	O
.	O

During	O
the	O
8th	O
-	O
12th	O
week	O
,	O
the	O
cell	B-ANAT
counts	O
of	O
CD4	B-ANAT
+	I-ANAT
cell	I-ANAT
[(	O
578	O
+/-	O

It	O
will	O
take	O
more	O
than	O
8	O
-	O
12	O
weeks	O
for	O
CD4	B-ANAT
+	I-ANAT
cell	I-ANAT
and	O
naive	O
CD4	O
+	O
subset	O
to	O
reach	O
to	O
normal	O
levels	O
.	O

Dyspnea	O
during	O
acute	O
phase	O
and	O
CT	O
during	O
the	O
convalescent	O
period	O
were	O
found	O
to	O
have	O
significant	O
influences	O
on	O
DLco	O
and	O
total	O
lung	B-ANAT
capacity	O
(	O
TLC	O
).	O

TITLE	O
:	O
[	O
Change	O
of	O
T	B-ANAT
lymphocyte	I-ANAT
and	O
its	O
activated	O
subsets	O
in	O
SARS	O
patients	O
].	O

Flow	O
cytometer	O
with	O
multi	O
-	O
color	O
flouroscence	O
and	O
hematology	O
analyzer	O
were	O
used	O
to	O
detect	O
the	O
expression	O
of	O
T	B-ANAT
lymphocyte	I-ANAT
and	O
its	O
activated	O
a	O
subsets	O
in	O
240	O
SARS	O
patients	O
including	O
50	O
cases	O
of	O
critical	O
type	O
and	O
190	O
cases	O
of	O
common	O
type	O
.	O

RESULTS	O
:	O
Three	O
of	O
thirteen	O
patients	O
had	O
been	O
intubated	O
or	O
received	O
tracheotomy	O
before	O
they	O
entered	O
into	O
ICU	O
,	O
the	O
other	O
patients	O
received	O
treatment	O
of	O
nasal	B-ANAT
cannula	O
or	O
oxygen	O
mask	O
.	O

Cells	B-ANAT
expressing	O
S	O
fused	O
with	O
receptor	O
-	O
expressing	O
cells	B-ANAT
at	O
neutral	O
pH	O
suggesting	O
that	O
the	O
recombinant	O
glycoprotein	O
is	O
functional	O
,	O
its	O
membrane	B-ANAT
fusogenic	O
activity	O
does	O
not	O
require	O
other	O
viral	O
proteins	O
,	O
and	O
that	O
low	O
pH	O
is	O
not	O
required	O
for	O
triggering	O
membrane	B-ANAT
fusion	O
;	O
fusion	O
was	O
not	O
observed	O
at	O
low	O
receptor	O
concentrations	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
nucleic	B-ANAT
acid	O
-	O
based	O
molecular	O
techniques	O
has	O
significantly	O
enhanced	O
laboratory	O
diagnosis	O
and	O
monitoring	O
of	O
atypical	O
pneumonia	O
.	O

The	O
virus	O
gains	O
access	O
to	O
host	O
through	O
the	O
mucosa	B-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
the	O
eyes	B-ANAT
.	O

In	O
contrast	O
,	O
N	O
protein	O
association	O
in	O
the	O
majority	O
of	O
the	O
intracellular	B-ANAT
RNP	B-ANAT
complexes	O
was	O
susceptible	O
to	O
RNase	O
A	O
-	O
treatment	O
.	O

The	O
vaccinated	O
animals	O
all	O
had	O
antibody	O
responses	O
against	O
spike	O
protein	O
S1	O
fragment	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
against	O
the	O
nucleocapsid	B-ANAT
protein	O
.	O

Luciferase	O
expression	O
,	O
which	O
is	O
dependent	O
on	O
viral	O
RNA	O
replication	O
and	O
RNA	O
-	O
dependent	O
mRNA	O
synthesis	O
,	O
was	O
measured	O
in	O
intact	O
yeast	O
cells	B-ANAT
.	O

TITLE	O
:	O
Total	O
pancreatectomy	O
and	O
autologous	O
islet	B-ANAT
cell	I-ANAT
transplantation	O
as	O
a	O
means	O
to	O
treat	O
severe	O
chronic	O
pancreatitis	O
.	O

Live	O
attenuated	O
(	O
by	O
passage	O
in	O
chicken	O
embryonated	O
eggs	O
)	O
IBV	O
strains	O
were	O
introduced	O
as	O
vaccines	O
in	O
the	O
1950s	O
,	O
followed	O
a	O
couple	O
of	O
decades	O
later	O
by	O
inactivated	O
vaccines	O
for	O
boosting	O
protection	O
in	O
egg	B-ANAT
-	O
laying	O
birds	O
.	O

The	O
large	O
spike	O
glycoprotein	O
(	O
S	O
)	O
comprises	O
a	O
carboxy	O
-	O
terminal	O
S2	O
subunit	O
(	O
approximately	O
625	O
amino	O
acid	O
residues	O
),	O
which	O
anchors	O
S	O
in	O
the	O
virus	O
envelope	B-ANAT
,	O
and	O
an	O
amino	O
-	O
terminal	O
S1	O
subunit	O
(	O
approximately	O
520	O
residues	O
),	O
believed	O
to	O
largely	O
form	O
the	O
distal	O
bulbous	O
part	O
of	O
S	O
.	O
The	O
S1	O
subunit	O
(	O
purified	O
from	O
IBV	O
virus	O
,	O
expressed	O
using	O
baculovirus	O
or	O
expressed	O
in	O
birds	O
from	O
a	O
fowlpoxvirus	O
vector	O
)	O
induced	O
virus	O
neutralizing	O
antibody	O
.	O

Serum	B-ANAT
antibody	O
levels	O
do	O
not	O
correlate	O
with	O
protection	O
,	O
although	O
local	O
antibody	O
is	O
believed	O
to	O
play	O
a	O
role	O
.	O

Patients	O
usually	O
present	O
with	O
high	O
fever	O
,	O
chills	O
,	O
myalgia	O
and	O
dry	O
cough	O
,	O
with	O
or	O
without	O
chest	B-ANAT
X	O
-	O
ray	O
evidence	O
of	O
pneumonia	O
at	O
the	O
onset	O
of	O
disease	O
.	O

CONCLUSIONS	O
:	O
A	O
defined	O
pattern	O
of	O
HRCT	O
findings	O
is	O
observed	O
in	O
different	O
phases	O
of	O
SARS	O
,	O
which	O
is	O
characterized	O
by	O
focal	O
ground	O
-	O
glass	O
and	O
crazy	O
paving	O
patterns	O
in	O
a	O
scattered	O
distribution	O
at	O
presentation	O
,	O
followed	O
by	O
development	O
of	O
interstitial	B-ANAT
thickening	O
,	O
consolidation	O
,	O
pleural	O
reaction	O
,	O
and	O
scarring	O
.	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
shown	O
that	O
mitochondrial	B-ANAT
-	O
aconitase	O
binds	O
specifically	O
to	O
the	O
3	O
'	O
terminal	O
42	O
nucleotides	O
of	O
the	O
Murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
RNA	O
along	O
with	O
three	O
additional	O
proteins	O
of	O
70	O
,	O
58	O
and	O
40	O
kDa	O
to	O
form	O
a	O
stable	O
RNA	B-ANAT
-	I-ANAT
protein	I-ANAT
complex	I-ANAT
.	O

Within	O
the	O
first	O
days	O
the	O
patient	O
also	O
developed	O
cerebral	B-ANAT
seizures	O
.	O

TITLE	O
:	O
Potential	O
pathogens	O
in	O
feces	B-ANAT
from	O
unweaned	O
llamas	O
and	O
alpacas	O
with	O
diarrhea	O
.	O

The	O
interferon	O
alfacon	O
-	O
1	O
treatment	O
group	O
had	O
a	O
shorter	O
time	O
to	O
50	O
%	O
resolution	O
of	O
lung	B-ANAT
radiographic	O
abnormalities	O
(	O
median	O
time	O
,	O
4	O
days	O
vs	O
9	O
days	O
;	O
P	O
=.	O
001	O
),	O
had	O
better	O
oxygen	O
saturation	O
(	O
P	O
=.	O
02	O
),	O
resolved	O
their	O
need	O
for	O
supplemental	O
oxygen	O
more	O
rapidly	O
(	O
median	O
,	O
10	O
days	O
vs	O
16	O
days	O
;	O
P	O
=.	O
02	O
),	O
had	O
less	O
of	O
an	O
increase	O
in	O
creatine	O
kinase	O
levels	O
(	O
P	O
=.	O
03	O
),	O
and	O
showed	O
a	O
trend	O
toward	O
more	O
rapid	O
resolution	O
of	O
lactate	O
dehydrogenase	O
levels	O
compared	O
with	O
the	O
group	O
receiving	O
corticosteroids	O
alone	O
.	O

TITLE	O
:	O
CXC	O
chemokine	O
ligand	O
10	O
controls	O
viral	O
infection	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
:	O
evidence	O
for	O
a	O
role	O
in	O
innate	O
immune	O
response	O
through	O
recruitment	O
and	O
activation	O
of	O
natural	B-ANAT
killer	I-ANAT
cells	I-ANAT
.	O

In	O
MHV	O
and	O
BCoV	O
,	O
the	O
bulged	O
stem	B-ANAT
-	O
loop	O
and	O
pseudoknot	O
are	O
,	O
in	O
part	O
,	O
mutually	O
exclusive	O
,	O
because	O
of	O
the	O
overlap	O
of	O
the	O
last	O
segment	O
of	O
the	O
stem	B-ANAT
-	O
loop	O
and	O
stem	B-ANAT
1	O
of	O
the	O
pseudoknot	O
.	O

Treatment	O
with	O
oral	B-ANAT
prednisolone	O
and	O
ribavirin	O
normalized	O
her	O
lymphopenia	O
,	O
altered	O
transaminases	O
,	O
chest	B-ANAT
radiograph	O
and	O
high	O
-	O
resolution	O
computed	O
tomography	O
appearances	O
rapidly	O
.	O

MHV	O
replication	O
is	O
impaired	O
in	O
autophagy	O
knockout	O
,	O
APG5	O
-/-,	O
embryonic	B-ANAT
stem	I-ANAT
cell	I-ANAT
lines	O
,	O
but	O
wild	O
-	O
type	O
levels	O
of	O
MHV	O
replication	O
are	O
restored	O
by	O
expression	O
of	O
Apg5	O
in	O
the	O
APG5	O
-/-	O
cells	B-ANAT
.	O

Plasma	B-ANAT
inflammatory	O
cytokine	O
concentrations	O
(	O
interleukin	O
[	O
IL	O
]-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
12p70	O
,	O
and	O
TNF	O
-	O
alpha	O
)	O
were	O
monitored	O
longitudinally	O
on	O
admission	O
,	O
immediately	O
before	O
corticosteroids	O
,	O
and	O
1	O
to	O
2	O
days	O
and	O
7	O
to	O
10	O
days	O
after	O
the	O
drug	O
treatment	O
in	O
a	O
cohort	O
of	O
pediatric	O
patients	O
(	O
n	O
=	O
8	O
)	O
with	O
virologic	O
confirmed	O
SARS	O
-	O
associated	O
coronavirus	O
infection	O
.	O

Additionally	O
,	O
there	O
is	O
in	O
vitro	O
evidence	O
of	O
human	O
coronavirus	O
'	O
s	O
ability	O
to	O
infect	O
neural	O
cells	B-ANAT
.	O

Serum	B-ANAT
ALT	O
,	O
AST	O
,	O
LDH	O
and	O
CK	O
were	O
elevated	O
in	O
45	O
.	O
2	O
%,	O
29	O
.	O
4	O
%,	O
42	O
.	O
1	O
%,	O
and	O
18	O
.	O
3	O
%	O
of	O
the	O
patients	O
respectively	O
.	O

Among	O
these	O
proteins	O
,	O
spike	O
(	O
S	O
)	O
protein	O
is	O
responsible	O
for	O
binding	O
to	O
specific	O
cellular	B-ANAT
receptors	O
and	O
is	O
a	O
major	O
antigenic	O
determinant	O
,	O
which	O
induces	O
neutralizing	O
antibody	O
.	O

Infliximab	O
also	O
alleviated	O
alveolar	B-ANAT
edema	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
like	O
pulmonary	B-ANAT
complications	O
,	O
but	O
the	O
difference	O
was	O
not	O
significant	O
.	O

Significant	O
differences	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
epithelium	B-ANAT
thickness	O
and	O
tracheal	O
scores	O
were	O
observed	O
between	O
the	O
unvaccinated	O
-	O
unchallenged	O
group	O
and	O
the	O
groups	O
vaccinated	O
once	O
or	O
twice	O
with	O
the	O
Mass	O
-	O
Conn	O
vaccine	O
.	O

The	O
criteria	O
used	O
for	O
diagnosis	O
of	O
ARDS	O
was	O
based	O
upon	O
American	O
/	O
European	O
consensus	O
statement	O
for	O
definition	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
involvement	O
in	O
cryoglobulinemia	O
usually	O
is	O
mild	O
.	O

She	O
received	O
the	O
diagnosis	O
of	O
acute	O
lung	B-ANAT
injury	O
according	O
to	O
the	O
concept	O
proposed	O
by	O
the	O
American	O
-	O
European	O
Consensus	O
Conference	O
.	O

The	O
ACE2	O
sequence	O
is	O
similar	O
(	O
sequence	O
identities	O
43	O
%	O
and	O
35	O
%,	O
and	O
similarities	O
61	O
%	O
and	O
55	O
%,	O
respectively	O
)	O
to	O
those	O
of	O
the	O
testis	B-ANAT
-	O
specific	O
form	O
of	O
ACE	O
(	O
tACE	O
)	O
and	O
the	O
Drosophila	O
homolog	O
of	O
ACE	O
(	O
AnCE	O
).	O

Eighteen	O
subjects	O
were	O
investigated	O
,	O
and	O
results	O
indicated	O
that	O
blood	B-ANAT
samples	I-ANAT
contain	O
sufficient	O
virus	O
for	O
detection	O
by	O
using	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

Post	O
-	O
operative	O
complications	O
included	O
burst	O
abdomen	B-ANAT
(	O
one	O
case	O
)	O
and	O
reopened	O
pyoperitoneum	O
,	O
which	O
resulted	O
fecal	B-ANAT
fistula	O
in	O
three	O
cases	O
,	O
one	O
of	O
these	O
patients	O
died	O
.	O
:	O
Induced	O
abortion	O
was	O
proven	O
to	O
be	O
a	O
major	O
detrimental	O
factor	O
for	O
maternal	O
mortality	O
.	O

Early	O
diagnosis	O
can	O
be	O
made	O
with	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
of	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
samples	O
.	O

Coronavirus	O
-	O
like	O
particles	O
were	O
founded	O
in	O
the	O
leukocytes	B-ANAT
in	O
6	O
of	O
the	O
22	O
blood	B-ANAT
samples	I-ANAT
.	O

A	O
distinct	O
membrane	B-ANAT
and	O
club	O
-	O
shaped	O
surface	O
projections	O
were	O
seen	O
in	O
the	O
periphery	O
.	O

ABSTRACT	O
:	O
Both	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
are	O
required	O
for	O
clearance	O
of	O
the	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
during	O
acute	O
infection	O
.	O

More	O
than	O
90	O
%	O
of	O
the	O
viruses	O
recovered	O
from	O
brain	B-ANAT
lysates	O
of	O
such	O
protected	O
mice	O
,	O
at	O
5	O
days	O
postinfection	O
,	O
had	O
lost	O
the	O
ability	O
to	O
express	O
EGFP	O
and	O
had	O
deletions	O
in	O
their	O
genomes	O
encompassing	O
EGFP	O
and	O
gp33	O
-	O
41	O
.	O

On	O
the	O
other	O
hand	O
,	O
gp33	O
-	O
41	O
-	O
specific	O
cells	B-ANAT
failed	O
to	O
protect	O
perforin	O
-	O
deficient	O
mice	O
from	O
infection	O
by	O
the	O
recombinant	O
MHV	O
expressing	O
gp33	O
,	O
indicating	O
that	O
perforin	O
-	O
mediated	O
mechanisms	O
were	O
needed	O
.	O

Three	O
hybridomas	B-ANAT
producing	O
mAbs	O
specific	O
to	O
the	O
S1	O
domain	O
was	O
obtained	O
,	O
with	O
a	O
relative	O
molecular	O
mass	O
of	O
48	O
,	O
500	O
.	O

RESULTS	O
:	O
Three	O
hybridomas	B-ANAT
producing	O
mAbs	O
specific	O
to	O
the	O
S1	O
domain	O
was	O
obtained	O
,	O
with	O
a	O
relative	O
molecular	O
mass	O
of	O
48	O
,	O
500	O
.	O

Chest	B-ANAT
radiographs	O
showed	O
hyperinflation	O
.	O

There	O
were	O
4	O
groups	O
:	O
Control	O
(	O
C	O
);	O
NO	O
,	O
iNO	O
at	O
1	O
,	O
10	O
,	O
20	O
and	O
40	O
x	O
10	O
(-	O
6	O
)	O
each	O
for	O
60	O
min	O
at	O
30	O
min	O
interval	O
of	O
disconnection	O
;	O
Surf	O
,	O
intratracheal	O
instillation	O
of	O
porcine	O
lung	B-ANAT
surfactant	O
phospholipids	O
(	O
100	O
mg	O
/	O
kg	O
);	O
SNO	O
,	O
both	O
iNO	O
and	O
surfactant	O
as	O
in	O
the	O
NO	O
and	O
Surf	O
groups	O
;	O
and	O
a	O
normal	O
group	O
(	O
N	O
),	O
which	O
did	O
not	O
undergo	O
meconium	B-ANAT
aspiration	O
but	O
received	O
sham	O
deliveries	O
of	O
normal	O
saline	O
.	O

iNO	O
synergistically	O
improved	O
surfactant	O
effects	O
on	O
oxygenation	O
and	O
lung	B-ANAT
mechanics	O
.	O

The	O
results	O
showed	O
that	O
all	O
the	O
three	O
fragments	O
of	O
S	O
protein	O
expressed	O
by	O
E	O
.	O
coli	O
was	O
able	O
to	O
react	O
with	O
sera	B-ANAT
of	O
SARS	O
patients	O
and	O
the	O
S	O
gene	O
DNA	O
candidate	O
vaccine	O
could	O
induce	O
the	O
production	O
of	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
against	O
SARS	O
-	O
CoV	O
efficiently	O
in	O
mice	O
with	O
seroconversion	O
ratio	O
of	O
75	O
%	O
after	O
3	O
times	O
of	O
immunization	O
.	O

No	O
differences	O
were	O
found	O
in	O
maximum	O
number	O
of	O
lung	B-ANAT
fields	O
involved	O
,	O
duration	O
from	O
the	O
onset	O
of	O
fever	O
to	O
the	O
occurrence	O
of	O
pulmonary	B-ANAT
infiltrates	O
and	O
time	O
from	O
the	O
initial	O
pulmonary	B-ANAT
infiltrate	O
to	O
its	O
peak	O
among	O
the	O
multiple	O
transmission	O
generations	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

No	O
statistical	O
differences	O
were	O
found	O
in	O
modes	O
of	O
oxygen	O
therapy	O
and	O
sorts	O
of	O
antibiotics	O
prescribed	O
among	O
the	O
various	O
transmission	O
generations	O
(	O
P	O
>	O
0	O
.	O
05	O
);	O
however	O
,	O
as	O
with	O
the	O
advanced	O
transmission	O
generations	O
,	O
the	O
number	O
of	O
cases	O
prescribed	O
with	O
methylprednisolone	O
,	O
human	O
gamma	O
-	O
globulin	O
,	O
interferon	O
-	O
alpha	O
,	O
antiviral	O
drugs	O
(	O
oral	B-ANAT
ribavirin	O
or	O
oseltamivir	O
)	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
time	O
from	O
admission	O
to	O
starting	O
these	O
medication	O
shortened	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Amplicons	O
with	O
the	O
sizes	O
of	O
368	O
bp	O
and	O
348	O
bp	O
were	O
obtained	O
from	O
a	O
throat	B-ANAT
swab	I-ANAT
specimen	O
collected	O
from	O
a	O
17	O
years	O
old	O
girl	O
,	O
who	O
was	O
admitted	O
to	O
the	O
isolated	O
ward	O
because	O
of	O
high	O
fever	O
(	O
39	O
.	O
5	O
degrees	O
C	O
)	O
for	O
7	O
days	O
,	O
cough	O
for	O
2	O
days	O
,	O
low	O
WBC	B-ANAT
count	O
,	O
and	O
pneumonia	O
shown	O
by	O
X	O
-	O
ray	O
when	O
she	O
visited	O
the	O
""""	O
Fever	O
and	O
Cough	O
""""	O
Clinic	O
,	O
and	O
without	O
known	O
history	O
of	O
contact	O
with	O
probable	O
SARS	O
patient	O
.	O

The	O
serum	B-ANAT
collected	O
before	O
her	O
discharge	B-ANAT
from	O
the	O
hospital	O
(	O
19	O
days	O
after	O
the	O
onset	O
of	O
the	O
disease	O
)	O
showed	O
SARS	O
specific	O
IgM	O
and	O
IgG	O
antibodies	O
.	O

Mean	O
total	O
white	O
count	O
of	O
peripheral	B-ANAT
blood	I-ANAT
was	O
(	O
2	O
.	O
96	O
-	O
6	O
.	O
9	O
)	O
x	O
10	O
(	O
9	O
)/	O
L	O
,	O
and	O
was	O
<	O
5	O
.	O
0	O
x	O
10	O
(	O
9	O
)/	O
L	O
in	O
4	O
cases	O
.	O

None	O
of	O
the	O
cases	O
had	O
any	O
signs	O
of	O
fibrosis	O
in	O
the	O
lungs	B-ANAT
.	O

In	O
4	O
of	O
the	O
8	O
SARS	O
patients	O
,	O
pulmonary	B-ANAT
thromboemboli	O
were	O
also	O
recognized	O
on	O
gross	O
examination	O
,	O
while	O
one	O
patient	O
had	O
marantic	O
cardiac	B-ANAT
valvular	O
vegetations	O
.	O

ABSTRACT	O
:	O
Purification	O
of	O
turkey	O
coronavirus	O
(	O
TCoV	O
)	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
,	O
expressed	O
in	O
a	O
prokaryotic	O
expression	O
system	O
as	O
histidine	O
-	O
tagged	O
fusion	O
protein	O
is	O
demonstrated	O
in	O
the	O
present	O
study	O
.	O

PaO2	O
,	O
pH	O
,	O
MAP	O
and	O
survival	O
rate	O
were	O
recorded	O
and	O
plasma	B-ANAT
NO	O
,	O
TNF	O
-	O
alpha	O
were	O
measured	O
during	O
5	O
-	O
hr	O
after	O
the	O
injection	O
of	O
LPS	O
.	O

RESULTS	O
:	O
Compared	O
with	O
the	O
endotoxemic	O
group	O
,	O
both	O
the	O
pretreatment	O
and	O
simultaneously	O
treatment	O
groups	O
,	O
significantly	O
improved	O
PaO2	O
,	O
pH	O
,	O
MAP	O
and	O
5th	O
hour	O
survival	O
rate	O
of	O
rats	O
,	O
and	O
attenuated	O
endotoxin	O
-	O
induced	O
increased	O
iNOSmRNA	O
,	O
NT	O
expression	O
,	O
MPO	O
activity	O
and	O
MDA	O
level	O
in	O
lung	B-ANAT
tissue	I-ANAT
,	O
and	O
decreased	O
pulmonary	B-ANAT
microvascular	O
permeability	O
,	O
TNF	O
-	O
alpha	O
,	O
NO	O
in	O
plasma	B-ANAT
.	O

We	O
previously	O
demonstrated	O
that	O
JHM	O
-	O
infected	O
mice	O
that	O
only	O
have	O
CD8	O
T	B-ANAT
cells	I-ANAT
specific	O
for	O
an	O
epitope	O
not	O
in	O
the	O
virus	O
develop	O
demyelination	O
on	O
specific	O
activation	O
of	O
these	O
cells	B-ANAT
.	O

The	O
absence	O
of	O
IFN	O
-	O
gamma	O
abrogated	O
demyelination	O
but	O
did	O
not	O
change	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
infiltration	O
or	O
expression	O
levels	O
of	O
inflammatory	O
cytokines	O
or	O
chemokines	O
in	O
the	O
spinal	B-ANAT
cord	I-ANAT
.	O

These	O
results	O
are	O
consistent	O
with	O
models	O
in	O
which	O
IFN	O
-	O
gamma	O
contributes	O
to	O
CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
mediated	O
demyelination	O
by	O
activation	O
of	O
macrophages	B-ANAT
/	O
microglia	B-ANAT
,	O
the	O
final	O
effector	O
cells	B-ANAT
in	O
the	O
disease	O
process	O
.	O

ABSTRACT	O
:	O
Inflammatory	O
response	O
leading	O
to	O
organ	B-ANAT
dysfunction	O
and	O
failure	O
continues	O
to	O
be	O
the	O
major	O
problem	O
after	O
injury	O
in	O
many	O
clinical	O
conditions	O
such	O
as	O
sepsis	O
,	O
severe	O
burns	O
,	O
acute	O
pancreatitis	O
,	O
haemorrhagic	O
shock	O
,	O
and	O
trauma	O
.	O

Thirteen	O
children	O
had	O
chest	B-ANAT
radiographic	O
consolidation	O
.	O

We	O
did	O
not	O
find	O
significant	O
lower	O
hemoglobin	O
and	O
platelet	B-ANAT
levels	O
.	O

TITLE	O
:	O
Perforin	O
and	O
gamma	O
interferon	O
-	O
mediated	O
control	O
of	O
coronavirus	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
infection	O
by	O
CD8	O
T	B-ANAT
cells	I-ANAT
in	O
the	O
absence	O
of	O
CD4	O
T	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
From	O
geographic	O
mapping	O
at	O
different	O
scales	B-ANAT
to	O
location	O
-	O
based	O
alerting	O
services	O
,	O
geoinformatics	O
plays	O
an	O
important	O
role	O
in	O
the	O
study	O
and	O
control	O
of	O
global	O
outbreaks	O
like	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
main	O
clinical	O
manifestations	O
were	O
high	O
fever	O
and	O
cough	O
while	O
no	O
severe	O
toxic	O
symptoms	O
,	O
nor	O
respiratory	O
failure	O
was	O
seen	O
;	O
few	O
symptoms	O
or	O
signs	O
suggesting	O
involvement	O
of	O
systems	O
other	O
than	O
respiratory	B-ANAT
system	I-ANAT
were	O
seen	O
.	O

Though	O
there	O
were	O
severe	O
changes	O
in	O
the	O
lung	B-ANAT
,	O
the	O
patients	O
might	O
not	O
have	O
corresponding	O
symptoms	O
or	O
signs	O
.	O

Images	O
were	O
evaluated	O
for	O
ground	O
-	O
glass	O
opacification	O
,	O
consolidation	O
,	O
interstitial	B-ANAT
thickening	O
,	O
evidence	O
of	O
fibrosis	O
,	O
and	O
any	O
other	O
abnormalities	O
.	O

Ground	O
-	O
glass	O
opacification	O
and	O
interstitial	B-ANAT
thickening	O
were	O
present	O
at	O
CT	O
in	O
all	O
eight	O
patients	O
.	O

TITLE	O
:	O
Surfactant	O
lavage	O
with	O
lidocaine	O
improves	O
pulmonary	B-ANAT
function	O
in	O
piglets	O
after	O
HCl	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

All	O
of	O
the	O
lungs	B-ANAT
are	O
markedly	O
enlarged	O
and	O
consolidated	O
.	O

During	O
the	O
acute	O
phase	O
of	O
SARS	O
,	O
lactate	O
dehydrogenase	O
level	O
,	O
degree	O
of	O
hypoxemia	O
,	O
respiratory	O
rate	O
,	O
alpha	O
-	O
hydroxybutyric	O
dehydrogenase	O
level	O
,	O
creatine	O
kinase	O
isoenzyme	O
-	O
MB	O
,	O
platelet	B-ANAT
count	O
,	O
and	O
number	O
of	O
involved	O
lobes	B-ANAT
noted	O
on	O
chest	B-ANAT
radiographs	O
,	O
and	O
so	O
on	O
,	O
correlated	O
markedly	O
with	O
the	O
prognosis	O
(	O
r	O
=	O
0	O
.	O
257	O
-	O
0	O
.	O
788	O
;	O
P	O
<.	O
05	O
).	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
without	O
respiratory	O
symptoms	O
or	O
abnormal	O
chest	B-ANAT
radiograph	O
findings	O
.	O

This	O
cell	B-ANAT
clone	I-ANAT
was	O
susceptible	O
to	O
HIV	O
/	O
SARS	O
pseudovirus	O
infection	O
and	O
the	O
presence	O
of	O
a	O
functional	O
receptor	O
for	O
S	O
protein	O
in	O
this	O
cell	B-ANAT
clone	I-ANAT
was	O
confirmed	O
by	O
the	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
assay	O
.	O

TITLE	O
:	O
Significant	O
changes	O
of	O
peripheral	O
T	B-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

RT	O
-	O
PCR	O
showed	O
evidence	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
in	O
the	O
liver	B-ANAT
tissues	I-ANAT
,	O
but	O
not	O
in	O
the	O
sera	B-ANAT
of	O
all	O
3	O
patients	O
.	O

G	O
-	O
CSF	B-ANAT
was	O
associated	O
with	O
alveolar	B-ANAT
neutrophilia	O
.	O

Given	O
the	O
potential	O
of	O
G	O
-	O
CSF	B-ANAT
to	O
directly	O
induce	O
anti	O
-	O
inflammatory	O
cytokines	O
in	O
vitro	O
,	O
significant	O
associations	O
of	O
endogenous	O
G	O
-	O
CSF	B-ANAT
levels	O
with	O
these	O
mediators	O
early	O
in	O
the	O
development	O
of	O
severe	O
lung	B-ANAT
injury	O
suggest	O
an	O
endogenous	O
anti	O
-	O
inflammatory	O
role	O
of	O
G	O
-	O
CSF	B-ANAT
in	O
vivo	O
.	O

In	O
the	O
brain	B-ANAT
,	O
MHV	O
-	O
JHM	O
infection	O
induced	O
strong	O
accumulation	O
of	O
IFNbeta	O
mRNA	O
relative	O
to	O
IFNgamma	O
mRNA	O
.	O

Furthermore	O
,	O
high	O
levels	O
of	O
macrophage	B-ANAT
-	O
inflammatory	O
protein	O
(	O
MIP	O
)-	O
1alpha	O
,	O
MIP	O
-	O
1beta	O
,	O
and	O
MIP	O
-	O
2	O
mRNA	O
were	O
observed	O
at	O
the	O
onset	O
of	O
MHV	O
-	O
JHM	O
infection	O
and	O
correlated	O
with	O
a	O
marked	O
elevation	O
in	O
the	O
number	O
of	O
macrophages	B-ANAT
in	O
the	O
brain	B-ANAT
on	O
day	O
7	O
compared	O
to	O
MHV	O
-	O
A59	O
infection	O
.	O

Thus	O
,	O
chloroquine	O
has	O
found	O
applications	O
in	O
autoimmune	O
diseases	O
where	O
it	O
apparently	O
facilitates	O
apoptosis	O
of	O
abnormally	O
persistent	O
T	O
-	O
cell	B-ANAT
clones	I-ANAT
.	O

Fever	O
with	O
or	O
without	O
chills	O
and	O
rigors	O
,	O
headache	O
,	O
abdominal	B-ANAT
pain	O
and	O
vomiting	O
were	O
the	O
four	O
commonest	O
presenting	O
complaints	O
for	O
P	O
.	O
falciparum	O
infections	O
.	O

We	O
found	O
significantly	O
higher	O
frequencies	O
of	O
SNV	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
in	O
patients	O
with	O
severe	O
HPS	O
requiring	O
mechanical	O
ventilation	O
(	O
up	O
to	O
44	O
.	O
2	O
%	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
)	O
than	O
in	O
moderately	O
ill	O
HPS	O
patients	O
hospitalized	O
but	O
not	O
requiring	O
mechanical	O
ventilation	O
(	O
up	O
to	O
9	O
.	O
8	O
%	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
).	O

Recruitment	O
maneuver	O
was	O
safe	O
and	O
useful	O
to	O
improve	O
oxygenation	O
and	O
Cs	O
in	O
patients	O
with	O
severe	O
ARDS	O
ventilated	O
with	O
lung	B-ANAT
-	O
protective	O
strategy	O
.	O

TITLE	O
:	O
Successful	O
treatment	O
of	O
acute	O
chest	B-ANAT
syndrome	O
with	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
in	O
pediatric	O
patients	O
.	O

Although	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
is	O
well	O
established	O
in	O
the	O
treatment	O
of	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
there	O
is	O
no	O
support	O
in	O
the	O
literature	O
for	O
its	O
role	O
in	O
managing	O
hypoxemia	O
in	O
acute	O
chest	B-ANAT
syndrome	O
.	O

Absolute	O
contraindications	O
to	O
NPPV	O
are	O
:	O
cardiac	B-ANAT
or	O
respiratory	O
arrest	O
;	O
nonrespiratory	O
organ	B-ANAT
failure	O
(	O
eg	O
,	O
severe	O
encephalopathy	O
,	O
severe	O
gastrointestinal	O
bleeding	O
,	O
hemodynamic	O
instability	O
with	O
or	O
without	O
unstable	O
cardiac	B-ANAT
angina	O
);	O
facial	B-ANAT
surgery	O
or	O
trauma	O
;	O
upper	O
-	O
airway	B-ANAT
obstruction	O
;	O
inability	O
to	O
protect	O
the	O
airway	B-ANAT
and	O
/	O
or	O
high	O
risk	O
of	O
aspiration	O
;	O
and	O
inability	O
to	O
clear	O
secretions	B-ANAT
.	O

Cells	B-ANAT
infected	O
with	O
HSV	O
-	O
1	O
demonstrated	O
cell	B-ANAT
cycle	O
arrest	O
at	O
the	O
G	O
(	O
1	O
)/	O
S	O
transition	O
;	O
however	O
,	O
treatment	O
with	O
GA	O
resulted	O
in	O
a	O
cell	B-ANAT
cycle	O
distribution	O
pattern	O
identical	O
to	O
that	O
of	O
untreated	O
cells	B-ANAT
,	O
indicating	O
a	O
restoration	O
of	O
cell	B-ANAT
growth	O
in	O
HSV	O
-	O
1	O
-	O
infected	O
cells	B-ANAT
by	O
GA	O
treatment	O
.	O

The	O
frequency	O
in	O
DC	O
cell	B-ANAT
subsets	O
returned	O
to	O
normal	O
level	O
in	O
convalescent	O
stage	O
.	O

These	O
macrophages	B-ANAT
frequently	O
showed	O
morphological	O
changes	O
,	O
such	O
as	O
cytoplasmic	B-ANAT
foaminess	O
,	O
vacuole	B-ANAT
formation	O
,	O
and	O
nuclear	O
changes	O
(	O
including	O
multinucleation	O
and	O
a	O
ground	O
glass	O
appearance	O
)	O
when	O
compared	O
with	O
the	O
control	O
samples	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
pathological	O
features	O
in	O
coronavirus	O
associated	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Viral	B-ANAT
particles	I-ANAT
,	O
consistent	O
with	O
coronavirus	O
,	O
could	O
be	O
detected	O
in	O
lung	B-ANAT
pneumocytes	B-ANAT
in	O
most	O
of	O
the	O
patients	O
.	O

These	O
features	O
suggested	O
that	O
pneumocytes	B-ANAT
are	O
probably	O
the	O
primary	O
target	O
of	O
infection	O
.	O

TITLE	O
:	O
Requirements	O
for	O
CEACAMs	O
and	O
cholesterol	O
during	O
murine	O
coronavirus	O
cell	B-ANAT
entry	O
.	O

To	O
move	O
toward	O
a	O
mechanistic	O
understanding	O
of	O
these	O
phenomena	O
,	O
we	O
used	O
growth	O
media	B-ANAT
enriched	O
with	O
methyl	O
-	O
beta	O
-	O
cyclodextrin	O
or	O
cholesterol	O
to	O
reduce	O
or	O
elevate	O
cellular	B-ANAT
membrane	I-ANAT
sterols	O
,	O
respectively	O
.	O

The	O
use	O
of	O
the	O
picornavirus	O
encephalomyocarditis	O
virus	O
(	O
EMCV	O
)	O
internal	O
ribosome	B-ANAT
entry	O
site	O
(	O
IRES	O
)	O
sequence	O
to	O
initiate	O
gene	O
translation	O
was	O
investigated	O
as	O
an	O
alternative	O
method	O
to	O
the	O
coronavirus	O
-	O
mediated	O
TAS	O
-	O
controlled	O
heterologous	O
gene	O
expression	O
system	O
.	O

Both	O
the	O
ISAV	O
esterase	O
and	O
recombinant	O
rat	O
coronavirus	O
esterase	O
specific	O
for	O
4	O
-	O
O	O
-	O
acetylated	O
sialic	O
acids	O
hydrolyzed	O
ISAV	O
receptors	O
on	O
horse	O
and	O
rabbit	O
erythrocytes	B-ANAT
,	O
indicating	O
that	O
this	O
sialic	O
acid	O
represents	O
a	O
receptor	O
determinant	O
for	O
ISAV	O
.	O

After	O
the	O
4th	O
week	O
,	O
12	O
(	O
55	O
%)	O
of	O
22	O
patients	O
had	O
irregular	O
linear	O
opacities	O
with	O
or	O
without	O
associated	O
ground	O
-	O
glass	O
opacities	O
and	O
CT	O
scores	O
greater	O
than	O
5	O
;	O
five	O
of	O
these	O
patients	O
had	O
bronchial	B-ANAT
dilatation	O
.	O

There	O
is	O
a	O
temporal	O
pattern	O
of	O
lung	B-ANAT
abnormalities	O
at	O
thin	O
-	O
section	O
CT	O
in	O
SARS	O
.	O

Study	O
groups	O
were	O
comparable	O
with	O
regard	O
to	O
baseline	O
physiological	O
and	O
clinical	O
characteristics	O
(	O
age	O
,	O
sex	O
ratio	O
,	O
autonomy	O
,	O
medical	O
history	O
,	O
cause	O
of	O
pulmonary	B-ANAT
edema	O
).	O

Severe	O
complications	O
occurred	O
in	O
17	O
patients	O
in	O
the	O
standard	O
treatment	O
group	O
,	O
vs	O
4	O
patients	O
in	O
the	O
noninvasive	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
group	O
(	O
p	O
=	O
0	O
.	O
002	O
).	O

CONCLUSIONS	O
:	O
Noninvasive	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
promotes	O
early	O
clinical	O
improvement	O
in	O
elderly	O
patients	O
attending	O
emergency	O
departments	O
for	O
a	O
severe	O
pulmonary	B-ANAT
edema	O
,	O
but	O
only	O
reduces	O
early	O
48	O
-	O
h	O
mortality	O
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

ABSTRACT	O
:	O
After	O
various	O
observational	O
studies	O
demonstrated	O
a	O
benefit	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
the	O
therapy	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
ECMO	O
now	O
represents	O
an	O
important	O
contribution	O
for	O
ARDS	O
therapy	O
using	O
clinical	O
algorithms	O
despite	O
a	O
lack	O
of	O
positive	O
controlled	O
studies	O
.	O

In	O
specialized	O
centers	O
patients	O
with	O
severe	O
ARDS	O
and	O
imminent	O
hypoxia	O
despite	O
intensive	O
conventional	O
therapy	O
,	O
are	O
treated	O
with	O
ECMO	O
using	O
blood	B-ANAT
pumps	O
and	O
artificial	O
membrane	B-ANAT
lungs	B-ANAT
(	O
oxygenators	O
)	O
for	O
extracorporeal	O
lung	B-ANAT
assist	O
.	O

Other	O
agents	O
,	O
including	O
the	O
HIV	O
protease	O
inhibitor	O
glycyrrhizin	O
and	O
convalescent	O
plasma	B-ANAT
,	O
remain	O
to	O
be	O
evaluated	O
.	O

All	O
of	O
the	O
blood	B-ANAT
abnormalities	O
returned	O
to	O
normal	O
in	O
the	O
convalescent	O
stage	O
.	O

Samples	O
were	O
obtained	O
from	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
from	O
children	O
hospitalised	O
for	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
in	O
hospitals	O
of	O
Caen	O
and	O
Flers	O
in	O
Basse	O
-	O
Normandie	O
.	O

Besides	O
infectious	O
causes	O
and	O
drug	O
hypersensitivity	O
to	O
methotrexate	O
or	O
acitretin	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
sometimes	O
due	O
to	O
a	O
pulmonary	B-ANAT
capillary	I-ANAT
leak	O
syndrome	O
,	O
is	O
a	O
rare	O
cause	O
of	O
pneumonitis	O
in	O
the	O
course	O
of	O
psoriasis	O
,	O
and	O
may	O
be	O
fatal	O
.	O

The	O
patient	O
in	O
this	O
report	O
had	O
severe	O
hypoxaemia	O
from	O
diffuse	O
alveolar	B-ANAT
haemorrhage	O
caused	O
by	O
vasculitis	O
with	O
positive	O
antineutrophil	O
cytoplasmic	B-ANAT
antibodies	O
(	O
ANCA	O
).	O

We	O
then	O
compared	O
it	O
to	O
a	O
novel	O
nucleocapsid	B-ANAT
gene	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
with	O
genomic	O
RNA	O
.	O

High	O
-	O
level	O
allergen	O
exposure	O
,	O
exposure	O
to	O
tobacco	O
smoke	O
,	O
and	O
lack	O
of	O
breast	B-ANAT
-	O
feeding	O
showed	O
no	O
association	O
with	O
wheezing	O
.	O

Numbers	O
of	O
cells	B-ANAT
induced	O
to	O
produce	O
IL	O
-	O
6	O
and	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
by	O
T	B-ANAT
cell	I-ANAT
or	O
monocyte	B-ANAT
activators	O
were	O
higher	O
than	O
normal	O
in	O
many	O
early	O
SARS	O
patients	O
and	O
were	O
still	O
increased	O
in	O
some	O
during	O
and	O
after	O
treatment	O
.	O

A	O
75	O
-	O
year	O
-	O
old	O
patient	O
had	O
a	O
gastric	B-ANAT
cancer	O
with	O
multiple	O
lung	B-ANAT
and	O
liver	B-ANAT
metastasis	O
.	O

ABSTRACT	O
:	O
Normal	O
piglets	O
weaned	O
onto	O
soy	O
-	O
or	O
egg	B-ANAT
-	O
based	O
diets	O
generated	O
antibody	O
responses	O
to	O
fed	O
protein	O
.	O

TITLE	O
:	O
Identification	O
of	O
an	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
SSp	O
-	O
1	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
.	O

Peptides	O
with	O
high	O
affinity	O
for	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
were	O
then	O
assessed	O
for	O
their	O
capacity	O
to	O
elicit	O
specific	O
immune	O
responses	O
mediated	O
by	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocytes	I-ANAT
(	O
CTLs	O
)	O
both	O
in	O
vivo	O
,	O
in	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
/	O
K	O
(	O
b	O
)	O
transgenic	O
mice	O
,	O
and	O
in	O
vitro	O
,	O
from	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
(	O
PBLs	O
)	O
harvested	O
from	O
healthy	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
(+)	O
donors	O
.	O

ABSTRACT	O
:	O
The	O
molecular	O
and	O
cellular	B-ANAT
basis	O
of	O
coronavirus	O
neurovirulence	O
is	O
poorly	O
understood	O
.	O

We	O
found	O
that	O
the	O
level	O
of	O
neurovirulence	O
of	O
the	O
virus	O
correlates	O
with	O
its	O
differential	O
ability	O
to	O
induce	O
proinflammatory	O
cytokines	O
(	O
interleukin	O
12	O
[	O
IL	O
-	O
12	O
]	O
p40	B-ANAT
,	O
tumor	O
necrosis	O
factor	O
alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
15	O
,	O
and	O
IL	O
-	O
1beta	O
)	O
in	O
astrocytes	B-ANAT
and	O
microglia	B-ANAT
and	O
in	O
mouse	O
brains	B-ANAT
and	O
spinal	B-ANAT
cords	I-ANAT
.	O

Seroconversion	O
for	O
SARS	O
-	O
CoV	O
using	O
immunofluorescence	O
on	O
infected	O
cells	B-ANAT
is	O
an	O
excellent	O
method	O
of	O
confirming	O
the	O
diagnosis	O
,	O
but	O
antibody	O
responses	O
only	O
appear	O
around	O
day	O
10	O
of	O
the	O
illness	O
.	O

Desquamation	O
of	O
pneumocytes	B-ANAT
is	O
prominent	O
and	O
consistent	O
.	O

The	O
utility	O
of	O
high	O
resolution	O
computed	O
tomography	O
(	O
HRCT	O
)	O
and	O
CT	O
scans	O
lies	O
in	O
the	O
confirmation	O
of	O
airspace	O
opacities	O
in	O
cases	O
with	O
normal	O
initial	O
chest	B-ANAT
radiographs	O
that	O
have	O
strong	O
contact	O
history	O
and	O
signs	O
and	O
symptoms	O
highly	O
suspicious	O
of	O
SARS	O
during	O
the	O
outbreak	O
,	O
allowing	O
early	O
treatment	O
and	O
prompt	O
isolation	O
.	O

By	O
simplifying	O
the	O
model	O
to	O
a	O
two	O
-	O
compartment	B-ANAT
suspect	O
-	O
probable	O
model	O
and	O
a	O
single	O
-	O
compartment	B-ANAT
probable	O
model	O
and	O
using	O
limited	O
data	O
,	O
we	O
are	O
able	O
to	O
simulate	O
the	O
SARS	O
outbreak	O
in	O
Beijing	O
.	O

We	O
have	O
shown	O
previously	O
that	O
fracture	O
hematoma	O
can	O
activate	O
neutrophils	B-ANAT
and	O
is	O
thus	O
a	O
putative	O
mediator	O
of	O
the	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
multiple	O
organ	B-ANAT
failure	O
(	O
MOF	O
)	O
in	O
those	O
patients	O
with	O
severe	O
skeletal	B-ANAT
trauma	O
.	O

The	O
appearance	O
of	O
the	O
lungs	B-ANAT
on	O
chest	B-ANAT
radiographs	O
of	O
patients	O
with	O
this	O
condition	O
may	O
be	O
normal	O
or	O
may	O
include	O
focal	O
airspace	O
opacity	O
or	O
multifocal	O
or	O
diffuse	O
opacities	O
.	O

The	O
C57BL	O
/	O
6	O
mice	O
also	O
developed	O
subclinical	O
intestinal	B-ANAT
infection	O
,	O
but	O
only	O
transmitted	O
virus	O
for	O
two	O
weeks	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
inflammatory	O
cytokines	O
and	O
chemokines	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

The	O
chemokine	O
profile	O
demonstrated	O
significant	O
elevation	O
of	O
neutrophil	B-ANAT
chemokine	O
IL	O
-	O
8	O
,	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
Th1	O
chemokine	O
IFN	O
-	O
gamma	O
-	O
inducible	O
protein	O
-	O
10	O
(	O
IP	O
-	O
10	O
).	O

To	O
address	O
speculations	O
that	O
the	O
virus	O
originated	O
in	O
domesticated	O
animals	O
,	O
or	O
that	O
domestic	O
species	O
were	O
susceptible	O
to	O
the	O
virus	O
,	O
we	O
inoculated	O
6	O
-	O
week	O
-	O
old	O
pigs	O
and	O
chickens	O
intravenously	O
,	O
intranasally	O
,	O
ocularly	O
,	O
and	O
orally	B-ANAT
with	O
106	O
PFU	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

We	O
investigated	O
a	O
possible	O
cluster	O
of	O
SARS	O
-	O
CoV	O
infections	O
in	O
healthcare	O
workers	O
who	O
used	O
contact	O
and	O
droplet	O
precautions	O
during	O
attempted	O
cardiopulmonary	B-ANAT
resuscitation	O
of	O
a	O
SARS	O
patient	O
.	O

We	O
cloned	O
and	O
purified	O
the	O
nucleocapsid	B-ANAT
protein	O
and	O
spike	O
polypeptide	O
of	O
SARS	O
-	O
CoV	O
and	O
examined	O
their	O
immunogenicity	O
with	O
serum	B-ANAT
from	O
patients	O
with	O
SARS	O
-	O
CoV	O
pneumonia	O
.	O

The	O
seroprevalence	O
of	O
SARS	O
-	O
CoV	O
was	O
studied	O
with	O
the	O
ELISA	O
in	O
healthy	O
blood	B-ANAT
donors	O
who	O
donated	O
during	O
the	O
SARS	O
outbreak	O
in	O
Hong	O
Kong	O
,	O
non	O
-	O
pneumonic	O
hospital	O
inpatients	O
,	O
and	O
symptom	O
-	O
free	O
health	O
-	O
care	O
workers	O
.	O

The	O
in	O
vitro	O
host	B-ANAT
cell	I-ANAT
range	O
of	O
HCoV	O
-	O
NL63	O
is	O
notable	O
because	O
it	O
replicates	O
on	O
tertiary	O
monkey	O
kidney	B-ANAT
cells	B-ANAT
and	O
the	O
monkey	O
kidney	B-ANAT
LLC	B-ANAT
-	O
MK2	O
cell	B-ANAT
line	I-ANAT
.	O

TITLE	O
:	O
Protective	O
effects	O
of	O
preischemic	O
treatment	O
with	O
pioglitazone	O
,	O
a	O
peroxisome	B-ANAT
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
ligand	O
,	O
on	O
lung	B-ANAT
ischemia	O
-	O
reperfusion	O
injury	O
in	O
rats	O
.	O

The	O
left	B-ANAT
lungs	I-ANAT
of	O
male	O
Wistar	O
rats	O
were	O
rendered	O
ischemic	O
for	O
90	O
min	O
and	O
then	O
reperfused	O
for	O
2	O
h	O
.	O
Treated	O
animals	O
received	O
pioglitazone	O
(	O
10	O
mg	O
/	O
kg	O
)	O
2	O
h	O
before	O
induction	O
of	O
ischemia	O
.	O

The	O
frequency	O
of	O
pulmonary	B-ANAT
edema	O
,	O
placental	B-ANAT
abruption	O
,	O
postpartum	O
hemorrhage	O
,	O
and	O
aspiration	O
pneumonia	O
was	O
not	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
.	O

The	O
data	O
indicate	O
that	O
measurement	O
of	O
sPLA2	O
can	O
be	O
useful	O
in	O
alerting	O
the	O
clinician	O
to	O
patients	O
with	O
impending	O
ACS	O
,	O
and	O
suggest	O
that	O
instituting	O
early	O
therapies	O
based	O
on	O
sPLA2	O
levels	O
,	O
including	O
inhibition	O
of	O
sPLA2	O
activity	O
,	O
may	O
be	O
useful	O
to	O
prevent	O
or	O
reduce	O
the	O
clinical	O
morbidity	O
of	O
ACS	O
in	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

CONCLUSIONS	O
:	O
A	O
real	O
-	O
time	O
CoV	O
PCR	O
test	O
is	O
able	O
to	O
detect	O
SARS	O
-	O
CoV	O
in	O
viremic	O
blood	B-ANAT
donor	O
samples	O
even	O
in	O
the	O
beginning	O
of	O
the	O
disease	O
when	O
patients	O
present	O
minor	O
clinical	O
symptoms	O
.	O

After	O
binding	O
to	O
the	O
target	B-ANAT
cell	I-ANAT
,	O
the	O
transmembrane	B-ANAT
spike	O
protein	O
might	O
change	O
conformation	O
by	O
association	O
between	O
the	O
HR1	O
and	O
HR2	O
regions	O
to	O
form	O
an	O
oligomeric	O
structure	O
,	O
leading	O
to	O
fusion	O
between	O
the	O
viral	O
and	O
target	O
-	O
cell	B-ANAT
membranes	I-ANAT
.	O

ABSTRACT	O
:	O
Transfusion	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
is	O
a	O
relatively	O
rare	O
but	O
potentially	O
severe	O
complication	O
of	O
blood	B-ANAT
transfusion	O
.	O

CD3	O
+,	O
CD4	O
+,	O
CD8	O
+	O
and	O
natural	B-ANAT
killer	I-ANAT
cell	I-ANAT
counts	O
were	O
promising	O
immunological	O
prognostic	O
indicators	O
for	O
predicting	O
admission	O
to	O
ICU	O
with	O
AUC	O
of	O
0	O
.	O
94	O
(	O
CI	O
=	O
0	O
.	O
86	O
-	O
0	O
.	O
98	O
),	O
0	O
.	O
91	O
(	O
CI	O
=	O
0	O
.	O
81	O
-	O
0	O
.	O
96	O
),	O
0	O
.	O
93	O
(	O
CI	O
=	O
0	O
.	O
85	O
-	O
0	O
.	O
98	O
),	O
and	O
0	O
.	O
87	O
(	O
CI	O
=	O
0	O
.	O
76	O
-	O
0	O
.	O
94	O
),	O
respectively	O
.	O

Blood	B-ANAT
CD3	O
+,	O
CD4	O
+,	O
CD8	O
+	O
and	O
natural	B-ANAT
killer	I-ANAT
cell	I-ANAT
counts	O
were	O
found	O
to	O
be	O
good	O
prognostic	O
indicators	O
for	O
predicting	O
admission	O
to	O
ICU	O
in	O
patients	O
with	O
SARS	O
compared	O
with	O
age	O
,	O
leucocyte	B-ANAT
count	O
and	O
LD	O
isoenzymes	O
.	O

Findings	O
in	O
the	O
viral	O
load	O
test	O
showed	O
that	O
there	O
was	O
a	O
significant	O
difference	O
in	O
the	O
contamination	O
of	O
the	O
face	B-ANAT
(	O
t	O
=	O
4	O
.	O
69	O
,	O
df	O
=	O
38	O
,	O
P	O
<.	O
00	O
)	O
between	O
1	O
and	O
2	O
strokes	O
.	O

We	O
noticed	O
significant	O
decrease	O
of	O
testosterone	O
and	O
LH	O
serum	B-ANAT
levels	O
in	O
septic	O
group	O
vs	O
the	O
controls	O
and	O
correlation	O
between	O
T	O
and	O
LH	O
serum	B-ANAT
levels	O
and	O
survival	O
.	O

TITLE	O
:	O
Ocular	B-ANAT
screening	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
ocular	B-ANAT
manifestations	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
to	O
monitor	O
the	O
possible	O
ocular	B-ANAT
complications	O
arising	O
from	O
the	O
treatment	O
regimen	O
with	O
high	O
-	O
dose	O
systemic	O
corticosteroid	O
drugs	O
.	O

Relevant	O
medical	O
and	O
ophthalmic	B-ANAT
histories	O
were	O
taken	O
.	O

There	O
was	O
no	O
loss	O
of	O
visual	O
acuity	O
,	O
cataract	O
progression	O
,	O
or	O
increased	O
cup	O
-	O
disk	B-ANAT
ratio	O
.	O

Serum	B-ANAT
concentrations	O
of	O
C3	O
,	O
C4	O
,	O
CRP	O
and	O
PA	O
were	O
(	O
1	O
.	O
18	O
+/-	O

TITLE	O
:	O
Pulmonary	B-ANAT
injury	O
from	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Preoperative	O
preparation	O
of	O
patients	O
with	O
advanced	O
liver	B-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Inhaled	O
nitric	O
oxide	O
has	O
been	O
shown	O
to	O
improve	O
oxygenation	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

CONCLUSIONS	O
:	O
Inhaled	O
nitric	O
oxide	O
at	O
a	O
dose	O
of	O
5	O
ppm	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
not	O
due	O
to	O
sepsis	O
and	O
without	O
evidence	O
of	O
nonpulmonary	O
organ	B-ANAT
system	I-ANAT
dysfunction	O
results	O
in	O
short	O
-	O
term	O
oxygenation	O
improvements	O
but	O
has	O
no	O
substantial	O
impact	O
on	O
the	O
duration	O
of	O
ventilatory	O
support	O
or	O
mortality	O
.	O

Testing	O
68	O
clinical	O
specimens	O
(	O
including	O
17	O
respiratory	B-ANAT
tract	I-ANAT
specimens	O
,	O
29	O
urine	B-ANAT
samples	O
,	O
and	O
22	O
stools	B-ANAT
or	O
rectal	O
swabs	O
)	O
demonstrated	O
that	O
six	O
of	O
the	O
seven	O
assays	O
detected	O
at	O
least	O
17	O
of	O
18	O
positives	O
(	O
defined	O
as	O
positive	O
in	O
at	O
least	O
two	O
assays	O
),	O
and	O
two	O
of	O
the	O
assays	O
had	O
a	O
sensitivity	O
of	O
100	O
%.	O

ABSTRACT	O
:	O
Investigation	O
of	O
oxygenation	O
and	O
lung	B-ANAT
aeration	O
during	O
mechanical	O
ventilation	O
according	O
to	O
the	O
open	O
lung	B-ANAT
concept	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
briefly	O
applied	O
high	O
inspiratory	O
pressures	O
for	O
opening	O
up	O
collapsed	O
alveoli	B-ANAT
.	O

Data	O
from	O
computed	O
tomography	O
before	O
and	O
after	O
the	O
open	O
lung	B-ANAT
concept	O
were	O
analyzed	O
for	O
volumetric	O
quantification	O
of	O
lung	B-ANAT
aeration	O
and	O
collapse	O
.	O

Lung	B-ANAT
recruitment	O
increased	O
arterial	B-ANAT
oxygenation	O
,	O
normally	O
aerated	O
lung	B-ANAT
volume	O
,	O
and	O
total	O
lung	B-ANAT
volume	O
while	O
decreasing	O
the	O
amount	O
of	O
collapsed	O
tissue	B-ANAT
.	O

These	O
results	O
indicate	O
that	O
the	O
open	O
lung	B-ANAT
concept	O
is	O
a	O
reasonable	O
mode	O
of	O
ventilation	O
for	O
patients	O
with	O
severe	O
chest	B-ANAT
trauma	O
.	O

In	O
all	O
types	O
of	O
critical	O
illness	O
,	O
such	O
as	O
sepsis	O
,	O
trauma	O
,	O
burn	O
injury	O
,	O
acute	O
pancreatitis	O
,	O
liver	B-ANAT
injury	O
,	O
severe	O
diabetes	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
AIDS	O
and	O
kidney	B-ANAT
failure	O
,	O
the	O
occurrence	O
of	O
increased	O
oxidative	O
stress	O
or	O
a	O
reduced	O
antioxidative	O
status	O
is	O
described	O
.	O

Chest	B-ANAT
radiographs	O
at	O
2	O
to	O
3	O
weeks	O
of	O
infection	O
revealed	O
an	O
atypical	O
pneumonia	O
with	O
pulmonary	B-ANAT
consolidation	O
,	O
a	O
clinical	O
characteristic	O
of	O
SARS	O
infection	O
.	O

Expression	O
of	O
SARS	O
virus	O
-	O
encoded	O
RNA	O
was	O
detected	O
in	O
all	O
3	O
cases	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
the	O
SARS	O
viral	O
signal	O
was	O
localized	O
in	O
pneumocytes	B-ANAT
by	O
using	O
in	O
situ	O
hybridization	O
.	O

To	O
determine	O
the	O
ability	O
of	O
SARS	O
-	O
Cov	O
nucleoprotein	O
(	O
N	O
protein	O
)	O
to	O
induce	O
antiviral	O
immunity	O
,	O
in	O
this	O
report	O
,	O
we	O
established	O
a	O
stable	O
C2C12	O
line	O
expressing	O
SARS	O
-	O
Cov	O
N	O
protein	O
,	O
which	O
was	O
used	O
as	O
a	O
target	O
for	O
specific	O
CTL	B-ANAT
assay	O
.	O

The	O
proportions	O
of	O
exposure	O
in	O
the	O
cases	O
were	O
18	O
%	O
and	O
8	O
%	O
in	O
the	O
control	O
group	O
;	O
the	O
adjusted	O
OR	O
(	O
fat	O
free	O
mass	O
,	O
anti	O
-	O
cytomegalovirus	O
antibodies	O
and	O
placental	B-ANAT
weight	O
)	O
was	O
2	O
.	O
33	O
(	O
p	O
=	O
0	O
.	O
04	O
).	O

Pediatric	O
considerations	O
included	O
a	O
more	O
likely	O
need	O
for	O
intubation	O
due	O
to	O
low	O
functional	O
residual	O
capacity	O
;	O
more	O
difficult	O
intravenous	O
access	O
;	O
fluid	O
resuscitation	O
based	O
on	O
weight	O
with	O
40	O
-	O
60	O
mL	O
/	O
kg	O
or	O
higher	O
needed	O
;	O
decreased	O
cardiac	B-ANAT
output	O
and	O
increased	O
systemic	O
vascular	B-ANAT
resistance	O
as	O
the	O
most	O
common	O
hemodynamic	O
profile	O
;	O
greater	O
use	O
of	O
physical	O
examination	O
therapeutic	O
end	O
points	O
;	O
unsettled	O
issue	O
of	O
high	O
-	O
dose	O
steroids	O
for	O
therapy	O
of	O
septic	O
shock	O
;	O
and	O
greater	O
risk	O
of	O
hypoglycemia	O
with	O
aggressive	O
glucose	O
control	O
.	O

At	O
the	O
peak	O
of	O
viraemia	O
,	O
viral	O
RNA	O
was	O
detectable	O
in	O
75	O
%	O
of	O
blood	B-ANAT
samples	I-ANAT
from	O
patients	O
who	O
were	O
clinically	O
diagnosed	O
with	O
SARS	O
1	O
or	O
2	O
weeks	O
before	O
the	O
test	O
.	O

Moreover	O
,	O
MVA	O
/	O
S	O
administered	O
by	O
either	O
route	O
elicited	O
protective	O
immunity	O
,	O
as	O
shown	O
by	O
reduced	O
titers	O
of	O
SARS	O
-	O
CoV	O
in	O
the	O
upper	O
and	O
lower	O
respiratory	B-ANAT
tracts	I-ANAT
of	O
mice	O
after	O
challenge	O
.	O

Nasal	B-ANAT
shedding	O
of	O
PRCV	O
was	O
detected	O
in	O
57	O
%	O
and	O
63	O
%	O
of	O
samples	O
by	O
nested	O
-	O
RT	O
-	O
PCR	O
and	O
cell	B-ANAT
culture	O
immunofluorescence	O
(	O
CCIF	O
),	O
respectively	O
.	O

We	O
retrospectively	O
reviewed	O
the	O
initial	O
radiograph	O
and	O
a	O
series	O
of	O
follow	O
-	O
up	O
chest	B-ANAT
radiographs	O
in	O
26	O
patients	O
who	O
had	O
symptoms	O
and	O
signs	O
consistent	O
with	O
SARS	O
.	O

Eighteen	O
patients	O
(	O
69	O
%)	O
had	O
air	O
-	O
space	O
consolidation	O
,	O
two	O
(	O
8	O
%)	O
had	O
ground	O
-	O
glass	O
attenuation	O
,	O
one	O
(	O
4	O
%)	O
had	O
nodules	B-ANAT
,	O
and	O
two	O
(	O
8	O
%)	O
had	O
mixed	O
consolidation	O
and	O
nodules	B-ANAT
.	O

RESULTS	O
:	O
Initial	O
chest	B-ANAT
radiographs	O
showed	O
abnormalities	O
in	O
23	O
(	O
88	O
%)	O
of	O
26	O
subjects	O
.	O

ABSTRACT	O
:	O
ECMO	O
(	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
)	O
involves	O
long	O
term	O
treatment	O
in	O
a	O
modified	O
heart	B-ANAT
lung	I-ANAT
machine	O
.	O

TITLE	O
:	O
SARS	O
CTL	B-ANAT
vaccine	O
candidates	O
;	O
HLA	B-ANAT
supertype	O
-,	O
genome	O
-	O
wide	O
scanning	O
and	O
biochemical	O
validation	O
.	O

ABSTRACT	O
:	O
An	O
effective	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
vaccine	O
is	O
likely	O
to	O
include	O
components	O
that	O
can	O
induce	O
specific	O
cytotoxic	B-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
(	O
CTL	B-ANAT
)	O
responses	O
.	O

TITLE	O
:	O
Inhaled	O
nitric	O
oxide	O
for	O
ARDS	O
due	O
to	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
are	O
syndromes	O
of	O
severe	O
respiratory	O
failure	O
.	O

Children	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
syndrome	O
have	O
high	O
mortality	O
and	O
significant	O
morbidity	O
.	O

In	O
particular	O
,	O
a	O
cluster	O
of	O
serine	O
residues	O
(	O
Ser139	O
,	O
Ser144	O
,	O
and	O
Ser147	O
)	O
was	O
identified	O
near	O
the	O
active	O
site	O
cavity	B-ANAT
and	O
was	O
susceptible	O
to	O
being	O
targeted	O
by	O
compounds	O
containing	O
boronic	O
acid	O
.	O

We	O
have	O
isolated	O
a	O
SARS	O
-	O
associated	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
strain	O
by	O
injecting	O
Vero	B-ANAT
cells	I-ANAT
with	O
a	O
sputum	B-ANAT
specimen	I-ANAT
from	O
an	O
Italian	O
patient	O
affected	O
by	O
a	O
severe	O
pneumonia	O
;	O
the	O
patient	O
traveled	O
from	O
Vietnam	O
to	O
Italy	O
in	O
March	O
2003	O
.	O

Loose	O
stools	B-ANAT
or	O
diarrhea	O
,	O
hemophagocytosis	O
syndrome	O
,	O
and	O
high	O
serum	B-ANAT
levels	O
of	O
interleukin	O
(	O
IL	O
)-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
a	O
associated	O
with	O
lung	B-ANAT
lesions	O
were	O
found	O
in	O
all	O
10	O
patients	O
.	O

We	O
show	O
a	O
potential	O
role	O
of	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DC	B-ANAT
)	O
in	O
murine	O
coronavirus	O
-	O
induced	O
immune	O
modulation	O
and	O
pathogenesis	O
by	O
demonstrating	O
that	O
the	O
JAW	B-ANAT
SII	O
DC	B-ANAT
line	O
and	O
primary	O
DC	B-ANAT
from	O
BALB	O
/	O
c	O
mice	O
and	O
p	O
/	O
p	O
mice	O
with	O
reduced	O
expression	O
of	O
the	O
murine	O
coronavirus	O
receptor	O
,	O
murine	O
CEACAM1a	O
,	O
are	O
susceptible	O
to	O
murine	O
coronavirus	O
infection	O
by	O
a	O
receptor	O
-	O
dependent	O
pathway	O
.	O

In	O
suspension	O
,	O
HCoV	O
-	O
229E	O
gradually	O
lost	O
its	O
infectivity	O
completely	O
while	O
SARS	O
-	O
CoV	O
retained	O
its	O
infectivity	O
for	O
up	O
to	O
9	O
days	O
;	O
in	O
the	O
dried	B-ANAT
state	O
,	O
survival	O
times	O
were	O
24	O
h	O
versus	O
6	O
days	O
.	O

A	O
better	O
system	O
of	O
getting	O
state	O
or	O
CDC	O
laboratory	O
results	O
back	B-ANAT
to	O
the	O
local	O
level	O
,	O
including	O
the	O
occupational	O
health	O
area	O
of	O
the	O
generating	O
facility	O
,	O
must	O
be	O
developed	O
.	O

They	O
generally	O
displayed	O
the	O
highest	O
viral	O
loads	O
in	O
colon	B-ANAT
,	O
ileum	B-ANAT
and	O
mesenteric	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
.	O

TITLE	O
:	O
Tissue	B-ANAT
distribution	O
of	O
a	O
feline	O
AGP	O
related	O
protein	O
(	O
fAGPrP	O
)	O
in	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

TITLE	O
:	O
Structural	O
basis	O
for	O
coronavirus	O
-	O
mediated	O
membrane	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
The	O
surface	O
transmembrane	B-ANAT
glycoprotein	O
is	O
responsible	O
for	O
mediating	O
virion	B-ANAT
attachment	O
to	O
cell	B-ANAT
and	O
subsequent	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
.	O

The	O
development	O
of	O
venous	B-ANAT
thrombosis	O
was	O
likely	O
to	O
have	O
been	O
multifactorial	O
.	O

It	O
is	O
recognized	O
that	O
there	O
is	O
an	O
increased	O
incidence	O
of	O
congenital	O
lymphatic	B-ANAT
anomalies	O
in	O
Down	O
syndrome	O
,	O
which	O
may	O
have	O
been	O
a	O
contributing	O
factor	O
in	O
the	O
development	O
of	O
chylothorax	O
in	O
this	O
patient	O
.	O

The	O
case	O
is	O
also	O
presented	O
to	O
contribute	O
to	O
the	O
expanding	O
evidence	O
in	O
support	O
of	O
catheter	O
-	O
directed	O
venous	B-ANAT
thrombolysis	O
in	O
selected	O
clinical	O
circumstances	O
.	O

The	O
subjects	O
comprised	O
594	O
consecutive	O
patients	O
(	O
318	O
males	O
,	O
276	O
females	O
)	O
aged	O
>	O
or	O
=	O
21	O
years	O
who	O
presented	O
with	O
complaints	O
of	O
any	O
one	O
of	O
cough	O
,	O
nasal	B-ANAT
or	O
throat	B-ANAT
symptoms	O
of	O
<	O
7	O
days	O
duration	O
.	O

Some	O
patients	O
have	O
residual	O
symptoms	O
(	O
such	O
as	O
cough	O
,	O
fatigue	O
,	O
dyspnea	O
,	O
abnormality	O
of	O
liver	B-ANAT
function	O
,	O
hyperglycemia	O
and	O
hyperglyceridemia	O
),	O
and	O
only	O
few	O
patients	O
have	O
lung	B-ANAT
fibrosis	O
.	O

This	O
finding	O
suggests	O
that	O
lung	B-ANAT
fibrosis	O
caused	O
by	O
SARS	O
mostly	O
occurs	O
in	O
severe	O
patients	O
,	O
and	O
it	O
can	O
resolve	O
spontaneously	O
.	O

Specific	O
antibodies	O
to	O
SARS	O
virus	O
in	O
1	O
127	O
serum	B-ANAT
specimens	O
from	O
health	O
-	O
care	O
professionals	O
who	O
had	O
a	O
close	O
contact	O
history	O
with	O
patients	O
of	O
SARS	O
and	O
92	O
healthy	O
persons	O
were	O
assayed	O
with	O
ELISA	O
.	O

Clinical	O
manifestations	O
,	O
pathology	O
of	O
organs	B-ANAT
in	O
canine	O
were	O
observed	O
.	O

Dilutions	O
of	O
gamma	O
-	O
irradiated	O
cell	B-ANAT
culture	O
supernatants	O
of	O
SARS	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
were	O
prepared	O
to	O
determine	O
the	O
precisions	O
,	O
linear	O
ranges	O
,	O
and	O
accuracies	O
of	O
the	O
assays	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
evaluation	O
of	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
protein	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)-	O
based	O
antibody	O
tests	O
for	O
serodiagnosis	O
of	O
SARS	O
-	O
CoV	O
pneumonia	O
and	O
compare	O
the	O
sensitivities	O
and	O
specificities	O
of	O
this	O
ELISA	O
for	O
detection	O
of	O
immunoglobulin	O
G	O
(	O
IgG	O
),	O
IgM	O
,	O
IgA	O
,	O
and	O
their	O
combinations	O
with	O
serum	B-ANAT
samples	O
from	O
149	O
healthy	O
blood	B-ANAT
donors	O
who	O
donated	O
blood	B-ANAT
3	O
years	O
ago	O
as	O
controls	O
and	O
106	O
SARS	O
-	O
CoV	O
pneumonia	O
patients	O
in	O
Hong	O
Kong	O
.	O

The	O
incidence	O
of	O
pneumothorax	O
and	O
mediastinal	B-ANAT
emphysema	O
in	O
serious	O
SARS	O
patients	O
with	O
NIPPV	O
is	O
significantly	O
higher	O
than	O
that	O
in	O
SARS	O
patients	O
without	O
receiving	O
MV	O
.	O

This	O
might	O
be	O
related	O
to	O
SARS	O
related	O
pulmonary	B-ANAT
injuries	O
,	O
intensive	O
cough	O
and	O
high	O
mechanical	O
ventilation	O
pressure	O
.	O

RESULTS	O
:	O
Pneumothorax	O
and	O
mediastinal	B-ANAT
emphysema	O
occurred	O
in	O
7	O
of	O
27	O
serious	O
cases	O
of	O
SARS	O
with	O
NIPPV	O
,	O
and	O
mediastinal	B-ANAT
emphysema	O
occurred	O
in	O
1	O
of	O
189	O
cases	O
of	O
SARS	O
without	O
mechanical	O
ventilation	O
(	O
MV	O
).	O

ABSTRACT	O
:	O
To	O
investigate	O
a	O
new	O
therapy	O
for	O
effectively	O
correcting	O
severe	O
hypoxemia	O
in	O
patients	O
with	O
infectious	O
diseases	O
by	O
infusion	O
of	O
oxygen	O
-	O
enriched	O
liquid	O
,	O
in	O
order	O
to	O
raise	O
the	O
partial	O
pressure	O
of	O
blood	B-ANAT
oxygen	O
without	O
passing	O
through	O
pathologically	O
damaged	O
alveoli	B-ANAT
of	O
such	O
patients	O
.	O

The	O
fragments	O
amplified	O
from	O
the	O
sputum	B-ANAT
specimens	O
of	O
SARS	O
patients	O
were	O
shown	O
to	O
share	O
100	O
%	O
homology	O
with	O
the	O
published	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

Chi	O
-	O
square	O
for	O
trend	O
test	O
revealed	O
that	O
the	O
positive	O
rates	O
of	O
stools	B-ANAT
and	O
sputa	O
of	O
SARS	O
patients	O
decreased	O
with	O
the	O
development	O
of	O
the	O
disease	O
(	O
chi	O
(	O
2	O
)	O
for	O
trend	O
=	O
12	O
.	O
55	O
and	O
16	O
.	O
408	O
,	O
P	O
=	O
0	O
.	O
0004	O
and	O
P	O
=	O
0	O
.	O
000	O
05	O
respectively	O
).	O

CONCLUSIONS	O
:	O
The	O
absolute	O
numbers	O
of	O
peripheral	B-ANAT
blood	I-ANAT
lymphocytes	B-ANAT
and	O
their	O
subpopulations	O
in	O
SARS	O
patients	O
might	O
be	O
used	O
as	O
one	O
of	O
the	O
methods	O
for	O
diagnosis	O
on	O
the	O
severity	O
and	O
prognosis	O
of	O
the	O
disease	O
.	O

We	O
developed	O
reverse	O
transcription	O
(	O
RT	O
)	O
PCR	O
and	O
nested	O
PCR	O
to	O
detect	O
HEV	B-ANAT
.	O

In	O
this	O
study	O
,	O
we	O
demonstrated	O
that	O
multiplication	O
of	O
SARS	O
-	O
CoV	O
in	O
cell	B-ANAT
culture	O
can	O
be	O
strongly	O
inhibited	O
by	O
pretreatment	O
with	O
interferon	O
-	O
beta	O
.	O

This	O
study	O
presents	O
a	O
purification	O
method	O
for	O
feline	O
AGP	O
(	O
fAGP	O
)	O
from	O
serum	B-ANAT
,	O
using	O
an	O
ion	O
exchange	O
chromatography	O
strategy	O
.	O

Antibodies	O
against	O
red	O
cells	B-ANAT
,	O
platelets	B-ANAT
,	O
lymphocytes	B-ANAT
and	O
granulocytes	B-ANAT
were	O
detected	O
in	O
extremely	O
high	O
titers	O
.	O

Serum	B-ANAT
samples	O
were	O
collected	O
between	O
1993	O
and	O
2001	O
from	O
119	O
animals	O
in	O
a	O
single	O
clan	O
for	O
which	O
behavioral	O
data	O
on	O
social	O
structure	O
were	O
available	O
and	O
from	O
121	O
hyenas	O
ill	O
several	O
other	O
clans	O
.	O

We	O
employed	O
online	O
database	O
analysis	O
to	O
compare	O
the	O
differences	O
in	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
homologous	O
T	O
epitopes	O
of	O
HCoV	O
-	O
229e	O
and	O
SARS	O
-	O
CoV	O
.	O
The	O
identified	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
peptides	O
were	O
synthesized	O
,	O
and	O
their	O
binding	O
affinities	O
for	O
HLA	B-ANAT
-	O
A2	O
were	O
validated	O
and	O
compared	O
in	O
the	O
T2	O
cell	B-ANAT
system	O
.	O

HLA	B-ANAT
-	O
A2	O
typing	O
by	O
indirect	O
immunofluorescent	O
antibody	O
staining	O
showed	O
that	O
51	O
.	O
6	O
%	O
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
patients	O
were	O
HLA	B-ANAT
-	O
A2	O
positive	O
.	O

Coronavirus	O
replication	O
and	O
transcription	O
are	O
highly	O
specialized	O
processes	O
of	O
cytoplasmic	B-ANAT
RNA	O
synthesis	O
that	O
localize	O
to	O
virus	O
-	O
induced	O
membrane	B-ANAT
structures	O
and	O
were	O
recently	O
proposed	O
to	O
involve	O
a	O
complex	O
enzymatic	O
machinery	O
that	O
,	O
besides	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
,	O
helicase	O
,	O
and	O
protease	O
activities	O
,	O
also	O
involves	O
a	O
series	O
of	O
RNA	O
-	O
processing	O
enzymes	O
that	O
are	O
not	O
found	O
in	O
most	O
other	O
RNA	O
virus	O
families	O
.	O

Finally	O
,	O
we	O
established	O
that	O
,	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
,	O
nsp13	O
localizes	O
to	O
membranes	B-ANAT
that	O
appear	O
to	O
be	O
derived	O
from	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
and	O
are	O
the	O
likely	O
site	O
of	O
SARS	O
-	O
CoV	O
RNA	O
synthesis	O
.	O

Infection	O
also	O
resulted	O
in	O
a	O
decrease	O
in	O
Cdk2	O
activity	O
in	O
both	O
cell	B-ANAT
lines	I-ANAT
.	O

MHV	O
infection	O
in	O
quiescent	O
17Cl	O
-	O
1	O
cells	B-ANAT
prevented	O
normal	O
increases	O
in	O
Cdk4	O
,	O
Cdk6	O
,	O
cyclin	O
D1	O
,	O
and	O
cyclin	O
D3	O
levels	O
after	O
serum	B-ANAT
stimulation	O
.	O

The	O
amounts	O
of	O
cyclin	O
D2	O
and	O
cyclin	O
E	O
were	O
not	O
increased	O
significantly	O
after	O
serum	B-ANAT
stimulation	O
in	O
mock	O
-	O
infected	O
cells	B-ANAT
,	O
whereas	O
they	O
were	O
decreased	O
in	O
MHV	O
-	O
infected	O
cells	B-ANAT
,	O
suggesting	O
the	O
possibility	O
that	O
MHV	O
infection	O
may	O
induce	O
cyclin	O
D2	O
and	O
cyclin	O
E	O
degradation	O
.	O

Our	O
data	O
suggested	O
that	O
a	O
reduction	O
in	O
the	O
amounts	O
of	O
G	O
(	O
1	O
)	O
cyclin	O
-	O
Cdk	O
complexes	O
in	O
MHV	O
-	O
infected	O
cells	B-ANAT
led	O
to	O
a	O
reduction	O
in	O
Cdk	O
activities	O
and	O
insufficient	O
hyperphosphorylation	O
of	O
pRb	O
,	O
resulting	O
in	O
inhibition	O
of	O
the	O
cell	B-ANAT
cycle	O
in	O
the	O
G	O
(	O
0	O
)/	O
G	O
(	O
1	O
)	O
phase	O
.	O

Specific	O
antisense	O
activity	O
designed	O
to	O
block	O
translation	O
of	O
the	O
viral	O
replicase	O
polyprotein	O
was	O
first	O
confirmed	O
by	O
reduction	O
of	O
luciferase	O
expression	O
from	O
a	O
target	O
sequence	O
-	O
containing	O
reporter	O
construct	O
in	O
both	O
cell	B-ANAT
-	O
free	O
and	O
transfected	O
cell	B-ANAT
culture	O
assays	O
.	O

The	O
inherent	O
differences	O
in	O
S	O
-	O
protein	O
trafficking	O
could	O
point	O
to	O
interesting	O
variations	O
in	O
pathogenesis	O
of	O
coronaviruses	O
,	O
since	O
increased	O
levels	O
of	O
surface	O
S	O
protein	O
could	O
promote	O
syncytium	B-ANAT
formation	O
and	O
direct	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
spread	O
of	O
the	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
p28	B-ANAT
and	O
p65	O
proteins	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
are	O
the	O
most	O
amino	O
-	O
terminal	O
protein	O
domains	O
of	O
the	O
replicase	O
polyprotein	O
.	O

No	O
p28	B-ANAT
or	O
p65	O
was	O
detected	O
in	O
cells	B-ANAT
infected	O
with	O
predicted	O
noncleaving	O
CS1	O
mutants	O
or	O
the	O
CS1	O
deletion	O
mutant	O
;	O
however	O
,	O
a	O
new	O
protein	O
of	O
93	O
kDa	O
was	O
detected	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
identified	O
the	O
major	O
pathological	O
changes	O
in	O
the	O
respiratory	O
and	O
immune	B-ANAT
systems	I-ANAT
of	O
patients	O
who	O
died	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
but	O
gained	O
little	O
information	O
on	O
the	O
organ	B-ANAT
distribution	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

In	O
conclusion	O
,	O
ACE2	O
is	O
abundantly	O
present	O
in	O
humans	O
in	O
the	O
epithelia	O
of	O
the	O
lung	B-ANAT
and	O
small	B-ANAT
intestine	I-ANAT
,	O
which	O
might	O
provide	O
possible	O
routes	O
of	O
entry	O
for	O
the	O
SARS	O
-	O
CoV	O
.	O
This	O
epithelial	O
expression	O
,	O
together	O
with	O
the	O
presence	O
of	O
ACE2	O
in	O
vascular	B-ANAT
endothelium	I-ANAT
,	O
also	O
provides	O
a	O
first	O
step	O
in	O
understanding	O
the	O
pathogenesis	O
of	O
the	O
main	O
SARS	O
disease	O
manifestations	O
.	O

Early	O
applying	O
of	O
CH	O
-	O
HZ	O
treatment	O
showed	O
good	O
effects	O
in	O
improving	O
CK	O
,	O
LDH	O
,	O
oxygenation	O
index	O
and	O
absolute	O
value	O
of	O
neutrophils	B-ANAT
,	O
and	O
could	O
reduce	O
the	O
daily	O
maximal	O
dosage	O
of	O
glucocorticoid	O
needed	O
for	O
SARS	O
patients	O
.	O

With	O
the	O
aim	O
of	O
developing	O
therapeutic	O
agents	O
,	O
we	O
have	O
tested	O
peptides	O
derived	O
from	O
the	O
membrane	B-ANAT
-	O
proximal	O
(	O
HR2	O
)	O
and	O
membrane	B-ANAT
-	O
distal	O
(	O
HR1	O
)	O
heptad	O
repeat	O
region	O
of	O
the	O
spike	O
protein	O
as	O
inhibitors	O
of	O
SARS	O
-	O
CoV	O
infection	O
of	O
Vero	B-ANAT
cells	I-ANAT
.	O

To	O
examine	O
the	O
effect	O
of	O
storage	B-ANAT
temperature	O
on	O
the	O
ability	O
to	O
detect	O
PEDV	O
and	O
TGEV	O
RNA	O
by	O
multiplex	O
RT	O
-	O
PCR	O
,	O
fecal	B-ANAT
samples	O
were	O
stored	O
for	O
different	O
temperatures	O
(	O
4	O
,	O
21	O
,	O
36	O
,	O
and	O
45	O
C	O
)	O
before	O
extracting	O
viral	O
RNA	O
.	O

The	O
PEDV	O
and	O
TGEV	O
nucleic	B-ANAT
acids	O
in	O
fecal	B-ANAT
samples	O
were	O
stable	O
up	O
to	O
3	O
days	O
at	O
4	O
C	O
.	O
The	O
PEDV	O
and	O
TGEV	O
nucleic	B-ANAT
acids	O
were	O
consistently	O
detected	O
in	O
fecal	B-ANAT
samples	O
up	O
to	O
60	O
hours	O
at	O
21	O
C	O
and	O
24	O
hours	O
only	O
at	O
36	O
and	O
45	O
C	O
.	O
Thereafter	O
,	O
the	O
number	O
of	O
positive	O
signals	O
declined	O
.	O

The	O
PEDV	O
and	O
TGEV	O
nucleic	B-ANAT
acids	O
were	O
consistently	O
detected	O
in	O
fecal	B-ANAT
samples	O
up	O
to	O
60	O
hours	O
at	O
21	O
C	O
and	O
24	O
hours	O
only	O
at	O
36	O
and	O
45	O
C	O
.	O
The	O
results	O
of	O
this	O
study	O
suggested	O
that	O
storage	B-ANAT
temperature	O
has	O
significant	O
effect	O
on	O
the	O
detection	O
of	O
PEDV	O
and	O
TGEV	O
nucleic	B-ANAT
acids	O
from	O
fecal	B-ANAT
samples	O
by	O
multiplex	O
RT	O
-	O
PCR	O
.	O

In	O
this	O
issue	O
of	O
Critical	O
Care	O
,	O
two	O
experts	O
face	B-ANAT
off	O
over	O
the	O
need	O
to	O
isolate	O
patients	O
infected	O
with	O
methicillin	O
-	O
resistant	O
Staphylococcus	O
aureus	O
.	O

Chest	B-ANAT
auscultation	O
was	O
abnormal	O
in	O
71	O
%	O
of	O
P	O
patients	O
,	O
with	O
mild	O
crepitations	O
detected	O
.	O

The	O
3	O
'	O
UTR	O
of	O
t	O
-	O
PA	O
mRNA	O
is	O
known	O
to	O
be	O
involved	O
in	O
the	O
reversible	O
deadenylation	O
and	O
translational	O
repression	O
of	O
transcripts	O
in	O
mouse	O
oocytes	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
substantial	O
proportion	O
of	O
hitherto	O
unexplained	O
respiratory	B-ANAT
tract	I-ANAT
illnesses	O
is	O
associated	O
with	O
human	O
metapneumovirus	O
(	O
hMPV	O
)	O
infection	O
.	O

Fusion	O
of	O
coronaviruses	O
with	O
the	O
host	B-ANAT
cell	I-ANAT
is	O
mediated	O
by	O
the	O
envelope	B-ANAT
spike	O
protein	O
.	O

TITLE	O
:	O
S	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
mediates	O
entry	O
into	O
hepatoma	B-ANAT
cell	I-ANAT
lines	O
and	O
is	O
targeted	O
by	O
neutralizing	O
antibodies	O
in	O
infected	O
patients	O
.	O

TITLE	O
:	O
Fiber	B-ANAT
-	O
optic	B-ANAT
bronchoscopic	O
classification	O
of	O
inhalation	O
injury	O
:	O
prediction	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Fiber	B-ANAT
-	O
optic	B-ANAT
bronchoscopy	O
is	O
a	O
safe	O
and	O
effective	O
method	O
for	O
the	O
early	O
diagnosis	O
of	O
inhalation	O
injuries	O
.	O

The	O
diagnosis	O
of	O
Pneumoniae	O
was	O
defined	O
according	O
to	O
the	O
criteria	O
:	O
clinical	O
symptoms	O
abnormal	O
shadow	O
in	O
both	O
Chest	B-ANAT
X	O
-	O
p	O
and	O
Chest	B-ANAT
CT	O
,	O
increased	O
level	O
of	O
CRP	O
,	O
number	O
of	O
WBC	B-ANAT
.	O

Underlying	O
disease	O
includes	O
leukemias	O
,	O
malignant	O
lymphoma	O
,	O
myelodysplastic	O
syndrome	O
(	O
MDS	O
),	O
multiple	O
myeloma	O
,	O
idiopathic	O
thrombocytopenia	O
purpura	O
(	O
ITP	O
),	O
multiple	O
injury	O
(	O
bone	B-ANAT
fracture	O
),	O
cerebral	B-ANAT
hemorrhage	O
,	O
enterocolitis	O
,	O
Appendicitis	O
,	O
lung	B-ANAT
cancer	O
,	O
larynx	B-ANAT
cancer	O
,	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
(	O
BOOP	O
),	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
),	O
sepsis	O
.	O

Sometimes	O
the	O
diagnosis	O
may	O
be	O
difficult	O
,	O
as	O
in	O
case	O
1	O
,	O
identified	O
initially	O
as	O
brainstem	B-ANAT
stroke	O
.	O

Intraperitoneal	O
injection	O
of	O
cerulein	O
in	O
mice	O
resulted	O
in	O
severe	O
,	O
acute	O
pancreatitis	O
characterised	O
by	O
oedema	O
,	O
neutrophil	B-ANAT
infiltration	O
,	O
tissue	B-ANAT
haemorrhage	O
and	O
necrosis	O
and	O
elevated	O
serum	B-ANAT
levels	O
of	O
amylase	O
and	O
lipase	O
.	O

To	O
date	O
,	O
Vero	O
E6	O
cells	B-ANAT
are	O
the	O
only	O
cell	B-ANAT
line	I-ANAT
that	O
could	O
be	O
used	O
to	O
replicate	O
the	O
virus	O
with	O
obvious	O
CPE	O
(	O
cytopathic	O
effect	O
)	O
in	O
vitro	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
establish	O
the	O
life	O
cycle	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
CoV	O
)	O
in	O
host	O
cells	B-ANAT
and	O
determine	O
the	O
pathogenesis	O
of	O
SARS	O
.	O

The	O
smooth	O
vesicles	B-ANAT
fused	O
with	O
the	O
cell	B-ANAT
membrane	I-ANAT
,	O
and	O
the	O
mature	O
particles	O
were	O
released	O
.	O

However	O
,	O
randomised	O
controlled	O
trials	O
performed	O
to	O
evaluate	O
long	O
-	O
term	O
effects	O
revealed	O
different	O
results	O
:	O
thus	O
,	O
in	O
chronic	O
pulmonary	B-ANAT
hypertension	O
inhaled	O
vasodilators	O
improved	O
outcome	O
whereas	O
the	O
results	O
for	O
the	O
treatment	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
revealed	O
beneficial	O
effects	O
only	O
when	O
used	O
as	O
a	O
rescue	O
and	O
/	O
or	O
bridging	O
therapy	O
in	O
severe	O
hypoxemia	O
.	O

In	O
cardiothoracic	O
surgery	O
,	O
inhaled	O
vasodilators	O
have	O
been	O
shown	O
to	O
improve	O
pulmonary	B-ANAT
circulation	O
when	O
severe	O
pulmonary	B-ANAT
hypertension	O
is	O
present	O
.	O

The	O
specificity	O
of	O
the	O
kit	O
was	O
determined	O
using	O
animal	O
coronaviruses	O
and	O
other	O
bacterial	O
and	O
viral	O
strains	O
,	O
causing	O
acute	O
respiratory	O
and	O
intestinal	B-ANAT
infections	O
,	O
and	O
was	O
shown	O
to	O
be	O
100	O
%.	O

CONCLUSIONS	O
:	O
The	O
kit	O
""""	O
AmpliSens	O
SARS	O
""""	O
for	O
qualitative	O
detection	O
of	O
SARS	O
-	O
related	O
coronavirus	O
RNA	O
by	O
reverse	O
transcription	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
nasopharyngeal	B-ANAT
wash	O
/	O
aspirates	B-ANAT
,	O
naso	O
/	O
oropharyngeal	B-ANAT
swabs	O
,	O
plasma	B-ANAT
,	O
and	O
extract	O
from	O
feces	B-ANAT
has	O
been	O
developed	O
in	O
the	O
Central	O
Research	O
Institute	O
for	O
Epidemiology	O
of	O
the	O
RF	O
Ministry	O
of	O
Health	O
.	O

Her	O
CXR	O
showed	O
features	O
suggestive	O
of	O
pneumomediastinum	O
,	O
which	O
was	O
confirmed	O
by	O
high	O
-	O
resolution	O
CT	O
scan	O
of	O
the	O
thorax	B-ANAT
.	O

Dynamic	O
changes	O
of	O
chest	B-ANAT
X	O
-	O
ray	O
images	O
and	O
laboratory	O
tests	O
in	O
45	O
SARS	O
patients	O
managed	O
from	O
March	O
to	O
May	O
,	O
2003	O
were	O
analyzed	O
.	O

Noticeably	O
,	O
the	O
time	O
to	O
pan	B-ANAT
-	O
consolidation	O
of	O
the	O
lung	B-ANAT
were	O
less	O
than	O
7	O
days	O
in	O
7	O
fatal	O
cases	O
.	O

The	O
Western	O
blotting	O
demonstrated	O
that	O
SARS	O
patient	O
convalescent	O
serum	B-ANAT
could	O
recognize	O
the	O
recombinant	O
fusion	O
protein	O
.	O

The	O
sensitivity	O
of	O
the	O
assay	O
was	O
84	O
.	O
6	O
%	O
in	O
13	O
serologically	O
confirmed	O
SARS	O
patients	O
with	O
blood	B-ANAT
taken	O
during	O
the	O
first	O
10	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
(	O
11	O
of	O
13	O
).	O

The	O
convalescent	O
SARS	O
patients	O
'	O
immune	O
function	O
gradually	O
recovers	O
,	O
and	O
the	O
effect	O
of	O
SARS	O
virus	O
on	O
activation	O
of	O
T	B-ANAT
cells	I-ANAT
gradually	O
disappears	O
.	O

Using	O
antibody	O
specific	O
for	O
the	O
C	O
terminus	O
of	O
U274	O
,	O
we	O
show	O
U274	O
to	O
be	O
expressed	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
and	O
,	O
in	O
addition	O
to	O
the	O
full	O
-	O
length	O
protein	O
,	O
two	O
other	O
processed	O
forms	O
were	O
also	O
detected	O
.	O

Deletion	O
of	O
a	O
cytoplasmic	B-ANAT
domain	I-ANAT
of	O
U274	O
,	O
which	O
contains	O
Yxxphi	O
and	O
diacidic	O
motifs	O
,	O
abolished	O
its	O
transport	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
.	O

Flow	O
cytometric	O
analysis	O
revealed	O
that	O
both	O
normal	O
and	O
larger	O
splenic	B-ANAT
or	O
myeloid	O
NK	B-ANAT
cells	I-ANAT
decreased	O
more	O
in	O
pathogenic	O
L2	O
-	O
MHV3	O
-	O
infected	O
mice	O
than	O
in	O
attenuated	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	O
.	O

The	O
NK	B-ANAT
cell	I-ANAT
decreases	O
were	O
due	O
to	O
the	O
viral	O
permissivity	O
leading	O
to	O
cytopathic	O
effects	O
characterized	O
by	O
cell	B-ANAT
rounding	O
,	O
syncytia	B-ANAT
formation	O
and	O
apoptosis	O
.	O

One	O
example	O
,	O
the	O
PiCCO	O
monitor	O
,	O
combines	O
arterial	B-ANAT
thermodilution	O
with	O
analysis	O
of	O
the	O
pulse	O
waveform	O
,	O
providing	O
a	O
series	O
of	O
hemodynamic	O
parameters	O
useful	O
for	O
managing	O
the	O
critically	O
ill	O
patient	O
.	O

Viral	O
RNA	O
templates	O
for	O
the	O
S	O
-	O
gene	O
amplification	O
were	O
directly	O
extracted	O
from	O
raw	O
clinical	O
samples	O
,	O
including	O
plasma	B-ANAT
,	O
throat	B-ANAT
swab	I-ANAT
,	O
sputum	B-ANAT
,	O
and	O
stool	B-ANAT
,	O
during	O
the	O
course	O
of	O
the	O
epidemic	O
in	O
the	O
Beijing	O
area	O
.	O

The	O
latest	O
stool	B-ANAT
sample	I-ANAT
that	O
was	O
positive	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
was	O
collected	O
on	O
day	O
75	O
while	O
the	O
patient	O
was	O
receiving	O
intensive	O
care	O
.	O

The	O
collection	O
procedures	O
for	O
stool	B-ANAT
and	O
pooled	O
nasal	B-ANAT
and	O
throat	B-ANAT
swab	I-ANAT
specimens	O
were	O
the	O
least	O
likely	O
to	O
transmit	O
infection	O
,	O
and	O
the	O
combination	O
gave	O
the	O
highest	O
yield	O
for	O
coronavirus	O
detection	O
by	O
RT	O
-	O
PCR	O
.	O

We	O
have	O
recently	O
shown	O
that	O
21	O
aa	O
substitutions	O
and	O
a	O
7	O
-	O
aa	O
insert	O
in	O
the	O
N	O
-	O
terminal	O
region	O
of	O
S	O
are	O
associated	O
with	O
the	O
extended	O
host	O
range	O
of	O
a	O
virus	O
variant	O
derived	O
from	O
murine	O
cells	B-ANAT
persistently	O
infected	O
with	O
the	O
A59	O
strain	O
of	O
MHV	O
(	O
MHV	O
-	O
A59	O
).	O

Sixty	O
-	O
seven	O
SARS	O
patients	O
who	O
had	O
large	O
joint	B-ANAT
pain	O
between	O
March	O
2003	O
and	O
May	O
2003	O
underwent	O
both	O
plain	O
radiographs	O
and	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
examination	O
on	O
the	O
same	O
day	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
life	O
-	O
threatening	O
ailment	O
characterized	O
by	O
severe	O
lung	B-ANAT
injury	O
involving	O
inflammatory	B-ANAT
cell	I-ANAT
recruitment	O
to	O
the	O
lung	B-ANAT
,	O
cytokine	O
production	O
,	O
surfactant	O
dysfunction	O
,	O
and	O
up	O
-	O
regulation	O
of	O
nitric	O
oxide	O
synthase	O
2	O
(	O
NOS2	O
)	O
resulting	O
in	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
.	O

Pulmonary	B-ANAT
responses	O
to	O
nebulized	O
endotoxin	O
(	O
lipopolysaccharide	O
,	O
LPS	O
)	O
were	O
evaluated	O
in	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	O
,	O
NOS2	O
null	O
(-/-)	O
mice	O
,	O
and	O
NOS2	O
-	O
chimeric	O
animals	O
derived	O
from	O
bone	B-ANAT
marrow	I-ANAT
transplantation	O
.	O

This	O
study	O
demonstrates	O
that	O
expression	O
of	O
NOS2	O
in	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
is	O
critical	O
for	O
the	O
development	O
of	O
lung	B-ANAT
injury	O
and	O
mediates	O
surfactant	O
dysfunction	O
independent	O
of	O
NOS2	O
inflammatory	B-ANAT
cell	I-ANAT
expression	O
and	O
cytokine	O
production	O
.	O

A	O
single	O
intranasal	O
administration	O
of	O
BHPIV3	O
expressing	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
(	O
S	O
)	O
induced	O
a	O
high	O
titer	O
of	O
SARS	O
-	O
CoV	O
-	O
neutralizing	O
serum	B-ANAT
antibodies	O
,	O
only	O
2	O
-	O
fold	O
less	O
than	O
that	O
induced	O
by	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
expression	O
of	O
S	O
with	O
the	O
two	O
other	O
putative	O
virion	B-ANAT
envelope	B-ANAT
proteins	O
,	O
the	O
matrix	O
M	O
and	O
small	O
envelope	B-ANAT
E	O
proteins	O
,	O
did	O
not	O
augment	O
the	O
neutralizing	O
antibody	O
response	O
.	O

S2	O
undergoes	O
more	O
significant	O
structural	O
fluctuation	O
than	O
S1	O
during	O
the	O
400	O
ps	O
molecular	O
dynamics	O
simulations	O
because	O
it	O
is	O
located	O
at	O
the	O
open	O
mouth	B-ANAT
of	O
the	O
catalytic	O
cleft	O
,	O
while	O
S1	O
is	O
situated	O
in	O
the	O
very	O
bottom	O
of	O
this	O
cleft	O
.	O

TITLE	O
:	O
Retrospective	O
comparison	O
of	O
convalescent	O
plasma	B-ANAT
with	O
continuing	O
high	O
-	O
dose	O
methylprednisolone	O
treatment	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
Detection	O
of	O
the	O
mouse	O
hepatitis	O
virus	O
receptor	O
within	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
has	O
been	O
elusive	O
.	O

Receptor	O
expression	O
on	O
microglia	B-ANAT
was	O
reduced	O
during	O
acute	O
infection	O
and	O
restored	O
following	O
immune	O
-	O
mediated	O
virus	O
control	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
lung	B-ANAT
assist	O
has	O
been	O
proposed	O
as	O
an	O
invasive	O
measure	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
when	O
oxygenation	O
is	O
critically	O
impaired	O
.	O

In	O
30	O
patients	O
with	O
ARDS	O
due	O
to	O
multitrauma	O
,	O
pneumonia	O
or	O
after	O
surgery	O
(	O
p	O
(	O
a	O
)	O
O	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)-	O
ratio	O
67	O
+/-	O
23	O
mmHg	O
)	O
pECLA	O
was	O
established	O
by	O
insertion	O
of	O
cannulae	O
to	O
the	O
femoral	B-ANAT
artery	I-ANAT
and	O
vein	B-ANAT
followed	O
by	O
connection	O
with	O
a	O
membrane	B-ANAT
gas	O
exchanger	O
.	O

TITLE	O
:	O
Exploring	O
the	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
):	O
the	O
tissue	B-ANAT
distribution	O
of	O
the	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
its	O
putative	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

Despite	O
the	O
fact	O
that	O
SARS	O
-	O
CoV	O
can	O
infect	O
the	O
lung	B-ANAT
and	O
intestine	B-ANAT
,	O
the	O
tissue	B-ANAT
responses	O
in	O
these	O
two	O
organs	B-ANAT
are	O
different	O
.	O

Moreover	O
,	O
the	O
interaction	O
between	O
SARS	O
-	O
CoV	O
and	O
the	O
immunological	O
or	O
lymphoid	B-ANAT
system	I-ANAT
remains	O
to	O
be	O
defined	O
.	O

In	O
each	O
colibacillosis	O
flock	O
,	O
blood	B-ANAT
samples	I-ANAT
were	O
taken	O
from	O
20	O
hens	O
at	O
the	O
onset	O
of	O
clinical	O
disease	O
and	O
three	O
times	O
thereafter	O
at	O
2	O
-	O
week	O
intervals	O
.	O

The	O
eggs	O
and	O
the	O
respective	O
embryos	B-ANAT
were	O
weighed	O
and	O
embryo	B-ANAT
:	O
egg	B-ANAT
weight	O
(	O
EE	O
)	O
ratios	O
were	O
calculated	O
.	O

The	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	O
was	O
first	O
determined	O
in	O
sera	B-ANAT
on	O
the	O
9th	O
day	O
by	O
Euroimmun	O
IFA	O
,	O
12th	O
day	O
by	O
EIA	O
No	O
.	O
B	O
,	O
13th	O
day	O
by	O
Australian	O
IFA	O
,	O
and	O
16th	O
day	O
by	O
EIA	O
No	O
.	O
A	O
.	O
The	O
positive	O
rates	O
of	O
antibody	O
on	O
the	O
3rd	O
week	O
after	O
onset	O
were	O
84	O
.	O
2	O
%	O
(	O
16	O
/	O
19	O
),	O
94	O
.	O
7	O
%	O
(	O
18	O
/	O
19	O
),	O
78	O
.	O
9	O
%	O
(	O
15	O
/	O
19	O
)	O
and	O
52	O
.	O
6	O
%	O
(	O
10	O
/	O
19	O
)	O
respectively	O
.	O

Through	O
detection	O
of	O
123	O
negative	O
reference	O
sera	B-ANAT
,	O
the	O
specificity	O
of	O
EIA	O
No	O
.	O
A	O
and	O
two	O
IFA	O
was	O
100	O
%,	O
with	O
exception	O
of	O
94	O
.	O
9	O
%	O
for	O
EIA	O
No	O
.	O
B	O
.	O
CONCLUSIONS	O
:	O
The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
two	O
IFAs	O
were	O
relatively	O
higher	O
than	O
that	O
of	O
the	O
two	O
EIAs	O
.	O

CONCLUSIONS	O
:	O
The	O
A	O
value	O
of	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
in	O
serum	B-ANAT
of	O
convalescent	O
patients	O
tended	O
to	O
elevate	O
in	O
half	O
an	O
year	O
after	O
SARS	O
onset	O
.	O

TITLE	O
:	O
Longitudinal	O
profile	O
of	O
immunoglobulin	O
G	O
(	O
IgG	O
),	O
IgM	O
,	O
and	O
IgA	O
antibodies	O
against	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
in	O
patients	O
with	O
pneumonia	O
due	O
to	O
the	O
SARS	O
coronavirus	O
.	O

The	O
assay	O
was	O
carried	O
out	O
with	O
hyperimmune	O
polyclonal	O
nucleocapsid	B-ANAT
-	O
specific	O
antibodies	O
from	O
guinea	O
pigs	O
and	O
rabbits	O
immunized	O
with	O
recombinant	O
His	O
(	O
6	O
)-	O
tagged	O
SARS	O
CoV	O
nucleocapsid	B-ANAT
protein	O
.	O

Mv1Lu	O
cells	B-ANAT
produce	O
little	O
SARS	O
-	O
CoV	O
compared	O
to	O
that	O
produced	O
by	O
VeroE6	O
cells	B-ANAT
,	O
which	O
indicates	O
that	O
they	O
are	O
a	O
safer	O
alternative	O
for	O
SARS	O
-	O
CoV	O
diagnostics	O
.	O

By	O
studying	O
the	O
human	O
leukocyte	B-ANAT
antigen	O
(	O
HLA	B-ANAT
)	O
types	O
A	O
,	O
B	O
,	O
DR	O
,	O
and	O
DQ	O
alleles	O
in	O
90	O
Chinese	O
patients	O
with	O
serologically	O
confirmed	O
SARS	O
infections	O
,	O
we	O
identified	O
a	O
strong	O
association	O
between	O
HLA	B-ANAT
-	O
B	O
*	O
0703	O
(	O
OR	O
,	O
4	O
.	O
08	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
03	O
-	O
8	O
.	O
18	O
;	O
P	O
=.	O
00072	O
[	O
Bonferroni	O
-	O
corrected	O
P	O
value	O
,	O
P	O
(	O
c	O
)	O
<.	O
0022	O
])	O
and	O
-	O
DRB1	O
*	O
0301	O
(	O
OR	O
,	O
0	O
.	O
06	O
;	O
95	O
%,	O
0	O
.	O
01	O
-	O
0	O
.	O
47	O
;	O
P	O
=.	O
00008	O
[	O
after	O
Bonferroni	O
correction	O
,	O
P	O
<.	O
0042	O
])	O
and	O
the	O
development	O
of	O
SARS	O
.	O

Glycocorticosteroid	O
and	O
Chinese	O
herbal	O
medicine	O
treatments	O
could	O
promote	O
the	O
recovery	O
of	O
T	B-ANAT
-	I-ANAT
lymphocyte	I-ANAT
profile	O
,	O
rationally	O
use	O
of	O
them	O
is	O
the	O
effective	O
therapeutic	O
method	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
immunological	O
reactions	O
between	O
the	O
peptides	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
Cov	O
)	O
S	O
-	O
protein	O
and	O
the	O
serum	B-ANAT
of	O
SARS	O
patients	O
for	O
identifying	O
the	O
SARS	O
-	O
Cov	O
epitope	O
.	O

The	O
8	O
peptides	O
from	O
S1	O
domain	O
of	O
S	O
protein	O
appear	O
to	O
have	O
low	O
immunogenicity	O
to	O
the	O
serum	B-ANAT
of	O
SARS	O
patients	O
,	O
indicating	O
that	O
these	O
peptides	O
may	O
not	O
be	O
the	O
epitope	O
of	O
the	O
SARS	O
-	O
Cov	O
.	O

TITLE	O
:	O
Persistent	O
infection	O
of	O
SARS	O
coronavirus	O
in	O
colonic	B-ANAT
cells	B-ANAT
in	O
vitro	O
.	O

The	O
results	O
showed	O
that	O
only	O
LoVo	O
cells	B-ANAT
were	O
permissive	O
to	O
SARS	O
-	O
CoV	O
infection	O
as	O
evident	O
by	O
positive	O
findings	O
from	O
indirect	O
immunofluorescence	O
staining	O
for	O
intracellular	B-ANAT
viral	O
antigens	O
,	O
in	O
situ	O
hybridization	O
for	O
intracellular	B-ANAT
viral	O
RNA	O
,	O
and	O
electron	O
microscopy	O
for	O
intracellular	B-ANAT
viral	B-ANAT
particles	I-ANAT
.	O

Finally	O
,	O
in	O
the	O
51	O
acute	O
pneumonias	O
hospitalised	O
with	O
respiratory	O
distress	O
syndrome	O
,	O
a	O
virus	O
was	O
identified	O
in	O
17	O
(	O
33	O
.	O
3	O
%)	O
cases	O
,	O
including	O
3	O
(	O
5	O
.	O
5	O
%)	O
RSV	O
,	O
6	O
influenza	O
A	O
,	O
3	O
rhinovirus	O
,	O
2	O
adenovirus	O
,	O
2	O
herpes	O
simplex	B-ANAT
virus	O
and	O
1	O
cytomegalovirus	O
.	O

The	O
patient	O
subsequently	O
developed	O
ipsilateral	O
pulmonary	B-ANAT
edema	O
and	O
ultimately	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
which	O
required	O
vigorous	O
treatment	O
over	O
the	O
next	O
several	O
days	O
.	O

To	O
begin	O
to	O
understand	O
its	O
biochemical	O
and	O
immunological	O
properties	O
,	O
we	O
expressed	O
both	O
full	O
-	O
length	O
and	O
ectodomain	O
of	O
the	O
protein	O
in	O
various	O
primate	O
cells	B-ANAT
.	O

The	O
detection	O
of	O
S	O
-	O
protein	O
by	O
immunoassays	O
was	O
difficult	O
using	O
human	O
convalescent	O
sera	B-ANAT
,	O
suggesting	O
that	O
the	O
protein	O
may	O
not	O
elicit	O
strong	O
humoral	O
immune	O
response	O
in	O
virus	O
-	O
infected	O
patients	O
.	O

We	O
were	O
able	O
to	O
pseudotype	O
murine	O
leukemia	O
virus	B-ANAT
particles	I-ANAT
with	O
S	O
-	O
protein	O
and	O
produce	O
SARS	O
pseudoviruses	O
.	O

MULTIPRED	O
predicted	O
HLA	B-ANAT
-	O
A2	O
and	O
HLA	B-ANAT
-	O
A3	O
hot	O
spots	O
in	O
each	O
of	O
these	O
proteins	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
acute	O
infectious	O
disease	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
.	O

Our	O
findings	O
indicate	O
that	O
the	O
lungs	B-ANAT
of	O
patients	O
who	O
die	O
of	O
SARS	O
are	O
almost	O
always	O
positive	O
for	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
may	O
show	O
features	O
of	O
both	O
diffuse	O
alveolar	B-ANAT
damage	O
and	O
acute	O
fibrinous	O
and	O
organizing	O
pneumonia	O
patterns	O
of	O
acute	O
injury	O
.	O

ABSTRACT	O
:	O
The	O
health	O
profession	O
faces	B-ANAT
a	O
new	O
challenge	O
with	O
the	O
emergence	O
of	O
a	O
novel	O
viral	O
disease	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
a	O
form	O
of	O
atypical	O
pneumonia	O
caused	O
by	O
a	O
coronavirus	O
termed	O
SARS	O
-	O
CoV	O
.	O
This	O
highly	O
infectious	O
disease	O
has	O
spread	O
through	O
32	O
countries	O
,	O
infecting	O
more	O
than	O
8	O
,	O
400	O
patients	O
with	O
over	O
790	O
deaths	O
in	O
just	O
over	O
6	O
months	O
.	O

Forty	O
-	O
nine	O
immunopositive	O
phage	O
clones	O
that	O
bound	O
specifically	O
to	O
serum	B-ANAT
from	O
patients	O
with	O
SARS	O
were	O
selected	O
.	O

The	O
method	O
is	O
based	O
on	O
counting	O
the	O
appearance	O
frequency	O
of	O
oligopeptides	O
of	O
a	O
fixed	B-ANAT
length	O
(	O
up	O
to	O
K	O
=	O
6	O
)	O
in	O
the	O
collection	O
of	O
protein	O
sequences	O
of	O
a	O
species	O
.	O

The	O
method	O
has	O
also	O
been	O
used	O
to	O
compare	O
chloroplast	B-ANAT
genomes	O
and	O
to	O
the	O
phylogeny	O
of	O
Coronaviruses	O
including	O
human	O
SARS	O
-	O
CoV	O
.	O
A	O
key	O
point	O
in	O
our	O
approach	O
is	O
subtraction	O
of	O
a	O
random	O
background	O
from	O
the	O
original	O
counts	O
by	O
using	O
a	O
Markov	O
model	O
of	O
order	O
K	O
-	O
2	O
in	O
order	O
to	O
highlight	O
the	O
shaping	O
role	O
of	O
natural	O
selection	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
:	O
prognostic	O
implications	O
of	O
chest	B-ANAT
radiographic	O
findings	O
in	O
52	O
patients	O
.	O

ABSTRACT	O
:	O
This	O
study	O
established	O
a	O
modified	O
alkaline	O
phosphatase	O
-	O
labelled	O
avidin	O
-	O
biotin	O
-	O
complex	O
(	O
ABC	O
-	O
AP	O
)	O
method	O
for	O
diagnosis	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
and	O
Mycoplasma	O
pulmonis	O
infection	O
from	O
formalin	O
-	O
fixed	B-ANAT
,	O
paraffin	O
wax	B-ANAT
-	O
embedded	O
sections	O
,	O
murine	O
antibody	O
-	O
positive	O
serum	B-ANAT
being	O
used	O
as	O
the	O
primary	O
reagent	O
.	O

Cg	O
-	O
Foxn1	O
(	O
nu	O
)/	O
Foxn1	O
(	O
nu	O
)	O
mice	O
and	O
M	O
.	O
pulmonis	O
antigen	O
in	O
Wistar	O
rats	O
were	O
immunolabelled	O
in	O
tissue	B-ANAT
sections	O
.	O

The	O
HCoV	O
-	O
229E	O
virus	B-ANAT
particle	I-ANAT
showed	O
a	O
binding	O
and	O
redistribution	O
pattern	O
that	O
was	O
similar	O
to	O
that	O
caused	O
by	O
the	O
anti	O
-	O
CD13	O
antibody	O
:	O
the	O
virus	O
bound	O
to	O
the	O
cell	B-ANAT
evenly	O
when	O
incubated	O
on	O
ice	O
but	O
became	O
colocalized	O
with	O
caveolin	O
-	O
1	O
at	O
37	O
degrees	O
C	O
;	O
importantly	O
,	O
the	O
virus	O
also	O
caused	O
sequestration	O
of	O
CD13	O
to	O
the	O
caveolin	O
-	O
1	O
-	O
positive	O
area	O
.	O

These	O
six	O
mutations	O
are	O
scattered	O
throughout	O
the	O
genome	O
and	O
give	O
rise	O
to	O
only	O
two	O
amino	O
acid	O
substitutions	O
:	O
one	O
in	O
the	O
spike	O
protein	O
gene	O
(	O
I958F	O
)	O
and	O
the	O
other	O
in	O
the	O
nucleocapsid	B-ANAT
protein	O
gene	O
(	O
V81A	O
).	O

Furthermore	O
,	O
the	O
two	O
variants	O
were	O
shown	O
to	O
reach	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
after	O
intranasal	O
inoculation	O
in	O
BALB	O
/	O
c	O
mice	O
,	O
demonstrating	O
neuroinvasive	O
properties	O
.	O

We	O
conclusively	O
show	O
that	O
SCoV	O
E	O
protein	O
contains	O
an	O
unusually	O
short	O
,	O
palindromic	O
transmembrane	B-ANAT
helical	O
hairpin	O
around	O
a	O
previously	O
unidentified	O
pseudo	O
-	O
center	O
of	O
symmetry	O
,	O
a	O
structural	O
feature	O
which	O
seems	O
to	O
be	O
unique	O
to	O
SCoV	O
.	O
The	O
hairpin	O
deforms	O
lipid	B-ANAT
bilayers	I-ANAT
by	O
way	O
of	O
increasing	O
their	O
curvature	O
,	O
providing	O
for	O
the	O
first	O
time	O
a	O
molecular	O
explanation	O
of	O
E	O
protein	O
'	O
s	O
pivotal	O
role	O
in	O
viral	O
budding	O
.	O

An	O
immunofluorescence	O
assay	O
indicated	O
high	O
levels	O
of	O
exposure	O
to	O
coronavirus	O
among	O
Serengeti	O
hyenas	O
:	O
95	O
%	O
when	O
considering	O
sera	B-ANAT
with	O
titer	O
levels	O
of	O
>	O
or	O
=	O
1	O
:	O
10	O
and	O
74	O
%	O
when	O
considering	O
sera	B-ANAT
with	O
titer	O
levels	O
of	O
>	O
or	O
=	O
1	O
:	O
40	O
.	O

No	O
viral	O
RNA	O
was	O
detected	O
in	O
tissue	B-ANAT
samples	O
(	O
lymph	B-ANAT
node	I-ANAT
,	O
intestine	B-ANAT
,	O
lung	B-ANAT
)	O
from	O
11	O
individuals	O
.	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
induces	O
actin	O
reorganization	O
and	O
apoptosis	O
in	O
COS	B-ANAT
-	I-ANAT
1	I-ANAT
cells	I-ANAT
in	O
the	O
absence	O
of	O
growth	O
factors	O
.	O

Twenty	O
-	O
four	O
hours	O
after	O
the	O
induction	O
of	O
acute	O
lung	B-ANAT
injury	O
by	O
intravenous	O
oleic	O
acid	O
(	O
0	O
.	O
25	O
ml	O
/	O
kg	O
),	O
5	O
%	O
albumin	O
solution	O
with	O
1	O
.	O
5	O
microCi	O
(	O
125	O
)	O
I	O
-	O
labeled	O
albumin	O
(	O
5	O
ml	O
/	O
kg	O
)	O
was	O
delivered	O
into	O
both	O
lungs	B-ANAT
via	O
trachea	B-ANAT
.	O

Routine	O
procedures	O
such	O
as	O
management	O
of	O
feces	B-ANAT
and	O
respiratory	O
secretions	B-ANAT
(	O
eg	O
,	O
airway	B-ANAT
suctioning	O
,	O
tracheotomy	O
care	O
)	O
have	O
been	O
classified	O
as	O
high	O
risk	O
.	O

Intracellular	B-ANAT
viral	O
RNA	O
copies	O
were	O
reduced	O
50	O
%	O
by	O
IFN	O
-	O
alpha	O
at	O
a	O
concentration	O
of	O
25	O
U	O
/	O
ml	O
and	O
by	O
IFN	O
-	O
beta	O
at	O
a	O
concentration	O
of	O
14	O
U	O
/	O
ml	O
.	O

Histologically	O
,	O
interstitial	B-ANAT
nephritis	O
was	O
evident	O
in	O
chickens	O
infected	O
with	O
these	O
same	O
3	O
strains	O
.	O

However	O
,	O
viral	O
nucleic	B-ANAT
acid	O
and	O
antigen	O
were	O
detected	O
only	O
with	O
Wolgemuth	O
-	O
infected	O
kidneys	B-ANAT
by	O
ISH	O
and	O
IHC	O
.	O

These	O
results	O
indicate	O
that	O
the	O
pathological	O
changes	O
in	O
kidneys	B-ANAT
from	O
chickens	O
infected	O
with	O
Gray	O
and	O
CV56b	O
may	O
not	O
have	O
resulted	O
from	O
the	O
cytolytic	O
action	O
of	O
the	O
virus	O
.	O

Here	O
,	O
we	O
report	O
the	O
emergence	O
and	O
isolation	O
of	O
two	O
temperature	O
sensitive	O
(	O
ts	O
)	O
mutants	O
and	O
a	O
revertant	O
in	O
the	O
process	O
of	O
cold	O
-	O
adaptation	O
of	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
to	O
a	O
monkey	O
kidney	B-ANAT
cell	I-ANAT
line	O
.	O

Consequently	O
,	O
some	O
essential	O
functions	O
of	O
the	O
S	O
protein	O
,	O
including	O
mediation	O
of	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
fusion	O
and	O
its	O
incorporation	O
into	O
virions	B-ANAT
,	O
were	O
completely	O
abolished	O
.	O

Thirty	O
-	O
one	O
patients	O
(	O
59	O
%)	O
had	O
abnormal	O
findings	O
on	O
chest	B-ANAT
radiographs	O
on	O
hospital	O
admission	O
,	O
and	O
all	O
but	O
1	O
patient	O
(	O
98	O
%)	O
eventually	O
developed	O
lung	B-ANAT
infiltrates	O
that	O
were	O
consistent	O
with	O
pneumonia	O
.	O

The	O
data	O
extracted	O
included	O
patient	O
demographics	O
,	O
etiology	O
of	O
respiratory	O
failure	O
,	O
ventilator	O
settings	O
,	O
and	O
gas	O
exchange	O
and	O
cardiovascular	B-ANAT
data	O
from	O
baseline	O
to	O
72	O
h	O
of	O
treatment	O
,	O
as	O
well	O
as	O
at	O
the	O
transition	O
from	O
HFOV	O
to	O
conventional	O
ventilation	O
(	O
CV	O
).	O

Significant	O
changes	O
in	O
hemodynamics	O
following	O
HFOV	O
initiation	O
included	O
an	O
increase	O
in	O
central	O
venous	B-ANAT
pressure	O
and	O
a	O
reduction	O
in	O
cardiac	B-ANAT
output	O
(	O
throughout	O
the	O
72	O
h	O
),	O
and	O
an	O
increase	O
in	O
pulmonary	B-ANAT
artery	I-ANAT
occlusion	O
pressure	O
(	O
at	O
3	O
and	O
6	O
h	O
).	O

Here	O
we	O
showed	O
that	O
the	O
major	O
surface	O
protein	O
S	O
of	O
a	O
porcine	O
CoV	O
(	O
transmissible	O
gastroenteritis	O
virus	O
)	O
is	O
not	O
transported	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
but	O
is	O
retained	O
intracellularly	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
indicated	O
that	O
a	O
tyrosine	O
-	O
dependent	O
signal	O
(	O
YXXI	O
)	O
in	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
is	O
essential	O
for	O
intracellular	B-ANAT
localization	O
of	O
the	O
S	O
protein	O
.	O

Single	O
-	O
stranded	O
RNA	O
was	O
cleaved	B-ANAT
less	O
specifically	O
and	O
effectively	O
,	O
suggesting	O
that	O
double	O
-	O
stranded	O
RNA	O
is	O
the	O
biologically	O
relevant	O
NendoU	O
substrate	O
.	O

The	O
initial	O
frontal	O
chest	B-ANAT
radiographs	O
of	O
these	O
201	O
patients	O
were	O
assessed	O
in	O
a	O
blinded	O
fashion	O
by	O
3	O
radiologists	O
;	O
individual	O
findings	O
were	O
accepted	O
if	O
at	O
least	O
2	O
of	O
the	O
radiologists	O
concurred	O
.	O

Multivariate	O
analysis	O
showed	O
that	O
lung	B-ANAT
involvement	O
of	O
more	O
than	O
two	O
zones	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
=	O
7	O
.	O
0	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]:	O
2	O
.	O
7	O
to	O
17	O
.	O
9	O
),	O
older	O
age	O
(	O
OR	O
for	O
each	O
decade	O
of	O
life	O
=	O
1	O
.	O
5	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
1	O
to	O
2	O
.	O
0	O
),	O
and	O
shortness	O
of	O
breath	B-ANAT
on	O
admission	O
(	O
OR	O
=	O
2	O
.	O
8	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
1	O
to	O
7	O
.	O
4	O
)	O
were	O
independent	O
predictors	O
of	O
an	O
adverse	O
outcome	O
.	O

ABSTRACT	O
:	O
Although	O
murine	O
coronaviruses	O
naturally	O
infect	O
only	O
mice	O
,	O
several	O
virus	O
variants	O
derived	O
from	O
persistently	O
infected	O
murine	O
cell	B-ANAT
cultures	O
have	O
an	O
extended	O
host	O
range	O
.	O

However	O
,	O
renal	B-ANAT
biopsy	O
findings	O
were	O
normal	O
.	O

After	O
lung	B-ANAT
injury	O
,	O
the	O
results	O
of	O
effective	O
local	O
lung	B-ANAT
blood	B-ANAT
perfusion	O
index	O
(	O
including	O
upper	O
area	O
,	O
abdominal	B-ANAT
area	O
,	O
and	O
dorsal	O
area	O
)	O
under	O
right	B-ANAT
lung	I-ANAT
of	O
ARDS	O
rabbits	O
decreased	O
in	O
the	O
experimental	O
ARDS	O
groups	O
.	O

TITLE	O
:	O
Medium	O
-	O
term	O
results	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
acute	O
lung	B-ANAT
injury	O
after	O
lung	B-ANAT
transplantation	O
.	O

The	O
purposes	O
of	O
this	O
study	O
are	O
to	O
:	O
(	O
1	O
)	O
document	O
the	O
medium	O
-	O
term	O
survival	O
of	O
patients	O
treated	O
with	O
ECMO	O
;	O
and	O
(	O
2	O
)	O
assess	O
the	O
extent	O
of	O
recovery	O
of	O
their	O
pulmonary	B-ANAT
function	O
.	O

RESULTS	O
:	O
(	O
1	O
)	O
The	O
thermal	O
scanner	O
can	O
be	O
used	O
as	O
a	O
first	O
line	O
tool	O
for	O
the	O
mass	O
blind	O
screening	O
of	O
hyperthermia	O
,	O
(	O
2	O
)	O
the	O
readings	O
from	O
the	O
scanner	O
suggest	O
good	O
correlation	O
with	O
the	O
ear	B-ANAT
temperature	O
readings	O
,	O
(	O
3	O
)	O
an	O
imager	O
temperature	O
threshold	O
should	O
be	O
determined	O
by	O
the	O
environmental	O
factors	O
,	O
outdoor	O
condition	O
in	O
particular	O
,	O
the	O
physiological	O
site	O
offset	O
and	O
the	O
performance	O
characteristics	O
of	O
thermal	O
imager	O
to	O
warrant	O
the	O
most	O
accurate	O
and	O
reliable	O
screening	O
operation	O
.	O

ABSTRACT	O
:	O
Viral	B-ANAT
envelope	I-ANAT
glycoproteins	O
are	O
oligomeric	O
and	O
the	O
quaternary	O
structure	O
is	O
critical	O
for	O
their	O
membrane	B-ANAT
fusion	O
activity	O
.	O

Furthermore	O
,	O
the	O
UV	O
-	O
inactivated	O
virion	B-ANAT
induced	O
regional	B-ANAT
lymph	I-ANAT
node	I-ANAT
T	B-ANAT
-	I-ANAT
cell	I-ANAT
proliferation	O
and	O
significant	O
levels	O
of	O
cytokine	O
production	O
(	O
IL	O
-	O
2	O
,	O
IL	O
-	O
4	O
,	O
IL	O
-	O
5	O
,	O
IFN	O
-	O
gamma	O
and	O
TNF	O
-	O
alpha	O
)	O
upon	O
restimulation	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
virion	B-ANAT
in	O
vitro	O
.	O

Bronchial	B-ANAT
wall	I-ANAT
thickening	O
on	O
HRCT	O
associated	O
with	O
cavitating	O
nodules	B-ANAT
is	O
suggestive	O
of	O
Wegner	O
granulomatosis	O
in	O
the	O
appropriate	O
clinical	O
setting	O
.	O

Caco	O
-	O
2	O
and	O
CL	O
-	O
14	O
cell	B-ANAT
lines	I-ANAT
were	O
found	O
to	O
be	O
highly	O
permissive	O
to	O
SARS	O
-	O
CoV	O
,	O
due	O
to	O
the	O
presence	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
as	O
a	O
functional	O
receptor	O
.	O

We	O
developed	O
a	O
highly	O
sensitive	O
and	O
safe	O
neutralization	O
assay	O
using	O
the	O
SARS	O
-	O
CoV	O
pseudotyped	O
virus	O
and	O
used	O
this	O
assay	O
to	O
determine	O
the	O
titers	O
of	O
the	O
NAbs	O
in	O
serum	B-ANAT
samples	O
from	O
patients	O
with	O
SARS	O
.	O

We	O
found	O
that	O
85	O
.	O
9	O
%	O
of	O
serum	B-ANAT
samples	O
contained	O
NAbs	O
against	O
SARS	O
-	O
CoV	O
and	O
that	O
most	O
of	O
the	O
NAb	O
activities	O
could	O
be	O
attributed	O
to	O
immunoglobulin	O
G	O
.	O
The	O
NAbs	O
became	O
detectable	O
first	O
at	O
5	O
-	O
10	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
,	O
and	O
their	O
levels	O
peaked	O
at	O
20	O
-	O
30	O
days	O
and	O
then	O
were	O
sustained	O
for	O
>	O
150	O
days	O
.	O

The	O
serum	B-ANAT
samples	O
could	O
neutralize	O
the	O
pseudotype	O
particles	O
bearing	O
the	O
spike	O
glycoproteins	O
from	O
different	O
SARS	O
-	O
CoV	O
strains	O
,	O
suggesting	O
that	O
the	O
NAbs	O
to	O
SARS	O
-	O
CoV	O
were	O
broadly	O
reactive	O
.	O

Furthermore	O
,	O
APC	B-ANAT
reduced	O
the	O
spinal	B-ANAT
cord	I-ANAT
injury	O
induced	O
by	O
compression	O
-	O
trauma	O
or	O
ischemia	O
/	O
reperfusion	O
by	O
inhibiting	O
TNF	O
-	O
alpha	O
production	O
in	O
rats	O
,	O
suggesting	O
that	O
APC	B-ANAT
may	O
be	O
a	O
potential	O
therapeutic	O
agent	O
for	O
spinal	B-ANAT
cord	I-ANAT
injury	O
in	O
which	O
only	O
limited	O
therapeutic	O
measures	O
are	O
currently	O
available	O
.	O

TITLE	O
:	O
Low	O
stability	O
of	O
nucleocapsid	B-ANAT
protein	O
in	O
SARS	O
virus	O
.	O

All	O
sera	B-ANAT
tested	O
contained	O
Ab	O
to	O
cryptic	O
FAH	O
epitopes	O
according	O
with	O
results	O
from	O
western	O
-	O
blot	O
tests	O
,	O
whereas	O
ELISA	O
data	O
indicated	O
that	O
some	O
of	O
these	O
same	O
sera	B-ANAT
did	O
recognize	O
native	O
epitopes	O
of	O
the	O
autoantigen	O
(	O
autoAg	O
).	O

Thus	O
,	O
binding	O
of	O
autoAb	O
to	O
insolubilized	O
FAH	O
could	O
be	O
inhibited	O
by	O
MHV	O
depending	O
on	O
the	O
mouse	O
serum	B-ANAT
or	O
the	O
experimental	O
protocol	O
used	O
.	O

A	O
72	O
-	O
year	O
-	O
old	O
African	O
American	O
man	O
developed	O
an	O
acute	O
confusional	O
state	O
(	O
ACS	O
)	O
one	O
month	O
after	O
receiving	O
celecoxib	O
for	O
osteoarthritis	O
of	O
his	O
knee	B-ANAT
joints	I-ANAT
.	O

His	O
symptoms	O
improved	O
substantially	O
,	O
and	O
serum	B-ANAT
methemoglobin	O
levels	O
decreased	O
to	O
0	O
.	O
7	O
%	O
after	O
the	O
initiation	O
of	O
methylene	O
blue	O
therapy	O
.	O

The	O
S	O
protein	O
is	O
a	O
type	O
I	O
transmembrane	B-ANAT
protein	O
that	O
is	O
very	O
large	O
compared	O
to	O
other	O
viral	O
fusion	O
proteins	O
,	O
and	O
all	O
except	O
a	O
short	O
carboxy	O
-	O
terminal	O
segment	O
of	O
the	O
S	O
molecule	O
constitutes	O
the	O
ectodomain	O
.	O

We	O
have	O
genetically	O
dissected	O
these	O
domains	O
in	O
the	O
MHV	O
S	O
protein	O
to	O
localize	O
the	O
determinants	O
of	O
S	O
incorporation	O
into	O
virions	B-ANAT
.	O

Our	O
results	O
establish	O
that	O
assembly	O
competence	O
maps	O
to	O
the	O
endodomain	O
of	O
S	O
,	O
which	O
was	O
shown	O
to	O
be	O
sufficient	O
to	O
target	O
a	O
heterologous	O
integral	O
membrane	B-ANAT
protein	O
for	O
incorporation	O
into	O
MHV	O
virions	B-ANAT
.	O

In	O
this	O
report	O
,	O
we	O
generated	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
predicted	O
replicase	O
protein	O
and	O
used	O
the	O
antibodies	O
to	O
identify	O
and	O
characterize	O
12	O
of	O
the	O
16	O
predicted	O
mature	O
replicase	O
proteins	O
(	O
nsp1	O
,	O
nsp2	O
,	O
nsp3	O
,	O
nsp4	O
,	O
nsp5	O
,	O
nsp8	O
,	O
nsp9	O
,	O
nsp12	O
,	O
nsp13	O
,	O
nsp14	O
,	O
nsp15	O
,	O
and	O
nsp16	O
)	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
.	O

Virus	O
was	O
recovered	O
from	O
liver	B-ANAT
and	O
spinal	B-ANAT
cord	I-ANAT
tissues	B-ANAT
of	O
+/+	O
mice	O
but	O
not	O
of	O
-/-	O
mice	O
.	O

These	O
results	O
indicate	O
that	O
CEACAM1a	O
is	O
the	O
sole	B-ANAT
receptor	O
for	O
MHV	O
-	O
A59	O
in	O
both	O
liver	B-ANAT
and	O
brain	B-ANAT
and	O
that	O
its	O
deletion	O
from	O
the	O
mouse	O
renders	O
the	O
mouse	O
completely	O
resistant	O
to	O
infection	O
by	O
this	O
virus	O
.	O

But	O
glucocorticoids	O
had	O
some	O
effect	O
on	O
SARS	O
patients	O
recovery	O
of	O
cellular	B-ANAT
immune	O
function	O
,	O
i	O
.	O
e	O
.,	O
it	O
delayed	O
the	O
recovery	O
by	O
about	O
6	O
days	O
.	O

The	O
damage	O
of	O
several	O
organs	B-ANAT
was	O
common	O
,	O
including	O
the	O
elevated	O
ALT	O
or	O
AST	O
in	O
20	O
patients	O
(	O
37	O
.	O
7	O
%),	O
elevated	O
BUN	O
or	O
SCR	O
in	O
6	O
patients	O
(	O
11	O
.	O
3	O
%)	O
and	O
elevated	O
LDH	O
or	O
CK	O
or	O
HBDH	O
in	O
23	O
patients	O
(	O
43	O
.	O
4	O
%).	O

Their	O
corpuscles	O
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
were	O
tested	O
every	O
two	O
days	O
,	O
and	O
the	O
results	O
were	O
analyzed	O
.	O

Low	O
counts	O
of	O
leukocytes	B-ANAT
,	O
lymphocytes	B-ANAT
and	O
platelets	B-ANAT
were	O
common	O
among	O
patients	O
in	O
the	O
early	O
stage	O
of	O
SARS	O
.	O

CONCLUSIONS	O
:	O
Low	O
counts	O
of	O
leukocytes	B-ANAT
,	O
lymphocytes	B-ANAT
and	O
platelets	B-ANAT
were	O
common	O
among	O
patients	O
in	O
the	O
early	O
stage	O
of	O
SARS	O
.	O

Pathological	O
features	O
of	O
2	O
cases	O
of	O
full	O
autopsy	O
and	O
4	O
cases	O
of	O
needle	O
biopsy	O
tissue	B-ANAT
samples	O
from	O
the	O
patients	O
who	O
died	O
from	O
SARS	O
were	O
studied	O
by	O
light	O
and	O
electron	O
microscopy	O
.	O

Among	O
6	O
cases	O
,	O
2	O
biopsy	O
cases	O
presented	O
early	O
pulmonary	B-ANAT
fibrosis	O
and	O
alveolar	B-ANAT
organization	O
.	O

However	O
,	O
spleen	B-ANAT
and	O
bone	B-ANAT
marrow	I-ANAT
biopsy	O
tissue	B-ANAT
samples	O
from	O
4	O
dead	O
SARS	O
cases	O
whose	O
clinical	O
course	O
lasted	O
from	O
21	O
to	O
40	O
days	O
presented	O
repairing	O
changes	O
.	O

Histologically	O
,	O
the	O
pulmonary	B-ANAT
changes	O
could	O
be	O
divided	O
into	O
acute	O
inflammatory	O
exudative	O
,	O
terminal	O
bronchiolar	B-ANAT
and	O
alveolar	B-ANAT
desquamative	O
and	O
proliferative	O
repair	O
stages	O
or	O
types	O
during	O
the	O
pathological	O
process	O
of	O
SARS	O
.	O

This	O
structure	O
shares	O
significant	O
similarity	O
with	O
the	O
fusion	O
core	O
structure	O
of	O
mouse	O
hepatitis	O
virus	O
spike	O
protein	O
and	O
other	O
viral	O
fusion	O
proteins	O
,	O
suggesting	O
a	O
conserved	O
mechanism	O
of	O
membrane	B-ANAT
fusion	O
.	O

These	O
results	O
suggested	O
that	O
weak	O
activation	O
of	O
Akt	O
cannot	O
prevent	O
apoptosis	O
induced	O
by	O
SARS	O
-	O
CoV	O
infection	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

Inflammatory	O
cytokines	O
(	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
),	O
protein	O
concentration	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
,	O
lung	B-ANAT
wet	O
-	O
to	O
-	O
dry	O
weight	O
ratio	O
,	O
histology	O
,	O
immunohistochemistry	O
,	O
and	O
AQP1	O
Western	O
blot	O
were	O
performed	O
.	O

In	O
this	O
study	O
,	O
we	O
employed	O
mammalian	O
two	O
-	O
hybrid	O
system	O
to	O
investigate	O
possible	O
interactions	O
between	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
proteins	O
.	O

TITLE	O
:	O
Mechanisms	O
of	O
host	O
defense	O
following	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
pulmonary	B-ANAT
infection	O
of	O
mice	O
.	O

In	O
this	O
species	O
,	O
proinflammatory	O
chemokines	O
may	O
coordinate	O
a	O
rapid	O
and	O
highly	O
effective	O
innate	O
antiviral	O
response	O
in	O
the	O
lung	B-ANAT
,	O
but	O
NK	B-ANAT
cells	I-ANAT
and	O
adaptive	O
cellular	B-ANAT
immunity	O
are	O
not	O
required	O
for	O
viral	O
clearance	O
.	O

Swab	O
samples	O
of	O
respiratory	O
secretions	B-ANAT
from	O
each	O
of	O
the	O
4	O
patients	O
examined	O
tested	O
positive	O
by	O
RT	O
-	O
PCR	O
,	O
as	O
were	O
12	O
of	O
43	O
swabs	O
from	O
patient	O
rooms	O
and	O
10	O
of	O
47	O
swabs	O
from	O
other	O
parts	O
of	O
the	O
hospital	O
,	O
including	O
the	O
computer	O
mouses	O
at	O
2	O
nursing	O
stations	O
and	O
the	O
handrail	O
of	O
the	O
public	O
elevator	O
.	O

TITLE	O
:	O
Chemokine	O
-	O
like	O
factor	O
1	O
,	O
a	O
novel	O
cytokine	O
,	O
contributes	O
to	O
airway	B-ANAT
damage	O
,	O
remodeling	O
and	O
pulmonary	B-ANAT
fibrosis	O
.	O

We	O
questioned	O
whether	O
CKLF1	O
could	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
inflammation	O
and	O
proliferation	O
in	O
the	O
lung	B-ANAT
.	O

These	O
changes	O
included	O
peribronchial	O
leukocyte	B-ANAT
infiltration	O
,	O
epithelial	O
shedding	O
,	O
collagen	B-ANAT
deposition	O
,	O
proliferation	O
of	O
bronchial	B-ANAT
smooth	B-ANAT
muscle	I-ANAT
cells	I-ANAT
and	O
fibrosis	O
of	O
the	O
lung	B-ANAT
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
progression	O
in	O
morphologic	O
changes	O
of	O
lungs	B-ANAT
in	O
SARS	O
patients	O
.	O

Histochemical	O
study	O
for	O
VG	O
,	O
Masson	O
,	O
reticulin	O
,	O
orcein	O
,	O
PAS	B-ANAT
,	O
sirius	O
red	O
stains	O
and	O
immunohistochemical	O
study	O
for	O
vimentin	B-ANAT
,	O
desmin	B-ANAT
,	O
smooth	B-ANAT
muscle	I-ANAT
actin	O
,	O
HHF	O
-	O
35	O
,	O
CD34	O
,	O
F8	O
,	O
collagen	B-ANAT
types	O
I	O
and	O
III	O
were	O
also	O
performed	O
.	O

According	O
to	O
the	O
morphologic	O
changes	O
,	O
lung	B-ANAT
lesions	O
in	O
SARS	O
were	O
subcategorized	O
into	O
3	O
phases	O
:	O
acute	O
exudative	O
inflammation	O
,	O
fibrous	O
proliferation	O
and	O
the	O
final	O
fibrotic	O
stage	O
.	O

There	O
was	O
also	O
evidence	O
of	O
organizing	O
pneumonia	O
,	O
with	O
an	O
increase	O
in	O
reticulin	O
fiber	B-ANAT
formation	O
,	O
which	O
had	O
a	O
glomeruloid	O
appearance	O
on	O
special	O
stain	O
.	O

RESULTS	O
:	O
According	O
to	O
the	O
morphologic	O
changes	O
,	O
lung	B-ANAT
lesions	O
in	O
SARS	O
were	O
subcategorized	O
into	O
3	O
phases	O
:	O
acute	O
exudative	O
inflammation	O
,	O
fibrous	O
proliferation	O
and	O
the	O
final	O
fibrotic	O
stage	O
.	O

Serum	B-ANAT
immunological	O
examination	O
had	O
been	O
conducted	O
in	O
37	O
of	O
the	O
persons	O
in	O
the	O
TCM	O
group	O
.	O

While	O
the	O
expressed	O
full	O
-	O
length	O
S	O
glycoprotein	O
was	O
exclusively	O
cell	B-ANAT
associated	I-ANAT
,	O
a	O
truncation	O
of	O
S	O
by	O
excluding	O
the	O
C	O
-	O
terminal	O
transmembrane	B-ANAT
and	O
cytoplasmic	B-ANAT
tail	I-ANAT
domains	O
resulted	O
in	O
the	O
expression	O
of	O
an	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	O
localized	O
glycoprotein	O
(	O
gp160	O
)	O
as	O
well	O
as	O
a	O
Golgi	B-ANAT
-	O
specific	O
form	O
(	O
gp170	O
)	O
which	O
was	O
ultimately	O
secreted	O
into	O
the	O
cell	B-ANAT
culture	O
medium	O
.	O

The	O
intracellular	B-ANAT
form	O
of	O
the	O
C	O
-	O
terminally	O
truncated	O
S	O
protein	O
(	O
but	O
not	O
the	O
secreted	O
form	O
)	O
also	O
forms	O
trimers	O
,	O
but	O
with	O
much	O
less	O
efficiency	O
than	O
full	O
-	O
length	O
S	O
.	O
Deglycosylation	O
of	O
the	O
full	O
-	O
length	O
homotrimer	O
with	O
peptide	O
N	O
-	O
glycosidase	O
-	O
F	O
under	O
native	O
conditions	O
abolished	O
recognition	O
of	O
the	O
protein	O
by	O
virus	O
-	O
neutralizing	O
antisera	O
raised	O
against	O
purified	O
virions	B-ANAT
,	O
suggesting	O
the	O
importance	O
of	O
the	O
carbohydrate	O
in	O
the	O
correct	O
folding	O
of	O
the	O
S	O
protein	O
.	O

The	O
functions	O
are	O
unknown	O
for	O
most	O
of	O
these	O
nonstructural	O
proteins	O
,	O
including	O
p28	B-ANAT
,	O
which	O
is	O
encoded	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
MHV	O
genome	O
.	O

Transient	O
expression	O
of	O
cloned	O
p28	B-ANAT
in	O
several	O
different	O
cultured	B-ANAT
cells	I-ANAT
inhibited	O
cell	B-ANAT
growth	O
,	O
indicating	O
that	O
p28	B-ANAT
expression	O
suppressed	O
cell	B-ANAT
proliferation	O
.	O

Expression	O
of	O
p28	B-ANAT
did	O
not	O
alter	O
the	O
amount	O
of	O
p53	O
transcripts	O
yet	O
increased	O
the	O
amount	O
of	O
p21	O
(	O
Cip1	O
)	O
transcripts	O
,	O
suggesting	O
that	O
p28	B-ANAT
expression	O
increased	O
p53	O
stability	O
and	O
that	O
p21	O
(	O
Cip1	O
)	O
was	O
transcriptionally	O
activated	O
in	O
a	O
p53	O
-	O
dependent	O
manner	O
.	O

ABSTRACT	O
:	O
This	O
study	O
analyzed	O
the	O
effect	O
of	O
phasic	O
tracheal	O
gas	O
insufflation	O
at	O
mid	O
-	O
to	O
end	O
-	O
expiration	O
in	O
patients	O
with	O
severe	O
head	B-ANAT
trauma	O
and	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Diagnosis	O
,	O
initiated	O
on	O
the	O
results	O
of	O
questioning	O
,	O
must	O
be	O
supported	O
by	O
immunological	O
tests	O
whenever	O
possible	O
and	O
notably	O
on	O
functional	O
respiratory	O
explorations	O
(	O
longitudinal	O
monitoring	O
of	O
peak	O
flow	O
or	O
spirometry	O
,	O
repeated	O
measurements	O
of	O
non	O
-	O
specific	O
bronchial	B-ANAT
reactivity	O
),	O
which	O
objectifies	O
significant	O
variations	O
in	O
the	O
parameters	O
measured	O
and	O
related	O
to	O
professional	O
activity	O
.	O

TITLE	O
:	O
[	O
Factors	O
of	O
avascular	O
necrosis	O
of	O
femoral	B-ANAT
head	I-ANAT
and	O
osteoporosis	O
in	O
SARS	O
patients	O
'	O
convalescence	O
].	O

Two	O
patients	O
were	O
suffering	O
from	O
osteoporosis	O
and	O
30	O
patients	O
were	O
with	O
bone	B-ANAT
density	O
decrement	O
.	O

The	O
influencing	O
factors	O
of	O
the	O
bone	B-ANAT
fabric	O
and	O
flexibility	O
included	O
the	O
use	O
and	O
length	O
of	O
ictus	O
therapy	O
.	O

The	O
incidence	O
rates	O
of	O
avascular	O
necrosis	O
of	O
femoral	B-ANAT
head	I-ANAT
and	O
of	O
osteoporosis	O
were	O
higher	O
in	O
convalescent	O
SARS	O
patients	O
than	O
in	O
general	O
population	O
.	O

Our	O
results	O
showed	O
that	O
the	O
antibodies	O
could	O
efficiently	O
and	O
specifically	O
bind	O
to	O
their	O
corresponding	O
proteins	O
from	O
E	O
.	O
coli	O
expressed	O
or	O
lysate	O
of	O
SARS	O
-	O
CoV	O
infected	O
Vero	O
-	O
E6	O
cells	B-ANAT
by	O
Western	O
blot	O
analysis	O
.	O

The	O
data	O
demonstrated	O
that	O
the	O
cleavage	O
of	O
S	O
protein	O
was	O
observed	O
in	O
the	O
lysate	O
,	O
indicating	O
that	O
proteolytic	O
processing	O
of	O
S	O
protein	O
is	O
present	O
in	O
host	O
cells	B-ANAT
.	O

The	O
coronavirus	O
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
)	O
utilizes	O
the	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
to	O
infect	O
cells	B-ANAT
.	O

This	O
study	O
tests	O
the	O
hypothesis	O
that	O
standard	O
ARDS	O
criteria	O
applied	O
to	O
the	O
trauma	O
population	O
will	O
capture	O
widely	O
disparate	O
forms	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
are	O
too	O
nonspecific	O
to	O
identify	O
a	O
population	O
at	O
risk	O
for	O
prolonged	O
respiratory	O
failure	O
and	O
associated	O
complications	O
.	O

ABSTRACT	O
:	O
Heat	O
stroke	O
(	O
HS	O
)	O
is	O
a	O
serious	O
and	O
potentially	O
life	O
-	O
threatening	O
condition	O
defined	O
as	O
a	O
core	O
body	B-ANAT
temperature	O
>	O
40	O
.	O
6	O
degrees	O
C	O
.	O
Two	O
forms	O
of	O
HS	O
are	O
recognized	O
,	O
classic	O
heat	O
stroke	O
,	O
usually	O
occurring	O
in	O
very	O
young	O
or	O
elderly	O
persons	O
,	O
and	O
exertional	O
heat	O
stroke	O
,	O
more	O
common	O
in	O
physically	O
active	O
individuals	O
.	O

With	O
the	O
above	O
RM	O
algorithm	O
,	O
the	O
need	O
in	O
sedatives	O
,	O
muscle	B-ANAT
relaxants	O
and	O
vasopressins	O
went	O
down	O
from	O
day	O
2	O
.	O

Surprisingly	O
,	O
canine	O
adenovirus	O
was	O
not	O
detected	O
in	O
samples	O
from	O
this	O
population	O
,	O
whereas	O
19	O
.	O
4	O
%	O
of	O
tracheal	O
and	O
10	O
.	O
4	O
%	O
of	O
lung	B-ANAT
samples	O
were	O
positive	O
for	O
CPIV	O
and	O
12	O
.	O
8	O
%	O
of	O
tracheal	O
and	O
9	O
.	O
6	O
%	O
of	O
lung	B-ANAT
samples	O
were	O
positive	O
for	O
CHV	O
.	O

In	O
addition	O
,	O
immunofluorescence	O
and	O
FACS	O
analysis	O
confirmed	O
the	O
cell	B-ANAT
surface	I-ANAT
expression	O
of	O
the	O
S	O
protein	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
VLPs	B-ANAT
are	O
morphological	O
mimics	O
of	O
virion	B-ANAT
particles	O
.	O

The	O
term	O
is	O
strictly	O
related	O
to	O
plague	O
and	O
dates	O
back	B-ANAT
to	O
1377	O
,	O
when	O
the	O
Rector	O
of	O
the	O
seaport	O
of	O
Ragusa	O
(	O
then	O
belonging	O
to	O
the	O
Venetian	O
Republic	O
)	O
officially	O
issued	O
a	O
30	O
-	O
day	O
isolation	O
period	O
for	O
ships	O
,	O
that	O
became	O
40	O
days	O
for	O
land	B-ANAT
travellers	O
.	O

ABSTRACT	O
:	O
Upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
(	O
ie	O
,	O
""""	O
the	O
common	O
cold	O
""")"	O
have	O
several	O
hundred	O
causes	O
,	O
the	O
most	O
common	O
of	O
which	O
include	O
rhino	O
-	O
virus	O
,	O
coronavirus	O
,	O
and	O
respiratory	O
syncytial	O
virus	O
.	O

To	O
facilitate	O
the	O
solution	O
of	O
the	O
crystal	B-ANAT
structure	O
of	O
this	O
fusion	O
core	O
,	O
we	O
deployed	O
an	O
Escherichia	O
coli	O
in	O
vitro	O
expression	O
system	O
to	O
express	O
the	O
HR1	O
and	O
HR2	O
regions	O
linked	O
together	O
by	O
a	O
flexible	O
linker	O
as	O
a	O
single	O
chain	O
(	O
named	O
2	O
-	O
helix	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
peptide	O
-	O
based	O
enzyme	O
immunoassay	O
for	O
anti	O
-	O
SARS	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
.	O

ABSTRACT	O
:	O
High	O
throughput	O
assays	O
for	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
detection	O
are	O
need	O
for	O
large	O
-	O
scale	O
epidemiologic	O
studies	O
.	O

Our	O
aim	O
was	O
to	O
assess	O
the	O
occurrence	O
,	O
aetiology	O
,	O
and	O
clinical	O
significance	O
of	O
a	O
platelet	B-ANAT
count	O
greater	O
than	O
600	O
x	O
10	O
(	O
3	O
)/	O
mm	O
(	O
3	O
)	O
in	O
trauma	O
patients	O
.	O

Three	O
venous	B-ANAT
thromboembolic	O
complications	O
occurred	O
in	O
the	O
ICU	O
(	O
1	O
.	O
7	O
%)	O
and	O
one	O
during	O
follow	O
-	O
up	O
.	O

The	O
blood	B-ANAT
glucose	O
grew	O
up	O
significantly	O
in	O
the	O
first	O
and	O
the	O
second	O
weeks	O
in	O
the	O
treatment	O
with	O
GCS	O
,	O
and	O
then	O
returned	O
to	O
normal	O
level	O
gradually	O
.	O

The	O
lowest	O
serum	B-ANAT
potassium	O
during	O
the	O
treatment	O
and	O
the	O
duration	O
of	O
hypokalemia	O
in	O
GCS	O
group	O
were	O
significantly	O
different	O
from	O
that	O
in	O
non	O
-	O
GCS	O
group	O
[(	O
3	O
.	O
66	O
+/-	O
0	O
.	O
50	O
)	O
mmol	O
/	O
L	O
vs	O
(	O
4	O
.	O
01	O
+/-	O
0	O
.	O
51	O
)	O
mmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
1	O
(	O
1	O
,	O
75	O
)	O
days	O
vs	O
1	O
(	O
1	O
,	O
9	O
)	O
days	O
,	O
P	O
<	O
0	O
.	O
05	O
,	O
respectively	O
].	O

Appropriate	O
low	O
dosage	O
of	O
GCS	O
(	O
MP	O
(	O
Initial	O
)	O
and	O
MP	O
(	O
Maximal	O
)	O
<	O
159	O
mg	O
/	O
d	O
,	O
MP	O
(	O
Cumulative	O
)<	O
2999	O
mg	O
)	O
causes	O
few	O
changes	O
of	O
blood	B-ANAT
glucose	O
,	O
serum	B-ANAT
potassium	O
,	O
and	O
blood	B-ANAT
calcium	O
.	O

ABSTRACT	O
:	O
The	O
ratio	O
of	O
PaO2	O
to	O
the	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
PaO2	O
/	O
FIO2	O
)	O
is	O
commonly	O
used	O
to	O
determine	O
the	O
severity	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
considered	O
an	O
important	O
therapeutic	O
target	O
for	O
controlling	O
cardiovascular	B-ANAT
diseases	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreaks	O
.	O

Recently	O
solved	O
high	O
-	O
resolution	O
crystal	B-ANAT
structures	O
of	O
the	O
apo	O
-	O
bound	O
and	O
inhibitor	O
-	O
bound	O
forms	O
of	O
ACE2	O
have	O
provided	O
the	O
basis	O
for	O
a	O
novel	O
molecular	O
docking	O
approach	O
in	O
an	O
attempt	O
to	O
identify	O
ACE2	O
inhibitors	O
and	O
compounds	O
that	O
block	O
SARS	O
coronavirus	O
spike	O
protein	O
-	O
mediated	O
cell	B-ANAT
fusion	O
.	O

Serum	B-ANAT
anti	O
-	O
SARS	O
IgG	O
was	O
checked	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
at	O
the	O
convalescent	O
phase	O
.	O

In	O
contrast	O
to	O
the	O
high	O
positive	O
rate	O
of	O
feces	B-ANAT
RT	O
-	O
PCR	O
(	O
97	O
%)	O
in	O
Amoy	O
Gardens	O
,	O
our	O
positive	O
rate	O
in	O
rectal	B-ANAT
swab	I-ANAT
RT	O
-	O
PCT	O
(	O
0	O
%)	O
was	O
significantly	O
lower	O
(	O
P	O
=	O
0	O
.	O
00000002	O
).	O

In	O
contrast	O
to	O
the	O
high	O
positive	O
rate	O
of	O
feces	B-ANAT
RT	O
-	O
PCR	O
(	O
97	O
%)	O
in	O
Amoy	O
Gardens	O
,	O
our	O
positive	O
rate	O
in	O
rectal	B-ANAT
swab	I-ANAT
RT	O
-	O
PCT	O
(	O
0	O
%)	O
was	O
significantly	O
lower	O
(	O
P	O
=	O
0	O
.	O
00000002	O
).	O

AEP	O
must	O
be	O
included	O
in	O
the	O
differential	O
diagnosis	O
of	O
community	O
adquired	O
pneumonia	O
,	O
as	O
well	O
as	O
a	O
cause	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
its	O
diagnosis	O
is	O
suggested	O
by	O
the	O
presence	O
of	O
eosinophilic	O
alveolitis	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
.	O

TITLE	O
:	O
Effects	O
of	O
early	O
corticosteroid	O
treatment	O
on	O
plasma	B-ANAT
SARS	O
-	O
associated	O
Coronavirus	O
RNA	O
concentrations	O
in	O
adult	O
patients	O
.	O

To	O
compare	O
the	O
plasma	B-ANAT
SARS	O
-	O
CoV	O
RNA	O
concentrations	O
in	O
ribavirin	O
-	O
treated	O
patients	O
who	O
received	O
early	O
hydrocortisone	O
therapy	O
with	O
those	O
who	O
received	O
placebo	O
.	O

Consequently	O
,	O
we	O
tested	O
for	O
the	O
reactivity	O
of	O
these	O
42	O
peptides	O
to	O
patients	O
'	O
sera	B-ANAT
(	O
n	O
=	O
45	O
)	O
at	O
6	O
-	O
month	O
post	O
-	O
infection	O
.	O

TITLE	O
:	O
Leukocyte	B-ANAT
antibodies	O
and	O
biologically	O
active	O
mediators	O
in	O
the	O
pathogenesis	O
of	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
.	O

Clones	O
of	O
transduced	O
cells	B-ANAT
that	O
bound	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
were	O
inoculated	O
with	O
SARS	O
-	O
CoV	O
,	O
and	O
increases	O
in	O
subgenomic	O
viral	O
RNA	O
from	O
1	O
-	O
16	O
h	O
or	O
more	O
were	O
detected	O
by	O
multiplex	O
RT	O
-	O
PCR	O
in	O
four	O
cloned	O
cell	B-ANAT
lines	I-ANAT
.	O

TITLE	O
:	O
In	O
vitro	O
biochemical	O
and	O
thermodynamic	O
characterization	O
of	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
.	O

The	O
diffraction	O
pattern	O
of	O
the	O
crystal	B-ANAT
extends	O
to	O
2	O
.	O
8	O
A	O
resolution	O
at	O
100	O
K	O
in	O
-	O
house	O
.	O

Conjunctival	O
,	O
throat	B-ANAT
,	O
stool	B-ANAT
,	O
and	O
urine	B-ANAT
specimens	O
were	O
collected	O
weekly	O
from	O
64	O
patients	O
and	O
tested	O
for	O
SARS	O
-	O
CoV	O
RNA	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
;	O
serum	B-ANAT
samples	O
were	O
collected	O
weekly	O
and	O
tested	O
for	O
SARS	O
-	O
CoV	O
antibody	O
with	O
indirect	O
enzyme	O
immunoassay	O
and	O
immunofluorescence	O
assay	O
.	O

Five	O
patients	O
had	O
positive	O
stool	B-ANAT
samples	O
,	O
collected	O
in	O
weeks	O
5	O
-	O
9	O
.	O

Two	O
patients	O
seroconverted	O
in	O
weeks	O
7	O
and	O
8	O
;	O
the	O
others	O
were	O
seropositive	O
at	O
the	O
first	O
serum	B-ANAT
sample	I-ANAT
collection	O
.	O

The	O
median	O
(	O
range	O
)	O
duration	O
of	O
virus	O
excretion	O
in	O
sputa	O
and	O
stools	B-ANAT
was	O
21	O
(	O
14	O
-	O
52	O
)	O
and	O
27	O
(	O
16	O
-	O
126	O
)	O
days	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
is	O
an	O
alternate	O
mechanism	O
of	O
translation	O
used	O
by	O
coronavirus	O
to	O
synthesize	O
replication	O
proteins	O
encoded	O
by	O
two	O
overlapping	O
open	O
reading	O
frames	O
.	O

For	O
some	O
coronaviruses	O
,	O
the	O
mRNA	O
cis	O
-	O
acting	O
stimulatory	O
structures	O
involved	O
in	O
this	O
process	O
have	O
been	O
characterized	O
,	O
but	O
their	O
precise	O
contribution	O
to	O
ribosomal	B-ANAT
frameshifting	O
is	O
not	O
completely	O
understood	O
.	O

This	O
review	O
describes	O
the	O
mRNA	O
motifs	O
involved	O
in	O
programmed	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
in	O
this	O
virus	O
.	O

Immunized	O
ferrets	O
developed	O
a	O
more	O
rapid	O
and	O
vigorous	O
neutralizing	O
antibody	O
response	O
than	O
control	O
animals	O
after	O
challenge	O
with	O
SARS	O
-	O
CoV	O
;	O
however	O
,	O
they	O
also	O
exhibited	O
strong	O
inflammatory	O
responses	O
in	O
liver	B-ANAT
tissue	I-ANAT
.	O

TITLE	O
:	O
Radiological	O
and	O
pulmonary	B-ANAT
function	O
outcomes	O
of	O
children	O
with	O
SARS	O
.	O

The	O
paucity	O
in	O
T	B-ANAT
cell	I-ANAT
accumulation	O
within	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
of	O
MHV	O
-	O
infected	O
CCR2	O
(-/-)	O
mice	O
was	O
not	O
the	O
result	O
of	O
either	O
a	O
deficiency	O
in	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cell	I-ANAT
(	O
APC	B-ANAT
)	O
accumulation	O
within	O
draining	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
(	O
CLN	O
)	O
or	O
the	O
generation	O
of	O
virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
within	O
this	O
compartment	B-ANAT
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	O
(	O
CCoV	O
)	O
is	O
one	O
of	O
the	O
most	O
important	O
viral	O
agents	O
affecting	O
the	O
gastrointestinal	B-ANAT
system	I-ANAT
of	O
dogs	O
.	O

Fourteen	O
(	O
15	O
.	O
5	O
%)	O
faeces	B-ANAT
were	O
positive	O
for	O
CCoV	O
RNA	O
,	O
five	O
of	O
which	O
were	O
characterized	O
as	O
CCoV	O
type	O
I	O
.	O
The	O
widespread	O
CCoV	O
infection	O
in	O
the	O
Turkish	O
dog	O
population	O
may	O
be	O
attributed	O
as	O
an	O
important	O
cause	O
of	O
viral	O
diarrhoea	O
in	O
dogs	O
.	O

CONCLUSIONS	O
:	O
Integrated	O
traditional	O
Chinese	O
and	O
Western	O
medicines	O
has	O
some	O
positive	O
effects	O
on	O
lung	B-ANAT
infiltrate	O
absorption	O
in	O
SARS	O
patients	O
,	O
and	O
is	O
recommended	O
as	O
an	O
adjunct	O
treatment	O
for	O
SARS	O
.	O

TITLE	O
:	O
Tyrosine	O
dephosphorylation	O
of	O
STAT3	O
in	O
SARS	O
coronavirus	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
.	O

Coronaviruses	O
including	O
SARS	O
-	O
CoV	O
encode	O
an	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
,	O
a	O
small	O
,	O
hydrophobic	O
membrane	B-ANAT
protein	O
.	O

TITLE	O
:	O
Differential	O
regulation	O
of	O
primary	O
and	O
secondary	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

Differential	O
susceptibilities	O
of	O
primary	O
and	O
recall	O
CD8	O
+	O
T	B-ANAT
cell	I-ANAT
responses	O
to	O
the	O
inhibitory	O
CNS	B-ANAT
environment	O
were	O
monitored	O
in	O
naive	O
and	O
CD8	O
+	O
T	B-ANAT
cell	I-ANAT
-	O
immune	O
mice	O
challenged	O
with	O
a	O
neurotropic	O
coronavirus	O
.	O

CNS	B-ANAT
-	O
derived	O
secondary	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
exhibited	O
increased	O
cytolytic	O
activity	O
and	O
IFN	O
-	O
gamma	O
expression	O
per	O
cell	B-ANAT
compared	O
with	O
primary	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

The	O
test	O
was	O
optimized	O
for	O
use	O
with	O
intestines	B-ANAT
/	O
feces	B-ANAT
from	O
naturally	O
infected	O
turkeys	O
.	O

The	O
improved	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assays	O
are	O
critical	O
in	O
the	O
early	O
diagnosis	O
of	O
SARS	O
,	O
with	O
sensitivity	O
approaching	O
80	O
%	O
in	O
the	O
first	O
3	O
days	O
of	O
illness	O
when	O
performed	O
on	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
the	O
preferred	O
specimens	O
.	O

A	O
diagnosis	O
of	O
SARS	O
was	O
based	O
on	O
the	O
demonstration	O
of	O
serum	B-ANAT
coronavirus	O
antibodies	O
.	O

TITLE	O
:	O
High	O
-	O
yield	O
expression	O
of	O
recombinant	O
SARS	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
in	O
methylotrophic	O
yeast	O
Pichia	O
pastoris	O
.	O

The	O
rSCoVN	O
protein	O
had	O
a	O
high	O
specificity	O
against	O
mouse	O
-	O
anti	O
-	O
SARS	O
-	O
CoVN	O
-	O
mAb	O
and	O
SARS	O
positive	O
sera	B-ANAT
,	O
but	O
had	O
no	O
cross	O
-	O
reaction	O
with	O
normal	O
human	O
serum	B-ANAT
.	O

The	O
main	O
dysfunctioning	O
organs	B-ANAT
were	O
the	O
lung	B-ANAT
(	O
76	O
.	O
9x	O
),	O
the	O
immune	B-ANAT
system	I-ANAT
(	O
92	O
.	O
3x	O
),	O
the	O
cardiovascular	B-ANAT
system	I-ANAT
(	O
30	O
.	O
8x	O
),	O
the	O
blood	B-ANAT
system	O
(	O
61	O
.	O
5x	O
),	O
the	O
liver	B-ANAT
(	O
38	O
.	O
5x	O
),	O
and	O
the	O
kidney	B-ANAT
(	O
53	O
.	O
8x	O
).	O

Above	O
90	O
.	O
00	O
%	O
patients	O
had	O
normal	O
or	O
low	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
WBC	B-ANAT
)	O
count	O
on	O
the	O
first	O
day	O
.	O

CONCLUSIONS	O
:	O
SARS	O
cases	O
may	O
develop	O
leucocytosis	O
,	O
low	O
lymphocyte	B-ANAT
count	O
,	O
low	O
platelet	B-ANAT
count	O
,	O
low	O
hemoglobin	O
level	O
and	O
abnormal	O
liver	B-ANAT
function	O
.	O

TITLE	O
:	O
[	O
Comparison	O
of	O
serum	B-ANAT
biochemical	O
features	O
between	O
SARS	O
and	O
other	O
viral	O
pneumonias	O
].	O

Special	O
RNA	O
fragment	O
of	O
SARS	O
virus	O
has	O
not	O
been	O
detected	O
in	O
gargling	O
fluid	O
and	O
serum	B-ANAT
of	O
SARS	O
convalescents	O
and	O
medical	O
staff	O
.	O

The	O
positions	O
of	O
bands	O
corresponding	O
to	O
some	O
of	O
the	O
structural	O
proteins	O
immobilized	O
on	O
the	O
membrane	B-ANAT
were	O
then	O
located	O
and	O
verified	O
with	O
mouse	O
or	O
rabbit	O
antisera	O
specific	O
to	O
the	O
respective	O
proteins	O
.	O

To	O
investigate	O
the	O
functional	O
significance	O
of	O
SYNCRIP	O
in	O
MHV	O
replication	O
,	O
we	O
expressed	O
a	O
full	O
-	O
length	O
or	O
a	O
C	O
-	O
terminally	O
truncated	O
form	O
of	O
SYNCRIP	O
in	O
mammalian	O
cells	B-ANAT
expressing	O
the	O
MHV	O
receptor	O
.	O

ARDS	O
can	O
cause	O
significant	O
long	O
-	O
term	O
,	O
brain	B-ANAT
-	O
related	O
morbidity	O
manifest	O
by	O
neurocognitive	O
impairments	O
and	O
decreased	O
quality	O
of	O
life	O
.	O

The	O
role	O
of	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
and	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
in	O
ARDS	O
is	O
uncertain	O
.	O

The	O
need	O
for	O
mechanical	O
ventilation	O
was	O
associated	O
with	O
bilateral	O
lung	B-ANAT
involvement	O
on	O
the	O
initial	O
chest	B-ANAT
radiograph	O
and	O
higher	O
peak	O
levels	O
of	O
LDH	O
and	O
CRP	O
.	O

ABSTRACT	O
:	O
Following	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
outbreak	O
,	O
remote	O
-	O
sensing	O
infrared	O
thermography	O
(	O
IRT	O
)	O
has	O
been	O
advocated	O
as	O
a	O
possible	O
means	O
of	O
screening	O
for	O
fever	O
in	O
travelers	O
at	O
airports	O
and	O
border	B-ANAT
crossings	O
,	O
but	O
its	O
applicability	O
has	O
not	O
been	O
established	O
.	O

IRT	O
readings	O
from	O
the	O
side	O
of	O
the	O
face	B-ANAT
,	O
especially	O
from	O
the	O
ear	B-ANAT
at	O
0	O
.	O
5	O
m	O
,	O
yielded	O
the	O
most	O
reliable	O
,	O
precise	O
and	O
consistent	O
estimates	O
of	O
conventionally	O
determined	O
body	B-ANAT
temperatures	O
.	O

Our	O
results	O
have	O
important	O
implications	O
for	O
walk	O
-	O
through	O
IRT	O
scanning	O
/	O
screening	O
systems	O
at	O
airports	O
and	O
border	B-ANAT
crossings	O
,	O
particularly	O
as	O
the	O
point	O
prevalence	O
of	O
fever	O
in	O
such	O
subjects	O
would	O
be	O
very	O
low	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
patterns	O
of	O
behaviours	O
and	O
attitudes	O
related	O
to	O
SARS	O
prevention	O
in	O
the	O
Hong	O
Kong	O
cross	O
border	B-ANAT
traveller	O
population	O
.	O

A	O
physiological	O
role	O
for	O
ACE2	O
has	O
been	O
implicated	O
in	O
hypertension	O
,	O
cardiac	B-ANAT
function	O
,	O
heart	B-ANAT
function	O
and	O
diabetes	O
,	O
and	O
as	O
a	O
receptor	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
.	O

TITLE	O
:	O
Topographic	O
changes	O
in	O
SARS	O
coronavirus	O
-	O
infected	O
cells	B-ANAT
at	O
late	O
stages	O
of	O
infection	O
.	O

The	O
final	O
expulsion	O
step	O
of	O
the	O
maturing	O
virus	B-ANAT
particles	I-ANAT
seemed	O
to	O
result	O
in	O
some	O
disruptions	O
to	O
the	O
plasma	B-ANAT
membrane	I-ANAT
.	O

The	O
use	O
of	O
the	O
highly	O
sensitive	O
IHA	O
test	O
made	O
it	O
possible	O
to	O
determine	O
the	O
potential	O
for	O
both	O
serum	B-ANAT
and	O
local	O
antibodies	O
production	O
in	O
the	O
patients	O
under	O
observation	O
.	O

Considering	O
that	O
large	O
and	O
medium	O
droplets	O
may	O
infect	O
floors	O
and	O
surfaces	O
,	O
in	O
addition	O
to	O
gloves	O
,	O
gowns	O
,	O
masks	O
and	O
eyes	B-ANAT
protection	O
,	O
the	O
available	O
list	O
of	O
viral	O
and	O
bacterial	O
factors	O
implicated	O
in	O
SARS	O
ethiology	O
suggests	O
a	O
better	O
hand	O
antisepsis	O
using	O
frequently	O
the	O
alcohol	O
based	O
gels	O
(	O
containing	O
an	O
high	O
percentage	O
of	O
emollients	O
substances	O
),	O
if	O
available	O
.	O

RESULTS	O
:	O
The	O
absolute	O
numbers	O
of	O
peripheral	B-ANAT
blood	I-ANAT
B	B-ANAT
lymphocytes	I-ANAT
and	O
NK	B-ANAT
cells	I-ANAT
in	O
SARS	O
patients	O
were	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
normal	O
population	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
were	O
much	O
lower	O
in	O
SARS	O
patients	O
with	O
severe	O
or	O
extremely	O
severe	O
types	O
,	O
as	O
compared	O
with	O
that	O
of	O
moderate	O
or	O
mild	O
type	O
cases	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

In	O
accordance	O
with	O
mandated	O
city	O
-	O
wide	O
infection	O
control	O
measures	O
,	O
the	O
Hospital	O
for	O
Sick	O
Children	O
(	O
HSC	B-ANAT
)	O
drastically	O
reduced	O
all	O
services	O
while	O
maintaining	O
a	O
fully	O
operational	O
emergency	O
department	O
.	O

Macrophages	B-ANAT
from	O
mice	O
with	O
different	O
genetic	O
backgrounds	O
behave	O
differently	O
at	O
the	O
molecular	O
level	O
and	O
comparison	O
of	O
the	O
patterns	O
of	O
non	O
-	O
activated	O
and	O
IFN	O
-	O
gamma	O
-	O
activated	O
A	O
/	O
J	O
or	O
BALB	O
/	O
c	O
mouse	O
macrophages	B-ANAT
revealed	O
,	O
for	O
instance	O
,	O
an	O
up	O
-	O
regulation	O
and	O
a	O
down	O
-	O
regulation	O
of	O
genes	O
coding	O
for	O
biological	O
functions	O
such	O
as	O
enzymatic	O
reactions	O
,	O
nucleic	B-ANAT
acid	O
synthesis	O
and	O
transport	O
,	O
protein	O
synthesis	O
,	O
transport	O
and	O
metabolism	O
,	O
cytoskeleton	B-ANAT
arrangement	O
and	O
extracellular	B-ANAT
matrix	I-ANAT
,	O
phagocytosis	O
,	O
resistance	O
and	O
susceptibility	O
to	O
infection	O
and	O
tumors	O
,	O
inflammation	O
,	O
and	O
cell	B-ANAT
differentiation	O
or	O
activation	O
.	O

The	O
possible	O
implication	O
of	O
the	O
role	O
of	O
some	O
of	O
the	O
gene	O
products	O
relevant	O
to	O
macrophage	B-ANAT
biology	O
can	O
now	O
be	O
further	O
scrutinized	O
.	O

In	O
this	O
respect	O
,	O
a	O
down	O
-	O
regulation	O
of	O
the	O
main	O
murine	O
hepatitis	O
virus	O
3	O
receptor	O
gene	O
was	O
detected	O
only	O
in	O
IFN	O
-	O
gamma	O
-	O
activated	O
macrophages	B-ANAT
of	O
resistant	O
mice	O
.	O

To	O
assess	O
the	O
adherence	O
to	O
PPE	O
and	O
the	O
possibility	O
of	O
transmission	O
to	O
exposed	O
staff	O
a	O
structured	O
questionnaire	O
was	O
administered	O
and	O
serum	B-ANAT
samples	O
tested	O
for	O
SARS	O
coronavirus	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

Serum	B-ANAT
samples	O
from	O
35	O
close	O
contacts	O
obtained	O
after	O
day	O
28	O
had	O
a	O
negative	O
result	O
for	O
SARS	O
coronavirus	O
antibody	O
.	O

Thus	O
,	O
the	O
hydrophobic	O
domain	O
may	O
anchor	O
the	O
replication	O
complex	O
to	O
intracellular	B-ANAT
membranes	B-ANAT
.	O

There	O
were	O
no	O
consistent	O
differences	O
in	O
pathogenicity	O
between	O
the	O
recombinant	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
and	O
its	O
apathogenic	O
parent	O
Beau	O
-	O
R	O
(	O
based	O
on	O
snicking	O
,	O
nasal	B-ANAT
discharge	B-ANAT
,	O
wheezing	O
,	O
watery	O
eyes	B-ANAT
,	O
rales	O
,	O
and	O
ciliostasis	O
in	O
trachea	B-ANAT
),	O
and	O
both	O
replicated	O
poorly	O
in	O
trachea	B-ANAT
and	O
nose	B-ANAT
compared	O
to	O
M41	O
;	O
the	O
S	O
protein	O
from	O
the	O
pathogenic	O
M41	O
had	O
not	O
altered	O
the	O
apathogenic	O
nature	O
of	O
Beau	O
-	O
R	O
.	O
Both	O
Beau	O
-	O
R	O
and	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
induced	O
protection	O
against	O
challenge	O
with	O
M41	O
as	O
assessed	O
by	O
absence	O
of	O
recovery	O
of	O
challenge	O
virus	O
and	O
nasal	B-ANAT
exudate	B-ANAT
.	O

ABSTRACT	O
:	O
Fibroproliferation	O
markers	O
like	O
procollagen	O
I	O
predict	O
mortality	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Acute	O
lung	B-ANAT
injury	O
/	O
ARDS	O
,	O
cardiogenic	O
edema	O
(	O
negative	O
controls	O
)	O
and	O
pulmonary	B-ANAT
fibrosis	O
(	O
positive	O
controls	O
)	O
patients	O
.	O

AV	O
-	O
ECMO	O
therapy	O
in	O
lambs	O
subjected	O
to	O
severe	O
ALI	O
requires	O
continuous	O
hemodynamic	O
support	O
to	O
maintain	O
cardiovascular	B-ANAT
stability	O
and	O
normocapnia	O
,	O
as	O
compared	O
with	O
lambs	O
receiving	O
CMV	O
support	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
are	O
major	O
challenges	O
in	O
critically	O
ill	O
patients	O
.	O

Traditional	O
approaches	O
to	O
mechanical	O
ventilatory	O
support	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
require	O
adaptation	O
of	O
the	O
patient	O
to	O
the	O
mechanical	O
ventilator	O
using	O
heavy	O
sedation	O
and	O
even	O
muscle	B-ANAT
relaxation	O
.	O

Based	O
on	O
currently	O
available	O
data	O
,	O
we	O
suggest	O
considering	O
the	O
use	O
of	O
techniques	O
of	O
mechanical	O
ventilatory	O
support	O
that	O
maintain	O
,	O
rather	O
than	O
suppress	O
,	O
spontaneous	O
ventilatory	O
effort	O
,	O
especially	O
in	O
patients	O
with	O
severe	O
pulmonary	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	O
replication	O
in	O
human	O
peripheral	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
.	O

229E	O
was	O
previously	O
shown	O
to	O
productively	O
infect	O
human	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
,	O
whereas	O
OC43	O
poorly	O
infected	O
the	O
cells	B-ANAT
.	O

The	O
titers	O
of	O
specific	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
were	O
determined	O
by	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
and	O
the	O
neutralizing	O
antibody	O
titers	O
were	O
detected	O
with	O
micro	O
-	O
cytopathic	O
effect	O
neutralization	O
test	O
.	O

The	O
coronavirus	O
is	O
a	O
common	O
pathogen	O
for	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
and	O
is	O
the	O
most	O
probable	O
pathogen	O
for	O
SARS	O
.	O

The	O
majority	O
of	O
studies	O
have	O
been	O
conducted	O
on	O
DNA	O
and	O
retroviruses	O
whose	O
primary	O
site	O
of	O
replication	O
is	O
the	O
nucleus	B-ANAT
,	O
but	O
increasingly	O
a	O
number	O
of	O
researchers	O
are	O
demonstrating	O
that	O
RNA	O
viruses	O
,	O
whose	O
primary	O
site	O
of	O
replication	O
is	O
normally	O
the	O
cytoplasm	B-ANAT
,	O
also	O
interfere	O
with	O
the	O
cell	B-ANAT
cycle	O
.	O

The	O
nucleolus	B-ANAT
and	O
associated	O
subnuclear	O
structures	O
can	O
sequester	O
cell	B-ANAT
cycle	O
regulatory	O
complexes	O
,	O
and	O
nucleolar	B-ANAT
proteins	O
also	O
have	O
a	O
direct	O
and	O
indirect	O
effect	O
on	O
the	O
cycling	O
cell	B-ANAT
.	O

Manuscripts	O
address	O
the	O
use	O
of	O
molecular	O
techniques	O
in	O
the	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
bacterial	O
ribosome	B-ANAT
mutations	O
,	O
which	O
may	O
lead	O
to	O
ribosome	B-ANAT
-	O
targeted	O
drug	O
resistance	O
;	O
pharmacogenomics	O
as	O
a	O
clinical	O
laboratory	O
service	O
and	O
example	O
of	O
warfarin	O
dosing	O
using	O
CYP2C9	O
mutation	O
analysis	O
;	O
definition	O
of	O
the	O
potential	O
of	O
cytosine	O
arabinoside	O
incorporation	O
into	O
DNA	O
to	O
disrupt	O
transcription	O
using	O
an	O
in	O
vitro	O
model	O
of	O
oligonucleotides	O
;	O
use	O
of	O
laser	O
capture	O
microdissection	O
to	O
isolate	O
solid	O
tumor	B-ANAT
cells	I-ANAT
free	O
of	O
nontumor	O
cells	B-ANAT
;	O
and	O
molecular	O
methods	O
used	O
to	O
classify	O
lymphomas	O
.	O

The	O
use	O
of	O
gloves	O
,	O
gowns	O
,	O
N95	O
masks	O
,	O
and	O
eye	B-ANAT
protection	O
was	O
effective	O
in	O
preventing	O
transmission	O
.	O

ABSTRACT	O
:	O
Using	O
paired	O
serum	B-ANAT
samples	O
obtained	O
from	O
patients	O
with	O
illness	O
associated	O
with	O
increases	O
in	O
anti	O
-	O
human	O
coronavirus	O
OC43	O
(	O
HCoV	O
-	O
OC43	O
)	O
or	O
anti	O
-	O
HCoV	O
-	O
229E	O
antibodies	O
,	O
we	O
examined	O
the	O
possibility	O
of	O
false	O
-	O
positive	O
results	O
detected	O
in	O
a	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
protein	O
immunoglobulin	O
G	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

ABSTRACT	O
:	O
The	O
occurrence	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
after	O
thoracic	B-ANAT
surgery	O
are	O
perplexing	O
and	O
persistent	O
problems	O
.	O

SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
-	O
encoding	O
plasmid	O
induced	O
activations	O
of	O
IL	O
-	O
8	O
promoter	O
and	O
AP	O
-	O
1	O
,	O
but	O
not	O
NF	O
-	O
kappaB	O
in	O
these	O
cells	B-ANAT
.	O

These	O
results	O
suggested	O
that	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
CoV	O
could	O
induce	O
release	O
of	O
IL	O
-	O
8	O
in	O
the	O
lung	B-ANAT
cells	B-ANAT
via	O
activations	O
of	O
MAPKs	O
and	O
AP	O
-	O
1	O
.	O

Systemic	O
inflammatory	O
response	O
syndrome	O
involves	O
activation	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
sequestered	O
neutrophils	B-ANAT
in	O
the	O
lung	B-ANAT
.	O

Adjuvant	O
treatments	O
recommended	O
include	O
prevention	O
of	O
venous	B-ANAT
thromboembolism	O
,	O
stress	O
ulcer	O
prophylaxis	O
,	O
and	O
semirecumbent	O
positioning	O
during	O
ventilation	O
.	O

Criteria	O
of	O
admission	O
were	O
impaired	O
consciousness	O
in	O
69	O
%,	O
acute	O
renal	B-ANAT
failure	O
in	O
19	O
%	O
and	O
isolated	O
high	O
parasitemia	O
in	O
19	O
%	O
of	O
the	O
cases	O
.	O

Causes	O
of	O
death	O
were	O
refractory	O
shock	O
,	O
cerebral	B-ANAT
edema	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
causes	O
persistent	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
in	O
rodents	O
,	O
which	O
has	O
been	O
associated	O
with	O
demyelination	O
.	O

Here	O
we	O
show	O
that	O
the	O
progenitor	O
oligodendrocytes	B-ANAT
(	O
central	O
glial	B-ANAT
4	O
[	O
CG	O
-	O
4	O
]	O
cells	B-ANAT
)	O
derived	O
from	O
newborn	O
rat	B-ANAT
brain	I-ANAT
were	O
permissive	O
to	O
MHV	O
infection	O
,	O
which	O
resulted	O
in	O
cell	B-ANAT
death	O
,	O
although	O
viral	O
replication	O
was	O
restricted	O
.	O

Peak	O
replication	O
in	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
was	O
noted	O
on	O
day	O
2	O
postinfection	O
(	O
p	O
.	O
i	O
.)	O
and	O
was	O
cleared	O
by	O
day	O
7	O
p	O
.	O
i	O
.	O

Viral	O
replication	O
in	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
was	O
accompanied	O
by	O
cellular	B-ANAT
necrosis	O
early	O
in	O
infection	O
,	O
followed	O
by	O
an	O
inflammatory	O
response	O
coincident	O
with	O
viral	O
clearance	O
,	O
focal	O
consolidation	O
in	O
pulmonary	B-ANAT
tissue	B-ANAT
,	O
and	O
eventual	O
pulmonary	B-ANAT
tissue	B-ANAT
repair	O
.	O

Comparing	O
these	O
data	O
to	O
the	O
mouse	O
model	O
,	O
SARS	O
CoV	O
replicates	O
to	O
a	O
higher	O
titer	O
and	O
for	O
a	O
longer	O
duration	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
hamsters	O
and	O
is	O
accompanied	O
by	O
significant	O
pathology	O
that	O
is	O
absent	O
in	O
mice	O
.	O

TITLE	O
:	O
The	O
ubiquitin	O
-	O
proteasome	O
system	O
facilitates	O
the	O
transfer	O
of	O
murine	O
coronavirus	O
from	O
endosome	B-ANAT
to	O
cytoplasm	B-ANAT
during	O
virus	O
entry	O
.	O

One	O
female	O
patient	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
treated	O
with	O
inhaled	O
nitric	O
oxide	O
,	O
who	O
developed	O
a	O
simultaneous	O
increase	O
in	O
blood	B-ANAT
methemoglobin	O
and	O
carboxyhemoglobin	O
.	O

ABSTRACT	O
:	O
In	O
the	O
winter	O
season	O
2001	O
-	O
2002	O
,	O
239	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
and	O
15	O
bronchoalveolar	O
lavage	O
samples	O
from	O
208	O
patients	O
(	O
135	O
pediatric	O
and	O
73	O
adults	O
,	O
including	O
19	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
)	O
admitted	O
to	O
hospital	O
because	O
of	O
an	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
were	O
examined	O
for	O
rapid	O
diagnosis	O
of	O
respiratory	O
viruses	O
by	O
two	O
diagnostic	O
approaches	O
:	O
immunological	O
,	O
using	O
specific	O
monoclonal	O
antibodies	O
(	O
MAb	O
);	O
and	O
molecular	O
,	O
using	O
specific	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
assays	O
.	O

The	O
results	O
on	O
150	O
sera	B-ANAT
from	O
SARS	O
patients	O
and	O
450	O
sera	B-ANAT
from	O
non	O
-	O
SARS	O
controls	O
showed	O
that	O
this	O
assay	O
had	O
a	O
high	O
level	O
of	O
sensitivity	O
(	O
96	O
.	O
2	O
%	O
for	O
late	O
serum	B-ANAT
samples	O
)	O
and	O
specificity	O
(	O
97	O
.	O
8	O
%).	O

CoVs	O
enter	O
target	B-ANAT
cells	I-ANAT
through	O
fusion	O
of	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
mediated	O
by	O
the	O
viral	B-ANAT
envelope	I-ANAT
glycoprotein	O
S	O
.	O
We	O
have	O
determined	O
by	O
x	O
-	O
ray	O
crystallography	O
the	O
structure	O
of	O
a	O
proteolytically	O
stable	O
core	O
fragment	O
from	O
the	O
heptad	O
repeat	O
(	O
HR	O
)	O
regions	O
HR1	O
and	O
HR2	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
.	O

We	O
have	O
also	O
determined	O
the	O
structure	O
of	O
an	O
HR1	O
-	O
HR2	O
S	O
core	O
fragment	O
,	O
containing	O
a	O
shorter	O
HR1	O
peptide	O
and	O
a	O
C	O
-	O
terminally	O
longer	O
HR2	O
peptide	O
that	O
extends	O
up	O
to	O
the	O
transmembrane	B-ANAT
region	O
.	O

The	O
kinetics	O
of	O
neutralisation	O
antibodies	O
obtained	O
with	O
100x	O
the	O
tissue	B-ANAT
culture	O
infective	O
dose	O
(	O
TCID50	O
)	O
of	O
the	O
SARS	O
-	O
CoV	O
TW1	O
strain	O
in	O
five	O
patients	O
with	O
SARS	O
nearly	O
paralleled	O
those	O
for	O
IgG	O
.	O
There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
kinetics	O
of	O
the	O
IgG	O
,	O
IgM	O
and	O
IgA	O
responses	O
between	O
patients	O
with	O
or	O
without	O
underlying	O
medical	O
disease	O
,	O
steroid	O
or	O
intravenous	O
immunoglobulin	O
therapy	O
,	O
or	O
mechanical	O
ventilation	O
.	O

We	O
report	O
on	O
the	O
distribution	O
and	O
viral	O
load	O
of	O
SARS	O
-	O
CoV	O
in	O
multiple	O
organ	B-ANAT
samples	O
from	O
patients	O
who	O
died	O
of	O
SARS	O
during	O
the	O
Toronto	O
outbreak	O
.	O

The	O
replicase	O
complex	O
is	O
believed	O
to	O
be	O
comprised	O
of	O
up	O
to	O
16	O
viral	O
subunits	O
and	O
a	O
number	O
of	O
cellular	B-ANAT
proteins	O
.	O

TITLE	O
:	O
A	O
complex	O
zinc	O
finger	B-ANAT
controls	O
the	O
enzymatic	O
activities	O
of	O
nidovirus	O
helicases	O
.	O

ABSTRACT	O
:	O
Despite	O
extensive	O
laboratory	O
investigations	O
in	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
no	O
microbiological	O
cause	O
can	O
be	O
identified	O
in	O
a	O
significant	O
proportion	O
of	O
patients	O
.	O

TITLE	O
:	O
Natural	O
history	O
of	O
a	O
recurrent	O
feline	O
coronavirus	O
infection	O
and	O
the	O
role	O
of	O
cellular	B-ANAT
immunity	O
in	O
survival	O
and	O
disease	O
.	O

A	O
severe	O
recurrent	O
infection	O
developed	O
,	O
typified	O
by	O
viral	O
persistence	O
and	O
acute	O
lymphopenia	O
,	O
with	O
waves	O
of	O
enhanced	O
viral	O
replication	O
coinciding	O
with	O
fever	O
,	O
weight	O
loss	O
,	O
and	O
depletion	O
of	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

Rising	O
amounts	O
of	O
viral	O
RNA	O
in	O
the	O
blood	B-ANAT
,	O
consistently	O
seen	O
in	O
animals	O
with	O
end	O
-	O
stage	O
FIP	O
,	O
indicate	O
that	O
progression	O
to	O
fatal	O
disease	O
is	O
the	O
direct	O
consequence	O
of	O
a	O
loss	O
of	O
immune	O
control	O
,	O
resulting	O
in	O
unchecked	O
viral	O
replication	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
:	O
quantitative	O
assessment	O
from	O
chest	B-ANAT
radiographs	O
with	O
clinical	O
and	O
prognostic	O
correlation	O
.	O

In	O
addition	O
to	O
the	O
chest	B-ANAT
radiographic	O
abnormalities	O
and	O
percentage	O
of	O
involvement	O
,	O
several	O
quantitative	O
improvement	O
parameters	O
,	O
including	O
the	O
peak	O
to	O
50	O
%	O
improvement	O
time	O
(	O
PIT	O
(	O
50	O
)),	O
were	O
collected	O
.	O

RESULTS	O
:	O
The	O
most	O
common	O
initial	O
findings	O
were	O
unifocal	O
air	O
-	O
space	O
disease	O
in	O
the	O
periphery	O
of	O
the	O
lower	O
lungs	B-ANAT
occurring	O
a	O
mean	O
of	O
3	O
.	O
6	O
+/-	O
2	O
.	O
4	O
(	O
SD	O
)	O
days	O
from	O
symptoms	O
onset	O
.	O

Current	O
trends	O
in	O
the	O
management	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
consist	O
of	O
maintaining	O
acceptable	O
gas	O
exchange	O
while	O
limiting	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
.	O

Currently	O
,	O
two	O
distinct	O
forms	O
of	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
are	O
recognized	O
to	O
produce	O
alveolar	B-ANAT
stress	O
failure	O
and	O
have	O
been	O
termed	O
low	O
-	O
volume	O
lung	B-ANAT
injury	O
(	O
intratidal	O
alveolar	B-ANAT
recruitment	O
and	O
derecruitment	O
)	O
and	O
high	O
-	O
volume	O
lung	B-ANAT
injury	O
(	O
alveolar	B-ANAT
stretch	O
and	O
overdistension	O
).	O

Pathologically	O
,	O
alveolar	B-ANAT
stress	O
failure	O
from	O
low	O
-	O
and	O
high	O
-	O
volume	O
ventilation	O
can	O
produce	O
lung	B-ANAT
injury	O
in	O
animal	O
models	O
and	O
is	O
termed	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Use	O
of	O
convalescent	O
plasma	B-ANAT
therapy	O
in	O
SARS	O
patients	O
in	O
Hong	O
Kong	O
.	O

Electron	O
microscopy	O
revealed	O
""""	O
hump	O
""""	O
electron	O
-	O
dense	O
deposits	O
on	O
the	O
epithelial	O
side	O
of	O
the	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
.	O

TITLE	O
:	O
RT	O
-	O
PCR	O
-	O
based	O
dot	O
blot	O
hybridization	O
for	O
the	O
detection	O
and	O
differentiation	O
between	O
porcine	O
epidemic	O
diarrhea	O
virus	O
and	O
transmissible	O
gastroenteritis	O
virus	O
in	O
fecal	B-ANAT
samples	O
using	O
a	O
non	O
-	O
radioactive	O
digoxigenin	O
cDNA	O
probe	O
.	O

ABSTRACT	O
:	O
Multiplex	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)-	O
based	O
dot	O
blot	O
hybridization	O
was	O
developed	O
to	O
increase	O
the	O
sensitivity	O
for	O
the	O
detection	O
and	O
differentiation	O
between	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
and	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
in	O
fecal	B-ANAT
samples	O
.	O

TITLE	O
:	O
Predictive	O
value	O
of	O
the	O
user	O
seal	O
check	O
in	O
determining	O
half	O
-	O
face	B-ANAT
respirator	O
fit	O
.	O

In	O
this	O
series	O
,	O
lymphopenia	O
and	O
anemia	O
were	O
more	O
severe	O
in	O
SARS	O
than	O
in	O
M	O
.	O
pneumoniae	O
infection	O
,	O
and	O
SARS	O
patients	O
had	O
more	O
persistent	O
and	O
more	O
new	O
pulmonary	B-ANAT
infiltrates	O
after	O
hospitalization	O
.	O

The	O
predicted	O
high	O
extent	O
of	O
phosphorylation	O
of	O
the	O
N	O
protein	O
on	O
multiple	O
candidate	O
phosphorylation	O
sites	O
demonstrates	O
that	O
it	O
would	O
be	O
related	O
to	O
important	O
functions	O
,	O
such	O
as	O
RNA	O
-	O
binding	O
and	O
localization	O
to	O
the	O
nucleolus	B-ANAT
of	O
host	O
cells	B-ANAT
.	O

We	O
report	O
a	O
4	O
1	O
/	O
2	O
-	O
year	O
-	O
old	O
boy	O
with	O
B	O
.	O
pertussis	O
infection	O
who	O
developed	O
severe	O
ARDS	O
and	O
pulmonary	B-ANAT
hypertension	O
.	O

ABSTRACT	O
:	O
To	O
express	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
coronavirus	O
and	O
produce	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
to	O
N	O
protein	O
.	O

This	O
expressed	O
protein	O
could	O
be	O
further	O
confirmed	O
in	O
Western	O
blot	O
by	O
using	O
serum	B-ANAT
from	O
a	O
convalescent	O
SARS	O
patient	O
as	O
primary	O
antibody	O
.	O

RESULTS	O
:	O
The	O
percentages	O
of	O
CD3	O
(+)	O
and	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
were	O
lower	O
than	O
normal	O
reference	O
(	O
P	O
<	O
0	O
.	O
05	O
and	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
).	O

And	O
the	O
expressions	O
of	O
TCR	B-ANAT
Vbeta4	O
,	O
Vbeta22	O
and	O
Vbeta23	O
in	O
SARS	O
patients	O
treated	O
with	O
glucocorticoid	O
(>	O
1	O
000	O
U	O
)	O
were	O
higher	O
than	O
those	O
in	O
SARS	O
patients	O
without	O
treatment	O
.	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
immune	O
responses	O
of	O
DNA	O
vaccine	O
encoded	O
different	O
gene	O
fragments	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
Cov	O
),	O
SARS	O
-	O
Cov	O
gene	O
fragments	O
of	O
membrane	B-ANAT
(	O
M	O
),	O
nucleocapsid	B-ANAT
(	O
N	O
),	O
spike	O
a	O
(	O
Sa	O
),	O
and	O
spike	O
b	O
(	O
Sb	O
)	O
proteins	O
were	O
cloned	O
into	O
pcDNA3	O
.	O
1	O
(	O
Invitrogen	O
)	O
vector	O
to	O
form	O
plasmids	O
pcDNAM	O
,	O
pcDNAN	O
,	O
pcDNASa	O
,	O
and	O
pcDNASb	O
,	O
respectively	O
.	O

Based	O
on	O
tertiary	O
structural	O
comparisons	O
,	O
we	O
propose	O
the	O
s2m	O
RNA	O
binds	O
one	O
or	O
more	O
proteins	O
possessing	O
an	O
oligomer	O
-	O
binding	O
-	O
like	O
fold	O
,	O
and	O
we	O
suggest	O
a	O
possible	O
mechanism	O
for	O
SARS	O
viral	O
RNA	O
hijacking	O
of	O
host	O
protein	O
synthesis	O
,	O
both	O
based	O
upon	O
observed	O
s2m	O
RNA	O
macromolecular	O
mimicry	O
of	O
a	O
relevant	O
ribosomal	B-ANAT
RNA	I-ANAT
fold	O
.	O

Fixation	O
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
with	O
a	O
fixative	O
including	O
formalin	O
,	O
glutaraldehyde	O
,	O
methanol	O
,	O
and	O
acetone	O
for	O
5	O
min	O
or	O
longer	O
eliminated	O
all	O
infectivity	O
.	O

The	O
present	O
study	O
aimed	O
to	O
preliminarily	O
examine	O
the	O
presence	O
of	O
serum	B-ANAT
specific	O
antibodies	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
virus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
pediatric	O
SARS	O
patients	O
and	O
explore	O
the	O
possibility	O
of	O
subclinical	O
infection	O
in	O
children	O
/	O
adults	O
through	O
close	O
association	O
with	O
SARS	O
cases	O
.	O

(	O
1	O
)	O
Clinicians	O
and	O
nurses	O
visited	O
families	O
and	O
collected	O
general	O
and	O
epidemiological	O
information	O
about	O
the	O
subjects	O
using	O
a	O
standard	O
questionnaire	O
and	O
took	O
serum	B-ANAT
specimens	O
.	O

Serum	B-ANAT
from	O
one	O
medical	O
worker	O
who	O
had	O
been	O
close	O
contact	O
to	O
SARS	O
patients	O
was	O
positive	O
for	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	O
and	O
total	O
antibodies	O
.	O

IgG	B-ANAT
antibody	I-ANAT
in	O
sera	B-ANAT
continued	O
to	O
be	O
at	O
higher	O
levels	O
among	O
SARS	O
cases	O
22	O
-	O
24	O
weeks	O
after	O
onset	O
.	O

Autopsy	O
lung	B-ANAT
tissue	I-ANAT
sections	O
from	O
SARS	O
patients	O
were	O
stained	O
with	O
ascites	O
of	O
monoclonal	O
antibody	O
(	O
M2	O
strain	O
)	O
by	O
immunohistochemical	O
technique	O
.	O

Six	O
strains	O
of	O
hybridomas	B-ANAT
that	O
produced	O
the	O
monoclonal	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
were	O
obtained	O
.	O

Of	O
the	O
6	O
strains	O
,	O
1	O
was	O
identified	O
as	O
the	O
immunoglobulin	O
G3	O
(	O
IgG3	B-ANAT
)	O
isotype	O
,	O
5	O
were	O
IgG1	O
.	O

TITLE	O
:	O
[	O
Report	O
on	O
the	O
investigation	O
of	O
lower	B-ANAT
extremity	I-ANAT
osteonecrosis	O
with	O
magnetic	O
resonance	O
imaging	O
in	O
recovered	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
Guangzhou	O
].	O

ABSTRACT	O
:	O
To	O
report	O
the	O
occurrence	O
of	O
lower	B-ANAT
extremity	I-ANAT
avascular	O
abnormalities	O
in	O
124	O
cases	O
of	O
recovered	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
health	O
care	O
workers	O
of	O
four	O
hospitals	O
in	O
Guangzhou	O
and	O
preliminary	O
investigate	O
the	O
correlation	O
with	O
the	O
treatment	O
of	O
steroid	O
.	O

Bilateral	O
femoral	B-ANAT
and	O
tibial	B-ANAT
marrow	O
edema	O
were	O
found	O
in	O
one	O
case	O
.	O

TITLE	O
:	O
Arginine	O
metabolism	O
during	O
macrophage	B-ANAT
autocrine	O
activation	O
and	O
infection	O
with	O
mouse	O
hepatitis	O
virus	O
3	O
.	O

ABSTRACT	O
:	O
In	O
contrast	O
to	O
BALB	O
/	O
c	O
mouse	O
macrophages	B-ANAT
(	O
Mphi	B-ANAT
),	O
Mphi	B-ANAT
from	O
the	O
A	O
/	O
J	O
mouse	O
strain	O
,	O
upon	O
activation	O
by	O
exogenous	O
interferon	O
gamma	O
(	O
IFNgamma	O
),	O
develop	O
an	O
anti	O
-	O
mouse	O
hepatitis	O
virus	O
3	O
(	O
MHV3	O
)	O
state	O
which	O
correlates	O
with	O
resistance	O
to	O
virus	O
infection	O
.	O

Nucleic	B-ANAT
acid	O
amplification	O
tests	O
(	O
NAATs	O
)	O
have	O
been	O
evaluated	O
for	O
detecting	O
most	O
respiratory	O
pathogens	O
,	O
and	O
commercial	O
assays	O
are	O
available	O
for	O
some	O
pathogens	O
.	O

For	O
pneumococcal	O
pneumonia	O
in	O
adults	O
,	O
PCR	O
adds	O
little	O
to	O
existing	O
diagnostic	O
tests	O
,	O
and	O
is	O
unable	O
to	O
distinguish	O
pneumococcal	O
colonization	O
from	O
infection	O
when	O
testing	O
respiratory	B-ANAT
samples	I-ANAT
.	O

TITLE	O
:	O
Dynamic	O
changes	O
of	O
serum	B-ANAT
SARS	O
-	O
coronavirus	O
IgG	O
,	O
pulmonary	B-ANAT
function	O
and	O
radiography	O
in	O
patients	O
recovering	O
from	O
SARS	O
after	O
hospital	O
discharge	B-ANAT
.	O

Those	O
individuals	O
who	O
were	O
found	O
to	O
have	O
lung	B-ANAT
diffusion	O
abnormities	O
(	O
transfer	O
coefficient	O
for	O
carbon	O
monoxide	O
[	O
DLCO	O
]	O
<	O
80	O
%	O
of	O
predicted	O
value	O
[	O
pred	O
])	O
received	O
regular	O
lung	B-ANAT
function	O
tests	O
and	O
HRCT	O
examinations	O
in	O
the	O
follow	O
-	O
up	O
phase	O
in	O
order	O
to	O
document	O
the	O
changes	O
in	O
their	O
lung	B-ANAT
condition	O
.	O

Some	O
patients	O
who	O
complained	O
of	O
joint	B-ANAT
pain	O
were	O
given	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
examinations	O
of	O
their	O
femoral	B-ANAT
heads	I-ANAT
.	O

Of	O
those	O
testing	O
positive	O
,	O
the	O
serum	B-ANAT
levels	O
of	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
decreased	O
significantly	O
during	O
the	O
12	O
months	O
after	O
hospital	O
discharge	B-ANAT
.	O

After	O
hemorrhage	O
,	O
in	O
addition	O
to	O
positively	O
staining	O
endothelial	B-ANAT
cells	I-ANAT
and	O
macrophages	B-ANAT
,	O
neutrophils	B-ANAT
expressing	O
HMGB1	O
were	O
present	O
in	O
the	O
lungs	B-ANAT
.	O

Blockade	O
of	O
HMGB1	O
by	O
administration	O
of	O
anti	O
-	O
HMGB1	O
antibodies	O
prevented	O
hemorrhage	O
-	O
induced	O
increases	O
in	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
the	O
lungs	B-ANAT
and	O
pulmonary	B-ANAT
levels	O
of	O
proinflammatory	O
cytokines	O
,	O
including	O
keratinocyte	B-ANAT
-	O
derived	O
chemokine	O
,	O
IL	O
-	O
6	O
,	O
and	O
IL	O
-	O
1	O
beta	O
.	O

In	O
conclusion	O
,	O
decreased	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
levels	O
in	O
lung	B-ANAT
tissue	I-ANAT
may	O
participate	O
in	O
the	O
decrease	O
in	O
lung	B-ANAT
perfusion	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
positive	O
cells	B-ANAT
were	O
cloned	O
and	O
injected	O
into	O
abdominal	B-ANAT
cavity	I-ANAT
.	O

They	O
were	O
subjected	O
to	O
influenza	O
virus	O
detection	O
by	O
fluorescent	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
,	O
MDCK	B-ANAT
cell	I-ANAT
culture	O
,	O
and	O
hemagglutinin	O
inhibition	O
assay	O
.	O

ABSTRACT	O
:	O
To	O
construct	O
a	O
recombinant	O
plasmid	O
Pet23a	O
-	O
M	O
,	O
the	O
gene	O
encoding	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
membrane	B-ANAT
protein	O
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
and	O
cloned	O
into	O
the	O
expression	O
plasmid	O
Pet23a	O
.	O

We	O
also	O
demonstrate	O
that	O
,	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
,	O
the	O
orf7a	O
protein	O
is	O
expressed	O
and	O
retained	O
intracellularly	O
.	O

On	O
-	O
column	B-ANAT
refolding	O
and	O
purification	O
was	O
performed	O
.	O

The	O
positive	O
rates	O
of	O
N	O
protein	O
for	O
sera	B-ANAT
collected	O
at	O
1	O
to	O
5	O
,	O
6	O
to	O
10	O
,	O
11	O
to	O
15	O
,	O
and	O
16	O
to	O
20	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
for	O
414	O
samples	O
from	O
298	O
serologically	O
confirmed	O
patients	O
were	O
92	O
.	O
9	O
,	O
69	O
.	O
8	O
,	O
36	O
.	O
4	O
,	O
and	O
21	O
.	O
1	O
%,	O
respectively	O
.	O

For	O
294	O
sera	B-ANAT
from	O
248	O
serological	O
test	O
-	O
negative	O
patients	O
,	O
the	O
rates	O
were	O
25	O
.	O
6	O
,	O
16	O
.	O
7	O
,	O
9	O
.	O
3	O
,	O
and	O
0	O
%,	O
respectively	O
.	O

The	O
N	O
protein	O
was	O
not	O
detected	O
in	O
66	O
patients	O
with	O
cases	O
of	O
what	O
was	O
initially	O
suspected	O
to	O
be	O
SARS	O
but	O
serologically	O
proven	O
to	O
be	O
negative	O
for	O
SARS	O
and	O
in	O
197	O
serum	B-ANAT
samples	O
from	O
healthy	O
donors	O
and	O
non	O
-	O
SARS	O
febrile	O
patients	O
.	O

Beneath	O
Vero	O
E6	O
cells	B-ANAT
SARS	O
-	O
Coronavirus	O
infection	O
could	O
also	O
be	O
demonstrated	O
in	O
two	O
pig	O
cell	B-ANAT
lines	I-ANAT
(	O
POEK	O
,	O
PS	O
)	O
and	O
one	O
human	B-ANAT
cell	I-ANAT
line	I-ANAT
(	O
Huh	O
-	O
7	O
)	O
using	O
the	O
indirect	O
immunofluorescence	O
assay	O
and	O
a	O
newly	O
established	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

TITLE	O
:	O
High	O
-	O
dose	O
hydrocortisone	O
reduces	O
expression	O
of	O
the	O
pro	O
-	O
inflammatory	O
chemokines	O
CXCL8	O
and	O
CXCL10	O
in	O
SARS	O
coronavirus	O
-	O
infected	O
intestinal	B-ANAT
cells	B-ANAT
.	O

The	O
clinical	O
diagnosis	O
was	O
commonly	O
supported	O
by	O
an	O
abnormal	O
chest	B-ANAT
X	O
-	O
ray	O
(	O
56	O
%)	O
together	O
with	O
respiratory	O
distress	O
(	O
50	O
%),	O
wheeze	O
(	O
44	O
%),	O
and	O
rales	O
(	O
25	O
%)	O
on	O
first	O
presentation	O
with	O
HCoV	O
-	O
NL63	O
infection	O
.	O

BALB	O
/	O
c	O
mice	O
were	O
immunized	O
with	O
purified	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
Hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
secreting	O
monoclonal	O
antibodies	O
against	O
SARS	O
-	O
associated	O
coronavirus	O
nucleocapsid	B-ANAT
were	O
established	O
after	O
cell	B-ANAT
fusion	O
with	O
mouse	O
splenic	B-ANAT
cells	B-ANAT
and	O
SP2	B-ANAT
/	O
0	O
cells	B-ANAT
.	O

The	O
levels	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
were	O
measured	O
by	O
ELISA	O
.	O

RESULTS	O
:	O
SARS	O
coronavirus	O
IgG	B-ANAT
antibody	I-ANAT
was	O
detected	O
positive	O
in	O
6	O
of	O
the	O
9	O
patients	O
,	O
it	O
was	O
still	O
positive	O
in	O
the	O
sera	B-ANAT
twelve	O
months	O
after	O
recovery	O
;	O
1	O
of	O
the	O
closely	O
contacted	O
persons	O
and	O
3	O
normal	O
subjects	O
were	O
found	O
positive	O
.	O

His	O
chest	B-ANAT
radiography	O
showed	O
patchy	O
consolidations	O
in	O
the	O
lower	B-ANAT
lobe	I-ANAT
of	I-ANAT
the	I-ANAT
right	I-ANAT
lung	I-ANAT
and	O
in	O
the	O
middle	O
field	O
of	O
the	O
left	B-ANAT
lung	I-ANAT
,	O
and	O
severe	O
hypoxia	O
was	O
present	O
.	O

TITLE	O
:	O
The	O
aromatic	O
domain	O
of	O
the	O
coronavirus	O
class	O
I	O
viral	O
fusion	O
protein	O
induces	O
membrane	B-ANAT
permeabilization	O
:	O
putative	O
role	O
during	O
viral	O
entry	O
.	O

During	O
viral	O
and	O
target	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
,	O
the	O
heptad	O
repeat	O
(	O
HR	O
)	O
regions	O
of	O
the	O
S2	O
subunit	O
assume	O
a	O
trimer	O
-	O
of	O
-	O
hairpins	O
structure	O
,	O
positioning	O
the	O
fusion	O
peptide	O
in	O
close	O
proximity	O
to	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
ectodomain	O
.	O

At	O
present	O
,	O
the	O
knowledge	O
of	O
the	O
pathology	O
of	O
the	O
digestive	B-ANAT
system	I-ANAT
in	O
SARS	O
patients	O
is	O
limited	O
.	O

The	O
main	O
histopathological	O
finding	O
was	O
atrophy	O
of	O
the	O
mucosal	B-ANAT
lymphoid	B-ANAT
tissue	I-ANAT
.	O

The	O
findings	O
provide	O
possible	O
explanations	O
for	O
the	O
gastrointestinal	O
symptoms	O
and	O
the	O
presence	O
of	O
virus	O
in	O
the	O
stool	B-ANAT
of	O
SARS	O
patients	O
.	O

RESULTS	O
:	O
The	O
main	O
histopathological	O
finding	O
was	O
atrophy	O
of	O
the	O
mucosal	B-ANAT
lymphoid	B-ANAT
tissue	I-ANAT
.	O

We	O
sought	O
to	O
determine	O
whether	O
novel	O
human	O
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
circulating	O
in	O
New	O
Haven	O
,	O
Connecticut	O
,	O
and	O
,	O
if	O
so	O
,	O
whether	O
they	O
are	O
associated	O
with	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
infants	O
and	O
young	O
children	O
.	O

Specimens	O
of	O
respiratory	O
secretions	B-ANAT
from	O
8	O
(	O
72	O
.	O
7	O
%)	O
of	O
11	O
children	O
with	O
Kawasaki	O
disease	O
and	O
from	O
1	O
(	O
4	O
.	O
5	O
%)	O
of	O
22	O
control	O
subjects	O
(	O
children	O
without	O
Kawasaki	O
disease	O
matched	O
by	O
age	O
and	O
the	O
time	O
the	O
specimens	O
were	O
obtained	O
)	O
tested	O
positive	O
for	O
HCoV	O
-	O
NH	O
by	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
Mantel	O
-	O
Haenszel	O
matched	O
odds	O
ratio	O
,	O
16	O
.	O
0	O
[	O
95	O
%	O
confidence	O
interval	O
,	O
3	O
.	O
4	O
-	O
74	O
.	O
4	O
];	O
P	O
=.	O
0015	O
).	O

The	O
main	O
clinical	O
presentations	O
were	O
fever	O
(	O
15	O
/	O
19	O
),	O
sore	O
throat	B-ANAT
(	O
5	O
/	O
19	O
),	O
and	O
cough	O
(	O
9	O
/	O
19	O
),	O
and	O
4	O
patients	O
were	O
hospitalized	O
.	O

TITLE	O
:	O
A	O
molecular	O
beacon	O
,	O
bead	O
-	O
based	O
assay	O
for	O
the	O
detection	O
of	O
nucleic	B-ANAT
acids	O
by	O
flow	O
cytometry	O
.	O

Although	O
partial	O
ventilatory	O
support	O
modalities	O
were	O
initially	O
developed	O
for	O
weaning	O
from	O
mechanical	O
ventilation	O
,	O
they	O
are	O
increasingly	O
used	O
as	O
primary	O
modes	O
of	O
ventilation	O
,	O
even	O
in	O
patients	O
in	O
the	O
acute	O
phase	O
of	O
pulmonary	B-ANAT
dysfunction	O
.	O

Recent	O
investigations	O
have	O
questioned	O
the	O
utility	O
of	O
sedation	O
,	O
muscle	B-ANAT
paralysis	O
,	O
and	O
mechanical	O
control	O
of	O
ventilation	O
.	O

Recent	O
articles	O
have	O
strengthened	O
the	O
evidence	O
supporting	O
the	O
use	O
of	O
noninvasive	O
ventilation	O
for	O
patients	O
with	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
and	O
exacerbation	O
of	O
severe	O
chronic	O
pulmonary	B-ANAT
obstructive	O
disease	O
.	O

The	O
SARS	O
-	O
CoV	O
N	O
protein	O
was	O
also	O
expressed	O
in	O
Lactococcus	O
lactis	O
in	O
the	O
cytoplasm	B-ANAT
or	O
secreted	O
into	O
the	O
medium	O
.	O

In	O
conclusion	O
,	O
our	O
work	O
provides	O
a	O
novel	O
strategy	O
to	O
produce	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
for	O
serodiagnosis	O
and	O
for	O
L	O
.	O
lactis	O
-	O
based	O
mucosal	B-ANAT
vaccines	O
.	O

Vaccination	O
would	O
offer	O
the	O
most	O
attractive	O
approach	O
to	O
prevent	O
new	O
epidemics	O
of	O
SARS	O
,	O
but	O
the	O
development	O
of	O
vaccines	O
is	O
difficult	O
due	O
to	O
missing	O
data	O
on	O
the	O
role	O
of	O
immune	B-ANAT
system	I-ANAT
-	O
virus	O
interactions	O
and	O
the	O
potential	O
mutability	O
of	O
the	O
virus	O
.	O

In	O
vitro	O
transcribed	O
RNA	O
from	O
a	O
cDNA	O
template	O
that	O
had	O
been	O
constructed	O
from	O
seven	O
cDNA	O
fragments	O
,	O
encompassing	O
the	O
entire	O
genome	O
of	O
IBV	O
,	O
was	O
electroporated	O
into	O
BHK	O
-	O
21	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Pathogens	O
causing	O
bovine	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
Finland	O
were	O
investigated	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
taken	O
from	O
the	O
calves	O
at	O
the	O
time	O
of	O
the	O
investigation	O
and	O
from	O
86	O
calves	O
3	O
-	O
4	O
weeks	O
later	O
.	O

The	O
test	O
was	O
applied	O
to	O
1075	O
feline	O
blood	B-ANAT
samples	I-ANAT
(	O
424	O
from	O
healthy	O
,	O
651	O
from	O
sick	O
cats	O
suspected	O
of	O
FIP	O
)	O
and	O
returned	O
46	O
%	O
of	O
the	O
diseased	O
cats	O
as	O
positive	O
for	O
feline	O
coronavirus	O
mRNA	O
in	O
their	O
peripheral	B-ANAT
blood	I-ANAT
cells	B-ANAT
;	O
of	O
the	O
healthy	O
cats	O
,	O
5	O
%	O
tested	O
positive	O
.	O

The	O
addition	O
of	O
a	O
second	O
""""	O
hit	O
""""	O
(	O
SMA	O
occlusion	O
,	O
I	O
/	O
R	O
)	O
to	O
a	O
FC	O
sepsis	O
model	O
resulted	O
in	O
severe	O
lung	B-ANAT
injury	O
that	O
developed	O
within	O
a	O
3	O
-	O
day	O
period	O
.	O

The	O
vaccine	O
was	O
administered	O
orally	B-ANAT
at	O
2	O
,	O
4	O
,	O
10	O
,	O
and	O
14	O
wk	O
of	O
age	O
.	O

A	O
significant	O
correlation	O
was	O
found	O
between	O
changes	O
in	O
intracranial	B-ANAT
pressure	O
and	O
elastance	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
8	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
between	O
changes	O
in	O
PaCO	O
(	O
2	O
)	O
and	O
intracranial	B-ANAT
pressure	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
4	O
)	O
and	O
elastance	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
4	O
),	O
respectively	O
.	O

When	O
PEEP	O
induced	O
alveolar	B-ANAT
hyperinflation	O
leading	O
to	O
a	O
significant	O
increase	O
in	O
PaCO	O
(	O
2	O
),	O
intracranial	B-ANAT
pressure	O
significantly	O
increased	O
,	O
whereas	O
when	O
PEEP	O
caused	O
alveolar	B-ANAT
recruitment	O
intracranial	B-ANAT
pressure	O
did	O
not	O
change	O
.	O

Seven	O
patients	O
with	O
histories	O
of	O
only	O
urban	O
exposure	O
to	O
leptospires	O
had	O
severe	O
pulmonary	B-ANAT
manifestations	O
;	O
of	O
these	O
,	O
5	O
patients	O
died	O
;	O
4	O
of	O
the	O
deaths	O
were	O
caused	O
by	O
pulmonary	B-ANAT
hemorrhage	O
,	O
and	O
1	O
was	O
caused	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multiorgan	O
failure	O
.	O

To	O
date	O
,	O
there	O
have	O
been	O
no	O
reported	O
case	O
fatalities	O
in	O
children	O
,	O
probably	O
due	O
to	O
their	O
more	O
immature	O
immune	B-ANAT
system	I-ANAT
.	O

Kidney	B-ANAT
tissues	B-ANAT
from	O
seven	O
other	O
patients	O
with	O
postmortem	O
examinations	O
were	O
studied	O
by	O
light	O
microscopy	O
and	O
electron	O
microscopy	O
.	O

By	O
multivariate	O
analysis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
age	O
were	O
the	O
most	O
significant	O
independent	O
risk	O
factors	O
predicting	O
the	O
development	O
of	O
acute	O
renal	B-ANAT
impairment	O
in	O
SARS	O
.	O

However	O
,	O
by	O
2	O
weeks	O
,	O
mice	O
developed	O
peritonitis	O
,	O
and	O
viral	O
RNA	O
was	O
detected	O
in	O
mesentery	B-ANAT
and	O
visceral	B-ANAT
peritoneum	I-ANAT
.	O

All	O
of	O
the	O
21	O
SARS	O
-	O
positive	O
serum	B-ANAT
samples	O
could	O
be	O
recognized	O
by	O
our	O
IFA	O
,	O
giving	O
a	O
specificity	O
and	O
sensitivity	O
of	O
100	O
%,	O
which	O
was	O
compatible	O
with	O
both	O
whole	O
virus	O
-	O
based	O
IFA	O
assays	O
.	O

Comparative	O
analysis	O
of	O
the	O
frameshift	O
region	O
reveals	O
a	O
universal	O
shift	O
site	O
U_UUA_AAC	O
,	O
followed	O
by	O
a	O
predicted	O
downstream	O
RNA	O
structure	O
in	O
the	O
form	O
of	O
either	O
a	O
pseudoknot	O
or	O
kissing	O
stem	B-ANAT
loops	O
.	O

Analysis	O
of	O
the	O
downstream	O
pseudoknot	O
stimulator	O
of	O
frameshifting	O
in	O
SARS	O
-	O
CoV	O
shows	O
that	O
a	O
proposed	O
RNA	O
secondary	O
structure	O
in	O
loop	O
II	O
and	O
two	O
unpaired	O
nucleotides	O
at	O
the	O
stem	B-ANAT
I	O
-	O
stem	B-ANAT
II	O
junction	O
in	O
SARS	O
-	O
CoV	O
are	O
important	O
for	O
frameshift	O
stimulation	O
.	O

TITLE	O
:	O
Surviving	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
utility	O
of	O
open	O
-	O
lung	B-ANAT
biopsy	O
and	O
large	O
doses	O
of	O
dexamethasone	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
was	O
proven	O
and	O
other	O
etiologies	O
of	O
respiratory	O
failure	O
were	O
ruled	O
out	O
by	O
a	O
bedside	O
open	O
-	O
lung	B-ANAT
biopsy	O
.	O

The	O
virus	O
was	O
detected	O
in	O
fecal	B-ANAT
and	O
respiratory	B-ANAT
samples	I-ANAT
from	O
three	O
bat	O
species	O
(	O
Miniopterus	O
spp	O
.).	O

By	O
contrast	O
,	O
IRF	O
-	O
3	O
remained	O
in	O
the	O
nucleus	B-ANAT
of	O
cells	B-ANAT
infected	O
with	O
the	O
IFN	O
-	O
inducing	O
control	O
virus	O
Bunyamwera	O
delNSs	O
.	O

ABSTRACT	O
:	O
Within	O
a	O
few	O
minutes	O
of	O
an	O
intravenous	O
injection	O
of	O
a	O
lipopolysaccharide	O
(	O
LPS	O
)	O
into	O
mice	O
,	O
platelets	B-ANAT
accumulate	O
,	O
largely	O
in	O
the	O
lung	B-ANAT
.	O

These	O
results	O
suggest	O
that	O
platelets	B-ANAT
play	O
important	O
roles	O
in	O
the	O
development	O
of	O
both	O
the	O
rapid	O
and	O
delayed	O
types	O
of	O
shock	O
induced	O
by	O
LPS	O
.	O

The	O
recombinant	O
protein	O
could	O
be	O
used	O
as	O
an	O
antigen	O
for	O
detecting	O
the	O
serum	B-ANAT
of	O
SARS	O
CoV	O
-	O
infected	O
patients	O
.	O

The	O
maximum	O
diameter	O
of	O
experimentally	O
induced	O
lesions	O
in	O
muscle	B-ANAT
at	O
necropsy	O
60	O
days	O
after	O
injection	O
with	O
the	O
recommended	O
dose	O
of	O
the	O
bacterin	O
-	O
toxoid	O
vaccines	O
was	O
12	O
cm	O
.	O

Acute	O
transient	O
lameness	O
on	O
the	O
ranch	O
was	O
attributed	O
to	O
use	O
of	O
2	O
irritating	O
biological	O
vaccines	O
in	O
the	O
hip	B-ANAT
muscles	I-ANAT
of	O
cows	O
that	O
were	O
close	O
to	O
parturition	O
.	O

ABSTRACT	O
:	O
Chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
is	O
a	O
major	O
public	O
health	O
problem	O
and	O
its	O
prevalence	O
and	O
mortality	O
are	O
increasing	O
throughout	O
the	O
world	O
,	O
including	O
the	O
Asia	O
-	O
Pacific	O
region	O
.	O

To	O
arrest	O
these	O
worldwide	O
trends	O
,	O
the	O
Global	O
Initiative	O
for	O
Chronic	O
Obstructive	O
Lung	B-ANAT
Disease	O
(	O
GOLD	O
)	O
Expert	O
Panel	O
'	O
s	O
global	O
strategy	O
for	O
the	O
diagnosis	O
,	O
management	O
,	O
and	O
prevention	O
of	O
COPD	O
was	O
published	O
in	O
2001	O
.	O

The	O
key	O
issues	O
identified	O
by	O
the	O
COPD	O
Roundtable	O
Group	O
for	O
comment	O
are	O
:	O
(	O
i	O
)	O
where	O
there	O
is	O
no	O
access	O
to	O
spirometry	O
,	O
diagnosis	O
of	O
COPD	O
could	O
be	O
suspected	O
on	O
the	O
basis	O
of	O
history	O
,	O
symptoms	O
and	O
physical	O
signs	O
;	O
(	O
ii	O
)	O
inhaled	O
bronchodilators	O
are	O
the	O
preferred	O
regular	O
treatment	O
for	O
COPD	O
in	O
the	O
region	O
,	O
but	O
oral	B-ANAT
bronchodilators	O
may	O
be	O
considered	O
if	O
the	O
cost	O
of	O
inhaled	O
bronchodilators	O
is	O
a	O
barrier	O
to	O
treatment	O
;	O
(	O
iii	O
)	O
the	O
use	O
of	O
a	O
Metered	O
Dose	O
Inhaler	O
with	O
spacer	O
in	O
place	O
of	O
a	O
nebulizer	O
is	O
recommended	O
in	O
the	O
treatment	O
of	O
acute	O
airflow	O
obstruction	O
in	O
patients	O
with	O
COPD	O
;	O
(	O
iv	O
)	O
influenza	O
vaccination	O
is	O
recommended	O
for	O
all	O
patients	O
with	O
COPD	O
in	O
communities	O
where	O
there	O
is	O
a	O
high	O
likelihood	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
;	O
and	O
(	O
v	O
)	O
simplified	O
pulmonary	B-ANAT
rehabilitation	O
programmes	O
should	O
be	O
established	O
in	O
areas	O
where	O
comprehensive	O
programmes	O
are	O
unavailable	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
the	O
incidence	O
of	O
atypical	O
presentation	O
of	O
chronic	O
lung	B-ANAT
disease	O
(	O
CLD	O
)	O
that	O
develops	O
in	O
infants	O
without	O
a	O
history	O
of	O
preceding	O
respiratory	O
distress	O
syndrome	O
(	O
RDS	O
)	O
is	O
increasing	O
.	O

Chorioamnionitis	O
was	O
significantly	O
more	O
common	O
in	O
CLD	O
without	O
RDS	O
,	O
while	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
was	O
more	O
common	O
in	O
CLD	O
with	O
RDS	O
.	O

Analysis	O
of	O
sequential	O
SARS	O
-	O
CoV	O
load	O
in	O
plasma	B-ANAT
from	O
six	O
cases	O
revealed	O
different	O
patterns	O
of	O
viremia	O
,	O
with	O
the	O
peak	O
between	O
day	O
4	O
and	O
day	O
8	O
.	O

Pulmonary	B-ANAT
lesions	O
in	O
patients	O
with	O
SARS	O
are	O
thought	O
to	O
result	O
from	O
proinflammatory	O
cytokine	O
dysregulation	O
.	O

Serum	B-ANAT
IL	O
-	O
8	O
levels	O
correlated	O
significantly	O
with	O
FE	O
UA	O
(	O
P	O
<	O
0	O
.	O
001	O
;	O
r	O
=	O
0	O
.	O
785	O
)	O
and	O
inversely	O
with	O
serum	B-ANAT
UA	O
level	O
(	O
P	O
=	O
0	O
.	O
044	O
;	O
r	O
=	O
-	O
0	O
.	O
509	O
);	O
neither	O
IL	O
-	O
6	O
nor	O
TNF	O
-	O
alpha	O
level	O
showed	O
such	O
correlations	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
N195	O
-	O
Sc	O
fusion	O
protein	O
was	O
highly	O
expressed	O
in	O
insect	O
(	O
Sf9	O
)	O
cells	B-ANAT
infected	O
with	O
a	O
recombinant	O
baculovirus	O
bearing	O
the	O
hybrid	O
gene	O
under	O
the	O
control	O
of	O
a	O
polyhedrin	O
promoter	O
.	O

ABSTRACT	O
:	O
A	O
recent	O
publication	O
reported	O
that	O
a	O
tyrosine	O
-	O
dependent	O
sorting	O
signal	O
,	O
present	O
in	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
the	O
spike	O
protein	O
of	O
most	O
coronaviruses	O
,	O
mediates	O
the	O
intracellular	B-ANAT
retention	O
of	O
the	O
spike	O
protein	O
.	O

ABSTRACT	O
:	O
Reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
amplification	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
successfully	O
detected	O
36	O
strains	O
from	O
the	O
faeces	B-ANAT
of	O
mice	O
that	O
had	O
been	O
housed	O
in	O
animal	O
facilities	O
in	O
Japan	O
from	O
2000	O
to	O
2003	O
.	O

Clinical	O
profiles	O
,	O
joint	B-ANAT
symptoms	O
,	O
relevant	O
past	O
medical	O
and	O
drug	O
history	O
,	O
steroid	O
dose	O
,	O
and	O
radiographic	O
and	O
MR	O
imaging	O
evidence	O
of	O
osteonecrosis	O
and	O
other	O
bone	B-ANAT
abnormalities	O
were	O
evaluated	O
.	O

No	O
relationship	O
was	O
found	O
between	O
additional	O
nonspecific	O
bone	B-ANAT
marrow	I-ANAT
abnormalities	O
and	O
steroid	O
dose	O
.	O

Joint	B-ANAT
pain	O
was	O
common	O
after	O
SARS	O
infection	O
and	O
was	O
not	O
a	O
useful	O
clinical	O
indicator	O
of	O
osteonecrosis	O
.	O

No	O
relationship	O
was	O
found	O
between	O
additional	O
nonspecific	O
bone	B-ANAT
marrow	I-ANAT
abnormalities	O
and	O
steroid	O
dose	O
.	O

After	O
the	O
intramuscular	O
introduction	O
into	O
animals	O
,	O
we	O
observed	O
that	O
the	O
constructs	O
of	O
the	O
E	O
,	O
M	O
,	O
and	O
N	O
genes	O
could	O
induce	O
high	O
levels	O
of	O
specific	O
antibodies	O
,	O
T	B-ANAT
cell	I-ANAT
proliferations	O
,	O
IFN	O
-	O
gamma	O
,	O
DTH	O
responses	O
,	O
and	O
in	O
vivo	O
cytotoxic	B-ANAT
T	I-ANAT
cells	I-ANAT
activities	O
specifically	O
against	O
SARS	O
-	O
CoV	O
antigens	O
.	O

These	O
investigations	O
can	O
be	O
broadly	O
classified	O
into	O
three	O
groups	O
:	O
(	O
a	O
)	O
studies	O
on	O
the	O
replicase	O
1a	O
/	O
1b	O
gene	O
products	O
which	O
are	O
important	O
for	O
viral	O
replication	O
,	O
(	O
b	O
)	O
studies	O
on	O
the	O
structural	O
proteins	O
,	O
spike	O
,	O
nucleocapsid	B-ANAT
,	O
membrane	B-ANAT
and	O
envelope	B-ANAT
,	O
which	O
have	O
homologues	O
in	O
all	O
coronaviruses	O
,	O
and	O
are	O
important	O
for	O
viral	O
assembly	O
and	O
(	O
c	O
)	O
expression	O
and	O
functional	O
studies	O
of	O
the	O
""""	O
accessory	O
""""	O
proteins	O
that	O
are	O
specifically	O
encoded	O
by	O
SARS	O
-	O
CoV	O
.	O
A	O
comparison	O
of	O
the	O
properties	O
of	O
these	O
three	O
groups	O
of	O
SARS	O
-	O
CoV	O
proteins	O
with	O
the	O
knowledge	O
that	O
coronavirologists	O
have	O
generated	O
over	O
more	O
than	O
30	O
years	O
of	O
research	O
can	O
help	O
us	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
SARS	O
in	O
the	O
event	O
of	O
the	O
re	O
-	O
emergence	O
of	O
this	O
new	O
infectious	O
disease	O
.	O

It	O
is	O
often	O
due	O
to	O
an	O
immunological	O
conflict	O
between	O
transfused	O
plasma	B-ANAT
antibodies	O
and	O
recipients	O
'	O
blood	B-ANAT
cells	I-ANAT
.	O

After	O
two	O
intramuscular	O
vaccinations	O
with	O
ADS	O
-	O
MVA	O
alone	O
,	O
the	O
50	O
%	O
inhibitory	O
concentration	O
in	O
serum	B-ANAT
was	O
achieved	O
with	O
reciprocal	O
sera	B-ANAT
dilutions	O
of	O
more	O
than	O
1	O
,	O
000	O
-	O
to	O
10	O
,	O
000	O
-	O
fold	O
in	O
these	O
animals	O
.	O

Our	O
data	O
suggest	O
that	O
a	O
major	O
mechanism	O
for	O
neutralizing	O
SARS	O
-	O
CoV	O
likely	O
occurs	O
through	O
blocking	O
the	O
interaction	O
between	O
virus	O
and	O
the	O
cellular	B-ANAT
receptor	O
ACE2	O
.	O

TITLE	O
:	O
West	O
Nile	O
virus	O
infection	O
:	O
MR	O
imaging	O
findings	O
in	O
the	O
nervous	B-ANAT
system	I-ANAT
.	O

We	O
reviewed	O
14	O
brain	B-ANAT
and	O
three	O
spinal	O
MR	O
images	O
:	O
nonenhanced	O
and	O
contrast	O
-	O
enhanced	O
T1	O
-	O
weighted	O
images	O
(	O
T1WIs	O
)	O
and	O
T2	O
-	O
weighted	O
images	O
(	O
T2WIs	O
),	O
nonenhanced	O
fluid	O
-	O
attenuated	O
inversion	O
recovery	O
(	O
FLAIR	O
)	O
images	O
(	O
11	O
patients	O
)	O
and	O
enhanced	O
FLAIR	O
images	O
(	O
three	O
patients	O
),	O
with	O
diffusion	O
-	O
weighted	O
(	O
DW	O
)	O
images	O
and	O
apparent	O
diffusion	O
coefficient	O
maps	O
.	O

The	O
neutrophil	B-ANAT
count	O
was	O
determined	O
hourly	O
.	O

CONCLUSIONS	O
:	O
Histopathology	O
suggests	O
that	O
acid	O
aspiration	O
induced	O
acute	O
lung	B-ANAT
injury	O
can	O
be	O
effectively	O
treated	O
by	O
lidocaine	O
and	O
methylprednisolone	O
,	O
if	O
applied	O
early	O
.	O

In	O
support	O
of	O
this	O
,	O
we	O
have	O
observed	O
only	O
dimeric	O
,	O
trimeric	O
,	O
and	O
pentameric	O
aggregates	O
for	O
the	O
synthetic	O
transmembrane	B-ANAT
domain	O
of	O
SARS	O
protein	O
E	O
in	O
SDS	O
.	O

The	O
cerebrospinal	B-ANAT
fluid	I-ANAT
contained	O
1	O
white	B-ANAT
cell	I-ANAT
per	O
cubic	O
millimeter	O
,	O
normal	O
glucose	O
levels	O
,	O
and	O
increased	O
levels	O
of	O
protein	O
(	O
0	O
.	O
81	O
g	O
per	O
liter	O
).	O

TITLE	O
:	O
[	O
How	O
to	O
choose	O
the	O
duration	O
of	O
prone	O
-	O
position	O
ventilation	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
pulmonary	B-ANAT
or	O
extrapulmonary	O
diseases	O
?].	O

In	O
ARDSp	O
,	O
the	O
airway	B-ANAT
resistance	O
was	O
(	O
10	O
.	O
8	O
+/-	O
1	O
.	O
4	O
)	O
cm	O
H2O	O
.	O
s	O
(-	O
1	O
).	O
L	O
(-	O
1	O
)	O
in	O
the	O
supine	O
position	O
,	O
and	O
it	O
was	O
significantly	O
decreased	O
after	O
2	O
h	O
in	O
the	O
prone	O
position	O
(	O
8	O
.	O
4	O
+/-	O

The	O
numbers	O
of	O
peripheral	O
white	B-ANAT
blood	I-ANAT
cells	I-ANAT
and	O
lymphocytes	B-ANAT
were	O
in	O
the	O
normal	O
range	O
without	O
any	O
specific	O
changes	O
typical	O
of	O
SARS	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
explore	O
the	O
clinical	O
characteristics	O
and	O
mechanisms	O
of	O
liver	B-ANAT
damage	O
.	O

The	O
algorithm	O
converges	O
extremely	O
rapidly	O
,	O
gives	O
accurate	O
results	O
on	O
simulated	O
data	O
that	O
are	O
an	O
improvement	O
over	O
parsimonious	O
estimates	O
(	O
which	O
are	O
shown	O
to	O
underestimate	O
the	O
true	O
indel	O
rate	O
),	O
and	O
gives	O
plausible	O
results	O
on	O
experimental	O
data	O
(	O
coronavirus	O
envelope	B-ANAT
domains	O
).	O

We	O
determined	O
the	O
continuous	O
viral	O
epitopes	O
targeted	O
by	O
antibodies	O
in	O
plasma	B-ANAT
samples	O
from	O
convalescent	O
SARS	O
patients	O
through	O
biopanning	O
with	O
a	O
vast	O
M13	O
phage	O
display	O
dodecapeptide	O
library	O
.	O

SARS	O
-	O
CoV	O
produced	O
a	O
lytic	O
infection	O
in	O
Vero	O
,	O
Vero	O
E6	O
,	O
and	O
MA104	O
cells	B-ANAT
,	O
but	O
there	O
was	O
no	O
visible	O
cytopathic	O
effect	O
in	O
Caco	O
-	O
2	O
,	O
Mv	O
1	O
Lu	O
,	O
or	O
PK	O
(	O
15	O
)	O
cells	B-ANAT
.	O

RESULTS	O
:	O
The	O
number	O
of	O
mononuclear	B-ANAT
cells	I-ANAT
collected	O
from	O
bone	B-ANAT
marrow	I-ANAT
or	O
peripheral	B-ANAT
blood	I-ANAT
was	O
equal	O
to	O
(	O
5	O
.	O
4	O
+/-	O
2	O
.	O
1	O
)	O
x	O
10	O
(	O
8	O
)/	O
kg	O
and	O
(	O
4	O
.	O
1	O
+/-	O
1	O
.	O
9	O
)	O
x	O
10	O
(	O
8	O
)/	O
kg	O
,	O
respectively	O
.	O

Random	O
-	O
digit	B-ANAT
dialing	O
of	O
the	O
local	O
residential	O
telephone	O
directory	O
was	O
used	O
to	O
select	O
respondents	O
,	O
who	O
were	O
asked	O
to	O
provide	O
information	O
on	O
their	O
practice	O
of	O
SARS	O
preventive	O
health	O
behaviors	O
and	O
associated	O
factors	O
as	O
specified	O
by	O
the	O
Health	O
Belief	O
Model	O
.	O

A	O
total	O
of	O
10	O
anesthetised	O
/	O
paralysed	O
,	O
mechanically	O
ventilated	O
(	O
V	O
(	O
T	O
)	O
=	O
9	O
.	O
0	O
+/-	O
0	O
.	O
9	O
mL	O
.	O
kg	O
(-	O
1	O
)	O
predicted	O
body	B-ANAT
weight	O
;	O
flow	O
=	O
0	O
.	O
91	O
+/-	O
0	O
.	O
04	O
L	O
.	O
s	O
(-	O
1	O
);	O
PEEP	O
=	O
9	O
.	O
4	O
+/-	O
1	O
.	O
3	O
cmH	O
(	O
2	O
)	O
O	O
)	O
patients	O
with	O
early	O
/	O
severe	O
ARDS	O
were	O
studied	O
in	O
pre	O
-	O
prone	O
semirecumbent	O
(	O
SR	O
(	O
BAS	O
)),	O
prone	O
,	O
and	O
SR	O
(	O
PP	O
)	O
positions	O
.	O

Occurrence	O
of	O
CoV	O
disease	O
at	O
mucosal	B-ANAT
surfaces	O
necessitates	O
the	O
stimulation	O
of	O
local	O
immunity	O
,	O
having	O
an	O
impact	O
on	O
the	O
vaccine	O
type	O
,	O
delivery	O
and	O
adjuvant	O
needed	O
to	O
achieve	O
mucosal	B-ANAT
immunity	O
.	O

ABSTRACT	O
:	O
Catastrophic	O
antiphospholipid	O
syndrome	O
(	O
CAPS	O
)	O
is	O
a	O
severe	O
and	O
rare	O
variant	O
of	O
antiphospholipid	O
syndrome	O
(	O
APS	O
)	O
characterized	O
by	O
acute	O
multiorgan	O
failure	O
due	O
to	O
small	B-ANAT
vessel	I-ANAT
thrombi	O
in	O
patients	O
with	O
positive	O
antiphospholipid	O
antibodies	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
hospital	O
because	O
of	O
severe	O
foot	B-ANAT
pain	O
following	O
several	O
weeks	O
of	O
skin	B-ANAT
ulcerations	O
.	O

ABSTRACT	O
:	O
Mice	O
infected	O
with	O
mouse	O
hepatitis	O
virus	O
strain	O
JHM	O
develop	O
an	O
inflammatory	O
demyelinating	O
disease	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
with	O
many	O
similarities	O
to	O
human	O
multiple	O
sclerosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
anti	O
-	O
JHM	O
antibodies	O
,	O
in	O
the	O
absence	O
of	O
T	O
or	O
B	B-ANAT
cells	I-ANAT
,	O
caused	O
demyelination	O
in	O
JHM	O
-	O
infected	O
mice	O
.	O

This	O
viral	B-ANAT
genome	I-ANAT
consists	O
of	O
29	O
,	O
728	O
nucleotides	O
with	O
overall	O
organization	O
in	O
agreement	O
with	O
that	O
of	O
published	O
isolates	O
.	O

In	O
order	O
to	O
understand	O
the	O
efficacy	O
and	O
safety	O
of	O
this	O
approach	O
,	O
it	O
is	O
important	O
to	O
know	O
the	O
antibody	O
specificities	O
generated	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
.	O
In	O
the	O
current	O
study	O
,	O
a	O
panel	O
of	O
twelve	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
was	O
established	O
by	O
immunizing	O
Balb	O
/	O
c	O
mice	O
with	O
the	O
inactivated	O
BJ01	O
strain	O
of	O
SARS	O
-	O
CoV	O
isolated	O
from	O
the	O
lung	B-ANAT
tissue	I-ANAT
of	O
a	O
SARS	O
-	O
infected	O
Chinese	O
patient	O
.	O

These	O
mAbs	O
could	O
recognize	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
by	O
immunofluorescence	O
analysis	O
(	O
IFA	O
).	O

Therefore	O
,	O
we	O
investigated	O
the	O
causative	O
agents	O
of	O
WD	O
by	O
using	O
electron	O
microscopy	O
,	O
ELISA	O
,	O
RT	O
-	O
PCR	O
,	O
and	O
nested	O
PCR	O
from	O
97	O
fecal	B-ANAT
samples	O
of	O
32	O
WD	O
-	O
affected	O
herds	O
collected	O
from	O
8	O
provinces	O
during	O
2002	O
-	O
2004	O
.	O

Adverse	O
effects	O
occur	O
with	O
G	O
-	O
CSF	B-ANAT
use	O
in	O
approximately	O
30	O
%	O
of	O
cases	O
,	O
comprised	O
predominantly	O
of	O
bone	B-ANAT
pain	O
,	O
headache	O
,	O
and	O
general	O
fatigue	O
.	O

Pulmonary	B-ANAT
complications	O
caused	O
by	O
G	O
-	O
CSF	B-ANAT
include	O
cough	O
,	O
dyspnea	O
,	O
and	O
interstitial	B-ANAT
or	O
alveolar	B-ANAT
pulmonary	B-ANAT
edema	O
with	O
mild	O
-	O
to	O
-	O
severe	O
deterioration	O
of	O
blood	B-ANAT
oxygen	O
level	O
.	O

A	O
specific	O
protocol	O
was	O
used	O
for	O
weaning	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
,	O
for	O
transitioning	O
to	O
conventional	O
ventilation	O
,	O
and	O
for	O
judging	O
intolerance	O
of	O
conventional	O
ventilation	O
whereby	O
patients	O
should	O
be	O
put	O
back	B-ANAT
on	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
.	O

TITLE	O
:	O
Secondary	O
effects	O
of	O
femoral	B-ANAT
instrumentation	O
on	O
pulmonary	B-ANAT
physiology	O
in	O
a	O
standardised	O
sheep	O
model	O
:	O
what	O
is	O
the	O
effect	O
of	O
lung	B-ANAT
contusion	O
and	O
reaming	O
?	O

In	O
control	O
groups	O
,	O
only	O
a	O
sham	O
operation	O
(	O
thoracotomy	O
)	O
was	O
performed	O
,	O
whereas	O
in	O
study	O
groups	O
,	O
lung	B-ANAT
contusion	O
was	O
induced	O
prior	O
to	O
femoral	B-ANAT
stabilisation	O
either	O
by	O
external	O
fixation	O
or	O
reamed	O
femoral	B-ANAT
nailing	O
.	O

In	O
this	O
communication	O
,	O
we	O
evaluated	O
the	O
efficacy	O
and	O
safety	O
of	O
two	O
SARS	O
vaccine	O
candidates	O
based	O
on	O
the	O
recombinant	O
modified	O
vaccinia	O
Ankara	O
(	O
MVA	O
)	O
expressing	O
SARS	O
-	O
CoV	O
spike	O
or	O
nucleocapsid	B-ANAT
proteins	O
in	O
ferrets	O
.	O

Reduced	O
dose	O
effective	O
and	O
less	O
expensive	O
post	O
-	O
exposure	O
vaccination	O
regimens	O
have	O
helped	O
eliminate	O
nerve	B-ANAT
tissue	I-ANAT
vaccines	O
in	O
Thailand	O
,	O
Philippines	O
and	O
Sri	O
Lanka	O
.	O

India	O
and	O
Pakistan	O
,	O
the	O
major	O
users	O
of	O
dangerous	O
nerve	B-ANAT
tissue	I-ANAT
derived	O
Semple	O
type	O
vaccine	O
,	O
are	O
now	O
considering	O
following	O
suite	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
3a	O
protein	O
was	O
a	O
unique	O
protein	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
which	O
was	O
identified	O
in	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
and	O
SARS	O
patients	O
'	O
specimen	O
.	O

With	O
the	O
assay	O
of	O
truncated	O
3a	O
protein	O
,	O
it	O
was	O
shown	O
that	O
3a	O
might	O
contain	O
three	O
transmembrane	B-ANAT
regions	O
,	O
and	O
the	O
second	O
or	O
third	O
region	O
was	O
properly	O
responsible	O
for	O
Golgi	B-ANAT
localization	O
.	O

By	O
ultra	O
-	O
centrifugation	O
experiment	O
with	O
different	O
extraction	O
buffers	O
,	O
it	O
was	O
confirmed	O
that	O
3a	O
was	O
an	O
integral	O
membrane	B-ANAT
protein	O
and	O
embedded	O
in	O
the	O
phospholipid	O
bilayer	O
.	O

Immunofluorescence	O
assay	O
indicated	O
that	O
3a	O
was	O
co	O
-	O
localized	O
with	O
M	O
protein	O
in	O
Golgi	B-ANAT
complex	I-ANAT
in	O
co	O
-	O
transfected	O
cells	B-ANAT
.	O

These	O
findings	O
suggest	O
that	O
oxymatrine	O
has	O
a	O
beneficial	O
effect	O
on	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
oleic	O
acid	O
in	O
mice	O
and	O
may	O
inhibit	O
the	O
production	O
of	O
proinflammatory	O
cytokine	O
,	O
TNF	O
-	O
alpha	O
,	O
by	O
means	O
of	O
the	O
inhibition	O
of	O
p38	O
MAPK	O
.	O

The	O
mortality	O
that	O
occurred	O
using	O
this	O
less	O
-	O
attenuated	O
vaccine	O
was	O
significantly	O
influenced	O
by	O
the	O
genetic	O
line	O
,	O
and	O
the	O
MHC	B-ANAT
(	O
B	O
)	O
haplotype	O
in	O
chickens	O
of	O
three	O
B	O
congenic	O
lines	O
.	O

The	O
experiments	O
were	O
performed	O
using	O
in	O
vitro	O
cultivated	O
monkey	O
Vero	O
E6	O
cells	B-ANAT
.	O

Only	O
focal	O
pulmonary	B-ANAT
edema	O
or	O
hemorrhage	O
was	O
seen	O
.	O

The	O
lung	B-ANAT
biopsy	O
specimen	B-ANAT
from	I-ANAT
patient	I-ANAT
4	O
taken	O
21	O
days	O
after	O
symptom	O
onset	O
showed	O
characteristics	O
of	O
the	O
fibrotic	O
stage	O
,	O
with	O
significant	O
myofibroblastic	O
proliferation	O
in	O
the	O
alveolar	B-ANAT
space	O
and	O
interstitium	B-ANAT
resulting	O
in	O
loss	O
of	O
pulmonary	B-ANAT
architecture	O
.	O

TITLE	O
:	O
Viral	O
induction	O
of	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
innate	O
immune	O
responses	O
.	O

In	O
addition	O
,	O
mRNA	O
expression	O
of	O
nonclassical	O
class	O
I	O
molecules	O
H2	O
-	O
T10	B-ANAT
,	O
-	O
T17	O
,	O
-	O
M2	O
,	O
and	O
-	O
Q10	O
,	O
were	O
enhanced	O
three	O
-	O
to	O
fivefold	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
compared	O
to	O
sham	O
-	O
infected	O
cells	B-ANAT
.	O

The	O
lab	O
detective	O
method	O
of	O
ELISA	O
was	O
adopted	O
for	O
these	O
serum	B-ANAT
samples	O
.	O

Physical	O
parameters	O
such	O
as	O
SCL	O
-	O
90	O
,	O
chest	B-ANAT
CT	O
,	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
subset	O
and	O
SaO2	O
were	O
studied	O
in	O
29	O
SARS	O
patients	O
at	O
three	O
different	O
stages	O
(	O
initial	O
stage	O
,	O
serious	O
stage	O
,	O
rehabilitating	O
stage	O
).	O

TITLE	O
:	O
Multimodal	O
percutaneous	O
intervention	O
for	O
critical	O
venous	B-ANAT
occlusive	O
disease	O
.	O

The	O
venous	B-ANAT
access	O
site	O
was	O
determined	O
by	O
the	O
anatomic	B-ANAT
location	I-ANAT
of	O
the	O
lesion	O
and	O
included	O
popliteal	B-ANAT
,	O
femoral	B-ANAT
,	O
brachial	O
,	O
and	O
lesser	O
saphenous	O
.	O

ABSTRACT	O
:	O
The	O
medical	O
records	O
of	O
62	O
cats	O
with	O
clinical	O
signs	O
of	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
disease	O
and	O
accompanying	O
inflammatory	O
cerebrospinal	B-ANAT
fluid	I-ANAT
(	O
CSF	B-ANAT
)	O
analysis	O
were	O
examined	O
retrospectively	O
to	O
determine	O
if	O
signalment	O
,	O
clinical	O
signs	O
,	O
CSF	B-ANAT
analysis	O
and	O
ancillary	O
testing	O
could	O
accurately	O
predict	O
the	O
type	O
of	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
disease	O
that	O
was	O
present	O
.	O

ABSTRACT	O
:	O
Few	O
investigations	O
have	O
prospectively	O
examined	O
extravascular	O
lung	B-ANAT
water	O
(	O
EVLW	O
)	O
in	O
patients	O
with	O
severe	O
sepsis	O
.	O

Eight	O
out	O
of	O
14	O
patients	O
(	O
57	O
%)	O
with	O
non	O
-	O
ARDS	O
severe	O
sepsis	O
had	O
high	O
EVLW	O
with	O
significantly	O
greater	O
hypoxemia	O
than	O
did	O
those	O
patient	O
with	O
low	O
EVLW	O
(	O
mean	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
fractional	O
inspired	O
oxygen	O
ratio	O
230	O
.	O
7	O
+/-	O

Lung	B-ANAT
function	O
and	O
lung	B-ANAT
imaging	O
were	O
abnormal	O
in	O
some	O
patients	O
with	O
SARS	O
after	O
recovery	O
.	O

It	O
is	O
suggested	O
that	O
the	O
lung	B-ANAT
damage	O
is	O
chronic	O
,	O
and	O
follow	O
-	O
up	O
is	O
needed	O
.	O

TITLE	O
:	O
The	O
influence	O
of	O
iloprost	O
on	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
hind	B-ANAT
limb	I-ANAT
ischemia	O
-	O
reperfusion	O
in	O
rats	O
.	O

ABSTRACT	O
:	O
The	O
local	O
ischemia	O
-	O
reperfusion	O
(	O
I	O
/	O
R	O
)	O
process	O
gains	O
a	O
systemic	O
nature	O
and	O
affects	O
distal	O
organs	B-ANAT
.	O

In	O
this	O
hind	B-ANAT
limb	I-ANAT
I	O
/	O
R	O
induced	O
experimental	O
lung	B-ANAT
injury	O
model	O
two	O
groups	O
of	O
rats	O
as	O
IR	O
and	O
ILO	O
were	O
determined	O
.	O

Iloprost	O
has	O
been	O
found	O
to	O
be	O
effective	O
in	O
attenuating	O
ischemia	O
reperfusion	O
-	O
induced	O
remote	O
organ	B-ANAT
damage	O
,	O
in	O
this	O
case	O
,	O
lung	B-ANAT
injury	O
,	O
in	O
rats	O
.	O

ABSTRACT	O
:	O
Vero	O
E6	O
African	O
green	O
monkey	O
kidney	B-ANAT
cells	B-ANAT
are	O
highly	O
susceptible	O
to	O
infection	O
with	O
the	O
newly	O
emerging	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
and	O
they	O
are	O
permissive	O
for	O
rapid	O
viral	O
replication	O
,	O
with	O
resultant	O
cytopathic	O
effects	O
.	O

Immunofluorescence	O
techniques	O
,	O
immunohistochemical	O
(	O
IH	O
)	O
staining	O
and	O
electron	O
microscopy	O
were	O
subsequently	O
employed	O
to	O
investigate	O
the	O
cell	B-ANAT
layers	B-ANAT
.	O

ABSTRACT	O
:	O
Entry	O
of	O
SARS	O
-	O
CoV	O
into	O
a	O
target	B-ANAT
cell	I-ANAT
is	O
initiated	O
by	O
binding	O
of	O
the	O
S1	O
domain	O
of	O
spike	O
protein	O
to	O
a	O
receptor	O
,	O
followed	O
by	O
conformational	O
changes	O
of	O
the	O
spike	O
protein	O
S2	O
domain	O
,	O
resulting	O
in	O
the	O
formation	O
of	O
a	O
six	O
-	O
helix	O
bundle	O
by	O
the	O
heptad	O
-	O
repeat	O
(	O
HR1	O
and	O
HR2	O
)	O
regions	O
.	O

Furthermore	O
,	O
co	O
-	O
expression	O
of	O
3a	O
,	O
membrane	B-ANAT
and	O
envelope	B-ANAT
proteins	O
using	O
the	O
baculovirus	O
system	O
showed	O
that	O
both	O
full	O
-	O
length	O
and	O
truncated	O
3a	O
can	O
be	O
assembled	O
into	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
.	O

All	O
had	O
raised	O
plasma	B-ANAT
interferon	O
gamma	O
inducible	O
protein	O
(	O
IP	O
-	O
10	O
)	O
concentrations	O
,	O
which	O
suggested	O
an	O
active	O
type	O
1	O
T	B-ANAT
-	I-ANAT
helper	I-ANAT
lymphocyte	I-ANAT
mediated	O
immune	O
response	O
.	O

Serum	B-ANAT
,	O
faecal	B-ANAT
and	O
nasal	B-ANAT
swab	O
samples	O
were	O
collected	O
from	O
a	O
total	O
of	O
96	O
cattle	O
with	O
clinical	O
signs	O
in	O
29	O
barns	O
of	O
23	O
villages	O
in	O
Northwestern	O
Turkey	O
.	O

An	O
indirect	O
antigen	O
-	O
capture	O
ELISA	O
and	O
an	O
antibody	O
-	O
detection	O
ELISA	O
as	O
well	O
as	O
geometric	O
mean	O
BCoV	O
antibody	O
titres	O
were	O
used	O
to	O
detect	O
BoCV	O
shed	O
in	O
the	O
faeces	B-ANAT
and	O
in	O
the	O
nasal	B-ANAT
secretions	B-ANAT
,	O
respectively	O
.	O

Regulated	O
on	O
activation	O
normally	O
T	B-ANAT
cell	I-ANAT
-	O
expressed	O
and	O
secreted	O
(	O
RANTES	O
)	O
levels	O
were	O
decreased	O
,	O
while	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
)	O
was	O
elevated	O
in	O
acute	O
patients	O
.	O

Moreover	O
isotope	O
-	O
coded	O
affinity	O
tag	O
technology	O
coupled	O
with	O
two	O
-	O
dimensional	O
LC	O
-	O
MS	O
/	O
MS	O
were	O
also	O
applied	O
to	O
the	O
differential	O
proteins	O
of	O
infected	O
cells	B-ANAT
.	O

The	O
mechanism	O
for	O
viral	O
persistence	O
is	O
consistent	O
with	O
the	O
formation	O
of	O
a	O
carrier	O
culture	O
whereby	O
a	O
limited	O
number	O
of	O
cells	B-ANAT
are	O
infected	O
with	O
each	O
round	O
of	O
virus	O
replication	O
and	O
release	O
.	O

TITLE	O
:	O
Persistent	O
shedding	O
of	O
viable	O
SARS	O
-	O
CoV	O
in	O
urine	B-ANAT
and	O
stool	B-ANAT
of	O
SARS	O
patients	O
during	O
the	O
convalescent	O
phase	O
.	O

TITLE	O
:	O
Recombinant	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
IgG	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
the	O
serological	O
diagnosis	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
The	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
(	O
rNP	B-ANAT
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
was	O
expressed	O
in	O
a	O
baculovirus	O
system	O
.	O

TITLE	O
:	O
Virus	O
-	O
specific	O
and	O
bystander	O
CD8	O
T	B-ANAT
cells	I-ANAT
recruited	O
during	O
virus	O
-	O
induced	O
encephalomyelitis	O
.	O

HIV	O
-	O
specific	O
memory	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
recruited	O
early	O
into	O
the	O
CNS	B-ANAT
as	O
components	O
of	O
the	O
innate	O
immune	O
response	O
,	O
preceding	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
specific	O
for	O
the	O
dominant	O
coronavirus	O
epitope	O
,	O
designated	O
pN	O
.	O
Although	O
pN	O
-	O
specific	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
numbers	O
gradually	O
exceeded	O
bystander	O
p18	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
numbers	O
,	O
both	O
populations	O
peaked	O
concurrently	O
within	O
the	O
CNS	B-ANAT
.	O

During	O
inflammation	O
TIMP	O
-	O
1	O
mRNA	O
was	O
most	O
prominently	O
expressed	O
by	O
infiltrating	O
cells	B-ANAT
.	O

Analysis	O
of	O
cytokine	O
and	O
chemokine	O
mRNA	O
induction	O
within	O
the	O
infected	O
CNS	B-ANAT
of	O
healthy	O
and	O
immunocompromised	O
mice	O
suggested	O
a	O
possible	O
correlation	O
between	O
increased	O
viral	O
replication	O
and	O
increased	O
levels	O
of	O
beta	O
interferon	O
,	O
MMP	O
-	O
3	O
,	O
MMP	O
-	O
12	O
,	O
and	O
TIMP	O
-	O
1	O
mRNA	O
.	O

RESULTS	O
:	O
In	O
the	O
SARS	O
epidemic	O
,	O
Artus	O
and	O
Roche	O
PCR	O
assays	O
exhibited	O
sensitivities	O
of	O
87	O
%	O
and	O
85	O
%	O
for	O
respiratory	O
specimens	O
(	O
n	O
=	O
64	O
),	O
91	O
%	O
and	O
88	O
%	O
for	O
stool	B-ANAT
(	O
n	O
=	O
44	O
),	O
and	O
82	O
%	O
for	O
urine	B-ANAT
(	O
n	O
=	O
29	O
).	O

Of	O
27	O
cases	O
with	O
fever	O
,	O
pneumonia	O
and	O
a	O
total	O
white	O
count	O
of	O
less	O
than	O
10	O
,	O
000	O
cells	B-ANAT
per	O
cubic	O
mm	O
as	O
per	O
Ministry	O
of	O
Health	O
,	O
Singapore	O
criteria	O
for	O
the	O
diagnosis	O
of	O
atypical	O
pneumonia	O
,	O
only	O
five	O
were	O
identified	O
by	O
clinicians	O
.	O

In	O
the	O
absence	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
,	O
fewer	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
are	O
found	O
within	O
the	O
CNS	B-ANAT
in	O
association	O
with	O
a	O
coordinate	O
increase	O
in	O
apoptotic	O
lymphocytes	B-ANAT
.	O

To	O
determine	O
the	O
in	O
vivo	O
role	O
of	O
IL	O
-	O
2	O
during	O
CNS	B-ANAT
infection	O
,	O
IL	O
-	O
2	O
signaling	O
was	O
inhibited	O
via	O
administration	O
of	O
a	O
neutralizing	O
IL	O
-	O
2	O
-	O
specific	O
monoclonal	O
antibody	O
(	O
mAb	O
).	O

Lung	B-ANAT
biopsy	O
confirmed	O
a	O
non	O
-	O
specific	O
interstitial	B-ANAT
pneumonia	O
,	O
and	O
the	O
patient	O
was	O
commenced	O
on	O
immune	O
suppressive	O
therapy	O
.	O

Most	O
patients	O
have	O
been	O
treated	O
throughout	O
the	O
illness	O
with	O
broad	O
-	O
spectrum	O
antimicrobials	O
,	O
supplemental	O
oxygen	O
,	O
intravenous	O
fluids	B-ANAT
,	O
and	O
other	O
supportive	O
measures	O
.	O

By	O
analysing	O
the	O
total	O
reporting	O
on	O
SARS	O
of	O
five	O
major	O
national	O
newspapers	O
during	O
the	O
epidemic	O
of	O
spring	O
2003	O
,	O
we	O
investigate	O
how	O
the	O
reporting	O
of	O
SARS	O
in	O
the	O
UK	O
press	O
was	O
framed	O
,	O
and	O
how	O
this	O
related	O
to	O
media	B-ANAT
,	O
public	O
and	O
governmental	O
responses	O
to	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
A	O
Saccharomyces	O
cerevisiae	O
-	O
expressed	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
polypeptide	O
of	O
the	O
M41	O
strain	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
was	O
used	O
as	O
antigen	O
in	O
a	O
recombinant	O
yeast	O
-	O
expressed	O
N	O
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
Y	O
-	O
N	O
-	O
ELISA	O
).	O

Common	O
clinical	O
manifestations	O
were	O
cough	O
(	O
74	O
%),	O
rhinorrhoea	O
(	O
59	O
%)	O
and	O
sore	O
throat	B-ANAT
(	O
53	O
%).	O

The	O
analysis	O
revealed	O
that	O
distributions	O
of	O
hexanucleotide	O
patterns	O
in	O
ribosomal	B-ANAT
RNA	I-ANAT
and	O
virus	O
genome	O
were	O
different	O
.	O

In	O
a	O
model	O
experiment	O
,	O
when	O
non	O
-	O
ribosomal	B-ANAT
hexanucleotides	O
were	O
used	O
as	O
primers	O
,	O
in	O
vitro	O
transcribed	O
plasmid	O
RNA	O
was	O
efficiently	O
reverse	O
transcribed	O
when	O
compared	O
with	O
ribosomal	B-ANAT
RNA	I-ANAT
of	O
rat	O
cells	B-ANAT
.	O

TITLE	O
:	O
Hepatobiliary	B-ANAT
pathology	O
.	O

Liver	B-ANAT
biopsy	O
findings	O
in	O
three	O
cases	O
were	O
reported	O
that	O
showed	O
a	O
generic	O
picture	O
of	O
hepatitis	O
,	O
with	O
exceptionally	O
increased	O
mitotic	O
activity	O
.	O

After	O
liver	B-ANAT
transplantation	O
,	O
differentiating	O
recurrent	O
HCV	O
infection	O
from	O
acute	O
rejection	O
on	O
liver	B-ANAT
biopsy	O
is	O
problematic	O
,	O
with	O
exceptionally	O
low	O
inter	O
-	O
and	O
intra	O
-	O
observer	O
reliability	O
shown	O
in	O
one	O
study	O
.	O

We	O
studied	O
the	O
pathologic	O
specimens	O
from	O
6	O
SARS	O
patients	O
by	O
immunohistochemical	O
staining	O
using	O
a	O
specific	O
antibody	O
against	O
SARS	O
-	O
CoV	O
.	O
Positive	O
viral	O
staining	O
was	O
only	O
found	O
in	O
the	O
lung	B-ANAT
tissue	I-ANAT
taken	O
from	O
the	O
patients	O
who	O
died	O
in	O
the	O
early	O
stage	O
of	O
the	O
disease	O
,	O
usually	O
less	O
than	O
10	O
days	O
after	O
symptom	O
onset	O
.	O

Occasional	O
intra	O
-	O
alveolar	B-ANAT
macrophages	I-ANAT
were	O
also	O
weakly	O
reactive	O
to	O
SARS	O
-	O
CoV	O
antibody	O
.	O

Recently	O
immigrated	O
children	O
face	B-ANAT
many	O
different	O
health	O
risks	O
when	O
compared	O
to	O
children	O
born	O
in	O
the	O
United	O
States	O
.	O

We	O
report	O
a	O
50	O
-	O
year	O
-	O
old	O
patient	O
with	O
recurrent	O
Candida	O
-	O
septicemia	O
:	O
rupture	O
of	O
the	O
distal	O
esophagus	B-ANAT
after	O
dilatation	O
because	O
of	O
cardiac	B-ANAT
achalasia	O
with	O
mediastinal	B-ANAT
emphysema	O
and	O
mediastinitis	O
.	O

Long	O
-	O
term	O
mechanical	O
ventilation	O
,	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
and	O
multifarious	O
antibiotic	O
therapy	O
.	O

In	O
the	O
further	O
clinical	O
course	O
,	O
detection	O
of	O
Pseudomonas	O
species	O
in	O
bronchoalveolar	O
lavages	O
and	O
Staphylococci	O
as	O
well	O
as	O
Enterococci	O
in	O
a	O
number	O
of	O
positive	O
blood	B-ANAT
cultures	O
.	O

developed	O
in	O
both	O
patients	O
owing	O
to	O
immunosuppression	O
,	O
in	O
one	O
patient	O
iatrogenically	O
induced	O
by	O
immunosuppressive	O
drugs	O
after	O
organ	B-ANAT
transplantation	O
,	O
in	O
the	O
other	O
as	O
a	O
result	O
of	O
prolonged	O
severe	O
sepsis	O
.	O

Acute	O
normovolaemic	O
haemodilution	O
is	O
a	O
consistent	O
and	O
cost	O
-	O
effective	O
blood	B-ANAT
conservation	O
strategy	O
in	O
reducing	O
allogenic	O
blood	B-ANAT
transfusion	O
for	O
radical	O
retropubic	O
prostatectomy	O
.	O

Presumed	O
viral	O
fever	O
and	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
were	O
the	O
most	O
common	O
diagnosis	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
investigate	O
,	O
in	O
rabbits	O
with	O
hydrochloric	O
(	O
HCl	O
)	O
acid	O
-	O
induced	O
Acute	O
Lung	B-ANAT
Injury	O
(	O
ALI	O
),	O
the	O
effects	O
of	O
intra	O
-	O
tracheal	O
(	O
i	O
.	O
t	O
.)	O
dexamethasone	O
administration	O
on	O
neutrophil	B-ANAT
and	O
platelet	B-ANAT
counts	O
,	O
plasma	B-ANAT
malonyl	O
dialdehyde	O
(	O
MDA	O
)	O
level	O
,	O
histopathology	O
,	O
and	O
arterial	B-ANAT
blood	I-ANAT
gases	O
.	O

RESULTS	O
:	O
Neutrophil	B-ANAT
and	O
platelets	B-ANAT
counts	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
PaO2	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
were	O
greater	O
in	O
the	O
dexamethasone	O
group	O
than	O
the	O
controls	O
at	O
five	O
hours	O
.	O

The	O
microtubule	B-ANAT
disruption	O
is	O
attributed	O
to	O
two	O
amino	O
acid	O
differences	O
in	O
M	O
protein	O
.	O

The	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
),	O
three	O
N	O
fragments	O
(	O
N1	O
,	O
N2	O
,	O
and	O
N3	O
)	O
and	O
the	O
intraviral	O
domain	O
of	O
the	O
membrane	B-ANAT
protein	O
(	O
M2	O
)	O
were	O
cloned	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
as	O
histidine	O
-	O
tagged	O
proteins	O
.	O

By	O
reviewing	O
past	O
similar	O
reports	O
,	O
we	O
noticed	O
that	O
AIP	O
associated	O
with	O
ITP	O
tends	O
to	O
manifest	O
severe	O
sensory	O
impairment	O
and	O
is	O
often	O
preceded	O
by	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
but	O
not	O
by	O
gastrointestinal	O
infection	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
was	O
not	O
present	O
in	O
any	O
SARS	O
patients	O
but	O
was	O
seen	O
in	O
6	O
of	O
26	O
non	O
-	O
SARS	O
cases	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

The	O
use	O
of	O
FTA	O
cards	O
for	O
the	O
collection	O
,	O
transport	O
,	O
and	O
storage	B-ANAT
of	O
IBV	O
-	O
containing	O
samples	O
is	O
safe	O
,	O
inexpensive	O
,	O
and	O
adequate	O
for	O
molecular	O
diagnosis	O
.	O

Herein	O
,	O
we	O
report	O
the	O
design	O
,	O
synthesis	O
,	O
and	O
in	O
vitro	O
analysis	O
of	O
a	O
hammerhead	O
ribozyme	O
targeted	O
to	O
the	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
nucleocapsid	B-ANAT
mRNA	O
.	O

TITLE	O
:	O
Cells	B-ANAT
of	O
human	O
aminopeptidase	O
N	O
(	O
CD13	O
)	O
transgenic	O
mice	O
are	O
infected	O
by	O
human	O
coronavirus	O
-	O
229E	O
in	O
vitro	O
,	O
but	O
not	O
in	O
vivo	O
.	O

As	O
expected	O
,	O
the	O
HR1	O
and	O
HR2	O
segments	O
are	O
organized	O
in	O
antiparallel	O
orientations	O
within	O
a	O
rod	B-ANAT
-	O
like	O
molecule	O
.	O

All	O
of	O
17	O
patients	O
with	O
injury	O
of	O
retroperitoneal	B-ANAT
rectum	B-ANAT
underwent	O
diverting	B-ANAT
colostomy	I-ANAT
of	O
the	O
proximal	O
end	O
of	O
sigmoid	B-ANAT
with	O
presacral	O
drainage	B-ANAT
,	O
but	O
4	O
received	O
primary	O
repair	O
without	O
colostomy	O
.	O

We	O
found	O
that	O
the	O
feline	O
infectious	O
peritonitis	O
virus	O
(	O
FIPV	O
)	O
and	O
a	O
felinized	O
murine	O
hepatitis	O
virus	O
(	O
fMHV	O
),	O
both	O
normally	O
incapable	O
of	O
infecting	O
human	O
cells	B-ANAT
,	O
could	O
rapidly	O
and	O
effectively	O
kill	O
human	O
cancer	B-ANAT
cells	I-ANAT
artificially	O
expressing	O
the	O
feline	O
coronavirus	O
receptor	O
aminopeptidase	O
N	O
.	O
Also	O
3	O
-	O
D	O
multilayer	O
tumor	O
spheroids	O
established	O
from	O
such	O
cells	B-ANAT
were	O
effectively	O
eradicated	O
.	O

The	O
targeting	O
antibody	O
mediated	O
specific	O
infection	O
of	O
EGFR	O
-	O
expressing	O
human	O
cancer	B-ANAT
cells	I-ANAT
by	O
both	O
coronaviruses	O
.	O

By	O
their	O
potent	O
cytotoxicity	O
,	O
the	O
selective	O
targeting	O
of	O
non	O
-	O
human	O
coronaviruses	O
to	O
human	O
cancer	B-ANAT
cells	I-ANAT
provides	O
a	O
rationale	O
for	O
further	O
investigations	O
into	O
the	O
use	O
of	O
these	O
viruses	O
as	O
anticancer	O
agents	O
.	O

Real	O
-	O
time	O
qRT	O
-	O
PCR	O
was	O
used	O
to	O
confirm	O
the	O
regulated	O
expression	O
of	O
genes	O
related	O
to	O
several	O
functional	O
classes	O
including	O
kinases	O
,	O
interferon	O
induced	O
genes	O
,	O
chemokines	O
and	O
adhesion	O
molecules	O
,	O
vesicular	O
trafficking	O
and	O
fusion	O
protein	O
genes	O
,	O
extracellular	B-ANAT
matrix	I-ANAT
protein	O
genes	O
,	O
cell	B-ANAT
cycle	O
,	O
metabolism	O
,	O
cell	B-ANAT
physiology	O
and	O
development	O
,	O
translation	O
,	O
RNA	O
binding	O
,	O
lysosomal	B-ANAT
,	O
protein	O
degradation	O
and	O
ubiquitination	O
related	O
genes	O
.	O

Forty	O
six	O
patients	O
had	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
and	O
26	O
required	O
ventilatory	O
support	O
.	O

In	O
vitro	O
experiments	O
demonstrated	O
that	O
the	O
virus	O
could	O
only	O
persist	O
for	O
2	O
days	O
in	O
hospital	O
wastewater	O
,	O
domestic	O
sewage	O
and	O
dechlorinated	O
tap	O
water	O
,	O
while	O
3	O
days	O
in	O
feces	B-ANAT
,	O
14	O
days	O
in	O
PBS	O
and	O
17	O
days	O
in	O
urine	B-ANAT
at	O
20	O
degrees	O
C	O
.	O
However	O
,	O
at	O
4	O
degrees	O
C	O
,	O
the	O
SARS	O
-	O
CoV	O
could	O
persist	O
for	O
14	O
days	O
in	O
wastewater	O
and	O
at	O
least	O
17	O
days	O
in	O
feces	B-ANAT
or	O
urine	B-ANAT
.	O

The	O
method	O
employed	O
was	O
to	O
have	O
subjects	O
wear	O
a	O
small	O
photometer	O
that	O
recorded	O
total	O
ultraviolet	O
dose	O
over	O
the	O
period	O
of	O
exposure	O
while	O
subjects	O
went	O
about	O
their	O
normal	O
routine	O
,	O
and	O
comparing	O
this	O
value	O
with	O
a	O
hypothetical	O
dose	O
calculated	O
from	O
the	O
highest	O
measured	O
eye	B-ANAT
-	O
level	O
irradiance	O
.	O

Except	O
for	O
two	O
,	O
all	O
other	O
patients	O
improved	O
after	O
aggressive	O
blood	B-ANAT
transfusions	O
.	O

TITLE	O
:	O
Receptor	O
-	O
independent	O
spread	O
of	O
a	O
highly	O
neurotropic	O
murine	O
coronavirus	O
JHMV	O
strain	O
from	O
initially	O
infected	O
microglial	B-ANAT
cells	B-ANAT
in	O
mixed	O
neural	O
cultures	O
.	O

These	O
puncta	O
did	O
not	O
overlap	O
cellular	B-ANAT
organelles	B-ANAT
or	O
other	O
punctate	O
structures	O
.	O

B	B-ANAT
cell	I-ANAT
hybridomas	B-ANAT
were	O
generated	O
from	O
mice	O
that	O
were	O
hyper	O
-	O
immunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
virion	B-ANAT
.	O

Then	O
more	O
or	O
less	O
severe	O
acute	O
kidney	B-ANAT
failure	O
appears	O
in	O
slightly	O
more	O
than	O
50	O
%	O
of	O
cases	O
.	O

TITLE	O
:	O
Chemokine	O
up	O
-	O
regulation	O
in	O
SARS	O
-	O
coronavirus	O
-	O
infected	O
,	O
monocyte	B-ANAT
-	O
derived	O
human	O
dendritic	B-ANAT
cells	I-ANAT
.	O

Yeast	O
two	O
-	O
hybrid	O
assays	O
further	O
indicated	O
in	O
vivo	O
that	O
such	O
binding	O
relates	O
to	O
the	O
fragment	O
(	O
aa	O
161	O
-	O
210	O
)	O
of	O
SARS_N	O
and	O
the	O
Gly	O
-	O
rich	O
domain	O
(	O
aa	O
203	O
-	O
320	O
)	O
of	O
hnRNP	B-ANAT
A1	O
.	O

Moreover	O
,	O
kinetic	O
analyses	O
by	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
technology	O
revealed	O
that	O
SARS_N	O
protein	O
has	O
a	O
specific	O
binding	O
affinity	O
against	O
human	O
hnRNP	B-ANAT
A1	O
with	O
K	O
(	O
D	O
)	O
at	O
0	O
.	O
35	O
+/-	O

The	O
cut	O
-	O
off	O
O	O
.	O
D	O
.	O
value	O
was	O
defined	O
as	O
0	O
.	O
175	O
by	O
calculating	O
the	O
mean	O
O	O
.	O
D	O
.	O
value	O
of	O
the	O
86	O
sera	B-ANAT
plus	O
3	O
standard	O
deviations	O
.	O

The	O
recombinant	O
plasmid	O
pET30a	O
(+)-	O
nsp13	O
was	O
confirmed	O
by	O
restriction	O
enzymes	O
and	O
sequencing	O
analysis	O
,	O
and	O
transformed	O
into	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
).	O

We	O
report	O
the	O
personal	O
respiratory	O
protection	O
and	O
environmental	O
control	O
measures	O
implemented	O
to	O
minimize	O
the	O
risk	O
of	O
droplets	O
spread	O
during	O
these	O
procedures	O
,	O
including	O
re	O
-	O
engineering	O
of	O
the	O
ventilation	O
system	O
of	O
the	O
cardiac	B-ANAT
catheterization	O
laboratory	O
(	O
CCL	O
).	O

ABSTRACT	O
:	O
This	O
paper	O
describes	O
mapping	O
of	O
antigenic	O
and	O
host	O
-	O
protective	O
epitopes	O
of	O
infectious	O
bronchitis	O
virus	O
proteins	O
by	O
assessing	O
the	O
ability	O
of	O
defined	O
peptide	O
regions	O
within	O
the	O
S1	O
,	O
S2	O
and	O
N	O
proteins	O
to	O
elicit	O
humoral	O
,	O
cell	B-ANAT
-	O
mediated	O
and	O
protective	O
immune	O
responses	O
.	O

Peptides	O
corresponding	O
to	O
six	O
regions	O
in	O
the	O
S1	O
(	O
Sp1	B-ANAT
-	O
Sp6	B-ANAT
),	O
one	O
in	O
the	O
S2	O
(	O
Sp7	B-ANAT
)	O
and	O
four	O
in	O
the	O
N	O
protein	O
(	O
Np1	O
-	O
Np4	O
)	O
were	O
synthesized	O
and	O
coupled	O
to	O
either	O
diphtheria	O
toxoid	O
(	O
dt	O
)	O
or	O
biotin	O
(	O
bt	O
).	O

TITLE	O
:	O
Development	O
and	O
evaluation	O
of	O
a	O
multitarget	O
real	O
-	O
time	O
Taqman	O
reverse	O
transcription	O
-	O
PCR	O
assay	O
for	O
detection	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
and	O
surveillance	O
for	O
an	O
apparently	O
related	O
coronavirus	O
found	O
in	O
masked	O
palm	B-ANAT
civets	O
.	O

This	O
study	O
describes	O
the	O
morphologic	O
features	O
of	O
granulomatous	O
vasculitis	O
in	O
FIP	O
as	O
well	O
as	O
its	O
development	O
in	O
the	O
course	O
of	O
monocyte	B-ANAT
-	O
associated	O
feline	O
CoV	O
(	O
FCoV	O
)	O
viremia	O
in	O
five	O
naturally	O
infected	O
Domestic	O
Shorthair	O
cats	O
with	O
FIP	O
.	O

A	O
56	O
-	O
year	O
-	O
old	O
woman	O
had	O
undergone	O
a	O
low	O
anterior	O
resection	O
in	O
2002	O
because	O
of	O
a	O
Duke	O
'	O
s	O
stage	O
D	O
adenocarcinoma	O
of	O
the	O
rectum	B-ANAT
.	O

Abdominal	B-ANAT
radiograph	O
revealed	O
multiple	O
air	O
-	O
fluid	O
levels	O
,	O
while	O
a	O
computed	O
tomography	O
scan	O
showed	O
disease	O
dissemination	O
.	O

Moderate	O
to	O
severe	O
GERD	O
is	O
common	O
following	O
lung	B-ANAT
transplantation	O
in	O
children	O
.	O

It	O
was	O
discovered	O
that	O
CMV	O
was	O
the	O
prime	O
driving	O
force	O
behind	O
most	O
of	O
the	O
oligoclonal	O
expansions	O
and	O
altered	O
phenotypes	O
and	O
functions	O
of	O
CD8	B-ANAT
cells	I-ANAT
.	O

CCL2	O
has	O
been	O
implicated	O
in	O
macrophage	B-ANAT
infiltration	O
into	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
and	O
is	O
involved	O
in	O
demyelination	O
in	O
many	O
experimental	O
models	O
of	O
demyelination	O
.	O

Oral	B-ANAT
treatment	O
of	O
VV	O
and	O
CV	O
infected	O
mice	O
with	O
CDV	O
ether	O
lipid	O
esters	O
,	O
as	O
effective	O
as	O
i	O
.	O
p	O
.	O

Here	O
,	O
cell	B-ANAT
tropism	O
and	O
receptor	O
usage	O
of	O
HCoV	O
-	O
NL63	O
were	O
analyzed	O
.	O

ABSTRACT	O
:	O
During	O
the	O
epidemic	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
2003	O
,	O
a	O
27	O
-	O
year	O
-	O
old	O
Japanese	O
woman	O
presented	O
a	O
high	O
fever	O
and	O
acute	O
respiratory	O
distress	O
with	O
pulmonary	B-ANAT
infiltrates	O
after	O
traveling	O
to	O
a	O
high	O
-	O
risk	O
area	O
.	O

An	O
alternative	O
diagnosis	O
was	O
made	O
as	O
Epstein	O
-	O
Barr	O
virus	O
-	O
associated	O
hemophagocytic	O
syndrome	O
,	O
based	O
on	O
the	O
proliferation	O
of	O
macrophages	B-ANAT
with	O
hemophagocytosis	O
in	O
the	O
bone	B-ANAT
marrow	I-ANAT
and	O
Epstein	O
-	O
Barr	O
viral	O
marker	O
profiles	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
obtained	O
at	O
baseline	O
and	O
on	O
days	O
1	O
through	O
4	O
,	O
and	O
were	O
evaluated	O
for	O
proinflammatory	O
and	O
anti	O
-	O
inflammatory	O
cytokine	O
concentrations	O
,	O
as	O
well	O
as	O
for	O
procalcitonin	O
and	O
total	O
protein	O
C	O
levels	O
.	O

Baseline	O
concentrations	O
and	O
changes	O
in	O
the	O
concentrations	O
of	O
these	O
mediators	O
were	O
evaluated	O
in	O
relationship	O
to	O
the	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
II	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
(	O
MOD	O
)	O
scores	O
,	O
and	O
28	O
-	O
day	O
all	O
-	O
cause	O
mortality	O
.	O

The	O
eukaryotic	O
expression	O
plasmid	O
pEGFP	O
-	O
C1	O
-	O
N	O
,	O
containing	O
SARS	O
-	O
CoV	O
N	O
gene	O
,	O
was	O
co	O
-	O
transfected	O
into	O
293	O
cells	B-ANAT
with	O
either	O
the	O
RNAi	O
plasmid	O
pshRNA	O
-	O
N	O
or	O
unrelated	O
control	O
plasmid	O
pshRNA	O
-	O
HBV	O
-	O
C4	O
.	O

The	O
counts	O
of	O
WBC	B-ANAT
(	O
in	O
22	O
.	O
56	O
%	O
of	O
patients	O
)	O
lymphocyte	B-ANAT
(	O
70	O
.	O
25	O
%)	O
and	O
CD3	O
,	O
CD4	O
,	O
CD8	O
positive	O
T	B-ANAT
cells	I-ANAT
(	O
70	O
%)	O
decreased	O
.	O

From	O
8	O
to	O
16	O
d	O
,	O
the	O
patients	O
presented	O
progressive	O
cough	O
(	O
29	O
.	O
96	O
%),	O
sputum	B-ANAT
production	O
(	O
13	O
.	O
09	O
%),	O
chest	B-ANAT
distress	O
(	O
29	O
.	O
96	O
%)	O
and	O
shortness	O
of	O
breath	B-ANAT
(	O
35	O
.	O
34	O
%).	O

CONCLUSIONS	O
:	O
The	O
data	O
reported	O
here	O
provide	O
evidence	O
that	O
the	O
course	O
of	O
SARS	O
could	O
be	O
divided	O
into	O
four	O
stages	O
,	O
namely	O
the	O
initial	O
stage	O
,	O
progressive	O
stage	O
,	O
fastigium	B-ANAT
and	O
convalescent	O
stage	O
.	O

Mizoribine	O
and	O
ribavirin	O
selectively	O
inhibited	O
replication	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
50	O
%	O
inhibitory	O
concentration	O
(	O
IC50	O
)	O
of	O
mizoribine	O
for	O
SARS	O
-	O
CoV	O
Frankfurt	O
-	O
1	O
and	O
SARS	O
-	O
CoV	O
HKU39849	O
,	O
as	O
determined	O
by	O
plaque	O
reduction	O
was	O
3	O
.	O
5	O
microg	O
/	O
ml	O
and	O
16	O
microg	O
/	O
ml	O
,	O
respectively	O
,	O
and	O
the	O
IC50	O
of	O
ribavirin	O
for	O
SARS	O
-	O
CoV	O
Frankfurt	O
-	O
1	O
and	O
SARS	O
-	O
CoV	O
HKU39849	O
was	O
20	O
microg	O
/	O
ml	O
and	O
80	O
microg	O
/	O
ml	O
,	O
while	O
the	O
50	O
%	O
cytotoxic	O
concentration	O
of	O
mizoribine	O
and	O
ribavirin	O
for	O
Vero	O
E6	O
cells	B-ANAT
exceeded	O
200	O
microg	O
/	O
ml	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
furosemide	O
infusion	O
on	O
serum	B-ANAT
epidermal	B-ANAT
growth	O
factor	O
concentration	O
after	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
serum	B-ANAT
specimens	O
were	O
analyzed	O
with	O
enzyme	O
-	O
linked	O
immunoassay	O
(	O
ELISA	O
)	O
for	O
epidermal	B-ANAT
growth	O
factor	O
at	O
baseline	O
,	O
then	O
3	O
and	O
7	O
days	O
after	O
acute	O
lung	B-ANAT
injury	O
.	O

Coronaviruses	O
were	O
found	O
in	O
cloacal	B-ANAT
swab	O
samples	O
from	O
all	O
the	O
three	O
bird	O
species	O
.	O

The	O
infected	O
graylag	O
geese	O
showed	O
lower	B-ANAT
body	I-ANAT
weights	O
compared	O
with	O
virus	O
-	O
negative	O
birds	O
,	O
suggesting	O
clinical	O
significance	O
of	O
the	O
infection	O
.	O

Phylogenetic	O
analyses	O
performed	O
on	O
the	O
replicase	O
gene	O
and	O
nucleocapsid	B-ANAT
protein	O
sequences	O
,	O
indicated	O
that	O
the	O
novel	O
coronaviruses	O
described	O
in	O
the	O
present	O
study	O
all	O
branch	B-ANAT
off	O
from	O
group	O
III	O
coronaviruses	O
.	O

CONCLUSIONS	O
:	O
Serum	B-ANAT
levels	O
of	O
Hsp60	O
detected	O
within	O
30	O
min	O
after	O
trauma	O
correlate	O
with	O
the	O
development	O
of	O
ALI	O
.	O

The	O
ensuing	O
challenges	O
to	O
hospital	O
and	O
public	O
health	O
workers	O
rose	O
to	O
a	O
level	O
never	O
before	O
seen	O
in	O
healthcare	O
,	O
in	O
part	O
due	O
to	O
the	O
unknown	O
nature	O
of	O
the	O
disease	O
,	O
the	O
fear	O
of	O
the	O
human	O
-	O
to	O
-	O
human	O
transmission	O
and	O
the	O
significant	O
media	B-ANAT
involvement	O
.	O

Among	O
674	O
patients	O
,	O
71	O
%	O
suffered	O
respiratory	O
insufficiency	O
,	O
43	O
%	O
were	O
unconscious	O
and	O
32	O
%	O
had	O
congestive	O
heart	B-ANAT
failure	O
during	O
the	O
24h	O
before	O
death	O
.	O

The	O
""""	O
catastrophic	O
""""	O
variant	O
of	O
the	O
antiphospholipid	O
syndrome	O
(	O
APS	O
)	O
is	O
an	O
accelerated	O
form	O
of	O
this	O
systemic	O
autoimmune	O
condition	O
which	O
results	O
in	O
multiorgan	O
failure	O
because	O
of	O
multiple	O
small	B-ANAT
vessel	I-ANAT
occlusions	O
.	O

Pulmonary	B-ANAT
involvement	O
was	O
reported	O
in	O
150	O
of	O
220	O
patients	O
with	O
catastrophic	O
APS	O
(	O
68	O
%)	O
and	O
47	O
patients	O
(	O
21	O
%)	O
were	O
diagnosed	O
as	O
having	O
ARDS	O
.	O

ARDS	O
is	O
the	O
dominant	O
pulmonary	B-ANAT
manifestation	O
of	O
catastrophic	O
APS	O
.	O

TITLE	O
:	O
Cytokine	O
responses	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
-	O
infected	O
macrophages	B-ANAT
in	O
vitro	O
:	O
possible	O
relevance	O
to	O
pathogenesis	O
.	O

These	O
antipeptide	O
antibodies	O
can	O
be	O
useful	O
for	O
the	O
diagnosis	O
of	O
SARS	O
at	O
the	O
tissue	B-ANAT
level	O
.	O

In	O
162	O
serum	B-ANAT
samples	O
,	O
90	O
.	O
2	O
%	O
(	O
55	O
/	O
61	O
)	O
became	O
N	O
protein	O
positive	O
in	O
1	O
-	O
5	O
days	O
and	O
92	O
.	O
8	O
%	O
(	O
13	O
/	O
14	O
)	O
became	O
positive	O
IgM	O
and	O
IgG	O
in	O
15	O
-	O
18	O
days	O
after	O
the	O
onset	O
of	O
disease	O
,	O
respectively	O
.	O

However	O
,	O
of	O
12	O
and	O
10	O
palm	B-ANAT
civets	O
sampled	O
in	O
November	O
and	O
December	O
including	O
five	O
of	O
which	O
had	O
been	O
at	O
the	O
live	O
animals	O
market	O
for	O
2	O
days	O
,	O
none	O
of	O
them	O
was	O
tested	O
positive	O
.	O

Three	O
types	O
of	O
organic	O
load	O
were	O
used	O
:	O
0	O
.	O
3	O
%	O
albumin	O
,	O
10	O
%	O
fetal	B-ANAT
calf	B-ANAT
serum	B-ANAT
,	O
and	O
0	O
.	O
3	O
%	O
albumin	O
with	O
0	O
.	O
3	O
%	O
sheep	O
erythrocytes	B-ANAT
.	O

ABSTRACT	O
:	O
Because	O
the	O
right	O
side	O
of	O
the	O
heart	B-ANAT
supplies	O
blood	B-ANAT
to	O
the	O
pulmonary	B-ANAT
circulation	O
,	O
its	O
integrity	O
is	O
required	O
for	O
both	O
adequate	O
respiratory	O
and	O
circulatory	O
function	O
.	O

Only	O
single	O
cases	O
were	O
presented	O
with	O
ARF	O
of	O
other	O
intoxication	O
etiology	O
,	O
crush	O
syndrome	O
,	O
or	O
acute	O
vascular	B-ANAT
diseases	O
.	O

Lung	B-ANAT
injury	O
score	O
(	O
LIS	O
),	O
which	O
is	O
composed	O
of	O
four	O
components	O
,	O
is	O
used	O
for	O
making	O
a	O
distinction	O
between	O
two	O
separate	O
but	O
rather	O
similar	O
syndromes	O
.	O

The	O
study	O
was	O
aimed	O
at	O
the	O
assessment	O
of	O
the	O
severity	O
of	O
the	O
lung	B-ANAT
injury	O
in	O
patients	O
who	O
had	O
suffered	O
from	O
sepsis	O
of	O
the	O
gynecological	O
origin	O
and	O
its	O
influence	O
on	O
the	O
outcome	O
of	O
the	O
disease	O
.	O

As	O
for	O
the	O
patients	O
with	O
the	O
acute	O
lung	B-ANAT
injury	O
,	O
the	O
score	O
values	O
ranged	O
from	O
0	O
.	O
3	O
to	O
1	O
.	O
3	O
and	O
only	O
one	O
patient	O
from	O
this	O
group	O
died	O
(	O
4	O
.	O
34	O
%).	O

TITLE	O
:	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
):	O
a	O
serious	O
adverse	O
event	O
of	O
blood	B-ANAT
transfusion	O
.	O

TRALI	O
is	O
characterized	O
by	O
acute	O
respiratory	O
distress	O
and	O
non	O
-	O
cardiogenic	O
lung	B-ANAT
oedema	O
developing	O
during	O
,	O
or	O
within	O
6	O
h	O
of	O
,	O
transfusion	O
.	O

The	O
severity	O
of	O
TRALI	O
depends	O
upon	O
the	O
susceptibility	O
of	O
the	O
patient	O
to	O
develop	O
a	O
more	O
clinically	O
significant	O
reaction	O
as	O
a	O
result	O
of	O
an	O
underlying	O
disease	O
process	O
,	O
and	O
upon	O
the	O
nature	O
of	O
triggers	O
in	O
the	O
transfused	O
blood	B-ANAT
components	I-ANAT
,	O
including	O
granulocyte	B-ANAT
-	O
binding	O
alloantibodies	O
(	O
immune	O
TRALI	O
)	O
or	O
neutrophil	B-ANAT
-	O
priming	O
substances	O
such	O
as	O
biologically	O
active	O
lipids	O
(	O
non	O
-	O
immune	O
TRALI	O
).	O

Immune	O
TRALI	O
,	O
which	O
occurs	O
mainly	O
after	O
the	O
transfusion	O
of	O
fresh	B-ANAT
-	O
frozen	O
plasma	B-ANAT
and	O
platelet	B-ANAT
concentrates	O
,	O
is	O
a	O
rare	O
event	O
(	O
about	O
one	O
incidence	O
per	O
5000	O
transfusions	O
)	O
but	O
frequently	O
(	O
approximately	O
70	O
%)	O
requires	O
mechanical	O
ventilation	O
(	O
severe	O
TRALI	O
)	O
and	O
is	O
not	O
uncommonly	O
fatal	O
(	O
6	O
-	O
9	O
%	O
of	O
cases	O
).	O

TITLE	O
:	O
Serum	B-ANAT
C	O
-	O
reactive	O
protein	O
elevation	O
predicts	O
poor	O
clinical	O
outcome	O
in	O
patients	O
with	O
distal	O
type	O
acute	O
aortic	B-ANAT
dissection	O
:	O
association	O
with	O
the	O
occurrence	O
of	O
oxygenation	O
impairment	O
.	O

ABSTRACT	O
:	O
Acute	O
aortic	B-ANAT
dissection	O
(	O
AAD	O
)	O
is	O
sometimes	O
complicated	O
by	O
respiratory	O
failure	O
due	O
to	O
severe	O
lung	B-ANAT
oxygenation	O
impairment	O
.	O

Manufacturing	O
processes	O
of	O
all	O
plasma	B-ANAT
derivatives	O
are	O
required	O
to	O
comprise	O
dedicated	O
virus	O
inactivation	O
/	O
removal	O
steps	O
.	O

This	O
study	O
not	O
only	O
first	O
made	O
a	O
human	O
neutralizing	O
antibody	O
,	O
which	O
recognized	O
an	O
epitope	O
on	O
S2	O
protein	O
like	O
natural	O
antibody	O
in	O
sera	B-ANAT
,	O
but	O
also	O
may	O
help	O
us	O
to	O
better	O
understand	O
the	O
immunological	O
characteristics	O
of	O
SARS	O
protein	O
and	O
SARS	O
vaccine	O
design	O
.	O

IgG	B-ANAT
antibody	I-ANAT
was	O
detected	O
positive	O
on	O
each	O
testing	O
of	O
all	O
the	O
convalescent	O
patients	O
and	O
its	O
peak	O
appeared	O
35	O
days	O
after	O
recovery	O
.	O

IgG	B-ANAT
antibody	I-ANAT
level	O
showed	O
a	O
35	O
.	O
8	O
%	O
decrease	O
within	O
one	O
year	O
.	O

When	O
tested	O
with	O
420	O
serum	B-ANAT
specimens	O
from	O
serologically	O
confirmed	O
SARS	O
patients	O
,	O
the	O
positive	O
rates	O
of	O
serum	B-ANAT
N	O
protein	O
were	O
90	O
.	O
1	O
%,	O
23	O
%	O
and	O
0	O
%,	O
in	O
which	O
sera	B-ANAT
collected	O
from	O
1	O
to	O
10	O
days	O
,	O
11	O
to	O
20	O
days	O
and	O
beyond	O
21	O
days	O
respectively	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

After	O
6	O
hrs	O
of	O
mechanical	O
ventilation	O
after	O
intervention	O
,	O
S	O
+	O
IN	O
group	O
piglets	O
showed	O
decreased	O
extravascular	O
lung	B-ANAT
water	O
(	O
S	O
+	O
IN	O
vs	O
.	O
S	O
,	O
20	O
+/-	O
3	O
vs	O
.	O
28	O
+/-	O

A	O
topically	O
applied	O
nuclear	O
factor	O
-	O
kappaB	O
inhibitor	O
improves	O
lung	B-ANAT
edema	O
and	O
lung	B-ANAT
volumes	O
and	O
reduces	O
inflammation	O
in	O
this	O
newborn	O
piglet	O
model	O
of	O
airway	B-ANAT
lavage	O
.	O

We	O
found	O
neither	O
cell	B-ANAT
to	O
be	O
permissive	O
for	O
SARS	O
-	O
CoV	O
replication	O
.	O

Poor	O
awareness	O
of	O
TRALI	O
outside	O
of	O
the	O
blood	B-ANAT
transfusion	O
medicine	O
community	O
has	O
led	O
to	O
a	O
serious	O
underestimation	O
of	O
this	O
condition	O
,	O
currently	O
the	O
most	O
Important	O
severe	O
complication	O
of	O
blood	B-ANAT
transfusion	O
.	O

As	O
many	O
as	O
one	O
third	O
of	O
all	O
patients	O
who	O
develop	O
acute	O
lung	B-ANAT
injury	O
have	O
been	O
exposed	O
to	O
blood	B-ANAT
products	O
.	O

Immunofluorescence	O
assay	O
(	O
IFA	O
)	O
technique	O
and	O
plaque	O
reduction	O
neutralization	O
test	O
(	O
PRNT	O
)	O
were	O
used	O
to	O
detect	O
7	O
samples	O
of	O
sera	B-ANAT
of	O
4	O
newly	O
diagnosed	O
SARS	O
patients	O
collected	O
in	O
different	O
days	O
,	O
48	O
samples	O
of	O
convalescent	O
sera	B-ANAT
of	O
SARS	O
patients	O
,	O
24	O
serum	B-ANAT
samples	O
of	O
healthy	O
person	O
undergoing	O
physical	O
examination	O
,	O
and	O
40	O
serum	B-ANAT
samples	O
from	O
non	O
-	O
SARS	O
patients	O
with	O
fever	O
by	O
double	O
blind	O
test	O
.	O

Double	O
blind	O
test	O
showed	O
that	O
45	O
of	O
the	O
46	O
PRNT	O
positive	O
sera	B-ANAT
were	O
IFA	O
positive	O
with	O
an	O
accordance	O
rate	O
of	O
97	O
.	O
8	O
%.	O

In	O
vitro	O
experiments	O
of	O
chromatin	B-ANAT
condensation	O
and	O
DNA	O
fragmentation	O
suggested	O
that	O
the	O
3a	O
protein	O
may	O
trigger	O
apoptosis	O
.	O

Cell	B-ANAT
lines	I-ANAT
were	O
engineered	O
to	O
constitutively	O
express	O
an	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
and	O
used	O
to	O
detect	O
(	O
1	O
)	O
antiviral	O
potency	O
in	O
SARS	O
-	O
CoV	O
infection	O
tests	O
;	O
(	O
2	O
)	O
antiviral	O
specificity	O
in	O
tests	O
using	O
the	O
porcine	O
coronavirus	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
);	O
and	O
(	O
3	O
)	O
cytotoxicity	O
in	O
the	O
same	O
assays	O
without	O
virus	O
challenge	O
.	O

No	O
infectious	O
SARS	O
-	O
CoV	O
contamination	O
was	O
found	O
in	O
any	O
of	O
the	O
samples	O
collected	O
,	O
but	O
the	O
nucleic	B-ANAT
acid	O
of	O
SARS	O
-	O
CoV	O
could	O
be	O
detected	O
in	O
the	O
sewage	O
from	O
the	O
two	O
hospitals	O
before	O
disinfection	O
.	O

Our	O
novel	O
findings	O
thus	O
suggest	O
that	O
the	O
acute	O
SARS	O
-	O
coronavirus	O
infection	O
probably	O
contributes	O
to	O
the	O
initial	O
reduction	O
of	O
DC	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
subsets	I-ANAT
in	O
blood	B-ANAT
,	O
and	O
that	O
high	O
-	O
dose	O
steroid	O
administration	O
may	O
subsequently	O
exacerbate	O
and	O
prolong	O
low	O
expression	O
of	O
the	O
cell	B-ANAT
subsets	O
.	O

TITLE	O
:	O
[	O
Over	O
-	O
expression	O
in	O
Escherichia	O
coli	O
and	O
purification	O
of	O
nucleocaspid	O
and	O
membrane	B-ANAT
protein	O
of	O
SARS	O
coronavirus	O
].	O

TITLE	O
:	O
[	O
Changes	O
in	O
pulmonary	B-ANAT
function	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
patients	O
during	O
convalescent	O
period	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
changes	O
and	O
pattern	O
of	O
pulmonary	B-ANAT
function	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
patients	O
during	O
convalescent	O
period	O
.	O

Restrictive	O
pulmonary	B-ANAT
ventilation	O
function	O
and	O
diffusing	O
dysfunction	O
of	O
the	O
lung	B-ANAT
were	O
found	O
in	O
one	O
third	O
of	O
the	O
patients	O
during	O
third	O
to	O
sixth	O
month	O
from	O
onset	O
.	O

However	O
,	O
there	O
was	O
an	O
obvious	O
improvement	O
in	O
total	O
lung	B-ANAT
capacity	O
(	O
TLC	O
)	O
and	O
diffusing	O
capacity	O
of	O
the	O
lung	B-ANAT
for	O
carbon	O
monoxide	O
(	O
DLCO	O
)	O
with	O
the	O
elapse	O
of	O
time	O
,	O
and	O
also	O
a	O
significant	O
difference	O
was	O
found	O
between	O
the	O
later	O
stage	O
and	O
the	O
earlier	O
stage	O
.	O

The	O
antigenic	O
structures	O
identified	O
for	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
,	O
the	O
epitope	O
-	O
specific	O
mAbs	O
,	O
and	O
the	O
serum	B-ANAT
antibody	O
profile	O
in	O
SARS	O
patients	O
have	O
potential	O
use	O
in	O
the	O
clinical	O
diagnosis	O
and	O
understanding	O
of	O
the	O
protective	O
immunity	O
to	O
SARS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
We	O
identified	O
5	O
conformational	O
and	O
3	O
linear	O
epitopes	O
within	O
the	O
entire	O
N	O
protein	O
;	O
3	O
conformational	O
and	O
3	O
linear	O
epitopes	O
were	O
immunodominant	O
.	O

TITLE	O
:	O
Recurrent	O
mutations	O
associated	O
with	O
isolation	O
and	O
passage	O
of	O
SARS	O
coronavirus	O
in	O
cells	B-ANAT
from	O
non	O
-	O
human	O
primates	O
.	O

A	O
mutation	O
in	O
the	O
spike	O
gene	O
(	O
residue	O
24079	O
)	O
appeared	O
to	O
be	O
unique	O
to	O
adaptation	O
in	O
FRhK4	O
cells	B-ANAT
.	O

One	O
of	O
the	O
region	O
,	O
Rbinding	O
(	O
754	O
-	O
766	O
in	O
SARS	O
-	O
CoV	O
'	O
s	O
RdRp	O
),	O
located	O
in	O
the	O
palm	B-ANAT
sub	O
-	O
domain	O
mainly	O
constituted	O
of	O
anti	O
-	O
parallel	O
beta	O
-	O
strand	O
-	O
turn	O
-	O
beta	O
-	O
strand	O
hairpin	O
structures	O
that	O
covers	O
two	O
of	O
the	O
three	O
RdRp	O
catalytic	O
sites	O
(	O
Asp	O
760	O
,	O
Asp761	O
),	O
was	O
also	O
predicted	O
by	O
molecular	O
docking	O
method	O
(	O
based	O
on	O
free	O
energy	O
of	O
binding	O
DeltaG	O
)	O
to	O
be	O
important	O
binding	O
motif	O
recognized	O
by	O
ATA	O
.	O

TITLE	O
:	O
The	O
virion	B-ANAT
N	O
protein	O
of	O
infectious	O
bronchitis	O
virus	O
is	O
more	O
phosphorylated	O
than	O
the	O
N	O
protein	O
from	O
infected	O
cell	B-ANAT
lysates	O
.	O

TITLE	O
:	O
Heterogeneous	O
airway	B-ANAT
versus	O
tissue	B-ANAT
mechanics	O
and	O
their	O
relation	O
to	O
gas	O
exchange	O
function	O
during	O
mechanical	O
ventilation	O
.	O

The	O
EVW	O
allows	O
breath	B-ANAT
-	O
by	O
-	O
breath	B-ANAT
estimates	O
of	O
frequency	O
dependence	O
of	O
lung	B-ANAT
and	O
total	O
respiratory	O
resistance	O
(	O
R	O
)	O
and	O
elastance	O
(	O
E	O
)	O
from	O
0	O
.	O
2	O
to	O
8	O
Hz	O
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
-	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
critical	O
regulator	O
of	O
heart	B-ANAT
function	O
and	O
a	O
cellular	B-ANAT
receptor	O
for	O
the	O
causative	O
agent	O
of	O
severe	O
-	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
SARS	O
-	O
CoV	O
(	O
coronavirus	O
).	O

Young	O
pigs	O
that	O
were	O
fed	O
the	O
TGEV	O
corn	O
orally	B-ANAT
were	O
protected	O
against	O
challenge	O
with	O
virulent	O
TGEV	O
.	O

CONCLUSIONS	O
:	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
and	O
neutrophil	B-ANAT
activator	O
production	O
by	O
the	O
isolated	O
perfused	O
liver	B-ANAT
,	O
in	O
response	O
to	O
a	O
'	O
second	O
hit	O
'	O
of	O
portal	B-ANAT
LPS	O
,	O
does	O
not	O
appear	O
to	O
be	O
enhanced	O
during	O
AP	O
.	O

ABSTRACT	O
:	O
Transplant	B-ANAT
patients	O
are	O
uniquely	O
predisposed	O
to	O
emerging	O
infections	O
for	O
a	O
number	O
of	O
reasons	O
.	O

Transplant	B-ANAT
patients	O
may	O
acquire	O
West	O
Nile	O
virus	O
through	O
blood	B-ANAT
transfusion	O
,	O
donor	O
transmission	O
,	O
or	O
community	O
exposure	O
.	O

These	O
include	O
nucleic	B-ANAT
acid	O
testing	O
of	O
blood	B-ANAT
products	O
and	O
potentially	O
also	O
screening	O
organ	B-ANAT
donors	O
in	O
a	O
similar	O
manner	O
.	O

During	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
transplant	B-ANAT
patients	O
with	O
severe	O
and	O
rapidly	O
progressive	O
disease	O
were	O
reported	O
.	O

Higher	O
viral	O
burdens	O
appeared	O
to	O
be	O
present	O
in	O
transplant	B-ANAT
patients	O
and	O
may	O
have	O
implications	O
for	O
the	O
increased	O
infectivity	O
of	O
these	O
patients	O
.	O

Transplant	B-ANAT
programmes	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
areas	O
were	O
also	O
adversely	O
affected	O
because	O
of	O
donor	O
concerns	O
,	O
recipient	O
issues	O
and	O
resource	O
problems	O
.	O

TITLE	O
:	O
Purification	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
hyperimmune	O
globulins	O
for	O
intravenous	O
injection	O
from	O
convalescent	O
plasma	B-ANAT
.	O

IV	O
-	O
injectable	O
,	O
purified	O
,	O
and	O
concentrated	O
human	O
SARS	O
hyperimmune	O
globulins	O
were	O
prepared	O
from	O
pooled	O
convalescent	O
plasma	B-ANAT
samples	O
,	O
which	O
are	O
ready	O
to	O
be	O
further	O
evaluated	O
.	O

It	O
was	O
composed	O
mainly	O
of	O
spindle	B-ANAT
-	O
shaped	O
cells	B-ANAT
without	O
malignant	O
features	O
.	O

Results	O
derived	O
from	O
analysis	O
of	O
various	O
deletion	O
mutations	O
show	O
that	O
the	O
region	O
containing	O
amino	O
acids	O
226	O
-	O
289	O
is	O
able	O
to	O
mediate	O
nucleolar	B-ANAT
localization	O
.	O

Six	O
percent	O
of	O
men	O
had	O
a	O
hip	B-ANAT
BMD	O
Z	O
score	O
of	O
<	O
or	O
=-	O
2	O
(	O
P	O
=	O
0	O
.	O
057	O
for	O
testing	O
the	O
hypothesis	O
that	O
>	O
2	O
.	O
5	O
%	O
of	O
subjects	O
should	O
have	O
a	O
Z	O
score	O
of	O
<	O
or	O
=-	O
2	O
).	O

S	O
-	O
peptide	O
,	O
mice	O
primed	O
with	O
oral	B-ANAT
live	O
-	O
attenuated	O
S	O
.	O
typhimurium	O
that	O
contained	O
tPA	O
-	O
optimize800	O
DNA	O
vaccine	O
(	O
Salmonella	O
-	O
tPA	O
-	O
S	O
-	O
DNA	O
)	O
and	O
boosted	O
with	O
i	O
.	O
p	O
.	O

S	O
-	O
peptide	O
,	O
and	O
mice	O
primed	O
with	O
oral	B-ANAT
live	O
-	O
attenuated	O
S	O
.	O
typhimurium	O
that	O
contained	O
CTLA4HingeSARS800	O
DNA	O
vaccine	O
(	O
Salmonella	O
-	O
tPA	O
-	O
S	O
-	O
DNA	O
)	O
and	O
boosted	O
with	O
i	O
.	O
p	O
.	O

The	O
sensitivity	O
of	O
all	O
primers	O
was	O
between	O
0	O
.	O
0004	O
and	O
0	O
.	O
04	O
PFU	O
with	O
viral	O
cell	B-ANAT
lysate	O
and	O
between	O
0	O
.	O
004	O
and	O
0	O
.	O
4	O
PFU	O
in	O
spiked	O
stool	B-ANAT
specimen	I-ANAT
per	O
PCR	O
assay	O
.	O

The	O
former	O
was	O
less	O
laborious	O
with	O
shorter	O
time	O
for	O
completion	O
and	O
can	O
easily	O
be	O
adapted	O
to	O
an	O
automated	O
system	O
such	O
as	O
the	O
MagNa	O
Pure	O
-	O
LC	O
,	O
which	O
can	O
extract	O
nucleic	B-ANAT
acid	O
from	O
clinical	O
samples	O
and	O
load	O
it	O
into	O
the	O
sample	O
capillaries	B-ANAT
of	O
the	O
LightCycler	O
.	O

The	O
cell	B-ANAT
-	O
based	O
assays	O
also	O
indicate	O
that	O
18c	O
is	O
a	O
nontoxic	O
anti	O
-	O
SARS	O
agent	O
with	O
an	O
EC50	O
value	O
of	O
0	O
.	O
18	O
microM	O
.	O

TITLE	O
:	O
VEGF	O
levels	O
in	O
the	O
alveolar	B-ANAT
compartment	B-ANAT
do	O
not	O
distinguish	O
between	O
ARDS	O
and	O
hydrostatic	O
pulmonary	B-ANAT
oedema	O
.	O

The	O
current	O
authors	O
hypothesised	O
that	O
VEGF	O
levels	O
in	O
pulmonary	B-ANAT
oedema	O
fluid	O
would	O
be	O
lower	O
in	O
ALI	O
patients	O
compared	O
with	O
control	O
patients	O
with	O
severe	O
hydrostatic	O
pulmonary	B-ANAT
oedema	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
manifestations	O
of	O
multicentric	O
Castleman	O
'	O
s	O
disease	O
in	O
HIV	O
infection	O
:	O
a	O
clinical	O
,	O
biological	O
and	O
radiological	O
study	O
.	O

All	O
patients	O
had	O
nasopharyngeal	B-ANAT
and	O
throat	B-ANAT
swabs	O
taken	O
for	O
respiratory	O
virus	O
antigen	O
detection	O
,	O
culture	O
and	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Short	O
-	O
term	O
effects	O
of	O
prone	O
position	O
in	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
patients	O
with	O
severe	O
acute	O
hypoxemic	O
and	O
hypercapnic	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
short	O
-	O
term	O
effects	O
of	O
prone	O
positioning	O
(	O
PP	O
)	O
in	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
patients	O
with	O
severe	O
hypoxemic	O
and	O
hypercapnic	O
respiratory	O
failure	O
requiring	O
invasive	O
mechanical	O
ventilation	O
.	O

Patients	O
with	O
adult	O
respiratory	O
distress	O
syndrome	O
or	O
left	O
ventricular	B-ANAT
failure	O
were	O
excluded	O
.	O

The	O
SARS	O
-	O
CoV	O
S	O
-	O
based	O
immunoglobulin	O
M	O
(	O
IgM	O
)	O
and	O
IgG	O
ELISAs	O
were	O
evaluated	O
and	O
compared	O
with	O
the	O
corresponding	O
N	O
-	O
based	O
ELISA	O
for	O
serodiagnosis	O
of	O
SARS	O
-	O
CoV	O
pneumonia	O
,	O
using	O
sera	B-ANAT
from	O
148	O
healthy	O
blood	B-ANAT
donors	O
who	O
donated	O
blood	B-ANAT
3	O
years	O
ago	O
as	O
controls	O
and	O
95	O
SARS	O
-	O
CoV	O
pneumonia	O
patients	O
in	O
Hong	O
Kong	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
is	O
a	O
devastating	O
clinical	O
syndrome	O
with	O
a	O
high	O
mortality	O
rate	O
(	O
30	O
-	O
60	O
%)	O
(	O
refs	O
1	O
-	O
3	O
).	O

Of	O
the	O
17	O
hypoxemic	O
patients	O
,	O
11	O
(	O
65	O
%)	O
had	O
a	O
drop	O
in	O
hemoglobin	O
of	O
>	O
2	O
g	O
/	O
dL	O
,	O
and	O
4	O
patients	O
(	O
24	O
%)	O
required	O
a	O
blood	B-ANAT
transfusion	O
.	O

NF	O
-	O
kappaB	O
activation	O
in	O
the	O
lung	B-ANAT
was	O
greatest	O
when	O
the	O
liver	B-ANAT
was	O
in	O
the	O
perfusion	O
circuit	O
.	O

Intense	O
activation	O
of	O
the	O
inflammatory	O
response	O
and	O
oxidative	O
injury	O
that	O
results	O
in	O
pulmonary	B-ANAT
edema	O
and	O
hypoxemia	O
(	O
acute	O
lung	B-ANAT
injury	O
)	O
requires	O
interaction	O
of	O
the	O
lungs	B-ANAT
with	O
the	O
liver	B-ANAT
.	O

Three	O
patients	O
had	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
without	O
any	O
evidence	O
of	O
bacterial	O
infection	O
.	O

Only	O
intestinal	B-ANAT
parasites	O
and	O
Campylobacterjejuni	O
infection	O
were	O
significant	O
risk	O
factors	O
for	O
diarrhea	O
by	O
univariate	O
odds	O
ratio	O
analysis	O
.	O

However	O
,	O
the	O
nature	O
and	O
cause	O
of	O
myopathy	O
associated	O
with	O
a	O
SARS	O
infection	O
are	O
unknown	O
because	O
,	O
to	O
our	O
knowledge	O
,	O
there	O
has	O
been	O
no	O
report	O
of	O
histological	O
or	O
postmortem	O
examination	O
of	O
the	O
skeletal	B-ANAT
muscle	I-ANAT
from	O
SARS	O
-	O
infected	O
patients	O
.	O

The	O
introduction	O
of	O
the	O
nucleic	B-ANAT
acid	O
amplification	O
can	O
avoid	O
the	O
window	O
period	O
of	O
these	O
viral	O
infections	O
.	O

Stem	O
cell	B-ANAT
lines	I-ANAT
should	O
be	O
tested	O
for	O
prion	O
particles	O
and	O
a	O
virus	O
of	O
animal	O
origin	O
that	O
assure	O
an	O
acceptable	O
quality	O
.	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
almost	O
exclusively	O
entered	O
and	O
was	O
released	O
from	O
the	O
apical	O
domain	O
of	O
polarized	O
Calu	O
-	O
3	O
cells	B-ANAT
,	O
which	O
might	O
provide	O
important	O
insight	O
into	O
the	O
mechanism	O
of	O
transmission	O
and	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
.	O

Correspondingly	O
,	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
induced	O
by	O
MHV	O
was	O
retarded	O
by	O
cholesterol	O
depletion	O
,	O
consistent	O
with	O
the	O
association	O
of	O
the	O
spike	O
protein	O
with	O
lipid	B-ANAT
rafts	I-ANAT
in	O
the	O
plasma	B-ANAT
membrane	I-ANAT
.	O

These	O
findings	O
suggest	O
that	O
MHV	O
entry	O
requires	O
specific	O
interactions	O
between	O
the	O
spike	O
protein	O
and	O
lipid	B-ANAT
rafts	I-ANAT
,	O
probably	O
during	O
the	O
virus	O
internalization	O
step	O
.	O

ABSTRACT	O
:	O
Using	O
clinical	O
samples	O
from	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
we	O
showed	O
that	O
the	O
sensitivities	O
of	O
a	O
quantitative	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
80	O
%	O
for	O
fecal	B-ANAT
samples	O
and	O
25	O
%	O
for	O
urine	B-ANAT
samples	O
)	O
were	O
higher	O
than	O
those	O
of	O
the	O
polyclonal	O
(	O
50	O
%	O
and	O
5	O
%)	O
and	O
monoclonal	O
(	O
35	O
%	O
and	O
8	O
%)	O
antibody	O
-	O
based	O
nucleocapsid	B-ANAT
antigen	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
(	O
NPA	O
)	O
were	O
taken	O
from	O
306	O
pediatric	O
patients	O
during	O
the	O
winter	O
-	O
spring	O
season	O
2003	O
-	O
2004	O
,	O
and	O
examined	O
for	O
conventional	O
respiratory	O
viruses	O
by	O
direct	O
fluorescent	O
staining	O
and	O
cell	B-ANAT
culture	O
,	O
while	O
human	O
coronavirus	O
and	O
human	O
metapneumovirus	O
were	O
sought	O
by	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Thermal	O
aggregation	O
of	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
.	O

TITLE	O
:	O
Novel	O
rapid	O
immunochromatographic	O
test	O
based	O
on	O
an	O
enzyme	O
immunoassay	O
for	O
detecting	O
nucleocapsid	B-ANAT
antigen	O
in	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

Immunofluorescence	O
was	O
used	O
to	O
localize	O
the	O
targets	O
antigens	O
in	O
slides	O
with	O
biochips	O
of	O
lung	B-ANAT
(	O
monkey	O
)	O
of	O
SARS	O
associated	O
antibodies	O
.	O

No	O
antibodies	O
against	O
organs	B-ANAT
but	O
lung	B-ANAT
were	O
found	O
in	O
SARS	O
patients	O
.	O

The	O
toxicity	O
of	O
beta	O
-	O
propiolactone	O
was	O
hydrolyzed	O
completely	O
when	O
the	O
inactivated	O
virus	O
was	O
cultured	O
for	O
16	O
hours	O
at	O
2	O
degrees	O
C	O
,	O
8	O
degrees	O
C	O
and	O
in	O
water	O
bath	O
for	O
2	O
hours	O
at	O
37	O
degrees	O
C	O
.	O
CONCLUSIONS	O
:	O
The	O
titer	O
of	O
SARS	O
-	O
CoV	O
was	O
the	O
highest	O
when	O
it	O
was	O
cultured	O
in	O
Vero	O
or	O
Vero	O
-	O
E6	O
cells	B-ANAT
for	O
72	O
hours	O
at	O
37	O
degrees	O
C	O
in	O
5	O
percent	O
CO2	O
incubator	O
.	O

It	O
was	O
demonstrated	O
that	O
there	O
was	O
no	O
live	O
SARS	O
-	O
CoV	O
in	O
all	O
samples	O
collected	O
,	O
but	O
the	O
RNA	O
of	O
SARS	O
-	O
CoV	O
could	O
be	O
detected	O
in	O
seven	O
stool	B-ANAT
samples	O
from	O
SARS	O
patients	O
with	O
any	O
one	O
of	O
the	O
symptoms	O
of	O
fever	O
,	O
malaise	O
,	O
cough	O
,	O
or	O
dyspnea	O
,	O
in	O
10	O
sewage	O
samples	O
before	O
disinfection	O
and	O
3	O
samples	O
after	O
disinfection	O
from	O
the	O
two	O
hospitals	O
.	O

CONCLUSIONS	O
:	O
Nucleic	B-ANAT
acid	O
of	O
SARS	O
-	O
CoV	O
can	O
be	O
excreted	O
through	O
the	O
stool	B-ANAT
of	O
patients	O
into	O
sewage	O
system	O
,	O
and	O
the	O
possibility	O
of	O
SARS	O
-	O
CoV	O
transmitting	O
through	O
digestive	B-ANAT
system	I-ANAT
cannot	O
be	O
excluded	O
.	O

No	O
lymphadenopathy	O
,	O
effusion	B-ANAT
of	O
pericadiaum	O
and	O
pleura	B-ANAT
were	O
found	O
on	O
the	O
initial	O
chest	B-ANAT
radiographs	O
.	O

The	O
main	O
abnormal	O
radiographic	O
appearance	O
of	O
lung	B-ANAT
in	O
patients	O
with	O
SARS	O
is	O
exudative	O
changes	O
.	O

No	O
lymphadenopathy	O
,	O
effusion	B-ANAT
of	O
pericadiaum	O
and	O
pleura	B-ANAT
were	O
found	O
on	O
the	O
initial	O
chest	B-ANAT
radiographs	O
.	O

Following	O
coronavirus	O
injection	O
,	O
TNF	O
-	O
alpha	O
mRNA	O
was	O
detected	O
at	O
higher	O
levels	O
within	O
the	O
retinas	B-ANAT
,	O
and	O
concentrations	O
of	O
TNF	O
-	O
alpha	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
and	O
sTNFR1	O
(	O
p	O
<	O
0	O
.	O
0005	O
)	O
proteins	O
were	O
increased	O
within	O
the	O
sera	B-ANAT
of	O
BALB	O
/	O
c	O
but	O
not	O
CD	O
-	O
1	O
mice	O
.	O

The	O
peptide	O
is	O
derived	O
from	O
the	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
positions	O
362	O
-	O
370	O
(	O
SNP362	O
-	O
370	O
).	O

The	O
SNP362	O
-	O
370	O
peptide	O
is	O
held	O
in	O
place	O
by	O
17	O
hydrogen	O
bonds	O
to	O
the	O
alpha	O
-	O
chain	O
residues	O
and	O
by	O
nine	O
water	O
molecules	O
which	O
are	O
also	O
tightly	O
bound	O
in	O
the	O
peptide	O
-	O
binding	O
groove	B-ANAT
.	O

During	O
the	O
period	O
from	O
April	O
13	O
to	O
May	O
12	O
2003	O
,	O
72	O
,	O
327	O
outpatients	O
and	O
visitors	O
entered	O
Taipei	O
Medical	O
University	O
-	O
Wan	O
Fang	B-ANAT
Hospital	O
,	O
Taipei	O
,	O
Taiwan	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
in	O
SARS	O
patient	O
sera	B-ANAT
there	O
were	O
autoantibodies	O
(	O
autoAbs	O
)	O
that	O
reacted	O
with	O
A549	O
cells	B-ANAT
,	O
the	O
type	O
-	O
2	O
pneumocytes	B-ANAT
,	O
and	O
that	O
these	O
autoAbs	O
were	O
mainly	O
IgG	O
.	O
The	O
autoAbs	O
were	O
detectable	O
20	O
days	O
after	O
fever	O
onset	O
.	O

Furthermore	O
,	O
treatment	O
of	O
A549	O
cells	B-ANAT
with	O
anti	O
-	O
S2	O
Abs	O
and	O
IFN	O
-	O
gamma	O
resulted	O
in	O
an	O
increase	O
in	O
the	O
adherence	O
of	O
human	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
to	O
these	O
epithelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
[	O
Bacterial	O
tracheitis	O
:	O
an	O
infectious	O
cause	O
of	O
upper	O
airway	B-ANAT
obstruction	O
to	O
be	O
considered	O
in	O
children	O
].	O

With	O
construction	O
of	O
serial	O
truncated	O
mutants	O
of	O
3b	O
,	O
a	O
region	O
(	O
residues	O
134	O
-	O
154	O
aa	O
)	O
responsible	O
for	O
nucleolar	B-ANAT
localization	O
was	O
determinated	O
in	O
3b	O
protein	O
.	O

Our	O
results	O
showed	O
that	O
SARS	O
-	O
CoV	O
E	O
protein	O
induced	O
apoptosis	O
in	O
the	O
transfected	O
Jurkat	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
,	O
which	O
was	O
amplified	O
to	O
higher	O
apoptosis	O
rates	O
in	O
the	O
absence	O
of	O
growth	O
factors	O
.	O

However	O
,	O
apoptosis	O
was	O
inhibited	O
by	O
overexpressed	O
antiapoptotic	O
protein	O
Bcl	O
-	O
xL	O
.	O
Moreover	O
,	O
we	O
found	O
that	O
SARS	O
-	O
CoV	O
E	O
protein	O
interacted	O
with	O
Bcl	O
-	O
xL	O
in	O
vitro	O
and	O
endogenous	O
Bcl	O
-	O
xL	O
in	O
vivo	O
and	O
that	O
Bcl	O
-	O
xL	O
interaction	O
with	O
SARS	O
-	O
CoV	O
E	O
protein	O
was	O
mediated	O
by	O
BH3	O
(	O
Bcl	O
-	O
2	O
homology	O
domain	O
3	O
)	O
of	O
Bcl	O
-	O
xL	O
.	O
Finally	O
,	O
we	O
identified	O
a	O
novel	O
BH3	O
-	O
like	O
region	O
located	O
in	O
the	O
C	O
-	O
terminal	O
cytosolic	B-ANAT
domain	I-ANAT
of	O
SARS	O
-	O
CoV	O
E	O
protein	O
,	O
which	O
mediates	O
its	O
binding	O
to	O
Bcl	O
-	O
xL	O
.	O
These	O
results	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
a	O
novel	O
molecular	O
mechanism	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
apoptosis	O
that	O
contributes	O
to	O
the	O
SARS	O
-	O
CoV	O
-	O
induced	O
lymphopenia	O
observed	O
in	O
most	O
SARS	O
patients	O
.	O

TITLE	O
:	O
Fatal	O
herpes	O
simplex	B-ANAT
virus	O
infection	O
in	O
Darier	O
disease	O
under	O
corticotherapy	O
.	O

In	O
2003	O
,	O
he	O
presented	O
a	O
widespread	O
atypical	O
exacerbation	O
of	O
his	O
Darier	O
disease	O
,	O
involving	O
the	O
face	B-ANAT
,	O
trunk	B-ANAT
,	O
buttocks	B-ANAT
,	O
intertriginous	O
areas	O
and	O
arms	B-ANAT
.	O

Viral	O
antigen	O
localized	O
primarily	O
to	O
infected	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
type	O
-	O
1	O
pneumocytes	B-ANAT
by	O
immunohistochemistry	O
.	O

These	O
and	O
other	O
emerging	O
agents	O
have	O
arisen	O
or	O
have	O
been	O
introduced	O
partly	O
through	O
changes	O
in	O
donor	O
demographics	O
,	O
international	O
travel	O
,	O
microbial	O
adaptations	O
,	O
land	B-ANAT
use	O
,	O
and	O
human	O
behaviour	O
.	O

ABSTRACT	O
:	O
Cellular	B-ANAT
attachment	O
factors	O
like	O
the	O
C	O
-	O
type	O
lectins	O
DC	O
-	O
SIGN	O
and	O
DC	O
-	O
SIGNR	O
(	O
collectively	O
referred	O
to	O
as	O
DC	O
-	O
SIGN	O
/	O
R	O
)	O
can	O
augment	O
viral	O
infection	O
and	O
might	O
promote	O
viral	O
dissemination	O
in	O
and	O
between	O
hosts	O
.	O

Here	O
,	O
we	O
show	O
that	O
LSECtin	O
enhances	O
infection	O
driven	O
by	O
filovirus	O
glycoproteins	O
(	O
GP	O
)	O
and	O
the	O
S	O
protein	O
of	O
SARS	O
coronavirus	O
,	O
but	O
does	O
not	O
interact	O
with	O
human	O
immunodeficiency	O
virus	O
type	O
-	O
1	O
and	O
hepatitis	O
C	O
virus	O
envelope	B-ANAT
proteins	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
LSECtin	O
is	O
N	O
-	O
linked	O
glycosylated	O
and	O
that	O
glycosylation	O
is	O
required	O
for	O
cell	B-ANAT
surface	I-ANAT
expression	O
.	O

In	O
monocytes	B-ANAT
of	O
a	O
larger	O
cat	O
population	O
(	O
n	O
=	O
19	O
)	O
the	O
3	O
infection	O
patterns	O
were	O
also	O
found	O
.	O

TITLE	O
:	O
[	O
Pathophysiological	O
aspects	O
of	O
severe	O
acute	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
].	O

TITLE	O
:	O
Peptide	O
domain	O
involved	O
in	O
the	O
interaction	O
between	O
membrane	B-ANAT
protein	O
and	O
nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

In	O
this	O
study	O
,	O
we	O
employed	O
an	O
in	O
vitro	O
GST	O
pull	O
-	O
down	O
assay	O
to	O
investigate	O
the	O
interaction	O
between	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
and	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
proteins	O
.	O

ABSTRACT	O
:	O
Myocardial	O
stunning	O
frequently	O
has	O
been	O
described	O
in	O
patients	O
with	O
an	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

Transthoracic	O
and	O
transoesophageal	O
echocardiography	O
was	O
used	O
to	O
assess	O
left	O
ventricular	B-ANAT
ejection	O
fraction	O
(	O
LVEF	O
)	O
and	O
disturbances	O
of	O
segmental	O
contractility	O
.	O

TITLE	O
:	O
Report	O
of	O
a	O
patient	O
with	O
severe	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
after	O
multiple	O
transfusions	O
,	O
resuscitated	O
with	O
albumin	O
.	O

Chest	B-ANAT
radiograph	O
revealed	O
diffuse	O
bilateral	O
infiltrates	O
.	O

An	O
atypical	O
RNA	O
pseudoknot	O
with	O
an	O
extra	O
stem	B-ANAT
formed	O
by	O
complementary	O
sequences	O
within	O
loop	O
2	O
of	O
an	O
H	O
-	O
type	O
pseudoknot	O
is	O
characterized	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
CoV	O
)	O
genome	O
.	O

TITLE	O
:	O
[	O
Severe	O
ARDS	O
following	O
perioperative	O
aspiration	O
of	O
gastric	B-ANAT
content	I-ANAT
associated	O
with	O
the	O
use	O
of	O
a	O
""""	O
ProSeal	O
""""	O
laryngeal	B-ANAT
mask	O
airway	B-ANAT
].	O

After	O
reviewing	O
these	O
newer	O
investigations	O
in	O
the	O
context	O
of	O
previously	O
published	O
literature	O
,	O
we	O
have	O
drawn	O
several	O
preliminary	O
conclusions	O
:	O
(	O
1	O
)	O
Long	O
-	O
term	O
survival	O
after	O
hospital	O
discharge	B-ANAT
is	O
unaffected	O
by	O
ARDS	O
,	O
but	O
is	O
strongly	O
affected	O
by	O
ARDS	O
risk	O
factor	O
and	O
comorbidities	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infection	O
caused	O
by	O
a	O
novel	O
coronavirus	O
known	O
as	O
SARS	O
-	O
CoV	O
,	O
characterized	O
by	O
an	O
over	O
-	O
exuberant	O
immune	O
response	O
with	O
lung	B-ANAT
lymphomononuclear	O
cells	B-ANAT
infiltration	O
and	O
proliferation	O
that	O
may	O
account	O
for	O
tissue	B-ANAT
damage	O
more	O
than	O
the	O
direct	O
effect	O
of	O
viral	O
replication	O
.	O

Concomitant	O
activation	O
of	O
IFN	O
-	O
alpha	O
and	O
-	O
gamma	O
gene	O
expression	O
by	O
SARS	O
-	O
CoV	O
in	O
vivo	O
may	O
be	O
relevant	O
for	O
the	O
pathogenesis	O
of	O
the	O
disease	O
,	O
both	O
for	O
the	O
possible	O
involvement	O
in	O
immunomediated	O
damage	O
of	O
the	O
tissues	B-ANAT
and	O
for	O
the	O
strong	O
inhibition	O
of	O
SARS	O
-	O
CoV	O
replication	O
as	O
a	O
result	O
of	O
combined	O
cytokine	O
action	O
.	O

The	O
lymphopenia	O
was	O
prolonged	O
,	O
reaching	O
a	O
nadir	O
during	O
days	O
7	O
-	O
9	O
in	O
the	O
second	O
week	O
of	O
illness	O
before	O
returning	O
towards	O
normal	O
after	O
five	O
weeks	O
,	O
with	O
the	O
lowest	O
mean	O
CD4	B-ANAT
+	I-ANAT
cell	I-ANAT
count	O
of	O
317	O
cellsx10	O
(	O
6	O
)/	O
L	O
at	O
day	O
7	O
,	O
and	O
CD8	O
+	O
cell	B-ANAT
count	O
of	O
239	O
cellsx10	O
(	O
6	O
)/	O
L	O
at	O
day	O
8	O
.	O

The	O
number	O
of	O
adherent	O
leukocytes	B-ANAT
was	O
increased	O
significantly	O
in	O
the	O
lipopolysaccharide	O
group	O
at	O
30	O
,	O
45	O
,	O
and	O
60	O
mins	O
after	O
lipopolysaccharide	O
administration	O
(	O
vs	O
.	O
control	O
p	O
<	O
.	O
01	O
,	O
vs	O
.	O
sivelestat	O
p	O
<	O
.	O
05	O
).	O

Neutrophil	B-ANAT
elastase	O
activities	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
,	O
serum	B-ANAT
,	O
and	O
lung	B-ANAT
tissue	I-ANAT
were	O
all	O
significantly	O
lower	O
in	O
the	O
sivelestat	O
group	O
than	O
in	O
the	O
lipopolysaccharide	O
group	O
(	O
p	O
<	O
.	O
05	O
).	O

Lipopolysaccharide	O
induces	O
leukocyte	B-ANAT
adhesion	O
in	O
the	O
pulmonary	B-ANAT
microcirculation	O
,	O
resulting	O
in	O
decreased	O
tissue	B-ANAT
hemoglobin	O
oxygen	O
and	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
edema	O
.	O

Surprisingly	O
,	O
a	O
carboxyl	O
-	O
terminal	O
truncation	O
of	O
17	O
amino	O
acids	O
substantially	O
increased	O
S	O
glycoprotein	O
-	O
mediated	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
fusion	O
suggesting	O
that	O
the	O
terminal	O
17	O
amino	O
acids	O
regulated	O
the	O
S	O
fusogenic	O
properties	O
.	O

This	O
nucleic	B-ANAT
acid	O
capture	O
system	O
was	O
effective	O
in	O
improving	O
the	O
sensitivity	O
of	O
the	O
RT	O
-	O
PCR	O
,	O
due	O
to	O
enriching	O
and	O
purifying	O
SARS	O
-	O
CoV	O
RNA	O
.	O

ABSTRACT	O
:	O
The	O
S2	O
domain	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
is	O
responsible	O
for	O
fusion	O
between	O
virus	O
and	O
target	O
cell	B-ANAT
membranes	I-ANAT
,	O
and	O
is	O
expected	O
to	O
be	O
immungenic	O
.	O

The	O
vaccine	O
group	O
demonstrated	O
significantly	O
higher	O
S1	O
protein	O
lymphocyte	B-ANAT
proliferation	O
index	O
(	O
LPI	O
)	O
than	O
the	O
control	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

No	O
infectious	O
virus	O
was	O
detected	O
after	O
treatment	O
when	O
up	O
to	O
one	O
-	O
third	O
of	O
the	O
APC	B-ANAT
unit	O
was	O
assayed	O
,	O
demonstrating	O
a	O
mean	O
log10	O
-	O
reduction	O
of	O
>	O
6	O
.	O
2	O
.	O

Tissue	B-ANAT
viability	O
decreased	O
52	O
%	O
after	O
4	O
hours	O
of	O
reperfusion	O
and	O
did	O
not	O
change	O
significantly	O
by	O
24	O
hours	O
.	O

The	O
persistent	O
increase	O
in	O
muscle	B-ANAT
chemokine	O
levels	O
at	O
24	O
hours	O
of	O
reperfusion	O
was	O
not	O
associated	O
with	O
increased	O
edema	O
or	O
injury	O
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
is	O
phosphorylated	O
and	O
localizes	O
in	O
the	O
cytoplasm	B-ANAT
by	O
14	O
-	O
3	O
-	O
3	O
-	O
mediated	O
translocation	O
.	O

Further	O
,	O
we	O
show	O
that	O
the	O
phosphorylated	O
protein	O
is	O
translocated	O
to	O
the	O
cytoplasm	B-ANAT
by	O
binding	O
to	O
14	O
-	O
3	O
-	O
3	O
(	O
tyrosine	O
3	O
-	O
monooxygenase	O
/	O
tryptophan	O
5	O
-	O
monooxygenase	O
activation	O
protein	O
).	O

Coincidentally	O
,	O
the	O
N	O
protein	O
was	O
also	O
found	O
to	O
downregulate	O
the	O
expression	O
of	O
the	O
theta	O
isoform	O
of	O
14	O
-	O
3	O
-	O
3	O
(	O
14	O
-	O
3	O
-	O
3theta	O
),	O
leading	O
to	O
the	O
accumulation	O
of	O
phosphorylated	O
N	O
protein	O
in	O
the	O
nucleus	B-ANAT
,	O
in	O
the	O
absence	O
of	O
growth	O
factors	O
.	O

This	O
14	O
-	O
3	O
-	O
3	O
-	O
mediated	O
transport	O
of	O
the	O
phosphorylated	O
N	O
protein	O
and	O
its	O
possible	O
implications	O
in	O
interfering	O
with	O
the	O
cellular	B-ANAT
machinery	O
are	O
discussed	O
.	O

Amino	O
acids	O
369	O
to	O
389	O
,	O
which	O
contain	O
putative	O
nuclear	O
localization	O
signal	O
(	O
NLS	O
)	O
and	O
nucleolar	B-ANAT
localization	O
signal	O
motifs	O
,	O
failed	O
to	O
restore	O
nuclear	O
localization	O
to	O
an	O
NLS	O
-	O
minus	O
mutant	O
Rev	O
protein	O
.	O

Anti	O
-	O
SARS	O
-	O
CoV	O
IgG	B-ANAT
antibody	I-ANAT
was	O
detected	O
using	O
indirect	O
immunofluorescence	O
technique	O
and	O
quantified	O
by	O
two	O
-	O
fold	O
serial	O
dilutions	O
.	O

A	O
total	O
of	O
325	O
laboratory	O
-	O
confirmed	O
SARS	O
cases	O
were	O
analyzed	O
;	O
of	O
which	O
301	O
(	O
92	O
.	O
6	O
%)	O
had	O
anti	O
-	O
SARS	O
-	O
CoV	O
IgG	O
detected	O
in	O
their	O
sera	B-ANAT
at	O
the	O
time	O
of	O
sampling	O
.	O

This	O
region	O
spanning	O
amino	O
acids	O
249	O
-	O
395	O
contains	O
predominant	O
B	B-ANAT
cell	I-ANAT
epitopes	O
located	O
at	O
the	O
C	O
-	O
terminus	O
of	O
N	O
protein	O
.	O

Favorable	O
inhibition	O
of	O
virus	O
spread	O
was	O
observed	O
when	O
the	O
cells	B-ANAT
were	O
either	O
treated	O
with	O
chloroquine	O
prior	O
to	O
or	O
after	O
SARS	O
CoV	O
infection	O
.	O

Only	O
two	O
phenolic	O
compounds	O
aloe	O
emodin	O
and	O
hesperetin	O
dose	O
-	O
dependently	O
inhibited	O
cleavage	O
activity	O
of	O
the	O
3CLpro	O
,	O
in	O
which	O
the	O
IC50	O
was	O
366	O
microM	O
for	O
aloe	O
emodin	O
and	O
8	O
.	O
3	O
microM	O
for	O
hesperetin	O
in	O
the	O
cell	B-ANAT
-	O
based	O
assay	O
.	O

We	O
found	O
that	O
proteases	O
such	O
as	O
trypsin	O
and	O
thermolysin	O
enabled	O
SARS	O
-	O
CoV	O
adsorbed	O
onto	O
the	O
cell	B-ANAT
surface	I-ANAT
to	O
enter	O
cells	B-ANAT
directly	O
from	O
that	O
site	O
.	O

The	O
siRNAs	O
used	O
provided	O
relief	O
from	O
SCV	O
infection	O
-	O
induced	O
fever	O
,	O
diminished	O
SCV	O
viral	O
levels	O
and	O
reduced	O
acute	O
diffuse	O
alveoli	B-ANAT
damage	O
.	O

The	O
technology	O
was	O
applied	O
to	O
pooled	O
human	O
respiratory	B-ANAT
tract	I-ANAT
samples	O
.	O

The	O
relative	O
sensitivities	O
for	O
detecting	O
cell	B-ANAT
culture	O
-	O
derived	O
SARS	O
-	O
CoV	O
were	O
0	O
.	O
01	O
,	O
0	O
.	O
01	O
,	O
and	O
0	O
.	O
001	O
PFU	O
/	O
test	O
,	O
respectively	O
.	O

The	O
cell	B-ANAT
culture	O
-	O
adapted	O
strains	O
of	O
influenza	O
viruses	O
A	O
and	O
B	O
,	O
parainfluenza	O
viruses	O
1	O
-	O
4	O
,	O
respiratory	O
syncytial	O
viruses	O
A	O
and	O
B	O
,	O
both	O
strains	O
of	O
the	O
human	O
metapneumoviruses	O
,	O
numerous	O
rhinoviruses	O
,	O
most	O
of	O
the	O
adenoviruses	O
,	O
coronaviruses	O
229E	O
and	O
OC43	O
,	O
and	O
a	O
number	O
of	O
enteroviruses	O
(	O
poliovirus	O
type	O
3	O
,	O
coxsackie	O
virus	O
B1	O
,	O
echovirus	O
type	O
30	O
)	O
replicate	O
in	O
HuH7	O
.	O

Analysis	O
of	O
these	O
data	O
and	O
the	O
mapping	O
of	O
these	O
mutations	O
on	O
the	O
recently	O
determined	O
crystal	B-ANAT
structure	O
of	O
a	O
fragment	O
containing	O
the	O
RBD	O
complexed	O
to	O
ACE2	O
(	O
Li	O
,	O
F	O
,	O
Li	O
,	O
W	O
,	O
Farzan	O
,	O
M	O
,	O
and	O
Harrison	O
,	O
S	O
.	O
C	O
.,	O
submitted	O
)	O
suggested	O
the	O
existence	O
of	O
two	O
hot	O
spots	O
on	O
the	O
S	O
RBD	O
surface	O
,	O
R426	O
and	O
N473	O
,	O
which	O
are	O
likely	O
to	O
contribute	O
significant	O
portion	O
of	O
the	O
binding	O
energy	O
.	O

The	O
others	O
are	O
used	O
in	O
the	O
treatment	O
of	O
herpesvirus	O
(	O
e	O
.	O
g	O
.	O
herpes	O
simplex	B-ANAT
virus	O
,	O
varicella	O
zoster	O
virus	O
and	O
cytomegalo	O
virus	O
),	O
hepatitis	O
B	O
virus	O
,	O
hepatitis	O
C	O
virus	O
or	O
influenza	O
virus	O
infections	O
.	O

We	O
thus	O
hypothesized	O
that	O
IFN	O
-	O
gamma	O
may	O
play	O
a	O
major	O
role	O
in	O
the	O
pathology	O
by	O
triggering	O
immune	O
-	O
mediated	O
alveolar	B-ANAT
damage	O
.	O

As	O
we	O
assessed	O
or	O
re	O
-	O
assessed	O
some	O
effects	O
of	O
IFN	O
-	O
gamma	O
on	O
a	O
number	O
of	O
human	O
lung	B-ANAT
epithelial	O
and	O
fibroblast	B-ANAT
cell	I-ANAT
lines	O
,	O
chosen	O
for	O
their	O
wide	O
use	O
in	O
the	O
literature	O
,	O
we	O
found	O
that	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
were	O
more	O
sensitive	O
to	O
IFN	O
-	O
gamma	O
,	O
in	O
terms	O
of	O
proliferation	O
inhibition	O
and	O
enhancement	O
of	O
Fas	O
-	O
mediated	O
apoptosis	O
.	O

The	O
expression	O
of	O
haPrP	O
protein	O
reduced	O
to	O
21	O
.	O
8	O
%	O
in	O
the	O
preparation	O
of	O
Sf9	O
cells	B-ANAT
infected	O
with	O
recombinant	O
baculovirus	O
exposed	O
for	O
5	O
min	O
and	O
was	O
undetectable	O
exposed	O
for	O
20	O
min	O
.	O

Bacterial	O
membranes	B-ANAT
seemed	O
to	O
be	O
cracked	O
and	O
the	O
cytoplasm	B-ANAT
seemed	O
to	O
be	O
effluent	O
from	O
cell	B-ANAT
bodies	O
.	O

We	O
therefore	O
studied	O
patient	O
factors	O
associated	O
with	O
the	O
development	O
of	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
(	O
IAH	O
),	O
the	O
incidence	O
of	O
organ	B-ANAT
failure	O
associated	O
with	O
IAH	O
,	O
and	O
the	O
effect	O
on	O
outcome	O
in	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
).	O

CONCLUSIONS	O
:	O
IAH	O
is	O
a	O
frequent	O
finding	O
in	O
patients	O
admitted	O
to	O
the	O
ICU	O
because	O
of	O
SAP	O
,	O
and	O
is	O
associated	O
with	O
a	O
high	O
occurrence	O
rate	O
of	O
organ	B-ANAT
dysfunction	O
.	O

Evidence	O
present	O
suggests	O
that	O
the	O
dominant	O
Vero	B-ANAT
cell	I-ANAT
-	O
adapted	O
IBV	O
strain	O
may	O
be	O
derived	O
from	O
the	O
chicken	O
embryo	B-ANAT
passages	O
by	O
selection	O
of	O
and	O
potential	O
recombination	O
between	O
the	O
minor	O
variants	O
.	O

Primers	O
were	O
designed	O
from	O
conserved	O
or	O
variable	O
regions	O
of	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
or	O
spike	O
(	O
S	O
)	O
protein	O
gene	O
among	O
TCoV	O
,	O
IBV	O
,	O
and	O
BCoV	O
and	O
used	O
in	O
the	O
same	O
PCR	O
reaction	O
.	O

The	O
genus	O
Torovirus	O
,	O
within	O
the	O
family	O
Coronaviridae	O
,	O
is	O
less	O
well	O
characterized	O
,	O
in	O
part	O
because	O
toroviruses	O
cannot	O
yet	O
be	O
grown	O
in	O
cell	B-ANAT
culture	O
(	O
except	O
for	O
the	O
Berne	O
virus	O
).	O

Fecal	B-ANAT
and	O
respiratory	B-ANAT
samples	I-ANAT
can	O
remain	O
infectious	O
for	O
a	O
long	O
period	O
of	O
time	O
at	O
room	O
temperature	O
.	O

The	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
is	O
a	O
key	O
transcription	O
factor	O
that	O
activates	O
numerous	O
genes	O
involved	O
in	O
cellular	B-ANAT
immune	O
response	O
and	O
inflammation	O
.	O

Many	O
studies	O
have	O
shown	O
that	O
NF	O
-	O
kappaB	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
lung	B-ANAT
diseases	O
.	O

ABSTRACT	O
:	O
A	O
dataset	O
of	O
103	O
SARS	O
-	O
CoV	O
isolates	O
(	O
101	O
human	O
patients	O
and	O
2	O
palm	B-ANAT
civets	O
)	O
was	O
investigated	O
on	O
different	O
aspects	O
of	O
genome	O
polymorphism	O
and	O
isolate	O
classification	O
.	O

Obstructive	O
sleep	O
apnea	O
is	O
characterized	O
by	O
abnormal	O
collapse	O
of	O
the	O
pharyngeal	B-ANAT
airway	B-ANAT
during	O
sleep	O
,	O
snoring	O
,	O
vigorous	O
inspiratory	O
efforts	O
causing	O
frequent	O
arousal	O
,	O
and	O
excessive	O
daytime	O
drowsiness	O
.	O

Surges	O
in	O
sympathetic	O
activity	O
,	O
blood	B-ANAT
pressure	O
,	O
ventricular	B-ANAT
wall	I-ANAT
tension	O
and	O
afterload	O
adversely	O
affect	O
ventricular	B-ANAT
function	O
.	O

When	O
PaCO2	O
falls	O
below	O
the	O
threshold	O
required	O
to	O
stimulate	O
breathing	O
,	O
the	O
central	O
drive	O
to	O
respiratory	B-ANAT
muscles	I-ANAT
and	O
air	O
inflow	O
ceases	O
and	O
central	O
apnea	O
ensues	O
.	O

The	O
study	O
demonstrated	O
that	O
S	O
(	O
471	O
-	O
503	O
)	O
peptide	O
was	O
a	O
potential	O
immunoantigen	O
for	O
the	O
development	O
of	O
peptide	O
-	O
based	O
vaccine	O
or	O
a	O
candidate	O
for	O
further	O
drug	O
evaluation	O
against	O
the	O
SARS	O
-	O
CoV	O
virus	O
-	O
cell	B-ANAT
fusion	O
.	O

The	O
application	O
of	O
PEEP	O
resulted	O
in	O
a	O
decrease	O
in	O
venous	B-ANAT
admixture	O
,	O
increase	O
in	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
,	O
and	O
return	O
of	O
the	O
sound	O
transmission	O
to	O
preinjury	O
levels	O
.	O

Acute	O
lung	B-ANAT
injury	O
causes	O
regional	O
acoustic	O
transmission	O
abnormalities	O
that	O
are	O
reversed	O
during	O
alveolar	B-ANAT
recruitment	O
with	O
PEEP	O
.	O

ABSTRACT	O
:	O
Beginning	O
in	O
the	O
1950s	O
respiratory	O
viruses	O
have	O
been	O
gradually	O
discovered	O
by	O
isolation	O
in	O
cell	B-ANAT
cultures	O
The	O
last	O
were	O
the	O
coronaviruses	O
in	O
the	O
1960s	O
.	O

TITLE	O
:	O
Stem	B-ANAT
-	O
loop	O
IV	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
is	O
a	O
cis	O
-	O
acting	O
element	O
in	O
bovine	O
coronavirus	O
defective	O
interfering	O
RNA	O
replication	O
.	O

He	O
had	O
endotracheal	O
tube	O
(	O
artificially	O
ventilated	O
)	O
and	O
hypovolemic	O
shock	O
with	O
circulatory	O
insufficiency	O
(	O
blood	B-ANAT
pressure	O
was	O
supported	O
by	O
3	O
catecholamines	O
).	O

One	O
year	O
after	O
recovery	O
from	O
SARS	O
,	O
persistent	O
pulmonary	B-ANAT
function	O
impairment	O
was	O
found	O
in	O
about	O
one	O
third	O
of	O
patients	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
have	O
shown	O
that	O
common	O
human	O
coronavirus	O
might	O
be	O
neurotropic	O
,	O
although	O
it	O
was	O
first	O
isolated	O
as	O
a	O
pathogen	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Fifteen	O
cytokines	O
and	O
chemokines	O
were	O
detected	O
in	O
the	O
blood	B-ANAT
of	O
the	O
patient	O
with	O
SARS	O
by	O
means	O
of	O
a	O
bead	O
-	O
based	O
multiassay	O
system	O
.	O

Cytokine	O
/	O
chemokine	O
assay	O
revealed	O
that	O
levels	O
of	O
interferon	O
-	O
gamma	O
-	O
inducible	O
protein	O
10	O
and	O
Mig	O
in	O
the	O
blood	B-ANAT
were	O
highly	O
elevated	O
,	O
although	O
the	O
levels	O
of	O
other	O
cytokines	O
and	O
chemokines	O
were	O
close	O
to	O
normal	O
.	O

This	O
study	O
provides	O
direct	O
evidence	O
that	O
SARS	O
human	O
coronavirus	O
is	O
capable	O
of	O
infecting	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
,	O
and	O
that	O
Mig	O
might	O
be	O
involved	O
in	O
the	O
brain	B-ANAT
immunopathology	O
of	O
SARS	O
.	O

TITLE	O
:	O
T	B-ANAT
-	I-ANAT
Cell	I-ANAT
response	O
profiling	O
to	O
biological	O
threat	O
agents	O
including	O
the	O
SARS	O
coronavirus	O
.	O

Using	O
a	O
matrix	O
of	O
antigens	O
specific	O
for	O
different	O
pathogens	O
,	O
a	O
specific	O
T	B-ANAT
cell	I-ANAT
profile	O
was	O
generated	O
for	O
each	O
individual	O
by	O
monitoring	O
the	O
intracellular	B-ANAT
production	O
of	O
interferon	O
-	O
gamma	O
by	O
flow	O
cytometry	O
.	O

ABSTRACT	O
:	O
Although	O
the	O
finding	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
caged	O
palm	B-ANAT
civets	O
from	O
live	O
animal	O
markets	O
in	O
China	O
has	O
provided	O
evidence	O
for	O
interspecies	O
transmission	O
in	O
the	O
genesis	O
of	O
the	O
SARS	O
epidemic	O
,	O
subsequent	O
studies	O
suggested	O
that	O
the	O
civet	O
may	O
have	O
served	O
only	O
as	O
an	O
amplification	O
host	O
for	O
SARS	O
-	O
CoV	O
.	O
In	O
a	O
surveillance	O
study	O
for	O
CoV	O
in	O
noncaged	O
animals	O
from	O
the	O
wild	O
areas	O
of	O
the	O
Hong	O
Kong	O
Special	O
Administration	O
Region	O
,	O
we	O
identified	O
a	O
CoV	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
(	O
bat	O
-	O
SARS	O
-	O
CoV	O
)	O
from	O
23	O
(	O
39	O
%)	O
of	O
59	O
anal	B-ANAT
swabs	O
of	O
wild	O
Chinese	O
horseshoe	O
bats	O
(	O
Rhinolophus	O
sinicus	O
)	O
by	O
using	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Generation	O
of	O
human	O
antibody	O
fragments	O
recognizing	O
distinct	O
epitopes	O
of	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
SARS	O
-	O
CoV	O
protein	O
using	O
a	O
phage	O
display	O
approach	O
.	O

These	O
in	O
vitro	O
selected	O
human	O
scFvs	O
specifically	O
recognize	O
in	O
ELISA	O
and	O
western	O
blotting	O
studies	O
distinct	O
epitopes	O
in	O
N	O
protein	O
domains	O
and	O
detect	O
in	O
immunohistochemistry	O
investigations	O
SARS	O
-	O
CoV	O
particles	O
in	O
infected	O
Vero	B-ANAT
cells	I-ANAT
.	O

When	O
patients	O
deteriorate	O
clinically	O
despite	O
treatment	O
with	O
ribavirin	O
and	O
corticosteroids	O
,	O
rescue	O
treatment	O
with	O
convalescent	O
plasma	B-ANAT
and	O
immunoglobulin	O
may	O
be	O
beneficial	O
.	O

Although	O
immunopathological	O
damages	O
may	O
account	O
for	O
the	O
severity	O
of	O
respiratory	O
distress	O
,	O
little	O
is	O
known	O
about	O
how	O
the	O
genome	O
-	O
wide	O
gene	O
expression	O
of	O
the	O
host	O
changes	O
under	O
the	O
attack	O
of	O
SARS	O
-	O
CoV	O
.	O
Based	O
on	O
changes	O
in	O
gene	O
expression	O
of	O
peripheral	B-ANAT
blood	I-ANAT
,	O
we	O
identified	O
52	O
signature	O
genes	O
that	O
accurately	O
discriminated	O
acute	O
SARS	O
patients	O
from	O
non	O
-	O
SARS	O
controls	O
.	O

The	O
rank	O
of	O
SARS	O
severity	O
was	O
significantly	O
correlated	O
with	O
the	O
recovery	O
period	O
(	O
in	O
days	O
)	O
and	O
with	O
the	O
clinical	O
pulmonary	B-ANAT
infection	O
score	O
.	O

The	O
changes	O
in	O
body	B-ANAT
temperature	O
were	O
compared	O
between	O
the	O
SARS	O
patients	O
and	O
those	O
with	O
other	O
respiratory	O
diseases	O
and	O
the	O
effect	O
of	O
glucocorticoid	O
hormone	O
on	O
controlling	O
body	B-ANAT
temperature	O
of	O
the	O
SARS	O
patients	O
was	O
explored	O
.	O

At	O
each	O
time	O
point	O
of	O
measurement	O
,	O
the	O
body	B-ANAT
temperature	O
of	O
SARS	O
patients	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
patients	O
with	O
other	O
diseases	O
(	O
P	O
<	O
0	O
.	O
03	O
),	O
with	O
a	O
fluctuation	O
of	O
0	O
.	O
2	O
to	O
0	O
.	O
5	O
degrees	O
C	O
;	O
and	O
following	O
a	O
pattern	O
of	O
variation	O
similar	O
to	O
those	O
of	O
the	O
other	O
diseases	O
.	O

All	O
infected	O
HCW	O
whose	O
condition	O
had	O
progressed	O
severely	O
and	O
who	O
had	O
failed	O
to	O
respond	O
to	O
the	O
available	O
treatment	O
,	O
survived	O
after	O
transfusion	O
with	O
convalescent	O
plasma	B-ANAT
.	O

The	O
most	O
suitable	O
media	B-ANAT
were	O
Ex	O
Cell	B-ANAT
520	O
and	O
Ex	O
Cell	B-ANAT
302	O
.	O

ABSTRACT	O
:	O
Replication	O
of	O
the	O
approximately	O
30	O
-	O
kb	O
plus	O
-	O
strand	O
RNA	O
genome	O
of	O
coronaviruses	O
and	O
synthesis	O
of	O
an	O
extensive	O
set	O
of	O
subgenome	O
-	O
length	O
RNAs	O
are	O
mediated	O
by	O
the	O
replicase	O
-	O
transcriptase	O
,	O
a	O
membrane	B-ANAT
-	O
bound	O
protein	B-ANAT
complex	I-ANAT
containing	O
several	O
cellular	B-ANAT
proteins	O
and	O
up	O
to	O
16	O
viral	O
nonstructural	O
proteins	O
(	O
nsps	O
)	O
with	O
multiple	O
enzymatic	O
activities	O
,	O
including	O
protease	O
,	O
polymerase	O
,	O
helicase	O
,	O
methyltransferase	O
,	O
and	O
RNase	O
activities	O
.	O

Guided	O
by	O
the	O
crystal	B-ANAT
structure	O
of	O
AF1521	O
,	O
an	O
X	O
domain	O
homolog	O
from	O
Archaeoglobus	O
fulgidus	O
,	O
potential	O
active	O
-	O
site	O
residues	O
of	O
the	O
HCoV	O
-	O
229E	O
X	O
domain	O
were	O
targeted	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O

Within	O
4	O
h	O
after	O
injection	O
her	O
arterial	B-ANAT
oxygen	O
tension	O
was	O
8	O
.	O
1	O
kPa	O
(	O
60	O
mm	O
Hg	O
)	O
at	O
an	O
inspired	O
oxygen	O
fraction	O
(	O
F	O
(	O
IO2	O
))	O
of	O
0	O
.	O
7	O
(	O
P	O
/	O
F	O
ratio	O
:	O
85	O
)	O
despite	O
a	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
of	O
20	O
mbar	O
,	O
therefore	O
meeting	O
criteria	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
patient	O
rapidly	O
developed	O
severe	O
fluid	O
overload	O
of	O
the	O
lung	B-ANAT
and	O
subsequent	O
lung	B-ANAT
injury	O
that	O
required	O
intubation	O
,	O
mechanical	O
ventilation	O
,	O
and	O
intensive	O
care	O
therapy	O
for	O
13	O
days	O
.	O

Lung	B-ANAT
damage	O
due	O
to	O
OPP	O
ingestion	O
has	O
not	O
been	O
reported	O
in	O
humans	O
.	O

Seventy	O
-	O
nine	O
SARS	O
patients	O
with	O
hip	B-ANAT
pain	O
underwent	O
both	O
conventional	O
and	O
diffusion	O
-	O
weighted	O
MRI	O
(	O
b	O
-	O
value	O
=	O
0	O
-	O
1000	O
seconds	O
/	O
mm	O
(	O
2	O
)).	O

There	O
was	O
no	O
overlap	O
between	O
the	O
normal	O
and	O
AVN	O
femoral	B-ANAT
heads	I-ANAT
.	O

A	O
truncated	O
S	O
protein	O
of	O
the	O
TW1	O
strain	O
,	O
STR2	O
(	O
88	O
kDa	O
),	O
carrying	O
three	O
S	O
fragments	O
(	O
S74	O
-	O
253	O
,	O
S294	O
-	O
739	O
,	O
and	O
S1129	O
-	O
1255	O
)	O
was	O
investigated	O
to	O
study	O
the	O
influences	O
of	O
intron	O
and	O
exon	O
splicing	O
enhancers	O
to	O
improve	O
STR2	O
protein	O
expression	O
in	O
mammalian	O
cells	B-ANAT
.	O

Histopathologic	O
evaluation	O
of	O
the	O
lung	B-ANAT
tissues	I-ANAT
was	O
also	O
performed	O
.	O

Screening	O
for	O
viral	O
contamination	O
is	O
done	O
by	O
the	O
mouse	O
antibody	O
production	O
(	O
MAP	O
)	O
test	O
,	O
by	O
cell	B-ANAT
culture	O
,	O
or	O
alternatively	O
by	O
direct	O
detection	O
of	O
the	O
viral	O
agents	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O

Serological	O
examination	O
of	O
the	O
mice	O
transplanted	B-ANAT
with	O
tumours	O
as	O
well	O
as	O
their	O
cage	O
mates	O
in	O
the	O
quarantine	O
colony	O
did	O
not	O
detect	O
any	O
antibodies	O
against	O
MHV	O
.	O

TITLE	O
:	O
[	O
Molecular	O
cloning	O
and	O
expression	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
and	O
its	O
clinical	O
application	O
].	O

A	O
combination	O
of	O
the	O
sequence	O
comparison	O
method	O
BLAST	B-ANAT
and	O
SVMProt	O
can	O
further	O
improve	O
the	O
prediction	O
accuracy	O
of	O
SMVProt	O
such	O
that	O
the	O
functional	O
class	O
of	O
two	O
additional	O
SARS	O
-	O
CoV	O
proteins	O
is	O
correctly	O
predicted	O
.	O

CD4	O
+	O
T	B-ANAT
cell	I-ANAT
responses	O
against	O
the	O
N	O
protein	O
have	O
been	O
observed	O
in	O
SARS	O
patients	O
and	O
an	O
HLA	B-ANAT
-	O
A2	O
-	O
restricted	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocyte	I-ANAT
epitope	O
in	O
the	O
S	O
protein	O
has	O
been	O
identified	O
.	O

ABSTRACT	O
:	O
A	O
double	O
-	O
inactivated	O
,	O
candidate	O
whole	O
virus	O
vaccine	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
was	O
developed	O
and	O
manufactured	O
at	O
large	O
scale	O
using	O
fermenter	O
cultures	O
of	O
serum	B-ANAT
protein	O
free	O
Vero	B-ANAT
cells	I-ANAT
.	O

ARDS	O
represents	O
the	O
expression	O
of	O
an	O
acute	O
,	O
diffuse	O
,	O
inflammatory	O
process	O
in	O
the	O
lungs	B-ANAT
consequent	O
to	O
a	O
variety	O
of	O
infectious	O
and	O
noninfectious	O
conditions	O
.	O

Keeping	O
the	O
lung	B-ANAT
open	O
could	O
also	O
potentially	O
be	O
lung	B-ANAT
protective	O
.	O

Interleukin	O
-	O
8	O
increased	O
significantly	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
in	O
supine	O
-	O
HFOV	O
and	O
prone	O
-	O
HFOV	O
groups	O
compared	O
with	O
prone	O
-	O
CV	O
and	O
supine	O
-	O
CV	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effects	O
of	O
acute	O
lung	B-ANAT
injury	O
on	O
the	O
gut	B-ANAT
epithelium	I-ANAT
and	O
examine	O
mechanisms	O
underlying	O
changes	O
in	O
crypt	B-ANAT
proliferation	O
and	O
apoptosis	O
.	O

The	O
relationship	O
between	O
severity	O
and	O
timing	O
of	O
lung	B-ANAT
injury	O
to	O
intestinal	B-ANAT
pathology	O
was	O
also	O
examined	O
.	O

Following	O
induction	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
gut	B-ANAT
epithelial	O
proliferation	O
and	O
apoptosis	O
were	O
assessed	O
in	O
a	O
)	O
C3H	O
/	O
HeN	O
wild	O
-	O
type	O
and	O
C3H	O
/	O
HeJ	O
mice	O
,	O
which	O
lack	O
functional	O
Toll	O
-	O
like	O
receptor	O
4	O
(	O
n	O
=	O
17	O
);	O
b	O
)	O
C57Bl	O
/	O
6	O
mice	O
that	O
received	O
monoclonal	O
anti	O
-	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
or	O
control	O
antibody	O
(	O
n	O
=	O
22	O
);	O
and	O
c	O
)	O
C57Bl	O
/	O
6	O
wild	O
-	O
type	O
and	O
transgenic	O
mice	O
that	O
overexpress	O
Bcl	O
-	O
2	O
in	O
their	O
gut	B-ANAT
epithelium	I-ANAT
(	O
n	O
=	O
21	O
).	O

Acute	O
lung	B-ANAT
injury	O
caused	O
decreased	O
proliferation	O
and	O
increased	O
apoptosis	O
in	O
crypt	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
in	O
all	O
animals	O
studied	O
.	O

Proliferation	O
and	O
apoptosis	O
were	O
not	O
correlated	O
to	O
severity	O
of	O
lung	B-ANAT
injury	O
,	O
as	O
gut	B-ANAT
alterations	O
were	O
lost	O
in	O
mice	O
with	O
more	O
severe	O
acute	O
lung	B-ANAT
injury	O
.	O

In	O
all	O
situations	O
they	O
were	O
significantly	O
more	O
likely	O
to	O
perform	O
mouth	B-ANAT
-	O
to	O
-	O
mouth	B-ANAT
ventilation	O
for	O
a	O
family	O
member	O
compared	O
with	O
a	O
stranger	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
to	O
withhold	O
mouth	B-ANAT
-	O
to	O
-	O
mouth	B-ANAT
ventilation	O
if	O
either	O
vomit	B-ANAT
or	O
blood	B-ANAT
were	O
present	O
in	O
the	O
victim	O
'	O
s	O
mouth	B-ANAT
.	O

They	O
are	O
concerned	O
about	O
the	O
risk	O
of	O
disease	O
transmission	O
,	O
including	O
SARS	O
,	O
during	O
resuscitation	O
,	O
but	O
would	O
be	O
more	O
likely	O
to	O
withhold	O
mouth	B-ANAT
-	O
to	O
-	O
mouth	B-ANAT
resuscitation	O
in	O
the	O
presence	O
of	O
vomit	B-ANAT
or	O
blood	B-ANAT
than	O
due	O
to	O
a	O
fear	O
of	O
contracting	O
SARS	O
.	O

Respective	O
serum	B-ANAT
samples	O
of	O
embryo	B-ANAT
recipients	O
and	O
their	O
offspring	O
were	O
tested	O
for	O
MHV	O
antibodies	O
using	O
ELISA	O
.	O

TITLE	O
:	O
[	O
Expression	O
of	O
SARS	O
-	O
CoV	O
in	O
various	O
types	O
of	O
cells	B-ANAT
in	O
lung	B-ANAT
tissues	I-ANAT
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
cell	B-ANAT
types	O
infected	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
lung	B-ANAT
tissues	I-ANAT
and	O
explore	O
the	O
mechanism	O
of	O
lung	B-ANAT
injury	O
in	O
SARS	O
.	O

The	O
positive	O
results	O
of	O
double	O
staining	O
indicated	O
that	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
,	O
endothelial	B-ANAT
cells	I-ANAT
,	O
macrophages	B-ANAT
,	O
fibroblasts	B-ANAT
and	O
T	B-ANAT
lymphocytes	I-ANAT
were	O
diffusely	O
infected	O
by	O
SARS	O
-	O
CoV	O
.	O
This	O
study	O
of	O
ISH	O
-	O
IHC	O
double	O
staining	O
in	O
lung	B-ANAT
tissues	I-ANAT
of	O
SARS	O
patients	O
showed	O
that	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
,	O
endothelial	B-ANAT
cells	I-ANAT
,	O
macrophages	B-ANAT
,	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
fibroblasts	B-ANAT
were	O
attacked	O
diffusely	O
in	O
SARS	O
lungs	B-ANAT
.	O

Balb	O
/	O
c	O
mice	O
were	O
immunized	O
with	O
recombinant	O
Protein	O
X4	O
,	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
secreting	O
monoclonal	O
antibodies	O
against	O
protein	O
X4	O
were	O
screened	O
by	O
regular	O
cell	B-ANAT
fusion	O
and	O
subcloning	O
approach	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
significance	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
antibody	O
,	O
detected	O
by	O
ELISA	O
and	O
indirect	O
immunofluorescence	O
assays	O
(	O
IFA	O
)	O
for	O
the	O
SARS	O
-	O
CoV	O
Vero	O
E6	O
cell	B-ANAT
lysates	O
,	O
in	O
non	O
-	O
SARS	O
subjects	O
,	O
114	O
serum	B-ANAT
samples	O
from	O
healthy	O
controls	O
and	O
104	O
serum	B-ANAT
specimens	O
from	O
autoimmune	O
disease	O
patients	O
were	O
collected	O
.	O

The	O
results	O
of	O
ELISA	O
showed	O
that	O
among	O
114	O
sera	B-ANAT
from	O
healthy	O
controls	O
,	O
4	O
(	O
3	O
.	O
5	O
%)	O
were	O
positive	O
of	O
SARS	O
-	O
CoV	O
-	O
IgG	B-ANAT
antibody	I-ANAT
and	O
114	O
(	O
100	O
%)	O
were	O
all	O
negative	O
of	O
SARS	O
-	O
CoV	O
-	O
IgM	B-ANAT
antibody	I-ANAT
;	O
the	O
specificity	O
of	O
SARS	O
-	O
CoV	O
-	O
IgG	B-ANAT
antibody	I-ANAT
for	O
SARS	O
patients	O
was	O
96	O
.	O
5	O
%,	O
but	O
the	O
specificity	O
of	O
both	O
SARS	O
-	O
CoV	O
-	O
IgG	O
and	O
-	O
IgM	O
antibodies	O
for	O
SARS	O
patients	O
was	O
100	O
%.	O

The	O
M	O
endodomain	O
interacts	O
with	O
the	O
viral	B-ANAT
nucleocapsid	I-ANAT
,	O
which	O
consists	O
of	O
the	O
positive	O
-	O
strand	O
RNA	O
genome	O
helically	O
encapsidated	O
by	O
N	O
protein	O
monomers	O
.	O

Further	O
,	O
we	O
found	O
that	O
fusion	O
of	O
domain	O
3	O
of	O
the	O
N	O
protein	O
to	O
the	O
carboxy	O
terminus	O
of	O
a	O
heterologous	O
protein	O
caused	O
it	O
to	O
be	O
incorporated	O
into	O
MHV	O
virions	B-ANAT
.	O

ABSTRACT	O
:	O
Activation	O
of	O
host	O
innate	O
immune	O
responses	O
was	O
studied	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SCV	O
)-	O
infected	O
human	O
A549	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
macrophages	B-ANAT
,	O
and	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
).	O

The	O
positive	O
rate	O
of	O
SARS	O
case	O
(	O
10	O
/	O
47	O
)	O
were	O
21	O
.	O
27	O
%,	O
the	O
positive	O
rate	O
of	O
the	O
throat	B-ANAT
swab	I-ANAT
of	O
SARS	O
cases	O
(	O
10	O
/	O
23	O
)	O
were	O
43	O
.	O
87	O
%	O
.	O

Other	O
forms	O
of	O
infectious	O
disease	O
that	O
district	O
nurses	O
encounter	O
--	O
such	O
as	O
hepatitis	O
B	O
and	O
C	O
and	O
the	O
HIV	O
virus	O
that	O
are	O
spread	O
through	O
contact	O
with	O
blood	B-ANAT
or	O
sexual	O
intercourse	O
--	O
rely	O
far	O
more	O
on	O
the	O
infected	O
individual	O
to	O
act	O
responsibly	O
in	O
preventing	O
others	O
from	O
being	O
infected	O
.	O

Whereas	O
the	O
usual	O
surveillance	O
systems	O
are	O
based	O
on	O
established	O
diagnoses	O
and	O
emergency	O
department	O
discharge	B-ANAT
data	O
,	O
syndromic	O
surveillance	O
uses	O
preliminary	O
outcomes	O
and	O
derived	O
data	O
such	O
as	O
absenteeism	O
,	O
prescription	O
medication	O
and	O
requests	O
for	O
laboratory	O
tests	O
.	O

The	O
numbers	O
of	O
CD3	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
CD68	O
+	O
macrophages	B-ANAT
increased	O
significantly	O
in	O
the	O
interstitial	B-ANAT
tissue	I-ANAT
compared	O
with	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Additionally	O
,	O
the	O
TW	O
I	O
attenuated	O
vaccine	O
strain	O
had	O
no	O
reversion	O
to	O
virulence	O
after	O
five	O
back	B-ANAT
passages	O
in	O
chicks	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
has	O
been	O
used	O
successfully	O
in	O
critically	O
ill	O
adult	O
trauma	O
patients	O
and	O
can	O
offer	O
an	O
additional	O
treatment	O
modality	O
.	O

Lung	B-ANAT
injury	O
and	O
injury	O
severity	O
scores	O
,	O
patient	O
age	O
,	O
ECMO	O
duration	O
and	O
oxygenation	O
indices	O
pre	O
-	O
ECMO	O
(	O
PaO2	O
/	O
FiO2	O
)	O
were	O
similar	O
in	O
both	O
the	O
survivor	O
and	O
non	O
-	O
survivor	O
groups	O
.	O

CONCLUSIONS	O
:	O
A	O
high	O
proportion	O
of	O
trauma	O
patients	O
treated	O
with	O
ECMO	O
for	O
severe	O
lung	B-ANAT
injury	O
survived	O
.	O

Bulbar	B-ANAT
dysfunction	O
was	O
the	O
independent	O
risk	O
factor	O
for	O
failure	O
of	O
noninvasive	O
treatment	O
(	O
P	O
<	O
0	O
.	O
05	O
;	O
odds	O
ratio	O
,	O
35	O
.	O
99	O
%;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
71	O
-	O
757	O
.	O
68	O
).	O

Plasma	B-ANAT
concentrations	O
of	O
granulocyte	B-ANAT
elastase	O
derived	O
-	O
XDP	O
(	O
GEXDP	O
)	O
levels	O
correlated	O
with	O
D	O
-	O
dimer	O
levels	O
,	O
suggesting	O
that	O
almost	O
all	O
elevated	O
D	O
-	O
dimer	O
is	O
GE	O
-	O
XDP	O
.	O

The	O
complete	O
S1	O
expression	O
cassette	O
was	O
subcloned	O
into	O
the	O
shuttle	O
vector	O
pVAXE3	O
,	O
then	O
further	O
cloned	O
into	O
the	O
backbone	B-ANAT
vector	O
pPoly2	O
-	O
CAV2	O
containing	O
complete	O
genome	O
of	O
CAV	O
-	O
2	O
.	O

ABSTRACT	O
:	O
The	O
mannose	O
binding	O
proteins	O
on	O
the	O
surface	O
of	O
the	O
dendritic	B-ANAT
cells	I-ANAT
are	O
responsible	O
for	O
capture	O
of	O
pathogens	O
in	O
the	O
early	O
stages	O
of	O
immune	O
response	O
.	O

At	O
zero	O
PEEP	O
PV	O
curves	O
of	O
respiratory	B-ANAT
system	I-ANAT
,	I-ANAT
lung	I-ANAT
,	O
and	O
chest	B-ANAT
wall	I-ANAT
were	O
constructed	O
.	O

An	O
X	O
-	O
ray	O
crystal	B-ANAT
structure	O
of	O
our	O
lead	O
inhibitor	O
(	O
4	O
)	O
bound	O
to	O
SARS	O
-	O
3CLpro	O
provided	O
important	O
drug	O
-	O
design	O
templates	O
for	O
the	O
design	O
of	O
small	O
-	O
molecule	O
inhibitors	O
.	O

Multiple	O
factors	O
contributed	O
to	O
this	O
vascular	B-ANAT
insult	O
included	O
hypercoagulabe	O
status	O
related	O
to	O
both	O
SARS	O
coronavirous	O
and	O
the	O
usage	O
of	O
intravenous	O
immunoglobulin	O
,	O
septic	O
and	O
cardiogenic	O
shock	O
,	O
and	O
possible	O
vasculitis	O
.	O

The	O
GFP	O
-	O
PS	O
-	O
containing	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
are	O
powerful	O
tools	O
for	O
investigating	O
the	O
tissue	B-ANAT
tropism	O
and	O
pathogenesis	O
of	O
SARS	O
-	O
CoV	O
.	O

Here	O
,	O
the	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
elicited	O
by	O
different	O
combinations	O
of	O
gene	O
-	O
based	O
and	O
inactivated	O
viral	B-ANAT
particles	I-ANAT
with	O
various	O
adjuvants	O
have	O
been	O
assessed	O
.	O

The	O
adaptation	O
of	O
the	O
virus	O
through	O
the	O
use	O
of	O
heparan	O
sulfate	O
as	O
an	O
attachment	O
/	O
entry	O
receptor	O
was	O
demonstrated	O
by	O
increased	O
heparin	O
binding	O
as	O
well	O
as	O
by	O
inhibition	O
of	O
infection	O
through	O
treatment	O
of	O
cells	B-ANAT
and	O
the	O
virus	O
with	O
heparinase	O
and	O
heparin	O
,	O
respectively	O
.	O

Recombinant	O
N	O
protein	O
reacted	O
strongly	O
and	O
specifically	O
with	O
the	O
sera	B-ANAT
from	O
immunized	O
mice	O
and	O
SARS	O
patients	O
.	O

Similarly	O
,	O
the	O
sera	B-ANAT
of	O
immunized	O
mice	O
could	O
also	O
react	O
specifically	O
with	O
SARS	O
-	O
CoV	O
particles	O
.	O

These	O
results	O
suggest	O
that	O
HIV	O
-	O
NS	O
provides	O
an	O
efficient	O
vaccine	O
delivery	O
system	O
for	O
the	O
induction	O
of	O
a	O
mucosal	B-ANAT
immune	O
response	O
and	O
the	O
development	O
of	O
a	O
mucosal	B-ANAT
vaccine	O
.	O

HBoV	O
was	O
found	O
to	O
coincide	O
with	O
another	O
virus	O
in	O
more	O
than	O
half	O
of	O
all	O
instances	O
and	O
displayed	O
a	O
single	O
genetic	O
lineage	O
,	O
whilst	O
HCoV	O
-	O
HKU1	O
was	O
more	O
likely	O
to	O
occur	O
in	O
the	O
absence	O
of	O
another	O
microbe	O
and	O
strains	O
could	O
be	O
divided	O
into	O
two	O
genetic	O
lineages	O
which	O
we	O
propose	O
be	O
termed	O
HCoV	O
-	O
HKU1	O
type	O
A	O
and	O
type	O
B	O
.	O
Children	O
under	O
the	O
age	O
of	O
2	O
years	O
were	O
most	O
at	O
risk	O
of	O
infection	O
by	O
these	O
viruses	O
which	O
contribute	O
significantly	O
to	O
the	O
microbial	O
burden	O
among	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
during	O
the	O
colder	O
months	O
.	O

TITLE	O
:	O
[	O
A	O
field	O
trial	O
of	O
recombinant	O
human	O
interferon	O
alpha	O
-	O
2b	O
for	O
nasal	B-ANAT
spray	O
to	O
prevent	O
SARS	O
and	O
other	O
respiratory	O
viral	O
infections	O
].	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE	O
-	O
2	O
)	O
has	O
been	O
identified	O
as	O
a	O
functional	O
receptor	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
so	O
its	O
gene	O
was	O
cloned	O
and	O
eukaryotic	O
expressed	O
for	O
further	O
insight	O
into	O
mechanisms	O
in	O
SARS	O
-	O
CoV	O
entry	O
and	O
pathogenesis	O
,	O
as	O
well	O
as	O
development	O
of	O
a	O
safe	O
and	O
reliable	O
neutralization	O
assay	O
for	O
SARS	O
-	O
CoV	O
.	O
Total	O
RNA	O
was	O
extracted	O
from	O
right	O
atrial	B-ANAT
tissue	B-ANAT
of	O
a	O
patient	O
with	O
right	B-ANAT
heart	I-ANAT
failure	O
resected	O
during	O
a	O
valvular	O
replacement	O
surgery	O
by	O
Trizol	O
one	O
-	O
step	O
method	O
,	O
and	O
the	O
full	O
-	O
length	O
ACE	O
-	O
2	O
encoding	O
gene	O
was	O
acquired	O
by	O
RT	O
-	O
nested	O
-	O
PCR	O
.	O

The	O
recombinant	O
plasmid	O
pcDNA4	O
/	O
ACE	O
-	O
2	O
could	O
express	O
ACE	O
-	O
2	O
protein	O
in	O
eukaryotic	B-ANAT
cells	I-ANAT
and	O
induce	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
between	O
S	O
protein	O
-	O
and	O
ACE2	O
-	O
expressing	O
cells	B-ANAT
.	O

This	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
assay	O
could	O
be	O
used	O
to	O
detect	O
SARS	O
-	O
CoV	O
neutralizing	O
antibody	O
.	O

Western	O
Blot	O
and	O
ELISA	O
analysis	O
showed	O
that	O
the	O
S1c	O
protein	O
could	O
be	O
specifically	O
recognized	O
by	O
the	O
sera	B-ANAT
from	O
SARS	O
patients	O
.	O

In	O
a	O
neutralization	O
assay	O
,	O
IL	O
-	O
11	O
-	O
induced	O
STAT	O
3	O
phosphorylation	O
in	O
rat	O
intestinal	B-ANAT
epithelial	O
IEC	O
-	O
18	O
cells	B-ANAT
was	O
completely	O
suppressed	O
by	O
the	O
anti	O
-	O
N	O
scFv	O
clone	O
L9N01	O
.	O

The	O
availability	O
of	O
structures	O
of	O
SARS	O
coronavirus	O
macromolecules	O
has	O
enabled	O
the	O
elucidation	O
of	O
their	O
important	O
functions	O
,	O
such	O
as	O
mediating	O
the	O
fusion	O
of	O
viral	O
and	O
host	O
cellular	B-ANAT
membranes	B-ANAT
,	O
and	O
in	O
replication	O
and	O
transcription	O
.	O

The	O
extent	O
and	O
severity	O
of	O
the	O
lung	B-ANAT
disease	O
associated	O
with	O
ALI	O
varies	O
with	O
those	O
patients	O
having	O
the	O
most	O
severe	O
manifestations	O
of	O
lung	B-ANAT
disease	O
being	O
grouped	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
pathological	O
injury	O
associated	O
with	O
this	O
disease	O
process	O
,	O
termed	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
),	O
has	O
three	O
overlapping	O
phases	O
(	O
exudative	O
,	O
proliferative	O
and	O
fibrotic	O
)	O
which	O
are	O
the	O
consequences	O
of	O
severe	O
injury	O
to	O
the	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
unit	O
.	O

ABSTRACT	O
:	O
A	O
24	O
-	O
year	O
-	O
old	O
woman	O
with	O
a	O
4	O
-	O
year	O
history	O
of	O
bronchial	B-ANAT
asthma	O
suffered	O
from	O
bloody	O
sputum	B-ANAT
,	O
numbness	O
of	O
the	O
extremities	B-ANAT
,	O
elevated	O
eosinophil	B-ANAT
count	O
,	O
and	O
hypoxemia	O
.	O

Nine	O
of	O
these	O
patients	O
were	O
adults	O
,	O
and	O
4	O
had	O
underlying	O
diseases	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

In	O
the	O
animals	O
given	O
3H	O
-	O
OA	O
,	O
we	O
measured	O
3H	O
-	O
OA	O
in	O
different	O
tissues	B-ANAT
(	O
lungs	B-ANAT
,	O
heart	B-ANAT
,	O
liver	B-ANAT
,	O
kidney	B-ANAT
,	O
stomach	B-ANAT
,	O
jejunum	B-ANAT
,	O
colon	B-ANAT
and	O
arterial	B-ANAT
blood	I-ANAT
).	O

Convalescent	O
serum	B-ANAT
was	O
collected	O
from	O
clinical	O
confirmed	O
patient	O
.	O

In	O
this	O
study	O
,	O
we	O
established	O
persistent	O
infection	O
of	O
SARS	O
-	O
CoV	O
in	O
the	O
Vero	O
E6	O
cell	B-ANAT
line	I-ANAT
.	O

Upon	O
subsequent	O
culturing	O
of	O
the	O
remaining	O
adherent	O
cells	B-ANAT
,	O
the	O
cells	B-ANAT
gradually	O
proliferated	O
and	O
recovered	O
normal	O
morphology	O
similar	O
to	O
that	O
of	O
the	O
parental	O
cells	B-ANAT
,	O
and	O
continued	O
to	O
produce	O
large	O
numbers	O
of	O
infectious	O
viral	B-ANAT
particles	I-ANAT
during	O
the	O
observation	O
period	O
of	O
5	O
months	O
.	O

This	O
rapid	O
immunoturbidimetric	O
assay	O
for	O
measurement	O
of	O
feline	O
AGP	O
in	O
serum	B-ANAT
and	O
peritoneal	B-ANAT
fluid	I-ANAT
may	O
be	O
of	O
value	O
in	O
the	O
diagnosis	O
of	O
FIP	O
and	O
possibly	O
other	O
inflammatory	O
diseases	O
in	O
cats	O
.	O

ABSTRACT	O
:	O
The	O
crystal	B-ANAT
structure	O
of	O
a	O
conserved	O
domain	O
of	O
nonstructural	O
protein	O
3	O
(	O
nsP3	O
)	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
solved	O
by	O
single	O
-	O
wavelength	O
anomalous	O
dispersion	O
to	O
1	O
.	O
4	O
A	O
resolution	O
.	O

And	O
ACE2	O
was	O
proved	O
as	O
a	O
cellular	B-ANAT
receptor	O
that	O
meditated	O
an	O
initial	O
-	O
affinity	O
interaction	O
with	O
SARS	O
-	O
Cov	O
spike	O
protein	O
.	O

CONCLUSIONS	O
:	O
In	O
this	O
paper	O
,	O
we	O
get	O
sufficient	O
soluble	O
N	O
terminal	O
GST	O
tagged	O
RBD	O
protein	O
expressed	O
in	O
E	O
.	O
coli	O
BL21	B-ANAT
(	O
DE3	O
);	O
data	O
from	O
ELISA	O
and	O
flow	O
cytometry	O
assay	O
demonstrate	O
that	O
the	O
recombinant	O
protein	O
is	O
functional	O
and	O
binding	O
to	O
ACE2	O
positive	O
Vero	O
E6	O
cell	B-ANAT
efficiently	O
.	O

RESULTS	O
:	O
The	O
viscosity	O
of	O
total	O
blood	B-ANAT
and	O
plasma	B-ANAT
,	O
the	O
hematocrit	O
,	O
and	O
the	O
erythrocyte	B-ANAT
osmotic	O
fragility	O
were	O
all	O
increased	O
.	O

ICAM	O
-	O
1	O
genetic	O
expression	O
moved	O
up	O
after	O
1	O
h	O
and	O
reached	O
its	O
peak	O
value	O
after	O
9	O
h	O
.	O
CONCLUSIONS	O
:	O
MD	O
plays	O
an	O
important	O
role	O
in	O
ASP	O
following	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

TITLE	O
:	O
Elevated	O
plasma	B-ANAT
tissue	B-ANAT
-	O
type	O
plasminogen	O
activator	O
(	O
t	O
-	O
PA	O
)	O
and	O
soluble	O
thrombomodulin	O
in	O
patients	O
suffering	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
as	O
a	O
possible	O
index	O
for	O
prognosis	O
and	O
treatment	O
strategy	O
.	O

As	O
assessed	O
by	O
immunofluorescence	O
staining	O
and	O
membrane	B-ANAT
biotinylation	O
,	O
ACE2	O
protein	O
was	O
more	O
abundantly	O
expressed	O
on	O
the	O
apical	O
than	O
the	O
basolateral	O
surface	O
of	O
polarized	O
airway	B-ANAT
epithelia	O
.	O

The	O
results	O
indicate	O
that	O
infection	O
of	O
human	O
airway	B-ANAT
epithelia	O
by	O
SARS	O
coronavirus	O
correlates	O
with	O
the	O
state	O
of	O
cell	B-ANAT
differentiation	O
and	O
ACE2	O
expression	O
and	O
localization	O
.	O

TITLE	O
:	O
A	O
novel	O
fingerprint	O
map	O
for	O
detecting	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Spike	O
(	O
S	O
)	O
protein	O
is	O
the	O
most	O
important	O
membrane	B-ANAT
protein	O
on	O
the	O
surface	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

Effective	O
and	O
safe	O
discharge	B-ANAT
criteria	O
were	O
established	O
from	O
the	O
lessons	O
learnt	O
.	O

ABSTRACT	O
:	O
Transplantation	O
of	O
remyelination	O
-	O
competent	O
cells	B-ANAT
represents	O
a	O
promising	O
strategy	O
for	O
the	O
treatment	O
of	O
demyelinating	O
diseases	O
.	O

We	O
found	O
that	O
the	O
supernatants	O
of	O
human	O
PBMCs	O
stimulated	O
by	O
BW001	O
significantly	O
protected	O
Vero	B-ANAT
cells	I-ANAT
from	O
SARS	O
-	O
CoV	O
infection	O
.	O

A	O
previous	O
report	O
(	O
Virology	O
2003	O
,	O
311	O
:	O
16	O
-	O
27	O
)	O
indicated	O
that	O
transfected	O
IBV	O
3b	O
localized	O
to	O
the	O
nucleus	B-ANAT
in	O
mammalian	O
cells	B-ANAT
using	O
a	O
vaccinia	O
-	O
virus	O
expression	O
system	O
.	O

Yet	O
the	O
expression	O
of	O
HE	O
was	O
rapidly	O
lost	O
during	O
serial	O
cell	B-ANAT
culture	O
passaging	O
.	O

The	O
soR	O
and	O
soR	O
-	O
425	O
proteins	O
,	O
both	O
produced	O
with	O
the	O
vaccinia	O
virus	O
system	O
,	O
were	O
able	O
to	O
neutralize	O
MHV	O
infection	O
of	O
murine	O
LR7	B-ANAT
cells	B-ANAT
.	O

However	O
,	O
only	O
soR	O
-	O
425	O
was	O
able	O
to	O
target	O
MHV	O
to	O
human	O
EGFR	O
-	O
expressing	O
cancer	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
2002	O
as	O
an	O
important	O
cause	O
of	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
humans	O
,	O
and	O
in	O
vitro	O
models	O
of	O
the	O
lung	B-ANAT
are	O
needed	O
to	O
elucidate	O
cellular	B-ANAT
targets	O
and	O
the	O
consequences	O
of	O
viral	O
infection	O
.	O

The	O
SARS	O
-	O
CoV	O
receptor	O
,	O
human	O
angiotensin	O
1	O
-	O
converting	O
enzyme	O
2	O
(	O
hACE2	O
),	O
was	O
detected	O
in	O
ciliated	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
of	O
human	O
airway	B-ANAT
tissues	B-ANAT
derived	O
from	O
nasal	B-ANAT
or	O
tracheobronchial	O
regions	O
,	O
suggesting	O
that	O
SARS	O
-	O
CoV	O
may	O
infect	O
the	O
proximal	O
airways	O
.	O

Single	O
crown	B-ANAT
-	O
like	O
virion	B-ANAT
was	O
directly	O
visualized	O
and	O
quantitative	O
measurements	O
of	O
the	O
dimensions	O
for	O
the	O
structural	O
proteins	O
were	O
provided	O
.	O

Epithelial	B-ANAT
cell	I-ANAT
injury	O
,	O
diffuse	O
alveolar	B-ANAT
damage	O
and	O
surfactant	O
dysfunction	O
ensue	O
leading	O
to	O
refractory	O
hypoxemic	O
respiratory	O
failure	O
.	O

HO	O
-	O
1	O
null	O
(	O
HO	O
-	O
1	O
(-/-))	O
mice	O
exhibited	O
severe	O
physiologic	O
lung	B-ANAT
dysfunction	O
following	O
lipopolysaccharide	O
(	O
LPS	O
)	O
nebulization	O
,	O
but	O
had	O
similar	O
inflammatory	O
responses	O
as	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	O
.	O

Using	O
reciprocal	O
bone	B-ANAT
marrow	I-ANAT
transplantation	O
(	O
BMT	O
)	O
to	O
generate	O
HO	O
-	O
1	O
-	O
chimeric	O
mice	O
,	O
we	O
found	O
that	O
absence	O
of	O
HO	O
-	O
1	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
,	O
not	O
in	O
bone	B-ANAT
marrow	I-ANAT
-	O
derived	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
was	O
responsible	O
for	O
enhanced	O
SP	O
-	O
B	O
downregulation	O
and	O
severe	O
physiologic	O
lung	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
Adenovirus	O
-	O
mediated	O
expression	O
of	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
is	O
sufficient	O
to	O
induce	O
apoptosis	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

Further	O
studies	O
by	O
immunoblot	O
and	O
confocal	O
microscopy	O
analyses	O
revealed	O
the	O
expression	O
and	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
localization	O
of	O
the	O
recombinant	O
SARS	O
6	O
protein	O
in	O
mammalian	O
cells	B-ANAT
.	O

After	O
repeated	O
episodes	O
,	O
areas	O
of	O
tissue	B-ANAT
loss	O
coalesce	O
with	O
older	O
lesions	O
to	O
become	O
larger	O
cystic	O
regions	O
in	O
brain	B-ANAT
or	O
spinal	B-ANAT
cord	I-ANAT
.	O

Familial	O
occurrence	O
and	O
consanguinity	O
suggest	O
autosomal	B-ANAT
recessive	O
inheritance	O
of	O
this	O
distinct	O
entity	O
.	O

Retrospective	O
clinical	O
study	O
:	O
the	O
clinical	O
records	O
of	O
all	O
cats	O
with	O
histopathologically	O
confirmed	O
feline	O
infectious	O
peritonitis	O
at	O
the	O
University	O
Veterinary	O
Centre	O
Sydney	O
and	O
a	O
private	O
cat	O
hospital	O
in	O
Sydney	O
between	O
1990	O
and	O
2002	O
were	O
reviewed	O
for	O
signalment	O
,	O
history	O
,	O
physical	O
findings	O
,	O
diagnostic	O
test	O
results	O
and	O
the	O
distribution	O
of	O
histological	O
lesions	O
throughout	O
the	O
body	B-ANAT
at	O
necropsy	O
.	O

Twenty	O
-	O
nine	O
(	O
69	O
%)	O
of	O
these	O
RT	O
-	O
PCR	O
-	O
positive	O
,	O
and	O
none	O
of	O
the	O
RT	O
-	O
PCR	O
-	O
negative	O
,	O
samples	O
yielded	O
virus	O
by	O
isolation	O
in	O
chicken	O
embryos	B-ANAT
.	O

As	O
discussed	O
in	O
this	O
Review	O
,	O
studies	O
of	O
animals	O
that	O
are	O
infected	O
with	O
other	O
coronaviruses	O
indicate	O
that	O
excessive	O
and	O
sometimes	O
dysregulated	O
responses	O
by	O
macrophages	B-ANAT
and	O
other	O
pro	O
-	O
inflammatory	B-ANAT
cells	I-ANAT
might	O
be	O
particularly	O
important	O
in	O
the	O
pathogenesis	O
of	O
disease	O
that	O
is	O
caused	O
by	O
infection	O
with	O
these	O
viruses	O
.	O

Following	O
extubation	O
the	O
patient	O
s	O
condition	O
improved	O
until	O
the	O
onset	O
of	O
several	O
choking	O
episodes	O
caused	O
by	O
a	O
dislodged	O
laryngotracheal	O
cast	B-ANAT
in	O
the	O
subglottic	B-ANAT
region	O
.	O

This	O
approach	O
has	O
not	O
been	O
able	O
to	O
identify	O
active	O
inhibitors	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
using	O
solely	O
the	O
crystal	B-ANAT
structures	O
of	O
a	O
SARS	O
-	O
CoV	O
cysteine	O
proteinase	O
with	O
a	O
flexible	O
loop	O
in	O
the	O
active	O
site	O
[	O
Yang	O
,	O
H	O
.	O
T	O
.;	O
Yang	O
,	O
M	O
.	O
J	O
.;	O
Ding	O
,	O
Y	O
.;	O
Liu	O
,	O
Y	O
.	O
W	O
.;	O
Lou	O
,	O
Z	O
.	O
Y	O
.	O
Proc	O
.	O

Treatment	O
consisting	O
of	O
regular	O
and	O
repeated	O
plasma	B-ANAT
exchanges	O
using	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
,	O
and	O
IV	O
immunoglobulins	O
in	O
addition	O
to	O
parenteral	O
steroids	O
and	O
anticoagulation	O
are	O
necessary	O
to	O
improve	O
the	O
survival	O
in	O
a	O
condition	O
where	O
the	O
mortality	O
is	O
still	O
of	O
the	O
order	O
of	O
50	O
%.	O

Accurate	O
determination	O
of	O
the	O
dimer	O
dissociation	O
constant	O
and	O
the	O
role	O
of	O
the	O
N	O
-	O
finger	B-ANAT
(	O
residues	O
1	O
-	O
7	O
)	O
will	O
provide	O
more	O
insights	O
into	O
the	O
enzyme	O
catalytic	O
mechanism	O
of	O
SARS	O
3CL	O
proteinase	O
.	O

RESULTS	O
:	O
Prior	O
to	O
the	O
recognition	O
of	O
the	O
SARS	O
outbreak	O
in	O
March	O
2003	O
,	O
35	O
.	O
2	O
%	O
of	O
the	O
students	O
washed	O
their	O
hands	B-ANAT
before	O
and	O
72	O
.	O
5	O
%	O
after	O
they	O
physically	O
examined	O
patients	O
in	O
the	O
wards	O
.	O

The	O
45	O
kDa	O
recombinant	O
nucleocapsid	B-ANAT
N	O
protein	O
of	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
is	O
highly	O
sensitive	O
to	O
proteolysis	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
replicase	O
-	O
transcriptase	O
complex	O
is	O
an	O
assembly	O
of	O
viral	O
and	O
cellular	B-ANAT
proteins	O
that	O
mediate	O
the	O
synthesis	O
of	O
genome	O
and	O
subgenome	O
-	O
sized	O
mRNAs	O
in	O
the	O
virus	O
-	O
infected	O
cell	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
,	O
many	O
investigators	O
have	O
focused	O
on	O
potential	O
associations	O
between	O
infections	O
and	O
vascular	B-ANAT
inflammation	O
.	O

A	O
recent	O
study	O
has	O
identified	O
higher	O
frequency	O
of	O
a	O
novel	O
human	O
virus	O
,	O
the	O
'	O
New	O
Haven	O
coronavirus	O
',	O
in	O
respiratory	O
secretions	B-ANAT
of	O
children	O
with	O
Kawasaki	O
disease	O
.	O

In	O
an	O
effort	O
to	O
develop	O
a	O
novel	O
microfluidic	O
based	O
drug	O
screening	O
platform	O
,	O
systematic	O
studies	O
on	O
the	O
interaction	O
between	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factor	O
(	O
G	O
-	O
CSF	B-ANAT
)	O
and	O
sulfated	O
oligosaccharides	O
were	O
carried	O
out	O
at	O
both	O
molecular	O
and	O
cellular	B-ANAT
levels	O
.	O

A	O
subpopulation	O
of	O
the	O
released	O
3a	O
protein	O
is	O
associated	O
with	O
detergent	O
-	O
resistant	O
membranes	B-ANAT
.	O

TITLE	O
:	O
Role	O
of	O
the	O
mitochondrial	B-ANAT
signaling	O
pathway	O
in	O
murine	O
coronavirus	O
-	O
induced	O
oligodendrocyte	B-ANAT
apoptosis	O
.	O

Training	O
involved	O
a	O
seminar	O
,	O
practice	O
in	O
wearing	O
the	O
mandatory	O
personal	O
protection	O
system	O
(	O
PPS	O
),	O
and	O
cardiac	B-ANAT
arrest	O
simulations	O
with	O
subsequent	O
debriefing	O
.	O

Errors	O
in	O
infection	O
control	O
as	O
well	O
as	O
in	O
medical	O
management	O
of	O
advanced	O
cardiac	B-ANAT
life	O
support	O
(	O
ACLS	O
)	O
were	O
corrected	O
.	O

In	O
particular	O
,	O
we	O
used	O
x	O
-	O
ray	O
reflectivity	O
to	O
study	O
the	O
location	O
of	O
an	O
iodine	O
-	O
labeled	O
residue	O
within	O
the	O
lipid	B-ANAT
bilayer	I-ANAT
.	O

Serum	B-ANAT
,	O
peripheral	O
-	O
blood	B-ANAT
mononuclear	B-ANAT
cells	I-ANAT
,	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
throat	B-ANAT
swabs	O
,	O
and	O
rectal	O
swabs	O
from	O
these	O
patients	O
were	O
assayed	O
for	O
HCoV	O
-	O
NL63	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
(	O
RT	O
)	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
),	O
and	O
the	O
throat	B-ANAT
swabs	O
,	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
,	O
and	O
rectal	O
swabs	O
were	O
also	O
assayed	O
for	O
HCoV	O
-	O
NH	O
by	O
RT	O
-	O
PCR	O
.	O

This	O
issue	O
of	O
The	O
Journal	O
of	O
Pathology	O
contains	O
articles	O
that	O
address	O
the	O
roles	O
that	O
cell	B-ANAT
and	O
tissue	B-ANAT
biology	O
and	O
pathology	O
are	O
playing	O
in	O
the	O
elucidation	O
of	O
these	O
mechanisms	O
.	O

Reviews	O
on	O
Helicobacter	O
and	O
gastric	B-ANAT
neoplasia	O
,	O
innate	O
defences	O
against	O
methicillin	O
-	O
resistant	O
Staphylococcus	O
aureus	O
(	O
MRSA	O
)	O
infection	O
,	O
and	O
the	O
function	O
of	O
granulomas	O
in	O
tuberculosis	O
also	O
address	O
aspects	O
of	O
tissue	B-ANAT
responses	O
to	O
bacterial	O
infection	O
.	O

The	O
reviews	O
assembled	O
here	O
bridge	O
several	O
gaps	O
:	O
between	O
microbiology	O
and	O
cellular	B-ANAT
pathology	O
;	O
between	O
host	O
and	O
infecting	O
organism	O
;	O
and	O
between	O
disease	O
and	O
therapy	O
.	O

TITLE	O
:	O
Pretreatment	O
with	O
simvastatin	O
reduces	O
lung	B-ANAT
injury	O
related	O
to	O
intestinal	B-ANAT
ischemia	O
-	O
reperfusion	O
in	O
rats	O
.	O

Fungal	O
blood	B-ANAT
cultures	O
were	O
positive	O
for	O
Penicillium	O
chrysogenum	O
and	O
the	O
patient	O
completed	O
a	O
6	O
week	O
course	O
of	O
amphotericin	O
B	O
lipid	O
complex	O
,	O
followed	O
by	O
an	O
extended	O
course	O
oral	B-ANAT
intraconazole	O
.	O

TITLE	O
:	O
Management	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
using	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
the	O
use	O
of	O
a	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
device	O
in	O
the	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
A	O
new	O
human	O
coronavirus	O
(	O
HCoV	O
),	O
HCoV	O
-	O
NL	O
,	O
was	O
recently	O
reported	O
for	O
Dutch	O
patients	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
ARTI	O
).	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
subarachnoid	O
hemorrhage	O
:	O
incidence	O
,	O
risk	O
factors	O
,	O
and	O
outcome	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
complications	O
account	O
for	O
significant	O
morbidity	O
and	O
mortality	O
following	O
aneurysmal	O
subarachnoid	O
hemorrhage	O
;	O
however	O
,	O
the	O
effect	O
of	O
acute	O
lung	B-ANAT
injury	O
is	O
largely	O
unknown	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
induction	O
of	O
apoptosis	O
by	O
the	O
7a	O
protein	O
may	O
be	O
related	O
to	O
its	O
ability	O
to	O
inhibit	O
cellular	B-ANAT
translation	O
and	O
activate	O
p38	O
MAPK	O
.	O

In	O
order	O
to	O
elucidate	O
the	O
pathogenic	O
mechanisms	O
of	O
SARS	O
,	O
we	O
analyzed	O
clinical	O
manifestations	O
and	O
levels	O
of	O
serum	B-ANAT
cytokines	O
of	O
SARS	O
patients	O
.	O

At	O
the	O
first	O
re	O
-	O
examination	O
,	O
the	O
rate	O
of	O
abnormal	O
chest	B-ANAT
CT	O
was	O
65	O
%,	O
and	O
the	O
main	O
abnormal	O
images	O
included	O
ground	O
glass	O
opacities	O
,	O
thickening	O
of	O
inter	O
-	O
lobular	O
and	O
intra	O
-	O
lobular	O
septa	O
,	O
distorted	O
lobular	O
structure	O
,	O
thickened	O
bronchovascular	O
bundles	O
,	O
thickened	O
pleura	B-ANAT
,	O
arc	B-ANAT
shadow	O
under	O
the	O
pleura	B-ANAT
,	O
bronchiolar	B-ANAT
dilation	O
,	O
and	O
honey	O
comb	B-ANAT
like	O
shadows	O
.	O

At	O
the	O
first	O
re	O
-	O
examination	O
,	O
the	O
abnormal	O
rate	O
of	O
KCO	O
was	O
highest	O
,	O
accompanied	O
by	O
abnormalities	O
of	O
forced	O
expiratory	O
volume	O
in	O
1	O
second	O
(	O
FEV1	O
)	O
and	O
the	O
diffusing	O
capacity	O
of	O
the	O
lung	B-ANAT
for	O
carbon	O
monoxide	O
(	O
DLCO	O
),	O
and	O
it	O
began	O
to	O
recover	O
since	O
the	O
third	O
examination	O
.	O

The	O
recovery	O
of	O
chest	B-ANAT
CT	O
to	O
normal	O
may	O
take	O
a	O
long	O
time	O
.	O

Both	O
the	O
low	O
and	O
high	O
intensity	O
of	O
UV	O
-	O
B	O
exposure	O
increased	O
the	O
concentration	O
of	O
glycyrrhizin	O
in	O
the	O
root	B-ANAT
tissues	B-ANAT
of	O
3	O
-	O
month	O
-	O
old	O
pot	O
plants	O
,	O
the	O
values	O
being	O
nearly	O
X1	O
.	O
5	O
those	O
of	O
the	O
control	O
.	O

ABSTRACT	O
:	O
Evaluation	O
of	O
a	O
wide	O
variety	O
of	O
pyridine	O
N	O
-	O
oxide	O
derivatives	O
on	O
their	O
inhibitory	O
activity	O
against	O
feline	O
coronavirus	O
(	O
FIPV	O
strain	O
)	O
and	O
human	O
SARS	O
-	O
CoV	O
(	O
Frankfurt	O
strain	O
-	O
1	O
)	O
in	O
cell	B-ANAT
culture	O
.	O

FIPV	O
and	O
SARS	O
-	O
CoV	O
were	O
exposed	O
to	O
confluent	O
Crandel	O
feline	O
kidney	B-ANAT
(	O
CRFK	O
)	O
and	O
simian	O
kidney	B-ANAT
(	O
Vero	O
)	O
cell	B-ANAT
cultures	O
in	O
the	O
presence	O
of	O
serial	O
concentrations	O
of	O
the	O
test	O
compounds	O
.	O

TITLE	O
:	O
Immunogenicity	O
and	O
protective	O
efficacy	O
in	O
monkeys	O
of	O
purified	O
inactivated	O
Vero	O
-	O
cell	B-ANAT
SARS	O
vaccine	O
.	O

Diagnostic	O
modeling	O
using	O
a	O
newly	O
modified	O
receiver	O
operator	O
characteristic	O
approach	O
was	O
applied	O
to	O
recently	O
published	O
data	O
from	O
our	O
laboratory	O
on	O
lavaged	O
inflammatory	O
mediators	O
from	O
rodents	O
given	O
intratracheal	O
normal	O
saline	O
,	O
hydrochloric	O
acid	O
,	O
small	O
nonacidified	O
gastric	B-ANAT
particles	O
,	O
or	O
a	O
combination	O
of	O
acid	O
and	O
small	O
gastric	B-ANAT
particles	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
controlled	O
mechanical	O
ventilation	O
is	O
generally	O
used	O
in	O
the	O
initial	O
phase	O
to	O
ensure	O
adequate	O
alveolar	B-ANAT
ventilation	O
,	O
arterial	B-ANAT
oxygenation	O
,	O
and	O
to	O
reduce	O
work	O
of	O
breathing	O
without	O
causing	O
further	O
damage	O
to	O
the	O
lungs	B-ANAT
.	O

TITLE	O
:	O
Ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
is	O
reduced	O
in	O
transgenic	O
mice	O
that	O
overexpress	O
endothelial	B-ANAT
nitric	O
oxide	O
synthase	O
.	O

In	O
this	O
paper	O
,	O
we	O
report	O
on	O
the	O
development	O
of	O
a	O
Geographical	O
Information	O
System	O
(	O
GIS	O
)	O
based	O
on	O
a	O
novel	O
Digital	B-ANAT
Ring	O
Fence	O
(	O
DRiF	O
)	O
strategy	O
for	O
the	O
containment	O
of	O
acute	O
infectious	O
diseases	O
.	O

The	O
viruses	O
were	O
isolated	O
from	O
tracheas	B-ANAT
,	O
lungs	B-ANAT
,	O
and	O
cecal	B-ANAT
tonsils	B-ANAT
of	O
birds	O
,	O
previously	O
vaccinated	O
with	O
the	O
Massachusetts	O
strain	O
,	O
that	O
were	O
showing	O
respiratory	O
signs	O
.	O

For	O
example	O
,	O
infliximab	O
,	O
a	O
monoclonal	O
TNF	O
antibody	O
,	O
was	O
experimentally	O
tested	O
in	O
rats	O
and	O
it	O
was	O
able	O
to	O
significantly	O
reduce	O
the	O
pathologic	O
score	O
and	O
serum	B-ANAT
amylase	O
activity	O
,	O
and	O
also	O
alleviate	O
alveolar	B-ANAT
edema	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
no	O
studies	O
are	O
available	O
in	O
clinical	O
human	O
acute	O
pancreatitis	O
.	O

A	O
randomized	O
study	O
has	O
been	O
published	O
to	O
test	O
the	O
hypothesis	O
that	O
probiotics	O
and	O
specific	O
fibres	B-ANAT
used	O
as	O
supplements	O
in	O
early	O
enteral	O
nutrition	O
may	O
be	O
effective	O
in	O
reducing	O
pancreatic	B-ANAT
sepsis	O
and	O
the	O
number	O
of	O
surgical	O
interventions	O
.	O

(	O
2	O
)	O
Compared	O
with	O
the	O
total	O
WBC	B-ANAT
of	O
BALF	O
in	O
Nc	O
group	O
[(	O
95	O
+/-	O
29	O
)	O
x	O
10	O
(	O
7	O
)],	O
that	O
in	O
P2	O
group	O
[(	O
160	O
+/-	O
60	O
)	O
x	O
10	O
(	O
7	O
)]	O
was	O
significantly	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
);	O
but	O
compared	O
with	O
P2	O
group	O
,	O
that	O
in	O
P	O
+	O
D	O
group	O
[(	O
62	O
+/-	O
23	O
)	O
x	O
10	O
(	O
7	O
)]	O
was	O
significantly	O
decreased	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

(	O
4	O
)	O
Compared	O
with	O
Nc	O
group	O
,	O
the	O
levels	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
,	O
TGF	O
-	O
beta1	O
in	O
both	O
serum	B-ANAT
and	O
BALF	O
of	O
P1	O
group	O
were	O
significantly	O
increased	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
the	O
levels	O
of	O
these	O
cytokines	O
in	O
P2	O
group	O
were	O
significantly	O
higher	O
than	O
those	O
in	O
P1	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
but	O
significantly	O
lower	O
in	O
P	O
+	O
D	O
group	O
compared	O
with	O
P2	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

(	O
4	O
)	O
Compared	O
with	O
Nc	O
group	O
,	O
the	O
levels	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
10	O
,	O
TGF	O
-	O
beta1	O
in	O
both	O
serum	B-ANAT
and	O
BALF	O
of	O
P1	O
group	O
were	O
significantly	O
increased	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
the	O
levels	O
of	O
these	O
cytokines	O
in	O
P2	O
group	O
were	O
significantly	O
higher	O
than	O
those	O
in	O
P1	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
but	O
significantly	O
lower	O
in	O
P	O
+	O
D	O
group	O
compared	O
with	O
P2	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
The	O
human	O
coronavirus	O
HCoV	O
-	O
OC43	O
causes	O
a	O
significant	O
fraction	O
of	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

We	O
have	O
utilized	O
Andes	O
virus	O
infection	O
of	O
primary	O
,	O
differentiated	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
to	O
investigate	O
the	O
ability	O
of	O
the	O
virus	O
to	O
interact	O
with	O
and	O
cross	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
.	O

To	O
demonstrate	O
that	O
MHV	O
can	O
be	O
retargeted	O
to	O
a	O
nonnative	O
receptor	O
on	O
human	O
cells	B-ANAT
,	O
we	O
produced	O
bispecific	O
adapter	O
proteins	O
composed	O
of	O
the	O
N	O
-	O
terminal	O
D1	O
domain	O
of	O
mCEACAM1a	O
linked	O
to	O
a	O
short	O
targeting	O
peptide	O
,	O
the	O
six	O
-	O
amino	O
-	O
acid	O
His	O
tag	O
.	O

This	O
is	O
achieved	O
by	O
cellular	B-ANAT
palmitoyl	O
acyltransferases	O
(	O
PATs	O
),	O
which	O
can	O
modify	O
newly	O
synthesized	O
S	O
proteins	O
before	O
they	O
are	O
assembled	O
into	O
virion	B-ANAT
envelopes	O
at	O
the	O
intermediate	O
compartment	B-ANAT
of	O
the	O
exocytic	O
pathway	O
.	O

At	O
defined	O
2	O
-	O
BP	O
doses	O
,	O
underpalmitoylated	O
S	O
proteins	O
instead	O
trafficked	O
to	O
infected	O
cell	B-ANAT
surfaces	O
and	O
elicited	O
cell	B-ANAT
-	O
cell	B-ANAT
membrane	I-ANAT
fusions	O
,	O
suggesting	O
that	O
the	O
acyl	O
chain	O
adducts	O
are	O
more	O
critical	O
to	O
virion	B-ANAT
assembly	O
than	O
to	O
S	O
-	O
induced	O
syncytial	O
developments	O
.	O

Notably	O
,	O
some	O
mutations	O
(	O
C1347F	O
and	O
C1348S	O
)	O
did	O
not	O
interfere	O
with	O
S	O
incorporation	O
into	O
virions	B-ANAT
,	O
indicating	O
that	O
only	O
a	O
subset	O
of	O
the	O
cysteine	O
-	O
rich	O
region	O
provides	O
the	O
essential	O
S	O
-	O
assembly	O
functions	O
.	O

The	O
two	O
recombinant	O
proteins	O
were	O
separately	O
verified	O
by	O
Western	O
blot	O
,	O
purified	O
by	O
nickel	O
-	O
affinity	O
chromatography	O
,	O
and	O
incubated	O
with	O
Vero	B-ANAT
cells	I-ANAT
,	O
a	O
susceptible	O
cell	B-ANAT
line	I-ANAT
of	O
SARS	O
-	O
CoV	O
infection	O
,	O
for	O
cell	B-ANAT
binding	O
assay	O
.	O

The	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
is	O
the	O
major	O
organ	B-ANAT
system	I-ANAT
affected	O
,	O
although	O
the	O
renal	B-ANAT
,	O
gastrointestinal	O
(	O
GI	O
),	O
endocrine	O
,	O
and	O
cardiovascular	B-ANAT
(	O
CV	O
)	O
systems	O
also	O
may	O
be	O
involved	O
.	O

Mental	O
status	O
,	O
vital	O
signs	O
,	O
and	O
all	O
laboratory	O
parameters	O
including	O
thyroid	B-ANAT
function	O
tests	O
,	O
normalized	O
.	O

In	O
addition	O
,	O
virus	O
/	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
occurred	O
in	O
the	O
presence	O
of	O
sulfhydryl	O
-	O
blocking	O
reagents	O
and	O
oxidoreductase	O
inhibitors	O
.	O

In	O
this	O
paper	O
,	O
we	O
investigate	O
whether	O
the	O
expression	O
of	O
membrane	B-ANAT
protein	O
can	O
affect	O
the	O
immune	O
responses	O
induced	O
by	O
nucleocapsid	B-ANAT
DNA	O
immunization	O
.	O

TITLE	O
:	O
Serum	B-ANAT
proteomic	O
fingerprints	O
of	O
adult	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Specific	O
proteomic	O
fingerprints	O
in	O
the	O
sera	B-ANAT
of	O
adult	O
SARS	O
patients	O
could	O
be	O
used	O
to	O
identify	O
SARS	O
cases	O
early	O
during	O
onset	O
with	O
high	O
specificity	O
and	O
sensitivity	O
.	O

ABSTRACT	O
:	O
The	O
3a	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	O
is	O
expressed	O
and	O
transported	O
to	O
the	O
plasma	B-ANAT
membrane	I-ANAT
in	O
tissue	B-ANAT
cells	B-ANAT
of	O
infected	O
patients	O
.	O

Four	O
factors	O
have	O
been	O
associated	O
with	O
increased	O
risk	O
of	O
perforation	O
:	O
catheter	O
rigidity	O
and	O
diameter	O
,	O
the	O
angle	O
between	O
the	O
tip	O
of	O
the	O
catheter	O
and	O
the	O
vessel	B-ANAT
wall	O
,	O
and	O
insertion	O
from	O
the	O
left	O
.	O

Three	O
catheter	O
positions	O
have	O
been	O
described	O
as	O
safe	O
when	O
radiologically	O
confirmed	O
:	O
the	O
superior	B-ANAT
vena	I-ANAT
cava	I-ANAT
,	O
the	O
point	O
where	O
the	O
superior	B-ANAT
vena	I-ANAT
cava	I-ANAT
meets	O
the	O
atrium	B-ANAT
,	O
and	O
the	O
midpoint	O
of	O
the	O
innominate	B-ANAT
vein	I-ANAT
.	O

However	O
,	O
it	O
should	O
not	O
be	O
forgotten	O
that	O
a	O
radiograph	O
is	O
2	O
-	O
dimensional	O
and	O
a	O
single	O
image	O
of	O
a	O
catheter	O
tip	O
can	O
correspond	O
to	O
a	O
variety	O
of	O
locations	O
(	O
superior	B-ANAT
vena	I-ANAT
cava	I-ANAT
,	O
vena	B-ANAT
innominata	O
,	O
extravascular	O
location	O
,	O
and	O
more	O
).	O

TITLE	O
:	O
CNS	B-ANAT
viral	O
infection	O
diverts	O
homing	O
of	O
antibody	B-ANAT
-	I-ANAT
secreting	I-ANAT
cells	I-ANAT
from	O
lymphoid	B-ANAT
organs	I-ANAT
to	O
the	O
CNS	B-ANAT
.	O

Virus	O
-	O
specific	O
ASC	O
within	O
the	O
CNS	B-ANAT
peaked	O
rapidly	O
1	O
wk	O
after	O
control	O
of	O
infectious	O
virus	O
and	O
were	O
retained	O
throughout	O
chronic	O
infection	O
,	O
consistent	O
with	O
intrathecal	B-ANAT
Ab	O
synthesis	O
.	O

Irrespective	O
of	O
Ag	O
deprivation	O
,	O
CNS	B-ANAT
retention	O
of	O
ASC	O
coincided	O
with	O
elevated	O
BAFF	O
expression	O
and	O
ongoing	O
differentiation	O
of	O
class	O
II	O
+	O
to	O
class	O
II	O
-	O
CD138	O
+	O
CD19	O
+	O
plasmablasts	O
.	O

Balb	O
/	O
cJ	O
or	O
A	O
/	O
J	O
mice	O
were	O
infected	O
intraperitoneally	O
(	O
ip	O
)	O
with	O
100	O
PFU	O
of	O
murine	O
hepatitis	O
virus	O
type	O
3	O
(	O
MHV	O
-	O
3	O
),	O
liver	B-ANAT
and	O
serum	B-ANAT
were	O
harvested	O
at	O
24	O
,	O
48	O
,	O
and	O
72	O
h	O
post	O
infection	O
for	O
further	O
use	O
.	O

Alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
total	O
bilirubin	O
(	O
TBil	O
)	O
in	O
serum	B-ANAT
were	O
measured	O
to	O
assess	O
the	O
severity	O
of	O
liver	B-ANAT
injury	O
.	O

RESULTS	O
:	O
Histological	O
changes	O
were	O
found	O
in	O
liver	B-ANAT
sections	O
12	O
-	O
24	O
h	O
post	O
MHV	O
-	O
3	O
infection	O
in	O
Balb	O
/	O
cJ	O
mice	O
.	O

PCA	B-ANAT
significantly	O
increased	O
in	O
PBMC	O
in	O
patients	O
with	O
severe	O
AOC	O
hepatitis	O
B	O
.	O
CONCLUSIONS	O
:	O
The	O
molecular	O
and	O
cellular	B-ANAT
results	O
reported	O
here	O
in	O
both	O
mice	O
and	O
patients	O
with	O
severe	O
viral	O
hepatitis	O
suggest	O
that	O
virus	O
-	O
induced	O
hfgl2	O
prothrombinase	O
/	O
fibroleukin	O
expression	O
and	O
the	O
coagulation	O
activity	O
associated	O
with	O
the	O
encoded	O
fgl2	O
protein	O
play	O
a	O
pivotal	O
role	O
in	O
initiating	O
severe	O
hepatitis	O
.	O

TITLE	O
:	O
Headaches	O
and	O
the	O
N95	O
face	B-ANAT
-	O
mask	O
amongst	O
healthcare	O
providers	O
.	O

Multivariate	O
logistic	O
regression	O
showed	O
that	O
pre	O
-	O
existing	O
headaches	O
[	O
P	O
=	O
0	O
.	O
041	O
,	O
OR	O
=	O
1	O
.	O
97	O
(	O
95	O
%	O
CI	O
1	O
.	O
03	O
-	O
3	O
.	O
77	O
)]	O
and	O
continuous	O
use	O
of	O
the	O
N95	O
face	B-ANAT
-	O
mask	O
exceeding	O
4	O
h	O
[	O
P	O
=	O
0	O
.	O
053	O
,	O
OR	O
=	O
1	O
.	O
85	O
(	O
95	O
%	O
CI	O
0	O
.	O
99	O
-	O
3	O
.	O
43	O
)]	O
were	O
associated	O
with	O
development	O
of	O
headaches	O
.	O

RESULTS	O
:	O
HCoV	O
-	O
HKU1	O
was	O
detected	O
in	O
6	O
(	O
4	O
.	O
4	O
%)	O
of	O
the	O
135	O
nasal	B-ANAT
specimens	O
and	O
in	O
2	O
(	O
33	O
.	O
3	O
%)	O
of	O
the	O
6	O
stool	B-ANAT
samples	O
;	O
the	O
positive	O
samples	O
were	O
obtained	O
from	O
6	O
patients	O
(	O
5	O
children	O
and	O
1	O
adult	O
).	O

Cardiovascular	B-ANAT
profiles	O
remained	O
stable	O
in	O
both	O
groups	O
.	O

After	O
a	O
hamster	O
is	O
treated	O
with	O
MAb	O
201	O
,	O
its	O
viral	O
burden	O
is	O
reduced	O
by	O
102	O
.	O
4	O
-	O
103	O
.	O
9	O
50	O
%	O
tissue	B-ANAT
-	O
culture	O
infectious	O
doses	O
per	O
gram	O
of	O
tissue	B-ANAT
,	O
and	O
the	O
severity	O
of	O
associated	O
pathological	O
findings	O
,	O
including	O
interstitial	B-ANAT
pneumonitis	O
and	O
consolidation	O
,	O
is	O
also	O
remarkably	O
reduced	O
.	O

TITLE	O
:	O
[	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
):	O
emerging	O
or	O
main	O
transfusion	O
hazard	O
?].	O

TITLE	O
:	O
Effects	O
of	O
single	O
intratracheal	O
exposure	O
to	O
chlorhexidine	O
gluconate	O
on	O
the	O
rat	B-ANAT
lung	I-ANAT
.	O

It	O
is	O
highly	O
possible	O
that	O
CHX	O
at	O
a	O
concentration	O
of	O
more	O
than	O
0	O
.	O
1	O
%	O
might	O
directly	O
induce	O
ARDS	O
when	O
aspirated	O
and	O
reaching	O
to	O
the	O
alveoli	B-ANAT
.	O

In	O
this	O
review	O
we	O
explore	O
the	O
biotrauma	O
hypothesis	O
,	O
the	O
causal	O
relationship	O
between	O
biophysical	O
injury	O
and	O
organ	B-ANAT
failure	O
,	O
and	O
its	O
implications	O
for	O
the	O
future	O
therapy	O
and	O
management	O
of	O
critically	O
ill	O
patients	O
.	O

By	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
antibodies	O
against	O
ADV	O
were	O
detected	O
in	O
55	O
sera	B-ANAT
(	O
31	O
%),	O
against	O
PRCV	O
in	O
five	O
sera	B-ANAT
(	O
3	O
%),	O
PPV	O
in	O
87	O
sera	B-ANAT
(	O
49	O
%),	O
APP	O
in	O
93	O
sera	B-ANAT
(	O
52	O
%),	O
M	O
.	O
hyopneumoniae	O
in	O
38	O
sera	B-ANAT
(	O
21	O
%),	O
Salmonella	O
spp	O
.	O

in	O
85	O
sera	B-ANAT
(	O
47	O
%)	O
and	O
HPS	O
in	O
33	O
sera	B-ANAT
(	O
18	O
%).	O

TITLE	O
:	O
Cardiovascular	B-ANAT
complications	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

121	O
patients	O
(	O
37	O
.	O
5	O
(	O
SD13	O
.	O
2	O
)	O
years	O
,	O
36	O
%	O
male	O
)	O
diagnosed	O
to	O
have	O
SARS	O
were	O
assessed	O
continuously	O
for	O
blood	B-ANAT
pressure	O
,	O
pulse	O
,	O
and	O
temperature	O
during	O
their	O
stay	O
in	O
hospital	O
.	O

Reversible	O
cardiomegaly	O
was	O
reported	O
in	O
13	O
(	O
10	O
.	O
7	O
%)	O
patients	O
,	O
but	O
without	O
clinical	O
evidence	O
of	O
heart	B-ANAT
failure	O
.	O

Epitopes	O
at	O
the	O
N	O
-	O
terminus	O
of	O
the	O
membrane	B-ANAT
protein	O
and	O
the	O
C	O
-	O
terminus	O
of	O
nucleocapsid	B-ANAT
protein	O
elicited	O
strong	O
antibody	O
responses	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
prevalence	O
of	O
antibodies	O
to	O
group	O
2	O
coronaviruses	O
in	O
domestic	O
dogs	O
and	O
cats	O
in	O
Japan	O
by	O
a	O
neutralization	O
test	O
using	O
BCoV	O
.	O
All	O
104	O
feline	O
serum	B-ANAT
samples	O
were	O
negative	O
(<	O
1	O
:	O
5	O
)	O
for	O
anti	O
-	O
BCoV	O
antibodies	O
.	O

Chest	B-ANAT
X	O
-	O
Ray	O
and	O
computed	O
tomography	O
revealed	O
bilateral	O
pneumonia	O
.	O

Despite	O
intensive	O
care	O
treatment	O
and	O
high	O
dosage	O
penicillin	O
G	O
therapy	O
the	O
patient	O
died	O
two	O
days	O
after	O
admission	O
from	O
septic	O
shock	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

However	O
,	O
the	O
automated	O
method	O
was	O
found	O
to	O
be	O
less	O
sensitive	O
,	O
less	O
precise	O
and	O
led	O
to	O
consistently	O
lower	O
serum	B-ANAT
SARS	O
-	O
coronavirus	O
concentrations	O
when	O
compared	O
with	O
the	O
column	B-ANAT
-	O
based	O
extraction	O
method	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
5	O
'	O
UTR	O
sequence	O
in	O
different	O
SARS	O
-	O
CoV	O
isolates	O
,	O
to	O
identify	O
the	O
secondary	O
structure	O
,	O
and	O
to	O
test	O
the	O
promoter	O
activity	O
of	O
the	O
cDNA	O
sequence	O
corresponding	O
to	O
SARS	O
-	O
CoV	O
5	O
'	O
UTR	O
in	O
eukaryotic	B-ANAT
cells	I-ANAT
.	O

And	O
then	O
the	O
total	O
RNA	O
of	O
the	O
transfected	O
cells	B-ANAT
was	O
extracted	O
.	O

The	O
referring	O
veterinarian	O
euthanized	O
the	O
puppy	O
,	O
and	O
the	O
entire	O
body	B-ANAT
was	O
submitted	O
for	O
diagnostic	O
evaluation	O
.	O

Electron	O
microscopy	O
of	O
the	O
intestinal	B-ANAT
contents	I-ANAT
was	O
positive	O
for	O
coronavirus	O
and	O
negative	O
for	O
parvovirus	O
.	O

The	O
whole	O
killed	O
virus	O
(	O
WKV	O
)	O
vaccine	O
given	O
subcutaneously	O
to	O
129S6	O
/	O
SvEv	O
mice	O
was	O
more	O
effective	O
than	O
the	O
Ad	O
S	O
/	O
N	O
vaccine	O
administered	O
either	O
intranasally	O
or	O
intramuscularly	O
in	O
inhibiting	O
SARS	O
-	O
CoV	O
replication	O
in	O
the	O
murine	O
respiratory	B-ANAT
tract	I-ANAT
.	O

By	O
using	O
an	O
antiserum	O
raised	O
against	O
the	O
pp1a	O
/	O
pp1ab	O
residues	O
526	O
-	O
713	O
,	O
the	O
upstream	O
processing	O
product	O
,	O
nsp2	O
,	O
was	O
identified	O
as	O
an	O
85	O
kDa	O
protein	O
in	O
TGEV	O
-	O
infected	O
cells	B-ANAT
.	O

The	O
marker	O
for	O
surfactant	O
degradation	O
was	O
associated	O
with	O
ongoing	O
alveolar	B-ANAT
inflammation	O
(	O
cellularity	O
of	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
concentration	O
).	O

TITLE	O
:	O
Differential	O
roles	O
for	O
CXCR3	O
in	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cell	I-ANAT
trafficking	O
following	O
viral	O
infection	O
of	O
the	O
CNS	B-ANAT
.	O

ABSTRACT	O
:	O
Lymphocyte	B-ANAT
infiltration	O
into	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
following	O
viral	O
infection	O
represents	O
an	O
important	O
component	O
of	O
host	O
defense	O
and	O
is	O
required	O
for	O
control	O
of	O
viral	O
replication	O
.	O

The	O
CXC	O
chemokine	O
ligand	O
10	O
(	O
CXCL10	O
)	O
is	O
expressed	O
following	O
MHV	O
infection	O
and	O
signals	O
T	B-ANAT
cells	I-ANAT
to	O
migrate	O
into	O
the	O
CNS	B-ANAT
.	O

Therefore	O
,	O
CXCR3	O
signaling	O
has	O
a	O
non	O
-	O
redundant	O
role	O
in	O
T	B-ANAT
cell	I-ANAT
subset	I-ANAT
trafficking	O
in	O
response	O
to	O
viral	O
infection	O
.	O

We	O
compared	O
the	O
cytokine	O
profile	O
in	O
Caco2	O
cells	B-ANAT
after	O
infection	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
with	O
other	O
respiratory	O
viruses	O
including	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
influenza	O
A	O
virus	O
(	O
FluAV	O
),	O
and	O
human	O
parainfluenza	O
virus	O
type	O
2	O
(	O
hPIV2	O
).	O

Phylogenetic	O
analysis	O
showed	O
that	O
SARS	O
-	O
CoV	O
from	O
palm	B-ANAT
civets	O
in	O
the	O
restaurant	O
was	O
most	O
closely	O
related	O
to	O
animal	O
isolates	O
.	O

Infection	O
of	O
Vero	O
E6	O
cells	B-ANAT
with	O
SARS	O
-	O
CoV	O
inhibits	O
cell	B-ANAT
proliferation	O
.	O

To	O
identify	O
the	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
immunodominant	O
epitopes	O
of	O
the	O
rN	O
protein	O
in	O
the	O
mouse	O
and	O
monkey	O
,	O
the	O
reactivities	O
of	O
antisera	O
raised	O
against	O
purified	O
rN	O
proteins	O
formulated	O
in	O
ISA	O
-	O
51	O
/	O
CpG	O
were	O
tested	O
with	O
a	O
panel	O
of	O
overlapping	O
synthetic	O
peptides	O
covering	O
the	O
entire	O
N	O
protein	O
sequence	O
.	O

Three	O
immunodominant	O
linear	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
regions	O
were	O
mapped	O
to	O
residues	O
166	O
-	O
180	O
,	O
356	O
-	O
375	O
,	O
and	O
396	O
-	O
410	O
of	O
the	O
rN	O
protein	O
.	O

Our	O
current	O
results	O
together	O
with	O
those	O
of	O
others	O
suggest	O
that	O
some	O
immunodominant	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
are	O
conserved	O
in	O
the	O
mouse	O
,	O
monkey	O
,	O
and	O
human	O
.	O

An	O
increased	O
concentration	O
of	O
NO	O
in	O
exhaled	B-ANAT
air	I-ANAT
has	O
been	O
reported	O
in	O
airway	B-ANAT
diseases	O
,	O
characterized	O
by	O
airway	B-ANAT
inflammation	O
,	O
such	O
as	O
bronchial	B-ANAT
asthma	O
,	O
where	O
its	O
concentration	O
is	O
related	O
to	O
bronchial	B-ANAT
hyperresponsiveness	O
and	O
sputum	B-ANAT
eosinophilia	O
.	O

An	O
increased	O
NO	O
production	O
from	O
alveolar	B-ANAT
source	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
oxygenation	O
impairment	O
of	O
patients	O
with	O
liver	B-ANAT
disease	O
,	O
particularly	O
in	O
case	O
of	O
hepato	O
-	O
pulmonary	B-ANAT
syndrome	O
.	O

A	O
truncated	O
version	O
of	O
S	O
glycoprotein	O
,	O
containing	O
only	O
the	O
ecto	O
-	O
domain	O
,	O
as	O
well	O
as	O
a	O
His	O
-	O
tagged	O
full	O
-	O
length	O
version	O
were	O
cloned	O
and	O
expressed	O
in	O
a	O
serum	B-ANAT
-	O
free	O
insect	O
cell	B-ANAT
line	I-ANAT
,	O
ExpresSF	O
+.	O

Significantly	O
enhanced	O
immune	O
responses	O
,	O
manifested	O
by	O
higher	O
titers	O
of	O
serum	B-ANAT
ELISA	O
and	O
viral	O
neutralizing	O
antibodies	O
,	O
were	O
achieved	O
in	O
adjuvanted	O
groups	O
with	O
fewer	O
doses	O
and	O
lower	O
concentration	O
of	O
S	O
glycoprotein	O
.	O

The	O
results	O
of	O
these	O
analyses	O
highlight	O
different	O
aspects	O
of	O
each	O
system	O
,	O
suggesting	O
in	O
general	O
that	O
(	O
1	O
)	O
differences	O
can	O
be	O
due	O
to	O
the	O
assay	O
systems	O
themselves	O
;	O
(	O
2	O
)	O
phylogenetic	O
differences	O
in	O
ribosome	B-ANAT
structure	O
can	O
affect	O
frameshifting	O
efficiency	O
;	O
and	O
(	O
3	O
)	O
care	O
must	O
be	O
taken	O
to	O
employ	O
the	O
closest	O
phylogenetic	O
match	O
between	O
a	O
specific	O
-	O
1	O
PRF	O
signal	O
and	O
the	O
choice	O
of	O
translational	O
assay	O
system	O
.	O

CDV	O
1	O
mg	O
/	O
kg	O
was	O
given	O
three	O
times	O
per	O
week	O
intravenously	O
with	O
intravenous	O
hydration	O
and	O
oral	B-ANAT
probenecid	O
.	O

Subsequently	O
,	O
the	O
complete	O
sequences	O
of	O
the	O
nucleocapsid	B-ANAT
gene	O
and	O
the	O
last	O
two	O
open	O
reading	O
frames	O
at	O
the	O
3	O
'	O
terminus	O
of	O
the	O
FECV	O
genome	O
were	O
obtained	O
.	O

This	O
article	O
discusses	O
some	O
of	O
the	O
important	O
causes	O
of	O
acute	O
lung	B-ANAT
infections	O
in	O
normal	O
and	O
immunocompromised	O
hosts	O
.	O

ABSTRACT	O
:	O
The	O
clinical	O
picture	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
characterized	O
by	O
pulmonary	B-ANAT
inflammation	O
and	O
respiratory	O
failure	O
,	O
resembling	O
that	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

To	O
study	O
the	O
cellular	B-ANAT
response	O
in	O
the	O
acute	O
phase	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
host	B-ANAT
cell	I-ANAT
interaction	O
,	O
we	O
investigated	O
the	O
induction	O
of	O
chemokines	O
,	O
adhesion	O
molecules	O
,	O
and	O
DC	O
-	O
SIGN	O
(	O
dendritic	B-ANAT
cell	I-ANAT
-	O
specific	O
ICAM	O
-	O
3	O
-	O
grabbing	O
nonintegrin	O
)	O
by	O
SARS	O
-	O
CoV	O
.	O
Immunohistochemistry	O
revealed	O
neutrophil	B-ANAT
,	O
macrophage	B-ANAT
,	O
and	O
CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
infiltration	O
in	O
the	O
lung	B-ANAT
autopsy	O
of	O
a	O
SARS	O
patient	O
who	O
died	O
during	O
the	O
acute	O
phase	O
of	O
illness	O
.	O

TITLE	O
:	O
Biochemical	O
and	O
functional	O
characterization	O
of	O
the	O
membrane	B-ANAT
association	O
and	O
membrane	B-ANAT
permeabilizing	O
activity	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
envelope	B-ANAT
protein	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
expression	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
protein	O
in	O
mammalian	O
cells	B-ANAT
alters	O
the	O
membrane	B-ANAT
permeability	O
of	O
these	O
cells	B-ANAT
.	O

To	O
examine	O
the	O
anti	O
-	O
viral	O
and	O
/	O
or	O
regulatory	O
role	O
of	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
signaling	O
in	O
the	O
cell	B-ANAT
that	O
synthesizes	O
and	O
maintains	O
the	O
myelin	B-ANAT
sheath	I-ANAT
,	O
we	O
analyzed	O
JHMV	O
pathogenesis	O
in	O
transgenic	O
mice	O
expressing	O
a	O
dominant	O
-	O
negative	O
IFN	O
-	O
gamma	O
receptor	O
on	O
oligodendroglia	B-ANAT
.	O

Despite	O
the	O
absence	O
of	O
NK	B-ANAT
cells	I-ANAT
and	O
suboptimal	O
CD8	O
+	O
T	B-ANAT
cell	I-ANAT
responses	O
,	O
IL	O
-	O
15	O
-/-	O
mice	O
controlled	O
JHMV	O
replication	O
as	O
efficiently	O
as	O
wild	O
-	O
type	O
mice	O
.	O

Similar	O
kinetics	O
of	O
class	O
I	O
and	O
class	O
II	O
upregulation	O
on	O
microglia	B-ANAT
further	O
suggested	O
no	O
role	O
of	O
NK	B-ANAT
cells	I-ANAT
in	O
regulating	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
(	O
MHC	B-ANAT
)	O
molecule	O
expression	O
on	O
resident	O
CNS	B-ANAT
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
fusogenic	O
potential	O
of	O
Class	O
I	O
viral	B-ANAT
envelope	I-ANAT
glycoproteins	O
is	O
activated	O
by	O
proteloytic	O
cleavage	O
of	O
the	O
precursor	O
glycoprotein	O
to	O
generate	O
the	O
mature	O
receptor	O
-	O
binding	O
and	O
transmembrane	B-ANAT
fusion	O
subunits	O
.	O

Topics	O
that	O
are	O
discussed	O
include	O
:	O
the	O
interaction	O
between	O
the	O
S1	O
domain	O
of	O
the	O
SARS	O
spike	O
protein	O
and	O
the	O
cellular	B-ANAT
receptor	O
,	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
and	O
the	O
structural	O
features	O
of	O
the	O
ectodomain	O
of	O
ACE2	O
;	O
the	O
antigenic	O
determinants	O
presented	O
by	O
the	O
S	O
protein	O
and	O
the	O
nature	O
of	O
neutralizing	O
monoclonal	O
antibodies	O
that	O
are	O
elicited	O
in	O
vivo	O
;	O
the	O
structure	O
of	O
the	O
4	O
,	O
3	O
-	O
hydrophobic	O
heptad	O
repeats	O
HR1	O
and	O
HR2	O
of	O
the	O
S2	O
domain	O
and	O
their	O
interaction	O
to	O
form	O
a	O
six	O
-	O
helical	O
bundle	O
during	O
the	O
final	O
stages	O
of	O
fusion	O
.	O

Alveolar	B-ANAT
fibrin	O
deposition	O
is	O
an	O
important	O
feature	O
of	O
ALI	O
/	O
ARDS	O
and	O
pulmonary	B-ANAT
infection	O
.	O

Acute	O
mortality	O
was	O
due	O
to	O
respiratory	O
involvement	O
,	O
sepsis	O
and	O
acute	O
autonomic	B-ANAT
system	O
dysfunction	O
.	O

Mechanically	O
ventilated	O
patients	O
had	O
a	O
low	O
GBS	O
disability	O
score	O
on	O
discharge	B-ANAT
compared	O
with	O
patients	O
not	O
mechanically	O
ventilated	O
(	O
P	O
=	O
0	O
.	O
05	O
).	O

As	O
antigen	O
for	O
detection	O
of	O
SARS	O
-	O
CoV	O
,	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
)	O
showed	O
high	O
sensitivity	O
and	O
strong	O
reactivity	O
with	O
all	O
samples	O
from	O
SARS	O
-	O
CoV	O
patients	O
and	O
cross	O
-	O
reacted	O
with	O
all	O
serum	B-ANAT
samples	O
from	O
healthy	O
subjects	O
,	O
with	O
either	O
those	O
obtained	O
from	O
China	O
(	O
10	O
samples	O
)	O
or	O
those	O
obtained	O
from	O
France	O
(	O
38	O
serum	B-ANAT
samples	O
),	O
giving	O
then	O
a	O
significant	O
rate	O
of	O
false	O
positives	O
.	O

ABSTRACT	O
:	O
The	O
notion	O
that	O
an	O
infectious	O
respiratory	O
pathogen	O
can	O
damage	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
and	O
lead	O
to	O
neurological	O
disease	O
was	O
tested	O
using	O
a	O
human	O
respiratory	O
coronavirus	O
,	O
the	O
OC43	O
strain	O
of	O
human	O
coronavirus	O
(	O
HCoV	O
-	O
OC43	O
).	O

Many	O
therapeutic	O
strategies	O
for	O
this	O
complication	O
are	O
employed	O
,	O
ranging	O
from	O
conservative	O
methods	O
like	O
reduction	O
of	O
the	O
volume	O
of	O
the	O
dialysate	O
and	O
the	O
transitory	O
interruption	O
of	O
the	O
PD	O
,	O
to	O
more	O
aggressive	O
therapies	O
as	O
the	O
closure	O
of	O
diaphragmatic	B-ANAT
defects	O
by	O
videothoracoscopy	O
with	O
or	O
without	O
pleurodesis	O
.	O

ABSTRACT	O
:	O
Acute	O
polyradiuloneuritis	O
is	O
acute	O
inflammatory	O
demyelinizing	O
polyneuropathy	O
,	O
with	O
still	O
unknown	O
cause	O
,	O
and	O
which	O
main	O
pathophysiological	O
disorder	O
is	O
degeneration	O
of	O
axons	B-ANAT
which	O
affects	O
peripheral	B-ANAT
nerves	I-ANAT
.	O

Diagnostic	O
criteria	O
'	O
s	O
besides	O
anamnesis	O
was	O
detailed	O
neurological	O
exam	O
,	O
blood	B-ANAT
tests	O
,	O
analysis	O
of	O
the	O
cerebrospinal	O
liquor	B-ANAT
,	O
EMG	O
,	O
ECG	O
and	O
cardiac	B-ANAT
tests	O
.	O

(	O
3	O
)	O
Type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
,	O
with	O
mild	O
hyperplasia	O
,	O
atypia	O
,	O
cytomegaly	B-ANAT
with	O
granular	B-ANAT
amphophilic	O
cytoplasm	B-ANAT
and	O
intracytoplasmic	O
lipid	O
accumulation	O
(	O
5	O
/	O
6	O
).	O

(	O
4	O
)	O
Giant	B-ANAT
cells	I-ANAT
in	O
the	O
alveoli	B-ANAT
were	O
seen	O
in	O
five	O
of	O
6	O
patients	O
(	O
5	O
/	O
6	O
)	O
,	O
most	O
of	O
which	O
were	O
positive	O
for	O
the	O
epithelial	O
marker	O
AE1	O
/	O
AE3	O
(	O
5	O
/	O
6	O
),	O
but	O
some	O
cells	B-ANAT
were	O
positive	O
for	O
the	O
macrophage	B-ANAT
marker	O
CD68	O
(	O
2	O
/	O
6	O
).	O

TITLE	O
:	O
[	O
Correlations	O
of	O
preoperative	O
pulmonary	B-ANAT
function	O
tests	O
for	O
esophageal	O
cancer	O
to	O
postoperative	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

Traditional	O
pulmonary	B-ANAT
function	O
test	O
have	O
some	O
correlations	O
to	O
postoperative	O
ARDS	O
.	O

Twenty	O
years	O
ago	O
a	O
coronavirus	O
was	O
isolated	O
after	O
inoculation	O
of	O
mice	O
with	O
tissue	B-ANAT
from	O
the	O
coastal	O
shearwater	O
(	O
Puffinus	O
puffinus	O
).	O

The	O
microarray	O
also	O
identified	O
patients	O
with	O
sera	B-ANAT
reactive	O
against	O
other	O
coronavirus	O
proteins	O
.	O

We	O
show	O
that	O
protein	O
microarrays	O
can	O
serve	O
as	O
a	O
rapid	O
,	O
sensitive	O
,	O
and	O
simple	O
tool	O
for	O
large	O
-	O
scale	O
identification	O
of	O
viral	O
-	O
specific	O
antibodies	O
in	O
sera	B-ANAT
.	O

TITLE	O
:	O
The	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
undergoes	O
direct	O
low	O
-	O
pH	O
-	O
dependent	O
fusion	O
activation	O
during	O
entry	O
into	O
host	O
cells	B-ANAT
.	O

We	O
carried	O
out	O
fluorescence	O
-	O
dequenching	O
fusion	O
assays	O
of	O
R18	O
-	O
labeled	O
virions	B-ANAT
and	O
show	O
that	O
for	O
IBV	O
,	O
coronavirus	O
-	O
cell	B-ANAT
fusion	O
occurs	O
in	O
a	O
low	O
-	O
pH	O
-	O
dependent	O
manner	O
,	O
with	O
a	O
half	O
-	O
maximal	O
rate	O
of	O
fusion	O
occurring	O
at	O
pH	O
5	O
.	O
5	O
.	O

TITLE	O
:	O
A	O
new	O
pumpless	O
extracorporeal	O
interventional	O
lung	B-ANAT
assist	O
in	O
critical	O
hypoxemia	O
/	O
hypercapnia	O
.	O

The	O
incidence	O
of	O
complications	O
was	O
24	O
.	O
4	O
%,	O
mostly	O
due	O
to	O
ischemia	O
in	O
a	O
lower	B-ANAT
limb	I-ANAT
.	O

Among	O
four	O
corticosteroid	O
groups	O
studied	O
,	O
mortality	O
was	O
lowest	O
in	O
the	O
low	O
-	O
dose	O
oral	B-ANAT
prednisolone	O
(	O
Group	O
P	O
)	O
and	O
high	O
-	O
dose	O
methylprednisolone	O
(	O
Group	O
MP	O
)	O
groups	O
.	O

CONCLUSIONS	O
:	O
The	O
SARS	O
-	O
CoV	O
spike	O
protein	O
and	O
membrane	B-ANAT
proteins	O
are	O
able	O
to	O
elicite	O
efficient	O
neutralizing	O
antibodies	O
in	O
SARS	O
patients	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
protein	O
of	O
SARS	O
-	O
CoV	O
activates	O
the	O
expression	O
of	O
cyclooxygenase	O
-	O
2	O
by	O
binding	O
directly	O
to	O
regulatory	O
elements	O
for	O
nuclear	O
factor	O
-	O
kappa	O
B	O
and	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
.	O

We	O
propose	O
that	O
SARS	O
-	O
CoV	O
N	O
protein	O
causes	O
inflammation	O
of	O
the	O
lungs	B-ANAT
by	O
activating	O
COX	O
-	O
2	O
gene	O
expression	O
by	O
binding	O
directly	O
to	O
the	O
promoter	O
resulting	O
in	O
inflammation	O
through	O
multiple	O
COX	O
-	O
2	O
signaling	O
cascades	O
.	O

For	O
this	O
study	O
,	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
88	O
patients	O
with	O
post	O
-	O
SARS	O
ON	O
and	O
52	O
healthy	O
people	O
.	O

TITLE	O
:	O
High	O
expression	O
level	O
of	O
soluble	O
SARS	O
spike	O
protein	O
mediated	O
by	O
adenovirus	O
in	O
HEK293	O
cells	B-ANAT
.	O

Purified	O
soluble	O
S	O
-	O
protein	O
was	O
readily	O
detected	O
by	O
Western	O
blot	O
with	O
anti	O
-	O
Myc	O
antibody	O
and	O
showed	O
the	O
ability	O
to	O
bind	O
to	O
surface	O
of	O
Vero	B-ANAT
cells	I-ANAT
,	O
demonstrating	O
that	O
the	O
soluble	O
S	O
-	O
protein	O
could	O
remain	O
the	O
biologic	O
activity	O
in	O
the	O
native	O
molecule	O
.	O

The	O
fluorescence	O
intensity	O
of	O
dihydrorhodamine	O
123	O
staining	O
indicated	O
that	O
cellular	B-ANAT
reactive	O
oxygen	O
species	O
were	O
markedly	O
increased	O
in	O
SARS	O
-	O
CoV	O
3CLpro	O
-	O
expressing	O
cells	B-ANAT
.	O

Flu	O
A	O
and	O
B	O
Plus	O
test	O
(	O
Meridian	B-ANAT
Bioscience	O
,	O
Cincinnati	O
,	O
OH	O
)	O
is	O
a	O
new	O
point	O
of	O
care	O
(	O
POC	O
)	O
test	O
utilizing	O
influenza	O
-	O
specific	O
monoclonal	O
antibodies	O
for	O
rapid	O
diagnosis	O
.	O

Procedure	O
Serum	B-ANAT
samples	O
from	O
owned	O
cats	O
presented	O
to	O
three	O
inner	O
city	O
veterinary	O
clinics	O
in	O
Sydney	O
and	O
feral	O
cats	O
from	O
a	O
colony	O
in	O
South	O
Western	O
Sydney	O
over	O
an	O
11	O
-	O
month	O
period	O
were	O
tested	O
for	O
FCoV	O
antibodies	O
using	O
the	O
Immunocomb	O
test	O
kit	O
.	O

NaÃ¯ve	O
peripheral	O
blood	B-ANAT
leukocytes	I-ANAT
(	O
PBL	O
)	O
were	O
exposed	O
to	O
longitudinal	O
(	O
days	O
1	O
-	O
10	O
)	O
plasma	B-ANAT
samples	O
from	O
ARDS	O
patients	O
divided	O
into	O
three	O
groups	O
based	O
on	O
physiological	O
improvement	O
and	O
clinical	O
outcome	O
by	O
days	O
7	O
-	O
10	O
:	O
improvers	O
,	O
nonimprovers	O
-	O
survivors	O
,	O
and	O
nonimprovers	O
-	O
nonsurvivors	O
.	O

We	O
found	O
that	O
exposure	O
of	O
naÃ¯ve	O
cells	B-ANAT
to	O
longitudinal	O
plasma	B-ANAT
samples	O
led	O
to	O
divergent	O
directions	O
in	O
NF	O
-	O
kappaB	O
and	O
GRalpha	O
activation	O
that	O
reflected	O
the	O
severity	O
of	O
systemic	O
inflammation	O
.	O

In	O
both	O
groups	O
,	O
Fio2	O
was	O
set	O
to	O
maintain	O
arterial	B-ANAT
oxygen	O
saturation	O
>	O
90	O
%	O
and	O
Pao2	O
70	O
-	O
100	O
mm	O
Hg	O
,	O
and	O
respiratory	O
rate	O
was	O
adjusted	O
to	O
maintain	O
Paco2	O
between	O
35	O
and	O
50	O
mm	O
Hg	O
.	O

Acute	O
pancreatitis	O
is	O
an	O
acute	O
inflammatory	O
disorder	O
of	O
the	O
pancreas	B-ANAT
caused	O
by	O
an	O
intracellular	B-ANAT
activation	O
of	O
pancreatic	B-ANAT
digestive	O
enzymes	O
.	O

Acute	O
pancreatitis	O
is	O
a	O
benign	O
abdominal	B-ANAT
disorder	O
in	O
up	O
to	O
85	O
%	O
of	O
cases	O
.	O

TITLE	O
:	O
Respiratory	O
considerations	O
in	O
the	O
patient	O
with	O
renal	B-ANAT
failure	O
.	O

Sleep	O
disturbances	O
are	O
extremely	O
common	O
in	O
patients	O
with	O
end	O
-	O
stage	O
renal	B-ANAT
disease	O
,	O
with	O
sleep	O
apnea	O
occurring	O
in	O
60	O
%	O
or	O
more	O
of	O
such	O
patients	O
.	O

Hemodialysis	O
-	O
related	O
hypoxemia	O
,	O
which	O
was	O
once	O
believed	O
to	O
be	O
the	O
result	O
of	O
pulmonary	B-ANAT
leukostasis	O
and	O
complement	O
activation	O
,	O
is	O
explained	O
by	O
diffusion	O
of	O
CO2	O
into	O
the	O
dialysate	O
,	O
with	O
concomitant	O
alveolar	B-ANAT
hypoventilation	O
in	O
the	O
process	O
of	O
maintaining	O
a	O
normal	O
P	O
(	O
aCO2	O
).	O

An	O
increasing	O
body	B-ANAT
of	O
evidence	O
also	O
supports	O
the	O
notion	O
that	O
the	O
kidneys	B-ANAT
,	O
like	O
the	O
lungs	B-ANAT
,	O
are	O
susceptible	O
to	O
injury	O
induced	O
as	O
a	O
result	O
of	O
positive	O
-	O
pressure	O
mechanical	O
ventilation	O
.	O

Pneumocytes	B-ANAT
are	O
the	O
primary	O
target	O
of	O
infection	O
resulting	O
in	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
induces	O
a	O
more	O
fibrocellular	O
intra	O
-	O
alveolar	B-ANAT
organization	O
with	O
a	O
""""	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
"""-"	O
like	O
pattern	O
and	O
presence	O
of	O
multinucleated	O
histiocytes	B-ANAT
and	O
pneumocytes	B-ANAT
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	O
disseminates	O
to	O
blood	B-ANAT
,	O
urine	B-ANAT
,	O
feces	B-ANAT
,	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
and	O
liver	B-ANAT
.	O

TITLE	O
:	O
Lipoxin	O
A	O
(	O
4	O
)	O
regulates	O
bronchial	B-ANAT
epithelial	I-ANAT
cell	I-ANAT
responses	O
to	O
acid	O
injury	O
.	O

ABSTRACT	O
:	O
Aspiration	O
of	O
gastric	B-ANAT
acid	I-ANAT
commonly	O
injures	O
airway	B-ANAT
epithelium	B-ANAT
and	O
,	O
if	O
severe	O
,	O
can	O
lead	O
to	O
respiratory	O
failure	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
As	O
influenza	O
A	O
/	O
H5N1	O
spreads	O
around	O
the	O
globe	B-ANAT
the	O
risk	O
of	O
an	O
epidemic	O
increases	O
.	O

A	O
total	O
of	O
178	O
reports	O
of	O
gencitabine	O
-	O
associated	O
lung	B-ANAT
injury	O
were	O
identified	O
;	O
in	O
AERS	O
,	O
there	O
were	O
55	O
cases	O
from	O
clinical	O
trials	O
and	O
92	O
spontaneous	O
reports	O
.	O

TITLE	O
:	O
Toxicological	O
safety	O
evaluation	O
of	O
DNA	O
plasmid	O
vaccines	O
against	O
HIV	O
-	O
1	O
,	O
Ebola	O
,	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
,	O
or	O
West	O
Nile	O
virus	O
is	O
similar	O
despite	O
differing	O
plasmid	O
backbones	B-ANAT
or	O
gene	O
-	O
inserts	O
.	O

ABSTRACT	O
:	O
Triaryl	O
pyrazoline	O
{[	O
5	O
-(	O
4	O
-	O
chloro	O
-	O
phenyl	O
)-	O
3	O
-	O
thiophen	O
-	O
2	O
-	O
yl	O
-	O
4	O
,	O
5	O
-	O
dihydro	O
-	O
pyrazol	O
-	O
1	O
-	O
yl	O
]-	O
phenyl	O
-	O
methanone	O
}	O
inhibits	O
flavivirus	O
infection	O
in	O
cell	B-ANAT
culture	O
.	O

Indeed	O
,	O
studies	O
with	O
a	O
neurotropic	O
murine	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
have	O
provided	O
important	O
insight	O
into	O
the	O
functional	O
roles	O
of	O
chemokines	O
and	O
chemokine	O
receptors	O
in	O
participating	O
in	O
various	O
aspects	O
of	O
host	O
defense	O
as	O
well	O
as	O
disease	O
development	O
within	O
the	O
CNS	B-ANAT
.	O

This	O
chapter	O
will	O
highlight	O
recent	O
discoveries	O
that	O
have	O
provided	O
insight	O
into	O
the	O
diverse	O
biologic	O
roles	O
of	O
chemokines	O
and	O
their	O
receptors	O
in	O
coordinating	O
immune	O
responses	O
following	O
viral	O
infection	O
of	O
the	O
CNS	B-ANAT
.	O

Interestingly	O
,	O
however	O
,	O
SARS	O
-	O
CoV	O
strongly	O
induced	O
the	O
chemokines	O
IP	O
-	O
10	O
and	O
IL	O
-	O
8	O
in	O
the	O
colon	B-ANAT
carcinoma	B-ANAT
cell	I-ANAT
line	O
Caco	O
-	O
2	O
,	O
but	O
not	O
in	O
the	O
embryonic	B-ANAT
kidney	B-ANAT
cell	I-ANAT
line	O
293	O
.	O

Our	O
data	O
indicate	O
that	O
SARS	O
-	O
CoV	O
suppresses	O
the	O
antiviral	O
cytokine	O
system	O
of	O
non	O
-	O
immune	O
cells	B-ANAT
to	O
a	O
large	O
extent	O
,	O
thus	O
buying	O
time	O
for	O
dissemination	O
in	O
the	O
host	O
.	O

TITLE	O
:	O
Mucosal	B-ANAT
immunization	O
with	O
surface	O
-	O
displayed	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
on	O
Lactobacillus	O
casei	O
induces	O
neutralizing	O
antibodies	O
in	O
mice	O
.	O

We	O
assessed	O
the	O
impact	O
of	O
the	O
perturbations	O
on	O
the	O
cell	B-ANAT
cycle	O
for	O
virus	O
-	O
infected	O
cells	B-ANAT
and	O
found	O
that	O
IBV	O
-	O
infected	O
G2	O
/	O
M	O
-	O
phase	O
-	O
synchronized	O
cells	B-ANAT
exhibited	O
increased	O
viral	O
protein	O
production	O
when	O
released	O
from	O
the	O
block	O
when	O
compared	O
to	O
cells	B-ANAT
synchronized	O
in	O
the	O
G0	O
phase	O
or	O
asynchronously	O
replicating	O
cells	B-ANAT
.	O

Here	O
,	O
we	O
report	O
the	O
characterization	O
of	O
the	O
M	O
(	O
pro	O
)	O
of	O
toroviruses	O
,	O
the	O
fourth	O
main	O
Nidovirus	O
branch	B-ANAT
.	O

Guillain	O
-	O
BarrÃ©	O
syndrome	O
is	O
characterised	O
by	O
an	O
acute	O
ascending	O
weakness	O
1	O
-	O
3	O
weeks	O
after	O
a	O
gastrointestinal	O
or	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

Critical	O
illness	O
polyneuropathy	O
and	O
critical	O
illness	O
myopathy	O
often	O
coexist	O
in	O
the	O
critically	O
ill	O
patient	O
and	O
are	O
probably	O
caused	O
by	O
a	O
small	O
number	O
of	O
activated	O
leucocytes	B-ANAT
that	O
infiltrate	O
skeletal	B-ANAT
muscle	I-ANAT
and	O
produce	O
pro	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
.	O

Axonal	O
degeneration	O
of	O
both	O
motor	O
and	O
sensory	O
fibres	B-ANAT
with	O
preservation	O
of	O
the	O
myelin	B-ANAT
sheath	I-ANAT
cause	O
the	O
neuropathy	O
,	O
and	O
muscle	B-ANAT
fibre	I-ANAT
necrosis	O
and	O
atrophy	O
causes	O
the	O
myopathy	O
.	O

They	O
come	O
in	O
a	O
large	O
variety	O
and	O
are	O
differentially	O
expressed	O
in	O
cells	B-ANAT
and	O
tissues	B-ANAT
.	O

The	O
Sia	O
of	O
choice	O
might	O
still	O
be	O
abundantly	O
present	O
on	O
non	O
-	O
cell	B-ANAT
associated	I-ANAT
molecules	O
,	O
on	O
non	O
-	O
target	B-ANAT
cells	I-ANAT
(	O
including	O
cells	B-ANAT
already	O
infected	O
)	O
and	O
even	O
on	O
virus	B-ANAT
particles	I-ANAT
themselves	O
.	O

Some	O
enveloped	O
RNA	O
viruses	O
deal	O
with	O
this	O
problem	O
by	O
encoding	O
virion	B-ANAT
-	O
associated	O
receptor	O
-	O
destroying	O
enzymes	O
(	O
RDEs	O
).	O

TITLE	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
in	O
lung	B-ANAT
diseases	O
.	O

Thus	O
,	O
the	O
RAS	O
appears	O
to	O
play	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
crystals	B-ANAT
belong	O
to	O
space	O
group	O
P2	O
(	O
1	O
),	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
37	O
.	O
5	O
,	O
b	O
=	O
55	O
.	O
6	O
,	O
c	O
=	O
108	O
.	O
9	O
angstroms	O
,	O
beta	O
=	O
91	O
.	O
4	O
degrees	O
,	O
and	O
the	O
asymmetric	O
unit	O
contains	O
either	O
two	O
or	O
three	O
molecules	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
,	O
or	O
SCV	O
),	O
which	O
caused	O
a	O
world	O
-	O
wide	O
epidemic	O
in	O
2002	O
and	O
2003	O
,	O
binds	O
to	O
a	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
through	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
its	O
envelope	B-ANAT
(	O
spike	O
,	O
S	O
)	O
glycoprotein	O
.	O

TITLE	O
:	O
[	O
More	O
than	O
muscle	B-ANAT
stiffness	O
].	O

TITLE	O
:	O
Sialic	O
acid	O
is	O
a	O
receptor	O
determinant	O
for	O
infection	O
of	O
cells	B-ANAT
by	O
avian	O
Infectious	O
bronchitis	O
virus	O
.	O

The	O
first	O
group	O
included	O
only	O
RBCV	O
,	O
while	O
the	O
second	O
group	O
contained	O
calf	B-ANAT
diarrhea	O
BCoV	O
,	O
RBCV	O
,	O
WD	O
and	O
EBCV	O
,	O
respectively	O
.	O

Measurements	O
were	O
repeated	O
at	O
different	O
degrees	O
of	O
pulmonary	B-ANAT
gas	O
exchange	O
impairment	O
with	O
the	O
pulmonary	B-ANAT
venous	B-ANAT
admixture	O
ranging	O
from	O
35	O
.	O
0	O
%	O
to	O
70	O
.	O
6	O
%.	O

Pulmonary	B-ANAT
artery	I-ANAT
pressures	O
were	O
significantly	O
reduced	O
when	O
ILA	O
was	O
in	O
operation	O
.	O

Combined	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
frequently	O
results	O
in	O
acute	O
lung	B-ANAT
injury	O
due	O
to	O
a	O
combination	O
of	O
airway	B-ANAT
obstruction	O
and	O
inflammation	O
.	O

We	O
hypothesized	O
that	O
albuterol	O
administered	O
via	O
continuous	O
nebulization	O
would	O
mitigate	O
acute	O
lung	B-ANAT
injury	O
after	O
smoke	O
inhalation	O
injury	O
and	O
burn	O
.	O

Continuous	O
nebulization	O
of	O
albuterol	O
improves	O
pulmonary	B-ANAT
function	O
via	O
improved	O
airway	B-ANAT
clearance	O
and	O
decreased	O
fluid	O
flux	O
in	O
a	O
combined	O
burn	O
/	O
smoke	O
inhalation	O
injury	O
model	O
.	O

TITLE	O
:	O
Acute	O
renal	B-ANAT
failure	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Hypotension	O
(	O
77	O
%)	O
caused	O
by	O
nosocomial	O
infections	O
,	O
gastrointestinal	O
bleeding	O
,	O
or	O
SARS	O
per	O
se	O
,	O
and	O
rhabdomyolysis	O
(	O
43	O
%)	O
was	O
associated	O
with	O
ARF	O
in	O
addition	O
to	O
pre	O
-	O
renal	B-ANAT
factors	O
.	O

The	O
cause	O
of	O
ARF	O
in	O
SARS	O
patients	O
is	O
often	O
associated	O
with	O
pre	O
-	O
renal	B-ANAT
factors	O
,	O
hypotension	O
,	O
rhabdomyolysis	O
,	O
and	O
previous	O
comorbidities	O
including	O
diabetes	O
and	O
old	O
age	O
.	O

TITLE	O
:	O
Nucleic	B-ANAT
-	O
acid	O
-	O
based	O
antiviral	O
agents	O
against	O
positive	O
single	O
-	O
stranded	O
RNA	O
viruses	O
.	O

TITLE	O
:	O
Identification	O
of	O
functionally	O
important	O
negatively	O
charged	O
residues	O
in	O
the	O
carboxy	O
end	O
of	O
mouse	O
hepatitis	O
coronavirus	O
A59	O
nucleocapsid	B-ANAT
protein	O
.	O

Radiation	O
therapy	O
has	O
also	O
been	O
associated	O
with	O
the	O
development	O
of	O
eosinophilic	O
pneumonia	O
in	O
patients	O
receiving	O
this	O
treatment	O
for	O
breast	B-ANAT
cancer	O
.	O

We	O
also	O
demonstrated	O
that	O
the	O
RBD	O
-	O
Fc	O
bearing	O
R441A	O
mutation	O
could	O
not	O
bind	O
to	O
soluble	O
and	O
cell	B-ANAT
-	O
associated	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
the	O
functional	O
receptor	O
for	O
SARS	O
-	O
CoV	O
and	O
failed	O
to	O
block	O
S	O
protein	O
-	O
mediated	O
pseudovirus	O
entry	O
,	O
indicating	O
that	O
this	O
point	O
mutation	O
also	O
disrupted	O
the	O
receptor	O
-	O
binding	O
motif	O
(	O
RBM	O
)	O
in	O
the	O
RBD	O
.	O

This	O
is	O
generally	O
accompanied	O
by	O
B	O
and	O
T	B-ANAT
cell	I-ANAT
depletion	O
.	O

The	O
obvious	O
functional	O
differences	O
of	O
lymphatic	B-ANAT
tissues	I-ANAT
in	O
FCoV	O
-	O
infected	O
cats	O
with	O
and	O
without	O
FIP	O
suggest	O
that	O
they	O
contribute	O
to	O
the	O
outcome	O
of	O
FCoV	O
infection	O
.	O

In	O
cats	O
with	O
FIP	O
,	O
however	O
,	O
IL	O
-	O
12	O
p40	B-ANAT
levels	O
were	O
significantly	O
lower	O
in	O
lymphatic	B-ANAT
tissues	I-ANAT
in	O
comparison	O
to	O
both	O
SPF	O
cats	O
and	O
FCoV	O
-	O
infected	O
cats	O
without	O
FIP	O
.	O

Ribavirin	O
given	O
at	O
75	O
mg	O
/	O
kg	O
4	O
h	O
prior	O
to	O
virus	O
exposure	O
and	O
then	O
given	O
twice	O
daily	O
for	O
3	O
days	O
beginning	O
at	O
day	O
0	O
was	O
found	O
to	O
increase	O
virus	O
lung	B-ANAT
titers	O
and	O
extend	O
the	O
length	O
of	O
time	O
that	O
virus	O
could	O
be	O
detected	O
in	O
the	O
lungs	B-ANAT
of	O
mice	O
.	O

In	O
addition	O
,	O
ribavirin	O
treatment	O
seemed	O
also	O
to	O
promote	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
4	O
days	O
after	O
cessation	O
of	O
treatment	O
,	O
although	O
after	O
3	O
days	O
of	O
treatment	O
ribavirin	O
inhibited	O
pro	O
-	O
inflammatory	O
cytokine	O
production	O
in	O
infected	O
mice	O
,	O
significantly	O
reducing	O
the	O
levels	O
of	O
the	O
cytokines	O
IL	O
-	O
1alpha	O
,	O
interleukin	O
-	O
5	O
(	O
IL	O
-	O
5	O
),	O
monocyte	B-ANAT
chemotactic	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
granulocyte	B-ANAT
-	O
macrophage	B-ANAT
colony	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	B-ANAT
).	O

By	O
not	O
inhibiting	O
viral	O
replication	O
in	O
the	O
lungs	B-ANAT
of	O
infected	O
mice	O
,	O
ribavirin	O
treatment	O
may	O
have	O
provided	O
a	O
continual	O
source	O
of	O
stimulation	O
for	O
the	O
inflammatory	O
response	O
thought	O
to	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
the	O
infection	O
.	O

Acute	O
lung	B-ANAT
injury	O
was	O
induced	O
by	O
lung	B-ANAT
lavage	O
.	O

In	O
acute	O
lung	B-ANAT
injury	O
,	O
P	O
-	O
ACV	O
preserves	O
oxygenation	O
and	O
hemodynamic	O
function	O
with	O
less	O
respiratory	O
effort	O
compared	O
with	O
BIPAP	O
and	O
reduces	O
the	O
need	O
for	O
sedation	O
compared	O
with	O
PCV	O
.	O

Despite	O
this	O
challenge	O
,	O
professional	O
codes	O
of	O
ethics	O
are	O
silent	O
on	O
the	O
issue	O
of	O
duty	O
to	O
care	O
during	O
communicable	O
disease	O
outbreaks	O
,	O
thus	O
providing	O
no	O
guidance	O
on	O
what	O
is	O
expected	O
of	O
HCPs	O
or	O
how	O
they	O
ought	O
to	O
approach	O
their	O
duty	O
to	O
care	O
in	O
the	O
face	B-ANAT
of	O
risk	O
.	O

ABSTRACT	O
:	O
The	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
the	O
SARS	O
-	O
associated	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
.	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
plays	O
an	O
essential	O
role	O
in	O
SARS	O
-	O
CoV	O
genome	O
packaging	O
and	O
virion	B-ANAT
assembly	O
.	O

TITLE	O
:	O
Detection	O
of	O
bovine	O
torovirus	O
in	O
neonatal	O
calf	B-ANAT
diarrhoea	O
in	O
Lower	O
Austria	O
and	O
Styria	O
(	O
Austria	O
).	O

ABSTRACT	O
:	O
Maturation	O
of	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DC	O
)	O
is	O
a	O
key	O
immunological	O
process	O
regulating	O
immune	O
responses	O
to	O
pathogens	O
and	O
vaccines	O
,	O
as	O
well	O
as	O
tolerance	O
and	O
autoimmune	O
processes	O
.	O

These	O
matured	O
MoDCs	O
displayed	O
an	O
enhanced	O
ability	O
to	O
present	O
antigen	O
to	O
and	O
thus	O
stimulate	O
T	B-ANAT
cells	I-ANAT
.	O

This	O
study	O
demonstrates	O
that	O
by	O
using	O
this	O
novel	O
strategy	O
one	O
can	O
rapidly	O
predict	O
and	O
identify	O
a	O
neutralizing	O
antibody	O
epitope	O
,	O
even	O
in	O
the	O
absence	O
of	O
the	O
crystal	B-ANAT
structure	O
of	O
its	O
target	O
protein	O
.	O

Here	O
,	O
we	O
report	O
effective	O
siRNAs	O
targeting	O
structural	O
genes	O
(	O
i	O
.	O
e	O
.,	O
spike	O
,	O
envelope	B-ANAT
,	O
membrane	B-ANAT
,	O
and	O
nucleocapsid	B-ANAT
)	O
and	O
their	O
antiviral	O
kinetics	O
.	O

Attachment	O
of	O
S	O
protein	O
on	O
cells	B-ANAT
without	O
MHVR	O
during	O
the	O
S	O
-	O
protein	O
activation	O
process	O
seems	O
to	O
be	O
a	O
key	O
condition	O
.	O

TITLE	O
:	O
Cross	O
-	O
neutralization	O
of	O
human	O
and	O
palm	B-ANAT
civet	O
severe	O
acute	O
respiratory	O
syndrome	O
coronaviruses	O
by	O
antibodies	O
targeting	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
spike	O
protein	O
.	O

CONCLUSIONS	O
:	O
In	O
addition	O
to	O
fat	O
conversion	O
in	O
the	O
proximal	O
femoral	B-ANAT
marrow	O
due	O
to	O
steroid	O
treatment	O
,	O
the	O
infection	O
of	O
SARS	O
itself	O
may	O
promote	O
an	O
excessively	O
conversion	O
of	O
the	O
red	B-ANAT
marrow	I-ANAT
to	O
yellow	B-ANAT
marrow	I-ANAT
of	O
the	O
femoral	B-ANAT
neck	I-ANAT
in	O
SARS	O
patients	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
and	O
computed	O
tomography	O
were	O
retrospectively	O
analyzed	O
.	O

The	O
sputum	B-ANAT
blood	B-ANAT
was	O
present	O
in	O
3	O
patients	O
(	O
20	O
%).	O

The	O
patchy	O
shadows	O
were	O
found	O
in	O
2	O
patients	O
,	O
and	O
pulmonary	B-ANAT
consolidation	O
associated	O
with	O
the	O
local	O
pulmonary	B-ANAT
edema	O
in	O
1	O
patient	O
.	O

RESULTS	O
:	O
All	O
patients	O
presented	O
fever	O
,	O
headache	O
,	O
sore	O
throat	B-ANAT
,	O
hoarseness	O
,	O
muscular	B-ANAT
ache	O
,	O
and	O
dry	O
cough	O
.	O

The	O
dissociation	O
constant	O
of	O
AS3	O
-	O
3	O
was	O
1	O
.	O
98	O
x	O
10	O
(-	O
8	O
)	O
M	O
.	O
Immunofluorescent	O
microscopy	O
revealed	O
that	O
it	O
reacted	O
with	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Mitochondrial	B-ANAT
location	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
3b	O
protein	O
.	O

We	O
reported	O
previously	O
that	O
SARS	O
-	O
CoV	O
3b	O
is	O
predominantly	O
localized	O
in	O
the	O
nucleolus	B-ANAT
,	O
and	O
induces	O
G0	O
/	O
G1	O
arrest	O
and	O
apoptosis	O
in	O
transfected	O
cells	B-ANAT
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
3b	O
fused	O
with	O
EGFP	O
at	O
its	O
N	O
-	O
or	O
C	O
-	O
terminus	O
co	O
-	O
localized	O
with	O
a	O
mitochondria	B-ANAT
-	O
specific	O
marker	O
in	O
some	O
transfected	O
cells	B-ANAT
.	O

They	O
included	O
emotional	O
upheaval	O
,	O
changes	O
in	O
parental	O
and	O
professional	O
roles	O
,	O
and	O
familial	O
experiences	O
following	O
hospital	O
discharge	B-ANAT
.	O

TITLE	O
:	O
Biochemical	O
evidence	O
for	O
the	O
presence	O
of	O
mixed	O
membrane	B-ANAT
topologies	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
envelope	B-ANAT
protein	O
expressed	O
in	O
mammalian	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Coronavirus	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
is	O
a	O
small	O
integral	O
membrane	B-ANAT
protein	O
with	O
multi	O
-	O
functions	O
in	O
virion	B-ANAT
assembly	O
,	O
morphogenesis	O
and	O
virus	O
-	O
host	O
interaction	O
.	O

It	O
was	O
revealed	O
that	O
both	O
the	O
N	O
-	O
and	O
C	O
-	O
termini	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
protein	O
are	O
exposed	O
to	O
the	O
cytoplasmic	B-ANAT
side	O
of	O
the	O
membranes	B-ANAT
(	O
N	O
(	O
cyto	O
)	O
C	O
(	O
cyto	O
)).	O

Systemic	O
and	O
pulmonary	B-ANAT
hemodynamic	O
index	O
were	O
monitored	O
intermittently	O
.	O

CONCLUSIONS	O
:	O
CVVH	O
can	O
reduce	O
pulmonary	B-ANAT
edema	O
and	O
the	O
severity	O
of	O
PALI	O
in	O
pigs	O
with	O
high	O
-	O
volume	O
CVVH	O
being	O
significantly	O
better	O
than	O
low	O
-	O
volume	O
CVVH	O
.	O

Cl2	O
causes	O
severe	O
,	O
dose	O
-	O
related	O
lung	B-ANAT
injury	O
,	O
with	O
features	O
seen	O
in	O
both	O
smoke	O
inhalation	O
and	O
in	O
ARDS	O
secondary	O
to	O
systemic	O
disease	O
.	O

The	O
activity	O
and	O
safety	O
of	O
arsenic	O
trioxide	O
in	O
refractory	O
germ	B-ANAT
cell	I-ANAT
tumors	O
was	O
assessed	O
.	O

In	O
the	O
current	O
study	O
,	O
arsenic	O
trioxide	O
in	O
the	O
dose	O
regimen	O
and	O
schedule	O
employed	O
was	O
found	O
to	O
have	O
no	O
activity	O
in	O
men	O
with	O
refractory	O
germ	B-ANAT
cell	I-ANAT
malignancies	O
.	O

Global	O
expression	O
patterns	O
showed	O
limited	O
correlation	O
between	O
end	O
-	O
stage	O
ARDS	O
and	O
the	O
initiating	O
pathogen	O
,	O
but	O
when	O
focusing	O
on	O
a	O
subset	O
of	O
genes	O
implicated	O
in	O
pulmonary	B-ANAT
pathogenesis	O
,	O
molecular	O
signatures	O
of	O
pulmonary	B-ANAT
disease	O
were	O
obtained	O
and	O
appeared	O
to	O
be	O
influenced	O
by	O
preexisting	O
pulmonary	B-ANAT
complications	O
and	O
also	O
bacterial	O
components	O
of	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
a	O
structural	O
component	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
can	O
induce	O
antibody	O
responses	O
in	O
SARS	O
patients	O
during	O
infection	O
.	O

The	O
results	O
indicated	O
that	O
human	O
memory	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
specific	O
for	O
SARS	O
-	O
CoV	O
N	O
protein	O
could	O
persist	O
for	O
2	O
years	O
in	O
the	O
absence	O
of	O
antigen	O
,	O
which	O
would	O
be	O
a	O
valuable	O
for	O
the	O
design	O
of	O
effective	O
vaccines	O
against	O
SARS	O
-	O
CoV	O
and	O
for	O
basic	O
studies	O
of	O
human	O
T	O
-	O
cell	B-ANAT
memory	I-ANAT
.	O

Here	O
,	O
we	O
present	O
algorithmic	O
and	O
methodological	O
enhancements	O
in	O
the	O
Cavbase	O
property	O
description	O
and	O
in	O
the	O
cavity	B-ANAT
comparison	O
step	O
.	O

ABSTRACT	O
:	O
Reproductive	O
losses	O
in	O
camelids	O
are	O
due	O
to	O
infertility	O
,	O
pregnancy	O
loss	O
,	O
udder	B-ANAT
diseases	O
and	O
neonatal	O
mortality	O
caused	O
by	O
a	O
variety	O
of	O
infectious	O
diseases	O
.	O

It	O
contains	O
two	O
hydrophobic	O
heptad	O
repeat	O
(	O
HR	O
)	O
regions	O
,	O
denoted	O
HRN	O
and	O
HRC	O
,	O
which	O
oligomerize	O
the	O
S	O
glycoprotein	O
into	O
a	O
trimer	O
in	O
the	O
native	O
state	O
and	O
when	O
activated	O
collapse	O
into	O
a	O
six	O
-	O
helix	O
bundle	O
structure	O
driving	O
fusion	O
of	O
the	O
host	O
and	O
viral	O
membranes	B-ANAT
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
PRCV	O
could	O
sensitize	O
the	O
lungs	B-ANAT
to	O
LPS	O
throughout	O
the	O
infection	O
,	O
but	O
the	O
response	O
to	O
LPS	O
appeared	O
less	O
enhanced	O
at	O
the	O
end	O
of	O
infection	O
(	O
7DPI	O
).	O

Herein	O
,	O
we	O
have	O
studied	O
multiple	O
isotopically	O
labeled	O
ETM	O
peptides	O
reconstituted	O
in	O
model	O
lipid	B-ANAT
bilayers	I-ANAT
,	O
using	O
the	O
orientational	O
parameters	O
derived	O
from	O
infrared	O
dichroic	O
data	O
.	O

TITLE	O
:	O
Integrating	O
acute	O
lung	B-ANAT
injury	O
and	O
regulation	O
of	O
alveolar	B-ANAT
fluid	O
clearance	O
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
and	O
flooding	O
of	O
the	O
alveolar	B-ANAT
air	I-ANAT
spaces	O
with	O
proteinaceous	O
fluid	O
.	O

We	O
report	O
an	O
outbreak	O
of	O
fatal	O
disease	O
in	O
puppies	O
caused	O
by	O
a	O
pathogenic	O
variant	O
of	O
CCoV	O
that	O
was	O
isolated	O
from	O
organs	B-ANAT
with	O
severe	O
lesions	O
.	O

Two	O
patients	O
had	O
disease	O
beyond	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Underlying	O
hematologic	O
disorders	O
included	O
lymphoma	O
(	O
2	O
),	O
acute	O
leukemia	O
(	O
2	O
),	O
cutaneous	O
T	O
-	O
cell	B-ANAT
lymphoma	I-ANAT
(	O
1	O
),	O
and	O
myelodysplastic	O
syndrome	O
(	O
1	O
).	O

OP	O
was	O
diagnosed	O
by	O
surgical	O
lung	B-ANAT
biopsy	O
in	O
4	O
and	O
bronchoscopic	O
biopsy	O
in	O
2	O
.	O

Two	O
patients	O
were	O
alive	O
without	O
respiratory	O
complaints	O
more	O
than	O
1	O
year	O
after	O
lung	B-ANAT
biopsy	O
.	O

The	O
prognosis	O
is	O
not	O
markedly	O
influenced	O
by	O
cancer	O
characteristics	O
;	O
it	O
is	O
determined	O
chiefly	O
by	O
the	O
cause	O
of	O
ARF	O
,	O
need	O
for	O
mechanical	O
ventilation	O
,	O
and	O
presence	O
of	O
other	O
organ	B-ANAT
failures	O
.	O

As	O
a	O
label	O
free	O
method	O
,	O
the	O
biosensor	O
based	O
on	O
imaging	O
ellipsometry	O
proved	O
to	O
be	O
a	O
more	O
competent	O
mechanism	O
for	O
measuring	O
serum	B-ANAT
samples	O
from	O
SARS	O
patients	O
and	O
the	O
affinity	O
between	O
these	O
antibodies	O
and	O
the	O
SARS	O
coronavirus	O
.	O

Opposite	O
to	O
what	O
was	O
described	O
for	O
mouse	O
hepatitis	O
virus	O
,	O
we	O
did	O
not	O
observe	O
the	O
late	O
relocalization	O
of	O
specific	O
replicase	O
subunits	O
to	O
the	O
presumed	O
site	O
of	O
virus	O
assembly	O
,	O
which	O
was	O
labeled	O
using	O
an	O
antiserum	O
against	O
the	O
viral	B-ANAT
membrane	I-ANAT
protein	O
.	O

Similar	O
morphological	O
studies	O
and	O
labeling	O
experiments	O
argued	O
against	O
the	O
previously	O
proposed	O
involvement	O
of	O
the	O
autophagic	O
pathway	O
as	O
the	O
source	O
for	O
the	O
vesicles	B-ANAT
with	O
which	O
the	O
replicase	O
is	O
associated	O
and	O
instead	O
suggested	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
to	O
be	O
the	O
most	O
likely	O
donor	O
of	O
the	O
membranes	B-ANAT
that	O
carry	O
the	O
SARS	O
-	O
CoV	O
replication	O
complex	O
.	O

TITLE	O
:	O
[	O
Dynamic	O
changes	O
of	O
T	B-ANAT
lymphocyte	I-ANAT
subsets	I-ANAT
in	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
patients	O
].	O

ABSTRACT	O
:	O
Ulcerative	O
colitis	O
(	O
UC	O
)	O
can	O
manifest	O
with	O
a	O
variety	O
of	O
extra	O
-	O
intestinal	B-ANAT
disorders	O
frequently	O
affecting	O
the	O
skin	B-ANAT
,	O
joints	B-ANAT
,	O
and	O
liver	B-ANAT
.	O

Femoral	B-ANAT
pulses	O
were	O
absent	O
.	O

Following	O
the	O
gastric	B-ANAT
decompression	O
,	O
the	O
mesenteric	B-ANAT
and	O
femoral	B-ANAT
pulses	O
reappeared	O
.	O

Acute	O
gastric	B-ANAT
dilatation	O
is	O
very	O
uncommon	O
and	O
is	O
of	O
various	O
etiologies	O
,	O
two	O
of	O
these	O
being	O
anorexia	O
nervosa	O
and	O
bulimia	O
.	O

Further	O
studies	O
are	O
required	O
to	O
delineate	O
the	O
relationship	O
between	O
severe	O
maternal	O
respiratory	O
disease	O
,	O
placental	B-ANAT
pathology	O
and	O
pregnancy	O
outcome	O
.	O

The	O
aetiology	O
of	O
the	O
FTV	O
might	O
be	O
related	O
to	O
thrombotic	O
tendency	O
due	O
to	O
SARS	O
or	O
placental	B-ANAT
hypoxia	O
.	O

Various	O
risk	O
factors	O
for	O
the	O
development	O
of	O
osteonecrosis	O
were	O
assessed	O
using	O
receiver	O
operating	O
characteristics	O
curve	O
comparison	O
with	O
appropriate	O
test	O
statistics	O
and	O
Spearman	O
'	O
s	O
coefficients	O
of	O
rank	O
correlation	O
with	O
biochemical	O
bone	B-ANAT
markers	O
.	O

With	O
tapering	O
down	O
of	O
corticosteroid	O
dosage	O
,	O
CTx	O
started	O
to	O
return	O
to	O
previous	O
baseline	O
level	O
from	O
Day	O
51	O
onwards	O
,	O
while	O
other	O
bone	B-ANAT
formation	O
markers	O
,	O
serum	B-ANAT
osteocalcin	O
and	O
bone	B-ANAT
-	O
specific	O
alkaline	O
phosphatase	O
concentrations	O
(	O
OC	O
and	O
BALP	O
,	O
respectively	O
),	O
started	O
to	O
increase	O
.	O

The	O
Day	O
28	O
-	O
44	O
increase	O
in	O
the	O
serum	B-ANAT
CTx	O
coincided	O
with	O
the	O
timing	O
of	O
corticosteroid	O
use	O
.	O

RESULTS	O
:	O
Biochemical	O
markers	O
of	O
bone	B-ANAT
metabolism	O
showed	O
significant	O
bone	B-ANAT
resorption	O
as	O
evidenced	O
by	O
a	O
marked	O
increase	O
in	O
serum	B-ANAT
C	O
-	O
terminal	O
telopeptide	O
concentration	O
(	O
CTx	O
)	O
from	O
Day	O
28	O
-	O
44	O
after	O
the	O
onset	O
of	O
fever	O
.	O

ABSTRACT	O
:	O
Serum	B-ANAT
antibody	O
responses	O
and	O
haemolytic	O
complement	O
activity	O
were	O
evaluated	O
in	O
White	O
Leghorn	O
(	O
WLH	O
)	O
and	O
Rhode	O
Island	O
Red	O
(	O
RIR	O
)	O
chickens	O
that	O
were	O
vaccinated	O
with	O
live	O
-	O
attenuated	O
vaccines	O
of	O
Newcastle	O
disease	O
virus	O
,	O
or	O
infectious	O
bronchitis	O
virus	O
,	O
or	O
infectious	O
bursal	O
disease	O
virus	O
by	O
means	O
of	O
ocular	B-ANAT
challenge	O
at	O
10	O
times	O
the	O
normal	O
vaccination	O
dose	O
.	O

Compounds	O
in	O
which	O
the	O
base	O
moiety	O
was	O
substituted	O
by	O
5	O
-	O
chloro	O
-	O
(	O
25	O
),	O
5	O
-(	O
2	O
-	O
bromovinyl	O
)-	O
(	O
32	O
),	O
or	O
5	O
-	O
bromo	O
-	O
6	O
-	O
methyl	O
-	O
(	O
37	O
)	O
groups	O
possess	O
significant	O
activity	O
against	O
duck	O
-	O
HBV	O
,	O
wild	O
-	O
type	O
human	O
HBV	O
(	O
2	O
.	O
2	O
.	O
15	O
cells	B-ANAT
),	O
and	O
lamivudine	O
-	O
resistant	O
HBV	O
containing	O
single	O
and	O
double	O
mutations	O
.	O

No	O
cytotoxicity	O
was	O
seen	O
in	O
host	O
HepG2	O
and	O
Vero	B-ANAT
cells	I-ANAT
,	O
up	O
to	O
the	O
highest	O
concentration	O
tested	O
.	O

The	O
virus	O
induces	O
severe	O
injury	O
of	O
lung	B-ANAT
tissue	I-ANAT
,	O
as	O
well	O
as	O
lymphopenia	O
and	O
destruction	O
of	O
the	O
architecture	O
of	O
lymphatic	B-ANAT
tissue	I-ANAT
by	O
as	O
-	O
yet	O
-	O
unknown	O
mechanisms	O
.	O

The	O
increase	O
in	O
workload	O
and	O
new	O
infection	O
control	O
procedures	O
were	O
thought	O
to	O
affect	O
resuscitation	O
and	O
airway	B-ANAT
management	O
.	O

There	O
were	O
significant	O
increases	O
in	O
the	O
proportion	O
of	O
resuscitation	O
cases	O
and	O
airway	B-ANAT
interventions	O
during	O
the	O
SARS	O
period	O
compared	O
to	O
the	O
pre	O
-	O
SARS	O
period	O
.	O

Reduced	O
lung	B-ANAT
volumes	O
and	O
severe	O
ventilation	O
maldistribution	O
are	O
found	O
in	O
the	O
acute	O
phase	O
but	O
may	O
persist	O
during	O
childhood	O
.	O

Bronchoalveolar	O
lavage	O
,	O
transbronchial	O
lung	B-ANAT
biopsy	O
,	O
and	O
open	O
lung	B-ANAT
biopsies	O
can	O
be	O
safely	O
performed	O
in	O
patients	O
with	O
ARDS	O
.	O

These	O
observations	O
imply	O
the	O
possible	O
involvement	O
of	O
lung	B-ANAT
stem	B-ANAT
/	O
progenitor	B-ANAT
cells	I-ANAT
,	O
in	O
addition	O
to	O
pneumocytes	B-ANAT
,	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
,	O
accounting	O
for	O
the	O
continued	O
deterioration	O
of	O
lung	B-ANAT
tissues	I-ANAT
and	O
apparent	O
loss	O
of	O
capacity	O
for	O
lung	B-ANAT
repair	O
.	O

The	O
NTD	O
of	O
the	O
IBV	O
Gray	O
strain	O
at	O
1	O
.	O
3	O
-	O
A	O
resolution	O
exhibits	O
a	O
U	O
-	O
shaped	O
structure	O
,	O
with	O
two	O
arms	B-ANAT
rich	O
in	O
basic	O
residues	O
,	O
providing	O
a	O
module	O
for	O
specific	O
interaction	O
with	O
RNA	O
.	O

This	O
anti	O
-	O
3a	O
N	O
-	O
terminal	O
antibody	O
could	O
detect	O
3a	O
protein	O
in	O
infected	O
cells	B-ANAT
,	O
as	O
did	O
an	O
anti	O
-	O
3a	O
C	O
-	O
terminal	O
antibody	O
previously	O
described	O
.	O

The	O
latter	O
targeted	O
the	O
C	O
-	O
terminal	O
cytoplasmic	B-ANAT
domain	I-ANAT
of	O
3a	O
(	O
aa	O
134	O
-	O
274	O
).	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
memory	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
against	O
the	O
spike	O
(	O
S	O
)	O
protein	O
were	O
persistent	O
for	O
more	O
than	O
1	O
year	O
after	O
SARS	O
-	O
CoV	O
infection	O
by	O
detecting	O
the	O
production	O
of	O
IFN	O
-	O
gamma	O
using	O
ELISA	O
and	O
ELISpot	O
assays	O
.	O

Flow	O
cytometric	O
analysis	O
showed	O
that	O
both	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
were	O
involved	O
in	O
cellular	B-ANAT
responses	O
against	O
SARS	O
-	O
CoV	O
infection	O
.	O

Interestingly	O
,	O
most	O
of	O
SARS	O
-	O
CoV	O
S	O
-	O
specific	O
memory	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
were	O
central	O
memory	B-ANAT
cells	I-ANAT
expressing	O
CD45RO	O
(+)	O
CCR7	O
(+)	O
CD62L	O
(-).	O

However	O
,	O
the	O
majority	O
of	O
memory	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
revealed	O
effector	O
memory	O
phenotype	O
expressing	O
CD45RO	O
(-)	O
CCR7	O
(-)	O
CD62L	O
(-).	O

Lung	B-ANAT
mechanical	O
parameters	O
were	O
recorded	O
at	O
0	O
,	O
1	O
,	O
2	O
and	O
4	O
hours	O
after	O
the	O
change	O
in	O
ventilatory	O
protocol	O
.	O

After	O
4	O
hours	O
of	O
mechanical	O
ventilation	O
,	O
animals	O
were	O
sacrificed	O
,	O
and	O
the	O
lung	B-ANAT
was	O
harvested	O
.	O

The	O
lung	B-ANAT
is	O
the	O
most	O
frequently	O
identified	O
organ	B-ANAT
to	O
fail	O
in	O
sepsis	O
and	O
is	O
also	O
the	O
most	O
frequent	O
primary	O
site	O
of	O
infection	O
.	O

Interestingly	O
,	O
both	O
saikosaponins	O
A	O
(	O
50	O
%	O
cellular	B-ANAT
cytotoxicity	O
(	O
CC50	O
)	O
concentration	O
=	O
228	O
.	O
1	O
+/-	O

Comparisons	O
were	O
made	O
for	O
perinatal	O
survival	O
and	O
neonatal	O
morbidities	O
including	O
abnormalities	O
on	O
brain	B-ANAT
imaging	O
.	O

On	O
brain	B-ANAT
imaging	O
,	O
ischemic	O
brain	B-ANAT
injury	O
was	O
seen	O
in	O
12	O
%	O
of	O
the	O
amnioreduction	O
group	O
and	O
none	O
of	O
the	O
laser	O
group	O
of	O
infants	O
(	O
p	O
=	O
.	O
01	O
).	O

In	O
conclusion	O
,	O
these	O
findings	O
indicate	O
that	O
perinatal	O
outcomes	O
are	O
improved	O
with	O
less	O
neonatal	O
morbidity	O
for	O
monochorionic	O
pregnancies	O
with	O
severe	O
TTTS	O
treated	O
by	O
laser	O
ablation	O
of	O
communicating	O
placental	B-ANAT
vessels	B-ANAT
when	O
compared	O
to	O
treatment	O
by	O
amnioreduction	O
.	O

ABSTRACT	O
:	O
To	O
compare	O
the	O
effect	O
of	O
a	O
sustained	O
inflation	O
followed	O
by	O
an	O
incremental	O
mean	O
airway	B-ANAT
pressure	O
trial	O
during	O
conventional	O
and	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
on	O
oxygenation	O
and	O
hemodynamics	O
in	O
a	O
large	O
porcine	O
model	O
of	O
early	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Severe	O
lung	B-ANAT
injury	O
(	O
Ali	O
)	O
was	O
induced	O
in	O
18	O
healthy	O
pigs	O
(	O
55	O
.	O
3	O
+/-	O

Human	O
mAb	O
CR3014	O
has	O
been	O
shown	O
to	O
completely	O
prevent	O
lung	B-ANAT
pathology	O
and	O
abolish	O
pharyngeal	B-ANAT
shedding	O
of	O
SARS	O
-	O
CoV	O
in	O
infected	O
ferrets	O
.	O

TITLE	O
:	O
Biologic	O
markers	O
of	O
mortality	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

We	O
would	O
like	O
to	O
emphasize	O
that	O
expert	O
nursing	O
care	O
and	O
close	O
supervision	O
with	O
the	O
help	O
of	O
parents	O
play	O
a	O
very	O
important	O
role	O
in	O
achieving	O
the	O
best	O
possible	O
clinical	O
outcome	O
from	O
cleft	O
palate	B-ANAT
surgery	O
in	O
pediatric	O
patients	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
remains	O
a	O
devastating	O
condition	O
with	O
a	O
high	O
mortality	O
.	O

Problems	O
in	O
the	O
late	O
recovery	O
period	O
include	O
increased	O
risk	O
of	O
diving	O
complications	O
(	O
such	O
as	O
pulmonary	B-ANAT
barotrauma	O
)	O
resulting	O
from	O
fibrosis	O
and	O
scarring	O
within	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
,	O
which	O
are	O
known	O
complications	O
of	O
SARS	O
.	O

Among	O
the	O
signaling	O
pathways	O
in	O
persistently	O
infected	O
cells	B-ANAT
,	O
Akt	O
and	O
JNK	O
were	O
phosphorylated	O
in	O
SARS	O
-	O
CoV	O
-	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
-	O
expressing	O
Vero	O
E6	O
cells	B-ANAT
using	O
vaccinia	O
viral	O
vector	O
(	O
DIs	O
),	O
strongly	O
suggesting	O
that	O
N	O
protein	O
-	O
induced	O
phosphorylation	O
of	O
Akt	O
and	O
JNK	O
are	O
necessary	O
to	O
establish	O
persistence	O
.	O

They	O
are	O
S	O
-	O
e	O
monomers	O
,	O
uncleaved	O
S	O
-	O
e	O
trimers	O
,	O
cleaved	B-ANAT
S	O
-	O
e	O
trimers	O
,	O
and	O
dissociated	O
S1	O
monomers	O
and	O
S2	O
trimer	O
rosettes	O
.	O

However	O
,	O
the	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocyte	I-ANAT
(	O
CTL	B-ANAT
)	O
response	O
was	O
not	O
significantly	O
altered	O
by	O
the	O
different	O
prime	O
-	O
boost	O
immunizations	O
or	O
the	O
recombinant	O
adenovirus	O
of	O
pcDNA3	O
.	O
1	O
-	O
N	O
prime	O
-	O
rAd	O
-	O
N	O
boost	O
regimen	O
alone	O
,	O
but	O
lymphoproliferation	O
and	O
interferon	O
-	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
secretion	B-ANAT
were	O
all	O
enhanced	O
by	O
heterologous	O
combination	O
immunizations	O
compared	O
to	O
homologous	O
combinations	O
.	O

CONCLUSIONS	O
:	O
Taken	O
together	O
,	O
of	O
all	O
the	O
combinations	O
,	O
the	O
prime	O
-	O
triple	O
boost	O
immunization	O
of	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
pcDNA3	O
.	O
1	O
-	O
N	O
/	O
rAd	O
-	O
N	O
can	O
effectively	O
induce	O
SARS	O
-	O
CoV	O
-	O
N	O
-	O
specific	O
and	O
strong	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
mice	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
E	O
protein	O
from	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
forms	O
cation	O
-	O
selective	O
ion	O
channels	O
in	O
planar	O
lipid	B-ANAT
bilayers	I-ANAT
(	O
Wilson	O
,	O
L	O
.,	O
McKinlay	O
,	O
C	O
.,	O
Gage	O
,	O
P	O
.,	O
Ewart	O
,	O
G	O
.,	O
2004	O
.	O

TITLE	O
:	O
Pathogenic	O
role	O
for	O
virus	O
-	O
specific	O
CD4	O
T	B-ANAT
cells	I-ANAT
in	O
mice	O
with	O
coronavirus	O
-	O
induced	O
acute	O
encephalitis	O
.	O

We	O
engineered	O
a	O
recombinant	O
JHMV	O
with	O
mutations	O
in	O
the	O
immunodominant	O
CD4	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitope	O
(	O
rJ	O
.	O
M	O
(	O
Y135Q	O
)).	O

RESULTS	O
:	O
All	O
the	O
specimens	O
were	O
negative	O
for	O
SARS	O
-	O
CoV	O
and	O
reovirus	O
by	O
RT	O
-	O
PCR	O
,	O
but	O
the	O
fecal	B-ANAT
specimens	O
from	O
4	O
persons	O
were	O
positive	O
for	O
poliovirus	O
.	O

End	O
point	O
real	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
PCR	O
-	O
based	O
Restriction	O
Fragment	O
Length	O
Polymorphism	O
(	O
RFLP	O
)	O
analysis	O
were	O
used	O
to	O
detect	O
the	O
single	O
nucleic	B-ANAT
polymorphisms	O
(	O
SNPs	O
)	O
in	O
OAS1	O
and	O
MxA	O
genes	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
influence	O
of	O
ambroxol	O
on	O
paraquat	O
poisoning	O
induced	O
acute	O
lung	B-ANAT
tissue	I-ANAT
injury	O
and	O
the	O
change	O
of	O
pulmonary	B-ANAT
surfactant	O
associated	O
protein	O
A	O
in	O
the	O
experimental	O
rats	O
.	O

Chest	B-ANAT
radiographs	O
of	O
children	O
admitted	O
with	O
suspected	O
or	O
probable	O
SARS	O
as	O
well	O
as	O
other	O
febrile	O
illness	O
during	O
this	O
period	O
were	O
retrospectively	O
and	O
independently	O
reviewed	O
by	O
3	O
radiologists	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
67	O
patients	O
'	O
serial	O
chest	B-ANAT
radiographs	O
were	O
interpreted	O
.	O

At	O
the	O
same	O
time	O
,	O
however	O
,	O
countries	O
are	O
increasingly	O
seeking	O
to	O
collaborate	O
internationally	O
in	O
infectious	O
disease	O
surveillance	O
and	O
response	O
,	O
as	O
shown	O
in	O
the	O
current	O
situation	O
of	O
avian	O
influenza	O
(	O
H5N1	O
),	O
and	O
in	O
the	O
formal	O
agreement	O
leading	O
to	O
the	O
revised	O
International	O
Health	O
Regulations	O
(	O
IHR	O
),	O
suggesting	O
that	O
a	O
new	O
world	O
order	O
prevails	O
over	O
issues	O
that	O
once	O
had	O
been	O
considered	O
the	O
sole	B-ANAT
domain	O
of	O
a	O
sovereign	O
nation	O
.	O

Jumbo	O
(	O
600	O
mL	O
)	O
plasma	B-ANAT
units	O
were	O
inoculated	O
with	O
high	O
titers	O
of	O
test	O
pathogens	O
and	O
treated	O
with	O
150	O
micromol	O
per	O
L	O
amotosalen	O
and	O
3	O
J	O
per	O
cm	O
(	O
2	O
)	O
long	O
-	O
wavelength	O
ultraviolet	O
light	O
.	O

Plasma	B-ANAT
function	O
was	O
evaluated	O
through	O
measurement	O
of	O
coagulation	O
factors	O
and	O
antithrombotic	O
protein	O
activities	O
.	O

RESULTS	O
:	O
The	O
levels	O
of	O
inactivation	O
expressed	O
as	O
log	O
-	O
reduction	O
were	O
as	O
follows	O
:	O
cell	B-ANAT
-	O
free	O
human	O
immunodeficiency	O
virus	O
-	O
1	O
(	O
HIV	O
-	O
1	O
),	O
greater	O
than	O
6	O
.	O
8	O
;	O
cell	B-ANAT
-	O
associated	O
HIV	O
-	O
1	O
,	O
greater	O
than	O
6	O
.	O
4	O
;	O
human	O
T	O
-	O
lymphotropic	O
virus	O
-	O
I	O
(	O
HTLV	O
-	O
I	O
),	O
4	O
.	O
5	O
;	O
HTLV	O
-	O
II	O
,	O
greater	O
than	O
5	O
.	O
7	O
;	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
and	O
hepatitis	O
C	O
virus	O
,	O
greater	O
than	O
4	O
.	O
5	O
;	O
duck	O
HBV	O
,	O
4	O
.	O
4	O
to	O
4	O
.	O
5	O
;	O
bovine	O
viral	O
diarrhea	O
virus	O
,	O
6	O
.	O
0	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
5	O
.	O
5	O
;	O
West	O
Nile	O
virus	O
,	O
6	O
.	O
8	O
;	O
bluetongue	O
virus	O
,	O
5	O
.	O
1	O
;	O
human	O
adenovirus	O
5	O
,	O
6	O
.	O
8	O
;	O
Klebsiella	O
pneumoniae	O
,	O
greater	O
than	O
7	O
.	O
4	O
;	O
Staphylococcus	O
epidermidis	O
and	O
Yersinia	O
enterocolitica	O
,	O
greater	O
than	O
7	O
.	O
3	O
;	O
Treponema	O
pallidum	B-ANAT
,	O
greater	O
than	O
5	O
.	O
9	O
;	O
Borrelia	O
burgdorferi	O
,	O
greater	O
than	O
10	O
.	O
6	O
;	O
Plasmodium	O
falciparum	O
,	O
6	O
.	O
9	O
;	O
Trypanosoma	O
cruzi	O
,	O
greater	O
than	O
5	O
.	O
0	O
;	O
and	O
Babesia	O
microti	O
,	O
greater	O
than	O
5	O
.	O
3	O
.	O

ABSTRACT	O
:	O
E	O
protein	O
is	O
a	O
membrane	B-ANAT
component	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

Furthermore	O
,	O
the	O
cells	B-ANAT
that	O
were	O
co	O
-	O
transfected	O
with	O
M	O
and	O
N	O
proteins	O
showed	O
more	O
obvious	O
phenomena	O
of	O
cell	B-ANAT
death	O
(	O
about	O
36	O
.	O
03	O
%).	O

ABSTRACT	O
:	O
Viruses	O
are	O
the	O
major	O
cause	O
of	O
pediatric	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
(	O
ARTI	O
)	O
and	O
yet	O
many	O
suspected	O
cases	O
of	O
infection	O
remain	O
uncharacterized	O
.	O

ABSTRACT	O
:	O
The	O
early	O
release	O
of	O
cytokines	O
by	O
cells	B-ANAT
involved	O
in	O
innate	O
immunity	O
is	O
an	O
important	O
host	O
response	O
to	O
intracellular	B-ANAT
pathogens	O
.	O

Gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)	O
is	O
an	O
important	O
cytokine	O
produced	O
during	O
the	O
early	O
stages	O
of	O
an	O
infection	O
by	O
macrophages	B-ANAT
,	O
natural	O
killer	O
(	O
NK	O
)	O
cells	B-ANAT
,	O
and	O
other	O
cell	B-ANAT
types	O
,	O
and	O
it	O
is	O
also	O
a	O
central	O
cytokine	O
mediator	O
for	O
the	O
induction	O
of	O
cellular	B-ANAT
or	O
Th1	O
immunity	O
.	O

However	O
,	O
individual	O
pigs	O
manifested	O
short	O
,	O
sporadic	O
increases	O
in	O
the	O
serum	B-ANAT
concentration	O
of	O
IFN	O
-	O
gamma	O
from	O
18	O
to	O
50	O
d	O
after	O
inoculation	O
.	O

Two	O
other	O
respiratory	O
viruses	O
of	O
pigs	O
,	O
Porcine	O
respiratory	O
coronavirus	O
and	O
Swine	O
influenza	O
virus	O
,	O
do	O
not	O
appear	O
to	O
induce	O
serum	B-ANAT
IFN	O
-	O
gamma	O
.	O

The	O
early	O
production	O
of	O
IFN	O
-	O
gamma	O
in	O
PRRSV	O
-	O
infected	O
pigs	O
might	O
result	O
from	O
activation	O
of	O
NK	B-ANAT
cells	I-ANAT
,	O
a	O
response	O
that	O
is	O
more	O
characteristic	O
of	O
immune	O
pathways	O
stimulated	O
by	O
intracellular	B-ANAT
bacterial	O
and	O
protozoan	O
infections	O
.	O

TITLE	O
:	O
Interferon	O
-	O
gamma	O
and	O
interleukin	O
-	O
4	O
downregulate	O
expression	O
of	O
the	O
SARS	O
coronavirus	O
receptor	O
ACE2	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
treatment	O
of	O
Vero	O
E6	O
cells	B-ANAT
with	O
interleukin	O
-	O
4	O
(	O
IL	O
-	O
4	O
)	O
decreased	O
the	O
susceptibility	O
of	O
these	O
cells	B-ANAT
to	O
SARS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
Eight	O
poultry	O
farms	O
in	O
Nigeria	O
,	O
including	O
chickens	O
from	O
nine	O
breeder	O
,	O
14	O
broiler	O
,	O
28	O
pullet	O
,	O
11	O
layer	B-ANAT
,	O
and	O
three	O
cockerel	O
flocks	O
,	O
were	O
tested	O
for	O
antibody	O
seroprevalence	O
to	O
the	O
following	O
poultry	O
viruses	O
of	O
potential	O
economic	O
importance	O
:	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
avian	O
reovirus	O
,	O
avian	O
pneumovirus	O
(	O
APV	O
),	O
infectious	O
laryngotracheitis	O
virus	O
(	O
ILTV	O
),	O
avian	O
influenza	O
virus	O
(	O
AIV	O
),	O
and	O
avian	O
leukosis	O
virus	O
(	O
ALV	O
).	O

Serum	B-ANAT
samples	O
were	O
collected	O
between	O
1999	O
and	O
2004	O
and	O
were	O
tested	O
for	O
antibodies	O
using	O
commercial	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
kits	O
.	O

In	O
general	O
,	O
the	O
Mass	O
strain	O
was	O
more	O
frequently	O
recovered	O
from	O
the	O
tracheal	O
and	O
cecal	B-ANAT
tonsil	I-ANAT
tissues	B-ANAT
at	O
earlier	O
stages	O
of	O
infection	O
and	O
the	O
Ark	O
strain	O
was	O
recovered	O
at	O
later	O
stages	O
of	O
infection	O
.	O

Totally	O
927	O
bats	O
of	O
9	O
species	O
(	O
Cynopterus	O
sphinx	O
,	O
Rousettus	O
leschenaulti	O
,	O
Miniopterus	O
schreibersi	O
,	O
Hipposideros	O
pratti	O
,	O
Rhinolophusasinicus	O
,	O
Scotophilusakuhlii	O
,	O
Hipposideros	O
Pomona	O
,	O
Rhinolophus	O
affinis	O
,	O
and	O
Rhinolophus	O
pusillus	O
)	O
captured	O
in	O
Guangzhou	O
and	O
its	O
vicinity	O
from	O
September	O
2004	O
to	O
November	O
2005	O
were	O
available	O
for	O
this	O
investigation	O
,	O
from	O
which	O
3	O
,	O
043	O
samples	O
(	O
813	O
throat	B-ANAT
swasb	O
,	O
524	O
sera	B-ANAT
,	O
853	O
lung	B-ANAT
tissues	I-ANAT
and	O
853	O
colorectal	O
tissue	B-ANAT
specimens	O
)	O
were	O
obtained	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	B-ANAT
structure	O
of	O
SARS	O
-	O
CoV	O
nsp10	O
at	O
a	O
resolution	O
of	O
1	O
.	O
8	O
A	O
as	O
determined	O
by	O
single	O
-	O
wavelength	O
anomalous	O
dispersion	O
using	O
phases	O
derived	O
from	O
hexatantalum	O
dodecabromide	O
.	O

The	O
zinc	O
finger	B-ANAT
sequence	O
motifs	O
are	O
conserved	O
among	O
all	O
three	O
coronavirus	O
antigenic	O
groups	O
,	O
implicating	O
an	O
essential	O
function	O
for	O
nsp10	O
in	O
all	O
coronaviruses	O
.	O

The	O
crystal	B-ANAT
structure	O
of	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
nsp15	O
is	O
reported	O
at	O
2	O
.	O
15	O
-	O
A	O
resolution	O
.	O

Trimeric	O
glycoprotein	O
spikes	O
were	O
in	O
register	O
with	O
four	O
underlying	O
ribonucleoprotein	B-ANAT
densities	O
.	O

Independent	O
predictors	O
of	O
mortality	O
were	O
age	O
(	O
odds	O
ratio	O
1	O
.	O
044	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
014	O
-	O
1	O
.	O
075	O
,	O
p	O
=	O
0	O
.	O
004	O
),	O
mean	O
pulmonary	B-ANAT
artery	I-ANAT
pressure	O
(	O
1	O
.	O
082	O
,	O
1	O
.	O
026	O
-	O
1	O
.	O
141	O
,	O
p	O
=	O
0	O
.	O
036	O
),	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
score	O
(	O
1	O
.	O
148	O
,	O
1	O
.	O
018	O
-	O
1	O
.	O
294	O
,	O
p	O
=	O
0	O
.	O
024	O
),	O
and	O
days	O
of	O
mechanical	O
ventilation	O
prior	O
to	O
referral	O
(	O
1	O
.	O
064	O
,	O
1	O
.	O
008	O
-	O
1	O
.	O
123	O
,	O
p	O
=	O
0	O
.	O
025	O
).	O

TITLE	O
:	O
The	O
human	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
8b	O
protein	O
is	O
distinct	O
from	O
its	O
counterpart	O
in	O
animal	O
SARS	O
-	O
CoV	O
and	O
down	O
-	O
regulates	O
the	O
expression	O
of	O
the	O
envelope	B-ANAT
protein	O
in	O
infected	O
cells	B-ANAT
.	O

This	O
review	O
summarizes	O
both	O
classical	O
and	O
contemporary	O
discoveries	O
in	O
the	O
study	O
of	O
the	O
molecular	O
biology	O
of	O
these	O
infectious	O
agents	O
,	O
with	O
particular	O
emphasis	O
on	O
the	O
nature	O
and	O
recognition	O
of	O
viral	O
receptors	O
,	O
viral	O
RNA	O
synthesis	O
,	O
and	O
the	O
molecular	O
interactions	O
governing	O
virion	B-ANAT
assembly	O
.	O

Blood	B-ANAT
collection	O
was	O
performed	O
on	O
admission	O
and	O
on	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
.	O

We	O
observed	O
4	O
in	O
-	O
hospital	O
deaths	O
,	O
one	O
of	O
which	O
was	O
due	O
to	O
an	O
infarct	O
and	O
three	O
due	O
to	O
extra	O
-	O
cardiac	B-ANAT
causes	O
(	O
1	O
non	O
-	O
cardiogenic	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
1	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
and	O
1	O
pyelonephritis	O
).	O

Bovine	O
coronavirus	O
infection	O
was	O
significantly	O
associated	O
with	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
and	O
decreased	O
growth	O
performance	O
in	O
AR	O
calves	O
.	O

TITLE	O
:	O
Crystal	B-ANAT
structure	O
and	O
mechanistic	O
determinants	O
of	O
SARS	O
coronavirus	O
nonstructural	O
protein	O
15	O
define	O
an	O
endoribonuclease	O
family	O
.	O

NendoU	O
(	O
nsp15	O
)	O
is	O
a	O
Mn	O
(	O
2	O
+)-	O
dependent	O
,	O
uridylate	O
-	O
specific	O
enzyme	O
,	O
which	O
leaves	O
2	O
'-	O
3	O
'-	O
cyclic	O
phosphates	O
5	O
'	O
to	O
the	O
cleaved	B-ANAT
bond	O
.	O

We	O
therefore	O
monitored	O
oxyhemoglobin	O
saturation	O
,	O
a	O
measure	O
of	O
arterial	B-ANAT
blood	I-ANAT
oxygen	O
content	O
,	O
before	O
and	O
after	O
insertion	O
of	O
the	O
bronchoscope	O
,	O
during	O
bronchoalveolar	O
lavage	O
,	O
and	O
after	O
initiation	O
of	O
oxygen	O
supplementation	O
.	O

Finally	O
,	O
we	O
show	O
a	O
simple	O
and	O
cost	O
-	O
effective	O
method	O
of	O
using	O
human	O
nasal	B-ANAT
cannulas	O
for	O
delivering	O
oxygen	O
to	O
pigtailed	O
macaques	O
during	O
bronchoscopic	O
procedures	O
,	O
and	O
we	O
believe	O
that	O
,	O
after	O
further	O
testing	O
,	O
this	O
method	O
could	O
be	O
used	O
safely	O
and	O
effectively	O
in	O
other	O
nonhuman	O
primate	O
species	O
.	O

Specifically	O
,	O
that	O
of	O
travelers	O
disguising	O
symptoms	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
at	O
international	O
airports	O
,	O
in	O
order	O
to	O
board	O
aircraft	O
to	O
return	O
to	O
their	O
home	O
countries	O
-	O
notwithstanding	O
the	O
infection	O
risks	O
this	O
involves	O
to	O
others	O
.	O

P15	O
could	O
significantly	O
enhance	O
the	O
expression	O
of	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
molecules	O
on	O
the	O
T2	O
cell	B-ANAT
surface	I-ANAT
,	O
stimulate	O
IFN	O
-	O
gamma	O
-	O
producing	O
CTLs	O
from	O
the	O
PBMCs	O
of	O
former	O
SARS	O
patients	O
,	O
and	O
induce	O
specific	O
CTLs	O
from	O
P15	O
-	O
immunized	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
transgenic	O
mice	O
in	O
vivo	O
.	O

Furthermore	O
,	O
significant	O
P15	O
-	O
specific	O
CTLs	O
were	O
induced	O
from	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
-	O
transgenic	O
mice	O
immunized	O
by	O
a	O
DNA	O
vaccine	O
encoding	O
the	O
S	O
protein	O
;	O
suggesting	O
that	O
P15	O
was	O
a	O
naturally	O
processed	O
epitope	O
.	O

These	O
two	O
protozoa	O
were	O
detected	O
together	O
in	O
4	O
animals	O
upon	O
faeces	B-ANAT
examination	O
.	O

The	O
mortality	O
in	O
patients	O
with	O
ARDS	O
is	O
more	O
commonly	O
associated	O
with	O
the	O
sequels	O
of	O
sepsis	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
than	O
with	O
respiratory	O
failure	O
although	O
the	O
latest	O
papers	O
on	O
protective	O
ventilation	O
suggest	O
that	O
death	O
in	O
these	O
patients	O
directly	O
results	O
from	O
lung	B-ANAT
lesion	O
in	O
a	O
number	O
of	O
cases	O
.	O

There	O
have	O
been	O
encouraging	O
data	O
on	O
the	O
reduced	O
mortality	O
rates	O
due	O
to	O
acute	O
lung	B-ANAT
lesion	O
/	O
ARDS	O
in	O
the	O
past	O
decade	O
.	O

Engineering	O
regulatory	O
transcription	O
circuits	O
of	O
intercommunicating	O
alleles	O
successfully	O
introduces	O
genetic	O
traps	O
into	O
a	O
viral	B-ANAT
genome	I-ANAT
that	O
are	O
lethal	O
in	O
RNA	O
recombinant	O
progeny	O
viruses	O
.	O

TITLE	O
:	O
Multicenter	O
comparison	O
of	O
nucleic	B-ANAT
acid	O
extraction	O
methods	O
for	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
RNA	O
in	O
stool	B-ANAT
specimens	O
.	O

Our	O
study	O
objectives	O
were	O
to	O
determine	O
the	O
optimal	O
extraction	O
method	O
for	O
SARS	O
CoV	O
RNA	O
detection	O
and	O
to	O
examine	O
the	O
effect	O
of	O
increased	O
specimen	O
volume	O
for	O
the	O
detection	O
of	O
SARS	O
CoV	O
RNA	O
in	O
stool	B-ANAT
specimens	O
.	O

Genetic	O
analysis	O
of	O
these	O
viruses	O
indicates	O
that	O
there	O
are	O
at	O
least	O
four	O
different	O
,	O
but	O
closely	O
related	O
,	O
group	O
1	O
coronaviruses	O
(	O
bat	O
-	O
CoV	O
1A	O
,	O
1B	O
,	O
HKU7	O
and	O
HKU8	O
)	O
circulating	O
in	O
bent	O
-	O
winged	B-ANAT
bats	O
.	O

Chicks	O
synthesized	O
IgM	O
first	O
,	O
followed	O
by	O
IgA	O
and	O
IgY	O
.	O
Anti	O
-	O
NDV	O
and	O
anti	O
-	O
IBV	O
antibodies	O
were	O
detected	O
in	O
the	O
dams	O
'	O
plasma	B-ANAT
,	O
egg	B-ANAT
yolks	O
,	O
and	O
in	O
the	O
chicks	O
'	O
plasma	B-ANAT
on	O
d	O
3	O
and	O
7	O
,	O
with	O
line	O
2	O
having	O
higher	O
anti	O
-	O
IBV	O
and	O
lower	O
anti	O
-	O
NDV	O
levels	O
than	O
line	O
1	O
in	O
all	O
samples	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

This	O
knowledge	O
,	O
together	O
with	O
the	O
observed	O
time	O
course	O
of	O
endogenous	O
antibody	O
production	O
in	O
broiler	O
chicks	O
,	O
may	O
find	O
direct	O
application	O
in	O
formulating	O
strategies	O
for	O
protecting	O
chicks	O
,	O
especially	O
during	O
the	O
first	O
few	O
weeks	O
of	O
age	O
when	O
their	O
immune	B-ANAT
system	I-ANAT
is	O
not	O
yet	O
fully	O
functional	O
.	O

The	O
full	O
length	O
NP	O
could	O
be	O
expressed	O
in	O
E	O
.	O
coli	O
at	O
very	O
high	O
level	O
within	O
inclusion	B-ANAT
bodies	I-ANAT
.	O

Here	O
we	O
characterized	O
the	O
activation	O
of	O
an	O
immediate	O
-	O
early	O
transcription	O
factor	O
Egr	O
-	O
1	O
by	O
MHV	O
infection	O
in	O
an	O
astrocytoma	O
cell	B-ANAT
line	I-ANAT
.	O

Using	O
various	O
inhibitors	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
,	O
we	O
identified	O
that	O
the	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinases	O
1	O
/	O
2	O
were	O
involved	O
in	O
the	O
activation	O
of	O
Egr	O
-	O
1	O
transcription	O
by	O
MHV	O
infection	O
.	O

Severe	O
and	O
unexpected	O
depletion	O
of	O
lymphocytes	B-ANAT
and	O
monocytes	B-ANAT
occurred	O
within	O
24	O
hours	O
after	O
infusion	O
.	O

ABSTRACT	O
:	O
Transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
is	O
an	O
immune	O
-	O
mediated	O
transfusion	O
reaction	O
that	O
can	O
cause	O
severe	O
complications	O
or	O
even	O
death	O
.	O

In	O
1992	O
,	O
diagnostic	O
criteria	O
for	O
ARDS	O
were	O
published	O
in	O
an	O
American	O
-	O
European	O
Consensus	O
Conference	O
and	O
the	O
term	O
ACUTE	O
LUNG	B-ANAT
INJURY	O
(	O
ALI	O
)	O
was	O
adopted	O
to	O
encompass	O
patients	O
with	O
a	O
spectrum	O
of	O
less	O
severe	O
forms	O
of	O
the	O
same	O
pathological	O
entity	O
.	O

Then	O
,	O
in	O
2003	O
,	O
a	O
novel	O
member	O
of	O
the	O
coronavirus	O
family	O
was	O
introduced	O
into	O
the	O
human	O
population	O
:	O
SARS	O
-	O
CoV	O
,	O
causing	O
an	O
aggressive	O
lung	B-ANAT
disease	O
.	O

Information	O
derived	O
from	O
structural	O
,	O
mutational	O
,	O
and	O
sequence	O
analyses	O
suggests	O
a	O
close	O
phylogenetic	O
and	O
,	O
most	O
probably	O
,	O
functional	O
relationship	O
between	O
viral	O
and	O
cellular	B-ANAT
macro	O
domain	O
homologs	O
.	O

TITLE	O
:	O
A	O
convenient	O
cell	B-ANAT
fusion	O
assay	O
for	O
the	O
study	O
of	O
SARS	O
-	O
CoV	O
entry	O
and	O
inhibition	O
.	O

Specific	O
modalities	O
reviewed	O
include	O
low	O
-	O
tidal	O
volume	O
ventilation	O
,	O
permissive	O
hypercapnia	O
,	O
the	O
open	O
lung	B-ANAT
approach	O
,	O
recruitment	O
maneuvers	O
,	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
,	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
,	O
prone	O
positioning	O
,	O
and	O
extracorporeal	O
life	O
support	O
.	O

In	O
addition	O
,	O
amino	O
acids	O
286	O
-	O
295	O
,	O
316	O
-	O
325	O
and	O
361	O
-	O
367	O
that	O
represent	O
the	O
epitope	O
recognised	O
by	O
monoclonal	O
antibody	O
6D11C1	O
converge	O
indicating	O
a	O
well	O
-	O
structured	O
C	O
-	O
terminal	O
region	O
of	O
the	O
SARS	O
virus	O
nucleocapsid	B-ANAT
protein	O
and	O
functional	O
relationship	O
of	O
the	O
peptide	O
regions	O
involved	O
.	O

TITLE	O
:	O
Putative	O
cis	O
-	O
acting	O
stem	B-ANAT
-	O
loops	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
can	O
substitute	O
for	O
their	O
mouse	O
hepatitis	O
virus	O
counterparts	O
.	O

The	O
SCoV	O
5	O
'	O
UTR	O
was	O
predicted	O
to	O
contain	O
a	O
fourth	O
stem	B-ANAT
-	O
loop	O
,	O
named	O
SL3	O
,	O
in	O
which	O
the	O
leader	O
transcriptional	O
regulatory	O
sequence	O
(	O
TRS	O
)	O
is	O
folded	O
into	O
a	O
hairpin	O
loop	O
.	O

Chimeric	O
genomes	O
were	O
transcribed	O
in	O
vitro	O
,	O
and	O
viruses	O
were	O
recovered	O
after	O
electroporation	O
into	O
permissive	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
30	O
-	O
year	O
old	O
man	O
was	O
admitted	O
to	O
our	O
hospital	O
with	O
cough	O
,	O
slight	O
fever	O
,	O
and	O
dyspnea	O
that	O
he	O
had	O
developed	O
several	O
hours	O
after	O
inhaling	O
the	O
fumes	O
produced	O
from	O
a	O
Teflon	O
-	O
coated	O
pan	B-ANAT
,	O
after	O
evaporation	O
of	O
the	O
water	O
in	O
the	O
pan	B-ANAT
.	O

Chest	B-ANAT
radiography	O
revealed	O
diffuse	O
infiltrations	O
,	O
and	O
a	O
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
revealed	O
patchy	O
interstitial	B-ANAT
shadows	O
in	O
both	O
lungs	B-ANAT
.	O

We	O
conclude	O
that	O
a	O
subset	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
refractory	O
hypoxaemia	O
may	O
have	O
right	O
-	O
to	O
-	O
left	O
shunting	O
of	O
blood	B-ANAT
through	O
a	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
.	O

Herein	O
,	O
we	O
screened	O
12	O
,	O
000	O
people	O
in	O
a	O
community	O
stricken	O
by	O
SARS	O
10	O
months	O
previously	O
and	O
found	O
53	O
individuals	O
(	O
0	O
.	O
44	O
%)	O
who	O
had	O
immunoglobulin	O
G	O
antibodies	O
to	O
the	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
produced	O
in	O
bacteria	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
infection	O
with	O
SARS	O
-	O
CoV	O
induces	O
the	O
UPR	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

We	O
inoculated	O
hamsters	O
with	O
leptospires	O
and	O
collected	O
24	O
-	O
h	O
urine	B-ANAT
samples	O
on	O
postinoculation	O
day	O
4	O
.	O

We	O
found	O
that	O
leptospirosis	O
profoundly	O
influences	O
the	O
sodium	O
transport	O
capacity	O
of	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
that	O
impaired	O
pulmonary	B-ANAT
fluid	O
handling	O
can	O
impair	O
pulmonary	B-ANAT
function	O
,	O
increasing	O
the	O
chance	O
of	O
lung	B-ANAT
injury	O
.	O

Pleural	B-ANAT
effusion	I-ANAT
and	O
thickened	O
interlobular	O
septa	O
were	O
present	O
in	O
16	O
and	O
15	O
studies	O
,	O
respectively	O
.	O

Relevant	O
laboratory	O
findings	O
included	O
hypoalbuminemia	O
in	O
14	O
,	O
elevated	O
liver	B-ANAT
enzymes	O
in	O
11	O
,	O
hypocholesterolemia	O
in	O
nine	O
,	O
and	O
elevated	O
LDH	O
levels	O
in	O
six	O
cases	O
.	O

These	O
mAbs	O
were	O
found	O
to	O
have	O
significant	O
reactivity	O
with	O
both	O
non	O
-	O
phosphorylated	O
and	O
phosphorylated	O
N	O
proteins	O
,	O
which	O
resulted	O
in	O
high	O
reactivity	O
with	O
native	O
N	O
protein	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
;	O
however	O
,	O
they	O
did	O
not	O
show	O
cross	O
-	O
reactivity	O
with	O
human	O
coronavirus	O
.	O

ABSTRACT	O
:	O
Plants	O
are	O
promising	O
candidates	O
as	O
bioreactors	O
for	O
the	O
production	O
of	O
oral	B-ANAT
recombinant	O
proteins	O
in	O
the	O
biopharmaceutical	O
industry	O
.	O

Recombinant	O
M13	O
phages	O
displaying	O
the	O
peptides	O
SHRLP	O
(	O
Y	O
/	O
Q	O
)(	O
P	O
/	O
V	O
)	O
or	O
GPRPVTH	O
on	O
the	O
g3p	O
minor	O
coat	B-ANAT
protein	O
showed	O
strong	O
binding	O
affinity	O
with	O
2C10	O
(	O
70	O
%	O
and	O
30	O
%	O
of	O
recovered	O
phages	O
,	O
respectively	O
)	O
after	O
multiple	O
panning	O
.	O

Lungs	B-ANAT
and	O
kidneys	B-ANAT
were	O
the	O
most	O
common	O
severely	O
affected	O
organs	B-ANAT
by	O
SSc	O
in	O
our	O
patients	O
.	O

TITLE	O
:	O
The	O
Strength	O
-	O
Focused	O
and	O
Meaning	O
-	O
Oriented	O
Approach	O
to	O
Resilience	O
and	O
Transformation	O
(	O
SMART	O
):	O
A	O
body	B-ANAT
-	O
mind	O
-	O
spirit	O
approach	O
to	O
trauma	O
management	O
.	O

In	O
particular	O
,	O
research	O
should	O
focus	O
on	O
costly	O
interventions	O
such	O
as	O
24	O
-	O
hr	O
intensivist	O
availability	O
,	O
early	O
goal	O
-	O
directed	O
therapy	O
,	O
and	O
renal	B-ANAT
replacement	O
therapy	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
toxic	O
epidermal	B-ANAT
necrolysis	O
(	O
TEN	O
)	O
have	O
been	O
known	O
to	O
have	O
various	O
complications	O
.	O

Such	O
cases	O
are	O
usually	O
classified	O
into	O
chronic	O
bronchitis	O
/	O
bronchiolitis	O
with	O
obstructive	O
change	O
(	O
including	O
bronchiolitis	O
obliterans	O
and	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
),	O
respiratory	B-ANAT
tract	I-ANAT
obstruction	O
and	O
bronchiectasis	O
.	O

In	O
addition	O
,	O
eccrine	B-ANAT
gland	I-ANAT
involvement	O
and	O
an	O
extremely	O
high	O
level	O
of	O
serum	B-ANAT
salivary	O
amylase	O
were	O
observed	O
at	O
the	O
onset	O
of	O
TEN	O
,	O
furthermore	O
,	O
SjÃ¶gren	O
-	O
like	O
symptoms	O
occurred	O
after	O
recovery	O
from	O
TEN	O
.	O

No	O
significant	O
correlation	O
between	O
exercise	O
capacity	O
and	O
pulmonary	B-ANAT
function	O
was	O
found	O
.	O

In	O
Rhabdomyosarcoma	O
cells	B-ANAT
,	O
Madin	O
-	O
Darby	O
-	O
Canine	O
-	O
kidney	B-ANAT
cells	B-ANAT
and	O
in	O
an	O
undefined	O
monkey	O
kidney	B-ANAT
cell	I-ANAT
line	O
some	O
replication	O
was	O
observed	O
but	O
massive	O
exponential	O
rise	O
in	O
virus	O
yield	O
lacked	O
The	O
results	O
will	O
lead	O
to	O
an	O
improved	O
routine	O
diagnostic	O
algorithm	O
for	O
the	O
detection	O
of	O
the	O
human	O
coronavirus	O
NL63	O
.	O

CONCLUSIONS	O
:	O
Substantial	O
exposure	O
to	O
exhaled	B-ANAT
air	I-ANAT
occurs	O
within	O
a	O
0	O
.	O
5	O
-	O
m	O
radius	B-ANAT
of	O
patients	O
receiving	O
NPPV	O
.	O

TITLE	O
:	O
Over	O
-	O
expression	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
3b	O
protein	O
induces	O
both	O
apoptosis	O
and	O
necrosis	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

To	O
determine	O
whether	O
HECV	O
-	O
4408	O
infects	O
gnotobiotic	O
calves	O
and	O
induces	O
cross	O
-	O
protective	O
immunity	O
against	O
the	O
virulent	O
enteric	O
BCoV	O
DB2	O
strain	O
,	O
gnotobiotic	O
calves	O
(	O
n	O
=	O
4	O
)	O
were	O
orally	B-ANAT
inoculated	O
with	O
HECV	O
-	O
4408	O
and	O
then	O
challenged	O
with	O
BCoV	O
DB2	O
at	O
postinoculation	O
day	O
(	O
PID	O
)	O
21	O
.	O

After	O
challenge	O
with	O
bovine	O
coronavirus	O
,	O
no	O
diarrhea	O
or	O
virus	O
shedding	O
was	O
detected	O
in	O
calves	O
inoculated	O
with	O
HECV	O
-	O
4408	O
,	O
but	O
a	O
mock	O
-	O
inoculated	O
calf	B-ANAT
developed	O
diarrhea	O
and	O
fecal	B-ANAT
and	O
nasal	B-ANAT
shedding	O
.	O

Hemodynamics	O
were	O
analyzed	O
after	O
insertion	O
of	O
biventricular	O
conductance	O
catheters	O
and	O
a	O
pulmonary	B-ANAT
artery	I-ANAT
catheter	O
.	O

By	O
using	O
Western	O
blot	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
we	O
showed	O
that	O
the	O
purified	O
recombinant	O
M	O
protein	O
could	O
be	O
recognized	O
by	O
four	O
SARS	O
-	O
CoV	O
-	O
positive	O
human	O
sera	B-ANAT
even	O
when	O
those	O
sera	B-ANAT
were	O
12	O
,	O
800	O
-	O
fold	O
diluted	O
.	O

TITLE	O
:	O
Coronavirus	O
nucleocapsid	B-ANAT
protein	O
is	O
an	O
RNA	O
chaperone	O
.	O

As	O
the	O
elevation	O
of	O
body	B-ANAT
temperature	O
is	O
a	O
common	O
presenting	O
symptom	O
for	O
many	O
illnesses	O
,	O
including	O
infectious	O
diseases	O
such	O
as	O
SARS	O
,	O
thermal	O
imagers	O
are	O
useful	O
and	O
essential	O
tools	O
for	O
mass	O
screening	O
of	O
body	B-ANAT
temperature	O
.	O

TITLE	O
:	O
A	O
trimerizing	O
GxxxG	O
motif	O
is	O
uniquely	O
inserted	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	O
spike	O
protein	O
transmembrane	B-ANAT
domain	O
.	O

This	O
unique	O
orientation	O
of	O
the	O
glycine	O
residues	O
also	O
stabilizes	O
the	O
trimeric	O
bundle	O
during	O
multi	O
-	O
nanosecond	O
molecular	O
dynamics	O
simulation	O
in	O
a	O
hydrated	O
lipid	B-ANAT
bilayer	I-ANAT
.	O

In	O
all	O
,	O
372	O
(	O
69	O
%)	O
of	O
540	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
specimens	O
were	O
negative	O
for	O
bacteria	O
,	O
and	O
2	O
persons	O
were	O
coinfected	O
with	O
other	O
respiratory	O
viruses	O
.	O

TITLE	O
:	O
Control	O
of	O
coronavirus	O
infection	O
through	O
plasmacytoid	O
dendritic	B-ANAT
-	O
cell	B-ANAT
-	O
derived	O
type	O
I	O
interferon	O
.	O

Protection	O
based	O
criteria	O
were	O
:	O
virus	O
re	O
-	O
isolation	O
attempts	O
from	O
trachea	B-ANAT
,	O
tracheal	O
and	O
renal	B-ANAT
histopathology	O
as	O
well	O
as	O
IBV	O
antigens	O
detection	O
by	O
immunofluorescent	O
antibody	O
technique	O
in	O
kidney	B-ANAT
sections	O
.	O

Clinical	O
trials	O
of	O
one	O
of	O
these	O
,	O
recombinant	O
protective	O
antigen	O
(	O
rPA	B-ANAT
)	O
102	O
,	O
are	O
underway	O
.	O

Patients	O
with	O
ARDS	O
required	O
more	O
colloids	O
(	O
P	O
=	O
.	O
005	O
)	O
and	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
units	O
(	O
P	O
=	O
.	O
02	O
)	O
than	O
patients	O
without	O
ARDS	O
during	O
the	O
first	O
24	O
hours	O
.	O

Follicular	B-ANAT
architecture	O
was	O
altered	O
and	O
showed	O
distortion	O
,	O
dilatation	O
,	O
and	O
collapse	O
.	O

ABSTRACT	O
:	O
Safety	O
and	O
efficacy	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
pregnancy	O
is	O
unknown	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
can	O
be	O
life	O
saving	O
when	O
initiated	O
early	O
in	O
pregnant	O
patients	O
with	O
severe	O
acute	O
respiratory	O
insufficiency	O
unresponsive	O
to	O
conventional	O
mechanical	O
ventilation	O
.	O

TITLE	O
:	O
Transmission	O
of	O
mouse	O
minute	O
virus	O
(	O
MMV	O
)	O
but	O
not	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
following	O
embryo	B-ANAT
transfer	O
with	O
experimentally	O
exposed	O
in	O
vivo	O
-	O
derived	O
embryos	B-ANAT
.	O

Recipients	O
receiving	O
embryos	B-ANAT
exposed	O
to	O
a	O
minimum	O
of	O
10	O
(	O
7	O
)	O
mean	O
tissue	B-ANAT
culture	O
infective	O
dose	O
(	O
TCID	O
(	O
50	O
))/	O
ml	O
of	O
MHV	O
-	O
A59	O
and	O
10	O
(	O
2	O
)	O
TCID	O
(	O
50	O
)/	O
ml	O
of	O
MMVp	O
seroconverted	O
by	O
Day	O
42	O
after	O
embryo	B-ANAT
transfer	O
.	O

Distant	O
structural	O
homology	O
between	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
nsp8	O
and	O
the	O
catalytic	O
palm	B-ANAT
subdomain	O
of	O
RdRps	O
of	O
RNA	O
viruses	O
suggests	O
a	O
common	O
origin	O
of	O
the	O
two	O
coronavirus	O
RdRps	O
,	O
which	O
however	O
may	O
have	O
evolved	O
different	O
sets	O
of	O
catalytic	O
residues	O
.	O

We	O
found	O
that	O
genes	O
encoded	O
by	O
mitochondrial	B-ANAT
DNA	I-ANAT
(	O
mtDNA	B-ANAT
)	O
were	O
obviously	O
upregulated	O
,	O
while	O
mitochondria	B-ANAT
were	O
now	O
found	O
to	O
be	O
closely	O
connected	O
with	O
antiviral	O
immunity	O
.	O

All	O
patients	O
were	O
treated	O
with	O
i	O
.	O
v	O
./	O
oral	B-ANAT
quinine	O
.	O

Similarly	O
,	O
the	O
important	O
cause	O
of	O
mortality	O
in	O
2001	O
was	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
71	O
.	O
10	O
%)	O
with	O
predominant	O
presentation	O
of	O
jaundice	O
and	O
renal	B-ANAT
failure	O
,	O
whereas	O
in	O
1994	O
,	O
it	O
was	O
cerebral	B-ANAT
malaria	O
(	O
77	O
.	O
96	O
%).	O

RESULTS	O
:	O
In	O
a	O
prospective	O
study	O
in	O
1994	O
the	O
spectrum	O
of	O
complication	O
was	O
dominated	O
by	O
cerebral	B-ANAT
malaria	O
(	O
25	O
.	O
75	O
%)	O
followed	O
by	O
jaundice	O
(	O
11	O
.	O
47	O
%),	O
bleeding	O
tendencies	O
(	O
9	O
.	O
59	O
%),	O
severe	O
anaemia	O
(	O
5	O
.	O
83	O
%),	O
shock	O
(	O
5	O
.	O
26	O
%),	O
Acute	O
respiratory	O
distress	O
syndrome	O
-	O
ARDS	O
(	O
3	O
.	O
01	O
%),	O
renal	B-ANAT
failure	O
(	O
2	O
.	O
07	O
%)	O
and	O
hypoglycemia	O
(	O
2	O
.	O
07	O
%)	O
whereas	O
in	O
2001	O
it	O
was	O
dominated	O
by	O
jaundice	O
(	O
58	O
.	O
85	O
%)	O
followed	O
by	O
severe	O
anaemia	O
(	O
26	O
.	O
04	O
%),	O
bleeding	O
tendencies	O
(	O
25	O
.	O
52	O
%),	O
shock	O
(	O
10	O
.	O
94	O
%),	O
cerebral	B-ANAT
malaria	O
(	O
10	O
.	O
94	O
%),	O
renal	B-ANAT
failure	O
(	O
6	O
.	O
25	O
%),	O
ARDS	O
(	O
2	O
.	O
08	O
%)	O
and	O
hypoglycemia	O
(	O
1	O
.	O
56	O
%).	O

64	O
(	O
21	O
.	O
4	O
%)	O
of	O
the	O
299	O
who	O
used	O
gloves	O
regularly	O
reported	O
dry	O
skin	B-ANAT
(	O
73	O
.	O
4	O
%),	O
itch	O
(	O
56	O
.	O
3	O
%),	O
and	O
rash	O
(	O
37	O
.	O
5	O
%).	O

ABSTRACT	O
:	O
A	O
novel	O
two	O
-	O
step	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
using	O
SYBR	O
Green	O
I	O
was	O
developed	O
for	O
the	O
detection	O
of	O
acute	O
Bovine	O
Viral	O
Diarrhoea	O
virus	O
(	O
BVDV	O
)	O
infection	O
in	O
whole	B-ANAT
blood	I-ANAT
from	O
cattle	O
.	O

SARS	O
-	O
CoV	O
S	O
protein	O
and	O
its	O
RNA	O
were	O
only	O
detected	O
in	O
ACE2	O
+	O
cells	B-ANAT
in	O
the	O
lungs	B-ANAT
and	O
other	O
organs	B-ANAT
,	O
indicating	O
that	O
ACE2	O
-	O
expressing	O
cells	B-ANAT
are	O
the	O
primary	O
targets	O
for	O
SARS	O
-	O
CoV	O
infection	O
in	O
vivo	O
in	O
humans	O
.	O

High	O
levels	O
of	O
PICs	O
were	O
expressed	O
in	O
the	O
SARS	O
-	O
CoV	O
-	O
infected	O
ACE2	O
+	O
cells	B-ANAT
,	O
but	O
not	O
in	O
the	O
uninfected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Acute	O
uremia	O
but	O
not	O
renal	B-ANAT
inflammation	O
attenuates	O
aseptic	O
acute	O
lung	B-ANAT
injury	O
:	O
a	O
critical	O
role	O
for	O
uremic	O
neutrophils	B-ANAT
.	O

Uremic	O
mice	O
,	O
by	O
contrast	O
,	O
showed	O
a	O
significant	O
protection	O
from	O
ALI	O
(	O
decrease	O
in	O
arterial	B-ANAT
partial	O
pressure	O
of	O
O	O
(	O
2	O
)	O
<	O
40	O
%);	O
this	O
was	O
independent	O
of	O
the	O
type	O
of	O
AU	O
.	O

Between	O
normal	O
and	O
uremic	O
neutrophils	B-ANAT
,	O
there	O
were	O
no	O
differences	O
in	O
apoptosis	O
or	O
superoxide	O
production	O
.	O

These	O
results	O
,	O
demonstrate	O
that	O
SARS	O
M	O
and	O
N	O
DNA	O
vaccines	O
induced	O
human	O
CTL	B-ANAT
and	O
human	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
proliferative	O
responses	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
uses	O
dendritic	B-ANAT
cell	I-ANAT
-	O
specific	O
ICAM	O
-	O
3	O
grabbing	O
nonintegrin	O
(	O
DC	O
-	O
SIGN	O
)	O
to	O
facilitate	O
cell	B-ANAT
entry	O
via	O
cellular	B-ANAT
receptor	O
-	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

Therefore	O
we	O
applied	O
an	O
alveolar	B-ANAT
recruitment	O
manoeuvre	O
7	O
h	O
after	O
admission	O
.	O

RESULTS	O
:	O
Oxygenation	O
and	O
lung	B-ANAT
compliance	O
improved	O
rapidly	O
and	O
aeration	O
of	O
the	O
entire	B-ANAT
lung	I-ANAT
was	O
confirmed	O
by	O
computed	O
tomography	O
27	O
h	O
after	O
the	O
recruitment	O
manoeuvre	O
.	O

A	O
role	O
for	O
nitric	O
oxide	O
in	O
controlling	O
infection	O
remains	O
debatable	O
;	O
thus	O
,	O
we	O
monitored	O
nitric	O
oxide	O
levels	O
in	O
blood	B-ANAT
and	O
liver	B-ANAT
of	O
immunized	O
and	O
nonimmunized	O
spf	O
mice	O
during	O
infection	O
by	O
electron	O
paramagnetic	O
resonance	O
.	O

Thereafter	O
,	O
nitric	O
oxide	O
levels	O
decreased	O
but	O
remained	O
detectable	O
in	O
blood	B-ANAT
up	O
to	O
96	O
hpi	O
.	O

In	O
contrast	O
,	O
the	O
dynamic	O
changes	O
in	O
IL	O
-	O
6	O
,	O
C	O
-	O
reactive	O
protein	O
and	O
neutrophils	B-ANAT
occurred	O
synchronously	O
with	O
the	O
changes	O
in	O
radiographic	O
scores	O
.	O

ABSTRACT	O
:	O
During	O
the	O
2003	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
outbreak	O
,	O
traditional	O
intervention	O
measures	O
such	O
as	O
quarantine	O
and	O
border	B-ANAT
control	O
were	O
found	O
to	O
be	O
useful	O
in	O
containing	O
the	O
outbreak	O
.	O

Fusion	O
protein	O
between	O
green	O
fluorescence	O
protein	O
(	O
GFP	O
)	O
and	O
S450	O
-	O
650	O
(	O
S450	O
-	O
650	O
-	O
GFP	O
)	O
was	O
able	O
to	O
stain	O
Vero	O
E6	O
cells	B-ANAT
and	O
deletion	O
of	O
the	O
beta6	O
fragment	O
rendered	O
the	O
fusion	O
product	O
(	O
S511	O
-	O
650	O
-	O
GFP	O
)	O
unable	O
to	O
do	O
so	O
.	O

ABSTRACT	O
:	O
A	O
capillary	B-ANAT
zone	O
electrophoresis	O
method	O
was	O
developed	O
for	O
fingerprint	O
determination	O
of	O
allantoic	B-ANAT
fluid	I-ANAT
in	O
specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
embryonated	O
chicken	O
eggs	O
.	O

Thus	O
,	O
the	O
VSV	O
-	O
SARS	O
-	O
St19	B-ANAT
is	O
a	O
useful	O
tool	O
for	O
detecting	O
Nabs	O
against	O
SARS	O
-	O
CoV	O
.	O

Real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
revealed	O
HCoV	O
infection	O
in	O
79	O
cases	O
(	O
3	O
.	O
8	O
%):	O
33	O
HCoV	O
-	O
229E	O
(	O
1	O
.	O
6	O
%),	O
13	O
HCoV	O
-	O
NL63	O
(	O
0	O
.	O
6	O
%),	O
11	O
HCoV	O
-	O
OC43	O
(	O
0	O
.	O
5	O
%),	O
none	O
HCoV	O
-	O
HKU1	O
genotype	O
A	O
,	O
and	O
22	O
(	O
1	O
.	O
1	O
%)	O
co	O
-	O
detections	O
of	O
a	O
HCoV	O
and	O
another	O
respiratory	O
virus	O
.	O

The	O
sepsis	O
-	O
derived	O
lesions	O
can	O
involve	O
many	O
organs	B-ANAT
and	O
apparatus	B-ANAT
leading	O
to	O
the	O
picture	O
of	O
sepsis	O
syndrome	O
.	O

TITLE	O
:	O
The	O
spleen	B-ANAT
as	O
a	O
target	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

SARS	O
genomic	O
sequences	O
were	O
detected	O
in	O
all	O
SARS	O
spleens	B-ANAT
.	O

Immunocytes	O
in	O
the	O
red	B-ANAT
pulp	I-ANAT
were	O
decreased	O
by	O
68	O
.	O
0	O
-	O
90	O
.	O
7	O
%	O
except	O
for	O
CD68	O
+	O
macrophages	B-ANAT
and	O
human	O
leukocyte	B-ANAT
antigen	O
(	O
HLA	B-ANAT
)-	O
DR	O
positive	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
(	O
APC	B-ANAT
),	O
which	O
were	O
decreased	O
to	O
a	O
lesser	O
degree	O
.	O

Of	O
the	O
eight	O
putative	O
accessory	O
proteins	O
encoded	O
by	O
the	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
only	O
two	O
-	O
open	O
reading	O
frame	O
3a	O
(	O
ORF3a	O
)	O
and	O
ORF7a	O
-	O
have	O
been	O
identified	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
to	O
date	O
.	O

The	O
translation	O
of	O
ORF7b	O
appears	O
to	O
be	O
mediated	O
by	O
ribosome	B-ANAT
leaky	O
scanning	O
,	O
and	O
the	O
protein	O
has	O
biochemical	O
properties	O
consistent	O
with	O
that	O
of	O
an	O
integral	O
membrane	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
demonstrated	O
that	O
infection	O
of	O
cultured	B-ANAT
cells	I-ANAT
with	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
resulted	O
in	O
activation	O
of	O
the	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
Raf	O
/	O
MEK	O
/	O
ERK	O
)	O
signal	O
transduction	O
pathway	O
(	O
Y	O
.	O
Cai	O
et	O
al	O
.,	O
Virology	O
355	O
:	O
152	O
-	O
163	O
,	O
2006	O
).	O

ABSTRACT	O
:	O
Acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
worsens	O
outcome	O
in	O
various	O
scenarios	O
.	O

AKI	O
was	O
defined	O
as	O
at	O
least	O
one	O
measurement	O
of	O
serum	B-ANAT
creatinine	O
of	O
>	O
or	O
=	O
1	O
.	O
5	O
mg	O
/	O
dL	O
during	O
the	O
ICU	O
stay	O
.	O

This	O
study	O
shows	O
that	O
renal	B-ANAT
dysfunction	O
has	O
serious	O
consequences	O
in	O
the	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
weaning	O
from	O
mechanical	O
ventilation	O
,	O
and	O
mortality	O
in	O
critically	O
ill	O
cancer	O
patients	O
.	O

We	O
tested	O
two	O
hypotheses	O
in	O
patients	O
with	O
ALI	O
:	O
(	O
1	O
)	O
higher	O
levels	O
of	O
urine	B-ANAT
NO	O
would	O
be	O
associated	O
with	O
worse	O
clinical	O
outcomes	O
,	O
and	O
(	O
2	O
)	O
ventilation	O
with	O
lower	O
VT	O
would	O
reduce	O
urine	B-ANAT
NO	O
as	O
a	O
result	O
of	O
less	O
stretch	O
injury	O
.	O

Urine	B-ANAT
NO	O
levels	O
were	O
measured	O
by	O
chemiluminescence	O
in	O
566	O
patients	O
enrolled	O
in	O
the	O
National	O
Heart	B-ANAT
Lung	I-ANAT
and	O
Blood	B-ANAT
Institute	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Network	O
trial	O
of	O
6	O
ml	O
/	O
kg	O
versus	O
12	O
ml	O
/	O
kg	O
VT	O
ventilation	O
.	O

Therefore	O
,	O
even	O
in	O
CD8	O
T	B-ANAT
cell	I-ANAT
responses	O
that	O
appear	O
to	O
be	O
oligoclonotypic	O
,	O
the	O
total	O
response	O
is	O
highly	O
diverse	O
.	O

TITLE	O
:	O
Nucleocapsid	B-ANAT
amino	O
acids	O
211	O
to	O
254	O
,	O
in	O
particular	O
,	O
tetrad	O
glutamines	O
,	O
are	O
essential	O
for	O
the	O
interaction	O
between	O
the	O
nucleocapsid	B-ANAT
and	O
membrane	B-ANAT
proteins	O
of	O
SARS	O
-	O
associated	O
coronavirus	O
.	O

TITLE	O
:	O
[	O
Continuous	O
blood	B-ANAT
purification	O
in	O
the	O
treatment	O
of	O
pediatric	O
septic	O
shock	O
].	O

Nine	O
children	O
weighted	O
3	O
.	O
1	O
kg	O
-	O
14	O
.	O
0	O
kg	O
with	O
septic	O
shock	O
were	O
treated	O
with	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemofiltration	O
(	O
CVVH	O
)	O
which	O
is	O
also	O
referred	O
to	O
as	O
CBP	O
with	O
blood	B-ANAT
access	O
of	O
double	O
-	O
lumen	B-ANAT
hemodialysis	O
catheter	O
of	O
6	O
.	O
5	O
to	O
8Fr	O
inserted	O
via	O
central	B-ANAT
vein	I-ANAT
,	O
hemofilters	O
of	O
Minifilter	O
plus	O
(	O
for	O
children	O
with	O
body	B-ANAT
weight	O
<	O
5	O
kg	O
)	O
or	O
AV400s	O
(	O
for	O
children	O
with	O
body	B-ANAT
weight	O
>	O
or	O
=	O
5	O
kg	O
),	O
child	O
'	O
s	O
type	O
extracorporeal	O
circuit	O
vessel	B-ANAT
and	O
heparin	O
anticoagulation	O
.	O

The	O
blood	B-ANAT
pH	O
was	O
7	O
.	O
14	O
+/-	O

TITLE	O
:	O
Conventional	O
mechanical	O
ventilation	O
in	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
majority	O
of	O
patients	O
who	O
have	O
ARDS	O
die	O
from	O
multiple	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
),	O
and	O
ARDS	O
should	O
,	O
therefore	O
,	O
be	O
seen	O
as	O
a	O
systemic	O
disease	O
.	O

Sodium	O
taurocholate	O
was	O
infused	O
through	O
the	O
pancreatic	B-ANAT
membrane	B-ANAT
to	O
induce	O
ANP	O
.	O

Compared	O
with	O
C	O
group	O
,	O
the	O
lung	B-ANAT
wet	O
/	O
dry	O
ratios	O
in	O
both	O
the	O
P	O
and	O
T	O
groups	O
were	O
significantly	O
increased	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
them	O
.	O

Microcirculatory	O
disorder	O
is	O
an	O
important	O
factor	O
of	O
lung	B-ANAT
injury	O
in	O
ANP	O
.	O

TITLE	O
:	O
Preventive	O
effect	O
of	O
Hochu	O
-	O
ekki	O
-	O
to	O
on	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
BALB	O
/	O
c	O
mice	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
effect	O
of	O
Hochu	O
-	O
ekki	O
-	O
to	O
(	O
TJ	O
-	O
41	O
),	O
a	O
Japanese	O
herbal	O
medicine	O
,	O
on	O
the	O
development	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
in	O
mice	O
.	O

CONCLUSIONS	O
:	O
It	O
was	O
found	O
that	O
complications	O
such	O
as	O
DIC	O
,	O
diastolic	O
dysfunction	O
,	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
,	O
ARDS	O
and	O
hepatic	B-ANAT
dysfunction	O
were	O
more	O
frequent	O
in	O
severe	O
established	O
shock	O
.	O

Mice	O
induced	O
with	O
SARS	O
-	O
CoV	O
alone	O
did	O
not	O
display	O
clinical	O
signs	O
,	O
characteristically	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
,	O
hemorrhage	O
and	O
early	O
pulmonary	B-ANAT
fibrosis	O
in	O
lung	B-ANAT
tissue	I-ANAT
.	O

In	O
contrast	O
,	O
high	O
copies	O
of	O
SARS	O
-	O
CoV	O
RNA	O
and	O
virus	O
replication	O
were	O
detected	O
,	O
and	O
pathological	O
changes	O
were	O
observed	O
in	O
the	O
lung	B-ANAT
tissues	I-ANAT
of	O
the	O
control	O
mice	O
.	O

Encompassing	O
the	O
upstream	O
end	O
of	O
the	O
3	O
'	O
UTR	O
are	O
a	O
bulged	O
stem	B-ANAT
-	O
loop	O
and	O
an	O
overlapping	O
RNA	O
pseudoknot	O
,	O
both	O
of	O
which	O
are	O
essential	O
to	O
MHV	O
and	O
common	O
to	O
all	O
group	O
2	O
coronaviruses	O
.	O

Most	O
striking	O
,	O
a	O
mutant	O
deleted	O
of	O
the	O
entire	O
HVR	O
was	O
only	O
minimally	O
impaired	O
in	O
tissue	B-ANAT
culture	O
relative	O
to	O
the	O
wild	O
type	O
.	O

Correspondingly	O
,	O
replication	O
of	O
the	O
HVR	O
deletion	O
mutant	O
in	O
the	O
brains	B-ANAT
of	O
mice	O
was	O
greatly	O
reduced	O
compared	O
to	O
that	O
of	O
the	O
wild	O
type	O
.	O

For	O
the	O
antibiotic	O
-	O
resistant	O
cell	B-ANAT
lines	I-ANAT
thus	O
generated	O
,	O
the	O
expression	O
of	O
reporter	O
gene	O
was	O
ensured	O
by	O
continued	O
monitoring	O
using	O
fluorescent	O
microscopy	O
and	O
flow	O
cytometry	O
.	O

Pathologic	O
examination	O
suggests	O
that	O
the	O
extensive	O
involvement	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
likely	O
contributed	O
to	O
the	O
death	O
of	O
Tg	O
+	O
mice	O
,	O
even	O
though	O
viral	O
pneumonia	O
was	O
present	O
.	O

The	O
rSARS	O
-	O
CoV	O
-	O
DeltaE	O
virus	O
replicated	O
to	O
titers	O
100	O
-	O
to	O
1	O
,	O
000	O
-	O
fold	O
lower	O
than	O
the	O
recombinant	O
wild	O
-	O
type	O
virus	O
in	O
the	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
of	O
hamsters	O
,	O
and	O
the	O
lower	O
viral	O
load	O
was	O
accompanied	O
by	O
less	O
inflammation	O
in	O
the	O
lungs	B-ANAT
of	O
hamsters	O
infected	O
with	O
rSARS	O
-	O
CoV	O
-	O
DeltaE	O
virus	O
than	O
with	O
the	O
recombinant	O
wild	O
-	O
type	O
virus	O
.	O

The	O
SARS	O
coronavirus	O
encodes	O
a	O
novel	O
membrane	B-ANAT
protein	O
6	O
that	O
can	O
accelerate	O
replication	O
of	O
a	O
related	O
mouse	O
virus	O
,	O
a	O
property	O
that	O
may	O
explain	O
its	O
ability	O
to	O
increase	O
in	O
vivo	O
virus	O
virulence	O
.	O

TITLE	O
:	O
Naturally	O
occurring	O
anti	O
-	O
Escherichia	O
coli	O
protein	O
antibodies	O
in	O
the	O
sera	B-ANAT
of	O
healthy	O
humans	O
cause	O
analytical	O
interference	O
in	O
a	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
serodiagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

We	O
examined	O
the	O
roles	O
of	O
STAT4	O
and	O
STAT6	O
in	O
lung	B-ANAT
injury	O
after	O
caerulein	O
-	O
induced	O
severe	O
acute	O
pancreatitis	O
.	O

We	O
hypothesized	O
that	O
a	O
modified	O
organ	B-ANAT
expression	O
of	O
cytokines	O
and	O
chemokines	O
that	O
occurs	O
in	O
transgenic	O
mice	O
may	O
affect	O
the	O
systemic	O
response	O
to	O
severe	O
acute	O
pancreatitis	O
.	O

The	O
two	O
new	O
SNVs	O
reported	O
here	O
are	O
most	O
likely	O
due	O
to	O
the	O
tissue	B-ANAT
-	O
culture	O
passaging	O
of	O
the	O
clinical	O
samples	O
.	O

TITLE	O
:	O
Postoperative	O
severe	O
pneumonia	O
in	O
adult	O
liver	B-ANAT
transplant	B-ANAT
recipients	O
.	O

TITLE	O
:	O
Predictors	O
of	O
acute	O
lung	B-ANAT
injury	O
and	O
severe	O
hypoxemia	O
in	O
patients	O
undergoing	O
operative	O
talc	O
pleurodesis	O
.	O

ABSTRACT	O
:	O
Respiratory	O
distress	O
syndrome	O
(	O
RDS	O
)	O
is	O
a	O
multifactorial	O
developmental	O
disease	O
caused	O
by	O
lung	B-ANAT
immaturity	O
and	O
presenting	O
as	O
high	O
-	O
permeability	O
lung	B-ANAT
edema	O
"("""	O
hyaline	B-ANAT
membrane	B-ANAT
disease	O
""")."	O

TITLE	O
:	O
[	O
The	O
possible	O
mechanism	O
of	O
lung	B-ANAT
injury	O
induced	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
glycoprotein	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
role	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
the	O
induction	O
of	O
acute	O
lung	B-ANAT
injury	O
by	O
promoting	O
the	O
synthesis	O
of	O
chemokine	O
/	O
cytokines	O
in	O
human	O
endothelial	B-ANAT
cells	I-ANAT
.	O

Spike	O
glycoprotein	O
of	O
SARS	O
-	O
CoV	O
was	O
recombined	O
by	O
using	O
insect	O
-	O
baculovirus	O
expression	O
system	O
and	O
Nickel	O
affinity	O
Magnet	O
Beads	O
,	O
and	O
then	O
used	O
to	O
stimulate	O
cultured	O
human	O
umbilical	B-ANAT
vein	I-ANAT
endothelial	B-ANAT
cells	I-ANAT
(	O
HUVEC	O
).	O

Moreover	O
,	O
IP	O
-	O
10	O
was	O
highly	O
expressed	O
in	O
the	O
lung	B-ANAT
.	O

A	O
strong	O
IP	O
-	O
10	O
protein	O
expression	O
was	O
also	O
found	O
in	O
SARS	O
-	O
CoV	O
infected	O
lung	B-ANAT
in	O
autopsy	O
.	O

An	O
early	O
type	O
I	O
IFN	O
production	O
was	O
also	O
found	O
in	O
coronavirus	O
infected	O
pigs	O
,	O
including	O
at	O
mucosal	B-ANAT
sites	O
.	O

Thus	O
,	O
nasal	B-ANAT
and	O
pulmonary	B-ANAT
antibody	O
responses	O
were	O
analyzed	O
in	O
influenza	O
virus	O
infected	O
or	O
vaccinated	O
pigs	O
showing	O
short	O
-	O
lived	O
,	O
but	O
potentially	O
protective	O
local	O
IgA	O
and	O
IgG	B-ANAT
antibody	I-ANAT
(	O
Ab	O
)	O
responses	O
.	O

Although	O
the	O
chickens	O
were	O
not	O
vaccinated	O
against	O
any	O
poultry	O
diseases	O
,	O
serum	B-ANAT
antibodies	O
to	O
Newcastle	O
disease	O
,	O
infectious	O
bursal	O
disease	O
and	O
infectious	O
bronchitis	O
were	O
detected	O
.	O

During	O
April	O
2004	O
-	O
April	O
2006	O
,	O
nasopharyngeal	B-ANAT
specimens	O
from	O
children	O
hospitalized	O
with	O
acute	O
respiratory	O
disease	O
were	O
tested	O
for	O
common	O
respiratory	O
viruses	O
,	O
including	O
RSV	O
,	O
influenza	O
A	O
,	O
influenza	O
B	O
,	O
parainfluenza	O
viruses	O
,	O
and	O
adenovirus	O
by	O
IFA	O
.	O

HCoV	O
-	O
NL63	O
may	O
be	O
one	O
of	O
the	O
causative	O
agents	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
,	O
especially	O
croup	O
.	O

RESULTS	O
:	O
Out	O
of	O
872	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
from	O
children	O
aged	O
under	O
16	O
years	O
,	O
14	O
(	O
1	O
.	O
7	O
%)	O
were	O
positive	O
for	O
HCoV	O
-	O
NL63	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
support	O
a	O
strong	O
association	O
between	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
and	O
asthma	O
exacerbations	O
.	O

Furthermore	O
,	O
3a	O
/	O
X1	O
and	O
7a	O
/	O
X4	O
expression	O
in	O
A549	O
cells	B-ANAT
enhanced	O
production	O
of	O
inflammatory	O
chemokines	O
that	O
were	O
known	O
to	O
be	O
up	O
-	O
regulated	O
in	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
goal	O
of	O
our	O
article	O
is	O
to	O
recall	O
that	O
it	O
is	O
necessary	O
to	O
think	O
systematically	O
about	O
a	O
pulmonary	B-ANAT
shape	O
of	O
leptospirose	O
facing	O
an	O
atypical	O
pneumopahie	O
.	O

Blocking	O
CXCL10	O
signaling	O
results	O
in	O
increased	O
mortality	O
accompanied	O
by	O
reduced	O
T	B-ANAT
cell	I-ANAT
infiltration	O
and	O
increased	O
viral	O
titers	O
within	O
the	O
brain	B-ANAT
suggesting	O
that	O
CXCL10	O
functions	O
in	O
host	O
defense	O
by	O
attracting	O
T	B-ANAT
cells	I-ANAT
into	O
the	O
CNS	B-ANAT
.	O

ABSTRACT	O
:	O
Lung	B-ANAT
involvement	O
in	O
malaria	O
has	O
been	O
recognized	O
for	O
more	O
than	O
200	O
hundred	O
years	O
,	O
yet	O
our	O
knowledge	O
of	O
its	O
pathogenesis	O
and	O
management	O
is	O
limited	O
.	O

Pregnant	O
women	O
are	O
particularly	O
prone	O
to	O
developing	O
pulmonary	B-ANAT
edema	O
.	O

However	O
,	O
falciparum	O
malaria	O
with	O
severe	O
metabolic	O
acidosis	O
or	O
acute	O
pulmonary	B-ANAT
edema	O
may	O
present	O
with	O
a	O
clinical	O
picture	O
of	O
pneumonia	O
,	O
i	O
.	O
e	O
.	O
with	O
tachypnea	O
,	O
intercostal	O
recession	O
,	O
wheeze	O
or	O
inspiratory	O
crepitations	O
.	O

TITLE	O
:	O
Bronchoalveolar	O
lavage	O
with	O
diluted	O
porcine	O
surfactant	O
in	O
mechanically	O
ventilated	O
term	O
infants	O
with	O
meconium	B-ANAT
aspiration	O
syndrome	O
.	O

Compared	O
with	O
C	O
group	O
,	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
edema	O
,	O
inflammation	O
and	O
hemorrhage	O
were	O
more	O
severe	O
in	O
GC1	O
(	O
all	O
P	O
<	O
0	O
.	O
01	O
),	O
hyaline	B-ANAT
membrane	B-ANAT
was	O
less	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
no	O
difference	O
in	O
atelectasis	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

The	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
edema	O
and	O
inflammation	O
in	O
GC2	O
were	O
more	O
severe	O
than	O
in	O
C	O
group	O
(	O
all	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
there	O
was	O
no	O
difference	O
in	O
hemorrhage	O
and	O
hyaline	B-ANAT
membrane	B-ANAT
formation	O
(	O
both	O
P	O
>	O
0	O
.	O
05	O
).	O

The	O
KxHxx	O
motif	O
also	O
partially	O
retained	O
two	O
different	O
reporter	O
proteins	O
in	O
the	O
ERGIC	B-ANAT
region	O
and	O
reduced	O
their	O
rates	O
of	O
trafficking	O
,	O
although	O
the	O
motif	O
was	O
less	O
potent	O
than	O
the	O
canonical	O
dilysine	O
signal	O
.	O

The	O
dibasic	O
motif	O
bound	O
the	O
coatomer	B-ANAT
complex	B-ANAT
I	I-ANAT
(	O
COPI	O
)	O
in	O
an	O
in	O
vitro	O
binding	O
assay	O
,	O
suggesting	O
that	O
ER	O
retrieval	O
may	O
contribute	O
to	O
the	O
accumulation	O
of	O
SARS	O
CoV	O
S	O
protein	O
near	O
the	O
virus	O
assembly	O
site	O
for	O
interaction	O
with	O
other	O
viral	O
structural	O
proteins	O
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
regulator	O
of	O
the	O
renin	B-ANAT
angiotensin	I-ANAT
system	I-ANAT
involved	O
in	O
acute	O
lung	B-ANAT
failure	O
,	O
cardiovascular	B-ANAT
functions	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infections	O
in	O
mammals	O
.	O

These	O
data	O
identify	O
collectrin	O
as	O
a	O
key	O
regulator	O
of	O
renal	B-ANAT
amino	O
acid	O
uptake	O
.	O

To	O
investigate	O
the	O
potential	O
of	O
these	O
molecules	O
to	O
provide	O
protection	O
against	O
enteric	O
infections	O
when	O
supplied	O
orally	B-ANAT
,	O
SIPs	O
were	O
generated	O
against	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
a	O
highly	O
pathogenic	O
porcine	O
virus	O
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
)	O
has	O
recently	O
been	O
identified	O
as	O
a	O
causative	O
agent	O
of	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
illnesses	O
in	O
infants	O
and	O
young	O
children	O
.	O

HCoV	O
-	O
NL63	O
S	O
is	O
expressed	O
as	O
a	O
single	O
-	O
chain	O
glycoprotein	O
and	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
receptor	O
-	O
binding	O
domain	O
(	O
S1	O
)	O
and	O
a	O
C	O
-	O
terminal	O
transmembrane	B-ANAT
fusion	O
domain	O
(	O
S2	O
).	O

The	O
crystal	B-ANAT
structure	O
of	O
this	O
complex	O
reveals	O
three	O
C42	O
helices	O
entwined	O
in	O
an	O
oblique	O
and	O
antiparallel	O
manner	O
around	O
a	O
central	O
triple	O
-	O
stranded	O
coiled	O
coil	O
formed	O
by	O
three	O
N57	O
helices	O
.	O

Nelfinavir	O
,	O
beta	O
-	O
D	O
-	O
N4	O
-	O
hydroxycytidine	O
,	O
calpain	O
inhibitor	O
VI	O
,	O
3	O
-	O
deazaneplanocin	O
A	O
and	O
Alferon	O
(	O
human	O
leukocyte	B-ANAT
IFN	O
-	O
alpha	O
-	O
n3	O
)	O
did	O
not	O
significantly	O
reduce	O
lung	B-ANAT
virus	O
titres	O
in	O
mice	O
.	O

Thus	O
,	O
anti	O
-	O
inflammatory	O
agents	O
may	O
only	O
be	O
useful	O
in	O
treating	O
virus	O
lung	B-ANAT
infections	O
if	O
used	O
in	O
combination	O
with	O
agents	O
that	O
inhibit	O
virus	O
replication	O
.	O

However	O
,	O
pathological	O
changes	O
in	O
the	O
kidney	B-ANAT
were	O
mild	O
in	O
T	O
-	O
and	O
N1	O
/	O
88	O
-	O
infected	O
cockerels	O
.	O

Protein	O
kinase	O
R	O
(	O
PKR	O
)	O
and	O
the	O
alpha	O
subunit	O
of	O
eukaryotic	O
translation	O
initiation	O
factor	O
are	O
not	O
phosphorylated	O
in	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Exceptional	O
flexibility	O
in	O
the	O
sequence	O
requirements	O
for	O
coronavirus	O
small	O
envelope	B-ANAT
protein	O
function	O
.	O

The	O
mature	O
SARS	O
-	O
CoV	O
protein	O
is	O
present	O
in	O
cells	B-ANAT
several	O
hours	O
post	O
-	O
infection	O
and	O
co	O
-	O
localizes	O
to	O
the	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
,	O
but	O
its	O
function	O
in	O
the	O
viral	O
life	O
cycle	O
remains	O
unknown	O
.	O

The	O
majority	O
of	O
the	O
infected	O
cells	B-ANAT
were	O
confirmed	O
to	O
be	O
cells	B-ANAT
from	O
the	O
monocyte	B-ANAT
/	O
macrophage	B-ANAT
lineage	O
.	O

No	O
surface	O
expression	O
of	O
viral	O
antigens	O
was	O
detected	O
on	O
FIPV	O
positive	O
cells	B-ANAT
.	O

The	O
highly	O
synergistic	O
anti	O
-	O
SARS	O
-	O
CoV	O
action	O
of	O
type	O
I	O
IFNs	O
and	O
IFN	O
-	O
gamma	O
parallels	O
the	O
marked	O
increase	O
in	O
2	O
'-	O
5	O
'-	O
oligoadenylate	O
synthetase	O
and	O
p56	O
mRNAs	O
following	O
exposure	O
in	O
Vero	B-ANAT
cells	I-ANAT
to	O
either	O
IFN	O
-	O
alpha	O
or	O
-	O
beta	O
and	O
IFN	O
-	O
gamma	O
compared	O
with	O
the	O
transcriptional	O
levels	O
obtained	O
after	O
stimulation	O
with	O
either	O
IFN	O
alone	O
.	O

Thus	O
,	O
ATA	O
inhibits	O
vaccinia	O
virus	O
replication	O
by	O
targeting	O
both	O
cellular	B-ANAT
and	O
viral	O
factors	O
essential	O
for	O
the	O
early	O
stage	O
of	O
replication	O
.	O

The	O
pathological	O
findings	O
in	O
this	O
period	O
,	O
the	O
grades	O
of	O
vascular	B-ANAT
congestion	O
,	O
tracheobronchial	O
exfoliation	O
,	O
and	O
alveolar	B-ANAT
rupture	O
were	O
significant	O
.	O

In	O
the	O
rats	O
exposed	O
to	O
lowest	O
concentration	O
,	O
the	O
pulmonary	B-ANAT
parenchymal	O
density	O
and	O
pathologic	O
findings	O
rapidly	O
returned	O
to	O
normal	O
within	O
1	O
week	O
.	O

TITLE	O
:	O
Lipid	B-ANAT
rafts	I-ANAT
play	O
an	O
important	O
role	O
in	O
the	O
early	O
stage	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
life	O
cycle	O
.	O

Interestingly	O
,	O
no	O
apparent	O
evidence	O
for	O
colocalization	O
of	O
angiotensin	O
converting	O
enzyme	O
2	O
with	O
lipid	B-ANAT
rafts	I-ANAT
in	O
the	O
membrane	B-ANAT
of	O
Vero	O
E6	O
cells	B-ANAT
was	O
obtained	O
.	O

These	O
results	O
suggest	O
that	O
lipid	B-ANAT
rafts	I-ANAT
could	O
contribute	O
to	O
SARS	O
-	O
CoV	O
infection	O
in	O
the	O
early	O
replication	O
process	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
serum	B-ANAT
levels	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
in	O
patients	O
diagnosed	O
with	O
severe	O
leptospirosis	O
.	O

Here	O
,	O
we	O
report	O
the	O
crystal	B-ANAT
structure	O
of	O
M	O
(	O
pro	O
)	O
at	O
a	O
resolution	O
of	O
1	O
.	O
82	O
Angstroms	O
,	O
in	O
space	O
group	O
P2	O
(	O
1	O
)	O
at	O
pH	O
6	O
.	O
0	O
.	O

The	O
luminescent	O
-	O
based	O
assay	O
measures	O
the	O
inhibition	O
of	O
SARS	O
CoV	O
-	O
induced	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

AV	O
-	O
ECLA	O
'	O
s	O
contribution	O
to	O
oxygenation	O
during	O
severe	O
hypoxemia	O
was	O
antagonized	O
by	O
a	O
significant	O
increase	O
in	O
the	O
pulmonary	B-ANAT
shunt	O
fraction	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
nuclear	O
export	O
signal	O
in	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
nucleocapsid	B-ANAT
protein	O
.	O

However	O
,	O
export	O
of	O
N	O
protein	O
from	O
the	O
nucleus	B-ANAT
/	O
nucleolus	B-ANAT
was	O
not	O
inhibited	O
by	O
leptomycin	O
B	O
treatment	O
,	O
indicating	O
that	O
N	O
protein	O
nuclear	O
export	O
is	O
independent	O
of	O
the	O
CRM1	O
-	O
mediated	O
export	O
pathway	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
development	O
of	O
an	O
immunoglobulin	O
M	O
(	O
IgM	O
)	O
antibody	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
MAC	B-ANAT
-	O
ELISA	O
)	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
by	O
using	O
recombinant	O
truncated	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
as	O
the	O
antigen	O
.	O

Dynamic	O
monitorings	O
of	O
metabolic	O
status	O
of	O
tissue	B-ANAT
and	O
cell	B-ANAT
are	O
valuable	O
in	O
predicting	O
the	O
development	O
of	O
MODS	O
after	O
severe	O
trauma	O
.	O

RESULTS	O
:	O
Oxygen	O
metabolism	O
abnormality	O
was	O
found	O
after	O
trauma	O
,	O
and	O
it	O
was	O
correlated	O
with	O
ISS	O
,	O
RTS	O
,	O
injured	O
organ	B-ANAT
or	O
region	O
and	O
number	O
of	O
injured	O
organs	B-ANAT
,	O
shock	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
and	O
respiratory	O
complications	O
.	O

The	O
SARS	O
-	O
CoV	O
nsp1	O
protein	O
increases	O
cellular	B-ANAT
RNA	O
degradation	O
and	O
thus	O
might	O
facilitate	O
SARS	O
-	O
CoV	O
replication	O
or	O
block	O
immune	O
responses	O
.	O

In	O
addition	O
to	O
its	O
presence	O
at	O
the	O
replication	O
sites	O
,	O
N	O
also	O
accumulated	O
in	O
the	O
Golgi	B-ANAT
region	O
and	O
colocalized	O
with	O
the	O
viral	O
spike	O
protein	O
.	O

Approximately	O
three	O
-	O
quarters	O
of	O
reported	O
malaria	O
cases	O
in	O
the	O
UK	O
are	O
caused	O
by	O
Plasmodium	O
falciparum	O
,	O
which	O
is	O
capable	O
of	O
invading	O
a	O
high	O
proportion	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
and	O
rapidly	O
leading	O
to	O
severe	O
or	O
life	O
-	O
threatening	O
multi	O
-	O
organ	B-ANAT
disease	O
.	O

Uncomplicated	O
P	O
.	O
falciparum	O
malaria	O
can	O
be	O
treated	O
orally	B-ANAT
with	O
quinine	O
,	O
atovaquone	O
plus	O
proguanil	O
(	O
Malarone	O
)	O
or	O
co	O
-	O
artemether	O
(	O
Riamet	O
);	O
quinine	O
is	O
highly	O
effective	O
but	O
poorly	O
tolerated	O
in	O
prolonged	O
dosage	O
and	O
is	O
always	O
supplemented	O
by	O
additional	O
treatment	O
,	O
usually	O
with	O
oral	B-ANAT
doxycycline	O
.	O

Severe	O
falciparum	O
malaria	O
,	O
or	O
infections	O
complicated	O
by	O
a	O
relatively	O
high	O
parasite	O
count	O
(	O
more	O
than	O
2	O
%	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
parasitized	O
),	O
should	O
be	O
treated	O
with	O
intravenous	O
therapy	O
until	O
the	O
patient	O
is	O
well	O
enough	O
to	O
continue	O
with	O
oral	B-ANAT
treatment	O
.	O

Falciparum	O
malaria	O
in	O
pregnancy	O
is	O
more	O
likely	O
to	O
be	O
severe	O
and	O
complicated	O
:	O
the	O
placenta	B-ANAT
contains	O
high	O
levels	O
of	O
parasites	O
.	O

ABSTRACT	O
:	O
Canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
)	O
is	O
a	O
group	O
II	O
coronavirus	O
that	O
was	O
firstly	O
identified	O
in	O
lung	B-ANAT
samples	O
of	O
dogs	O
with	O
canine	O
infectious	O
respiratory	O
disease	O
(	O
CIRD	O
)	O
in	O
UK	O
in	O
2003	O
.	O

TITLE	O
:	O
Features	O
discriminating	O
SARS	O
from	O
other	O
severe	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

In	O
a	O
case	O
-	O
control	O
study	O
,	O
clinical	O
,	O
laboratory	O
and	O
radiological	O
data	O
from	O
322	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
SARS	O
from	O
the	O
2003	O
SARS	O
outbreak	O
were	O
compared	O
with	O
the	O
data	O
of	O
253	O
non	O
-	O
SARS	O
adult	O
patients	O
with	O
confirmed	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
from	O
2004	O
in	O
order	O
to	O
identify	O
discriminatory	O
features	O
.	O

Recent	O
studies	O
in	O
relevant	O
animal	O
models	O
as	O
well	O
as	O
in	O
human	O
subjects	O
are	O
identifying	O
common	O
mechanisms	O
by	O
which	O
alcohol	O
abuse	O
targets	O
both	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
and	O
the	O
alveolar	B-ANAT
macrophage	I-ANAT
,	O
such	O
that	O
the	O
risks	O
for	O
acute	O
lung	B-ANAT
injury	O
and	O
pulmonary	B-ANAT
infections	O
are	O
inextricably	O
linked	O
.	O

These	O
changes	O
are	O
often	O
subclinical	O
and	O
may	O
not	O
manifest	O
as	O
detectable	O
lung	B-ANAT
impairment	O
until	O
challenged	O
by	O
an	O
acute	O
insult	O
such	O
as	O
sepsis	O
or	O
trauma	O
.	O

We	O
adapted	O
the	O
SARS	O
-	O
CoV	O
(	O
Urbani	O
strain	O
)	O
by	O
serial	O
passage	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
young	O
BALB	O
/	O
c	O
mice	O
.	O

TITLE	O
:	O
Membrane	B-ANAT
topology	O
of	O
murine	O
coronavirus	O
replicase	O
nonstructural	O
protein	O
3	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
membrane	B-ANAT
topology	O
of	O
nsp3	O
-	O
TM	O
and	O
showed	O
that	O
TM	O
-	O
mediated	O
tethering	O
of	O
PLP2	O
is	O
important	O
for	O
processing	O
at	O
cleavage	O
site	O
3	O
.	O

Measurement	O
of	O
anti	O
-	O
coronavirus	O
IgG	O
in	O
CSF	B-ANAT
was	O
of	O
equivocal	O
clinical	O
use	O
.	O

Surprisingly	O
,	O
IgA	O
plasma	B-ANAT
cells	I-ANAT
infiltrate	O
inflamed	O
tissues	B-ANAT
in	O
acute	O
Kawasaki	O
disease	O
,	O
including	O
the	O
coronary	B-ANAT
artery	I-ANAT
,	O
and	O
are	O
oligoclonal	O
,	O
or	O
antigen	O
-	O
driven	O
.	O

Thirty	O
-	O
six	O
underwent	O
pulmonary	B-ANAT
function	O
testing	O
and	O
a	O
6	O
-	O
minute	O
walk	O
test	O
,	O
and	O
35	O
underwent	O
HRQoL	O
evaluation	O
by	O
Short	O
Form	O
-	O
36	O
questionnaire	O
at	O
3	O
,	O
6	O
,	O
and	O
12	O
months	O
after	O
illness	O
onset	O
.	O

Physical	O
examination	O
showed	O
dilated	O
pupils	B-ANAT
and	O
coma	O
with	O
no	O
focal	O
neurological	O
signs	O
.	O

Laboratory	O
data	O
showed	O
a	O
severe	O
anion	O
gap	O
metabolic	O
acidosis	O
,	O
with	O
a	O
serum	B-ANAT
lactate	O
level	O
of	O
185	O
mg	O
/	O
dL	O
.	O
An	O
initial	O
diagnosis	O
of	O
cyanide	O
intoxication	O
was	O
considered	O
and	O
she	O
was	O
given	O
sodium	O
nitrite	O
and	O
sodium	O
thiosulfate	O
i	O
.	O
v	O
.	O

The	O
protein	O
is	O
a	O
minor	O
virion	B-ANAT
structural	O
component	O
that	O
plays	O
an	O
important	O
,	O
not	O
fully	O
understood	O
role	O
in	O
virus	O
production	O
.	O

TITLE	O
:	O
Recombinant	O
protein	O
-	O
based	O
assays	O
for	O
detection	O
of	O
antibodies	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
and	O
nucleocapsid	B-ANAT
proteins	O
.	O

ABSTRACT	O
:	O
Recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
nucleocapsid	B-ANAT
and	O
spike	O
protein	O
-	O
based	O
immunoglobulin	O
G	O
immunoassays	O
were	O
developed	O
and	O
evaluated	O
.	O

120	O
-	O
150	O
)	O
with	O
the	O
E	O
.	O
R	O
.-	O
associated	O
domain	O
(	O
a	O
.	O
a	O
.	O
1	O
-	O
50	O
)	O
of	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
results	O
in	O
the	O
failure	O
of	O
cleavage	O
of	O
this	O
recombinant	O
protein	O
by	O
SPP	O
,	O
though	O
this	O
protein	O
still	O
is	O
E	O
.	O
R	O
.-	O
associated	O
.	O

Although	O
the	O
virus	O
infects	O
the	O
lungs	B-ANAT
,	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	I-ANAT
liver	I-ANAT
,	O
and	O
kidneys	B-ANAT
,	O
the	O
disease	O
is	O
limited	O
to	O
the	O
lungs	B-ANAT
,	O
where	O
diffuse	O
alveolar	B-ANAT
damage	O
is	O
accompanied	O
by	O
a	O
disproportionately	O
sparse	O
inflammatory	O
infiltrate	O
.	O

Following	O
CCoV	O
infection	O
A	O
-	O
72	O
cell	B-ANAT
line	I-ANAT
,	O
which	O
is	O
permissive	O
to	O
CCoV	O
,	O
showed	O
reduced	O
growth	O
rate	O
,	O
as	O
detected	O
by	O
MTT	O
assay	O
,	O
a	O
standard	O
colorimetric	O
assay	O
for	O
measuring	O
cellular	B-ANAT
proliferation	O
,	O
and	O
underwent	O
to	O
apoptotic	O
death	O
.	O

Apoptotic	O
death	O
of	O
infected	O
cells	B-ANAT
is	O
detrimental	O
as	O
it	O
causes	O
cell	B-ANAT
and	O
tissue	B-ANAT
destruction	O
as	O
well	O
as	O
inflammatory	O
responses	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
performed	O
double	O
labeling	O
combining	O
in	O
situ	O
hybridization	O
with	O
immunohistochemistry	O
and	O
alternating	O
each	O
of	O
these	O
techniques	O
separately	O
in	O
consecutive	O
sections	O
to	O
evaluate	O
the	O
viral	O
distribution	O
on	O
various	O
cell	B-ANAT
types	O
in	O
the	O
lungs	B-ANAT
of	O
seven	O
patients	O
affected	O
with	O
SARS	O
.	O

The	O
panel	O
systematically	O
assessed	O
40	O
original	O
studies	O
through	O
both	O
individual	O
assessment	O
and	O
a	O
2	O
-	O
day	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
consensus	O
meeting	O
.	O

We	O
describe	O
three	O
cases	O
of	O
adult	O
respiratory	O
distress	O
syndrome	O
with	O
sepsis	O
,	O
shock	O
and	O
multiple	O
organ	B-ANAT
failure	O
in	O
patients	O
with	O
severe	O
liver	B-ANAT
failure	O
among	O
whom	O
two	O
had	O
positive	O
Aspergillus	O
antigenemia	O
and	O
one	O
had	O
a	O
positive	O
Aspergillus	O
serology	O
.	O

We	O
evaluated	O
the	O
immunization	O
strategies	O
for	O
HIV	O
-	O
1	O
-	O
capturing	O
core	O
-	O
corona	O
type	O
polystyrene	O
nanospheres	O
that	O
would	O
efficiently	O
induce	O
HIV	O
-	O
1	O
-	O
specific	O
IgA	O
responses	O
in	O
female	O
mice	O
and	O
the	O
macaque	O
genital	B-ANAT
tract	O
.	O

TITLE	O
:	O
Epididymal	B-ANAT
stone	B-ANAT
formation	O
and	O
decreased	O
sperm	B-ANAT
production	O
in	O
roosters	O
vaccinated	O
with	O
a	O
killed	O
strain	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
.	O

Epididymal	B-ANAT
stones	O
were	O
present	O
in	O
13	O
%	O
of	O
NONVAC	O
,	O
50	O
%	O
of	O
KVAC	O
,	O
and	O
64	O
%	O
of	O
LVAC	O
roosters	O
.	O

ABSTRACT	O
:	O
This	O
paper	O
characterises	O
a	O
virulent	O
strain	O
(	O
CB	O
/	O
05	O
)	O
of	O
canine	O
coronavirus	O
(	O
CCoV	O
)	O
isolated	O
from	O
the	O
internal	O
organs	B-ANAT
of	O
pups	O
that	O
had	O
died	O
of	O
a	O
systemic	O
disease	O
without	O
evidence	O
of	O
other	O
common	O
canine	O
pathogens	O
.	O

PTX3	O
plays	O
an	O
important	O
role	O
in	O
preventing	O
infection	O
of	O
certain	O
fungi	O
,	O
bacteria	O
,	O
and	O
viruses	O
in	O
the	O
lung	B-ANAT
.	O

The	O
wet	O
/	O
dry	O
weight	O
ratios	O
and	O
histopathological	O
changes	O
of	O
the	O
lungs	B-ANAT
were	O
also	O
evaluated	O
.	O

Serum	B-ANAT
IL	O
-	O
1beta	O
levels	O
in	O
SAP	O
-	O
S	O
group	O
were	O
276	O
.	O
77	O
+/-	O

The	O
wet	O
/	O
dry	O
weight	O
ratios	O
of	O
the	O
lungs	B-ANAT
in	O
the	O
SAP	O
-	O
S	O
group	O
were	O
increased	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
at	O
6	O
h	O
,	O
P	O
<	O
0	O
.	O
01	O
at	O
12	O
h	O
and	O
18	O
h	O
,	O
vs	O
HC	O
)	O
and	O
they	O
were	O
decreased	O
significantly	O
in	O
the	O
SAP	O
-	O
ICE	O
-	O
I	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
vs	O
SAP	O
-	O
S	O
).	O

In	O
contrast	O
to	O
human	O
influenza	O
A	O
H1NI	O
viruses	O
,	O
the	O
H5N1	O
viruses	O
hyper	O
-	O
induce	O
cytokines	O
(	O
tumour	O
necrosis	O
factor	O
[	O
TNF	O
]	O
alpha	O
,	O
interferon	O
beta	O
)	O
and	O
chemokines	O
(	O
IP10	O
,	O
MIP1alpha	O
,	O
MCP	O
)	O
in	O
in	O
vitro	O
cultures	O
of	O
primary	O
human	O
macrophages	B-ANAT
.	O

TITLE	O
:	O
The	O
3a	O
Protein	O
of	O
SARS	O
-	O
coronavirus	O
Induces	O
Apoptosis	O
in	O
Vero	O
E6	O
Cells	B-ANAT
.	O

TITLE	O
:	O
[	O
Expression	O
of	O
predicted	O
B	B-ANAT
cell	I-ANAT
epitope	O
peptide	O
in	O
S2	O
subunit	O
of	O
SARS	O
coronavirus	O
spike	O
protein	O
in	O
E	O
.	O
coli	O
and	O
identification	O
of	O
its	O
mimic	O
antigenicity	O
].	O

ABSTRACT	O
:	O
To	O
study	O
the	O
expression	O
of	O
predicted	O
B	B-ANAT
cell	I-ANAT
epitope	O
peptide	O
in	O
S2	O
subunit	O
of	O
SARS	O
coronavirus	O
spike	O
protein	O
in	O
E	O
.	O
coli	O
and	O
its	O
mimic	O
antigenicity	O
to	O
S2	O
protein	O
.	O

ABSTRACT	O
:	O
To	O
elucidate	O
the	O
potential	O
role	O
of	O
circulating	O
levels	O
of	O
transforming	O
growth	O
factor	O
-	O
beta1	O
(	O
TGF	O
-	O
beta1	O
),	O
soluble	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
(	O
sICAM	O
-	O
1	O
),	O
soluble	O
L	O
-	O
and	O
sE	O
-	O
Selectins	O
(	O
sL	O
-	O
and	O
sE	O
-	O
Selectins	O
)	O
in	O
children	O
with	O
sepsis	O
,	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Levels	O
of	O
TGF	O
-	O
beta1	O
,	O
sICAM	O
-	O
1	O
,	O
L	O
-	O
and	O
sE	O
-	O
Selectins	O
were	O
determined	O
using	O
solid	O
-	O
phase	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
in	O
plasma	B-ANAT
of	O
10	O
patients	O
with	O
sepsis	O
,	O
10	O
patients	O
with	O
TBI	O
,	O
10	O
patients	O
with	O
ARDS	O
,	O
compared	O
to	O
10	O
ventilated	O
controls	O
with	O
chronic	O
illness	O
but	O
not	O
in	O
acute	O
stress	O
,	O
on	O
days	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
and	O
10	O
.	O

TITLE	O
:	O
The	O
association	O
between	O
body	B-ANAT
mass	O
index	O
and	O
clinical	O
outcomes	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

Using	O
multivariate	O
analysis	O
,	O
patients	O
in	O
the	O
abnormal	O
BMI	O
groups	O
were	O
compared	O
to	O
normal	O
patients	O
in	O
the	O
following	O
areas	O
:	O
mortality	O
,	O
hospital	O
length	O
of	O
stay	O
(	O
LOS	O
),	O
ICU	O
LOS	O
,	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
and	O
discharge	B-ANAT
disposition	O
.	O

Antiviral	O
efficacy	O
in	O
vivo	O
was	O
determined	O
by	O
evaluating	O
virus	O
titres	O
in	O
CCoV	O
-	O
infected	O
dogs	O
treated	O
orally	B-ANAT
with	O
1	O
mg	O
/	O
kg	O
body	B-ANAT
weight	O
indomethacin	O
(	O
INDO	O
).	O

TITLE	O
:	O
The	O
SARS	O
-	O
Coronavirus	O
Membrane	B-ANAT
protein	O
induces	O
apoptosis	O
through	O
modulating	O
the	O
Akt	O
survival	O
pathway	O
.	O

Convalescence	O
-	O
phase	O
sera	B-ANAT
from	O
humans	O
were	O
similarly	O
ineffective	O
against	O
the	O
dominant	O
civet	O
pseudovirus	O
.	O

ABSTRACT	O
:	O
Blood	B-ANAT
samples	I-ANAT
were	O
analyzed	O
from	O
30	O
domestic	O
cats	O
(	O
Felis	O
domesticus	O
)	O
from	O
the	O
PetÃ©n	O
region	O
of	O
Guatemala	O
to	O
determine	O
the	O
seroprevalence	O
of	O
common	O
pathogens	O
that	O
may	O
pose	O
a	O
potential	O
risk	O
to	O
native	O
wild	O
felids	O
.	O

The	O
CRP	O
levels	O
were	O
independently	O
associated	O
with	O
platelet	B-ANAT
aggregation	O
and	O
aspirin	O
non	O
-	O
responsiveness	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
).	O

Eggs	O
with	O
watery	O
whites	O
which	O
were	O
laid	O
by	O
infected	O
hens	O
could	O
be	O
attributed	O
to	O
cytopathological	O
changes	O
in	O
the	O
granular	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
tubular	O
gland	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
magnum	O
resulting	O
in	O
reduced	O
synthesis	O
of	O
albumen	O
proteins	O
.	O

IBV	O
can	O
cause	O
pathology	O
in	O
parts	O
of	O
the	O
fully	O
functional	O
oviduct	B-ANAT
which	O
may	O
persist	O
up	O
to	O
the	O
30th	O
day	O
p	O
.	O
i	O
.	O

A	O
27	O
-	O
year	O
-	O
old	O
male	O
,	O
previously	O
treated	O
with	O
bleomycin	O
for	O
a	O
testicular	O
germ	B-ANAT
cell	I-ANAT
tumour	O
presented	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
on	O
the	O
second	O
postoperative	O
day	O
following	O
an	O
extensive	O
retroperitoneal	B-ANAT
dissection	O
.	O

ABSTRACT	O
:	O
Ranpirnase	O
[	O
Onconase	O
]	O
is	O
an	O
amphibian	O
oocyte	B-ANAT
/	O
early	O
embryo	B-ANAT
ribonuclease	O
(	O
RNase	O
)	O
of	O
105	O
amino	O
acids	O
in	O
length	O
that	O
is	O
capable	O
of	O
controlling	O
tumour	O
growth	O
by	O
degrading	O
RNA	O
within	O
cancer	B-ANAT
cells	I-ANAT
,	O
resulting	O
in	O
inhibition	O
of	O
protein	O
synthesis	O
and	O
arresting	O
mitosis	O
in	O
G	O
(	O
1	O
)	O
phase	O
.	O

Following	O
infusion	O
of	O
LPS	O
,	O
plasma	B-ANAT
nitrate	O
/	O
nitrite	O
,	O
methyl	O
guanidine	O
,	O
pro	O
-	O
inflammatory	O
cytokines	O
(	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
and	O
interleukin	O
-	O
1beta	O
)	O
were	O
markedly	O
elevated	O
.	O

Inhibition	O
of	O
iNOS	O
is	O
effective	O
in	O
mitigating	O
the	O
endotoxaemic	O
changes	O
and	O
lung	B-ANAT
pathology	O
.	O

Arch	B-ANAT
Virol	O
2002	O
,	O
147	O
:	O
2047	O
-	O
2056	O
.	O

RESULTS	O
:	O
Here	O
we	O
show	O
that	O
,	O
whereas	O
both	O
transient	O
transfection	O
and	O
constitutive	O
expression	O
of	O
fAPN	O
on	O
BHK	O
-	O
21	O
cells	B-ANAT
can	O
rescue	O
FIPV	O
and	O
TGEV	O
infection	O
in	O
non	O
-	O
permissive	O
BHK	O
cells	B-ANAT
,	O
fAPN	O
expression	O
does	O
not	O
rescue	O
infection	O
by	O
the	O
prototype	O
IBV	O
strain	O
Mass41	O
.	O

It	O
is	O
clear	O
that	O
other	O
regions	O
within	O
the	O
tail	O
must	O
also	O
be	O
involved	O
in	O
helping	O
mediate	O
interactions	O
between	O
the	O
M	O
protein	O
and	O
the	O
nucleocapsid	B-ANAT
.	O

Cells	B-ANAT
with	O
nuclear	O
Myt1	O
immunoreactivity	O
were	O
mainly	O
OP	O
cells	B-ANAT
,	O
identified	O
by	O
co	O
-	O
localization	O
with	O
platelet	B-ANAT
-	O
derived	O
growth	O
factor	O
alpha	O
receptor	O
,	O
with	O
additional	O
phenotypes	O
being	O
either	O
oligodendrocytes	B-ANAT
or	O
neural	B-ANAT
stem	I-ANAT
cells	I-ANAT
,	O
identified	O
by	O
CC1	O
antigen	O
and	O
Musashi1	O
,	O
respectively	O
.	O

These	O
results	O
suggesta	O
potential	O
role	O
for	O
Myt1	O
in	O
the	O
regeneration	O
of	O
oligodendrocyte	B-ANAT
lineage	O
cells	B-ANAT
in	O
response	O
to	O
demyelination	O
.	O

Here	O
,	O
we	O
demonstrated	O
that	O
efficient	O
expression	O
of	O
S	O
from	O
the	O
wild	O
-	O
type	O
spike	O
gene	O
in	O
cultured	B-ANAT
cells	I-ANAT
required	O
the	O
use	O
of	O
improved	O
plasmid	O
vectors	O
containing	O
donor	O
and	O
acceptor	O
splice	O
sites	O
,	O
as	O
well	O
as	O
heterologous	O
viral	O
RNA	O
export	O
elements	O
,	O
such	O
as	O
the	O
CTE	O
of	O
Mazon	O
-	O
Pfizer	O
monkey	O
virus	O
or	O
the	O
PRE	O
of	O
Woodchuck	O
hepatitis	O
virus	O
(	O
WPRE	O
).	O

Patient	O
purified	O
IgG	O
recognized	O
a	O
band	B-ANAT
of	O
approximately	O
110	O
kDa	O
on	O
protein	O
extracts	O
of	O
mouse	B-ANAT
cerebellum	I-ANAT
,	O
cortex	B-ANAT
and	O
brainstem	B-ANAT
and	O
immunolabelled	O
cultured	O
Chinese	O
hamster	O
ovary	B-ANAT
(	O
CHO	B-ANAT
)	O
cells	B-ANAT
,	O
transfected	O
with	O
human	O
GABA	O
(	O
B	O
)	O
R1	O
and	O
rat	O
GABA	O
(	O
B	O
)	O
R2	O
receptors	O
.	O

In	O
order	O
to	O
establish	O
whether	O
these	O
fluctuations	O
depend	O
on	O
the	O
FCoV	O
status	O
,	O
the	O
serum	B-ANAT
concentration	O
of	O
AGP	O
and	O
anti	O
-	O
FCoV	O
antibody	O
titres	O
and	O
/	O
or	O
faecal	B-ANAT
shedding	O
of	O
FCoVs	O
in	O
clinically	O
healthy	O
cats	O
from	O
catteries	O
with	O
different	O
levels	O
of	O
prevalence	O
of	O
FCoV	O
infection	O
were	O
monitored	O
over	O
time	O
.	O

Detailed	O
sequence	O
analysis	O
of	O
the	O
GiCoV	O
-	O
OH3	O
spike	O
gene	O
demonstrated	O
the	O
presence	O
of	O
a	O
deletion	O
in	O
the	O
variable	O
region	O
of	O
the	O
S1	O
subunit	O
(	O
from	O
amino	O
acid	O
543	O
to	O
amino	O
acid	O
547	O
),	O
which	O
is	O
a	O
region	O
associated	O
with	O
pathogenicity	O
and	O
tissue	B-ANAT
tropism	O
for	O
other	O
CoVs	O
.	O

The	O
SARS	O
-	O
CoV	O
pandemic	O
took	O
774	O
lives	O
around	O
the	O
globe	B-ANAT
and	O
infected	O
more	O
than	O
8000	O
people	O
in	O
29	O
countries	O
.	O

The	O
4	O
human	O
coronaviruses	O
HCoV	O
-	O
229E	O
,	O
HCoV	O
-	O
OC43	O
,	O
HCoV	O
-	O
NL63	O
and	O
HCoV	O
-	O
HKU1	O
cause	O
mild	O
respiratory	O
illnesses	O
when	O
compared	O
to	O
SARS	O
,	O
but	O
these	O
infections	O
are	O
involved	O
in	O
10	O
-	O
20	O
%	O
of	O
hospitalizations	O
of	O
young	O
children	O
and	O
immunocompromised	O
adults	O
with	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
.	O

A	O
consensus	O
secondary	O
structural	O
model	O
of	O
the	O
5	O
'	O
140	O
nucleotides	O
of	O
the	O
5	O
'	O
UTRs	O
of	O
nine	O
coronaviruses	O
(	O
CoVs	O
)	O
derived	O
from	O
all	O
three	O
major	O
CoV	O
groups	O
is	O
presented	O
and	O
characterized	O
by	O
three	O
major	O
stem	B-ANAT
-	O
loops	O
,	O
SL1	O
,	O
SL2	O
,	O
and	O
SL4	O
.	O

The	O
latter	O
phenomenon	O
will	O
result	O
in	O
creating	O
'	O
holes	O
'	O
in	O
the	O
protective	O
glycan	O
shield	O
of	O
the	O
HIV	O
envelope	B-ANAT
,	O
whereby	O
the	O
immune	B-ANAT
system	I-ANAT
may	O
become	O
triggered	O
to	O
produce	O
neutralizing	O
antibodies	O
against	O
previously	O
hidden	O
immunogenic	O
epitopes	O
of	O
gp120	O
.	O

In	O
emphysema	O
patients	O
,	O
there	O
is	O
a	O
loss	O
of	O
lung	B-ANAT
microvessels	O
,	O
and	O
in	O
many	O
forms	O
of	O
severe	O
PH	O
there	O
is	O
obliteration	O
of	O
precapillary	O
arterioles	B-ANAT
by	O
angioproliferation	O
.	O

RESULTS	O
:	O
The	O
mean	O
age	O
was	O
42	O
.	O
9	O
+/-	O
15	O
.	O
9	O
years	O
(	O
range	O
:	O
18	O
-	O
80	O
years	O
)	O
and	O
the	O
etiology	O
of	O
the	O
pancreatitis	O
was	O
gallstones	B-ANAT
in	O
29	O
patients	O
,	O
alcohol	O
in	O
22	O
patients	O
while	O
no	O
cause	O
could	O
be	O
ascertained	O
in	O
9	O
.	O

Confocal	O
microscopy	O
revealed	O
that	O
cyclin	O
D1	O
decreased	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
as	O
infection	O
progressed	O
and	O
inhibition	O
studies	O
indicated	O
that	O
a	O
population	O
of	O
cyclin	O
D1	O
could	O
be	O
targeted	O
for	O
degradation	O
by	O
a	O
virus	O
mediated	O
pathway	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
last	O
century	O
,	O
changes	O
in	O
land	B-ANAT
-	O
use	O
,	O
modification	O
of	O
agriculture	O
-	O
livestock	O
production	O
systems	O
,	O
disruption	O
of	O
wildlife	O
habitats	O
,	O
increase	O
of	O
human	O
activities	O
,	O
higher	O
frequency	O
of	O
international	O
and	O
intercontinental	O
travels	O
,	O
wider	O
circulation	O
of	O
animals	O
and	O
animal	O
products	O
have	O
contributed	O
to	O
alter	O
the	O
distribution	O
,	O
presence	O
and	O
density	O
of	O
hosts	O
and	O
vectors	O
.	O

ABSTRACT	O
:	O
The	O
known	O
etiology	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
immensely	O
varied	O
and	O
includes	O
severe	O
burns	O
and	O
trauma	O
.	O

The	O
literature	O
contains	O
no	O
reference	O
to	O
the	O
association	O
between	O
ALI	O
and	O
cutaneous	O
burns	O
or	O
blunt	O
chest	B-ANAT
trauma	O
secondary	O
to	O
defibrillation	O
.	O

Moreover	O
,	O
Bcl	O
-	O
2	O
has	O
a	O
role	O
in	O
halting	O
the	O
cell	B-ANAT
cycle	O
(	O
though	O
p27	O
),	O
which	O
may	O
slow	O
down	O
tumor	O
growth	O
;	O
and	O
Bcl	O
-	O
2	O
even	O
has	O
pro	O
-	O
apoptotic	O
roles	O
in	O
the	O
execution	O
of	O
apoptosis	O
initiated	O
by	O
external	O
death	O
signals	O
(	O
via	O
Fas	O
/	O
CD95	O
and	O
caspase	O
3	O
).	O

TITLE	O
:	O
Anti	O
-	O
viral	O
effector	O
T	B-ANAT
cell	I-ANAT
responses	O
and	O
trafficking	O
are	O
not	O
dependent	O
upon	O
DRAK2	O
signaling	O
following	O
viral	O
infection	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
.	O

In	O
order	O
to	O
further	O
characterize	O
the	O
molecular	O
mechanisms	O
governing	O
T	B-ANAT
cell	I-ANAT
activation	O
and	O
accumulation	O
within	O
the	O
CNS	B-ANAT
in	O
response	O
to	O
viral	O
infection	O
,	O
MHV	O
was	O
instilled	O
into	O
the	O
CNS	B-ANAT
of	O
Drak2	O
-	O
/	O
-	O
mice	O
.	O

Six	O
risk	O
factors	O
were	O
significant	O
in	O
the	O
final	O
multiple	O
-	O
logistic	O
regression	O
model	O
:	O
minimum	O
distance	O
between	O
beds	O
of	O
<	O
or	O
=	O
1	O
m	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
6	O
.	O
94	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
68	O
-	O
28	O
.	O
75	O
),	O
availability	O
of	O
washing	O
or	O
changing	O
facilities	O
for	O
staff	O
(	O
OR	O
,	O
0	O
.	O
12	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
02	O
-	O
0	O
.	O
97	O
),	O
whether	O
resuscitation	O
was	O
ever	O
performed	O
in	O
the	O
ward	O
(	O
OR	O
,	O
3	O
.	O
81	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
04	O
-	O
13	O
.	O
87	O
),	O
whether	O
staff	O
members	O
worked	O
while	O
experiencing	O
symptoms	O
(	O
OR	O
,	O
10	O
.	O
55	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
28	O
-	O
48	O
.	O
87	O
),	O
whether	O
any	O
host	O
patients	O
(	O
index	O
patient	O
or	O
the	O
first	O
patient	O
with	O
SARS	O
admitted	O
to	O
a	O
ward	O
)	O
required	O
oxygen	O
therapy	O
(	O
OR	O
,	O
4	O
.	O
30	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
00	O
-	O
18	O
.	O
43	O
),	O
and	O
whether	O
any	O
host	O
patients	O
required	O
bi	O
-	O
level	O
positive	O
airway	B-ANAT
pressure	O
ventilation	O
(	O
OR	O
,	O
11	O
.	O
82	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
97	O
-	O
70	O
.	O
80	O
).	O

A	O
total	O
of	O
six	O
phosphorylated	O
sites	O
(	O
S162	O
,	O
S170	O
,	O
T177	O
,	O
S389	O
,	O
S424	O
and	O
T428	O
)	O
were	O
identified	O
on	O
the	O
protein	O
from	O
infected	O
cells	B-ANAT
.	O

TITLE	O
:	O
Development	O
and	O
evaluation	O
of	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
based	O
on	O
recombinant	O
nucleocapsid	B-ANAT
protein	O
for	O
detection	O
of	O
porcine	O
epidemic	O
diarrhea	O
(	O
PEDV	O
)	O
antibodies	O
.	O

ABSTRACT	O
:	O
The	O
sequential	O
determination	O
of	O
crystal	B-ANAT
structures	O
of	O
the	O
SARS	O
coronavirus	O
spike	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
in	O
complex	O
with	O
its	O
cellular	B-ANAT
receptor	O
or	O
neutralizing	O
antibody	O
opened	O
a	O
door	O
for	O
the	O
design	O
and	O
development	O
of	O
antiviral	O
competitive	O
inhibitors	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
exogenous	O
surfactant	O
in	O
patients	O
with	O
lung	B-ANAT
contusions	O
and	O
acute	O
lung	B-ANAT
injury	O
.	O

To	O
determine	O
the	O
molecular	O
basis	O
of	O
this	O
activity	O
,	O
we	O
have	O
also	O
solved	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
NP248	O
-	O
365	O
region	O
.	O

Severe	O
pneumonitis	O
developed	O
twice	O
at	O
the	O
time	O
of	O
neutrophil	B-ANAT
recovery	O
and	O
acute	O
graft	B-ANAT
-	O
versus	O
-	O
host	O
disease	O
.	O

TITLE	O
:	O
The	O
hypothalamic	B-ANAT
pituitary	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
in	O
sepsis	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
TNF	O
-	O
alpha	O
production	O
was	O
increased	O
with	O
viral	O
replication	O
in	O
macrophages	B-ANAT
inoculated	O
with	O
a	O
mixture	O
of	O
FIPV	O
and	O
anti	O
-	O
S	O
antibody	O
,	O
and	O
demonstrated	O
that	O
this	O
culture	O
supernatant	O
had	O
feline	O
PBMC	O
apoptosis	O
-	O
inducing	O
activity	O
.	O

For	O
upregulation	O
of	O
TNF	O
-	O
alpha	O
and	O
fAPN	O
in	O
macrophages	B-ANAT
,	O
viral	O
replication	O
in	O
macrophages	B-ANAT
is	O
necessary	O
,	O
and	O
their	O
expressions	O
were	O
increased	O
by	O
ADE	O
of	O
FIPV	O
infection	O
.	O

It	O
was	O
demonstrated	O
that	O
a	O
heat	O
-	O
resistant	O
fAPN	O
-	O
inducing	O
factor	O
was	O
present	O
in	O
the	O
culture	O
supernatant	O
of	O
FIPV	O
-	O
infected	O
macrophages	B-ANAT
,	O
and	O
this	O
factor	O
was	O
TNF	O
-	O
alpha	O
:	O
fAPN	O
expression	O
was	O
upregulated	O
in	O
recombinant	O
feline	O
TNF	O
-	O
alpha	O
-	O
treated	O
macrophages	B-ANAT
,	O
and	O
FIPV	O
infectivity	O
was	O
increased	O
in	O
these	O
macrophages	B-ANAT
.	O

These	O
findings	O
suggested	O
that	O
FIPV	O
replication	O
in	O
macrophages	B-ANAT
increases	O
TNF	O
-	O
alpha	O
production	O
in	O
macrophages	B-ANAT
,	O
and	O
the	O
produced	O
TNF	O
-	O
alpha	O
acts	O
and	O
upregulates	O
fAPN	O
expression	O
,	O
increasing	O
FIPV	O
sensitivity	O
.	O

We	O
found	O
that	O
HCoV	O
-	O
NL63	O
replicase	O
products	O
can	O
be	O
detected	O
at	O
24	O
h	O
postinfection	O
and	O
that	O
these	O
proteins	O
accumulate	O
in	O
perinuclear	O
sites	O
,	O
consistent	O
with	O
membrane	B-ANAT
-	O
associated	O
replication	O
complexes	O
.	O

Positive	O
SARS	O
-	O
CoV	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
was	O
found	O
25	O
.	O
61	O
%	O
(	O
n	O
=	O
328	O
),	O
13	O
.	O
03	O
%	O
(	O
n	O
=	O
238	O
),	O
12	O
.	O
59	O
%	O
(	O
n	O
=	O
135	O
),	O
5	O
.	O
04	O
%	O
(	O
n	O
=	O
139	O
)	O
and	O
9	O
.	O
43	O
%	O
(	O
n	O
=	O
53	O
)	O
among	O
volunteers	O
,	O
which	O
were	O
sampled	O
in	O
May	O
2003	O
,	O
Dec	O
.	O
2003	O
,	O
Jan	O
.	O
2004	O
,	O
July	O
2004	O
and	O
June	O
2005	O
respectively	O
.	O

Unlike	O
SARS	O
,	O
direct	O
contact	O
with	O
patient	O
contracted	O
with	O
avian	O
influenza	O
at	O
the	O
end	O
of	O
incubation	O
period	O
and	O
in	O
the	O
stage	O
of	O
illness	O
through	O
flying	O
droplets	O
,	O
saliva	B-ANAT
,	O
mucous	B-ANAT
membrane	I-ANAT
and	O
skin	B-ANAT
injuries	O
will	O
not	O
lead	O
to	O
human	O
-	O
to	O
-	O
human	O
transmission	O
,	O
indicating	O
the	O
virus	O
'	O
ability	O
to	O
pass	O
from	O
human	O
to	O
human	O
is	O
limited	O
.	O

In	O
this	O
study	O
we	O
established	O
a	O
novel	O
animal	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
the	O
dysfunction	O
of	O
alveolar	B-ANAT
epithelial	O
type	O
II	O
(	O
AE2	O
)	O
cells	B-ANAT
and	O
examined	O
the	O
roles	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
in	O
the	O
acute	O
lung	B-ANAT
injury	O
.	O

When	O
DT	O
was	O
administrated	O
to	O
the	O
mice	O
they	O
suffered	O
from	O
acute	O
lung	B-ANAT
injury	O
and	O
died	O
within	O
4	O
days	O
.	O

It	O
suggests	O
that	O
SARS	O
-	O
CoV	O
interacts	O
with	O
innate	O
immune	O
mechanisms	O
in	O
the	O
lung	B-ANAT
through	O
its	O
S	O
-	O
protein	O
and	O
regulates	O
pulmonary	B-ANAT
inflammation	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
3a	O
is	O
a	O
structural	O
protein	O
,	O
mainly	O
localizing	O
to	O
Golgi	B-ANAT
apparatus	I-ANAT
and	O
co	O
-	O
localizing	O
with	O
SARS	O
-	O
CoV	O
M	O
in	O
co	O
-	O
transfected	O
cells	B-ANAT
.	O

Cell	B-ANAT
cycle	O
analysis	O
demonstrated	O
that	O
3a	O
expression	O
was	O
associated	O
with	O
blockage	O
of	O
cell	B-ANAT
cycle	O
progression	O
at	O
G1	O
phase	O
in	O
HEK	O
293	O
,	O
COS	O
-	O
7	O
,	O
and	O
Vero	B-ANAT
cells	I-ANAT
24	O
-	O
60	O
h	O
after	O
transfection	O
.	O

Topological	O
analysis	O
showed	O
that	O
3a	O
predominantly	O
located	O
in	O
Golgi	B-ANAT
apparatus	I-ANAT
,	O
with	O
its	O
N	O
-	O
terminus	O
residing	O
in	O
the	O
lumen	B-ANAT
(	O
Nlum	O
)	O
and	O
C	O
-	O
terminus	O
in	O
the	O
cytosol	B-ANAT
(	O
Ccyt	O
).	O

Increases	O
in	O
p53	O
phosphorylation	O
on	O
Ser	B-ANAT
-	O
15	O
were	O
observed	O
in	O
both	O
SARS	O
-	O
CoV	O
M	O
and	O
3a	O
transfected	O
cells	B-ANAT
,	O
suggesting	O
that	O
it	O
might	O
not	O
correlate	O
with	O
the	O
3a	O
-	O
induced	O
G0	O
/	O
G1	O
phase	O
arrest	O
.	O

The	O
reduction	O
of	O
cyclin	O
D3	O
level	O
and	O
phosphorylation	O
of	O
Rb	O
were	O
further	O
confirmed	O
in	O
SARS	O
-	O
CoV	O
infected	O
Vero	B-ANAT
cells	I-ANAT
.	O

These	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
3a	O
protein	O
,	O
through	O
limiting	O
the	O
expression	O
of	O
cyclin	O
D3	O
,	O
may	O
inhibit	O
Rb	O
phosphorylation	O
,	O
which	O
in	O
turn	O
leads	O
to	O
a	O
block	O
in	O
the	O
G1	O
phase	O
of	O
the	O
cell	B-ANAT
cycle	O
and	O
an	O
inhibition	O
of	O
cell	B-ANAT
proliferation	O
.	O

A	O
chronic	O
mild	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
has	O
been	O
found	O
to	O
persist	O
in	O
tropical	O
pulmonary	B-ANAT
eosinophilia	O
despite	O
treatment	O
.	O

Forty	O
-	O
five	O
patients	O
met	O
the	O
inclusion	O
criteria	O
for	O
the	O
study	O
cohort	O
(	O
severe	O
thoracic	B-ANAT
trauma	O
and	O
femoral	B-ANAT
fracture	O
stabilized	O
with	O
unreamed	O
intramedullary	O
nailing	O
[	O
IMN	O
]	O
within	O
the	O
first	O
24	O
hours	O
)	O
and	O
107	O
patients	O
were	O
selected	O
for	O
the	O
control	O
cohort	O
(	O
severe	O
thoracic	B-ANAT
trauma	O
without	O
any	O
lower	B-ANAT
extremity	I-ANAT
fracture	O
).	O

Early	O
unreamed	O
IMN	O
of	O
femoral	B-ANAT
fractures	O
in	O
multiply	O
injured	O
patients	O
with	O
severe	O
thoracic	B-ANAT
trauma	O
is	O
a	O
safe	O
procedure	O
and	O
seems	O
to	O
be	O
justified	O
to	O
achieve	O
early	O
definitive	O
care	O
.	O

S100A12	O
was	O
also	O
analyzed	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
from	O
eight	O
healthy	O
subjects	O
after	O
challenge	O
with	O
lipopolysaccharide	O
and	O
compared	O
with	O
eight	O
controls	O
who	O
received	O
placebo	O
inhalation	O
.	O

ABSTRACT	O
:	O
Lung	B-ANAT
protective	O
ventilation	O
can	O
reduce	O
mortality	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
discuss	O
the	O
management	O
of	O
a	O
patient	O
suffering	O
from	O
severe	O
ARDS	O
as	O
a	O
result	O
of	O
severe	O
bilateral	O
lung	B-ANAT
contusions	O
and	O
pulmonary	B-ANAT
aspiration	O
.	O

HFOV	O
(	O
8	O
-	O
10	O
Hz	O
)	O
was	O
started	O
using	O
a	O
recruitment	O
strategy	O
and	O
oxygenation	O
improved	O
within	O
2	O
h	O
.	O
After	O
5	O
days	O
,	O
the	O
patient	O
was	O
switched	O
back	B-ANAT
to	O
CV	O
uneventfully	O
and	O
av	O
-	O
ECLA	O
was	O
removed	O
after	O
8	O
days	O
.	O

HFOV	O
(	O
8	O
-	O
10	O
Hz	O
)	O
was	O
started	O
using	O
a	O
recruitment	O
strategy	O
and	O
oxygenation	O
improved	O
within	O
2	O
h	O
.	O
After	O
5	O
days	O
,	O
the	O
patient	O
was	O
switched	O
back	B-ANAT
to	O
CV	O
uneventfully	O
and	O
av	O
-	O
ECLA	O
was	O
removed	O
after	O
8	O
days	O
.	O

TITLE	O
:	O
Cell	B-ANAT
cycle	O
dependent	O
nucleolar	B-ANAT
localization	O
of	O
the	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
The	O
nucleolus	B-ANAT
is	O
a	O
dynamic	O
sub	O
-	O
nuclear	B-ANAT
structure	I-ANAT
which	O
is	O
involved	O
in	O
ribosome	B-ANAT
subunit	I-ANAT
biogenesis	O
,	O
modulation	O
of	O
cell	B-ANAT
growth	O
and	O
response	O
to	O
cell	B-ANAT
stress	O
.	O

Specimens	O
from	O
a	O
nasopharyngeal	B-ANAT
swab	I-ANAT
or	O
bronchial	B-ANAT
washing	O
were	O
analyzed	O
for	O
influenza	O
A	O
,	O
B	O
,	O
parainfluenza	O
,	O
adenovirus	O
,	O
respiratory	O
syncytial	O
virus	O
and	O
avian	O
flu	O
and	O
SARS	O
by	O
using	O
technique	O
of	O
PCR	O
and	O
immunofluorescence	O
by	O
the	O
Department	O
of	O
Medical	O
Sciences	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
7a	O
protein	O
,	O
which	O
is	O
not	O
expressed	O
by	O
other	O
known	O
coronaviruses	O
,	O
can	O
induce	O
apoptosis	O
in	O
various	O
cell	B-ANAT
lines	I-ANAT
.	O

Interestingly	O
,	O
amino	O
acids	O
224	O
and	O
225	O
within	O
the	O
C	O
-	O
terminal	O
transmembrane	B-ANAT
domain	O
of	O
Bcl	O
-	O
XL	O
are	O
essential	O
for	O
the	O
interaction	O
with	O
the	O
7a	O
protein	O
,	O
although	O
the	O
BH3	O
domain	O
of	O
Bcl	O
-	O
XL	O
also	O
contributes	O
to	O
this	O
interaction	O
.	O

These	O
results	O
indicated	O
that	O
recombinant	O
SL7207	O
(	O
pVAX1	O
-	O
S1	O
)	O
induced	O
both	O
systemic	O
and	O
local	O
mucosal	B-ANAT
immunity	O
.	O

During	O
HFO	O
-	O
TGI	O
,	O
shunt	O
fraction	O
and	O
mixed	O
venous	B-ANAT
oxygen	O
saturation	O
improved	O
relative	O
to	O
CMV	O
(	O
0	O
.	O
36	O
+/-	O
0	O
.	O
01	O
vs	O
.	O
0	O
.	O
45	O
+/-	O
0	O
.	O
01	O
and	O
77	O
.	O
8	O
%	O
+/-	O

Thirty	O
-	O
day	O
mortality	O
was	O
different	O
and	O
opposite	O
in	O
the	O
liberal	O
compared	O
with	O
the	O
restrictive	O
arm	B-ANAT
depending	O
on	O
presence	O
(	O
21	O
vs	O
.	O
26	O
%)	O
or	O
absence	O
(	O
25	O
vs	O
.	O
16	O
%)	O
of	O
ischemic	O
heart	B-ANAT
disease	O
(	O
p	O
=	O
.	O
03	O
).	O

At	O
baseline	O
in	O
ARMA	O
,	O
consistent	O
with	O
prior	O
publications	O
,	O
physicians	O
set	O
ventilator	O
volumes	O
lower	O
in	O
patients	O
with	O
high	O
airway	B-ANAT
pressures	O
and	O
poor	O
compliance	O
(	O
8	O
.	O
4	O
-	O
10	O
.	O
6	O
mL	O
/	O
kg	O
interquartile	O
range	O
)	O
than	O
patients	O
with	O
less	O
severe	O
abnormalities	O
(	O
9	O
.	O
6	O
-	O
12	O
mL	O
/	O
kg	O
)	O
(	O
p	O
=	O
.	O
0001	O
).	O

Upper	B-ANAT
gastrointestinal	I-ANAT
endoscopy	O
showed	O
a	O
foreign	O
body	B-ANAT
and	O
CT	O
examination	O
revealed	O
subcutaneous	O
emphysema	O
.	O

Emergency	O
T	O
-	O
tube	O
drainage	B-ANAT
was	O
therefore	O
scheduled	O
.	O

TNF	O
excessively	O
produced	O
by	O
monocytes	B-ANAT
or	O
macrophages	B-ANAT
activates	O
endothelial	B-ANAT
cells	I-ANAT
and	O
neutrophils	B-ANAT
,	O
thereby	O
inducing	O
endothelial	B-ANAT
cell	I-ANAT
injury	O
.	O

Sensory	B-ANAT
neurons	I-ANAT
play	O
an	O
important	O
role	O
in	O
promotion	O
of	O
the	O
endothelial	B-ANAT
production	O
of	O
prostaglandins	O
by	O
releasing	O
calcitonin	O
gene	O
-	O
related	O
peptide	O
.	O

ABSTRACT	O
:	O
The	O
genitourinary	B-ANAT
tract	I-ANAT
is	O
the	O
most	O
common	O
site	O
for	O
extrapulmonary	O
tuberculosis	O
(	O
TB	O
).	O

TITLE	O
:	O
Long	O
-	O
term	O
human	O
coronavirus	O
-	O
myelin	B-ANAT
cross	O
-	O
reactive	O
T	O
-	O
cell	B-ANAT
clones	I-ANAT
derived	O
from	O
multiple	O
sclerosis	O
patients	O
.	O

The	O
ELSO	O
registry	O
currently	O
includes	O
31	O
,	O
340	O
ECMO	O
cases	O
,	O
of	O
which	O
151	O
were	O
post	O
-	O
LTx	O
patients	O
with	O
primary	O
graft	B-ANAT
dysfunction	O
(	O
PGD	O
).	O

TITLE	O
:	O
SARS	O
-	O
CoV	O
replication	O
and	O
pathogenesis	O
in	O
an	O
in	O
vitro	O
model	O
of	O
the	O
human	O
conducting	O
airway	B-ANAT
epithelium	B-ANAT
.	O

The	O
first	O
culture	O
model	O
is	O
a	O
human	O
bronchial	B-ANAT
epithelial	I-ANAT
cell	I-ANAT
line	O
Calu	O
-	O
3	O
that	O
can	O
be	O
inoculated	O
by	O
viruses	O
either	O
as	O
a	O
non	O
-	O
polarized	O
monolayer	O
of	O
cells	B-ANAT
or	O
polarized	O
cells	B-ANAT
with	O
tight	B-ANAT
junctions	I-ANAT
and	O
microvilli	B-ANAT
.	O

Cytochrome	O
C	O
,	O
cleaved	B-ANAT
caspase	O
(	O
cysteine	O
aspartic	O
acid	O
protease	O
)-	O
3	O
,	O
9	O
,	O
and	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
(	O
PARP	O
)	O
were	O
detected	O
by	O
Western	O
blot	O
.	O

After	O
removal	O
of	O
serum	B-ANAT
in	O
COS	B-ANAT
-	I-ANAT
1	I-ANAT
cells	I-ANAT
,	O
we	O
observed	O
the	O
loss	O
of	O
DeltaPsim	O
,	O
the	O
increase	O
of	O
ROS	O
and	O
cytochrome	O
C	O
release	O
into	O
cytosol	B-ANAT
and	O
subsequent	O
activation	O
of	O
caspase	O
-	O
3	O
and	O
PARP	O
cleavage	O
.	O

Aspiration	O
resulted	O
from	O
the	O
patient	O
'	O
s	O
father	O
inducing	O
emesis	B-ANAT
by	O
digital	B-ANAT
stimulation	O
of	O
the	O
boy	O
'	O
s	O
throat	B-ANAT
after	O
the	O
patient	O
had	O
ingested	O
an	O
unknown	O
amount	O
of	O
lamp	O
oil	O
.	O

His	O
course	O
was	O
further	O
complicated	O
by	O
anuric	O
renal	B-ANAT
failure	O
,	O
rhabdomyolysis	O
,	O
severe	O
hepatitis	O
,	O
pancytopenia	O
,	O
elevation	O
of	O
cardiac	B-ANAT
enzymes	O
,	O
and	O
disseminated	O
intravascular	O
coagulation	O
over	O
the	O
following	O
days	O
.	O

Ordinary	O
logistic	O
regression	O
analysis	O
was	O
performed	O
to	O
derive	O
an	O
estimate	O
of	O
the	O
continuous	O
likelihood	O
ratio	O
to	O
produce	O
the	O
posttest	O
probability	O
of	O
disease	O
for	O
any	O
combination	O
of	O
pretest	O
probability	O
and	O
serum	B-ANAT
AGP	O
value	O
.	O

The	O
Bayesian	O
approach	O
demonstrated	O
that	O
when	O
the	O
pretest	O
probability	O
of	O
FIP	O
is	O
high	O
,	O
based	O
on	O
history	O
and	O
clinical	O
signs	O
(	O
groups	O
1	O
or	O
2a	O
),	O
moderate	O
serum	B-ANAT
AGP	O
levels	O
(	O
1	O
.	O
5	O
-	O
2	O
mg	O
/	O
ml	O
)	O
can	O
discriminate	O
cats	O
with	O
FIP	O
from	O
others	O
,	O
while	O
only	O
high	O
serum	B-ANAT
AGP	O
levels	O
(>	O
3	O
mg	O
/	O
ml	O
)	O
can	O
support	O
a	O
diagnosis	O
of	O
FIP	O
in	O
cats	O
with	O
a	O
low	O
pretest	O
probability	O
of	O
disease	O
(	O
groups	O
2b	O
to	O
2e	O
).	O

While	O
MHV	O
strain	O
A59	O
appeared	O
to	O
induce	O
IFN	O
-	O
beta	O
gene	O
transcription	O
and	O
low	O
levels	O
of	O
nuclear	O
translocation	O
of	O
the	O
IFN	O
-	O
beta	O
transcription	O
factor	O
interferon	O
regulatory	O
factor	O
3	O
(	O
IRF	O
-	O
3	O
),	O
MHV	O
did	O
not	O
induce	O
IFN	O
-	O
beta	O
protein	O
production	O
during	O
the	O
course	O
of	O
infection	O
in	O
L2	O
mouse	B-ANAT
fibroblast	I-ANAT
cells	B-ANAT
.	O

Our	O
results	O
indicate	O
that	O
HS	O
plays	O
a	O
role	O
as	O
an	O
attachment	O
factor	O
for	O
IBV	O
,	O
working	O
in	O
concert	O
with	O
other	O
factors	O
like	O
sialic	O
acid	O
to	O
mediate	O
virus	O
binding	O
to	O
cells	B-ANAT
,	O
and	O
may	O
explain	O
in	O
part	O
the	O
extended	O
tropism	O
of	O
IBV	O
Beaudette	O
.	O

The	O
media	B-ANAT
have	O
the	O
power	O
to	O
sway	O
public	O
perception	O
of	O
health	O
issues	O
by	O
choosing	O
what	O
to	O
publish	O
and	O
the	O
context	O
in	O
which	O
to	O
present	O
information	O
.	O

One	O
hundred	O
news	O
media	B-ANAT
reports	O
(	O
print	O
,	O
radio	O
,	O
television	O
,	O
and	O
Internet	O
)	O
were	O
analyzed	O
in	O
terms	O
of	O
message	O
repetition	O
,	O
context	O
,	O
source	O
,	O
and	O
grammar	O
.	O

The	O
genetic	O
diversity	O
was	O
determined	O
by	O
direct	O
sequencing	O
of	O
the	O
partial	O
RdRp	O
region	O
of	O
12	O
BNoVs	O
detected	O
from	O
the	O
fecal	B-ANAT
samples	O
by	O
nested	O
PCR	O
.	O

Serum	B-ANAT
samples	O
obtained	O
from	O
73	O
red	O
pandas	O
in	O
10	O
captive	O
facilities	O
in	O
southwest	O
,	O
east	O
,	O
and	O
northeast	O
China	O
from	O
October	O
to	O
December	O
2004	O
were	O
tested	O
for	O
antibodies	O
against	O
nine	O
common	O
infectious	O
pathogens	O
of	O
carnivores	O
.	O

Two	O
conflicting	O
cellular	B-ANAT
programs	O
,	O
apoptosis	O
to	O
eliminate	O
virus	O
-	O
infected	O
cells	B-ANAT
and	O
survival	O
to	O
delay	O
apoptosis	O
by	O
producing	O
antiviral	O
cytokines	O
,	O
occur	O
in	O
SARS	O
patients	O
.	O

This	O
review	O
highlights	O
recent	O
progress	O
regarding	O
SARS	O
-	O
CoV	O
biology	O
,	O
especially	O
signal	O
transduction	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
.	O

Renal	B-ANAT
biopsy	O
revealed	O
linear	O
IgG	O
deposits	O
along	O
the	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
(	O
GBM	B-ANAT
)	O
and	O
cellular	B-ANAT
crescents	O
in	O
13	O
/	O
16	O
glomeruli	O
,	O
simultaneously	O
increased	O
anti	O
-	O
GBM	B-ANAT
antibodies	O
were	O
detected	O
.	O

Thus	O
,	O
anti	O
-	O
GBM	B-ANAT
glomerulonephritis	O
was	O
diagnosed	O
.	O

Anti	O
-	O
GBM	B-ANAT
antibodies	O
were	O
negative	O
.	O

He	O
was	O
under	O
intermittent	O
hemodialysis	O
until	O
laboratory	O
measurements	O
showed	O
improved	O
renal	B-ANAT
function	O
.	O

Serum	B-ANAT
samples	O
from	O
100	O
healthy	O
blood	B-ANAT
donors	O
(	O
set	O
3	O
),	O
collected	O
in	O
2002	O
,	O
were	O
also	O
included	O
.	O

TITLE	O
:	O
The	O
detection	O
of	O
feline	O
coronaviruses	O
in	O
blood	B-ANAT
samples	I-ANAT
from	O
cats	O
by	O
mRNA	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
26	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
25	O
healthy	O
cats	O
and	O
one	O
cat	O
with	O
clinical	O
signs	O
suggestive	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
),	O
namely	O
,	O
fever	O
,	O
weight	O
loss	O
,	O
enlarged	O
abdomen	B-ANAT
,	O
and	O
ascites	O
.	O

Literature	O
was	O
searched	O
through	O
PubMed	O
,	O
Cochrane	O
Library	O
,	O
Wan	O
Fang	B-ANAT
database	O
and	O
Google	O
.	O

Type	O
I	O
viruses	O
,	O
which	O
are	O
prevalent	O
in	O
the	O
field	O
but	O
are	O
difficult	O
to	O
isolate	O
and	O
propagate	O
in	O
cell	B-ANAT
culture	O
,	O
and	O
type	O
II	O
viruses	O
,	O
which	O
are	O
less	O
prevalent	O
but	O
replicate	O
well	O
in	O
cell	B-ANAT
culture	O
.	O

This	O
RNA	O
binding	O
motif	O
of	O
3a	O
does	O
not	O
share	O
homology	O
with	O
any	O
other	O
known	O
RNA	O
binding	O
protein	O
and	O
may	O
have	O
an	O
important	O
role	O
in	O
viral	B-ANAT
capsid	I-ANAT
assembly	O
and	O
pathogenesis	O
.	O

Another	O
patient	O
developed	O
ARDS	O
after	O
attempted	O
suicide	O
with	O
multiple	O
fractures	O
together	O
with	O
blunt	O
abdominal	B-ANAT
and	O
thoracic	B-ANAT
trauma	O
.	O

There	O
are	O
no	O
skin	B-ANAT
lesions	O
and	O
it	O
improves	O
promptly	O
with	O
antibiotics	O
.	O

This	O
downregulation	O
,	O
which	O
is	O
reminiscent	O
of	O
a	O
cellular	B-ANAT
stress	O
response	O
,	O
was	O
dependent	O
on	O
viral	O
replication	O
and	O
caused	O
by	O
mRNA	O
decay	O
.	O

Results	O
showed	O
that	O
the	O
viral	B-ANAT
nucleocapsid	I-ANAT
(	O
N	O
)	O
protein	O
activated	O
IL	O
-	O
6	O
expression	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O

We	O
also	O
showed	O
that	O
N	O
protein	O
activated	O
IL	O
-	O
6	O
expression	O
through	O
NF	O
-	O
kappaB	O
by	O
facilitating	O
the	O
translocation	O
of	O
NF	O
-	O
kappaB	O
from	O
cytosol	B-ANAT
to	O
nucleus	B-ANAT
.	O

The	O
results	O
showed	O
that	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immunities	O
could	O
be	O
induced	O
in	O
mice	O
by	O
inoculating	O
them	O
with	O
SARS	O
-	O
CoV	O
spike	O
DNA	O
vaccine	O
alone	O
or	O
by	O
coinoculation	O
with	O
IL	O
-	O
2	O
-	O
expressing	O
plasmids	O
.	O

Early	O
administration	O
of	O
rFVIIa	O
decreased	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
use	O
by	O
20	O
%	O
in	O
trauma	O
patients	O
requiring	O
massive	O
transfusion	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	O
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
was	O
attenuated	O
by	O
serial	O
passage	O
in	O
chicken	O
embryos	B-ANAT
.	O

A	O
coronavirus	O
was	O
detected	O
by	O
electron	O
microscopy	O
and	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
in	O
the	O
faeces	B-ANAT
and	O
in	O
the	O
intestinal	B-ANAT
content	I-ANAT
of	O
the	O
dead	O
quails	O
.	O

ABSTRACT	O
:	O
Acute	O
tonsillitis	O
or	O
pharyngitis	O
may	O
lead	O
to	O
suppurative	O
thrombophlebitis	O
of	O
the	O
internal	B-ANAT
jugular	I-ANAT
vein	I-ANAT
.	O

The	O
unusual	O
clinical	O
manifestation	O
of	O
this	O
case	O
involves	O
severe	O
acute	O
renal	B-ANAT
and	O
respiratory	O
deficiency	O
in	O
addition	O
to	O
microangiopathic	O
consumption	O
coagulopathy	O
in	O
a	O
young	O
patient	O
treated	O
with	O
macrolides	O
five	O
days	O
after	O
the	O
onset	O
of	O
acute	O
tonsillitis	O
.	O

Expression	O
of	O
viral	O
proteins	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
and	O
the	O
formation	O
of	O
VLPs	B-ANAT
was	O
studied	O
by	O
transmission	O
electron	O
microscopy	O
.	O

TITLE	O
:	O
Expression	O
,	O
glycosylation	O
,	O
and	O
modification	O
of	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
SARS	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
coronaviruses	O
is	O
known	O
to	O
be	O
essential	O
in	O
the	O
binding	O
of	O
the	O
virus	O
to	O
the	O
host	B-ANAT
cell	I-ANAT
at	O
the	O
advent	O
of	O
the	O
infection	O
process	O
.	O

TITLE	O
:	O
Red	B-ANAT
blood	I-ANAT
cell	I-ANAT
deformability	O
in	O
patients	O
with	O
sepsis	O
:	O
a	O
marker	O
for	O
prognosis	O
and	O
monitoring	O
of	O
severity	O
.	O

For	O
this	O
purpose	O
a	O
filtration	O
method	O
and	O
the	O
hemorheometer	O
,	O
was	O
used	O
to	O
determine	O
experimentally	O
the	O
RBC	B-ANAT
'	O
s	O
deformability	O
,	O
by	O
measuring	O
the	O
RBC	B-ANAT
'	O
s	O
Index	O
of	O
Rigidity	O
(	O
IR	O
).	O

Using	O
synthetic	O
biology	O
and	O
reverse	O
genetics	O
,	O
we	O
describe	O
the	O
construction	O
of	O
a	O
panel	O
of	O
isogenic	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
strains	O
bearing	O
variant	O
spike	O
glycoproteins	O
that	O
are	O
representative	O
of	O
zoonotic	O
strains	O
found	O
in	O
palm	B-ANAT
civets	O
and	O
raccoon	O
dogs	O
,	O
as	O
well	O
as	O
isolates	O
spanning	O
the	O
early	O
,	O
middle	O
,	O
and	O
late	O
phases	O
of	O
the	O
SARS	O
-	O
CoV	O
epidemic	O
.	O

The	O
human	O
but	O
not	O
the	O
zoonotic	O
variants	O
replicated	O
efficiently	O
in	O
human	O
airway	B-ANAT
epithelial	O
cultures	O
,	O
supporting	O
earlier	O
hypotheses	O
that	O
zoonotic	O
isolates	O
are	O
less	O
pathogenic	O
in	O
humans	O
but	O
can	O
evolve	O
into	O
highly	O
pathogenic	O
strains	O
.	O

Evidence	O
suggests	O
that	O
infants	O
with	O
meconium	B-ANAT
aspiration	O
syndrome	O
and	O
children	O
with	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
may	O
benefit	O
,	O
while	O
no	O
positive	O
effect	O
of	O
surfactant	O
is	O
seen	O
in	O
infants	O
with	O
congenital	O
diaphragmatic	B-ANAT
hernia	O
.	O

It	O
is	O
important	O
to	O
consider	O
these	O
disorders	O
in	O
the	O
differential	O
diagnosis	O
of	O
unexplained	O
respiratory	O
distress	O
although	O
no	O
established	O
treatment	O
is	O
yet	O
available	O
besides	O
lung	B-ANAT
transplantation	O
for	O
the	O
most	O
severe	O
cases	O
.	O

Research	O
around	O
surfactant	O
is	O
evolving	O
and	O
recent	O
developments	O
include	O
further	O
evolution	O
of	O
synthetic	O
surfactants	O
,	O
evaluation	O
of	O
surfactant	O
as	O
a	O
therapeutic	O
option	O
in	O
lung	B-ANAT
diseases	O
other	O
than	O
RDS	O
and	O
the	O
discovery	O
of	O
genetic	O
disorders	O
of	O
surfactant	O
metabolism	O
.	O

CONCLUSIONS	O
:	O
Research	O
around	O
surfactant	O
is	O
evolving	O
and	O
recent	O
developments	O
include	O
further	O
evolution	O
of	O
synthetic	O
surfactants	O
,	O
evaluation	O
of	O
surfactant	O
as	O
a	O
therapeutic	O
option	O
in	O
lung	B-ANAT
diseases	O
other	O
than	O
RDS	O
and	O
the	O
discovery	O
of	O
genetic	O
disorders	O
of	O
surfactant	O
metabolism	O
.	O

TITLE	O
:	O
Human	O
immunodeficiency	O
viral	O
vector	O
pseudotyped	O
with	O
the	O
spike	O
envelope	B-ANAT
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
transduces	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
dendritic	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
makes	O
up	O
a	O
spectrum	O
of	O
disease	O
that	O
is	O
commonly	O
defined	O
as	O
""""	O
acute	O
non	O
-	O
cardiogenic	O
edematous	O
lung	B-ANAT
injury	O
"""."	O

Lung	B-ANAT
tissue	I-ANAT
was	O
fixed	B-ANAT
in	O
formaldehyde	O
and	O
stained	O
with	O
HE	O
,	O
and	O
examined	O
under	O
a	O
light	O
microscope	O
.	O

The	O
OA	O
-	O
induced	O
elevation	O
of	O
arterial	B-ANAT
blood	I-ANAT
oxygen	O
pressure	O
was	O
inhibited	O
,	O
as	O
well	O
as	O
PAF	O
,	O
ICAM	O
-	O
1	O
,	O
IL	O
-	O
8	O
in	O
BALF	O
in	O
rupatadine	O
group	O
.	O

In	O
the	O
case	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
,	O
viral	O
entry	O
is	O
reported	O
to	O
require	O
a	O
low	O
pH	O
in	O
intracytoplasmic	O
vesicles	B-ANAT
;	O
however	O
,	O
little	O
is	O
known	O
about	O
how	O
SARS	O
-	O
CoV	O
invades	O
such	O
compartments	B-ANAT
.	O

These	O
results	O
suggest	O
that	O
when	O
SARS	O
-	O
CoV	O
binds	O
ACE2	O
it	O
is	O
internalized	O
and	O
penetrates	O
early	O
endosomes	O
in	O
a	O
clathrin	O
-	O
dependent	O
manner	O
and	O
that	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
ACE2	O
is	O
not	O
required	O
for	O
the	O
penetration	O
of	O
SARS	O
-	O
CoV	O
.	O

Differential	O
inhibition	O
of	O
intracellular	B-ANAT
signaling	O
steps	O
suggested	O
significant	O
contribution	O
of	O
phosphatidylcholine	O
-	O
specific	O
phospholipase	O
C	O
and	O
protein	O
kinase	O
C	O
and	O
of	O
the	O
Rho	O
/	O
Rho	O
-	O
kinase	O
pathway	O
to	O
PLY	O
-	O
induced	O
pulmonary	B-ANAT
vasoconstriction	O
.	O

Using	O
a	O
combination	O
of	O
live	O
-	O
cell	B-ANAT
and	O
confocal	O
microscopy	O
coupled	O
to	O
mutagenesis	O
we	O
identified	O
a	O
cryptic	O
nucleolar	B-ANAT
localisation	O
signal	O
in	O
the	O
central	O
part	O
of	O
the	O
N	O
protein	O
.	O

Here	O
we	O
review	O
recent	O
progress	O
in	O
characterization	O
of	O
the	O
biochemical	O
properties	O
,	O
membrane	B-ANAT
topology	O
and	O
functions	O
of	O
the	O
protein	O
.	O

To	O
understand	O
how	O
cells	B-ANAT
response	O
in	O
the	O
early	O
stage	O
of	O
virus	O
-	O
host	B-ANAT
cell	I-ANAT
interaction	O
,	O
in	O
this	O
study	O
,	O
a	O
purified	O
recombinant	O
S	O
protein	O
was	O
studied	O
for	O
stimulating	O
murine	O
macrophages	B-ANAT
(	O
RAW264	O
.	O
7	O
)	O
to	O
produce	O
proinflammatory	O
cytokines	O
(	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
)	O
and	O
chemokine	O
IL	O
-	O
8	O
.	O

ABSTRACT	O
:	O
Acute	O
pancreatitis	O
begins	O
with	O
pancreatic	B-ANAT
injury	O
,	O
elicits	O
an	O
acute	O
inflammatory	O
response	O
,	O
and	O
encompasses	O
a	O
variety	O
of	O
potential	O
complications	O
in	O
a	O
subset	O
of	O
patients	O
.	O

This	O
article	O
reviews	O
recent	O
advancements	O
in	O
understanding	O
the	O
pathogenesis	O
,	O
immunology	O
,	O
and	O
genetics	O
of	O
severe	O
acute	O
pancreatitis	O
,	O
and	O
the	O
literature	O
on	O
laboratory	O
-	O
based	O
markers	O
,	O
which	O
predict	O
a	O
severe	O
clinical	O
course	O
and	O
pancreatic	B-ANAT
necrosis	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
known	O
to	O
recognize	O
and	O
bind	O
to	O
host	O
receptors	O
,	O
whose	O
conformational	O
changes	O
then	O
facilitate	O
fusion	O
between	O
the	O
viral	B-ANAT
envelope	I-ANAT
and	O
host	B-ANAT
cell	I-ANAT
membrane	I-ANAT
,	O
leading	O
to	O
viral	O
entry	O
into	O
target	B-ANAT
cells	I-ANAT
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
required	O
dose	O
and	O
anticoagulatory	O
effect	O
of	O
argatroban	O
(	O
Mitsubishi	O
,	O
Pharma	O
Deutschland	O
GmbH	O
,	O
DÃ¼sseldorf	O
,	O
Germany	O
),	O
a	O
direct	O
thrombin	O
inhibitor	O
approved	O
for	O
anticoagulation	O
in	O
patients	O
with	O
heparin	O
-	O
induced	O
thrombocytopenia	O
(	O
HIT	O
)	O
undergoing	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

In	O
addition	O
,	O
emerging	O
evidence	O
suggests	O
that	O
the	O
use	O
of	O
anticoagulants	O
,	O
such	O
as	O
tissue	B-ANAT
factor	O
pathway	O
inhibitor	O
,	O
antithrombin	O
,	O
thrombomodulin	O
,	O
heparin	O
,	O
activated	O
protein	O
C	O
,	O
and	O
fibrinolytics	O
(	O
plasminogen	O
activators	O
and	O
particularly	O
tissue	B-ANAT
plasminogen	O
activator	O
),	O
may	O
be	O
useful	O
in	O
the	O
treatment	O
of	O
ALI	O
and	O
ARDS	O
.	O

13	O
patients	O
were	O
considered	O
immunocompetent	O
and	O
10	O
were	O
immunocompromised	O
when	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
was	O
started	O
.	O

Pulmonary	B-ANAT
-	O
renal	B-ANAT
syndromes	O
are	O
not	O
a	O
single	O
entity	O
,	O
but	O
are	O
caused	O
by	O
a	O
wide	O
variety	O
of	O
diseases	O
,	O
including	O
various	O
forms	O
of	O
primary	O
systemic	O
vasculitis	O
(	O
especially	O
Wegener	O
'	O
s	O
granulomatosis	O
and	O
microscopic	O
polyangiitis	O
),	O
Goodpasture	O
'	O
s	O
syndrome	O
(	O
associated	O
with	O
autoantibodies	O
to	O
the	O
alveolar	B-ANAT
and	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
)	O
and	O
systemic	O
lupus	O
erythematosus	O
.	O

In	O
the	O
clinical	O
setting	O
of	O
an	O
acute	O
nephritis	O
syndrome	O
,	O
percutaneous	O
renal	B-ANAT
biopsy	O
is	O
commonly	O
performed	O
for	O
histopathology	O
and	O
immunofluorescence	O
studies	O
.	O

Although	O
much	O
of	O
the	O
cytokine	O
signaling	O
responsible	O
for	O
the	O
initial	O
phase	O
of	O
ALI	O
has	O
been	O
elaborated	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
governing	O
the	O
recruitment	O
of	O
neutrophils	B-ANAT
from	O
the	O
bone	B-ANAT
marrow	I-ANAT
to	O
the	O
lung	B-ANAT
in	O
the	O
later	O
period	O
of	O
this	O
disease	O
.	O

We	O
further	O
determined	O
that	O
both	O
lung	B-ANAT
SDF	O
-	O
1	O
protein	O
expression	O
and	O
mRNA	O
expression	O
rise	O
in	O
a	O
delayed	O
but	O
sustained	O
pattern	O
in	O
this	O
mouse	O
model	O
and	O
that	O
the	O
major	O
source	O
of	O
the	O
increase	O
in	O
expression	O
appears	O
to	O
be	O
the	O
lung	B-ANAT
epithelium	B-ANAT
.	O

Lastly	O
,	O
we	O
found	O
that	O
expression	O
of	O
the	O
SDF	O
-	O
1	O
receptor	O
CXCR4	O
rises	O
in	O
a	O
similar	O
temporal	O
pattern	O
on	O
neutrophils	B-ANAT
in	O
both	O
the	O
blood	B-ANAT
and	O
airspace	O
of	O
LPS	O
-	O
injured	O
mice	O
and	O
that	O
Ab	O
-	O
mediated	O
SDF	O
-	O
1	O
blockade	O
significantly	O
attenuates	O
late	O
but	O
not	O
early	O
pulmonary	B-ANAT
neutrophilia	O
in	O
this	O
model	O
.	O

External	O
genital	B-ANAT
samples	O
(	O
glans	O
/	O
corona	O
,	O
shaft	O
,	O
and	O
scrotum	B-ANAT
)	O
were	O
more	O
likely	O
than	O
anal	B-ANAT
samples	O
to	O
contain	O
oncogenic	O
HPV	O
(	O
25	O
.	O
1	O
%	O
versus	O
5	O
.	O
0	O
%).	O

HPV	O
-	O
positive	O
penile	B-ANAT
shaft	O
and	O
glans	O
/	O
corona	O
samples	O
were	O
also	O
more	O
likely	O
to	O
be	O
infected	O
with	O
multiple	O
HPV	O
types	O
than	O
other	O
sites	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
OC43	O
pneumonia	O
in	O
a	O
pediatric	O
cancer	O
patient	O
with	O
down	O
syndrome	O
and	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
.	O

Cross	O
-	O
sectional	O
study	O
with	O
301	O
patients	O
aged	O
up	O
to	O
16	O
years	O
admitted	O
to	O
an	O
intensive	O
care	O
unit	O
due	O
to	O
moderate	O
to	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
,	O
carried	O
out	O
over	O
a	O
5	O
-	O
year	O
period	O
.	O

The	O
authors	O
report	O
a	O
second	O
case	O
of	O
HbS	O
/	O
QuÃ©bec	O
-	O
CHORI	O
,	O
a	O
severe	O
compound	O
heterozygous	O
sickling	B-ANAT
disorder	O
and	O
their	O
experience	O
managing	O
this	O
patient	O
with	O
hydroxyurea	O
.	O

TITLE	O
:	O
The	O
use	O
of	O
hepatitis	O
C	O
virus	O
NS3	O
/	O
4A	O
and	O
secreted	O
alkaline	O
phosphatase	O
to	O
quantitate	O
cell	B-ANAT
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
mediated	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
S	O
protein	O
and	O
the	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
.	O

On	O
admission	O
,	O
severe	O
hypoxemia	O
and	O
diffuse	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
images	O
suggested	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Fever	O
and	O
radiological	O
patterns	O
including	O
diffuse	O
patchy	O
ground	O
-	O
glass	O
opacities	O
,	O
basal	O
irregular	O
lines	O
and	O
consolidation	O
on	O
high	O
-	O
resolution	O
CT	O
scan	O
were	O
more	O
frequent	O
in	O
group	O
A	O
than	O
in	O
group	O
G	O
.	O
More	O
patients	O
in	O
group	O
G	O
had	O
neutrophils	B-ANAT
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
and	O
autoantibodies	O
other	O
than	O
anti	O
-	O
Jo	O
-	O
1	O
(	O
rheumatoid	O
factor	O
,	O
anti	O
SSa	O
/	O
SSb	B-ANAT
)	O
than	O
in	O
group	O
A	O
.	O
The	O
percentage	O
of	O
patients	O
in	O
whom	O
the	O
ILD	O
improved	O
at	O
3	O
months	O
was	O
significantly	O
higher	O
in	O
group	O
A	O
than	O
in	O
group	O
G	O
(	O
13	O
/	O
15	O
vs	O
9	O
/	O
17	O
;	O
p	O
=	O
0	O
.	O
006	O
).	O

At	O
6	O
and	O
18	O
h	O
after	O
intratracheal	O
instillation	O
,	O
we	O
performed	O
histological	O
examination	O
and	O
bronchoalveolar	O
lavage	O
and	O
assessed	O
the	O
lung	B-ANAT
wet	O
/	O
dry	O
weight	O
ratio	O
as	O
an	O
index	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Moreover	O
,	O
recent	O
studies	O
have	O
demonstrated	O
that	O
ACE2	O
protects	O
murine	O
lungs	B-ANAT
from	O
acute	O
lung	B-ANAT
injury	O
as	O
well	O
as	O
SARS	O
-	O
Spike	O
protein	O
-	O
mediated	O
lung	B-ANAT
injury	O
,	O
suggesting	O
a	O
dual	O
role	O
of	O
ACE2	O
in	O
SARS	O
infections	O
and	O
protection	O
from	O
ARDS	O
.	O

Fourteen	O
of	O
38	O
patients	O
developed	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
in	O
22	O
.	O
9	O
+/-	O

CONCLUSIONS	O
:	O
Intra	O
-	O
abdominal	B-ANAT
hypertension	O
induced	O
acute	O
lung	B-ANAT
injury	O
and	O
MODS	O
with	O
IL	O
-	O
8	O
elevation	O
,	O
even	O
though	O
AD	O
improved	O
hemodynamic	O
parameters	O
in	O
extensively	O
burned	O
patients	O
.	O

The	O
WD	O
-	O
BCoV	O
-	O
inoculated	O
calves	O
showed	O
gradual	O
villous	O
atrophy	O
in	O
the	O
small	B-ANAT
intestine	I-ANAT
and	O
a	O
gradual	O
increase	O
in	O
the	O
crypt	B-ANAT
depth	O
of	O
the	O
large	B-ANAT
intestine	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
expression	O
of	O
the	O
2	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
receptors	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
and	O
CD209L	O
in	O
different	O
human	O
organ	B-ANAT
/	O
tissue	B-ANAT
derived	O
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
.	O

Endothelial	B-ANAT
cells	I-ANAT
from	O
the	O
microvessels	O
in	O
human	O
brain	B-ANAT
,	O
lung	B-ANAT
,	O
hepatic	B-ANAT
sennoside	O
,	O
fat	O
adipose	B-ANAT
tissue	I-ANAT
,	O
adrenal	B-ANAT
gland	I-ANAT
,	O
esophagus	B-ANAT
,	O
lymph	B-ANAT
nodes	I-ANAT
,	O
and	O
bone	B-ANAT
were	O
culture	O
.	O

Study	O
of	O
the	O
activation	O
of	O
HIV	O
envelope	B-ANAT
fusogenicity	O
has	O
revealed	O
new	O
knowledge	O
about	O
how	O
redox	O
changes	O
within	O
a	O
viral	B-ANAT
envelope	I-ANAT
trigger	O
fusion	O
.	O

In	O
addition	O
,	O
to	O
compare	O
and	O
contrast	O
the	O
situation	O
outlined	O
for	O
HIV	O
with	O
an	O
enveloped	O
virus	O
that	O
can	O
fuse	O
with	O
the	O
cell	O
plasma	B-ANAT
membrane	I-ANAT
independent	O
of	O
the	O
redox	O
status	O
of	O
its	O
envelope	B-ANAT
protein	O
,	O
we	O
review	O
parallel	O
data	O
obtained	O
on	O
SARS	O
coronavirus	O
entry	O
.	O

An	O
antiserum	O
against	O
bovine	O
torovirus	O
(	O
BToV	O
)	O
reacted	O
with	O
the	O
infected	O
cells	B-ANAT
by	O
immunofluorescence	O
and	O
neutralized	O
the	O
isolate	O
.	O

They	O
were	O
initially	O
ventilated	O
with	O
significantly	O
higher	O
tidal	O
volume	O
per	O
predicted	O
body	B-ANAT
weight	O
(	O
9	O
.	O
5	O
+/-	O

After	O
the	O
onset	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
patients	O
remained	O
ventilated	O
with	O
similar	O
tidal	O
volumes	O
to	O
maintain	O
mild	O
hypocapnia	O
and	O
had	O
a	O
longer	O
length	O
of	O
stay	O
in	O
the	O
intensive	O
care	O
unit	O
and	O
fewer	O
ventilator	O
-	O
free	O
days	O
(	O
p	O
<	O
.	O
05	O
).	O

In	O
addition	O
to	O
a	O
lower	O
Pao2	O
/	O
Fio2	O
,	O
the	O
use	O
of	O
high	O
tidal	O
volume	O
and	O
high	O
respiratory	O
rate	O
are	O
independent	O
predictors	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
severe	O
brain	B-ANAT
injury	O
.	O

Nasopharyngeal	B-ANAT
aspirate	I-ANAT
was	O
collected	O
and	O
assessed	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
viral	O
culture	O
.	O

Spirometry	O
was	O
performed	O
in	O
the	O
stable	O
phase	O
at	O
2	O
to	O
3	O
months	O
after	O
hospital	O
discharge	B-ANAT
.	O

Two	O
groups	O
of	O
12	O
conventional	O
,	O
colostrum	B-ANAT
-	O
deprived	O
,	O
1	O
-	O
day	O
-	O
old	O
,	O
large	O
White	O
-	O
Duroc	O
cross	O
breed	O
piglets	O
were	O
inoculated	O
orally	B-ANAT
with	O
PEDV	O
(	O
3	O
x	O
10	O
(	O
5	O
)	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
doses	O
),	O
with	O
or	O
without	O
EGF	O
(	O
10	O
microg	O
/	O
kg	O
/	O
day	O
,	O
intraperitoneally	O
once	O
daily	O
for	O
4	O
days	O
after	O
infection	O
)	O
and	O
compared	O
to	O
12	O
uninfected	O
,	O
untreated	O
control	O
piglets	O
.	O

Histologically	O
,	O
the	O
ratio	O
of	O
villous	O
height	O
:	O
crypt	B-ANAT
depth	O
of	O
PEDV	O
+	O
EGF	O
piglets	O
was	O
significantly	O
higher	O
than	O
PEDV	O
only	O
piglets	O
at	O
36	O
and	O
48	O
hpi	O
.	O

Immunohistochemistry	O
for	O
Ki67	O
demonstrated	O
increased	O
proliferation	O
in	O
intestinal	B-ANAT
crypt	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
of	O
PEDV	O
+	O
EGF	O
piglets	O
compared	O
to	O
PEDV	O
only	O
piglets	O
at	O
36	O
,	O
48	O
and	O
60	O
hpi	O
.	O

The	O
M	O
-	O
41	O
antigen	O
was	O
also	O
detected	O
in	O
lungs	B-ANAT
and	O
tracheal	O
tissues	B-ANAT
of	O
the	O
clinically	O
positive	O
infectious	O
bronchitis	O
cases	O
.	O

This	O
patient	O
had	O
pulmonary	B-ANAT
fibrosis	O
of	O
unknown	O
etiology	O
with	O
a	O
right	O
upper	O
bulla	O
.	O

Furthermore	O
,	O
the	O
new	O
method	O
has	O
been	O
successfully	O
applied	O
to	O
the	O
screening	O
of	O
inhibitors	O
for	O
influenza	O
A	O
virus	O
and	O
SARS	O
coronavirus	O
,	O
as	O
well	O
as	O
the	O
construction	O
of	O
quartz	O
crystal	B-ANAT
microbalance	O
(	O
QCM	O
)	O
biosensor	O
for	O
human	O
interferon	O
-	O
beta	O
.	O

Presence	O
of	O
anti	O
-	O
KC	O
:	O
KC	O
complexes	O
was	O
associated	O
with	O
development	O
of	O
severe	O
pulmonary	B-ANAT
inflammation	O
that	O
was	O
,	O
however	O
,	O
dramatically	O
suppressed	O
in	O
gamma	O
-	O
chain	O
-	O
deficient	O
mice	O
.	O

We	O
detected	O
complexes	O
between	O
anti	O
-	O
KC	O
autoantibodies	O
and	O
KC	O
in	O
lung	B-ANAT
lavages	O
and	O
tissues	B-ANAT
of	O
mice	O
treated	O
with	O
LPS	O
.	O

ABSTRACT	O
:	O
The	O
susceptibility	O
of	O
the	O
chicken	O
embryo	B-ANAT
related	O
(	O
CER	O
)	O
cell	B-ANAT
line	I-ANAT
to	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
M41	O
)	O
was	O
characterized	O
after	O
five	O
consecutive	O
passages	O
in	O
CER	O
cells	B-ANAT
.	O

At	O
96	O
h	O
post	O
-	O
infection	O
(	O
p	O
.	O
i	O
.),	O
the	O
cytopathic	O
effect	O
was	O
graded	O
75	O
%	O
by	O
cell	B-ANAT
fusion	O
,	O
rounding	O
up	O
of	O
cells	B-ANAT
and	O
monolayer	O
detachment	O
,	O
and	O
the	O
electron	O
microscopy	O
image	O
characterized	O
by	O
coronavirus	O
morphology	O
.	O

Cytoplasmic	B-ANAT
fluorescence	O
was	O
readily	O
observed	O
by	O
from	O
24	O
h	O
p	O
.	O
i	O
.	O

Extra	O
-	O
cellular	B-ANAT
virus	O
was	O
measured	O
by	O
virus	O
titration	O
performed	O
on	O
chicken	O
kidney	B-ANAT
cells	B-ANAT
and	O
embryonated	O
chicken	O
eggs	O
,	O
and	O
respective	O
titres	O
ranged	O
from	O
4	O
.	O
0	O
to	O
6	O
.	O
0	O
log10	O
EID50	O
/	O
ml	O
on	O
embryonated	O
chicken	O
eggs	O
,	O
and	O
from	O
2	O
.	O
0	O
to	O
6	O
.	O
0	O
log10	O
TCID50	O
/	O
ml	O
on	O
both	O
CER	O
cells	B-ANAT
and	O
chicken	O
kidney	B-ANAT
cells	B-ANAT
studied	O
from	O
24	O
to	O
120	O
h	O
p	O
.	O
i	O
.	O

This	O
large	O
-	O
scale	O
analysis	O
identified	O
important	O
discriminatory	O
parameters	O
related	O
to	O
the	O
patients	O
'	O
demographic	O
profile	O
(	O
age	O
and	O
gender	O
),	O
severity	O
of	O
illness	O
(	O
pulse	O
rate	O
and	O
neutrophil	B-ANAT
count	O
),	O
and	O
multisystem	O
derangement	O
(	O
platelet	B-ANAT
count	O
,	O
CPK	O
,	O
ALT	O
and	O
LDH	O
),	O
all	O
of	O
which	O
prognosticated	O
adverse	O
outcomes	O
during	O
the	O
SARS	O
episode	O
.	O

Histologically	O
,	O
pancreatic	B-ANAT
and	O
lung	B-ANAT
damage	O
was	O
less	O
severe	O
following	O
leptin	O
administration	O
.	O

Patients	O
were	O
interviewed	O
and	O
underwent	O
physical	O
examination	O
,	O
pulmonary	B-ANAT
function	O
testing	O
,	O
chest	B-ANAT
radiography	O
,	O
a	O
6	O
-	O
minute	O
-	O
walk	O
test	O
,	O
quality	O
-	O
of	O
-	O
life	O
measures	O
,	O
and	O
self	O
-	O
report	O
of	O
health	O
care	O
utilization	O
.	O

ABSTRACT	O
:	O
Attenuated	O
Salmonella	O
enterica	O
serovar	O
Typhi	O
strains	O
have	O
been	O
considered	O
to	O
be	O
attractive	O
as	O
potential	O
live	O
oral	B-ANAT
delivery	O
vector	O
vaccines	O
because	O
of	O
their	O
ability	O
to	O
elicit	O
the	O
full	O
array	O
of	O
immune	O
responses	O
in	O
humans	O
.	O

SARS	O
-	O
CoV	O
HKU39849	O
was	O
used	O
to	O
infect	O
stable	O
clones	O
expressing	O
ORF8a	O
and	O
cells	B-ANAT
transfected	O
with	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
).	O

Critical	O
illness	O
-	O
related	O
corticosteroid	O
insufficiency	O
leads	O
to	O
an	O
exaggerated	O
proinflammatory	O
response	O
with	O
increased	O
tissue	B-ANAT
injury	O
and	O
organ	B-ANAT
dysfunction	O
.	O

Despite	O
a	O
decline	O
of	O
IFN	O
-	O
gamma	O
concomitant	O
to	O
virus	O
clearance	O
,	O
MHC	B-ANAT
molecule	O
expression	O
on	O
glia	B-ANAT
was	O
sustained	O
.	O

TITLE	O
:	O
Calf	B-ANAT
-	O
level	O
risk	O
factors	O
for	O
neonatal	O
diarrhea	O
and	O
shedding	O
of	O
Cryptosporidium	O
parvum	O
in	O
Ontario	O
dairy	O
calves	O
.	O

Factors	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
diarrhea	O
were	O
leaving	O
the	O
calf	B-ANAT
with	O
the	O
dam	O
for	O
more	O
than	O
an	O
hour	O
after	O
birth	O
,	O
and	O
the	O
birth	O
of	O
a	O
calf	B-ANAT
in	O
the	O
summer	O
as	O
opposed	O
to	O
winter	O
.	O

At	O
the	O
height	O
of	O
the	O
disease	O
,	O
60	O
%	O
of	O
patients	O
were	O
unable	O
to	O
walk	O
and	O
24	O
%	O
could	O
not	O
use	O
their	O
arms	B-ANAT
.	O

ABSTRACT	O
:	O
Recent	O
experiences	O
of	O
emerging	O
infections	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
avian	O
influenza	O
(	O
H5N1	O
),	O
have	O
highlighted	O
the	O
risks	O
of	O
serious	O
pulmonary	B-ANAT
infections	O
from	O
occupational	O
exposures	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
Hsp90	O
inhibitors	O
prolong	O
survival	O
,	O
attenuate	O
inflammation	O
,	O
and	O
reduce	O
lung	B-ANAT
injury	O
in	O
a	O
murine	O
model	O
of	O
sepsis	O
.	O

TITLE	O
:	O
Outcomes	O
and	O
prognostic	O
factors	O
in	O
patients	O
with	O
head	B-ANAT
and	I-ANAT
neck	I-ANAT
cancer	O
and	O
severe	O
acute	O
illnesses	O
.	O

Ex	O
vivo	O
generated	O
,	O
characterized	O
and	O
cultivated	O
rat	B-ANAT
bone	I-ANAT
marrow	I-ANAT
-	O
derived	O
EPC	O
were	O
investigated	O
for	O
proliferation	O
and	O
vasculogenic	O
properties	O
in	O
vitro	O
.	O

Virtually	O
no	O
cells	B-ANAT
were	O
found	O
in	O
the	O
right	B-ANAT
lung	I-ANAT
or	O
in	O
other	O
organs	B-ANAT
.	O

However	O
,	O
few	O
EPC	O
were	O
found	O
in	O
subcutaneous	O
Matrigel	O
in	O
transplanted	B-ANAT
rats	O
.	O

We	O
showed	O
that	O
IBV	O
strains	O
M41	O
,	O
H52	O
,	O
H120	O
and	O
Gray	O
could	O
be	O
propagated	O
in	O
HeLa	B-ANAT
cells	I-ANAT
with	O
distinct	O
cytopathic	O
effect	O
.	O

Here	O
we	O
report	O
that	O
two	O
hmAbs	O
,	O
m396	O
and	O
S230	O
.	O
15	O
,	O
potently	O
neutralized	O
GD03	O
and	O
representative	O
isolates	O
from	O
the	O
first	O
SARS	O
outbreak	O
(	O
Urbani	O
,	O
Tor2	O
)	O
and	O
from	O
palm	B-ANAT
civets	O
(	O
SZ3	O
,	O
SZ16	O
).	O

Therefore	O
,	O
the	O
role	O
of	O
complement	O
and	O
neutrophils	B-ANAT
was	O
determined	O
in	O
bilateral	O
lung	B-ANAT
injury	O
induced	O
by	O
a	O
single	O
blast	B-ANAT
wave	O
.	O

Here	O
,	O
the	O
entry	O
pathway	O
of	O
MHV	O
-	O
A59	O
into	O
murine	O
fibroblast	B-ANAT
cells	B-ANAT
was	O
studied	O
by	O
independent	O
approaches	O
.	O

Infection	O
was	O
only	O
slightly	O
reduced	O
in	O
the	O
presence	O
of	O
substances	O
inhibiting	O
proteases	O
of	O
endosomal	O
compartments	B-ANAT
,	O
precluding	O
that	O
the	O
endocytic	O
uptake	O
is	O
required	O
to	O
activate	O
the	O
fusion	O
potential	O
of	O
the	O
S	O
protein	O
by	O
its	O
cleavage	O
.	O

The	O
results	O
imply	O
that	O
endocytosis	O
plays	O
a	O
major	O
role	O
in	O
MHV	O
-	O
A59	O
infection	O
and	O
the	O
acidic	O
pH	O
of	O
the	O
endosomal	O
compartment	B-ANAT
triggers	O
a	O
conformational	O
change	O
of	O
the	O
S	O
protein	O
mediating	O
fusion	O
.	O

Birds	O
were	O
challenged	O
via	O
the	O
trachea	B-ANAT
with	O
PAMP	O
for	O
5	O
consecutive	O
days	O
prior	O
to	O
primary	O
and	O
secondary	O
immunization	O
with	O
HuSA	O
.	O

ABSTRACT	O
:	O
The	O
cellular	B-ANAT
uptake	O
of	O
PMOs	O
(	O
phosphorodiamidate	O
morpholino	O
oligomers	O
)	O
can	O
be	O
enhanced	O
by	O
their	O
conjugation	O
to	O
arginine	O
-	O
rich	O
CPPs	O
(	O
cell	B-ANAT
-	O
penetrating	O
peptides	O
).	O

A	O
32	O
-	O
year	O
-	O
old	O
primipara	O
at	O
37	O
week	O
of	O
gestation	O
was	O
hospitalised	O
with	O
a	O
10	O
-	O
day	O
history	O
of	O
nausea	O
,	O
vomiting	O
,	O
and	O
abdominal	B-ANAT
pain	O
without	O
fever	O
.	O

Also	O
,	O
several	O
lines	O
of	O
breakthroughs	O
have	O
been	O
record	O
-	O
brokenly	O
obtained	O
,	O
that	O
included	O
the	O
finding	O
of	O
ACE2	O
,	O
a	O
functional	O
receptor	O
for	O
the	O
SARS	O
-	O
CoV	O
,	O
solution	O
of	O
the	O
3CL	O
(	O
pro	O
)	O
structure	O
,	O
a	O
first	O
crystal	B-ANAT
structure	O
of	O
SARS	O
-	O
related	O
macromolecules	O
,	O
revealing	O
of	O
bats	O
as	O
natural	O
reservoirs	O
for	O
SARS	O
-	O
like	O
viruses	O
and	O
the	O
possible	O
involvement	O
of	O
civet	O
cats	O
in	O
the	O
SARS	O
emergence	O
.	O

In	O
both	O
young	O
and	O
aged	O
mice	O
,	O
an	O
intranasal	O
Protollin	O
-	O
formulated	O
S	O
-	O
protein	O
vaccine	O
elicited	O
high	O
levels	O
of	O
antigen	O
-	O
specific	O
IgG	O
in	O
serum	B-ANAT
,	O
comparable	O
to	O
those	O
elicited	O
by	O
an	O
intramuscular	O
Alum	O
-	O
adsorbed	O
S	O
-	O
protein	O
vaccine	O
.	O

Serum	B-ANAT
antibodies	O
were	O
shown	O
to	O
be	O
virus	O
neutralizing	O
.	O

The	O
results	O
showed	O
that	O
recombinant	O
proteins	O
of	O
SARS	O
coronavirus	O
spike	O
protein	O
induced	O
hormonal	O
and	O
cellular	B-ANAT
immune	O
response	O
in	O
Balb	O
/	O
c	O
mice	O
.	O

Acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
III	O
(	O
APACHE	O
III	O
),	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
score	O
(	O
MODS	O
score	O
),	O
and	O
lung	B-ANAT
injury	O
score	O
(	O
LIS	O
)	O
were	O
determined	O
on	O
the	O
onset	O
day	O
of	O
ARDS	O
for	O
all	O
the	O
patients	O
.	O

The	O
main	O
cause	O
of	O
death	O
is	O
multiple	O
organ	B-ANAT
failure	O
.	O

After	O
15	O
passages	O
,	O
the	O
virus	O
(	O
Rat	O
-	O
P15	O
)	O
came	O
to	O
replicate	O
effectively	O
in	O
rat	O
ACE2	O
-	O
expressing	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Feline	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
fACE2	O
)	O
gene	O
was	O
amplified	O
from	O
domestic	O
cat	O
lung	B-ANAT
with	O
RT	O
-	O
PCR	O
,	O
cloned	O
and	O
sequenced	O
.	O

Careful	O
attention	O
to	O
experimental	O
design	O
,	O
sample	O
handling	O
and	O
storage	B-ANAT
,	O
and	O
the	O
use	O
of	O
appropriate	O
internal	O
controls	O
is	O
crucial	O
to	O
success	O
.	O

CONCLUSIONS	O
:	O
We	O
concluded	O
that	O
a	O
profound	O
impairment	O
of	O
pulmonary	B-ANAT
surfactant	O
composition	O
and	O
function	O
occurs	O
in	O
the	O
very	O
early	O
stage	O
of	O
the	O
disease	O
and	O
only	O
gradually	O
resolves	O
over	O
time	O
.	O

Analysis	O
of	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
immunized	O
mice	O
demonstrated	O
that	O
pcDNA	O
-	O
SS	O
and	O
pcDNA	O
-	O
St	O
-	O
VP22C	O
are	O
the	O
most	O
immunogenic	O
SARS	O
vaccine	O
candidates	O
.	O

Moreover	O
,	O
an	O
in	O
vitro	O
chemotaxis	O
assay	O
showed	O
that	O
motility	O
towards	O
chemokines	O
of	O
THP	O
-	O
1	O
cells	B-ANAT
and	O
primary	O
monocytes	B-ANAT
was	O
increased	O
following	O
an	O
acute	O
or	O
persistent	O
HCoV	O
-	O
229E	O
infection	O
.	O

We	O
previously	O
showed	O
that	O
one	O
such	O
protein	O
,	O
encoded	O
by	O
ORF6	O
,	O
enhanced	O
the	O
growth	O
of	O
mouse	O
hepatitis	O
virus	O
in	O
tissue	B-ANAT
culture	O
cells	B-ANAT
and	O
in	O
mice	O
.	O

However	O
,	O
at	O
that	O
point	O
in	O
infection	O
,	O
translation	O
of	O
host	O
mRNA	O
is	O
already	O
severely	O
reduced	O
in	O
infected	O
cells	B-ANAT
,	O
preventing	O
the	O
synthesis	O
of	O
CXCL2	O
and	O
ER	O
stress	O
proteins	O
despite	O
their	O
increased	O
mRNA	O
concentrations	O
.	O

Thirty	O
-	O
five	O
children	O
underwent	O
lung	B-ANAT
resections	O
between	O
1998	O
and	O
2006	O
,	O
their	O
age	O
ranging	O
from	O
8	O
days	O
to	O
12	O
years	O
(	O
mean	O
3	O
years	O
),	O
with	O
a	O
male	O
:	O
female	O
ratio	O
of	O
4	O
:	O
1	O
.	O

Blood	B-ANAT
gases	O
showed	O
severe	O
hypoxemia	O
associated	O
with	O
hypocapnia	O
.	O

Because	O
of	O
the	O
persistent	O
hemodynamic	O
instability	O
,	O
a	O
mitral	O
valvular	O
replacement	O
and	O
tricuspid	B-ANAT
valve	I-ANAT
annuloplasty	O
were	O
performed	O
.	O

Apelin	O
mutant	O
mice	O
are	O
viable	O
and	O
fertile	O
,	O
appear	O
healthy	O
,	O
and	O
exhibit	O
normal	O
body	B-ANAT
weight	O
,	O
water	O
and	O
food	O
intake	O
,	O
heart	B-ANAT
rates	O
,	O
and	O
heart	B-ANAT
morphology	O
.	O

We	O
also	O
report	O
that	O
pressure	O
overload	O
induces	O
upregulation	O
of	O
Apelin	O
expression	O
in	O
the	O
heart	B-ANAT
.	O

Mice	O
immunized	O
four	O
times	O
with	O
VLPs	B-ANAT
developed	O
high	O
antibody	O
titres	O
against	O
SARS	O
CoV	O
.	O
In	O
addition	O
,	O
VLPs	B-ANAT
elicited	O
cell	B-ANAT
-	O
mediated	O
immunity	O
as	O
demonstrated	O
by	O
enhanced	O
interferon	O
-	O
gamma	O
and	O
interleukin	O
-	O
4	O
production	O
.	O

Our	O
findings	O
demonstrate	O
that	O
SARS	O
CoV	O
VLPs	B-ANAT
are	O
immunogenic	O
and	O
can	O
elicit	O
strong	O
SARS	O
CoV	O
-	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
mice	O
.	O

RNA	O
and	O
protein	O
composition	O
analysis	O
by	O
RNase	O
-	O
gold	O
and	O
immunoelectron	O
microscopy	O
showed	O
that	O
rTGEV	O
-	O
DeltaE	O
virions	B-ANAT
contained	O
RNA	O
and	O
also	O
all	O
the	O
structural	O
TGEV	O
proteins	O
,	O
except	O
the	O
deleted	O
E	O
protein	O
.	O

In	O
this	O
report	O
,	O
we	O
examined	O
the	O
effect	O
of	O
clinical	O
P	O
falciparum	O
isolates	O
on	O
barrier	O
function	O
of	O
primary	O
dermal	O
and	O
lung	B-ANAT
microvascular	O
endothelium	B-ANAT
in	O
vitro	O
.	O

ABSTRACT	O
:	O
Between	O
50	O
%	O
and	O
80	O
%	O
of	O
asthma	O
exacerbations	O
are	O
associated	O
with	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTIs	O
),	O
yet	O
the	O
influence	O
of	O
viral	O
pathogen	O
diversity	O
on	O
asthma	O
outcomes	O
is	O
poorly	O
understood	O
because	O
of	O
the	O
limited	O
scope	O
and	O
throughput	O
of	O
conventional	O
viral	O
detection	O
methods	O
.	O

There	O
was	O
no	O
decline	O
in	O
egg	B-ANAT
production	O
in	O
either	O
of	O
the	O
infected	O
groups	O
.	O

Severe	O
cytopathology	O
was	O
recorded	O
in	O
the	O
shell	B-ANAT
-	O
forming	O
region	O
of	O
hens	O
that	O
were	O
out	O
of	O
production	O
,	O
and	O
virus	B-ANAT
particles	I-ANAT
were	O
observed	O
in	O
hens	O
that	O
had	O
stopped	O
laying	O
.	O

Although	O
a	O
decrease	O
in	O
egg	B-ANAT
production	O
and	O
deterioration	O
in	O
eggshell	O
quality	O
were	O
not	O
observed	O
in	O
this	O
trial	O
,	O
cessation	O
of	O
egg	B-ANAT
production	O
in	O
a	O
small	O
number	O
of	O
hens	O
could	O
be	O
due	O
to	O
severe	O
cytopathology	O
in	O
the	O
eggshell	O
-	O
forming	O
regions	O
of	O
the	O
oviduct	B-ANAT
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
infects	O
many	O
organs	B-ANAT
,	O
such	O
as	O
lung	B-ANAT
,	O
liver	B-ANAT
,	O
and	O
immune	O
organs	B-ANAT
and	O
causes	O
life	O
-	O
threatening	O
atypical	O
pneumonia	O
,	O
SARS	O
causes	O
high	O
morbidity	O
and	O
mortality	O
rates	O
.	O

In	O
this	O
work	O
,	O
we	O
found	O
that	O
the	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
physically	O
interacted	O
with	O
IKKbeta	O
using	O
a	O
co	O
-	O
immunoprecipitation	O
assay	O
(	O
IPA	O
).	O

More	O
caution	O
is	O
required	O
on	O
the	O
allegation	O
about	O
the	O
efficacy	O
of	O
herbal	O
medicine	O
for	O
the	O
treatment	O
or	O
prevention	O
of	O
viral	O
infection	O
affecting	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
while	O
more	O
clinical	O
studies	O
are	O
indicated	O
.	O

Extra	O
cerebral	B-ANAT
organ	B-ANAT
complications	O
were	O
also	O
recorded	O
as	O
well	O
as	O
outcome	O
at	O
6	O
months	O
.	O

Age	O
,	O
GCS	O
,	O
hypotension	O
during	O
the	O
first	O
day	O
of	O
treatment	O
,	O
elevated	O
blood	B-ANAT
sugar	O
and	O
low	O
albumin	O
predicted	O
an	O
unfavourable	O
outcome	O
.	O

Deviations	O
of	O
key	O
physiological	O
variables	O
and	O
pulmonary	B-ANAT
complications	O
were	O
frequent	O
in	O
patients	O
suffering	O
from	O
severe	O
head	B-ANAT
injury	O
.	O

Age	O
,	O
GCS	O
,	O
hypotension	O
during	O
the	O
first	O
day	O
of	O
treatment	O
,	O
elevated	O
blood	B-ANAT
sugar	O
and	O
low	O
albumin	O
predicted	O
an	O
unfavourable	O
outcome	O
.	O

Apoptosis	O
was	O
observed	O
in	O
vitro	O
,	O
while	O
both	O
apoptosis	O
and	O
necrosis	O
were	O
observed	O
in	O
tissues	B-ANAT
obtained	O
from	O
SARS	O
patients	O
.	O

However	O
,	O
mutant	O
virus	O
replication	O
was	O
strongly	O
attenuated	O
in	O
cells	B-ANAT
with	O
an	O
intact	O
IFN	O
response	O
.	O

Fever	O
,	O
cough	O
,	O
chest	B-ANAT
pain	O
,	O
tachypnoea	O
,	O
reduced	O
breath	B-ANAT
sounds	O
,	O
crackles	O
and	O
chest	B-ANAT
radiograph	O
opacities	O
were	O
the	O
main	O
manifestations	O
.	O

Weaker	O
evidence	O
supports	O
consideration	O
of	O
noninvasive	O
ventilation	O
for	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
patients	O
with	O
postoperative	O
or	O
postextubation	O
respiratory	O
failure	O
;	O
patients	O
with	O
acute	O
respiratory	O
failure	O
due	O
to	O
asthma	O
exacerbations	O
,	O
pneumonia	O
,	O
acute	O
lung	B-ANAT
injury	O
,	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
during	O
bronchoscopy	O
;	O
or	O
as	O
a	O
means	O
of	O
preoxygenation	O
before	O
intubation	O
in	O
critically	O
ill	O
patients	O
with	O
severe	O
hypoxemia	O
.	O

Follow	O
-	O
up	O
HRCT	O
after	O
2	O
weeks	O
of	O
therapy	O
demonstrated	O
resolution	O
of	O
the	O
pulmonary	B-ANAT
parenchymal	O
abnormalities	O
.	O

These	O
findings	O
failed	O
to	O
detect	O
any	O
interaction	O
between	O
PEDV	O
and	O
porcine	O
rotavirus	O
in	O
the	O
small	B-ANAT
intestines	I-ANAT
of	O
piglets	O
,	O
suggesting	O
that	O
concurrent	O
infection	O
of	O
PGAR	O
may	O
not	O
synergistically	O
enhance	O
intestinal	B-ANAT
villous	O
atrophy	O
of	O
piglets	O
with	O
PEDV	O
disease	O
.	O

The	O
oxygenation	O
indices	O
at	O
the	O
postoperative	O
hours	O
2	O
(	O
P	O
=	O
0	O
.	O
019	O
),	O
4	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
8	O
(	O
P	O
=	O
0	O
.	O
035	O
),	O
12	O
(	O
P	O
=	O
0	O
.	O
035	O
)	O
and	O
24	O
(	O
P	O
=	O
0	O
.	O
046	O
)	O
were	O
significantly	O
higher	O
in	O
the	O
NAC	B-ANAT
group	O
.	O

Passive	O
immunisation	O
with	O
sera	B-ANAT
from	O
surviving	O
patients	O
leads	O
to	O
partial	O
success	O
.	O

HBoV	O
was	O
detected	O
in	O
30	O
(	O
2	O
.	O
1	O
%)	O
of	O
1	O
,	O
435	O
fecal	B-ANAT
samples	O
.	O

Genomes	O
of	O
HBoVs	O
from	O
NPAs	O
and	O
fecal	B-ANAT
samples	O
displayed	O
minimal	O
sequence	O
variations	O
.	O

However	O
,	O
seizures	O
were	O
significantly	O
more	O
frequent	O
in	O
animals	O
with	O
marked	O
extension	O
of	O
the	O
inflammatory	O
lesions	O
to	O
the	O
forebrain	B-ANAT
(	O
P	O
=	O
0	O
.	O
038	O
).	O

TITLE	O
:	O
Conductance	O
and	O
amantadine	O
binding	O
of	O
a	O
pore	B-ANAT
formed	O
by	O
a	O
lysine	O
-	O
flanked	O
transmembrane	B-ANAT
domain	O
of	O
SARS	O
coronavirus	O
envelope	B-ANAT
protein	O
.	O

Results	O
obtained	O
from	O
single	O
or	O
double	O
mutants	O
indicate	O
that	O
the	O
organization	O
of	O
the	O
transmembrane	B-ANAT
pore	B-ANAT
is	O
consistent	O
with	O
our	O
previously	O
reported	O
pentameric	O
alpha	O
-	O
helical	O
bundle	O
model	O
.	O

Compared	O
with	O
the	O
healthy	O
controls	O
,	O
there	O
were	O
significant	O
decrease	O
in	O
forced	O
vital	O
capacity	O
(	O
FVC	O
),	O
vital	O
capacity	O
(	O
VC	O
),	O
one	O
second	O
forced	O
expiratory	O
volume	O
(	O
FEV1	O
),	O
25	O
%-	O
75	O
%	O
forced	O
expiratory	O
flow	O
(	O
25	O
%-	O
75	O
%	O
FEF	O
)	O
of	O
SARS	O
patients	O
within	O
three	O
years	O
after	O
their	O
discharge	B-ANAT
from	O
hospital	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

CONCLUSIONS	O
:	O
The	O
lung	B-ANAT
diffusion	O
function	O
of	O
the	O
SARS	O
patients	O
had	O
recovered	O
after	O
they	O
were	O
discharged	O
from	O
hospital	O
within	O
three	O
years	O
,	O
but	O
in	O
20	O
%-	O
30	O
%	O
patients	O
there	O
is	O
still	O
mild	O
or	O
moderate	O
restrictive	O
ventilation	O
function	O
abnormality	O
and	O
small	O
airway	B-ANAT
function	O
impairment	O
.	O

ALI	O
is	O
characterized	O
by	O
disruption	O
of	O
the	O
lung	B-ANAT
alveolar	B-ANAT
-	O
capillary	B-ANAT
membrane	B-ANAT
barrier	O
and	O
resultant	O
pulmonary	B-ANAT
edema	O
associated	O
with	O
a	O
proteinaceous	O
alveolar	B-ANAT
exudate	B-ANAT
.	O

Furthermore	O
,	O
administration	O
of	O
MSCs	O
transfected	O
with	O
pANGPT1	O
resulted	O
in	O
nearly	O
complete	O
reversal	O
of	O
LPS	O
-	O
induced	O
increases	O
in	O
lung	B-ANAT
permeability	O
as	O
assessed	O
by	O
reductions	O
in	O
IgM	O
and	O
albumin	O
levels	O
in	O
BAL	O
(	O
96	O
%,	O
CI	O
6	O
%-	O
185	O
%;	O
and	O
74	O
%,	O
CI	O
23	O
%-	O
126	O
%,	O
respectively	O
).	O

These	O
results	O
suggest	O
a	O
potential	O
role	O
for	O
cell	B-ANAT
-	O
based	O
ANGPT1	O
gene	O
therapy	O
to	O
treat	O
clinical	O
ALI	O
/	O
ARDS	O
.	O

Type	O
I	O
cells	B-ANAT
were	O
productively	O
infected	O
with	O
SDAV	O
and	O
RCoV	O
-	O
P	O
,	O
and	O
both	O
live	O
virus	O
and	O
UV	O
-	O
inactivated	O
virus	O
induced	O
mRNA	O
and	O
protein	O
expression	O
of	O
three	O
CXC	O
chemokines	O
:	O
CINC	O
-	O
2	O
,	O
CINC	O
-	O
3	O
,	O
and	O
LIX	O
,	O
which	O
are	O
neutrophil	B-ANAT
chemoattractants	O
.	O

Virus	O
-	O
induced	O
chemokine	O
expression	O
was	O
reduced	O
by	O
the	O
IL	O
-	O
1	O
receptor	O
antagonist	O
,	O
suggesting	O
that	O
IL	O
-	O
1	O
produced	O
by	O
infected	O
cells	B-ANAT
induces	O
uninfected	O
cells	B-ANAT
to	O
express	O
chemokines	O
.	O

Primary	O
cultures	O
of	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
are	O
an	O
important	O
model	O
for	O
the	O
early	O
events	O
in	O
viral	O
infection	O
that	O
lead	O
to	O
pulmonary	B-ANAT
inflammation	O
.	O

The	O
primary	O
target	B-ANAT
cells	I-ANAT
are	O
pneumocytes	B-ANAT
and	O
enterocytes	B-ANAT
,	O
both	O
cell	B-ANAT
types	O
abundantly	O
expressing	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
which	O
is	O
the	O
main	O
SARS	O
-	O
CoV	O
receptor	O
.	O

In	O
this	O
review	O
,	O
we	O
summarize	O
the	O
major	O
pathological	O
findings	O
at	O
the	O
gross	O
,	O
cellular	B-ANAT
and	O
molecular	O
levels	O
and	O
discuss	O
the	O
various	O
possible	O
mechanisms	O
that	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
SARS	O
.	O

The	O
criteria	O
of	O
severe	O
sepsis	O
were	O
based	O
on	O
the	O
American	O
College	O
of	O
Chest	B-ANAT
Physicians	O
/	O
Society	O
of	O
Critical	O
Care	O
Medicine	O
Consensus	O
Conference	O
definition	O
.	O

When	O
the	O
cat	O
was	O
gently	O
restrained	O
for	O
blood	B-ANAT
sampling	O
,	O
the	O
skin	B-ANAT
on	O
the	O
dorsal	O
neck	B-ANAT
tore	O
,	O
leaving	O
a	O
15	O
cm	O
x	O
7	O
cm	O
flap	B-ANAT
of	O
skin	B-ANAT
.	O

Feline	O
skin	B-ANAT
fragility	O
syndrome	O
has	O
not	O
previously	O
been	O
reported	O
in	O
association	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
).	O

13	O
,	O
17	O
and	O
13	O
sera	B-ANAT
samples	O
were	O
collected	O
in	O
the	O
5th	O
,	O
20th	O
and	O
35th	O
month	O
after	O
onset	O
.	O

RESULTS	O
:	O
HBoV	O
DNA	O
was	O
detected	O
in	O
11	O
(	O
2	O
.	O
8	O
%)	O
of	O
389	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
from	O
symptomatic	O
hospitalized	O
children	O
(	O
median	O
age	O
9	O
.	O
0	O
months	O
;	O
range	O
:	O
3	O
-	O
17	O
months	O
).	O

These	O
observations	O
imply	O
nsp4	O
to	O
assemble	O
in	O
the	O
membrane	B-ANAT
as	O
a	O
tetraspanning	O
transmembrane	B-ANAT
protein	O
with	O
a	O
Nendo	O
/	O
Cendo	O
topology	O
.	O

nsp4	O
contains	O
four	O
predicted	O
transmembrane	B-ANAT
-	O
spanning	O
regions	O
(	O
TM1	O
,	O
-	O
2	O
,	O
-	O
3	O
,	O
and	O
-	O
4	O
),	O
demonstrates	O
characteristics	O
of	O
an	O
integral	O
membrane	B-ANAT
protein	O
,	O
and	O
is	O
thought	O
to	O
be	O
essential	O
for	O
the	O
formation	O
and	O
function	O
of	O
viral	O
replication	O
complexes	O
on	O
cellular	B-ANAT
membranes	B-ANAT
.	O

We	O
identified	O
two	O
patients	O
with	O
early	O
-	O
onset	O
glomerular	B-ANAT
lesions	O
that	O
harbored	O
mutations	O
in	O
the	O
COQ2	O
gene	O
.	O

In	O
conclusion	O
,	O
we	O
suggest	O
that	O
inherited	O
COQ2	O
mutations	O
cause	O
a	O
primary	O
glomerular	B-ANAT
disease	O
with	O
renal	B-ANAT
lesions	O
that	O
vary	O
in	O
severity	O
and	O
are	O
not	O
necessarily	O
associated	O
with	O
neurological	O
signs	O
.	O

COQ2	O
nephropathy	O
should	O
be	O
suspected	O
when	O
electron	O
microscopy	O
shows	O
an	O
increased	O
number	O
of	O
abnormal	O
mitochondria	B-ANAT
in	O
podocytes	O
and	O
other	O
glomerular	B-ANAT
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Seven	O
novel	O
gammaherpesviruses	O
(	O
GHV	O
)	O
and	O
one	O
novel	O
betaherpesvirus	O
were	O
discovered	O
in	O
seven	O
different	O
European	O
bat	O
species	O
(	O
order	O
Chiroptera	O
,	O
family	O
Vespertilionidae	O
)	O
with	O
a	O
pan	B-ANAT
-	O
herpesvirus	O
PCR	O
assay	O
,	O
targeting	O
the	O
DNA	O
polymerase	O
(	O
DPOL	O
)	O
gene	O
.	O

Furthermore	O
,	O
memory	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
displayed	O
an	O
effector	O
memory	B-ANAT
cell	I-ANAT
phenotype	O
expressing	O
CD45RO	O
-	O
CCR7	O
-	O
CD62L	O
-.	O

To	O
address	O
this	O
hypothesis	O
,	O
gene	O
expression	O
following	O
BRV	O
and	O
BCV	O
infection	O
was	O
analysed	O
in	O
surgically	O
prepared	O
intestinal	B-ANAT
loops	O
from	O
1	O
-	O
day	O
-	O
old	O
colostrum	B-ANAT
-	O
deprived	O
calves	O
.	O

When	O
delivered	O
to	O
the	O
lungs	B-ANAT
,	O
ricin	O
causes	O
severe	O
pulmonary	B-ANAT
damage	O
with	O
symptoms	O
that	O
are	O
similar	O
to	O
those	O
observed	O
in	O
acute	O
lung	B-ANAT
injury	O
and	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

Exposure	O
of	O
cultured	O
primary	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
to	O
ricin	O
resulted	O
in	O
the	O
activation	O
of	O
SAPKs	O
and	O
NF	O
-	O
kappaB	O
and	O
in	O
the	O
increased	O
expression	O
of	O
multiple	O
proinflammatory	O
molecules	O
.	O

Although	O
airway	B-ANAT
cells	B-ANAT
secrete	O
TNF	O
-	O
alpha	O
in	O
response	O
to	O
ricin	O
,	O
blocking	O
TNF	O
-	O
alpha	O
did	O
not	O
prevent	O
ricin	O
-	O
induced	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O
Decreased	O
levels	O
of	O
IkappaB	O
-	O
alpha	O
in	O
airway	B-ANAT
cells	B-ANAT
exposed	O
to	O
ricin	O
suggest	O
that	O
translational	O
suppression	O
may	O
be	O
responsible	O
for	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O
Inhibition	O
of	O
p38	O
MAPK	O
by	O
a	O
chemical	O
inhibitor	O
or	O
NF	O
-	O
kappaB	O
by	O
short	O
interfering	O
RNA	O
resulted	O
in	O
a	O
marked	O
reduction	O
in	O
the	O
expression	O
of	O
proinflammatory	O
genes	O
,	O
demonstrating	O
the	O
importance	O
of	O
these	O
two	O
pathways	O
in	O
ricin	O
intoxication	O
.	O

RESULTS	O
:	O
Virus	O
was	O
not	O
detected	O
in	O
faecal	B-ANAT
samples	O
after	O
the	O
first	O
or	O
second	O
vaccinations	O
by	O
virus	O
isolation	O
assays	O
and	O
PCR	O
.	O

It	O
was	O
found	O
that	O
low	O
-	O
avidity	O
IgG	O
antibodies	O
were	O
detected	O
in	O
15	O
/	O
15	O
(	O
100	O
%),	O
1	O
/	O
5	O
(	O
20	O
%),	O
and	O
0	O
/	O
8	O
(	O
0	O
%)	O
serum	B-ANAT
samples	O
collected	O
during	O
the	O
first	O
,	O
third	O
,	O
and	O
ninth	O
months	O
after	O
the	O
onset	O
of	O
symptoms	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
BehÃ§et	O
'	O
s	O
disease	O
(	O
BD	O
),	O
a	O
systemic	O
inflammatory	O
disorder	O
of	O
unknown	O
aetiology	O
,	O
is	O
characterised	O
by	O
recurrent	O
attacks	O
of	O
oral	B-ANAT
aphthous	O
ulcers	O
,	O
genital	B-ANAT
ulcers	O
,	O
skin	B-ANAT
lesions	O
,	O
uveitis	O
or	O
other	O
manifestations	O
affecting	O
the	O
blood	B-ANAT
vessels	I-ANAT
,	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
and	O
respiratory	O
and	O
central	B-ANAT
nervous	I-ANAT
systems	I-ANAT
.	O

They	O
all	O
mention	O
its	O
use	O
for	O
symptoms	O
of	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
and	O
hepatitis	O
.	O

TITLE	O
:	O
[	O
Sequence	O
analysis	O
for	O
genes	O
encoding	O
nucleoprotein	O
and	O
envelope	B-ANAT
protein	O
of	O
a	O
new	O
human	O
coronavirus	O
NL63	O
identified	O
from	O
a	O
pediatric	O
patient	O
in	O
Beijing	O
by	O
bioinformatics	O
].	O

Cells	B-ANAT
infected	O
with	O
mNsp15	O
mutant	O
viruses	O
accumulated	O
lesser	O
amounts	O
of	O
plus	O
-	O
and	O
minus	O
-	O
sense	O
subgenomic	O
RNAs	O
and	O
spike	O
protein	O
than	O
WT	O
virus	O
.	O

Additionally	O
,	O
a	O
marked	O
increase	O
of	O
CD4	O
T	B-ANAT
cell	I-ANAT
immune	O
responses	O
and	O
high	O
levels	O
of	O
anti	O
-	O
SARS	O
-	O
CoV	O
humoral	O
responses	O
were	O
also	O
detected	O
in	O
the	O
vAc	O
-	O
N	O
or	O
vAc	O
-	O
S	O
immunized	O
groups	O
.	O

We	O
evaluated	O
the	O
safety	O
of	O
continuous	O
prone	O
position	O
ventilation	O
(	O
PRONE	O
)	O
and	O
its	O
effects	O
on	O
oxygenation	O
and	O
plasma	B-ANAT
cytokine	O
concentrations	O
in	O
patients	O
with	O
ARDS	O
caused	O
by	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
).	O

The	O
levels	O
of	O
plasma	B-ANAT
IL	O
-	O
6	O
concentration	O
at	O
enrolment	O
,	O
24	O
hours	O
and	O
72	O
hours	O
after	O
enrolment	O
also	O
predicted	O
the	O
14th	O
day	O
mortality	O
of	O
all	O
patients	O
.	O

It	O
is	O
supportive	O
in	O
cases	O
of	O
neonatal	O
abstinence	O
syndrome	O
and	O
infants	O
with	O
neonatal	O
cerebral	B-ANAT
lesions	O
.	O

Herein	O
,	O
we	O
tested	O
whether	O
antiviral	O
antibody	O
-	O
mediated	O
suppression	O
of	O
virus	O
replication	O
and	O
subsequent	O
virus	O
clearance	O
were	O
necessary	O
for	O
preventing	O
CTL	B-ANAT
escape	O
in	O
coronavirus	O
-	O
infected	O
mice	O
.	O

Demyelinating	O
disease	O
during	O
MHV	O
-	O
JHM	O
infection	O
is	O
immune	O
-	O
mediated	O
,	O
as	O
mice	O
that	O
lack	O
T	B-ANAT
lymphocytes	I-ANAT
fail	O
to	O
develop	O
disease	O
despite	O
succumbing	O
to	O
encephalitis	O
with	O
high	O
levels	O
of	O
infectious	O
virus	O
in	O
the	O
CNS	B-ANAT
.	O

The	O
mechanisms	O
by	O
which	O
these	O
immune	O
effectors	O
induce	O
demyelination	O
share	O
an	O
ability	O
to	O
activate	O
and	O
recruit	O
macrophages	B-ANAT
and	O
microglia	B-ANAT
,	O
thus	O
increasing	O
the	O
putative	O
role	O
of	O
these	O
cells	B-ANAT
in	O
myelin	B-ANAT
destruction	O
.	O

TITLE	O
:	O
The	O
presence	O
of	O
the	O
adult	O
respiratory	O
distress	O
syndrome	O
does	O
not	O
worsen	O
mortality	O
or	O
discharge	B-ANAT
disability	O
in	O
blunt	O
trauma	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
.	O

There	O
were	O
no	O
differences	O
between	O
the	O
two	O
groups	O
with	O
respect	O
to	O
age	O
,	O
sex	O
,	O
ISS	O
,	O
Glasgow	O
coma	O
score	O
(	O
GCS	O
),	O
head	B-ANAT
,	O
abdomen	B-ANAT
and	O
extremity	B-ANAT
AIS	O
.	O

A	O
19	O
year	O
old	O
man	O
was	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
distress	O
with	O
fever	O
(	O
400C	O
),	O
lymph	B-ANAT
node	I-ANAT
enlargement	O
,	O
hepatomegaly	O
,	O
splenomegaly	O
and	O
eosinophilia	O
(	O
1640	O
/	O
mm3	O
).	O

Bilateral	O
alveolar	B-ANAT
opacities	O
were	O
observed	O
on	O
the	O
chest	B-ANAT
x	O
-	O
ray	O
.	O

TITLE	O
:	O
Type	O
I	O
interferons	O
are	O
essential	O
in	O
controlling	O
neurotropic	O
coronavirus	O
infection	O
irrespective	O
of	O
functional	O
CD8	O
T	B-ANAT
cells	I-ANAT
.	O

Furthermore	O
,	O
increased	O
pathogenesis	O
was	O
associated	O
with	O
significantly	O
enhanced	O
accumulation	O
of	O
neutrophils	B-ANAT
,	O
tumor	O
necrosis	O
factor	O
alpha	O
,	O
interleukin	O
-	O
6	O
,	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
2	O
,	O
and	O
IFN	O
-	O
gamma	O
within	O
the	O
CNS	B-ANAT
.	O

The	O
absence	O
of	O
IFN	O
-	O
I	O
signaling	O
did	O
not	O
impair	O
induction	O
or	O
recruitment	O
of	O
virus	O
-	O
specific	O
CD8	O
T	B-ANAT
cells	I-ANAT
,	O
the	O
primary	O
adaptive	O
mediators	O
of	O
virus	O
clearance	O
in	O
wt	O
mice	O
.	O

Despite	O
similar	O
IFN	O
-	O
gamma	O
-	O
mediated	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
class	O
II	O
upregulation	O
on	O
microglia	B-ANAT
in	O
infected	O
IFNAR	O
(-/-)	O
mice	O
,	O
class	O
I	O
expression	O
was	O
reduced	O
compared	O
to	O
that	O
on	O
microglia	B-ANAT
in	O
wt	O
mice	O
,	O
suggesting	O
a	O
synergistic	O
role	O
of	O
IFN	O
-	O
I	O
and	O
IFN	O
-	O
gamma	O
in	O
optimizing	O
class	O
I	O
antigen	O
presentation	O
.	O

ABSTRACT	O
:	O
One	O
of	O
the	O
most	O
striking	O
and	O
dramatic	O
genomic	O
changes	O
observed	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
isolated	O
from	O
humans	O
soon	O
after	O
its	O
zoonotic	O
transmission	O
from	O
palm	B-ANAT
civets	O
was	O
the	O
acquisition	O
of	O
a	O
characteristic	O
29	O
-	O
nucleotide	O
deletion	O
.	O

ORF8b	O
appeared	O
not	O
to	O
be	O
expressed	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
or	O
when	O
expressed	O
from	O
mRNA	O
'	O
s	O
mimicking	O
mRNA8	O
.	O

Even	O
after	O
adjusting	O
for	O
these	O
baseline	O
differences	O
,	O
trauma	O
patients	O
had	O
significantly	O
lower	O
plasma	B-ANAT
levels	O
of	O
intercellular	O
adhesion	O
molecule	O
-	O
1	O
,	O
von	O
Willebrand	O
factor	O
antigen	O
,	O
surfactant	O
protein	O
-	O
D	O
,	O
and	O
soluble	O
tumor	O
necrosis	O
factor	O
receptor	O
-	O
1	O
,	O
which	O
are	O
biomarkers	O
of	O
lung	B-ANAT
epithelial	O
and	O
endothelial	B-ANAT
injury	O
previously	O
found	O
to	O
be	O
prognostic	O
in	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Six	O
-	O
month	O
survival	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
:	O
prospective	O
cohort	O
study	O
.	O

ABSTRACT	O
:	O
Both	O
short	O
-	O
and	O
long	O
-	O
term	O
outcome	O
studies	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
performed	O
thus	O
far	O
were	O
conducted	O
before	O
the	O
implementation	O
of	O
recent	O
advances	O
in	O
mechanical	O
ventilation	O
and	O
supportive	O
care	O
and	O
/	O
or	O
in	O
the	O
context	O
of	O
clinical	O
trials	O
with	O
restricted	O
inclusion	O
criteria	O
.	O

Animals	O
were	O
randomized	O
to	O
an	O
interventional	O
group	O
with	O
a	O
tidal	O
volume	O
of	O
3	O
mL	O
/	O
kg	O
with	O
interventional	O
lung	B-ANAT
assist	O
(	O
n	O
=	O
7	O
)	O
or	O
to	O
a	O
control	O
group	O
with	O
a	O
tidal	O
volume	O
of	O
6	O
mL	O
/	O
kg	O
without	O
interventional	O
lung	B-ANAT
assist	O
(	O
n	O
=	O
7	O
)	O
for	O
24	O
hrs	O
.	O

Organ	B-ANAT
function	O
in	O
vivo	O
was	O
determined	O
by	O
laboratory	O
analyses	O
,	O
including	O
calculations	O
of	O
pulmonary	B-ANAT
ventilation	O
/	O
perfusion	O
distribution	O
.	O

However	O
,	O
in	O
contrast	O
to	O
control	O
animals	O
,	O
animals	O
with	O
lower	O
tidal	O
volumes	O
and	O
interventional	O
lung	B-ANAT
assist	O
had	O
severe	O
ventilation	O
/	O
perfusion	O
mismatch	O
,	O
as	O
indicated	O
by	O
increased	O
perfusion	O
to	O
lung	B-ANAT
areas	O
with	O
a	O
low	O
ventilation	O
/	O
perfusion	O
ratio	O
(	O
p	O
<	O
.	O
05	O
).	O

Identification	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
an	O
obligate	O
cellular	B-ANAT
receptor	O
for	O
SARS	O
-	O
CoV	O
contributed	O
to	O
understanding	O
of	O
the	O
SARS	O
-	O
CoV	O
entry	O
process	O
,	O
and	O
helped	O
to	O
characterize	O
two	O
targets	O
of	O
antiviral	O
therapeutics	O
:	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
and	O
ACE2	O
.	O

ABSTRACT	O
:	O
The	O
orf3a	O
(	O
also	O
called	O
X1	O
or	O
U274	O
)	O
gene	O
is	O
the	O
largest	O
unique	O
open	O
reading	O
frame	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
genome	O
and	O
has	O
been	O
proposed	O
to	O
encode	O
a	O
protein	O
with	O
three	O
transmembrane	B-ANAT
domains	O
and	O
a	O
large	O
cytoplasmic	B-ANAT
domain	I-ANAT
.	O

Here	O
,	O
the	O
expression	O
of	O
the	O
3a	O
protein	O
in	O
various	O
in	O
vitro	O
systems	O
is	O
shown	O
,	O
it	O
has	O
been	O
localized	O
to	O
the	O
Golgi	B-ANAT
region	O
and	O
its	O
membrane	B-ANAT
topology	O
in	O
transfected	O
cells	B-ANAT
has	O
been	O
confirmed	O
.	O

Vaccination	O
with	O
killed	O
AIBV	O
vaccine	O
did	O
not	O
diminish	O
effects	O
on	O
sperm	B-ANAT
function	O
in	O
vivo	O
.	O

Diagnosis	O
is	O
based	O
on	O
a	O
finding	O
of	O
elevated	O
serum	B-ANAT
levels	O
of	O
components	O
that	O
are	O
normally	O
found	O
within	O
the	O
muscle	B-ANAT
cell	I-ANAT
,	O
chiefly	O
muscle	B-ANAT
enzymes	O
and	O
myoglobin	O
.	O

In	O
this	O
study	O
we	O
have	O
produced	O
purified	O
,	O
irradiated	O
SARS	O
-	O
CoV	O
virions	B-ANAT
that	O
retain	O
their	O
morphology	O
,	O
and	O
are	O
fusogenic	O
in	O
cell	B-ANAT
culture	O
.	O

Furthermore	O
,	O
our	O
results	O
show	O
that	O
receptor	O
binding	O
and	O
subsequent	O
membrane	B-ANAT
fusion	O
are	O
distinct	O
steps	O
,	O
and	O
that	O
each	O
spike	O
can	O
bind	O
up	O
to	O
three	O
ACE2	O
molecules	O
.	O

ABSTRACT	O
:	O
Virus	O
infection	O
in	O
vitro	O
can	O
either	O
result	O
in	O
a	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
or	O
proceed	O
without	O
visible	O
changes	O
in	O
infected	O
cells	B-ANAT
(	O
noncytopathic	O
infection	O
).	O

In	O
contrast	O
,	O
using	O
quantitative	O
reverse	O
transcription	O
-	O
PCR	O
and	O
metabolic	O
labeling	O
of	O
RNA	O
,	O
we	O
found	O
that	O
the	O
rate	O
of	O
viral	O
RNA	O
amplification	O
in	O
NIH	B-ANAT
3T3	I-ANAT
cells	I-ANAT
was	O
lower	O
than	O
the	O
rate	O
in	O
cells	B-ANAT
in	O
which	O
MHV	O
induces	O
a	O
CPE	O
.	O

TITLE	O
:	O
Transcriptional	O
profiling	O
of	O
Vero	O
E6	O
cells	B-ANAT
over	O
-	O
expressing	O
SARS	O
-	O
CoV	O
S2	O
subunit	O
:	O
insights	O
on	O
viral	O
regulation	O
of	O
apoptosis	O
and	O
proliferation	O
.	O

However	O
,	O
toxin	O
positive	O
stools	B-ANAT
were	O
more	O
common	O
among	O
nondiarrheic	O
calves	O
,	O
but	O
diarrheic	O
calves	O
were	O
nearly	O
twice	O
as	O
likely	O
to	O
be	O
culture	O
positive	O
.	O

TITLE	O
:	O
DRAK2	O
regulates	O
memory	O
T	B-ANAT
cell	I-ANAT
responses	O
following	O
murine	O
coronavirus	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
DRAK2	O
[	O
death	O
-	O
associated	O
protein	O
kinase	O
(	O
DAPK	O
)-	O
related	O
apoptosis	O
-	O
inducing	O
kinase	O
2	O
]	O
to	O
anti	O
-	O
viral	O
memory	O
T	B-ANAT
cell	I-ANAT
responses	O
following	O
infection	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
was	O
examined	O
.	O

We	O
designed	O
a	O
RNA	O
-	O
cleaving	O
10	O
-	O
23	O
DNAzyme	O
targeting	O
at	O
the	O
loop	O
region	O
of	O
the	O
5	O
'	O
UTR	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
designed	O
DNAzyme	O
,	O
Dz	O
-	O
104	O
,	O
and	O
its	O
mutant	O
version	O
,	O
Dz	O
-	O
104	O
(	O
mut	O
),	O
as	O
a	O
control	O
consist	O
of	O
9	O
+	O
9	O
arm	B-ANAT
sequences	O
with	O
a	O
10	O
-	O
23	O
catalytic	O
core	O
.	O

ABSTRACT	O
:	O
Negative	O
air	O
pressure	O
ventilation	O
has	O
been	O
used	O
to	O
maintain	O
adequate	O
functional	O
residual	O
capacity	O
in	O
patients	O
with	O
chronic	O
muscular	B-ANAT
disease	O
and	O
to	O
decrease	O
transpulmonary	O
pressure	O
and	O
improve	O
cardiac	B-ANAT
output	O
during	O
right	B-ANAT
heart	I-ANAT
surgery	O
.	O

CONCLUSIONS	O
:	O
Adequate	O
CNEP	O
combined	O
with	O
HFO	O
improves	O
oxygenation	O
with	O
less	O
impact	O
on	O
blood	B-ANAT
pressure	O
than	O
high	O
-	O
frequency	O
oscillation	O
alone	O
in	O
an	O
animal	O
model	O
of	O
respiratory	O
failure	O
.	O

Totally	O
148	O
patients	O
with	O
SARS	O
were	O
divided	O
into	O
the	O
following	O
groups	O
:	O
initial	O
stage	O
group	O
(	O
44	O
cases	O
)	O
and	O
after	O
the	O
initial	O
stage	O
group	O
(	O
104	O
cases	O
),	O
common	O
type	O
group	O
(	O
87	O
cases	O
)	O
and	O
severe	O
type	O
group	O
(	O
61	O
cases	O
),	O
unilobar	O
lung	B-ANAT
involvement	O
group	O
(	O
49	O
cases	O
),	O
bilobar	O
lung	B-ANAT
involvement	O
group	O
(	O
53	O
cases	O
)	O
and	O
diffuse	O
lung	B-ANAT
involvement	O
group	O
(	O
46	O
cases	O
).	O

Other	O
pathologic	O
changes	O
,	O
including	O
vasculitis	O
,	O
degeneration	O
,	O
and	O
necrosis	O
,	O
were	O
found	O
in	O
the	O
extrapulmonary	O
organs	B-ANAT
of	O
transgenic	O
mice	O
,	O
and	O
viral	O
antigen	O
was	O
found	O
in	O
brain	B-ANAT
.	O

In	O
an	O
effort	O
to	O
characterize	O
molecular	O
components	O
of	O
the	O
virus	O
that	O
are	O
absent	O
in	O
other	O
coronaviruses	O
,	O
all	O
of	O
which	O
are	O
considerably	O
less	O
pathogenic	O
for	O
humans	O
,	O
we	O
recombinantly	O
produced	O
the	O
SARS	O
-	O
unique	O
domain	O
(	O
SUD	O
)	O
within	O
non	O
-	O
structural	O
protein	O
3	O
(	O
Nsp3	O
)	O
of	O
SARS	O
-	O
CoV	O
and	O
characterized	O
its	O
nucleic	B-ANAT
-	O
acid	O
binding	O
properties	O
.	O

A	O
putative	O
role	O
of	O
SUD	O
in	O
virus	O
-	O
induced	O
apoptosis	O
or	O
survival	O
of	O
host	O
cells	B-ANAT
is	O
discussed	O
.	O

Probably	O
because	O
of	O
their	O
particular	O
immune	B-ANAT
system	I-ANAT
,	O
bats	O
can	O
be	O
considered	O
an	O
important	O
reservoir	O
for	O
new	O
emerging	O
viral	O
diseases	O
like	O
SARS	O
-	O
Coronavirus	O
,	O
Marburg	O
fever	O
,	O
Ebola	O
fever	O
and	O
Nipah	O
virus	O
encephalitis	O
.	O

Z	O
protein	O
was	O
used	O
as	O
antigen	O
to	O
immunize	O
the	O
rabbit	O
and	O
anti	O
-	O
Z	O
sera	B-ANAT
was	O
collected	O
.	O

Z	O
gene	O
was	O
successfully	O
designed	O
and	O
expressed	O
in	O
E	O
.	O
coli	O
BL21	B-ANAT
(	O
DE3	O
).	O

ELISA	O
analysis	O
indicated	O
the	O
SARS	O
-	O
CoV	O
antigen	O
prepared	O
from	O
SARS	O
-	O
CoV	O
lysates	O
can	O
be	O
detected	O
by	O
anti	O
-	O
Z	O
sera	B-ANAT
.	O

Anoxic	O
-	O
ischemic	O
brain	B-ANAT
injury	O
was	O
the	O
immediate	O
cause	O
of	O
death	O
in	O
all	O
delayed	O
SIDS	O
cases	O
.	O

We	O
conclude	O
that	O
iNO	O
therapy	O
leads	O
to	O
an	O
improvement	O
in	O
oxygenation	O
without	O
short	O
-	O
term	O
side	O
effects	O
(	O
such	O
as	O
pulmonary	B-ANAT
hemorrhage	O
,	O
intracranial	B-ANAT
hemorrhage	O
,	O
pneumothorax	O
or	O
acute	O
deterioration	O
)	O
in	O
premature	O
infants	O
with	O
severe	O
RDS	O
and	O
respiratory	O
failure	O
.	O

From	O
an	O
applied	O
perspective	O
,	O
these	O
results	O
indicate	O
that	O
vaccinated	O
commercial	O
outbred	O
chickens	O
with	O
these	O
MHC	B-ANAT
genotypes	O
are	O
equally	O
resistant	O
to	O
IBV	O
.	O

TITLE	O
:	O
Presence	O
of	O
cytokeratins	O
in	O
exhaled	O
breath	B-ANAT
condensate	O
of	O
mechanical	O
ventilated	O
patients	O
.	O

ABSTRACT	O
:	O
Exhaled	O
breath	B-ANAT
condensate	O
(	O
EBC	O
)	O
contains	O
small	O
amounts	O
of	O
protein	O
leaving	O
the	O
lung	B-ANAT
by	O
aerosol	O
droplet	O
generation	O
.	O

Among	O
several	O
important	O
ventilator	O
parameters	O
,	O
the	O
use	O
of	O
low	O
tidal	O
volumes	O
is	O
probably	O
the	O
most	O
important	O
feature	O
of	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
endogenous	O
ferret	O
CXCL10	O
exhibits	O
similar	O
mRNA	O
expression	O
patterns	O
in	O
the	O
lungs	B-ANAT
of	O
deceased	O
SARS	O
patients	O
and	O
ferrets	O
experimentally	O
infected	O
with	O
SARS	O
coronavirus	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
protein	O
7a	O
binds	O
directly	O
and	O
specifically	O
to	O
human	O
lymphocyte	B-ANAT
function	O
-	O
associated	O
antigen	O
1	O
(	O
LFA	O
-	O
1	O
)	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
of	O
Jurkat	B-ANAT
cells	I-ANAT
.	O

In	O
order	O
to	O
investigate	O
the	O
potential	O
role	O
of	O
proinflammatory	O
cytokines	O
in	O
disease	O
severity	O
after	O
coinfection	O
,	O
a	O
second	O
experiment	O
was	O
performed	O
to	O
examine	O
cytokine	O
transcription	O
in	O
alveolar	B-ANAT
macrophages	I-ANAT
from	O
single	O
and	O
dually	O
infected	O
pigs	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
disease	O
characterized	O
by	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Amniotic	B-ANAT
fluid	I-ANAT
embolism	O
or	O
anaphylactoid	O
syndrome	O
of	O
pregnancy	O
is	O
a	O
life	O
-	O
threatening	O
condition	O
.	O

ABSTRACT	O
:	O
The	O
upstream	O
end	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
mouse	O
hepatitis	O
virus	O
genome	O
contains	O
two	O
essential	O
and	O
overlapping	O
RNA	O
secondary	O
structures	O
,	O
a	O
bulged	O
stem	B-ANAT
-	O
loop	O
and	O
a	O
pseudoknot	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
elements	O
of	O
a	O
molecular	O
switch	O
that	O
is	O
critical	O
for	O
viral	O
RNA	O
synthesis	O
.	O

The	O
CLEIA	O
was	O
capable	O
of	O
detecting	O
recombinant	O
N	O
protein	O
at	O
1	O
.	O
56	O
pg	O
/	O
ml	O
and	O
viral	O
N	O
protein	O
in	O
SARS	O
CoV	O
cell	B-ANAT
culture	O
lysates	O
at	O
0	O
.	O
087	O
of	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
doses	O
/	O
ml	O
.	O

The	O
CLEIA	O
showed	O
no	O
cross	O
-	O
reactivities	O
to	O
recombinant	O
N	O
proteins	O
of	O
common	O
human	O
CoV	O
(	O
229E	O
,	O
OC43	O
,	O
and	O
NL63	O
)	O
or	O
lysates	O
of	O
cells	B-ANAT
infected	O
with	O
229E	O
and	O
OC43	O
.	O

TITLE	O
:	O
Theoretically	O
estimated	O
risk	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
transmission	O
through	O
blood	B-ANAT
transfusion	O
during	O
an	O
epidemic	O
in	O
Shenzhen	O
,	O
Guangdong	O
,	O
China	O
in	O
2003	O
.	O

Although	O
the	O
risk	O
is	O
low	O
,	O
with	O
its	O
rapid	O
spread	O
of	O
the	O
disease	O
,	O
appearance	O
of	O
alarmingly	O
high	O
infectivity	O
and	O
high	O
fatality	O
rate	O
,	O
public	O
health	O
authorities	O
need	O
to	O
consider	O
strategies	O
for	O
blood	B-ANAT
donor	O
recruitment	O
and	O
virus	O
inactivation	O
during	O
an	O
epidemic	O
to	O
further	O
ensure	O
blood	B-ANAT
safety	O
.	O

Herein	O
,	O
we	O
show	O
that	O
IFN	O
-	O
alpha	O
,	O
IFN	O
-	O
beta	O
and	O
IFN	O
-	O
gamma	O
act	O
in	O
concert	O
as	O
part	O
of	O
the	O
innate	O
immune	O
response	O
to	O
the	O
retinal	B-ANAT
infection	O
.	O

After	O
intranasal	O
inoculation	O
,	O
the	O
virus	O
was	O
isolated	O
from	O
respiratory	O
swabs	O
on	O
days	O
2	O
-	O
7	O
postinoculation	O
(	O
p	O
.	O
i	O
.)	O
and	O
virus	O
genome	O
was	O
detected	O
in	O
intestinal	B-ANAT
tissues	B-ANAT
on	O
day	O
7	O
p	O
.	O
i	O
.	O

After	O
intratracheal	O
(	O
i	O
.	O
t	O
.)	O
inoculation	O
,	O
virus	O
antigen	O
-	O
positive	O
alveolar	B-ANAT
cells	B-ANAT
and	O
macrophages	B-ANAT
were	O
found	O
in	O
lung	B-ANAT
and	O
infectious	O
virus	O
was	O
detected	O
in	O
lymphoid	O
and	O
intestinal	B-ANAT
tissues	B-ANAT
.	O

ABSTRACT	O
:	O
Human	O
respiratory	O
syncytial	O
virus	O
(	O
HRSV	O
)	O
is	O
the	O
major	O
viral	O
cause	O
of	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
children	O
.	O

HRSV	O
was	O
detected	O
in	O
43	O
%	O
(	O
140	O
/	O
326	O
)	O
of	O
the	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
.	O

A	O
neutral	O
red	O
uptake	O
assay	O
was	O
used	O
to	O
determine	O
50	O
%	O
virus	O
-	O
inhibitory	O
concentrations	O
(	O
EC50	O
)	O
of	O
test	O
compounds	O
and	O
their	O
50	O
%	O
cytotoxicity	O
concentration	O
(	O
CC50	O
)	O
in	O
uninfected	O
Madin	O
-	O
Darby	O
canine	O
kidney	B-ANAT
,	O
Vero	O
,	O
and	O
Vero	O
76	O
cells	B-ANAT
;	O
selectivity	O
indices	O
(	O
ratio	O
of	O
CC50	O
to	O
EC50	O
)	O
were	O
derived	O
from	O
the	O
data	O
.	O

We	O
treated	O
her	O
with	O
antituberculosis	O
chemotherapy	O
,	O
corticosteroid	O
,	O
sivelestat	O
sodium	O
hydrate	O
,	O
direct	O
hemoperfusion	O
using	O
a	O
polymyxin	O
B	O
immobilized	O
column	B-ANAT
,	O
and	O
mechanical	O
ventilation	O
,	O
but	O
she	O
died	O
due	O
to	O
respiratory	O
failure	O
.	O

We	O
demonstrated	O
that	O
CQ	O
affects	O
the	O
activation	O
of	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
(	O
ERK	O
).	O

TITLE	O
:	O
Human	O
monoclonal	O
antibodies	O
by	O
immortalization	O
of	O
memory	O
B	B-ANAT
cells	I-ANAT
.	O

Although	O
IMS	O
is	O
well	O
recognized	O
as	O
a	O
disorder	O
of	O
neuromuscular	B-ANAT
junctions	I-ANAT
,	O
its	O
exact	O
etiology	O
,	O
incidence	O
,	O
and	O
risk	O
factors	O
are	O
not	O
clearly	O
defined	O
because	O
existing	O
studies	O
are	O
largely	O
small	O
-	O
scale	O
case	O
series	O
and	O
do	O
not	O
employ	O
a	O
consistent	O
and	O
rigorous	O
definition	O
of	O
IMS	O
.	O

ABSTRACT	O
:	O
Endoluminal	O
aortic	B-ANAT
stent	O
grafting	B-ANAT
offers	O
a	O
potentially	O
less	O
invasive	O
alternative	O
to	O
open	O
chest	B-ANAT
surgery	O
,	O
especially	O
in	O
patients	O
with	O
polytrauma	O
.	O

We	O
compare	O
the	O
results	O
of	O
conventional	O
surgical	O
repair	O
and	O
endovascular	B-ANAT
treatment	O
of	O
traumatic	O
aortic	B-ANAT
rupture	O
.	O

The	O
most	O
common	O
cause	O
of	O
death	O
in	O
the	O
surgical	O
group	O
was	O
brain	B-ANAT
death	O
in	O
severe	O
traumatic	O
patients	O
.	O

Ten	O
surgical	O
complications	O
occurred	O
in	O
5	O
patients	O
:	O
respiratory	O
insufficiency	O
(	O
n	O
=	O
3	O
),	O
pulmonary	B-ANAT
infection	O
(	O
n	O
=	O
2	O
),	O
recurrent	O
nerve	B-ANAT
palsy	O
(	O
n	O
=	O
2	O
),	O
repeat	O
thoracotomy	O
(	O
n	O
=	O
2	O
),	O
and	O
compartment	B-ANAT
syndrome	O
(	O
n	O
=	O
1	O
).	O

Two	O
patients	O
underwent	O
surgical	O
repair	O
15	O
days	O
and	O
4	O
months	O
after	O
endografting	O
because	O
of	O
injury	O
of	O
the	O
aortic	B-ANAT
wall	I-ANAT
by	O
the	O
stent	O
and	O
development	O
of	O
a	O
spurious	O
aneurysm	O
,	O
respectively	O
.	O

In	O
the	O
treatment	O
of	O
traumatic	O
thoracic	B-ANAT
aortic	B-ANAT
rupture	O
,	O
the	O
early	O
outcome	O
of	O
patients	O
treated	O
with	O
endovascular	B-ANAT
stent	O
grafts	B-ANAT
appears	O
to	O
be	O
better	O
than	O
that	O
with	O
conventional	O
surgical	O
repair	O
.	O

Two	O
patients	O
underwent	O
surgical	O
repair	O
15	O
days	O
and	O
4	O
months	O
after	O
endografting	O
because	O
of	O
injury	O
of	O
the	O
aortic	B-ANAT
wall	I-ANAT
by	O
the	O
stent	O
and	O
development	O
of	O
a	O
spurious	O
aneurysm	O
,	O
respectively	O
.	O

The	O
National	O
Heart	B-ANAT
,	O
Lung	B-ANAT
,	O
and	O
Blood	B-ANAT
Institute	O
(	O
NHLBI	O
)	O
and	O
Canadian	O
Consensus	O
Conference	O
definitions	O
of	O
TRALI	O
exclude	O
cases	O
of	O
mild	O
TRALI	O
.	O

Despite	O
the	O
sudden	O
onset	O
of	O
a	O
pulmonary	B-ANAT
syndrome	O
in	O
association	O
with	O
transfusion	O
,	O
clinicians	O
caring	O
for	O
these	O
patients	O
did	O
not	O
consider	O
TRALI	O
,	O
and	O
no	O
case	O
would	O
meet	O
recent	O
consensus	O
definitions	O
.	O

TITLE	O
:	O
Comparison	O
of	O
acute	O
non	O
-	O
haemolytic	O
transfusion	O
reactions	O
in	O
female	O
and	O
male	O
patients	O
receiving	O
female	O
or	O
male	O
blood	B-ANAT
components	I-ANAT
.	O

The	O
patients	O
were	O
also	O
screened	O
for	O
anti	O
-	O
plasma	B-ANAT
protein	O
antibodies	O
.	O

The	O
frequency	O
of	O
the	O
anti	O
-	O
HLA	B-ANAT
antibodies	O
,	O
but	O
not	O
that	O
of	O
the	O
non	O
-	O
HLA	B-ANAT
antibodies	O
,	O
was	O
significantly	O
higher	O
in	O
females	O
.	O

Four	O
main	O
types	O
of	O
lesions	O
were	O
observed	O
:	O
diffuse	O
granulomatous	O
inflammation	O
on	O
serosal	B-ANAT
surfaces	O
;	O
granulomas	O
with	O
areas	O
of	O
necrosis	O
;	O
granulomas	O
without	O
necrosis	O
;	O
and	O
granulomas	O
with	O
neutrophils	B-ANAT
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
-	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
regulatory	O
protein	O
of	O
the	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
(	O
RAS	O
)	O
and	O
a	O
receptor	O
for	O
the	O
causative	O
agent	O
of	O
severe	O
-	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
the	O
SARS	O
-	O
coronavirus	O
.	O

The	O
maximal	O
radiographic	O
score	O
correlated	O
best	O
with	O
the	O
percentage	O
of	O
lymphocytes	B-ANAT
in	O
a	O
leukocyte	B-ANAT
count	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
while	O
the	O
second	O
most	O
significant	O
factor	O
was	O
the	O
number	O
of	O
hospitalized	O
days	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
third	O
most	O
significant	O
factor	O
was	O
the	O
absolute	O
lymphocyte	B-ANAT
count	O
(	O
p	O
=	O
0	O
.	O
013	O
).	O

The	O
severity	O
of	O
abnormalities	O
quantified	O
on	O
chest	B-ANAT
radiographs	O
in	O
patients	O
with	O
SARS	O
correlates	O
with	O
the	O
clinical	O
parameters	O
.	O

CONCLUSIONS	O
:	O
The	O
severity	O
of	O
abnormalities	O
quantified	O
on	O
chest	B-ANAT
radiographs	O
in	O
patients	O
with	O
SARS	O
correlates	O
with	O
the	O
clinical	O
parameters	O
.	O

High	O
doses	O
of	O
vasopressors	O
along	O
with	O
massive	O
amounts	O
of	O
parenteral	O
fluids	B-ANAT
were	O
necessary	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
receptor	O
usage	O
of	O
the	O
SL	O
-	O
CoV	O
S	O
by	O
combining	O
a	O
human	O
immunodeficiency	O
virus	O
-	O
based	O
pseudovirus	O
system	O
with	O
cell	B-ANAT
lines	I-ANAT
expressing	O
the	O
ACE2	O
molecules	O
of	O
human	O
,	O
civet	O
,	O
or	O
horseshoe	O
bat	O
.	O

Prevention	O
includes	O
epidemiological	O
control	O
of	O
donor	O
populations	O
;	O
checks	O
on	O
each	O
donor	O
'	O
s	O
health	O
condition	O
;	O
analysis	O
of	O
each	O
donation	O
for	O
the	O
main	O
pathogens	O
using	O
serological	O
methods	O
;	O
additional	O
analysis	O
of	O
all	O
plasma	B-ANAT
for	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
),	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
),	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
),	O
hepatitis	O
A	O
virus	O
(	O
HAV	O
)	O
and	O
the	O
B19	O
virus	O
,	O
using	O
nucleic	B-ANAT
acid	O
amplification	O
techniques	O
(	O
NAT	O
).	O

A	O
60	O
days	O
or	O
longer	O
inventory	O
hold	O
of	O
all	O
plasma	B-ANAT
donations	O
is	O
applied	O
,	O
to	O
allow	O
additional	O
time	O
to	O
discard	O
previous	O
donations	O
from	O
potential	O
seroconverting	O
or	O
otherwise	O
rejectable	O
donors	O
.	O

Analytical	O
methods	O
capable	O
of	O
detecting	O
the	O
vCJD	O
agent	O
in	O
patients	O
'	O
brains	B-ANAT
(	O
where	O
high	O
titres	O
are	O
found	O
)	O
and	O
other	O
tissues	B-ANAT
(	O
such	O
as	O
the	O
spleen	B-ANAT
,	O
appendix	B-ANAT
and	O
lymph	B-ANAT
nodes	I-ANAT
,	O
where	O
much	O
lower	O
concentrations	O
are	O
found	O
)	O
are	O
unable	O
to	O
detect	O
the	O
agent	O
in	O
blood	B-ANAT
or	O
plasma	B-ANAT
from	O
patients	O
with	O
vCJD	O
,	O
even	O
in	O
the	O
clinical	O
phase	O
of	O
the	O
disease	O
.	O

In	O
this	O
study	O
,	O
RNA	O
aptamers	O
against	O
SCV	O
NTPase	O
/	O
Helicase	O
(	O
nsP10	O
)	O
were	O
isolated	O
from	O
RNA	O
library	O
containing	O
random	O
sequences	O
of	O
40	O
nts	B-ANAT
using	O
in	O
vitro	O
selection	O
technique	O
.	O

All	O
had	O
liver	B-ANAT
biopsies	O
revealing	O
histologic	O
evidence	O
of	O
alcoholic	O
hepatitis	O
.	O

TITLE	O
:	O
[	O
Epidemiology	O
of	O
acute	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
children	O
].	O

In	O
addition	O
culture	O
of	O
secretions	B-ANAT
from	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
is	O
not	O
useful	O
since	O
the	O
normal	O
flora	O
includes	O
the	O
bacteria	O
commonly	O
responsible	O
for	O
pneumonia	O
.	O

Deletion	O
of	O
a	O
dilysine	O
motif	O
that	O
has	O
previously	O
been	O
suggested	O
to	O
function	O
as	O
a	O
retrieval	O
signal	O
did	O
not	O
abolish	O
intracellular	B-ANAT
retention	O
.	O

In	O
coexpression	O
experiments	O
,	O
the	O
S	O
protein	O
was	O
found	O
to	O
colocalize	O
with	O
a	O
Golgi	B-ANAT
marker	O
.	O

Both	O
wild	O
-	O
type	O
donor	O
CD90	O
.	O
1	O
and	O
recipient	O
CD90	O
.	O
2	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
trafficked	O
into	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
parenchyma	B-ANAT
and	O
localized	O
to	O
infected	O
white	B-ANAT
matter	I-ANAT
,	O
correlating	O
with	O
decreased	O
numbers	O
of	O
virus	O
-	O
infected	O
oligodendrocytes	B-ANAT
in	O
the	O
CNS	B-ANAT
.	O

We	O
have	O
reported	O
that	O
IL	O
-	O
1beta	O
is	O
elevated	O
in	O
pulmonary	B-ANAT
edema	O
fluid	O
in	O
those	O
with	O
ALI	O
and	O
mediates	O
an	O
autocrine	O
-	O
acting	O
,	O
fibroblast	B-ANAT
mitogenic	O
pathway	O
.	O

Taken	O
together	O
,	O
these	O
data	O
demonstrate	O
that	O
PGE2	O
can	O
stimulate	O
or	O
inhibit	O
fibroblast	B-ANAT
proliferation	O
at	O
clinically	O
relevant	O
concentrations	O
,	O
via	O
preferential	O
signaling	O
through	O
EP3	O
or	O
EP2	O
receptors	O
,	O
respectively	O
.	O

Management	O
included	O
placement	O
of	O
the	O
arteriovenous	O
femoral	B-ANAT
transcutaneous	O
interventional	O
lung	B-ANAT
-	O
assist	O
membrane	B-ANAT
ventilator	O
,	O
lung	B-ANAT
rest	O
at	O
minimal	O
mechanical	O
ventilator	O
settings	O
,	O
and	O
optimization	O
of	O
systemic	O
oxygen	O
consumption	O
and	O
delivery	O
.	O

Among	O
239	O
pulmonary	B-ANAT
resections	O
performed	O
between	O
2005	O
and	O
2006	O
,	O
7	O
patients	O
(	O
2	O
.	O
9	O
%)	O
experienced	O
,	O
4	O
+/-	O

ABSTRACT	O
:	O
The	O
transmission	O
of	O
Mycobacterium	O
tuberculosis	O
(	O
TB	O
)	O
requires	O
extensive	O
damage	O
to	O
the	O
lungs	B-ANAT
to	O
facilitate	O
bacterial	O
release	O
into	O
the	O
airways	O
,	O
and	O
it	O
is	O
therefore	O
likely	O
that	O
the	O
microorganism	O
has	O
evolved	O
mechanisms	O
to	O
exacerbate	O
its	O
local	O
pathology	O
.	O

In	O
Vero	O
E6	O
and	O
A549	O
cells	B-ANAT
,	O
a	O
high	O
proportion	O
of	O
N	O
was	O
cleaved	B-ANAT
by	O
caspases	O
.	O

In	O
the	O
absence	O
of	O
tissue	B-ANAT
hypoperfusion	O
,	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
or	O
acute	O
hemorrhage	O
,	O
target	O
a	O
hemoglobin	O
of	O
7	O
-	O
9	O
g	O
/	O
dL	O
(	O
1B	O
);	O
a	O
low	O
tidal	O
volume	O
(	O
1B	O
)	O
and	O
limitation	O
of	O
inspiratory	O
plateau	O
pressure	O
strategy	O
(	O
1C	O
)	O
for	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
application	O
of	O
at	O
least	O
a	O
minimal	O
amount	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
1C	O
);	O
head	B-ANAT
of	O
bed	O
elevation	O
in	O
mechanically	O
ventilated	O
patients	O
unless	O
contraindicated	O
(	O
1B	O
);	O
avoiding	O
routine	O
use	O
of	O
pulmonary	B-ANAT
artery	I-ANAT
catheters	O
in	O
ALI	O
/	O
ARDS	O
(	O
1A	O
);	O
to	O
decrease	O
days	O
of	O
mechanical	O
ventilation	O
and	O
ICU	O
length	O
of	O
stay	O
,	O
a	O
conservative	O
fluid	O
strategy	O
for	O
patients	O
with	O
established	O
ALI	O
/	O
ARDS	O
who	O
are	O
not	O
in	O
shock	O
(	O
1C	O
);	O
protocols	O
for	O
weaning	O
and	O
sedation	O
/	O
analgesia	O
(	O
1B	O
);	O
using	O
either	O
intermittent	O
bolus	O
sedation	O
or	O
continuous	O
infusion	O
sedation	O
with	O
daily	O
interruptions	O
or	O
lightening	O
(	O
1B	O
);	O
avoidance	O
of	O
neuromuscular	O
blockers	O
,	O
if	O
at	O
all	O
possible	O
(	O
1B	O
);	O
institution	O
of	O
glycemic	O
control	O
(	O
1B	O
),	O
targeting	O
a	O
blood	B-ANAT
glucose	O
<	O
150	O
mg	O
/	O
dL	O
after	O
initial	O
stabilization	O
(	O
2C	O
);	O
equivalency	O
of	O
continuous	O
veno	O
-	O
veno	O
hemofiltration	O
or	O
intermittent	O
hemodialysis	O
(	O
2B	O
);	O
prophylaxis	O
for	O
deep	B-ANAT
vein	I-ANAT
thrombosis	O
(	O
1A	O
);	O
use	O
of	O
stress	O
ulcer	O
prophylaxis	O
to	O
prevent	O
upper	B-ANAT
gastrointestinal	I-ANAT
bleeding	O
using	O
H2	O
blockers	O
(	O
1A	O
)	O
or	O
proton	O
pump	O
inhibitors	O
(	O
1B	O
);	O
and	O
consideration	O
of	O
limitation	O
of	O
support	O
where	O
appropriate	O
(	O
1D	O
).	O

RESULTS	O
:	O
Key	O
recommendations	O
,	O
listed	O
by	O
category	O
,	O
include	O
early	O
goal	O
-	O
directed	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
hrs	O
after	O
recognition	O
(	O
1C	O
);	O
blood	B-ANAT
cultures	O
before	O
antibiotic	O
therapy	O
(	O
1C	O
);	O
imaging	O
studies	O
performed	O
promptly	O
to	O
confirm	O
potential	O
source	O
of	O
infection	O
(	O
1C	O
);	O
administration	O
of	O
broad	O
-	O
spectrum	O
antibiotic	O
therapy	O
within	O
1	O
hr	O
of	O
diagnosis	O
of	O
septic	O
shock	O
(	O
1B	O
)	O
and	O
severe	O
sepsis	O
without	O
septic	O
shock	O
(	O
1D	O
);	O
reassessment	O
of	O
antibiotic	O
therapy	O
with	O
microbiology	O
and	O
clinical	O
data	O
to	O
narrow	O
coverage	O
,	O
when	O
appropriate	O
(	O
1C	O
);	O
a	O
usual	O
7	O
-	O
10	O
days	O
of	O
antibiotic	O
therapy	O
guided	O
by	O
clinical	O
response	O
(	O
1D	O
);	O
source	O
control	O
with	O
attention	O
to	O
the	O
balance	O
of	O
risks	O
and	O
benefits	O
of	O
the	O
chosen	O
method	O
(	O
1C	O
);	O
administration	O
of	O
either	O
crystalloid	B-ANAT
or	O
colloid	B-ANAT
fluid	O
resuscitation	O
(	O
1B	O
);	O
fluid	O
challenge	O
to	O
restore	O
mean	O
circulating	O
filling	O
pressure	O
(	O
1C	O
);	O
reduction	O
in	O
rate	O
of	O
fluid	O
administration	O
with	O
rising	O
filing	O
pressures	O
and	O
no	O
improvement	O
in	O
tissue	B-ANAT
perfusion	O
(	O
1D	O
);	O
vasopressor	O
preference	O
for	O
norepinephrine	O
or	O
dopamine	O
to	O
maintain	O
an	O
initial	O
target	O
of	O
mean	O
arterial	B-ANAT
pressure	O
>	O
or	O
=	O
65	O
mm	O
Hg	O
(	O
1C	O
);	O
dobutamine	O
inotropic	O
therapy	O
when	O
cardiac	B-ANAT
output	O
remains	O
low	O
despite	O
fluid	O
resuscitation	O
and	O
combined	O
inotropic	O
/	O
vasopressor	O
therapy	O
(	O
1C	O
);	O
stress	O
-	O
dose	O
steroid	O
therapy	O
given	O
only	O
in	O
septic	O
shock	O
after	O
blood	B-ANAT
pressure	O
is	O
identified	O
to	O
be	O
poorly	O
responsive	O
to	O
fluid	O
and	O
vasopressor	O
therapy	O
(	O
2C	O
);	O
recombinant	O
activated	O
protein	O
C	O
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
clinical	O
assessment	O
of	O
high	O
risk	O
for	O
death	O
(	O
2B	O
except	O
2C	O
for	O
postoperative	O
patients	O
).	O

TITLE	O
:	O
Mannan	O
-	O
binding	O
lectin	O
(	O
MBL	O
)	O
serum	B-ANAT
concentration	O
in	O
relation	O
to	O
propagation	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
in	O
chickens	O
.	O

Results	O
suggested	O
that	O
MBL	O
plays	O
a	O
role	O
in	O
the	O
innate	O
immunity	O
against	O
IBV	O
in	O
the	O
way	O
that	O
it	O
performs	O
an	O
acute	O
phase	O
response	O
,	O
is	O
able	O
to	O
activate	O
complement	O
,	O
and	O
inhibits	O
the	O
propagation	O
of	O
the	O
virus	O
in	O
the	O
trachea	B-ANAT
.	O

ABSTRACT	O
:	O
We	O
intended	O
to	O
evaluate	O
the	O
diagnostic	O
usefulness	O
of	O
a	O
multiplex	O
reverse	O
transcriptase	O
-	O
PCR	O
(	O
mRT	B-ANAT
-	O
PCR	O
)	O
assay	O
kit	O
under	O
dual	O
priming	O
oligonucleotide	O
system	O
(	O
DPO	O
)	O
for	O
the	O
childhood	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

Two	O
hundred	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
taken	O
from	O
children	O
<	O
or	O
=	O
5	O
yr	O
old	O
admitted	O
due	O
to	O
acute	O
respiratory	O
infections	O
in	O
2004	O
.	O

FA	O
assays	O
for	O
five	O
common	O
respiratory	O
viruses	O
showed	O
positive	O
results	O
in	O
66	O
patients	O
(	O
33	O
.	O
0	O
%),	O
while	O
mRT	B-ANAT
-	O
PCR	O
detected	O
causative	O
viruses	O
in	O
112	O
patients	O
(	O
56	O
.	O
0	O
%),	O
including	O
16	O
co	O
-	O
infected	O
cases	O
(	O
8	O
.	O
0	O
%).	O

DPO	O
-	O
based	O
mRT	B-ANAT
-	O
PCR	O
was	O
found	O
as	O
a	O
sensitive	O
tool	O
for	O
the	O
detection	O
of	O
the	O
viruses	O
that	O
cause	O
childhood	O
respiratory	O
infections	O
.	O

TITLE	O
:	O
Severe	O
pulmonary	B-ANAT
oedema	O
following	O
therapeutic	O
embolization	O
with	O
Onyx	O
for	O
cerebral	B-ANAT
arteriovenous	O
malformation	O
.	O

It	O
is	O
associated	O
with	O
absence	O
of	O
left	B-ANAT
heart	I-ANAT
failure	O
and	O
a	O
PaO2	O
/	O
FiO2	O
ratio	O
of	O
<	O
or	O
=	O
200	O
.	O

Differences	O
in	O
growth	O
rate	O
and	O
CPE	O
between	O
the	O
KT2	O
-	O
L	O
and	O
KT2	O
-	O
H	O
strains	O
were	O
discovered	O
in	O
swine	O
testicular	O
cells	B-ANAT
(	O
STCs	O
).	O

ABSTRACT	O
:	O
Steady	O
-	O
state	O
mild	O
pulmonary	B-ANAT
hypertension	O
is	O
a	O
risk	O
factor	O
for	O
death	O
in	O
adults	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

Pulmonary	B-ANAT
pressures	O
increase	O
during	O
severe	O
acute	O
chest	B-ANAT
syndrome	O
,	O
and	O
pulmonary	B-ANAT
hypertension	O
is	O
associated	O
with	O
cardiac	B-ANAT
biomarker	O
elevation	O
and	O
a	O
higher	O
risk	O
of	O
death	O
.	O

vaccination	O
against	O
SARS	O
-	O
CoV	O
challenge	O
in	O
mice	O
;	O
4	O
)	O
higher	O
titers	O
of	O
mucosal	B-ANAT
IgA	O
and	O
serum	B-ANAT
-	O
neutralizing	O
Ab	O
were	O
associated	O
with	O
lower	O
viral	O
load	O
and	O
less	O
pulmonary	B-ANAT
pathological	O
damage	O
,	O
while	O
no	O
Ab	O
-	O
mediated	O
disease	O
enhancement	O
effect	O
was	O
observed	O
;	O
and	O
5	O
)	O
the	O
vaccination	O
could	O
provide	O
long	O
-	O
term	O
protection	O
against	O
SARS	O
-	O
CoV	O
infection	O
.	O

vaccination	O
may	O
be	O
the	O
preferred	O
route	O
of	O
administration	O
due	O
to	O
its	O
ability	O
to	O
induce	O
SARS	O
-	O
CoV	O
-	O
specific	O
systemic	O
and	O
mucosal	B-ANAT
immune	O
responses	O
and	O
its	O
better	O
safety	O
profile	O
.	O

One	O
hundred	O
twenty	O
sera	B-ANAT
collected	O
from	O
cats	O
belonging	O
to	O
catteries	O
or	O
community	O
shelters	O
and	O
to	O
households	O
were	O
tested	O
for	O
FCoV	O
type	O
I	O
and	O
II	O
antibodies	O
.	O

A	O
comparison	O
of	O
intracellular	B-ANAT
and	O
extracellular	B-ANAT
virus	O
yields	O
suggested	O
that	O
release	O
is	O
only	O
slightly	O
impaired	O
.	O

Many	O
of	O
these	O
observations	O
were	O
corroborated	O
in	O
the	O
context	O
of	O
natural	O
MHV	O
infections	O
,	O
with	O
native	O
E	O
,	O
but	O
not	O
E	O
.	O
T	O
,	O
complementing	O
debilitated	O
recombinant	O
MHVs	O
lacking	O
E	O
.	O
Our	O
findings	O
suggest	O
that	O
palmitoylations	O
are	O
essential	O
for	O
E	O
to	O
act	O
as	O
a	O
vesicle	B-ANAT
morphogenetic	O
protein	O
and	O
further	O
argue	O
that	O
palmitoylated	O
E	O
proteins	O
operate	O
by	O
allowing	O
the	O
primary	O
coronavirus	O
assembly	O
subunits	O
to	O
assume	O
configurations	O
that	O
can	O
mobilize	O
into	O
secreted	O
lipid	O
vesicles	B-ANAT
and	O
virions	B-ANAT
.	O

TITLE	O
:	O
Lack	O
of	O
association	O
between	O
HLA	B-ANAT
-	O
A	O
,	O
-	O
B	O
and	O
-	O
DRB1	O
alleles	O
and	O
the	O
development	O
of	O
SARS	O
:	O
a	O
cohort	O
of	O
95	O
SARS	O
-	O
recovered	O
individuals	O
in	O
a	O
population	O
of	O
Guangdong	O
,	O
southern	O
China	O
.	O

HLA	B-ANAT
-	O
A	O
,	O
-	O
B	O
and	O
-	O
DRB1	O
alleles	O
were	O
genotyped	O
using	O
polymerase	O
chain	O
reaction	O
with	O
sequence	O
-	O
specific	O
primers	O
.	O

The	O
severity	O
of	O
the	O
disease	O
was	O
assessed	O
according	O
to	O
the	O
history	O
of	O
lung	B-ANAT
infiltration	O
,	O
usage	O
of	O
assisted	O
ventilation	O
and	O
occurrence	O
of	O
lymphocytopenia	O
.	O

The	O
novel	O
immunoassay	O
is	O
highly	O
useful	O
for	O
epidemiologic	O
surveys	O
,	O
where	O
use	O
of	O
nucleic	B-ANAT
acid	O
diagnostics	O
often	O
is	O
limited	O
.	O

However	O
,	O
the	O
potential	O
of	O
this	O
assay	O
could	O
clearly	O
be	O
demonstrated	O
employing	O
SARS	O
-	O
positive	O
serum	B-ANAT
samples	O
,	O
where	O
nonspecific	O
binding	O
to	O
nucleocapsids	O
of	O
other	O
HCoVs	O
was	O
not	O
observed	O
.	O

When	O
the	O
patient	O
was	O
re	O
-	O
exposed	O
to	O
amoxapine	O
(	O
52	O
.	O
5	O
mg	O
total	O
dose	O
),	O
high	O
fever	O
,	O
reduced	O
SaO	O
(	O
2	O
)	O
and	O
pulmonary	B-ANAT
infiltrates	O
reappeared	O
.	O

Twenty	O
-	O
five	O
percent	O
of	O
these	O
patients	O
had	O
severe	O
acute	O
lung	B-ANAT
injury	O
requiring	O
artificial	O
ventilation	O
support	O
.	O

ABSTRACT	O
:	O
Two	O
years	O
after	O
the	O
SARS	O
outbreak	O
in	O
Hong	O
Kong	O
,	O
128	O
healthcare	O
workers	O
continued	O
to	O
present	O
with	O
musculoskeletal	O
complaints	O
and	O
38	O
workers	O
were	O
diagnosed	O
with	O
avascular	O
necrosis	O
(	O
AVN	O
)	O
in	O
different	O
joints	B-ANAT
.	O

A	O
reporter	O
gene	O
encoding	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
was	O
inserted	O
into	O
one	O
segment	O
,	O
and	O
a	O
red	O
fluorescent	O
protein	O
dsRed	O
gene	O
was	O
inserted	O
into	O
the	O
other	O
segment	O
in	O
order	O
to	O
easily	O
detect	O
the	O
replication	O
and	O
transcription	O
of	O
segments	O
in	O
infected	O
cells	B-ANAT
.	O

The	O
aromatic	O
amino	O
acids	O
in	O
the	O
JMD	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
play	O
critical	O
roles	O
in	O
receptor	O
-	O
dependent	O
virus	O
-	O
cell	B-ANAT
and	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
a	O
major	O
cause	O
of	O
acute	O
respiratory	O
failure	O
in	O
the	O
critically	O
ill	O
patient	O
.	O

The	O
pathophysiology	O
of	O
ALI	O
/	O
ARDS	O
involves	O
resident	O
lung	B-ANAT
cells	B-ANAT
,	O
including	O
endothelial	B-ANAT
and	O
epithelial	B-ANAT
cells	I-ANAT
,	O
as	O
well	O
as	O
neutrophils	B-ANAT
,	O
monocytes	B-ANAT
/	O
macrophages	B-ANAT
,	O
and	O
platelets	B-ANAT
.	O

TITLE	O
:	O
Induction	O
of	O
class	O
I	O
antigen	O
processing	O
components	O
in	O
oligodendroglia	B-ANAT
and	O
microglia	B-ANAT
during	O
viral	O
encephalomyelitis	O
.	O

Flow	O
cytometry	O
demonstrated	O
delayed	O
Class	O
I	O
surface	O
expression	O
by	O
oligodendroglia	B-ANAT
compared	O
with	O
microglia	B-ANAT
.	O

Microglia	B-ANAT
isolated	O
from	O
naÃ¯ve	O
mice	O
expressed	O
high	O
levels	O
of	O
these	O
mRNAs	O
,	O
whereas	O
they	O
were	O
near	O
detection	O
limits	O
in	O
oligodendroglia	B-ANAT
;	O
nevertheless	O
,	O
Class	O
I	O
protein	O
was	O
undetectable	O
on	O
both	O
cell	B-ANAT
types	O
.	O

The	O
delayed	O
,	O
yet	O
robust	O
,	O
IFN	O
gamma	O
dependent	O
capacity	O
of	O
oligodendroglia	B-ANAT
to	O
express	O
Class	O
I	O
suggests	O
strict	O
control	O
of	O
immune	O
interactions	O
to	O
avoid	O
CD8	O
T	B-ANAT
cell	I-ANAT
recognition	O
and	O
potential	O
presentation	O
of	O
autoantigen	O
to	O
preserve	O
myelin	B-ANAT
maintenance	O
.	O

TITLE	O
:	O
[	O
Pulmonary	B-ANAT
function	O
in	O
children	O
after	O
neonatal	O
meconium	B-ANAT
aspiration	O
syndrome	O
].	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
assess	O
long	O
term	O
respiratory	O
residual	O
damage	O
from	O
meconium	B-ANAT
aspiration	O
syndrome	O
.	O

During	O
a	O
seven	O
-	O
year	O
period	O
going	O
from	O
1994	O
to	O
2000	O
,	O
we	O
reviewed	O
the	O
files	O
of	O
children	O
hospitalized	O
in	O
neonatology	O
department	O
of	O
Sfax	O
for	O
meconium	B-ANAT
aspiration	O
syndrome	O
.	O

Spirometry	O
revealed	O
a	O
total	O
pulmonary	B-ANAT
capacity	O
in	O
an	O
average	O
of	O
133	O
+/-	O
55	O
.	O
65	O
%	O
of	O
theoretical	O
(	O
group	O
M	O
)	O
versus	O
105	O
.	O
5	O
+/-	O
27	O
.	O
96	O
%	O
of	O
theoretical	O
(	O
group	O
C	O
)	O
(	O
P	O
<	O
0	O
,	O
01	O
),	O
testifying	O
to	O
alveolar	B-ANAT
hyperinflation	O
.	O

Patients	O
admitted	O
during	O
an	O
L1	O
designation	O
with	O
a	O
severe	O
head	B-ANAT
,	O
chest	B-ANAT
,	O
or	O
abdominal	B-ANAT
or	O
pelvic	B-ANAT
injury	O
diagnosis	O
had	O
a	O
significant	O
decrease	O
in	O
mortality	O
(	O
9	O
.	O
96	O
%	O
vs	O
14	O
.	O
51	O
%	O
[	O
P	O
=	O
.	O
005	O
],	O
7	O
.	O
14	O
%	O
vs	O
11	O
.	O
27	O
%	O
[	O
P	O
=	O
.	O
01	O
],	O
and	O
6	O
.	O
76	O
%	O
vs	O
17	O
.	O
05	O
%	O
[	O
P	O
=	O
.	O
002	O
],	O
respectively	O
),	O
as	O
did	O
patients	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
during	O
their	O
hospital	O
stay	O
(	O
9	O
.	O
51	O
%	O
vs	O
26	O
.	O
87	O
%;	O
P	O
=	O
.	O
02	O
).	O

ABSTRACT	O
:	O
Six	O
porcine	O
epidemic	O
diarrhea	O
viruses	O
(	O
PEDVs	O
)	O
were	O
isolated	O
from	O
the	O
fecal	B-ANAT
samples	O
of	O
piglets	O
infected	O
with	O
PEDV	O
in	O
2006	O
in	O
China	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	O
entry	O
into	O
host	O
cells	B-ANAT
through	O
a	O
novel	O
clathrin	O
-	O
and	O
caveolae	B-ANAT
-	O
independent	O
endocytic	O
pathway	O
.	O

Endocytic	O
entry	O
of	O
SARS	O
-	O
CoV	O
may	O
expand	O
the	O
cellular	B-ANAT
range	O
of	O
SARS	O
-	O
CoV	O
infection	O
,	O
and	O
our	O
findings	O
here	O
contribute	O
to	O
the	O
understanding	O
of	O
SARS	O
-	O
CoV	O
pathogenesis	O
,	O
providing	O
new	O
information	O
for	O
anti	O
-	O
viral	O
drug	O
research	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
causes	O
of	O
severe	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
obstruction	O
in	O
neonates	O
.	O

Sera	B-ANAT
were	O
negative	O
for	O
antibodies	O
against	O
the	O
other	O
six	O
pathogens	O
.	O

Decompressive	O
laparostomy	O
for	O
ACS	O
is	O
a	O
life	O
-	O
saving	O
procedure	O
usually	O
performed	O
through	O
a	O
midline	B-ANAT
incision	B-ANAT
followed	O
by	O
a	O
negative	O
pressure	O
wound	O
dressing	O
.	O

Immediately	O
after	O
decompression	O
,	O
the	O
intra	O
-	O
abdominal	B-ANAT
pressure	O
dropped	O
from	O
23	O
mmHg	O
to	O
10	O
mmHg	O
,	O
and	O
the	O
respiratory	O
,	O
cardiovascular	B-ANAT
and	O
renal	B-ANAT
functions	O
improved	O
markedly	O
leading	O
to	O
full	O
recovery	O
.	O

Presented	O
here	O
is	O
a	O
review	O
of	O
recently	O
reported	O
agents	O
present	O
in	O
pomegranate	O
juice	O
(	O
polyphenols	O
,	O
beta	O
-	O
sitosterol	O
,	O
sugars	O
and	O
ellagic	O
acid	O
)	O
and	O
fulvic	O
acid	O
,	O
described	O
here	O
as	O
the	O
envelope	B-ANAT
virus	O
neutralising	O
compounds	O
(	O
EVNCs	O
)	O
and	O
complex	O
molecules	O
like	O
lectins	O
and	O
mucins	O
.	O

Neurological	O
conditions	O
most	O
likely	O
result	O
in	O
cardiopulmonary	B-ANAT
sequelae	O
as	O
a	O
result	O
of	O
an	O
interplay	O
between	O
enhanced	O
sympathetic	O
tone	O
,	O
inflammatory	O
cytokine	O
release	O
and	O
other	O
factors	O
.	O

The	O
-	O
1082	O
GG	O
genotype	O
was	O
a	O
marker	O
of	O
decreased	O
risk	O
to	O
develop	O
acute	O
respiratory	O
failure	O
in	O
univariate	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
0	O
.	O
2	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
0	O
.	O
1	O
-	O
0	O
.	O
6	O
;	O
P	O
=	O
.	O
004	O
)	O
and	O
multivariate	O
(	O
OR	O
,	O
0	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
9	O
;	O
P	O
=	O
.	O
03	O
)	O
logistic	O
regression	O
analysis	O
,	O
with	O
male	O
gender	O
,	O
severe	O
abdominal	B-ANAT
injury	O
,	O
and	O
an	O
APACHE	O
II	O
score	O
>	O
19	O
being	O
significant	O
risk	O
factors	O
.	O

Nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
encapsidates	O
the	O
viral	O
RNA	O
and	O
plays	O
an	O
important	O
role	O
in	O
virus	B-ANAT
particle	I-ANAT
assembly	O
and	O
release	O
.	O

Twenty	O
-	O
three	O
patients	O
(	O
40	O
%)	O
had	O
underlying	O
diagnoses	O
of	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
,	O
11	O
(	O
19	O
%)	O
had	O
solid	O
tumors	O
,	O
and	O
24	O
(	O
41	O
%)	O
were	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
recipients	O
,	O
had	O
acute	O
myeloid	O
leukemia	O
,	O
or	O
had	O
severe	O
combined	O
immunodeficiency	O
syndrome	O
.	O

Independent	O
predictors	O
of	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
were	O
profound	O
lymphopenia	O
,	O
with	O
absolute	O
lymphocyte	B-ANAT
counts	O
of	O
<	O
100	O
cells	B-ANAT
per	O
mm3	O
,	O
and	O
age	O
of	O
<	O
or	O
=	O
2	O
years	O
.	O

Coinfection	O
of	O
infectious	O
bronchitis	O
live	O
vaccine	O
and	O
H9N2	O
avian	O
influenza	O
virus	O
led	O
to	O
an	O
extension	O
of	O
the	O
shedding	O
period	O
of	O
H9N2	O
virus	O
,	O
increasing	O
the	O
severity	O
of	O
clinical	O
signs	O
and	O
mortality	O
rates	O
,	O
causing	O
macroscopic	O
lesions	O
in	O
the	O
embryos	B-ANAT
.	O

It	O
should	O
also	O
be	O
stressed	O
that	O
part	O
of	O
the	O
cellular	B-ANAT
damage	O
is	O
caused	O
by	O
tissue	B-ANAT
reperfusion	O
.	O

Moreover	O
,	O
it	O
strongly	O
stimulates	O
pro	O
-	O
inflammatory	O
activation	O
of	O
the	O
macrophages	B-ANAT
and	O
the	O
release	O
of	O
vasoactive	O
substances	O
,	O
such	O
as	O
prostaglandins	O
and	O
thromboxanes	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
how	O
the	O
capsid	B-ANAT
proteins	O
from	O
medically	O
relevant	O
RNA	O
viruses	O
interact	O
with	O
host	B-ANAT
cell	I-ANAT
signaling	O
pathways	O
.	O

ABSTRACT	O
:	O
Hybrid	O
hybridomas	B-ANAT
(	O
quadromas	O
)	O
are	O
derived	O
by	O
fusing	O
at	O
least	O
two	O
hybridomas	B-ANAT
,	O
each	O
producing	O
a	O
different	O
antibody	O
of	O
predefined	O
specificity	O
.	O

This	O
pre	O
-	O
enriched	O
fraction	O
was	O
subsequently	O
passed	O
through	O
the	O
aminophenyleboronic	O
acid	O
column	B-ANAT
super	O
saturated	O
with	O
HRPO	O
.	O

Neutrophils	B-ANAT
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
ALI	O
/	O
ARDS	O
,	O
and	O
IL	O
-	O
8	O
(	O
interleukin	O
-	O
8	O
)	O
has	O
been	O
identified	O
as	O
the	O
main	O
chemotactic	O
factor	O
for	O
neutrophils	B-ANAT
in	O
lung	B-ANAT
fluids	B-ANAT
of	O
patients	O
with	O
ALI	O
/	O
ARDS	O
.	O

These	O
complexes	O
are	O
present	O
in	O
various	O
human	B-ANAT
tissues	I-ANAT
,	O
including	O
the	O
lung	B-ANAT
,	O
as	O
they	O
have	O
been	O
detected	O
in	O
lung	B-ANAT
fluids	B-ANAT
from	O
patients	O
with	O
ALI	O
/	O
ARDS	O
.	O

TITLE	O
:	O
Cardiovascular	B-ANAT
lesions	O
in	O
leptospirosis	O
:	O
an	O
autopsy	O
study	O
.	O

This	O
report	O
studied	O
the	O
cardiovascular	B-ANAT
changes	O
in	O
fatal	O
cases	O
of	O
leptospirosis	O
in	O
Mumbai	O
city	O
,	O
India	O
in	O
the	O
year	O
2005	O
.	O

Involvement	O
of	O
the	O
cardiovascular	B-ANAT
system	I-ANAT
was	O
found	O
in	O
41	O
cases	O
,	O
an	O
incidence	O
of	O
93	O
.	O
2	O
%.	O

We	O
assessed	O
the	O
role	O
of	O
lymphocytic	O
bronchiolitis	O
as	O
a	O
risk	O
factor	O
for	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	O
)	O
and	O
death	O
after	O
lung	B-ANAT
transplantation	O
.	O

Multivariable	O
Cox	O
proportional	O
hazards	O
analysis	O
showed	O
significant	O
risks	O
for	O
BOS	O
were	O
highest	O
B	O
grade	O
(	O
relative	O
risk	O
[	O
RR	O
],	O
1	O
.	O
62	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
31	O
-	O
2	O
.	O
00	O
)	O
(	O
P	O
<	O
0	O
.	O
001	O
),	O
longer	O
ischemic	O
time	O
(	O
RR	O
,	O
1	O
.	O
00	O
;	O
CI	O
,	O
1	O
.	O
00	O
-	O
1	O
.	O
00	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
recent	O
year	O
of	O
transplant	B-ANAT
(	O
RR	O
,	O
0	O
.	O
93	O
;	O
CI	O
,	O
0	O
.	O
87	O
-	O
1	O
.	O
00	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
whereas	O
risks	O
for	O
death	O
were	O
BOS	O
as	O
a	O
time	O
-	O
dependent	O
covariable	O
(	O
RR	O
,	O
19	O
.	O
10	O
;	O
CI	O
,	O
11	O
.	O
07	O
-	O
32	O
.	O
96	O
)	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
highest	O
B	O
grade	O
(	O
RR	O
,	O
1	O
.	O
36	O
;	O
CI	O
,	O
1	O
.	O
07	O
-	O
1	O
.	O
72	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Common	O
signs	O
included	O
diarrhoea	O
,	O
lethargy	O
,	O
weight	O
loss	O
,	O
and	O
weakness	O
in	O
the	O
hindlimbs	B-ANAT
.	O

In	O
patients	O
suffering	O
from	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
life	O
-	O
threatening	O
hypoxaemia	O
,	O
a	O
pump	O
-	O
driven	O
,	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
has	O
been	O
established	O
.	O

ABSTRACT	O
:	O
The	O
host	O
cellular	B-ANAT
environment	O
is	O
a	O
key	O
determinant	O
of	O
pathogen	O
infectivity	O
.	O

Viral	O
gene	O
expression	O
and	O
viral	B-ANAT
particle	I-ANAT
production	O
of	O
glucose	O
-	O
6	O
-	O
phosphate	O
dehydrogenase	O
(	O
G6PD	O
)-	O
deficient	O
and	O
G6PD	O
-	O
knockdown	O
cells	B-ANAT
were	O
much	O
higher	O
than	O
their	O
counterparts	O
when	O
human	O
coronavirus	O
(	O
HCoV	O
)	O
229E	O
was	O
applied	O
at	O
0	O
.	O
1	O
multiplicity	O
of	O
infection	O
.	O

Use	O
of	O
inhaled	O
nitric	O
oxide	O
in	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
will	O
show	O
a	O
benefit	O
through	O
improved	O
physiological	O
parameters	O
,	O
a	O
decrease	O
in	O
biochemical	O
markers	O
of	O
inflammation	O
and	O
brain	B-ANAT
injury	O
,	O
thus	O
leading	O
to	O
better	O
outcomes	O
.	O

We	O
postulated	O
that	O
additional	O
factors	O
should	O
regulate	O
transcription	O
of	O
sg	O
mRNA	O
N	O
.	O
In	O
this	O
report	O
,	O
we	O
have	O
described	O
a	O
novel	O
transcription	O
regulation	O
mechanism	O
operating	O
in	O
CoV	O
by	O
which	O
a	O
9	O
-	O
nucleotide	O
(	O
nt	O
)	O
sequence	O
located	O
449	O
nt	O
upstream	O
of	O
the	O
N	O
gene	O
TRS	O
core	O
sequence	O
(	O
CS	O
-	O
N	O
)	O
interacts	O
with	O
a	O
complementary	O
sequence	O
just	O
upstream	O
of	O
CS	O
-	O
N	O
,	O
specifically	O
increasing	O
the	O
accumulation	O
of	O
sg	O
mRNA	O
N	O
.	O
Alteration	O
of	O
this	O
complementarity	O
in	O
mutant	O
replicon	O
genomes	O
showed	O
a	O
correlation	O
between	O
the	O
predicted	O
stability	O
of	O
the	O
base	O
pairing	O
between	O
9	O
-	O
nt	O
sequences	O
and	O
the	O
accumulation	O
of	O
sg	O
mRNA	O
N	O
.	O
This	O
interaction	O
is	O
exclusively	O
conserved	O
in	O
group	O
1a	O
CoVs	O
,	O
the	O
only	O
CoV	O
subgroup	O
in	O
which	O
the	O
N	O
gene	O
is	O
not	O
the	O
most	O
3	O
'	O
gene	O
in	O
the	O
viral	B-ANAT
genome	I-ANAT
.	O

ABSTRACT	O
:	O
Lipid	B-ANAT
rafts	I-ANAT
often	O
serve	O
as	O
an	O
entry	O
site	O
for	O
certain	O
viruses	O
.	O

At	O
discharge	B-ANAT
,	O
no	O
major	O
neurological	O
deficits	O
were	O
present	O
.	O

SARS	O
and	O
bioterrorism	O
killed	O
less	O
than	O
a	O
dozen	O
people	O
in	O
2003	O
,	O
but	O
together	O
generated	O
over	O
100	O
000	O
media	B-ANAT
reports	O
,	O
far	O
more	O
than	O
those	O
covering	O
smoking	O
and	O
physical	O
inactivity	O
,	O
which	O
killed	O
nearly	O
a	O
million	O
Americans	O
.	O

The	O
incidence	O
of	O
AKI	O
in	O
ICU	O
patients	O
is	O
increasing	O
;	O
severe	O
AKI	O
,	O
treated	O
by	O
renal	B-ANAT
replacement	O
therapy	O
(	O
RRT	O
),	O
has	O
now	O
an	O
incidence	O
comparable	O
to	O
that	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
),	O
and	O
less	O
severe	O
AKI	O
has	O
an	O
incidence	O
comparable	O
to	O
that	O
of	O
sepsis	O
.	O

Overall	O
,	O
HPV	O
DNA	O
prevalence	O
ranged	O
from	O
6	O
%	O
in	O
semen	B-ANAT
to	O
52	O
%	O
in	O
the	O
penile	B-ANAT
shaft	O
.	O

TITLE	O
:	O
Serological	O
evidence	O
of	O
coronavirus	O
infection	O
in	O
mithuns	O
(	O
Bos	O
frontalis	B-ANAT
)	O
from	O
India	O
.	O

TITLE	O
:	O
Mutation	O
in	O
murine	O
coronavirus	O
replication	O
protein	O
nsp4	O
alters	O
assembly	O
of	O
double	O
membrane	B-ANAT
vesicles	B-ANAT
.	O

Analysis	O
of	O
Alb	O
ts6	O
icv	O
-	O
infected	O
cells	B-ANAT
revealed	O
that	O
there	O
was	O
a	O
dramatic	O
reduction	O
in	O
DMVs	O
and	O
that	O
both	O
nsp4	O
and	O
nsp3	O
partially	O
localized	O
to	O
mitochondria	B-ANAT
when	O
cells	B-ANAT
were	O
incubated	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
mice	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
strain	O
JHM	O
(	O
RJHM	O
)	O
induces	O
lethal	O
encephalitis	O
,	O
with	O
high	O
macrophage	B-ANAT
and	O
neutrophil	B-ANAT
,	O
but	O
minimal	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
,	O
infiltration	O
into	O
the	O
brain	B-ANAT
when	O
compared	O
to	O
the	O
neuroattenuated	O
strain	O
RA59	O
.	O

Recent	O
studies	O
have	O
attempted	O
to	O
better	O
characterize	O
the	O
epidemiology	O
of	O
viral	O
infections	O
in	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
,	O
identify	O
unique	O
clinical	O
manifestations	O
of	O
virus	O
-	O
associated	O
exacerbations	O
,	O
and	O
develop	O
new	O
diagnostic	O
tools	O
and	O
treatments	O
.	O

Rhinovirus	O
,	O
the	O
organism	O
most	O
often	O
responsible	O
for	O
causing	O
the	O
common	O
cold	O
,	O
is	O
also	O
the	O
most	O
common	O
infectious	O
cause	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
exacerbations	O
.	O

The	O
use	O
of	O
biomarkers	O
represents	O
an	O
exciting	O
new	O
potential	O
diagnostic	O
tool	O
that	O
may	O
lend	O
new	O
insights	O
into	O
the	O
pathogenesis	O
of	O
viral	O
infections	O
in	O
patients	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
.	O

We	O
generated	O
an	O
nsp1	O
mutant	O
(	O
nsp1	O
-	O
mt	O
)	O
that	O
neither	O
promoted	O
host	O
mRNA	O
degradation	O
nor	O
suppressed	O
host	O
protein	O
synthesis	O
in	O
expressing	O
cells	B-ANAT
.	O

However	O
,	O
the	O
length	O
of	O
RNA	O
packaged	O
in	O
the	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
with	O
high	O
efficiency	O
is	O
usually	O
less	O
than	O
500	O
bases	O
.	O

TITLE	O
:	O
Acute	O
pulmonary	B-ANAT
capillary	I-ANAT
leak	O
syndrome	O
during	O
elective	O
surgery	O
under	O
general	O
anesthesia	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
-	O
863	O
AC	O
genotype	O
was	O
manifested	O
as	O
another	O
risk	O
effect	O
associated	O
with	O
femoral	B-ANAT
head	I-ANAT
necrosis	O
with	O
OR	O
(	O
95	O
%	O
CI	O
)	O
of	O
6	O
.	O
42	O
(	O
1	O
.	O
53	O
-	O
26	O
.	O
88	O
)	O
and	O
the	O
adjusted	O
OR	O
was	O
8	O
.	O
40	O
(	O
95	O
%	O
CI	O
1	O
.	O
76	O
-	O
40	O
.	O
02	O
)	O
in	O
cured	O
SARS	O
patients	O
compared	O
to	O
CC	O
genotype	O
.	O

Thus	O
,	O
our	O
results	O
present	O
the	O
first	O
potential	O
chemical	O
leads	O
against	O
SARS	O
-	O
CoV	O
PLpro	O
,	O
which	O
might	O
be	O
used	O
as	O
lead	O
compounds	O
for	O
further	O
optimization	O
to	O
enhance	O
their	O
potency	O
against	O
SARS	O
-	O
CoV	O
.	O
Both	O
6MP	O
and	O
6TG	O
are	O
still	O
used	O
extensively	O
in	O
clinics	O
,	O
especially	O
for	O
children	O
with	O
acute	O
lymphoblastic	B-ANAT
or	O
myeloblastic	B-ANAT
leukemia	O
.	O

In	O
addition	O
,	O
the	O
plasma	B-ANAT
from	O
active	O
SARS	O
patients	O
had	O
an	O
inhibitory	O
effect	O
on	O
CFU	O
-	O
MK	O
formation	O
,	O
which	O
could	O
be	O
neutralized	O
by	O
anti	O
-	O
TGF	O
-	O
beta	O
antibodies	O
.	O

ABSTRACT	O
:	O
Amiodarone	O
interferes	O
with	O
the	O
endocytic	O
pathway	O
,	O
inhibits	O
proteolysis	O
,	O
and	O
causes	O
the	O
formation	O
of	O
vacuoles	B-ANAT
,	O
but	O
uptake	O
and	O
intracellular	B-ANAT
distribution	O
of	O
the	O
drug	O
,	O
origin	O
of	O
vacuoles	B-ANAT
,	O
and	O
functional	O
consequences	O
of	O
amiodarone	O
accumulation	O
remain	O
unclear	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
hypothesized	O
that	O
a	O
parenteral	O
formulation	O
of	O
H2S	O
would	O
reduce	O
the	O
lung	B-ANAT
injury	O
induced	O
by	O
burn	O
and	O
smoke	O
inhalation	O
in	O
a	O
novel	O
murine	O
model	O
.	O

In	O
conclusion	O
,	O
these	O
results	O
suggest	O
that	O
H2S	O
exerts	O
protective	O
effects	O
in	O
acute	O
lung	B-ANAT
injury	O
,	O
at	O
least	O
in	O
part	O
through	O
the	O
activation	O
of	O
anti	O
-	O
inflammatory	O
and	O
antioxidant	O
pathways	O
.	O

TITLE	O
:	O
Peptide	O
mimicrying	O
between	O
SARS	O
coronavirus	O
spike	O
protein	O
and	O
human	O
proteins	O
reacts	O
with	O
SARS	O
patient	O
serum	B-ANAT
.	O

ABSTRACT	O
:	O
Molecular	O
mimicry	O
,	O
defined	O
as	O
similar	O
structures	O
shared	O
by	O
molecules	O
from	O
dissimilar	O
genes	O
or	O
proteins	O
,	O
is	O
a	O
general	O
strategy	O
used	O
by	O
pathogens	O
to	O
infect	O
host	O
cells	B-ANAT
.	O

Blood	B-ANAT
was	O
collected	O
periodically	O
.	O

Thus	O
,	O
while	O
structural	O
analyses	O
of	O
the	O
S510	O
/	O
D	O
(	O
b	O
)	O
complex	O
provide	O
a	O
strong	O
basis	O
for	O
why	O
some	O
CTL	B-ANAT
escape	O
variants	O
are	O
selected	O
,	O
our	O
results	O
also	O
show	O
that	O
factors	O
other	O
than	O
effects	O
on	O
virus	O
fitness	O
limit	O
the	O
diversification	O
of	O
CD8	O
T	B-ANAT
cell	I-ANAT
epitopes	O
.	O

TITLE	O
:	O
Intrahepatic	O
endothelial	B-ANAT
and	O
Kupffer	B-ANAT
cells	I-ANAT
involved	O
in	O
immunosuppressive	O
cytokines	O
and	O
natural	O
killer	O
(	O
NK	O
)/	O
NK	O
T	B-ANAT
cell	I-ANAT
disorders	O
in	O
viral	O
acute	O
hepatitis	O
.	O

Results	O
showed	O
that	O
IL	O
-	O
10	O
,	O
TGF	O
-	O
beta	O
and	O
PGE2	O
production	O
in	O
the	O
liver	B-ANAT
decreased	O
in	O
L2	O
-	O
MHV3	O
-	O
infected	O
mice	O
and	O
increased	O
in	O
51	O
.	O
6	O
-	O
MHV3	O
-	O
and	O
CL12	O
-	O
MHV3	O
-	O
infected	O
mice	O
.	O

Interestingly	O
,	O
a	O
novel	O
homologue	O
of	O
angiotensin	O
converting	O
-	O
enzyme	O
(	O
ACE	O
),	O
termed	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
has	O
been	O
identified	O
as	O
a	O
receptor	O
for	O
SARS	O
-	O
CoV	O
.	O
ACE	O
and	O
ACE2	O
share	O
homology	O
in	O
their	O
catalytic	O
domain	O
and	O
provide	O
different	O
key	O
functions	O
in	O
the	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
.	O

TITLE	O
:	O
Na	O
,	O
K	O
-	O
ATPase	O
expression	O
is	O
increased	O
in	O
the	O
lungs	B-ANAT
of	O
alcohol	O
-	O
fed	O
rats	O
.	O

ABSTRACT	O
:	O
Alcohol	O
abuse	O
independently	O
increases	O
the	O
risk	O
of	O
developing	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
a	O
disease	O
characterized	O
by	O
diffuse	O
alveolar	B-ANAT
epithelial	O
damage	O
,	O
lung	B-ANAT
edema	O
,	O
and	O
consequent	O
severe	O
hypoxemia	O
.	O

Chronic	O
alcohol	O
ingestion	O
significantly	O
increased	O
gene	O
and	O
protein	O
expression	O
of	O
each	O
Na	O
,	O
K	O
-	O
ATPase	O
subunit	O
in	O
rat	O
lungs	B-ANAT
.	O

RESULTS	O
:	O
Chronic	O
alcohol	O
ingestion	O
significantly	O
increased	O
gene	O
and	O
protein	O
expression	O
of	O
each	O
Na	O
,	O
K	O
-	O
ATPase	O
subunit	O
in	O
rat	O
lungs	B-ANAT
.	O

Strikingly	O
,	O
immunofluorescence	O
assays	O
reveal	O
that	O
mimicyp	O
localizes	O
to	O
the	O
surface	O
of	O
the	O
mature	O
virion	B-ANAT
,	O
as	O
recently	O
proposed	O
for	O
several	O
viruses	O
that	O
recruit	O
host	B-ANAT
cell	I-ANAT
cyclophilins	O
such	O
as	O
SARS	O
and	O
HIV	O
-	O
1	O
.	O

Thus	O
,	O
this	O
study	O
suggests	O
that	O
cyclophilins	O
,	O
whether	O
recruited	O
from	O
host	O
cells	B-ANAT
(	O
i	O
.	O
e	O
.	O
HIV	O
-	O
1	O
and	O
SARS	O
)	O
or	O
virally	O
encoded	O
(	O
i	O
.	O
e	O
.	O
Mimivirus	O
),	O
are	O
localized	O
on	O
viral	O
surfaces	O
for	O
at	O
least	O
a	O
subset	O
of	O
viruses	O
.	O

Moreover	O
,	O
significant	O
N	O
-	O
specific	O
cellular	B-ANAT
immune	O
responses	O
were	O
measured	O
by	O
IFN	O
-	O
gamma	O
ELISPOT	O
assays	O
.	O

39	O
.	O
5	O
%	O
had	O
complications	O
,	O
with	O
acute	O
renal	B-ANAT
failure	O
being	O
the	O
most	O
common	O
(	O
25	O
.	O
5	O
%).	O

We	O
describe	O
the	O
case	O
of	O
a	O
64	O
-	O
year	O
-	O
old	O
patient	O
who	O
had	O
developed	O
an	O
acute	O
respiratory	O
insufficiency	O
due	O
to	O
right	O
-	O
to	O
-	O
left	O
shunt	O
in	O
a	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
one	O
month	O
after	O
right	O
intrapericardiac	O
pneumonectomy	O
.	O

The	O
presence	O
of	O
a	O
right	O
-	O
to	O
-	O
left	O
interatrial	O
shunt	O
through	O
a	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
was	O
documented	O
by	O
transesophageal	O
echocardiography	O
24	O
h	O
after	O
admission	O
to	O
intensive	O
care	O
.	O

The	O
mRNA	O
of	O
human	O
beta	O
actin	O
gene	O
could	O
be	O
amplified	O
efficiently	O
in	O
all	O
the	O
tissue	B-ANAT
samples	O
.	O

Phylogenetic	O
analysis	O
showed	O
co	O
-	O
circulation	O
of	O
hMPV	O
and	O
HCoV	O
NL63	O
A	O
and	O
B	O
lineages	O
,	O
although	O
only	O
HBoV	O
genotype	O
st2	B-ANAT
was	O
found	O
.	O

ABSTRACT	O
:	O
Respiratory	O
syncytial	O
virus	O
is	O
a	O
common	O
cause	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
children	O
,	O
predominantly	O
presenting	O
with	O
mild	O
symptoms	O
.	O

Respiratory	O
syncytial	O
virus	O
was	O
cultured	O
as	O
the	O
only	O
pathogen	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
in	O
four	O
of	O
these	O
patients	O
.	O

#	O
21	O
is	O
a	O
long	O
-	O
term	O
producer	O
of	O
the	O
infectious	O
SARS	O
-	O
coronavirus	O
,	O
although	O
the	O
incorporation	O
rate	O
of	O
spike	O
(	O
S	O
)	O
protein	O
into	O
virions	B-ANAT
is	O
significantly	O
lower	O
.	O

The	O
fetus	B-ANAT
was	O
severely	O
hydropic	O
.	O

The	O
normal	O
twin	O
had	O
a	O
protracted	O
course	O
complicated	O
with	O
respiratory	O
distress	O
syndrome	O
,	O
moderate	O
secundum	O
atrial	B-ANAT
septal	O
defect	O
with	O
left	O
to	O
right	O
shunt	O
,	O
and	O
thrombocytopenia	O
of	O
prematurity	O
.	O

In	O
addition	O
to	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
acute	O
lung	B-ANAT
injury	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
disseminated	O
intravascular	O
coagulation	O
),	O
she	O
developed	O
tenderness	O
in	O
the	O
right	O
neck	B-ANAT
followed	O
by	O
septic	O
arthritis	O
of	O
the	O
right	B-ANAT
sternoclavicular	I-ANAT
joint	I-ANAT
a	O
few	O
days	O
later	O
.	O

This	O
results	O
in	O
a	O
positive	O
skin	B-ANAT
test	O
and	O
,	O
with	O
rare	O
exception	O
,	O
lifelong	O
immunity	O
.	O

ABSTRACT	O
:	O
Many	O
retroviruses	O
use	O
-	O
1	O
ribosomal	B-ANAT
frameshifting	O
as	O
part	O
of	O
the	O
mechanism	O
in	O
translational	O
control	O
of	O
viral	O
protein	O
synthesis	O
.	O

Observations	O
of	O
SCV	O
-	O
induced	O
SARS	O
-	O
like	O
symptoms	O
,	O
measurements	O
of	O
SCV	O
RNA	O
presence	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
microscopic	O
inspections	O
of	O
lung	B-ANAT
histopathology	O
,	O
and	O
immunohistochemistry	O
sections	O
from	O
21	O
tested	O
macaques	O
consistently	O
demonstrated	O
siRNA	O
-	O
mediated	O
anti	O
-	O
SCV	O
activity	O
.	O

The	O
appearance	O
of	O
fluorescent	O
flecks	O
on	O
young	O
leaves	O
was	O
first	O
found	O
on	O
and	O
near	O
the	O
class	O
III	O
and	O
IV	O
veins	B-ANAT
.	O

25	O
kg	O
,	O
and	O
had	O
failed	O
conventional	O
lung	B-ANAT
-	O
protective	O
ventilation	O
due	O
to	O
refractory	O
hypoxia	O
or	O
respiratory	O
acidosis	O
and	O
high	O
plateau	O
airway	B-ANAT
pressures	O
.	O

TITLE	O
:	O
Protective	O
effects	O
of	O
propofol	O
on	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
oleic	O
acid	O
in	O
conscious	O
rats	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
grows	O
in	O
a	O
variety	O
of	O
tissues	B-ANAT
that	O
express	O
its	O
receptor	O
,	O
although	O
the	O
mechanism	O
for	O
high	O
replication	O
in	O
the	O
lungs	B-ANAT
and	O
severe	O
respiratory	O
illness	O
is	O
not	O
well	O
understood	O
.	O

TITLE	O
:	O
Demyelinating	O
and	O
nondemyelinating	O
strains	O
of	O
mouse	O
hepatitis	O
virus	O
differ	O
in	O
their	O
neural	B-ANAT
cell	I-ANAT
tropism	O
.	O

Based	O
on	O
the	O
phylogenetic	O
analysis	O
of	O
the	O
hypervariable	O
region	O
of	O
the	O
S1	O
subunit	O
,	O
these	O
strains	O
clustered	O
with	O
the	O
American	O
(	O
BCoV	O
-	O
ENT	B-ANAT
,	O
182NS	O
)	O
and	O
Canadian	O
(	O
BCQ20	O
,	O
BCQ2070	O
,	O
BCQ9	O
,	O
BCQ571	O
,	O
BCQ1523	O
)	O
calf	B-ANAT
diarrhea	O
and	O
the	O
Canadian	O
winter	O
dysentery	O
(	O
BCQ7373	O
,	O
BCQ2590	O
)	O
strains	O
,	O
but	O
clustered	O
on	O
a	O
separate	O
branch	B-ANAT
of	I-ANAT
the	O
Korean	O
and	O
respiratory	O
BCoV	O
strains	O
.	O

Our	O
results	O
,	O
along	O
with	O
earlier	O
studies	O
showing	O
potent	O
induction	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
by	O
single	O
-	O
cycle	O
vectors	O
,	O
indicate	O
that	O
these	O
vectors	O
are	O
excellent	O
alternatives	O
to	O
live	O
-	O
attenuated	O
VSV	O
.	O

The	O
binding	O
of	O
coronaviruses	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
is	O
mediated	O
by	O
the	O
viral	O
surface	O
protein	O
S	O
.	O
Recently	O
we	O
demonstrated	O
that	O
alpha2	O
,	O
3	O
-	O
linked	O
sialic	O
acid	O
serves	O
as	O
a	O
receptor	O
determinant	O
for	O
IBV	O
on	O
Vero	B-ANAT
cells	I-ANAT
and	O
primary	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
cells	B-ANAT
.	O

These	O
results	O
indicate	O
that	O
alpha2	O
,	O
3	O
-	O
linked	O
sialic	O
acid	O
plays	O
an	O
important	O
role	O
for	O
infection	O
of	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
by	O
IBV	O
.	O

ARDS	O
cases	O
were	O
selected	O
from	O
the	O
12	O
018	O
patients	O
admitted	O
in	O
25	O
pediatric	O
intensive	O
care	O
units	O
in	O
China	O
from	O
January	O
1	O
to	O
December	O
31	O
,	O
2004	O
,	O
aged	O
29	O
days	O
to	O
14	O
years	O
,	O
using	O
the	O
Chinese	O
Pediatric	O
Critical	O
Index	O
of	O
Severity	O
(	O
PCIS	O
)	O
and	O
American	O
Guidelines	O
for	O
Admission	O
and	O
Discharge	B-ANAT
Policies	O
for	O
PICU	O
.	O

As	O
expected	O
,	O
the	O
second	O
and	O
third	O
trans	O
-	O
membrane	B-ANAT
regions	O
were	O
able	O
to	O
insert	O
a	O
cytoplasmic	B-ANAT
protein	O
into	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
membrane	I-ANAT
more	O
efficiently	O
than	O
the	O
first	O
one	O
.	O

Vascular	B-ANAT
lesions	O
,	O
e	O
.	O
g	O
.	O
degeneration	O
of	O
endothelial	B-ANAT
cells	I-ANAT
,	O
perivascular	O
and	O
intramural	O
oedema	O
,	O
fibrinoid	O
necrosis	O
,	O
vasculitis	O
,	O
perivasculitis	O
,	O
and	O
vascular	B-ANAT
thrombi	O
were	O
observed	O
in	O
all	O
cases	O
,	O
associated	O
with	O
the	O
presence	O
of	O
PCV2	O
antigen	O
.	O

The	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE	O
-	O
2	O
)	O
has	O
been	O
identified	O
as	O
a	O
functional	O
receptor	O
for	O
SARS	O
-	O
CoV	O
.	O
ACE	O
-	O
2	O
has	O
been	O
shown	O
to	O
be	O
expressed	O
at	O
the	O
apical	O
domain	O
of	O
polarized	O
Calu	O
-	O
3	O
cells	B-ANAT
.	O

TITLE	O
:	O
Interferon	O
-	O
gamma	O
in	O
the	O
serum	B-ANAT
and	O
effusions	O
of	O
cats	O
with	O
feline	O
coronavirus	O
infection	O
.	O

Nasopharyngeal	B-ANAT
swabs	O
were	O
analyzed	O
by	O
polymerase	O
chain	O
reaction	O
for	O
rhinovirus	O
and	O
enterovirus	O
,	O
coronavirus	O
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
parainfluenza	O
virus	O
(	O
PIV	O
),	O
influenza	O
A	O
and	O
B	O
virus	O
,	O
human	O
bocavirus	O
,	O
human	O
metapneumovirus	O
,	O
adenovirus	O
,	O
and	O
Mycoplasma	O
pneumoniae	O
.	O

RESULTS	O
:	O
The	O
unadjusted	O
odds	O
ratio	O
and	O
95	O
%	O
confidence	O
intervals	O
of	O
mortality	O
rate	O
were	O
found	O
to	O
be	O
associated	O
with	O
6	O
(	O
out	O
of	O
22	O
)	O
risk	O
factors	O
,	O
namely	O
,	O
(	O
1	O
)	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
,	O
(	O
2	O
)	O
duration	O
of	O
trauma	O
factor	O
,	O
(	O
3	O
)	O
aspiration	O
of	O
gastric	B-ANAT
contents	I-ANAT
,	O
(	O
4	O
)	O
sepsis	O
,	O
(	O
5	O
)	O
pulmonary	B-ANAT
contusion	O
,	O
and	O
(	O
6	O
)	O
duration	O
of	O
mechanical	O
ventilation	O
.	O

The	O
possibility	O
of	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
was	O
excluded	O
by	O
transesophageal	O
echocardiography	O
.	O

While	O
RA59	O
and	O
SJHM	O
/	O
RA59	O
infections	O
resulted	O
in	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
priming	O
within	O
the	O
first	O
2	O
days	O
postinfection	O
,	O
RJHM	O
infection	O
did	O
not	O
lead	O
to	O
proliferation	O
of	O
naÃ¯ve	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
.	O

These	O
findings	O
suggest	O
that	O
the	O
failure	O
of	O
RJHM	O
to	O
prime	O
a	O
robust	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
during	O
CNS	B-ANAT
infection	O
is	O
likely	O
due	O
to	O
its	O
failure	O
to	O
replicate	O
in	O
the	O
CLN	O
.	O

Intravenous	O
pazufloxacin	O
and	O
oral	B-ANAT
clarithromycin	O
were	O
started	O
.	O

Here	O
we	O
report	O
that	O
Toll	O
-	O
like	O
receptor	O
4	O
(	O
TLR4	O
)	O
mutant	O
mice	O
display	O
natural	O
resistance	O
to	O
acid	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

Pulmonary	B-ANAT
challenge	O
with	O
an	O
inactivated	O
H5N1	O
avian	O
influenza	O
virus	O
rapidly	O
induces	O
ALI	O
and	O
OxPL	O
formation	O
in	O
mice	O
.	O

Intraperitoneal	O
treatment	O
with	O
promazine	O
using	O
a	O
prophylactic	O
(-	O
4h	O
)/	O
therapeutic	O
regimen	O
of	O
1	O
,	O
10	O
,	O
or	O
50mg	O
/(	O
kg	O
day	O
)	O
did	O
not	O
reduce	O
virus	O
lung	B-ANAT
titers	O
at	O
day	O
3	O
,	O
yet	O
prolonged	O
virus	O
replication	O
to	O
14	O
days	O
.	O

During	O
the	O
viral	O
and	O
host	O
cellular	B-ANAT
membrane	I-ANAT
fusion	O
,	O
HR1	O
and	O
HR2	O
form	O
6	O
-	O
helix	O
bundle	O
,	O
positioning	O
the	O
fusion	O
peptide	O
closely	O
to	O
the	O
C	O
-	O
terminal	O
region	O
of	O
ectodomain	O
to	O
drive	O
apposition	O
and	O
subsequent	O
membrane	B-ANAT
fusion	O
.	O

Double	O
immunostaining	O
showed	O
macrophages	B-ANAT
that	O
were	O
immunopositive	O
for	O
either	O
CCV2	O
-	O
2	O
alone	O
or	O
alternatively	O
for	O
CCV2	O
-	O
2	O
and	O
FIPV3	O
-	O
70	O
mAbs	O
.	O

We	O
also	O
demonstrated	O
iNOS	O
in	O
the	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
debris	O
in	O
both	O
cases	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
gene	O
was	O
previously	O
isolated	O
from	O
a	O
cDNA	O
library	O
of	O
human	B-ANAT
embryo	I-ANAT
lung	B-ANAT
tissue	I-ANAT
by	O
its	O
encoded	O
protein	O
,	O
which	O
interacts	O
with	O
non	O
-	O
structural	O
protein	O
10	O
(	O
nsp	O
-	O
10	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

To	O
compare	O
conventional	O
and	O
high	O
frequency	O
ventilation	O
using	O
the	O
lower	O
inflection	O
point	O
of	O
the	O
pressure	O
-	O
volume	O
curve	O
as	O
the	O
determinant	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
to	O
obtain	O
similar	O
levels	O
of	O
recruitment	O
and	O
alveolar	B-ANAT
stability	O
.	O

This	O
case	O
suggests	O
that	O
the	O
initial	O
neuropathological	O
changes	O
in	O
PSP	O
is	O
located	O
in	O
the	O
dorsal	O
brainstem	B-ANAT
.	O

TITLE	O
:	O
Search	O
for	O
potential	O
target	O
site	O
of	O
nucleocapsid	B-ANAT
gene	O
for	O
the	O
design	O
of	O
an	O
epitope	O
-	O
based	O
SARS	O
DNA	O
vaccine	O
.	O

Humoral	O
(	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
ELISA	O
)	O
and	O
cellular	B-ANAT
(	O
by	O
cell	B-ANAT
proliferation	O
and	O
CD4	O
(+):	O
CD8	O
(+)	O
assay	O
)	O
immunity	O
was	O
detected	O
by	O
using	O
recombinant	O
N1	O
and	O
N3	O
specific	O
antigen	O
.	O

Molecular	O
modeling	O
analysis	O
suggested	O
that	O
ADS	O
-	O
J1	O
may	O
bind	O
to	O
the	O
deep	O
pocket	O
of	O
the	O
hydrophobic	O
groove	B-ANAT
on	O
the	O
surface	O
of	O
the	O
central	O
coiled	O
-	O
coil	O
of	O
SARS	O
-	O
CoV	O
S	O
HR	O
protein	O
and	O
prevent	O
the	O
entrance	O
of	O
the	O
SARS	O
-	O
CoV	O
into	O
the	O
host	O
cells	B-ANAT
.	O

Acute	O
lung	B-ANAT
injury	O
was	O
induced	O
successfully	O
by	O
intratracheal	O
administration	O
of	O
LPS	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
in	O
male	O
BALB	O
/	O
c	O
mice	O
.	O

Ethyl	O
pyruvate	O
has	O
been	O
shown	O
to	O
improve	O
cardiac	B-ANAT
function	O
after	O
coronary	B-ANAT
ischemia	O
and	O
reperfusion	O
.	O

Patients	O
who	O
died	O
were	O
more	O
likely	O
than	O
survivors	O
to	O
have	O
a	O
temperature	O
>	O
37	O
.	O
8	O
degrees	O
C	O
,	O
altered	O
mental	O
status	O
,	O
difficulty	O
breathing	O
,	O
and	O
abnormal	O
plantar	B-ANAT
reflexes	O
.	O

Nipah	O
virus	O
infection	O
produced	O
rapidly	O
progressive	O
severe	O
illness	O
affecting	O
the	O
central	O
nervous	O
and	O
respiratory	B-ANAT
systems	I-ANAT
.	O

The	O
most	O
common	O
indication	O
for	O
HFOV	O
was	O
oxygenation	O
failure	O
,	O
which	O
was	O
due	O
to	O
pneumonia	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
15	O
(	O
45	O
.	O
5	O
%),	O
severe	O
lobar	O
pneumonia	O
in	O
nine	O
(	O
27	O
.	O
3	O
%),	O
pulmonary	B-ANAT
hemorrhage	O
in	O
eight	O
(	O
24	O
.	O
2	O
%)	O
and	O
pneumothorax	O
in	O
one	O
(	O
3	O
%).	O

The	O
oxygenation	O
index	O
and	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
oxygen	O
difference	O
P	O
(	O
A	O
-	O
a	O
)	O
O2	O
,	O
however	O
,	O
did	O
not	O
change	O
markedly	O
.	O

Patients	O
with	O
heavier	O
body	B-ANAT
weight	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
and	O
of	O
the	O
male	O
gender	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
had	O
a	O
higher	O
risk	O
of	O
mortality	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
(	O
ECMO	O
)	O
is	O
a	O
technology	O
used	O
in	O
treatment	O
of	O
patients	O
with	O
severe	O
but	O
potentially	O
reversible	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
During	O
several	O
months	O
of	O
2002	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
SARS	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spread	O
rapidly	O
from	O
China	O
throughout	O
the	O
world	O
,	O
causing	O
more	O
than	O
800	O
deaths	O
due	O
to	O
the	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
which	O
is	O
the	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

Interestingly	O
,	O
a	O
novel	O
homologue	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
,	O
termed	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
has	O
been	O
identified	O
as	O
a	O
receptor	O
for	O
SARS	O
-	O
CoV	O
.	O
Angiotensin	O
-	O
converting	O
enzyme	O
and	O
ACE2	O
share	O
homology	O
in	O
their	O
catalytic	O
domain	O
and	O
provide	O
different	O
key	O
functions	O
in	O
the	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
(	O
RAS	O
).	O

Notably	O
,	O
injection	O
of	O
SARS	O
-	O
CoV	O
Spike	O
into	O
mice	O
worsens	O
acute	O
lung	B-ANAT
failure	O
in	O
vivo	O
,	O
which	O
can	O
be	O
attenuated	O
by	O
blocking	O
the	O
renin	O
-	O
angiotensin	O
pathway	O
,	O
suggesting	O
that	O
the	O
activation	O
of	O
the	O
pulmonary	B-ANAT
RAS	O
influences	O
the	O
pathogenesis	O
of	O
ALI	O
/	O
ARDS	O
and	O
SARS	O
.	O

To	O
investigate	O
the	O
link	O
between	O
these	O
structures	O
and	O
viral	O
RNA	O
synthesis	O
,	O
and	O
to	O
dissect	O
RTC	O
organization	O
and	O
function	O
,	O
we	O
isolated	O
active	O
RTCs	O
from	O
infected	O
cells	B-ANAT
and	O
used	O
them	O
to	O
develop	O
the	O
first	O
robust	O
assay	O
for	O
their	O
in	O
vitro	O
activity	O
.	O

Furthermore	O
,	O
in	O
Vero	O
E6	O
cells	B-ANAT
,	O
all	O
the	O
viruses	O
showed	O
the	O
formation	O
of	O
particles	O
with	O
the	O
same	O
morphology	O
as	O
the	O
wt	O
virus	O
,	O
indicating	O
that	O
these	O
proteins	O
do	O
not	O
have	O
a	O
high	O
impact	O
in	O
the	O
final	O
morphology	O
of	O
the	O
virions	B-ANAT
.	O

TITLE	O
:	O
Total	O
hepatectomy	O
and	O
liver	B-ANAT
transplantation	O
as	O
a	O
two	O
-	O
stage	O
procedure	O
for	O
toxic	O
liver	B-ANAT
:	O
case	O
reports	O
.	O

ABSTRACT	O
:	O
Total	O
hepatectomy	O
with	O
temporary	O
portocaval	O
shunt	O
was	O
employed	O
as	O
a	O
bridging	O
procedure	O
before	O
liver	B-ANAT
transplantation	O
,	O
in	O
the	O
setting	O
of	O
fulminant	O
hepatic	B-ANAT
failure	O
with	O
""""	O
toxic	O
liver	B-ANAT
syndrome	O
""";"	O
acute	O
,	O
severe	O
,	O
and	O
extensive	O
liver	B-ANAT
necrosis	O
associated	O
with	O
cardiovascular	B-ANAT
shock	O
and	O
acute	O
renal	B-ANAT
failure	O
with	O
or	O
without	O
respiratory	O
failure	O
.	O

This	O
procedure	O
sought	O
to	O
improve	O
metabolic	O
acidosis	O
and	O
hemodynamic	O
instability	O
related	O
to	O
advanced	O
liver	B-ANAT
necrosis	O
.	O

At	O
the	O
present	O
time	O
,	O
diagnostics	O
have	O
progressed	O
to	O
the	O
point	O
that	O
RT	O
-	O
PCR	O
has	O
a	O
sensitivity	O
approaching	O
80	O
%	O
within	O
the	O
first	O
few	O
days	O
of	O
onset	O
of	O
illness	O
,	O
while	O
serology	O
has	O
a	O
sensitivity	O
close	O
to	O
100	O
%	O
on	O
convalescent	O
sera	B-ANAT
taken	O
>	O
21	O
days	O
after	O
illness	O
onset	O
.	O

Clinical	O
and	O
general	O
laboratory	O
manifestations	O
included	O
fever	O
,	O
chills	O
,	O
rigor	O
,	O
myalgia	O
,	O
malaise	O
,	O
diarrhoea	O
,	O
cough	O
,	O
dyspnoea	O
,	O
pneumonia	O
,	O
lymphopenia	O
,	O
neutrophilia	O
,	O
thrombocytopenia	O
,	O
and	O
elevated	O
serum	B-ANAT
lactate	O
dehydrogenase	O
(	O
LD	O
),	O
alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
creatine	O
kinase	O
(	O
CK	O
)	O
activities	O
.	O

These	O
patients	O
often	O
have	O
longer	O
courses	O
of	O
viral	O
shedding	O
and	O
undergo	O
higher	O
-	O
risk	O
procedures	O
that	O
may	O
potentially	O
generate	O
aerosols	O
,	O
such	O
as	O
intubation	O
,	O
bronchoscopy	O
,	O
bag	O
-	O
valve	B-ANAT
mask	O
ventilation	O
,	O
noninvasive	O
positive	O
pressure	O
ventilation	O
,	O
and	O
medication	O
nebulization	O
,	O
further	O
illustrating	O
the	O
importance	O
of	O
early	O
detection	O
and	O
isolation	O
.	O

TITLE	O
:	O
[	O
Traumatic	O
mitral	O
regurgitation	O
with	O
acute	O
pulmonary	B-ANAT
edema	O
].	O

Eleven	O
days	O
after	O
the	O
accident	O
,	O
she	O
was	O
admitted	O
to	O
our	O
hospital	O
with	O
severe	O
respiratory	O
distress	O
syndrome	O
by	O
acute	O
pulmonary	B-ANAT
edema	O
.	O

Echocardiography	O
showed	O
severe	O
mitral	O
regurgitation	O
due	O
to	O
tendon	B-ANAT
rupture	O
of	O
posterior	O
leaflet	O
.	O

Animal	O
models	O
have	O
provided	O
powerful	O
insights	O
into	O
the	O
pathogenesis	O
of	O
severe	O
malaria	O
syndromes	O
such	O
as	O
cerebral	B-ANAT
malaria	O
(	O
CM	O
);	O
however	O
,	O
no	O
model	O
of	O
malaria	O
-	O
induced	O
lung	B-ANAT
injury	O
has	O
been	O
definitively	O
established	O
.	O

In	O
contrast	O
to	O
sepsis	O
-	O
induced	O
ALI	O
,	O
BAL	O
fluid	O
cell	B-ANAT
counts	O
remained	O
constant	O
with	O
no	O
infiltration	O
of	O
neutrophils	B-ANAT
.	O

Histopathology	O
showed	O
septal	O
inflammation	O
without	O
cellular	B-ANAT
transmigration	O
into	O
the	O
alveolar	B-ANAT
spaces	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
report	O
a	O
study	O
of	O
the	O
binding	O
and	O
interaction	O
with	O
model	O
membranes	B-ANAT
of	O
a	O
peptide	O
pertaining	O
to	O
the	O
putative	O
fusion	O
domain	O
of	O
SARS	O
-	O
CoV	O
,	O
SARS	O
FP	O
,	O
as	O
well	O
as	O
the	O
structural	O
changes	O
that	O
take	O
place	O
in	O
both	O
the	O
phospholipid	O
and	O
the	O
peptide	O
molecules	O
upon	O
this	O
interaction	O
.	O

Remarkably	O
,	O
the	O
virus	O
induces	O
minimal	O
cellular	B-ANAT
infiltration	O
in	O
the	O
brain	B-ANAT
.	O

The	O
serology	O
data	O
of	O
the	O
cross	O
-	O
sectional	O
serum	B-ANAT
samples	O
revealed	O
that	O
75	O
%	O
and	O
65	O
%	O
of	O
the	O
children	O
in	O
the	O
age	O
group	O
2	O
.	O
5	O
to	O
3	O
.	O
5	O
years	O
were	O
HCoV	O
-	O
NL63	O
and	O
HCoV	O
-	O
229E	O
seropositive	O
,	O
respectively	O
.	O

Critical	O
illness	O
-	O
related	O
corticosteroid	O
insufficiency	O
should	O
be	O
suspected	O
in	O
hypotensive	O
patients	O
who	O
have	O
responded	O
poorly	O
to	O
fluids	B-ANAT
and	O
vasopressor	O
agents	O
,	O
particularly	O
in	O
the	O
setting	O
of	O
sepsis	O
.	O

At	O
this	O
time	O
,	O
the	O
diagnosis	O
of	O
tissue	B-ANAT
corticosteroid	O
resistance	O
remains	O
problematic	O
.	O

TITLE	O
:	O
Accurate	O
characterization	O
of	O
extravascular	O
lung	B-ANAT
water	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Indexing	O
EVLW	O
to	O
PBW	O
or	O
AdjBW	O
reduces	O
the	O
number	O
of	O
ARDS	O
patients	O
with	O
normal	O
EVLW	O
and	O
correlates	O
better	O
to	O
Lung	B-ANAT
Injury	O
Score	O
and	O
oxygenation	O
than	O
using	O
ActBW	O
.	O

ABSTRACT	O
:	O
The	O
identification	O
and	O
characterization	O
of	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
play	O
an	O
important	O
role	O
in	O
vaccine	O
design	O
,	O
immunodiagnostic	O
tests	O
,	O
and	O
antibody	O
production	O
.	O

Furthermore	O
,	O
we	O
compared	O
BCPred	O
with	O
AAP	O
and	O
ABCPred	O
,	O
a	O
method	O
that	O
uses	O
recurrent	O
neural	O
networks	O
,	O
using	O
two	O
data	O
sets	O
of	O
unique	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
that	O
had	O
been	O
previously	O
used	O
to	O
evaluate	O
ABCPred	O
.	O

TITLE	O
:	O
Prone	O
positioning	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
cardiac	B-ANAT
surgery	O
:	O
a	O
feasibility	O
study	O
.	O

Intensive	O
care	O
unit	O
mortality	O
of	O
37	O
.	O
5	O
%	O
reflected	O
the	O
number	O
of	O
organ	B-ANAT
failure	O
(	O
s	O
);	O
there	O
were	O
no	O
deaths	O
with	O
2	O
failures	O
,	O
and	O
60	O
%	O
with	O
>	O
or	O
=	O
3	O
organ	B-ANAT
failures	O
died	O
(	O
p	O
=	O
0	O
.	O
03	O
).	O

Microscopic	O
examination	O
and	O
blood	B-ANAT
gas	O
analysis	O
indicated	O
severe	O
injury	O
of	O
the	O
lung	B-ANAT
tissues	I-ANAT
in	O
ALI	O
group	O
.	O

TITLE	O
:	O
[	O
Development	O
of	O
a	O
SPA	O
-	O
ELISA	O
method	O
for	O
detecting	O
anti	O
-	O
coronavirus	O
IgG	O
antibodies	O
in	O
serum	B-ANAT
samples	O
from	O
fulvous	O
fruit	O
bats	O
].	O

The	O
test	O
results	O
of	O
the	O
positive	O
and	O
negative	O
controls	O
in	O
the	O
kit	O
and	O
the	O
serum	B-ANAT
samples	O
from	O
convalescent	O
;	O
patient	O
were	O
consistent	O
with	O
expectation	O
.	O

This	O
SPA	O
-	O
ELISA	O
method	O
is	O
applicable	O
for	O
detecting	O
coronavirus	O
antibody	O
in	O
bat	O
sera	B-ANAT
.	O

RESULTS	O
:	O
The	O
test	O
results	O
of	O
the	O
positive	O
and	O
negative	O
controls	O
in	O
the	O
kit	O
and	O
the	O
serum	B-ANAT
samples	O
from	O
convalescent	O
;	O
patient	O
were	O
consistent	O
with	O
expectation	O
.	O

Serum	B-ANAT
neutralization	O
test	O
confirmed	O
the	O
validity	O
of	O
the	O
SPA	O
-	O
ELISA	O
method	O
.	O

TITLE	O
:	O
A	O
step	O
-	O
by	O
-	O
step	O
diagnosis	O
of	O
exclusion	O
in	O
a	O
twin	O
pregnancy	O
with	O
acute	O
respiratory	O
failure	O
due	O
to	O
non	O
-	O
fatal	O
amniotic	B-ANAT
fluid	I-ANAT
embolism	O
:	O
a	O
case	O
report	O
.	O

However	O
,	O
direct	O
contact	O
with	O
the	O
maternal	O
body	B-ANAT
fluid	I-ANAT
which	O
contained	O
SARS	O
-	O
CoV	O
,	O
has	O
put	O
the	O
infants	O
in	O
great	O
danger	O
of	O
perinatal	O
infection	O
.	O

The	O
conventional	O
answer	O
,	O
repeated	O
on	O
the	O
heels	B-ANAT
of	O
the	O
SARS	O
epidemic	O
,	O
is	O
that	O
they	O
do	O
.	O

We	O
therefore	O
considered	O
the	O
use	O
of	O
an	O
DeltaE1	O
/	O
DeltaE2	O
type	O
5	O
vector	O
(	O
Ad5	O
)	O
to	O
deliver	O
genes	O
to	O
PER	O
.	O
C6	O
cells	B-ANAT
growing	O
in	O
suspension	O
with	O
the	O
aim	O
to	O
achieve	O
high	O
protein	O
yield	O
.	O

Exposure	O
of	O
PER	O
.	O
C6	O
cells	B-ANAT
to	O
low	O
amounts	O
(	O
30	O
vp	O
/	O
cell	B-ANAT
)	O
of	O
DeltaE1	O
/	O
DeltaE2	O
vectors	O
resulted	O
in	O
highly	O
efficient	O
(>	O
80	O
%)	O
transduction	O
of	O
PER	O
.	O
C6	O
cells	B-ANAT
growing	O
in	O
suspension	O
.	O

A	O
total	O
of	O
13	O
ORFs	O
were	O
predicted	O
for	O
TCoV	O
.	O
Five	O
subgenomic	O
RNAs	O
were	O
detected	O
from	O
ATCC	O
-	O
infected	O
turkey	O
small	B-ANAT
intestines	I-ANAT
by	O
Northern	O
blotting	O
.	O

Oxygen	O
radicals	O
and	O
active	O
neutrophils	B-ANAT
in	O
the	O
lung	B-ANAT
are	O
important	O
sources	O
for	O
severe	O
pulmonary	B-ANAT
inflammation	O
leading	O
to	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
light	O
microscopic	O
evaluation	O
showed	O
that	O
pulmonary	B-ANAT
architecture	O
was	O
preserved	O
,	O
and	O
infiltration	O
of	O
neutrophil	B-ANAT
and	O
edema	O
decreased	O
in	O
sepsis	O
+	O
leflunomide	O
group	O
.	O

Intra	O
-	O
abdominal	B-ANAT
hypertension	O
,	O
diagnosed	O
either	O
with	O
IAP	O
(	O
max	O
)	O
or	O
IAP	O
(	O
mean	O
),	O
was	O
frequent	O
and	O
showed	O
an	O
independent	O
association	O
with	O
mortality	O
.	O

Intra	O
-	O
abdominal	B-ANAT
hypertension	O
was	O
significantly	O
associated	O
with	O
more	O
severe	O
organ	B-ANAT
failures	O
,	O
particularly	O
renal	B-ANAT
and	O
respiratory	O
,	O
and	O
a	O
prolonged	O
intensive	O
care	O
unit	O
stay	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
four	O
B	B-ANAT
cell	I-ANAT
epitopes	O
from	O
the	O
spike	O
(	O
S	O
)	O
and	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
through	O
bioinformatics	O
analysis	O
and	O
constructed	O
a	O
multi	O
-	O
epitope	O
DNA	O
vaccine	O
.	O

CSF	B-ANAT
-	O
total	O
protein	O
(	O
TP	O
)	O
was	O
measured	O
and	O
albumin	O
and	O
IgG	O
concentrations	O
were	O
measured	O
in	O
paired	O
CSF	B-ANAT
/	O
serum	B-ANAT
samples	O
;	O
Q	O
(	O
alb	O
)	O
and	O
IgG	O
index	O
were	O
calculated	O
.	O

The	O
organ	B-ANAT
samples	O
at	O
5	O
days	O
post	O
challenge	O
showed	O
that	O
the	O
viral	O
detection	O
rates	O
were	O
50	O
%-	O
90	O
%	O
and	O
10	O
%-	O
30	O
%	O
for	O
trachea	B-ANAT
and	O
kidney	B-ANAT
,	O
respectively	O
.	O

Twenty	O
-	O
nine	O
of	O
these	O
cats	O
were	O
FECV	O
naÃ¯ve	O
before	O
infection	O
and	O
followed	O
sequentially	O
for	O
fecal	B-ANAT
virus	O
shedding	O
and	O
antibody	O
responses	O
over	O
a	O
period	O
of	O
8	O
-	O
48	O
months	O
.	O

ABSTRACT	O
:	O
Viral	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
vURI	O
)	O
may	O
or	O
may	O
not	O
present	O
with	O
a	O
cold	O
/	O
flu	O
-	O
like	O
illness	O
(	O
CFLI	O
).	O

This	O
was	O
followed	O
by	O
observation	O
(	O
group	O
III	O
);	O
treatment	O
with	O
conventional	O
therapy	O
including	O
protective	O
ventilation	O
,	O
steroids	O
,	O
and	O
nitric	O
oxide	O
(	O
group	O
IV	O
);	O
or	O
femoral	B-ANAT
arteriovenous	O
iLA	O
Novalung	O
placement	O
,	O
near	O
-	O
static	O
ventilation	O
,	O
steroids	O
,	O
and	O
nitric	O
oxide	O
(	O
group	O
V	O
).	O

Imported	O
diseases	O
at	O
risk	O
of	O
secondary	O
transmission	O
were	O
also	O
diagnosed	O
,	O
including	O
pulmonary	B-ANAT
tuberculosis	O
(	O
n	O
=	O
8	O
),	O
viral	O
hepatitis	O
(	O
n	O
=	O
8	O
),	O
typhoid	O
fever	O
(	O
n	O
=	O
6	O
),	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
(	O
six	O
new	O
diagnosis	O
),	O
non	O
-	O
typhoid	O
salmonellosis	O
(	O
n	O
=	O
5	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
and	O
Crimean	O
-	O
Congo	O
hemorrhagic	O
fever	O
.	O

(	O
1	O
)	O
Contents	O
of	O
caspase	O
-	O
3	O
and	O
p73	O
in	O
lung	B-ANAT
tissue	I-ANAT
homogenates	O
in	O
HFOV	O
group	O
and	O
HFOV	O
+	O
PS	O
group	O
were	O
significantly	O
lower	O
than	O
those	O
in	O
CMV	O
group	O
and	O
CMV	O
+	O
PS	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
or	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
also	O
contents	O
of	O
caspase	O
-	O
3	O
and	O
p73	O
in	O
lung	B-ANAT
tissue	I-ANAT
homogenates	O
in	O
groups	O
with	O
exogenous	O
PS	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
groups	O
without	O
exogenous	O
PS	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

Caspase	O
-	O
3	O
and	O
p73	O
mRNA	O
expression	O
in	O
lung	B-ANAT
tissue	I-ANAT
in	O
groups	O
with	O
exogenous	O
PS	O
group	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
the	O
corresponding	O
group	O
without	O
exogenous	O
PS	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

ARF1	O
,	O
the	O
cellular	B-ANAT
effector	O
of	O
GBF1	O
,	O
also	O
appeared	O
to	O
be	O
involved	O
in	O
MHV	O
replication	O
,	O
as	O
siRNAs	O
targeting	O
this	O
small	O
GTPase	O
inhibited	O
MHV	O
infection	O
significantly	O
.	O

Due	O
to	O
edema	O
reducing	O
thoracic	B-ANAT
compliance	O
,	O
producing	O
severe	O
encephalopathy	O
and	O
leading	O
to	O
severe	O
ischemia	O
with	O
generation	O
of	O
significant	O
quantities	O
of	O
reactive	O
oxygen	O
free	O
radicals	O
as	O
well	O
peroxidation	O
products	O
released	O
from	O
the	O
intestine	B-ANAT
,	O
liver	B-ANAT
and	I-ANAT
spleen	I-ANAT
.	O

The	O
occurrence	O
of	O
bronchitis	O
(	O
P	O
=.	O
007	O
),	O
pneumonia	O
(	O
P	O
=.	O
02	O
),	O
and	O
any	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
P	O
=.	O
002	O
)	O
was	O
significantly	O
associated	O
with	O
having	O
a	O
viral	O
diagnosis	O
.	O

Upon	O
enrollment	O
,	O
nasopharyngeal	B-ANAT
swabs	O
were	O
collected	O
for	O
the	O
real	O
-	O
time	O
PCR	O
detection	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
types	O
A	O
and	O
B	O
,	O
influenza	O
virus	O
types	O
A	O
and	O
B	O
,	O
adenovirus	O
,	O
parainfluenza	O
viruses	O
types	O
1	O
,	O
2	O
,	O
3	O
and	O
4	O
,	O
rhinovirus	O
,	O
human	O
metapneumovirus	O
,	O
human	O
coronavirus	O
types	O
229E	O
,	O
OC43	O
,	O
NL63	O
,	O
and	O
HKU1	O
,	O
bocavirus	O
,	O
enterovirus	O
,	O
and	O
paraechovirus	O
;	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
also	O
obtained	O
to	O
detect	O
atypical	O
bacteria	O
.	O

Studies	O
of	O
the	O
chemical	O
shift	O
perturbations	O
caused	O
by	O
the	O
binding	O
of	O
single	O
-	O
stranded	O
DNA	O
and	O
mutational	O
analyses	O
have	O
identified	O
the	O
disordered	O
region	O
at	O
the	O
N	O
-	O
termini	O
as	O
the	O
prime	O
site	O
for	O
nucleic	B-ANAT
acid	O
binding	O
.	O

Here	O
we	O
demonstrate	O
that	O
cathepsin	O
L	O
indeed	O
activates	O
the	O
membrane	B-ANAT
fusion	O
function	O
of	O
the	O
spike	O
protein	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
therefore	O
to	O
determine	O
whether	O
severely	O
burned	O
pediatric	O
patients	O
with	O
concomitant	O
inhalation	O
injury	O
who	O
had	O
a	O
fatal	O
outcome	O
exhibited	O
a	O
different	O
serum	B-ANAT
cytokine	O
profile	O
compared	O
with	O
burn	O
patients	O
with	O
inhalation	O
injury	O
who	O
survived	O
.	O

Blood	B-ANAT
was	O
collected	O
within	O
24	O
hours	O
of	O
admission	O
and	O
5	O
to	O
7	O
days	O
later	O
.	O

The	O
number	O
of	O
days	O
on	O
the	O
ventilator	O
,	O
peak	O
inspiratory	O
pressure	O
rates	O
,	O
arterial	B-ANAT
oxygen	O
tension	O
(	O
PaO2	O
)/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FiO2	O
)	O
ratio	O
and	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
were	O
recorded	O
for	O
those	O
patients	O
.	O

RESULTS	O
:	O
Significantly	O
altered	O
levels	O
of	O
IL	O
-	O
4	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
7	O
,	O
IL	O
-	O
10	O
,	O
and	O
IL	O
-	O
13	O
were	O
detected	O
within	O
the	O
first	O
7	O
days	O
after	O
admission	O
in	O
serum	B-ANAT
from	O
burn	O
pediatric	O
patients	O
with	O
concomitant	O
inhalation	O
injury	O
who	O
did	O
not	O
survive	O
when	O
compared	O
with	O
similar	O
patients	O
who	O
did	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Participants	O
were	O
randomized	O
to	O
receive	O
APC	B-ANAT
(	O
24	O
microg	O
/	O
kg	O
/	O
h	O
for	O
96	O
h	O
)	O
or	O
placebo	O
in	O
a	O
double	O
-	O
blind	O
fashion	O
within	O
72	O
hours	O
of	O
the	O
onset	O
of	O
ALI	O
.	O

Therapeutic	O
administration	O
of	O
either	O
anti	O
-	O
IL	O
-	O
23p19	O
or	O
anti	O
-	O
IL	O
-	O
12	O
/	O
23p40	O
to	O
mice	O
with	O
viral	O
-	O
induced	O
demyelination	O
did	O
not	O
attenuate	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
or	O
macrophage	B-ANAT
infiltration	O
into	O
the	O
CNS	B-ANAT
nor	O
improve	O
clinical	O
disease	O
or	O
diminish	O
white	B-ANAT
matter	I-ANAT
damage	O
.	O

Two	O
hundred	O
and	O
twenty	O
clinical	O
specimens	O
(	O
92	O
rectal	O
,	O
82	O
nasal	B-ANAT
and	O
46	O
ocular	B-ANAT
swabs	O
)	O
were	O
subjected	O
to	O
gel	O
-	O
based	O
and	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Optic	B-ANAT
neuritis	O
(	O
ON	O
),	O
an	O
inflammatory	O
demyelinating	O
optic	B-ANAT
nerve	I-ANAT
disease	O
,	O
occurs	O
in	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

TITLE	O
:	O
C3d	O
and	O
C4d	O
deposition	O
early	O
after	O
lung	B-ANAT
transplantation	O
.	O

In	O
a	O
sub	O
-	O
group	O
analysis	O
we	O
identified	O
9	O
LTRs	O
who	O
developed	O
early	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	O
)	O
in	O
the	O
absence	O
of	O
acute	O
cellular	B-ANAT
rejection	O
or	O
cytomegalovirus	O
reactivation	O
,	O
but	O
they	O
had	O
significant	O
lung	B-ANAT
allograft	O
C3d	O
/	O
C4d	O
deposition	O
along	O
with	O
corroborative	O
light	O
-	O
microscopic	O
features	O
suggestive	O
of	O
AMR	O
.	O

We	O
demonstrate	O
that	O
the	O
compounds	O
inhibited	O
SARS	O
-	O
CoV	O
replication	O
-	O
dependent	O
GFP	O
expression	O
in	O
the	O
replicon	O
cells	B-ANAT
and	O
reduced	O
SARS	O
-	O
CoV	O
viral	O
protein	O
accumulation	O
and	O
viral	O
RNA	O
copy	O
number	O
in	O
the	O
replicon	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
pathology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
in	O
cats	O
and	O
ferrets	O
is	O
poorly	O
described	O
,	O
and	O
the	O
distribution	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
a	O
receptor	O
for	O
SARS	O
-	O
CoV	O
,	O
in	O
the	O
respiratory	B-ANAT
tracts	I-ANAT
of	O
these	O
species	O
is	O
unknown	O
.	O

Guillain	O
-	O
BarrÃ©	O
syndrome	O
in	O
trauma	O
patients	O
is	O
rare	O
and	O
is	O
limited	O
to	O
case	O
reports	O
following	O
head	B-ANAT
trauma	O
.	O

Since	O
precise	O
mechanism	O
of	O
malarial	O
ARF	O
is	O
not	O
known	O
,	O
several	O
hypotheses	O
including	O
mechanical	O
obstruction	O
by	O
infected	O
erythrocytes	B-ANAT
,	O
immune	O
mediated	O
glomerular	B-ANAT
and	O
tubular	O
pathology	O
,	O
fluid	O
loss	O
due	O
to	O
multiple	O
mechanisms	O
and	O
alterations	O
in	O
the	O
renal	B-ANAT
microcirculation	O
,	O
etc	O
,	O
have	O
been	O
proposed	O
.	O

Chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
showed	O
bilateral	O
ground	O
-	O
glass	O
opacity	O
,	O
consolidation	O
,	O
and	O
the	O
case	O
fulfilled	O
the	O
criteria	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Despite	O
immediate	O
improvement	O
in	O
oxygenation	O
,	O
the	O
value	O
of	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWI	O
)	O
measured	O
by	O
the	O
PiCCO	O
system	O
consistently	O
remained	O
over	O
30	O
ml	O
/	O
Kg	O
through	O
her	O
clinical	O
course	O
.	O

ABSTRACT	O
:	O
DUBs	O
(	O
deubiquitinating	O
enzymes	O
)	O
are	O
a	O
family	O
of	O
proteases	O
responsible	O
for	O
the	O
specific	O
removal	O
of	O
ubiquitin	O
attached	O
to	O
target	O
proteins	O
and	O
thus	O
control	O
the	O
free	O
cellular	B-ANAT
pools	O
of	O
this	O
molecule	O
.	O

TITLE	O
:	O
[	O
Role	O
of	O
coagulation	O
in	O
acute	O
pulmonary	B-ANAT
lesion	O
physiopathology	O
.	O

Future	O
clinical	O
trials	O
should	O
consider	O
the	O
potential	O
benefit	O
of	O
anticoagulants	O
administrated	O
systemically	O
or	O
locally	O
in	O
the	O
lungs	B-ANAT
to	O
determine	O
the	O
role	O
of	O
anticoagulants	O
in	O
the	O
treatment	O
of	O
acute	O
pulmonary	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
contrast	O
,	O
host	B-ANAT
cell	I-ANAT
entry	O
by	O
the	O
FIPV	O
strains	O
WSU	O
79	O
-	O
1146	O
(	O
FIPV	O
-	O
1146	O
)	O
and	O
FIPV	O
-	O
DF2	O
proceeds	O
independently	O
of	O
cathepsin	O
L	O
activity	O
and	O
low	O
pH	O
,	O
but	O
is	O
still	O
highly	O
dependent	O
on	O
cathepsin	O
B	O
activity	O
.	O

Employing	O
the	O
MAb	O
-	O
based	O
immunoswab	O
,	O
an	O
NP	O
concentration	O
of	O
200	O
pg	O
/	O
mL	O
in	O
saline	O
and	O
pig	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
,	O
and	O
500	O
pg	O
/	O
mL	O
in	O
rabbit	O
serum	B-ANAT
were	O
detected	O
.	O

Polyclonal	O
IgY	O
-	O
based	O
immunoswabs	O
detected	O
an	O
NP	O
concentration	O
of	O
10	O
pg	O
/	O
mL	O
in	O
pig	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
providing	O
the	O
most	O
sensitive	O
SARS	O
point	O
of	O
care	O
assay	O
.	O

Studies	O
in	O
human	O
beings	O
and	O
animals	O
have	O
shown	O
increased	O
urinary	O
fractional	O
excretion	O
of	O
potassium	O
and	O
sodium	O
,	O
as	O
well	O
as	O
an	O
increased	O
potassium	O
/	O
sodium	O
ratio	O
,	O
suggesting	O
increased	O
distal	O
potassium	O
secretion	B-ANAT
caused	O
by	O
increased	O
distal	O
sodium	O
delivery	O
consequent	O
to	O
functional	O
impairment	O
of	O
proximal	O
sodium	O
reabsorption	O
.	O

For	O
critically	O
ill	O
leptospirosis	O
patients	O
,	O
the	O
following	O
are	O
recommended	O
:	O
daily	O
hemodialysis	O
,	O
low	O
daily	O
net	O
fluid	O
intake	O
(	O
because	O
of	O
the	O
risk	O
for	O
pulmonary	B-ANAT
hemorrhage	O
),	O
and	O
lung	B-ANAT
-	O
protective	O
strategies	O
(	O
low	O
tidal	O
volumes	O
and	O
high	O
positive	O
end	O
-	O
expiratory	O
pressures	O
after	O
recruitment	O
maneuvers	O
).	O

In	O
agreement	O
,	O
SL	O
-	O
CoV	O
S	O
DNA	O
vaccine	O
evoked	O
a	O
more	O
vigorous	O
antibody	O
response	O
and	O
a	O
stronger	O
T	B-ANAT
cell	I-ANAT
response	O
than	O
SARS	O
-	O
CoV	O
S	O
DNA	O
in	O
mice	O
.	O

Two	O
different	O
patterns	O
of	O
pulmonary	B-ANAT
host	O
responses	O
to	O
virus	O
were	O
observed	O
when	O
gene	O
expression	O
profiles	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
infected	O
young	O
mice	O
that	O
show	O
minimal	O
disease	O
were	O
compared	O
to	O
those	O
from	O
SARS	O
-	O
CoV	O
-	O
infected	O
aged	O
mice	O
that	O
develop	O
pneumonitis	O
.	O

This	O
study	O
showed	O
that	O
the	O
3a	O
protein	O
modulates	O
the	O
mitochondrial	B-ANAT
death	O
pathway	O
in	O
two	O
possible	O
ways	O
.	O

A	O
block	O
in	O
nuclear	O
translocation	O
of	O
the	O
STAT3	O
transcription	O
factor	O
in	O
cells	B-ANAT
expressing	O
the	O
3a	O
protein	O
was	O
also	O
observed	O
.	O

Pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
is	O
a	O
simple	O
and	O
efficient	O
method	O
to	O
support	O
patients	O
with	O
deteriorating	O
gas	O
exchange	O
for	O
prolonged	O
periods	O
to	O
allow	O
the	O
lung	B-ANAT
protective	O
ventilation	O
and	O
transportation	O
.	O

ABSTRACT	O
:	O
Antiphospholipid	O
syndrome	O
(	O
APS	O
)	O
is	O
a	O
systemic	O
autoimmune	O
disorder	O
characterized	O
by	O
a	O
combination	O
of	O
arterial	B-ANAT
or	O
venous	B-ANAT
thrombosis	O
and	O
recurrent	O
fetal	B-ANAT
loss	O
,	O
accompanied	O
by	O
elevated	O
titers	O
of	O
antiphospholipid	O
antibodies	O
(	O
aPL	O
).	O

ABSTRACT	O
:	O
Macrophage	B-ANAT
activation	O
syndrome	O
(	O
MAS	B-ANAT
)	O
is	O
a	O
severe	O
,	O
potentially	O
life	O
-	O
threatening	O
condition	O
induced	O
by	O
chronic	O
rheumatic	O
diseases	O
,	O
especially	O
systemic	O
-	O
onset	O
juvenile	O
idiopathic	O
arthritis	O
(	O
SoJIA	O
)	O
in	O
childhood	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
induces	O
a	O
minimal	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
response	O
in	O
several	O
cell	B-ANAT
types	O
in	O
vitro	O
despite	O
the	O
fact	O
that	O
the	O
type	O
I	O
IFN	O
response	O
is	O
important	O
in	O
protecting	O
the	O
mouse	O
from	O
infection	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Viral	O
infections	O
are	O
common	O
causes	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
in	O
the	O
outpatient	O
setting	O
but	O
much	O
less	O
common	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

We	O
tested	O
sera	B-ANAT
collected	O
from	O
12	O
ocelots	O
(	O
Leopardus	O
pardalis	O
)	O
native	O
to	O
Barro	O
Colorado	O
Island	O
,	O
Panama	O
,	O
which	O
is	O
free	O
of	O
domestic	O
animals	O
,	O
for	O
antibodies	O
to	O
feline	O
herpes	O
virus	O
,	O
feline	O
calicivirus	O
,	O
feline	O
corona	O
virus	O
,	O
feline	O
panleukopenia	O
virus	O
,	O
canine	O
distemper	O
virus	O
,	O
and	O
feline	O
immunodeficiency	O
virus	O
(	O
FIV	O
),	O
typically	O
a	O
species	O
-	O
specific	O
infection	O
.	O

The	O
corresponding	O
mutations	O
in	O
SARS	O
-	O
CoV	O
Nsp9	O
do	O
not	O
hamper	O
nucleic	B-ANAT
acid	O
binding	O
.	O

We	O
propose	O
that	O
both	O
forms	O
of	O
the	O
Nsp9	O
dimer	O
are	O
biologically	O
relevant	O
;	O
the	O
occurrence	O
of	O
the	O
disulfide	O
-	O
bonded	O
form	O
may	O
be	O
correlated	O
with	O
oxidative	O
stress	O
induced	O
in	O
the	O
host	B-ANAT
cell	I-ANAT
by	O
the	O
viral	O
infection	O
.	O

ABSTRACT	O
:	O
Severe	O
pulmonary	B-ANAT
contusions	O
are	O
a	O
common	O
cause	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
are	O
associated	O
with	O
significant	O
morbidity	O
.	O

ABSTRACT	O
:	O
Critical	O
illness	O
is	O
generally	O
hallmarked	O
by	O
activation	O
of	O
the	O
hypothalamic	B-ANAT
-	I-ANAT
pituitary	I-ANAT
-	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
.	O

TITLE	O
:	O
Internalization	O
of	O
cystatin	O
C	O
in	O
human	O
cell	B-ANAT
lines	I-ANAT
.	O

We	O
investigated	O
whether	O
internalization	O
of	O
cystatin	O
C	O
occurs	O
in	O
a	O
set	O
of	O
human	O
cell	B-ANAT
lines	I-ANAT
.	O

Variations	O
of	O
AGP	O
sialylation	O
were	O
recorded	O
only	O
in	O
cats	O
from	O
group	O
C	O
,	O
on	O
which	O
viral	O
shedding	O
peaked	O
before	O
the	O
occurrence	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
the	O
cattery	O
,	O
and	O
decreased	O
1	O
month	O
later	O
,	O
when	O
serum	B-ANAT
AGP	O
had	O
an	O
increase	O
of	O
alpha	O
(	O
2	O
,	O
3	O
)-	O
linked	O
sialic	O
acid	O
.	O

To	O
identify	O
region	O
(	O
s	O
)	O
of	O
the	O
N	O
molecule	O
required	O
for	O
pseudoparticle	O
formation	O
,	O
we	O
performed	O
biochemical	O
analysis	O
of	O
the	O
interaction	O
of	O
N	O
mutants	O
and	O
M	O
in	O
HEK293	O
cells	B-ANAT
.	O

Aspiration	O
of	O
gastric	B-ANAT
contents	I-ANAT
could	O
lead	O
to	O
incremental	O
mortality	O
due	O
to	O
severe	O
ventilation	O
associated	O
pneumonia	O
.	O

Haplotype	O
H125	O
in	O
CSA	O
and	O
H97	O
in	O
CSB	O
as	O
well	O
as	O
SNPs	O
in	O
high	O
linkage	O
disequilibrium	O
with	O
these	O
two	O
haplotypes	O
were	O
significantly	O
associated	O
with	O
a	O
13	O
%	O
to	O
15	O
%	O
reduction	O
in	O
the	O
mean	O
number	O
of	O
chromatid	B-ANAT
breaks	O
per	O
cell	B-ANAT
(	O
P	O
<	O
0	O
.	O
05	O
).	O

This	O
study	O
implicates	O
transcription	O
-	O
coupled	O
repair	O
in	O
protecting	O
the	O
cell	B-ANAT
from	O
BPDE	O
-	O
induced	O
DNA	O
damage	O
.	O

The	O
adenovirus	O
-	O
mediated	O
overexpression	O
of	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
(	O
S	O
)	O
and	O
its	O
C	O
-	O
terminal	O
domain	O
(	O
S2	O
)	O
induce	O
apoptosis	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

Direct	O
infection	O
/	O
interaction	O
between	O
viruses	O
and	O
lymphocytes	B-ANAT
/	O
monocytes	B-ANAT
is	O
unlikely	O
to	O
be	O
the	O
cause	O
of	O
lymphopaenia	O
in	O
SARS	O
patients	O
.	O

Nested	O
polymerase	O
chain	O
reaction	O
(	O
nPCR	O
)	O
and	O
nested	O
reverse	O
transcription	O
-	O
PCR	O
(	O
nRT	O
-	O
PCR	O
)	O
were	O
carried	O
out	O
on	O
fresh	B-ANAT
heart	B-ANAT
muscle	I-ANAT
and	O
lung	B-ANAT
tissue	I-ANAT
to	O
analyze	O
the	O
genomic	O
sequences	O
of	O
adenovirus	O
,	O
CMV	O
,	O
HHV	O
-	O
6	O
,	O
herpes	O
simplex	B-ANAT
virus	O
,	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
),	O
varizella	O
zoster	O
virus	O
,	O
influenza	O
virus	O
A	O
,	O
B	O
,	O
C	O
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
A	O
and	O
B	O
,	O
parainfluenza	O
viruses	O
,	O
rhinoviruses	O
,	O
coronavirus	O
,	O
flaviruses	O
and	O
enteroviruses	O
.	O

As	O
these	O
pathogens	O
partly	O
use	O
the	O
DNA	O
synthesis	O
machinery	O
for	O
their	O
replication	O
,	O
they	O
aim	O
to	O
drive	O
cells	B-ANAT
into	O
a	O
proliferative	O
state	O
.	O

The	O
diagnosis	O
of	O
haemophagocytic	O
lymphohistiocytosis	O
should	O
be	O
considered	O
in	O
young	O
patients	O
with	O
marked	O
bone	B-ANAT
marrow	I-ANAT
dysfunction	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

Pulmonary	B-ANAT
histopathology	O
showed	O
acute	O
interstitial	B-ANAT
pneumonia	O
in	O
40	O
%	O
(	O
99	O
),	O
diffuse	O
alveolar	B-ANAT
damage	O
in	O
36	O
%	O
(	O
89	O
),	O
pulmonary	B-ANAT
edema	O
in	O
13	O
%	O
(	O
33	O
),	O
and	O
alveolar	B-ANAT
hemorrhage	O
in	O
12	O
%	O
(	O
29	O
)	O
of	O
patients	O
.	O

Further	O
studies	O
are	O
necessary	O
to	O
elucidate	O
the	O
complete	O
pulmonary	B-ANAT
physiopathological	O
mechanism	O
involved	O
with	O
each	O
HIV	O
/	O
AIDS	O
-	O
associated	O
disease	O
.	O

Multivariate	O
analysis	O
showed	O
a	O
significant	O
and	O
positive	O
association	O
between	O
Pneumocystis	O
jiroveci	O
pneumonia	O
and	O
acute	O
interstitial	B-ANAT
pneumonia	O
(	O
Odds	O
ratio	O
,	O
4	O
.	O
51	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
46	O
-	O
8	O
.	O
24	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
severe	O
sepsis	O
and	O
/	O
or	O
septic	O
shock	O
and	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
Odds	O
ratio	O
,	O
3	O
.	O
60	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
78	O
-	O
7	O
.	O
27	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
cytomegalovirus	O
and	O
acute	O
interstitial	B-ANAT
pneumonia	O
(	O
Odds	O
ratio	O
,	O
2	O
.	O
22	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
01	O
-	O
4	O
.	O
93	O
;	O
p	O
=	O
0	O
.	O
05	O
).	O

More	O
sevenre	O
course	O
with	O
great	O
risk	O
of	O
myocardial	O
infarction	O
with	O
Q	O
wave	O
(	O
twice	O
,	O
p	O
<	O
0	O
.	O
001	O
),	O
prolongation	O
of	O
painless	O
ischemia	O
(	O
62	O
.	O
4	O
+/-	O
11	O
.	O
5	O
min	O
/	O
day	O
vs	O
.	O
22	O
.	O
8	O
+/-	O
11	O
.	O
1	O
min	O
/	O
day	O
),	O
inclination	O
to	O
complicated	O
rhythm	O
disturbances	O
(	O
38	O
vs	O
.	O
21	O
.	O
9	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
earlier	O
clinical	O
manifestations	O
of	O
heart	B-ANAT
failure	O
(	O
4	O
.	O
3	O
+/-	O
0	O
.	O
6	O
years	O
earlier	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
is	O
typical	O
for	O
CHD	O
with	O
COPD	O
vs	O
.	O
patients	O
without	O
pulmonary	B-ANAT
pathology	O
.	O

Decrease	O
in	O
number	O
of	O
supraventricular	O
and	O
ventricular	B-ANAT
extrasystoles	O
(	O
42	O
.	O
7	O
+/-	O
1	O
.	O
48	O
vs	O
.	O
20	O
.	O
5	O
+/-	O
1	O
.	O
07	O
cases	O
in	O
a	O
day	O
,	O
a	O
<	O
0	O
.	O
0001	O
),	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
increase	O
in	O
ejection	O
fraction	O
and	O
decrease	O
in	O
left	B-ANAT
ventricle	I-ANAT
end	O
-	O
diastolic	O
volume	O
(	O
12	O
.	O
2	O
+/-	O
0	O
.	O
4	O
%	O
E	O
12	O
.	O
2	O
+/-	O
0	O
.	O
3	O
%	O
respectively	O
),	O
in	O
dimensions	O
of	O
left	O
(	O
10	O
.	O
9	O
+/-	O
0	O
.	O
03	O
%)	O
and	O
right	O
(	O
8	O
.	O
8	O
+/-	O
0	O
.	O
9	O
%)	O
atrium	B-ANAT
,	O
in	O
risk	O
of	O
development	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
were	O
noticed	O
in	O
the	O
patients	O
of	O
main	O
group	O
received	O
TMZ	O
.	O

In	O
contrast	O
with	O
previous	O
studies	O
,	O
we	O
successfully	O
used	O
lung	B-ANAT
protective	O
ventilation	O
with	O
HFO	O
immediately	O
.	O

Recent	O
studies	O
have	O
identified	O
three	O
membrane	B-ANAT
-	O
active	O
regions	O
in	O
the	O
S2	O
domain	O
of	O
SARS	O
-	O
CoV	O
glycoprotein	O
,	O
one	O
situated	O
downstream	O
of	O
the	O
minimum	O
furin	O
cleavage	O
,	O
which	O
is	O
considered	O
the	O
fusion	O
peptide	O
(	O
SARSFP	O
),	O
an	O
internal	O
fusion	O
peptide	O
located	O
immediately	O
upstream	O
of	O
the	O
HR1	O
region	O
(	O
SARSIFP	O
)	O
and	O
the	O
pre	O
-	O
transmembrane	B-ANAT
domain	O
(	O
SARSPTM	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
most	O
severe	O
extreme	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
refer	O
to	O
increased	O
-	O
permeability	O
pulmonary	B-ANAT
edema	O
caused	O
by	O
a	O
variety	O
of	O
pulmonary	B-ANAT
or	O
systemic	O
insults	O
.	O

The	O
S2	O
domain	O
mediates	O
membrane	B-ANAT
fusion	O
between	O
the	O
virus	O
and	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

Although	O
rates	O
of	O
invasive	O
cardiac	B-ANAT
procedures	O
for	O
acute	O
myocardial	O
infarction	O
patients	O
decreased	O
11	O
-	O
37	O
%	O
in	O
Toronto	O
,	O
rates	O
of	O
nonfatal	O
cardiac	B-ANAT
outcomes	O
did	O
not	O
change	O
.	O

ABSTRACT	O
:	O
Mouse	O
susceptibility	O
to	O
experimental	O
infections	O
with	O
flaviviruses	O
is	O
significantly	O
influenced	O
by	O
a	O
cluster	O
of	O
genes	O
on	O
chromosome	B-ANAT
5	I-ANAT
encoding	O
a	O
family	O
of	O
proteins	O
with	O
enzymatic	O
properties	O
,	O
the	O
2	O
'-	O
5	O
'	O
oligoadenylate	O
synthetases	O
(	O
OAS	O
).	O

Infectivity	O
was	O
also	O
reduced	O
after	O
depleting	O
cholesterol	O
from	O
the	O
viral	B-ANAT
envelope	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
production	O
of	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
constitutes	O
a	O
relevant	O
and	O
safe	O
model	O
to	O
study	O
molecular	O
determinants	O
of	O
virion	B-ANAT
egress	O
.	O

The	O
minimal	O
requirement	O
for	O
the	O
assembly	O
of	O
VLPs	B-ANAT
for	O
the	O
coronavirus	O
responsible	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
humans	O
(	O
SARS	O
-	O
CoV	O
)	O
is	O
still	O
controversial	O
.	O

When	O
coexpressed	O
,	O
the	O
native	O
envelope	B-ANAT
trimeric	O
S	O
glycoprotein	O
is	O
incorporated	O
onto	O
VLPs	B-ANAT
.	O

TITLE	O
:	O
[	O
Antiviral	O
activity	O
of	O
arbidol	O
and	O
its	O
derivatives	O
against	O
the	O
pathogen	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
the	O
cell	B-ANAT
cultures	O
].	O

They	O
belonged	O
to	O
space	O
group	O
P1	O
,	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
41	O
.	O
1	O
,	O
b	O
=	O
43	O
.	O
2	O
,	O
c	O
=	O
48	O
.	O
9	O
A	O
,	O
alpha	O
=	O
78	O
.	O
0	O
,	O
beta	O
=	O
80	O
.	O
0	O
,	O
gamma	O
=	O
73	O
.	O
6	O
degrees	O
.	O

Patients	O
with	O
recurrent	O
wheeze	O
and	O
risk	O
factors	O
for	O
asthma	O
,	O
age	O
2	O
months	O
to	O
3	O
years	O
,	O
hospitalized	O
with	O
bronchial	B-ANAT
obstruction	O
were	O
included	O
.	O

Furthermore	O
,	O
only	O
E	O
.	O
coli	O
was	O
isolated	O
from	O
all	O
18	O
faeces	B-ANAT
samples	O
of	O
healthy	O
calves	O
.	O

The	O
nucleolar	B-ANAT
trafficking	O
of	O
wild	O
type	O
viral	O
proteins	O
and	O
chimeric	O
proteins	O
,	O
which	O
contain	O
altered	O
NoLSs	O
,	O
were	O
compared	O
to	O
investigate	O
the	O
role	O
of	O
NoLSs	O
in	O
dynamic	O
nucleolar	B-ANAT
trafficking	O
.	O

In	O
addition	O
to	O
the	O
granulomatous	O
host	O
response	O
,	O
necrosis	O
,	O
digestion	O
chambers	O
,	O
Gitter	O
cells	B-ANAT
,	O
spheroids	O
and	O
lymphocytic	O
perivascular	O
cuffs	O
were	O
features	O
of	O
the	O
malacic	O
areas	O
.	O

Both	O
antibody	O
-	O
displaying	O
human	O
cells	B-ANAT
and	O
virus	B-ANAT
particles	I-ANAT
bound	O
antigen	O
specifically	O
.	O

Furthermore	O
,	O
a	O
pseudotype	O
virus	O
bearing	O
a	O
cleaved	B-ANAT
S	O
protein	O
was	O
revealed	O
to	O
infect	O
cells	B-ANAT
in	O
the	O
presence	O
of	O
a	O
lysosomotropic	O
agent	O
as	O
well	O
as	O
a	O
protease	O
inhibitor	O
,	O
both	O
of	O
which	O
are	O
known	O
to	O
block	O
SARS	O
-	O
CoV	O
infection	O
via	O
an	O
endosome	B-ANAT
,	O
whereas	O
the	O
infection	O
of	O
pseudotypes	O
with	O
an	O
uncleaved	O
,	O
wild	O
-	O
type	O
S	O
protein	O
was	O
blocked	O
by	O
these	O
agents	O
.	O

In	O
different	O
models	O
of	O
pulmonary	B-ANAT
injury	O
,	O
SOD3	O
is	O
reduced	O
;	O
however	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
contributes	O
to	O
lung	B-ANAT
injury	O
.	O

To	O
study	O
the	O
role	O
of	O
acute	O
SOD3	O
reduction	O
in	O
lung	B-ANAT
injury	O
,	O
the	O
SOD3	O
gene	O
was	O
deleted	O
in	O
adult	O
mice	O
by	O
using	O
the	O
Cre	O
-	O
Lox	O
technology	O
.	O

Acute	O
reduction	O
of	O
SOD3	O
led	O
to	O
a	O
fivefold	O
increase	O
in	O
lung	B-ANAT
superoxide	O
,	O
marked	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
,	O
a	O
threefold	O
increase	O
in	O
the	O
arterial	B-ANAT
-	O
alveolar	B-ANAT
gradient	O
,	O
respiratory	O
acidosis	O
,	O
histological	O
changes	O
similar	O
to	O
those	O
observed	O
in	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
85	O
%	O
mortality	O
.	O

The	O
cytoplasmic	B-ANAT
C	O
-	O
terminus	O
domain	O
of	O
SARS	O
-	O
CoV	O
M	O
protein	O
was	O
responsible	O
for	O
binding	O
to	O
NC	O
protein	O
.	O

Exposure	O
to	O
live	O
birds	O
,	O
perceived	O
similar	O
symptoms	O
between	O
influenza	O
and	O
bird	O
-	O
to	O
-	O
human	O
H5N1	O
avian	O
influenza	O
,	O
that	O
bird	O
-	O
to	O
-	O
human	O
avian	O
influenza	O
was	O
more	O
lethal	O
than	O
SARS	O
were	O
predictive	O
use	O
of	O
face	B-ANAT
mask	O
when	O
having	O
ILI	O
symptoms	O
(	O
OR	O
=	O
4	O
.	O
25	O
-	O
8	O
.	O
34	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Evaluating	O
pulmonary	B-ANAT
complications	O
in	O
childhood	O
acute	O
leukemias	O
.	O

ABSTRACT	O
:	O
The	O
aims	O
of	O
this	O
study	O
were	O
firstly	O
to	O
evaluate	O
the	O
pathogenicity	O
of	O
an	O
Italian	O
isolate	O
of	O
the	O
QX	O
strain	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
virus	O
using	O
1	O
-	O
day	O
-	O
old	O
female	O
specific	O
pathogen	O
free	O
chicks	O
(	O
layer	B-ANAT
type	O
)	O
and	O
1	O
-	O
day	O
-	O
old	O
female	O
commercial	O
broiler	O
type	O
chickens	O
,	O
and	O
secondly	O
to	O
assess	O
the	O
level	O
of	O
protection	O
induced	O
in	O
these	O
birds	O
by	O
a	O
vaccination	O
programme	O
including	O
the	O
IB	O
Massachusetts	O
and	O
4	O
/	O
91	O
serotype	O
live	O
attenuated	O
vaccines	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
strand	O
RNA	O
viruses	O
,	O
a	O
large	O
group	O
including	O
human	O
pathogens	O
such	O
as	O
SARS	O
-	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
replicate	O
in	O
the	O
cytoplasm	B-ANAT
of	O
infected	O
host	O
cells	B-ANAT
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
susceptibility	O
of	O
murine	O
embryonic	B-ANAT
stem	B-ANAT
(	O
mESCs	O
)	O
to	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
-	O
A59	O
)	O
and	O
mouse	O
minute	O
virus	O
(	O
MMVp	O
)	O
and	O
the	O
effect	O
of	O
these	O
viruses	O
on	O
germline	O
transmission	O
(	O
GLT	O
)	O
and	O
the	O
serological	O
status	O
of	O
recipients	O
and	O
pups	O
.	O

ABSTRACT	O
:	O
Malaria	O
is	O
an	O
important	O
treatable	O
cause	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
the	O
tropics	O
and	O
in	O
the	O
returning	O
traveller	O
in	O
the	O
non	O
-	O
endemic	O
areas	O
.	O

Increased	O
alveolar	B-ANAT
capillary	B-ANAT
permeability	O
resulting	O
in	O
intravascular	O
fluid	O
loss	O
into	O
the	O
lungs	B-ANAT
appears	O
to	O
be	O
the	O
key	O
pathophysiologic	O
mechanism	O
.	O

By	O
contrast	O
,	O
salt	O
and	O
water	O
retention	O
can	O
be	O
severe	O
and	O
complicated	O
with	O
hypertension	O
,	O
congestive	O
heart	B-ANAT
failure	O
or	O
pulmonary	B-ANAT
edema	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
described	O
isolation	O
of	O
a	O
potentially	O
new	O
mammalian	O
reovirus	O
,	O
designated	O
BYD1	O
,	O
which	O
can	O
cause	O
clinical	O
symptoms	O
similar	O
to	O
that	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
guinea	O
pigs	O
and	O
macaques	O
,	O
from	O
throat	B-ANAT
swabs	O
of	O
one	O
SARS	O
patient	O
of	O
Beijing	O
,	O
in	O
2003	O
.	O

For	O
this	O
study	O
,	O
we	O
determined	O
the	O
genome	O
sequences	O
of	O
BYD1	O
and	O
the	O
S1	O
gene	O
sequences	O
of	O
other	O
five	O
mammalian	O
reovirus	O
isolates	O
(	O
BLD	O
,	O
JP	O
,	O
and	O
BYL	O
were	O
isolated	O
from	O
different	O
SARS	O
patients	O
during	O
the	O
outbreak	O
,	O
302I	O
and	O
302II	O
were	O
isolated	O
from	O
fecal	B-ANAT
specimens	O
of	O
two	O
children	O
of	O
Beijing	O
in	O
1982	O
)	O
to	O
allow	O
molecular	O
comparison	O
with	O
other	O
previously	O
reported	O
mammalian	O
reoviruses	O
(	O
MRVs	O
).	O

TITLE	O
:	O
[	O
Decompensated	O
pulmonary	B-ANAT
hypertension	O
].	O

ABSTRACT	O
:	O
Cholesterol	O
present	O
in	O
the	O
plasma	B-ANAT
membrane	I-ANAT
of	O
target	B-ANAT
cells	I-ANAT
has	O
been	O
shown	O
to	O
be	O
important	O
for	O
the	O
infection	O
by	O
SARS	O
-	O
CoV	O
.	O
We	O
show	O
that	O
cholesterol	O
depletion	O
by	O
treatment	O
with	O
methyl	O
-	O
beta	O
-	O
cyclodextrin	O
(	O
m	O
beta	O
CD	O
)	O
affects	O
infection	O
by	O
SARS	O
-	O
CoV	O
to	O
the	O
same	O
extent	O
as	O
infection	O
by	O
vesicular	O
stomatitis	O
virus	O
-	O
based	O
pseudotypes	O
containing	O
the	O
surface	O
glycoprotein	O
S	O
of	O
SARS	O
-	O
CoV	O
(	O
VSV	O
-	O
Delta	O
G	O
-	O
S	O
).	O

To	O
understand	O
the	O
involvement	O
of	O
cholesterol	O
in	O
the	O
initial	O
steps	O
of	O
the	O
viral	O
life	O
cycle	O
,	O
we	O
applied	O
a	O
cell	B-ANAT
-	O
based	O
binding	O
assay	O
with	O
cells	B-ANAT
expressing	O
the	O
S	O
protein	O
and	O
cells	B-ANAT
containing	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

This	O
result	O
suggests	O
that	O
optimal	O
infection	O
requires	O
a	O
multivalent	O
interaction	O
between	O
viral	O
attachment	O
protein	O
and	O
cellular	B-ANAT
receptors	O
.	O

More	O
recently	O
,	O
three	O
novel	O
coronaviruses	O
associated	O
with	O
severe	O
human	O
respiratory	O
disease	O
were	O
found	O
,	O
including	O
(	O
i	O
)	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
associated	O
with	O
a	O
significant	O
atypical	O
pneumonia	O
and	O
10	O
%	O
mortality	O
;	O
(	O
ii	O
)	O
HKU	O
-	O
1	O
,	O
associated	O
with	O
chronic	O
pulmonary	B-ANAT
disease	O
;	O
and	O
(	O
iii	O
)	O
NL63	O
,	O
associated	O
with	O
both	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
in	O
children	O
and	O
adults	O
worldwide	O
.	O

Throat	B-ANAT
swab	I-ANAT
specimens	O
from	O
242	O
adults	O
admitted	O
to	O
hospital	O
with	O
CAP	O
were	O
tested	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
role	O
of	O
liver	B-ANAT
natural	B-ANAT
killer	I-ANAT
cells	I-ANAT
(	O
NK	B-ANAT
cells	I-ANAT
)	O
in	O
murine	O
hepatitis	O
virus	O
strain	O
3	O
(	O
MHV	O
-	O
3	O
)	O
induced	O
murine	O
fulminant	O
hepatitis	O
.	O

Following	O
MHV	O
-	O
3	O
infection	O
,	O
the	O
proportion	O
of	O
liver	B-ANAT
NK	B-ANAT
cells	I-ANAT
in	O
the	O
mice	O
increased	O
remarkably	O
and	O
reached	O
the	O
peak	O
(	O
43	O
.	O
9	O
%+/-	O
2	O
.	O
3	O
%)	O
at	O
48	O
h	O
,	O
then	O
kept	O
a	O
high	O
proportion	O
until	O
the	O
mice	O
were	O
sacrificed	O
.	O

The	O
proportion	O
of	O
NK	B-ANAT
cells	I-ANAT
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
also	O
significantly	O
increased	O
and	O
reached	O
the	O
peak	O
(	O
18	O
.	O
0	O
%+/-	O
5	O
.	O
4	O
%)	O
at	O
48	O
h	O
.	O
However	O
,	O
there	O
were	O
few	O
NK	B-ANAT
cells	I-ANAT
in	O
the	O
peripheral	B-ANAT
blood	I-ANAT
at	O
70	O
h	O
after	O
infection	O
;	O
the	O
ratio	O
was	O
only	O
1	O
.	O
3	O
%+/-	O
0	O
.	O
6	O
%.	O

Our	O
results	O
suggest	O
that	O
liver	B-ANAT
NK	B-ANAT
cells	I-ANAT
may	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
pathogenesis	O
of	O
fulminant	O
viral	O
hepatitis	O
.	O

SARS	O
-	O
CoV	O
-	O
specific	O
CD4	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
were	O
detected	O
in	O
all	O
vaccinees	O
,	O
and	O
CD8	O
+	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
in	O
approximately	O
20	O
%	O
of	O
individuals	O
.	O

In	O
this	O
way	O
,	O
it	O
would	O
be	O
possible	O
to	O
quickly	O
create	O
and	O
distribute	O
large	O
quantities	O
of	O
milk	O
-	O
based	O
and	O
serum	B-ANAT
-	O
based	O
passive	O
immune	O
globulin	O
active	O
against	O
the	O
strains	O
of	O
avian	O
influenza	O
present	O
in	O
a	O
particular	O
geographic	O
area	O
and	O
gain	O
time	O
for	O
production	O
of	O
human	O
convalescent	O
plasma	B-ANAT
and	O
other	O
public	O
health	O
measures	O
.	O

Our	O
inability	O
to	O
predict	O
an	O
individual	O
'	O
s	O
susceptibility	O
to	O
acute	O
lung	B-ANAT
injury	O
has	O
long	O
suggested	O
that	O
genetic	O
factors	O
influence	O
ALI	O
risk	O
.	O

There	O
is	O
substantial	O
evidence	O
for	O
heritable	O
predispositions	O
to	O
severe	O
infections	O
and	O
an	O
emerging	O
body	B-ANAT
of	O
literature	O
implicating	O
genetic	O
factors	O
in	O
ALI	O
pathogenesis	O
.	O

The	O
serum	B-ANAT
cytokine	O
profile	O
during	O
acute	O
infection	O
indicated	O
a	O
significant	O
elevation	O
of	O
innate	O
immune	O
responses	O
.	O

In	O
children	O
with	O
community	O
-	O
acquired	O
pneumonia	O
,	O
absence	O
of	O
the	O
A1	O
allele	O
at	O
the	O
interleukin	O
-	O
1	O
receptor	O
antagonist	O
intron	O
2	O
polymorphic	O
site	O
is	O
associated	O
with	O
increased	O
risk	O
for	O
more	O
severe	O
lung	B-ANAT
injury	O
,	O
as	O
measured	O
by	O
the	O
need	O
for	O
positive	O
pressure	O
ventilation	O
or	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
804	O
goat	O
sera	B-ANAT
were	O
collected	O
from	O
144	O
goat	O
farms	O
in	O
five	O
regions	O
of	O
South	O
Korea	O
during	O
a	O
period	O
between	O
2005	O
and	O
2006	O
and	O
screened	O
for	O
the	O
antibodies	O
of	O
viral	O
pathogens	O
in	O
ruminants	O
.	O

TITLE	O
:	O
Topology	O
and	O
membrane	B-ANAT
anchoring	O
of	O
the	O
coronavirus	O
replication	O
complex	O
:	O
not	O
all	O
hydrophobic	O
domains	O
of	O
nsp3	O
and	O
nsp6	O
are	O
membrane	B-ANAT
spanning	O
.	O

Control	O
of	O
neurotropic	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
requires	O
the	O
collaboration	O
of	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
,	O
with	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
providing	O
direct	O
perforin	O
and	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)-	O
mediated	O
antiviral	O
activity	O
.	O

These	O
data	O
support	O
a	O
role	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
virus	O
clearance	O
and	O
demyelination	O
.	O

IFN	O
-	O
gamma	O
reduced	O
neutrophil	B-ANAT
accumulation	O
and	O
directed	O
macrophages	B-ANAT
to	O
white	B-ANAT
matter	I-ANAT
but	O
did	O
not	O
ameliorate	O
myelin	B-ANAT
loss	O
.	O

ABSTRACT	O
:	O
Apolipoprotein	O
D	O
(	O
apoD	O
)	O
is	O
a	O
lipocalin	O
upregulated	O
in	O
the	O
nervous	B-ANAT
system	I-ANAT
after	O
injury	O
or	O
pathologies	O
such	O
as	O
Alzheimer	O
'	O
s	O
disease	O
,	O
Parkinson	O
'	O
s	O
disease	O
,	O
and	O
multiple	O
sclerosis	O
.	O

The	O
apoD	O
upregulation	O
coincides	O
with	O
glial	B-ANAT
activation	O
,	O
and	O
its	O
expression	O
returns	O
to	O
normal	O
levels	O
when	O
the	O
virus	O
is	O
cleared	O
,	O
concomitantly	O
to	O
a	O
resolved	O
glial	B-ANAT
reactivity	O
.	O

Lung	B-ANAT
biopsy	O
at	O
the	O
time	O
of	O
the	O
AE	O
,	O
explant	O
,	O
or	O
autopsy	O
revealed	O
organizing	O
diffuse	O
alveolar	B-ANAT
damage	O
superimposed	O
on	O
fibrotic	O
lung	B-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Acute	O
rhabdomyolysis	O
is	O
a	O
syndrome	O
characterized	O
by	O
the	O
lesion	O
of	O
skeletal	B-ANAT
muscle	I-ANAT
resulting	O
in	O
subsequent	O
release	O
of	O
intracellular	B-ANAT
contents	O
into	O
the	O
circulatory	B-ANAT
system	I-ANAT
,	O
which	O
can	O
cause	O
potentially	O
lethal	O
complications	O
.	O

Upon	O
pressure	O
relief	O
and	O
beginning	O
of	O
tissue	B-ANAT
recovery	O
,	O
post	O
ischemic	O
compartment	B-ANAT
syndrome	O
occurred	O
with	O
subsequent	O
rhabdomyolysis	O
.	O

Laboratory	O
findings	O
showed	O
high	O
levels	O
of	O
creatine	O
phosphokinase	O
as	O
the	O
most	O
sensitive	O
marker	O
of	O
muscular	B-ANAT
damage	O
.	O

Of	O
course	O
,	O
creatine	O
phosphokinase	O
is	O
the	O
most	O
sensitive	O
indicator	O
of	O
muscle	B-ANAT
injury	O
and	O
the	O
degree	O
of	O
creatine	O
phosphokinase	O
elevation	O
correlates	O
with	O
the	O
amount	O
of	O
muscle	B-ANAT
injury	O
and	O
disease	O
severity	O
.	O

Other	O
laboratory	O
findings	O
can	O
help	O
identify	O
common	O
complications	O
of	O
rhabdomyolysis	O
such	O
as	O
acute	O
renal	B-ANAT
failure	O
,	O
metabolic	O
derangements	O
and	O
disseminated	O
intravascular	O
coagulopathy	O
.	O

Lesions	O
with	O
reduced	O
diffusion	O
were	O
noted	O
on	O
day	O
3	O
in	O
the	O
deep	O
zone	O
of	O
gray	B-ANAT
matter	I-ANAT
of	O
the	O
left	O
occipito	O
-	O
temporo	O
-	O
parietal	B-ANAT
cortex	I-ANAT
,	O
but	O
on	O
day	O
7	O
they	O
shifted	O
to	O
the	O
subcortical	B-ANAT
white	B-ANAT
matter	I-ANAT
of	O
both	O
the	O
cerebral	B-ANAT
hemispheres	I-ANAT
.	O

It	O
was	O
predominantly	O
cleaved	B-ANAT
into	O
subdomains	O
S1	O
and	O
S2	O
during	O
maturation	O
.	O

TITLE	O
:	O
Mechanistic	O
analysis	O
of	O
macrophage	B-ANAT
response	O
to	O
IRAK	O
-	O
1	O
gene	O
knockdown	O
by	O
a	O
smart	O
polymer	O
-	O
antisense	O
oligonucleotide	O
therapeutic	O
.	O

Following	O
LPS	O
stimulation	O
,	O
the	O
anti	O
-	O
inflammatory	O
activity	O
of	O
ASODN	O
against	O
the	O
IRAK	O
-	O
1	O
gene	O
expression	O
is	O
evidenced	O
by	O
the	O
lower	O
expression	O
of	O
inflammatory	O
chemokines	O
,	O
cytokines	O
and	O
acute	O
-	O
phase	O
proteins	O
compared	O
to	O
control	O
cells	B-ANAT
.	O

Dyspnea	O
increased	O
significantly	O
after	O
challenge	O
in	O
all	O
three	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
p	O
=	O
0	O
.	O
04	O
,	O
and	O
p	O
=	O
0	O
.	O
002	O
,	O
respectively	O
),	O
and	O
blood	B-ANAT
oxygen	O
saturation	O
dropped	O
post	O
-	O
challenge	O
in	O
the	O
Dead	O
Worm	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
20	O
ng	O
/	O
mL	O
Ag	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
groups	O
.	O

Clinical	O
observations	O
included	O
dyspnea	O
,	O
gastrointestinal	O
signs	O
(	O
retching	O
,	O
defecation	O
,	O
or	O
flatulence	O
),	O
urination	O
,	O
and	O
less	O
commonly	O
,	O
hemorrhage	O
from	O
the	O
nostrils	B-ANAT
or	O
anus	B-ANAT
,	O
or	O
cutaneous	O
swelling	O
(	O
general	O
or	O
specifically	O
facial	B-ANAT
).	O

Factors	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
the	O
diagnosis	O
of	O
PE	O
included	O
:	O
revision	O
THA	O
,	O
female	O
gender	O
,	O
dementia	O
,	O
obesity	O
,	O
renal	B-ANAT
and	O
cerebrovascular	O
disease	O
.	O

As	O
the	O
disease	O
progressed	O
,	O
more	O
clinical	O
signs	O
consistent	O
with	O
FIP	O
,	O
including	O
renal	B-ANAT
involvement	O
and	O
later	O
pleural	B-ANAT
effusion	I-ANAT
,	O
became	O
evident	O
.	O

Here	O
,	O
the	O
internalization	O
and	O
subsequent	O
trafficking	O
of	O
the	O
antigen	O
-	O
antibody	O
complexes	O
were	O
characterized	O
using	O
biochemical	O
,	O
cell	B-ANAT
biological	O
and	O
genetic	O
approaches	O
.	O

Gastric	B-ANAT
juice	I-ANAT
from	O
an	O
intensive	O
care	O
unit	O
patient	O
supporting	O
high	O
proinflammatory	O
activity	O
in	O
vitro	O
also	O
induced	O
a	O
more	O
severe	O
and	O
persistent	O
drop	O
in	O
PaO2	O
/	O
FIO2	O
and	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
in	O
ventilated	O
rabbits	O
,	O
a	O
worse	O
histologic	O
score	O
,	O
higher	O
lung	B-ANAT
lavage	O
concentrations	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
interleukin	O
-	O
8	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
and	O
growth	O
-	O
related	O
oncogene	O
-	O
alpha	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
than	O
one	O
fluid	O
with	O
low	O
proinflammatory	O
activity	O
.	O

A	O
human	O
gastric	B-ANAT
juice	I-ANAT
with	O
high	O
proinflammatory	O
activity	O
is	O
more	O
""""	O
toxic	O
""""	O
to	O
the	O
lung	B-ANAT
than	O
one	O
with	O
low	O
proinflammatory	O
activity	O
in	O
a	O
ventilated	O
rabbit	O
model	O
,	O
an	O
effect	O
that	O
is	O
independent	O
of	O
pH	O
and	O
particulate	O
matter	O
content	O
.	O

CONCLUSIONS	O
:	O
Gastric	B-ANAT
juice	I-ANAT
from	O
critically	O
ill	O
patients	O
is	O
proinflammatory	O
and	O
stimulates	O
human	O
pulmonary	B-ANAT
cells	B-ANAT
in	O
vitro	O
.	O

Tropical	O
eosinophilia	O
is	O
believed	O
to	O
be	O
a	O
hyper	O
-	O
sensitivity	O
reaction	O
to	O
degenerating	O
microfilariae	O
trapped	O
in	O
the	O
lungs	B-ANAT
.	O

ABSTRACT	O
:	O
High	O
affinity	O
antigen	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
play	O
a	O
critical	O
role	O
during	O
protective	O
immune	O
responses	O
.	O

The	O
virus	O
was	O
also	O
detectable	O
in	O
the	O
oviduct	B-ANAT
of	O
vaccinated	O
,	O
challenged	O
hens	O
although	O
the	O
viral	O
load	O
was	O
much	O
lower	O
compared	O
to	O
the	O
viral	O
load	O
in	O
the	O
oviduct	B-ANAT
of	O
unvaccinated	O
,	O
challenged	O
hens	O
.	O

Most	O
vaccination	O
trials	O
investigating	O
the	O
efficacy	O
of	O
vaccines	O
for	O
layer	B-ANAT
and	O
breeder	O
hens	O
have	O
been	O
conducted	O
based	O
on	O
the	O
respiratory	B-ANAT
tract	I-ANAT
response	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
lifethreatening	O
emerging	O
respiratory	O
disease	O
caused	O
by	O
the	O
coronavirus	O
,	O
SARS	O
-	O
CoV	O
.	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
is	O
highly	O
antigenic	O
and	O
may	O
be	O
a	O
suitable	O
candidate	O
for	O
diagnostic	O
applications	O
.	O

None	O
of	O
50	O
healthy	O
sera	B-ANAT
gave	O
positive	O
results	O
in	O
either	O
assay	O
.	O

ABSTRACT	O
:	O
Descending	O
necrotising	O
mediastinitis	O
is	O
a	O
severe	O
infection	O
spreading	O
from	O
the	O
cervical	B-ANAT
region	I-ANAT
to	O
the	O
mediastinal	B-ANAT
connective	B-ANAT
tissue	I-ANAT
.	O

It	O
is	O
used	O
as	O
temporary	O
support	O
,	O
usually	O
awaiting	O
recovery	O
of	O
organs	B-ANAT
,	O
or	O
can	O
be	O
used	O
as	O
a	O
bridge	O
to	O
a	O
more	O
permanent	O
device	O
or	O
cardiac	B-ANAT
transplantation	O
.	O

This	O
is	O
usually	O
seen	O
post	O
-	O
cardiotomy	O
,	O
post	O
-	O
heart	B-ANAT
transplant	B-ANAT
and	O
in	O
severe	O
cardiac	B-ANAT
failure	O
due	O
to	O
almost	O
any	O
other	O
cause	O
(	O
e	O
.	O
g	O
.	O
cardiomyopathy	O
,	O
myocarditis	O
,	O
acute	O
coronary	B-ANAT
syndrome	O
with	O
cardiogenic	O
shock	O
).	O

We	O
also	O
found	O
229E	O
virion	B-ANAT
S	O
protein	O
to	O
be	O
cleaved	B-ANAT
by	O
CPL	O
.	O

Survival	O
in	O
MHV	O
-	O
CXCL9	O
-	O
infected	O
CXCL9	O
-/-	O
mice	O
was	O
associated	O
with	O
reduced	O
viral	O
burden	O
within	O
the	O
brain	B-ANAT
that	O
coincided	O
with	O
increased	O
T	B-ANAT
cell	I-ANAT
infiltration	O
.	O

Similarly	O
,	O
viral	O
clearance	O
from	O
the	O
livers	B-ANAT
of	O
MHV	O
-	O
CXCL9	O
-	O
infected	O
mice	O
was	O
accelerated	O
but	O
independent	O
of	O
increased	O
T	B-ANAT
cell	I-ANAT
or	O
NK	B-ANAT
cell	I-ANAT
infiltration	O
.	O

These	O
observations	O
indicate	O
that	O
CXCL9	O
promotes	O
protection	O
from	O
coronavirus	O
-	O
induced	O
neurological	O
and	O
liver	B-ANAT
disease	O
.	O

Because	O
sera	B-ANAT
endotoxins	O
were	O
elevated	O
,	O
she	O
was	O
treated	O
by	O
endotoxin	O
adsorption	O
therapy	O
on	O
hospital	O
day	O
3	O
.	O

The	O
disease	O
in	O
the	O
lungs	B-ANAT
of	O
the	O
E	O
.	O
coli	O
group	O
and	O
both	O
IBV	O
/	O
E	O
.	O
coli	O
groups	O
was	O
similar	O
.	O

TITLE	O
:	O
Crystal	B-ANAT
structures	O
of	O
two	O
coronavirus	O
ADP	O
-	O
ribose	O
-	O
1	O
''-	O
monophosphatases	O
and	O
their	O
complexes	O
with	O
ADP	O
-	O
Ribose	O
:	O
a	O
systematic	O
structural	O
analysis	O
of	O
the	O
viral	O
ADRP	O
domain	O
.	O

No	O
clear	O
difference	O
existed	O
between	O
single	O
and	O
dual	O
inoculated	O
birds	O
regarding	O
the	O
presence	O
of	O
E	O
.	O
coli	O
in	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Extracorporeal	O
pumpless	O
interventional	O
lung	B-ANAT
assist	O
in	O
clinical	O
practice	O
:	O
determinants	O
of	O
efficacy	O
.	O

Within	O
two	O
hours	O
of	O
iLA	O
treatment	O
,	O
arterial	B-ANAT
oxygen	O
partial	O
pressure	O
/	O
inspired	O
oxygen	O
fraction	O
ratio	O
increased	O
significantly	O
and	O
a	O
fast	O
improvement	O
in	O
arterial	B-ANAT
carbon	O
dioxide	O
partial	O
pressure	O
and	O
pH	O
was	O
observed	O
.	O

A	O
real	O
-	O
time	O
PCR	O
assay	O
was	O
developed	O
for	O
the	O
detection	O
of	O
CRCoV	O
.	O
The	O
assay	O
was	O
validated	O
against	O
cell	B-ANAT
culture	O
grown	O
virus	O
and	O
shown	O
to	O
have	O
a	O
high	O
level	O
of	O
sensitivity	O
.	O

A	O
range	O
of	O
tissue	B-ANAT
samples	O
were	O
collected	O
from	O
dogs	O
at	O
a	O
re	O
-	O
homing	O
centre	O
with	O
a	O
history	O
of	O
endemic	O
respiratory	O
disease	O
.	O

In	O
conclusion	O
,	O
CRCoV	O
appears	O
to	O
infect	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
preferentially	O
.	O

In	O
the	O
beginning	O
of	O
such	O
a	O
strategy	O
a	O
roller	O
-	O
pump	O
-	O
driven	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
used	O
,	O
which	O
was	O
characterized	O
by	O
high	O
complication	O
rate	O
.	O

The	O
TCoV	O
nsp15	O
gene	O
was	O
cloned	O
into	O
pTriEX1	O
and	O
expressed	O
as	O
a	O
C	O
-	O
terminal	O
His	O
-	O
tagged	O
recombinant	O
protein	O
in	O
BL21	B-ANAT
(	O
DE3	O
).	O

TITLE	O
:	O
Human	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
culture	O
to	O
identify	O
new	O
respiratory	O
viruses	O
:	O
coronavirus	O
NL63	O
as	O
a	O
model	O
.	O

She	O
was	O
rewarmed	O
to	O
obtain	O
a	O
rectal	O
and	O
nasal	B-ANAT
temperature	O
of	O
34	O
degrees	O
C	O
.	O
After	O
272	O
minutes	O
,	O
the	O
patient	O
was	O
weaned	O
successfully	O
from	O
CPB	O
.	O

TITLE	O
:	O
Efficiency	O
in	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
-	O
cellular	B-ANAT
deposits	O
on	O
polymethylpentene	O
membranes	B-ANAT
increase	O
resistance	O
to	O
blood	B-ANAT
flow	O
and	O
reduce	O
gas	O
exchange	O
capacity	O
.	O

The	O
membrane	B-ANAT
surface	O
of	O
the	O
MO	O
was	O
covered	O
with	O
a	O
fibrous	O
network	O
with	O
imbedded	O
platelets	B-ANAT
and	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
.	O

Surgeons	O
should	O
be	O
aware	O
of	O
the	O
potential	O
for	O
fatality	O
and	O
life	O
-	O
threatening	O
events	O
that	O
occur	O
in	O
patients	O
with	O
hypoplastic	O
chest	B-ANAT
wall	I-ANAT
and	O
spine	B-ANAT
deformity	O
undergoing	O
surgical	O
treatment	O
.	O

Serum	B-ANAT
amyloid	O
P	O
components	O
might	O
be	O
one	O
of	O
the	O
potential	O
biomarkers	O
in	O
serum	B-ANAT
of	O
recovered	O
SARS	O
patients	O
complicating	O
avascular	O
necrosis	O
of	O
femoral	B-ANAT
head	I-ANAT
.	O

Genes	O
encoding	O
truncated	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
spike	O
(	O
S	O
)	O
proteins	O
of	O
SARSCoV	O
were	O
cloned	O
into	O
the	O
expression	O
vector	O
pQE30	O
and	O
fusionally	O
expressed	O
in	O
Escherichia	O
coli	O
M15	O
.	O

The	O
fusion	O
protein	O
was	O
analyzed	O
for	O
reactivity	O
with	O
SARS	O
patients	O
'	O
sera	B-ANAT
and	O
with	O
anti	O
-	O
sera	B-ANAT
against	O
the	O
two	O
human	O
coronaviruses	O
HCoV	O
229E	O
and	O
HCoV	O
OC43	O
by	O
ELISA	O
,	O
IFA	O
and	O
immunoblot	O
assays	O
.	O

RESULTS	O
:	O
Genes	O
encoding	O
truncated	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
and	O
spike	O
(	O
S	O
)	O
proteins	O
of	O
SARSCoV	O
were	O
cloned	O
into	O
the	O
expression	O
vector	O
pQE30	O
and	O
fusionally	O
expressed	O
in	O
Escherichia	O
coli	O
M15	O
.	O

Immunization	O
with	O
a	O
cocktail	O
of	O
these	O
four	O
polypeptides	O
yielded	O
a	O
specific	O
polyclonal	O
antibody	O
that	O
is	O
able	O
to	O
recognize	O
SARS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
by	O
an	O
immunofluorescence	O
assay	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
efficacy	O
and	O
patient	O
discomfort	O
between	O
four	O
techniques	O
for	O
obtaining	O
nasal	B-ANAT
secretions	B-ANAT
.	O

Many	O
surviving	O
victims	O
developed	O
significant	O
pulmonary	B-ANAT
signs	O
and	O
severe	O
airway	B-ANAT
inflammation	O
;	O
41	O
(	O
58	O
%)	O
hospitalized	O
persons	O
met	O
PO2	O
/	O
FiO2	O
criteria	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
activation	O
in	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
by	O
FIP	O
-	O
virus	O
-	O
induced	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
differentiation	O
/	O
survival	O
factors	O
.	O

TITLE	O
:	O
[	O
Efficacy	O
of	O
sivelestat	O
for	O
acute	O
lung	B-ANAT
injury	O
due	O
to	O
severe	O
bacterial	O
pneumonia	O
with	O
systemic	O
inflammatory	O
response	O
syndrome	O
].	O

TITLE	O
:	O
[	O
Pharyngeal	B-ANAT
-	O
cervical	B-ANAT
-	O
brachial	O
variant	O
of	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
:	O
a	O
well	O
-	O
defined	O
clinical	O
condition	O
with	O
a	O
heterogeneous	O
immunological	O
profile	O
].	O

Several	O
such	O
compounds	O
exhibited	O
significant	O
activity	O
specifically	O
against	O
influenza	O
A	O
virus	O
in	O
cell	B-ANAT
culture	O
but	O
had	O
no	O
effect	O
on	O
the	O
replication	O
of	O
another	O
RNA	O
virus	O
,	O
respiratory	O
syncytial	O
virus	O
.	O

The	O
emergence	O
of	O
the	O
highly	O
pathogenic	O
coronavirus	O
severe	O
acute	O
respiratory	O
virus	O
(	O
SARS	O
-	O
CoV	O
)	O
serves	O
as	O
a	O
robust	O
model	O
system	O
to	O
elucidate	O
the	O
virus	O
-	O
host	O
interactions	O
that	O
mediate	O
severe	O
end	O
-	O
stage	O
lung	B-ANAT
disease	O
in	O
humans	O
and	O
animals	O
.	O

ABSTRACT	O
:	O
To	O
review	O
the	O
epidemiology	O
of	O
pediatric	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
and	O
summarize	O
current	O
concepts	O
regarding	O
the	O
pathophysiology	O
of	O
shock	O
,	O
organ	B-ANAT
dysfunction	O
,	O
and	O
nosocomial	O
infections	O
in	O
this	O
population	O
.	O

B	B-ANAT
cell	I-ANAT
hybridomas	B-ANAT
are	O
generated	O
from	O
mice	O
that	O
are	O
hyperimmunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
virions	B-ANAT
.	O

However	O
,	O
EM	O
sample	O
preparation	O
requires	O
that	O
the	O
specimen	O
be	O
dried	B-ANAT
onto	O
a	O
carbon	O
support	O
film	O
before	O
imaging	O
,	O
collapsing	O
internal	O
particle	O
structure	O
in	O
the	O
case	O
of	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
The	O
embryonated	O
egg	B-ANAT
is	O
a	O
complex	O
structure	O
comprising	O
an	O
embryo	B-ANAT
and	O
its	O
supporting	O
membranes	B-ANAT
(	O
chorioallantoic	O
,	O
amniotic	B-ANAT
,	O
yolk	B-ANAT
).	O

TITLE	O
:	O
Activation	O
of	O
p38	O
MAPK	O
by	O
feline	O
infectious	O
peritonitis	O
virus	O
regulates	O
pro	O
-	O
inflammatory	O
cytokine	O
production	O
in	O
primary	O
blood	B-ANAT
-	O
derived	O
feline	O
mononuclear	B-ANAT
cells	I-ANAT
.	O

Also	O
,	O
direct	O
treatment	O
of	O
infected	O
glial	B-ANAT
cultures	O
with	O
recombinant	O
mouse	O
IFN	O
-	O
alpha	O
or	O
IFN	O
-	O
beta	O
inhibits	O
viral	O
replication	O
.	O

IFN	O
-	O
gamma	O
-	O
mediated	O
control	O
of	O
JHMV	O
replication	O
is	O
dampened	O
in	O
glial	B-ANAT
cultures	O
derived	O
from	O
the	O
neural	O
progenitor	B-ANAT
cells	I-ANAT
of	O
type	O
I	O
receptor	O
knock	O
-	O
out	O
mice	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
is	O
a	O
critical	O
syndrome	O
associated	O
with	O
respiratory	O
dysfunction	O
,	O
and	O
neutrophils	B-ANAT
are	O
considered	O
to	O
be	O
central	O
to	O
the	O
pathogenesis	O
of	O
ALI	O
.	O

Serum	B-ANAT
phosphorus	O
(	O
P	O
)	O
level	O
was	O
extremely	O
low	O
at	O
<	O
0	O
.	O
7	O
mg	O
/	O
dL	O
.	O
Serum	B-ANAT
potassium	O
(	O
K	O
)	O
and	O
magnesium	O
(	O
Mg	O
)	O
levels	O
were	O
also	O
low	O
.	O

Similar	O
malnutrition	O
-	O
attributable	O
fractions	O
were	O
seen	O
for	O
the	O
major	O
causes	O
of	O
severe	O
disease	O
(	O
severe	O
malaria	O
,	O
gastroenteritis	O
,	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
HIV	O
,	O
and	O
invasive	O
bacterial	O
disease	O
).	O

ABSTRACT	O
:	O
Numerous	O
studies	O
have	O
evaluated	O
human	O
papillomavirus	O
(	O
HPV	O
)	O
DNA	O
load	O
in	O
women	O
,	O
especially	O
HPV	O
-	O
16	O
viral	O
load	O
,	O
and	O
its	O
role	O
in	O
cervical	B-ANAT
carcinogenicity	O
.	O

Penile	B-ANAT
shaft	O
specimens	O
had	O
significantly	O
higher	O
viral	O
load	O
than	O
any	O
other	O
anatomic	B-ANAT
site	I-ANAT
evaluated	O
except	O
for	O
the	O
anal	B-ANAT
canal	I-ANAT
.	O

Unraveling	O
a	O
long	O
-	O
standing	O
mystery	O
of	O
MIRR	O
triggering	O
and	O
transmembrane	B-ANAT
signaling	O
,	O
the	O
SCHOOL	O
model	O
reveals	O
the	O
intrareceptor	O
transmembrane	B-ANAT
interactions	O
and	O
interreceptor	O
cytoplasmic	B-ANAT
homointeractions	O
as	O
universal	O
therapeutic	O
targets	O
for	O
a	O
diverse	O
variety	O
of	O
disorders	O
mediated	O
by	O
immune	O
cells	B-ANAT
.	O

Thus	O
,	O
an	O
important	O
application	O
of	O
the	O
SCHOOL	O
model	O
is	O
that	O
global	O
therapeutic	O
strategies	O
targeting	O
key	O
protein	O
-	O
protein	O
interactions	O
involved	O
in	O
MIRR	O
triggering	O
and	O
transmembrane	B-ANAT
signal	O
transduction	O
may	O
be	O
used	O
to	O
treat	O
a	O
diverse	O
set	O
of	O
immune	O
-	O
mediated	O
diseases	O
.	O

Since	O
the	O
presence	O
of	O
V	O
/	O
Q	O
mismatch	O
in	O
pulmonary	B-ANAT
perfusion	O
and	O
ventilation	O
scintigrams	O
and	O
lupus	O
anticoagulant	O
were	O
detected	O
,	O
we	O
finally	O
diagnosed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
pulmonary	B-ANAT
thromboembolism	O
(	O
PTE	O
)	O
associated	O
with	O
antiphospholipid	O
syndrome	O
(	O
APS	O
).	O

The	O
genetic	O
absence	O
of	O
MyD88	O
resulted	O
in	O
enhanced	O
pulmonary	B-ANAT
pathology	O
and	O
greater	O
than	O
90	O
%	O
mortality	O
by	O
day	O
6	O
post	O
-	O
infection	O
.	O

These	O
data	O
suggest	O
that	O
MyD88	O
-	O
mediated	O
innate	O
immune	O
signaling	O
and	O
inflammatory	B-ANAT
cell	I-ANAT
recruitment	O
to	O
the	O
lung	B-ANAT
are	O
required	O
for	O
protection	O
from	O
lethal	O
rMA15	O
infection	O
.	O

The	O
clinical	O
signs	O
,	O
gross	O
,	O
and	O
histological	O
lesions	O
in	O
specific	O
pathogen	O
-	O
free	O
chickens	O
indicated	O
that	O
all	O
5	O
isolates	O
caused	O
mild	O
lesions	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

TITLE	O
:	O
Associations	O
between	O
male	O
anogenital	O
human	O
papillomavirus	O
infection	O
and	O
circumcision	O
by	O
anatomic	B-ANAT
site	I-ANAT
sampled	O
and	O
lifetime	O
number	O
of	O
female	O
sex	O
partners	O
.	O

Men	O
were	O
eligible	O
if	O
they	O
reported	O
sex	O
with	O
a	O
woman	O
within	O
the	O
past	O
year	O
,	O
no	O
history	O
of	O
genital	B-ANAT
warts	O
or	O
penile	B-ANAT
or	O
anal	B-ANAT
cancer	O
,	O
and	O
no	O
current	O
diagnosis	O
of	O
a	O
sexually	O
transmitted	O
infection	O
.	O

The	O
distribution	O
of	O
GFP	O
determined	O
by	O
immunohistochemistry	O
in	O
both	O
brain	B-ANAT
regions	I-ANAT
correlated	O
closely	O
with	O
distribution	O
of	O
GDL	O
determined	O
by	O
MRI	O
.	O

TITLE	O
:	O
Glycogen	O
synthase	O
kinase	O
-	O
3	O
regulates	O
the	O
phosphorylation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
and	O
viral	O
replication	O
.	O

Finally	O
,	O
GSK	O
-	O
3	O
inhibitor	O
was	O
found	O
to	O
reduce	O
N	O
phosphorylation	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
-	O
infected	O
VeroE6	O
cells	B-ANAT
and	O
decrease	O
the	O
viral	O
titer	O
and	O
cytopathic	O
effects	O
.	O

CONCLUSIONS	O
:	O
LSECtin	O
is	O
expressed	O
by	O
liver	B-ANAT
myeloid	B-ANAT
cells	I-ANAT
,	O
and	O
its	O
expression	O
is	O
dependent	O
on	O
the	O
PU	O
.	O
1	O
transcription	O
factor	O
.	O

These	O
findings	O
indicate	O
that	O
lung	B-ANAT
edema	O
in	O
SARS	O
infection	O
may	O
be	O
due	O
at	O
least	O
in	O
part	O
to	O
activation	O
of	O
PKC	O
by	O
SARS	O
proteins	O
,	O
leading	O
to	O
decreasing	O
levels	O
and	O
activity	O
of	O
ENaC	O
at	O
the	O
apical	O
surfaces	O
of	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Co	O
-	O
immunoprecipitation	O
analyses	O
demonstrated	O
an	O
interaction	O
between	O
the	O
N	O
and	O
M	O
proteins	O
,	O
suggesting	O
that	O
N	O
protein	O
binds	O
directly	O
to	O
M	O
protein	O
to	O
be	O
incorporated	O
into	O
VLP	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
hyperinduction	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
such	O
as	O
TNF	O
-	O
alpha	O
,	O
IFN	O
-	O
beta	O
,	O
and	O
CCL2	O
/	O
MCP	O
-	O
1	O
in	O
primary	O
human	O
macrophages	B-ANAT
and	O
respiratory	O
epithelial	B-ANAT
cells	I-ANAT
by	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
H5N1	O
is	O
believed	O
to	O
contribute	O
to	O
the	O
unusual	O
severity	O
of	O
human	O
H5N1	O
disease	O
.	O

TITLE	O
:	O
Type	O
I	O
IFN	O
-	O
mediated	O
protection	O
of	O
macrophages	B-ANAT
and	O
dendritic	B-ANAT
cells	I-ANAT
secures	O
control	O
of	O
murine	O
coronavirus	O
infection	O
.	O

To	O
establish	O
which	O
cell	B-ANAT
population	O
responds	O
most	O
efficiently	O
to	O
type	O
I	O
IFNs	O
,	O
mice	O
conditionally	O
deficient	O
for	O
the	O
IFNAR	O
on	O
different	O
leukocyte	B-ANAT
subsets	O
were	O
infected	O
with	O
MHV	O
.	O

This	O
genetic	O
analysis	O
revealed	O
that	O
IFNAR	O
expression	O
on	O
LysM	O
+	O
macrophages	B-ANAT
and	O
CD11c	O
+	O
dendritic	B-ANAT
cells	I-ANAT
was	O
most	O
important	O
for	O
the	O
early	O
containment	O
of	O
MHV	O
within	O
secondary	B-ANAT
lymphoid	I-ANAT
organs	I-ANAT
and	O
to	O
prevent	O
lethal	O
liver	B-ANAT
disease	O
.	O

MHV	O
particles	O
have	O
a	O
distinctly	O
spherical	O
shape	O
and	O
a	O
relatively	O
homogenous	O
size	O
(	O
approximately	O
85	O
nm	O
envelope	B-ANAT
diameter	O
).	O

Reducing	O
tidal	O
volume	O
to	O
3	O
ml	O
.	O
kg	O
(-	O
1	O
)	O
together	O
with	O
interventional	O
lung	B-ANAT
assist	O
resulted	O
in	O
a	O
decrease	O
in	O
severe	O
hypercapnia	O
without	O
alveolar	B-ANAT
collapse	O
or	O
hypoxaemia	O
but	O
with	O
a	O
decrease	O
in	O
serum	B-ANAT
levels	O
of	O
interleukin	O
-	O
6	O
.	O

ABSTRACT	O
:	O
To	O
estimate	O
the	O
coincidence	O
of	O
new	O
otitis	O
media	B-ANAT
(	O
OM	O
)	O
for	O
first	O
nasopharyngeal	B-ANAT
detections	O
of	O
the	O
more	O
common	O
viruses	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O

TITLE	O
:	O
Direct	O
metagenomic	O
detection	O
of	O
viral	O
pathogens	O
in	O
nasal	B-ANAT
and	O
fecal	B-ANAT
specimens	O
using	O
an	O
unbiased	O
high	O
-	O
throughput	O
sequencing	O
approach	O
.	O

In	O
fecal	B-ANAT
samples	O
,	O
bacteria	O
and	O
host	O
cells	B-ANAT
were	O
removed	O
by	O
centrifugation	O
,	O
resulting	O
in	O
gain	O
of	O
484	O
-	O
15	O
,	O
260	O
reads	O
of	O
norovirus	O
sequence	O
(	O
78	O
-	O
98	O
%	O
of	O
the	O
whole	O
genome	O
was	O
covered	O
),	O
except	O
for	O
one	O
specimen	O
that	O
was	O
under	O
-	O
detectable	O
by	O
RT	O
-	O
PCR	O
.	O

A	O
protective	O
effect	O
in	O
the	O
4	O
/	O
91	O
and	O
TM	O
-	O
86w	O
vaccine	O
groups	O
was	O
indicated	O
by	O
evaluation	O
of	O
the	O
ciliostasis	O
score	O
of	O
the	O
trachea	B-ANAT
,	O
the	O
respiratory	O
symptom	O
score	O
,	O
and	O
virus	O
isolation	O
from	O
trachea	B-ANAT
swab	O
samples	O
after	O
challenge	O
.	O

In	O
nonoutbreak	O
conditions	O
,	O
only	O
the	O
antimicrobial	O
airway	B-ANAT
filter	O
was	O
most	O
often	O
reported	O
to	O
be	O
always	O
used	O
(	O
52	O
.	O
0	O
%),	O
while	O
other	O
items	O
were	O
used	O
at	O
an	O
intermediate	O
frequency	O
.	O

These	O
results	O
indicate	O
that	O
the	O
A3	O
and	O
Vic	O
S	O
strains	O
replicate	O
at	O
a	O
low	O
level	O
in	O
the	O
oviduct	B-ANAT
without	O
causing	O
significant	O
damage	O
and	O
hence	O
are	O
safe	O
for	O
the	O
oviduct	B-ANAT
.	O

Each	O
of	O
these	O
agents	O
leads	O
to	O
diarrhea	O
through	O
either	O
secretion	B-ANAT
or	O
malabsorption	O
/	O
maldigestion	O
,	O
though	O
the	O
specific	O
mechanisms	O
and	O
pathways	O
may	O
differ	O
.	O

Rats	O
were	O
administered	O
with	O
NACA	B-ANAT
(	O
i	O
.	O
p	O
.	O

No	O
changes	O
were	O
detected	O
in	O
the	O
lung	B-ANAT
manganase	O
superoxide	O
dismutase	O
(	O
MnSOD	O
)	O
or	O
glutathione	O
reductase	O
(	O
GR	O
)	O
mRNA	O
expression	O
after	O
blast	B-ANAT
.	O

N	O
-	O
Acetylcysteine	O
amide	O
significantly	O
reduced	O
infiltration	O
of	O
neutrophils	B-ANAT
and	O
CD11b	O
mRNA	O
activation	O
in	O
lungs	B-ANAT
,	O
and	O
completely	O
blocked	O
activation	O
of	O
MIP	O
-	O
1	O
,	O
MCP	O
-	O
1	O
and	O
CINC	O
-	O
1	O
mRNA	O
.	O

ABSTRACT	O
:	O
The	O
Murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
strain	O
A59	O
ns2	O
protein	O
is	O
a	O
30	O
-	O
kDa	O
nonstructural	O
protein	O
that	O
is	O
expressed	O
from	O
a	O
subgenomic	O
mRNA	O
in	O
the	O
cytoplasm	B-ANAT
of	O
virus	O
-	O
infected	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
polyproteins	O
of	O
coronaviruses	O
are	O
cleaved	B-ANAT
by	O
viral	O
proteases	O
into	O
at	O
least	O
15	O
nonstructural	O
proteins	O
(	O
Nsps	O
).	O

ABSTRACT	O
:	O
The	O
fibroproliferative	O
phase	O
of	O
late	O
ALI	O
/	O
ARDS	O
as	O
described	O
by	O
Hudson	O
and	O
Hough	O
(	O
Clin	O
Chest	B-ANAT
Med	O
27	O
:	O
671	O
-	O
677	O
,	O
2006	O
)	O
is	O
associated	O
with	O
pronounced	O
reductions	O
in	O
pulmonary	B-ANAT
compliance	O
and	O
an	O
accompanying	O
hypercapnia	O
complicating	O
low	O
tidal	O
volume	O
mechanical	O
ventilation	O
.	O

Extracorporeal	O
CO	O
(	O
2	O
)	O
removal	O
enabled	O
significant	O
reduction	O
in	O
tidal	O
volumes	O
(	O
to	O
below	O
4	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
)	O
and	O
inspiratory	O
plateau	O
pressures	O
[	O
30	O
(	O
28	O
.	O
5	O
/	O
32	O
.	O
3	O
)	O
cmH	O
(	O
2	O
)	O
O	O
,	O
median	O
25	O
,	O
75	O
%	O
percentiles	O
].	O

Elimination	O
of	O
CO	O
(	O
2	O
)	O
by	O
p	O
-	O
ECLA	O
therapy	O
allowed	O
reduction	O
of	O
ventilator	O
-	O
induced	O
shear	O
stress	O
through	O
ventilation	O
with	O
tidal	O
volumes	O
below	O
4	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
in	O
pneumonia	O
patients	O
with	O
severely	O
impaired	O
pulmonary	B-ANAT
compliance	O
during	O
late	O
-	O
phase	O
ARDS	O
.	O

At	O
post	O
mortem	O
examination	O
,	O
the	O
main	O
gross	O
features	O
were	O
fluid	O
caecal	O
and	O
intestinal	B-ANAT
contents	I-ANAT
.	O

Negative	O
contrast	O
electron	O
microscopy	O
of	O
caecal	O
contents	O
revealed	O
virus	B-ANAT
particles	I-ANAT
,	O
which	O
in	O
size	O
and	O
morphology	O
had	O
the	O
appearance	O
of	O
a	O
coronavirus	O
.	O

Following	O
general	O
PCR	O
,	O
the	O
DNA	O
products	O
are	O
commonly	O
analyzed	O
by	O
restriction	O
endonuclease	O
mapping	O
(	O
restriction	O
fragment	O
length	O
polymorphism	O
),	O
using	O
a	O
small	O
number	O
of	O
restriction	O
endonucleases	O
,	O
based	O
on	O
a	O
large	O
body	B-ANAT
of	O
sequence	O
data	O
.	O

ABSTRACT	O
:	O
A	O
purified	O
recombinant	O
spike	O
(	O
S	O
)	O
protein	O
was	O
studied	O
for	O
its	O
effect	O
on	O
stimulating	O
human	O
peripheral	B-ANAT
blood	I-ANAT
monocyte	I-ANAT
macrophages	B-ANAT
(	O
PBMC	O
).	O

The	O
role	O
of	O
NMBAs	O
in	O
the	O
occurrence	O
of	O
ICU	O
-	O
acquired	O
neuromyopathies	O
and	O
lung	B-ANAT
atelectasis	O
in	O
ARDS	O
patients	O
remains	O
largely	O
questioned	O
.	O

0	O
.	O
07	O
)	O
ng	O
/	O
ml	O
at	O
6	O
hours	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
significantly	O
attenuated	O
the	O
fall	O
in	O
protein	O
S	O
(	O
PS	O
;	O
control	O
group	O
was	O
(	O
2	O
.	O
32	O
+/-	O
0	O
.	O
03	O
)	O
microg	O
/	O
ml	O
at	O
2	O
hours	O
,	O
(	O
2	O
.	O
24	O
+/-	O
0	O
.	O
06	O
)	O
microg	O
/	O
ml	O
at	O
4	O
hours	O
and	O
(	O
2	O
.	O
21	O
+/-	O
0	O
.	O
09	O
)	O
microg	O
/	O
ml	O
at	O
6	O
hours	O
,	O
vs	O
APC	B-ANAT
group	O
(	O
2	O
.	O
46	O
+/-	O
0	O
.	O
04	O
)	O
microg	O
/	O
ml	O
at	O
2	O
hours	O
,	O
(	O
2	O
.	O
40	O
+/-	O
0	O
.	O
05	O
)	O
microg	O
/	O
ml	O
at	O
4	O
hours	O
and	O
(	O
2	O
.	O
39	O
+/-	O
0	O
.	O
07	O
)	O
microg	O
/	O
ml	O
at	O
6	O
hours	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

In	O
addition	O
,	O
APC	B-ANAT
limited	O
the	O
increase	O
in	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
both	O
in	O
plasma	B-ANAT
(	O
control	O
group	O
was	O
(	O
0	O
.	O
68	O
+/-	O
0	O
.	O
12	O
)	O
ng	O
/	O
ml	O
at	O
1	O
hour	O
,	O
(	O
0	O
.	O
84	O
+/-	O
0	O
.	O
06	O
)	O
ng	O
/	O
ml	O
at	O
2	O
hours	O
,	O
(	O
0	O
.	O
87	O
+/-	O
0	O
.	O
08	O
)	O
ng	O
/	O
ml	O
at	O
4	O
hours	O
and	O
(	O
0	O
.	O
91	O
+/-	O
0	O
.	O
05	O
)	O
ng	O
/	O
ml	O
at	O
6	O
hours	O
,	O
vs	O
APC	B-ANAT
group	O
(	O
0	O
.	O
42	O
+/-	O
0	O
.	O
16	O
)	O
ng	O
/	O
ml	O
at	O
1	O
hour	O
,	O
(	O
0	O
.	O
43	O
+/-	O
0	O
.	O
04	O
)	O
ng	O
/	O
ml	O
at	O
2	O
hours	O
,	O
(	O
0	O
.	O
45	O
+/-	O
0	O
.	O
09	O
)	O
ng	O
/	O
ml	O
at	O
4	O
hours	O
and	O
(	O
0	O
.	O
45	O
+/-	O
0	O
.	O
14	O
)	O
ng	O
/	O
ml	O
at	O
6	O
hours	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
at	O
6	O
hours	O
:	O
sham	O
,	O
(	O
1	O
.	O
05	O
+/-	O
0	O
.	O
05	O
)	O
ng	O
/	O
ml	O
;	O
control	O
,	O
(	O
1	O
.	O
13	O
+/-	O
0	O
.	O
06	O
)	O
ng	O
/	O
ml	O
;	O
APC	B-ANAT
,	O
(	O
1	O
.	O
06	O
+/-	O
0	O
.	O
06	O
)	O
ng	O
/	O
ml	O
;	O
P	O
<	O
0	O
.	O
05	O
).	O

RESULTS	O
:	O
In	O
comparison	O
with	O
nontreatment	O
in	O
the	O
control	O
group	O
,	O
the	O
infusion	O
of	O
APC	B-ANAT
significantly	O
reduced	O
the	O
increase	O
of	O
thrombomodulin	O
level	O
(	O
TM	O
;	O
control	O
group	O
was	O
(	O
0	O
.	O
68	O
+/-	O
0	O
.	O
06	O
)	O
ng	O
/	O
ml	O
,	O
vs	O
APC	B-ANAT
group	O
of	O
(	O
0	O
.	O
62	O
+/-	O

The	O
respiratory	B-ANAT
tract	I-ANAT
was	O
the	O
most	O
common	O
site	O
of	O
infection	O
(	O
50	O
%).	O

ABSTRACT	O
:	O
To	O
analyze	O
the	O
early	O
risk	O
factors	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
following	O
orthotopic	O
liver	B-ANAT
transplantation	O
(	O
OLT	O
).	O

53	O
patients	O
(	O
58	O
.	O
2	O
%)	O
suffered	O
from	O
pulmonary	B-ANAT
complications	O
following	O
OLT	O
,	O
including	O
ALI	O
(	O
27	O
.	O
5	O
%)	O
and	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
5	O
.	O
5	O
%).	O

Logistic	O
stepwise	O
regression	O
analysis	O
screened	O
out	O
serum	B-ANAT
total	O
bilirubin	O
as	O
an	O
independent	O
predictor	O
for	O
ALI	O
following	O
OLT	O
.	O

Aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
by	O
immunohistochemistry	O
(	O
IHC	O
)	O
the	O
tissue	B-ANAT
tropism	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
strain	O
M41	O
in	O
experimentally	O
infected	O
chicken	O
embryos	B-ANAT
.	O

In	O
two	O
recent	O
randomized	O
,	O
controlled	O
studies	O
,	O
the	O
fish	O
oil	O
formula	O
that	O
was	O
previously	O
shown	O
to	O
be	O
effective	O
was	O
administered	O
to	O
patients	O
with	O
ARDS	O
/	O
acute	O
lung	B-ANAT
injury	O
(	O
in	O
which	O
hypoxia	O
is	O
less	O
severe	O
)	O
and	O
to	O
patients	O
with	O
severe	O
sepsis	O
and	O
hypoxia	O
,	O
respectively	O
.	O

The	O
three	O
major	O
diagnostic	O
methods	O
available	O
for	O
SARS	O
includes	O
viral	O
RNA	O
detection	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
virus	O
induced	O
antibodies	O
by	O
immunofluorescence	O
assay	O
(	O
IFA	O
)	O
or	O
by	O
enzyme	O
linked	O
immunosorbant	O
assay	O
(	O
ELISA	O
)	O
of	O
nucleocapsid	B-ANAT
protein	O
(	O
NP	O
).	O

A	O
68	O
-	O
year	O
-	O
old	O
female	O
presented	O
with	O
a	O
clinical	O
picture	O
of	O
community	O
-	O
acquired	O
pneumonia	O
and	O
exacerbation	O
of	O
asthma	O
that	O
was	O
supported	O
by	O
radiological	O
evidence	O
of	O
a	O
large	O
left	O
-	O
sided	O
pleural	B-ANAT
effusion	I-ANAT
.	O

Interestingly	O
,	O
coronavirus	O
nsp14	O
was	O
previously	O
characterized	O
as	O
a	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
,	O
and	O
by	O
mutational	O
analysis	O
,	O
we	O
mapped	O
the	O
N7	O
-	O
MTase	O
domain	O
to	O
the	O
carboxy	O
-	O
terminal	O
part	O
of	O
nsp14	O
that	O
shows	O
features	O
conserved	O
with	O
cellular	B-ANAT
N7	O
-	O
MTase	O
in	O
structure	O
-	O
based	O
sequence	O
alignment	O
.	O

When	O
we	O
fixed	B-ANAT
fever	O
prevalence	O
at	O
1	O
%	O
in	O
all	O
studies	O
to	O
allow	O
comparisons	O
,	O
the	O
derived	O
PPV	O
varied	O
from	O
3	O
.	O
5	O
%	O
to	O
65	O
.	O
4	O
%	O
and	O
NPV	O
was	O
>	O
or	O
=	O
99	O
%.	O

However	O
,	O
lung	B-ANAT
parenchymal	O
changes	O
on	O
HRCT	O
suggestive	O
of	O
fibrosis	O
and	O
minor	O
pulmonary	B-ANAT
function	O
abnormalities	O
remain	O
common	O
and	O
can	O
be	O
detected	O
more	O
than	O
1	O
year	O
after	O
ECMO	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
and	O
acute	O
respiratory	O
illness	O
in	O
older	O
adults	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
.	O

HCoV	O
infection	O
was	O
determined	O
on	O
the	O
basis	O
of	O
a	O
4	O
-	O
fold	O
increase	O
in	O
serum	B-ANAT
antibody	O
and	O
the	O
detection	O
of	O
HCoV	O
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

Cocktail	O
therapy	O
seems	O
promising	O
in	O
delaying	O
the	O
disease	O
progression	O
of	O
SARS	O
-	O
associated	O
femoral	B-ANAT
head	I-ANAT
necrosis	O
in	O
the	O
short	O
-	O
term	O
.	O

MRI	O
showed	O
a	O
trend	O
of	O
reduction	O
in	O
bone	B-ANAT
marrow	I-ANAT
edema	O
and	O
the	O
size	O
of	O
the	O
lesion	O
,	O
but	O
no	O
changes	O
in	O
the	O
stage	O
of	O
the	O
lesion	O
.	O

Clinically	O
,	O
the	O
patient	O
showed	O
a	O
deteriorating	O
spastic	O
paraparesis	O
of	O
her	O
lower	B-ANAT
extremities	I-ANAT
.	O

Despite	O
the	O
successful	O
salvage	O
procedure	O
,	O
the	O
patient	O
deteriorated	O
in	O
the	O
postoperative	O
phase	O
,	O
when	O
she	O
developed	O
multiple	O
complications	O
including	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
bacterial	O
meningitis	O
,	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
,	O
followed	O
by	O
septic	O
shock	O
with	O
multiple	O
organ	B-ANAT
failure	O
and	O
a	O
lethal	O
outcome	O
within	O
two	O
weeks	O
after	O
revision	O
surgery	O
.	O

ABSTRACT	O
:	O
Mouse	O
hepatitis	O
virus	O
strain	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
triggers	O
various	O
pathologies	O
in	O
several	O
mouse	O
strains	O
,	O
including	O
hypergammaglobulinaemia	O
,	O
hepatitis	O
and	O
thymus	B-ANAT
involution	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
see	O
whether	O
a	O
severe	O
liver	B-ANAT
injury	O
,	O
which	O
releases	O
endogenous	O
adjuvants	O
,	O
i	O
.	O
e	O
.	O
danger	O
signals	O
,	O
could	O
elicit	O
a	O
broader	O
spectrum	O
of	O
autoAb	O
and	O
perhaps	O
signs	O
of	O
autoimmune	O
hepatitis	O
.	O

Histological	O
examination	O
of	O
liver	B-ANAT
samples	O
showed	O
tissue	B-ANAT
damages	O
but	O
without	O
significant	O
differences	O
between	O
the	O
animals	O
submitted	O
to	O
MHV	O
+	O
CCl	O
(	O
4	O
)	O
and	O
controls	O
,	O
which	O
were	O
either	O
infected	O
by	O
MHV	O
without	O
CCl	O
(	O
4	O
),	O
or	O
poisoned	O
by	O
CCl	O
(	O
4	O
)	O
in	O
the	O
absence	O
of	O
MHV	O
infection	O
.	O

Infection	O
with	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
induces	O
a	O
cellular	B-ANAT
stress	O
condition	O
known	O
as	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
).	O

Afterward	O
,	O
sural	B-ANAT
nerve	I-ANAT
biopsy	O
showed	O
a	O
mild	O
neuropathy	O
,	O
but	O
muscle	B-ANAT
biopsy	O
revealed	O
abnormalities	O
compatible	O
with	O
severe	O
critical	O
illness	O
myopathy	O
.	O

BACM	O
causes	O
difficulty	O
walking	O
due	O
to	O
severe	O
bilateral	O
calf	B-ANAT
pain	O
.	O

Af	O
-	O
ter	B-ANAT
LA	O
diagnosis	O
,	O
intravenous	O
(	O
IV	O
)	O
antibiotic	O
(	O
AB	O
)	O
was	O
prescribed	O
for	O
16	O
.	O
5	O
(+/-	O
10	O
.	O
9	O
)	O
days	O
with	O
mean	O
total	O
AB	O
time	O
39	O
.	O
2	O
(+/-	O
15	O
.	O
7	O
)	O
days	O
.	O

One	O
patient	O
with	O
esophageal	B-ANAT
squamous	I-ANAT
cell	I-ANAT
carcinoma	O
experienced	O
an	O
acute	O
hypercalcemia	O
(	O
plasma	B-ANAT
calcium	O
4	O
.	O
8	O
-	O
5	O
.	O
1	O
mM	O
)	O
accompanied	O
by	O
ARDS	O
.	O

Our	O
recent	O
experiment	O
in	O
conscious	O
rats	O
and	O
isolated	O
rat	O
'	O
s	O
lungs	B-ANAT
supported	O
this	O
contention	O
.	O

In	O
addition	O
,	O
corticosteroid	O
and	O
calcitonin	O
were	O
able	O
to	O
reduce	O
the	O
plasma	B-ANAT
calcium	O
and	O
to	O
prevent	O
the	O
occurrence	O
of	O
ARDS	O
and	O
ALI	O
.	O

Neuroangiostrongyliasis	O
,	O
a	O
rodent	O
zoonosis	O
caused	O
by	O
the	O
rat	O
lungworm	O
,	O
Angiostrongylus	O
cantonensis	O
,	O
is	O
now	O
endemic	O
in	O
the	O
US	O
following	O
the	O
importation	O
of	O
infected	O
rats	O
on	O
container	O
ships	O
and	O
African	O
land	B-ANAT
snails	O
,	O
the	O
parasite	O
'	O
s	O
intermediate	O
hosts	O
,	O
as	O
biological	O
controls	O
and	O
exotic	O
pets	O
.	O

Viruses	O
potentially	O
pose	O
a	O
significant	O
threat	O
to	O
the	O
blood	B-ANAT
supply	O
.	O

The	O
current	O
risk	O
of	O
a	O
blood	B-ANAT
transfusion	O
is	O
very	O
low	O
but	O
the	O
potential	O
threat	O
is	O
ever	O
present	O
.	O

Prions	O
also	O
have	O
been	O
transmitted	O
by	O
a	O
blood	B-ANAT
transfusion	O
.	O

To	O
understand	O
the	O
cellular	B-ANAT
factors	O
that	O
may	O
be	O
involved	O
in	O
virion	B-ANAT
assembly	O
,	O
budding	O
and	O
maturation	O
processes	O
,	O
IBV	O
M	O
was	O
used	O
as	O
the	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
resulting	O
in	O
the	O
identification	O
of	O
beta	O
-	O
actin	O
as	O
a	O
potentially	O
interacting	O
partner	O
.	O

Disruption	O
of	O
actin	B-ANAT
filaments	I-ANAT
with	O
cell	B-ANAT
-	O
permeable	O
agent	O
cytochalasin	O
D	O
at	O
early	O
stages	O
of	O
the	O
infection	O
cycle	O
led	O
to	O
the	O
detection	O
of	O
viral	O
protein	O
synthesis	O
in	O
infected	O
cells	B-ANAT
but	O
not	O
release	O
of	O
virus	B-ANAT
particles	I-ANAT
to	O
the	O
cultured	O
media	B-ANAT
.	O

Vaccinated	O
mice	O
were	O
protected	O
from	O
severe	O
respiratory	O
disease	O
in	O
parallel	O
with	O
a	O
low	O
virus	O
titer	O
in	O
the	O
lungs	B-ANAT
and	O
a	O
high	O
neutralizing	O
antibody	O
titer	O
in	O
the	O
plasma	B-ANAT
.	O

Some	O
investigators	O
have	O
suggested	O
early	O
and	O
aggressive	O
treatment	O
of	O
the	O
trauma	O
-	O
induced	O
coagulopathy	O
by	O
transfusion	O
of	O
fresh	B-ANAT
-	O
frozen	O
plasma	B-ANAT
(	O
FFP	O
)	O
and	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
PRBC	O
)	O
in	O
a	O
1	O
:	O
1	O
ratio	O
.	O

Studies	O
were	O
selected	O
for	O
inclusion	O
if	O
they	O
included	O
trauma	O
patients	O
who	O
required	O
blood	B-ANAT
transfusion	O
.	O

In	O
the	O
present	O
work	O
,	O
the	O
method	O
for	O
purification	O
of	O
duck	O
immunoglobulin	O
A	O
was	O
developed	O
,	O
and	O
the	O
induction	O
of	O
intestinal	B-ANAT
mucosal	B-ANAT
immune	O
responses	O
against	O
DEV	O
was	O
studied	O
by	O
orally	B-ANAT
infected	O
ducklings	O
with	O
virulent	O
DEV	O
.	O

Furthermore	O
,	O
a	O
marked	O
increased	O
level	O
of	O
DEV	O
-	O
specific	O
IgA	O
and	O
IgG	O
antibodies	O
in	O
bile	B-ANAT
,	O
serum	B-ANAT
and	O
the	O
intestinal	B-ANAT
tract	I-ANAT
,	O
as	O
well	O
as	O
the	O
density	O
of	O
IgA	O
(+)	O
cells	B-ANAT
in	O
intestine	B-ANAT
were	O
detected	O
between	O
1	O
and	O
12days	O
p	O
.	O
i	O
.,	O
followed	O
by	O
a	O
drastic	O
reduction	O
of	O
the	O
antibody	O
levels	O
and	O
the	O
density	O
of	O
IgA	O
(+)	O
cells	B-ANAT
at	O
15days	O
p	O
.	O
i	O
.	O

A	O
30	O
-	O
year	O
-	O
old	O
,	O
previously	O
healthy	O
man	O
presented	O
with	O
sore	O
throat	B-ANAT
,	O
fever	O
,	O
rigor	O
,	O
and	O
dyspnea	O
.	O

While	O
IMS	O
remains	O
a	O
clinically	O
important	O
entity	O
,	O
the	O
early	O
occurrence	O
of	O
abnormalities	O
on	O
repetitive	O
nerve	B-ANAT
stimulation	O
studies	O
suggest	O
that	O
this	O
is	O
part	O
of	O
the	O
continuum	O
of	O
nicotinic	O
receptor	O
stimulation	O
.	O

The	O
nasopharyngeal	B-ANAT
swab	I-ANAT
specimens	O
from	O
13	O
patients	O
with	O
symptoms	O
of	O
RTI	O
were	O
obtained	O
and	O
analyzed	O
.	O

As	O
expected	O
,	O
these	O
two	O
transmembrane	B-ANAT
regions	O
inserted	O
a	O
cytoplasmic	B-ANAT
protein	O
into	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
membrane	I-ANAT
.	O

Either	O
of	O
these	O
two	O
transmembrane	B-ANAT
domains	O
co	O
-	O
localized	O
with	O
M	O
protein	O
.	O

The	O
effects	O
of	O
grafting	B-ANAT
either	O
type	O
of	O
BMMSCs	O
on	O
fibrotic	O
lung	B-ANAT
injury	O
were	O
then	O
assessed	O
by	O
transfer	O
experiments	O
in	O
a	O
murine	O
bleomycin	O
-	O
induced	O
lung	B-ANAT
fibrosis	O
model	O
,	O
in	O
which	O
donor	O
cells	B-ANAT
were	O
administered	O
3	O
days	O
after	O
challenge	O
.	O

Grafting	B-ANAT
2	O
-	O
h	O
adherent	O
BMMSCs	O
ameliorated	O
inflammatory	O
and	O
fibrotic	O
lung	B-ANAT
disorders	O
,	O
and	O
reduced	O
mortality	O
equally	O
well	O
or	O
better	O
than	O
9	O
-	O
day	O
cultured	O
BMMSCs	O
.	O

This	O
study	O
was	O
to	O
determine	O
whether	O
the	O
damage	O
was	O
correlated	O
with	O
expression	O
of	O
the	O
SARS	O
coronavirus	O
receptor	O
,	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
in	O
different	O
organs	B-ANAT
,	O
especially	O
in	O
the	O
endocrine	O
tissues	B-ANAT
of	O
the	O
pancreas	B-ANAT
,	O
and	O
to	O
elucidate	O
the	O
pathogenesis	O
of	O
glucose	O
intolerance	O
in	O
SARS	O
patients	O
.	O

Abundant	O
ACE2	O
immunostaining	O
was	O
found	O
in	O
lung	B-ANAT
,	O
kidney	B-ANAT
,	O
heart	B-ANAT
,	O
and	O
islets	O
of	O
pancreas	B-ANAT
,	O
but	O
not	O
in	O
hepatocytes	B-ANAT
.	O

The	O
organ	B-ANAT
involvements	O
of	O
SARS	O
correlated	O
with	O
organ	B-ANAT
expression	O
of	O
ACE2	O
.	O

TITLE	O
:	O
[	O
Role	O
of	O
CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
in	O
the	O
murine	O
hepatitis	O
virus	O
type	O
3	O
induced	O
chronic	O
viral	O
hepatitis	O
].	O

The	O
surface	O
markers	O
of	O
CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
were	O
determined	O
by	O
flow	O
cytometry	O
.	O

The	O
phenotype	O
of	O
these	O
CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
detected	O
by	O
flow	O
cytometry	O
is	O
TCR	B-ANAT
alpha	O
beta	O
+	O
CD3	O
+	O
CD4	O
-	O
CD8	O
-	O
CD25	O
-	O
CD28	O
-	O
CD30	O
-	O
CD44	O
+.	O

Infectious	O
bronchitis	O
virus	O
nucleic	B-ANAT
acid	O
was	O
detected	O
in	O
16	O
broiler	O
(	O
64	O
%),	O
8	O
layer	B-ANAT
(	O
53	O
%),	O
and	O
6	O
broiler	O
breeder	O
(	O
54	O
.	O
54	O
%)	O
flocks	O
affected	O
with	O
respiratory	O
disease	O
.	O

Most	O
neonates	O
receiving	O
ECMO	O
suffer	O
from	O
meconium	B-ANAT
aspiration	O
syndrome	O
(	O
MAS	B-ANAT
),	O
congenital	O
diaphragmatic	B-ANAT
hernia	O
(	O
CDH	O
),	O
sepsis	O
or	O
persistent	O
pulmonary	B-ANAT
hypertension	O
(	O
PPH	O
).	O

Chi	O
-	O
squared	O
tests	O
showed	O
adverse	O
outcome	O
in	O
MABC	O
scores	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
compared	O
with	O
the	O
reference	O
population	O
in	O
children	O
with	O
CDH	O
,	O
sepsis	O
and	O
PPH	O
,	O
but	O
not	O
in	O
children	O
with	O
MAS	B-ANAT
.	O

These	O
observations	O
suggest	O
that	O
sustained	O
production	O
of	O
neutrophil	B-ANAT
survival	O
factors	O
by	O
macrophages	B-ANAT
during	O
FCoV	O
infection	O
is	O
sufficient	O
for	O
neutrophil	B-ANAT
survival	O
and	O
contributes	O
to	O
development	O
of	O
granulomatous	O
lesions	O
.	O

Here	O
,	O
we	O
studied	O
the	O
effects	O
of	O
EtP	O
on	O
the	O
reactions	O
in	O
and	O
between	O
human	O
neutrophils	B-ANAT
and	O
lung	B-ANAT
epithelial	O
(	O
A549	O
)	O
cells	B-ANAT
in	O
vitro	O
.	O

By	O
the	O
third	O
day	O
of	O
life	O
,	O
some	O
neonatal	O
infants	O
without	O
clinical	O
signs	O
of	O
RDS	O
were	O
observed	O
to	O
have	O
signs	O
of	O
intensive	O
hemodynamic	O
adaptation	O
:	O
increases	O
in	O
peak	O
blood	B-ANAT
flow	O
velocity	O
and	O
in	O
peak	O
pressure	O
gradient	O
through	O
the	O
valves	B-ANAT
of	O
the	O
pulmonary	B-ANAT
trunk	I-ANAT
.	O

Irrespective	O
of	O
the	O
specific	O
features	O
of	O
the	O
course	O
of	O
an	O
early	O
neonatal	O
period	O
,	O
neonatal	O
infants	O
need	O
Doppler	O
echocardiographic	O
monitoring	O
for	O
the	O
evaluation	O
of	O
intracardiac	B-ANAT
hemodynamics	O
.	O

There	O
are	O
often	O
pulmonary	B-ANAT
complications	O
in	O
such	O
patients	O
.	O

The	O
mechanisms	O
through	O
which	O
lung	B-ANAT
injury	O
is	O
induced	O
in	O
AP	O
are	O
not	O
fully	O
clear	O
.	O

At	O
IL	O
-	O
18	O
concentrations	O
>	O
650	O
pg	O
/	O
ml	O
,	O
AP	O
patients	O
are	O
likely	O
to	O
develop	O
pulmonary	B-ANAT
dysfunction	O
(	O
sensitivity	O
58	O
%,	O
specificity	O
100	O
%,	O
LR	O
-	O
positive	O
>	O
58	O
)	O
which	O
allows	O
us	O
to	O
use	O
it	O
as	O
a	O
screening	O
test	O
.	O

Recently	O
,	O
a	O
30	O
-	O
nucleotide	O
(	O
nt	O
)	O
cis	O
-	O
replication	O
stem	B-ANAT
-	O
loop	O
VI	O
(	O
SLVI	O
)	O
has	O
been	O
mapped	O
at	O
nt	O
101	O
to	O
130	O
within	O
a	O
288	O
-	O
nt	O
5	O
'-	O
terminal	O
segment	O
of	O
the	O
738	O
-	O
nt	O
nsp1	O
cistron	O
in	O
a	O
BCoV	O
defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
.	O

Here	O
,	O
we	O
(	O
i	O
)	O
establish	O
by	O
mutation	O
analysis	O
that	O
the	O
72	O
-	O
nt	O
intracistronic	O
SLV	O
immediately	O
upstream	O
of	O
SLVI	O
is	O
also	O
a	O
DI	O
RNA	O
cis	O
-	O
replication	O
signal	O
,	O
(	O
ii	O
)	O
show	O
by	O
gel	O
shift	O
and	O
UV	O
-	O
cross	O
-	O
linking	O
analyses	O
that	O
cellular	B-ANAT
proteins	O
of	O
approximately	O
60	O
and	O
100	O
kDa	O
,	O
but	O
not	O
viral	O
proteins	O
,	O
bind	O
SLV	O
and	O
SLVI	O
,	O
(	O
SLV	O
-	O
VI	O
)	O
and	O
(	O
iii	O
)	O
demonstrate	O
by	O
gel	O
shift	O
analysis	O
that	O
nsp1	O
purified	O
from	O
Escherichia	O
coli	O
does	O
not	O
bind	O
SLV	O
-	O
VI	O
but	O
does	O
bind	O
three	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)-	O
and	O
one	O
3	O
'	O
UTR	O
-	O
located	O
cis	O
-	O
replication	O
SLs	O
.	O

The	O
Acute	O
Lung	B-ANAT
Rescue	O
Team	O
(	O
ALRT	O
)	O
was	O
developed	O
to	O
facilitate	O
transport	O
of	O
these	O
patients	O
out	O
of	O
the	O
combat	O
theater	O
.	O

Lung	B-ANAT
injury	O
in	O
the	O
combat	O
theater	O
severe	O
enough	O
to	O
exceed	O
the	O
capability	O
of	O
CCATT	O
transport	O
is	O
uncommon	O
.	O

TITLE	O
:	O
Form	O
and	O
function	O
of	O
joint	B-ANAT
health	O
and	O
safety	O
committees	O
in	O
Ontario	O
acute	O
care	O
hospitals	O
.	O

TITLE	O
:	O
The	O
SR	O
-	O
rich	O
motif	O
in	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
is	O
important	O
for	O
virus	O
replication	O
.	O

TITLE	O
:	O
Frequency	O
of	O
BCoV	O
detection	O
by	O
a	O
semi	O
-	O
nested	O
PCR	O
assay	O
in	O
faeces	B-ANAT
of	O
calves	O
from	O
Brazilian	O
cattle	O
herds	O
.	O

Several	O
diagnostic	O
assays	O
have	O
been	O
employed	O
to	O
detect	O
the	O
presence	O
of	O
the	O
virus	O
in	O
stool	B-ANAT
samples	O
from	O
calves	O
.	O

The	O
specific	O
BCoV	O
amplicon	O
was	O
detected	O
in	O
15	O
.	O
6	O
%	O
(	O
44	O
/	O
282	O
)	O
of	O
the	O
faecal	B-ANAT
specimens	O
examined	O
,	O
of	O
which	O
95	O
.	O
4	O
%	O
(	O
42	O
/	O
44	O
)	O
were	O
from	O
diarrhoeic	O
and	O
4	O
.	O
6	O
%	O
(	O
2	O
/	O
44	O
)	O
from	O
asymptomatic	O
calves	O
.	O

The	O
MultiCode	O
-	O
PLx	O
assay	O
frequently	O
identified	O
respiratory	O
viral	O
infections	O
which	O
are	O
not	O
detected	O
by	O
rapid	O
viral	O
culture	O
/	O
DFA	O
;	O
40	O
%	O
of	O
these	O
patients	O
had	O
pneumonia	O
in	O
addition	O
to	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
.	O

The	O
patient	O
'	O
s	O
condition	O
improved	O
day	O
by	O
day	O
without	O
developing	O
multiple	O
organ	B-ANAT
dysfunction	O
.	O

ABSTRACT	O
:	O
Plants	O
are	O
low	O
-	O
cost	O
bioreactors	O
for	O
the	O
production	O
of	O
various	O
biopharmaceuticals	O
including	O
oral	B-ANAT
vaccines	O
.	O

Plant	O
-	O
derived	O
oral	B-ANAT
vaccines	O
are	O
potentially	O
useful	O
in	O
combating	O
viral	O
infections	O
involving	O
mucosal	B-ANAT
immunity	O
.	O

Transgenic	O
plants	O
have	O
been	O
generated	O
to	O
successfully	O
produce	O
mucosal	B-ANAT
vaccines	O
against	O
cholera	O
,	O
hepatitis	O
B	O
,	O
foot	B-ANAT
-	O
and	O
-	O
mouth	B-ANAT
disease	O
,	O
and	O
Norwalk	O
virus	O
.	O

Oligodendroglia	B-ANAT
and	O
microglia	B-ANAT
up	O
-	O
regulated	O
B7	O
-	O
H1	O
following	O
infection	O
;	O
however	O
,	O
although	O
B7	O
-	O
H1	O
expression	O
on	O
oligodendroglia	B-ANAT
was	O
prominent	O
and	O
sustained	O
,	O
it	O
was	O
significantly	O
reduced	O
and	O
transient	O
on	O
microglia	B-ANAT
.	O

More	O
efficient	O
virus	O
control	O
within	O
the	O
CNS	B-ANAT
of	O
B7	O
-	O
H1	O
-	O
deficient	O
mice	O
confirmed	O
inhibition	O
of	O
CD8	O
T	B-ANAT
cell	I-ANAT
function	O
in	O
vivo	O
.	O

However	O
,	O
the	O
beneficial	O
role	O
of	O
PD	O
-	O
1	O
:	O
B7	O
-	O
H1	O
interactions	O
in	O
limiting	O
morbidity	O
highlights	O
the	O
need	O
to	O
evaluate	O
tissue	B-ANAT
-	O
specific	O
intervention	O
strategies	O
.	O

TITLE	O
:	O
Detection	O
of	O
nonstructural	O
protein	O
6	O
in	O
murine	O
coronavirus	O
-	O
infected	O
cells	B-ANAT
and	O
analysis	O
of	O
the	O
transmembrane	B-ANAT
topology	O
by	O
using	O
bioinformatics	O
and	O
molecular	O
approaches	O
.	O

This	O
article	O
reviews	O
the	O
clinical	O
signs	O
,	O
pathophysiology	O
,	O
diagnosis	O
,	O
treatment	O
and	O
prognosis	O
of	O
four	O
important	O
systemic	O
diseases	O
with	O
neurological	O
consequences	O
:	O
feline	O
infectious	O
peritonitis	O
,	O
toxoplasmosis	O
,	O
hypertension	O
and	O
hepatic	B-ANAT
encephalopathy	O
.	O

This	O
outcome	O
suggests	O
that	O
drotrecogin	O
alfa	O
(	O
activated	O
)	O
may	O
be	O
useful	O
therapy	O
for	O
transplant	B-ANAT
recipients	O
who	O
develop	O
severe	O
sepsis	O
or	O
septic	O
shock	O
secondary	O
to	O
potentially	O
lethal	O
opportunistic	O
infections	O
.	O

The	O
SARS	O
-	O
CoV	O
viral	B-ANAT
genome	I-ANAT
encodes	O
several	O
proteins	O
which	O
have	O
no	O
homology	O
to	O
proteins	O
in	O
any	O
other	O
coronaviruses	O
,	O
and	O
a	O
number	O
of	O
these	O
proteins	O
have	O
been	O
implicated	O
in	O
viral	O
cytopathies	O
.	O

Various	O
pre	O
-	O
and	O
postnatal	O
factors	O
,	O
such	O
as	O
exposure	O
to	O
chorioamnionitis	O
,	O
pneumonia	O
,	O
sepsis	O
and	O
asphyxia	O
,	O
induce	O
an	O
injurious	O
inflammatory	O
response	O
in	O
the	O
lungs	B-ANAT
of	O
preterm	O
infants	O
,	O
which	O
may	O
subsequently	O
affect	O
surfactant	O
function	O
,	O
synthesis	O
and	O
alveolar	B-ANAT
stability	O
.	O

ABSTRACT	O
:	O
Viruses	O
such	O
as	O
hepatitis	O
C	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
encode	O
proteins	O
that	O
are	O
distributed	O
between	O
mitochondria	B-ANAT
and	O
the	O
nucleus	B-ANAT
,	O
but	O
little	O
is	O
known	O
about	O
the	O
factors	O
that	O
control	O
partitioning	O
between	O
these	O
sites	O
.	O

We	O
demonstrate	O
unique	O
shuttling	O
behavior	O
of	O
ORF	O
3b	O
,	O
whereby	O
the	O
protein	O
initially	O
accumulates	O
in	O
the	O
nucleus	B-ANAT
and	O
subsequently	O
translocates	O
to	O
mitochondria	B-ANAT
.	O

MAVS	O
-	O
induced	O
cell	B-ANAT
death	O
requires	O
mitochondrial	B-ANAT
localization	O
,	O
is	O
caspase	O
dependent	O
,	O
and	O
displays	O
hallmarks	O
of	O
apoptosis	O
.	O

Furthermore	O
,	O
MAVS	O
(-/-)	O
fibroblasts	B-ANAT
are	O
resistant	O
to	O
Sendai	O
virus	O
-	O
induced	O
apoptosis	O
.	O

The	O
crystals	B-ANAT
diffracted	O
to	O
2	O
.	O
7	O
A	O
resolution	O
and	O
belonged	O
to	O
space	O
group	O
P2	O
(	O
1	O
)	O
2	O
(	O
1	O
)	O
2	O
,	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
83	O
.	O
5	O
,	O
b	O
=	O
88	O
.	O
4	O
,	O
c	O
=	O
31	O
.	O
2	O
A	O
,	O
alpha	O
=	O
beta	O
=	O
gamma	O
=	O
90	O
degrees	O
and	O
two	O
molecules	O
per	O
asymmetric	O
unit	O
.	O

By	O
using	O
an	O
infectious	O
cloning	O
system	O
developed	O
recently	O
for	O
the	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
gene	O
,	O
the	O
firefly	O
luciferase	O
gene	O
and	O
several	O
host	O
and	O
viral	O
genes	O
(	O
eIF3f	O
,	O
SARS	O
ORF6	O
,	O
Dengue	O
virus	O
1	O
core	O
protein	O
gene	O
)	O
were	O
inserted	O
into	O
various	O
positions	O
of	O
the	O
IBV	O
genome	O
,	O
and	O
the	O
effects	O
on	O
gene	O
expression	O
,	O
virus	O
recovery	O
,	O
and	O
stability	O
in	O
cell	B-ANAT
culture	O
were	O
studied	O
.	O

We	O
report	O
that	O
ACE2	O
is	O
shed	O
from	O
human	O
airway	B-ANAT
epithelia	O
,	O
a	O
site	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Interaction	O
of	O
a	O
peptide	O
corresponding	O
to	O
the	O
loop	O
domain	O
of	O
the	O
S2	O
SARS	O
-	O
CoV	O
virus	O
protein	O
with	O
model	O
membranes	B-ANAT
.	O

Our	O
results	O
show	O
that	O
SARS	O
(	O
L	O
)	O
strongly	O
partitions	O
into	O
phospholipid	O
membranes	B-ANAT
and	O
organizes	O
differently	O
in	O
lipid	O
environments	O
,	O
displaying	O
membrane	B-ANAT
activity	O
modulated	O
by	O
the	O
lipid	O
composition	O
of	O
the	O
membrane	B-ANAT
.	O

This	O
protein	O
was	O
purified	O
and	O
used	O
to	O
develop	O
an	O
indirect	O
ELISA	O
for	O
detection	O
of	O
antibodies	O
against	O
TCoV	O
.	O
Using	O
experimentally	O
derived	O
positive	O
and	O
negative	O
turkey	O
serum	B-ANAT
samples	O
this	O
ELISA	O
showed	O
high	O
sensitivity	O
(	O
95	O
%)	O
and	O
specificity	O
(	O
92	O
%)	O
for	O
TCoV	O
.	O
To	O
further	O
evaluate	O
the	O
potential	O
of	O
the	O
ELISA	O
,	O
360	O
serum	B-ANAT
samples	O
from	O
commercial	O
turkey	O
farms	O
in	O
Ontario	O
were	O
tested	O
for	O
TCoV	O
-	O
specific	O
antibodies	O
using	O
the	O
recombinant	O
TCoV	O
ELISA	O
.	O

We	O
found	O
that	O
two	O
of	O
these	O
GFP	O
-	O
N	O
-	O
domain	O
fusion	O
proteins	O
were	O
selectively	O
packaged	O
into	O
virions	B-ANAT
as	O
the	O
result	O
of	O
tight	O
binding	O
to	O
the	O
N	O
protein	O
in	O
the	O
viral	B-ANAT
nucleocapsid	I-ANAT
,	O
in	O
a	O
manner	O
that	O
did	O
not	O
involve	O
association	O
with	O
either	O
M	O
protein	O
or	O
RNA	O
.	O

SARS	O
-	O
CoV	O
infection	O
induced	O
a	O
range	O
of	O
interferon	O
,	O
cytokine	O
,	O
and	O
pulmonary	B-ANAT
wound	O
-	O
healing	O
genes	O
,	O
as	O
well	O
as	O
several	O
genes	O
associated	O
with	O
the	O
onset	O
of	O
ARDS	O
.	O

Mice	O
that	O
died	O
also	O
showed	O
unique	O
transcriptional	O
profiles	O
of	O
immune	O
response	O
,	O
apoptosis	O
,	O
cell	B-ANAT
cycle	O
control	O
,	O
and	O
stress	O
.	O

Effects	O
of	O
the	O
chimeric	O
ribozyme	O
on	O
expression	O
of	O
SARS	O
-	O
CoV	O
were	O
evaluated	O
in	O
cultured	O
3T3	O
cells	B-ANAT
.	O

Taken	O
together	O
,	O
our	O
findings	O
did	O
not	O
support	O
the	O
model	O
in	O
which	O
SARS	O
-	O
CoV	O
N	O
protein	O
specifically	O
modulates	O
transcription	O
of	O
the	O
FGL2	O
gene	O
to	O
cause	O
fibrosis	O
and	O
vascular	B-ANAT
thrombosis	O
.	O

The	O
signal	O
sequence	O
and	O
autotransporter	O
beta	O
domain	O
of	O
protease	O
IgA	O
(	O
IgAP	O
)	O
of	O
Neisseria	O
gonorrhoeae	O
were	O
introduced	O
to	O
endow	O
scFvs	O
with	O
the	O
direction	O
to	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
the	O
support	O
as	O
a	O
transmembrane	B-ANAT
domain	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
SP	O
-	O
D	O
is	O
a	O
defence	O
lectin	O
promoting	O
clearance	O
of	O
viral	O
infections	O
.	O

To	O
investigate	O
this	O
potential	O
,	O
we	O
redirected	O
the	O
coronavirus	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
which	O
is	O
normally	O
unable	O
to	O
infect	O
human	O
cells	B-ANAT
,	O
to	O
human	O
tumor	B-ANAT
cells	I-ANAT
by	O
using	O
a	O
soluble	O
receptor	O
(	O
soR	O
)-	O
based	O
expression	O
construct	O
fused	O
to	O
an	O
epidermal	B-ANAT
growth	O
factor	O
(	O
EGF	O
)	O
receptor	O
targeting	O
moiety	O
.	O

However	O
,	O
some	O
adverse	O
effects	O
were	O
seen	O
in	O
normal	O
mouse	O
brain	B-ANAT
tissues	I-ANAT
that	O
were	O
likely	O
caused	O
by	O
the	O
natural	O
murine	O
tropism	O
of	O
MHV	O
.	O

Mutagenesis	O
studies	O
of	O
these	O
residues	O
in	O
SARS	O
-	O
CoV	O
S	O
,	O
followed	O
by	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
and	O
pseudotyped	O
virion	B-ANAT
infectivity	O
assays	O
,	O
showed	O
a	O
critical	O
role	O
for	O
residues	O
L803	O
,	O
L804	O
,	O
and	O
F805	O
in	O
membrane	B-ANAT
fusion	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
conduct	O
fast	O
screening	O
of	O
passengers	O
with	O
infections	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
or	O
pandemic	O
influenza	O
at	O
a	O
quarantine	O
depot	O
,	O
we	O
developed	O
a	O
non	O
-	O
contact	O
screening	O
system	O
with	O
a	O
self	O
-	O
produced	O
program	O
to	O
conduct	O
a	O
human	O
screening	O
within	O
five	O
seconds	O
,	O
via	O
a	O
linear	O
discriminant	O
function	O
from	O
non	O
-	O
contact	O
derived	O
variables	O
,	O
i	O
.	O
e	O
.	O
palmer	O
pulse	O
derived	O
from	O
a	O
laser	O
Doppler	O
blood	B-ANAT
-	O
flow	O
meter	O
,	O
respiration	O
rate	O
determined	O
by	O
a	O
10	O
-	O
GHz	O
microwave	O
radar	O
,	O
and	O
facial	B-ANAT
temperature	O
measured	O
by	O
a	O
thermography	O
.	O

TITLE	O
:	O
Intestinal	B-ANAT
mucosal	B-ANAT
immune	O
response	O
in	O
ducklings	O
following	O
oral	B-ANAT
immunisation	O
with	O
an	O
attenuated	O
Duck	O
enteritis	O
virus	O
vaccine	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
intestinal	B-ANAT
mucosal	B-ANAT
immune	O
responses	O
in	O
ducklings	O
orally	B-ANAT
inoculated	O
with	O
attenuated	O
Duck	O
enteritis	O
virus	O
(	O
DEV	O
),	O
the	O
kinetics	O
of	O
the	O
viral	O
load	O
,	O
the	O
specific	O
humoral	O
immune	O
responses	O
,	O
and	O
the	O
distribution	O
of	O
immunoglobulin	O
(	O
Ig	O
)	O
A	O
-	O
secreting	O
cells	B-ANAT
in	O
the	O
intestine	B-ANAT
were	O
evaluated	O
.	O

This	O
review	O
serves	O
to	O
focus	O
on	O
some	O
of	O
the	O
recent	O
literature	O
on	O
these	O
agents	O
and	O
the	O
clinical	O
impact	O
they	O
have	O
on	O
pediatric	O
lung	B-ANAT
infection	O
.	O

HLA	B-ANAT
-	O
DRB1	O
*	O
1202	O
,	O
the	O
predominant	O
allele	O
in	O
the	O
Vietnamese	O
population	O
showed	O
the	O
strongest	O
association	O
with	O
SARS	O
in	O
a	O
dominant	O
model	O
(	O
corrected	O
p	O
=	O
0	O
.	O
0065	O
and	O
0	O
.	O
0052	O
,	O
depending	O
on	O
the	O
controls	O
to	O
be	O
compared	O
).	O

Plasma	B-ANAT
drug	O
concentrations	O
were	O
determined	O
using	O
high	O
-	O
performance	O
liquid	O
chromatography	O
coupled	O
with	O
tandem	O
mass	O
spectrometry	O
.	O

Several	O
pharmacokinetic	O
pararameters	O
,	O
including	O
C	O
(	O
max	O
),	O
T	O
(	O
max	O
),	O
t	O
((	O
1	O
/	O
2	O
)),	O
AUC	O
(	O
0	O
-	O
t	O
),	O
and	O
AUC	O
(	O
0	O
-	O
infinity	O
),	O
were	O
determined	O
from	O
the	O
plasma	B-ANAT
concentrations	O
of	O
the	O
2	O
formulations	O
of	O
arbidol	O
using	O
noncompartmental	O
analysis	O
.	O

Autopsy	O
heart	B-ANAT
samples	O
from	O
patients	O
who	O
succumbed	O
to	O
the	O
SARS	O
crisis	O
in	O
Toronto	O
(	O
Canada	O
)	O
were	O
used	O
to	O
investigate	O
the	O
impact	O
of	O
SARS	O
on	O
myocardial	O
structure	O
,	O
inflammation	O
and	O
ACE2	O
protein	O
expression	O
.	O

Our	O
data	O
show	O
that	O
SARS	O
-	O
CoV	O
can	O
mediate	O
myocardial	O
inflammation	O
and	O
damage	O
associated	O
with	O
down	O
-	O
regulation	O
of	O
myocardial	O
ACE2	O
system	O
,	O
which	O
may	O
be	O
responsible	O
for	O
the	O
myocardial	O
dysfunction	O
and	O
adverse	O
cardiac	B-ANAT
outcomes	O
in	O
patients	O
with	O
SARS	O
.	O

TITLE	O
:	O
Surveillance	O
of	O
human	O
papilloma	O
virus	O
infection	O
and	O
cervical	B-ANAT
cancer	O
in	O
kidney	B-ANAT
transplant	I-ANAT
recipients	O
:	O
preliminary	O
data	O
.	O

We	O
report	O
the	O
preliminary	O
findings	O
of	O
a	O
prospective	O
study	O
that	O
evaluated	O
the	O
incidence	O
of	O
HPV	O
infection	O
and	O
cervical	B-ANAT
carcinoma	O
in	O
a	O
population	O
of	O
kidney	B-ANAT
transplant	I-ANAT
recipients	O
.	O

These	O
preliminary	O
data	O
demonstrated	O
a	O
high	O
incidence	O
of	O
HPV	O
infection	O
in	O
renal	B-ANAT
transplant	B-ANAT
recipients	O
.	O

Increased	O
insight	O
into	O
the	O
structure	O
-	O
function	O
relationships	O
of	O
APC	B-ANAT
facilitated	O
design	O
of	O
APC	B-ANAT
variants	O
that	O
conserve	O
cytoprotective	O
effects	O
and	O
reduce	O
anticoagulant	O
features	O
,	O
thereby	O
attenuating	O
the	O
risk	O
of	O
severe	O
bleeding	O
with	O
APC	B-ANAT
therapy	O
.	O

On	O
the	O
whole	O
,	O
these	O
studies	O
have	O
not	O
supported	O
the	O
use	O
of	O
APC	B-ANAT
in	O
these	O
populations	O
and	O
challenge	O
the	O
field	O
of	O
APC	B-ANAT
research	O
to	O
search	O
for	O
additional	O
answers	O
.	O

The	O
cell	B-ANAT
infection	O
was	O
not	O
alleviated	O
by	O
either	O
pre	O
-	O
treatment	O
of	O
cells	B-ANAT
with	O
GD	O
or	O
addition	O
of	O
the	O
drug	O
post	O
infection	O
,	O
confirming	O
that	O
the	O
inhibitory	O
effect	O
of	O
GD	O
,	O
unlike	O
LiCl	O
,	O
on	O
IBV	O
is	O
a	O
viral	O
factor	O
,	O
rather	O
than	O
a	O
cellular	B-ANAT
factor	O
.	O

The	O
inhibitory	O
effect	O
of	O
both	O
drugs	O
was	O
confirmed	O
by	O
infecting	O
primary	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
cells	B-ANAT
.	O

The	O
results	O
suggested	O
that	O
rapid	O
pulmonary	B-ANAT
fibrosis	O
could	O
be	O
induced	O
by	O
ALI	O
via	O
LPS	O
three	O
-	O
hits	O
.	O

The	O
investigation	O
was	O
not	O
only	O
performed	O
to	O
establish	O
a	O
new	O
rapid	O
pulmonary	B-ANAT
fibrosis	O
model	O
,	O
but	O
also	O
to	O
provide	O
the	O
elicitation	O
for	O
mechanism	O
of	O
ALI	O
changed	O
into	O
the	O
rapid	O
pulmonary	B-ANAT
fibrosis	O
.	O

TITLE	O
:	O
Characterization	O
of	O
cytotoxic	B-ANAT
T	I-ANAT
-	I-ANAT
lymphocyte	I-ANAT
epitopes	O
and	O
immune	O
responses	O
to	O
SARS	O
coronavirus	O
spike	O
DNA	O
vaccine	O
expressing	O
the	O
RGD	O
-	O
integrin	O
-	O
binding	O
motif	O
.	O

DNA	O
vaccines	O
incorporating	O
the	O
Spike	O
-	O
RGD	O
/	O
His	O
motif	O
or	O
the	O
Spike	O
-	O
His	O
construct	O
generated	O
robust	O
cell	B-ANAT
-	O
mediated	O
immune	O
responses	O
.	O

The	O
'	O
wet	O
'	O
or	O
effusive	O
form	O
,	O
characterised	O
by	O
polyserositis	O
(	O
abdominal	B-ANAT
and	O
/	O
or	O
thoracic	B-ANAT
effusion	B-ANAT
)	O
and	O
vasculitis	O
,	O
and	O
the	O
'	O
dry	O
'	O
or	O
non	O
-	O
effusive	O
form	O
(	O
pyogranulomatous	O
lesions	O
in	O
organs	B-ANAT
)	O
reflect	O
clinical	O
extremes	O
of	O
a	O
continuum	O
.	O

ABSTRACT	O
:	O
Severe	O
lung	B-ANAT
injury	O
,	O
responsible	O
for	O
up	O
to	O
15	O
%	O
of	O
mortality	O
in	O
acute	O
necrotizing	O
pancreatitis	O
patients	O
,	O
is	O
promoted	O
by	O
neutrophil	B-ANAT
(	O
PMN	B-ANAT
)	O
migration	O
into	O
the	O
lung	B-ANAT
.	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
ability	O
of	O
the	O
broad	O
-	O
spectrum	O
MMP	O
inhibitor	O
doxycycline	O
to	O
prevent	O
secondary	O
pulmonary	B-ANAT
injury	O
in	O
acute	O
pancreatitis	O
.	O

3	O
.	O
68	O
ng	O
/	O
ml	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
as	O
a	O
result	O
decreased	O
pulmonary	B-ANAT
infiltration	O
of	O
PMNs	O
(	O
21	O
.	O
2	O
+/-	O
5	O
.	O
1	O
vs	O
.	O
32	O
.	O
5	O
+/-	O

Inhibition	O
of	O
MMP	O
-	O
9	O
activity	O
with	O
doxycycline	O
reduced	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
and	O
expression	O
of	O
MMP	O
-	O
9	O
in	O
pulmonary	B-ANAT
tissue	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
chimeric	O
gene	O
encoding	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
and	O
a	O
S	B-ANAT
-	I-ANAT
layer	I-ANAT
protein	O
from	O
Lactobacillus	O
brevis	O
KCTC3102	O
,	O
and	O
/	O
or	O
two	O
copies	O
of	O
the	O
Fc	O
-	O
binding	O
Z	O
-	O
domain	O
,	O
a	O
synthetic	O
analog	O
of	O
the	O
B	O
-	O
domain	O
of	O
protein	O
A	O
,	O
was	O
constructed	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
).	O

Pheochromocytoma	O
describes	O
various	O
clinical	O
manifestations	O
attributable	O
to	O
the	O
excessive	O
secretion	B-ANAT
of	O
catecholamine	O
by	O
the	O
tumor	O
,	O
however	O
the	O
disease	O
is	O
not	O
typically	O
included	O
the	O
differential	O
diagnoses	O
of	O
massive	O
hemoptysis	O
.	O

ABSTRACT	O
:	O
Swine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
HEV	B-ANAT
)	O
causes	O
encephalomyelitis	O
or	O
vomiting	O
and	O
wasting	O
disease	O
in	O
suckling	O
piglets	O
.	O

The	O
results	O
of	O
rapid	O
diagnostic	O
test	O
for	O
malaria	O
(	O
OptiMAL	O
test	O
,	O
Diamed	O
AG	O
,	O
Switzerland	O
)	O
were	O
correlated	O
with	O
the	O
peripheral	B-ANAT
blood	I-ANAT
smear	O
findings	O
in	O
the	O
patients	O
in	O
whom	O
it	O
was	O
requested	O
.	O

TITLE	O
:	O
Duration	O
of	O
symptom	O
onset	O
to	O
hospital	O
admission	O
and	O
admission	O
to	O
discharge	B-ANAT
or	O
death	O
in	O
SARS	O
in	O
mainland	O
China	O
:	O
a	O
descriptive	O
study	O
.	O

M	O
,	O
N	O
and	O
S2	O
proteins	O
of	O
SARS	O
-	O
CoV	O
were	O
detected	O
in	O
the	O
cytoplasm	B-ANAT
of	O
transfected	O
CHO	B-ANAT
cells	I-ANAT
.	O

CONCLUSIONS	O
:	O
Significant	O
toxicity	O
of	O
neonicotinoids	O
can	O
occur	O
following	O
large	O
amount	O
of	O
oral	B-ANAT
ingestion	O
.	O

ABSTRACT	O
:	O
This	O
review	O
article	O
describes	O
the	O
pathophysiological	O
aspects	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
induced	O
by	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
and	O
examines	O
various	O
therapeutic	O
approaches	O
.	O

The	O
virus	O
was	O
partially	O
attenuated	O
at	O
passage	O
40	O
(	O
P40	B-ANAT
)	O
and	O
P70	O
,	O
and	O
was	O
fully	O
attenuated	O
at	O
P110	O
.	O

Substitutions	O
in	O
the	O
S1	O
subunit	O
occurred	O
between	O
P3	O
and	O
P40	B-ANAT
and	O
all	O
subpopulations	O
in	O
a	O
virus	O
passage	O
showed	O
the	O
same	O
substitutions	O
.	O

Antibodies	O
of	O
the	O
subclasses	O
IgG1	O
and	O
IgG2a	O
were	O
abundantly	O
present	O
in	O
the	O
mouse	O
sera	B-ANAT
.	O

4	O
.	O
3	O
scores	O
,	O
P	O
<	O
0	O
.	O
01	O
);	O
the	O
incidence	O
of	O
shock	O
was	O
lesser	O
(	O
1	O
/	O
20	O
vs	O
7	O
/	O
19	O
);	O
the	O
duration	O
of	O
ARDS	O
,	O
renal	B-ANAT
failure	O
,	O
cardiac	B-ANAT
insufficiency	O
,	O
hepatic	B-ANAT
dysfunction	O
,	O
cerebropathy	O
and	O
enteroplegia	O
,	O
as	O
well	O
as	O
the	O
duration	O
in	O
hospital	O
and	O
the	O
requirement	O
of	O
operation	O
shifting	O
were	O
all	O
shorter	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
ET	O
group	O
than	O
those	O
in	O
the	O
LT	O
group	O
,	O
but	O
no	O
statistical	O
difference	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
was	O
shown	O
in	O
terms	O
of	O
the	O
infection	O
incidence	O
and	O
the	O
mortality	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
devastating	O
disorders	O
of	O
overwhelming	O
pulmonary	B-ANAT
inflammation	O
and	O
hypoxemia	O
,	O
resulting	O
in	O
high	O
morbidity	O
and	O
mortality	O
.	O

Compounds	O
were	O
tested	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
against	O
viruses	O
representative	O
of	O
:	O
i	O
)	O
two	O
of	O
the	O
three	O
genera	O
of	O
the	O
Flaviviridae	O
family	O
,	O
i	O
.	O
e	O
.	O
Flaviviruses	O
and	O
Pestiviruses	O
;	O
ii	O
)	O
other	O
RNA	O
virus	O
families	O
,	O
such	O
as	O
Retroviridae	O
,	O
Picornaviridae	O
,	O
Paramyxoviridae	O
,	O
Rhabdoviridae	O
and	O
Reoviridae	O
;	O
iii	O
)	O
two	O
DNA	O
virus	O
families	O
(	O
Herpesviridae	O
and	O
Poxviridae	O
).	O

TITLE	O
:	O
Studies	O
on	O
membrane	B-ANAT
topology	O
,	O
N	O
-	O
glycosylation	O
and	O
functionality	O
of	O
SARS	O
-	O
CoV	O
membrane	B-ANAT
protein	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
co	O
-	O
administration	O
of	O
a	O
plasmid	O
containing	O
a	O
chicken	O
granulocyte	B-ANAT
-	O
macrophage	B-ANAT
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	B-ANAT
)	O
gene	O
and	O
a	O
plasmid	O
containing	O
the	O
S1	O
gene	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
could	O
enhance	O
the	O
immune	O
response	O
and	O
protection	O
efficacy	O
in	O
chickens	O
against	O
challenge	O
by	O
virulent	O
IBV	O
.	O

Under	O
the	O
condition	O
of	O
the	O
establishment	O
of	O
dendrtic	O
cells	B-ANAT
(	O
DC	B-ANAT
)	O
culture	O
method	O
,	O
we	O
used	O
recombinant	O
adenovirus	O
to	O
infect	O
mature	O
DC	B-ANAT
to	O
make	O
clear	O
the	O
development	O
changes	O
in	O
mRNA	O
levels	O
and	O
secreted	O
protein	O
levels	O
of	O
proinflammatory	O
cytokines	O
of	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
TNF	O
-	O
alpha	O
by	O
using	O
RT	O
-	O
PCR	O
and	O
ELISA	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
most	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
remain	O
leading	O
factors	O
for	O
morbidity	O
and	O
mortality	O
in	O
critically	O
ill	O
patients	O
.	O

TITLE	O
:	O
[	O
Synthesis	O
in	O
Escherichia	O
coli	O
cells	B-ANAT
and	O
characterization	O
of	O
the	O
active	O
exoribonuclease	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
].	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
proteolysis	O
at	O
a	O
novel	O
XXXR	O
/	O
S	O
motif	O
in	O
the	O
S2	O
subunit	O
might	O
be	O
a	O
common	O
mechanism	O
for	O
the	O
entry	O
of	O
CoV	O
into	O
cells	B-ANAT
.	O

Though	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
are	O
reported	O
triggers	O
for	O
exacerbations	O
,	O
information	O
on	O
these	O
infections	O
with	O
asthma	O
is	O
sparse	O
in	O
Caribbean	O
territories	O
.	O

In	O
addition	O
,	O
we	O
observed	O
that	O
CTLDs	O
which	O
showed	O
the	O
similar	O
relative	O
synonymous	O
codon	O
usage	O
(	O
RSCU	O
)	O
patterns	O
with	O
CoVs	O
were	O
commonly	O
derived	O
from	O
the	O
human	B-ANAT
chromosome	I-ANAT
12	O
,	O
and	O
mouse	O
chromosome	B-ANAT
6	I-ANAT
and	O
12	O
,	O
suggesting	O
that	O
there	O
might	O
be	O
a	O
specific	O
genomic	O
region	O
or	O
chromosomes	B-ANAT
which	O
show	O
a	O
more	O
similar	O
synonymous	O
codon	O
usage	O
pattern	O
with	O
viral	O
genes	O
.	O

All	O
patients	O
had	O
fever	O
,	O
cough	O
,	O
dyspnea	O
or	O
respiratory	O
distress	O
,	O
increased	O
serum	B-ANAT
lactate	O
dehydrogenase	O
levels	O
,	O
and	O
bilateral	O
patchy	O
pneumonia	O
.	O

In	O
A	O
/	O
J	O
and	O
C3H	O
/	O
HeJ	O
mice	O
,	O
which	O
are	O
highly	O
susceptible	O
to	O
MHV	O
-	O
1	O
-	O
induced	O
disease	O
,	O
we	O
demonstrate	O
that	O
both	O
CD4	O
and	O
CD8	O
T	B-ANAT
cells	I-ANAT
contribute	O
to	O
morbidity	O
during	O
primary	O
infection	O
,	O
and	O
memory	O
responses	O
can	O
enhance	O
morbidity	O
and	O
mortality	O
during	O
subsequent	O
reexposure	O
to	O
MHV	O
-	O
1	O
.	O

Furthermore	O
,	O
a	O
G405	O
-	O
D	O
point	O
mutation	O
in	O
the	O
S1	O
domain	O
,	O
which	O
was	O
acquired	O
during	O
further	O
propagation	O
of	O
Vero	O
-	O
adapted	O
IBV	O
in	O
Vero	B-ANAT
cells	I-ANAT
,	O
could	O
enhance	O
the	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
activity	O
of	O
the	O
protein	O
.	O

However	O
,	O
compensatory	O
mutations	O
in	O
S1	O
and	O
some	O
distant	O
regions	O
of	O
S2	O
were	O
required	O
for	O
restoration	O
of	O
the	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
activity	O
of	O
S	O
protein	O
carrying	O
L857	O
and	O
for	O
the	O
infectivity	O
of	O
the	O
recovered	O
variants	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

This	O
process	O
requires	O
the	O
specific	O
recognition	O
of	O
RNA	O
cis	O
-	O
acting	O
signals	O
located	O
at	O
the	O
ends	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
.	O

Here	O
,	O
we	O
report	O
the	O
creation	O
of	O
anisotropic	O
,	O
branched	B-ANAT
and	O
crosslinkable	O
building	O
blocks	O
(	O
ABC	O
monomers	O
)	O
from	O
which	O
multifunctional	O
nanoarchitectures	O
have	O
been	O
assembled	O
.	O

In	O
a	O
multivariate	O
adjusted	O
model	O
,	O
multiple	O
system	B-ANAT
organ	I-ANAT
failure	O
was	O
1	O
.	O
82	O
times	O
more	O
likely	O
in	O
severely	O
obese	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
14	O
-	O
2	O
.	O
90	O
)	O
and	O
1	O
.	O
74	O
times	O
more	O
likely	O
in	O
the	O
obese	O
patients	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
14	O
-	O
2	O
.	O
66	O
)	O
when	O
compared	O
with	O
patients	O
with	O
normal	O
BMI	O
after	O
DCL	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

The	O
concentrations	O
of	O
TNF	O
-	O
alpha	O
in	O
BALF	O
and	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
10	O
,	O
and	O
TNF	O
-	O
alpha	O
in	O
serum	B-ANAT
were	O
higher	O
in	O
nonsurvivors	O
than	O
in	O
survivor	O
patients	O
with	O
CAP	O
.	O

Of	O
these	O
112	O
patients	O
with	O
severe	O
CAP	O
(	O
39	O
%),	O
44	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
these	O
patients	O
seemed	O
to	O
have	O
higher	O
serum	B-ANAT
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IL	O
-	O
10	O
levels	O
than	O
did	O
the	O
non	O
-	O
ARDS	O
group	O
.	O

Common	O
causes	O
of	O
non	O
-	O
malarial	O
fever	O
include	O
from	O
Africa	O
rickettsial	O
diseases	O
,	O
amoebic	O
liver	B-ANAT
abscess	O
and	O
Katayama	O
syndrome	O
;	O
from	O
South	O
and	O
South	O
East	O
Asia	O
,	O
enteric	O
fever	O
and	O
arboviral	O
infection	O
;	O
from	O
the	O
Middle	O
East	O
,	O
brucellosis	O
and	O
from	O
the	O
Horn	B-ANAT
of	O
Africa	O
visceral	O
leishmaniasis	O
.	O

TITLE	O
:	O
Successful	O
treatment	O
of	O
crush	O
syndrome	O
complicated	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
using	O
hybrid	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
.	O

In	O
this	O
paper	O
,	O
we	O
will	O
discuss	O
a	O
new	O
pragmatic	O
approach	O
for	O
entry	O
and	O
exit	O
screening	O
procedures	O
at	O
international	O
airports	O
,	O
propose	O
a	O
new	O
classification	O
system	O
for	O
contacts	O
within	O
the	O
aircraft	O
,	O
and	O
discuss	O
changing	O
the	O
fixed	B-ANAT
enforcement	O
of	O
standardized	O
community	O
mitigation	O
measures	O
to	O
the	O
implementation	O
of	O
measures	O
that	O
correspond	O
to	O
specific	O
characteristics	O
of	O
individual	O
pathogenic	O
agents	O
.	O

Of	O
the	O
10	O
patients	O
,	O
nine	O
were	O
obese	O
(	O
body	B-ANAT
mass	O
index	O
[	O
BMI	O
]	O
>	O
or	O
=	O
30	O
),	O
including	O
seven	O
who	O
were	O
extremely	O
obese	O
(	O
BMI	O
=	O
40	O
);	O
five	O
had	O
pulmonary	B-ANAT
emboli	O
;	O
and	O
nine	O
had	O
multiorgan	O
dysfunction	O
syndrome	O
(	O
MODS	O
).	O

We	O
show	O
the	O
potential	O
for	O
biomimetic	O
polymers	O
targeted	O
to	O
lung	B-ANAT
endothelium	B-ANAT
as	O
a	O
viable	O
therapy	O
to	O
enhance	O
endothelial	B-ANAT
barrier	O
function	O
thereby	O
attenuating	O
a	O
major	O
component	O
of	O
vascular	B-ANAT
inflammation	O
.	O

ABSTRACT	O
:	O
An	O
ideal	O
animal	O
model	O
for	O
hepatitis	O
E	O
virus	O
(	O
HEV	B-ANAT
)	O
research	O
is	O
still	O
unavailable	O
.	O

Research	O
results	O
demonstrated	O
that	O
Mongolian	O
gerbils	O
in	O
Group	O
1	O
were	O
successfully	O
infected	O
with	O
HEV	B-ANAT
.	O

The	O
results	O
indicate	O
that	O
Mongolian	O
gerbils	O
could	O
be	O
used	O
as	O
an	O
ideal	O
animal	O
model	O
for	O
the	O
study	O
of	O
HEV	B-ANAT
.	O

Human	O
immunodeficiency	O
virus	O
-	O
backboned	O
pseudoviruses	O
expressing	O
spike	O
proteins	O
derived	O
from	O
human	O
SARS	O
-	O
CoV	O
or	O
SARS	O
-	O
CoV	O
-	O
like	O
viruses	O
of	O
masked	O
palm	B-ANAT
civets	O
and	O
raccoon	O
dogs	O
were	O
tested	O
for	O
their	O
entry	O
efficiency	O
into	O
these	O
cell	B-ANAT
lines	I-ANAT
.	O

Treatment	O
of	O
mice	O
with	O
anti	O
-	O
CXCL10	O
neutralizing	O
antibody	O
results	O
in	O
limited	O
CD4	O
+	O
T	B-ANAT
cell	I-ANAT
infiltration	O
into	O
the	O
CNS	B-ANAT
accompanied	O
by	O
a	O
reduction	O
in	O
white	B-ANAT
matter	I-ANAT
damage	O
.	O

CXCL10	O
neutralization	O
selectively	O
reduced	O
accumulation	O
and	O
/	O
or	O
retention	O
of	O
virus	O
-	O
specific	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
yet	O
exhibited	O
limited	O
effect	O
on	O
virus	O
-	O
specific	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Oral	B-ANAT
immunization	O
of	O
mice	O
with	O
recombinant	O
Lactococcus	O
lactis	O
expressing	O
porcine	O
transmissible	O
gastroenteritis	O
virus	O
spike	O
glycoprotein	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
coverage	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
vaccine	O
field	O
boost	O
in	O
commercial	O
broilers	O
,	O
estimate	O
the	O
relative	O
amount	O
of	O
vaccine	O
virus	O
in	O
the	O
trachea	B-ANAT
,	O
and	O
follow	O
the	O
clearance	O
of	O
the	O
vaccine	O
,	O
we	O
collected	O
approximately	O
100	O
tracheal	O
swabs	O
at	O
various	O
times	O
postvaccination	O
from	O
10	O
different	O
flocks	O
and	O
used	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
to	O
detect	O
the	O
virus	O
.	O

Significant	O
expression	O
levels	O
were	O
identified	O
for	O
ANPEP	O
(	O
a	O
receptor	O
for	O
CoV	O
),	O
as	O
well	O
as	O
inhibition	O
of	O
the	O
STAT1	O
pathway	O
,	O
IFNs	O
production	O
and	O
CXCL10	O
(	O
a	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
recruiter	O
).	O

Laparotomy	O
was	O
performed	O
,	O
but	O
no	O
intra	O
-	O
abdominal	B-ANAT
focus	O
of	O
infection	O
could	O
be	O
detected	O
.	O

Patients	O
with	O
a	O
platelet	B-ANAT
count	O
significantly	O
lower	O
than	O
their	O
baseline	O
on	O
admission	O
had	O
an	O
increased	O
risk	O
of	O
mechanical	O
ventilation	O
.	O

Six	O
deaths	O
occurred	O
(	O
mortality	O
rate	O
9	O
.	O
2	O
%),	O
4	O
of	O
which	O
were	O
due	O
to	O
septic	O
shock	O
/	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
(	O
2	O
patients	O
)	O
or	O
interstitial	B-ANAT
pneumonia	O
/	O
pulmonary	B-ANAT
fibrosis	O
after	O
Legionella	O
pneumonia	O
(	O
2	O
patients	O
),	O
whereas	O
the	O
other	O
2	O
deaths	O
were	O
due	O
to	O
causes	O
unrelated	O
to	O
Legionella	O
pneumonia	O
.	O

Mortality	O
rates	O
for	O
each	O
severe	O
complication	O
were	O
as	O
follows	O
:	O
acute	O
respiratory	O
distress	O
syndrome	O
27	O
.	O
3	O
%	O
(	O
3	O
of	O
11	O
);	O
renal	B-ANAT
failure	O
33	O
.	O
3	O
%	O
(	O
2	O
of	O
6	O
);	O
disseminated	O
intravascular	O
coagulation	O
33	O
.	O
3	O
%	O
(	O
2	O
of	O
6	O
);	O
severe	O
sepsis	O
0	O
%	O
(	O
0	O
of	O
1	O
);	O
septic	O
shock	O
/	O
MODS	O
66	O
.	O
7	O
%	O
(	O
2	O
of	O
3	O
);	O
interstitial	B-ANAT
pneumonia	O
/	O
pulmonary	B-ANAT
fibrosis	O
50	O
%	O
(	O
2	O
of	O
4	O
).	O

During	O
treatment	O
,	O
sudden	O
fever	O
,	O
hypoxemia	O
and	O
chest	B-ANAT
radiography	O
-	O
confirmed	O
interstitial	B-ANAT
shadows	O
throughout	O
the	O
lung	B-ANAT
fields	O
were	O
noted	O
,	O
and	O
the	O
patient	O
was	O
referred	O
to	O
the	O
Department	O
of	O
Internal	O
Medicine	O
.	O

Understanding	O
the	O
molecular	O
details	O
of	O
these	O
interactions	O
will	O
be	O
critical	O
for	O
the	O
design	O
of	O
effective	O
strategies	O
to	O
prevent	O
and	O
treat	O
coronavirus	O
infections	O
in	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nonstructural	O
protein	O
2	O
interacts	O
with	O
a	O
host	O
protein	B-ANAT
complex	I-ANAT
involved	O
in	O
mitochondrial	B-ANAT
biogenesis	O
and	O
intracellular	B-ANAT
signaling	O
.	O

Our	O
results	O
suggest	O
that	O
nsp2	O
may	O
be	O
involved	O
in	O
the	O
disruption	O
of	O
intracellular	B-ANAT
host	O
signaling	O
during	O
SARS	O
-	O
CoV	O
infections	O
.	O

Chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
is	O
the	O
first	O
cause	O
of	O
cor	B-ANAT
pulmonale	O
,	O
far	O
before	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
and	O
obesity	O
-	O
hypoventilation	O
syndrome	O
.	O

At	O
present	O
long	O
-	O
term	O
oxygen	O
therapy	O
(	O
LTOT	O
)	O
is	O
the	O
logical	O
treatment	O
of	O
PH	O
since	O
alveolar	B-ANAT
hypoxia	O
is	O
considered	O
to	O
be	O
the	O
major	O
determinant	O
of	O
the	O
elevation	O
of	O
PAP	O
and	O
PVR	O
.	O

After	O
induction	O
of	O
ARDS	O
in	O
eight	O
female	O
pigs	O
(	O
56	O
.	O
1	O
+/-	O
3	O
.	O
2	O
kg	O
),	O
lung	B-ANAT
recruitment	O
was	O
performed	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
was	O
set	O
3	O
cmH2O	O
above	O
the	O
lower	O
inflection	O
point	O
of	O
the	O
pressure	O
-	O
volume	O
curve	O
.	O

It	O
was	O
also	O
shown	O
that	O
the	O
""""	O
open	O
-	O
lung	B-ANAT
""""	O
strategy	O
chosen	O
was	O
associated	O
with	O
sustained	O
improvements	O
in	O
oxygenation	O
,	O
even	O
though	O
VTs	O
were	O
minimized	O
.	O

RESULTS	O
:	O
After	O
lung	B-ANAT
recruitment	O
,	O
oxygenation	O
remained	O
significantly	O
improved	O
although	O
VTs	O
were	O
minimized	O
to	O
0	O
ml	O
/	O
kg	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Upon	O
the	O
basis	O
of	O
the	O
X	O
-	O
ray	O
crystal	B-ANAT
structure	O
of	O
inhibitor	O
24	O
-	O
bound	O
to	O
SARS	O
-	O
CoV	O
PLpro	O
,	O
a	O
drug	O
design	O
template	O
was	O
created	O
.	O

For	O
field	O
isolates	O
of	O
JP	O
-	O
III	O
,	O
even	O
though	O
there	O
are	O
no	O
homologous	O
genotype	O
vaccine	O
strain	O
,	O
some	O
strains	O
of	O
JP	O
-	O
III	O
were	O
neutralized	O
with	O
immune	O
serum	B-ANAT
from	O
vaccine	O
strains	O
of	O
the	O
heterologous	O
genotype	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
reference	O
ranges	O
of	O
normal	O
oral	B-ANAT
temperatures	O
of	O
students	O
in	O
Singapore	O
and	O
recommend	O
the	O
cut	O
-	O
off	O
values	O
for	O
febrile	O
patients	O
.	O

This	O
study	O
has	O
provided	O
empirical	O
data	O
on	O
normal	O
oral	B-ANAT
temperature	O
cut	O
-	O
offs	O
which	O
could	O
be	O
used	O
during	O
temperature	O
screening	O
in	O
schools	O
.	O

Temperatures	O
of	O
37	O
.	O
8	O
degrees	O
C	O
and	O
37	O
.	O
5	O
degrees	O
C	O
are	O
therefore	O
recommended	O
as	O
the	O
oral	B-ANAT
temperature	O
cut	O
-	O
offs	O
for	O
those	O
<	O
or	O
=	O
12	O
years	O
old	O
and	O
>	O
12	O
years	O
old	O
,	O
respectively	O
.	O

TITLE	O
:	O
Impact	O
of	O
acute	O
hypercapnia	O
and	O
augmented	O
positive	O
end	O
-	O
expiratory	O
pressure	O
on	O
right	B-ANAT
ventricle	I-ANAT
function	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
effects	O
of	O
acute	O
hypercapnia	O
induced	O
by	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
variations	O
at	O
constant	O
plateau	O
pressure	O
(	O
P	O
(	O
plat	O
))	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
on	O
right	O
ventricular	B-ANAT
(	O
RV	O
)	O
function	O
.	O

The	O
subsequent	O
PRCV	O
infection	O
led	O
to	O
enhanced	O
PRRSV	O
replication	O
in	O
the	O
lungs	B-ANAT
and	O
a	O
trend	O
towards	O
increased	O
serum	B-ANAT
T	O
-	O
helper	O
type	O
1	O
(	O
Th1	O
)	O
(	O
IFN	O
-	O
gamma	O
)	O
but	O
decreased	O
Th2	O
[	O
interleukin	O
(	O
IL	O
)-	O
4	O
]	O
responses	O
,	O
further	O
exacerbating	O
PRRSV	O
pneumonia	O
.	O

Following	O
PRCV	O
infection	O
,	O
more	O
severe	O
PRRSV	O
-	O
related	O
pulmonary	B-ANAT
alveolar	B-ANAT
macrophage	I-ANAT
(	O
PAM	O
)	O
apoptosis	O
occurred	O
,	O
as	O
determined	O
by	O
an	O
in	O
situ	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	O
nick	O
end	O
labelling	O
assay	O
,	O
suggesting	O
increased	O
PRRSV	O
replication	O
in	O
PAMs	O
.	O

Mutations	O
in	O
the	O
BIG2	O
Arf1	O
GEF	O
have	O
been	O
linked	O
to	O
autosomal	B-ANAT
recessive	O
periventricular	O
heterotopia	O
,	O
a	O
disorder	O
of	O
neuronal	O
migration	O
that	O
leads	O
to	O
severe	O
malformation	O
of	O
the	O
cerebral	B-ANAT
cortex	I-ANAT
.	O

ABSTRACT	O
:	O
Ribosomal	B-ANAT
preparations	O
(	O
ribosome	B-ANAT
-	O
component	O
immune	O
modulators	O
[	O
RCIMs	O
])	O
do	O
not	O
contain	O
attenuated	O
bacteria	O
and	O
,	O
in	O
contrast	O
to	O
live	O
bacterial	O
extracts	O
,	O
which	O
may	O
induce	O
severe	O
side	O
effects	O
,	O
retain	O
immune	O
stimulating	O
activity	O
without	O
infectious	O
capability	O
.	O

TITLE	O
:	O
Multiply	O
organ	B-ANAT
dysfunction	O
syndrome	O
due	O
to	O
tramadol	O
intoxication	O
alone	O
.	O

Therefore	O
,	O
a	O
series	O
of	O
detection	O
including	O
virus	O
isolation	O
,	O
electron	O
microscopy	O
,	O
cytobiological	O
assay	O
,	O
serum	B-ANAT
neutralization	O
and	O
RT	O
-	O
PCR	O
were	O
used	O
to	O
identify	O
the	O
virus	O
.	O

The	O
mechanism	O
of	O
axonal	O
loss	O
and	O
demyelination	O
in	O
MHV	O
infection	O
is	O
dependent	O
on	O
successful	O
transport	O
of	O
virus	O
from	O
gray	B-ANAT
matter	I-ANAT
to	O
white	B-ANAT
matter	I-ANAT
using	O
the	O
MHV	O
host	O
attachment	O
spike	O
glycoprotein	O
.	O

Despite	O
the	O
autopsy	O
findings	O
,	O
all	O
intravital	O
specimens	O
collected	O
(	O
blood	B-ANAT
,	O
urine	B-ANAT
,	O
and	O
tracheal	B-ANAT
mucus	I-ANAT
)	O
and	O
all	O
clinical	O
Candida	O
antigen	O
tests	O
were	O
unsuspicious	O
.	O

Despite	O
antibiotic	O
administration	O
,	O
infiltration	O
progressed	O
to	O
the	O
entire	B-ANAT
right	I-ANAT
lung	I-ANAT
and	O
upper	O
left	B-ANAT
lung	I-ANAT
after	O
12	O
hours	O
,	O
and	O
he	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

As	O
opposed	O
to	O
all	O
other	O
SARS	O
-	O
Coronavirus	O
strains	O
,	O
Frankfurt	O
-	O
1	O
has	O
a	O
45	O
-	O
nucleotide	O
deletion	O
in	O
the	O
transmembrane	B-ANAT
domain	O
of	O
its	O
ORF	O
7b	O
protein	O
.	O

Despite	O
an	O
increase	O
in	O
the	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
,	O
the	O
leukaemic	O
leukocytes	B-ANAT
are	O
non	O
-	O
functional	O
.	O

RTD	O
-	O
1	O
-	O
treated	O
,	O
SARS	O
-	O
CoV	O
-	O
infected	O
mice	O
displayed	O
altered	O
lung	B-ANAT
tissue	I-ANAT
cytokine	O
responses	O
2	O
and	O
4	O
days	O
postinfection	O
compared	O
to	O
those	O
of	O
untreated	O
animals	O
,	O
suggesting	O
that	O
one	O
possible	O
mechanism	O
of	O
action	O
for	O
RTD	O
-	O
1	O
is	O
immunomodulatory	O
.	O

This	O
heterogeneity	O
has	O
been	O
measured	O
for	O
gene	O
transcription	O
,	O
phosphorylation	O
,	O
cell	B-ANAT
morphology	O
and	O
drug	O
perturbations	O
,	O
and	O
used	O
to	O
explain	O
various	O
aspects	O
of	O
cellular	B-ANAT
physiology	O
.	O

Acute	O
renal	B-ANAT
failure	O
is	O
common	O
among	O
pilgrims	O
who	O
presented	O
with	O
septic	O
shock	O
,	O
and	O
carries	O
high	O
mortality	O
.	O

ABSTRACT	O
:	O
Hemagglutinin	O
esterases	O
(	O
HEs	O
),	O
closely	O
related	O
envelope	B-ANAT
glycoproteins	O
in	O
influenza	O
C	O
and	O
corona	O
-	O
and	O
toroviruses	O
,	O
mediate	O
reversible	O
attachment	O
to	O
O	O
-	O
acetylated	O
sialic	O
acids	O
(	O
Sias	O
).	O

RESULTS	O
:	O
In	O
the	O
period	O
of	O
45	O
-	O
72	O
day	O
after	O
renal	B-ANAT
transplantation	O
,	O
36	O
cases	O
were	O
found	O
to	O
have	O
significantly	O
lower	O
number	O
of	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
than	O
that	O
before	O
operation	O
.	O

But	O
in	O
4	O
non	O
-	O
survival	O
patients	O
,	O
the	O
number	O
of	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
kept	O
continuously	O
in	O
lower	O
level	O
.	O

We	O
also	O
found	O
that	O
the	O
p	O
-	O
LAMP	O
/	O
N	O
(	O
70	O
-	O
122	O
)	O
construct	O
promoted	O
a	O
long	O
-	O
lasting	O
T	O
-	O
cell	B-ANAT
memory	I-ANAT
response	O
without	O
an	O
additional	O
boost	O
6	O
months	O
after	O
three	O
immunizations	O
.	O

Using	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
with	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
as	O
a	O
bait	O
,	O
the	O
N	O
protein	O
was	O
found	O
to	O
interact	O
with	O
MAP19	O
,	O
a	O
non	O
-	O
enzymatic	O
protein	O
of	O
MASP	O
(	O
mannan	O
-	O
associated	O
serine	O
protease	O
).	O

The	O
synergistic	O
IFN	O
-	O
gamma	O
production	O
involves	O
the	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
rather	O
than	O
the	O
extracellular	B-ANAT
signal	O
-	O
regulated	O
kinase	O
-	O
1	O
/	O
2	O
MAPK	O
signalling	O
pathway	O
.	O

TITLE	O
:	O
Rat	O
respiratory	O
coronavirus	O
infection	O
:	O
replication	O
in	O
airway	B-ANAT
and	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
the	O
innate	O
immune	O
response	O
.	O

A	O
viral	O
suspension	O
in	O
the	O
form	O
of	O
a	O
microspray	O
aerosol	O
was	O
delivered	O
by	O
intratracheal	O
instillation	O
into	O
the	O
distal	O
lung	B-ANAT
of	O
6	O
-	O
8	O
-	O
week	O
-	O
old	O
Fischer	O
344	O
rats	O
.	O

In	O
contrast	O
,	O
non	O
-	O
structural	O
proteins	O
encoded	O
by	O
two	O
-	O
thirds	O
of	O
viral	B-ANAT
genome	I-ANAT
are	O
poorly	O
characterized	O
for	O
cell	B-ANAT
-	O
mediated	O
immunity	O
.	O

ALI	O
-	O
P	O
and	O
ALI	O
-	O
EX	O
were	O
induced	O
by	O
injection	O
into	O
the	O
trachea	B-ANAT
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
and	O
intraperitoneally	O
(	O
20	O
mg	O
/	O
kg	O
)	O
24	O
hours	O
prior	O
to	O
tissue	B-ANAT
collection	O
.	O

ICU	O
:	O
28	O
severe	O
pneumonia	O
patients	O
were	O
admitted	O
(	O
21	O
with	O
associated	O
conditions	O
);	O
24	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
received	O
mechanical	O
ventilation	O
,	O
21	O
of	O
them	O
had	O
shock	O
;	O
8	O
/	O
9	O
acute	O
renal	B-ANAT
failure	O
cases	O
required	O
hemodialysis	O
.	O

TITLE	O
:	O
The	O
making	O
of	O
a	O
Chinese	O
head	B-ANAT
of	O
the	O
WHO	O
:	O
a	O
study	O
of	O
the	O
media	B-ANAT
discourse	O
on	O
Margaret	O
Chan	O
'	O
s	O
contest	O
for	O
the	O
WHO	O
director	O
-	O
generalship	O
and	O
its	O
implications	O
for	O
the	O
collective	O
memory	O
of	O
SARS	O
.	O

This	O
article	O
tackles	O
these	O
questions	O
by	O
reviewing	O
relevant	O
reportage	O
and	O
commentary	O
in	O
major	O
local	O
(	O
Hong	O
Kong	O
),	O
national	O
(	O
China	O
),	O
and	O
international	O
media	B-ANAT
.	O

ABSTRACT	O
:	O
A	O
56	O
-	O
year	O
-	O
old	O
previously	O
healthy	O
man	O
was	O
admitted	O
to	O
our	O
hospital	O
with	O
a	O
severe	O
chest	B-ANAT
pain	O
that	O
started	O
shortly	O
after	O
being	O
stung	O
by	O
a	O
honeybee	O
.	O

TITLE	O
:	O
Inducible	O
bronchus	B-ANAT
-	I-ANAT
associated	I-ANAT
lymphoid	I-ANAT
tissue	I-ANAT
elicited	O
by	O
a	O
protein	O
cage	O
nanoparticle	O
enhances	O
protection	O
in	O
mice	O
against	O
diverse	O
respiratory	O
viruses	O
.	O

The	O
immunoprophylactic	O
strategy	O
described	O
here	O
utilizes	O
a	O
protein	O
cage	O
nanoparticle	O
(	O
PCN	O
)	O
to	O
significantly	O
accelerate	O
clearance	O
of	O
diverse	O
respiratory	O
viruses	O
after	O
primary	O
infection	O
and	O
also	O
results	O
in	O
a	O
host	O
immune	O
response	O
that	O
causes	O
less	O
lung	B-ANAT
damage	O
.	O

The	O
enhanced	O
protection	O
appears	O
to	O
be	O
dependent	O
upon	O
the	O
prior	O
development	O
of	O
inducible	O
bronchus	B-ANAT
-	I-ANAT
associated	I-ANAT
lymphoid	I-ANAT
tissue	I-ANAT
(	O
iBALT	O
)	O
in	O
the	O
lung	B-ANAT
in	O
response	O
to	O
the	O
PCN	O
treatment	O
and	O
to	O
be	O
mediated	O
through	O
CD4	O
+	O
T	B-ANAT
cell	I-ANAT
and	O
B	B-ANAT
cell	I-ANAT
dependent	O
mechanisms	O
.	O

TITLE	O
:	O
[	O
Induction	O
of	O
immune	O
response	O
after	O
oral	B-ANAT
inoculation	O
of	O
mice	O
with	O
Lactobacillus	O
casei	O
surface	O
-	O
displayed	O
porcine	O
epidemic	O
diarrhea	O
viral	O
N	O
protein	O
].	O

ABSTRACT	O
:	O
A	O
previous	O
study	O
demonstrated	O
that	O
infection	O
of	O
a	O
canine	O
fibrosarcoma	O
cell	B-ANAT
line	I-ANAT
(	O
A	O
-	O
72	O
cells	B-ANAT
)	O
by	O
canine	O
coronavirus	O
(	O
CCoV	O
)	O
resulted	O
in	O
apoptosis	O
(	O
Ruggieri	O
et	O
al	O
.,	O
2007	O
).	O

In	O
rFPV	O
-	O
IBVS1	O
-	O
ChIFNgamma	O
-	O
vaccinated	O
chickens	O
,	O
pathological	O
changes	O
were	O
also	O
observed	O
in	O
those	O
organs	B-ANAT
,	O
but	O
were	O
milder	O
and	O
lasted	O
shorter	O
.	O

In	O
this	O
study	O
,	O
using	O
adoptive	O
transfer	O
experiments	O
and	O
bone	B-ANAT
marrow	I-ANAT
chimeras	O
,	O
we	O
show	O
that	O
at	O
least	O
some	O
of	O
these	O
cells	B-ANAT
are	O
recruited	O
from	O
the	O
periphery	O
,	O
predominantly	O
from	O
the	O
viral	O
Ag	O
-	O
experienced	O
T	B-ANAT
cell	I-ANAT
pool	O
.	O

The	O
serum	B-ANAT
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
level	O
recovered	O
more	O
quickly	O
in	O
patients	O
in	O
the	O
PCD	O
group	O
compared	O
to	O
those	O
in	O
the	O
surgery	O
group	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

In	O
addition	O
,	O
5	O
membrane	B-ANAT
protein	O
amino	O
acid	O
residues	O
with	O
functional	O
potential	O
differentiated	O
healthy	O
cats	O
from	O
cats	O
with	O
FIP	O
.	O

The	O
ATE	O
medium	O
,	O
which	O
contains	O
chicken	O
embryo	B-ANAT
extract	O
and	O
fetal	B-ANAT
bovine	O
serum	B-ANAT
,	O
supports	O
the	O
growth	O
of	O
ciliated	O
cells	B-ANAT
,	I-ANAT
goblet	I-ANAT
cells	B-ANAT
and	O
basal	B-ANAT
cells	I-ANAT
from	O
chicken	O
tracheas	B-ANAT
on	O
fibronectin	O
-	O
or	O
matrigel	O
-	O
coated	O
dishes	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
suggest	O
that	O
primary	O
ATE	O
cells	B-ANAT
provide	O
a	O
novel	O
cell	B-ANAT
culture	O
system	O
for	O
the	O
amplification	O
of	O
IBV	O
and	O
the	O
in	O
vitro	O
characterization	O
of	O
viral	O
cytopathogenesis	O
.	O

Protective	O
function	O
is	O
rather	O
associated	O
with	O
cell	B-ANAT
type	I-ANAT
specific	O
and	O
regional	O
restriction	O
of	O
viral	O
replication	O
in	O
grey	B-ANAT
matter	I-ANAT
and	O
ameliorated	O
neurodegeneration	O
and	O
demyelination	O
.	O

A	O
/	O
H5N1	O
nucleic	B-ANAT
acid	O
was	O
detected	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
in	O
a	O
nasopharyngeal	B-ANAT
aspirate	I-ANAT
.	O

After	O
comprehensive	O
management	O
with	O
antiviral	O
agents	O
,	O
antibiotics	O
,	O
convalescent	O
serum	B-ANAT
and	O
invasive	O
ventilation	O
,	O
her	O
clinical	O
condition	O
improved	O
and	O
turned	O
to	O
stable	O
.	O

After	O
partly	O
failure	O
of	O
beside	O
assist	O
thoracoscopy	O
to	O
fix	O
the	O
pleural	O
fistula	O
,	O
transbronchoscopic	O
bronchial	B-ANAT
occlusion	O
by	O
autoblood	O
was	O
explored	O
and	O
the	O
air	O
leakage	O
stopped	O
soon	O
after	O
occlusion	O
.	O

ABSTRACT	O
:	O
In	O
a	O
patient	O
with	O
acute	O
respiratory	O
illness	O
(	O
cough	O
,	O
sputum	B-ANAT
production	O
,	O
chest	B-ANAT
pain	O
,	O
and	O
/	O
or	O
dyspnea	O
),	O
the	O
need	O
for	O
chest	B-ANAT
imaging	O
depends	O
on	O
the	O
severity	O
of	O
illness	O
,	O
age	O
of	O
the	O
patient	O
,	O
clinical	O
history	O
,	O
physical	O
and	O
laboratory	O
findings	O
,	O
and	O
other	O
risk	O
factors	O
.	O

TITLE	O
:	O
Ascaris	O
lumbricoides	O
infection	O
causing	O
respiratory	O
distress	O
after	O
coronary	B-ANAT
artery	I-ANAT
bypass	O
grafting	B-ANAT
.	O

Such	O
hypothetical	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
could	O
be	O
present	O
in	O
any	O
viral	O
protein	O
,	O
originating	O
a	O
cross	O
-	O
reaction	O
leading	O
to	O
the	O
autoimmune	O
response	O
induced	O
by	O
MHV	O
.	O

H5N1	O
virus	O
infection	O
was	O
also	O
associated	O
with	O
an	O
elevated	O
rate	O
of	O
cell	B-ANAT
death	O
.	O

Overall	O
,	O
avian	O
H5N1	O
viruses	O
have	O
a	O
particular	O
receptor	O
specificity	O
targeting	O
endothelial	B-ANAT
cells	I-ANAT
that	O
is	O
different	O
from	O
human	O
influenza	O
viruses	O
,	O
and	O
this	O
H5N1	O
receptor	O
specificity	O
could	O
contribute	O
to	O
disease	O
pathogenesis	O
.	O

Hemocompatibility	O
of	O
devices	O
depends	O
on	O
the	O
size	O
and	O
modification	O
of	O
blood	B-ANAT
contacting	O
surfaces	O
as	O
well	O
as	O
blood	B-ANAT
flow	O
rates	O
.	O

Canine	O
adenovirus	O
-	O
2	O
was	O
isolated	O
from	O
1	O
conjunctival	O
sample	O
and	O
detected	O
by	O
use	O
of	O
PCR	O
assay	O
in	O
2	O
conjunctiva	B-ANAT
samples	O
.	O

Virus	O
replication	O
predominantly	O
occurs	O
on	O
the	O
rough	B-ANAT
endoplasmic	I-ANAT
reticulum	I-ANAT
(	O
RER	B-ANAT
),	O
both	O
perinuclear	O
and	O
cytoplasmic	B-ANAT
,	O
and	O
the	O
Golgi	B-ANAT
.	O

TITLE	O
:	O
A	O
human	O
coronavirus	O
OC43	O
variant	O
harboring	O
persistence	O
-	O
associated	O
mutations	O
in	O
the	O
S	O
glycoprotein	O
differentially	O
induces	O
the	O
unfolded	O
protein	O
response	O
in	O
human	O
neurons	B-ANAT
as	O
compared	O
to	O
wild	O
-	O
type	O
virus	O
.	O

ABSTRACT	O
:	O
We	O
have	O
reported	O
that	O
human	O
respiratory	O
coronavirus	O
OC43	O
(	O
HCoV	O
-	O
OC43	O
)	O
is	O
neurotropic	O
and	O
neuroinvasive	O
in	O
humans	O
and	O
mice	O
,	O
and	O
that	O
neurons	B-ANAT
are	O
the	O
primary	O
target	O
of	O
infection	O
in	O
mice	O
,	O
leading	O
to	O
neurodegenerative	O
disabilities	O
.	O

We	O
now	O
report	O
that	O
an	O
HCoV	O
-	O
OC43	O
mutant	O
harboring	O
two	O
persistence	O
-	O
associated	O
S	O
glycoprotein	O
point	O
mutations	O
(	O
H183R	O
and	O
Y241H	O
),	O
induced	O
a	O
stronger	O
unfolded	O
protein	O
response	O
(	O
UPR	O
)	O
and	O
translation	O
attenuation	O
in	O
infected	O
human	O
neurons	B-ANAT
.	O

Our	O
results	O
suggest	O
that	O
the	O
strategy	O
of	O
amplification	O
of	O
the	O
3	O
'	O
UTR	O
region	O
,	O
followed	O
by	O
sequencing	O
of	O
genes	O
3	O
and	O
5	O
,	O
has	O
proven	O
to	O
be	O
an	O
effective	O
means	O
of	O
detecting	O
TCoV	O
in	O
intestinal	B-ANAT
contents	I-ANAT
.	O

Systemic	O
and	O
pulmonary	B-ANAT
hemodynamics	O
,	O
blood	B-ANAT
gas	O
exchange	O
parameters	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
,	O
and	O
angiotensin	O
II	O
levels	O
were	O
examined	O
before	O
acute	O
respiratory	O
distress	O
syndrome	O
induction	O
and	O
at	O
various	O
time	O
points	O
after	O
administering	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
or	O
saline	O
.	O

Angiotensin	O
-	O
converting	O
enzyme	O
2	O
attenuates	O
arterial	B-ANAT
hypoxemia	O
,	O
pulmonary	B-ANAT
hypertension	O
,	O
and	O
redistribution	O
of	O
pulmonary	B-ANAT
blood	B-ANAT
flow	O
in	O
a	O
piglet	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
may	O
be	O
a	O
promising	O
substance	O
for	O
clinical	O
use	O
.	O

ABSTRACT	O
:	O
The	O
objective	O
of	O
this	O
investigation	O
is	O
to	O
review	O
existing	O
research	O
pertaining	O
to	O
cognitive	O
impairment	O
and	O
decline	O
following	O
critical	O
illness	O
and	O
describe	O
a	O
case	O
involving	O
a	O
49	O
-	O
year	O
-	O
old	O
female	O
with	O
sepsis	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
no	O
prior	O
neurologic	O
history	O
who	O
,	O
compared	O
to	O
baseline	O
neuropsychological	O
test	O
data	O
,	O
experienced	O
dramatic	O
cognitive	O
decline	O
and	O
brain	B-ANAT
atrophy	O
following	O
treatment	O
in	O
the	O
medical	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
at	O
Vanderbilt	O
University	O
Medical	O
Center	O
.	O

Although	O
many	O
methods	O
have	O
been	O
proposed	O
for	O
protein	O
structure	O
alignment	O
or	O
comparison	O
,	O
alternative	O
similarity	O
measures	O
are	O
still	O
strongly	O
demanded	O
due	O
to	O
the	O
requirement	O
of	O
fast	O
screening	O
and	O
query	O
in	O
large	O
-	O
scale	B-ANAT
structure	I-ANAT
databases	O
.	O

The	O
purified	O
recombinant	O
polypeptide	O
was	O
employed	O
to	O
develop	O
an	O
ELISA	O
test	O
for	O
the	O
detection	O
of	O
TGEV	O
-	O
like	O
CCoV	O
-	O
specific	O
antibodies	O
in	O
dog	O
sera	B-ANAT
.	O

Weekly	O
blood	B-ANAT
samples	I-ANAT
were	O
collected	O
to	O
estimate	O
hematocrit	O
.	O

There	O
are	O
three	O
recognized	O
stages	O
in	O
the	O
inflammatory	O
response	O
with	O
progressively	O
increased	O
risk	O
of	O
end	O
-	O
organ	B-ANAT
failure	O
and	O
death	O
:	O
sepsis	O
,	O
severe	O
sepsis	O
,	O
and	O
septic	O
shock	O
.	O

Clinical	O
,	O
post	O
-	O
mortem	O
and	O
virological	O
investigations	O
showed	O
that	O
,	O
despite	O
the	O
high	O
serum	B-ANAT
antibody	O
titres	O
induced	O
by	O
the	O
prior	O
natural	O
infection	O
with	O
enteric	O
CCoV	O
,	O
dogs	O
were	O
susceptible	O
to	O
experimental	O
infection	O
with	O
strain	O
CB	O
/	O
05	O
.	O

This	O
was	O
shown	O
by	O
the	O
occurrence	O
of	O
faecal	B-ANAT
shedding	O
,	O
and	O
dogs	O
displaying	O
moderate	O
clinical	O
signs	O
,	O
mainly	O
vomiting	O
and	O
diarrhoea	O
.	O

We	O
investigated	O
the	O
functions	O
of	O
the	O
largest	O
of	O
the	O
accessory	O
proteins	O
,	O
the	O
ORF	O
3a	O
protein	O
,	O
using	O
a	O
3a	O
-	O
deficient	O
strain	O
of	O
SARS	O
-	O
CoV	O
.	O
Cell	B-ANAT
death	O
of	O
Vero	B-ANAT
cells	I-ANAT
after	O
infection	O
with	O
SARS	O
-	O
CoV	O
was	O
reduced	O
upon	O
deletion	O
of	O
ORF	O
3a	O
.	O

Electron	O
microscopy	O
of	O
infected	O
cells	B-ANAT
revealed	O
a	O
role	O
for	O
ORF	O
3a	O
in	O
SARS	O
-	O
CoV	O
induced	O
vesicle	B-ANAT
formation	O
,	O
a	O
prominent	O
feature	O
of	O
cells	B-ANAT
from	O
SARS	O
patients	O
.	O

Other	O
medical	O
concerns	O
include	O
recurrent	O
oral	B-ANAT
staphylococcal	O
infections	O
,	O
otitis	O
media	B-ANAT
,	O
ocular	B-ANAT
herpes	O
simplex	B-ANAT
virus	O
keratitis	O
,	O
asthma	O
,	O
steroid	O
-	O
induced	O
gastritis	O
,	O
steroid	O
-	O
induced	O
cataracts	O
,	O
recurrent	O
upper	O
respiratory	O
infections	O
,	O
and	O
acute	O
pharyngitis	O
.	O

Migration	O
of	O
PMNs	O
to	O
the	O
CNS	B-ANAT
coincided	O
with	O
increased	O
expression	O
of	O
transcripts	O
specific	O
for	O
the	O
CXCR2	O
ELR	O
-	O
positive	O
chemokine	O
ligands	O
CXCL1	O
,	O
CXCL2	O
,	O
and	O
CXCL5	O
within	O
the	O
brain	B-ANAT
.	O

Treatment	O
of	O
JHMV	O
-	O
infected	O
mice	O
with	O
anti	O
-	O
CXCR2	O
blocking	O
antibody	O
reduced	O
PMN	B-ANAT
trafficking	O
into	O
the	O
CNS	B-ANAT
by	O
>	O
95	O
%,	O
dampened	O
MMP	O
-	O
9	O
activity	O
,	O
and	O
abrogated	O
blood	B-ANAT
-	O
brain	B-ANAT
-	O
barrier	O
(	O
BBB	B-ANAT
)	O
breakdown	O
.	O

Low	O
-	O
dose	O
corticosteroids	O
administered	O
within	O
14	O
days	O
of	O
disease	O
onset	O
may	O
reduce	O
all	O
-	O
cause	O
mortality	O
in	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
severe	O
pneumonia	O
.	O

The	O
drowning	O
especially	O
took	O
place	O
in	O
fresh	B-ANAT
water	O
(	O
71	O
%),	O
particularly	O
in	O
swimming	O
pools	O
(	O
51	O
.	O
8	O
%).	O

Aspiration	O
pneumonia	O
(	O
33	O
.	O
7	O
%)	O
was	O
present	O
in	O
both	O
cases	O
and	O
a	O
pulmonary	B-ANAT
oedema	O
(	O
6	O
%)	O
was	O
only	O
noticed	O
during	O
stage	O
IV	O
drowning	O
.	O

We	O
determined	O
the	O
crystal	B-ANAT
structure	O
of	O
NL63	O
-	O
CoV	O
spike	O
protein	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
complexed	O
with	O
human	O
ACE2	O
.	O

Anti	O
-	O
CD134	O
binding	O
caused	O
displacement	O
of	O
SU	O
from	O
the	O
surface	O
of	O
the	O
cell	B-ANAT
and	O
inhibition	O
of	O
infection	O
.	O

Depletion	O
of	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
at	O
the	O
time	O
of	O
infection	O
did	O
not	O
affect	O
viral	O
replication	O
or	O
clearance	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
fibrosis	O
induced	O
by	O
H5N1	O
viral	O
infection	O
in	O
mice	O
.	O

H5N1	O
-	O
inoculated	O
mice	O
presented	O
two	O
stages	O
of	O
pulmonary	B-ANAT
disease	O
over	O
a	O
30	O
-	O
d	O
period	O
after	O
infection	O
.	O

The	O
dramatically	O
elevated	O
hydroxyproline	O
levels	O
in	O
H5N1	O
-	O
infected	O
mice	O
showed	O
deposition	O
of	O
collagen	B-ANAT
in	O
lungs	B-ANAT
,	O
and	O
confirmed	O
fibrosis	O
of	O
lungs	B-ANAT
.	O

The	O
dry	O
lung	B-ANAT
-	O
to	O
-	O
body	B-ANAT
weight	O
ratio	O
was	O
significantly	O
increased	O
in	O
infected	O
group	O
,	O
which	O
might	O
be	O
associated	O
with	O
the	O
formation	O
of	O
PF	O
in	O
H5N1	O
-	O
infected	O
mice	O
.	O

ABSTRACT	O
:	O
As	O
one	O
of	O
the	O
most	O
important	O
endogenous	O
chemotactic	O
factors	O
for	O
neutrophils	B-ANAT
,	O
the	O
chemokine	O
CXCL8	O
(	O
IL	O
-	O
8	O
)	O
is	O
involved	O
in	O
the	O
pathogenesis	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
characterized	O
by	O
massive	O
neutrophil	B-ANAT
infiltration	O
in	O
the	O
lung	B-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
its	O
more	O
severe	O
form	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
characterized	O
by	O
diffuse	O
impairment	O
of	O
alveolocapillary	B-ANAT
membrane	I-ANAT
in	O
the	O
settings	O
of	O
different	O
predisposing	O
conditions	O
such	O
as	O
sepsis	O
,	O
trauma	O
and	O
shock	O
.	O

ABSTRACT	O
:	O
Serum	B-ANAT
samples	O
from	O
92	O
giant	O
pandas	O
in	O
three	O
captive	O
facilities	O
were	O
tested	O
for	O
antibodies	O
against	O
five	O
viruses	O
of	O
carnivores	O
.	O

A	O
typical	O
clinical	O
feature	O
associated	O
with	O
SARS	O
is	O
pulmonary	B-ANAT
fibrosis	O
and	O
associated	O
lung	B-ANAT
failure	O
.	O

Overall	O
,	O
this	O
investigation	O
reveals	O
another	O
mode	O
of	O
exploitation	O
of	O
cellular	B-ANAT
miRNA	O
machinery	O
by	O
virus	O
to	O
their	O
own	O
advantage	O
.	O

The	O
viral	O
RNA	O
in	O
the	O
intestine	B-ANAT
segments	O
reached	O
the	O
highest	O
level	O
,	O
6x10	O
(	O
15	O
)	O
copies	O
/	O
microl	O
,	O
in	O
the	O
jejunum	B-ANAT
at	O
5	O
DPI	O
.	O

Taken	O
together	O
,	O
the	O
results	O
indicated	O
that	O
the	O
developed	O
RRT	O
-	O
PCR	O
assay	O
is	O
rapid	O
,	O
sensitive	O
,	O
and	O
specific	O
for	O
detection	O
,	O
differentiation	O
,	O
and	O
quantitation	O
of	O
TCoV	O
in	O
the	O
turkey	O
tissues	B-ANAT
and	O
should	O
be	O
helpful	O
in	O
monitoring	O
the	O
progression	O
of	O
TCoV	O
induced	O
acute	O
enteritis	O
in	O
the	O
turkey	O
flocks	O
.	O

For	O
SARS	O
treatment	O
,	O
Glucocorticosteroids	O
can	O
effectively	O
ameliorate	O
the	O
SARS	O
patients	O
'	O
lung	B-ANAT
symptoms	O
and	O
improve	O
the	O
lung	B-ANAT
function	O
.	O

In	O
ARDS	O
patients	O
,	O
with	O
and	O
without	O
confirmed	O
H1N1	O
influenza	O
,	O
prolonged	O
low	O
-	O
to	O
-	O
moderate	O
dose	O
corticosteroid	O
treatment	O
was	O
well	O
tolerated	O
and	O
associated	O
with	O
significant	O
improvement	O
in	O
lung	B-ANAT
injury	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
scores	O
and	O
a	O
low	O
hospital	O
mortality	O
.	O

A	O
total	O
of	O
156	O
faecal	B-ANAT
samples	O
were	O
collected	O
from	O
dogs	O
with	O
diarrhoea	O
in	O
Spain	O
(	O
n	O
=	O
47	O
),	O
Italy	O
(	O
n	O
=	O
39	O
),	O
France	O
(	O
n	O
=	O
26	O
),	O
Germany	O
(	O
n	O
=	O
21	O
),	O
the	O
United	O
Kingdom	O
(	O
n	O
=	O
8	O
),	O
Belgium	O
(	O
n	O
=	O
10	O
),	O
and	O
the	O
Netherlands	O
(	O
n	O
=	O
5	O
).	O

TITLE	O
:	O
The	O
first	O
case	O
of	O
severe	O
novel	O
H1N1	O
influenza	O
successfully	O
rescued	O
by	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
Taiwan	O
.	O

Because	O
of	O
compromised	O
cardiopulmonary	B-ANAT
function	O
,	O
venoarterial	O
ECMO	O
support	O
was	O
started	O
4	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
and	O
he	O
was	O
transferred	O
to	O
Hospital	O
B	O
on	O
July	O
25	O
,	O
2009	O
.	O

Real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
of	O
respiratory	B-ANAT
sample	I-ANAT
for	O
novel	O
H1N1	O
virus	O
revealed	O
positive	O
results	O
.	O

However	O
,	O
experimental	O
evidence	O
clearly	O
shows	O
that	O
lung	B-ANAT
damage	O
occurs	O
even	O
in	O
the	O
absence	O
of	O
positive	O
fluid	O
balance	O
.	O

However	O
,	O
acute	O
lung	B-ANAT
injury	O
with	O
its	O
attendant	O
hypoxemia	O
,	O
hypercapnia	O
and	O
mechanical	O
ventilation	O
worsens	O
renal	B-ANAT
hemodynamics	O
and	O
function	O
.	O

An	O
increasing	O
body	B-ANAT
of	O
evidence	O
suggests	O
that	O
kidney	B-ANAT
and	O
lung	B-ANAT
interact	O
(	O
crosstalk	O
)	O
during	O
severe	O
insults	O
,	O
such	O
as	O
shock	O
,	O
trauma	O
,	O
and	O
sepsis	O
,	O
due	O
to	O
a	O
loss	O
of	O
the	O
normal	O
balance	O
of	O
immune	O
,	O
inflammatory	O
and	O
soluble	O
mediators	O
.	O

Clear	O
differences	O
in	O
pathogenicity	O
and	O
in	O
organ	B-ANAT
distribution	O
of	O
the	O
three	O
serotypes	O
were	O
found	O
.	O

The	O
QX	O
-	O
like	O
strains	O
generally	O
replicated	O
to	O
higher	O
titres	O
,	O
although	O
differences	O
were	O
found	O
among	O
the	O
five	O
strains	O
in	O
their	O
pathogenicity	O
and	O
affinity	O
for	O
different	O
organs	B-ANAT
.	O

Severe	O
kidney	B-ANAT
damage	O
and	O
dilatation	O
of	O
the	O
oviduct	B-ANAT
were	O
the	O
prominent	O
lesions	O
that	O
could	O
be	O
related	O
to	O
the	O
QX	O
-	O
like	O
IBV	O
strains	O
,	O
although	O
neither	O
marked	O
virus	O
replication	O
nor	O
histopathological	O
lesions	O
were	O
detected	O
in	O
the	O
oviduct	B-ANAT
.	O

In	O
addition	O
to	O
being	O
a	O
potent	O
source	O
of	O
IFN	O
-	O
alpha	O
,	O
other	O
properties	O
of	O
these	O
porcine	O
CD4	O
(	O
hi	O
)	O
CD172	O
(	O
lo	O
)	O
cells	B-ANAT
including	O
their	O
morphological	O
transition	O
from	O
a	O
plasma	B-ANAT
cell	I-ANAT
-	O
like	O
shape	O
during	O
quiescence	O
to	O
one	O
resembling	O
a	O
dendritic	B-ANAT
cell	I-ANAT
(	O
DC	O
)	O
after	O
activation	O
by	O
TGEV	O
and	O
their	O
relatively	O
strong	O
constitutive	O
expression	O
of	O
interferon	O
regulatory	O
factor	O
-	O
7	O
(	O
IRF	O
-	O
7	O
)	O
conformed	O
to	O
the	O
expectations	O
of	O
genuine	O
pDCs	O
.	O

TITLE	O
:	O
Lung	B-ANAT
parenchyma	I-ANAT
remodeling	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
addition	O
,	O
H9N2	O
viral	O
infection	O
resulted	O
in	O
severe	O
progressive	O
hypoxemia	O
,	O
lymphopenia	O
,	O
and	O
a	O
significant	O
increase	O
in	O
neutrophils	B-ANAT
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
and	O
interleukin	O
-	O
6	O
in	O
BALF	O
.	O

TITLE	O
:	O
[	O
24	O
-	O
year	O
old	O
male	O
with	O
fever	O
,	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
and	O
fast	O
progressing	O
ARDS	O
].	O

ABSTRACT	O
:	O
A	O
24	O
-	O
year	O
-	O
old	O
man	O
presented	O
with	O
cough	O
,	O
sore	O
throat	B-ANAT
,	O
fever	O
,	O
maculopapulous	O
exanthema	O
,	O
pericardial	B-ANAT
and	O
pleural	B-ANAT
effusion	I-ANAT
.	O

During	O
a	O
2	O
-	O
yr	O
period	O
,	O
50	O
patients	O
underwent	O
PCPS	O
for	O
the	O
treatment	O
of	O
severe	O
cardiopulmonary	B-ANAT
failure	O
,	O
and	O
of	O
those	O
,	O
22	O
(	O
44	O
%)	O
were	O
classified	O
as	O
survivors	O
and	O
28	O
(	O
56	O
%)	O
as	O
non	O
-	O
survivors	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
complications	O
following	O
cardiopulmonary	B-ANAT
bypass	O
(	O
CPB	O
)	O
are	O
relatively	O
common	O
,	O
with	O
up	O
to	O
12	O
%	O
of	O
patients	O
experiencing	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
).	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
manifestations	O
in	O
leptospirosis	O
are	O
considered	O
a	O
major	O
complication	O
,	O
and	O
are	O
related	O
to	O
a	O
poor	O
prognosis	O
.	O

TITLE	O
:	O
Coronavirus	O
nucleocapsid	B-ANAT
protein	O
facilitates	O
template	O
switching	O
and	O
is	O
required	O
for	O
efficient	O
transcription	O
.	O

Plasma	B-ANAT
CC16	O
had	O
a	O
good	O
diagnostic	O
capacity	O
for	O
ALI	O
/	O
ARDS	O
as	O
shown	O
by	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
with	O
an	O
area	O
under	O
the	O
curve	O
of	O
0	O
.	O
91	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
79	O
-	O
1	O
.	O
00	O
;	O
p	O
<	O
0	O
.	O
001	O
).	O

Here	O
,	O
we	O
describe	O
a	O
study	O
that	O
leads	O
to	O
the	O
identification	O
of	O
a	O
novel	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
-	O
restricted	O
epitope	O
from	O
conserved	O
regions	O
of	O
S	O
protein	O
.	O

First	O
,	O
different	O
SARS	O
-	O
CoV	O
sequences	O
were	O
analyzed	O
to	O
predict	O
eight	O
candidate	O
peptides	O
from	O
conserved	O
regions	O
of	O
the	O
S	O
protein	O
based	O
upon	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
binding	O
and	O
proteosomal	O
cleavage	O
.	O

Among	O
the	O
four	O
candidate	O
peptides	O
,	O
Sp8	B-ANAT
(	O
S958	O
-	O
966	O
,	O
VLNDILSRL	O
)	O
induced	O
specific	O
CTLs	O
both	O
ex	O
vivo	O
in	O
PBLs	O
of	O
healthy	O
HLA	B-ANAT
-	O
A2	O
+	O
donors	O
and	O
in	O
HLA	B-ANAT
-	O
A2	O
.	O
1	O
/	O
Kb	O
transgenic	O
mice	O
immunized	O
with	O
a	O
plasmid	O
encoding	O
full	O
-	O
length	O
S	O
protein	O
.	O

These	O
results	O
suggest	O
that	O
Sp8	B-ANAT
is	O
a	O
naturally	O
processed	O
epitope	O
.	O

In	O
this	O
study	O
,	O
blood	B-ANAT
from	O
70	O
cats	O
with	O
FGS	O
and	O
61	O
healthy	O
control	O
cats	O
was	O
tested	O
for	O
Bartonella	O
species	O
antibodies	O
in	O
serum	B-ANAT
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
and	O
Western	O
blot	O
immunoassay	O
and	O
DNA	O
in	O
blood	B-ANAT
using	O
a	O
conventional	O
polymerase	O
chain	O
reaction	O
assay	O
.	O

The	O
prevalence	O
rates	O
for	O
Bartonella	O
species	O
antibodies	O
and	O
DNA	O
in	O
the	O
blood	B-ANAT
and	O
the	O
tissues	B-ANAT
did	O
not	O
differ	O
between	O
the	O
two	O
groups	O
.	O

Both	O
crystal	B-ANAT
forms	O
contained	O
large	O
solvent	O
channels	O
and	O
had	O
a	O
solvent	O
content	O
of	O
higher	O
than	O
70	O
%.	O

In	O
vitro	O
and	O
in	O
vivo	O
data	O
revealed	O
that	O
the	O
TACE	O
inhibitor	O
TAPI	O
-	O
2	O
attenuated	O
entry	O
of	O
both	O
pseudotyped	O
virus	O
expressing	O
the	O
SARS	O
-	O
S	O
protein	O
in	O
a	O
lentiviral	O
vector	O
backbone	B-ANAT
and	O
infectious	O
SARS	O
-	O
CoV	O
.	O
TAPI	O
-	O
2	O
blocked	O
both	O
the	O
SARS	O
-	O
S	O
protein	O
-	O
induced	O
shedding	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
a	O
receptor	O
of	O
SARS	O
-	O
CoV	O
,	O
and	O
TNF	O
-	O
alpha	O
production	O
in	O
lung	B-ANAT
tissues	I-ANAT
.	O

Expression	O
of	O
the	O
cGM	O
-	O
CSF	B-ANAT
protein	O
in	O
the	O
recombinant	O
Lactobacillus	O
was	O
confirmed	O
by	O
SDS	O
-	O
PAGE	O
and	O
Western	O
blotting	O
methods	O
.	O

The	O
best	O
way	O
to	O
assess	O
recruitment	O
is	O
computed	O
tomography	O
scanning	O
,	O
whereas	O
lung	B-ANAT
mechanics	O
are	O
a	O
reasonable	O
bedside	O
surrogate	O
.	O

This	O
review	O
focuses	O
on	O
the	O
pathogenesis	O
of	O
BHV	O
-	O
1	O
and	O
BRSV	O
,	O
two	O
very	O
different	O
agents	O
that	O
primarily	O
cause	O
disease	O
in	O
the	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
respectively	O
.	O

Here	O
,	O
we	O
have	O
investigated	O
the	O
role	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
in	O
MHV	O
-	O
induced	O
disease	O
.	O

The	O
multifunctional	O
nucleocapsid	B-ANAT
protein	O
is	O
complexed	O
with	O
the	O
genomic	O
RNA	O
,	O
interacts	O
with	O
the	O
viral	B-ANAT
membrane	I-ANAT
protein	O
during	O
virion	B-ANAT
assembly	O
,	O
and	O
plays	O
an	O
import	O
role	O
in	O
enhancing	O
the	O
efficiency	O
of	O
transcription	O
.	O

A	O
pair	O
of	O
chimeric	O
recombinant	O
viruses	O
in	O
which	O
the	O
nucleocapsid	B-ANAT
gene	O
was	O
exchanged	O
between	O
JHM	O
and	O
A59	O
was	O
selected	O
and	O
compared	O
to	O
wild	O
-	O
type	O
parental	O
strains	O
in	O
terms	O
of	O
virulence	O
.	O

ABSTRACT	O
:	O
This	O
study	O
uses	O
statistical	O
predictive	O
modeling	O
and	O
hierarchical	O
cluster	O
analyses	O
to	O
examine	O
inflammatory	O
mediators	O
and	O
cells	B-ANAT
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
as	O
putative	O
biomarkers	O
in	O
rats	O
with	O
blunt	O
trauma	O
lung	B-ANAT
contusion	O
(	O
LC	O
),	O
gastric	B-ANAT
aspiration	O
(	O
combined	O
acid	O
and	O
small	O
gastric	B-ANAT
food	O
particles	O
,	O
CASP	O
),	O
or	O
a	O
combination	O
of	O
the	O
two	O
.	O

New	O
stable	O
bat	O
cell	B-ANAT
lines	I-ANAT
are	O
needed	O
to	O
help	O
with	O
these	O
investigations	O
and	O
as	O
tools	O
to	O
assist	O
in	O
the	O
study	O
of	O
bat	O
immunology	O
and	O
virus	O
-	O
host	O
interactions	O
.	O

We	O
previously	O
showed	O
that	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
spike	O
domain	O
2	O
(	O
S2	O
)	O
in	O
the	O
patient	O
sera	B-ANAT
can	O
cross	O
-	O
react	O
with	O
human	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
;	O
however	O
,	O
the	O
autoantigen	O
is	O
not	O
yet	O
identified	O
.	O

In	O
this	O
study	O
,	O
we	O
performed	O
proteomic	O
studies	O
and	O
identified	O
several	O
candidate	O
autoantigens	O
recognized	O
by	O
SARS	O
patient	O
sera	B-ANAT
in	O
human	O
lung	B-ANAT
type	O
II	O
epithelial	B-ANAT
cell	I-ANAT
A549	O
.	O

The	O
chest	B-ANAT
was	O
the	O
most	O
common	O
region	O
traumatized	O
and	O
the	O
prevalence	O
of	O
polytrauma	O
was	O
72	O
.	O
3	O
%.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
could	O
represent	O
an	O
important	O
treatment	O
option	O
,	O
if	O
complications	O
were	O
reduced	O
by	O
new	O
technical	O
developments	O
.	O

Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
with	O
a	O
new	O
miniaturized	O
device	O
supports	O
gas	O
transfer	O
effectively	O
,	O
allows	O
for	O
highly	O
protective	O
ventilation	O
and	O
is	O
very	O
reliable	O
.	O

Since	O
the	O
3a	O
protein	O
localizes	O
to	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	B-ANAT
)-	O
Golgi	B-ANAT
compartment	B-ANAT
,	O
its	O
role	O
in	O
causing	O
ER	B-ANAT
stress	O
was	O
investigated	O
in	O
transiently	O
transfected	O
cells	B-ANAT
.	O

It	O
is	O
feasible	O
to	O
perform	O
a	O
primary	O
anastomosis	B-ANAT
in	O
critically	O
ill	O
patients	O
with	O
severe	O
secondary	O
peritonitis	O
managed	O
with	O
staged	O
laparotomies	O
.	O

We	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
early	O
enteral	O
feeding	O
is	O
a	O
protective	O
factor	O
for	O
EOVAP	O
,	O
and	O
this	O
result	O
could	O
have	O
clinical	O
implications	O
for	O
the	O
prevention	O
of	O
EOVAP	O
after	O
traumatic	O
brain	B-ANAT
injury	O
.	O

Among	O
hospitalizations	O
with	O
myocardial	O
disorders	O
,	O
the	O
rate	O
of	O
severe	O
complications	O
ranged	O
from	O
13	O
.	O
2	O
for	O
acute	O
myocardial	O
infarction	O
to	O
128	O
.	O
6	O
for	O
adult	O
respiratory	O
distress	O
syndrome	O
and	O
from	O
10	O
.	O
7	O
for	O
pulmonary	B-ANAT
edema	O
to	O
193	O
.	O
0	O
for	O
fluid	O
and	O
electrolyte	O
disorders	O
per	O
1	O
,	O
000	O
delivery	O
and	O
postpartum	O
hospitalizations	O
,	O
respectively	O
.	O

We	O
model	O
airborne	O
transmission	O
of	O
infectious	O
viral	B-ANAT
particles	I-ANAT
of	O
H1N1	O
within	O
a	O
Boeing	O
747	O
using	O
methodology	O
from	O
the	O
field	O
of	O
quantitative	O
microbial	O
risk	O
assessment	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
protein	O
(	O
S	O
)	O
of	O
SARS	O
Coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
mediates	O
entry	O
of	O
the	O
virus	O
into	O
target	B-ANAT
cells	I-ANAT
,	O
including	O
receptor	O
binding	O
and	O
membrane	B-ANAT
fusion	O
.	O

RESULTS	O
:	O
Mutagenesis	O
showed	O
that	O
the	O
aromatic	O
domain	O
was	O
crucial	O
for	O
SARSpp	O
entry	O
into	O
cells	B-ANAT
,	O
with	O
a	O
likely	O
role	O
in	O
pore	B-ANAT
enlargement	O
.	O

In	O
a	O
model	O
,	O
we	O
propose	O
that	O
during	O
fusion	O
,	O
the	O
lateral	O
flexibility	O
of	O
the	O
transmembrane	B-ANAT
domain	O
plays	O
a	O
critical	O
role	O
,	O
as	O
do	O
the	O
tryptophans	O
and	O
the	O
cysteines	O
.	O

ABSTRACT	O
:	O
Severe	O
respiratory	O
failure	O
(	O
including	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
)	O
caused	O
by	O
2009	O
H1N1	O
influenza	O
infection	O
has	O
been	O
reported	O
worldwide	O
.	O

Specific	O
modalities	O
covered	O
include	O
conservative	O
fluid	O
management	O
,	O
prone	O
positioning	O
,	O
inhaled	O
nitric	O
oxide	O
,	O
inhaled	O
vasodilatory	O
prostaglandins	O
,	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
and	O
life	O
support	O
.	O

Not	O
surprisingly	O
,	O
tempol	O
substantially	O
preserved	O
the	O
integrity	O
of	O
the	O
CNS	B-ANAT
,	O
including	O
the	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
.	O

Because	O
each	O
of	O
these	O
trials	O
had	O
design	O
problems	O
or	O
early	O
termination	O
,	O
prone	O
positioning	O
remains	O
a	O
rescue	O
therapy	O
for	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
ARDS	O
.	O

Mucosal	B-ANAT
vaccines	O
administered	O
either	O
orally	B-ANAT
or	O
nasally	O
have	O
been	O
shown	O
to	O
be	O
effective	O
in	O
inducing	O
antigen	O
-	O
specific	O
immune	O
responses	O
at	O
both	O
systemic	O
and	O
mucosal	B-ANAT
compartments	B-ANAT
.	O

It	O
is	O
characterized	O
by	O
fever	O
,	O
hepatosplenomegaly	O
,	O
lymphadenopathy	O
,	O
severe	O
cytopenia	O
,	O
serious	O
liver	B-ANAT
dysfunction	O
,	O
coagulopathy	O
and	O
neurologic	O
involvement	O
.	O

In	O
both	O
cases	O
,	O
the	O
left	B-ANAT
lung	I-ANAT
was	O
opaque	O
,	O
hyperinflated	O
,	O
and	O
associated	O
with	O
a	O
rightward	O
shift	O
of	O
the	O
mediastinum	B-ANAT
.	O

More	O
than	O
half	O
of	O
patients	O
had	O
patchy	O
alveolar	B-ANAT
infiltrates	O
on	O
chest	B-ANAT
X	O
ray	O
.	O

Patients	O
who	O
developed	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
typically	O
presented	O
with	O
normal	O
leukocyte	B-ANAT
count	O
,	O
lymphopenia	O
,	O
raised	O
C	O
-	O
reactive	O
protein	O
,	O
creatinkinase	O
,	O
transaminases	O
but	O
normal	O
urea	O
and	O
creatinine	O
.	O

The	O
presence	O
of	O
more	O
than	O
one	O
virus	O
and	O
changes	O
at	O
the	O
genetic	O
level	O
in	O
a	O
virus	O
may	O
affect	O
the	O
severity	O
of	O
PES	B-ANAT
in	O
turkey	O
flocks	O
.	O

Demographics	O
,	O
symptoms	O
,	O
and	O
forced	O
expiratory	O
volume	O
in	O
1	O
sec	O
were	O
prospectively	O
collected	O
for	O
93	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
enrolled	O
.	O

CONCLUSIONS	O
:	O
Community	O
-	O
acquired	O
RVIs	O
are	O
frequently	O
detected	O
in	O
BAL	O
samples	O
from	O
lung	B-ANAT
transplant	B-ANAT
patients	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
NL63	O
open	O
reading	O
frame	O
3	O
encodes	O
a	O
virion	B-ANAT
-	O
incorporated	O
N	O
-	O
glycosylated	O
membrane	B-ANAT
protein	O
.	O

Expression	O
in	O
infected	O
CaCo	O
-	O
2	O
and	O
LLC	B-ANAT
-	O
MK2	O
cells	B-ANAT
was	O
confirmed	O
by	O
immunofluorescence	O
and	O
Western	O
blot	O
analysis	O
.	O

TITLE	O
:	O
Genetic	O
variation	O
in	O
MYLK	O
and	O
lung	B-ANAT
injury	O
in	O
children	O
and	O
adults	O
with	O
community	O
-	O
acquired	O
pneumonia	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
characteristics	O
,	O
treatment	O
,	O
and	O
outcomes	O
of	O
critically	O
ill	O
patients	O
in	O
Canada	O
who	O
had	O
H1N1	O
-	O
2009	O
infection	O
and	O
were	O
treated	O
with	O
extracorporeal	O
lung	B-ANAT
support	O
(	O
ECLS	O
).	O

Disruption	O
of	O
epithelial	O
integrity	O
and	O
injury	O
to	O
endothelium	B-ANAT
are	O
contributing	O
factors	O
of	O
the	O
development	O
of	O
ALI	O
/	O
ARDS	O
,	O
and	O
alveolar	B-ANAT
damage	O
is	O
the	O
most	O
pronounced	O
feature	O
of	O
ALI	O
/	O
ARDS	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
FcgammaRIIa	O
is	O
substantially	O
elevated	O
in	O
lungs	B-ANAT
of	O
these	O
patients	O
.	O

It	O
should	O
be	O
noted	O
that	O
immune	O
complexes	O
formed	O
between	O
either	O
anti	O
-	O
neutrophil	B-ANAT
autoantibodies	O
and	O
their	O
specific	O
antigens	O
or	O
anti	O
-	O
HLA	B-ANAT
(	O
human	O
leucocyte	B-ANAT
antigen	O
)	O
antibodies	O
and	O
target	O
antigens	O
are	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
TRALI	O
(	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
),	O
and	O
importantly	O
,	O
animal	O
studies	O
indicate	O
that	O
FcgammaRs	O
are	O
essential	O
for	O
these	O
complexes	O
to	O
cause	O
damage	O
to	O
the	O
lungs	B-ANAT
.	O

To	O
shed	O
further	O
light	O
on	O
these	O
structures	O
,	O
we	O
have	O
performed	O
a	O
time	O
-	O
course	O
experiment	O
in	O
which	O
the	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)-	O
induced	O
membrane	B-ANAT
rearrangements	O
were	O
examined	O
qualitatively	O
and	O
quantitatively	O
by	O
(	O
immuno	O
)-	O
electron	O
microscopy	O
.	O

TITLE	O
:	O
Dynamic	O
innate	O
immune	O
responses	O
of	O
human	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
infection	O
.	O

Immunohistochemically	O
,	O
influenza	O
A	O
viral	O
protein	O
was	O
confirmed	O
in	O
the	O
damaged	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
and	O
also	O
in	O
the	O
infiltrated	O
macrophages	B-ANAT
.	O

The	O
disease	O
occurs	O
more	O
often	O
in	O
immunocompromised	O
persons	O
and	O
can	O
be	O
manifested	O
by	O
severe	O
pneumonia	O
,	O
multiple	O
organ	B-ANAT
failure	O
and	O
has	O
a	O
high	O
mortality	O
.	O

Laboratory	O
results	O
showed	O
increased	O
number	O
of	O
leukocytes	B-ANAT
,	O
increased	O
values	O
of	O
acute	O
phase	O
proteins	O
,	O
liver	B-ANAT
enzymes	O
and	O
hyponatremia	O
.	O

TITLE	O
:	O
Switch	O
from	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
to	O
arteriovenous	O
pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
.	O

Respiratory	O
support	O
by	O
an	O
extracorporeal	O
device	O
used	O
as	O
last	O
resort	O
therapy	O
allows	O
rapid	O
stabilization	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
failure	O
.	O

HCoV	O
infections	O
can	O
be	O
associated	O
with	O
respiratory	O
and	O
extrarespiratory	O
manifestations	O
,	O
including	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
involvement	O
.	O

Assessment	O
of	O
a	O
pulmonary	B-ANAT
embolism	O
by	O
radioisotope	O
imaging	O
was	O
not	O
possible	O
because	O
of	O
his	O
dependence	O
on	O
mechanical	O
ventilation	O
.	O

Analysis	O
of	O
TB	O
programme	O
data	O
from	O
clinics	O
taking	O
part	O
in	O
two	O
consecutive	O
randomised	O
trials	O
of	O
educational	O
outreach	O
aimed	O
at	O
improving	O
respiratory	O
and	O
human	O
immunodeficiency	O
virus	O
/	O
acquired	O
immune	O
-	O
deficiency	O
syndrome	O
care	O
based	O
on	O
the	O
Practical	O
Approach	O
to	O
Lung	B-ANAT
Health	O
.	O

TITLE	O
:	O
3D	O
Telomere	B-ANAT
FISH	O
defines	O
LMP1	O
-	O
expressing	O
Reed	B-ANAT
-	I-ANAT
Sternberg	I-ANAT
cells	I-ANAT
as	O
end	O
-	O
stage	O
cells	B-ANAT
with	O
telomere	B-ANAT
-	O
poor	O
'	B-ANAT
ghost	I-ANAT
'	O
nuclei	O
and	O
very	O
short	O
telomeres	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
negative	O
Hodgkin	B-ANAT
'	I-ANAT
s	I-ANAT
cell	I-ANAT
lines	O
and	O
classical	O
EBV	O
-	O
negative	O
Hodgkin	O
'	O
s	O
lymphoma	O
(	O
HL	O
),	O
Reed	B-ANAT
-	I-ANAT
Sternberg	I-ANAT
cells	I-ANAT
(	O
RS	O
cells	B-ANAT
)	O
represent	O
end	O
-	O
stage	O
tumor	B-ANAT
cells	I-ANAT
,	O
in	O
which	O
further	O
nuclear	O
division	O
becomes	O
impossible	O
because	O
of	O
sustained	O
telomere	B-ANAT
loss	O
,	O
shortening	O
and	O
aggregation	O
.	O

However	O
,	O
the	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
telomere	B-ANAT
organization	O
in	O
latent	O
membrane	B-ANAT
protein	O
1	O
(	O
LMP1	O
)-	O
expressing	O
RS	O
cells	B-ANAT
of	O
EBV	O
-	O
associated	O
HL	O
is	O
not	O
known	O
.	O

These	O
nuclei	O
and	O
their	O
telomere	B-ANAT
content	O
strongly	O
contrasted	O
with	O
the	O
corona	O
of	O
surrounding	O
lymphocytes	B-ANAT
showing	O
numerous	O
midsized	O
telomere	B-ANAT
hybridization	O
signals	O
.	O

ABSTRACT	O
:	O
A	O
typical	O
feature	O
of	O
Parkinson	O
'	O
s	O
disease	O
is	O
the	O
progressive	O
loss	O
of	O
dopaminergic	B-ANAT
neurons	I-ANAT
in	O
the	O
substantia	B-ANAT
nigra	I-ANAT
,	O
in	O
which	O
inhibition	O
of	O
mitochondrial	B-ANAT
complex	B-ANAT
I	I-ANAT
activity	O
may	O
play	O
an	O
important	O
role	O
.	O

Rotenone	O
or	O
1	O
-	O
methyl	O
-	O
4	O
-	O
phenyl	O
-	O
1	O
,	O
2	O
,	O
3	O
,	O
6	O
-	O
tetrahydropyridine	O
(	O
MPTP	O
)	O
inhibit	O
the	O
mitochondrial	B-ANAT
complex	B-ANAT
I	I-ANAT
and	O
they	O
cause	O
the	O
death	O
of	O
substantia	B-ANAT
nigra	I-ANAT
dopaminergic	B-ANAT
neurons	I-ANAT
,	O
thereby	O
providing	O
acute	O
murine	O
models	O
of	O
Parkinson	O
'	O
s	O
disease	O
.	O

Overexpression	O
of	O
hexokinase	O
II	O
prevented	O
both	O
rotenone	O
and	O
MPTP	O
-	O
induced	O
dopaminergic	O
neuronal	O
cell	B-ANAT
death	O
,	O
as	O
well	O
as	O
reducing	O
the	O
associated	O
motor	O
defects	O
.	O

TITLE	O
:	O
Thyroid	B-ANAT
function	O
in	O
term	O
and	O
late	O
preterm	O
infants	O
with	O
respiratory	O
distress	O
in	O
relation	O
to	O
severity	O
of	O
illness	O
.	O

Fusion	O
proteins	O
containing	O
M	O
amino	O
-	O
terminal	O
50	O
residues	O
encompassing	O
the	O
first	O
transmembrane	B-ANAT
domain	O
were	O
found	O
to	O
be	O
sufficient	O
for	O
membrane	B-ANAT
binding	O
,	O
multimerization	O
,	O
and	O
Golgi	B-ANAT
retention	O
.	O

ABSTRACT	O
:	O
Preventing	O
ventilator	O
-	O
associated	O
lung	B-ANAT
injury	O
(	O
VALI	O
)	O
has	O
become	O
pivotal	O
in	O
mechanical	O
ventilation	O
of	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Patients	O
were	O
ventilated	O
with	O
either	O
a	O
lung	B-ANAT
-	O
protective	O
strategy	O
using	O
lower	O
tidal	O
volumes	O
or	O
a	O
potentially	O
injurious	O
strategy	O
using	O
conventional	O
tidal	O
volumes	O
.	O

Lymphocytic	O
inflammation	O
was	O
present	O
in	O
these	O
tissues	B-ANAT
.	O

The	O
findings	O
of	O
these	O
analyses	O
all	O
support	O
a	O
""""	O
golden	O
mean	O
""""	O
model	O
in	O
which	O
viruses	O
use	O
both	O
programmed	O
ribosomal	B-ANAT
frameshifting	O
and	O
translational	O
attenuation	O
to	O
control	O
the	O
relative	O
ratios	O
of	O
their	O
encoded	O
proteins	O
.	O

TITLE	O
:	O
Chest	B-ANAT
computed	O
tomography	O
of	O
a	O
patient	O
revealing	O
severe	O
hypoxia	O
due	O
to	O
amniotic	B-ANAT
fluid	I-ANAT
embolism	O
:	O
a	O
case	O
report	O
.	O

TITLE	O
:	O
Bronchiolitis	O
obliterans	O
syndrome	O
development	O
in	O
lung	B-ANAT
transplantation	O
patients	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
factors	O
associated	O
with	O
BOS	O
and	O
its	O
impact	O
on	O
survival	O
among	O
lung	B-ANAT
transplantation	O
patients	O
.	O

Recent	O
observational	O
studies	O
suggest	O
,	O
that	O
preterm	O
infants	O
<	O
34	O
weeks	O
of	O
gestation	O
with	O
acute	O
hypoxic	O
lung	B-ANAT
failure	O
could	O
benefit	O
from	O
inhaled	O
NO	O
(	O
iNO	O
)	O
by	O
improved	O
oxygenation	O
.	O

We	O
found	O
that	O
NL63	O
PLP2	O
deconjugated	O
ubiquitin	O
(	O
Ub	O
)	O
and	O
the	O
Ub	O
-	O
line	O
molecule	O
ISG15	O
from	O
cellular	B-ANAT
substrates	O
and	O
processed	O
both	O
lysine	O
-	O
48	O
-	O
and	O
lysine	O
-	O
63	O
-	O
linked	O
polyubiquitin	O
chains	O
.	O

To	O
assess	O
the	O
in	O
vitro	O
antiviral	O
activity	O
of	O
swine	O
intestine	B-ANAT
antimicrobial	O
peptides	O
(	O
SIAMP	O
)	O
against	O
IBV	O
,	O
45	O
chick	B-ANAT
embryos	I-ANAT
were	O
randomly	O
assigned	O
into	O
3	O
groups	O
,	O
15	O
for	O
each	O
group	O
.	O

Weight	O
gain	O
of	O
embryos	B-ANAT
in	O
the	O
SIAMP	O
-	O
IBV	O
intermixture	O
group	O
was	O
significantly	O
higher	O
than	O
the	O
IBV	O
-	O
infected	O
embryos	B-ANAT
(	O
P	O
<	O
0	O
.	O
01	O
),	O
which	O
was	O
also	O
higher	O
than	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Despite	O
the	O
use	O
of	O
multimodal	O
therapy	O
to	O
include	O
empiric	O
antibiotics	O
,	O
intravenous	O
paralytics	O
,	O
intravenous	O
concentrated	O
albumin	O
,	O
high	O
-	O
dose	O
corticosteroids	O
as	O
well	O
as	O
sustained	O
high	O
mean	O
airway	B-ANAT
pressure	O
mechanical	O
ventilation	O
by	O
airway	B-ANAT
pressure	O
release	O
and	O
high	O
-	O
frequency	O
percussive	O
ventilation	O
(	O
HFPV	O
)	O
modes	O
,	O
the	O
patient	O
demonstrated	O
an	O
unchanging	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
ratio	O
of	O
only	O
57	O
mm	O
Hg	O
.	O

A	O
trial	O
of	O
nebulized	O
prostacyclin	O
was	O
initiated	O
during	O
HFPV	O
leading	O
to	O
a	O
significant	O
improvement	O
in	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
to	O
147	O
mm	O
Hg	O
.	O

ABSTRACT	O
:	O
Percutaneous	O
cryotherapy	O
(	O
PCT	O
)	O
under	O
computed	O
tomographic	O
guidance	O
is	O
minimally	O
invasive	O
,	O
with	O
satisfactory	O
local	O
control	O
of	O
primary	O
lung	B-ANAT
cancer	O
and	O
pulmonary	B-ANAT
metastatic	O
lesions	O
.	O

We	O
report	O
a	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
a	O
patient	O
who	O
underwent	O
PCT	O
for	O
lung	B-ANAT
metastasis	O
of	O
recurrent	O
esophageal	O
cancer	O
.	O

Clinicians	O
should	O
be	O
vigilant	O
for	O
the	O
potential	O
of	O
H1N1	O
infection	O
to	O
progress	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
a	O
variety	O
of	O
patient	O
demographics	O
,	O
including	O
younger	O
patients	O
without	O
baseline	O
cardiopulmonary	B-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Ventilating	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
the	O
prone	O
position	O
has	O
been	O
shown	O
to	O
improve	O
arterial	B-ANAT
oxygenation	O
,	O
but	O
prolonged	O
prone	O
positioning	O
frequently	O
requires	O
continuous	O
deep	O
sedation	O
,	O
which	O
may	O
be	O
harmful	O
to	O
patients	O
.	O

Additionally	O
non	O
vital	O
organ	B-ANAT
systems	I-ANAT
might	O
reduce	O
their	O
oxygen	O
uptake	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
central	O
lung	B-ANAT
cancer	O
,	O
lobectomy	O
can	O
be	O
achieved	O
without	O
pneumonectomy	O
by	O
surgical	O
reconstruction	O
of	O
the	O
pulmonary	B-ANAT
artery	I-ANAT
(	O
PA	O
).	O

Full	O
blood	B-ANAT
count	O
,	O
urea	O
,	O
electrolytes	O
and	O
blood	B-ANAT
sugar	O
were	O
done	O
for	O
all	O
the	O
patients	O
,	O
whereas	O
,	O
other	O
tests	O
were	O
carried	O
out	O
when	O
and	O
where	O
it	O
was	O
indicated	O
.	O

Stem	B-ANAT
loops	O
(	O
SL	O
)	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
5	O
were	O
predicted	O
in	O
all	O
CoVs	O
,	O
while	O
the	O
core	O
leader	O
transcription	O
-	O
regulating	O
sequence	O
(	O
L	O
-	O
TRS	O
)	O
forms	O
SL3	O
in	O
only	O
some	O
CoVs	O
.	O

In	O
addition	O
to	O
acute	O
bacterial	O
pneumonia	O
,	O
there	O
was	O
focally	O
alveolar	B-ANAT
septal	O
fibrosis	O
,	O
pneumocyte	B-ANAT
hypertrophy	O
,	O
and	O
clusters	O
of	O
airspace	O
macrophages	B-ANAT
.	O

Late	O
reactions	O
due	O
to	O
cow	O
'	O
s	O
milk	O
allergy	O
are	O
atopic	O
dermatitis	O
,	O
chronic	O
diarrhoea	O
,	O
blood	B-ANAT
in	O
the	O
stools	B-ANAT
,	O
iron	O
deficiency	O
anaemia	O
,	O
gastroesophageal	B-ANAT
reflux	O
disease	O
,	O
constipation	O
,	O
chronic	O
vomiting	O
,	O
colic	O
,	O
poor	O
growth	O
(	O
food	O
refusal	O
),	O
enterocolitis	O
syndrome	O
,	O
protein	O
-	O
losing	O
enteropathy	O
with	O
hypoalbuminemia	O
,	O
eosinophilic	O
oesophagogastroenteropathy	O
.	O

Transferred	O
Tregs	O
were	O
not	O
detected	O
in	O
the	O
CNS	B-ANAT
of	O
infected	O
RAG1	O
(-/-)	O
mice	O
,	O
but	O
rather	O
appeared	O
to	O
mediate	O
their	O
effects	O
in	O
the	O
draining	O
cervical	B-ANAT
lymph	I-ANAT
nodes	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
observe	O
the	O
effect	O
of	O
Qingyi	O
Decoction	O
(	O
QYD	O
)	O
in	O
treating	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
and	O
its	O
impacts	O
on	O
blood	B-ANAT
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
),	O
interleukin	O
6	O
and	O
8	O
(	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
).	O

QYD	O
could	O
markedly	O
improve	O
the	O
prognosis	O
of	O
SAP	O
patients	O
by	O
way	O
of	O
lowering	O
the	O
blood	B-ANAT
levels	O
of	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
.	O

RESULTS	O
:	O
The	O
incidences	O
of	O
the	O
two	O
severe	O
complications	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
intestinal	B-ANAT
paralysis	O
,	O
in	O
the	O
treated	O
group	O
was	O
3	O
.	O
6	O
%	O
and	O
5	O
.	O
4	O
%	O
respectively	O
,	O
while	O
in	O
the	O
control	O
group	O
,	O
12	O
.	O
7	O
%	O
and	O
18	O
.	O
2	O
%,	O
showing	O
statistical	O
significance	O
between	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

In	O
addition	O
,	O
the	O
efficacy	O
in	O
the	O
treated	O
group	O
was	O
also	O
superior	O
to	O
that	O
in	O
the	O
control	O
group	O
in	O
terms	O
of	O
reducing	O
mortality	O
,	O
operation	O
transferring	O
rate	O
,	O
and	O
blood	B-ANAT
levels	O
of	O
TNF	O
-	O
alpha	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
on	O
the	O
7th	O
and	O
9th	O
day	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

We	O
studied	O
the	O
cell	B-ANAT
entry	O
mechanisms	O
of	O
two	O
different	O
CoVs	O
,	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

The	O
latter	O
viruses	O
entered	O
directly	O
from	O
cell	B-ANAT
surface	I-ANAT
,	O
when	O
receptor	O
-	O
bound	O
viruses	O
were	O
treated	O
with	O
proteases	O
that	O
activate	O
fusion	O
activity	O
of	O
their	O
S	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
affected	O
South	O
Africa	O
late	O
during	O
the	O
2009	O
Southern	O
hemisphere	O
winter	O
and	O
placed	O
an	O
extra	O
burden	O
on	O
a	O
health	O
care	O
system	O
already	O
dealing	O
with	O
a	O
high	O
prevalence	O
of	O
chronic	O
lung	B-ANAT
diseases	O
and	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
infection	O
.	O

The	O
nucleocapsid	B-ANAT
protein	O
as	O
well	O
as	O
the	O
nsp1	O
and	O
nsp3	O
proteins	O
of	O
MHV	O
has	O
been	O
reported	O
to	O
have	O
IFN	O
antagonist	O
activity	O
.	O

We	O
found	O
that	O
some	O
serum	B-ANAT
samples	O
were	O
negative	O
for	O
antibodies	O
to	O
mouse	O
hepatitis	O
virus	O
and	O
Mycoplasma	O
pulmonis	O
but	O
positive	O
for	O
antibody	O
to	O
MNV	O
-	O
S7	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
the	O
etiological	O
agent	O
of	O
transmissible	O
gastroenteritis	O
(	O
TGE	O
),	O
is	O
the	O
major	O
cause	O
of	O
viral	O
enteritis	O
and	O
fetal	B-ANAT
diarrhea	O
in	O
swine	O
neonates	O
,	O
resulting	O
in	O
significant	O
economic	O
losses	O
to	O
the	O
swine	O
industry	O
.	O

Moreover	O
,	O
coronavirus	O
-	O
like	O
particles	O
have	O
been	O
seen	O
by	O
electron	O
microscope	O
in	O
stools	B-ANAT
,	O
and	O
SARS	O
-	O
HCoV	O
has	O
been	O
isolated	O
from	O
intestinal	B-ANAT
tissue	B-ANAT
and	O
detected	O
in	O
stool	B-ANAT
samples	O
.	O

878	O
stool	B-ANAT
specimens	O
from	O
children	O
with	O
acute	O
gastroenteritis	O
and	O
112	O
from	O
control	O
children	O
were	O
tested	O
by	O
RT	O
-	O
PCR	O
to	O
detect	O
HCoV	O
groups	O
1B	O
,	O
2A	O
and	O
SARS	O
.	O

TITLE	O
:	O
GeneReviews	O
ABSTRACT	O
:	O
Mitochondrial	B-ANAT
DNA	I-ANAT
(	O
mtDNA	B-ANAT
)-	O
associated	O
Leigh	O
syndrome	O
and	O
NARP	O
(	O
neurogenic	O
muscle	B-ANAT
weakness	O
,	O
ataxia	O
,	O
and	O
retinitis	O
pigmentosa	O
)	O
are	O
part	O
of	O
a	O
continuum	O
of	O
progressive	O
neurodegenerative	O
disorders	O
caused	O
by	O
abnormalities	O
of	O
mitochondrial	B-ANAT
energy	O
generation	O
.	O

Identification	O
of	O
a	O
pathogenic	O
variant	O
in	O
one	O
of	O
the	O
14	O
mitochondrial	B-ANAT
genes	O
known	O
to	O
be	O
involved	O
in	O
mtDNA	B-ANAT
-	O
associated	O
Leigh	O
syndrome	O
confirms	O
the	O
diagnosis	O
.	O

The	O
diagnosis	O
of	O
NARP	O
is	O
established	O
in	O
a	O
proband	O
with	O
suggestive	O
clinical	O
features	O
and	O
identification	O
of	O
a	O
heteroplasmic	O
pathogenic	O
variant	O
in	O
one	O
of	O
the	O
three	O
mitochondrial	B-ANAT
genes	O
known	O
to	O
be	O
involved	O
in	O
NARP	O
.	O

Occasionally	O
the	O
mother	O
has	O
a	O
substantial	O
proportion	O
of	O
abnormal	O
mtDNA	B-ANAT
and	O
develops	O
severe	O
symptoms	O
in	O
adulthood	O
.	O

Little	O
is	O
known	O
about	O
kidney	B-ANAT
outcomes	O
and	O
dialytic	O
requirements	O
in	O
critically	O
ill	O
patients	O
infected	O
with	O
pandemic	O
H1N1	O
.	O

Kidney	B-ANAT
failure	O
was	O
associated	O
with	O
increased	O
death	O
(	O
OR	O
,	O
11	O
.	O
29	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
29	O
-	O
98	O
.	O
9	O
),	O
whereas	O
the	O
need	O
for	O
dialysis	O
was	O
associated	O
with	O
an	O
increase	O
in	O
length	O
of	O
stay	O
(	O
RR	O
,	O
2	O
.	O
38	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
13	O
-	O
25	O
.	O
75	O
).	O

The	O
results	O
demonstrated	O
that	O
priming	O
with	O
a	O
DNA	O
vaccine	O
encoding	O
nucleocapsid	B-ANAT
protein	O
(	O
pVAX1	O
-	O
N	O
)	O
and	O
boosting	O
with	O
the	O
inactivated	O
IBV	O
vaccine	O
led	O
to	O
the	O
dramatic	O
augmentation	O
of	O
humoral	O
and	O
cellular	B-ANAT
responses	O
,	O
and	O
provided	O
up	O
to	O
86	O
.	O
7	O
%	O
rate	O
of	O
immune	O
protection	O
,	O
providing	O
an	O
effective	O
approach	O
to	O
protect	O
chickens	O
from	O
IBV	O
.	O

Modifications	O
in	O
a	O
patient	O
'	O
s	O
respiratory	O
assistance	O
were	O
made	O
depending	O
on	O
the	O
clinical	O
,	O
blood	B-ANAT
gas	O
,	O
and	O
radiologic	O
evolution	O
of	O
the	O
patient	O
.	O

Viroporins	O
E	O
from	O
mouse	O
hepatitis	O
virus	O
,	O
6K	O
from	O
Sindbis	O
virus	O
and	O
NS4A	O
protein	O
from	O
hepatitis	O
C	O
virus	O
were	O
also	O
able	O
to	O
permeabilize	O
neighbouring	O
cells	B-ANAT
to	O
different	O
extents	O
.	O

Finally	O
,	O
inhibition	O
of	O
HB	O
entry	O
to	O
neighbouring	O
cells	B-ANAT
was	O
observed	O
with	O
18alpha	O
-	O
glycyrrhethinic	O
acid	O
,	O
an	O
inhibitor	O
of	O
gap	B-ANAT
junctions	I-ANAT
.	O

Taken	O
together	O
,	O
these	O
findings	O
support	O
a	O
mechanism	O
involving	O
gap	O
junctional	O
intercellular	O
communication	O
in	O
the	O
bystander	O
permeabilization	O
effect	O
observed	O
in	O
healthy	O
cells	B-ANAT
co	O
-	O
cultured	O
with	O
poliovirus	O
2B	O
-	O
expressing	O
cells	B-ANAT
.	O

Two	O
early	O
postoperative	O
death	O
occurred	O
in	O
this	O
group	O
due	O
to	O
severe	O
low	O
cardiac	B-ANAT
output	O
syndrome	O
,	O
with	O
the	O
mortality	O
rate	O
of	O
1	O
.	O
57	O
%.	O

These	O
viruses	O
were	O
more	O
pathogenic	O
and	O
replicated	O
to	O
higher	O
titers	O
in	O
the	O
lungs	B-ANAT
of	O
mice	O
lacking	O
both	O
IFN	O
receptors	O
than	O
in	O
mice	O
with	O
single	O
IFN	O
receptor	O
defects	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
SARS	O
coronavirus	O
was	O
present	O
in	O
feces	B-ANAT
from	O
infected	O
mice	O
lacking	O
receptors	O
for	O
both	O
type	O
I	O
and	O
type	O
III	O
IFN	O
but	O
not	O
in	O
those	O
from	O
mice	O
lacking	O
single	O
receptors	O
,	O
supporting	O
the	O
view	O
that	O
IFN	O
-	O
lambda	O
contributes	O
to	O
the	O
control	O
of	O
viral	O
infections	O
in	O
epithelial	B-ANAT
cells	I-ANAT
of	O
both	O
respiratory	O
and	O
gastrointestinal	B-ANAT
tracts	I-ANAT
.	O

Recently	O
,	O
we	O
demonstrated	O
that	O
a	O
recombinant	O
MVTT	O
expressing	O
the	O
spike	O
glycoprotein	O
of	O
SARS	O
-	O
CoV	O
(	O
namely	O
MVTT	O
-	O
S	O
)	O
is	O
superior	O
to	O
the	O
non	O
-	O
replicating	O
modified	O
vaccinia	O
Ankara	O
(	O
MVA	O
-	O
S	O
)	O
for	O
inducing	O
high	O
level	O
of	O
neutralizing	O
antibodies	O
through	O
mucosal	B-ANAT
vaccination	O
.	O

Because	O
there	O
is	O
no	O
correlation	O
between	O
bronchoalveolar	O
lavage	O
protein	O
content	O
(	O
a	O
marker	O
of	O
permeability	O
)	O
and	O
sPLA2	O
,	O
the	O
enzyme	O
seems	O
mainly	O
produced	O
in	O
the	O
alveoli	B-ANAT
.	O

210	O
vs	O
42	O
+/-	O
8	O
.	O
14	O
)	O
coincided	O
with	O
a	O
marked	O
reduction	O
in	O
serum	B-ANAT
albumin	O
(	O
11	O
.	O
5	O
+/-	O
1	O
.	O
71	O
vs	O
25	O
+/-	O

Interestingly	O
,	O
MHV	O
has	O
a	O
cell	B-ANAT
-	O
type	O
-	O
dependent	O
ability	O
to	O
resist	O
the	O
antiviral	O
effects	O
of	O
IFN	O
-	O
alpha	O
/	O
beta	O
.	O

Replication	O
of	O
other	O
RNA	O
viruses	O
,	O
including	O
Theiler	O
'	O
s	O
murine	O
encephalitis	O
virus	O
(	O
TMEV	O
),	O
vesicular	O
stomatitis	O
virus	O
(	O
VSV	O
),	O
Sindbis	O
virus	O
,	O
Newcastle	O
disease	O
virus	O
(	O
NDV	O
),	O
and	O
Sendai	O
virus	O
(	O
SeV	O
),	O
was	O
significantly	O
inhibited	O
in	O
L2	O
cells	B-ANAT
treated	O
with	O
IFN	O
-	O
alpha	O
/	O
beta	O
,	O
and	O
MHV	O
had	O
the	O
ability	O
to	O
rescue	O
only	O
SeV	O
replication	O
.	O

Our	O
clinical	O
observation	O
and	O
animal	O
experimentation	O
revealed	O
that	O
infusion	O
of	O
fatty	O
acids	O
caused	O
physical	O
phase	O
,	O
resulting	O
in	O
microvascular	O
obstruction	O
accompanied	O
by	O
pulmonary	B-ANAT
hypertension	O
and	O
increased	O
capillary	B-ANAT
permeability	O
.	O

It	O
allows	O
us	O
to	O
show	O
that	O
the	O
SARS	O
-	O
CoV	O
is	O
most	O
closely	O
related	O
to	O
a	O
coronavirus	O
from	O
the	O
palm	B-ANAT
civet	O
not	O
from	O
a	O
bird	O
as	O
initially	O
suspected	O
,	O
and	O
the	O
newly	O
discovered	O
human	O
coronavirus	O
HCoV	O
-	O
HKU1	O
is	O
more	O
closely	O
related	O
to	O
SARS	O
than	O
to	O
any	O
other	O
known	O
member	O
of	O
group	O
2	O
coronavirus	O
.	O

After	O
that	O
,	O
the	O
protein	O
chip	O
was	O
reacted	O
with	O
the	O
corresponding	O
positive	O
serum	B-ANAT
against	O
these	O
viruses	O
,	O
hybridized	O
with	O
a	O
colloidal	O
gold	O
-	O
labeled	O
secondary	O
antibody	O
and	O
visualized	O
by	O
silver	O
staining	O
.	O

ABSTRACT	O
:	O
Since	O
DNA	O
sequencing	O
techniques	O
first	O
became	O
available	O
almost	O
30	O
years	O
ago	O
,	O
the	O
amount	O
of	O
nucleic	B-ANAT
acid	O
sequence	O
data	O
has	O
increased	O
enormously	O
.	O

ABSTRACT	O
:	O
Murine	O
coronavirus	O
(	O
mouse	O
hepatitis	O
virus	O
,	O
MHV	O
)	O
is	O
a	O
collection	O
of	O
strains	O
that	O
induce	O
disease	O
in	O
several	O
organ	B-ANAT
systems	I-ANAT
of	O
mice	O
.	O

B	B-ANAT
cells	I-ANAT
are	O
necessary	O
to	O
prevent	O
reactivation	O
of	O
virus	O
in	O
the	O
CNS	B-ANAT
following	O
clearance	O
of	O
acute	O
infection	O
.	O

Despite	O
advances	O
in	O
understanding	O
of	O
coronavirus	O
pathogenesis	O
,	O
questions	O
remain	O
regarding	O
the	O
mechanisms	O
of	O
viral	O
entry	O
and	O
spread	O
in	O
cell	B-ANAT
types	O
expressing	O
low	O
levels	O
of	O
receptor	O
,	O
as	O
well	O
as	O
the	O
unique	O
interplay	O
between	O
virus	O
and	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
during	O
acute	O
and	O
chronic	O
disease	O
.	O

During	O
the	O
examination	O
she	O
was	O
unconscious	O
,	O
pale	O
,	O
oedematous	O
with	O
scattered	O
ecchymoses	O
,	O
severe	O
hypertension	O
and	O
urine	B-ANAT
output	O
diminished	O
to	O
several	O
ml	O
per	O
day	O
.	O

Seven	O
days	O
after	O
completion	O
of	O
immunoglobulin	O
treatment	O
,	O
plasma	B-ANAT
exchange	O
was	O
started	O
with	O
an	O
exchange	O
of	O
about	O
three	O
litres	O
of	O
plasma	B-ANAT
every	O
day	O
for	O
three	O
days	O
and	O
every	O
second	O
day	O
on	O
two	O
further	O
occasions	O
.	O

Continued	O
infiltration	O
and	O
activation	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
,	O
a	O
result	O
of	O
the	O
lingering	O
viral	O
antigen	O
and	O
RNA	O
within	O
oligodendrocytes	B-ANAT
,	O
lead	O
directly	O
to	O
the	O
development	O
of	O
an	O
immune	O
-	O
mediated	O
demyelination	O
that	O
bears	O
remarkable	O
similarities	O
,	O
both	O
clinically	O
and	O
histologically	O
,	O
to	O
the	O
human	O
demyelinating	O
disease	O
multiple	O
sclerosis	O
.	O

However	O
,	O
virus	O
spread	O
beyond	O
the	O
lungs	B-ANAT
was	O
only	O
detected	O
in	O
the	O
H5N1	O
group	O
,	O
and	O
signs	O
of	O
extrapulmonary	O
tissue	B-ANAT
reactions	O
,	O
including	O
microglia	B-ANAT
activation	O
and	O
sustained	O
up	O
-	O
regulation	O
of	O
inflammatory	O
markers	O
,	O
most	O
notably	O
hypoxia	O
inducible	O
factor	O
-	O
1alpha	O
(	O
HIF	O
-	O
1alpha	O
),	O
were	O
largely	O
limited	O
to	O
this	O
group	O
.	O

It	O
could	O
induce	O
strong	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
and	O
high	O
titers	O
of	O
neutralizing	O
antibodies	O
in	O
the	O
vaccinated	O
mice	O
.	O

By	O
means	O
of	O
an	O
evidence	O
-	O
based	O
medicine	O
tool	O
(	O
CAT	O
)	O
we	O
approach	O
the	O
benefit	O
of	O
long	O
-	O
bone	B-ANAT
fracture	O
stabilization	O
in	O
polytraumatized	O
patients	O
trying	O
to	O
answer	O
a	O
specific	O
clinical	O
question	O
from	O
a	O
concrete	O
situation	O
:	O
What	O
is	O
the	O
evidence	O
of	O
the	O
safety	O
and	O
benefit	O
of	O
early	O
stabilization	O
of	O
long	O
-	O
bone	B-ANAT
fractures	O
in	O
polytraumatized	O
patients	O
?	O

Early	O
fracture	O
stabilization	O
contributes	O
to	O
reducing	O
the	O
ICU	O
stay	O
,	O
the	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
multiple	O
organ	B-ANAT
failure	O
(	O
MOF	O
)	O
and	O
sepsis	O
,	O
thus	O
improving	O
patient	O
survival	O
.	O

RESULTS	O
:	O
The	O
patient	O
group	O
whose	O
fractures	O
were	O
stabilized	O
after	O
48	O
hours	O
had	O
more	O
clinical	O
complications	O
,	O
alterations	O
of	O
lung	B-ANAT
parameters	O
and	O
a	O
longer	O
hospital	O
stay	O
.	O

Cardiopulmonary	B-ANAT
failure	O
was	O
treated	O
effectively	O
with	O
ECMO	O
and	O
systemic	O
gas	O
exchange	O
and	O
blood	B-ANAT
flow	O
improved	O
rapidly	O
within	O
2	O
h	O
on	O
ECMO	O
in	O
all	O
patients	O
(	O
median	O
OR	O
69	O
(	O
52	O
-	O
263	O
)	O
mmHg	O
,	O
median	O
paCO	O
(	O
2	O
)	O
41	O
(	O
22	O
-	O
85	O
)	O
mmHg	O
.	O

TITLE	O
:	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pneumonia	O
in	O
an	O
immunossupressed	O
patient	O
after	O
heart	B-ANAT
transplantation	O
.	O

The	O
5	O
-	O
fluoro	O
derivative	O
inhibited	O
the	O
HCV	O
RNA	O
synthesis	O
at	O
6	O
mug	O
/	O
ml	O
,	O
without	O
toxicity	O
at	O
a	O
concentration	O
up	O
to	O
42	O
mug	O
/	O
ml	O
in	O
Huh	O
5	O
-	O
2	O
cells	B-ANAT
.	O

In	O
the	O
first	O
,	O
the	O
results	O
of	O
the	O
alpha	O
-	O
IBV	O
IgM	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
on	O
post	O
-	O
vaccination	O
sera	B-ANAT
were	O
compared	O
with	O
the	O
efficacy	O
of	O
the	O
IBV	O
vaccination	O
against	O
homologous	O
challenge	O
of	O
the	O
same	O
broilers	O
.	O

The	O
results	O
showed	O
that	O
groups	O
with	O
at	O
least	O
50	O
%	O
positive	O
sera	B-ANAT
in	O
the	O
IgM	O
ELISA	O
at	O
10	O
days	O
post	O
vaccination	O
had	O
a	O
high	O
level	O
of	O
protection	O
against	O
challenge	O
.	O

This	O
eggshell	O
pathology	O
has	O
only	O
been	O
documented	O
in	O
table	O
egg	B-ANAT
layers	B-ANAT
both	O
spontaneously	O
and	O
experimentally	O
infected	O
with	O
M	O
.	O
synoviae	O
,	O
suggesting	O
that	O
meat	O
-	O
type	O
layers	B-ANAT
are	O
less	O
prone	O
to	O
this	O
condition	O
.	O

Our	O
previous	O
studies	O
have	O
shown	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
can	O
be	O
assembled	O
using	O
a	O
recombinant	O
baculovirus	O
(	O
rBV	O
)	O
expression	O
system	O
and	O
such	O
VLPs	B-ANAT
induce	O
specific	O
humoral	O
and	O
cellular	B-ANAT
immune	O
responses	O
in	O
mice	O
after	O
subcutaneous	O
injection	O
.	O

Here	O
,	O
we	O
investigated	O
mucosal	B-ANAT
immune	O
responses	O
to	O
SARS	O
-	O
CoV	O
VLPs	B-ANAT
in	O
a	O
mouse	O
model	O
.	O

In	O
addition	O
,	O
IgA	O
was	O
also	O
detected	O
in	O
mucosal	B-ANAT
tissues	I-ANAT
from	O
the	O
lung	B-ANAT
and	O
intestine	B-ANAT
,	O
while	O
CpG	O
induced	O
an	O
increased	O
level	O
of	O
IgA	O
in	O
the	O
intestine	B-ANAT
.	O

The	O
results	O
showed	O
that	O
all	O
of	O
the	O
examined	O
IBVs	O
were	O
accurately	O
genotyped	O
by	O
identifying	O
the	O
corresponding	O
bands	O
on	O
agarose	O
gels	O
(	O
TW	O
-	O
I	O
:	O
322	O
bp	O
,	O
TW	O
-	O
II	O
:	O
161	O
bp	O
,	O
Mass	O
type	O
:	O
256	O
bp	O
)	O
after	O
the	O
mRT	B-ANAT
-	O
PCR	O
,	O
in	O
agreement	O
with	O
the	O
viral	B-ANAT
genome	I-ANAT
sequence	O
data	O
.	O

The	O
mRT	B-ANAT
-	O
PCR	O
assay	O
was	O
able	O
to	O
detect	O
viral	O
RNA	O
copies	O
as	O
low	O
as	O
10	O
(	O
3	O
),	O
10	O
(	O
50	O
,	O
and	O
10	O
(	O
3	O
)	O
for	O
the	O
TW	O
-	O
I	O
,	O
TW	O
-	O
II	O
,	O
and	O
Mass	O
-	O
type	O
strains	O
,	O
respectively	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
focused	O
on	O
the	O
binding	O
of	O
E	O
protein	O
to	O
nsp3	O
in	O
infected	O
cells	B-ANAT
and	O
cell	B-ANAT
-	I-ANAT
free	I-ANAT
systems	I-ANAT
.	O

Moreover	O
,	O
NO	O
levels	O
in	O
cell	B-ANAT
culture	O
medium	O
of	O
PRRSV	O
-	O
infected	O
alveolar	B-ANAT
macrophages	I-ANAT
(	O
AMs	B-ANAT
)	O
did	O
not	O
differ	O
from	O
that	O
of	O
mock	O
-	O
infected	O
AMs	B-ANAT
.	O

Virus	O
titres	O
and	O
grossly	O
visible	O
pulmonary	B-ANAT
lesions	O
were	O
similar	O
in	O
the	O
PRCV	O
-	O
LTA	O
-	O
and	O
PRCV	O
-	O
inoculated	O
groups	O
and	O
were	O
not	O
detected	O
in	O
the	O
LTA	O
group	O
.	O

Analysis	O
of	O
stretched	O
versus	O
nonstretched	O
cells	B-ANAT
identified	O
significant	O
enrichment	O
for	O
genes	O
containing	O
putative	O
binding	O
sites	O
for	O
the	O
transcription	O
factor	O
activating	O
transcription	O
factor	O
3	O
(	O
ATF3	O
).	O

ATF3	O
protein	O
expression	O
and	O
nuclear	O
translocation	O
is	O
increased	O
in	O
the	O
lung	B-ANAT
after	O
mechanical	O
ventilation	O
in	O
wild	O
-	O
type	O
mice	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
complicated	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
from	O
severe	O
sepsis	O
,	O
in	O
which	O
we	O
measured	O
the	O
ratio	O
of	O
physiologic	O
dead	O
space	O
to	O
tidal	O
volume	O
(	O
V	O
(	O
D	O
)/	O
V	O
(	O
T	O
))	O
with	O
volumetric	O
capnography	O
prior	O
to	O
,	O
during	O
,	O
and	O
after	O
therapy	O
with	O
human	O
recombinant	O
activated	O
protein	O
C	O
.	O
Previous	O
studies	O
hypothesized	O
that	O
early	O
in	O
ARDS	O
,	O
elevated	O
V	O
(	O
D	O
)/	O
V	O
(	O
T	O
)	O
primarily	O
reflects	O
increased	O
alveolar	B-ANAT
V	O
(	O
D	O
),	O
probably	O
caused	O
by	O
pronounced	O
thrombi	O
formation	O
in	O
the	O
pulmonary	B-ANAT
microvasculature	B-ANAT
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
only	O
reported	O
surgical	O
management	O
of	O
thoracic	B-ANAT
insufficiency	O
syndrome	O
demonstrating	O
a	O
statistical	O
improvement	O
in	O
chest	B-ANAT
wall	I-ANAT
compliance	O
and	O
tidal	O
volume	O
.	O

We	O
show	O
that	O
MHV	O
infection	O
activated	O
both	O
transcription	O
factors	O
,	O
the	O
IFN	O
regulatory	O
factor	O
3	O
(	O
IRF	O
-	O
3	O
)	O
and	O
nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
),	O
as	O
evidenced	O
by	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
IRF	O
-	O
3	O
and	O
an	O
increased	O
promoter	O
binding	O
activity	O
for	O
IRF	O
-	O
3	O
and	O
NF	O
-	O
kappaB	O
.	O
Furthermore	O
,	O
the	O
cytoplasmic	B-ANAT
pattern	O
recognition	O
receptor	O
retinoic	O
acid	O
-	O
inducible	O
gene	O
I	O
(	O
RIG	O
-	O
I	O
)	O
was	O
induced	O
by	O
MHV	O
infection	O
.	O

Knockdown	O
of	O
another	O
cytoplasmic	B-ANAT
receptor	O
,	O
the	O
melanoma	O
-	O
differentiation	O
-	O
associated	O
gene	O
5	O
(	O
MDA5	O
),	O
by	O
small	O
interfering	O
RNAs	O
also	O
blocked	O
IFN	O
-	O
beta	O
induction	O
.	O

This	O
concept	O
arises	O
from	O
the	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
experience	O
.	O

The	O
rate	O
of	O
single	O
organ	B-ANAT
involvement	O
was	O
relatively	O
low	O
and	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
was	O
very	O
common	O
.	O

Jaundice	O
with	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
)	O
was	O
the	O
most	O
common	O
presentation	O
(	O
13	O
.	O
28	O
percent	O
),	O
followed	O
by	O
cerebral	B-ANAT
malaria	O
with	O
jaundice	O
and	O
ARF	O
(	O
6	O
.	O
37	O
percent	O
),	O
and	O
jaundice	O
,	O
ARF	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
5	O
.	O
31	O
percent	O
).	O

Treatment	O
with	O
plasma	B-ANAT
exchange	O
was	O
conducted	O
and	O
the	O
patient	O
had	O
satisfactory	O
recovery	O
.	O

In	O
our	O
study	O
,	O
serum	B-ANAT
procalcitonin	O
and	O
C	O
-	O
reactive	O
protein	O
did	O
not	O
discriminate	O
virus	O
-	O
associated	O
exacerbations	O
from	O
others	O
.	O

High	O
anti	O
-	O
TNF	O
-	O
alpha	O
activity	O
was	O
detected	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	B-ANAT
,	I-ANAT
peritoneal	I-ANAT
lavage	O
fluids	B-ANAT
and	O
serum	B-ANAT
of	O
all	O
animals	O
for	O
at	O
least	O
8h	O
post	O
-	O
inoculation	O
(	O
HPI	O
).	O

Samples	O
of	O
blood	B-ANAT
,	O
stool	B-ANAT
,	O
hair	B-ANAT
and	O
auricular	B-ANAT
swabs	O
were	O
collected	O
from	O
231	O
cats	O
in	O
27	O
colonies	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
renal	B-ANAT
vasculitis	O
syndromes	O
.	O

When	O
one	O
couples	O
these	O
grim	O
estimates	O
with	O
the	O
well	O
-	O
recognized	O
association	O
between	O
alcohol	O
abuse	O
and	O
severe	O
lung	B-ANAT
infections	O
,	O
such	O
as	O
bacterial	O
pneumonia	O
and	O
tuberculosis	O
,	O
it	O
is	O
apparent	O
that	O
alcohol	O
-	O
related	O
lung	B-ANAT
diseases	O
are	O
a	O
major	O
public	O
health	O
problem	O
.	O

However	O
,	O
in	O
contrast	O
to	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
in	O
which	O
biomarkers	O
in	O
plasma	B-ANAT
,	O
urine	B-ANAT
and	O
lung	B-ANAT
edema	O
fluid	O
have	O
prognostic	O
and	O
pathogenetic	O
value	O
,	O
the	O
role	O
of	O
biomarkers	O
in	O
primary	O
graft	B-ANAT
dysfunction	O
has	O
been	O
less	O
thoroughly	O
explored	O
.	O

Similarities	O
to	O
the	O
literature	O
in	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
are	O
highlighted	O
where	O
appropriate	O
,	O
and	O
future	O
directions	O
for	O
research	O
on	O
the	O
role	O
of	O
biomarkers	O
in	O
primary	O
graft	B-ANAT
dysfunction	O
are	O
suggested	O
.	O

p42	O
is	O
a	O
subunit	O
of	O
the	O
26S	B-ANAT
proteasome	I-ANAT
;	O
this	O
large	O
,	O
multi	O
-	O
protein	B-ANAT
complex	I-ANAT
is	O
a	O
component	O
of	O
the	O
ubiquitin	O
-	O
proteasome	O
pathway	O
,	O
which	O
is	O
involved	O
in	O
a	O
variety	O
of	O
basic	O
cellular	B-ANAT
processes	O
and	O
inflammatory	O
responses	O
.	O

RESULTS	O
:	O
Using	O
surface	O
plasmon	O
resonance	O
biomolecular	O
interaction	O
analysis	O
(	O
SPR	O
/	O
BIA	O
)	O
and	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
of	O
flight	O
(	O
MALDI	O
-	O
TOF	O
)	O
mass	O
spectrometry	O
,	O
we	O
found	O
that	O
only	O
the	O
proteasome	O
subunit	O
p42	O
from	O
human	O
fetal	B-ANAT
lung	I-ANAT
diploid	O
fibroblast	B-ANAT
(	O
2BS	O
)	O
cells	B-ANAT
bound	O
to	O
SARS	O
-	O
CoV	O
NP	O
.	O

CONCLUSIONS	O
:	O
To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
that	O
SARS	O
-	O
CoV	O
NP	O
interacts	O
with	O
the	O
proteasome	O
subunit	O
p42	O
within	O
host	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Viral	O
ion	O
channels	O
are	O
short	O
membrane	B-ANAT
proteins	O
with	O
50	O
-	O
120	O
amino	O
acids	O
and	O
play	O
an	O
important	O
role	O
either	O
in	O
regulating	O
virus	O
replication	O
,	O
such	O
as	O
virus	O
entry	O
,	O
assembly	O
and	O
release	O
or	O
modulating	O
the	O
electrochemical	O
balance	O
in	O
the	O
subcellular	O
compartments	B-ANAT
of	O
host	O
cells	B-ANAT
.	O

TITLE	O
:	O
Antiproliferative	O
effect	O
of	O
Toona	O
sinensis	O
leaf	O
extract	O
on	O
non	O
-	O
small	O
-	O
cell	B-ANAT
lung	B-ANAT
cancer	O
.	O

Thus	O
,	O
the	O
TSL	O
-	O
1	O
-	O
induced	O
apoptosis	O
was	O
further	O
confirmed	O
by	O
cell	B-ANAT
morphology	O
,	O
subG1	O
peak	O
accumulation	O
,	O
poly	O
(	O
adenosine	O
diphosphate	O
[	O
ADP	O
]-	O
ribose	O
)	O
polymerase	O
(	O
PARP	O
)	O
cleavage	O
,	O
propidium	O
iodide	O
(	O
PI	O
)-	O
Annexin	O
-	O
V	O
double	O
staining	O
,	O
and	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	O
nick	O
end	O
-	O
labeling	O
(	O
TUNEL	O
)	O
assay	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
serious	O
and	O
fatal	O
pulmonary	B-ANAT
manifestation	O
.	O

Ultrastructural	O
study	O
searching	O
for	O
viral	B-ANAT
particles	I-ANAT
in	O
CSF	B-ANAT
was	O
made	O
with	O
transmission	O
electron	O
microscopy	O
.	O

Viral	O
protein	O
expression	O
was	O
reduced	O
in	O
cells	B-ANAT
expressing	O
a	O
temperature	O
-	O
sensitive	O
ubiquitin	O
-	O
activating	O
enzyme	O
E1	O
at	O
the	O
restrictive	O
temperature	O
,	O
as	O
well	O
as	O
in	O
cells	B-ANAT
in	O
which	O
ubiquitin	O
was	O
depleted	O
by	O
using	O
small	O
interfering	O
RNAs	O
.	O

ABSTRACT	O
:	O
Many	O
viruses	O
,	O
including	O
coronaviruses	O
(	O
CoVs	O
),	O
depend	O
on	O
a	O
functional	O
cellular	B-ANAT
proteasome	O
for	O
efficient	O
infection	O
in	O
vitro	O
.	O

TITLE	O
:	O
Ultrastructural	O
and	O
biochemical	O
analyses	O
of	O
hepatitis	O
C	O
virus	O
-	O
associated	O
host	O
cell	B-ANAT
membranes	I-ANAT
.	O

We	O
studied	O
this	O
phenomenon	O
,	O
using	O
a	O
Huh7	O
.	O
5	O
cell	B-ANAT
clone	I-ANAT
displaying	O
high	O
levels	O
of	O
replication	O
of	O
a	O
subgenomic	O
replicon	O
of	O
the	O
JFH	O
-	O
1	O
strain	O
.	O

Some	O
sections	O
had	O
more	O
discrete	O
multivesicular	O
units	O
consisting	O
of	O
circular	O
concentric	O
membranes	B-ANAT
organized	O
into	O
clusters	O
surrounded	O
by	O
a	O
wrapping	O
membrane	B-ANAT
.	O

The	O
ECLS	O
team	O
consists	O
of	O
an	O
intensivist	O
,	O
a	O
cardiac	B-ANAT
surgeon	O
,	O
a	O
cardiologist	O
and	O
a	O
perfusionist	O
,	O
all	O
trained	O
in	O
ECLS	O
technique	O
.	O

No	O
patients	O
on	O
V	O
-	O
A	O
ECLS	O
support	O
after	O
cardiac	B-ANAT
arrest	O
survived	O
(	O
N	O
=	O
4	O
).	O

Similarly	O
,	O
the	O
amount	O
of	O
TGEV	O
in	O
intestinal	B-ANAT
tissues	B-ANAT
and	O
mesenteric	B-ANAT
lymph	I-ANAT
node	I-ANAT
of	O
chi8501	O
/	O
swIFN	O
-	O
alpha	O
-	O
administered	O
piglets	O
was	O
lower	O
than	O
in	O
piglets	O
that	O
were	O
treated	O
with	O
control	O
bacteria	O
.	O

Serum	B-ANAT
levels	O
of	O
ET	O
-	O
1	O
and	O
NO	O
increased	O
after	O
ALI	O
models	O
were	O
established	O
and	O
slightly	O
decreased	O
after	O
a	O
6	O
-	O
hour	O
ventilation	O
in	O
both	O
the	O
VT6	O
group	O
and	O
the	O
VT20	O
group	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
serum	B-ANAT
ratio	O
of	O
ET	O
-	O
1	O
/	O
NO	O
between	O
any	O
two	O
out	O
of	O
three	O
groups	O
(	O
P	O
>	O
0	O
.	O
05	O
),	O
although	O
there	O
was	O
a	O
significant	O
positive	O
relationship	O
between	O
serum	B-ANAT
ET	O
-	O
1	O
and	O
serum	B-ANAT
NO	O
(	O
r	O
=	O
0	O
.	O
80	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
lung	B-ANAT
ET	O
-	O
1	O
level	O
in	O
the	O
VT20	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
VT6	O
group	O
and	O
VT10	O
group	O
(	O
both	O
P	O
<	O
0	O
.	O
05	O
)	O
while	O
there	O
was	O
no	O
significant	O
difference	O
in	O
lung	B-ANAT
NO	O
levels	O
between	O
two	O
groups	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

In	O
the	O
lung	B-ANAT
tissue	I-ANAT
,	O
the	O
ratio	O
of	O
ET	O
-	O
1	O
/	O
NO	O
was	O
significantly	O
higher	O
in	O
the	O
VT20	O
group	O
than	O
in	O
the	O
VT6	O
group	O
and	O
VT10	O
group	O
after	O
the	O
6	O
-	O
hour	O
ventilation	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
as	O
there	O
was	O
a	O
significant	O
positive	O
relationship	O
between	O
ET	O
-	O
1	O
and	O
NO	O
in	O
the	O
lung	B-ANAT
(	O
r	O
=	O
0	O
.	O
54	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

In	O
multivariate	O
GEE	O
logistic	O
regression	O
models	O
,	O
presence	O
in	O
the	O
room	O
during	O
fiberoptic	O
intubation	O
(	O
OR	O
=	O
2	O
.	O
79	O
,	O
p	O
=	O
.	O
004	O
)	O
or	O
ECG	O
(	O
OR	O
=	O
3	O
.	O
52	O
,	O
p	O
=	O
.	O
002	O
),	O
unprotected	O
eye	B-ANAT
contact	O
with	O
secretions	B-ANAT
(	O
OR	O
=	O
7	O
.	O
34	O
,	O
p	O
=	O
.	O
001	O
),	O
patient	O
APACHE	O
II	O
score	O
>	O
or	O
=	O
20	O
(	O
OR	O
=	O
17	O
.	O
05	O
,	O
p	O
=	O
.	O
009	O
)	O
and	O
patient	O
Pa0	O
(	O
2	O
)/	O
Fi0	O
(	O
2	O
)	O
ratio	O
<	O
or	O
=	O
59	O
(	O
OR	O
=	O
8	O
.	O
65	O
,	O
p	O
=	O
.	O
001	O
)	O
were	O
associated	O
with	O
increased	O
risk	O
of	O
transmission	O
of	O
SARS	O
-	O
CoV	O
.	O
In	O
CART	O
analyses	O
,	O
the	O
four	O
covariates	O
which	O
explained	O
the	O
greatest	O
amount	O
of	O
variation	O
in	O
SARS	O
-	O
CoV	O
transmission	O
were	O
covariates	O
representing	O
individual	O
patients	O
.	O

The	O
child	O
was	O
observed	O
after	O
one	O
year	O
,	O
plaque	O
removal	O
was	O
carried	O
out	O
and	O
fluoride	O
varnish	O
was	O
placed	O
on	O
all	O
teeth	B-ANAT
.	O

ABSTRACT	O
:	O
Proteolytic	O
priming	O
is	O
a	O
common	O
method	O
of	O
controlling	O
the	O
activation	O
of	O
membrane	B-ANAT
fusion	O
mediated	O
by	O
viral	O
glycoproteins	O
.	O

An	O
abdominal	B-ANAT
radiography	O
was	O
performed	O
and	O
showed	O
that	O
the	O
nasojejunal	O
feeding	O
tube	O
was	O
kinking	O
on	O
the	O
third	B-ANAT
portion	I-ANAT
of	I-ANAT
the	I-ANAT
duodenum	I-ANAT
and	O
the	O
tip	O
of	O
the	O
nasojejunal	O
feeding	O
tube	O
was	O
inserted	O
into	O
the	O
right	B-ANAT
retroperitoneum	I-ANAT
on	O
the	O
second	B-ANAT
portion	I-ANAT
of	I-ANAT
the	I-ANAT
duodenum	I-ANAT
.	O

Other	O
lung	B-ANAT
findings	O
were	O
necrotizing	O
bronchiolitis	O
or	O
extensive	O
hemorrhage	O
.	O

ABSTRACT	O
:	O
To	O
outline	O
signaling	O
profiles	O
and	O
transmigration	O
capacity	O
of	O
monocytes	B-ANAT
of	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
.	O

The	O
transmigration	O
percentage	O
of	O
patients	O
'	O
monocytes	B-ANAT
was	O
significantly	O
lower	O
than	O
that	O
of	O
reference	O
monocytes	B-ANAT
.	O

Monitoring	O
of	O
monocyte	B-ANAT
signaling	O
profiles	O
may	O
aid	O
in	O
finding	O
new	O
therapeutic	O
approaches	O
and	O
predictors	O
of	O
outcome	O
of	O
severe	O
acute	O
pancreatitis	O
.	O

Right	O
ventricular	B-ANAT
(	O
RV	O
)	O
dilatation	O
(	O
50	O
-	O
80	O
%)	O
and	O
at	O
least	O
moderate	O
systolic	O
impairment	O
(	O
23	O
%)	O
were	O
common	O
,	O
higher	O
than	O
the	O
range	O
described	O
in	O
general	O
populations	O
with	O
ARDS	O
.	O

ABSTRACT	O
:	O
We	O
aimed	O
to	O
present	O
herein	O
the	O
case	O
of	O
a	O
potentially	O
preventable	O
death	O
involving	O
traumatic	O
aortic	B-ANAT
rupture	O
and	O
to	O
develop	O
a	O
critical	O
pathway	O
for	O
the	O
management	O
of	O
isthmic	O
aortic	B-ANAT
ruptures	O
consistent	O
with	O
the	O
available	O
resources	O
.	O

RESULTS	O
:	O
Apart	O
from	O
the	O
virus	O
-	O
encoded	O
structural	O
proteins	O
,	O
we	O
detected	O
60	O
host	O
proteins	O
in	O
the	O
purified	O
virions	B-ANAT
which	O
can	O
be	O
grouped	O
into	O
several	O
functional	O
categories	O
including	O
intracellular	B-ANAT
trafficking	O
proteins	O
(	O
20	O
%),	O
molecular	O
chaperone	O
(	O
18	O
%),	O
macromolcular	O
biosynthesis	O
proteins	O
(	O
17	O
%),	O
cytoskeletal	B-ANAT
proteins	O
(	O
15	O
%),	O
signal	O
transport	O
proteins	O
(	O
15	O
%),	O
protein	O
degradation	O
(	O
8	O
%),	O
chromosome	B-ANAT
associated	O
proteins	O
(	O
2	O
%),	O
ribosomal	B-ANAT
proteins	O
(	O
2	O
%),	O
and	O
other	O
function	O
proteins	O
(	O
3	O
%).	O

TITLE	O
:	O
Migration	O
of	O
engrafted	O
neural	B-ANAT
stem	I-ANAT
cells	I-ANAT
is	O
mediated	O
by	O
CXCL12	O
signaling	O
through	O
CXCR4	O
in	O
a	O
viral	O
model	O
of	O
multiple	O
sclerosis	O
.	O

Surgical	O
engraftment	O
of	O
GFP	O
+	O
neural	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
NSCs	O
)	O
into	O
spinal	B-ANAT
cords	I-ANAT
of	O
JHMV	O
-	O
infected	O
mice	O
with	O
established	O
demyelination	O
results	O
in	O
migration	O
,	O
proliferation	O
,	O
and	O
differentiation	O
of	O
the	O
cells	B-ANAT
into	O
OPCs	O
and	O
mature	O
oligodendrocytes	B-ANAT
that	O
is	O
associated	O
with	O
increased	O
axonal	O
remyelination	O
.	O

To	O
analyze	O
IBV	O
infection	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
we	O
applied	O
a	O
technique	O
that	O
uses	O
precision	O
-	O
cut	O
lung	B-ANAT
slices	O
(	O
PCLSs	O
).	O

Downregulation	O
of	O
LC3	O
,	O
but	O
not	O
inactivation	O
of	O
host	B-ANAT
cell	I-ANAT
autophagy	O
,	O
protects	O
cells	B-ANAT
from	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Amiodarone	O
:	O
review	O
of	O
pulmonary	B-ANAT
effects	O
and	O
toxicity	O
.	O

Cough	O
,	O
new	O
chest	B-ANAT
infiltrates	O
in	O
imaging	O
studies	O
and	O
reduced	O
lung	B-ANAT
diffusing	O
capacity	O
in	O
the	O
appropriate	O
clinical	O
setting	O
of	O
amiodarone	O
use	O
,	O
after	O
the	O
meticulous	O
exclusion	O
of	O
infection	O
,	O
malignancy	O
and	O
pulmonary	B-ANAT
oedema	O
,	O
are	O
the	O
cardinal	O
clinical	O
and	O
laboratory	O
elements	O
for	O
diagnosis	O
.	O

TITLE	O
:	O
T	B-ANAT
cell	I-ANAT
epitope	O
specificity	O
and	O
pathogenesis	O
of	O
mouse	O
hepatitis	O
virus	O
-	O
1	O
-	O
induced	O
disease	O
in	O
susceptible	O
and	O
resistant	O
hosts	O
.	O

Thus	O
,	O
identification	O
of	O
novel	O
CD4	O
and	O
CD8	O
T	B-ANAT
cell	I-ANAT
epitopes	O
for	O
MHV	O
-	O
1	O
permitted	O
high	O
-	O
resolution	O
analyses	O
of	O
pulmonary	B-ANAT
T	B-ANAT
cell	I-ANAT
responses	O
in	O
a	O
mouse	O
model	O
of	O
SARS	O
.	O

Infection	O
with	O
CB	O
/	O
05	O
resulted	O
in	O
a	O
profound	O
depletion	O
of	O
T	B-ANAT
cells	I-ANAT
and	O
a	O
slight	O
loss	O
of	O
B	B-ANAT
cells	I-ANAT
in	O
the	O
first	O
week	O
p	O
.	O
i	O
.	O

The	O
prolonged	O
depletion	O
of	O
peripheral	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
did	O
not	O
alter	O
the	O
levels	O
of	O
serum	B-ANAT
IgG	O
or	O
IgM	O
.	O
The	O
impact	O
of	O
CB	O
/	O
05	O
infection	O
on	O
the	O
immune	O
performance	O
of	O
infected	O
pups	O
is	O
discussed	O
.	O

Crush	O
syndrome	O
caused	O
by	O
extremely	O
long	O
compression	O
has	O
high	O
rates	O
of	O
renal	B-ANAT
failure	O
,	O
multiple	O
organ	B-ANAT
failure	O
,	O
sepsis	O
and	O
amputation	O
.	O

Pulmonary	B-ANAT
vascular	B-ANAT
dysfunction	O
is	O
common	O
in	O
ALI	O
,	O
and	O
is	O
independently	O
associated	O
with	O
poor	O
outcomes	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
possess	O
the	O
largest	O
known	O
RNA	O
genome	O
,	O
a	O
27	O
-	O
to	O
32	O
-	O
kb	O
(+)-	O
strand	O
molecule	O
that	O
replicates	O
in	O
the	O
cytoplasm	B-ANAT
.	O

All	O
clinical	O
trials	O
that	O
included	O
patients	O
with	O
severe	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
were	O
included	O
in	O
the	O
review	O
.	O

A	O
few	O
cases	O
of	O
acute	O
pneumonia	O
requiring	O
mechanical	O
ventilation	O
due	O
to	O
toxocara	O
have	O
been	O
published	O
but	O
this	O
is	O
,	O
to	O
our	O
knowledge	O
,	O
is	O
the	O
first	O
reported	O
case	O
of	O
ARDS	O
with	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Microscopical	O
and	O
immunohistochemical	O
examination	O
of	O
the	O
affected	O
oviducts	B-ANAT
did	O
not	O
help	O
to	O
elucidate	O
the	O
pathogenesis	O
of	O
this	O
lesion	O
.	O

This	O
study	O
reveals	O
that	O
DDX1	O
contributes	O
to	O
efficient	O
coronavirus	O
replication	O
in	O
cell	B-ANAT
culture	O
.	O

The	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
mediates	O
virus	O
entry	O
by	O
binding	O
cellular	B-ANAT
receptors	O
and	O
inducing	O
fusion	O
between	O
the	O
viral	B-ANAT
envelope	I-ANAT
and	O
the	O
host	B-ANAT
cell	I-ANAT
membrane	I-ANAT
.	O

Here	O
,	O
we	O
created	O
a	O
non	O
-	O
palmitoylated	O
SARS	O
-	O
CoV	O
S	O
protein	O
by	O
mutating	O
all	O
nine	O
cytoplasmic	B-ANAT
cysteine	O
residues	O
.	O

To	O
determine	O
role	O
of	O
the	O
combination	O
of	O
Systemic	O
Inflammatory	O
Response	O
Syndrome	O
(	O
SIRS	O
)	O
score	O
and	O
serum	B-ANAT
Interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
level	O
on	O
admission	O
as	O
predictor	O
of	O
illness	O
severity	O
and	O
outcome	O
of	O
Severe	O
Acute	O
Pancreatitis	O
(	O
SAP	O
).	O

27	O
pg	O
/	O
mL	O
.	O
The	O
values	O
of	O
C	O
-	O
reactive	O
Protein	O
(	O
CRP	O
)	O
measured	O
after	O
48h	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
II	O
)	O
score	O
on	O
admission	O
and	O
Ranson	O
score	O
showed	O
the	O
similar	O
correlation	O
,	O
but	O
serum	B-ANAT
amylase	O
level	O
did	O
not	O
correlate	O
significantly	O
with	O
Ranson	O
score	O
,	O
IL	O
-	O
6	O
concentration	O
and	O
APACHE	O
II	O
score	O
.	O

Telbivudine	O
had	O
no	O
effect	O
on	O
MHV	O
-	O
3	O
replication	O
in	O
macrophages	B-ANAT
.	O

Furthermore	O
,	O
telbivudine	O
treatment	O
enhanced	O
the	O
ability	O
of	O
T	B-ANAT
cells	I-ANAT
to	O
undergo	O
proliferation	O
and	O
secrete	O
cytokines	O
but	O
did	O
not	O
affect	O
cytotoxicity	O
of	O
infected	O
hepatocytes	B-ANAT
.	O

JHMV	O
infection	O
of	O
enriched	O
oligodendrocyte	B-ANAT
progenitor	B-ANAT
cell	I-ANAT
(	O
OPC	O
)	O
cultures	O
revealed	O
that	O
apoptosis	O
was	O
associated	O
with	O
elevated	O
expression	O
of	O
cleaved	B-ANAT
caspase	O
3	O
and	O
muted	O
Bcl	O
-	O
2	O
expression	O
.	O

These	O
findings	O
highlight	O
a	O
previously	O
unappreciated	O
role	O
for	O
CXCR2	O
signaling	O
in	O
protecting	O
oligodendrocyte	B-ANAT
lineage	O
cells	B-ANAT
from	O
apoptosis	O
during	O
inflammatory	O
demyelination	O
initiated	O
by	O
viral	O
infection	O
of	O
the	O
CNS	B-ANAT
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
HB	O
-	O
EGF	O
protects	O
the	O
intestines	B-ANAT
from	O
injury	O
in	O
several	O
different	O
animal	O
models	O
of	O
intestinal	B-ANAT
injury	O
.	O

These	O
data	O
demonstrate	O
that	O
HB	O
-	O
EGF	O
may	O
be	O
a	O
potential	O
novel	O
systemic	O
anti	O
-	O
inflammatory	O
agent	O
for	O
the	O
prevention	O
of	O
the	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
after	O
intestinal	B-ANAT
injury	O
.	O

Compared	O
with	O
mice	O
treated	O
with	O
HB	O
-	O
EGF	O
(	O
I	O
/	O
R	O
+	O
HB	O
-	O
EGF	O
),	O
the	O
I	O
/	O
R	O
group	O
had	O
more	O
severe	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
decreased	O
survival	O
.	O

However	O
,	O
when	O
the	O
two	O
agents	O
were	O
added	O
together	O
to	O
FCoV	O
-	O
infected	O
cells	B-ANAT
,	O
a	O
synergistic	O
antiviral	O
effect	O
defined	O
by	O
complete	O
blockage	O
of	O
viral	O
replication	O
was	O
observed	O
.	O

ABSTRACT	O
:	O
The	O
N	O
-	O
terminal	O
domain	O
of	O
nucleocapsid	B-ANAT
protein	O
from	O
human	O
coronavirus	O
OC43	O
(	O
HCoV	O
-	O
OC43	O
N	O
-	O
NTD	O
)	O
mostly	O
contains	O
positively	O
charged	O
residues	O
and	O
has	O
been	O
identified	O
as	O
being	O
responsible	O
for	O
RNA	O
binding	O
during	O
ribonucleocapsid	O
formation	O
in	O
the	O
coronavirus	O
.	O

The	O
crystals	B-ANAT
belonged	O
to	O
the	O
hexagonal	O
space	O
group	O
P6	O
(	O
5	O
),	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
81	O
.	O
57	O
,	O
c	O
=	O
42	O
.	O
87	O
A	O
.	O
Solvent	O
-	O
content	O
calculations	O
suggest	O
that	O
there	O
is	O
likely	O
to	O
be	O
one	O
subunit	O
of	O
N	O
-	O
NTD	O
in	O
the	O
asymmetric	O
unit	O
.	O

We	O
hypothesized	O
that	O
during	O
host	O
invasion	O
,	O
the	O
replicating	O
IBV	O
population	O
further	O
changes	O
as	O
it	O
confronts	O
the	O
distinct	O
environments	O
of	O
different	O
tissues	B-ANAT
,	O
leading	O
to	O
selection	O
of	O
the	O
most	O
fit	O
population	O
.	O

ABSTRACT	O
:	O
Multiple	O
lineages	O
of	O
Brazilian	O
strains	O
from	O
2007	O
to	O
2008	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
were	O
detected	O
in	O
flocks	O
of	O
breeders	O
,	O
broilers	O
,	O
and	O
layers	B-ANAT
.	O

Enhancement	O
of	O
the	O
number	O
of	O
virus	O
-	O
specific	O
CD8	O
T	B-ANAT
cells	I-ANAT
by	O
immunization	O
with	O
SARS	O
-	O
CoV	O
peptide	O
-	O
pulsed	O
dendritic	B-ANAT
cells	I-ANAT
also	O
resulted	O
in	O
a	O
robust	O
T	B-ANAT
cell	I-ANAT
response	O
,	O
earlier	O
virus	O
clearance	O
,	O
and	O
increased	O
survival	O
.	O

It	O
is	O
evident	O
that	O
there	O
is	O
a	O
dearth	O
of	O
therapeutic	O
regimes	O
available	O
to	O
treat	O
those	O
forms	O
of	O
lung	B-ANAT
damage	O
that	O
currently	O
require	O
intensive	O
care	O
management	O
.	O

GCS	O
score	O
and	O
the	O
need	O
for	O
CPR	O
at	O
the	O
scene	O
of	O
injury	O
were	O
associated	O
with	O
eventual	O
mortality	O
because	O
of	O
anoxic	O
brain	B-ANAT
injury	O
in	O
all	O
cases	O
.	O

CONCLUSIONS	O
:	O
Drowning	O
associated	O
with	O
combat	O
operations	O
was	O
associated	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
cardiovascular	B-ANAT
shock	O
.	O

The	O
strains	O
were	O
resistant	O
to	O
5	O
%	O
porcine	O
bile	B-ANAT
and	O
exhibited	O
antimicrobial	O
activity	O
against	O
all	O
the	O
13	O
enteric	O
bacterial	O
pathogens	O
tested	O
.	O

This	O
review	O
focuses	O
on	O
recent	O
studies	O
using	O
either	O
mouse	O
neural	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
NSCs	O
)	O
or	O
human	O
oligodendrocyte	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
(	O
OPCs	O
)	O
derived	O
from	O
human	B-ANAT
embryonic	I-ANAT
stem	I-ANAT
cell	I-ANAT
(	O
hESC	O
)	O
to	O
promote	O
remyelination	O
in	O
mice	O
persistently	O
infected	O
with	O
MHV	O
.	O

After	O
capturing	O
the	O
characteristic	O
SERS	O
spectral	O
patterns	O
,	O
multivariate	O
statistical	O
analyses	O
,	O
including	O
soft	O
independent	O
modeling	O
of	O
class	O
analogy	O
(	O
SIMCA	O
)	O
and	O
principal	O
component	O
analysis	O
(	O
PCA	B-ANAT
),	O
were	O
employed	O
to	O
analyze	O
SERS	O
spectral	O
data	O
for	O
characterization	O
and	O
identification	O
of	O
viruses	O
.	O

By	O
contrast	O
,	O
among	O
the	O
hens	O
in	O
the	O
vaccinated	O
group	O
,	O
N1	O
/	O
88	O
was	O
detectable	O
only	O
in	O
the	O
oviduct	B-ANAT
of	O
2	O
hens	O
at	O
8	O
and	O
12	O
d	O
p	O
.	O
i	O
.	O

After	O
indirect	O
injury	O
,	O
the	O
concentration	O
of	O
granulocyte	B-ANAT
-	O
macrophage	B-ANAT
colony	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	B-ANAT
)	O
was	O
approximately	O
5	O
-	O
fold	O
greater	O
in	O
Sftpd	O
(-/-)	O
mice	O
than	O
wild	O
-	O
type	O
mice	O
.	O

The	O
inhibitory	O
effect	O
of	O
these	O
proteins	O
to	O
cell	B-ANAT
infection	O
by	O
TGEV	O
was	O
analyzed	O
using	O
plaque	O
assays	O
.	O

However	O
,	O
up	O
to	O
now	O
there	O
has	O
been	O
no	O
direct	O
histological	O
investigation	O
on	O
the	O
endocrine	O
cells	B-ANAT
of	O
patients	O
'	O
pituitary	B-ANAT
.	O

A	O
monoclonal	O
gammopathy	O
occurred	O
in	O
four	O
cats	O
;	O
one	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
),	O
one	O
with	O
lymphoma	O
and	O
two	O
cases	O
of	O
splenic	B-ANAT
plasmacytoma	O
(	O
one	O
suspected	O
,	O
one	O
confirmed	O
).	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
a	O
protective	O
mechanical	O
ventilation	O
strategy	O
characterized	O
by	O
low	O
tidal	O
volumes	O
has	O
been	O
associated	O
with	O
reduced	O
mortality	O
.	O

Our	O
genetic	O
results	O
were	O
corroborated	O
by	O
the	O
demonstration	O
that	O
the	O
expressed	O
amino	O
-	O
terminal	O
segment	O
of	O
nsp3	O
bound	O
selectively	O
to	O
N	O
protein	O
from	O
infected	O
cells	B-ANAT
,	O
and	O
this	O
interaction	O
was	O
RNA	O
independent	O
.	O

We	O
assessed	O
the	O
sublingual	B-ANAT
microcirculation	O
in	O
seven	O
consecutive	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
related	O
to	O
influenza	O
A	O
(	O
H1N1	O
)	O
infection	O
.	O

All	O
patients	O
received	O
invasive	O
mechanical	O
ventilation	O
and	O
at	O
least	O
one	O
of	O
the	O
following	O
adjuvant	O
therapies	O
:	O
inhaled	O
nitric	O
oxide	O
(	O
n	O
=	O
4	O
),	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
n	O
=	O
1	O
),	O
prone	O
position	O
(	O
n	O
=	O
4	O
),	O
recruitment	O
maneuver	O
(	O
n	O
=	O
3	O
),	O
and	O
hydrocortisone	O
50	O
mg	O
Â·	O
hr	O
(-	O
6	O
)	O
(	O
n	O
=	O
6	O
).	O

Histopathological	O
changes	O
in	O
lungs	B-ANAT
from	O
2	O
of	O
these	O
seals	O
included	O
a	O
necrotizing	O
lymphocytic	O
and	O
histocytic	O
lobar	O
pneumonia	O
with	O
intra	O
-	O
lesional	O
bacteria	O
.	O

The	O
proteases	O
produced	O
in	O
the	O
lung	B-ANAT
during	O
inflammation	O
could	O
also	O
play	O
an	O
important	O
role	O
for	O
exacerbation	O
of	O
SARS	O
in	O
animals	O
.	O

The	O
analysis	O
of	O
protein	O
synthesis	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
showed	O
that	O
,	O
at	O
the	O
nonpermissive	O
temperature	O
,	O
MHV	O
-	O
Brtsc31	O
was	O
not	O
able	O
to	O
proteolytically	O
process	O
either	O
p150	O
,	O
the	O
precursor	O
polypeptide	O
of	O
the	O
replicase	O
nonstructural	O
proteins	O
nsp4	O
to	O
nsp10	O
,	O
or	O
the	O
replicase	O
polyprotein	O
pp1ab	O
to	O
produce	O
nsp12	O
.	O

In	O
combination	O
with	O
the	O
prior	O
characterization	O
of	O
PL2	O
(	O
pro	O
)	O
from	O
other	O
alphacoronaviruses	O
,	O
e	O
.	O
g	O
.,	O
human	O
coronaviruses	O
229E	O
and	O
NL63	O
,	O
our	O
results	O
unequivocally	O
establish	O
that	O
these	O
viruses	O
employ	O
two	O
PL	O
(	O
pro	O
)	O
s	O
with	O
overlapping	O
specificities	O
toward	O
both	O
viral	O
and	O
cellular	B-ANAT
substrates	O
.	O

TITLE	O
:	O
Quantification	O
of	O
circulating	O
cell	B-ANAT
-	O
free	O
DNA	O
in	O
the	O
serum	B-ANAT
of	O
patients	O
with	O
obstructive	O
sleep	O
apnea	O
-	O
hypopnea	O
syndrome	O
.	O

ABSTRACT	O
:	O
Serum	B-ANAT
cell	B-ANAT
-	O
free	O
DNA	O
concentrations	O
have	O
been	O
reported	O
to	O
increase	O
in	O
many	O
acute	O
diseases	O
as	O
well	O
as	O
in	O
some	O
chronic	O
conditions	O
such	O
as	O
cancer	O
and	O
autoimmune	O
diseases	O
.	O

One	O
hundred	O
twenty	O
-	O
seven	O
people	O
diagnosed	O
with	O
OSAHS	O
by	O
polysomnography	O
(	O
PSG	B-ANAT
)	O
were	O
admitted	O
into	O
the	O
OSAHS	O
group	O
,	O
and	O
52	O
subjects	O
without	O
OSAHS	O
were	O
recruited	O
for	O
the	O
control	O
group	O
.	O

The	O
increasing	O
concentration	O
of	O
serum	B-ANAT
DNA	O
in	O
patients	O
with	O
OSAHS	O
was	O
positively	O
correlated	O
with	O
disease	O
severity	O
.	O

TITLE	O
:	O
Treating	O
Infectious	O
Diseases	O
in	O
a	O
Microbial	O
World	O
:	O
Report	O
of	O
Two	O
Workshops	O
on	O
Novel	O
Antimicrobial	O
Therapeutics	O
ABSTRACT	O
:	O
At	O
the	O
request	O
of	O
the	O
National	O
Institute	O
of	O
Allergy	O
and	O
Infectious	O
Diseases	O
,	O
two	O
committees	O
established	O
by	O
the	O
National	O
Research	O
Council	O
organized	O
workshops	O
to	O
identify	O
promising	O
new	O
approaches	O
to	O
the	O
development	O
of	O
antimicrobial	O
therapeutics	O
(	O
Appendix	B-ANAT
A	O
).	O

The	O
strong	O
pathogenicity	O
of	O
the	O
virus	O
is	O
still	O
not	O
completely	O
explained	O
,	O
but	O
the	O
deep	O
location	O
of	O
infection	O
in	O
the	O
lungs	B-ANAT
and	O
the	O
deregulation	O
of	O
cytokine	O
production	O
by	O
the	O
target	B-ANAT
cells	I-ANAT
,	O
particularly	O
macrophages	B-ANAT
,	O
may	O
be	O
part	O
of	O
the	O
explanation	O
.	O

Other	O
problems	O
include	O
relative	O
hypoxia	O
,	O
gas	O
expansion	O
,	O
air	O
dryness	O
,	O
ozone	O
,	O
cosmic	O
rays	O
,	O
airsickness	O
,	O
jet	O
lag	O
,	O
the	O
effects	O
of	O
alcohol	O
and	O
tobacco	O
,	O
and	O
,	O
more	O
recently	O
,	O
deep	B-ANAT
vein	I-ANAT
thrombosis	O
(	O
DVT	O
)	O
and	O
pulmonary	B-ANAT
embolism	O
(	O
PE	O
),	O
collectively	O
known	O
as	O
""""	O
coach	O
class	O
syndrome	O
"""."	O

ABSTRACT	O
:	O
Occupational	O
pulmonary	B-ANAT
infectious	O
diseases	O
include	O
tuberculosis	O
(	O
TB	O
)	O
and	O
many	O
viral	O
pathogens	O
,	O
including	O
influenza	O
,	O
coronavirus	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
or	O
SARS	O
),	O
varicella	O
,	O
respiratory	O
syncytial	O
virus	O
,	O
and	O
hantavirus	O
.	O

The	O
inhibitory	O
effect	O
of	O
forsythoside	O
A	O
was	O
confirmed	O
by	O
infecting	O
primary	O
chicken	O
embryo	B-ANAT
kidney	B-ANAT
cells	B-ANAT
.	O

Surface	O
expression	O
of	O
spike	O
and	O
staining	O
with	O
sera	B-ANAT
of	O
SARS	O
survivors	O
suggested	O
low	O
antigenic	O
overlap	O
with	O
SARS	O
CoV	O
.	O
However	O
,	O
the	O
receptor	O
binding	O
domain	O
of	O
SARS	O
CoV	O
showed	O
higher	O
similarity	O
with	O
that	O
of	O
BtCoV	O
/	O
BM48	O
-	O
31	O
/	O
Bulgaria	O
/	O
2008	O
than	O
with	O
that	O
of	O
any	O
Chinese	O
bat	O
-	O
borne	O
CoV	O
.	O
Critical	O
spike	O
domains	O
472	O
and	O
487	O
were	O
identical	O
and	O
similar	O
,	O
respectively	O
.	O

In	O
dogs	O
,	O
CK	O
-	O
MB	O
was	O
essentially	O
absent	O
from	O
both	O
serum	B-ANAT
and	O
homogenized	O
hearts	B-ANAT
.	O

In	O
cats	O
,	O
CK	O
-	O
BB	O
was	O
essentially	O
absent	O
from	O
serum	B-ANAT
,	O
but	O
was	O
present	O
in	O
brain	B-ANAT
homogenates	O
.	O

RESULTS	O
:	O
CK	O
-	O
MM	O
was	O
the	O
predominant	O
isoenzyme	O
in	O
the	O
serum	B-ANAT
of	O
healthy	O
dogs	O
and	O
cats	O
,	O
followed	O
by	O
macro	O
-	O
CK2	O
and	O
CK	O
-	O
BB	O
in	O
dogs	O
and	O
by	O
both	O
macroenzymes	O
in	O
cats	O
.	O

The	O
infection	O
was	O
complicated	O
by	O
severe	O
respiratory	O
failure	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
requiring	O
ventilatory	O
support	O
,	O
including	O
extra	O
-	O
corporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

ABSTRACT	O
:	O
A	O
sero	O
-	O
epidemiological	O
study	O
was	O
carried	O
out	O
on	O
5660	O
sera	B-ANAT
collected	O
,	O
between	O
2006	O
and	O
2008	O
,	O
from	O
different	O
flocks	O
in	O
different	O
regions	O
of	O
the	O
country	O
.	O

Computational	O
modeling	O
studies	O
including	O
multi	O
nanosecond	O
molecular	O
dynamics	O
simulations	O
in	O
a	O
hydrated	O
POPC	O
lipid	B-ANAT
bilayer	I-ANAT
are	O
done	O
with	O
a	O
22	O
amino	O
acid	O
transmembrane	B-ANAT
helix	O
to	O
predict	O
a	O
putative	O
homooligomeric	O
helical	O
bundle	O
model	O
.	O

Sanguisorbae	O
radix	O
reduced	O
coronavirus	O
production	O
,	O
partly	O
as	O
a	O
result	O
of	O
decreased	O
protein	O
synthesis	O
,	O
but	O
without	O
a	O
significant	O
reduction	O
in	O
intracellular	B-ANAT
viral	O
RNA	O
levels	O
.	O

The	O
presence	O
of	O
multiple	O
respiratory	O
pathogens	O
in	O
23	O
/	O
40	O
(	O
57	O
.	O
5	O
%)	O
cases	O
indicated	O
the	O
complex	O
origin	O
of	O
fatal	O
calf	B-ANAT
pneumonia	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
and	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
,	O
establishment	O
of	O
the	O
indications	O
and	O
optimal	O
time	O
for	O
surgical	O
decompression	O
may	O
avoid	O
exacerbation	O
of	O
multiple	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

Calf	B-ANAT
faecal	B-ANAT
samples	O
were	O
also	O
analysed	O
for	O
rotavirus	O
,	O
coronavirus	O
and	O
Escherichia	O
coli	O
F5	O
+.	O

A	O
generated	O
MAb	O
(	O
7F9	O
)	O
was	O
identified	O
by	O
ELISA	O
and	O
the	O
chromosome	B-ANAT
number	O
of	O
the	O
hybridoma	B-ANAT
cell	B-ANAT
was	O
analyzed	O
.	O

TITLE	O
:	O
Culturing	O
the	O
unculturable	O
:	O
human	O
coronavirus	O
HKU1	O
infects	O
,	O
replicates	O
,	O
and	O
produces	O
progeny	O
virions	B-ANAT
in	O
human	O
ciliated	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
cultures	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
influenza	O
A	O
(	O
H1N1	O
)	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
prospective	O
observational	O
comparative	O
study	O
.	O

The	O
farrowing	O
rate	O
(	O
FR	O
),	O
return	O
rate	O
(	O
RR	O
),	O
abortion	O
rate	O
(	O
AR	O
),	O
number	O
of	O
total	O
piglets	O
born	O
per	O
litter	O
(	O
TB	O
),	O
number	O
of	O
piglets	O
born	O
alive	O
per	O
litter	O
(	O
BA	O
),	O
percentage	O
of	O
stillbirth	O
piglets	O
per	O
litter	O
(	O
SB	O
),	O
percentage	O
of	O
mummified	O
fetus	B-ANAT
per	O
litter	O
(	O
MM	O
)	O
and	O
piglet	O
'	O
s	O
birth	O
weight	O
(	O
BW	O
),	O
before	O
and	O
after	O
the	O
PEDV	O
outbreak	O
were	O
compared	O
.	O

In	O
addition	O
,	O
tylophorine	O
compounds	O
strongly	O
reduced	O
cytopathic	O
effect	O
in	O
Vero	O
76	O
cells	B-ANAT
induced	O
by	O
human	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
CoV	O
),	O
with	O
ECââ	O
values	O
ranging	O
from	O
less	O
than	O
5	O
to	O
340	O
nM	O
.	O
Moreover	O
,	O
a	O
pharmacokinetic	O
study	O
demonstrated	O
high	O
and	O
comparable	O
oral	B-ANAT
bioavailabilities	O
of	O
7	O
-	O
methoxycryptopleurine	O
(	O
52	O
.	O
7	O
%)	O
and	O
the	O
naturally	O
occurring	O
tylophorine	O
(	O
65	O
.	O
7	O
%)	O
in	O
rats	O
.	O

TITLE	O
:	O
Atrial	B-ANAT
natriuretic	O
peptide	O
attenuates	O
LPS	O
-	O
induced	O
lung	B-ANAT
vascular	B-ANAT
leak	O
:	O
role	O
of	O
PAK1	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
N	O
-	O
aryl	O
-	O
2	O
-	O
arylthioacetamide	O
derivatives	O
(	O
2	O
-	O
4	O
)	O
designed	O
as	O
non	O
-	O
nucleoside	O
reverse	O
transcriptase	O
inhibitors	O
was	O
synthesized	O
and	O
evaluated	O
for	O
their	O
inhibitory	O
activity	O
against	O
HIV	O
-	O
1	O
(	O
IIIB	O
)	O
replication	O
in	O
MT	O
-	O
4	O
cell	B-ANAT
cultures	O
.	O

The	O
assay	O
was	O
evaluated	O
further	O
in	O
tissue	B-ANAT
suspensions	O
prepared	O
from	O
the	O
ileum	B-ANAT
and	O
ileum	B-ANAT
-	O
caecal	O
junctions	O
of	O
infected	O
turkey	O
embryos	B-ANAT
;	O
100	O
%	O
of	O
these	O
samples	O
were	O
positive	O
in	O
the	O
RT	O
-	O
LAMP	O
assay	O
.	O

Of	O
the	O
95	O
respiratory	B-ANAT
samples	I-ANAT
tested	O
,	O
35	O
(	O
37	O
%)	O
were	O
positive	O
for	O
respiratory	O
viruses	O
other	O
than	O
influenza	O
A	O
/	O
H1N1v	O
virus	O
.	O

TITLE	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
is	O
dynamically	O
associated	O
with	O
the	O
replication	O
-	O
transcription	O
complexes	O
.	O

Quantification	O
of	O
mRNA	O
for	O
the	O
ceacam1a	O
-	O
related	O
genes	O
ceacam2	O
and	O
psg16	O
(	O
bCEA	O
),	O
which	O
encode	O
proposed	O
alternative	O
MHV	O
receptors	O
,	O
revealed	O
low	O
ceacam2	O
expression	O
in	O
microglia	B-ANAT
and	O
oligodendrocytes	B-ANAT
and	O
psg16	O
expression	O
exclusively	O
in	O
neurons	B-ANAT
;	O
however	O
,	O
only	O
CEACAM2	O
mediated	O
infection	O
in	O
human	O
293T	O
cells	B-ANAT
.	O

Intra	O
-	O
abdominal	B-ANAT
pressure	O
was	O
30	O
mm	O
Hg	O
.	O

Painful	O
and	O
repetitive	O
spasms	O
interfere	O
with	O
respiration	O
and	O
may	O
cause	O
metabolic	O
disturbances	O
such	O
as	O
hyperpyrexia	O
,	O
dehydration	O
,	O
respiratory	O
insufficiency	O
,	O
and	O
acute	O
renal	B-ANAT
failure	O
secondary	O
to	O
rhabdomyolysis	O
.	O

The	O
clinical	O
similarities	O
between	O
the	O
intrathecal	B-ANAT
baclofen	O
withdrawal	O
syndrome	O
and	O
status	O
dystonicus	O
have	O
not	O
previously	O
been	O
highlighted	O
.	O

ABSTRACT	O
:	O
The	O
phenolic	O
compounds	O
of	O
many	O
fruits	O
have	O
been	O
known	O
to	O
be	O
efficient	O
cellular	B-ANAT
protective	O
antioxidants	O
.	O

In	O
both	O
patients	O
,	O
CVVHDF	O
clearance	O
of	O
TMP	O
ranged	O
from	O
21	O
.	O
5	O
to	O
28	O
.	O
9	O
mL	O
/	O
min	O
,	O
corresponding	O
with	O
normal	O
renal	B-ANAT
clearance	O
(	O
20	O
-	O
80	O
mL	O
/	O
min	O
).	O

Overall	O
,	O
endotracheal	O
tube	O
(	O
ETT	O
)	O
ventilation	O
was	O
required	O
in	O
108	O
(	O
29	O
%),	O
nasal	B-ANAT
CPAP	O
in	O
166	O
(	O
45	O
%)	O
and	O
cot	O
oxygen	O
in	O
95	O
(	O
26	O
%)	O
patients	O
.	O

TITLE	O
:	O
Enhanced	O
cell	B-ANAT
fusion	O
activity	O
in	O
porcine	O
epidemic	O
diarrhea	O
virus	O
adapted	O
to	O
suckling	O
mice	O
.	O

In	O
pursuit	O
of	O
this	O
,	O
we	O
adapted	O
a	O
tissue	B-ANAT
-	O
culture	O
-	O
passed	O
PEDV	O
MK	O
strain	O
to	O
suckling	O
mouse	O
brains	B-ANAT
.	O

PEDV	O
obtained	O
after	O
ten	O
passages	O
through	O
the	O
brains	B-ANAT
(	O
MK	O
-	O
p10	O
)	O
had	O
increased	O
virulence	O
for	O
mice	O
,	O
and	O
its	O
fusion	O
activity	O
in	O
cultured	B-ANAT
cells	I-ANAT
exceeded	O
that	O
of	O
the	O
original	O
strain	O
.	O

One	O
of	O
these	O
(	O
an	O
H	O
-	O
to	O
-	O
R	O
substitution	O
at	O
residue	O
1	O
,	O
381	O
)	O
was	O
first	O
detected	O
in	O
PEDV	O
isolated	O
after	O
eight	O
passages	O
,	O
and	O
both	O
this	O
virus	O
(	O
MK	O
-	O
p8	O
)	O
and	O
MK	O
-	O
p10	O
showed	O
enhanced	O
syncytium	B-ANAT
formation	O
relative	O
to	O
the	O
original	O
MK	O
strain	O
and	O
viruses	O
isolated	O
after	O
two	O
,	O
four	O
,	O
and	O
six	O
passages	O
,	O
suggesting	O
the	O
possibility	O
that	O
the	O
H	O
-	O
to	O
-	O
R	O
mutation	O
was	O
responsible	O
for	O
this	O
activity	O
.	O

TITLE	O
:	O
Elucidation	O
of	O
the	O
avian	O
nucleolar	B-ANAT
proteome	O
by	O
quantitative	O
proteomics	O
using	O
SILAC	O
and	O
changes	O
in	O
cells	B-ANAT
infected	O
with	O
the	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
.	O

The	O
M	O
protein	O
of	O
SARS	O
-	O
CoV	O
holds	O
dominant	O
cellular	B-ANAT
immunogenicity	O
.	O

TITLE	O
:	O
The	O
influence	O
of	O
race	O
on	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
in	O
trauma	O
patients	O
.	O

TITLE	O
:	O
Impaired	O
immune	O
responses	O
following	O
spinal	B-ANAT
cord	I-ANAT
injury	O
lead	O
to	O
reduced	O
ability	O
to	O
control	O
viral	O
infection	O
.	O

ABSTRACT	O
:	O
Spinal	B-ANAT
cord	I-ANAT
injuries	O
disrupt	O
central	O
autonomic	B-ANAT
pathways	O
that	O
regulate	O
immune	O
function	O
,	O
and	O
increasing	O
evidence	O
suggests	O
that	O
this	O
may	O
cause	O
deficiencies	O
in	O
immune	O
responses	O
in	O
people	O
with	O
spinal	B-ANAT
cord	I-ANAT
injuries	O
.	O

TITLE	O
:	O
Muscarinic	O
receptor	O
antagonist	O
therapy	O
improves	O
acute	O
pulmonary	B-ANAT
dysfunction	O
after	O
smoke	O
inhalation	O
injury	O
in	O
sheep	O
.	O

This	O
study	O
tests	O
the	O
hypothesis	O
that	O
muscarinic	O
receptor	O
antagonist	O
therapy	O
with	O
tiotropium	O
bromide	O
,	O
an	O
M1	O
and	O
M3	O
muscarinic	O
receptor	O
antagonist	O
,	O
will	O
decrease	O
the	O
airway	B-ANAT
constrictive	O
response	O
and	O
acute	O
bronchial	B-ANAT
obstruction	O
to	O
improve	O
pulmonary	B-ANAT
function	O
compared	O
to	O
injured	O
animals	O
without	O
treatment	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
quality	O
of	O
life	O
at	O
least	O
12	O
months	O
after	O
discharge	B-ANAT
from	O
the	O
intensive	O
care	O
unit	O
of	O
adult	O
critically	O
ill	O
patients	O
,	O
to	O
evaluate	O
the	O
methodology	O
used	O
to	O
assess	O
long	O
-	O
term	O
quality	O
of	O
life	O
,	O
and	O
to	O
give	O
an	O
overview	O
of	O
factors	O
influencing	O
quality	O
of	O
life	O
.	O

Severe	O
ARDS	O
was	O
defined	O
as	O
a	O
ratio	O
of	O
the	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
(	O
PaO2	O
)	O
to	O
the	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FIO2	O
)	O
of	O
less	O
than	O
150	O
,	O
with	O
a	O
positive	O
end	O
-	O
expiratory	O
pressure	O
of	O
5	O
cm	O
or	O
more	O
of	O
water	O
and	O
a	O
tidal	O
volume	O
of	O
6	O
to	O
8	O
ml	O
per	O
kilogram	O
of	O
predicted	O
body	B-ANAT
weight	O
.	O

ABSTRACT	O
:	O
Antigenic	O
peptides	O
recognized	O
by	O
virus	O
-	O
specific	O
cytotoxic	B-ANAT
T	I-ANAT
lymphocytes	I-ANAT
(	O
CTLs	O
)	O
are	O
presented	O
by	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
(	O
MHC	B-ANAT
;	O
or	O
human	O
leukocyte	B-ANAT
antigen	O
[	O
HLA	B-ANAT
]	O
in	O
humans	O
)	O
molecules	O
,	O
and	O
the	O
peptide	O
selection	O
and	O
presentation	O
strategy	O
of	O
the	O
host	O
has	O
been	O
studied	O
to	O
guide	O
our	O
understanding	O
of	O
cellular	B-ANAT
immunity	O
and	O
vaccine	O
development	O
.	O

TITLE	O
:	O
Dendritic	B-ANAT
cell	I-ANAT
-	O
specific	O
antigen	O
delivery	O
by	O
coronavirus	O
vaccine	O
vectors	O
induces	O
long	O
-	O
lasting	O
protective	O
antiviral	O
and	O
antitumor	O
immunity	O
.	O

Furthermore	O
,	O
human	O
DCs	O
transduced	O
with	O
Melan	O
-	O
A	O
-	O
recombinant	O
human	O
coronavirus	O
229E	O
efficiently	O
activated	O
tumor	O
-	O
specific	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Protective	O
immune	O
responses	O
induced	O
by	O
in	O
ovo	O
immunization	O
with	O
recombinant	O
adenoviruses	O
expressing	O
spike	O
(	O
S1	O
)	O
glycoprotein	O
of	O
infectious	O
bronchitis	O
virus	O
fused	O
/	O
co	O
-	O
administered	O
with	O
granulocyte	B-ANAT
-	O
macrophage	B-ANAT
colony	O
stimulating	O
factor	O
.	O

It	O
indicated	O
that	O
the	O
single	O
dose	O
in	O
ovo	O
vaccination	O
of	O
the	O
GM	O
-	O
CSF	B-ANAT
fused	O
or	O
co	O
-	O
administered	O
with	O
S1	O
of	O
IBV	O
could	O
enhance	O
significantly	O
the	O
humoral	O
,	O
cellular	B-ANAT
immune	O
responses	O
and	O
provide	O
complete	O
protection	O
against	O
nephropathogenic	O
IBV	O
challenge	O
.	O

ABSTRACT	O
:	O
Heart	B-ANAT
failure	O
decompensation	O
is	O
the	O
most	O
common	O
reason	O
for	O
hospitalization	O
in	O
persons	O
over	O
65	O
years	O
old	O
.	O

The	O
variables	O
independently	O
associated	O
with	O
hospital	O
mortality	O
were	O
acute	O
renal	B-ANAT
failure	O
,	O
severe	O
hypoalbuminemia	O
,	O
systolic	O
blood	B-ANAT
pressure	O
<	O
110mmHg	O
,	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
>	O
10	O
.	O
000	O
per	O
mmÂ³	O
and	O
valvular	O
heart	B-ANAT
disease	O
.	O

The	O
blood	B-ANAT
gas	O
analysis	O
was	O
performed	O
24	O
hours	O
after	O
operation	O
.	O

Here	O
we	O
report	O
that	O
the	O
carboxy	O
-	O
terminal	O
domain	O
of	O
the	O
SARS	O
-	O
CoV	O
E	O
small	O
envelope	B-ANAT
protein	O
(	O
E	O
)	O
binds	O
to	O
human	O
PALS1	O
.	O

PALS1	O
redistributes	O
to	O
the	O
ERGIC	B-ANAT
/	O
Golgi	B-ANAT
region	O
,	O
where	O
E	O
accumulates	O
,	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	B-ANAT
.	O

Leucocytosis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
aseptic	O
meningitis	O
,	O
mild	O
serum	B-ANAT
transaminase	O
elevation	O
and	O
hypoalbuminaemia	O
were	O
independently	O
associated	O
with	O
scrub	O
typhus	O
.	O

Normal	O
leukocyte	B-ANAT
counts	O
,	O
moderate	O
to	O
severe	O
thrombocytopenia	O
,	O
renal	B-ANAT
failure	O
,	O
splenomegaly	O
and	O
hyperbilirubinaemia	O
with	O
mildly	O
elevated	O
serum	B-ANAT
transaminases	O
were	O
associated	O
with	O
malaria	O
.	O

However	O
,	O
higher	O
levels	O
of	O
IFN	O
-	O
Î³	O
mRNA	O
in	O
CNS	B-ANAT
-	O
infiltrating	O
virus	O
-	O
specific	O
CD8	O
T	B-ANAT
cells	I-ANAT
as	O
well	O
as	O
CD4	O
T	B-ANAT
cells	I-ANAT
contributed	O
to	O
elevated	O
IFN	O
-	O
Î³	O
protein	O
in	O
the	O
B7	O
-	O
H1	O
(-/-)	O
CNS	B-ANAT
.	O

Although	O
enhanced	O
T	B-ANAT
cell	I-ANAT
activity	O
accelerated	O
virus	O
control	O
,	O
50	O
%	O
of	O
mice	O
succumbed	O
to	O
infection	O
.	O

The	O
results	O
suggest	O
that	O
B7	O
-	O
H1	O
hinders	O
viral	O
control	O
in	O
B7	O
-	O
H1	O
expressing	O
glia	B-ANAT
cells	B-ANAT
,	O
but	O
does	O
not	O
mediate	O
resistance	O
to	O
CD8	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
cytolysis	O
.	O

Soluble	O
receptor	O
for	O
advanced	O
glycation	O
endproducts	O
(	O
sRAGE	O
)	O
plays	O
a	O
key	O
regulatory	O
role	O
during	O
the	O
acute	O
phase	O
of	O
inflammation	O
,	O
and	O
baseline	O
plasma	B-ANAT
levels	O
of	O
sRAGE	O
were	O
recently	O
found	O
to	O
be	O
associated	O
with	O
severity	O
of	O
ALI	O
/	O
ARDS	O
.	O

Causes	O
of	O
cardiac	B-ANAT
shock	O
were	O
:	O
myocarditis	O
(	O
28	O
.	O
1	O
%),	O
acute	O
heart	B-ANAT
failure	O
of	O
unknown	O
aetiology	O
(	O
21	O
.	O
9	O
%),	O
drug	O
-	O
induced	O
cardiovascular	B-ANAT
failure	O
(	O
18	O
.	O
8	O
%),	O
post	O
-	O
infarction	O
cardiac	B-ANAT
failure	O
(	O
12	O
.	O
5	O
%),	O
post	O
-	O
cardiac	B-ANAT
surgery	O
(	O
12	O
.	O
5	O
%)	O
and	O
refractory	O
cardiac	B-ANAT
arrest	O
(	O
6	O
.	O
2	O
%).	O

The	O
results	O
of	O
our	O
study	O
clarify	O
how	O
each	O
virus	O
modulates	O
the	O
host	O
innate	O
and	O
adaptive	O
immune	O
responses	O
,	O
leading	O
to	O
inflammatory	O
reactions	O
and	O
lung	B-ANAT
pathology	O
.	O

CD4	O
(+)	O
CD25	O
(+)	O
Foxp3	O
(+)	O
regulatory	B-ANAT
T	I-ANAT
Cells	I-ANAT
(	O
Foxp3	O
(+)	O
Tregs	O
),	O
iNOS	O
and	O
cytokines	O
may	O
affect	O
these	O
severe	O
conditions	O
such	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multiple	O
organ	B-ANAT
failure	O
after	O
hemorrhagic	O
shock	O
and	O
resuscitation	O
.	O

Evaluation	O
of	O
the	O
characteristics	O
of	O
droplet	O
/	O
aerosol	O
dispersion	O
around	O
delivery	O
systems	O
during	O
non	O
-	O
invasive	O
ventilation	O
(	O
NIV	O
),	O
oxygen	O
therapy	O
,	O
nebuliser	O
treatment	O
and	O
chest	B-ANAT
physiotherapy	O
by	O
measuring	O
droplet	O
size	O
,	O
geographical	O
distribution	O
of	O
droplets	O
,	O
decay	O
in	O
droplets	O
over	O
time	O
after	O
the	O
interventions	O
were	O
discontinued	O
.	O

Three	O
groups	O
were	O
studied	O
:	O
(	O
1	O
)	O
normal	O
controls	O
,	O
(	O
2	O
)	O
subjects	O
with	O
coryzal	O
symptoms	O
and	O
(	O
3	O
)	O
adult	O
patients	O
with	O
chronic	O
lung	B-ANAT
disease	O
who	O
were	O
admitted	O
to	O
hospital	O
with	O
an	O
infective	O
exacerbation	O
.	O

TITLE	O
:	O
Evolved	O
variants	O
of	O
the	O
membrane	B-ANAT
protein	O
can	O
partially	O
replace	O
the	O
envelope	B-ANAT
protein	O
in	O
murine	O
coronavirus	O
assembly	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
TMPRSS2	O
being	O
required	O
in	O
the	O
target	B-ANAT
cell	I-ANAT
for	O
activation	O
of	O
a	O
viral	O
fusion	O
protein	O
but	O
not	O
for	O
the	O
S	O
protein	O
synthesized	O
in	O
and	O
transported	O
to	O
the	O
surface	O
of	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
analyzed	O
the	O
respiratory	O
status	O
and	O
the	O
prognosis	O
of	O
patients	O
,	O
including	O
adults	O
with	O
acute	O
respiratory	O
failure	O
requiring	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
ECMO	O
)	O
to	O
maintain	O
respiratory	O
status	O
.	O

In	O
all	O
cases	O
,	O
vivax	O
malaria	O
was	O
diagnosed	O
by	O
peripheral	B-ANAT
blood	I-ANAT
film	O
(	O
PBF	O
)	O
examination	O
.	O

Mortality	O
has	O
been	O
markedly	O
reduced	O
with	O
a	O
lung	B-ANAT
-	O
protective	O
ventilatory	O
strategy	O
.	O

ABSTRACT	O
:	O
Despite	O
improvements	O
in	O
ventilation	O
support	O
techniques	O
,	O
lung	B-ANAT
protection	O
strategies	O
,	O
and	O
the	O
application	O
of	O
new	O
support	O
treatment	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
continues	O
to	O
have	O
a	O
high	O
mortality	O
rate	O
.	O

The	O
currently	O
available	O
extracorporeal	O
lung	B-ANAT
assist	O
systems	O
are	O
described	O
in	O
this	O
article	O
,	O
including	O
high	O
flow	O
systems	O
such	O
as	O
traditional	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
COâ	O
removal	O
systems	O
(	O
interventional	O
lung	B-ANAT
assist	O
or	O
iLA	O
,	O
with	O
or	O
without	O
associated	O
centrifugal	O
pumps	O
),	O
and	O
the	O
new	O
low	O
flow	O
and	O
less	O
invasive	O
systems	O
under	O
development	O
.	O

Seven	O
days	O
later	O
,	O
after	O
the	O
pulmonary	B-ANAT
situation	O
had	O
improved	O
,	O
the	O
device	O
was	O
successfully	O
removed	O
;	O
the	O
patient	O
was	O
discharged	O
in	O
a	O
satisfactory	O
condition	O
after	O
another	O
month	O
.	O

CONCLUSIONS	O
:	O
ECMO	O
is	O
a	O
another	O
treatment	O
option	O
for	O
serious	O
ARDS	O
in	O
infection	O
-	O
related	O
worsening	O
of	O
pulmonary	B-ANAT
cystic	O
fibrosis	O
.	O

The	O
rapid	O
induction	O
of	O
autoantibodies	O
in	O
ARDS	O
and	O
severe	O
sepsis	O
suggests	O
that	O
ongoing	O
systemic	O
inflammation	O
and	O
associated	O
tissue	B-ANAT
destruction	O
mediate	O
the	O
break	O
in	O
tolerance	O
against	O
these	O
self	O
proteins	O
.	O

In	O
some	O
cases	O
,	O
the	O
patient	O
autoantibody	O
titers	O
remained	O
elevated	O
through	O
the	O
last	O
serum	B-ANAT
sample	I-ANAT
collected	O
.	O

Therefore	O
,	O
the	O
S	O
protein	O
is	O
not	O
anchored	O
in	O
the	O
viral	B-ANAT
membrane	I-ANAT
DRMs	O
as	O
they	O
are	O
known	O
to	O
occur	O
in	O
the	O
plasma	B-ANAT
membrane	I-ANAT
.	O

Nucleotide	O
substitution	O
in	O
the	O
viral	B-ANAT
genome	I-ANAT
occurs	O
frequently	O
during	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
expression	O
of	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
was	O
tightly	O
regulated	O
by	O
the	O
varying	O
concentration	O
of	O
doxcycline	O
in	O
the	O
constructed	O
double	O
-	O
stable	B-ANAT
cell	I-ANAT
line	I-ANAT
.	O

Under	O
a	O
fluorescence	O
microscope	O
,	O
it	O
was	O
observed	O
that	O
the	O
purified	O
fusion	O
protein	O
SARS	O
-	O
CoVN	O
-	O
GFP	O
was	O
attached	O
to	O
the	O
cell	B-ANAT
membrane	I-ANAT
of	O
CXCL16	O
-	O
transfected	O
cells	B-ANAT
,	O
indicating	O
that	O
SARS	O
-	O
CoVN	O
and	O
CXCL16	O
can	O
be	O
mutually	O
combined	O
.	O

Moreover	O
,	O
a	O
strong	O
cellular	B-ANAT
immune	O
response	O
demonstrated	O
by	O
elevated	O
IFN	O
-	O
Î³	O
and	O
IL	O
-	O
6	O
levels	O
was	O
also	O
observed	O
in	O
these	O
mice	O
.	O

By	O
hydrodynamic	O
injection	O
of	O
mTNFR1shRNA	O
plasmid	O
,	O
the	O
survival	O
rate	O
of	O
mice	O
,	O
hepatic	B-ANAT
pathological	O
change	O
were	O
examined	O
and	O
compared	O
between	O
mice	O
with	O
/	O
without	O
mTNFR1shRNA	O
plasmid	O
intervention	O
.	O

TITLE	O
:	O
Complete	O
genomic	O
sequence	O
of	O
transmissible	O
gastroenteritis	O
virus	O
TS	O
and	O
3	O
'	O
end	O
sequence	O
characterization	O
following	O
cell	B-ANAT
culture	O
.	O

Histologic	O
lesions	O
included	O
vacuolated	O
to	O
malacic	O
white	B-ANAT
matter	I-ANAT
in	O
the	O
brain	B-ANAT
stem	I-ANAT
,	O
cerebellum	B-ANAT
,	O
and	O
thalamus	B-ANAT
,	O
with	O
associated	O
lymphocytic	O
meningoencephalitis	O
.	O

A	O
17	O
-	O
year	O
-	O
old	O
girl	O
with	O
hepatorenal	O
polycystosis	O
received	O
a	O
liver	B-ANAT
and	O
kidney	B-ANAT
transplant	I-ANAT
at	O
37	O
months	O
previously	O
.	O

She	O
was	O
admitted	O
in	O
November	O
2009	O
with	O
a	O
2	O
-	O
week	O
history	O
of	O
fever	O
,	O
myalgia	O
,	O
general	O
malaise	O
,	O
cough	O
,	O
and	O
expectoration	B-ANAT
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
secondary	O
to	O
blood	B-ANAT
transfusion	O
related	O
P	O
.	O
ovale	O
malaria	O
infection	O
in	O
a	O
non	O
-	O
endemic	O
country	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
efficiently	O
inhibit	O
interferon	O
(	O
IFN	O
)	O
induction	O
in	O
nonhematopoietic	O
cells	B-ANAT
and	O
conventional	O
dendritic	B-ANAT
cells	I-ANAT
(	O
cDC	O
).	O

The	O
pulmonary	B-ANAT
imaging	O
changes	O
were	O
varied	O
,	O
including	O
ground	O
-	O
glass	O
opacity	O
,	O
consolidation	O
,	O
atelectasis	O
,	O
fluid	O
pneumothorax	O
and	O
pleural	B-ANAT
effusion	I-ANAT
,	O
and	O
manifestations	O
of	O
acute	O
pneumonia	O
and	O
interstitial	B-ANAT
pneumonia	O
simultaneously	O
.	O

Extensive	O
pulmonary	B-ANAT
infiltration	O
developed	O
quickly	O
,	O
and	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
occurred	O
in	O
5	O
patients	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
3	O
cases	O
.	O

The	O
severity	O
of	O
the	O
respiratory	O
failure	O
contrasted	O
with	O
the	O
absence	O
of	O
significant	O
liver	B-ANAT
or	O
renal	B-ANAT
dysfunction	O
.	O

(	O
1	O
)	O
The	O
125	O
cases	O
included	O
94	O
male	O
and	O
31	O
female	O
infants	O
,	O
vaginal	B-ANAT
delivery	O
occurred	O
in	O
80	O
cases	O
and	O
cesarean	O
section	O
in	O
45	O
cases	O
.	O

ABSTRACT	O
:	O
Type	O
I	O
interferons	O
(	O
IFNs	O
)	O
are	O
essential	O
to	O
the	O
clearance	O
of	O
viral	O
diseases	O
,	O
however	O
,	O
a	O
clear	O
distinction	O
between	O
genes	O
upregulated	O
by	O
direct	O
virus	O
-	O
cell	B-ANAT
interactions	O
and	O
genes	O
upregulated	O
by	O
secondary	O
IFN	O
production	O
has	O
not	O
been	O
made	O
.	O

RESULTS	O
:	O
Despite	O
strong	O
evidence	O
for	O
vaccination	O
and	O
antiviral	O
prophylaxis	O
providing	O
significant	O
protection	O
,	O
clinicians	O
believed	O
they	O
required	O
the	O
additional	O
combinations	O
of	O
both	O
masks	O
and	O
face	B-ANAT
shields	O
.	O

Based	O
on	O
WNv	O
screening	O
of	O
kidney	B-ANAT
tissue	B-ANAT
,	O
IHC	O
and	O
RT	O
-	O
PCR	O
were	O
in	O
agreement	O
with	O
95	O
.	O
45	O
%	O
(	O
21	O
/	O
22	O
)	O
for	O
positive	O
dead	O
birds	O
and	O
were	O
in	O
100	O
%	O
(	O
22	O
/	O
22	O
)	O
agreement	O
when	O
multi	O
-	O
organ	B-ANAT
screening	O
by	O
IHC	O
was	O
performed	O
.	O

TITLE	O
:	O
Contribution	O
of	O
neutrophils	B-ANAT
to	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Alphacoronavirus	O
transmissible	O
gastroenteritis	O
virus	O
nsp1	O
protein	O
suppresses	O
protein	O
translation	O
in	O
mammalian	O
cells	B-ANAT
and	O
in	O
cell	B-ANAT
-	O
free	O
HeLa	O
cell	B-ANAT
extracts	I-ANAT
but	O
not	O
in	O
rabbit	O
reticulocyte	B-ANAT
lysate	O
.	O

The	O
E	O
protein	O
is	O
made	O
in	O
excess	O
during	O
infection	O
and	O
has	O
been	O
shown	O
to	O
have	O
ion	O
channel	O
activity	O
in	O
planar	O
lipid	B-ANAT
bilayers	I-ANAT
.	O

The	O
latter	O
membrane	B-ANAT
fusion	O
requires	O
an	O
S	O
protein	O
conformational	O
flexibility	O
that	O
is	O
facilitated	O
by	O
proteolytic	O
cleavages	O
.	O

ACE2	O
and	O
TMPRSS2	O
colocalized	O
on	O
cell	B-ANAT
surfaces	O
and	O
enhanced	O
the	O
cell	B-ANAT
entry	O
of	O
both	O
SARS	O
S	O
-	O
pseudotyped	O
HIV	O
and	O
authentic	O
SARS	O
-	O
CoV	O
.	O
Enhanced	O
entry	O
correlated	O
with	O
TMPRSS2	O
-	O
mediated	O
proteolysis	O
of	O
both	O
S	O
and	O
ACE2	O
.	O

TITLE	O
:	O
Long	O
pentraxin	O
PTX3	O
deficiency	O
worsens	O
LPS	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Long	O
pentraxin	O
PTX3	O
is	O
an	O
inflammatory	O
mediator	O
and	O
a	O
component	O
of	O
the	O
humoral	O
arm	B-ANAT
of	O
innate	O
immunity	O
.	O

Interestingly	O
,	O
PTX3	O
deficiency	O
significantly	O
increased	O
the	O
magnitude	O
/	O
extent	O
of	O
lung	B-ANAT
injury	O
compared	O
to	O
that	O
in	O
WT	O
mice	O
.	O

PTX3	O
deficiency	O
also	O
enhanced	O
LPS	O
-	O
induced	O
tissue	B-ANAT
factor	O
expression	O
/	O
activation	O
in	O
the	O
lung	B-ANAT
and	O
increased	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
and	O
monocyte	B-ANAT
chemoattractant	O
protein	O
-	O
1	O
levels	O
in	O
the	O
plasma	B-ANAT
.	O

CONCLUSIONS	O
:	O
Our	O
data	O
suggest	O
that	O
the	O
endogenously	O
expressed	O
PTX3	O
plays	O
a	O
protective	O
role	O
in	O
the	O
pathogenesis	O
of	O
ALI	O
and	O
that	O
a	O
lack	O
of	O
PTX3	O
may	O
enhance	O
neutrophil	B-ANAT
recruitment	O
,	O
cell	B-ANAT
death	O
,	O
activation	O
of	O
coagulation	O
cascades	O
,	O
and	O
inflammatory	O
responses	O
in	O
the	O
lung	B-ANAT
.	O

The	O
observation	O
that	O
JHM	O
.	O
SD	O
infects	O
more	O
cells	B-ANAT
and	O
expresses	O
more	O
antigen	O
,	O
but	O
produces	O
less	O
infectious	O
virus	O
per	O
cell	B-ANAT
than	O
A59	O
,	O
implies	O
that	O
efficient	O
replication	O
is	O
not	O
always	O
a	O
correlate	O
of	O
high	O
neurovirulence	O
.	O

TITLE	O
:	O
Nucleic	B-ANAT
acid	O
amplification	O
-	O
based	O
diagnosis	O
of	O
respiratory	O
virus	O
infections	O
.	O

Nucleic	B-ANAT
acid	O
amplification	O
tests	O
(	O
NATs	O
)	O
that	O
first	O
appeared	O
two	O
decades	O
ago	O
have	O
been	O
developed	O
for	O
both	O
conventional	O
and	O
emerging	O
viruses	O
and	O
now	O
form	O
the	O
backbone	B-ANAT
of	O
the	O
clinical	O
laboratory	O
.	O

Orthopedic	O
and	O
general	O
surgical	O
procedures	O
were	O
included	O
and	O
discharges	B-ANAT
with	O
a	O
diagnosis	O
code	O
for	O
SA	O
were	O
identified	O
.	O

Aspiration	O
pneumonia	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
pulmonary	B-ANAT
embolism	O
(	O
PE	O
),	O
and	O
the	O
need	O
for	O
intubation	O
and	O
mechanical	O
ventilation	O
were	O
the	O
primary	O
outcomes	O
.	O

Patients	O
with	O
SA	O
developed	O
pulmonary	B-ANAT
complications	O
more	O
frequently	O
than	O
their	O
matched	O
controls	O
after	O
both	O
orthopedic	O
and	O
general	O
surgical	O
procedures	O
,	O
respectively	O
(	O
i	O
.	O
e	O
.,	O
aspiration	O
pneumonia	O
:	O
1	O
.	O
18	O
%	O
vs	O
0	O
.	O
84	O
%	O
and	O
2	O
.	O
79	O
%	O
vs	O
2	O
.	O
05	O
%;	O
ARDS	O
:	O
1	O
.	O
06	O
%	O
vs	O
0	O
.	O
45	O
%	O
and	O
3	O
.	O
79	O
%	O
vs	O
2	O
.	O
44	O
%;	O
intubation	O
/	O
mechanical	O
ventilation	O
:	O
3	O
.	O
99	O
%	O
vs	O
0	O
.	O
79	O
%	O
and	O
10	O
.	O
8	O
%	O
vs	O
5	O
.	O
94	O
%,	O
all	O
P	O
values	O
<	O
0	O
.	O
0001	O
).	O

SA	O
was	O
associated	O
with	O
a	O
significantly	O
higher	O
adjusted	O
OR	O
of	O
developing	O
pulmonary	B-ANAT
complications	O
after	O
both	O
orthopedic	O
and	O
general	O
surgical	O
procedures	O
,	O
respectively	O
,	O
with	O
the	O
exception	O
of	O
PE	O
(	O
OR	O
for	O
aspiration	O
pneumonia	O
:	O
1	O
.	O
41	O
[	O
1	O
.	O
35	O
,	O
1	O
.	O
47	O
]	O
and	O
1	O
.	O
37	O
[	O
1	O
.	O
33	O
,	O
1	O
.	O
41	O
];	O
for	O
ARDS	O
:	O
2	O
.	O
39	O
[	O
2	O
.	O
28	O
,	O
2	O
.	O
51	O
]	O
and	O
1	O
.	O
58	O
[	O
1	O
.	O
54	O
,	O
1	O
.	O
62	O
];	O
for	O
PE	O
:	O
OR	O
1	O
.	O
22	O
[	O
1	O
.	O
15	O
,	O
1	O
.	O
29	O
]	O
and	O
0	O
.	O
90	O
[	O
0	O
.	O
84	O
,	O
0	O
.	O
97	O
];	O
for	O
intubation	O
/	O
mechanical	O
ventilation	O
:	O
5	O
.	O
20	O
[	O
5	O
.	O
05	O
,	O
5	O
.	O
37	O
]	O
and	O
1	O
.	O
95	O
[	O
1	O
.	O
91	O
,	O
1	O
.	O
98	O
]).	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
responsible	O
for	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
ranging	O
from	O
common	O
colds	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

There	O
are	O
multiple	O
factors	O
in	O
the	O
pathogenesis	O
of	O
Acute	O
decompression	O
syndrome	O
(	O
Caisson	O
'	O
s	O
disease	O
)	O
such	O
as	O
health	O
problems	O
in	O
divers	O
(	O
respiratory	O
problems	O
or	O
congenital	O
heart	B-ANAT
diseases	O
like	O
atrial	B-ANAT
septal	O
defect	O
,	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
etc	O
),	O
speed	O
of	O
ascent	O
from	O
the	O
depth	O
and	O
habits	O
like	O
smoking	O
that	O
render	O
divers	O
susceptible	O
for	O
such	O
neurological	O
emergency	O
.	O

adjusted	O
odds	O
ratios	O
describing	O
the	O
associations	O
between	O
chronic	O
maternal	O
heart	B-ANAT
disease	O
and	O
severe	O
obstetric	O
complications	O
were	O
obtained	O
from	O
multivariable	O
logistic	O
models	O
.	O

The	O
contribution	O
of	O
chronic	O
heart	B-ANAT
disease	O
to	O
severe	O
morbidity	O
was	O
estimated	O
using	O
adjusted	O
population	O
-	O
attributable	O
fractions	O
.	O

in	O
2004	O
-	O
2006	O
,	O
about	O
1	O
.	O
4	O
%	O
of	O
delivery	O
hospitalisations	O
were	O
complicated	O
with	O
chronic	O
heart	B-ANAT
disease	O
.	O

Even	O
so	O
,	O
a	O
linear	O
increase	O
was	O
found	O
for	O
specific	O
congenital	O
heart	B-ANAT
disease	O
,	O
cardiac	B-ANAT
dysrhythmias	O
,	O
and	O
cardiomyopathy	O
and	O
congestive	O
heart	B-ANAT
failure	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

in	O
the	O
USA	O
chronic	O
heart	B-ANAT
disease	O
among	O
women	O
hospitalised	O
during	O
pregnancy	O
may	O
have	O
increased	O
in	O
severity	O
from	O
1995	O
to	O
2006	O
.	O

Antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
FIPV	O
infection	O
has	O
been	O
recognized	O
,	O
and	O
cellular	B-ANAT
immunity	O
is	O
considered	O
to	O
play	O
an	O
important	O
role	O
in	O
preventing	O
the	O
onset	O
of	O
feline	O
infectious	O
peritonitis	O
.	O

The	O
blood	B-ANAT
test	O
for	O
toxoplasmosis	O
,	O
syphilis	O
,	O
varicella	O
-	O
zoster	O
,	O
rubella	O
,	O
cytomegalovirus	O
,	O
and	O
herpes	O
simplex	B-ANAT
virus	O
(	O
TORCH	O
)	O
complex	O
and	O
various	O
metabolic	O
tests	O
of	O
blood	B-ANAT
and	O
urine	B-ANAT
specimens	O
yielded	O
unremarkable	O
results	O
.	O

Severe	O
,	O
asymmetrical	O
ventricular	B-ANAT
dilation	O
associated	O
with	O
hydrocephalus	O
,	O
cerebellar	B-ANAT
and	O
brainstem	B-ANAT
hypoplasia	O
,	O
and	O
punctuate	O
calcifications	O
of	O
the	O
thalamus	B-ANAT
,	O
third	O
and	O
fourth	B-ANAT
ventricles	I-ANAT
,	O
around	O
the	O
aqueduct	B-ANAT
,	O
were	O
observed	O
on	O
computed	O
tomography	O
(	O
CT	O
).	O

Partial	O
protection	O
against	O
rotavirus	O
-	O
induced	O
diarrhea	O
was	O
achieved	O
in	O
suckling	O
BALB	O
/	O
c	O
mice	O
born	O
to	O
dams	O
immunized	O
with	O
the	O
recombinant	O
virus	O
expressing	O
VP7	O
when	O
they	O
were	O
orally	B-ANAT
challenged	O
with	O
the	O
homotypic	O
rotavirus	O
strain	O
.	O

ABSTRACT	O
:	O
The	O
results	O
of	O
meta	O
-	O
analyses	O
on	O
the	O
effectiveness	O
of	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
and	O
prone	O
positioning	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
not	O
consistent	O
.	O

When	O
overlap	O
with	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
or	O
development	O
to	O
Bickerstaff	O
brainstem	B-ANAT
encephalitis	O
occurs	O
,	O
plasma	B-ANAT
exchange	O
or	O
IVIg	O
should	O
be	O
administered	O
as	O
early	O
as	O
possible	O
because	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
can	O
cause	O
respiratory	O
failure	O
or	O
severe	O
weakness	O
with	O
axonal	O
degeneration	O
,	O
and	O
Bickerstaff	O
brainstem	B-ANAT
encephalitis	O
may	O
not	O
have	O
as	O
good	O
a	O
natural	O
course	O
as	O
Fisher	O
syndrome	O
alone	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
22	O
-	O
year	O
-	O
old	O
man	O
who	O
presented	O
,	O
two	O
days	O
after	O
industrial	O
accident	O
causing	O
an	O
opened	O
tibial	B-ANAT
fracture	O
,	O
acute	O
dyspnea	O
with	O
hemoptysis	O
.	O

Angio	O
-	O
CT	O
-	O
scan	O
didn	O
'	O
t	O
show	O
any	O
proximal	O
vascular	B-ANAT
obstruction	O
,	O
but	O
parenchymal	O
sections	O
showed	O
diffuse	O
,	O
bilateral	O
and	O
multifocal	O
hyperdensities	O
predominating	O
at	O
the	O
periphery	O
.	O

The	O
diagnosis	O
of	O
intra	O
-	O
alveolar	B-ANAT
hemorrhage	O
secondary	O
to	O
fat	O
embolism	O
was	O
established	O
.	O

It	O
is	O
mandatory	O
to	O
eliminate	O
the	O
other	O
causes	O
of	O
alveolar	B-ANAT
hemorrhage	O
before	O
holding	O
the	O
diagnosis	O
of	O
fat	O
embolism	O
.	O

In	O
an	O
experimental	O
study	O
,	O
we	O
induced	O
ALI	O
by	O
intratracheal	O
instillation	O
of	O
hydrochloric	O
acid	O
(	O
HCl	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
)	O
in	O
mice	O
,	O
and	O
similarly	O
measured	O
NEP	O
activity	O
in	O
plasma	B-ANAT
,	O
lung	B-ANAT
tissue	I-ANAT
,	O
and	O
broncho	O
-	O
alveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
).	O

We	O
also	O
studied	O
the	O
distribution	O
and	O
measured	O
the	O
amounts	O
of	O
NEP	O
protein	O
,	O
using	O
immuno	O
-	O
histochemical	O
and	O
immunoblot	O
analyses	O
,	O
and	O
measured	O
the	O
levels	O
of	O
NEP	O
mRNA	O
,	O
using	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
in	O
the	O
lungs	B-ANAT
of	O
mice	O
with	O
ALI	O
.	O

We	O
sought	O
to	O
determine	O
whether	O
the	O
degree	O
of	O
pulmonary	B-ANAT
hypoplasia	O
could	O
be	O
measured	O
using	O
bedside	O
pulmonary	B-ANAT
graphics	O
and	O
whether	O
survival	O
could	O
be	O
predicted	O
in	O
potential	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
candidates	O
.	O

We	O
conclude	O
that	O
bedside	O
V	O
(	O
T	O
)	O
can	O
be	O
easily	O
measured	O
and	O
that	O
values	O
<	O
3	O
mL	O
/	O
kg	O
or	O
<	O
0	O
.	O
2	O
mL	O
/	O
cm	O
length	O
demarcate	O
severe	O
lung	B-ANAT
hypoplasia	O
,	O
which	O
in	O
our	O
patient	O
population	O
was	O
incompatible	O
with	O
survival	O
.	O

TITLE	O
:	O
Comparison	O
of	O
two	O
oral	B-ANAT
symptom	O
-	O
triggered	O
pharmacological	O
inpatient	O
treatments	O
of	O
acute	O
alcohol	O
withdrawal	O
:	O
clomethiazole	O
vs	O
.	O
clonazepam	O
.	O

Secondary	O
outcome	O
values	O
were	O
heart	B-ANAT
rate	O
,	O
blood	B-ANAT
and	O
pulse	O
pressure	O
.	O

Tracheal	O
intubation	O
is	O
the	O
optimal	O
method	O
for	O
securing	O
the	O
airway	B-ANAT
during	O
resuscitation	O
but	O
should	O
be	O
performed	O
only	O
by	O
experienced	O
airway	B-ANAT
management	O
providers	O
.	O

ACUTE	O
CORONARY	B-ANAT
SYNDROME	O
:	O
Even	O
if	O
only	O
a	O
weak	O
suspicion	O
of	O
an	O
acute	O
coronary	B-ANAT
syndrome	O
is	O
present	O
,	O
record	O
a	O
prehospital	O
12	O
-	O
lead	O
ECG	O
.	O

TITLE	O
:	O
Clinical	O
,	O
serologic	O
and	O
magnetic	O
resonance	O
imaging	O
of	O
3	O
cases	O
of	O
inflammatory	O
myopathy	O
with	O
abundant	O
macrophages	B-ANAT
in	O
the	O
Japanese	O
population	O
.	O

The	O
unmodified	O
peptide	O
takes	O
on	O
an	O
orientation	O
within	O
lipid	B-ANAT
bilayers	I-ANAT
that	O
is	O
tilted	O
approximately	O
30	O
Â°	O
away	O
from	O
an	O
in	O
-	O
plane	O
position	O
.	O

TITLE	O
:	O
Rapid	O
and	O
sensitive	O
detection	O
of	O
bovine	O
coronavirus	O
and	O
group	O
a	O
bovine	O
rotavirus	O
from	O
fecal	B-ANAT
samples	O
by	O
using	O
one	O
-	O
step	O
duplex	O
RT	O
-	O
PCR	O
assay	O
.	O

ABSTRACT	O
:	O
Electrical	O
discharge	B-ANAT
processes	O
are	O
emerging	O
as	O
water	O
treatment	O
technologies	O
applicable	O
to	O
both	O
the	O
degradation	O
of	O
organic	O
contaminants	O
as	O
well	O
as	O
inactivation	O
of	O
pathogens	O
.	O

Two	O
children	O
received	O
treatment	O
with	O
oseltamivir	O
(	O
one	O
boy	O
with	O
congenital	O
heart	B-ANAT
defect	O
and	O
Down	O
'	O
s	O
syndrome	O
and	O
another	O
with	O
severe	O
bronchial	B-ANAT
asthma	O
).	O

TITLE	O
:	O
[	O
Study	O
on	O
the	O
changing	O
regularity	O
of	O
special	O
antibody	O
and	O
expression	O
of	O
stomach	B-ANAT
and	O
enteric	O
involvement	O
on	O
SARS	O
-	O
coronavirus	O
infection	O
in	O
the	O
recovery	O
period	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
].	O

The	O
other	O
two	O
cases	O
showed	O
negative	O
on	O
both	O
serum	B-ANAT
N	O
protein	O
antibody	O
and	O
immunohistochemical	O
expression	O
.	O

The	O
biopsy	O
results	O
of	O
the	O
5	O
patients	O
were	O
as	O
follows	O
:	O
1	O
case	O
diagnosed	O
as	O
""""	O
signet	O
-	O
ring	O
cell	B-ANAT
carcinoma	O
of	O
the	O
stomach	B-ANAT
and	O
rectum	B-ANAT
multiple	O
transfer	O
""","	O
1	O
case	O
of	O
gastric	B-ANAT
polyp	O
,	O
1	O
case	O
of	O
superficial	O
antral	O
gastritis	O
and	O
2	O
cases	O
were	O
normal	O
.	O

The	O
nucleocapsid	B-ANAT
antibody	O
titer	O
was	O
related	O
to	O
pathogenetic	O
condition	O
.	O

SARS	O
-	O
CoV	O
was	O
proved	O
to	O
be	O
still	O
present	O
in	O
stomach	B-ANAT
and	O
enteric	O
tissues	B-ANAT
of	O
SARS	O
patients	O
with	O
the	O
nucleocapsid	B-ANAT
antibody	O
titer	O
increased	O
significantly	O
after	O
the	O
7	O
(	O
th	O
)	O
year	O
.	O

RESULTS	O
:	O
When	O
testing	O
the	O
IgG	B-ANAT
antibody	I-ANAT
titer	O
of	O
the	O
14	O
SARS	O
patients	O
by	O
IFA	O
method	O
,	O
the	O
average	O
titer	O
was	O
1	O
/	O
71	O
(	O
95	O
%	O
CI	O
:	O
1	O
/	O
58	O
-	O
1	O
/	O
85	O
)	O
in	O
the	O
1	O
(	O
st	O
)	O
year	O
,	O
but	O
began	O
to	O
descend	O
in	O
the	O
following	O
years	O
,	O
and	O
the	O
IgG	B-ANAT
antibody	I-ANAT
of	O
the	O
most	O
SARS	O
patients	O
disappeared	O
in	O
the	O
7	O
(	O
th	O
)	O
year	O
.	O

The	O
biopsy	O
results	O
of	O
the	O
5	O
patients	O
were	O
as	O
follows	O
:	O
1	O
case	O
diagnosed	O
as	O
""""	O
signet	O
-	O
ring	O
cell	B-ANAT
carcinoma	O
of	O
the	O
stomach	B-ANAT
and	O
rectum	B-ANAT
multiple	O
transfer	O
""","	O
1	O
case	O
of	O
gastric	B-ANAT
polyp	O
,	O
1	O
case	O
of	O
superficial	O
antral	O
gastritis	O
and	O
2	O
cases	O
were	O
normal	O
.	O

All	O
cats	O
had	O
heart	B-ANAT
murmurs	O
and	O
echocardiographic	O
signs	O
consistent	O
with	O
hypertrophic	O
cardiomyopathy	O
.	O

An	O
enlarged	O
left	B-ANAT
atrium	I-ANAT
was	O
found	O
in	O
all	O
cats	O
and	O
two	O
of	O
three	O
cats	O
also	O
had	O
spontaneous	O
echocardiographic	O
contrast	O
.	O

Plasmapheresis	O
should	O
be	O
considered	O
in	O
cases	O
of	O
CHF	O
secondary	O
to	O
hyperviscosity	O
syndrome	O
to	O
rapidly	O
alleviate	O
clinical	O
signs	O
associated	O
with	O
heart	B-ANAT
failure	O
while	O
diagnosis	O
of	O
the	O
underlying	O
cause	O
is	O
made	O
and	O
appropriate	O
therapy	O
implemented	O
.	O

Coronavirus	O
particles	O
were	O
observed	O
in	O
the	O
feces	B-ANAT
via	O
electron	O
microscopy	O
.	O

ABSTRACT	O
:	O
Porcine	O
aminopeptidase	O
N	O
(	O
pAPN	O
)	O
is	O
a	O
cellular	B-ANAT
receptor	O
of	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
a	O
porcine	O
coronavirus	O
.	O

Interaction	O
between	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
TGEV	O
and	O
pAPN	O
initiates	O
cell	B-ANAT
infection	O
.	O

Transfection	O
of	O
small	O
interfering	O
RNAs	O
targeting	O
either	O
C11orf59	O
or	O
Golgi	B-ANAT
apparatus	I-ANAT
glycoprotein	O
1	O
resulted	O
in	O
increased	O
virus	O
replication	O
,	O
whereas	O
depletion	O
of	O
vesicle	B-ANAT
-	O
trafficking	O
protein	O
vesicle	B-ANAT
-	O
trafficking	O
protein	O
sec22b	O
enhanced	O
the	O
release	O
of	O
infectious	O
progeny	O
virus	O
.	O

Although	O
beneficial	O
or	O
detrimental	O
contributions	O
of	O
ASC	O
to	O
CNS	B-ANAT
diseases	O
remain	O
to	O
be	O
defined	O
,	O
virus	O
-	O
specific	O
ASC	O
are	O
crucial	O
in	O
controlling	O
persistent	O
CNS	B-ANAT
infection	O
following	O
coronavirus	O
-	O
induced	O
encephalomyelitis	O
.	O

Moreover	O
,	O
both	O
APRIL	O
and	O
BAFF	O
were	O
predominantly	O
localized	O
to	O
astrocytes	B-ANAT
.	O

However	O
,	O
the	O
cellular	B-ANAT
and	O
molecular	O
mechanisms	O
underlying	O
the	O
acute	O
disease	O
are	O
still	O
not	O
well	O
understood	O
.	O

Fluorescein	O
-	O
KCl	O
solution	O
was	O
sprayed	O
onto	O
the	O
faces	B-ANAT
of	O
participants	O
wearing	O
the	O
facemasks	O
and	O
performing	O
intermittent	O
exercises	O
on	O
a	O
treadmill	O
in	O
a	O
climatic	O
chamber	B-ANAT
.	O

RESULTS	O
:	O
Experimental	O
results	O
showed	O
that	O
when	O
droplets	O
spread	O
onto	O
a	O
person	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
over	O
short	O
distances	O
,	O
92	O
.	O
3	O
%	O
to	O
99	O
.	O
5	O
%	O
of	O
droplets	O
were	O
blocked	O
by	O
the	O
front	O
surface	O
of	O
the	O
facemask	O
,	O
whereas	O
only	O
0	O
.	O
5	O
%	O
to	O
7	O
.	O
7	O
%	O
of	O
droplets	O
reached	O
the	O
back	B-ANAT
of	O
the	O
facemask	O
.	O

Here	O
we	O
report	O
the	O
crystal	B-ANAT
structures	O
of	O
the	O
two	O
proteolytically	O
resistant	O
N	O
-	O
(	O
NTD	O
)	O
and	O
C	O
-	O
terminal	O
(	O
CTD	O
)	O
domains	O
of	O
the	O
N	O
protein	O
from	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

The	O
similarity	O
between	O
the	O
structures	O
of	O
these	O
two	O
domains	O
from	O
SARS	O
-	O
CoV	O
,	O
IBV	O
and	O
MHV	O
corroborates	O
a	O
conserved	O
mechanism	O
of	O
nucleocapsid	B-ANAT
formation	O
for	O
coronaviruses	O
.	O

TITLE	O
:	O
Sequence	O
analysis	O
of	O
the	O
nucleocapsid	B-ANAT
gene	O
of	O
feline	O
coronaviruses	O
circulating	O
in	O
Italy	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
was	O
isolated	O
from	O
trachea	B-ANAT
and	O
kidney	B-ANAT
tissues	B-ANAT
of	O
eight	O
broiler	O
farms	O
in	O
Kurdistan	O
region	O
of	O
North	O
Iraq	O
from	O
2008	O
to	O
2010	O
.	O

In	O
serial	O
blood	B-ANAT
examinations	O
of	O
the	O
effusive	O
group	O
,	O
anaemia	O
and	O
increases	O
in	O
bilirubin	O
and	O
aspartate	O
aminotransferase	O
(	O
AST	O
)	O
were	O
observed	O
from	O
2	O
weeks	O
to	O
0	O
-	O
3	O
days	O
before	O
death	O
.	O

However	O
,	O
it	O
is	O
not	O
known	O
whether	O
this	O
increase	O
is	O
linked	O
to	O
its	O
involvement	O
in	O
alveolar	B-ANAT
epithelium	I-ANAT
injury	O
or	O
in	O
systemic	O
inflammation	O
.	O

A	O
total	O
of	O
64	O
consecutive	O
subjects	O
,	O
divided	O
into	O
four	O
groups	O
:	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
15	O
);	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
plus	O
severe	O
sepsis	O
/	O
septic	O
shock	O
(	O
n	O
=	O
18	O
);	O
severe	O
sepsis	O
/	O
septic	O
shock	O
(	O
n	O
=	O
16	O
);	O
and	O
mechanically	O
ventilated	O
controls	O
(	O
n	O
=	O
15	O
).	O

Plasma	B-ANAT
sRAGE	O
levels	O
were	O
measured	O
at	O
baseline	O
and	O
on	O
days	O
3	O
,	O
6	O
,	O
and	O
28	O
(	O
or	O
at	O
intensive	O
care	O
unit	O
discharge	B-ANAT
,	O
whichever	O
occurred	O
first	O
).	O

The	O
plasma	B-ANAT
level	O
of	O
sRAGE	O
was	O
correlated	O
with	O
clinical	O
and	O
radiographic	O
severity	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
and	O
decreased	O
over	O
time	O
,	O
suggesting	O
resolution	O
of	O
the	O
injury	O
to	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
N	O
-	O
terminal	O
S1	O
region	O
of	O
the	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
spike	O
(	O
S	O
)	O
glycoprotein	O
contains	O
four	O
antigenic	O
sites	O
(	O
C	O
,	O
B	O
,	O
D	O
and	O
A	O
,	O
from	O
the	O
N	O
-	O
to	O
the	O
C	O
-	O
terminal	O
end	O
)	O
and	O
is	O
engaged	O
in	O
host	O
-	O
cell	B-ANAT
receptor	O
recognition	O
.	O

Autopsy	O
revealed	O
a	O
predominantly	O
lymphocytic	O
myocarditis	O
in	O
the	O
absence	O
of	O
a	O
significant	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
.	O

In	O
conclusion	O
,	O
sudden	O
death	O
by	O
myocarditis	O
may	O
be	O
a	O
rare	O
complication	O
of	O
novel	O
influenza	O
A	O
/	O
H1N1	O
infection	O
in	O
otherwise	O
healthy	O
individuals	O
,	O
even	O
in	O
the	O
absence	O
of	O
significant	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
.	O

Two	O
patients	O
most	O
likely	O
had	O
pre	O
-	O
existent	O
cardiac	B-ANAT
pathologies	O
,	O
and	O
three	O
required	O
catecholamine	O
therapy	O
to	O
maintain	O
hemodynamic	O
function	O
.	O

Symptoms	O
were	O
scored	O
and	O
nasal	B-ANAT
lavages	O
carried	O
out	O
.	O

Myeloperoxidase	O
(	O
MPO	O
)	O
and	O
Î±	O
-	O
defensins	O
were	O
monitored	O
as	O
indices	O
of	O
neutrophil	B-ANAT
activity	O
.	O

Supernatants	O
from	O
neutrophils	B-ANAT
activated	O
by	O
LTB4	O
in	O
vitro	O
were	O
assayed	O
for	O
virucidal	O
activity	O
against	O
respiratory	O
viruses	O
.	O

The	O
herd	O
status	O
regarding	O
the	O
calves	O
'	O
passive	O
transfer	O
(	O
total	O
protein	O
),	O
levels	O
of	O
Î±	O
-	O
tocopherol	O
,	O
Î²	O
-	O
carotene	O
and	O
retinol	O
,	O
and	O
excretion	O
of	O
faecal	B-ANAT
pathogens	O
(	O
Cryptosporidium	O
spp	O
.,	O
Escherichia	O
coli	O
F5	O
,	O
rota	O
and	O
corona	O
virus	O
)	O
was	O
evaluated	O
based	O
on	O
targeted	O
sampling	O
of	O
high	O
risk	O
calf	B-ANAT
groups	O
;	O
in	O
each	O
herd	O
,	O
blood	B-ANAT
and	O
faecal	B-ANAT
samples	O
were	O
collected	O
from	O
calves	O
1	O
-	O
7	O
and	O
1	O
-	O
14	O
days	O
old	O
,	O
respectively	O
.	O

The	O
variable	O
""""	O
Average	O
number	O
of	O
faecal	B-ANAT
pathogens	O
in	O
the	O
sampled	O
target	O
group	O
""""	O
was	O
significantly	O
associated	O
with	O
higher	O
odds	O
of	O
being	O
a	O
HM	O
herd	O
(	O
OR	O
=	O
4	O
.	O
65	O
;	O
p	O
=	O
0	O
.	O
015	O
),	O
with	O
a	O
higher	O
average	O
in	O
HM	O
herds	O
.	O

Acute	O
lung	B-ANAT
injury	O
was	O
diagnosed	O
in	O
23	O
(	O
27	O
.	O
7	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
was	O
diagnosed	O
in	O
34	O
(	O
41	O
%),	O
and	O
51	O
(	O
61	O
.	O
4	O
%)	O
patients	O
were	O
mechanically	O
ventilated	O
.	O

Multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
is	O
associated	O
with	O
increased	O
mortality	O
,	O
and	O
death	O
is	O
frequently	O
secondary	O
to	O
severe	O
lung	B-ANAT
infection	O
caused	O
by	O
pandemic	O
influenza	O
.	O

As	O
the	O
costs	O
of	O
next	O
-	O
generation	O
sequencing	O
decrease	O
,	O
the	O
pathogen	O
diversity	O
described	O
by	O
virus	O
metagenomes	O
will	O
provide	O
an	O
unbiased	O
guide	O
for	O
subsequent	O
cell	B-ANAT
culture	O
and	O
quantitative	O
pathogen	O
analyses	O
and	O
ensures	O
that	O
highly	O
enriched	O
and	O
relevant	O
pathogens	O
are	O
not	O
neglected	O
in	O
exposure	O
and	O
risk	O
assessments	O
.	O

ABSTRACT	O
:	O
A	O
new	O
equine	O
coronavirus	O
was	O
isolated	O
from	O
the	O
feces	B-ANAT
of	O
adult	O
horses	O
with	O
pyrogenic	O
and	O
enteric	O
disease	O
.	O

We	O
highlight	O
the	O
importance	O
of	O
high	O
index	O
of	O
suspicion	O
of	O
this	O
reversible	O
encephalopathy	O
in	O
obstetric	O
cases	O
with	O
intentional	O
or	O
inadvertent	O
dural	O
puncture	O
,	O
with	O
headache	O
similar	O
to	O
post	O
-	O
dural	O
punctural	O
headache	O
,	O
and	O
the	O
essential	O
role	O
of	O
neuroradiology	O
in	O
confirmation	O
of	O
the	O
diagnosis	O
,	O
as	O
placement	O
of	O
an	O
epidural	B-ANAT
blood	B-ANAT
patch	O
would	O
be	O
highly	O
detrimental	O
in	O
these	O
cases	O
.	O

LPS	O
administration	O
resulted	O
in	O
multiple	O
organ	B-ANAT
failure	O
,	O
leading	O
to	O
increased	O
mortality	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
whether	O
genetic	O
variations	O
in	O
the	O
gene	O
coding	O
for	O
surfactant	O
protein	O
B	O
are	O
associated	O
with	O
lung	B-ANAT
injury	O
in	O
African	O
American	O
children	O
with	O
community	O
-	O
acquired	O
pneumonia	O
.	O

Genetic	O
variations	O
in	O
the	O
gene	O
coding	O
for	O
surfactant	O
protein	O
B	O
are	O
associated	O
with	O
more	O
severe	O
lung	B-ANAT
injury	O
as	O
indicated	O
by	O
the	O
association	O
of	O
specific	O
single	O
nucleotide	O
polymorphism	O
genotypes	O
and	O
haplotypes	O
with	O
the	O
need	O
for	O
mechanical	O
ventilation	O
in	O
African	O
American	O
children	O
with	O
community	O
-	O
acquired	O
pneumonia	O
.	O

TITLE	O
:	O
[	O
Transfusion	O
policy	O
in	O
trauma	O
involving	O
massive	O
blood	B-ANAT
loss	O
].	O

Research	O
in	O
wounded	O
military	O
showed	O
that	O
a	O
high	O
ratio	O
of	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
to	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
FFP	O
:	O
PRBC	O
)	O
seemed	O
to	O
have	O
a	O
positive	O
effect	O
on	O
survival	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
prognostic	O
value	O
of	O
corpus	B-ANAT
callosum	I-ANAT
lesions	O
(	O
CCL	O
)	O
and	O
brain	B-ANAT
stem	I-ANAT
lesions	O
(	O
BSL	O
)	O
in	O
diffuse	O
axonal	O
injury	O
(	O
DAI	O
)	O
patients	O
.	O

In	O
this	O
article	O
,	O
we	O
show	O
that	O
IL	O
-	O
10	O
,	O
a	O
potent	O
anti	O
-	O
inflammatory	O
cytokine	O
,	O
is	O
produced	O
transiently	O
at	O
the	O
peak	O
of	O
infection	O
by	O
CD8	O
T	B-ANAT
cells	I-ANAT
in	O
the	O
brains	B-ANAT
of	O
coronavirus	O
-	O
infected	O
mice	O
.	O

TITLE	O
:	O
A	O
miniaturized	O
extracorporeal	O
membrane	B-ANAT
oxygenator	O
with	O
integrated	O
rotary	O
blood	B-ANAT
pump	O
:	O
preclinical	O
in	O
vivo	O
testing	O
.	O

Earlier	O
research	O
determined	O
metabolic	O
oxidative	O
stress	O
in	O
hosts	O
deficient	O
in	O
antioxidant	O
selenium	O
(	O
Se	O
)	O
(<	O
1	O
Î¼Mol	O
Se	O
/	O
L	O
of	O
blood	B-ANAT
)	O
induces	O
both	O
impaired	O
human	O
host	O
immunocompetence	O
and	O
rapidly	O
mutated	O
benign	O
variants	O
of	O
RNA	O
viruses	O
to	O
virulence	O
.	O

TITLE	O
:	O
Evidence	O
that	O
TMPRSS2	O
activates	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
protein	O
for	O
membrane	B-ANAT
fusion	O
and	O
reduces	O
viral	O
control	O
by	O
the	O
humoral	O
immune	O
response	O
.	O

This	O
study	O
assessed	O
the	O
effect	O
of	O
human	O
coronavirus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
)	O
on	O
the	O
adherence	O
of	O
bacterial	O
pathogens	O
associated	O
with	O
respiratory	B-ANAT
tract	I-ANAT
illnesses	O
.	O

Among	O
the	O
7	O
,	O
872	O
assembled	O
sequences	O
that	O
were	O
identified	O
as	O
from	O
human	O
genome	O
,	O
578	O
non	O
-	O
coding	O
genes	O
were	O
revealed	O
by	O
BLAST	B-ANAT
search	O
.	O

Four	O
genotypes	O
of	O
IBV	O
and	O
three	O
new	O
isolates	O
were	O
identified	O
by	O
phylogenetic	O
analysis	O
and	O
BLAST	B-ANAT
searches	O
of	O
the	O
entire	O
S1	O
gene	O
.	O

A	O
23	O
-	O
month	O
-	O
old	O
female	O
with	O
complete	O
immune	O
-	O
incompetent	O
DiGeorge	O
anomaly	O
65	O
days	O
after	O
allogenic	O
thymus	B-ANAT
transplantation	O
was	O
treated	O
in	O
our	O
pediatric	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
failure	O
secondary	O
to	O
bacterial	O
sepsis	O
.	O

Ribosomal	B-ANAT
protein	O
L18	O
was	O
identified	O
as	O
the	O
most	O
stable	O
internal	O
reference	O
gene	O
.	O

Patients	O
who	O
had	O
prehospital	O
use	O
of	O
both	O
statins	O
and	O
aspirin	O
had	O
the	O
lowest	O
rates	O
of	O
severe	O
sepsis	O
,	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
mortality	O
.	O

Catastrophic	O
antiphospholipid	O
syndrome	O
(	O
CAPS	O
),	O
in	O
contradistinction	O
to	O
APS	O
,	O
is	O
defined	O
as	O
three	O
or	O
more	O
organs	B-ANAT
affected	O
by	O
thrombotic	O
microangiopathy	O
in	O
patients	O
demonstrating	O
aPL	O
and	O
can	O
result	O
in	O
mortality	O
up	O
to	O
50	O
%.	O

We	O
describe	O
a	O
unique	O
SLE	O
patient	O
who	O
was	O
diagnosed	O
with	O
recurrent	O
APS	O
presented	O
with	O
axillary	B-ANAT
venous	B-ANAT
thrombosis	O
and	O
subsequent	O
superficial	O
edema	O
and	O
compartment	B-ANAT
syndrome	O
.	O

Though	O
emergency	O
transcatheter	O
arterial	B-ANAT
embolization	O
(	O
TAE	O
)	O
of	O
the	O
left	O
fourth	O
ICA	O
was	O
successfully	O
accomplished	O
by	O
the	O
radiologist	O
.	O

TITLE	O
:	O
Eosinophils	B-ANAT
:	O
collection	O
,	O
separation	O
,	O
and	O
activation	O
.	O

Apart	O
from	O
being	O
cytotoxic	O
,	O
these	O
cells	B-ANAT
are	O
also	O
involved	O
in	O
maintaining	O
inflammatory	O
reactions	O
by	O
the	O
release	O
of	O
cytokines	O
and	O
bioactive	O
lipids	O
such	O
as	O
platelet	B-ANAT
-	O
activating	O
factor	O
and	O
arachidonic	O
acid	O
metabolites	O
.	O

The	O
lack	O
of	O
foot	B-ANAT
flexion	O
ability	O
at	O
ICU	O
admission	O
and	O
at	O
the	O
end	O
of	O
immunotherapy	O
was	O
significantly	O
associated	O
with	O
MV	O
length	O
>	O
15	O
days	O
(	O
positive	O
predictive	O
value	O
:	O
82	O
%;	O
odds	O
ratio	O
:	O
5	O
.	O
4	O
[	O
1	O
.	O
2	O
-	O
23	O
.	O
8	O
]	O
and	O
82	O
%;	O
6	O
.	O
4	O
[	O
1	O
.	O
4	O
-	O
28	O
.	O
8	O
],	O
respectively	O
).	O

Treatment	O
with	O
UDA	O
at	O
5	O
mg	O
/	O
kg	O
significantly	O
protected	O
the	O
mice	O
against	O
a	O
lethal	O
infection	O
with	O
mouse	O
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
but	O
did	O
not	O
significantly	O
reduce	O
virus	O
lung	B-ANAT
titers	O
.	O

ABSTRACT	O
:	O
Virus	O
entry	O
into	O
and	O
release	O
from	O
epithelial	B-ANAT
cells	I-ANAT
are	O
polarized	O
as	O
a	O
result	O
of	O
the	O
distribution	O
of	O
the	O
viral	O
receptors	O
.	O

In	O
CrFK	O
cells	B-ANAT
,	O
CCoV	O
was	O
observed	O
in	O
both	O
compartments	B-ANAT
only	O
in	O
the	O
later	O
phase	O
of	O
the	O
infection	O
.	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
LJB	O
/	O
03	O
strain	O
was	O
isolated	O
from	O
the	O
feces	B-ANAT
of	O
piglets	O
suspected	O
to	O
be	O
suffering	O
from	O
a	O
severe	O
diarrhea	O
in	O
Heilongjiang	O
Province	O
,	O
and	O
was	O
identified	O
by	O
immunofluorescence	O
test	O
,	O
immunelectronmicroscopy	O
,	O
RT	O
-	O
PCR	O
and	O
indirect	O
ELISA	O
assay	O
.	O

ABSTRACT	O
:	O
Green	O
fluorescent	O
protein	O
(	O
GFP	O
)-	O
tagged	O
mouse	O
hepatitis	O
coronavirus	O
nonstructural	O
protein	O
4	O
(	O
nsp4	O
)	O
was	O
shown	O
to	O
localize	O
to	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
and	O
to	O
be	O
recruited	O
to	O
the	O
coronavirus	O
replicative	O
structures	O
.	O

ABSTRACT	O
:	O
A	O
coronavirus	O
(	O
CoV	O
)	O
previously	O
shown	O
to	O
be	O
associated	O
with	O
catarrhal	O
gastroenteritis	O
in	O
mink	O
(	O
Mustela	O
vison	O
)	O
was	O
identified	O
by	O
electron	O
microscopy	O
in	O
mink	O
faeces	B-ANAT
from	O
two	O
fur	O
farms	O
in	O
Wisconsin	O
and	O
Minnesota	O
in	O
1998	O
.	O

The	O
role	O
of	O
assisted	O
ventilation	O
during	O
exercise	O
training	O
in	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
patients	O
is	O
still	O
controversial	O
.	O

However	O
,	O
and	O
of	O
relevance	O
to	O
deployment	O
of	O
Plasmodium	O
vaccines	O
in	O
areas	O
endemic	O
to	O
malaria	O
,	O
attrition	O
of	O
memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
was	O
reversed	O
by	O
booster	O
immunization	O
,	O
which	O
restored	O
protection	O
.	O

Profound	O
knowledge	O
of	O
exfoliative	O
skin	B-ANAT
diseases	O
is	O
needed	O
to	O
improve	O
therapy	O
and	O
outcome	O
of	O
these	O
life	O
-	O
threatening	O
illnesses	O
.	O

TITLE	O
:	O
PLP2	O
of	O
mouse	O
hepatitis	O
virus	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
targets	O
TBK1	O
to	O
negatively	O
regulate	O
cellular	B-ANAT
type	O
I	O
interferon	O
signaling	O
pathway	O
.	O

An	O
additional	O
17	O
patients	O
(	O
68	O
%)	O
required	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
a	O
median	O
of	O
10	O
days	O
(	O
IQR	O
,	O
6	O
to	O
19	O
days	O
).	O

An	O
additional	O
17	O
patients	O
(	O
68	O
%)	O
required	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
a	O
median	O
of	O
10	O
days	O
(	O
IQR	O
,	O
6	O
to	O
19	O
days	O
).	O

Local	O
divisions	O
were	O
perceived	O
as	O
having	O
a	O
practical	O
and	O
useful	O
role	O
,	O
providing	O
hands	B-ANAT
-	O
on	O
support	O
to	O
practices	O
during	O
a	O
pandemic	O
outbreak	O
.	O

Further	O
characterisation	O
of	O
these	O
two	O
siRNAs	O
demonstrated	O
their	O
efficacy	O
when	O
used	O
at	O
low	O
concentrations	O
and	O
in	O
cells	B-ANAT
challenged	O
with	O
high	O
viral	O
loads	O
.	O

Stickler	O
syndrome	O
(	O
SS	O
)	O
is	O
a	O
rare	O
autosomal	B-ANAT
dominant	O
connective	B-ANAT
tissue	I-ANAT
disorder	O
estimated	O
to	O
affect	O
approximately	O
1	O
/	O
7500	O
newborns	O
.	O

TITLE	O
:	O
Production	O
of	O
IFN	O
-	O
Î³	O
in	O
feline	O
whole	B-ANAT
blood	I-ANAT
after	O
incubation	O
with	O
potential	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
feline	O
coronavirus	O
.	O

The	O
combined	O
approach	O
employed	O
in	O
this	O
study	O
allowed	O
us	O
to	O
identify	O
potentially	O
immunogenic	O
peptides	O
of	O
FCoV	O
N	O
protein	O
that	O
can	O
modulate	O
the	O
production	O
of	O
IFN	O
-	O
Î³	O
especially	O
in	O
cats	O
with	O
a	O
""""	O
pre	O
-	O
activated	O
""""	O
cell	B-ANAT
mediated	O
response	O
.	O

In	O
the	O
context	O
of	O
CoV	O
RNA	O
synthesis	O
,	O
these	O
cellular	B-ANAT
ribonucleoproteins	O
might	O
also	O
participate	O
in	O
RNA	O
-	O
protein	O
complexes	O
to	O
bring	O
into	O
physical	O
proximity	O
TRS	O
-	O
L	O
and	O
distant	O
TRS	O
-	O
B	O
,	O
as	O
proposed	O
for	O
CoV	O
discontinuous	O
transcription	O
.	O

In	O
a	O
small	O
percentage	O
of	O
infants	O
(	O
aged	O
6	O
months	O
to	O
3	O
years	O
),	O
HFMD	O
was	O
accompanied	O
by	O
acute	O
neurological	O
complications	O
,	O
such	O
as	O
serous	O
meningitis	O
,	O
poliomyelitis	O
-	O
like	O
syndrome	O
(	O
extremity	B-ANAT
pareses	O
and	O
muscle	B-ANAT
paralyses	O
);	O
brain	B-ANAT
stem	I-ANAT
encephalitis	O
(	O
myoclonic	O
jerks	O
,	O
tremor	O
,	O
lethargy	O
,	O
swallowing	O
and	O
speech	O
disorders	O
,	O
cardiopulmonary	B-ANAT
failure	O
,	O
pulmonary	B-ANAT
edema	O
,	O
shock	O
,	O
coma	O
,	O
death	O
).	O

Here	O
we	O
report	O
the	O
solution	O
structure	O
of	O
5	O
'-	O
UTR	O
derived	O
stem	B-ANAT
-	O
loop	O
2	O
(	O
SL2	O
)	O
of	O
SARS	O
-	O
CoV	O
determined	O
by	O
NMR	O
spectroscopy	O
.	O

The	O
highly	O
conserved	O
pentaloop	O
of	O
SL2	O
is	O
stacked	O
on	O
5	O
-	O
bp	O
stem	B-ANAT
and	O
adopts	O
a	O
canonical	O
CUYG	O
tetraloop	O
fold	O
with	O
the	O
3	O
'	O
nucleotide	O
(	O
U51	O
)	O
flipped	O
out	O
of	O
the	O
stack	O
.	O

Sore	O
throat	B-ANAT
was	O
more	O
frequently	O
found	O
in	O
patients	O
with	O
viral	O
pneumonia	O
than	O
in	O
those	O
with	O
non	O
-	O
viral	O
pneumonia	O
.	O

TITLE	O
:	O
Fatal	O
2009	O
pandemic	O
influenza	O
A	O
(	O
H1N1	O
)	O
in	O
a	O
bone	B-ANAT
marrow	I-ANAT
transplant	B-ANAT
recipient	O
.	O

The	O
crystals	B-ANAT
diffracted	O
to	O
a	O
resolution	O
of	O
1	O
.	O
9	O
Ã	O
resolution	O
and	O
crystal	B-ANAT
structure	O
determination	O
is	O
in	O
progress	O
.	O

Storage	B-ANAT
of	O
the	O
strips	O
at	O
room	O
temperature	O
for	O
6	O
months	O
or	O
at	O
4	O
Â°	O
C	O
for	O
12	O
months	O
did	O
not	O
change	O
their	O
sensitivity	O
and	O
specificity	O
.	O

Using	O
immunohistochemistry	O
,	O
virus	O
neutralization	O
,	O
fluorescent	O
antibody	O
test	O
,	O
and	O
nested	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
Porcine	O
teschovirus	O
was	O
identified	O
in	O
tissues	B-ANAT
from	O
affected	O
individuals	O
.	O

ABSTRACT	O
:	O
Kartagener	O
syndrome	O
is	O
a	O
rare	O
,	O
ciliopathic	O
,	O
autosomal	B-ANAT
recessive	O
genetic	O
disorder	O
that	O
causes	O
a	O
defect	O
in	O
the	O
action	O
of	O
the	O
cilia	B-ANAT
lining	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
fallopian	B-ANAT
tube	I-ANAT
.	O

Diagnosis	O
can	O
be	O
made	O
by	O
tests	O
to	O
prove	O
impaired	O
cilia	B-ANAT
function	O
,	O
biopsy	O
,	O
and	O
genetic	O
studies	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
the	O
next	O
viral	O
spread	O
was	O
observed	O
in	O
glial	B-ANAT
fibrillary	I-ANAT
acidic	I-ANAT
protein	I-ANAT
-	O
positive	O
cells	B-ANAT
or	O
nestin	O
-	O
positive	O
progenitor	B-ANAT
cells	I-ANAT
which	O
take	O
up	O
positions	O
in	O
the	O
subventricular	O
zone	O
(	O
SVZ	O
).	O

Histopathological	O
changes	O
included	O
satellitosis	O
and	O
neuronophagia	O
in	O
the	O
cerebral	B-ANAT
cortex	I-ANAT
.	O

This	O
viral	O
strain	O
(	O
isolate	O
PHEV	O
-	O
JLsp09	O
)	O
found	O
in	O
the	O
Siping	O
area	O
of	O
Jilin	O
Province	O
in	O
China	O
is	O
evolutionally	O
closest	O
to	O
the	O
HEV	B-ANAT
-	O
67N	O
stain	O
(	O
North	O
American	O
strain	O
),	O
indicating	O
that	O
this	O
viral	O
strain	O
evolved	O
from	O
the	O
PHEV	O
from	O
North	O
America	O
.	O

The	O
assay	O
performance	O
on	O
field	O
samples	O
was	O
evaluated	O
on	O
103	O
(	O
68	O
fecal	B-ANAT
and	O
35	O
nasal	B-ANAT
)	O
swab	O
specimens	O
and	O
compared	O
with	O
the	O
conventional	O
RT	O
-	O
PCR	O
assay	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
including	O
the	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
)	O
and	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
common	O
and	O
complex	O
inflammatory	O
lung	B-ANAT
diseases	O
potentially	O
affected	O
by	O
various	O
genetic	O
and	O
nongenetic	O
factors	O
.	O

TITLE	O
:	O
Histopathological	O
and	O
immunohistochemical	O
study	O
of	O
air	B-ANAT
sac	I-ANAT
lesions	O
induced	O
by	O
two	O
strains	O
of	O
infectious	O
bronchitis	O
virus	O
.	O

Early	O
implementation	O
of	O
extra	O
-	O
corporeal	O
membrane	B-ANAT
oxygenation	O
support	O
in	O
conjunction	O
with	O
a	O
specific	O
anti	O
-	O
influenza	O
viral	O
medication	O
(	O
Oseltamivir	O
)	O
led	O
to	O
the	O
patient	O
'	O
s	O
complete	O
recovery	O
from	O
cardiogenic	O
shock	O
in	O
2	O
weeks	O
.	O

ABSTRACT	O
:	O
Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
may	O
be	O
lifesaving	O
in	O
multiple	O
injured	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
due	O
to	O
chest	B-ANAT
trauma	O
.	O

Laboratory	O
data	O
revealed	O
severe	O
renal	B-ANAT
insufficiency	O
and	O
positive	O
titers	O
for	O
the	O
myeloperoxidase	O
anti	O
-	O
neutrophil	B-ANAT
cytoplasmic	B-ANAT
and	O
anti	O
-	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
antibodies	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
new	O
microsphere	O
-	O
based	O
multiplex	O
fluorescent	O
immunoassay	O
(	O
MFI	O
)	O
using	O
recombinant	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
proteins	O
to	O
detect	O
antibodies	O
to	O
coronaviruses	O
in	O
mouse	O
and	O
rat	O
sera	B-ANAT
.	O

The	O
MFI	O
was	O
evaluated	O
for	O
its	O
diagnostic	O
power	O
,	O
with	O
panels	O
of	O
mouse	O
sera	B-ANAT
classified	O
as	O
positive	O
or	O
negative	O
for	O
anti	O
-	O
MHV	O
antibodies	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
using	O
MHV	O
virion	B-ANAT
antigen	O
and	O
indirect	O
fluorescent	O
antibody	O
assay	O
.	O

The	O
total	O
leucocyte	B-ANAT
counts	O
were	O
significantly	O
lower	O
in	O
H1N1	O
+	O
patients	O
during	O
the	O
first	O
four	O
days	O
of	O
illness	O
but	O
incidence	O
of	O
renal	B-ANAT
failure	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
was	O
higher	O
in	O
H1N1	O
+	O
patients	O
.	O

ABSTRACT	O
:	O
Fundamental	O
step	O
of	O
an	O
adaptive	O
immune	O
response	O
to	O
pathogen	O
or	O
vaccine	O
is	O
the	O
binding	O
of	O
short	O
peptides	O
(	O
also	O
called	O
epitopes	O
)	O
to	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
(	O
MHC	B-ANAT
)	O
molecules	O
.	O

The	O
dataset	O
for	O
different	O
MHC	B-ANAT
class	O
I	O
alleles	O
for	O
SARS	O
Corona	O
virus	O
(	O
Tor2	O
Replicase	O
polyprotein	O
1ab	O
)	O
has	O
been	O
used	O
for	O
training	O
and	O
prediction	O
of	O
BNB	O
.	O

To	O
prevent	O
cross	O
-	O
border	B-ANAT
transmission	O
,	O
incoming	O
travellers	O
from	O
SARS	O
affected	O
areas	O
had	O
to	O
complete	O
health	O
declaration	O
cards	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenator	O
rescue	O
and	O
airborne	O
transportation	O
of	O
patients	O
with	O
influenza	O
A	O
(	O
H1N1	O
)	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
a	O
Mediterranean	O
underserved	O
area	O
.	O

We	O
report	O
our	O
experience	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenator	O
(	O
ECMO	O
)	O
rescue	O
and	O
transportation	O
of	O
patients	O
with	O
H1N1	O
ARDS	O
within	O
an	O
insular	O
and	O
rural	O
Mediterranean	O
area	O
of	O
seven	O
million	O
inhabitants	O
.	O

ABSTRACT	O
:	O
Photonic	O
crystals	B-ANAT
(	O
PCs	O
)	O
are	O
periodic	O
dielectric	O
structures	O
that	O
have	O
a	O
band	B-ANAT
-	O
gap	O
that	O
forbids	O
propagation	O
of	O
a	O
certain	O
range	O
of	O
wavelengths	O
of	O
light	O
.	O

TITLE	O
:	O
[	O
Acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
--	O
what	O
should	O
we	O
know	O
?].	O

In	O
contrast	O
to	O
many	O
well	O
-	O
studied	O
enveloped	O
viruses	O
that	O
assemble	O
and	O
bud	B-ANAT
at	O
the	O
plasma	B-ANAT
membrane	I-ANAT
,	O
coronaviruses	O
assemble	O
by	O
budding	O
into	O
the	O
lumen	B-ANAT
of	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	I-ANAT
Golgi	I-ANAT
intermediate	I-ANAT
compartment	I-ANAT
and	O
are	O
released	O
from	O
the	O
cell	B-ANAT
by	O
exocytosis	O
.	O

When	O
combined	O
,	O
diagnostic	O
yields	O
in	O
nose	B-ANAT
and	O
throat	B-ANAT
swabs	O
were	O
similar	O
to	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
.	O

To	O
gain	O
baseline	O
data	O
on	O
infectious	O
agents	O
in	O
this	O
area	O
,	O
including	O
those	O
with	O
zoonotic	O
potential	O
,	O
we	O
collected	O
blood	B-ANAT
and	O
stool	B-ANAT
samples	O
from	O
107	O
dogs	O
in	O
5	O
remote	O
communities	O
in	O
May	O
and	O
September	O
2007	O
.	O

Of	O
75	O
stool	B-ANAT
samples	O
,	O
31	O
contained	O
at	O
least	O
1	O
parasitic	O
infection	O
,	O
including	O
Taeniid	O
tapeworms	O
,	O
the	O
nematodes	O
Toxocara	O
canis	O
and	O
Toxascaris	O
leonina	O
,	O
and	O
the	O
protozoans	O
Isospora	O
sp	O
.,	O
Giardia	O
sp	O
.,	O
Cryptosporidium	O
sp	O
.,	O
and	O
Sarcocystis	O
sp	O
.	O
This	O
work	O
provides	O
a	O
sound	O
baseline	O
for	O
future	O
monitoring	O
of	O
infectious	O
agents	O
that	O
could	O
affect	O
dogs	O
,	O
sympatric	O
wild	O
canids	O
,	O
other	O
wildlife	O
,	O
and	O
humans	O
.	O

Almost	O
all	O
of	O
them	O
put	O
stress	O
on	O
analyzing	O
nucleic	B-ANAT
acid	O
sequences	O
or	O
protein	O
primary	O
sequences	O
.	O

TITLE	O
:	O
PIKA	O
provides	O
an	O
adjuvant	O
effect	O
to	O
induce	O
strong	O
mucosal	B-ANAT
and	O
systemic	O
humoral	O
immunity	O
against	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
a	O
deadly	O
infectious	O
disease	O
caused	O
by	O
SARS	O
Coronavirus	O
(	O
SARS	O
-	O
CoV	O
).	O

Exercise	O
limitation	O
,	O
physical	O
and	O
psychological	O
sequelae	O
,	O
decreased	O
physical	O
quality	O
of	O
life	O
,	O
and	O
increased	O
costs	O
and	O
use	O
of	O
health	O
care	O
services	O
are	O
important	O
legacies	O
of	O
severe	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Active	O
and	O
passive	O
cigarette	O
smoking	O
and	O
acute	O
lung	B-ANAT
injury	O
after	O
severe	O
blunt	O
trauma	O
.	O

We	O
measured	O
levels	O
of	O
cotinine	O
,	O
a	O
metabolite	O
of	O
nicotine	O
and	O
validated	O
biomarker	O
of	O
tobacco	O
use	O
,	O
in	O
plasma	B-ANAT
samples	O
obtained	O
immediately	O
on	O
arrival	O
at	O
the	O
emergency	O
department	O
from	O
144	O
adult	O
subjects	O
after	O
severe	O
blunt	O
trauma	O
.	O

An	O
acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
is	O
an	O
episode	O
of	O
acute	O
respiratory	O
worsening	O
without	O
an	O
identifiable	O
etiology	O
.	O

TITLE	O
:	O
[	O
Experimental	O
study	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
analysis	O
of	O
relevant	O
factors	O
in	O
rabbits	O
subjected	O
to	O
thoracic	B-ANAT
blast	B-ANAT
trauma	O
].	O

Pathological	O
examination	O
showed	O
extensive	O
and	O
constant	O
multi	O
focal	O
bleeding	O
involving	O
more	O
than	O
four	O
lobes	B-ANAT
.	O

Compared	O
with	O
control	O
group	O
,	O
the	O
wet	O
to	O
dry	O
weight	O
ratio	O
(	O
W	O
/	O
D	O
)	O
in	O
lungs	B-ANAT
increased	O
obviously	O
(	O
6	O
.	O
46	O
Â±	O
0	O
.	O
24	O
vs	O
.	O
3	O
.	O
98	O
Â±	O
0	O
.	O
19	O
,	O
P	O
<	O
0	O
.	O
01	O
)	O
in	O
group	O
C	O
within	O
6	O
hours	O
postinjury	O
.	O

The	O
contents	O
of	O
tumor	O
necrosis	O
factor	O
Î±	O
(	O
TNF	O
-	O
Î±	O
)	O
and	O
interleukin	O
6	O
(	O
IL	O
-	O
6	O
)	O
in	O
plasma	B-ANAT
and	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	B-ANAT
)	O
were	O
also	O
increased	O
distinctly	O
compared	O
with	O
the	O
control	O
group	O
[	O
TNF	O
-	O
Î±	O
(	O
ng	O
/	O
L	O
)	O
in	O
plasma	B-ANAT
:	O
328	O
.	O
89	O
Â±	O
6	O
.	O
26	O
vs	O
.	O
62	O
.	O
12	O
Â±	O
2	O
.	O
98	O
,	O
TNF	O
-	O
Î±	O
(	O
ng	O
/	O
L	O
)	O
in	O
BALF	B-ANAT
:	O
164	O
.	O
87	O
Â±	O
4	O
.	O
59	O
vs	O
.	O
29	O
.	O
51	O
Â±	O
1	O
.	O
12	O
;	O
IL	O
-	O
6	O
(	O
ng	O
/	O
L	O
)	O
in	O
plasma	B-ANAT
:	O
128	O
.	O
51	O
Â±	O
4	O
.	O
13	O
vs	O
.	O
19	O
.	O
32	O
Â±	O
1	O
.	O
53	O
,	O
IL	O
-	O
6	O
(	O
ng	O
/	O
L	O
)	O
in	O
BALF	B-ANAT
:	O
94	O
.	O
97	O
Â±	O
1	O
.	O
14	O
vs	O
.	O
22	O
.	O
72	O
Â±	O
0	O
.	O
19	O
,	O
all	O
P	O
<	O
0	O
.	O
05	O
].	O

Pneumothorax	O
as	O
a	O
result	O
of	O
lung	B-ANAT
rupture	O
is	O
the	O
chief	O
reason	O
for	O
early	O
death	O
and	O
dysfunction	O
of	O
circulatory	B-ANAT
system	I-ANAT
is	O
also	O
an	O
important	O
reason	O
in	O
producing	O
early	O
death	O
.	O

CONCLUSIONS	O
:	O
In	O
an	O
airtight	O
environment	O
,	O
rabbit	O
ARDS	O
model	O
can	O
be	O
reproduced	O
successfully	O
by	O
blast	B-ANAT
injury	O
with	O
1	O
917	O
.	O
3	O
mm	O
Hg	O
explosion	O
pressure	O
;	O
TNF	O
-	O
Î±	O
and	O
IL	O
-	O
6	O
are	O
involved	O
in	O
the	O
pathogenesis	O
and	O
development	O
of	O
ARDS	O
in	O
blast	B-ANAT
injury	O
.	O

Furthermore	O
,	O
the	O
culture	O
supernatant	O
of	O
FIPV	O
-	O
infected	O
macrophages	B-ANAT
induced	O
hyperpermeability	O
of	O
feline	O
vascular	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
.	O

Mixed	O
infection	O
of	O
both	O
subtypes	O
(	O
CCoV	O
-	O
IIa	O
/	O
IIb	O
)	O
was	O
detected	O
in	O
the	O
faeces	B-ANAT
,	O
while	O
only	O
CCoV	O
-	O
IIb	O
was	O
detected	O
in	O
the	O
organs	B-ANAT
.	O

By	O
means	O
of	O
RT	O
-	O
PCR	O
and	O
real	O
time	O
RT	O
-	O
PCR	O
assays	O
,	O
tissue	B-ANAT
distribution	O
and	O
quantitation	O
of	O
viral	O
loads	O
took	O
place	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
an	O
acute	O
hypoxic	O
respiratory	O
failure	O
due	O
to	O
non	O
-	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
with	O
diverse	O
etiologies	O
and	O
high	O
mortality	O
.	O

Learning	O
from	O
viruses	O
how	O
to	O
target	O
cell	B-ANAT
surface	I-ANAT
receptors	O
not	O
only	O
helps	O
us	O
understand	O
viral	O
strategies	O
to	O
escape	O
from	O
the	O
host	O
immune	O
surveillance	O
,	O
but	O
also	O
provides	O
novel	O
avenues	O
in	O
rational	O
drug	O
design	O
and	O
the	O
development	O
of	O
new	O
therapies	O
for	O
immune	O
disorders	O
.	O

After	O
treatment	O
with	O
prednisolone	O
,	O
vocal	B-ANAT
cord	I-ANAT
function	O
markedly	O
improved	O
within	O
8	O
weeks	O
,	O
whereas	O
paresis	O
of	O
the	O
diaphragm	B-ANAT
persisted	O
.	O

Shoulder	B-ANAT
pain	O
followed	O
by	O
diaphragmatic	B-ANAT
paralysis	O
with	O
dyspnea	O
and	O
hoarseness	O
may	O
be	O
a	O
manifestation	O
of	O
neuralgic	O
amyotrophy	O
even	O
if	O
upper	B-ANAT
limb	I-ANAT
or	O
shoulder	B-ANAT
girdle	I-ANAT
palsies	O
are	O
absent	O
.	O

Aerosol	O
inhalation	O
was	O
implicated	O
in	O
96	O
%	O
of	O
lymphocytic	O
choriomeningitis	O
virus	O
infections	O
,	O
99	O
%	O
of	O
hantavirus	O
infections	O
,	O
and	O
50	O
%	O
of	O
coxsackievirus	O
infections	O
,	O
but	O
infective	O
droplet	O
inhalation	O
was	O
the	O
leading	O
mode	O
of	O
infection	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
and	O
the	O
mucocutaneous	O
mode	O
of	O
infection	O
was	O
involved	O
in	O
the	O
case	O
of	O
infection	O
with	O
influenza	O
B	O
.	O
For	O
blood	B-ANAT
-	O
borne	O
viruses	O
,	O
92	O
%	O
of	O
infections	O
occurred	O
in	O
hospitals	O
and	O
93	O
%	O
of	O
these	O
had	O
percutaneous	O
mode	O
of	O
infection	O
,	O
while	O
among	O
laboratory	O
infections	O
77	O
%	O
were	O
due	O
to	O
infective	O
aerosol	O
inhalation	O
.	O

Among	O
blood	B-ANAT
-	O
borne	O
virus	O
infections	O
there	O
were	O
six	O
cases	O
of	O
particular	O
note	O
:	O
three	O
cases	O
of	O
acute	O
hepatitis	O
following	O
hepatitis	O
C	O
virus	O
infection	O
with	O
a	O
short	O
period	O
of	O
incubation	O
,	O
one	O
laboratory	O
case	O
of	O
human	O
immunodeficiency	O
virus	O
infection	O
through	O
aerosol	O
inhalation	O
,	O
one	O
case	O
of	O
hepatitis	O
following	O
hepatitis	O
G	O
virus	O
infection	O
,	O
and	O
one	O
case	O
of	O
fulminant	O
hepatitis	O
with	O
hepatitis	O
B	O
virus	O
infection	O
following	O
exposure	O
of	O
the	O
worker	O
'	O
s	O
conjunctiva	B-ANAT
to	O
hepatitis	O
B	O
virus	O
e	O
antigen	O
-	O
negative	O
patient	O
saliva	B-ANAT
.	O

Of	O
the	O
90	O
HBoV	O
infected	O
patients	O
,	O
45	O
(	O
50	O
%)	O
showed	O
a	O
co	O
-	O
infection	O
with	O
other	O
respiratory	B-ANAT
tract	I-ANAT
viruses	O
.	O

The	O
following	O
recommendations	O
are	O
the	O
result	O
of	O
evidence	O
-	O
based	O
consensus	O
by	O
the	O
American	O
College	O
of	O
Radiology	O
Appropriateness	O
Criteria	O
Expert	O
Panel	O
on	O
Thoracic	B-ANAT
Radiology	O
.	O

RESULTS	O
:	O
A	O
30	O
-	O
year	O
-	O
old	O
victim	O
of	O
a	O
motor	O
vehicle	O
crash	O
sustained	O
pelvic	B-ANAT
fractures	O
and	O
splenic	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
RNA	O
synthesis	O
is	O
a	O
sophisticated	O
process	O
performed	O
by	O
a	O
viral	O
multienzymatic	O
replicase	O
complex	O
,	O
together	O
with	O
cellular	B-ANAT
factors	O
.	O

ABSTRACT	O
:	O
Lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
(	O
LRTIs	O
)	O
comprise	O
a	O
great	O
proportion	O
of	O
diagnoses	O
among	O
hospitalized	O
children	O
.	O

TITLE	O
:	O
Shifting	O
hierarchies	O
of	O
interleukin	O
-	O
10	O
-	O
producing	O
T	B-ANAT
cell	I-ANAT
populations	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
during	O
acute	O
and	O
persistent	O
viral	O
encephalomyelitis	O
.	O

Infection	O
of	O
transgenic	O
IL	O
-	O
10	O
/	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
reporter	O
mice	O
revealed	O
that	O
CNS	B-ANAT
-	O
infiltrating	O
T	B-ANAT
cells	I-ANAT
were	O
the	O
major	O
source	O
of	O
IL	O
-	O
10	O
,	O
with	O
minimal	O
IL	O
-	O
10	O
production	O
by	O
macrophages	B-ANAT
and	O
resident	O
microglia	B-ANAT
.	O

Overall	O
,	O
these	O
data	O
demonstrate	O
significant	O
fluidity	O
in	O
the	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
-	O
mediated	O
IL	O
-	O
10	O
response	O
during	O
viral	O
encephalitis	O
and	O
persistence	O
.	O

ABSTRACT	O
:	O
The	O
bacterially	O
expressed	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
porcine	O
respiratory	O
and	O
reproductive	O
syndrome	O
virus	O
(	O
PRRSV	O
)	O
was	O
used	O
as	O
immunogen	O
to	O
generate	O
a	O
rabbit	O
-	O
derived	O
polyclonal	O
antibody	O
.	O

Researchers	O
have	O
recently	O
demonstrated	O
that	O
triggering	O
inflammation	O
in	O
the	O
brain	B-ANAT
exacerbates	O
tau	O
pathological	O
characteristics	O
in	O
animal	O
models	O
.	O

Tau	O
phosphorylation	O
was	O
increased	O
via	O
a	O
glycogen	O
synthase	O
kinase	O
-	O
3Î²	O
-	O
dependent	O
mechanism	O
,	O
and	O
there	O
was	O
a	O
prominent	O
shift	O
of	O
tau	O
from	O
the	O
detergent	O
-	O
soluble	O
to	O
the	O
detergent	O
-	O
insoluble	B-ANAT
fraction	I-ANAT
.	O

CONCLUSIONS	O
:	O
At	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Network	O
hospitals	O
,	O
the	O
addition	O
of	O
baseline	O
positive	O
end	O
-	O
expiratory	O
pressure	O
would	O
not	O
have	O
increased	O
the	O
value	O
of	O
PaOâ	O
/	O
Fioâ	O
for	O
predicting	O
mortality	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

SARS	O
-	O
CoV	O
is	O
a	O
zoonotic	O
pathogen	O
that	O
entered	O
the	O
human	O
population	O
through	O
an	O
intermediate	O
host	O
like	O
the	O
palm	B-ANAT
civet	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
in	O
which	O
a	O
2	O
-	O
year	O
-	O
old	O
girl	O
who	O
underwent	O
a	O
right	O
middle	O
and	O
lower	O
lung	B-ANAT
lobectomy	O
for	O
congenital	O
cystic	O
adenomatoid	O
malformation	O
suffered	O
massive	O
bleeding	O
and	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
during	O
the	O
operation	O
.	O

Following	O
transfer	O
to	O
the	O
ICU	O
,	O
continuous	O
hemodialysis	O
was	O
introduced	O
to	O
reduce	O
excessive	O
blood	B-ANAT
volume	O
.	O

TITLE	O
:	O
Coronaviruses	O
:	O
propagation	O
,	O
quantification	O
,	O
storage	B-ANAT
,	O
and	O
construction	O
of	O
recombinant	O
mouse	O
hepatitis	O
virus	O
.	O

Protocols	O
are	O
also	O
included	O
for	O
the	O
propagation	O
of	O
DBT	O
,	O
17CL	O
-	O
1	O
,	O
and	O
L2	O
cells	B-ANAT
used	O
for	O
growing	O
and	O
titrating	O
MHV	O
,	O
and	O
for	O
the	O
growth	O
of	O
BHK	O
-	O
R	O
cells	B-ANAT
and	O
FCWF	O
cells	B-ANAT
.	O

The	O
latter	O
two	O
cell	B-ANAT
lines	I-ANAT
are	O
used	O
for	O
regenerating	O
infectious	O
MHV	O
by	O
an	O
in	O
vitro	O
cDNA	O
assembly	O
protocol	O
and	O
by	O
a	O
targeted	O
recombination	O
protocol	O
,	O
respectively	O
,	O
allowing	O
reverse	O
genetic	O
manipulation	O
of	O
these	O
viruses	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
are	O
complex	O
illnesses	O
involving	O
the	O
interplay	O
of	O
both	O
environmental	O
(	O
such	O
as	O
mechanical	O
ventilation	O
)	O
and	O
genetic	O
factors	O
.	O

We	O
evaluated	O
the	O
antiviral	O
effects	O
of	O
antisense	O
peptide	O
nucleic	B-ANAT
acids	O
(	O
PNAs	O
)	O
targeting	O
a	O
highly	O
conserved	O
RNA	O
sequence	O
on	O
the	O
-	O
PRF	O
signal	O
.	O

Patient	O
with	O
significant	O
pneumothorax	O
should	O
have	O
a	O
chest	B-ANAT
tube	O
inserted	O
,	O
while	O
the	O
treatment	O
of	O
distal	O
intestinal	B-ANAT
obstruction	O
syndrome	O
will	O
most	O
often	O
be	O
medical	O
.	O

To	O
address	O
these	O
challenges	O
,	O
we	O
have	O
previously	O
developed	O
and	O
validated	O
a	O
pan	B-ANAT
-	O
viral	O
microarray	O
platform	O
called	O
the	O
Virochip	O
with	O
the	O
capacity	O
to	O
detect	O
all	O
known	O
viruses	O
as	O
well	O
as	O
novel	O
variants	O
on	O
the	O
basis	O
of	O
conserved	O
sequence	O
homology	O
.	O

Among	O
them	O
,	O
protein	O
3b	O
localizes	O
to	O
the	O
nucleus	B-ANAT
and	O
behaves	O
as	O
an	O
interferon	O
antagonist	O
by	O
inhibiting	O
IRF3	O
activation	O
.	O

In	O
summary	O
,	O
we	O
have	O
demonstrated	O
that	O
ADAM17	O
is	O
able	O
to	O
cleave	O
ACE2	O
peptide	O
sequence	O
analogues	O
between	O
Arg	O
(	O
708	O
)	O
and	O
Ser	B-ANAT
(	O
709	O
).	O

Prior	O
studies	O
using	O
recombinant	O
MHV	O
strains	O
that	O
differ	O
only	O
in	O
the	O
spike	O
gene	O
,	O
which	O
encodes	O
a	O
glycoprotein	O
involved	O
in	O
virus	O
-	O
host	O
cell	B-ANAT
attachment	I-ANAT
,	O
demonstrated	O
that	O
spike	O
mediates	O
anterograde	O
axonal	O
transport	O
of	O
virus	O
to	O
the	O
spinal	B-ANAT
cord	I-ANAT
.	O

In	O
multivariate	O
analysis	O
,	O
patients	O
with	O
ARDS	O
and	O
the	O
del	O
/	O
del	O
genotype	O
also	O
had	O
increased	O
60	O
day	O
mortality	O
(	O
HR	O
1	O
.	O
54	O
,	O
95	O
%	O
CI	O
1	O
.	O
01	O
-	O
2	O
.	O
36	O
)	O
and	O
more	O
severe	O
daily	O
organ	B-ANAT
dysfunction	O
(	O
P	O
<.	O
001	O
)	O
when	O
compared	O
to	O
ARDS	O
patients	O
with	O
other	O
genotypes	O
.	O

It	O
has	O
been	O
shown	O
that	O
respiratory	B-ANAT
system	I-ANAT
reactance	O
(	O
Xrs	O
),	O
measured	O
by	O
the	O
forced	O
oscillation	O
technique	O
(	O
FOT	O
)	O
at	O
5	O
Hz	O
,	O
may	O
be	O
used	O
to	O
identify	O
the	O
minimal	O
PEEP	O
level	O
required	O
to	O
maintain	O
lung	B-ANAT
recruitment	O
.	O

These	O
higher	O
values	O
of	O
PEEP	O
resulted	O
in	O
improved	O
lung	B-ANAT
mechanics	O
,	O
reduced	O
driving	O
pressure	O
,	O
improved	O
oxygenation	O
,	O
with	O
a	O
trend	O
for	O
higher	O
PaCO2	O
and	O
lower	O
systemic	O
and	O
pulmonary	B-ANAT
pressure	O
.	O

In	O
a	O
lavage	O
model	O
of	O
lung	B-ANAT
injury	O
a	O
PEEP	O
optimization	O
strategy	O
based	O
on	O
maximizing	O
Xrs	O
attenuated	O
the	O
signs	O
of	O
ventilator	O
induced	O
lung	B-ANAT
injury	O
.	O

After	O
12	O
hours	O
of	O
ventilation	O
,	O
histopathological	O
analysis	O
showed	O
a	O
significantly	O
lower	O
score	O
of	O
lung	B-ANAT
injury	O
in	O
the	O
FOT	O
group	O
compared	O
to	O
the	O
ARDSNet	O
group	O
.	O

In	O
contrast	O
,	O
specific	O
T	B-ANAT
cell	I-ANAT
anamnestic	O
responses	O
can	O
be	O
maintained	O
for	O
at	O
least	O
6	O
y	O
.	O
These	O
findings	O
have	O
applications	O
in	O
preparation	O
for	O
the	O
possible	O
reemergence	O
of	O
SARS	O
.	O

A	O
single	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
experience	O
with	O
management	O
of	O
laboratory	O
-	O
confirmed	O
2009	O
pandemic	O
influenza	O
A	O
(	O
H1N1	O
)	O
ARDS	O
with	O
a	O
combination	O
of	O
proning	O
and	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
APRV	O
)	O
is	O
described	O
.	O

The	O
protective	O
effects	O
of	O
increased	O
IL	O
-	O
10	O
levels	O
were	O
associated	O
with	O
reductions	O
in	O
microglial	B-ANAT
activation	O
,	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
into	O
the	O
brain	B-ANAT
,	O
and	O
proinflammatory	O
cytokine	O
and	O
chemokine	O
production	O
.	O

Chickens	O
were	O
then	O
challenged	O
with	O
IBV	O
strain	O
M41	O
by	O
the	O
nasal	B-ANAT
-	O
ocular	B-ANAT
route	O
3	O
weeks	O
after	O
boosting	O
.	O

The	O
current	O
study	O
shows	O
that	O
novel	O
DNA	O
vaccines	O
delivered	O
by	O
attenuated	O
S	O
.	O
Typhimurium	O
may	O
be	O
promising	O
candidates	O
for	O
the	O
prevention	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
).	O
These	O
vaccines	O
are	O
efficacious	O
,	O
easily	O
produced	O
economically	O
,	O
and	O
able	O
to	O
be	O
delivered	O
orally	B-ANAT
and	O
nasally	O
rather	O
than	O
injected	O
.	O

Polyclonal	O
antibodies	O
raised	O
against	O
expressed	O
S1	O
(	O
amino	O
acid	O
position	O
1	O
to	O
573	O
from	O
start	O
codon	O
of	O
S	O
protein	O
),	O
4F	O
/	O
4R	O
(	O
482	O
-	O
678	O
),	O
6F	O
/	O
6R	O
(	O
830	O
-	O
1071	O
),	O
or	O
Mod4F	O
/	O
Epi4R	O
(	O
476	O
-	O
520	O
)	O
S	O
fragment	O
recognized	O
native	O
S1	O
protein	O
and	O
TCoV	O
in	O
the	O
intestines	B-ANAT
of	O
TCoV	O
-	O
infected	O
turkey	O
embryos	B-ANAT
.	O

In	O
this	O
study	O
,	O
the	O
role	O
of	O
fAPN	O
and	O
fDC	O
-	O
SIGN	O
was	O
studied	O
at	O
different	O
stages	O
in	O
FIPV	O
infection	O
of	O
monocytes	B-ANAT
.	O

ABSTRACT	O
:	O
Upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
URTI	O
)	O
occurs	O
commonly	O
in	O
both	O
children	O
and	O
adults	O
and	O
is	O
a	O
major	O
cause	O
of	O
mild	O
morbidity	O
.	O

Because	O
it	O
has	O
been	O
proposed	O
that	O
the	O
immune	B-ANAT
system	I-ANAT
is	O
stimulated	O
by	O
alarm	O
signals	O
called	O
damage	O
-	O
associated	O
molecular	O
patterns	O
or	O
alarmins	O
,	O
we	O
investigated	O
the	O
participation	O
of	O
uric	O
acid	O
and	O
high	O
-	O
mobility	O
group	O
box	O
protein	O
1	O
(	O
HMGB1	O
)	O
in	O
the	O
autoimmune	O
response	O
elicited	O
by	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
).	O

We	O
report	O
the	O
characteristics	O
of	O
crush	O
syndrome	O
(	O
CS	O
)	O
and	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
brought	O
by	O
the	O
earthquake	O
,	O
which	O
took	O
place	O
in	O
a	O
mountainous	O
area	O
.	O

They	O
had	O
various	O
complications	O
,	O
including	O
different	O
kinds	O
of	O
infection	O
or	O
sepsis	O
,	O
AKI	O
,	O
hematological	O
abnormality	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
congestive	O
heart	B-ANAT
failure	O
,	O
multiple	O
organs	B-ANAT
dysfunction	O
syndrome	O
,	O
etc	O
.	O

AKI	O
occurred	O
in	O
62	O
patients	O
(	O
41	O
.	O
6	O
%	O
of	O
CS	O
patients	O
)	O
with	O
CS	O
and	O
33	O
of	O
them	O
received	O
renal	B-ANAT
replacement	O
therapy	O
.	O

Herein	O
,	O
we	O
used	O
a	O
cytospin	O
procedure	O
to	O
confirm	O
SAS	O
in	O
splenic	B-ANAT
cells	B-ANAT
derived	O
from	O
mice	O
whose	O
brains	B-ANAT
were	O
infected	O
with	O
these	O
viruses	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
patient	O
with	O
pulmonary	B-ANAT
tuberculosis	O
and	O
severe	O
ARDS	O
(	O
PaO2	O
/	O
FiO2	O
<	O
100	O
mmHg	O
)	O
who	O
was	O
initially	O
managed	O
with	O
advanced	O
up	O
-	O
to	O
-	O
date	O
treatments	O
(	O
protective	O
ventilation	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
ECMO	O
)	O
but	O
failed	O
to	O
improve	O
.	O

Radiographs	O
were	O
evaluated	O
for	O
consolidation	O
,	O
ground	O
-	O
glass	O
opacities	O
,	O
interstitial	B-ANAT
patterns	O
,	O
distribution	O
,	O
and	O
extent	O
of	O
findings	O
.	O

Initial	O
chest	B-ANAT
radiographs	O
show	O
acute	O
abnormalities	O
in	O
all	O
patients	O
with	O
severe	O
disease	O
.	O

The	O
findings	O
of	O
a	O
multifocal	O
patchy	O
consolidation	O
pattern	O
with	O
bilateral	O
or	O
diffuse	O
lung	B-ANAT
involvement	O
on	O
admission	O
should	O
alert	O
of	O
the	O
impending	O
severity	O
of	O
disease	O
and	O
the	O
risk	O
of	O
necessitating	O
ICU	O
admission	O
.	O

The	O
inhibition	O
model	O
could	O
be	O
via	O
a	O
direct	O
interaction	O
with	O
the	O
virus	O
envelope	B-ANAT
,	O
thereby	O
decreasing	O
the	O
infectivity	O
of	O
virus	O
.	O

Both	O
foals	O
required	O
whole	B-ANAT
blood	I-ANAT
transfusions	O
,	O
and	O
were	O
treated	O
with	O
the	O
antimicrobial	O
combination	O
of	O
rifampin	O
and	O
a	O
macrolide	O
(	O
eg	O
,	O
clarithromycin	O
,	O
erythromycin	O
,	O
or	O
azithromycin	O
).	O

Furthermore	O
,	O
PADRE	O
administration	O
amplified	O
the	O
MHV	O
effect	O
,	O
extending	O
the	O
duration	O
of	O
hypergammaglobulinemia	O
and	O
increasing	O
the	O
binding	O
of	O
autoAb	O
as	O
well	O
as	O
the	O
degree	O
of	O
hepatic	B-ANAT
infiltrates	O
.	O

ABSTRACT	O
:	O
Haemolytic	O
uraemic	O
syndrome	O
is	O
an	O
important	O
cause	O
of	O
acute	O
renal	B-ANAT
impairment	O
in	O
childhood	O
.	O

Using	O
various	O
cell	B-ANAT
cycle	O
inhibitors	O
,	O
we	O
have	O
shown	O
that	O
the	O
nuclear	O
entry	O
of	O
9b	O
is	O
independent	O
of	O
the	O
cell	B-ANAT
cycle	O
.	O

TITLE	O
:	O
Delayed	O
retroperitoneal	B-ANAT
bleeding	O
causing	O
acute	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
:	O
case	O
report	O
.	O

Streptococcus	O
pneumoniae	O
,	O
Haemophilus	O
influenzae	O
and	O
Moraxella	O
catarrhalis	O
are	O
the	O
primary	O
bacterial	O
pathogens	O
of	O
otitis	O
media	B-ANAT
and	O
their	O
loads	O
predict	O
clinical	O
ear	B-ANAT
state	O
.	O

HAdV	O
was	O
independently	O
associated	O
with	O
acute	O
ear	B-ANAT
states	O
.	O

A	O
recently	O
introduced	O
dual	O
-	O
lumen	B-ANAT
cannula	O
for	O
VV	O
-	O
ECMO	O
promises	O
single	O
vessel	B-ANAT
access	O
through	O
the	O
right	B-ANAT
internal	I-ANAT
jugular	I-ANAT
vein	I-ANAT
and	O
patient	O
ambulation	O
.	O

It	O
is	O
therefore	O
important	O
that	O
all	O
physicians	O
on	O
acute	O
medical	O
take	O
are	O
familiar	O
with	O
the	O
acute	O
management	O
of	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

Sometimes	O
,	O
the	O
pericardial	B-ANAT
effusion	I-ANAT
can	O
be	O
easily	O
related	O
to	O
a	O
known	O
underlying	O
disease	O
,	O
such	O
as	O
acute	O
myocardial	O
infarction	O
,	O
cardiac	B-ANAT
surgery	O
,	O
end	O
-	O
stage	O
renal	B-ANAT
disease	O
or	O
widespread	O
metastatic	O
neoplasm	O
.	O

Severe	O
effusion	B-ANAT
with	O
absence	O
of	O
inflammatory	O
signs	O
and	O
absence	O
of	O
tamponade	O
is	O
predictive	O
for	O
chronic	O
idiopathic	O
pericardial	B-ANAT
effusion	I-ANAT
,	O
and	O
tamponade	O
without	O
inflammatory	O
signs	O
for	O
neoplastic	O
pericardial	B-ANAT
effusion	I-ANAT
.	O

The	O
selection	O
of	O
the	O
pericardial	B-ANAT
drainage	B-ANAT
procedure	O
depends	O
on	O
the	O
etiology	O
of	O
the	O
effusion	B-ANAT
.	O

Here	O
we	O
present	O
the	O
crystal	B-ANAT
structure	O
of	O
MHV	O
NTD	O
complexed	O
with	O
its	O
receptor	O
murine	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	B-ANAT
adhesion	O
molecule	O
1a	O
(	O
mCEACAM1a	O
).	O

Although	O
these	O
agents	O
are	O
indicated	O
in	O
patients	O
with	O
chronic	O
,	O
severe	O
heart	B-ANAT
failure	O
with	O
reduced	O
ejection	O
fraction	O
(	O
HF	O
/	O
REF	O
)	O
and	O
in	O
patients	O
with	O
HF	O
/	O
REF	O
post	O
-	O
myocardial	O
infarction	O
(	O
MI	O
),	O
they	O
have	O
not	O
been	O
systematically	O
studied	O
in	O
patients	O
with	O
AHFS	O
.	O

Blood	B-ANAT
tests	O
,	O
including	O
complete	O
blood	B-ANAT
count	O
,	O
protein	O
C	O
,	O
protein	O
S	O
,	O
antithrombin	O
III	O
,	O
high	O
-	O
sensitivity	O
C	O
-	O
reactive	O
protein	O
,	O
immunologic	O
and	O
antibody	O
profiles	O
were	O
normal	O
.	O

However	O
,	O
dyspnoea	O
and	O
hypoxaemia	O
recurred	O
with	O
widened	O
alveolar	B-ANAT
-	O
arterial	B-ANAT
gradient	O
,	O
which	O
was	O
unusual	O
in	O
COPD	O
.	O

The	O
cells	B-ANAT
grew	O
well	O
and	O
showed	O
susceptibility	O
to	O
a	O
wide	O
variety	O
of	O
viruses	O
derived	O
from	O
ovine	O
,	O
bovine	O
,	O
and	O
porcine	O
species	O
,	O
including	O
orf	O
virus	O
,	O
maedi	O
visna	O
virus	O
,	O
bovine	O
herpesvirus	O
1	O
,	O
bovine	O
parainfluenza	O
virus	O
3	O
,	O
bovine	O
viral	O
diarrhea	O
viruses	O
1	O
and	O
2	O
,	O
bovine	O
coronavirus	O
,	O
bovine	O
respiratory	O
syncytial	O
virus	O
,	O
bovine	O
enterovirus	O
,	O
suid	O
herpesvirus	O
1	O
,	O
and	O
porcine	O
enterovirus	O
.	O

This	O
brief	O
article	O
is	O
based	O
on	O
the	O
hypothesis	O
that	O
neonatal	O
RDS	O
has	O
a	O
complex	O
and	O
multifactorial	O
pathogenesis	O
characterized	O
by	O
an	O
injurious	O
inflammatory	O
sequence	O
in	O
the	O
immature	O
lung	B-ANAT
.	O

Following	O
this	O
intrauterine	B-ANAT
'	O
first	O
hit	O
',	O
the	O
immature	O
infant	O
may	O
develop	O
severe	O
RDS	O
and	O
have	O
a	O
poor	O
response	O
to	O
surfactant	O
substitution	O
.	O

From	O
4	O
to	O
6	O
days	O
postinfection	O
,	O
interstitial	B-ANAT
pneumonia	O
with	O
alveolar	B-ANAT
collapse	O
expanded	O
throughout	O
the	O
lungs	B-ANAT
.	O

Furthermore	O
,	O
the	O
truncated	O
rS	O
-	O
AD	O
peptide	O
was	O
able	O
to	O
bind	O
to	O
the	O
surface	O
of	O
cells	B-ANAT
from	O
swine	O
testes	B-ANAT
in	O
a	O
competitive	O
manner	O
and	O
completely	O
inhibit	O
viral	O
infection	O
.	O

In	O
these	O
patients	O
,	O
rescue	O
therapies	O
such	O
as	O
high	O
-	O
frequency	O
ventilation	O
,	O
prone	O
ventilation	O
,	O
nitric	O
oxide	O
,	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
are	O
considered	O
.	O

Mean	O
airway	B-ANAT
pressures	O
were	O
higher	O
in	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
animals	O
between	O
6	O
and	O
48	O
hrs	O
(	O
p	O
<	O
.	O
05	O
).	O

In	O
this	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
severe	O
smoke	O
inhalation	O
in	O
swine	O
,	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
-	O
treated	O
animals	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
faster	O
than	O
conventional	O
mechanical	O
ventilation	O
-	O
treated	O
animals	O
,	O
showing	O
a	O
lower	O
PaO2	O
/	O
Fio2	O
ratio	O
at	O
12	O
,	O
18	O
,	O
and	O
24	O
hrs	O
after	O
injury	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
in	O
response	O
to	O
an	O
attenuated	O
mouse	O
hepatitis	O
virus	O
infection	O
,	O
DCs	O
fail	O
to	O
mobilize	O
and	O
up	O
-	O
regulate	O
CD40	O
,	O
CD80	O
,	O
CD86	O
,	O
and	O
MHC	B-ANAT
class	O
I	O
in	O
TNFR1	O
(-/-)	O
mice	O
as	O
compared	O
with	O
the	O
wild	O
-	O
type	O
and	O
TNFR2	O
(-/-)	O
mice	O
.	O

Interestingly	O
,	O
adoptive	O
transfer	O
of	O
TNFR1	O
-	O
expressing	O
naive	O
T	B-ANAT
cells	I-ANAT
also	O
restores	O
DC	O
mobilization	O
and	O
maturation	O
and	O
endogenous	O
CD8	O
T	B-ANAT
cell	I-ANAT
response	O
.	O

Even	O
the	O
induction	O
of	O
anaesthesia	O
disturbs	O
the	O
physiological	O
lung	B-ANAT
function	O
,	O
due	O
to	O
changes	O
in	O
chest	B-ANAT
wall	I-ANAT
mechanics	O
and	O
diaphragm	B-ANAT
relaxation	O
,	O
generating	O
atelectases	O
,	O
gas	O
exchange	O
disturbance	O
and	O
ventilation	O
-	O
perfusion	O
mismatch	O
.	O

Although	O
these	O
pathophysiological	O
changes	O
may	O
be	O
of	O
minor	O
importance	O
for	O
the	O
majority	O
of	O
ventilated	O
patients	O
in	O
the	O
operating	O
room	O
,	O
these	O
mechanisms	O
may	O
harm	O
patients	O
during	O
surgical	O
interventions	O
with	O
the	O
need	O
for	O
one	O
-	O
lung	B-ANAT
ventilation	O
or	O
with	O
underlying	O
co	O
-	O
morbidities	O
such	O
as	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Specifically	O
,	O
we	O
review	O
the	O
effects	O
of	O
hypercapnia	O
and	O
acidosis	O
on	O
the	O
attenuation	O
of	O
pulmonary	B-ANAT
inflammation	O
,	O
reduction	O
of	O
apoptosis	O
in	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
improvement	O
in	O
sepsis	O
-	O
induced	O
ALI	O
and	O
the	O
therapeutic	O
effects	O
on	O
other	O
organ	B-ANAT
systems	I-ANAT
,	O
as	O
well	O
as	O
the	O
potentially	O
harmful	O
effects	O
of	O
these	O
strategies	O
.	O

TITLE	O
:	O
High	O
-	O
frequency	O
oscillatory	O
ventilation	O
in	O
patients	O
with	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
.	O

TITLE	O
:	O
Mouse	O
hepatitis	O
virus	O
stem	B-ANAT
-	O
loop	O
4	O
functions	O
as	O
a	O
spacer	O
element	O
required	O
to	O
drive	O
subgenomic	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
P2Y	O
receptors	O
as	O
regulators	O
of	O
lung	B-ANAT
endothelial	B-ANAT
barrier	O
integrity	O
.	O

ABSTRACT	O
:	O
Endothelial	B-ANAT
cells	I-ANAT
(	O
ECs	O
),	O
forming	O
a	O
semi	O
-	O
permeable	O
barrier	O
between	O
the	O
interior	O
space	O
of	O
blood	B-ANAT
vessels	I-ANAT
and	O
underlying	O
tissues	B-ANAT
,	O
control	O
such	O
diverse	O
processes	O
as	O
vascular	B-ANAT
tone	O
,	O
homeostasis	O
,	O
adhesion	O
of	O
platelets	B-ANAT
,	O
and	O
leukocytes	B-ANAT
to	O
the	O
vascular	B-ANAT
wall	O
and	O
permeability	O
of	O
vascular	B-ANAT
wall	O
for	O
cells	B-ANAT
and	O
fluids	B-ANAT
.	O

The	O
secondary	O
end	O
-	O
points	O
are	O
:	O
evolution	O
of	O
lung	B-ANAT
disease	O
;	O
the	O
occurrence	O
of	O
nosocomial	O
respiratory	O
infection	O
;	O
duration	O
of	O
mechanical	O
ventilation	O
;	O
duration	O
of	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
stay	O
;	O
duration	O
of	O
hospital	O
stay	O
;	O
occurrence	O
of	O
other	O
infection	O
-	O
related	O
complications	O
;	O
other	O
respiratory	O
complications	O
;	O
and	O
adverse	O
effects	O
of	O
methylprednisolone	O
.	O

We	O
sought	O
to	O
evaluate	O
the	O
efficacy	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
associated	O
with	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
case	O
of	O
failure	O
of	O
conventional	O
management	O
.	O

During	O
a	O
1	O
-	O
year	O
period	O
,	O
this	O
protocol	O
management	O
was	O
used	O
in	O
5	O
patients	O
with	O
refractory	O
respiratory	O
failure	O
associated	O
with	O
bronchial	B-ANAT
fistula	O
after	O
thoracic	B-ANAT
operations	O
.	O

The	O
results	O
suggest	O
that	O
the	O
combined	O
administration	O
of	O
the	O
swIFN	O
-	O
Î±	O
and	O
swIL	O
-	O
18	O
cytokines	O
using	O
attenuated	O
S	O
.	O
enterica	O
serovar	O
Typhimurium	O
as	O
an	O
oral	B-ANAT
carrier	O
provides	O
enhanced	O
protection	O
against	O
intestinal	B-ANAT
tract	I-ANAT
infection	O
with	O
TGEV	O
.	O

Viral	O
gene	O
signatures	O
in	O
the	O
spike	O
,	O
non	O
-	O
structural	O
protein	O
3c	O
,	O
and	O
membrane	B-ANAT
of	O
the	O
coronavirus	O
genome	O
have	O
been	O
shown	O
to	O
often	O
correlate	O
with	O
disease	O
manifestation	O
.	O

TITLE	O
:	O
Sweet	O
syndrome	O
,	O
cutis	B-ANAT
laxa	O
,	O
and	O
fatal	O
cardiac	B-ANAT
manifestations	O
in	O
a	O
2	O
-	O
year	O
-	O
old	O
girl	O
.	O

At	O
that	O
presentation	O
,	O
a	O
cardiac	B-ANAT
evaluation	O
revealed	O
nothing	O
unusual	O
.	O

Measures	O
to	O
prevent	O
the	O
alteration	O
in	O
lung	B-ANAT
compliance	O
in	O
septic	O
shock	O
patients	O
may	O
prevent	O
RVD	O
and	O
improve	O
patients	O
'	O
outcomes	O
.	O

We	O
established	O
a	O
reliable	O
system	O
for	O
transfecting	O
TMV	O
-	O
RNA	O
into	O
HeLa	B-ANAT
cells	I-ANAT
and	O
found	O
that	O
TMV	O
-	O
RNA	O
triggered	O
autophagy	O
in	O
HeLa	B-ANAT
cells	I-ANAT
as	O
shown	O
by	O
the	O
appearance	O
of	O
autophagic	B-ANAT
vacuoles	I-ANAT
,	O
the	O
conversion	O
of	O
LC3	O
-	O
I	O
(	O
light	O
chain	O
protein	O
3	O
-	O
I	O
)	O
to	O
LC3	O
-	O
II	O
,	O
the	O
up	O
-	O
regulated	O
expression	O
of	O
Beclin1	O
and	O
the	O
accumulation	O
of	O
TMV	O
protein	O
on	O
autophagosomal	O
membranes	B-ANAT
.	O

Furthermore	O
,	O
we	O
found	O
that	O
TMV	O
-	O
RNA	O
was	O
translated	O
into	O
CP	O
(	O
coat	B-ANAT
protein	O
)	O
in	O
the	O
ER	O
(	O
endoplasmic	B-ANAT
reticulum	I-ANAT
)	O
and	O
that	O
TMV	O
-	O
positive	O
RNA	O
translocated	O
from	O
the	O
cytoplasm	B-ANAT
to	O
the	O
nucleolus	B-ANAT
.	O

Finally	O
,	O
we	O
detected	O
greatly	O
increased	O
expression	O
of	O
GRP78	O
(	O
78	O
kDa	O
glucose	O
-	O
regulated	O
protein	O
),	O
a	O
typical	O
marker	O
of	O
ERS	O
(	O
ER	O
stress	O
)	O
and	O
found	O
that	O
the	O
formation	O
of	O
autophagosomes	O
was	O
closely	O
related	O
to	O
the	O
expanded	O
ER	B-ANAT
membrane	I-ANAT
.	O

Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
HeLa	B-ANAT
cells	I-ANAT
used	O
ERS	O
and	O
ERS	O
-	O
related	O
autophagy	O
to	O
defend	O
against	O
TMV	O
-	O
RNA	O
.	O

pECLA	O
may	O
decrease	O
further	O
lung	B-ANAT
injury	O
by	O
minimizing	O
the	O
amount	O
of	O
time	O
for	O
which	O
the	O
lung	B-ANAT
is	O
exposed	O
to	O
high	O
stress	O
and	O
/	O
or	O
strain	O
.	O

In	O
ARDS	O
,	O
the	O
primary	O
objective	O
of	O
PEEP	O
is	O
to	O
increase	O
the	O
amount	O
of	O
non	O
-	O
aerated	O
lung	B-ANAT
at	O
the	O
end	O
of	O
expiration	O
.	O

Higher	O
PEEP	O
should	O
be	O
used	O
with	O
caution	O
in	O
patients	O
less	O
severe	O
hypoxemic	O
(	O
acute	O
lung	B-ANAT
injury	O
).	O
To	O
deliver	O
optimal	O
PEEP	O
to	O
those	O
ARDS	O
patients	O
with	O
the	O
highest	O
lung	B-ANAT
recruitability	O
,	O
this	O
technique	O
should	O
be	O
monitored	O
at	O
the	O
bedside	O
.	O

Heart	B-ANAT
and	O
pancreas	B-ANAT
were	O
positive	O
in	O
63	O
%	O
while	O
brain	B-ANAT
was	O
positive	O
in	O
36	O
.	O
5	O
%	O
of	O
the	O
infected	O
crows	O
.	O

Indeed	O
,	O
when	O
these	O
mice	O
were	O
challenged	O
with	O
a	O
low	O
dose	O
(<	O
0	O
.	O
5	O
LDââ	O
)	O
of	O
the	O
DENV	O
-	O
2	O
NSx	O
strain	O
,	O
but	O
not	O
the	O
NG	O
-	O
C	O
strain	O
,	O
they	O
all	O
generated	O
dramatic	O
and	O
lethal	O
DENV	O
-	O
2	O
AER	B-ANAT
/	O
AED	O
.	O

Lithium	O
poisoning	O
results	O
in	O
multisystem	O
toxicity	O
,	O
and	O
characteristic	O
clinical	O
manifestations	O
are	O
directly	O
correlated	O
to	O
serum	B-ANAT
lithium	O
concentration	O
.	O

ABSTRACT	O
:	O
Legionellosis	O
is	O
a	O
systemic	O
disease	O
that	O
primarily	O
affects	O
the	O
lungs	B-ANAT
.	O

There	O
are	O
only	O
a	O
few	O
reported	O
cases	O
of	O
renal	B-ANAT
dysfunction	O
in	O
patients	O
with	O
legionellosis	O
.	O

A	O
renal	B-ANAT
biopsy	O
showed	O
extracapillary	O
and	O
endocapillary	O
proliferative	O
glomerulonephritis	O
with	O
accompanying	O
chronic	O
and	O
acute	O
interstitial	B-ANAT
nephritis	O
.	O

He	O
was	O
diagnosed	O
with	O
influenza	O
A	O
(	O
H1N1	O
,	O
severe	O
type	O
),	O
severe	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
Evans	O
syndrome	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

A	O
significant	O
fraction	O
of	O
patients	O
present	O
mitochondrial	B-ANAT
DNA	I-ANAT
depletion	O
but	O
a	O
number	O
of	O
cases	O
remain	O
unexplained	O
.	O

It	O
suggests	O
that	O
mitochondrial	B-ANAT
translation	O
deficiency	O
represents	O
a	O
growing	O
cause	O
of	O
hepatic	B-ANAT
failure	O
of	O
mitochondrial	B-ANAT
origin	O
in	O
infants	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
supporting	O
adult	O
refractory	O
respiratory	O
failure	O
continues	O
to	O
evolve	O
.	O

Published	O
systematic	O
review	O
and	O
pooled	O
analyses	O
point	O
out	O
the	O
limitations	O
of	O
available	O
studies	O
,	O
however	O
,	O
a	O
growing	O
body	B-ANAT
of	O
evidence	O
suggest	O
potential	O
for	O
benefit	O
.	O

TITLE	O
:	O
The	O
immune	O
responses	O
of	O
HLA	B-ANAT
-	O
A	O
*	O
0201	O
restricted	O
SARS	O
-	O
CoV	O
S	O
peptide	O
-	O
specific	O
CD8	O
âº	O
T	B-ANAT
cells	I-ANAT
are	O
augmented	O
in	O
varying	O
degrees	O
by	O
CpG	O
ODN	O
,	O
PolyI	O
:	O
C	O
and	O
R848	O
.	O

TITLE	O
:	O
IFN	O
-	O
Î³	O
-	O
and	O
IL	O
-	O
10	O
-	O
expressing	O
virus	O
epitope	O
-	O
specific	O
Foxp3	O
(+)	O
T	B-ANAT
reg	I-ANAT
cells	B-ANAT
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
during	O
encephalomyelitis	O
.	O

However	O
,	O
identifying	O
pathogen	O
-	O
specific	O
epitopes	O
targeted	O
by	O
these	O
cells	B-ANAT
has	O
been	O
elusive	O
.	O

Identification	O
of	O
T	B-ANAT
reg	I-ANAT
cell	B-ANAT
target	O
epitopes	O
by	O
cytokine	O
production	O
is	O
also	O
applicable	O
in	O
autoimmune	O
disease	O
because	O
myelin	B-ANAT
oligodendrocyte	B-ANAT
glycoprotein	O
-	O
specific	O
Foxp3	O
(+)	O
T	B-ANAT
reg	I-ANAT
cells	B-ANAT
express	O
IL	O
-	O
10	O
and	O
IL	O
-	O
17	O
at	O
the	O
peak	O
of	O
disease	O
in	O
mice	O
with	O
experimental	O
autoimmune	O
encephalomyelitis	O
.	O

TITLE	O
:	O
Use	O
of	O
a	O
novel	O
virus	O
detection	O
assay	O
to	O
identify	O
coronavirus	O
HKU1	O
in	O
the	O
lungs	B-ANAT
of	O
a	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
recipient	O
with	O
fatal	O
pneumonia	O
.	O

ABSTRACT	O
:	O
A	O
38	O
-	O
year	O
-	O
old	O
female	O
patient	O
with	O
systemic	O
lupus	O
erythematosus	O
presented	O
with	O
pulmonary	B-ANAT
infiltrates	O
and	O
hypoxemia	O
for	O
several	O
months	O
following	O
immunodepleting	O
autologous	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
.	O

EC	O
-	O
SOD	O
attenuated	O
pulmonary	B-ANAT
inflammation	O
,	O
decreased	O
bronchoalveolar	O
lavage	O
neutrophil	B-ANAT
counts	O
,	O
and	O
reduced	O
interleukin	O
-	O
6	O
and	O
CINC	O
-	O
1	O
concentrations	O
.	O

Pulmonary	B-ANAT
overexpression	O
of	O
EC	O
-	O
SOD	O
protects	O
the	O
lung	B-ANAT
against	O
endotoxin	O
-	O
induced	O
ALI	O
.	O

The	O
AAV	O
vector	O
itself	O
did	O
not	O
contribute	O
to	O
inflammation	O
or	O
to	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Renin	O
-	O
angiotensin	O
II	O
-	O
aldosterone	O
axis	B-ANAT
has	O
long	O
been	O
known	O
as	O
a	O
regulator	O
of	O
blood	B-ANAT
pressure	O
and	O
fluid	O
homeostasis	O
.	O

The	O
enzyme	O
responsible	O
for	O
its	O
synthesis	O
,	O
Angiotensin	O
-	O
converting	O
-	O
enzyme	O
(	O
ACE	O
),	O
is	O
present	O
in	O
high	O
concentrations	O
in	O
lung	B-ANAT
tissue	I-ANAT
.	O

Thirteen	O
(	O
59	O
%)	O
had	O
respiratory	O
distress	O
;	O
12	O
(	O
55	O
%),	O
acute	O
renal	B-ANAT
failure	O
;	O
and	O
12	O
,	O
shock	O
.	O

TITLE	O
:	O
Chimeric	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
S	O
glycoprotein	O
and	O
influenza	O
matrix	O
1	O
efficiently	O
form	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
(	O
VLPs	B-ANAT
)	O
that	O
protect	O
mice	O
against	O
challenge	O
with	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
SARS	O
-	O
CoV	O
was	O
the	O
cause	O
of	O
the	O
global	O
pandemic	O
in	O
2003	O
that	O
infected	O
over	O
8000	O
people	O
in	O
8	O
months	O
.	O

ABSTRACT	O
:	O
High	O
-	O
frequency	O
oscillation	O
is	O
used	O
for	O
adults	O
with	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

During	O
high	O
-	O
frequency	O
oscillation	O
,	O
adjunctive	O
treatments	O
(	O
neuromuscular	O
blockade	O
,	O
75	O
.	O
6	O
%;	O
recruitment	O
maneuvers	O
,	O
49	O
.	O
5	O
%;	O
nitric	O
oxide	O
,	O
34	O
.	O
0	O
%;	O
steroids	O
,	O
63	O
.	O
1	O
%)	O
and	O
new	O
barotrauma	O
or	O
chest	B-ANAT
tube	O
placement	O
(	O
23	O
.	O
5	O
%)	O
were	O
common	O
.	O

TITLE	O
:	O
[	O
Expression	O
and	O
purification	O
of	O
different	O
segments	O
from	O
HCoV	O
-	O
NL63	O
nucleocapsid	B-ANAT
protein	O
and	O
their	O
application	O
in	O
detection	O
of	O
antibodies	O
].	O

Consequently	O
,	O
we	O
prepared	O
two	O
purified	O
proteins	O
,	O
Np	O
and	O
Cp	O
,	O
respectively	O
,	O
and	O
established	O
a	O
Western	O
blotting	O
-	O
based	O
line	O
assay	O
(	O
WBLA	O
)	O
for	O
detection	O
of	O
antibodies	O
against	O
HCoV	O
-	O
NL63	O
using	O
three	O
purified	O
proteins	O
:	O
Np	O
,	O
Cp	O
and	O
Nf	O
,	O
a	O
full	O
-	O
length	O
HCoV	O
-	O
NL63	O
nucleocapsid	B-ANAT
protein	O
as	O
previously	O
reported	O
.	O

Examination	O
of	O
the	O
cellular	B-ANAT
PDZ	O
proteins	O
that	O
are	O
targets	O
of	O
viral	O
PBMs	O
reveals	O
that	O
the	O
viral	O
proteins	O
often	O
interact	O
with	O
the	O
same	O
or	O
similar	O
types	O
of	O
PDZ	O
proteins	O
,	O
most	O
notably	O
Dlg1	O
and	O
other	O
members	O
of	O
the	O
membrane	B-ANAT
-	O
associated	O
guanylate	O
kinase	O
protein	O
family	O
,	O
as	O
well	O
as	O
Scribble	O
.	O

The	O
inhibition	O
or	O
perturbation	O
of	O
the	O
function	O
of	O
cellular	B-ANAT
PDZ	O
proteins	O
appears	O
to	O
be	O
a	O
widely	O
used	O
strategy	O
for	O
viruses	O
to	O
enhance	O
their	O
replication	O
,	O
disseminate	O
in	O
the	O
host	O
,	O
and	O
transmit	O
to	O
new	O
hosts	O
.	O

We	O
demonstrate	O
here	O
that	O
anti	O
-	O
Spike	O
immune	O
serum	B-ANAT
,	O
while	O
inhibiting	O
viral	O
entry	O
in	O
a	O
permissive	O
cell	B-ANAT
line	I-ANAT
,	O
potentiated	O
infection	O
of	O
immune	O
cells	B-ANAT
by	O
SARS	O
-	O
CoV	O
Spike	O
-	O
pseudotyped	O
lentiviral	O
particles	O
,	O
as	O
well	O
as	O
replication	O
-	O
competent	O
SARS	O
coronavirus	O
.	O

Different	O
SARS	O
vaccine	O
candidates	O
elicit	O
sera	B-ANAT
that	O
differ	O
in	O
their	O
capacity	O
to	O
induce	O
ADE	O
in	O
immune	O
cells	B-ANAT
despite	O
their	O
comparable	O
potency	O
to	O
neutralize	O
infection	O
in	O
ACE2	O
-	O
bearing	O
cells	B-ANAT
.	O

In	O
brief	O
,	O
we	O
provide	O
a	O
procedure	O
for	O
i	O
)	O
preparation	O
of	O
NSCs	O
prior	O
to	O
transplant	B-ANAT
,	O
ii	O
)	O
pre	O
-	O
operative	O
care	O
of	O
mice	O
,	O
iii	O
)	O
exposure	O
of	O
the	O
spinal	B-ANAT
cord	I-ANAT
via	O
laminectomy	O
,	O
iv	O
)	O
stereotactic	O
injection	O
of	O
NSCs	O
,	O
and	O
iv	O
)	O
post	O
-	O
operative	O
care	O
.	O

TITLE	O
:	O
Novel	O
interventional	O
approaches	O
for	O
ALI	O
/	O
ARDS	O
:	O
cell	B-ANAT
-	O
based	O
gene	O
therapy	O
.	O

Recently	O
,	O
the	O
combination	O
of	O
cell	B-ANAT
and	O
gene	O
therapy	O
which	O
has	O
been	O
demonstrated	O
to	O
provide	O
additive	O
benefit	O
has	O
opened	O
up	O
a	O
new	O
chapter	O
in	O
therapeutic	O
strategy	O
and	O
provides	O
a	O
basis	O
for	O
the	O
development	O
of	O
an	O
innovative	O
approach	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
ALI	O
/	O
ARDS	O
.	O

Coronavirus	O
HKU1	O
may	O
be	O
important	O
pathogens	O
in	O
children	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

CONCLUSIONS	O
:	O
Coronavirus	O
HKU1	O
may	O
be	O
important	O
pathogens	O
in	O
children	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

IBV	O
M41	O
and	O
Ark	O
were	O
detected	O
in	O
spermatogonia	B-ANAT
and	O
Sertoli	B-ANAT
cells	I-ANAT
of	O
testicles	B-ANAT
of	O
infected	O
roosters	O
by	O
immunofluorescence	O
,	O
without	O
evident	O
histopathological	O
changes	O
.	O

ABSTRACT	O
:	O
Nucleic	B-ANAT
acid	O
amplification	O
is	O
enormously	O
useful	O
to	O
the	O
biotechnology	O
and	O
clinical	O
diagnostic	O
communities	O
;	O
however	O
,	O
to	O
date	O
point	O
-	O
of	O
-	O
use	O
PCR	O
has	O
been	O
hindered	O
by	O
thermal	O
cycling	O
architectures	O
and	O
protocols	O
that	O
do	O
not	O
allow	O
for	O
near	O
-	O
instantaneous	O
results	O
.	O

Here	O
,	O
we	O
further	O
characterized	O
the	O
S	O
protein	O
by	O
investigating	O
the	O
roles	O
of	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
and	O
19	O
residues	O
located	O
in	O
the	O
RBD	O
in	O
protein	O
accumulation	O
,	O
receptor	O
binding	O
,	O
and	O
pseudotype	O
virus	O
entry	O
.	O

ABSTRACT	O
:	O
The	O
3	O
'-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
group	O
2	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
genome	O
contains	O
a	O
predicted	O
bulged	O
stem	B-ANAT
-	O
loop	O
(	O
designated	O
P0ab	O
),	O
a	O
conserved	O
cis	O
-	O
acting	O
pseudoknot	O
(	O
PK	O
),	O
and	O
a	O
more	O
distal	O
stem	B-ANAT
-	O
loop	O
(	O
designated	O
P2	O
).	O

We	O
find	O
that	O
an	O
RNA	O
capable	O
of	O
forming	O
only	O
the	O
predicted	O
PK	O
(	O
58	O
nt	O
;	O
3	O
'	O
nucleotides	O
241	O
-	O
185	O
)	O
adopts	O
the	O
P2	O
stem	B-ANAT
-	O
loop	O
with	O
little	O
evidence	O
for	O
P1	O
(	O
pk	O
)	O
pairing	O
in	O
0	O
.	O
1	O
M	O
KCl	O
and	O
the	O
absence	O
of	O
Mg	O
(	O
2	O
+);	O
as	O
Mg	O
(	O
2	O
+)	O
or	O
1	O
M	O
KCl	O
is	O
added	O
,	O
a	O
new	O
thermal	O
unfolding	O
transition	O
is	O
induced	O
and	O
assignable	O
to	O
P1	O
(	O
pk	O
)	O
pairing	O
.	O

Moreover	O
,	O
significantly	O
enhanced	O
MMP3	O
expression	O
by	O
astrocytes	B-ANAT
in	O
infected	O
MMP9	O
(-/-)	O
mice	O
suggests	O
an	O
active	O
role	O
of	O
resident	O
cells	B-ANAT
in	O
participating	O
and	O
potentially	O
collaborating	O
with	O
infiltrating	O
cells	B-ANAT
in	O
regulating	O
BBB	B-ANAT
permeability	O
.	O

CONCLUSIONS	O
:	O
The	O
results	O
will	O
help	O
to	O
identify	O
the	O
nucleolar	B-ANAT
localization	O
signals	O
in	O
PEDV	O
N	O
protein	O
and	O
to	O
elucidate	O
the	O
mechanism	O
of	O
N	O
protein	O
located	O
in	O
nucleus	B-ANAT
.	O

TITLE	O
:	O
Development	O
of	O
a	O
recombinant	O
truncated	O
nucleocapsid	B-ANAT
protein	O
based	O
immunoassay	O
for	O
detection	O
of	O
antibodies	O
against	O
human	O
coronavirus	O
OC43	O
.	O

In	O
contrast	O
,	O
adults	O
who	O
reported	O
recurrent	O
,	O
severe	O
episodes	O
of	O
wheezing	O
(	O
N	O
=	O
34	O
),	O
regardless	O
of	O
asthma	O
,	O
had	O
twice	O
the	O
rates	O
of	O
pain	O
and	O
ACS	O
,	O
decreased	O
lung	B-ANAT
function	O
and	O
increased	O
risk	O
of	O
death	O
compared	O
with	O
adults	O
without	O
recurrent	O
,	O
severe	O
wheezing	O
.	O

In	O
this	O
study	O
,	O
we	O
first	O
investigated	O
at	O
6	O
years	O
postinfection	O
whether	O
SARS	O
-	O
specific	O
memory	O
T	B-ANAT
cells	I-ANAT
persist	O
in	O
SARS	O
-	O
recovered	O
individuals	O
,	O
demonstrating	O
that	O
these	O
subjects	O
still	O
possess	O
polyfunctional	O
SARS	O
-	O
specific	O
memory	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Neurological	O
prognostication	O
in	O
cardiac	B-ANAT
arrest	O
survivors	O
is	O
difficult	O
,	O
especially	O
when	O
the	O
primary	O
etiology	O
is	O
respiratory	O
arrest	O
.	O

We	O
describe	O
here	O
a	O
pregnant	O
woman	O
resuscitated	O
from	O
a	O
cardiac	B-ANAT
arrest	O
due	O
to	O
acute	O
severe	O
asthma	O
,	O
and	O
an	O
inability	O
to	O
reach	O
a	O
consensus	O
based	O
on	O
published	O
guidelines	O
,	O
with	O
a	O
brief	O
overview	O
of	O
myoclonus	O
,	O
LAS	O
and	O
the	O
role	O
of	O
MRI	O
brain	B-ANAT
in	O
assisting	O
prognostication	O
.	O

ABSTRACT	O
:	O
Fat	O
embolization	O
(	O
FE	O
),	O
the	O
introduction	O
of	O
bone	B-ANAT
marrow	I-ANAT
elements	O
into	O
circulation	O
,	O
is	O
a	O
known	O
complication	O
of	O
bone	B-ANAT
fractures	O
.	O

Here	O
,	O
we	O
describe	O
a	O
rapid	O
and	O
safe	O
cell	B-ANAT
-	O
based	O
high	O
-	O
throughput	O
screening	O
system	O
,	O
dual	O
envelope	B-ANAT
pseudovirion	O
(	O
DEP	O
)	O
assay	O
,	O
for	O
specifically	O
screening	O
inhibitors	O
of	O
viral	O
entry	O
.	O

Further	O
,	O
an	O
increase	O
in	O
the	O
rate	O
of	O
spontaneous	O
recovery	O
of	O
liver	B-ANAT
function	O
has	O
been	O
described	O
.	O

All	O
patients	O
presented	O
with	O
respiratory	O
symptoms	O
and	O
pulmonary	B-ANAT
infiltrates	O
prior	O
to	O
AML	O
FAB	O
-	O
M5	O
diagnosis	O
.	O

These	O
results	O
warrant	O
a	O
controlled	O
trial	O
of	O
dexamethasone	O
versus	O
placebo	O
in	O
AML	O
FAB	O
-	O
M5	O
patients	O
with	O
noninfectious	O
pulmonary	B-ANAT
infiltrates	O
.	O

New	O
data	O
are	O
available	O
regarding	O
the	O
use	O
of	O
these	O
agents	O
for	O
treatment	O
of	O
ALI	O
/	O
ARDS	O
and	O
status	O
asthmaticus	O
,	O
management	O
of	O
elevated	O
ICP	O
,	O
and	O
provision	O
of	O
therapeutic	O
hypothermia	O
after	O
cardiac	B-ANAT
arrest	O
.	O

Vaccination	O
programmes	O
using	O
different	O
combinations	O
of	O
heterologous	O
live	O
vaccines	O
at	O
day	O
0	O
or	O
at	O
days	O
0	O
and	O
14	O
induced	O
a	O
reasonable	O
to	O
high	O
level	O
of	O
protection	O
in	O
the	O
trachea	B-ANAT
,	O
kidney	B-ANAT
,	O
oviduct	B-ANAT
and	O
air	B-ANAT
sacs	I-ANAT
against	O
challenge	O
with	O
the	O
D388	O
strain	O
at	O
28	O
days	O
of	O
age	O
.	O

Blunt	O
chest	B-ANAT
injury	O
resulted	O
in	O
the	O
activation	O
of	O
circulating	O
neutrophils	B-ANAT
,	O
as	O
characterized	O
by	O
a	O
decreased	O
expression	O
of	O
l	O
-	O
selectin	O
(	O
CD62L	O
),	O
CXCR2	O
(	O
CD182b	O
)	O
and	O
C5aR	O
(	O
CD88	O
)	O
compared	O
to	O
control	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

RESULTS	O
:	O
Blunt	O
chest	B-ANAT
injury	O
resulted	O
in	O
the	O
activation	O
of	O
circulating	O
neutrophils	B-ANAT
,	O
as	O
characterized	O
by	O
a	O
decreased	O
expression	O
of	O
l	O
-	O
selectin	O
(	O
CD62L	O
),	O
CXCR2	O
(	O
CD182b	O
)	O
and	O
C5aR	O
(	O
CD88	O
)	O
compared	O
to	O
control	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
Viruses	O
are	O
the	O
major	O
cause	O
of	O
pediatric	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
and	O
yet	O
many	O
suspected	O
cases	O
of	O
illness	O
remain	O
uncharacterized	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
transfusion	O
associated	O
circulatory	O
overload	O
(	O
TACO	O
)	O
and	O
transfusion	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
).	O

We	O
also	O
examined	O
the	O
distribution	O
of	O
these	O
S	O
proteins	O
;	O
the	O
MK	O
-	O
p10	O
and	O
MK	O
-	O
H1381R	O
S	O
proteins	O
were	O
transported	O
onto	O
the	O
cell	B-ANAT
surface	I-ANAT
more	O
efficiently	O
than	O
others	O
.	O

TITLE	O
:	O
Massive	O
systemic	O
air	O
embolism	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
of	O
a	O
neonate	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
cardiac	B-ANAT
surgery	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
effect	O
of	O
HC	O
on	O
cell	B-ANAT
infection	O
by	O
IBV	O
was	O
determined	O
using	O
plaque	O
assay	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Lack	O
of	O
recovery	O
of	O
platelet	B-ANAT
count	O
and	O
persistence	O
of	O
leukocytosis	O
were	O
characteristic	O
of	O
non	O
-	O
survivors	O
.	O

Diagnostic	O
techniques	O
for	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
parainfluenza	O
,	O
influenza	O
,	O
and	O
adenovirus	O
have	O
been	O
clinically	O
available	O
for	O
decades	O
,	O
and	O
these	O
infections	O
are	O
known	O
to	O
cause	O
serious	O
disease	O
in	O
transplant	B-ANAT
recipients	O
.	O

The	O
disorder	O
is	O
mainly	O
caused	O
by	O
a	O
delayed	O
resorption	O
of	O
foetal	O
lung	B-ANAT
fluid	O
.	O

Due	O
to	O
the	O
overall	O
improvement	O
in	O
perinatal	O
care	O
,	O
respiratory	O
disorders	O
still	O
remain	O
a	O
major	O
problem	O
in	O
pulmonary	B-ANAT
adaptation	O
.	O

They	O
were	O
evaluated	O
initially	O
on	O
RNA	O
templates	O
from	O
virus	O
-	O
infected	O
cells	B-ANAT
using	O
a	O
two	O
-	O
step	O
RT	O
-	O
PCR	O
protocol	O
that	O
was	O
further	O
advanced	O
to	O
a	O
one	O
-	O
step	O
assay	O
.	O

The	O
sensitivity	O
of	O
the	O
assay	O
ranged	O
from	O
10	O
(	O
2	O
)	O
to	O
10	O
(	O
6	O
)	O
and	O
from	O
10	O
(	O
5	O
)	O
to	O
10	O
(	O
9	O
)	O
RNA	O
copy	O
numbers	O
for	O
individual	O
corona	O
-/	O
torovirus	O
templates	O
when	O
tested	O
,	O
respectively	O
,	O
with	O
and	O
without	O
an	O
excess	O
of	O
RNA	O
from	O
human	O
cells	B-ANAT
.	O

TITLE	O
:	O
Sustained	O
high	O
-	O
efficiency	O
daily	O
diafiltration	O
using	O
a	O
mediator	O
-	O
adsorbing	O
membrane	B-ANAT
(	O
SHEDD	O
-	O
fA	O
)	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
severe	O
sepsis	O
.	O

Operation	O
conditions	O
were	O
as	O
follows	O
:	O
blood	B-ANAT
flow	O
rate	O
150	O
ml	O
/	O
min	O
,	O
filtration	O
rate	O
1	O
,	O
500	O
ml	O
/	O
h	O
(	O
post	O
-	O
dilution	O
),	O
and	O
dialysate	O
flow	O
rate	O
300	O
-	O
500	O
ml	O
/	O
min	O
over	O
8	O
-	O
12	O
h	O
daily	O
.	O

Total	O
fiber	B-ANAT
counts	O
,	O
nerve	B-ANAT
density	O
,	O
and	O
percent	O
neural	B-ANAT
tissue	I-ANAT
were	O
all	O
significantly	O
reduced	O
in	O
infected	O
animals	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Mechanical	O
support	O
in	O
the	O
form	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
may	O
increase	O
the	O
safety	O
of	O
transporting	O
such	O
patients	O
to	O
an	O
institution	O
where	O
they	O
will	O
have	O
access	O
to	O
advanced	O
medical	O
therapy	O
.	O

Here	O
we	O
demonstrate	O
that	O
RIPK3	O
and	O
FADD	O
have	O
opposing	O
and	O
complementary	O
roles	O
in	O
promoting	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
clonal	B-ANAT
expansion	O
and	O
homeostasis	O
.	O

In	O
fact	O
,	O
EFL	O
(	O
T	O
)	O
occurs	O
commonly	O
in	O
COPD	O
patients	O
(	O
mainly	O
in	O
Global	O
Initiative	O
for	O
Chronic	O
Obstructive	O
Lung	B-ANAT
Disease	O
III	O
and	O
IV	O
stage	O
),	O
in	O
whom	O
the	O
latter	O
symptoms	O
are	O
common	O
,	O
but	O
is	O
not	O
exclusive	O
to	O
COPD	O
,	O
since	O
it	O
can	O
also	O
be	O
detected	O
in	O
other	O
pulmonary	B-ANAT
and	O
nonpulmonary	O
diseases	O
like	O
asthma	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
heart	B-ANAT
failure	O
and	O
obesity	O
,	O
etc	O
.	O

The	O
primary	O
outcome	O
was	O
survival	O
to	O
hospital	O
discharge	B-ANAT
.	O

Decreased	O
wet	O
-	O
dry	O
weight	O
ratios	O
of	O
the	O
lungs	B-ANAT
,	O
lower	O
histological	O
lung	B-ANAT
injury	O
scores	O
and	O
higher	O
PaO	O
(	O
2	O
)	O
were	O
found	O
in	O
all	O
low	O
tidal	O
volume	O
/	O
hypercapnia	O
groups	O
(	O
group	O
2	O
,	O
3	O
,	O
4	O
)	O
as	O
compared	O
to	O
the	O
group	O
with	O
conventional	O
tidal	O
volume	O
/	O
normocapnia	O
(	O
group	O
1	O
).	O

TITLE	O
:	O
Inhibition	O
of	O
SARS	O
pseudovirus	O
cell	B-ANAT
entry	O
by	O
lactoferrin	O
binding	O
to	O
heparan	O
sulfate	O
proteoglycans	O
.	O

Healthcare	O
workers	O
,	O
predominantly	O
female	O
,	O
face	B-ANAT
occupational	O
and	O
personal	O
challenges	O
in	O
their	O
roles	O
as	O
first	O
responders	O
/	O
first	O
receivers	O
.	O

ABSTRACT	O
:	O
In	O
May	O
2011	O
,	O
an	O
outbreak	O
of	O
Shiga	O
toxin	O
-	O
producing	O
enterohaemorrhagic	O
E	O
coli	O
O104	O
:	O
H4	O
in	O
northern	O
Germany	O
led	O
to	O
a	O
high	O
proportion	O
of	O
patients	O
developing	O
post	O
-	O
enteritis	O
haemolytic	O
uraemic	O
syndrome	O
and	O
thrombotic	O
microangiopathy	O
that	O
were	O
unresponsive	O
to	O
therapeutic	O
plasma	B-ANAT
exchange	O
or	O
complement	O
-	O
blocking	O
antibody	O
(	O
eculizumab	O
).	O

The	O
identical	O
phenotype	O
was	O
observed	O
by	O
siRNA	O
-	O
mediated	O
knockdown	O
of	O
MTU1	O
in	O
HEK	B-ANAT
293	I-ANAT
cells	I-ANAT
.	O

No	O
or	O
minor	O
changes	O
have	O
been	O
detected	O
in	O
the	O
expression	O
of	O
ChPLA2	O
-	O
IIE	O
in	O
lungs	B-ANAT
and	O
small	B-ANAT
intestine	I-ANAT
,	O
but	O
it	O
shows	O
a	O
significant	O
increase	O
in	O
several	O
infected	O
tissues	B-ANAT
.	O

ABSTRACT	O
:	O
Face	B-ANAT
masks	O
or	O
respirators	O
are	O
commonly	O
worn	O
by	O
medical	O
professionals	O
and	O
patients	O
for	O
protection	O
against	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
and	O
the	O
spread	O
of	O
illnesses	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
pandemic	O
influenza	O
(	O
H1N1	O
).	O

Cytochrome	O
P450	O
Family	O
3A	O
(	O
CYP4F3A	O
)	O
is	O
an	O
Ï	O
-	O
oxidase	O
that	O
inactivates	O
Leukotriene	O
B4	O
(	O
LTB4	O
)	O
in	O
human	O
neutrophils	B-ANAT
and	O
the	O
liver	B-ANAT
.	O

Several	O
different	O
methods	O
have	O
been	O
used	O
to	O
generate	O
SARS	O
-	O
CoV	O
specific	O
neutralizing	O
hmAbs	O
including	O
the	O
immunization	O
of	O
transgenic	O
mice	O
,	O
cloning	O
of	O
small	O
chain	O
variable	O
regions	O
from	O
naÃ¯ve	O
and	O
convalescent	O
patients	O
,	O
and	O
the	O
immortalization	O
of	O
convalescent	O
B	B-ANAT
cells	I-ANAT
.	O

Additionally	O
,	O
postnatal	O
ETS	O
exposure	O
causes	O
acute	O
respiratory	O
infections	O
,	O
ear	B-ANAT
problems	O
,	O
respiratory	O
symptoms	O
,	O
more	O
severe	O
asthma	O
,	O
and	O
it	O
slows	O
lung	B-ANAT
growth	O
.	O

However	O
,	O
when	O
the	O
adsorption	O
time	O
was	O
reduced	O
to	O
5	O
min	O
the	O
infectivity	O
on	O
desialylated	O
cells	B-ANAT
decreased	O
by	O
more	O
than	O
60	O
%.	O

The	O
predefined	O
composite	O
endpoint	O
was	O
the	O
occurrence	O
of	O
any	O
of	O
the	O
following	O
:	O
death	O
(	O
any	O
cause	O
),	O
cardiac	B-ANAT
dysfunction	O
(	O
myocardial	O
infarction	O
or	O
congestive	O
heart	B-ANAT
failure	O
),	O
cerebral	B-ANAT
dysfunction	O
(	O
stroke	O
or	O
encephalopathy	O
),	O
renal	B-ANAT
dysfunction	O
(	O
dysfunction	O
or	O
failure	O
),	O
or	O
pulmonary	B-ANAT
dysfunction	O
(	O
acute	O
respiratory	O
distress	O
syndrome	O
).	O

The	O
PAC	O
group	O
had	O
an	O
increased	O
risk	O
of	O
all	O
-	O
cause	O
mortality	O
,	O
3	O
.	O
5	O
%	O
vs	O
1	O
.	O
7	O
%	O
(	O
AOR	O
,	O
2	O
.	O
08	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
11	O
to	O
3	O
.	O
88	O
;	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
an	O
increased	O
risk	O
of	O
cardiac	B-ANAT
(	O
AOR	O
,	O
1	O
.	O
58	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
14	O
to	O
2	O
.	O
20	O
;	O
P	O
=	O
0	O
.	O
007	O
),	O
cerebral	B-ANAT
(	O
AOR	O
,	O
2	O
.	O
02	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
08	O
to	O
3	O
.	O
77	O
;	O
P	O
=	O
0	O
.	O
03	O
)	O
and	O
renal	B-ANAT
(	O
AOR	O
,	O
2	O
.	O
47	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
68	O
to	O
3	O
.	O
62	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
morbid	O
outcomes	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
activation	O
of	O
cellular	B-ANAT
DNA	O
damage	O
response	O
is	O
one	O
of	O
the	O
mechanisms	O
exploited	O
by	O
Coronavirus	O
to	O
induce	O
cell	B-ANAT
cycle	O
arrest	O
.	O

We	O
included	O
patients	O
with	O
severe	O
acute	O
respiratory	O
infection	O
in	O
whom	O
a	O
nasopharyngeal	B-ANAT
swab	I-ANAT
was	O
positive	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
for	O
2009	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
virus	O
and	O
negative	O
for	O
seasonal	O
influenza	O
A	O
H1	O
and	O
H3	O
.	O

Enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
analysis	O
was	O
then	O
used	O
to	O
identify	O
the	O
aptamer	O
with	O
the	O
highest	O
binding	O
affinity	O
to	O
the	O
SARS	O
CoV	O
nucleocapsid	B-ANAT
protein	O
.	O

Their	O
mechanisms	O
of	O
action	O
in	O
pulmonary	B-ANAT
diseases	O
are	O
ill	O
defined	O
.	O

CS	O
have	O
proven	O
beneficial	O
roles	O
in	O
the	O
treatment	O
of	O
asthma	O
,	O
croup	O
,	O
allergic	O
bronchopulmonary	O
aspergillosis	O
,	O
and	O
subglottic	B-ANAT
hemangioma	O
.	O

ABSTRACT	O
:	O
In	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
the	O
envelope	B-ANAT
heptad	O
repeat	O
2	O
(	O
HR2	O
)	O
plays	O
a	O
critical	O
role	O
in	O
viral	O
entry	O
.	O

In	O
this	O
work	O
,	O
two	O
manikins	O
labelled	O
as	O
'	O
source	O
'	O
and	O
'	O
susceptible	O
'	O
were	O
used	O
to	O
measure	O
the	O
protection	O
provided	O
by	O
facemasks	O
under	O
various	O
emission	B-ANAT
scenarios	O
.	O

Using	O
an	O
adjuvanted	O
and	O
an	O
unadjuvanted	O
double	O
-	O
inactivated	O
SARS	O
-	O
CoV	O
(	O
DIV	O
)	O
vaccine	O
,	O
we	O
demonstrate	O
an	O
eosinophilic	O
immunopathology	O
in	O
aged	O
mice	O
comparable	O
to	O
that	O
seen	O
in	O
mice	O
immunized	O
with	O
the	O
SARS	O
nucleocapsid	B-ANAT
protein	O
,	O
and	O
poor	O
protection	O
against	O
a	O
nonlethal	O
heterologous	O
challenge	O
.	O

Better	O
understanding	O
of	O
the	O
relationship	O
between	O
inhalation	O
injury	O
and	O
lung	B-ANAT
physiologic	O
sequelae	O
is	O
a	O
burn	O
research	O
priority	O
.	O

The	O
bronchoscopic	O
grading	O
of	O
inhalation	O
injury	O
moderately	O
correlates	O
with	O
early	O
indices	O
of	O
impaired	O
gas	O
exchange	O
in	O
this	O
cohort	O
and	O
may	O
be	O
a	O
promising	O
tool	O
for	O
staging	O
lower	O
airway	B-ANAT
injury	O
.	O

Bronchoalveolar	O
lavage	O
revealed	O
massive	O
alveolar	B-ANAT
haemorrhage	O
.	O

The	O
clinic	O
symptomatology	O
was	O
the	O
muscular	B-ANAT
deficiency	O
observed	O
in	O
all	O
cases	O
with	O
absence	O
of	O
deep	O
reflex	O
an	O
albumincytologic	O
dissociation	O
was	O
observed	O
in	O
12	O
cases	O
.	O

To	O
examine	O
the	O
prevalence	O
of	O
Korean	O
cats	O
infected	O
with	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
type	O
I	O
and	O
II	O
,	O
fecal	B-ANAT
samples	O
were	O
obtained	O
from	O
212	O
cats	O
(	O
107	O
pet	O
and	O
105	O
feral	O
)	O
in	O
2009	O
.	O

TITLE	O
:	O
Cytokines	O
and	O
organ	B-ANAT
failure	O
in	O
acute	O
pancreatitis	O
:	O
inflammatory	O
response	O
in	O
acute	O
pancreatitis	O
.	O

The	O
prediction	O
of	O
single	O
-	O
organ	B-ANAT
and	O
multiorgan	O
failure	O
from	O
the	O
cytokine	O
profiles	O
was	O
evaluated	O
by	O
receiver	O
operating	O
characteristic	O
analyses	O
.	O

Interleukin	O
6	O
and	O
IL	O
-	O
8	O
levels	O
were	O
significantly	O
higher	O
in	O
patients	O
who	O
developed	O
renal	B-ANAT
,	O
respiratory	O
,	O
and	O
circulatory	O
failure	O
,	O
as	O
was	O
the	O
case	O
for	O
patients	O
with	O
multiorgan	O
failure	O
.	O

Tumor	O
necrosis	O
factor	O
Î±	O
was	O
significantly	O
elevated	O
in	O
all	O
types	O
of	O
organ	B-ANAT
failures	O
,	O
except	O
for	O
intestinal	B-ANAT
failure	O
.	O

TITLE	O
:	O
Human	O
-	O
leukocyte	B-ANAT
antigen	O
class	O
I	O
Cw	O
1502	O
and	O
class	O
II	O
DR	O
0301	O
genotypes	O
are	O
associated	O
with	O
resistance	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
systematically	O
reviewed	O
the	O
evidence	O
for	O
an	O
association	O
between	O
male	O
circumcision	O
and	O
Human	O
Papillomavirus	O
(	O
HPV	O
)	O
infection	O
and	O
genital	B-ANAT
warts	O
in	O
men	O
.	O

There	O
was	O
weak	O
evidence	O
that	O
circumcision	O
was	O
associated	O
with	O
decreased	O
HPV	O
incidence	O
(	O
summary	O
RR	O
,	O
0	O
.	O
75	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
57	O
-	O
0	O
.	O
99	O
;	O
3	O
studies	O
)	O
and	O
increased	O
HPV	O
clearance	O
(	O
summary	O
RR	O
,	O
1	O
.	O
33	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
89	O
-	O
1	O
.	O
98	O
;	O
3	O
studies	O
)	O
but	O
no	O
evidence	O
of	O
an	O
association	O
with	O
prevalent	O
genital	B-ANAT
warts	O
(	O
OR	O
,	O
0	O
.	O
93	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
65	O
-	O
1	O
.	O
33	O
;	O
15	O
studies	O
).	O

RESULTS	O
:	O
Of	O
80	O
ECMO	O
-	O
referred	O
patients	O
,	O
69	O
received	O
ECMO	O
(	O
86	O
.	O
3	O
%)	O
and	O
22	O
died	O
(	O
27	O
.	O
5	O
%)	O
prior	O
to	O
discharge	B-ANAT
from	O
the	O
hospital	O
.	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
HCoVs	O
)	O
cause	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
and	O
occasionally	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
diseases	O
.	O

The	O
causes	O
of	O
deaths	O
were	O
acute	O
renal	B-ANAT
failure	O
(	O
24	O
cases	O
,	O
42	O
.	O
1	O
%),	O
septicaemia	O
(	O
18	O
cases	O
,	O
31	O
.	O
6	O
%),	O
acute	O
respiratory	O
syndrome	O
(	O
5	O
cases	O
,	O
8	O
.	O
7	O
%),	O
shock	O
(	O
4	O
cases	O
,	O
7	O
.	O
0	O
%),	O
and	O
upper	B-ANAT
gastrointestinal	I-ANAT
bleeding	O
due	O
to	O
peptic	O
ulcer	O
and	O
severe	O
anaemia	O
(	O
1	O
case	O
each	O
,	O
1	O
.	O
8	O
%).	O

ABSTRACT	O
:	O
Toxic	O
epidermal	B-ANAT
necrolysis	O
(	O
TEN	O
),	O
also	O
known	O
as	O
Lyell	O
'	O
s	O
syndrome	O
,	O
is	O
a	O
severe	O
drug	O
reaction	O
characterized	O
by	O
extensive	O
destruction	O
of	O
the	O
epidermis	B-ANAT
and	O
mucosal	B-ANAT
epithelia	O
.	O

Thirty	O
-	O
five	O
per	O
cent	O
of	O
the	O
skin	B-ANAT
area	O
was	O
affected	O
by	O
the	O
syndrome	O
,	O
with	O
involvement	O
of	O
conjunctival	O
,	O
gastrointestinal	O
,	O
and	O
respiratory	O
mucous	B-ANAT
membranes	I-ANAT
.	O

There	O
were	O
acute	O
complications	O
,	O
consisting	O
of	O
infection	O
of	O
the	O
skin	B-ANAT
areas	O
(	O
Candida	O
),	O
gastrointestinal	O
bleeding	O
,	O
pleural	B-ANAT
effusion	I-ANAT
,	O
and	O
severe	O
ocular	B-ANAT
mucous	B-ANAT
membrane	I-ANAT
damage	O
.	O

Evidence	O
from	O
several	O
studies	O
indicates	O
that	O
a	O
complex	O
network	O
of	O
inflammatory	O
cytokines	O
and	O
mediators	O
play	O
a	O
key	O
role	O
in	O
mediation	O
,	O
amplification	O
,	O
and	O
perpetuation	O
of	O
the	O
process	O
of	O
lung	B-ANAT
injury	O
and	O
that	O
the	O
thoracotomy	O
itself	O
is	O
a	O
risk	O
factor	O
for	O
developing	O
ALI	O
or	O
ARDS	O
.	O

All	O
patients	O
displayed	O
significantly	O
increased	O
serum	B-ANAT
levels	O
of	O
IL6	O
and	O
IL8	O
after	O
thoracoabdominal	O
esophagectomy	O
.	O

Coronavirus	O
from	O
feces	B-ANAT
and	O
extraintestinal	O
FIP	O
lesions	O
from	O
the	O
same	O
cat	O
were	O
always	O
>	O
99	O
%	O
related	O
in	O
accessory	O
and	O
structural	O
gene	O
sequences	O
.	O

The	O
detailed	O
molecular	O
characterization	O
of	O
the	O
subversion	O
mechanisms	O
devised	O
by	O
pathogens	O
to	O
infect	O
host	O
cells	B-ANAT
is	O
crucial	O
to	O
generate	O
targets	O
for	O
therapeutic	O
intervention	O
.	O

Short	O
-	O
and	O
long	O
-	O
term	O
survival	O
decreased	O
by	O
the	O
number	O
of	O
failing	O
organs	B-ANAT
.	O

The	O
assays	O
were	O
performed	O
on	O
a	O
panel	O
of	O
192	O
nasopharyngeal	B-ANAT
-	O
secretion	B-ANAT
specimens	O
collected	O
from	O
81	O
children	O
under	O
1	O
year	O
of	O
age	O
with	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
.	O

Two	O
new	O
isolates	O
generated	O
from	O
recombination	O
were	O
found	O
with	O
nucleotide	O
sequence	O
diverging	O
1	O
.	O
7	O
-	O
2	O
.	O
4	O
%	O
from	O
the	O
D388	O
/	O
QX	O
-	O
like	O
branch	B-ANAT
,	O
indicating	O
the	O
emergence	O
of	O
a	O
new	O
lineage	O
.	O

This	O
does	O
not	O
completely	O
eliminate	O
exposure	O
to	O
expired	O
gases	O
,	O
but	O
provides	O
an	O
additional	O
layer	B-ANAT
of	O
protection	O
against	O
occupational	O
exposure	O
and	O
nosocomial	O
spread	O
of	O
respiratory	O
pathogens	O
.	O

Plasma	B-ANAT
angiotensin	O
-	O
II	O
levels	O
were	O
associated	O
with	O
genotype	O
in	O
the	O
ARDS	O
group	O
,	O
but	O
not	O
controls	O
,	O
being	O
higher	O
in	O
D	O
allele	O
carriers	O
(	O
p	O
=	O
0	O
.	O
016	O
).	O

Early	O
NIV	O
application	O
may	O
be	O
extremely	O
helpful	O
in	O
immunocompromised	O
patients	O
with	O
pulmonary	B-ANAT
infiltrates	O
,	O
in	O
whom	O
intubation	O
dramatically	O
increases	O
the	O
risk	O
of	O
infection	O
,	O
pneumonia	O
,	O
and	O
death	O
.	O

These	O
mishandling	O
treatments	O
simulated	O
different	O
conditions	O
that	O
might	O
occur	O
during	O
routine	O
blood	B-ANAT
collection	O
,	O
transport	O
or	O
storage	B-ANAT
in	O
a	O
clinical	O
practice	O
setting	O
.	O

Immunohistochemistry	O
was	O
strongly	O
positive	O
for	O
IBV	O
antigen	O
in	O
the	O
cytoplasm	B-ANAT
of	O
tubular	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
kidneys	B-ANAT
and	O
also	O
in	O
the	O
epithelium	B-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
salivary	B-ANAT
glands	I-ANAT
,	O
proventriculus	B-ANAT
,	O
intestine	B-ANAT
,	O
and	O
bursa	B-ANAT
of	I-ANAT
Fabricius	I-ANAT
.	O

Phylogenetic	O
analysis	O
on	O
a	O
527	O
base	O
pair	O
-	O
long	O
region	O
from	O
the	O
NS1	O
gene	O
revealed	O
two	O
main	O
clusters	O
,	O
a	O
chicken	O
parvovirus	O
(	O
ChPV	O
)	O
and	O
a	O
TuPV	O
group	O
,	O
but	O
also	O
the	O
presence	O
of	O
a	O
divergent	O
branch	B-ANAT
of	I-ANAT
tentatively	O
named	O
""""	O
TuPV	O
-	O
like	O
ChPV	O
""""	O
strains	O
.	O

TITLE	O
:	O
Post	O
-	O
ARDS	O
pulmonary	B-ANAT
fibrosis	O
in	O
patients	O
with	O
H1N1	O
pneumonia	O
:	O
role	O
of	O
follow	O
-	O
up	O
CT	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
the	O
evolution	O
of	O
20	O
patients	O
with	O
H1N1	O
pneumonia	O
,	O
focusing	O
our	O
attention	O
on	O
patients	O
with	O
severe	O
clinical	O
and	O
radiological	O
findings	O
who	O
developed	O
post	O
-	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
post	O
-	O
ARDS	O
)	O
pulmonary	B-ANAT
fibrosis	O
.	O

All	O
patients	O
were	O
hospitalised	O
in	O
consideration	O
of	O
the	O
severity	O
of	O
clinical	O
findings	O
,	O
and	O
all	O
underwent	O
chest	B-ANAT
X	O
-	O
ray	O
.	O

Twelve	O
of	O
them	O
underwent	O
at	O
least	O
one	O
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
of	O
the	O
chest	B-ANAT
.	O

Our	O
study	O
demonstrated	O
that	O
in	O
these	O
patients	O
,	O
fibrosis	O
could	O
present	O
a	O
different	O
spatial	O
distribution	O
and	O
a	O
different	O
temporal	O
trend	O
,	O
with	O
delayed	O
late	O
onset	O
;	O
moreover	O
,	O
in	O
one	O
case	O
,	O
the	O
signs	O
of	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
partially	O
regressed	O
over	O
time	O
.	O

ABSTRACT	O
:	O
The	O
5	O
'-	O
cap	O
structure	O
is	O
a	O
distinct	O
feature	O
of	O
eukaryotic	O
mRNAs	O
,	O
and	O
eukaryotic	O
viruses	O
generally	O
modify	O
the	O
5	O
'-	O
end	O
of	O
viral	O
RNAs	O
to	O
mimic	O
cellular	B-ANAT
mRNA	O
structure	O
,	O
which	O
is	O
important	O
for	O
RNA	O
stability	O
,	O
protein	O
translation	O
and	O
viral	O
immune	O
escape	O
.	O

The	O
structure	O
of	O
the	O
nsp16	O
/	O
nsp10	O
interaction	O
interface	O
shows	O
that	O
nsp10	O
may	O
stabilize	O
the	O
SAM	O
-	O
binding	O
pocket	O
and	O
extend	O
the	O
substrate	O
RNA	O
-	O
binding	O
groove	B-ANAT
of	O
nsp16	O
,	O
consistent	O
with	O
the	O
findings	O
in	O
biochemical	O
assays	O
.	O

For	O
17	O
sepsis	O
cases	O
diagnosed	O
with	O
secondary	O
AKI	O
,	O
comparisons	O
between	O
their	O
urine	B-ANAT
sTREM	O
-	O
1	O
,	O
urine	B-ANAT
output	O
,	O
CCr	O
,	O
SCr	O
and	O
BUN	O
at	O
diagnosis	O
and	O
48	O
h	O
before	O
diagnosis	O
were	O
made	O
.	O

TITLE	O
:	O
Estimating	O
the	O
Causal	O
Effect	O
of	O
Low	O
Tidal	O
Volume	O
Ventilation	O
on	O
Survival	O
in	O
Patients	O
with	O
Acute	O
Lung	B-ANAT
Injury	O
.	O

In	O
addition	O
,	O
immunofluorescence	O
analysis	O
revealed	O
that	O
the	O
subcellular	O
localization	O
of	O
ORF6	O
when	O
expressed	O
on	O
its	O
own	O
is	O
similar	O
to	O
that	O
observed	O
in	O
SARS	O
-	O
CoV	O
infected	O
cells	B-ANAT
.	O

The	O
indication	O
for	O
HFOV	O
was	O
severe	O
oxygenation	O
failure	O
(	O
PaO2	O
/	O
FiO2	O
<	O
120	O
mm	O
Hg	O
)	O
while	O
receiving	O
aggressive	O
CV	O
support	O
(	O
defined	O
by	O
either	O
PaO2	O
â¤	O
65	O
mm	O
Hg	O
with	O
FiO2	O
â¥	O
0	O
.	O
6	O
when	O
positive	O
end	O
-	O
expiratory	O
pressures	O
>	O
10	O
cmH2O	O
or	O
plateau	O
airway	B-ANAT
pressure	O
â¥	O
35	O
cm	O
H2O	O
).	O

To	O
identify	O
factors	O
that	O
contribute	O
to	O
rSARS	O
-	O
CoV	O
-	O
ÎE	O
attenuation	O
,	O
gene	O
expression	O
in	O
cells	B-ANAT
infected	O
by	O
SARS	O
-	O
CoV	O
with	O
or	O
without	O
E	O
gene	O
was	O
compared	O
.	O

In	O
addition	O
,	O
genes	O
involved	O
in	O
signal	O
transduction	O
,	O
transcription	O
,	O
cell	B-ANAT
metabolism	O
,	O
immunoregulation	O
,	O
inflammation	O
,	O
apoptosis	O
and	O
cell	B-ANAT
cycle	O
and	O
differentiation	O
were	O
differentially	O
regulated	O
in	O
cells	B-ANAT
infected	O
with	O
rSARS	O
-	O
CoV	O
with	O
or	O
without	O
the	O
E	O
gene	O
.	O

ABSTRACT	O
:	O
Limited	O
data	O
are	O
available	O
on	O
immunologic	O
responses	O
to	O
primary	O
pandemic	O
H1N1	O
(	O
2009	O
)	O
vaccination	O
in	O
recipients	O
of	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
(	O
HSCT	O
)	O
recipients	O
.	O

Severe	O
AH	O
is	O
associated	O
with	O
excess	O
in	O
-	O
hospital	O
mortality	O
for	O
patients	O
with	O
nervous	B-ANAT
system	I-ANAT
diseases	O
and	O
,	O
for	O
most	O
disease	O
categories	O
,	O
prolongs	O
hospitalization	O
.	O

iLA	O
showed	O
effective	O
CO	O
(	O
2	O
)	O
removal	O
,	O
allowed	O
for	O
reducing	O
the	O
invasiveness	O
of	O
mechanical	O
ventilation	O
in	O
patients	O
with	O
severe	O
respiratory	O
failure	O
from	O
various	O
causes	O
even	O
using	O
a	O
small	O
-	O
sized	O
catheter	O
and	O
was	O
safe	O
in	O
small	O
body	B-ANAT
-	O
sized	O
patients	O
.	O

Patients	O
'	O
lungs	B-ANAT
were	O
ventilated	O
by	O
a	O
volume	O
assist	O
-	O
controlled	O
mode	O
according	O
to	O
the	O
ARDS	O
Clinical	O
Network	O
Mechanical	O
Ventilation	O
Protocol	O
(	O
http	O
://	O
www	O
.	O
ardsnet	O
.	O
org	O
/)	O
with	O
the	O
goal	O
SpO	O
(	O
2	O
)	O
of	O
88	O
-	O
95	O
%	O
(	O
or	O
PaO	O
(	O
2	O
)	O
55	O
-	O
80	O
mmHg	O
)	O
and	O
goal	O
plateau	O
pressure	O
â¤	O
35	O
cm	O
H	O
(	O
2	O
)	O
O	O
.	O
Open	O
-	O
label	O
boluses	O
of	O
cisatracurium	O
20	O
mg	O
(	O
maximum	O
of	O
two	O
per	O
24	O
-	O
hr	O
period	O
)	O
were	O
allowed	O
if	O
plateau	O
pressures	O
remained	O
>	O
32	O
cm	O
H	O
(	O
2	O
)	O
O	O
despite	O
increased	O
sedation	O
and	O
despite	O
decreased	O
PEEP	O
and	O
decreased	O
tidal	O
volumes	O
.	O

It	O
was	O
also	O
associated	O
with	O
decreased	O
morbidity	O
,	O
which	O
included	O
increased	O
ventilator	O
-	O
free	O
days	O
,	O
increased	O
ICU	O
-	O
free	O
days	O
,	O
and	O
increased	O
organ	B-ANAT
failure	O
-	O
free	O
days	O
.	O

Knowledge	O
of	O
host	B-ANAT
cell	I-ANAT
proteins	O
that	O
take	O
part	O
in	O
pivotal	O
virus	O
-	O
host	O
interactions	O
could	O
define	O
broad	O
-	O
spectrum	O
antiviral	O
targets	O
.	O

The	O
therapeutic	O
effects	O
of	O
EC	O
-	O
SOD	O
and	O
copper	O
-	O
zinc	O
SOD	O
(	O
CuZn	O
-	O
SOD	O
)	O
via	O
an	O
aerosol	O
delivery	O
system	O
for	O
lung	B-ANAT
injury	O
and	O
systemic	O
oxidative	O
stress	O
at	O
24	O
,	O
48	O
,	O
72	O
and	O
96	O
h	O
of	O
hyperoxia	O
were	O
measured	O
by	O
bronchoalveolar	O
lavage	O
,	O
wet	O
/	O
dry	O
ratio	O
,	O
lung	B-ANAT
histology	O
,	O
and	O
8	O
-	O
oxo	O
-	O
2	O
'-	O
deoxyguanosine	O
(	O
8	O
-	O
oxo	O
-	O
dG	O
)	O
in	O
lung	B-ANAT
and	O
liver	B-ANAT
tissues	I-ANAT
.	O

In	O
1969	O
,	O
electron	O
microcopy	O
was	O
used	O
to	O
show	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
responsibility	O
of	O
a	O
virus	O
in	O
a	O
case	O
of	O
calf	B-ANAT
diarrhea	O
.	O

However	O
,	O
the	O
exact	O
phenotype	O
of	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
-	O
infiltrating	O
CD8	O
(+)	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
the	O
mechanism	O
by	O
which	O
these	O
cells	B-ANAT
cross	O
the	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
remain	O
largely	O
unknown	O
.	O

By	O
use	O
of	O
support	O
vector	O
analysis	O
,	O
a	O
quantitative	O
structure	O
-	O
activity	O
relationship	O
(	O
QSAR	O
)	O
model	O
was	O
obtained	O
,	O
showing	O
good	O
predictive	O
models	O
for	O
cell	B-ANAT
safety	O
.	O

Infectious	O
diseases	O
may	O
often	O
be	O
diagnosed	O
on	O
blood	B-ANAT
samples	I-ANAT
;	O
however	O
,	O
definitive	O
diagnosis	O
may	O
require	O
more	O
extensive	O
investigation	O
involving	O
cerebrospinal	B-ANAT
fluid	I-ANAT
analysis	O
or	O
advanced	O
imaging	O
necessitating	O
access	O
to	O
computed	O
tomography	O
or	O
magnetic	O
resonance	O
imaging	O
.	O

Specific	O
recommendations	O
are	O
made	O
regarding	O
ventilator	O
capacity	O
,	O
including	O
the	O
potential	O
use	O
of	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

The	O
ERIC	O
-	O
PCR	O
fingerprints	O
of	O
the	O
3	O
cecal	B-ANAT
samples	O
from	O
the	O
CPM	O
and	O
LPS	O
treatment	O
groups	O
clustered	O
together	O
with	O
high	O
coefficients	O
among	O
them	O
.	O

Group	O
B	O
received	O
turkey	O
astrovirus	O
-	O
containing	O
intestinal	B-ANAT
contents	I-ANAT
from	O
apparently	O
healthy	O
flocks	O
.	O

Chest	B-ANAT
radiography	O
reveals	O
diffuse	O
bilateral	O
infiltrates	O
,	O
and	O
hypoxemic	O
respiratory	O
failure	O
develops	O
despite	O
appropriate	O
antibiotic	O
therapy	O
.	O

This	O
study	O
determined	O
the	O
virus	O
susceptibility	O
of	O
primary	O
cultures	O
of	O
human	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
alveolar	B-ANAT
macrophages	I-ANAT
(	O
AMs	O
).	O

AMs	O
secreted	O
significant	O
amounts	O
of	O
tumour	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
Î±	O
),	O
regulated	O
on	O
activation	O
normal	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
expressed	O
and	O
secreted	O
(	O
RANTES	O
/	O
CCL5	O
)	O
and	O
macrophage	B-ANAT
inflammatory	O
protein	O
1Î²	O
(	O
MIP	O
-	O
1Î²	O
/	O
CCL4	O
)	O
in	O
response	O
to	O
HCoV	O
-	O
229E	O
infection	O
,	O
but	O
these	O
cells	B-ANAT
exhibited	O
no	O
detectable	O
increase	O
in	O
IFN	O
-	O
Î²	O
or	O
interleukin	O
-	O
29	O
in	O
mRNA	O
levels	O
.	O

We	O
evaluated	O
the	O
thoracic	B-ANAT
CT	O
findings	O
in	O
patients	O
with	O
2009	O
H1N1	O
virus	O
infection	O
to	O
describe	O
findings	O
compared	O
to	O
previously	O
reported	O
findings	O
,	O
and	O
to	O
suggest	O
patterns	O
that	O
may	O
be	O
suggestive	O
for	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
in	O
an	O
appropriate	O
clinical	O
setting	O
.	O

RESULTS	O
:	O
Patchy	O
infiltration	O
(	O
34	O
.	O
6	O
%),	O
lobar	O
consolidation	O
(	O
30	O
.	O
8	O
%),	O
and	O
interstitial	B-ANAT
infiltration	O
(	O
26	O
.	O
9	O
%)	O
with	O
airbronchogram	O
(	O
38	O
.	O
5	O
%)	O
were	O
the	O
predominant	O
findings	O
in	O
our	O
patients	O
.	O

ABSTRACT	O
:	O
Antibody	O
repertoires	O
for	O
library	O
construction	O
are	O
conventionally	O
harvested	O
from	O
mRNAs	O
of	O
immune	O
cells	B-ANAT
.	O

However	O
,	O
as	O
with	O
reports	O
from	O
studies	O
with	O
other	O
viruses	O
,	O
particularly	O
Epstein	O
Barr	O
virus	O
,	O
conflicting	O
results	O
on	O
confirmatory	O
studies	O
about	O
the	O
presence	O
of	O
viral	O
gene	O
products	O
in	O
brain	B-ANAT
tissue	I-ANAT
indicate	O
the	O
need	O
for	O
further	O
research	O
on	O
the	O
potential	O
participation	O
of	O
VZV	O
in	O
the	O
etiology	O
of	O
MS	O
.	O

We	O
retrospectively	O
evaluated	O
the	O
efficacy	O
of	O
ECMO	O
support	O
for	O
respiratory	O
and	O
heart	B-ANAT
failure	O
in	O
infants	O
and	O
children	O
.	O

Blocking	O
PGD	O
(	O
2	O
)	O
function	O
with	O
small	O
-	O
molecule	O
antagonists	O
enhanced	O
rDC	O
migration	O
,	O
T	B-ANAT
cell	I-ANAT
responses	O
,	O
and	O
survival	O
.	O

lung	B-ANAT
DCs	O
do	O
it	O
too	O
.	O

ABSTRACT	O
:	O
Decline	O
in	O
immune	O
function	O
with	O
age	O
has	O
been	O
attributed	O
to	O
defects	O
or	O
alterations	O
in	O
both	O
the	O
innate	O
and	O
the	O
adaptive	O
immune	B-ANAT
system	I-ANAT
.	O

Preclinical	O
and	O
clinical	O
studies	O
have	O
suggested	O
that	O
KGF	O
-	O
2	O
may	O
be	O
the	O
candidate	O
of	O
novel	O
therapies	O
for	O
alveolar	B-ANAT
epithelial	O
damage	O
during	O
ALI	O
/	O
ARDS	O
.	O

TITLE	O
:	O
Chronic	O
fatigue	O
syndrome	O
:	O
acute	O
infection	O
and	O
history	O
of	O
physical	O
activity	O
affect	O
resting	B-ANAT
levels	O
and	O
response	O
to	O
exercise	O
of	O
plasma	B-ANAT
oxidant	O
/	O
antioxidant	O
status	O
and	O
heat	O
shock	O
proteins	O
.	O

ABSTRACT	O
:	O
Cocaine	O
is	O
a	O
drug	O
notorious	O
for	O
its	O
ability	O
to	O
adversely	O
affect	O
almost	O
any	O
organ	B-ANAT
in	O
the	O
body	B-ANAT
and	O
cause	O
a	O
plethora	O
of	O
biochemical	O
abnormalities	O
secondary	O
to	O
its	O
severe	O
vasoconstrictive	O
properties	O
.	O

TITLE	O
:	O
Isolation	O
of	O
influenza	O
viruses	O
in	O
MDCK	O
33016PF	O
cells	B-ANAT
and	O
clearance	O
of	O
contaminating	O
respiratory	O
viruses	O
.	O

The	O
identity	O
and	O
high	O
purity	O
of	O
compound	O
1	O
were	O
confirmed	O
by	O
elemental	O
analysis	O
,	O
NMR	O
,	O
IR	O
analysis	O
and	O
single	O
-	O
crystal	B-ANAT
X	O
-	O
ray	O
diffraction	O
.	O

Ten	O
stool	B-ANAT
and	O
6	O
respiratory	O
specimens	O
were	O
obtained	O
from	O
individuals	O
meeting	O
case	O
definitions	O
for	O
diarrhea	O
or	O
respiratory	O
illness	O
.	O

TITLE	O
:	O
FXR	O
protects	O
lung	B-ANAT
from	O
lipopolysaccharide	O
-	O
induced	O
acute	O
injury	O
.	O

In	O
vitro	O
experiments	O
showed	O
that	O
FXR	O
activation	O
blocked	O
TNFÎ±	O
-	O
induced	O
expression	O
of	O
P	O
-	O
selectin	O
but	O
stimulated	O
proliferation	O
of	O
lung	B-ANAT
microvascular	O
endothelial	B-ANAT
cells	I-ANAT
through	O
up	O
-	O
regulation	O
of	O
Foxm1b	O
.	O

In	O
addition	O
,	O
expression	O
of	O
a	O
constitutively	O
active	O
FXR	O
repressed	O
the	O
expression	O
of	O
proinflammatory	O
genes	O
and	O
improved	O
lung	B-ANAT
permeability	O
and	O
lung	B-ANAT
regeneration	O
in	O
FXR	O
-/-	O
mice	O
.	O

The	O
acute	O
chest	B-ANAT
syndrome	O
represents	O
its	O
main	O
respiratory	O
complication	O
.	O

The	O
analysis	O
of	O
cytopathic	O
effects	O
(	O
CPE	O
)	O
demonstrated	O
that	O
shN2	O
-	O
1	O
and	O
shN2	O
-	O
2	O
were	O
capable	O
of	O
protecting	O
cells	B-ANAT
against	O
PHEV	O
infection	O
with	O
high	O
specificity	O
and	O
efficiency	O
.	O

Improvements	O
in	O
ECMO	O
circuitry	O
have	O
led	O
to	O
a	O
reduction	O
in	O
heparin	O
and	O
blood	B-ANAT
product	O
requirements	O
,	O
with	O
consequently	O
fewer	O
complications	O
.	O

His	O
H1N1	O
pneumonia	O
caused	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
respiratory	O
failure	O
requiring	O
mechanical	O
ventilation	O
,	O
rhabdomyolysis	O
,	O
myocarditis	O
,	O
hepatitis	O
,	O
encephalitis	O
,	O
and	O
renal	B-ANAT
failure	O
.	O

During	O
the	O
diagnostic	O
workup	O
,	O
a	O
bone	B-ANAT
marrow	I-ANAT
biopsy	O
was	O
performed	O
,	O
showing	O
hemophagocytosis	O
secondary	O
to	O
the	O
H1N1	O
infection	O
.	O

Notable	O
complications	O
that	O
can	O
arise	O
include	O
:	O
unplanned	O
extubation	O
,	O
lines	O
pulled	O
,	O
tubes	O
kinked	O
,	O
and	O
back	B-ANAT
and	O
other	O
injuries	O
to	O
personnel	O
.	O

Sequence	O
analysis	O
of	O
this	O
isolate	O
and	O
Aichi	O
/	O
2004	O
indicated	O
that	O
both	O
strains	O
have	O
truncated	O
HE	O
genes	O
with	O
deletions	O
in	O
the	O
3	O
'	O
region	O
that	O
occurred	O
through	O
cell	B-ANAT
culture	O
-	O
adaptation	O
.	O

In	O
this	O
study	O
chicks	O
and	O
old	O
hens	O
were	O
infected	O
by	O
oculo	O
-	O
nasal	B-ANAT
route	O
with	O
Italy	O
02	O
serotype	O
.	O

Italy	O
02	O
serotype	O
was	O
demonstrated	O
to	O
cause	O
severe	O
respiratory	O
and	O
renal	B-ANAT
damage	O
in	O
one	O
-	O
day	O
old	O
chicks	O
but	O
not	O
in	O
adult	O
hens	O
in	O
which	O
only	O
respiratory	O
disease	O
and	O
drop	O
in	O
egg	B-ANAT
production	O
was	O
observed	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	O
(	O
SCoV	O
)	O
nonstructural	O
protein	O
(	O
nsp	O
)	O
1	O
,	O
a	O
potent	O
inhibitor	O
of	O
host	O
gene	O
expression	O
,	O
possesses	O
a	O
unique	O
mode	O
of	O
action	O
:	O
it	O
binds	O
to	O
40S	O
ribosomes	B-ANAT
to	O
inactivate	O
their	O
translation	O
functions	O
and	O
induces	O
host	O
mRNA	O
degradation	O
.	O

By	O
using	O
primarily	O
cell	B-ANAT
-	O
free	O
,	O
in	O
vitro	O
translation	O
systems	O
,	O
the	O
present	O
study	O
revealed	O
that	O
the	O
nsp1	O
induced	O
endonucleolytic	O
RNA	O
cleavage	O
mainly	O
near	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
capped	O
mRNA	O
templates	O
.	O

Experiments	O
using	O
dicistronic	O
mRNAs	O
carrying	O
different	O
IRESes	O
showed	O
that	O
nsp1	O
induced	O
endonucleolytic	O
RNA	O
cleavage	O
within	O
the	O
ribosome	B-ANAT
loading	O
region	O
of	O
type	O
I	O
and	O
type	O
II	O
picornavirus	O
IRES	O
elements	O
,	O
but	O
not	O
that	O
of	O
classical	O
swine	O
fever	O
virus	O
IRES	O
,	O
which	O
is	O
characterized	O
as	O
a	O
hepatitis	O
C	O
virus	O
-	O
like	O
IRES	O
.	O

The	O
remaining	O
12	O
patients	O
were	O
transferred	O
on	O
veno	O
-	O
venous	B-ANAT
ECMO	O
with	O
extracorporeal	B-ANAT
blood	I-ANAT
flow	O
2	O
.	O
7	O
Â±	O
1	O
L	O
Â·	O
min	O
â»	O
Â¹	O
,	O
gas	O
flow	O
3	O
.	O
8	O
Â±	O
1	O
.	O
8	O
L	O
Â·	O
min	O
â»	O
Â¹	O
,	O
and	O
FiOâ	O
1	O
.	O

The	O
replicase	O
proteins	O
of	O
arteriviruses	O
are	O
associated	O
with	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
),	O
which	O
were	O
previously	O
proposed	O
to	O
derive	O
from	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
).	O

Nasal	B-ANAT
and	O
throat	B-ANAT
swabs	O
were	O
tested	O
for	O
18	O
respiratory	O
virus	O
types	O
and	O
subtypes	O
.	O

Lung	B-ANAT
injury	O
(	O
lavage	O
LDH	O
levels	O
)	O
and	O
lung	B-ANAT
inflammation	O
(	O
lavage	O
neutrophil	B-ANAT
numbers	O
)	O
were	O
measured	O
24h	O
after	O
cytokine	O
insufflation	O
.	O

However	O
,	O
the	O
contributions	O
of	O
CD4	O
T	B-ANAT
cell	I-ANAT
help	O
to	O
antiviral	O
CD8	O
T	B-ANAT
cell	I-ANAT
immunity	O
during	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
infection	O
are	O
not	O
well	O
established	O
.	O

Lesions	O
indicative	O
of	O
respiratory	O
disease	O
in	O
pig	O
lungs	B-ANAT
at	O
slaughter	O
e	O
.	O
g	O
.	O
pneumonia	O
and	O
pleuritis	O
are	O
frequently	O
recorded	O
to	O
assess	O
herd	O
health	O
or	O
provide	O
data	O
for	O
epidemiological	O
studies	O
.	O

TITLE	O
:	O
Bovine	O
coronavirus	O
(	O
BCV	O
)	O
infections	O
in	O
transported	O
commingled	O
beef	O
cattle	O
and	O
sole	B-ANAT
-	O
source	O
ranch	O
calves	O
.	O

The	O
BCV	O
was	O
identified	O
in	O
lung	B-ANAT
samples	O
[	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
collection	O
]	O
as	O
well	O
as	O
in	O
nasal	B-ANAT
swabs	O
.	O

To	O
approach	O
the	O
subject	O
,	O
we	O
investigated	O
immunological	O
etiology	O
focused	O
on	O
cytokines	O
and	O
an	O
acute	O
lung	B-ANAT
damage	O
factor	O
in	O
influenza	O
-	O
induced	O
ARDS	O
by	O
using	O
a	O
PR	O
-	O
8	O
(	O
A	O
/	O
H1N1	O
)-	O
infected	O
mouse	O
model	O
.	O

The	O
absence	O
of	O
MPO	O
reduced	O
inflammatory	O
damage	O
with	O
suppression	O
of	O
leakage	O
of	O
total	O
BALF	O
proteins	O
associated	O
with	O
alteration	O
of	O
claudins	O
in	O
the	O
lung	B-ANAT
.	O

Twenty	O
-	O
seven	O
patients	O
who	O
completed	O
both	O
pulmonary	B-ANAT
function	O
and	O
maximal	O
aerobic	O
capacity	O
tests	O
at	O
6	O
and	O
15	O
months	O
after	O
the	O
acute	O
illness	O
were	O
invited	O
to	O
return	O
for	O
reassessment	O
.	O

In	O
girls	O
,	O
ventilatory	O
efficiency	O
(	O
ventilatory	O
equivalents	O
for	O
oxygen	O
and	O
carbon	O
dioxide	O
)	O
and	O
perfusion	O
of	O
the	O
lungs	B-ANAT
(	O
end	O
-	O
tidal	O
partial	O
carbon	O
dioxide	O
pressure	O
)	O
had	O
not	O
increased	O
further	O
compared	O
with	O
the	O
values	O
measured	O
at	O
15	O
months	O
.	O

TITLE	O
:	O
Extravascular	O
lung	B-ANAT
water	O
index	O
improves	O
the	O
diagnostic	O
accuracy	O
of	O
lung	B-ANAT
injury	O
in	O
patients	O
with	O
shock	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
use	O
of	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
with	O
a	O
single	O
dual	O
lumen	B-ANAT
cannula	O
in	O
a	O
42	O
-	O
year	O
-	O
old	O
patient	O
suffering	O
from	O
a	O
post	O
-	O
pneumonectomy	O
fistula	O
and	O
severe	O
respiratory	O
insufficiency	O
,	O
avoiding	O
the	O
classical	O
approach	O
of	O
invasive	O
mechanical	O
ventilation	O
.	O

PK	O
deficiency	O
in	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
is	O
known	O
to	O
result	O
in	O
human	O
hereditary	O
non	O
-	O
spherocytic	O
hemolytic	O
anemia	O
.	O

ABSTRACT	O
:	O
This	O
case	O
report	O
describes	O
the	O
disease	O
progression	O
of	O
a	O
male	O
cat	O
with	O
pericardial	B-ANAT
effusion	I-ANAT
.	O

Detection	O
of	O
feline	O
coronavirus	O
antigen	O
in	O
macrophages	B-ANAT
was	O
negative	O
.	O

Vaccination	O
with	O
rS1	O
,	O
rN	O
,	O
or	O
H120	O
induced	O
a	O
cellular	B-ANAT
immune	O
response	O
as	O
demonstrated	O
by	O
in	O
vitro	O
ChIFN	O
-	O
Î³	O
production	O
by	O
splenocytes	O
of	O
vaccinated	O
birds	O
.	O

ABSTRACT	O
:	O
The	O
benefits	O
of	O
higher	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
have	O
been	O
modest	O
,	O
but	O
few	O
studies	O
have	O
fully	O
tested	O
the	O
""""	O
open	O
-	O
lung	B-ANAT
hypothesis	O
"""."	O

During	O
all	O
steps	O
,	O
we	O
calculated	O
the	O
size	O
of	O
the	O
non	O
-	O
aerated	O
(-	O
100	O
to	O
+	O
100	O
HU	O
)	O
compartment	B-ANAT
and	O
the	O
recruitability	O
of	O
the	O
lungs	B-ANAT
(	O
the	O
percent	O
mass	O
of	O
collapsed	O
tissue	B-ANAT
re	O
-	O
aerated	O
from	O
baseline	O
to	O
maximum	O
PEEP	O
).	O

We	O
compared	O
the	O
effects	O
of	O
five	O
bacteria	O
(	O
Staphlococcus	O
aureus	O
,	O
Escherichia	O
coli	O
,	O
Clostridium	O
difficile	O
,	O
Lactobacillus	O
rhamnosus	O
and	O
Bifidobacterium	O
bifidus	O
)	O
and	O
seven	O
virus	O
(	O
adenovirus	O
,	O
coronavirus	O
,	O
cytomegalovirus	O
,	O
herpes	O
simplex	B-ANAT
virus	O
,	O
influenza	O
virus	O
,	O
morbillivirus	O
and	O
poliovirus	O
)	O
on	O
the	O
Th1	O
/	O
Th2	O
cytokine	O
production	O
in	O
mixed	O
lymphocyte	B-ANAT
reactions	O
using	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
from	O
cord	B-ANAT
blood	I-ANAT
cocultured	O
with	O
allogenic	O
myeloid	O
or	O
plasmacytoid	B-ANAT
dendritic	I-ANAT
cells	I-ANAT
.	O

Moreover	O
,	O
HSA	O
is	O
widely	O
used	O
clinically	O
to	O
treat	O
several	O
diseases	O
,	O
including	O
hypovolemia	O
,	O
shock	O
,	O
burns	O
,	O
surgical	O
blood	B-ANAT
loss	O
,	O
trauma	O
,	O
hemorrhage	O
,	O
cardiopulmonary	B-ANAT
bypass	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
hemodialysis	O
,	O
acute	O
liver	B-ANAT
failure	O
,	O
chronic	O
liver	B-ANAT
disease	O
,	O
nutrition	O
support	O
,	O
resuscitation	O
,	O
and	O
hypoalbuminemia	O
.	O

Mice	O
infected	O
with	O
SD	O
/	O
09	O
virus	O
showed	O
typical	O
ARDS	O
symptoms	O
characterized	O
by	O
60	O
%	O
lethality	O
on	O
days	O
8	O
-	O
10	O
post	O
-	O
inoculation	O
,	O
highly	O
edematous	O
lungs	B-ANAT
,	O
inflammatory	O
cellular	B-ANAT
infiltration	O
,	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
edema	O
,	O
lung	B-ANAT
hemorrhage	O
,	O
progressive	O
and	O
severe	O
hypoxemia	O
,	O
and	O
elevated	O
levels	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
.	O

TITLE	O
:	O
Two	O
palmitylated	O
cysteine	O
residues	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
spike	O
(	O
S	O
)	O
protein	O
are	O
critical	O
for	O
S	O
incorporation	O
into	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
,	O
but	O
not	O
for	O
M	O
-	O
S	O
co	O
-	O
localization	O
.	O

Depalmitylation	O
of	O
mouse	O
hepatitis	O
virus	O
S	O
proteins	O
abolished	O
this	O
interaction	O
,	O
resulting	O
in	O
the	O
failure	O
of	O
S	O
incorporation	O
into	O
virions	B-ANAT
.	O

Recent	O
evidence	O
suggests	O
that	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
can	O
modulate	O
the	O
immune	O
response	O
to	O
reduce	O
injury	O
and	O
also	O
increase	O
resistance	O
to	O
infection	O
,	O
while	O
also	O
facilitating	O
regeneration	O
and	O
repair	O
of	O
the	O
injured	O
lung	B-ANAT
.	O

We	O
review	O
the	O
biological	O
characteristics	O
of	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
that	O
underlie	O
their	O
therapeutic	O
potential	O
for	O
ARDS	O
.	O

We	O
reviewed	O
all	O
patients	O
with	O
osteolysis	O
of	O
lymphatic	B-ANAT
origin	O
and	O
treated	O
in	O
our	O
department	O
who	O
had	O
died	O
in	O
the	O
last	O
15	O
years	O
,	O
and	O
we	O
reviewed	O
all	O
published	O
cases	O
of	O
death	O
with	O
this	O
disease	O
since	O
the	O
1950	O
'	O
s	O
.	O

Patients	O
with	O
severe	O
osteolysis	O
of	O
lymphatic	B-ANAT
origin	O
suffer	O
three	O
main	O
disorders	O
with	O
overlapping	O
comorbidity	O
:	O
the	O
lymphatic	B-ANAT
malformation	O
of	O
soft	B-ANAT
tissue	I-ANAT
,	O
the	O
bone	B-ANAT
resorption	O
and	O
the	O
chylothorax	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
57	O
patients	O
with	O
osteolysis	O
of	O
lymphatic	B-ANAT
origin	O
had	O
been	O
studied	O
at	O
our	O
institution	O
,	O
of	O
whom	O
three	O
died	O
,	O
two	O
from	O
sepsis	O
,	O
and	O
one	O
from	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ORF3	O
protein	O
can	O
be	O
detected	O
in	O
PEDV	O
-	O
infected	O
cells	B-ANAT
and	O
it	O
functions	O
as	O
an	O
ion	O
channel	O
in	O
both	O
Xenopus	O
laevis	O
oocytes	B-ANAT
and	O
yeast	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
will	O
be	O
advisable	O
if	O
all	O
other	O
options	O
have	O
failed	O
to	O
improve	O
oxygenation	O
.	O

The	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
(	O
RAS	O
)	O
through	O
Angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)-	O
generated	O
Angiotensin	O
II	O
contributes	O
to	O
lung	B-ANAT
injury	O
.	O

We	O
conclude	O
that	O
ACE2	O
gene	O
deletion	O
worsens	O
BLM	O
-	O
induced	O
lung	B-ANAT
injury	O
and	O
more	O
so	O
in	O
males	O
than	O
females	O
.	O

IBV	O
progeny	O
production	O
and	O
release	O
were	O
increased	O
in	O
infected	O
Mcl	O
-	O
1	O
knockdown	O
cells	B-ANAT
compared	O
to	O
similarly	O
infected	O
control	O
cells	B-ANAT
,	O
while	O
the	O
contrary	O
was	O
observed	O
in	O
infected	O
Bak	O
knockdown	O
cells	B-ANAT
.	O

The	O
placebo	O
group	O
developed	O
severe	O
ARDS	O
,	O
coagulopathy	O
,	O
and	O
histological	O
injury	O
to	O
the	O
bowel	B-ANAT
.	O

It	O
significantly	O
lowered	O
plasma	B-ANAT
concentrations	O
of	O
interleukin	O
1Î²	O
(	O
IL	O
-	O
1Î²	O
),	O
tumor	O
necrosis	O
factor	O
Î±	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IL	O
-	O
10	O
.	O

This	O
study	O
presents	O
a	O
clinically	O
relevant	O
model	O
of	O
lung	B-ANAT
injury	O
in	O
which	O
CMT	O
-	O
3	O
treatment	O
prevented	O
the	O
development	O
of	O
ARDS	O
due	O
in	O
part	O
to	O
reduction	O
of	O
multiple	O
plasma	B-ANAT
cytokines	O
.	O

We	O
analyse	O
the	O
monthly	O
mortality	O
rates	O
caused	O
by	O
infectious	O
diseases	O
,	O
cancer	O
,	O
diabetes	O
mellitus	O
,	O
nervous	B-ANAT
system	I-ANAT
diseases	O
,	O
cerebrovascular	O
diseases	O
,	O
heart	B-ANAT
and	O
other	O
vascular	B-ANAT
diseases	O
,	O
respiratory	B-ANAT
system	I-ANAT
diseases	O
,	O
digestive	B-ANAT
system	I-ANAT
diseases	O
,	O
genitourinary	B-ANAT
system	I-ANAT
diseases	O
and	O
accidents	O
.	O

In	O
order	O
to	O
confirm	O
these	O
assumptions	O
,	O
27	O
fecal	B-ANAT
and	O
32	O
FIP	O
coronavirus	O
isolates	O
were	O
obtained	O
from	O
resident	O
or	O
adopted	O
cats	O
from	O
a	O
large	O
metropolitan	O
shelter	O
during	O
2008	O
-	O
2009	O
and	O
their	O
3a	O
-	O
c	O
,	O
E	O
,	O
and	O
M	O
genes	O
sequenced	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
life	O
-	O
threatening	O
diseases	O
that	O
are	O
characterized	O
by	O
acute	O
onset	O
,	O
pulmonary	B-ANAT
inflammation	O
,	O
oedema	O
due	O
to	O
increased	O
vascular	B-ANAT
permeability	O
and	O
severe	O
hypoxemia	O
.	O

Our	O
analysis	O
showed	O
that	O
most	O
studies	O
have	O
focused	O
on	O
mechanisms	O
of	O
pulmonary	B-ANAT
neutrophil	B-ANAT
sequestration	O
and	O
models	O
with	O
moderate	O
forms	O
of	O
oedema	O
.	O

CONCLUSIONS	O
:	O
Persistence	O
of	O
respiratory	O
viruses	O
within	O
the	O
sinonasal	O
mucosa	B-ANAT
is	O
unlikely	O
to	O
be	O
a	O
cause	O
of	O
ongoing	O
inflammation	O
in	O
CRS	O
.	O

A	O
50	O
-	O
year	O
-	O
old	O
female	O
,	O
after	O
presenting	O
with	O
diarrhea	O
and	O
abdominal	B-ANAT
pain	O
,	O
developed	O
pancolitis	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
and	O
thrombocytopenia	O
.	O

The	O
diagnosis	O
of	O
Pf	O
and	O
Pv	O
was	O
confirmed	O
by	O
demonstrating	O
asexual	O
form	O
of	O
parasites	O
in	O
peripheral	B-ANAT
blood	I-ANAT
smear	O
and	O
OptiMal	O
test	O
.	O

Overexpression	O
of	O
pRb	O
delayed	O
the	O
viral	O
protein	O
production	O
by	O
wild	O
-	O
type	O
MHV	O
but	O
not	O
by	O
vLC	B-ANAT
.	O

He	O
completely	O
recovered	O
from	O
the	O
respiratory	O
and	O
cardiac	B-ANAT
failure	O
.	O

Consensus	O
of	O
the	O
Spanish	O
Society	O
of	O
Intensive	O
Care	O
Medicine	O
and	O
Coronary	B-ANAT
Units	O
-	O
Spanish	O
Society	O
of	O
Parenteral	O
and	O
Enteral	O
Nutrition	O
(	O
SEMICYUC	O
-	O
SENPE	O
):	O
respiratory	O
failure	O
].	O

Antibody	O
against	O
recombinant	O
bat	O
-	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
protein	O
was	O
detected	O
in	O
84	O
%	O
of	O
Chinese	O
horseshoe	O
bats	O
using	O
an	O
enzyme	O
immunoassay	O
.	O

Antibody	O
-	O
mediated	O
enhancement	O
of	O
SARS	O
-	O
CoV	O
infection	O
with	O
anti	O
-	O
SARS	O
-	O
CoV	O
Spike	O
immune	O
-	O
serum	B-ANAT
was	O
observed	O
in	O
vitro	O
.	O

Rat	O
coronavirus	O
(	O
RCoV	O
)	O
is	O
used	O
as	O
a	O
model	O
to	O
study	O
the	O
immune	O
response	O
to	O
viral	O
infection	O
in	O
the	O
lung	B-ANAT
of	O
the	O
natural	O
host	O
.	O

Use	O
of	O
a	O
selective	O
inhibitor	O
of	O
CXCR2	O
,	O
SB265610	O
,	O
demonstrated	O
that	O
CXCR2	O
signaling	O
was	O
required	O
for	O
RCoV	O
-	O
AT1	O
-	O
mediated	O
inhibition	O
of	O
PMN	B-ANAT
apoptosis	O
.	O

These	O
data	O
suggest	O
that	O
CXC	O
chemokines	O
produced	O
by	O
RCoV	O
-	O
infected	O
AT1	O
-	O
like	O
cells	B-ANAT
inhibit	O
PMN	B-ANAT
apoptosis	O
during	O
infection	O
.	O

Plasmacytoid	B-ANAT
dendritic	I-ANAT
cells	I-ANAT
(	O
pDCs	O
)	O
are	O
innate	O
immune	O
cells	B-ANAT
that	O
produce	O
type	O
I	O
interferon	O
(	O
IFN	O
-	O
I	O
)	O
and	O
other	O
cytokines	O
in	O
response	O
to	O
virus	O
-	O
derived	O
nucleic	B-ANAT
acids	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
therapeutic	O
effects	O
and	O
safety	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
effects	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
on	O
mortality	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Two	O
patients	O
were	O
treated	O
with	O
veno	O
-	O
arterial	B-ANAT
(	O
V	O
-	O
A	O
)	O
ECMO	O
for	O
severe	O
heart	B-ANAT
failure	O
,	O
and	O
7	O
with	O
veno	O
-	O
venous	B-ANAT
(	O
V	O
-	O
V	O
)	O
ECMO	O
due	O
to	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
ARDS	O
caused	O
by	O
2009	O
novel	O
H1N1	O
virus	O
infection	O
.	O

We	O
prospectively	O
assessed	O
184	O
consecutive	O
patients	O
;	O
102	O
had	O
""""	O
de	O
novo	O
""""	O
ARF	O
,	O
and	O
82	O
previous	O
cardiac	B-ANAT
or	O
respiratory	O
disease	O
.	O

Patients	O
with	O
""""	O
de	O
novo	O
""""	O
ARF	O
failed	O
NIV	O
more	O
frequently	O
than	O
patients	O
with	O
previous	O
cardiac	B-ANAT
or	O
respiratory	O
disease	O
(	O
47	O
,	O
46	O
%	O
versus	O
21	O
,	O
26	O
%,	O
p	O
=	O
0	O
.	O
007	O
).	O

Worsening	O
radiologic	O
infiltrate	O
24	O
h	O
after	O
admission	O
,	O
maximum	O
Sepsis	O
-	O
Related	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
SOFA	O
)	O
score	O
and	O
,	O
after	O
1	O
h	O
of	O
NIV	O
,	O
higher	O
heart	B-ANAT
rate	O
and	O
lower	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
and	O
bicarbonate	O
independently	O
predicted	O
NIV	O
failure	O
.	O

Histopathologically	O
,	O
multifocal	O
granulomas	O
consisting	O
of	O
necrotic	O
foci	O
,	O
macrophages	B-ANAT
,	O
fibroblasts	B-ANAT
and	O
plentiful	O
fibrous	O
connective	B-ANAT
tissues	I-ANAT
were	O
observed	O
in	O
the	O
mesenteric	B-ANAT
mass	O
.	O

Electron	O
microscopically	O
,	O
the	O
cytoplasm	B-ANAT
of	O
the	O
macrophages	B-ANAT
contained	O
viral	B-ANAT
particles	I-ANAT
,	O
which	O
were	O
identified	O
as	O
coronavirus	O
.	O

Fecal	B-ANAT
samples	O
from	O
935	O
dogs	O
with	O
acute	O
hemorrhagic	O
diarrhea	O
were	O
examined	O
by	O
electron	O
microscopy	O
.	O

More	O
than	O
one	O
virus	O
species	O
was	O
detected	O
in	O
6	O
.	O
5	O
%	O
of	O
all	O
fecal	B-ANAT
samples	O
.	O

Dogs	O
with	O
a	O
virus	O
-	O
positive	O
fecal	B-ANAT
sample	O
were	O
significantly	O
younger	O
than	O
dogs	O
that	O
tested	O
negative	O
on	O
electron	O
microscopy	O
.	O

ABSTRACT	O
:	O
Development	O
of	O
the	O
functionalization	O
of	O
triterpenoids	O
to	O
A	O
-	O
secoamidoximes	O
,	O
A	O
-	O
secomethylenamines	O
and	O
branched	B-ANAT
3	O
-(	O
3	O
-	O
aminopropylamino	O
)-	O
3	O
-(	O
3	O
-	O
aminopropoxy	O
)	O
amidoximes	O
is	O
illustrated	O
by	O
the	O
betulonic	O
acid	O
ketoxime	O
.	O

In	O
this	O
article	O
,	O
standard	O
methods	O
for	O
photometry	O
and	O
reporting	O
of	O
general	O
fluorescent	O
lighting	O
luminaire	O
photometric	O
data	O
are	O
adopted	O
to	O
provide	O
UVGI	O
fixture	O
spatial	O
emission	B-ANAT
distribution	O
data	O
in	O
an	O
electronic	O
file	O
format	O
.	O

ABSTRACT	O
:	O
To	O
summarize	O
the	O
clinical	O
experiences	O
and	O
indications	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
for	O
severe	O
ARDS	O
caused	O
by	O
novel	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
.	O

Settings	O
of	O
mechanical	O
ventilation	O
(	O
prior	O
to	O
ECMO	O
vs	O
2	O
hours	O
post	O
-	O
ECMO	O
)	O
were	O
:	O
peak	O
airway	B-ANAT
pressure	O
(	O
31	O
Â±	O
7	O
)	O
vs	O
(	O
25	O
Â±	O
6	O
)	O
cm	O
H2O	O
,	O
respiratory	O
rate	O
(	O
15	O
Â±	O
4	O
)	O
vs	O
(	O
22	O
Â±	O
6	O
)	O
breaths	O
/	O
min	O
,	O
FiO2	O
0	O
.	O
8	O
-	O
1	O
.	O
0	O
vs	O
0	O
.	O
35	O
-	O
0	O
.	O
50	O
,	O
PEEP	O
(	O
16	O
Â±	O
5	O
)	O
vs	O
(	O
12	O
Â±	O
4	O
)	O
cm	O
H2O	O
.	O

TITLE	O
:	O
A	O
novel	O
,	O
stable	O
and	O
reproducible	O
acute	O
lung	B-ANAT
injury	O
model	O
induced	O
by	O
oleic	O
acid	O
in	O
immature	O
piglet	O
.	O

ABSTRACT	O
:	O
Young	O
children	O
are	O
susceptible	O
to	O
pulmonary	B-ANAT
injury	O
,	O
and	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
often	O
results	O
in	O
a	O
high	O
mortality	O
and	O
financial	O
costs	O
in	O
pediatric	O
patients	O
.	O

The	O
lung	B-ANAT
histology	O
showed	O
severe	O
inflammation	O
,	O
hyaline	B-ANAT
membranes	B-ANAT
,	O
intra	O
-	O
alveolar	B-ANAT
and	O
interstitial	B-ANAT
hemorrhage	O
.	O

The	O
functional	O
receptor	O
for	O
the	O
virus	O
has	O
not	O
been	O
found	O
and	O
field	O
strains	O
of	O
IBV	O
do	O
not	O
infect	O
conventional	O
cell	B-ANAT
lines	I-ANAT
.	O

Here	O
,	O
we	O
describe	O
suppressor	O
mutations	O
within	O
the	O
transplanted	B-ANAT
BCoV	O
32	O
-	O
nt	O
domain	O
that	O
along	O
with	O
appearance	O
of	O
potential	O
base	O
pairings	O
identify	O
an	O
RNA	O
-	O
RNA	O
interaction	O
between	O
this	O
domain	O
and	O
a	O
32	O
-	O
nt	O
region	O
â¼	O
200	O
nt	O
downstream	O
within	O
the	O
nonstructural	O
protein	O
1	O
(	O
Nsp1	O
)-	O
coding	O
region	O
.	O

Interestingly	O
,	O
lung	B-ANAT
inflammation	O
was	O
more	O
prevalent	O
following	O
viral	O
clearance	O
,	O
as	O
leukocyte	B-ANAT
numbers	O
peaked	O
at	O
14	O
days	O
postinfection	O
(	O
dpi	O
)	O
and	O
remained	O
elevated	O
at	O
28	O
dpi	O
compared	O
to	O
those	O
of	O
mock	O
-	O
infected	O
controls	O
.	O

However	O
,	O
incidence	O
and	O
severity	O
of	O
lung	B-ANAT
inflammation	O
was	O
not	O
reduced	O
despite	O
the	O
limited	O
viral	O
replication	O
upon	O
rechallenge	O
.	O

Despite	O
an	O
F	O
(	O
IO	O
(	O
2	O
))	O
of	O
1	O
.	O
0	O
and	O
a	O
lung	B-ANAT
protective	O
strategy	O
,	O
the	O
patient	O
died	O
on	O
day	O
15	O
without	O
any	O
improvement	O
.	O

Acute	O
fibrinous	O
and	O
organizing	O
pneumonia	O
is	O
an	O
unusual	O
cause	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

We	O
then	O
started	O
mechanical	O
ventilation	O
with	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
and	O
treated	O
him	O
with	O
antibiotics	O
,	O
peramivir	O
,	O
and	O
corticosteroids	O
,	O
despite	O
negative	O
results	O
for	O
a	O
rapid	O
antigen	O
test	O
for	O
influenza	O
.	O

On	O
day	O
31	O
,	O
repeat	O
bronchoalveolar	O
lavage	O
showed	O
an	O
increase	O
in	O
the	O
number	O
of	O
total	O
cells	B-ANAT
which	O
were	O
lymphocyte	B-ANAT
-	O
predominant	O
,	O
but	O
there	O
were	O
no	O
pathogens	O
.	O

Because	O
of	O
acute	O
kidney	B-ANAT
injury	O
,	O
3	O
of	O
them	O
also	O
received	O
CVVHDF	O
.	O

TITLE	O
:	O
Binding	O
of	O
the	O
5	O
'-	O
untranslated	O
region	O
of	O
coronavirus	O
RNA	O
to	O
zinc	O
finger	B-ANAT
CCHC	O
-	O
type	O
and	O
RNA	O
-	O
binding	O
motif	O
1	O
enhances	O
viral	O
replication	O
and	O
transcription	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
of	O
Betacoronavirus	O
1	O
from	O
clinical	O
fecal	B-ANAT
specimens	O
by	O
a	O
novel	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
assay	O
.	O

The	O
primers	O
were	O
designed	O
to	O
target	O
the	O
highly	O
conserved	O
fragment	O
of	O
BCoV	O
-	O
1	O
nucleocapsid	B-ANAT
gene	O
.	O

She	O
developed	O
Staphylococcus	O
epidermidis	O
bacteremia	O
,	O
severe	O
sepsis	O
,	O
septic	O
shock	O
,	O
and	O
ARDS	O
following	O
chemotherapy	O
-	O
induced	O
severe	O
bone	B-ANAT
marrow	I-ANAT
failure	O
.	O

She	O
was	O
successfully	O
treated	O
with	O
extraordinary	O
life	O
support	O
measures	O
,	O
which	O
included	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
double	O
lumen	B-ANAT
lung	B-ANAT
ventilation	O
for	O
management	O
of	O
hemoptysis	O
,	O
and	O
lung	B-ANAT
assist	O
membrane	B-ANAT
ventilation	O
.	O

The	O
immunopathogenesis	O
of	O
MP	O
pneumonia	O
is	O
believed	O
to	O
be	O
a	O
hyperimmune	O
reaction	O
of	O
the	O
host	O
to	O
the	O
insults	O
from	O
MP	O
infection	O
,	O
including	O
cytokine	O
overproduction	O
and	O
immune	O
cell	B-ANAT
activation	O
(	O
T	B-ANAT
cells	I-ANAT
).	O

Of	O
the	O
4	O
deaths	O
,	O
2	O
were	O
caused	O
by	O
hemorrhagic	O
shock	O
;	O
1	O
,	O
by	O
irreversible	O
multiple	O
organ	B-ANAT
failure	O
;	O
and	O
1	O
,	O
by	O
refractory	O
septic	O
shock	O
.	O

We	O
analyzed	O
in	O
this	O
study	O
the	O
impact	O
of	O
Tregs	O
on	O
the	O
development	O
of	O
acute	O
viral	O
encephalomyelitis	O
,	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
antiviral	O
protection	O
,	O
and	O
prevention	O
of	O
CNS	B-ANAT
autoimmunity	O
following	O
intranasal	O
infection	O
with	O
the	O
gliatropic	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
.	O

To	O
assess	O
the	O
contribution	O
of	O
Tregs	O
in	O
vivo	O
,	O
we	O
specifically	O
depleted	O
CD4	O
(+)	O
Foxp3	O
(+)	O
T	B-ANAT
cells	I-ANAT
in	O
a	O
diphtheria	O
toxin	O
-	O
dependent	O
manner	O
.	O

However	O
,	O
Treg	O
depletion	O
led	O
to	O
a	O
more	O
severe	O
CNS	B-ANAT
inflammation	O
associated	O
with	O
neuronal	O
damage	O
.	O

ABSTRACT	O
:	O
Barth	O
syndrome	O
(	O
BTHS	O
)	O
is	O
an	O
X	O
-	O
linked	O
recessive	O
disorder	O
characterized	O
by	O
cardiomyopathy	O
,	O
skeletal	B-ANAT
myopathy	O
and	O
cyclic	O
neutropenia	O
in	O
male	O
patients	O
.	O

However	O
clinical	O
expression	O
in	O
a	O
carrier	O
female	O
requires	O
hemizygosity	O
for	O
the	O
mutated	O
allele	O
of	O
the	O
TAZ	O
gene	O
,	O
which	O
supposes	O
a	O
rearrangement	O
of	O
the	O
TAZ	O
gene	O
region	O
on	O
the	O
other	O
X	B-ANAT
chromosome	I-ANAT
.	O

ABSTRACT	O
:	O
Diffuse	O
alveolar	B-ANAT
hemorrhage	O
(	O
DAH	O
)	O
is	O
a	O
clinical	O
syndrome	O
with	O
typical	O
symptoms	O
dyspnea	O
and	O
hemoptysis	O
.	O

Such	O
an	O
algorithm	O
has	O
important	O
therapeutic	O
consequences	O
because	O
these	O
diseases	O
:	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
bronchiolitis	O
obliterans	O
organizing	O
pneumonia	O
(	O
BOOP	O
)	O
have	O
different	O
therapies	O
,	O
(	O
iii	O
)	O
to	O
evaluate	O
and	O
discuss	O
whether	O
local	O
pulmonary	B-ANAT
administration	O
may	O
improve	O
outcome	O
and	O
reduce	O
mortality	O
in	O
DAH	O
,	O
and	O
(	O
iv	O
)	O
to	O
suggest	O
a	O
treatment	O
schedule	O
.	O

Finally	O
50	O
,	O
000	O
-	O
100	O
,	O
000	O
patients	O
may	O
be	O
falsely	O
categorized	O
as	O
having	O
acute	O
respiratory	O
distress	O
syndrome	O
/	O
acute	O
lung	B-ANAT
injury	O
(	O
ARDS	O
/	O
ALI	O
)	O
because	O
DAH	O
and	O
ARDS	O
cannot	O
be	O
separated	O
clinically	O
.	O

Although	O
DOX	O
treatment	O
reduced	O
ALI	O
,	O
there	O
were	O
no	O
effects	O
on	O
virus	O
titers	O
and	O
body	B-ANAT
weights	O
.	O

The	O
disorder	O
may	O
present	O
many	O
complications	O
during	O
anesthesia	O
due	O
to	O
cardiac	B-ANAT
,	O
gastrointestinal	O
and	O
airway	B-ANAT
anomalies	O
.	O

TITLE	O
:	O
Acute	O
lung	B-ANAT
inflammatory	O
response	O
and	O
injury	O
after	O
hemorrhagic	O
shock	O
are	O
more	O
severe	O
in	O
postpartum	O
rabbits	O
.	O

Nonobstetric	O
and	O
obstetric	O
female	O
New	O
Zealand	O
white	O
rabbits	O
underwent	O
fixed	B-ANAT
-	O
pressure	O
or	O
fixed	B-ANAT
-	O
volume	O
hemorrhagic	O
shock	O
for	O
30	O
mins	O
and	O
then	O
were	O
rapidly	O
resuscitated	O
with	O
the	O
shed	O
blood	B-ANAT
and	O
Ringer	O
'	O
s	O
solution	O
.	O

The	O
complications	O
seen	O
in	O
the	O
P	O
.	O
vivax	O
cases	O
were	O
:	O
thrombocytopenia	O
;	O
hepatic	B-ANAT
dysfunction	O
;	O
renal	B-ANAT
damage	O
;	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

A	O
total	O
of	O
67	O
common	O
biological	O
pathways	O
were	O
identified	O
among	O
the	O
seven	O
different	O
respiratory	O
viruses	O
analyzed	O
,	O
representing	O
fifteen	O
laboratories	O
,	O
nine	O
different	O
cell	B-ANAT
types	O
,	O
and	O
seven	O
different	O
array	O
platforms	O
.	O

Compared	O
with	O
the	O
control	O
mice	O
,	O
the	O
expressions	O
of	O
KCTD9	O
mRNA	O
were	O
up	O
-	O
regulated	O
by	O
577	O
.	O
1	O
-,	O
8	O
.	O
8	O
-,	O
59	O
.	O
4	O
-	O
and	O
10	O
.	O
8	O
-	O
fold	O
in	O
hepatic	B-ANAT
NK	B-ANAT
cells	I-ANAT
,	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
,	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
and	O
splenic	B-ANAT
NK	B-ANAT
cells	I-ANAT
respectively	O
in	O
model	O
mice	O
of	O
fulminant	O
viral	O
hepatitis	O
48	O
hr	O
post	O
MHV	O
-	O
3	O
infection	O
,	O
whereas	O
down	O
-	O
regulation	O
by	O
43	O
%	O
and	O
69	O
%	O
in	O
splenic	B-ANAT
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
were	O
found	O
respectively	O
.	O

CONCLUSIONS	O
:	O
A	O
novel	O
potassium	O
channel	O
gene	O
KCTD9	O
was	O
highly	O
expressed	O
in	O
hepatic	B-ANAT
NK	B-ANAT
cells	I-ANAT
and	O
T	B-ANAT
cells	I-ANAT
of	O
fulminant	O
hepatitis	O
mice	O
induced	O
by	O
MHV	O
-	O
3	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
induce	O
in	O
infected	O
cells	B-ANAT
the	O
formation	O
of	O
replicative	O
structures	O
,	O
consisting	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
)	O
and	O
convoluted	O
membranes	B-ANAT
,	O
where	O
viral	O
RNA	O
synthesis	O
supposedly	O
takes	O
place	O
and	O
to	O
which	O
the	O
nonstructural	O
proteins	O
(	O
nsp	O
'	O
s	O
)	O
localize	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
feline	O
infectious	O
peritonitis	O
virus	O
strain	O
DF	O
-	O
2	O
and	O
studies	O
of	O
the	O
role	O
of	O
ORF3abc	O
in	O
viral	O
cell	B-ANAT
tropism	O
.	O

TITLE	O
:	O
Comparison	O
of	O
three	O
diagnostic	O
techniques	O
for	O
detection	O
of	O
rotavirus	O
and	O
coronavirus	O
in	O
calf	B-ANAT
faeces	B-ANAT
in	O
Australia	O
.	O

ABSTRACT	O
:	O
Compare	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
),	O
a	O
commercially	O
available	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
and	O
lateral	O
flow	O
immunochromatography	O
assay	O
(	O
LAT	O
)	O
for	O
the	O
detection	O
of	O
rotavirus	O
and	O
coronavirus	O
in	O
faecal	B-ANAT
samples	O
collected	O
from	O
diarrhoeic	O
calves	O
.	O

We	O
have	O
previously	O
shown	O
that	O
transplantation	O
of	O
neural	O
progenitor	B-ANAT
cells	I-ANAT
(	O
NPCs	O
)	O
into	O
mice	O
persistently	O
infected	O
with	O
the	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
results	O
in	O
enhanced	O
differentiation	O
into	O
oligodendrocyte	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
(	O
OPCs	O
)	O
that	O
is	O
associated	O
with	O
remyelination	O
and	O
axonal	O
sparing	O
.	O

Transplantation	O
of	O
Olig1	O
-/-	O
and	O
Olig1	O
+/+	O
NPCs	O
into	O
JHMV	O
-	O
infected	O
mice	O
resulted	O
in	O
similar	O
cell	B-ANAT
survival	O
,	O
proliferation	O
,	O
and	O
selective	O
migration	O
to	O
areas	O
of	O
demyelination	O
.	O

In	O
contrast	O
,	O
the	O
majority	O
of	O
transplanted	B-ANAT
Olig1	O
-/-	O
NPCs	O
differentiated	O
into	O
GFAP	O
-	O
positive	O
cells	B-ANAT
consistent	O
with	O
the	O
astrocyte	B-ANAT
lineage	O
.	O

Further	O
,	O
these	O
findings	O
reveal	O
that	O
Olig1function	O
is	O
required	O
for	O
the	O
remyelination	O
potential	O
of	O
NPCs	O
after	O
transplant	B-ANAT
,	O
through	O
specification	O
and	O
/	O
or	O
maintenance	O
of	O
oligodendroglial	O
identity	O
.	O

However	O
,	O
this	O
increases	O
the	O
exposure	O
of	O
the	O
porcine	O
lungs	B-ANAT
to	O
pathogens	O
and	O
potential	O
injury	O
.	O

The	O
authors	O
propose	O
that	O
increasing	O
the	O
concentration	O
of	O
the	O
inoculum	O
without	O
changing	O
the	O
bacterial	O
dose	O
will	O
lead	O
to	O
severe	O
sepsis	O
with	O
pronounced	O
pulmonary	B-ANAT
lesions	O
.	O

Furthermore	O
,	O
local	O
mRNA	O
expression	O
of	O
inflammatory	O
cytokines	O
appeared	O
to	O
be	O
dependent	O
on	O
the	O
magnitude	O
and	O
severity	O
of	O
tissue	B-ANAT
destruction	O
,	O
including	O
the	O
ability	O
to	O
confine	O
the	O
lesions	O
.	O

Vitamin	O
D	O
levels	O
were	O
measured	O
in	O
139	O
children	O
(	O
aged	O
7	O
.	O
9	O
to	O
15	O
.	O
1	O
years	O
)	O
to	O
study	O
its	O
association	O
with	O
SCA	B-ANAT
morbidities	O
;	O
severe	O
deficiency	O
<	O
10	O
ng	O
/	O
mL	O
was	O
present	O
in	O
64	O
.	O
0	O
%	O
and	O
only	O
2	O
.	O
2	O
%	O
were	O
sufficient	O
(>	O
30	O
ng	O
/	O
mL	O
).	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
considered	O
the	O
most	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
resulting	O
in	O
high	O
morbidity	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
Wound	O
control	O
in	O
laparostomy	O
for	O
the	O
treatment	O
of	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
remains	O
challenging	O
and	O
numerous	O
techniques	O
have	O
been	O
described	O
.	O

The	O
patient	O
decompensated	O
,	O
developing	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
with	O
renal	B-ANAT
and	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
,	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
common	O
complications	O
of	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

In	O
the	O
absence	O
of	O
TMPRSS2	O
,	O
SARS	O
-	O
CoV	O
achieves	O
cell	B-ANAT
entry	O
via	O
an	O
endosomal	O
pathway	O
in	O
which	O
cathepsin	O
L	O
may	O
play	O
an	O
important	O
role	O
,	O
i	O
.	O
e	O
.,	O
the	O
activation	O
of	O
spike	O
protein	O
fusogenicity	O
.	O

ABSTRACT	O
:	O
HELLP	O
syndrome	O
(	O
hemolysis	O
,	O
elevated	O
liver	B-ANAT
enzymes	O
,	O
low	O
platelets	B-ANAT
)	O
is	O
a	O
severe	O
microcirculatory	O
disturbance	O
during	O
pregnancy	O
,	O
associated	O
with	O
pre	O
-	O
eclampsia	O
,	O
but	O
it	O
may	O
occur	O
also	O
without	O
it	O
.	O

The	O
DNA	O
vaccine	O
was	O
found	O
to	O
mediate	O
primarily	O
a	O
cellular	B-ANAT
immune	O
response	O
with	O
high	O
levels	O
of	O
IgG2a	O
and	O
the	O
cytokines	O
IL	O
-	O
2	O
and	O
gamma	O
interferon	O
(	O
IFN	O
-	O
Î³	O
).	O

Whereas	O
a	O
high	O
viral	O
load	O
of	O
canine	O
parvovirus	O
type	O
2	O
significantly	O
impacted	O
feces	B-ANAT
quality	O
,	O
no	O
effect	O
was	O
recorded	O
for	O
canine	O
coronavirus	O
.	O

ABSTRACT	O
:	O
Fifty	O
-	O
seven	O
derivatives	O
of	O
glycyrrhetinic	O
acid	O
(	O
GA	O
)	O
were	O
synthesized	O
,	O
and	O
their	O
anti	O
-	O
hepatitis	O
B	O
virus	O
(	O
HBV	O
)	O
activity	O
was	O
evaluated	O
in	O
HepG	O
2	O
.	O
2	O
.	O
15	O
cells	B-ANAT
.	O

We	O
aimed	O
to	O
determine	O
the	O
incidence	O
,	O
outcome	O
,	O
and	O
risk	O
factors	O
of	O
bacterial	O
VAP	O
complicating	O
severe	O
ARDS	O
in	O
patients	O
ventilated	O
by	O
using	O
a	O
strictly	O
standardized	O
lung	B-ANAT
-	O
protective	O
strategy	O
.	O

This	O
review	O
gives	O
an	O
outline	O
of	O
recent	O
developments	O
in	O
PEEP	O
adjustment	O
for	O
patients	O
suffering	O
from	O
acute	O
hypoxic	O
and	O
hypercapnic	O
lung	B-ANAT
injury	O
and	O
explains	O
the	O
fundamental	O
pathophysiology	O
necessary	O
as	O
a	O
basis	O
for	O
correct	O
treatment	O
.	O

ABSTRACT	O
:	O
Recently	O
a	O
commercial	O
antigen	O
-	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
kit	O
in	O
the	O
form	O
of	O
a	O
dipstick	O
(	O
Bovine	O
Enterichek	O
,	O
Biovet	O
Inc	O
.)	O
was	O
made	O
available	O
to	O
bovine	O
practitioners	O
and	O
producers	O
for	O
the	O
rapid	O
detection	O
of	O
Betacoronavirus	O
1	O
(	O
BCV	O
-	O
1	O
),	O
Rotavirus	O
A	O
(	O
RV	O
-	O
A	O
),	O
Escherichia	O
coli	O
K99	O
(+),	O
and	O
Cryptosporidium	O
parvum	O
in	O
feces	B-ANAT
from	O
diarrheic	O
calves	O
.	O

ABSTRACT	O
:	O
Fragment	O
450	O
-	O
650	O
of	O
the	O
spike	O
(	O
S	O
)	O
protein	O
(	O
S450	O
-	O
650	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
contains	O
epitopes	O
capable	O
of	O
being	O
recognized	O
by	O
convalescent	O
sera	B-ANAT
of	O
SARS	O
patients	O
.	O

Our	O
aim	O
was	O
to	O
develop	O
a	O
new	O
vaccination	O
strategy	O
that	O
elicits	O
a	O
mucosal	B-ANAT
immune	O
response	O
.	O

A	O
new	O
scorpion	O
venom	O
peptide	O
derivative	O
Kn2	O
-	O
7	O
was	O
identified	O
as	O
the	O
most	O
potent	O
anti	O
-	O
HIV	O
-	O
1	O
peptide	O
by	O
screening	O
assays	O
with	O
an	O
EC	O
(	O
50	O
)	O
value	O
of	O
2	O
.	O
76	O
Âµg	O
/	O
ml	O
(	O
1	O
.	O
65	O
ÂµM	O
)	O
and	O
showed	O
low	O
cytotoxicity	O
to	O
host	O
cells	B-ANAT
with	O
a	O
selective	O
index	O
(	O
SI	O
)	O
of	O
13	O
.	O
93	O
.	O

This	O
evaluation	O
strengthens	O
the	O
expectation	O
that	O
MMP	O
inhibitors	O
,	O
in	O
particular	O
those	O
blocking	O
neutrophil	B-ANAT
proteases	O
,	O
may	O
become	O
useful	O
in	O
the	O
early	O
phase	O
of	O
acute	O
inflammatory	O
shock	O
syndromes	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
no	O
significant	O
pulmonary	B-ANAT
or	O
cardiac	B-ANAT
disease	O
who	O
presented	O
with	O
hypoxic	O
respiratory	O
failure	O
in	O
the	O
setting	O
of	O
opioid	O
overdose	O
.	O

Over	O
the	O
next	O
6	O
days	O
,	O
the	O
patient	O
'	O
s	O
cardiac	B-ANAT
and	O
respiratory	O
function	O
improved	O
,	O
and	O
a	O
repeat	O
echocardiogram	O
demonstrated	O
complete	O
normalization	O
of	O
RV	O
function	O
.	O

However	O
,	O
it	O
is	O
at	O
present	O
largely	O
unclear	O
to	O
what	O
extent	O
these	O
proteases	O
are	O
expressed	O
in	O
viral	O
target	B-ANAT
cells	I-ANAT
in	O
human	B-ANAT
tissues	I-ANAT
.	O

As	O
a	O
result	O
,	O
15	O
-	O
16kb	O
nucleotide	O
sequences	O
encoding	O
complete	O
RNA	O
dependent	O
RNA	O
polymerase	O
,	O
spike	O
,	O
envelope	B-ANAT
,	O
membrane	B-ANAT
,	O
and	O
nucleocapsid	B-ANAT
proteins	O
plus	O
other	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
were	O
generated	O
.	O

ABSTRACT	O
:	O
Virions	B-ANAT
are	O
one	O
kind	O
of	O
nanoscale	O
pathogen	O
and	O
are	O
able	O
to	O
infect	O
living	O
cells	B-ANAT
of	O
animals	O
,	O
plants	O
,	O
and	O
bacteria	O
.	O

The	O
bacteriophage	O
-	O
bacteria	O
interactions	O
are	O
also	O
introduced	O
to	O
elucidate	O
how	O
the	O
bacteriophage	O
conquers	O
the	O
barrier	O
of	O
cell	B-ANAT
walls	I-ANAT
in	O
the	O
prokaryotic	O
cells	B-ANAT
to	O
transport	O
genome	O
into	O
the	O
host	O
.	O

We	O
also	O
examined	O
how	O
the	O
membrane	B-ANAT
topology	O
of	O
IBV	O
E	O
affected	O
its	O
function	O
by	O
generating	O
mutant	O
versions	O
that	O
adopted	O
either	O
a	O
transmembrane	B-ANAT
or	O
membrane	B-ANAT
hairpin	O
topology	O
.	O

We	O
report	O
on	O
a	O
case	O
of	O
massive	O
aspiration	O
of	O
gastric	B-ANAT
content	I-ANAT
during	O
induction	O
of	O
general	O
anaesthesia	O
,	O
resulting	O
in	O
severe	O
prolonged	O
hypoxaemia	O
with	O
cardiac	B-ANAT
arrest	O
,	O
followed	O
by	O
rapid	O
onset	O
of	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
associated	O
with	O
severe	O
global	O
respiratory	O
insufficiency	O
and	O
severe	O
hypoxia	O
.	O

The	O
human	O
Corona	O
virus	O
NL63	O
(	O
HCoV	O
-	O
NL63	O
)	O
causes	O
only	O
limited	O
CPE	O
on	O
different	O
cell	B-ANAT
lines	I-ANAT
(	O
Schildgen	O
et	O
al	O
.,	O
2006	O
).	O

Following	O
different	O
rounds	O
of	O
optimization	O
a	O
screening	O
protocol	O
was	O
developed	O
:	O
Vero118	O
cells	B-ANAT
in	O
96	O
-	O
well	O
plate	O
format	O
were	O
infected	O
with	O
HCoV	O
-	O
NL63	O
(	O
MOI	O
=	O
0	O
.	O
01	O
;	O
200Î¼L	O
cell	B-ANAT
culture	O
;	O
2	O
.	O
10	O
(	O
4	O
)	O
cells	B-ANAT
/	O
mL	O
,	O
IMDM	O
5	O
%	O
FBS	O
medium	O
).	O

The	O
weaning	O
was	O
performed	O
while	O
keeping	O
the	O
blood	B-ANAT
flow	O
unchanged	O
,	O
only	O
gas	O
flows	O
were	O
gradually	O
decreased	O
.	O

ABSTRACT	O
:	O
Acylguanidines	O
are	O
a	O
new	O
class	O
of	O
antiviral	O
compounds	O
with	O
the	O
unique	O
ability	O
to	O
target	O
both	O
RNA	O
polymerase	O
and	O
transmembrane	B-ANAT
proteins	O
of	O
viruses	O
from	O
different	O
families	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
is	O
characterized	O
by	O
acute	O
inflammation	O
,	O
disruption	O
of	O
the	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
barrier	O
,	O
and	O
in	O
the	O
organizing	O
stage	O
by	O
alveolar	B-ANAT
pneumocytes	B-ANAT
hyperplasia	O
and	O
extensive	O
lung	B-ANAT
fibrosis	O
.	O

Among	O
all	O
ROS	O
-	O
producing	O
enzymes	O
,	O
the	O
members	O
of	O
NADPH	O
oxidases	O
(	O
NOXs	O
),	O
which	O
are	O
widely	O
expressed	O
in	O
different	O
lung	B-ANAT
cell	B-ANAT
types	O
,	O
have	O
been	O
shown	O
to	O
participate	O
in	O
cellular	B-ANAT
processes	O
involved	O
in	O
the	O
maintenance	O
of	O
lung	B-ANAT
integrity	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
safety	O
and	O
efficacy	O
of	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
ventilation	O
strategy	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
after	O
traumatic	O
brain	B-ANAT
injury	O
.	O

Abdominal	B-ANAT
XR	O
confirmed	O
these	O
findings	O
.	O

Routine	O
screening	O
for	O
HPeV	O
in	O
CSF	B-ANAT
and	O
blood	B-ANAT
should	O
thus	O
be	O
performed	O
more	O
extensively	O
and	O
could	O
improve	O
clinical	O
management	O
.	O

High	O
frequency	O
ventilation	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
are	O
used	O
as	O
rescue	O
modes	O
of	O
support	O
in	O
difficult	O
situations	O
.	O

TITLE	O
:	O
Mechanism	O
of	O
nucleic	B-ANAT
acid	O
unwinding	O
by	O
SARS	O
-	O
CoV	O
helicase	O
.	O

We	O
also	O
showed	O
that	O
nsp12	O
,	O
the	O
SARS	O
-	O
CoV	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
),	O
enhances	O
(	O
2	O
-	O
fold	O
)	O
the	O
catalytic	O
efficiency	O
of	O
nsp13	O
by	O
increasing	O
the	O
step	O
size	O
of	O
nucleic	B-ANAT
acid	O
(	O
RNA	O
/	O
RNA	O
or	O
DNA	O
/	O
DNA	O
)	O
unwinding	O
.	O

This	O
effect	O
is	O
specific	O
for	O
SARS	O
-	O
CoV	O
nsp12	O
,	O
as	O
no	O
change	O
in	O
nsp13	O
activity	O
was	O
observed	O
when	O
foot	B-ANAT
-	O
and	O
-	O
mouth	B-ANAT
-	O
disease	O
virus	O
RdRp	O
was	O
used	O
in	O
place	O
of	O
nsp12	O
.	O

When	O
expressed	O
as	O
N	O
-	O
terminal	O
enhanced	O
green	O
fluorescence	O
protein	O
(	O
EGFP	O
)	O
fusion	O
,	O
it	O
predominantly	O
formed	O
speckles	O
in	O
the	O
cytoplasm	B-ANAT
.	O

The	O
B	O
and	O
T	B-ANAT
lymphocyte	I-ANAT
attenuator	O
(	O
BTLA	O
)	O
is	O
an	O
immunoglobulin	O
-	O
domain	O
-	O
containing	O
protein	O
that	O
has	O
the	O
capacity	O
to	O
maintain	O
peripheral	O
tolerance	O
and	O
limit	O
immunopathological	O
damage	O
during	O
immune	O
responses	O
.	O

This	O
effect	O
is	O
due	O
to	O
rapid	O
,	O
TRAIL	O
(	O
TNF	O
-	O
related	O
apoptosis	O
-	O
inducing	O
ligand	O
)-	O
dependent	O
apoptosis	O
of	O
MHV	O
-	O
3	O
-	O
infected	O
macrophages	B-ANAT
in	O
BTLA	O
-/-	O
mice	O
.	O

ABSTRACT	O
:	O
The	O
interplay	O
between	O
IFN	O
-	O
Î³	O
,	O
IL	O
-	O
17	O
and	O
neutrophils	B-ANAT
during	O
CNS	B-ANAT
inflammatory	O
disease	O
is	O
complex	O
due	O
to	O
cross	O
-	O
regulatory	O
factors	O
affecting	O
both	O
positive	O
and	O
negative	O
feedback	O
loops	O
.	O

These	O
interactions	O
have	O
hindered	O
the	O
ability	O
to	O
distinguish	O
the	O
relative	O
contributions	O
of	O
neutrophils	B-ANAT
,	O
Th1	O
and	O
Th17	B-ANAT
cell	I-ANAT
-	O
derived	O
effector	O
molecules	O
from	O
secondary	O
mediators	O
to	O
tissue	B-ANAT
damage	O
and	O
morbidity	O
.	O

Furthermore	O
,	O
co	O
-	O
transfer	O
of	O
WT	O
and	O
GKO	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
prolonged	O
survival	O
in	O
an	O
IFN	O
-	O
Î³	O
dependent	O
manner	O
,	O
although	O
IL	O
-	O
17	O
transcription	O
was	O
not	O
reduced	O
.	O

Computer	O
tomography	O
of	O
the	O
chest	B-ANAT
as	O
well	O
as	O
bronchoscopy	O
also	O
revealed	O
no	O
pathologies	O
.	O

Rapid	O
diagnosis	O
by	O
blood	B-ANAT
gas	O
analysis	O
and	O
instant	O
therapy	O
by	O
toloudine	O
blue	O
(	O
TB	O
)	O
can	O
effectively	O
prevent	O
a	O
potentially	O
lethal	O
course	O
.	O

(	O
1	O
)	O
For	O
patients	O
with	O
severe	O
chest	B-ANAT
trauma	O
,	O
early	O
emergency	O
treatment	O
is	O
crucial	O
to	O
save	O
life	O
.	O

TITLE	O
:	O
Prolonged	O
heparin	O
-	O
free	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
multiple	O
injured	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
with	O
traumatic	O
brain	B-ANAT
injury	O
.	O

The	O
proportion	O
of	O
transcripts	O
encoding	O
secreted	O
isoforms	O
also	O
could	O
not	O
explain	O
the	O
selection	O
of	O
sites	O
for	O
virus	O
replication	O
,	O
as	O
it	O
was	O
constant	O
in	O
all	O
organs	B-ANAT
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
manifestation	O
of	O
novel	O
swine	O
-	O
origin	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
(	O
S	O
-	O
OIV	O
)	O
infection	O
in	O
immunocompromised	O
patients	O
:	O
initial	O
findings	O
with	O
multidetector	O
computed	O
tomography	O
.	O

Reticular	O
pattern	O
and	O
a	O
tree	O
-	O
in	O
-	O
bud	B-ANAT
appearance	O
were	O
found	O
in	O
3	O
/	O
12	O
(	O
25	O
%),	O
respectively	O
.	O

Bilateral	O
opacities	O
with	O
extensive	O
involvement	O
of	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
were	O
most	O
predictive	O
of	O
a	O
severe	O
clinical	O
course	O
.	O

Alveolar	B-ANAT
fluid	O
clearance	O
,	O
lung	B-ANAT
water	O
,	O
and	O
lung	B-ANAT
mechanics	O
were	O
measured	O
at	O
2	O
and	O
6	O
days	O
after	O
inoculation	O
in	O
live	O
,	O
ventilated	O
mice	O
by	O
BSA	O
instillation	O
,	O
magnetic	O
resonance	O
imaging	O
,	O
and	O
forced	O
-	O
oscillation	O
techniques	O
,	O
respectively	O
.	O

Nebulized	O
A77	O
-	O
1726	O
also	O
reversed	O
influenza	O
-	O
induced	O
increases	O
in	O
lung	B-ANAT
water	O
content	O
and	O
volume	O
,	O
improved	O
pulmonary	B-ANAT
mechanics	O
,	O
reduced	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
ATP	O
and	O
neutrophil	B-ANAT
content	O
,	O
and	O
increased	O
IL	O
-	O
6	O
concentrations	O
.	O

The	O
crystals	B-ANAT
diffracted	O
to	O
2	O
.	O
8	O
Ã	O
resolution	O
and	O
belonged	O
to	O
space	O
group	O
P2	O
(	O
1	O
),	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
57	O
.	O
0	O
,	O
b	O
=	O
192	O
.	O
3	O
,	O
c	O
=	O
105	O
.	O
7	O
Ã	O
,	O
Î²	O
=	O
90	O
.	O
8	O
Â°.	O

PP	O
also	O
significantly	O
complicates	O
burn	O
care	O
by	O
making	O
skin	B-ANAT
protection	O
and	O
wound	O
care	O
more	O
difficult	O
.	O

Subsequent	O
coagulopathy	O
was	O
assumed	O
to	O
be	O
caused	O
by	O
lack	O
of	O
the	O
labile	O
factors	O
(	O
FV	O
and	O
FVIII	O
)	O
which	O
were	O
then	O
replaced	O
by	O
fresh	B-ANAT
whole	B-ANAT
blood	I-ANAT
.	O

The	O
decade	O
of	O
1970s	O
saw	O
the	O
implementation	O
of	O
component	O
therapy	O
by	O
the	O
American	O
Blood	B-ANAT
Banking	O
Association	O
so	O
that	O
HS	O
was	O
treated	O
with	O
BES	O
and	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
RBC	B-ANAT
).	O

By	O
the	O
end	O
of	O
1970s	O
,	O
most	O
trauma	O
centers	O
were	O
supplementing	O
BES	O
and	O
RBC	B-ANAT
with	O
FFP	O
in	O
patients	O
with	O
severe	O
injuries	O
requiring	O
massive	O
transfusion	O
of	O
more	O
than	O
one	O
circulating	B-ANAT
blood	I-ANAT
volume	O
.	O

Here	O
,	O
random	O
mutagenesis	O
and	O
DNA	O
shuffling	O
of	O
the	O
single	O
-	O
chain	O
variable	O
fragment	O
of	O
the	O
neutralizing	O
antibody	O
80R	O
followed	O
by	O
bacterial	O
display	O
screening	O
using	O
anchored	O
periplasmic	B-ANAT
expression	O
(	O
APEx	O
)	O
were	O
used	O
to	O
generate	O
a	O
number	O
of	O
higher	O
-	O
affinity	O
variants	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)-	O
neutralizing	O
antibody	O
80R	O
with	O
equilibrium	O
dissociation	O
constants	O
(	O
K	O
(	O
D	O
))	O
as	O
low	O
as	O
37	O
pM	O
,	O
a	O
>	O
270	O
-	O
fold	O
improvement	O
relative	O
to	O
that	O
of	O
the	O
parental	O
80R	O
single	O
-	O
chain	O
variable	O
fragment	O
(	O
scFv	O
).	O

Retrocyclin	O
-	O
1	O
inhibits	O
the	O
cellular	B-ANAT
entry	O
of	O
HIV	O
-	O
1	O
,	O
HSV	O
,	O
and	O
influenza	O
A	O
virus	O
.	O

The	O
murine	O
coronavirus	O
,	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
causes	O
acute	O
hepatitis	O
in	O
its	O
natural	O
host	O
and	O
provides	O
a	O
useful	O
model	O
for	O
understanding	O
virus	O
interaction	O
with	O
liver	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Like	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
human	O
coronavirus	O
(	O
HCoV	O
)-	O
NL63	O
employs	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
a	O
receptor	O
for	O
cellular	B-ANAT
entry	O
.	O

157	O
of	O
the	O
981	O
(	O
16	O
.	O
0	O
%)	O
nasopharyngeal	B-ANAT
swabs	O
were	O
positive	O
for	O
HCoVs	O
.	O

Washes	O
and	O
flocked	O
swabs	O
collected	O
from	O
children	O
<	O
3	O
years	O
old	O
hospitalized	O
with	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
were	O
tested	O
for	O
parainfluenza	O
virus	O
1	O
-	O
3	O
,	O
respiratory	O
syncytial	O
virus	O
,	O
influenza	O
A	O
and	O
B	O
and	O
metapneumovirus	O
(	O
Group	O
1	O
)	O
and	O
adenovirus	O
,	O
rhinovirus	O
and	O
coronavirus	O
(	O
Group	O
2	O
)	O
using	O
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
(	O
rRT	O
-	O
PCR	O
).	O

A	O
rapidly	O
growing	O
number	O
of	O
studies	O
have	O
reported	O
the	O
appearance	O
of	O
distinct	O
populations	O
of	O
microparticles	O
(	O
MPs	O
)	O
in	O
both	O
the	O
vascular	B-ANAT
and	O
alveolar	B-ANAT
compartments	B-ANAT
in	O
animal	O
models	O
of	O
ALI	O
/	O
ARDS	O
or	O
respective	O
patient	O
populations	O
,	O
where	O
they	O
may	O
serve	O
as	O
diagnostic	O
and	O
prognostic	O
biomarkers	O
.	O

Owing	O
to	O
this	O
endowment	O
,	O
MPs	O
can	O
effectively	O
interact	O
with	O
other	O
cell	B-ANAT
types	O
via	O
fusion	O
,	O
receptor	O
-	O
mediated	O
interaction	O
,	O
uptake	O
,	O
or	O
mediator	O
release	O
,	O
thereby	O
acting	O
as	O
intrinsic	O
stimulators	O
,	O
modulators	O
,	O
or	O
even	O
attenuators	O
in	O
a	O
variety	O
of	O
disease	O
processes	O
.	O

MHV	O
-	O
1	O
infection	O
led	O
to	O
acute	O
lung	B-ANAT
injury	O
with	O
greater	O
severity	O
in	O
PTX3	O
-	O
deficient	O
mice	O
than	O
that	O
in	O
WT	O
mice	O
.	O

Administration	O
of	O
recombinant	O
PTX3	O
significantly	O
accelerated	O
viral	O
clearance	O
in	O
the	O
lung	B-ANAT
,	O
attenuated	O
MHV	O
-	O
1	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
and	O
reduced	O
early	O
neutrophil	B-ANAT
influx	O
and	O
elevation	O
of	O
inflammatory	O
mediators	O
in	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
replication	O
inhibitor	O
that	O
interferes	O
with	O
the	O
nucleic	B-ANAT
acid	O
unwinding	O
of	O
the	O
viral	O
helicase	O
.	O

Hence	O
,	O
it	O
is	O
possible	O
that	O
SSYA10	O
-	O
001	O
inhibits	O
unwinding	O
by	O
nsp13	O
by	O
affecting	O
conformational	O
changes	O
during	O
the	O
course	O
of	O
the	O
reaction	O
or	O
translocation	O
on	O
the	O
nucleic	B-ANAT
acid	O
.	O

In	O
one	O
patient	O
,	O
air	O
migrated	O
into	O
the	O
liver	B-ANAT
during	O
transvenous	O
obliteration	O
but	O
was	O
spontaneously	O
absorbed	O
.	O

TITLE	O
:	O
Immunogenicity	O
of	O
a	O
neutralizing	O
epitope	O
from	O
porcine	O
epidemic	O
diarrhea	O
virus	O
:	O
M	B-ANAT
cell	I-ANAT
targeting	O
ligand	O
fusion	O
protein	O
expressed	O
in	O
transgenic	O
rice	O
calli	O
.	O

ABSTRACT	O
:	O
To	O
increase	O
immune	O
responses	O
of	O
plant	O
-	O
based	O
vaccines	O
in	O
intestine	B-ANAT
mucosal	B-ANAT
immune	B-ANAT
systems	I-ANAT
,	O
a	O
synthetic	O
neutralizing	O
epitope	O
(	O
sCOE	O
)	O
gene	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
was	O
fused	O
with	O
M	B-ANAT
cell	I-ANAT
-	O
targeting	O
ligand	O
(	O
Co1	O
)	O
and	O
introduced	O
into	O
a	O
plant	O
expression	O
vector	O
under	O
the	O
control	O
of	O
rice	O
amylase	O
3D	O
promoter	O
.	O

Mice	O
immunized	O
with	O
transgenic	O
rice	O
calli	O
protein	O
extracts	O
induced	O
significant	O
serum	B-ANAT
IgG	O
and	O
fecal	B-ANAT
IgA	B-ANAT
antibody	I-ANAT
levels	O
against	O
purified	O
bacterial	O
COE	O
.	O

Nevertheless	O
,	O
the	O
dynamics	O
of	O
IFNÎ±	O
/	O
Î²	O
induction	O
and	O
responsiveness	O
by	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
resident	O
cells	B-ANAT
in	O
vivo	O
in	O
response	O
to	O
viral	O
infections	O
are	O
poorly	O
understood	O
.	O

Expression	O
of	O
genes	O
associated	O
with	O
the	O
IFNÎ±	O
/	O
Î²	O
pathways	O
was	O
monitored	O
in	O
microglia	B-ANAT
and	O
oligodendroglia	B-ANAT
purified	O
from	O
naÃ¯ve	O
and	O
infected	O
mice	O
by	O
fluorescent	O
activated	O
cell	B-ANAT
sorting	O
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
reveals	O
platelet	B-ANAT
factor	O
4	O
and	O
beta	O
-	O
thromboglobulin	O
as	O
prognostic	O
markers	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Two	O
hundred	O
and	O
three	O
patients	O
with	O
high	O
altitude	O
pulmonary	B-ANAT
edema	O
(	O
HAPE	O
)	O
or	O
high	O
altitude	O
cerebral	B-ANAT
edema	O
(	O
HACE	O
)	O
met	O
inclusion	O
criteria	O
were	O
included	O
,	O
and	O
were	O
randomly	O
divided	O
into	O
Bundle	O
treatment	O
group	O
(	O
n	O
=	O
125	O
)	O
and	O
conventional	O
treatment	O
control	O
group	O
(	O
n	O
=	O
78	O
).	O

ABSTRACT	O
:	O
The	O
mechanisms	O
of	O
each	O
subset	O
of	O
immune	O
cells	B-ANAT
contributing	O
to	O
the	O
pathogenesis	O
of	O
viral	O
hepatitis	O
remain	O
incompletely	O
understood	O
.	O

Type	O
1	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
(	O
Tr1	B-ANAT
cells	I-ANAT
)	O
produce	O
IL	O
-	O
10	O
,	O
while	O
T	O
helper	O
3	O
cells	B-ANAT
(	O
Th3	O
)	O
produce	O
TGF	O
-	O
Î²	O
.	O

TITLE	O
:	O
Protective	O
role	O
of	O
Toll	O
-	O
like	O
Receptor	O
3	O
-	O
induced	O
type	O
I	O
interferon	O
in	O
murine	O
coronavirus	O
infection	O
of	O
macrophages	B-ANAT
.	O

Viral	O
recognition	O
by	O
TLRs	O
and	O
other	O
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
has	O
been	O
proven	O
to	O
be	O
cell	B-ANAT
-	O
type	O
specific	O
.	O

In	O
contrast	O
,	O
pre	O
-	O
stimulation	O
of	O
TLR3	O
with	O
polyinosinic	O
-	O
polycytidylic	O
acid	O
(	O
poly	O
I	O
:	O
C	O
)	O
hindered	O
MHV	O
infection	O
through	O
induction	O
of	O
IFN	O
-	O
Î²	O
in	O
macrophages	B-ANAT
.	O

Main	O
:	O
To	O
analize	O
the	O
effectiveness	O
of	O
HFOV	O
in	O
everyday	O
practice	O
in	O
a	O
center	O
without	O
extra	O
corporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
capabilities	O
.	O

ABSTRACT	O
:	O
The	O
experience	O
with	O
high	O
-	O
flow	O
nasal	B-ANAT
cannula	O
(	O
HFNC	O
)	O
oxygen	O
therapy	O
in	O
severe	O
acute	O
respiratory	O
infection	O
(	O
SARI	O
)	O
is	O
limited	O
.	O

High	O
-	O
flow	O
nasal	B-ANAT
cannula	O
(	O
Optiflow	O
;	O
Fisher	O
&	O
Paykel	O
,	O
Auckland	O
,	O
New	O
Zealand	O
)	O
was	O
indicated	O
in	O
the	O
presence	O
of	O
acute	O
respiratory	O
failure	O
when	O
the	O
patient	O
was	O
unable	O
to	O
maintain	O
a	O
pulse	O
oxymetry	O
more	O
than	O
92	O
%	O
with	O
more	O
than	O
9	O
L	O
/	O
min	O
of	O
oxygen	O
using	O
a	O
standard	O
face	B-ANAT
mask	O
conventional	O
delivery	O
systems	O
.	O

CONCLUSIONS	O
:	O
High	O
-	O
flow	O
nasal	B-ANAT
cannula	O
O	O
(	O
2	O
)	O
therapy	O
appears	O
to	O
be	O
an	O
innovative	O
and	O
effective	O
modality	O
for	O
early	O
treatment	O
of	O
adults	O
with	O
SARI	O
.	O

Clinical	O
charts	O
,	O
macroscopic	O
autopsy	O
reports	O
,	O
and	O
stored	O
paraffinized	O
tissue	B-ANAT
blocks	O
were	O
retrieved	O
.	O

ABSTRACT	O
:	O
Ovarian	B-ANAT
hyperstimulation	O
syndrome	O
(	O
OHSS	O
)	O
is	O
an	O
iatrogenic	O
complication	O
that	O
occurs	O
in	O
the	O
luteal	O
phase	O
of	O
an	O
induced	O
hormonal	O
cycle	O
.	O

The	O
toxic	O
principles	O
in	O
the	O
leaf	O
include	O
arylnaphthalene	O
lignan	O
lactones	O
-	O
Diphyllin	O
and	O
its	O
glycoside	O
derivatives	O
Cleistanthin	O
A	O
and	O
B	O
.	O
Toxin	O
effect	O
in	O
animal	O
models	O
demonstrate	O
neuromuscular	O
blockade	O
with	O
muscle	B-ANAT
weakness	O
,	O
distal	O
renal	B-ANAT
tubular	O
acidosis	O
(	O
dRTA	O
)	O
and	O
type	O
2	O
respiratory	O
failure	O
with	O
conflicting	O
evidence	O
of	O
cardiac	B-ANAT
involvement	O
.	O

Cardiac	B-ANAT
rhythm	O
abnormalities	O
have	O
been	O
demonstrated	O
in	O
a	O
number	O
of	O
clinical	O
studies	O
,	O
though	O
the	O
role	O
of	O
temporary	O
cardiac	B-ANAT
pacemakers	O
in	O
reducing	O
mortality	O
is	O
uncertain	O
.	O

Our	O
previous	O
observation	O
revealed	O
a	O
partial	O
relief	O
of	O
lung	B-ANAT
fibrosis	O
in	O
patients	O
suffering	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

In	O
a	O
fibrotic	O
cell	B-ANAT
model	O
with	O
transforming	O
growth	O
factor	O
beta	O
-	O
1	O
induction	O
,	O
the	O
human	O
lung	B-ANAT
epithelial	O
A549	O
acquired	O
a	O
mesenchymal	O
phenotype	O
and	O
an	O
increase	O
of	O
vimentin	B-ANAT
expression	O
with	O
a	O
concomitant	O
decrease	O
of	O
E	O
-	O
cadherin	O
.	O

The	O
findings	O
provide	O
an	O
insight	O
into	O
the	O
preventive	O
and	O
therapeutic	O
potentials	O
of	O
Cordyceps	O
for	O
the	O
treatment	O
of	O
lung	B-ANAT
fibrosis	O
.	O

Pulmonary	B-ANAT
surfactant	O
has	O
been	O
successfully	O
used	O
in	O
treating	O
neonatal	O
respiratory	O
distress	O
syndrome	O
for	O
many	O
years	O
.	O

It	O
can	O
reduce	O
the	O
duration	O
of	O
mechanical	O
ventilation	O
and	O
cardiac	B-ANAT
care	O
unit	O
stay	O
and	O
improve	O
prognosis	O
.	O

CONCLUSIONS	O
:	O
In	O
this	O
study	O
,	O
a	O
satisfactory	O
curative	O
effect	O
was	O
observed	O
for	O
the	O
treatment	O
of	O
acute	O
lung	B-ANAT
injury	O
with	O
PS	O
intratracheal	O
instillation	O
after	O
heart	B-ANAT
surgery	O
under	O
cardiopulmonary	B-ANAT
bypass	O
in	O
infant	O
patients	O
.	O

TITLE	O
:	O
Flow	O
cytometric	O
detection	O
of	O
alpha	O
-	O
1	O
-	O
acid	O
glycoprotein	O
on	O
feline	O
circulating	O
leucocytes	B-ANAT
.	O

The	O
presence	O
of	O
AGP	O
on	O
circulating	O
leucocytes	B-ANAT
was	O
investigated	O
in	O
both	O
clinically	O
healthy	O
cats	O
and	O
cats	O
with	O
different	O
diseases	O
.	O

ABSTRACT	O
:	O
A	O
broad	O
spectrum	O
of	O
pathogens	O
is	O
causative	O
for	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
but	O
symptoms	O
are	O
mostly	O
similar	O
.	O

The	O
incidence	O
of	O
respiratory	O
viruses	O
was	O
compared	O
in	O
tracheal	O
secretion	B-ANAT
(	O
TS	O
)	O
samples	O
(	O
n	O
=	O
100	O
)	O
of	O
mechanically	O
ventilated	O
patients	O
in	O
winter	O
(	O
n	O
=	O
50	O
)	O
and	O
summer	O
(	O
n	O
=	O
50	O
).	O

ABSTRACT	O
:	O
Coronavirus	O
(	O
CoV	O
)	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
ion	O
channel	O
activity	O
was	O
determined	O
in	O
channels	O
formed	O
in	O
planar	O
lipid	B-ANAT
bilayers	I-ANAT
by	O
peptides	O
representing	O
either	O
the	O
transmembrane	B-ANAT
domain	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
)	O
E	O
protein	O
,	O
or	O
the	O
full	O
-	O
length	O
E	O
protein	O
.	O

The	O
ion	O
conductance	O
was	O
also	O
controlled	O
by	O
the	O
lipid	O
composition	O
of	O
the	O
membrane	B-ANAT
.	O

A	O
total	O
of	O
172	O
infants	O
(	O
84	O
males	O
and	O
88	O
females	O
)	O
had	O
retinal	B-ANAT
evaluation	O
by	O
indirect	O
ophthalmoscopy	O
from	O
the	O
fourth	O
postnatal	O
week	O
and	O
followed	O
up	O
periodically	O
.	O

CONCLUSIONS	O
:	O
The	O
prevalence	O
of	O
ROP	O
in	O
this	O
study	O
was	O
19	O
.	O
2	O
%;	O
low	O
gestational	O
age	O
,	O
sepsis	O
,	O
oxygen	O
therapy	O
,	O
and	O
frequent	O
blood	B-ANAT
transfusions	O
were	O
significant	O
risk	O
factors	O
for	O
ROP	O
.	O

There	O
were	O
no	O
differences	O
in	O
venous	B-ANAT
oxygen	O
saturation	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
between	O
the	O
groups	O
.	O

Current	O
insights	O
and	O
recommendations	O
by	O
the	O
Pediatric	O
Infectious	O
Diseases	O
Group	O
of	O
Switzerland	O
for	O
the	O
management	O
of	O
common	O
paediatric	O
diseases	O
,	O
such	O
as	O
acute	O
otitis	O
media	B-ANAT
,	O
pharyngitis	O
,	O
and	O
acute	O
viral	O
gastroenteritis	O
are	O
reviewed	O
.	O

Improved	O
survival	O
has	O
been	O
achieved	O
with	O
the	O
use	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

Future	O
progress	O
will	O
depend	O
on	O
developing	O
novel	O
therapeutics	O
that	O
can	O
facilitate	O
and	O
enhance	O
lung	B-ANAT
repair	O
.	O

Luciferase	O
activities	O
were	O
significantly	O
suppressed	O
in	O
cells	B-ANAT
expressing	O
nsp1	O
together	O
with	O
the	O
mRNA	O
carrying	O
a	O
luciferase	O
gene	O
,	O
while	O
nsp1	O
failed	O
to	O
suppress	O
luciferase	O
activities	O
of	O
the	O
mRNA	O
flanked	O
by	O
the	O
5	O
'	O
UTR	O
of	O
SCoV	O
.	O
An	O
RNA	O
-	O
protein	O
binding	O
assay	O
and	O
RNA	O
decay	O
assay	O
revealed	O
that	O
nsp1	O
bound	O
to	O
stem	B-ANAT
-	O
loop	O
1	O
(	O
SL1	O
)	O
in	O
the	O
5	O
'	O
UTR	O
of	O
SCoV	O
RNA	O
and	O
that	O
the	O
specific	O
interaction	O
with	O
nsp1	O
stabilized	O
the	O
mRNA	O
carrying	O
SL1	O
.	O

One	O
clinical	O
diagnostic	O
criterion	O
for	O
ARDS	O
is	O
the	O
P	O
(	O
a	O
)	O
O	O
(	O
2	O
):	O
F	O
(	O
i	O
)	O
O	O
(	O
2	O
)	O
ratio	O
,	O
which	O
is	O
an	O
index	O
of	O
alveolar	B-ANAT
gas	O
exchange	O
.	O

However	O
,	O
effects	O
of	O
H1N1	O
influenza	O
infection	O
on	O
P	O
(	O
a	O
)	O
O	O
(	O
2	O
):	O
F	O
(	O
i	O
)	O
O	O
(	O
2	O
)	O
ratios	O
and	O
related	O
pathophysiologic	O
readouts	O
of	O
lung	B-ANAT
function	O
have	O
not	O
been	O
reported	O
in	O
mice	O
.	O

Breast	B-ANAT
milk	I-ANAT
contains	O
several	O
unique	O
and	O
exclusive	O
elements	O
,	O
orchestrators	O
of	O
its	O
health	O
benefits	O
.	O

CONCLUSIONS	O
:	O
Despite	O
scientific	O
advances	O
,	O
breast	B-ANAT
milk	I-ANAT
continues	O
to	O
demonstrate	O
clear	O
advantages	O
for	O
human	O
health	O
in	O
the	O
short	O
and	O
long	O
term	O
.	O

An	O
indirect	O
ELISA	O
using	O
recombinant	O
N	O
protein	O
as	O
antigen	O
was	O
established	O
to	O
screen	O
antibody	O
-	O
producing	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
.	O

Plasma	B-ANAT
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
and	O
mini	O
-	O
BAL	O
protein	O
were	O
both	O
significantly	O
associated	O
with	O
increased	O
oxygenation	O
index	O
(	O
P	O
=	O
0	O
.	O
02	O
and	O
0	O
.	O
01	O
,	O
respectively	O
),	O
whereas	O
there	O
was	O
a	O
trend	O
toward	O
an	O
association	O
between	O
IL	O
-	O
6	O
and	O
oxygenation	O
index	O
(	O
P	O
=	O
0	O
.	O
057	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
and	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
represent	O
a	O
spectrum	O
of	O
lung	B-ANAT
disease	O
characterized	O
by	O
the	O
sudden	O
onset	O
of	O
inflammatory	O
pulmonary	B-ANAT
edema	O
secondary	O
to	O
myriad	O
local	O
or	O
systemic	O
insults	O
.	O

The	O
role	O
of	O
parasite	O
sequestration	O
in	O
the	O
pulmonary	B-ANAT
microvasculature	B-ANAT
is	O
unclear	O
,	O
because	O
sequestration	O
occurs	O
intensely	O
in	O
P	O
falciparum	O
,	O
less	O
so	O
in	O
P	O
knowlesi	O
,	O
and	O
has	O
not	O
been	O
shown	O
convincingly	O
in	O
P	O
vivax	O
.	O

ABSTRACT	O
:	O
Stool	B-ANAT
samples	O
from	O
two	O
healthy	O
infant	O
siblings	O
collected	O
at	O
about	O
weekly	O
intervals	O
during	O
their	O
first	O
year	O
of	O
life	O
were	O
analyzed	O
by	O
PCR	O
for	O
15	O
different	O
enteric	O
viral	O
genera	O
.	O

Repeated	O
administration	O
of	O
oral	B-ANAT
poliovirus	O
vaccine	O
resulted	O
in	O
progressively	O
shorter	O
periods	O
of	O
poliovirus	O
detection	O
.	O

Here	O
we	O
describe	O
the	O
crystal	B-ANAT
structures	O
of	O
the	O
receptor	O
-	O
binding	O
domains	O
(	O
RBDs	O
)	O
of	O
two	O
closely	O
related	O
CoV	O
strains	O
,	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
and	O
porcine	O
respiratory	O
CoV	O
(	O
PRCV	O
),	O
in	O
complex	O
with	O
their	O
receptor	O
,	O
porcine	O
APN	O
(	O
pAPN	O
),	O
or	O
with	O
a	O
neutralizing	O
antibody	O
.	O

Comparison	O
of	O
the	O
RBDs	O
of	O
TGEV	O
and	O
PRCV	O
to	O
those	O
of	O
other	O
related	O
CoVs	O
,	O
suggests	O
that	O
the	O
conformation	O
of	O
the	O
S	O
receptor	O
-	O
binding	O
region	O
determines	O
cell	B-ANAT
entry	O
receptor	O
specificity	O
.	O

Analysis	O
of	O
immune	O
-	O
related	O
gene	O
expression	O
profiles	O
showed	O
that	O
at	O
24	O
h	O
after	O
SARS	O
-	O
CoV	O
infection	O
:	O
(	O
1	O
)	O
IFN	O
-	O
Î±	O
/	O
Î²	O
-	O
inducible	O
and	O
cathepsin	O
/	O
proteasome	O
genes	O
were	O
downregulated	O
;	O
(	O
2	O
)	O
hypoxia	O
/	O
hyperoxia	O
-	O
related	O
genes	O
were	O
upregulated	O
;	O
and	O
(	O
3	O
)	O
TLR	O
/	O
TLR	O
-	O
signaling	O
,	O
cytokine	O
/	O
cytokine	O
receptor	O
-	O
related	O
,	O
chemokine	O
/	O
chemokine	O
receptor	O
-	O
related	O
,	O
lysosome	B-ANAT
-	O
related	O
,	O
MHC	B-ANAT
/	O
chaperon	O
-	O
related	O
,	O
and	O
fibrosis	O
-	O
related	O
genes	O
were	O
differentially	O
regulated	O
.	O

Combination	O
therapy	O
of	O
laninamivir	O
octanoate	O
with	O
artificial	O
surfactant	O
reduces	O
lethality	O
in	O
mice	O
infected	O
with	O
influenza	O
virus	O
,	O
and	O
eventually	O
suppresses	O
DAD	O
formation	O
and	O
preserves	O
lung	B-ANAT
function	O
.	O

The	O
correlation	O
between	O
IL	O
-	O
17	O
level	O
and	O
liver	B-ANAT
injury	O
was	O
studied	O
.	O

The	O
analysis	O
reveals	O
that	O
p7	O
and	O
2B	O
TMDs	O
align	O
with	O
the	O
pore	B-ANAT
-	O
facing	O
TMD	O
of	O
MscL	O
,	O
and	O
3a	O
-	O
TMDs	O
align	O
with	O
those	O
of	O
ligand	O
-	O
gated	O
ion	O
channels	O
.	O

ABSTRACT	O
:	O
Clara	B-ANAT
cell	I-ANAT
protein	O
16	O
(	O
CC16	O
)	O
has	O
recently	O
gained	O
acceptance	O
as	O
a	O
blood	B-ANAT
biomarker	O
for	O
detecting	O
direct	O
and	O
indirect	O
lung	B-ANAT
injury	O
.	O

Our	O
results	O
confirm	O
the	O
previously	O
described	O
association	O
between	O
initial	O
elevation	O
in	O
CC16	O
serum	B-ANAT
levels	O
and	O
severe	O
thoracic	B-ANAT
injury	O
in	O
patients	O
with	O
multiple	O
injuries	O
.	O

ABSTRACT	O
:	O
This	O
is	O
a	O
study	O
on	O
the	O
Avian	O
coronavirus	O
IBV	O
and	O
chicken	O
host	O
-	O
relationship	O
from	O
the	O
codon	O
usage	O
point	O
of	O
view	O
based	O
on	O
fifty	O
-	O
nine	O
non	O
-	O
redundant	O
IBV	O
S1	O
sequences	O
(	O
nt	O
1	O
-	O
507	O
)	O
from	O
strains	O
detected	O
worldwide	O
and	O
chicken	O
tissue	B-ANAT
-	O
specific	O
protein	O
genes	O
sequences	O
from	O
IBV	O
-	O
replicating	O
sites	O
.	O

Although	O
of	O
pivotal	O
importance	O
for	O
many	O
patients	O
suffering	O
from	O
respiratory	O
insufficiency	O
MV	O
itself	O
may	O
further	O
induce	O
pathophysiological	O
processes	O
due	O
to	O
the	O
mechanical	O
stress	O
exerted	O
on	O
the	O
lungs	B-ANAT
.	O

TITLE	O
:	O
Prevalence	O
of	O
acute	O
respiratory	O
symptoms	O
in	O
breath	B-ANAT
-	O
hold	O
divers	O
.	O

Variables	O
measured	O
in	O
effusion	B-ANAT
fluid	O
and	O
peripheral	B-ANAT
blood	I-ANAT
were	O
compared	O
between	O
cats	O
that	O
had	O
positive	O
or	O
negative	O
Rivalta	O
tests	O
using	O
the	O
Mann	O
-	O
Whitney	O
U	O
-	O
test	O
and	O
multivariate	O
analysis	O
.	O

TITLE	O
:	O
What	O
is	O
the	O
niche	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
?	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhea	O
(	O
scours	O
)	O
is	O
a	O
primary	O
cause	O
of	O
illness	O
and	O
death	O
in	O
young	O
calves	O
.	O

We	O
found	O
that	O
SARS	O
-	O
CoV	O
spike	O
glycoprotein	O
(	O
S	O
protein	O
),	O
a	O
key	O
molecule	O
for	O
viral	O
entry	O
,	O
binds	O
to	O
calnexin	O
,	O
a	O
molecular	O
chaperone	O
in	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
),	O
but	O
not	O
to	O
calreticulin	O
,	O
a	O
homolog	O
of	O
calnexin	O
.	O

In	O
S	O
-	O
pseudovirus	O
,	O
the	O
incorporation	O
of	O
S	O
protein	O
into	O
viral	B-ANAT
particles	I-ANAT
was	O
obviously	O
inhibited	O
.	O

Those	O
proteins	O
assemble	O
to	O
the	O
vesicles	B-ANAT
located	O
from	O
ER	O
to	O
Golgi	B-ANAT
(	O
ER	O
Golgi	B-ANAT
intermediate	O
compartment	B-ANAT
)	O
and	O
virions	B-ANAT
bud	B-ANAT
into	O
the	O
vesicles	B-ANAT
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
often	O
the	O
last	O
resort	O
for	O
serious	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
when	O
all	O
non	O
-	O
invasive	O
treatment	O
options	O
have	O
failed	O
to	O
improve	O
the	O
patient	O
'	O
s	O
pulmonary	B-ANAT
condition	O
.	O

Western	O
-	O
Bolt	O
results	O
show	O
that	O
all	O
the	O
six	O
fragments	O
have	O
reacted	O
with	O
the	O
SARS	O
patient	O
convalescent	O
sera	B-ANAT
,	O
but	O
the	O
PN360	O
and	O
PN301	O
showed	O
obvious	O
cross	O
-	O
reaction	O
with	O
sera	B-ANAT
from	O
SARS	O
-	O
CoV	O
-	O
negative	O
normal	O
adults	O
;	O
sensitivity	O
analysis	O
using	O
an	O
ELISA	O
coating	O
with	O
PN199	O
,	O
PN185	O
,	O
PN155b	O
,	O
PN125	O
as	O
antigen	O
showed	O
that	O
the	O
PN185	O
and	O
PN155b	O
are	O
better	O
than	O
PN125	O
.	O

Lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
in	O
rat	O
models	O
is	O
considered	O
similar	O
to	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
humans	O
.	O

Myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
in	O
lung	B-ANAT
tissue	I-ANAT
was	O
reduced	O
in	O
the	O
MCR	O
-	O
LPS	O
and	O
LPS	O
-	O
MCR	O
groups	O
at	O
16h	O
after	O
LPS	O
administration	O
.	O

We	O
enrolled	O
1006	O
children	O
less	O
than	O
5	O
years	O
of	O
age	O
of	O
whom	O
423	O
(	O
42	O
%),	O
428	O
(	O
42	O
%)	O
and	O
155	O
(	O
16	O
%)	O
had	O
pneumonia	O
,	O
bronchiolitis	O
and	O
unclassified	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
,	O
respectively	O
.	O

Observation	O
of	O
the	O
cytopathic	O
effect	O
and	O
apoptosis	O
,	O
as	O
well	O
as	O
a	O
cell	B-ANAT
proliferation	O
assay	O
demonstrated	O
that	O
the	O
three	O
shRNAs	O
were	O
capable	O
of	O
protecting	O
ST	O
cells	B-ANAT
against	O
TGEV	O
destruction	O
,	O
with	O
high	O
specificity	O
and	O
efficiency	O
.	O

Observation	O
of	O
the	O
cytopathic	O
effect	O
and	O
apoptosis	O
,	O
as	O
well	O
as	O
a	O
cell	B-ANAT
proliferation	O
assay	O
demonstrated	O
that	O
the	O
three	O
shRNAs	O
were	O
capable	O
of	O
protecting	O
ST	O
cells	B-ANAT
against	O
TGEV	O
destruction	O
,	O
with	O
high	O
specificity	O
and	O
efficiency	O
.	O

TITLE	O
:	O
[	O
Comprehensive	O
analysis	O
on	O
variation	O
of	O
cardiac	B-ANAT
enzyme	O
and	O
troponin	O
induced	O
by	O
acute	O
organophosphorous	O
poisoning	O
].	O

RESULTS	O
:	O
The	O
levels	O
of	O
creatine	O
kinase	O
(	O
CK	O
),	O
creatine	O
kinase	O
-	O
MB	O
(	O
CK	O
-	O
MB	O
)	O
and	O
cardiac	B-ANAT
troponin	O
I	O
(	O
cTnI	O
)	O
in	O
milder	O
,	O
moderate	O
and	O
severe	O
poisoning	O
groups	O
were	O
significantly	O
elevated	O
compared	O
by	O
the	O
healthy	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Although	O
infected	O
bats	O
appeared	O
to	O
be	O
healthy	O
,	O
Pomona	O
leaf	O
-	O
nosed	O
bats	O
carrying	O
Hi	O
-	O
BatCoV	O
HKU10	O
had	O
lower	B-ANAT
body	I-ANAT
weights	O
than	O
uninfected	O
bats	O
.	O

TITLE	O
:	O
Combined	O
action	O
of	O
type	O
I	O
and	O
type	O
III	O
interferon	O
restricts	O
initial	O
replication	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
in	O
the	O
lung	B-ANAT
but	O
fails	O
to	O
inhibit	O
systemic	O
virus	O
spread	O
.	O

TITLE	O
:	O
WFDC1	O
/	O
ps20	O
:	O
a	O
host	O
factor	O
that	O
influences	O
the	O
neutrophil	B-ANAT
response	O
to	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
1	O
infection	O
.	O

Development	O
of	O
rapid	O
and	O
broadly	O
applicable	O
methods	O
for	O
complete	O
viral	B-ANAT
genome	I-ANAT
sequencing	O
is	O
highly	O
desirable	O
to	O
fully	O
understand	O
all	O
aspects	O
of	O
these	O
infectious	O
agents	O
as	O
well	O
as	O
for	O
surveillance	O
of	O
viral	O
pandemic	O
threats	O
and	O
emerging	O
pathogens	O
.	O

The	O
most	O
common	O
DAI	O
type	O
was	O
catheter	O
-	O
associated	O
urinary	B-ANAT
tract	I-ANAT
infection	O
(	O
3	O
.	O
76	O
per	O
1000	O
urinary	O
catheter	O
-	O
days	O
).	O

ABSTRACT	O
:	O
We	O
were	O
able	O
to	O
treat	O
a	O
patient	O
with	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
who	O
also	O
suffered	O
from	O
sleep	O
-	O
disordered	O
breathing	O
by	O
using	O
the	O
average	O
volume	O
-	O
assured	O
pressure	O
support	O
mode	O
of	O
a	O
Respironics	O
V60	O
Ventilator	O
(	O
Philips	O
Respironics	O
:	O
United	O
States	O
).	O

He	O
was	O
diagnosed	O
with	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
and	O
full	O
-	O
time	O
biphasic	O
positive	O
airway	B-ANAT
pressure	O
support	O
ventilation	O
was	O
initiated	O
.	O

ABSTRACT	O
:	O
To	O
retrospectively	O
analyze	O
the	O
effect	O
of	O
restrictive	O
fluid	O
management	O
strategy	O
(	O
RFMS	O
)	O
on	O
the	O
early	O
pulmonary	B-ANAT
function	O
and	O
the	O
prognosis	O
of	O
patients	O
with	O
extremely	O
severe	O
and	O
extensive	O
burn	O
.	O

Occurrence	O
of	O
ARDS	O
,	O
occurrence	O
of	O
other	O
organ	B-ANAT
complications	O
,	O
and	O
mortality	O
were	O
fewer	O
in	O
treatment	O
group	O
than	O
in	O
control	O
group	O
within	O
PBW	O
2	O
,	O
though	O
the	O
differences	O
were	O
not	O
statistically	O
significant	O
(	O
P	O
values	O
all	O
above	O
0	O
.	O
05	O
).	O

We	O
reported	O
that	O
administration	O
of	O
PGRN	O
maintained	O
the	O
body	B-ANAT
weight	O
and	O
survival	O
of	O
ALI	O
mice	O
.	O

ABSTRACT	O
:	O
A	O
multiplex	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
mRT	B-ANAT
-	O
PCR	O
)	O
assay	O
was	O
developed	O
for	O
the	O
simultaneous	O
detection	O
of	O
canine	O
distemper	O
virus	O
(	O
CDV	O
),	O
canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
)	O
and	O
canine	O
influenza	O
virus	O
(	O
CIV	O
).	O

The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
mRT	B-ANAT
-	O
PCR	O
were	O
determined	O
by	O
comparing	O
it	O
to	O
a	O
rapid	O
antigen	O
test	O
(	O
RAT	O
)	O
or	O
immuno	O
-	O
chromatography	O
test	O
kit	O
and	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
in	O
the	O
detection	O
of	O
CDV	O
,	O
CRCoV	O
and	O
CIV	O
antigens	O
present	O
in	O
100	O
clinical	O
samples	O
(	O
nasal	B-ANAT
swabs	O
and	O
whole	O
blood	B-ANAT
samples	I-ANAT
)	O
from	O
50	O
dogs	O
with	O
respiratory	O
disease	O
symptoms	O
.	O

Blood	B-ANAT
gases	O
,	O
breathing	O
rate	O
,	O
lung	B-ANAT
index	O
,	O
total	O
protein	O
,	O
and	O
proinflammatory	O
cytokines	O
(	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
,	O
interleukin	O
1Î²	O
,	O
interleukin	O
6	O
)	O
in	O
the	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
),	O
and	O
lung	B-ANAT
histology	O
were	O
examined	O
.	O

In	O
the	O
O2	O
-	O
PS	O
-	O
Dex	O
group	O
,	O
lung	B-ANAT
edema	O
,	O
total	O
protein	O
,	O
and	O
inflammatory	O
cytokines	O
in	O
BALF	O
were	O
significantly	O
reduced	O
in	O
comparison	O
with	O
the	O
O2	O
-	O
PS	O
group	O
.	O

As	O
a	O
consequence	O
,	O
the	O
thymus	B-ANAT
begins	O
an	O
involution	O
process	O
,	O
producing	O
a	O
severe	O
impairment	O
in	O
cellular	B-ANAT
and	O
humoral	O
immunity	O
.	O

Nasal	B-ANAT
swabs	O
from	O
children	O
with	O
acute	O
respiratory	O
illnesses	O
were	O
collected	O
between	O
March	O
2006	O
and	O
October	O
2007	O
.	O

ABSTRACT	O
:	O
The	O
prevalence	O
of	O
various	O
viral	O
infections	O
was	O
examined	O
in	O
primary	O
accession	O
cases	O
of	O
feline	O
lower	B-ANAT
urinary	I-ANAT
tract	I-ANAT
disease	O
(	O
FLUTD	O
)	O
and	O
healthy	O
control	O
cats	O
in	O
Norway	O
.	O

Urine	B-ANAT
samples	O
from	O
102	O
cats	O
with	O
clinical	O
signs	O
of	O
FLUTD	O
and	O
73	O
healthy	O
control	O
cats	O
were	O
tested	O
for	O
the	O
presence	O
of	O
feline	O
calicivirus	O
(	O
FCV	O
),	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
and	O
feline	O
herpesvirus	O
-	O
1	O
(	O
FHV	O
-	O
1	O
)	O
by	O
polymerase	O
chain	O
reaction	O
.	O

Phylogenetic	O
analysis	O
showed	O
that	O
the	O
2	O
HBoV	O
strains	O
were	O
HBoV1	O
,	O
and	O
were	O
most	O
genetically	O
close	O
to	O
ST2	B-ANAT
(	O
GenBank	O
accession	O
number	O
DQ0000496	O
).	O

The	O
intensive	O
care	O
physician	O
must	O
understand	O
the	O
respiratory	O
,	O
cardiovascular	B-ANAT
,	O
metabolic	O
,	O
and	O
immunologic	O
consequences	O
of	O
trauma	O
resuscitation	O
and	O
massive	O
transfusion	O
in	O
order	O
to	O
evaluate	O
and	O
adjust	O
the	O
ongoing	O
resuscitative	O
needs	O
of	O
the	O
patient	O
and	O
address	O
potential	O
complications	O
.	O

immunization	O
with	O
rADV	O
encoding	O
spike	O
protein	O
(	O
S	O
)	O
(	O
rADV	O
-	O
S	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
induces	O
protective	O
immunity	O
against	O
SARS	O
-	O
CoV	O
and	O
could	O
serve	O
as	O
a	O
safe	O
mucosal	B-ANAT
route	O
for	O
delivery	O
of	O
rADV	O
.	O

In	O
other	O
cell	B-ANAT
lines	I-ANAT
,	O
the	O
virus	O
cannot	O
be	O
propagated	O
beyond	O
passage	O
5	O
.	O

The	O
full	O
-	O
length	O
genomic	O
cDNA	O
was	O
transcribed	O
and	O
its	O
transcript	O
was	O
transfected	O
by	O
electroporation	O
into	O
BHK	O
-	O
21	O
together	O
with	O
the	O
transcript	O
of	O
nucleocapsid	B-ANAT
gene	O
.	O

At	O
48	O
h	O
post	O
transfection	O
,	O
the	O
medium	O
to	O
culture	O
the	O
transfected	O
BHK	O
-	O
21	O
cells	B-ANAT
was	O
harvested	O
and	O
inoculated	O
into	O
10	O
-	O
days	O
old	O
SPF	O
embryonated	O
chicken	O
eggs	O
(	O
ECE	O
)	O
to	O
replicate	O
the	O
rescued	O
virus	O
.	O

Coronavirus	O
NL63	O
infection	O
exists	O
in	O
hospitalized	O
children	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
Changsha	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
the	O
diagnostic	O
value	O
of	O
urine	B-ANAT
soluble	O
CD163	O
(	O
sCD163	O
)	O
for	O
identification	O
of	O
sepsis	O
,	O
severity	O
of	O
sepsis	O
,	O
and	O
for	O
secondary	O
AKI	O
,	O
and	O
to	O
assess	O
the	O
patients	O
'	O
prognosis	O
.	O

Results	O
for	O
urine	B-ANAT
sCD163	O
were	O
recorded	O
on	O
the	O
day	O
of	O
admission	O
to	O
the	O
ICU	O
,	O
and	O
AKI	O
occurrence	O
was	O
noted	O
.	O

For	O
15	O
patients	O
with	O
AKI	O
,	O
urine	B-ANAT
sCD163	O
levels	O
at	O
AKI	O
diagnosis	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
the	O
remaining	O
35	O
sepsis	O
patients	O
upon	O
ICU	O
admission	O
(	O
121	O
.	O
0	O
;	O
74	O
.	O
6	O
-	O
299	O
.	O
1	O
ng	O
/	O
ml	O
vs	O
.	O
61	O
.	O
8	O
;	O
42	O
.	O
8	O
-	O
128	O
.	O
3	O
ng	O
/	O
ml	O
,	O
P	O
=	O
0	O
.	O
049	O
).	O

The	O
result	O
of	O
WB	O
analysis	O
showed	O
that	O
the	O
4D4	O
-	O
defined	O
epitope	O
could	O
be	O
recognized	O
by	O
PEDV	O
-	O
positive	O
serum	B-ANAT
,	O
but	O
not	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)-	O
positive	O
serum	B-ANAT
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
obtained	O
from	O
each	O
case	O
and	O
sent	O
for	O
viral	O
detection	O
by	O
tissue	B-ANAT
culture	O
,	O
antigen	O
test	O
,	O
and	O
polymerase	O
chain	O
reaction	O
.	O

These	O
results	O
indicate	O
that	O
it	O
is	O
feasible	O
to	O
use	O
L	O
.	O
lactis	O
as	O
an	O
antigen	O
delivery	O
vehicle	O
in	O
developing	O
oral	B-ANAT
vaccines	O
against	O
IBV	O
infection	O
.	O

In	O
such	O
potentially	O
dangerous	O
situations	O
,	O
we	O
advocate	O
a	O
method	O
of	O
clamping	O
and	O
severing	O
the	O
pulmonary	B-ANAT
lobar	O
root	B-ANAT
structure	O
en	O
masse	O
.	O

ABSTRACT	O
:	O
Cytokines	O
are	O
a	O
group	O
of	O
diverse	O
molecules	O
that	O
influence	O
the	O
function	O
of	O
every	O
organ	B-ANAT
system	I-ANAT
.	O

They	O
are	O
most	O
well	O
studied	O
in	O
their	O
effects	O
on	O
the	O
immune	B-ANAT
system	I-ANAT
and	O
their	O
integral	O
role	O
in	O
mediating	O
inflammation	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
frequency	O
rate	O
of	O
C	O
.	O
pneumoniae	O
,	O
rhinovirus	O
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
influenza	O
virus	O
,	O
metapneumovirus	O
,	O
adenovirus	O
',	O
parainfluenza	O
virus	O
and	O
coronavirus	O
in	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
children	O
.	O

Real	O
time	O
PCR	O
,	O
DFA	O
and	O
cell	B-ANAT
culture	O
method	O
were	O
used	O
for	O
detection	O
of	O
C	O
.	O
pneumoniae	O
,	O
RSV	O
antigen	O
and	O
influenza	O
virus	O
respectively	O
.	O

Plasma	B-ANAT
levels	O
of	O
Î±B	O
-	O
crystallin	O
were	O
studied	O
in	O
163	O
patients	O
:	O
52	O
healthy	O
non	O
-	O
COPD	O
smokers	O
;	O
20	O
COPD	O
smokers	O
in	O
Global	O
Initiative	O
for	O
Chronic	O
Obstructive	O
Lung	B-ANAT
Disease	O
(	O
GOLD	O
)	O
stages	O
I	O
-	O
II	O
;	O
43	O
COPD	O
smokers	O
in	O
GOLD	O
stages	O
III	O
-	O
IV	O
.	O

In	O
COPD	O
smokers	O
it	O
was	O
0	O
.	O
352	O
nm	O
and	O
,	O
in	O
patients	O
with	O
inflammatory	O
lung	B-ANAT
diseases	O
,	O
0	O
.	O
433	O
nm	O
.	O

CONCLUSIONS	O
:	O
Î±B	O
-	O
crystallin	O
is	O
increased	O
in	O
patients	O
with	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

TITLE	O
:	O
Extracorporeal	O
lung	B-ANAT
support	O
technologies	O
-	O
bridge	O
to	O
recovery	O
and	O
bridge	O
to	O
lung	B-ANAT
transplantation	O
in	O
adult	O
patients	O
:	O
an	O
evidence	O
-	O
based	O
analysis	O
.	O

As	O
a	O
bridge	O
to	O
LTx	O
-	O
for	O
patients	O
with	O
irreversible	O
end	O
stage	O
lung	B-ANAT
disease	O
requiring	O
LTx	O
.	O

The	O
ex	O
-	O
vivo	O
evaluation	O
and	O
reconditioning	O
of	O
donor	O
lungs	B-ANAT
is	O
currently	O
performed	O
at	O
the	O
Toronto	O
General	O
Hospital	O
(	O
TGH	O
)	O
and	O
preliminary	O
results	O
have	O
been	O
encouraging	O
(	O
Personal	O
communication	O
,	O
clinical	O
expert	O
,	O
December	O
17	O
,	O
2009	O
).	O

The	O
system	O
is	O
also	O
designed	O
to	O
operate	O
without	O
the	O
help	O
of	O
an	O
external	O
pump	O
,	O
though	O
one	O
can	O
be	O
added	O
if	O
higher	O
blood	B-ANAT
flow	O
is	O
required	O
.	O

Recently	O
,	O
the	O
first	O
commercially	O
available	O
extracorporeal	O
membrane	B-ANAT
ventilator	O
(	O
NovaLung	O
GmbH	O
,	O
Hechingen	O
,	O
Germany	O
)	O
was	O
approved	O
for	O
clinical	O
use	O
by	O
Health	O
Canada	O
for	O
patients	O
in	O
respiratory	O
failure	O
.	O

The	O
research	O
questions	O
addressed	O
in	O
this	O
report	O
are	O
:	O
Does	O
ILA	O
/	O
ECMO	O
facilitate	O
gas	O
exchange	O
in	O
the	O
lungs	B-ANAT
of	O
patients	O
with	O
severe	O
respiratory	O
failure	O
?	O
Does	O
ILA	O
/	O
ECMO	O
improve	O
the	O
survival	O
rate	O
of	O
patients	O
with	O
respiratory	O
failure	O
caused	O
by	O
a	O
range	O
of	O
underlying	O
conditions	O
including	O
patients	O
awaiting	O
LTx	O
?	O
What	O
are	O
the	O
possible	O
serious	O
adverse	O
events	O
associated	O
with	O
ILA	O
/	O
ECMO	O
therapy	O
?	O
To	O
address	O
these	O
questions	O
,	O
a	O
systematic	O
literature	O
search	O
was	O
performed	O
on	O
September	O
28	O
,	O
2009	O
using	O
OVID	O
MEDLINE	O
,	O
MEDLINE	O
In	O
-	O
Process	O
and	O
Other	O
Non	O
-	O
Indexed	O
Citations	O
,	O
EMBASE	O
,	O
the	O
Cumulative	O
Index	O
to	O
Nursing	O
&	O
Allied	O
Health	O
Literature	O
(	O
CINAHL	O
),	O
the	O
Cochrane	O
Library	O
,	O
and	O
the	O
International	O
Agency	O
for	O
Health	O
Technology	O
Assessment	O
(	O
INAHTA	O
)	O
for	O
studies	O
published	O
from	O
January	O
1	O
,	O
2005	O
to	O
September	O
28	O
,	O
2008	O
.	O

Liver	B-ANAT
dysfunction	O
was	O
present	O
in	O
cases	O
with	O
increased	O
morbidity	O
as	O
a	O
late	O
finding	O
and	O
was	O
the	O
least	O
frequent	O
organ	B-ANAT
injury	O
.	O

Patients	O
with	O
septic	O
shock	O
had	O
significantly	O
higher	O
rates	O
of	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
)	O
(	O
p	O
=	O
0	O
.	O
01	O
),	O
altered	O
mental	O
status	O
(	O
p	O
â¤	O
0	O
.	O
001	O
),	O
total	O
bilirubin	O
>	O
4	O
mg	O
/	O
dl	O
(	O
p	O
=	O
0	O
.	O
04	O
),	O
failure	O
in	O
â¥	O
3	O
organ	B-ANAT
systems	I-ANAT
(	O
70	O
%	O
vs	O
.	O
15	O
%,	O
p	O
=	O
0	O
.	O
005	O
),	O
and	O
maternal	O
death	O
(	O
30	O
%	O
vs	O
.	O
0	O
%,	O
p	O
=	O
0	O
.	O
03	O
).	O

Age	O
,	O
GCS	O
score	O
,	O
pupil	B-ANAT
dilation	O
,	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
),	O
ICP	O
>	O
25	O
mmHg	O
,	O
hyperglycaemia	O
and	O
pneumonia	O
predicted	O
a	O
worse	O
outcome	O
.	O

Clinical	O
diagnosis	O
relies	O
on	O
the	O
following	O
4	O
criteria	O
stated	O
by	O
the	O
American	O
-	O
European	O
Consensus	O
Conference	O
:	O
acute	O
onset	O
of	O
impaired	O
gas	O
exchange	O
,	O
severe	O
hypoxemia	O
defined	O
as	O
a	O
PaO2	O
to	O
FiO2	O
ratio	O
<	O
300	O
(	O
PaO2	O
in	O
mmHg	O
),	O
bilateral	O
diffuse	O
infiltration	O
on	O
chest	B-ANAT
X	O
-	O
ray	O
;	O
pulmonary	B-ANAT
artery	I-ANAT
wedge	O
pressure	O
of	O
â¤	O
18	O
mmHg	O
to	O
rule	O
out	O
cardiogenic	O
causes	O
of	O
pulmonary	B-ANAT
edema	O
.	O

A	O
potentially	O
new	O
vaccine	O
strategy	O
could	O
involve	O
searches	O
for	O
viral	O
strains	O
that	O
are	O
characterized	O
by	O
the	O
evolutionary	O
misfit	O
between	O
the	O
peculiarities	O
of	O
the	O
disorder	O
distribution	O
in	O
their	O
shells	B-ANAT
and	O
their	O
behavior	O
.	O

An	O
nsp4	O
mutant	O
(	O
N258T	O
)	O
of	O
murine	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
has	O
been	O
reported	O
to	O
be	O
temperature	O
-	O
sensitive	O
(	O
ts	O
)	O
and	O
to	O
alter	O
membrane	B-ANAT
targeting	O
.	O

However	O
,	O
in	O
the	O
last	O
ten	O
years	O
thanks	O
to	O
progress	O
in	O
molecular	O
technologies	O
,	O
newly	O
discovered	O
viruses	O
have	O
been	O
identified	O
including	O
human	O
Metapneumovirus	O
(	O
hMPV	O
),	O
coronaviruses	O
NL63	O
(	O
HcoV	O
-	O
NL63	O
)	O
and	O
HKU1	O
(	O
HcoV	O
-	O
HKU1	O
),	O
human	O
Bocavirus	O
(	O
HBoV	O
),	O
new	O
enterovirus	O
(	O
HEV	B-ANAT
),	O
parechovirus	O
(	O
HpeV	O
)	O
and	O
rhinovirus	O
(	O
HRV	O
)	O
strains	O
,	O
polyomaviruses	O
WU	O
(	O
WUPyV	O
)	O
and	O
KI	O
(	O
KIPyV	O
)	O
and	O
the	O
pandemic	O
H1N1v	O
influenza	O
A	O
virus	O
.	O

ABSTRACT	O
:	O
This	O
article	O
describes	O
the	O
clinical	O
presentation	O
of	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
lung	B-ANAT
abscess	O
,	O
and	O
empyema	O
:	O
life	O
-	O
threatening	O
infections	O
of	O
the	O
pulmonary	B-ANAT
system	I-ANAT
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
heptide	O
repeat	O
(	O
HR	O
)	O
region	O
in	O
the	O
spike	O
protein	O
induces	O
neutralizing	O
antibodies	O
that	O
block	O
the	O
postfusion	O
core	O
formation	O
and	O
inhibit	O
virus	O
entry	O
into	O
target	B-ANAT
cells	I-ANAT
.	O

Both	O
pathogens	O
have	O
a	O
major	O
impact	O
on	O
the	O
lung	B-ANAT
as	O
the	O
prime	O
target	O
organ	B-ANAT
for	O
aerogenic	O
Mycobacterium	O
tuberculosis	O
and	O
the	O
site	O
for	O
one	O
of	O
the	O
main	O
complications	O
in	O
severe	O
malaria	O
,	O
malaria	O
-	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
MA	O
-	O
ARDS	O
).	O

In	O
addition	O
to	O
respiratory	O
complications	O
,	O
several	O
complications	O
due	O
to	O
direct	O
and	O
indirect	O
effects	O
on	O
other	O
body	B-ANAT
systems	I-ANAT
were	O
associated	O
with	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	O
infection	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
clinical	O
,	O
hematological	O
and	O
fecal	B-ANAT
PCR	O
results	O
from	O
161	O
horses	O
involved	O
in	O
outbreaks	O
associated	O
with	O
ECoV	O
.	O
The	O
outbreaks	O
happened	O
at	O
four	O
separate	O
boarding	O
facilities	O
between	O
November	O
2011	O
and	O
April	O
2012	O
in	O
the	O
States	O
of	O
CA	O
,	O
TX	O
,	O
WI	O
and	O
MA	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
of	O
the	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
may	O
play	O
an	O
essential	O
role	O
in	O
the	O
replication	O
and	O
translation	O
of	O
viral	O
RNA	O
.	O

The	O
N	O
protein	O
can	O
also	O
induce	O
high	O
titers	O
of	O
cross	O
-	O
reactive	O
antibodies	O
and	O
cell	B-ANAT
-	O
mediated	O
immunity	O
,	O
which	O
protects	O
chickens	O
from	O
acute	O
infection	O
.	O

In	O
this	O
study	O
,	O
we	O
generated	O
two	O
monoclonal	O
antibodies	O
(	O
mAbs	O
),	O
designated	O
as	O
6D10	O
and	O
4F10	O
,	O
which	O
were	O
directed	O
against	O
the	O
N	O
protein	O
of	O
IBV	O
using	O
the	O
whole	O
viral	B-ANAT
particles	I-ANAT
as	O
immunogens	O
.	O

TITLE	O
:	O
Abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
caused	O
by	O
tension	O
pneumoperitoneum	O
in	O
a	O
scuba	O
diver	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
complications	O
in	O
patients	O
with	O
severe	O
brain	B-ANAT
injury	O
.	O

Direct	O
brain	B-ANAT
injury	O
,	O
depressed	O
level	O
of	O
consciousness	O
and	O
inability	O
to	O
protect	O
the	O
airway	B-ANAT
,	O
disruption	O
of	O
natural	O
defense	O
barriers	O
,	O
decreased	O
mobility	O
,	O
and	O
secondary	O
neurological	O
insults	O
inherent	O
to	O
severe	O
brain	B-ANAT
injury	O
are	O
the	O
main	O
cause	O
of	O
pulmonary	B-ANAT
complications	O
in	O
critically	O
ill	O
neurological	O
patients	O
.	O

Whether	O
central	O
venous	B-ANAT
lines	O
and	O
nonadherence	O
to	O
cardiac	B-ANAT
care	O
guidelines	O
influence	O
the	O
mortality	O
of	O
patients	O
with	O
IAT	O
should	O
be	O
investigated	O
in	O
further	O
studies	O
.	O

In	O
the	O
subgroup	O
of	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
(	O
AMI	O
),	O
those	O
with	O
IAT	O
(	O
n	O
=	O
41	O
)	O
were	O
treated	O
less	O
frequently	O
according	O
to	O
the	O
current	O
cardiac	B-ANAT
guidelines	O
than	O
those	O
without	O
(	O
n	O
=	O
124	O
)	O

The	O
incidence	O
of	O
nausea	O
and	O
vomit	B-ANAT
was	O
8	O
.	O
3	O
%;	O
patient	O
'	O
s	O
satisfaction	O
was	O
9	O
.	O
1	O
on	O
a	O
10	O
-	O
point	O
scale	O
system	O
.	O

Infection	O
,	O
nerve	B-ANAT
injury	O
and	O
respiratory	O
depression	O
were	O
absent	O
during	O
the	O
catheter	O
indwelling	O
.	O

Taken	O
together	O
,	O
LTB	O
-	O
COE	O
is	O
more	O
suitable	O
for	O
Lactobacillus	O
expressing	O
system	O
to	O
engineer	O
mucosal	B-ANAT
vaccine	O
against	O
PEDV	O
infection	O
.	O

Further	O
microbiological	O
work	O
-	O
up	O
of	O
the	O
biopsy	B-ANAT
specimen	I-ANAT
subsequently	O
revealed	O
O	O
gallopavum	O
as	O
the	O
causative	O
organism	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
effect	O
of	O
Chaiqinchengqi	O
decoction	O
(	O
CQCQD	O
)	O
on	O
serum	B-ANAT
amyloid	O
A	O
(	O
SAA	O
)	O
in	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
patients	O
.	O

Infectious	O
bronchitis	O
is	O
an	O
acute	O
and	O
highly	O
contagious	O
disease	O
of	O
economic	O
importance	O
due	O
to	O
the	O
reduction	O
in	O
weight	O
gain	O
observed	O
with	O
infected	O
broilers	O
and	O
the	O
drop	O
in	O
egg	B-ANAT
quality	O
and	O
production	O
associated	O
with	O
infected	O
laying	O
hens	O
.	O

This	O
work	O
aimed	O
to	O
study	O
the	O
relationship	O
between	O
deep	O
pectoral	O
myopathy	O
and	O
IBV	O
by	O
describing	O
tracheal	O
and	O
muscle	B-ANAT
lesions	O
and	O
comparing	O
the	O
frequency	O
of	O
IBV	O
detection	O
via	O
reverse	O
-	O
transcription	O
(	O
RT	O
)	O
PCR	O
in	O
muscle	B-ANAT
,	O
tracheal	O
,	O
and	O
cecal	B-ANAT
tonsil	I-ANAT
samples	O
from	O
broilers	O
with	O
and	O
without	O
myopathy	O
.	O

The	O
participants	O
self	O
-	O
collected	O
an	O
anterior	O
nasal	B-ANAT
swab	O
from	O
one	O
nostril	B-ANAT
,	O
and	O
trained	O
study	O
personnel	O
collected	O
one	O
from	O
the	O
other	O
nostril	B-ANAT
.	O

His	O
motor	O
function	O
has	O
been	O
improved	O
following	O
orthopedic	O
operation	O
at	O
one	O
year	O
after	O
discharge	B-ANAT
.	O

ECMO	O
is	O
a	O
justifiable	O
alternative	O
treatment	O
for	O
reversible	O
severe	O
cardiopulmonary	B-ANAT
failure	O
in	O
critically	O
ill	O
children	O
.	O

CONCLUSIONS	O
:	O
ECMO	O
is	O
a	O
justifiable	O
alternative	O
treatment	O
for	O
reversible	O
severe	O
cardiopulmonary	B-ANAT
failure	O
in	O
critically	O
ill	O
children	O
.	O

Of	O
the	O
5	O
patients	O
,	O
the	O
female	O
newborn	O
affected	O
by	O
the	O
Currarino	O
syndrome	O
,	O
associated	O
with	O
persistence	O
of	O
the	O
common	O
cloacal	B-ANAT
canal	B-ANAT
and	O
anal	B-ANAT
imperforation	O
,	O
died	O
two	O
days	O
after	O
surgery	O
,	O
of	O
cardiovascular	B-ANAT
and	O
respiratory	O
complications	O
.	O

Some	O
sacrococcygeal	O
teratomas	O
can	O
hide	B-ANAT
more	O
or	O
less	O
extensive	O
islands	O
of	O
immaturity	O
or	O
signs	O
of	O
malignant	O
transformation	O
that	O
are	O
clinically	O
evident	O
.	O

ABSTRACT	O
:	O
The	O
applicability	O
of	O
pulse	O
pressure	O
variation	O
(	O
ÎPP	O
)	O
to	O
predict	O
fluid	O
responsiveness	O
using	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategies	O
is	O
uncertain	O
in	O
clinical	O
practice	O
.	O

RESULTS	O
:	O
Thirty	O
-	O
four	O
patients	O
had	O
characteristics	O
consistent	O
with	O
acute	O
lung	B-ANAT
injury	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
were	O
ventilated	O
with	O
high	O
levels	O
of	O
PEEP	O
[	O
median	O
(	O
inter	O
-	O
quartile	O
range	O
)	O
10	O
.	O
0	O
(	O
10	O
.	O
0	O
-	O
13	O
.	O
5	O
)].	O

Nasopharyngeal	B-ANAT
and	O
oropharyngeal	B-ANAT
swabs	O
and	O
structured	O
questionnaires	O
were	O
collected	O
from	O
eligible	O
patients	O
and	O
samples	O
were	O
tested	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
for	O
influenza	O
virus	O
types	O
and	O
subtypes	O
.	O

In	O
accordance	O
with	O
the	O
guidelines	O
of	O
the	O
International	O
Committee	O
on	O
Taxonomy	O
of	O
Viruses	O
,	O
and	O
in	O
view	O
of	O
the	O
75	O
%	O
and	O
77	O
%	O
amino	O
acid	O
sequence	O
identity	O
in	O
7	O
conserved	O
replicase	O
domains	O
with	O
BtCoV	O
-	O
HKU4	O
and	O
BtCoV	O
-	O
HKU5	O
,	O
respectively	O
,	O
we	O
propose	O
that	O
HCoV	O
-	O
EMC	B-ANAT
/	O
2012	O
prototypes	O
a	O
novel	O
species	O
in	O
the	O
genus	O
Betacoronavirus	O
.	O

HCoV	O
-	O
EMC	B-ANAT
/	O
2012	O
is	O
the	O
sixth	O
coronavirus	O
known	O
to	O
infect	O
humans	O
and	O
the	O
first	O
human	O
virus	O
within	O
betacoronavirus	O
lineage	O
C	O
.	O
Coronaviruses	O
are	O
capable	O
of	O
infecting	O
humans	O
and	O
many	O
animal	O
species	O
.	O

Although	O
FCoV	O
is	O
prevalent	O
among	O
cats	O
;	O
the	O
fastidious	O
nature	O
of	O
type	O
I	O
FCoV	O
to	O
grow	O
on	O
cell	B-ANAT
culture	O
has	O
limited	O
further	O
studies	O
on	O
tissue	B-ANAT
tropism	O
and	O
pathogenesis	O
of	O
FCoV	O
.	O
While	O
several	O
studies	O
reported	O
serological	O
evidence	O
for	O
FCoV	O
in	O
Malaysia	O
,	O
neither	O
the	O
circulating	O
FCoV	O
isolated	O
nor	O
its	O
biotypes	O
determined	O
.	O

TITLE	O
:	O
Severe	O
transfuse	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
)	O
syndrome	O
in	O
a	O
14	O
years	O
old	O
girl	O
with	O
a	O
history	O
of	O
type	O
I	O
von	O
Willebrand	O
disease	O
.	O

Sera	B-ANAT
from	O
26	O
young	O
adults	O
,	O
17	O
middle	O
-	O
aged	O
and	O
elderly	O
patients	O
with	O
respiratory	O
infection	O
,	O
and	O
15	O
cord	O
blood	B-ANAT
samples	I-ANAT
were	O
also	O
tested	O
.	O

Three	O
different	O
patterns	O
for	O
the	O
immunoreactivities	O
of	O
the	O
three	O
structural	O
regions	O
of	O
HCoV	O
-	O
OC43	O
NP	O
were	O
observed	O
in	O
human	O
serum	B-ANAT
,	O
suggesting	O
variability	O
in	O
the	O
immune	O
responses	O
that	O
occur	O
during	O
HCoV	O
-	O
OC43	O
infection	O
in	O
humans	O
.	O

Real	O
time	O
RT	O
-	O
PCR	O
indicated	O
that	O
infection	O
was	O
cleared	O
more	O
efficiently	O
in	O
trachea	B-ANAT
,	O
lungs	B-ANAT
and	O
kidneys	B-ANAT
of	O
B2	O
/	O
B2	O
and	O
B8	O
/	O
B8	O
birds	O
compared	O
with	O
B19	O
/	O
B19	O
birds	O
.	O

Sixteen	O
children	O
underwent	O
home	O
collections	O
of	O
nasal	B-ANAT
aspirates	B-ANAT
when	O
they	O
were	O
without	O
cold	O
symptoms	O
and	O
again	O
during	O
self	O
-	O
reported	O
respiratory	O
illnesses	O
.	O

Compared	O
to	O
virus	O
-	O
negative	O
well	O
weeks	O
,	O
nasal	B-ANAT
aspirate	B-ANAT
IFN	O
-	O
Î³	O
,	O
CXCL8	O
/	O
IL	O
-	O
8	O
,	O
CXCL10	O
/	O
IP	O
-	O
10	O
,	O
CCL5	O
/	O
RANTES	O
,	O
CCL11	O
/	O
eotaxin	O
-	O
1	O
,	O
CCL2	O
/	O
MCP	O
-	O
1	O
,	O
CCL4	O
/	O
MIP	O
-	O
1Î²	O
,	O
CCL7	O
/	O
MCP	O
-	O
3	O
,	O
and	O
CCL20	O
/	O
MIP3Î±	O
protein	O
levels	O
increased	O
during	O
virus	O
-	O
positive	O
sick	O
weeks	O
.	O

Only	O
a	O
subset	O
of	O
cytokines	O
(	O
IFN	O
-	O
Î³	O
,	O
CXCL8	O
,	O
CCL2	O
,	O
CCL4	O
,	O
CCL5	O
,	O
and	O
CCL20	O
)	O
correlated	O
with	O
self	O
-	O
reported	O
respiratory	B-ANAT
tract	I-ANAT
symptoms	O
.	O

This	O
recombination	O
event	O
took	O
place	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
N	O
gene	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
may	O
account	O
for	O
differences	O
in	O
replication	O
efficiency	O
in	O
tissues	B-ANAT
of	O
chickens	O
inoculated	O
by	O
the	O
two	O
viruses	O
.	O

FIPV	O
-	O
Î3	O
could	O
still	O
sustain	O
its	O
replication	O
,	O
but	O
the	O
percentage	O
of	O
infected	O
monocytes	B-ANAT
was	O
always	O
lower	O
compared	O
to	O
wt	O
-	O
FIPV	O
.	O

ABSTRACT	O
:	O
Immune	O
sera	B-ANAT
from	O
convalescent	O
patients	O
have	O
been	O
shown	O
to	O
be	O
effective	O
in	O
the	O
treatment	O
of	O
patients	O
infected	O
with	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Virus	O
(	O
SARS	O
-	O
CoV	O
)	O
making	O
passive	O
immune	O
therapy	O
with	O
human	O
monoclonal	O
antibodies	O
an	O
attractive	O
treatment	O
strategy	O
for	O
SARS	O
.	O

Increased	O
production	O
of	O
nitric	O
oxide	O
in	O
the	O
cells	B-ANAT
treated	O
with	O
E	O
.	O
faecium	O
and	O
elevated	O
expression	O
of	O
interleukin	O
6	O
and	O
8	O
pointed	O
to	O
stimulated	O
cellular	B-ANAT
defense	O
as	O
a	O
mechanism	O
to	O
fight	O
TGEV	O
infection	O
.	O

Though	O
infected	O
children	O
commonly	O
present	O
mild	O
upper	O
airway	B-ANAT
symptoms	O
,	O
in	O
high	O
-	O
risk	O
patients	O
with	O
underlying	O
conditions	O
,	O
particularly	O
in	O
immunocompromised	O
children	O
these	O
pathogens	O
may	O
lead	O
to	O
severe	O
lung	B-ANAT
infection	O
and	O
extrapulmonary	O
disorders	O
.	O

A	O
current	O
focus	O
of	O
funding	O
agencies	O
,	O
and	O
hence	O
research	O
,	O
is	O
the	O
development	O
of	O
broad	O
-	O
spectrum	O
antivirals	O
,	O
and	O
in	O
particular	O
,	O
those	O
targeting	O
common	O
cellular	B-ANAT
pathways	O
.	O

To	O
date	O
,	O
genomic	O
analyses	O
of	O
Korean	O
IBV	O
strains	O
and	O
animal	O
models	O
to	O
test	O
the	O
pathogenicity	O
of	O
Korean	O
IBVs	O
to	O
the	O
reproductive	O
organs	B-ANAT
have	O
been	O
rare	O
.	O

A	O
recombination	O
analysis	O
revealed	O
that	O
SNU8067	O
was	O
a	O
recombinant	O
virus	O
with	O
a	O
KM91	O
-	O
like	O
backbone	B-ANAT
except	O
S1	O
,	O
3a	O
,	O
and	O
3b	O
genes	O
which	O
might	O
be	O
from	O
an	O
unknown	O
virus	O
.	O

ABSTRACT	O
:	O
The	O
Coronaviridae	O
family	O
,	O
an	O
enveloped	O
RNA	O
virus	O
family	O
,	O
and	O
,	O
more	O
particularly	O
,	O
human	O
coronaviruses	O
(	O
HCoV	O
),	O
were	O
historically	O
known	O
to	O
be	O
responsible	O
for	O
a	O
large	O
portion	O
of	O
common	O
colds	O
and	O
other	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

Indeed	O
,	O
several	O
studies	O
have	O
described	O
the	O
ability	O
of	O
HCoVs	O
(	O
i	O
.	O
e	O
.	O
HCoV	O
229E	O
,	O
HCoV	O
OC43	O
(	O
also	O
known	O
as	O
betacoronavirus	O
1	O
),	O
NL63	O
,	O
HKU1	O
or	O
SARS	O
-	O
CoV	O
)	O
to	O
survive	O
in	O
different	O
environmental	O
conditions	O
(	O
e	O
.	O
g	O
.	O
temperature	O
and	O
humidity	O
),	O
on	O
different	O
supports	O
found	O
in	O
hospital	O
settings	O
such	O
as	O
aluminum	O
,	O
sterile	O
sponges	O
or	O
latex	O
surgical	O
gloves	O
or	O
in	O
biological	O
fluids	B-ANAT
.	O

Upon	O
infection	O
,	O
coronaviruses	O
extensively	O
rearrange	O
cellular	B-ANAT
membranes	B-ANAT
into	O
organelle	B-ANAT
-	O
like	O
replicative	O
structures	O
that	O
consist	O
of	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
and	O
convoluted	O
membranes	B-ANAT
to	O
which	O
the	O
nonstructural	O
proteins	O
involved	O
in	O
RNA	O
synthesis	O
localize	O
.	O

ABSTRACT	O
:	O
Bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	O
)	O
after	O
allogeneic	O
hematopoietic	O
SCT	O
(	O
HSCT	O
)	O
is	O
recognized	O
as	O
a	O
new	O
-	O
onset	O
obstructive	O
lung	B-ANAT
defect	O
(	O
OLD	O
)	O
in	O
pulmonary	B-ANAT
function	O
testing	O
and	O
is	O
related	O
to	O
pulmonary	B-ANAT
chronic	O
GVHD	O
.	O

We	O
reviewed	O
the	O
data	O
of	O
all	O
allogeneic	O
HSCT	O
recipients	O
referred	O
to	O
our	O
pulmonary	B-ANAT
department	O
for	O
a	O
non	O
-	O
infectious	O
bronchial	B-ANAT
disease	O
between	O
1999	O
and	O
2010	O
.	O

TITLE	O
:	O
[	O
Acute	O
onset	O
pulmonary	B-ANAT
toxicity	O
associated	O
to	O
amiodarone	O
].	O

Still	O
,	O
the	O
patient	O
continued	O
in	O
progressive	O
respiratory	O
deterioration	O
with	O
acute	O
bilateral	O
infiltrates	O
on	O
chest	B-ANAT
x	O
-	O
ray	O
and	O
apparent	O
normal	O
cardiac	B-ANAT
filling	O
pressures	O
confirmed	O
by	O
echocardiography	O
.	O

ABSTRACT	O
:	O
Inoculation	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
into	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
of	O
susceptible	O
strains	O
of	O
mice	O
results	O
in	O
an	O
acute	O
encephalomyelitis	O
in	O
which	O
virus	O
preferentially	O
replicates	O
within	O
glial	B-ANAT
cells	I-ANAT
while	O
excluding	O
neurons	B-ANAT
.	O

Thirteen	O
effusions	O
,	O
one	O
plasma	B-ANAT
and	O
three	O
undefined	O
samples	O
from	O
cats	O
with	O
FIP	O
,	O
which	O
gave	O
unexpectedly	O
low	O
FCoV	O
antibody	O
titres	O
,	O
were	O
examined	O
by	O
real	O
-	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

Mechanical	O
ventilation	O
was	O
used	O
in	O
almost	O
three	O
fourths	O
of	O
the	O
patients	O
,	O
whereas	O
any	O
type	O
of	O
renal	B-ANAT
replacement	O
therapy	O
was	O
used	O
in	O
173	O
patients	O
(	O
13	O
.	O
3	O
%).	O

In	O
baby	O
hamster	O
kidney	B-ANAT
(	O
BHK	O
)	O
cells	B-ANAT
,	O
lentiviral	O
transduction	O
of	O
human	O
ACE2	O
(	O
hACE2	O
)	O
conferred	O
permissiveness	O
and	O
replication	O
for	O
SARS	O
-	O
CoV	O
but	O
not	O
for	O
hCoV	O
-	O
EMC	B-ANAT
.	O

Cardiac	B-ANAT
catheterisation	O
ruled	O
out	O
heart	B-ANAT
disease	O
and	O
a	O
ventriculography	O
scan	O
revealed	O
a	O
bloated	O
systolic	O
deformation	O
of	O
the	O
anterior	O
and	O
apical	O
segments	O
(	O
TTS	O
).	O

Newly	O
synthesized	O
compounds	O
were	O
evaluated	O
towards	O
HIV	O
type	O
-	O
1	O
(	O
HIV	O
-	O
1	O
)	O
replication	O
in	O
primary	O
human	O
lymphocytes	B-ANAT
.	O

A	O
putative	O
additional	O
open	O
-	O
reading	O
frame	O
was	O
identified	O
between	O
the	O
nucleocapsid	B-ANAT
gene	O
and	O
3	O
'	O
UTR	O
.	O

The	O
most	O
significant	O
laboratory	O
changes	O
were	O
decreases	O
in	O
the	O
hemoglobin	O
,	O
hematocrit	O
and	O
platelet	B-ANAT
levels	O
,	O
with	O
increased	O
levels	O
of	O
transaminases	O
and	O
bilirubin	O
.	O

ABSTRACT	O
:	O
All	O
positive	O
strand	O
RNA	O
viruses	O
are	O
known	O
to	O
replicate	O
their	O
genomes	O
in	O
close	O
association	O
with	O
intracellular	B-ANAT
membranes	B-ANAT
.	O

We	O
found	O
that	O
the	O
MW	O
is	O
derived	O
primarily	O
from	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
and	O
contains	O
markers	O
of	O
rough	B-ANAT
ER	I-ANAT
as	O
well	O
as	O
markers	O
of	O
early	O
and	O
late	O
endosomes	O
,	O
COP	O
vesicles	B-ANAT
,	O
mitochondria	B-ANAT
and	O
lipid	B-ANAT
droplets	I-ANAT
(	O
LDs	O
).	O

hMPV	O
was	O
detected	O
in	O
14	O
.	O
2	O
%	O
(	O
41	O
/	O
288	O
)	O
of	O
all	O
samples	O
:	O
17	O
%	O
(	O
28	O
/	O
165	O
)	O
of	O
immunocompetent	O
patients	O
with	O
suspected	O
H1N1	O
infection	O
and	O
10	O
.	O
6	O
%	O
(	O
13	O
/	O
123	O
)	O
among	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
recipients	O
.	O

IFN	O
-	O
Î±	O
and	O
IFN	O
-	O
Î²	O
mRNA	O
and	O
proteins	O
were	O
not	O
rapidly	O
induced	O
whereas	O
IFN	O
-	O
Î³	O
production	O
in	O
lung	B-ANAT
,	O
measured	O
by	O
Elispot	O
assay	O
,	O
increased	O
over	O
time	O
at	O
2	O
and	O
4	O
dpi	O
.	O

In	O
contrast	O
,	O
IFN	O
-	O
Î³	O
production	O
in	O
blood	B-ANAT
was	O
highest	O
at	O
1	O
dpi	O
and	O
decreased	O
over	O
time	O
down	O
to	O
levels	O
comparable	O
to	O
uninfected	O
birds	O
at	O
4	O
dpi	O
.	O

ABSTRACT	O
:	O
BoCV	O
isolated	O
from	O
respiratory	B-ANAT
tract	I-ANAT
,	O
nasal	B-ANAT
swab	O
and	O
broncho	B-ANAT
alveolar	I-ANAT
washing	O
fluid	O
samples	O
were	O
evaluated	O
for	O
genetic	O
and	O
antigenic	O
differences	O
.	O

In	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
the	O
following	O
viruses	O
were	O
analyzed	O
by	O
quantitative	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
:	O
cytomegalovirus	O
,	O
Epstein	O
-	O
Barr	O
virus	O
,	O
parvovirus	O
B19	O
,	O
influenza	O
A	O
and	O
B	O
,	O
parainfluenza	O
viruses	O
,	O
human	O
respiratory	O
syncytial	O
virus	O
A	O
and	O
B	O
,	O
human	O
metapneumovirus	O
,	O
rhinovirus	O
,	O
enterovirus	O
,	O
adenovirus	O
,	O
human	O
coronavirus	O
OC43	O
,	O
229E	O
,	O
NL63	O
and	O
human	O
bocavirus	O
.	O

Of	O
the	O
HCoV	O
-	O
positive	O
children	O
,	O
70	O
.	O
3	O
%	O
had	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
.	O

The	O
results	O
of	O
our	O
study	O
show	O
that	O
HCoV	O
are	O
frequently	O
detected	O
human	O
pathogens	O
,	O
often	O
associated	O
with	O
other	O
respiratory	O
viruses	O
and	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
hospitalized	O
children	O
.	O

These	O
results	O
lead	O
us	O
to	O
propose	O
that	O
the	O
prone	O
position	O
should	O
be	O
carefully	O
deployed	O
,	O
particularly	O
in	O
abdominally	O
obese	O
patients	O
,	O
and	O
that	O
frequent	O
checks	O
be	O
made	O
for	O
early	O
hepatic	B-ANAT
dysfunction	O
.	O

TITLE	O
:	O
CD4	O
-	O
CD8	O
-	O
T	B-ANAT
cells	I-ANAT
contribute	O
to	O
the	O
persistence	O
of	O
viral	O
hepatitis	O
by	O
striking	O
a	O
delicate	O
balance	O
in	O
immune	O
modulation	O
.	O

Both	O
strategies	O
will	O
require	O
accurate	O
monitoring	O
of	O
oxygen	O
administration	O
and	O
arterial	B-ANAT
oxygenation	O
.	O

RESULTS	O
:	O
Inadequate	O
tissue	B-ANAT
oxygenation	O
and	O
excessive	O
oxygen	O
administration	O
can	O
be	O
detrimental	O
to	O
outcome	O
but	O
safety	O
thresholds	O
lack	O
definition	O
in	O
critically	O
ill	O
patients	O
.	O

ABSTRACT	O
:	O
Protection	O
of	O
the	O
human	O
lung	B-ANAT
from	O
infectious	O
agents	O
,	O
allergens	O
,	O
and	O
ultrafine	O
particles	O
is	O
difficult	O
with	O
current	O
technologies	O
.	O

CCL2	O
Tg	O
mice	O
mounted	O
a	O
dysregulated	O
immune	O
response	O
,	O
characterized	O
by	O
augmented	O
accumulation	O
of	O
regulatory	O
Foxp3	O
(+)	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
and	O
of	O
nitric	O
-	O
oxide	O
-	O
and	O
YM	O
-	O
1	O
-	O
expressing	O
macrophages	B-ANAT
and	O
microglia	B-ANAT
,	O
suggestive	O
of	O
mixed	O
M1	O
/	O
M2	O
macrophage	B-ANAT
activation	O
.	O

Further	O
,	O
macrophages	B-ANAT
from	O
infected	O
CCL2	O
Tg	O
brains	B-ANAT
relative	O
to	O
non	O
-	O
Tg	O
controls	O
were	O
less	O
activated	O
/	O
mature	O
,	O
expressing	O
lower	O
levels	O
of	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
class	O
II	O
(	O
MHC	B-ANAT
-	O
II	O
),	O
CD86	O
,	O
and	O
CD40	O
.	O

High	O
concentrations	O
of	O
inspired	O
oxygen	O
may	O
play	O
a	O
role	O
in	O
such	O
injury	O
,	O
but	O
aggressive	O
measures	O
to	O
reduce	O
them	O
in	O
order	O
to	O
avoid	O
oxygen	O
toxicity	O
-	O
which	O
dominated	O
ventilator	O
management	O
in	O
previous	O
decades	O
-	O
have	O
been	O
tempered	O
in	O
the	O
present	O
era	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

We	O
have	O
previously	O
determined	O
the	O
minimal	O
mechanism	O
of	O
helicase	O
function	O
by	O
nsp13	O
where	O
we	O
demonstrated	O
that	O
the	O
enzyme	O
unwinds	O
nucleic	B-ANAT
acid	O
in	O
discrete	O
steps	O
of	O
9	O
.	O
3	O
base	O
â	O
pairs	O
each	O
with	O
a	O
catalytic	O
rate	O
of	O
30	O
steps	O
per	O
second	O
.	O

GST	O
â	O
nsp13	O
showed	O
much	O
more	O
efficient	O
nucleic	B-ANAT
acid	O
unwinding	O
than	O
the	O
H6	O
â	O
tagged	O
counterpart	O
.	O

Interestingly	O
,	O
the	O
two	O
constructs	O
have	O
the	O
same	O
binding	O
affinity	O
for	O
nucleic	B-ANAT
acids	O
.	O

Here	O
we	O
present	O
new	O
information	O
describing	O
structure	O
and	O
function	O
of	O
the	O
third	O
stem	B-ANAT
of	O
the	O
SARS	O
pseudoknot	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
adult	O
patients	O
with	O
severe	O
acute	O
respiratory	O
failure	O
.	O

In	O
these	O
patients	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
used	O
as	O
a	O
rescue	O
therapy	O
.	O

Immunomonitoring	O
platforms	O
typically	O
concentrate	O
on	O
restriction	O
elements	O
associated	O
with	O
European	O
ancestry	O
,	O
and	O
such	O
tools	O
are	O
scarce	O
for	O
Asian	O
HLA	B-ANAT
variants	O
.	O

TITLE	O
:	O
[	O
The	O
experience	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
acute	O
respiratory	O
failure	O
in	O
adults	O
].	O

After	O
hemofiltration	O
,	O
heart	B-ANAT
rate	O
was	O
decreased	O
gradually	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
hemofiltration	O
group	O
than	O
in	O
the	O
control	O
group	O
.	O

Mean	O
artery	B-ANAT
pressure	O
(	O
mAP	O
)	O
increased	O
gradually	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
in	O
the	O
hemofiltration	O
group	O
than	O
in	O
the	O
control	O
group	O
.	O

We	O
also	O
noted	O
respiratory	O
distress	O
(	O
3	O
/	O
10	O
),	O
cardiac	B-ANAT
arrhythmia	O
(	O
4	O
/	O
10	O
),	O
hyperkaleamia	O
,	O
impaired	O
renal	B-ANAT
function	O
(	O
2	O
/	O
10	O
),	O
hepatic	B-ANAT
toxicity	O
(	O
1	O
/	O
10	O
)	O
and	O
altered	O
consciousness	O
(	O
3	O
/	O
10	O
).	O

In	O
fatalities	O
,	O
the	O
common	O
symptoms	O
were	O
cardiovascular	B-ANAT
shock	O
,	O
cardiorespiratory	O
arrest	O
,	O
haemodynamic	O
disturbance	O
,	O
intravascular	O
disseminated	O
coagulation	O
and	O
multiple	O
organ	B-ANAT
failure	O
.	O

In	O
the	O
severe	O
intoxication	O
case	O
for	O
which	O
blood	B-ANAT
has	O
been	O
sampled	O
,	O
the	O
blood	B-ANAT
glyphosate	O
concentration	O
was	O
found	O
at	O
838	O
mg	O
/	O
L	O
.	O
Death	O
was	O
most	O
of	O
the	O
time	O
associated	O
with	O
larger	O
taken	O
dose	O
(	O
500	O
mL	O
in	O
one	O
patient	O
)	O
and	O
high	O
blood	B-ANAT
glyphosate	O
concentrations	O
.	O

For	O
severe	O
ARDS	O
patients	O
receiving	O
femoro	O
-	O
jugular	O
vv	O
-	O
ECMO	O
,	O
blood	B-ANAT
flow	O
was	O
the	O
main	O
determinant	O
of	O
arterial	B-ANAT
oxygenation	O
,	O
while	O
CO2	O
elimination	O
depended	O
on	O
sweep	O
gas	O
flow	O
through	O
the	O
oxygenator	O
.	O

Recent	O
evidence	O
suggests	O
that	O
human	O
stem	B-ANAT
cells	I-ANAT
may	O
provide	O
significant	O
therapeutic	O
options	O
for	O
ALI	O
and	O
ARDS	O
in	O
the	O
near	O
future	O
.	O

Moreover	O
,	O
the	O
few	O
ASC	O
recruited	O
to	O
the	O
CNS	B-ANAT
in	O
CXCL10	O
(-/-)	O
mice	O
were	O
confined	O
to	O
the	O
vasculature	B-ANAT
,	O
distinct	O
from	O
the	O
parenchymal	O
localization	O
in	O
wild	O
-	O
type	O
and	O
CXCL9	O
(-/-)	O
mice	O
.	O

The	O
causes	O
of	O
the	O
refeeding	O
syndrome	O
are	O
excess	O
or	O
unbalanced	O
enteral	O
,	O
parenteral	O
or	O
oral	B-ANAT
nutritional	O
intake	O
.	O

RESULTS	O
:	O
133	O
participants	O
had	O
one	O
or	O
more	O
of	O
the	O
following	O
risk	O
factors	O
:	O
body	B-ANAT
mass	O
index	O
<	O
16	O
-	O
18	O
.	O
5	O
â¥(	O
kg	O
/	O
m	O
(	O
2	O
)),	O
unintentional	O
weight	O
loss	O
>	O
15	O
%	O
in	O
the	O
preceding	O
3	O
-	O
6	O
months	O
,	O
very	O
little	O
or	O
no	O
nutritional	O
intake	O
>	O
10	O
days	O
,	O
history	O
of	O
alcohol	O
or	O
drug	O
abuse	O
and	O
low	O
baseline	O
levels	O
of	O
serum	B-ANAT
potassium	O
,	O
phosphate	O
or	O
magnesium	O
prior	O
to	O
recruitment	O
.	O

Death	O
of	O
these	O
participants	O
was	O
due	O
to	O
cerebrovascular	O
accident	O
,	O
traumatic	O
injury	O
,	O
respiratory	O
failure	O
,	O
organ	B-ANAT
failure	O
or	O
end	O
-	O
of	O
-	O
life	O
causes	O
.	O

RESULTS	O
:	O
We	O
found	O
no	O
correlation	O
between	O
individual	O
maximal	O
plasma	B-ANAT
HBP	O
levels	O
at	O
admission	O
and	O
ISS	O
,	O
admission	O
SOFA	O
or	O
APACHE	O
II	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
EMC	B-ANAT
is	O
not	O
the	O
same	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
.	O

Unlike	O
SARS	O
-	O
CoV	O
,	O
HCoV	O
-	O
EMC	B-ANAT
can	O
directly	O
infect	O
bat	O
cells	B-ANAT
.	O

Although	O
induction	O
of	O
the	O
heat	O
shock	O
response	O
can	O
restore	O
alveolar	B-ANAT
fluid	O
clearance	O
compromised	O
by	O
IL	O
-	O
1Î²	O
following	O
the	O
onset	O
of	O
severe	O
hemorrhagic	O
shock	O
in	O
rats	O
,	O
the	O
mechanisms	O
are	O
not	O
fully	O
understood	O
.	O

They	O
had	O
complications	O
of	O
respiratory	O
failure	O
(	O
53	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
24	O
%),	O
hypotension	O
(	O
40	O
%),	O
and	O
6	O
(	O
13	O
%)	O
patients	O
needed	O
extracorporeal	O
membranous	B-ANAT
oxygenation	O
.	O

These	O
vectors	O
can	O
be	O
used	O
as	O
tools	O
to	O
visualize	O
autophagosome	B-ANAT
formation	O
and	O
fusion	O
with	O
endosomes	O
/	O
lysosomes	B-ANAT
in	O
avian	O
cells	B-ANAT
and	O
provide	O
a	O
valuable	O
resource	O
for	O
studying	O
autophagy	O
in	O
avian	O
cells	B-ANAT
.	O

However	O
,	O
expression	O
of	O
IBV	O
nonstructural	O
protein	O
6	O
alone	O
did	O
induce	O
autophagic	O
signaling	O
in	O
avian	O
cells	B-ANAT
,	O
as	O
seen	O
previously	O
in	O
mammalian	O
cells	B-ANAT
.	O

Further	O
studies	O
show	O
that	O
PEDV	O
E	O
protein	O
induced	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
stress	O
and	O
activated	O
NF	O
-	O
ÎºB	O
which	O
is	O
responsible	O
for	O
the	O
up	O
-	O
regulation	O
of	O
IL	O
-	O
8	O
and	O
Bcl	O
-	O
2	O
expression	O
.	O

Chief	O
symptoms	O
of	O
HCoV	O
-	O
OC43	O
infection	O
were	O
fever	O
(	O
in	O
78	O
%	O
of	O
cases	O
),	O
cough	O
(	O
67	O
%)	O
and	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
symptoms	O
(	O
57	O
%).	O

CONCLUSIONS	O
:	O
In	O
summary	O
the	O
Puumala	O
infection	O
bears	O
the	O
potential	O
for	O
a	O
severe	O
multi	O
-	O
organ	B-ANAT
failure	O
,	O
which	O
is	O
not	O
typical	O
for	O
this	O
usually	O
benign	O
infection	O
.	O

TITLE	O
:	O
Adjuvant	O
activity	O
of	O
Sargassum	O
pallidum	B-ANAT
polysaccharides	O
against	O
combined	O
Newcastle	O
disease	O
,	O
infectious	O
bronchitis	O
and	O
avian	O
influenza	O
inactivated	O
vaccines	O
.	O

ABSTRACT	O
:	O
This	O
study	O
evaluates	O
the	O
effects	O
of	O
Sargassum	O
pallidum	B-ANAT
polysaccharides	O
(	O
SPP	O
)	O
on	O
the	O
immune	O
responses	O
in	O
a	O
chicken	O
model	O
.	O

Across	O
intracellular	B-ANAT
and	O
extracellular	B-ANAT
GSH	O
pools	O
in	O
alveolar	B-ANAT
type	O
II	O
cells	B-ANAT
and	O
alveolar	B-ANAT
macrophages	I-ANAT
,	O
chronic	O
alcohol	O
ingestion	O
consistently	O
induced	O
a	O
40	O
-	O
60	O
mV	O
oxidation	O
of	O
GSH	O
/	O
GSSG	O
suggesting	O
that	O
the	O
redox	O
potentials	O
of	O
different	O
alveolar	B-ANAT
GSH	O
pools	O
are	O
in	O
equilibrium	O
.	O

We	O
sought	O
to	O
determine	O
oxygen	O
-	O
derived	O
effects	O
on	O
the	O
anti	O
-	O
inflammatory	O
A2A	B-ANAT
adenosinergic	O
(	O
ADORA2A	O
)	O
receptor	O
in	O
macrophages	B-ANAT
,	O
and	O
the	O
role	O
of	O
the	O
ADORA2A	O
receptor	O
in	O
lung	B-ANAT
injury	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
revealed	O
diffuse	O
reticulonodular	O
shadows	O
and	O
high	O
-	O
resolution	O
computed	O
tomography	O
showed	O
randomly	O
distributed	O
small	O
nodules	B-ANAT
.	O

Examination	O
of	O
sputum	B-ANAT
and	O
urine	B-ANAT
revealed	O
acid	O
-	O
fast	O
bacilli	O
,	O
which	O
were	O
later	O
confirmed	O
as	O
Mycobacterium	O
tuberculosis	O
sensitive	O
to	O
all	O
drugs	O
.	O

ABSTRACT	O
:	O
Cyclic	O
recruitment	O
-	O
derecruitment	O
and	O
overdistension	O
contribute	O
to	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

A	O
stand	O
-	O
alone	O
meeting	O
was	O
held	O
for	O
all	O
subgroup	O
heads	B-ANAT
,	O
co	O
-	O
and	O
vice	O
-	O
chairs	O
,	O
and	O
selected	O
individuals	O
.	O

Recommendations	O
specific	O
to	O
pediatric	O
severe	O
sepsis	O
include	O
:	O
therapy	O
with	O
face	B-ANAT
mask	O
oxygen	O
,	O
high	O
flow	O
nasal	B-ANAT
cannula	O
oxygen	O
,	O
or	O
nasopharyngeal	B-ANAT
continuous	O
PEEP	O
in	O
the	O
presence	O
of	O
respiratory	O
distress	O
and	O
hypoxemia	O
(	O
2C	O
),	O
use	O
of	O
physical	O
examination	O
therapeutic	O
endpoints	O
such	O
as	O
capillary	B-ANAT
refill	O
(	O
2C	O
);	O
for	O
septic	O
shock	O
associated	O
with	O
hypovolemia	O
,	O
the	O
use	O
of	O
crystalloids	O
or	O
albumin	O
to	O
deliver	O
a	O
bolus	O
of	O
20	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
or	O
albumin	O
equivalent	O
)	O
over	O
5	O
to	O
10	O
mins	O
(	O
2C	O
);	O
more	O
common	O
use	O
of	O
inotropes	O
and	O
vasodilators	O
for	O
low	O
cardiac	B-ANAT
output	O
septic	O
shock	O
associated	O
with	O
elevated	O
systemic	O
vascular	B-ANAT
resistance	O
(	O
2C	O
);	O
and	O
use	O
of	O
hydrocortisone	O
only	O
in	O
children	O
with	O
suspected	O
or	O
proven	O
""""	O
absolute	O
"""'"	O
adrenal	O
insufficiency	O
(	O
2C	O
).	O

Key	O
recommendations	O
and	O
suggestions	O
,	O
listed	O
by	O
category	O
,	O
include	O
:	O
early	O
quantitative	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
h	O
after	O
recognition	O
(	O
1C	O
);	O
blood	B-ANAT
cultures	O
before	O
antibiotic	O
therapy	O
(	O
1C	O
);	O
imaging	O
studies	O
performed	O
promptly	O
to	O
confirm	O
a	O
potential	O
source	O
of	O
infection	O
(	O
UG	O
);	O
administration	O
of	O
broad	O
-	O
spectrum	O
antimicrobials	O
therapy	O
within	O
1	O
h	O
of	O
the	O
recognition	O
of	O
septic	O
shock	O
(	O
1B	O
)	O
and	O
severe	O
sepsis	O
without	O
septic	O
shock	O
(	O
1C	O
)	O
as	O
the	O
goal	O
of	O
therapy	O
;	O
reassessment	O
of	O
antimicrobial	O
therapy	O
daily	O
for	O
de	O
-	O
escalation	O
,	O
when	O
appropriate	O
(	O
1B	O
);	O
infection	O
source	O
control	O
with	O
attention	O
to	O
the	O
balance	O
of	O
risks	O
and	O
benefits	O
of	O
the	O
chosen	O
method	O
within	O
12	O
h	O
of	O
diagnosis	O
(	O
1C	O
);	O
initial	O
fluid	O
resuscitation	O
with	O
crystalloid	B-ANAT
(	O
1B	O
)	O
and	O
consideration	O
of	O
the	O
addition	O
of	O
albumin	O
in	O
patients	O
who	O
continue	O
to	O
require	O
substantial	O
amounts	O
of	O
crystalloid	B-ANAT
to	O
maintain	O
adequate	O
mean	O
arterial	B-ANAT
pressure	O
(	O
2C	O
)	O
and	O
the	O
avoidance	O
of	O
hetastarch	O
formulations	O
(	O
1B	O
);	O
initial	O
fluid	O
challenge	O
in	O
patients	O
with	O
sepsis	O
-	O
induced	O
tissue	B-ANAT
hypoperfusion	O
and	O
suspicion	O
of	O
hypovolemia	O
to	O
achieve	O
a	O
minimum	O
of	O
30	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
more	O
rapid	O
administration	O
and	O
greater	O
amounts	O
of	O
fluid	O
may	O
be	O
needed	O
in	O
some	O
patients	O
(	O
1C	O
);	O
fluid	O
challenge	O
technique	O
continued	O
as	O
long	O
as	O
hemodynamic	O
improvement	O
is	O
based	O
on	O
either	O
dynamic	O
or	O
static	O
variables	O
(	O
UG	O
);	O
norepinephrine	O
as	O
the	O
first	O
-	O
choice	O
vasopressor	O
to	O
maintain	O
mean	O
arterial	B-ANAT
pressure	O
â¥	O
65	O
mmHg	O
(	O
1B	O
);	O
epinephrine	O
when	O
an	O
additional	O
agent	O
is	O
needed	O
to	O
maintain	O
adequate	O
blood	B-ANAT
pressure	O
(	O
2B	O
);	O
vasopressin	O
(	O
0	O
.	O
03	O
U	O
/	O
min	O
)	O
can	O
be	O
added	O
to	O
norepinephrine	O
to	O
either	O
raise	O
mean	O
arterial	B-ANAT
pressure	O
to	O
target	O
or	O
to	O
decrease	O
norepinephrine	O
dose	O
but	O
should	O
not	O
be	O
used	O
as	O
the	O
initial	O
vasopressor	O
(	O
UG	O
);	O
dopamine	O
is	O
not	O
recommended	O
except	O
in	O
highly	O
selected	O
circumstances	O
(	O
2C	O
);	O
dobutamine	O
infusion	O
administered	O
or	O
added	O
to	O
vasopressor	O
in	O
the	O
presence	O
of	O
(	O
a	O
)	O
myocardial	O
dysfunction	O
as	O
suggested	O
by	O
elevated	O
cardiac	B-ANAT
filling	O
pressures	O
and	O
low	O
cardiac	B-ANAT
output	O
,	O
or	O
(	O
b	O
)	O
ongoing	O
signs	O
of	O
hypoperfusion	O
despite	O
achieving	O
adequate	O
intravascular	O
volume	O
and	O
adequate	O
mean	O
arterial	B-ANAT
pressure	O
(	O
1C	O
);	O
avoiding	O
use	O
of	O
intravenous	O
hydrocortisone	O
in	O
adult	O
septic	O
shock	O
patients	O
if	O
adequate	O
fluid	O
resuscitation	O
and	O
vasopressor	O
therapy	O
are	O
able	O
to	O
restore	O
hemodynamic	O
stability	O
(	O
2C	O
);	O
hemoglobin	O
target	O
of	O
7	O
-	O
9	O
g	O
/	O
dL	O
in	O
the	O
absence	O
of	O
tissue	B-ANAT
hypoperfusion	O
,	O
ischemic	O
coronary	B-ANAT
artery	I-ANAT
disease	O
,	O
or	O
acute	O
hemorrhage	O
(	O
1B	O
);	O
low	O
tidal	O
volume	O
(	O
1A	O
)	O
and	O
limitation	O
of	O
inspiratory	O
plateau	O
pressure	O
(	O
1B	O
)	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
application	O
of	O
at	O
least	O
a	O
minimal	O
amount	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
in	O
ARDS	O
(	O
1B	O
);	O
higher	O
rather	O
than	O
lower	O
level	O
of	O
PEEP	O
for	O
patients	O
with	O
sepsis	O
-	O
induced	O
moderate	O
or	O
severe	O
ARDS	O
(	O
2C	O
);	O
recruitment	O
maneuvers	O
in	O
sepsis	O
patients	O
with	O
severe	O
refractory	O
hypoxemia	O
due	O
to	O
ARDS	O
(	O
2C	O
);	O
prone	O
positioning	O
in	O
sepsis	O
-	O
induced	O
ARDS	O
patients	O
with	O
a	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
ratio	O
of	O
â¤	O
100	O
mm	O
Hg	O
in	O
facilities	O
that	O
have	O
experience	O
with	O
such	O
practices	O
(	O
2C	O
);	O
head	B-ANAT
-	O
of	O
-	O
bed	O
elevation	O
in	O
mechanically	O
ventilated	O
patients	O
unless	O
contraindicated	O
(	O
1B	O
);	O
a	O
conservative	O
fluid	O
strategy	O
for	O
patients	O
with	O
established	O
ARDS	O
who	O
do	O
not	O
have	O
evidence	O
of	O
tissue	B-ANAT
hypoperfusion	O
(	O
1C	O
);	O
protocols	O
for	O
weaning	O
and	O
sedation	O
(	O
1A	O
);	O
minimizing	O
use	O
of	O
either	O
intermittent	O
bolus	O
sedation	O
or	O
continuous	O
infusion	O
sedation	O
targeting	O
specific	O
titration	O
endpoints	O
(	O
1B	O
);	O
avoidance	O
of	O
neuromuscular	O
blockers	O
if	O
possible	O
in	O
the	O
septic	O
patient	O
without	O
ARDS	O
(	O
1C	O
);	O
a	O
short	O
course	O
of	O
neuromuscular	O
blocker	O
(	O
no	O
longer	O
than	O
48	O
h	O
)	O
for	O
patients	O
with	O
early	O
ARDS	O
and	O
a	O
PaO	O
(	O
2	O
)/	O
FI	O
O	O
(	O
2	O
)	O
<	O
150	O
mm	O
Hg	O
(	O
2C	O
);	O
a	O
protocolized	O
approach	O
to	O
blood	B-ANAT
glucose	O
management	O
commencing	O
insulin	O
dosing	O
when	O
two	O
consecutive	O
blood	B-ANAT
glucose	O
levels	O
are	O
>	O
180	O
mg	O
/	O
dL	O
,	O
targeting	O
an	O
upper	O
blood	B-ANAT
glucose	O
â¤	O
180	O
mg	O
/	O
dL	O
(	O
1A	O
);	O
equivalency	O
of	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemofiltration	O
or	O
intermittent	O
hemodialysis	O
(	O
2B	O
);	O
prophylaxis	O
for	O
deep	B-ANAT
vein	I-ANAT
thrombosis	O
(	O
1B	O
);	O
use	O
of	O
stress	O
ulcer	O
prophylaxis	O
to	O
prevent	O
upper	B-ANAT
gastrointestinal	I-ANAT
bleeding	O
in	O
patients	O
with	O
bleeding	O
risk	O
factors	O
(	O
1B	O
);	O
oral	B-ANAT
or	O
enteral	O
(	O
if	O
necessary	O
)	O
feedings	O
,	O
as	O
tolerated	O
,	O
rather	O
than	O
either	O
complete	O
fasting	O
or	O
provision	O
of	O
only	O
intravenous	O
glucose	O
within	O
the	O
first	O
48	O
h	O
after	O
a	O
diagnosis	O
of	O
severe	O
sepsis	O
/	O
septic	O
shock	O
(	O
2C	O
);	O
and	O
addressing	O
goals	O
of	O
care	O
,	O
including	O
treatment	O
plans	O
and	O
end	O
-	O
of	O
-	O
life	O
planning	O
(	O
as	O
appropriate	O
)	O
(	O
1B	O
),	O
as	O
early	O
as	O
feasible	O
,	O
but	O
within	O
72	O
h	O
of	O
intensive	O
care	O
unit	O
admission	O
(	O
2C	O
).	O

Recommendations	O
specific	O
to	O
pediatric	O
severe	O
sepsis	O
include	O
:	O
therapy	O
with	O
face	B-ANAT
mask	O
oxygen	O
,	O
high	O
flow	O
nasal	B-ANAT
cannula	O
oxygen	O
,	O
or	O
nasopharyngeal	B-ANAT
continuous	O
PEEP	O
in	O
the	O
presence	O
of	O
respiratory	O
distress	O
and	O
hypoxemia	O
(	O
2C	O
),	O
use	O
of	O
physical	O
examination	O
therapeutic	O
endpoints	O
such	O
as	O
capillary	B-ANAT
refill	O
(	O
2C	O
);	O
for	O
septic	O
shock	O
associated	O
with	O
hypovolemia	O
,	O
the	O
use	O
of	O
crystalloids	O
or	O
albumin	O
to	O
deliver	O
a	O
bolus	O
of	O
20	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
or	O
albumin	O
equivalent	O
)	O
over	O
5	O
-	O
10	O
min	O
(	O
2C	O
);	O
more	O
common	O
use	O
of	O
inotropes	O
and	O
vasodilators	O
for	O
low	O
cardiac	B-ANAT
output	O
septic	O
shock	O
associated	O
with	O
elevated	O
systemic	O
vascular	B-ANAT
resistance	O
(	O
2C	O
);	O
and	O
use	O
of	O
hydrocortisone	O
only	O
in	O
children	O
with	O
suspected	O
or	O
proven	O
""""	O
absolute	O
"""'"	O
adrenal	O
insufficiency	O
(	O
2C	O
).	O

TITLE	O
:	O
Release	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
nuclear	O
import	O
block	O
enhances	O
host	O
transcription	O
in	O
human	O
lung	B-ANAT
cells	B-ANAT
.	O

Virus	O
-	O
neutralizing	O
test	O
on	O
tracheal	O
organ	B-ANAT
cultures	O
(	O
TOC	O
)	O
with	O
chicken	O
embryo	B-ANAT
were	O
used	O
to	O
evaluate	O
relatedness	O
values	O
of	O
the	O
antigenicity	O
based	O
on	O
the	O
antibody	O
titer	O
,	O
to	O
analyze	O
the	O
antigenic	O
relationships	O
between	O
the	O
isolates	O
and	O
vaccine	O
strains	O
,	O
as	O
well	O
as	O
to	O
determine	O
the	O
serotypes	O
of	O
26	O
IB	O
viruses	O
isolated	O
from	O
the	O
field	O
in	O
Guangxi	O
between	O
1985	O
and	O
2008	O
.	O

Persons	O
with	O
asthma	O
were	O
more	O
likely	O
to	O
be	O
2	O
-	O
17	O
years	O
old	O
(	O
39	O
%	O
vs	O
.	O
30	O
%,	O
p	O
=	O
0	O
.	O
04	O
)	O
and	O
black	O
(	O
29	O
%	O
vs	O
.	O
18	O
%,	O
p	O
<	O
0	O
.	O
01	O
),	O
and	O
have	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
13	O
%	O
vs	O
.	O
9	O
%,	O
p	O
=	O
0	O
.	O
04	O
)	O
but	O
less	O
likely	O
to	O
have	O
pneumonia	O
(	O
37	O
%	O
vs	O
.	O
47	O
%,	O
p	O
=	O
0	O
.	O
05	O
),	O
need	O
mechanical	O
ventilation	O
(	O
13	O
%	O
vs	O
.	O
23	O
%,	O
p	O
=	O
0	O
.	O
02	O
),	O
and	O
die	O
(	O
4	O
%	O
vs	O
.	O
10	O
%,	O
p	O
=	O
0	O
.	O
04	O
)	O
than	O
those	O
without	O
asthma	O
.	O

The	O
American	O
Academy	O
of	O
Pediatric	O
Dentistry	O
,	O
Chicago	O
,	O
suggests	O
that	O
parents	O
gently	O
clean	O
infants	O
'	O
gums	B-ANAT
and	O
teeth	B-ANAT
after	O
breastfeeding	O
.	O

Stool	B-ANAT
samples	O
and	O
nasopharyngeal	B-ANAT
(	O
NP	O
)	O
swabs	O
collected	O
from	O
260	O
children	O
hospitalized	O
for	O
AGE	O
(	O
160	O
also	O
had	O
respiratory	O
symptoms	O
)	O
and	O
157	O
otherwise	O
healthy	O
control	O
children	O
admitted	O
for	O
elective	O
surgery	O
were	O
tested	O
for	O
the	O
presence	O
of	O
four	O
HCoVs	O
using	O
real	O
time	O
RT	O
-	O
PCR	O
.	O

All	O
four	O
HCoVs	O
species	O
were	O
detected	O
in	O
stool	B-ANAT
and	O
NP	O
samples	O
.	O

Although	O
HCoVs	O
were	O
more	O
frequently	O
detected	O
in	O
patients	O
with	O
AGE	O
than	O
in	O
the	O
control	O
group	O
,	O
high	O
prevalence	O
of	O
HCoVs	O
in	O
NP	O
swabs	O
compounded	O
by	O
their	O
low	O
occurrence	O
in	O
stool	B-ANAT
samples	O
and	O
detection	O
of	O
other	O
viruses	O
in	O
stool	B-ANAT
samples	O
,	O
indicate	O
that	O
HCoVs	O
probably	O
play	O
only	O
a	O
minor	O
role	O
in	O
causing	O
gastrointestinal	O
illness	O
in	O
children	O
<	O
6	O
years	O
old	O
.	O

All	O
four	O
HCoVs	O
species	O
were	O
detected	O
in	O
stool	B-ANAT
and	O
NP	O
samples	O
.	O

The	O
serum	B-ANAT
antibody	O
titers	O
in	O
the	O
prime	O
-	O
boost	O
birds	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
the	O
multivalent	O
DNA	O
vaccine	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
but	O
not	O
significantly	O
different	O
compared	O
to	O
the	O
inactivated	O
vaccine	O
group	O
at	O
49	O
days	O
of	O
age	O
.	O

TITLE	O
:	O
Sequence	O
and	O
phylogenetic	O
analysis	O
of	O
nucleocapsid	B-ANAT
genes	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
strains	O
in	O
China	O
.	O

Since	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
is	O
highly	O
conserved	O
,	O
it	O
is	O
a	O
candidate	O
protein	O
for	O
early	O
diagnosis	O
and	O
vaccine	O
development	O
.	O

It	O
is	O
also	O
possible	O
to	O
isolate	O
the	O
virus	O
in	O
the	O
tissue	B-ANAT
culture	O
.	O

Angiogenic	O
factors	O
and	O
their	O
receptors	O
,	O
including	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)/	O
VEGF	O
-	O
receptor	O
(	O
VEGFR	O
)	O
and	O
the	O
angiopoietin	O
(	O
Ang	O
)/	O
Tie2	O
signaling	O
pathways	O
,	O
play	O
pivotal	O
roles	O
in	O
both	O
angiogenesis	O
and	O
microvascular	O
permeability	O
.	O

Plasma	B-ANAT
kallistatin	O
was	O
significantly	O
consumed	O
in	O
severe	O
CAP	O
patients	O
compared	O
with	O
healthy	O
individuals	O
.	O

TITLE	O
:	O
[	O
Atrial	B-ANAT
chaotic	O
tachycardia	O
during	O
a	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
due	O
to	O
NL63	O
coronavirus	O
].	O

Two	O
ArkDPI	O
-	O
derived	O
vaccines	O
that	O
contain	O
a	O
higher	O
proportion	O
of	O
viruses	O
with	O
S1	O
genes	O
that	O
become	O
selected	O
during	O
replication	O
in	O
chickens	O
exhibited	O
more	O
rapid	O
establishment	O
of	O
those	O
selected	O
subpopulations	O
in	O
chickens	O
,	O
produced	O
significantly	O
higher	O
viral	O
loads	O
in	O
tears	B-ANAT
,	O
and	O
induced	O
higher	O
antibody	O
responses	O
compared	O
with	O
two	O
other	O
ArkDPI	O
vaccines	O
with	O
lower	O
proportions	O
of	O
viruses	O
that	O
become	O
selected	O
in	O
chickens	O
.	O

The	O
discovery	O
of	O
viruses	O
encoding	O
deubiquitinating	O
enzymes	O
(	O
DUBs	O
)	O
suggests	O
they	O
remove	O
ubiquitin	O
to	O
evade	O
ubiquitin	O
-	O
dependent	O
antiviral	O
responses	O
;	O
however	O
,	O
this	O
has	O
never	O
been	O
conclusively	O
demonstrated	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
.	O

HBP	O
concentrations	O
were	O
correlated	O
with	O
the	O
lowest	O
ratio	O
of	O
partial	O
pressure	O
of	O
oxygen	O
in	O
arterial	B-ANAT
blood	I-ANAT
to	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
PF	O
ratio	O
)	O
during	O
the	O
ICU	O
stay	O
(	O
rho	O
=	O
-	O
0	O
.	O
321	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

We	O
present	O
a	O
rare	O
case	O
of	O
postpneumonectomy	O
-	O
like	O
syndrome	O
as	O
sequelae	O
of	O
severe	O
pulmonary	B-ANAT
parenchymal	O
tuberculosis	O
infection	O
along	O
with	O
a	O
review	O
of	O
literature	O
,	O
in	O
the	O
hopes	O
of	O
aiding	O
clinicians	O
to	O
include	O
the	O
differential	O
of	O
postpneumonectomy	O
-	O
like	O
syndrome	O
in	O
patients	O
presenting	O
with	O
worsening	O
dyspnea	O
without	O
a	O
history	O
of	O
surgical	O
lung	B-ANAT
resection	O
.	O

CONCLUSIONS	O
:	O
We	O
present	O
a	O
rare	O
case	O
of	O
postpneumonectomy	O
-	O
like	O
syndrome	O
as	O
sequelae	O
of	O
severe	O
pulmonary	B-ANAT
parenchymal	O
tuberculosis	O
infection	O
along	O
with	O
a	O
review	O
of	O
literature	O
,	O
in	O
the	O
hopes	O
of	O
aiding	O
clinicians	O
to	O
include	O
the	O
differential	O
of	O
postpneumonectomy	O
-	O
like	O
syndrome	O
in	O
patients	O
presenting	O
with	O
worsening	O
dyspnea	O
without	O
a	O
history	O
of	O
surgical	O
lung	B-ANAT
resection	O
.	O

TITLE	O
:	O
Intra	O
-	O
abdominal	B-ANAT
hypertension	O
and	O
acute	O
pancreatitis	O
.	O

ABSTRACT	O
:	O
Intra	O
-	O
abdominal	B-ANAT
hypertension	O
(	O
IAH	O
)	O
contributes	O
to	O
organ	B-ANAT
dysfunction	O
and	O
leads	O
to	O
the	O
development	O
of	O
the	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
(	O
ACS	O
).	O

IAH	O
and	O
ACS	O
are	O
relatively	O
frequent	O
findings	O
in	O
patiens	O
with	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
and	O
are	O
associated	O
with	O
deterioration	O
in	O
organ	B-ANAT
functions	O
.	O

There	O
is	O
an	O
accumulating	O
evidence	O
in	O
human	O
and	O
animal	O
studies	O
that	O
changes	O
of	O
perfusion	O
,	O
particularly	O
to	O
the	O
microvasculature	B-ANAT
,	O
are	O
crucial	O
events	O
in	O
the	O
progression	O
of	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

Strategies	O
based	O
on	O
preoperative	O
and	O
immediate	O
postoperative	O
clinical	O
signs	O
and	O
symptoms	O
can	O
help	O
identify	O
patients	O
with	O
a	O
high	O
likelihood	O
of	O
OSA	O
,	O
postoperative	O
desaturations	O
,	O
and	O
pulmonary	B-ANAT
complications	O
.	O

Histological	O
analysis	O
showed	O
that	O
low	O
-	O
dose	O
IFN	O
-	O
Î±	O
treatment	O
improved	O
findings	O
of	O
diffuse	O
alveolar	B-ANAT
damage	O
in	O
fulminant	O
ARDS	O
mice	O
,	O
which	O
was	O
associated	O
with	O
reduction	O
in	O
the	O
wet	O
/	O
dry	O
(	O
W	O
/	O
D	O
)	O
lung	B-ANAT
weight	O
ratio	O
.	O

The	O
lesion	O
was	O
relatively	O
larger	O
,	O
and	O
there	O
was	O
relatively	O
less	O
viable	O
lateral	O
column	B-ANAT
in	O
hips	B-ANAT
that	O
exhibited	O
symptoms	O
or	O
collapsed	O
.	O

Most	O
of	O
the	O
title	O
compounds	O
displayed	O
excellent	O
anti	O
-	O
HIV	O
-	O
1	O
activity	O
at	O
submicromolar	O
concentrations	O
ranging	O
from	O
34	O
nM	O
to	O
5	O
.	O
08	O
Î¼M	O
.	O
The	O
most	O
promising	O
compound	O
8g	O
inhibited	O
HIV	O
-	O
1	O
IIIB	O
in	O
MT	O
-	O
4	O
cells	B-ANAT
at	O
a	O
low	O
EC50	O
value	O
(	O
0	O
.	O
034	O
Î¼M	O
),	O
which	O
was	O
lower	O
than	O
the	O
reference	O
drug	O
nevirapine	O
and	O
delavirdine	O
.	O

Evaluations	O
were	O
conducted	O
at	O
enrollment	O
and	O
on	O
day	O
28	O
,	O
with	O
the	O
collection	O
of	O
clinical	O
data	O
and	O
a	O
nasopharyngeal	B-ANAT
swab	I-ANAT
(	O
or	O
nasal	B-ANAT
aspirate	B-ANAT
in	O
children	O
).	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
use	O
was	O
greater	O
in	O
morbidly	O
obese	O
compared	O
to	O
non	O
-	O
obese	O
patients	O
(	O
17	O
.	O
4	O
%	O
vs	O
.	O
4	O
.	O
7	O
%,	O
p	O
=	O
0	O
.	O
04	O
).	O

Diagnosis	O
is	O
based	O
on	O
clinical	O
features	O
,	O
cerebrospinal	B-ANAT
fluid	I-ANAT
testing	O
,	O
and	O
nerve	B-ANAT
conduction	O
studies	O
.	O

TITLE	O
:	O
Clinical	O
safety	O
of	O
biosimilar	O
recombinant	O
human	O
granulocyte	B-ANAT
colony	O
-	O
stimulating	O
factors	O
.	O

Using	O
the	O
EMA	O
dossiers	O
(	O
all	O
three	O
agents	O
),	O
the	O
FDA	O
dossier	O
(	O
Tevagrastim	O
),	O
and	O
journal	O
publications	O
,	O
this	O
article	O
reviews	O
clinical	O
safety	O
data	O
for	O
these	O
products	O
with	O
emphasis	O
on	O
serious	O
/	O
severe	O
adverse	O
events	O
and	O
special	O
consideration	O
of	O
immunogenicity	O
,	O
bone	B-ANAT
pain	O
,	O
splenomegaly	O
,	O
allergic	O
reactions	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
mortality	O
.	O

TITLE	O
:	O
Plasmodium	O
vivax	O
malaria	O
complicated	O
by	O
acute	O
kidney	B-ANAT
injury	O
:	O
experience	O
at	O
a	O
referral	O
hospital	O
in	O
Uttarakhand	O
,	O
India	O
.	O

Thus	O
,	O
ideal	O
in	O
vitro	O
models	O
for	O
examining	O
cellular	B-ANAT
responses	O
to	O
respiratory	O
pathogens	O
polarize	O
,	O
forming	O
apical	O
and	O
basolateral	O
surfaces	O
.	O

Nowadays	O
,	O
four	O
HCoVs	O
,	O
HCoV	O
-	O
229E	O
,	O
HCoV	O
-	O
OC43	O
,	O
HCoV	O
-	O
HKU1	O
,	O
and	O
HCoV	O
-	O
NL63	O
,	O
are	O
known	O
to	O
be	O
circulating	O
worldwide	O
,	O
causing	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
nonhospitalized	O
and	O
hospitalized	O
children	O
.	O

In	O
contrast	O
,	O
mesentery	B-ANAT
and	O
kidney	B-ANAT
from	O
FIP	O
cats	O
did	O
not	O
show	O
any	O
difference	O
when	O
compared	O
to	O
healthy	O
non	O
-	O
infected	O
control	O
animals	O
.	O

However	O
,	O
these	O
results	O
will	O
also	O
open	O
possibilities	O
for	O
new	O
therapies	O
targeting	O
specifically	O
NK	B-ANAT
cells	I-ANAT
and	O
Tregs	O
to	O
enhance	O
their	O
numbers	O
and	O
/	O
or	O
functionality	O
during	O
FIPV	O
infection	O
.	O

The	O
effect	O
of	O
temperature	O
and	O
lighting	O
on	O
49	O
cellular	B-ANAT
or	O
microbial	O
antigens	O
was	O
evaluated	O
in	O
4	O
serial	O
paraffin	O
sections	O
,	O
cut	O
12	O
months	O
,	O
10	O
months	O
,	O
8	O
months	O
,	O
5	O
months	O
,	O
3	O
months	O
,	O
1	O
month	O
,	O
3	O
days	O
,	O
and	O
1	O
day	O
before	O
immunohistochemistry	O
.	O

Other	O
markers	O
with	O
complete	O
loss	O
of	O
immunoreactivity	O
were	O
bovine	O
viral	O
diarrhea	O
virus	O
,	O
CD18	O
(	O
only	O
with	O
fluorescent	O
light	O
),	O
CD31	O
,	O
CD68	O
,	O
canine	O
parvovirus	O
,	O
chromogranins	O
,	O
and	O
thyroid	B-ANAT
transcription	O
factor	O
-	O
1	O
.	O

Exchanging	O
the	O
endotracheal	O
tube	O
was	O
necessary	O
to	O
achieve	O
satisfactory	O
pulmonary	B-ANAT
ventilation	O
.	O

The	O
dose	O
of	O
tranexamic	O
acid	O
was	O
reduced	O
to	O
1000	O
mg	O
every	O
12	O
hours	O
,	O
adjusting	O
for	O
renal	B-ANAT
function	O
.	O

Results	O
of	O
a	O
skin	B-ANAT
biopsy	O
were	O
compatible	O
with	O
TEN	O
.	O

An	O
immunoassay	O
specific	O
for	O
p14	O
endocan	O
fragment	O
was	O
then	O
developed	O
,	O
and	O
revealed	O
increased	O
plasma	B-ANAT
levels	O
of	O
p14	O
in	O
20	O
out	O
of	O
55	O
severe	O
septic	O
patients	O
,	O
ranging	O
from	O
0	O
.	O
52	O
to	O
10	O
.	O
40	O
ng	O
/	O
mL	O
versus	O
undetectable	O
p14	O
in	O
plasma	B-ANAT
from	O
32	O
control	O
subjects	O
(	O
p	O
=	O
0	O
.	O
0011	O
).	O

The	O
immune	O
reaction	O
of	O
granuloma	O
formation	O
evolved	O
in	O
order	O
to	O
combat	O
mycobacteria	O
with	O
the	O
aim	O
of	O
localizing	O
mycobacteria	O
and	O
to	O
avoid	O
spreading	O
of	O
mycobacteria	O
throughout	O
the	O
body	B-ANAT
.	O

All	O
major	O
respiratory	O
viruses	O
and	O
their	O
association	O
with	O
human	O
ocular	B-ANAT
disease	O
are	O
discussed	O
.	O

Research	O
utilizing	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
to	O
study	O
the	O
ability	O
of	O
respiratory	O
viruses	O
to	O
use	O
the	O
eye	B-ANAT
as	O
a	O
portal	B-ANAT
of	O
entry	O
as	O
well	O
as	O
a	O
primary	O
site	O
of	O
virus	O
replication	O
is	O
highlighted	O
.	O

TITLE	O
:	O
Oral	B-ANAT
exposure	O
of	O
broiler	O
breeder	O
hens	O
to	O
extra	O
thyroxine	O
modulates	O
early	O
adaptive	O
immune	O
responses	O
in	O
progeny	O
chicks	O
.	O

Thereafter	O
,	O
the	O
male	O
hatchlings	O
(	O
n	O
=	O
288	O
)	O
were	O
reared	O
for	O
42	O
d	O
,	O
and	O
several	O
cellular	B-ANAT
and	O
humoral	O
immune	O
responses	O
were	O
evaluated	O
at	O
standard	O
or	O
low	O
ambient	O
temperature	O
.	O

Here	O
we	O
describe	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
detection	O
of	O
RNA	O
of	O
3	O
unique	O
coronavirus	O
species	O
in	O
the	O
tissues	B-ANAT
of	O
South	O
African	O
bats	O
.	O

A	O
total	O
of	O
217	O
serum	B-ANAT
samples	O
from	O
5	O
species	O
of	O
bats	O
were	O
collected	O
between	O
April	O
,	O
2010	O
,	O
and	O
August	O
,	O
2011	O
,	O
from	O
4	O
provinces	O
in	O
China	O
.	O

Approximately	O
10	O
%	O
of	O
patients	O
with	O
leptospirosis	O
develop	O
severe	O
disease	O
,	O
the	O
Weil	O
syndrome	O
,	O
with	O
jaundice	O
,	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
),	O
and	O
pulmonary	B-ANAT
hemorrhage	O
.	O

TITLE	O
:	O
Assembling	O
an	O
ion	O
channel	O
:	O
ORF	O
3a	O
from	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Protein	O
3a	O
is	O
a	O
274	O
amino	O
acid	O
polytopic	O
channel	O
protein	O
with	O
three	O
putative	O
transmembrane	B-ANAT
domains	O
(	O
TMDs	O
)	O
encoded	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
corona	O
virus	O
(	O
SARS	O
-	O
CoV	O
).	O

Synthetic	O
peptides	O
corresponding	O
to	O
each	O
of	O
its	O
three	O
individual	O
transmembrane	B-ANAT
domains	O
(	O
TMDs	O
)	O
are	O
reconstituted	O
into	O
artificial	O
lipid	B-ANAT
bilayers	I-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
describes	O
a	O
relatively	O
common	O
and	O
frequently	O
lethal	O
syndrome	O
at	O
the	O
severe	O
end	O
of	O
the	O
spectrum	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
predictive	O
value	O
of	O
the	O
MSA	O
and	O
CAM	B-ANAT
score	O
were	O
calculated	O
.	O

The	O
clinical	O
usefulness	O
of	O
the	O
MSA	O
and	O
CAM	B-ANAT
score	O
was	O
limited	O
.	O

These	O
patients	O
also	O
had	O
a	O
3	O
.	O
5	O
fold	O
greater	O
reduction	O
in	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
in	O
arterial	B-ANAT
blood	I-ANAT
(	O
PaCO2	O
).	O

Twenty	O
-	O
nine	O
out	O
of	O
150	O
pooled	O
fecal	B-ANAT
samples	O
tested	O
positive	O
by	O
reverse	O
transcription	O
-	O
PCR	O
contained	O
fragments	O
of	O
the	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
of	O
coronavirus	O
-	O
related	O
viruses	O
.	O

Patients	O
with	O
a	O
stiff	O
chest	B-ANAT
wall	I-ANAT
may	O
tolerate	O
higher	O
plateau	O
pressure	O
targets	O
(	O
approximately	O
35	O
cmH2O	O
)	O
while	O
those	O
with	O
severe	O
ARDS	O
and	O
ventilator	O
asynchrony	O
may	O
require	O
a	O
short	O
-	O
term	O
neuromuscular	O
blockade	O
.	O

Severe	O
head	B-ANAT
and	O
thoracic	B-ANAT
injuries	O
seem	O
to	O
be	O
important	O
drivers	O
for	O
the	O
development	O
postoperative	O
complications	O
.	O

ABSTRACT	O
:	O
Conventional	O
therapy	O
against	O
acute	O
pediatric	O
cardiopulmonary	B-ANAT
failure	O
(	O
APCPF	O
)	O
caused	O
by	O
a	O
variety	O
of	O
disease	O
entities	O
remains	O
unsatisfactory	O
with	O
extremely	O
high	O
morbidity	O
and	O
mortality	O
.	O

Lymphocyte	B-ANAT
proliferation	O
assay	O
,	O
virus	O
neutralization	O
assay	O
,	O
IFN	O
-	O
Î³	O
assay	O
and	O
CTL	B-ANAT
activity	O
assay	O
were	O
performed	O
.	O

TGEV	O
/	O
PEDV	O
specific	O
antibody	O
responses	O
as	O
well	O
as	O
kinetic	O
changes	O
of	O
T	B-ANAT
lymphocyte	I-ANAT
subgroups	O
of	O
the	O
immunized	O
mice	O
were	O
analyzed	O
.	O

In	O
the	O
end	O
,	O
2	O
patients	O
(	O
33	O
.	O
3	O
%)	O
died	O
from	O
multiple	O
-	O
organ	B-ANAT
failure	O
,	O
despite	O
intensive	O
resuscitation	O
.	O

We	O
performed	O
a	O
cell	B-ANAT
line	I-ANAT
susceptibility	O
study	O
with	O
28	O
cell	B-ANAT
lines	I-ANAT
.	O

A	O
recent	O
cell	B-ANAT
line	I-ANAT
susceptibility	O
study	O
showed	O
that	O
HCoV	O
-	O
EMC	B-ANAT
can	O
infect	O
primate	O
,	O
porcine	O
,	O
and	O
bat	O
cells	B-ANAT
and	O
therefore	O
may	O
jump	O
interspecies	O
barriers	O
.	O

These	O
findings	O
have	O
important	O
implications	O
for	O
the	O
diagnosis	O
,	O
pathogenesis	O
,	O
and	O
transmission	O
of	O
HCoV	O
-	O
EMC	B-ANAT
.	O

All	O
patients	O
developed	O
renal	B-ANAT
failure	O
,	O
six	O
pulmonary	B-ANAT
oedema	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
five	O
were	O
mechanically	O
ventilated	O
)	O
and	O
five	O
shock	O
.	O

For	O
each	O
patient	O
we	O
recorded	O
anthropometric	O
and	O
anamnestic	O
data	O
,	O
smoking	O
habits	O
,	O
respiratory	O
function	O
,	O
GOLD	O
(	O
Global	O
initiative	O
for	O
chronic	O
Obstructive	O
Lung	B-ANAT
Disease	O
)	O
severity	O
stage	O
,	O
Body	B-ANAT
Mass	O
Index	O
(	O
BMI	O
),	O
number	O
of	O
acute	O
COPD	O
exacerbations	O
in	O
previous	O
years	O
,	O
presence	O
and	O
type	O
of	O
comorbidities	O
,	O
and	O
the	O
Charlson	O
Comorbidity	O
Index	O
(	O
CCI	O
).	O

Transmission	O
electron	O
microscopy	O
showed	O
virions	B-ANAT
within	O
the	O
cytoplasm	B-ANAT
of	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
budding	O
virions	B-ANAT
from	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
(	O
type	O
II	O
).	O

In	O
this	O
study	O
,	O
investigation	O
is	O
made	O
to	O
determine	O
if	O
MCs	B-ANAT
are	O
associated	O
with	O
Canine	O
parvovirus	O
-	O
2	O
(	O
CPV	O
-	O
2	O
)-	O
induced	O
enteritis	O
with	O
crypt	B-ANAT
abscess	O
(	O
ECA	O
).	O

Analyzing	O
the	O
corona	B-ANAT
radiata	I-ANAT
,	O
axial	O
diffusivity	O
(	O
AD	O
)	O
and	O
MD	O
were	O
significantly	O
increased	O
in	O
the	O
left	O
superior	O
region	O
,	O
MD	O
and	O
RD	O
were	O
increased	O
in	O
the	O
left	O
posterior	O
area	O
,	O
and	O
,	O
furthermore	O
,	O
MD	O
was	O
also	O
increased	O
in	O
the	O
right	O
posterior	O
region	O
.	O

Since	O
the	O
DTI	O
can	O
detect	O
abnormalities	O
in	O
the	O
normal	O
-	O
appearing	O
white	B-ANAT
matter	I-ANAT
,	O
this	O
technique	O
may	O
play	O
a	O
role	O
as	O
an	O
early	O
marker	O
of	O
HIV	O
disease	O
progression	O
,	O
including	O
clinical	O
manifestations	O
such	O
as	O
cognitive	O
impairment	O
.	O

RESULTS	O
:	O
We	O
found	O
that	O
in	O
the	O
body	B-ANAT
of	I-ANAT
corpus	I-ANAT
callosum	I-ANAT
the	O
fractional	O
anisotropy	O
(	O
FA	O
)	O
was	O
significantly	O
reduced	O
,	O
whereas	O
mean	O
diffusivity	O
(	O
MD	O
)	O
and	O
radial	O
diffusivity	O
(	O
RD	O
)	O
were	O
increased	O
in	O
HIV	O
patients	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
N	O
protein	O
prolongs	O
S	O
-	O
phase	O
cell	B-ANAT
cycle	O
,	O
induces	O
endoplasmic	B-ANAT
reticulum	I-ANAT
stress	O
,	O
and	O
up	O
-	O
regulates	O
interleukin	O
-	O
8	O
expression	O
.	O

The	O
nerve	B-ANAT
conduction	O
study	O
was	O
consistent	O
with	O
GBS	O
.	O

The	O
second	O
patient	O
was	O
a	O
31	O
-	O
year	O
-	O
old	O
male	O
who	O
was	O
admitted	O
with	O
4	O
-	O
days	O
history	O
of	O
severe	O
back	B-ANAT
pain	O
which	O
occurred	O
when	O
he	O
lifted	O
a	O
heavy	O
weight	O
.	O

TITLE	O
:	O
Long	O
-	O
term	O
membrane	B-ANAT
oxygenator	O
use	O
to	O
support	O
an	O
infant	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
on	O
biventricular	O
assist	O
device	O
.	O

This	O
therapy	O
may	O
be	O
an	O
attractive	O
intermediate	O
step	O
in	O
the	O
transition	O
from	O
,	O
or	O
alternative	O
to	O
ECMO	O
,	O
in	O
patients	O
requiring	O
VAD	O
placement	O
with	O
associated	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
The	O
emergence	O
of	O
human	O
coronavirus	O
EMC	B-ANAT
:	O
how	O
scared	O
should	O
we	O
be	O
?	O

ABSTRACT	O
:	O
Immobilized	O
fibrinogen	B-ANAT
and	O
fibrin	O
facilitate	O
leukocyte	B-ANAT
adhesion	O
,	O
as	O
they	O
are	O
potent	O
ligands	O
for	O
leukocyte	B-ANAT
MAC	B-ANAT
-	O
1	O
(	O
CD11b	O
/	O
CD18	O
).	O

However	O
,	O
fibrinogen	B-ANAT
in	O
its	O
soluble	O
form	O
also	O
binds	O
to	O
MAC	B-ANAT
-	O
1	O
,	O
albeit	O
with	O
low	O
affinity	O
.	O

Soluble	O
fibrinogen	B-ANAT
reduced	O
MAC	B-ANAT
-	O
1	O
-	O
dependent	O
binding	O
of	O
interleukin	O
-	O
8	O
-	O
activated	O
neutrophils	B-ANAT
to	O
ICAM	O
-	O
1	O
-	O
expressing	O
cells	B-ANAT
under	O
flow	O
conditions	O
.	O

RESULTS	O
:	O
Soluble	O
fibrinogen	B-ANAT
functioned	O
as	O
a	O
natural	O
antagonist	O
of	O
neutrophil	B-ANAT
functions	O
that	O
are	O
dependent	O
on	O
MAC	B-ANAT
-	O
1	O
,	O
such	O
as	O
the	O
respiratory	O
burst	O
induced	O
by	O
unopsonized	O
zymosan	O
and	O
adhesion	O
to	O
ICAM	O
-	O
1	O
and	O
heparin	O
.	O

Importantly	O
soluble	O
fibrinogen	B-ANAT
in	O
acute	O
-	O
phase	O
concentrations	O
(	O
4	O
-	O
10	O
mg	O
mL	O
(-	O
1	O
)	O
)	O
dose	O
-	O
dependently	O
reduced	O
neutrophil	B-ANAT
firm	O
adhesion	O
to	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
-	O
activated	O
endothelium	B-ANAT
to	O
40	O
%	O
under	O
flow	O
conditions	O
.	O

The	O
localization	O
of	O
ORT	O
within	O
the	O
lung	B-ANAT
tissue	I-ANAT
was	O
demonstrated	O
by	O
fluorescent	O
in	O
-	O
situ	O
hybridization	O
in	O
the	O
bronchial	B-ANAT
exudate	B-ANAT
of	O
three	O
cases	O
,	O
although	O
not	O
within	O
the	O
granulomatous	O
lesions	O
themselves	O
.	O

ABSTRACT	O
:	O
A	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
disease	O
due	O
to	O
a	O
novel	O
betacoronavirus	O
,	O
human	O
coronavirus	O
EMC	B-ANAT
(	O
HCoV	O
-	O
EMC	B-ANAT
),	O
has	O
emerged	O
recently	O
.	O

We	O
conducted	O
a	O
seroprevalence	O
study	O
on	O
archived	O
sera	B-ANAT
from	O
94	O
game	O
-	O
food	O
animal	O
handlers	O
at	O
a	O
wild	O
life	O
market	O
,	O
28	O
SARS	O
patients	O
,	O
and	O
152	O
healthy	O
blood	B-ANAT
donors	O
in	O
Southern	O
China	O
to	O
assess	O
the	O
zoonotic	O
potential	O
and	O
evidence	O
for	O
intrusion	O
of	O
HCoV	O
-	O
EMC	B-ANAT
and	O
related	O
viruses	O
into	O
humans	O
.	O

ABSTRACT	O
:	O
In	O
addition	O
to	O
its	O
well	O
-	O
known	O
association	O
with	O
lung	B-ANAT
infection	O
(	O
i	O
.	O
e	O
.,	O
pneumonia	O
),	O
alcohol	O
abuse	O
now	O
is	O
recognized	O
as	O
an	O
independent	O
factor	O
that	O
increases	O
by	O
three	O
-	O
to	O
four	O
-	O
fold	O
the	O
incidence	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
a	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
with	O
a	O
mortality	O
rate	O
of	O
40	O
to	O
50	O
percent	O
.	O

This	O
translates	O
to	O
tens	O
of	O
thousands	O
of	O
excess	O
deaths	O
in	O
the	O
United	O
States	O
each	O
year	O
from	O
alcohol	O
-	O
mediated	O
lung	B-ANAT
injury	O
,	O
which	O
is	O
comparable	O
to	O
scarring	O
of	O
the	O
liver	B-ANAT
(	O
i	O
.	O
e	O
.,	O
cirrhosis	O
)	O
in	O
terms	O
of	O
alcohol	O
-	O
related	O
mortality	O
.	O

TITLE	O
:	O
[	O
Diffuse	O
infiltrative	O
lung	B-ANAT
disease	O
in	O
scleroderma	O
.	O

The	O
pulmonary	B-ANAT
function	O
objectified	O
a	O
severe	O
restrictive	O
ventilatory	O
defect	O
in	O
all	O
cases	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
lack	O
of	O
evidence	O
in	O
the	O
literature	O
,	O
we	O
report	O
the	O
case	O
of	O
a	O
25	O
-	O
year	O
-	O
old	O
man	O
involved	O
in	O
a	O
road	O
traffic	O
accident	O
,	O
who	O
had	O
an	O
inferior	B-ANAT
vena	I-ANAT
cava	I-ANAT
(	O
IVC	O
)	O
injury	O
and	O
severe	O
lung	B-ANAT
contusion	O
with	O
parenchymal	O
bleeding	O
requiring	O
an	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

The	O
blood	B-ANAT
agents	O
of	O
post	O
-	O
SARS	O
patients	O
changed	O
obviously	O
with	O
15	O
.	O
64	O
Â±	O
13	O
.	O
85	O
U	O
/	O
ml	O
while	O
the	O
control	O
group	O
7	O
.	O
96	O
Â±	O
4	O
.	O
27	O
U	O
/	O
ml	O
;	O
4G	O
/	O
4G	O
genotype	O
for	O
the	O
PAI	O
-	O
1	O
polymorphism	O
detected	O
in	O
post	O
-	O
SARS	O
group	O
was	O
more	O
than	O
that	O
of	O
the	O
control	O
group	O
,	O
but	O
had	O
no	O
statistical	O
significance	O
.	O

The	O
plasma	B-ANAT
PAI	O
activity	O
was	O
related	O
to	O
homozygote	O
4G	O
/	O
4G	O
genotype	O
.	O

Prospective	O
observational	O
study	O
was	O
conducted	O
after	O
hospital	O
discharge	B-ANAT
by	O
interviewing	O
with	O
respiratory	O
health	O
questionnaires	O
,	O
physical	O
examination	O
,	O
spirometry	O
,	O
methacholine	O
challenge	O
test	O
,	O
and	O
home	O
peak	O
expiratory	O
flow	O
(	O
PEF	O
)	O
monitoring	O
at	O
2	O
,	O
5	O
and	O
8	O
months	O
after	O
the	O
event	O
.	O

Three	O
most	O
common	O
symptoms	O
were	O
dyspnea	O
(	O
81	O
%),	O
chest	B-ANAT
tightness	O
(	O
71	O
%),	O
and	O
cough	O
(	O
67	O
%).	O

Obstructive	O
defect	O
from	O
spirometry	O
was	O
identified	O
in	O
2	O
participants	O
,	O
one	O
of	O
which	O
also	O
had	O
bronchial	B-ANAT
hyper	O
responsiveness	O
(	O
BHR	O
)	O
compatible	O
with	O
reactive	O
airway	B-ANAT
dysfunction	O
syndrome	O
(	O
RADS	O
).	O

ECMO	O
was	O
successfully	O
weaned	O
in	O
67	O
%	O
of	O
patients	O
,	O
and	O
60	O
%	O
survived	O
to	O
discharge	B-ANAT
.	O

ECMO	O
was	O
successfully	O
weaned	O
in	O
67	O
%	O
of	O
patients	O
,	O
and	O
60	O
%	O
survived	O
to	O
discharge	B-ANAT
.	O

The	O
assay	O
uses	O
the	O
S1	O
receptor	O
-	O
binding	O
subunit	O
of	O
the	O
spike	O
protein	O
of	O
hCoV	O
-	O
EMC	B-ANAT
and	O
SARS	O
-	O
CoV	O
as	O
antigens	O
.	O

ABSTRACT	O
:	O
The	O
identification	O
of	O
a	O
novel	O
Î²	O
coronavirus	O
,	O
nCoV	O
,	O
as	O
the	O
causative	O
agent	O
of	O
severe	O
respiratory	O
illness	O
in	O
humans	O
originating	O
in	O
Saudi	O
Arabia	O
,	O
Qatar	O
and	O
Jordan	O
has	O
raised	O
concerns	O
about	O
the	O
possibility	O
of	O
a	O
coronavirus	O
pandemic	O
similar	O
to	O
that	O
of	O
SARS	O
-	O
CoV	O
.	O
As	O
a	O
definitive	O
treatment	O
regimen	O
has	O
never	O
been	O
thoroughly	O
evaluated	O
for	O
coronavirus	O
infections	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
rapidly	O
identify	O
potential	O
therapeutics	O
to	O
address	O
future	O
cases	O
of	O
nCoV	O
.	O
To	O
determine	O
an	O
intervention	O
strategy	O
,	O
the	O
effect	O
of	O
interferon	O
-	O
Î±2b	O
and	O
ribavirin	O
on	O
nCoV	O
isolate	O
hCoV	O
-	O
EMC	B-ANAT
/	O
2012	O
replication	O
in	O
Vero	O
and	O
LLC	B-ANAT
-	O
MK2	O
cells	B-ANAT
was	O
evaluated	O
.	O

hCoV	O
-	O
EMC	B-ANAT
/	O
2012	O
was	O
sensitive	O
to	O
both	O
interferon	O
-	O
Î±2b	O
and	O
ribavirin	O
alone	O
in	O
Vero	O
and	O
LLC	B-ANAT
-	O
MK2	O
cells	B-ANAT
,	O
but	O
only	O
at	O
relatively	O
high	O
concentrations	O
;	O
however	O
,	O
when	O
combined	O
,	O
lower	O
concentrations	O
of	O
interferon	O
-	O
Î±2b	O
and	O
ribavirin	O
achieved	O
comparable	O
endpoints	O
.	O

We	O
use	O
the	O
LASM	O
to	O
identify	O
the	O
mechanical	O
ramifications	O
of	O
alveolar	B-ANAT
dynamics	O
associated	O
with	O
ARDS	O
.	O

TITLE	O
:	O
Airway	B-ANAT
management	O
in	O
an	O
infant	O
with	O
alobar	O
holoprosencephaly	O
and	O
cebocephaly	O
associated	O
with	O
maternal	O
diabetes	O
mellitus	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
case	O
represents	O
the	O
longest	O
reported	O
survival	O
of	O
an	O
infant	O
with	O
alobar	O
HPE	B-ANAT
and	O
cebocephaly	O
.	O

One	O
hundred	O
and	O
twenty	O
patients	O
with	O
SAP	O
were	O
enrolled	O
at	O
the	O
Pancreatic	B-ANAT
Disease	O
Institute	O
between	O
January	O
2007	O
and	O
March	O
2010	O
.	O

Complications	O
and	O
outcomes	O
including	O
respiratory	O
and	O
abdominal	B-ANAT
infection	O
,	O
sepsis	O
,	O
abdominal	B-ANAT
hemorrhage	O
,	O
intra	O
-	O
abdominal	B-ANAT
hypertension	O
,	O
abdominal	B-ANAT
compartment	I-ANAT
syndrome	O
(	O
ACS	O
),	O
renal	B-ANAT
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
),	O
operation	O
intervention	O
,	O
length	O
of	O
intensive	O
care	O
unit	O
stay	O
,	O
length	O
of	O
hospital	O
stay	O
,	O
and	O
mortality	O
at	O
60	O
d	O
were	O
compared	O
.	O

Furthermore	O
,	O
incidence	O
of	O
respiratory	O
and	O
abdominal	B-ANAT
infection	O
was	O
significantly	O
decreased	O
in	O
the	O
SH	O
and	O
SHG	O
groups	O
,	O
while	O
no	O
significant	O
difference	O
in	O
sepsis	O
was	O
seen	O
.	O

Blood	B-ANAT
SpO2	O
and	O
gastric	B-ANAT
mucosal	B-ANAT
pHi	O
in	O
the	O
SH	O
and	O
SHG	O
groups	O
increased	O
more	O
quickly	O
than	O
in	O
the	O
NS	O
group	O
,	O
while	O
IAP	O
was	O
significantly	O
decreased	O
in	O
the	O
SH	O
and	O
SHG	O
group	O
.	O

ABSTRACT	O
:	O
The	O
variable	O
regions	O
of	O
the	O
heavy	O
chain	O
(	O
VH	O
)	O
and	O
light	O
chain	O
(	O
VL	O
)	O
were	O
amplified	O
by	O
RT	O
-	O
PCR	O
from	O
the	O
hybridoma	B-ANAT
6E6	O
,	O
which	O
secretes	O
the	O
monoclonal	O
antibody	O
against	O
PEDV	O
S	O
protein	O
.	O

Herein	O
,	O
DNA	O
plasmid	O
bearing	O
TGEV	O
S1	O
gene	O
(	O
the	O
N	O
terminal	O
half	O
of	O
TGEV	O
S	O
gene	O
)	O
was	O
used	O
to	O
immunize	O
BALB	O
/	O
c	O
mice	O
followed	O
by	O
generation	O
of	O
a	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
using	O
the	O
hybridoma	B-ANAT
technique	O
.	O

Additionally	O
,	O
although	O
the	O
type	O
of	O
MAb	O
1H4	O
was	O
IgM	O
,	O
it	O
could	O
reduce	O
cell	B-ANAT
infection	O
by	O
TGEV	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Near	O
-	O
absolute	O
indications	O
selected	O
by	O
most	O
respondents	O
included	O
known	O
adrenal	O
insufficiency	O
(	O
99	O
%)	O
and	O
suspicion	O
of	O
cryptogenic	O
organizing	O
pneumonia	O
(	O
89	O
%),	O
connective	B-ANAT
tissue	I-ANAT
disease	O
(	O
85	O
%),	O
or	O
other	O
potentially	O
corticosteroid	O
-	O
responsive	O
illnesses	O
(	O
85	O
%).	O

High	O
mobility	O
group	O
box	O
1	O
(	O
HMGB1	O
),	O
which	O
was	O
identified	O
originally	O
as	O
a	O
DNA	O
binding	O
protein	O
,	O
has	O
been	O
proposed	O
as	O
a	O
mediator	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

Histopathologically	O
,	O
the	O
skin	B-ANAT
lesions	O
were	O
characterized	O
by	O
perivascular	O
infiltrates	O
of	O
macrophages	B-ANAT
,	O
neutrophils	B-ANAT
,	O
with	O
fewer	O
plasma	B-ANAT
cells	I-ANAT
,	O
mast	B-ANAT
cells	I-ANAT
,	O
and	O
small	O
lymphocytes	B-ANAT
in	O
the	O
mid	O
-	O
to	O
deep	O
dermis	B-ANAT
.	O

TITLE	O
:	O
[	O
Complications	O
in	O
patients	O
undergoing	O
thoracotomy	O
for	O
lung	B-ANAT
carcinoma	O
].	O

ABSTRACT	O
:	O
Lung	B-ANAT
cancer	O
is	O
a	O
common	O
fatal	O
disease	O
,	O
and	O
fewer	O
than	O
20	O
%	O
of	O
all	O
lung	B-ANAT
cancer	O
patients	O
are	O
candidates	O
for	O
a	O
curative	O
resection	O
.	O

Histories	O
of	O
heavy	O
smoking	O
,	O
chronic	O
lung	B-ANAT
disease	O
,	O
coexisting	O
medical	O
conditions	O
,	O
and	O
the	O
nature	O
of	O
the	O
procedure	O
contribute	O
.	O

ABSTRACT	O
:	O
Factor	O
V	O
Leiden	O
is	O
a	O
procoagulant	O
mutation	O
associated	O
with	O
venous	B-ANAT
and	O
arterial	B-ANAT
thrombosis	O
and	O
pregnancy	O
complications	O
.	O

However	O
,	O
the	O
patient	O
again	O
developed	O
persistent	O
hypoxaemia	O
and	O
,	O
after	O
unsuccessful	O
treatment	O
for	O
a	O
hospital	O
-	O
acquired	O
pneumonia	O
,	O
the	O
problems	O
further	O
expanded	O
to	O
include	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
ILD	O
).	O

These	O
characteristics	O
were	O
used	O
to	O
develop	O
an	O
assay	O
for	O
antiviral	O
compound	O
screening	O
in	O
96	O
-	O
well	O
format	O
,	O
which	O
was	O
used	O
to	O
identify	O
cyclosporin	O
A	O
as	O
an	O
inhibitor	O
of	O
MERS	O
-	O
CoV	O
replication	O
in	O
cell	B-ANAT
culture	O
.	O

Autonomic	B-ANAT
instability	O
characterizes	O
the	O
hyperkinetic	O
phase	O
.	O

ABSTRACT	O
:	O
The	O
stromal	O
scaffold	O
of	O
the	O
lymph	B-ANAT
node	I-ANAT
(	O
LN	O
)	O
paracortex	O
is	O
built	O
by	O
fibroblastic	O
reticular	O
cells	B-ANAT
(	O
FRCs	O
).	O

Thus	O
,	O
myofibroblasic	O
FRC	O
precursors	O
are	O
able	O
to	O
generate	O
the	O
basic	O
T	O
cell	B-ANAT
zone	I-ANAT
infrastructure	O
,	O
whereas	O
LTÎ²R	O
-	O
dependent	O
maturation	O
of	O
FRCs	O
guarantees	O
full	O
immunocompetence	O
and	O
hence	O
optimal	O
LN	O
function	O
during	O
infection	O
.	O

Based	O
on	O
the	O
208	O
base	O
pair	O
(	O
bp	O
)	O
sequence	O
of	O
novel	O
HCoV	O
reported	O
by	O
HPA	B-ANAT
of	O
UK	O
,	O
we	O
designed	O
and	O
obtained	O
several	O
pairs	O
of	O
primer	O
(	O
F	O
-	O
1	O
,	O
R	O
-	O
1	O
;	O
F	O
-	O
2	O
,	O
R	O
-	O
2	O
)	O
and	O
Taqman	O
probes	O
(	O
TZ1	O
,	O
TZ2	O
)	O
for	O
detection	O
of	O
novel	O
HCoV	O
.	O
Two	O
of	O
probes	O
were	O
modified	O
with	O
LNA	O
(	O
LNA	O
-	O
TZ1	O
,	O
LNA	O
-	O
TZ2	O
).	O

From	O
November	O
2006	O
to	O
October	O
2009	O
,	O
1169	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
(	O
NPA	O
)	O
were	O
collected	O
from	O
children	O
under	O
14	O
years	O
old	O
with	O
ARTIs	O
.	O

Later	O
in	O
infection	O
,	O
HCoV	O
-	O
EMC	B-ANAT
induced	O
a	O
massive	O
dysregulation	O
of	O
the	O
host	O
transcriptome	O
,	O
to	O
a	O
much	O
greater	O
extent	O
than	O
SARS	O
-	O
CoV	O
.	O
Both	O
viruses	O
induced	O
a	O
similar	O
activation	O
of	O
pattern	O
recognition	O
receptors	O
and	O
the	O
interleukin	O
17	O
(	O
IL	O
-	O
17	O
)	O
pathway	O
,	O
but	O
HCoV	O
-	O
EMC	B-ANAT
specifically	O
down	O
-	O
regulated	O
the	O
expression	O
of	O
several	O
genes	O
within	O
the	O
antigen	O
presentation	O
pathway	O
,	O
including	O
both	O
type	O
I	O
and	O
II	O
major	B-ANAT
histocompatibility	I-ANAT
complex	I-ANAT
(	O
MHC	B-ANAT
)	O
genes	O
.	O

Overall	O
,	O
HCoV	O
-	O
EMC	B-ANAT
and	O
SARS	O
-	O
CoV	O
elicit	O
distinct	O
host	O
gene	O
expression	O
responses	O
,	O
which	O
might	O
impact	O
in	O
vivo	O
pathogenesis	O
and	O
could	O
orient	O
therapeutic	O
strategies	O
against	O
that	O
emergent	O
virus	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
plays	O
a	O
multifunctional	O
role	O
in	O
the	O
virus	O
life	O
cycle	O
,	O
from	O
regulation	O
of	O
replication	O
and	O
transcription	O
and	O
genome	O
packaging	O
to	O
modulation	O
of	O
host	O
cell	B-ANAT
processes	I-ANAT
.	O

The	O
association	O
of	O
selected	O
cellular	B-ANAT
proteins	O
with	O
IBV	O
N	O
protein	O
was	O
confirmed	O
by	O
immunoblotting	O
,	O
cosedimentation	O
,	O
and	O
confocal	O
microscopy	O
.	O

Further	O
,	O
the	O
localization	O
of	O
selected	O
proteins	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
as	O
well	O
as	O
their	O
activity	O
during	O
virus	O
infection	O
was	O
assessed	O
by	O
small	O
interfering	O
RNA	O
-	O
mediated	O
depletion	O
,	O
demonstrating	O
the	O
functional	O
importance	O
of	O
cellular	B-ANAT
proteins	O
in	O
the	O
biology	O
of	O
IBV	O
.	O

This	O
in	O
vitro	O
model	O
will	O
be	O
critical	O
for	O
future	O
studies	O
to	O
determine	O
the	O
roles	O
of	O
these	O
specialized	O
cell	B-ANAT
types	O
in	O
the	O
pathogenesis	O
of	O
respiratory	O
viral	O
infection	O
.	O

Gross	O
lesions	O
,	O
white	O
exudate	B-ANAT
and	O
mucous	B-ANAT
membrane	I-ANAT
congestion	O
in	O
the	O
trachea	B-ANAT
as	O
well	O
as	O
blue	O
to	O
purple	O
color	O
changes	O
and	O
sclerosis	O
in	O
lungs	B-ANAT
were	O
observed	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
to	O
achieve	O
gas	O
exchange	O
independent	O
of	O
pulmonary	B-ANAT
function	O
in	O
patients	O
with	O
severe	O
respiratory	O
failure	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
should	O
be	O
considered	O
in	O
patients	O
with	O
Legionella	O
-	O
associated	O
respiratory	O
failure	O
,	O
who	O
have	O
failed	O
conventional	O
ventilation	O
.	O

RESULTS	O
:	O
The	O
indexes	O
of	O
pulmonary	B-ANAT
function	O
were	O
improved	O
after	O
treatment	O
in	O
both	O
groups	O
.	O

Prominent	O
unusual	O
presentations	O
included	O
acute	O
renal	B-ANAT
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
myocarditis	O
with	O
pericarditis	O
,	O
and	O
hemorrhages	O
over	O
the	O
brain	B-ANAT
and	O
heart	B-ANAT
.	O

TITLE	O
:	O
Phylogeny	O
and	O
expression	O
of	O
the	O
nucleocapsid	B-ANAT
gene	O
of	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
.	O

TITLE	O
:	O
A	O
combination	O
of	O
epitope	O
prediction	O
and	O
molecular	O
docking	O
allows	O
for	O
good	O
identification	O
of	O
MHC	B-ANAT
class	O
I	O
restricted	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
.	O

ABSTRACT	O
:	O
In	O
silico	O
identification	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
epitopes	O
is	O
emerging	O
as	O
a	O
new	O
methodology	O
for	O
the	O
study	O
of	O
epitope	O
-	O
based	O
vaccines	O
against	O
viruses	O
and	O
cancer	O
.	O

Urine	B-ANAT
studies	O
revealed	O
renal	B-ANAT
potassium	O
wasting	O
.	O

Multivariate	O
analysis	O
of	O
the	O
risk	O
factors	O
generated	O
a	O
new	O
predictive	O
model	O
of	O
mortality	O
applicable	O
within	O
the	O
first	O
24h	O
after	O
ICU	O
admission	O
and	O
comprising	O
5	O
main	O
factors	O
:	O
age	O
,	O
CURB	O
severity	O
score	O
3	O
-	O
4	O
,	O
septic	O
shock	O
,	O
ARDS	O
,	O
and	O
acute	O
renal	B-ANAT
failure	O
.	O

TITLE	O
:	O
Another	O
case	O
of	O
""""	O
European	O
hantavirus	O
pulmonary	B-ANAT
syndrome	O
""""	O
with	O
severe	O
lung	B-ANAT
,	O
prior	O
to	O
kidney	B-ANAT
,	O
involvement	O
,	O
and	O
diagnosed	O
by	O
viral	O
inclusions	O
in	O
lung	B-ANAT
macrophages	B-ANAT
.	O

ABSTRACT	O
:	O
Puumala	O
virus	O
(	O
PUUV	O
)	O
is	O
considered	O
a	O
classic	O
Old	O
World	O
etiologic	O
agent	O
of	O
nephropathia	O
epidemica	O
(	O
NE	O
),	O
or	O
hemorrhagic	O
fever	O
with	O
renal	B-ANAT
syndrome	O
(	O
HFRS	O
).	O

Cor	B-ANAT
pulmonale	O
was	O
associated	O
with	O
sepsis	O
and	O
higher	O
values	O
of	O
driving	O
pressure	O
and	O
was	O
an	O
independent	O
risk	O
factor	O
for	O
28	O
-	O
day	O
mortality	O
in	O
our	O
series	O
.	O

RESULTS	O
:	O
Cor	B-ANAT
pulmonale	O
was	O
detected	O
in	O
49	O
patients	O
(	O
prevalence	O
of	O
22	O
%;	O
95	O
%	O
confidence	O
interval	O
,	O
16	O
-	O
27	O
%).	O

Indirect	O
immunofluorescent	O
assay	O
(	O
IFA	O
)	O
and	O
double	O
-	O
antigen	O
sandwich	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
were	O
used	O
to	O
detect	O
the	O
SARS	O
coronavirus	O
-	O
specific	O
IgG	O
antibodies	O
in	O
sera	B-ANAT
of	O
1700	O
,	O
including	O
1453	O
general	O
populations	O
from	O
Hongkong	O
,	O
Marco	O
,	O
Guangzhou	O
and	O
Peking	O
and	O
257	O
SARS	O
patients	O
from	O
Guangzhou	O
and	O
Peking	O
.	O

ABSTRACT	O
:	O
Induction	O
of	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
)	O
is	O
an	O
adaptive	O
cellular	B-ANAT
response	O
to	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	B-ANAT
)	O
stress	O
that	O
allows	O
a	O
cell	B-ANAT
to	O
reestablish	O
ER	B-ANAT
homeostasis	O
.	O

Meanwhile	O
,	O
activating	O
transcription	O
factor	O
4	O
(	O
ATF4	O
)	O
was	O
upregulated	O
at	O
the	O
protein	O
level	O
in	O
the	O
infected	O
cells	B-ANAT
,	O
resulting	O
in	O
the	O
induction	O
in	O
trans	O
of	O
the	O
transcription	O
factor	O
ATF3	O
and	O
the	O
proapoptotic	O
growth	O
arrest	O
and	O
DNA	O
damage	O
-	O
inducible	O
protein	O
GADD153	O
.	O

Analysis	O
of	O
the	O
pathways	O
downstream	O
of	O
GADD153	O
revealed	O
much	O
more	O
activation	O
of	O
the	O
extracellular	B-ANAT
signal	O
-	O
related	O
kinase	O
(	O
ERK	O
)	O
pathway	O
in	O
GADD153	O
-	O
knockdown	O
cells	B-ANAT
during	O
IBV	O
infection	O
,	O
indicating	O
that	O
GADD153	O
may	O
modulate	O
apoptosis	O
through	O
suppression	O
of	O
the	O
pathway	O
.	O

Although	O
numerically	O
fewer	O
chickens	O
vaccinated	O
with	O
Mass	O
+	O
Conn	O
had	O
interstitial	B-ANAT
nephritis	O
compared	O
with	O
those	O
vaccinated	O
with	O
Mass	O
+	O
Ark	O
,	O
neither	O
vaccine	O
combination	O
offered	O
greater	O
protection	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
than	O
observed	O
in	O
unvaccinated	O
chickens	O
challenged	O
with	O
DMV	O
/	O
1639	O
/	O
11	O
.	O

ABSTRACT	O
:	O
Three	O
weanling	O
Thoroughbred	O
fillies	O
were	O
presented	O
during	O
autumn	O
with	O
depression	O
,	O
muscle	B-ANAT
rigidity	O
and	O
,	O
in	O
one	O
case	O
,	O
colic	O
symptoms	O
and	O
cardiovascular	B-ANAT
shock	O
.	O

We	O
describe	O
a	O
number	O
of	O
experimental	O
therapies	O
that	O
have	O
shown	O
promise	O
in	O
preventing	O
or	O
reversing	O
increased	O
vascular	B-ANAT
leak	O
in	O
animal	O
models	O
of	O
sepsis	O
or	O
influenza	O
.	O

ABSTRACT	O
:	O
CblD	O
disorder	O
is	O
an	O
autosomal	B-ANAT
recessive	O
,	O
rare	O
,	O
heterogeneous	O
disease	O
with	O
variable	O
clinical	O
presentations	O
,	O
depending	O
on	O
the	O
nature	O
and	O
location	O
of	O
the	O
MMADHC	O
gene	O
mutations	O
.	O

We	O
set	O
out	O
to	O
measure	O
changes	O
in	O
HDL	O
in	O
sepsis	O
-	O
mediated	O
ARDS	O
patients	O
,	O
and	O
to	O
study	O
the	O
potential	O
of	O
L	O
-	O
4F	O
to	O
prevent	O
sepsis	O
-	O
mediated	O
ARDS	O
in	O
a	O
rodent	O
model	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
mediated	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
a	O
combination	O
of	O
primary	O
human	O
leukocytes	B-ANAT
and	O
human	O
ARDS	O
serum	B-ANAT
.	O

In	O
a	O
rat	O
model	O
of	O
severe	O
endotoxemia	O
,	O
L	O
-	O
4F	O
significantly	O
decreased	O
mortality	O
and	O
reduces	O
lung	B-ANAT
and	O
liver	B-ANAT
injury	O
,	O
even	O
when	O
administered	O
1	O
hour	O
post	O
LPS	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
beneficial	O
strategy	O
for	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
.	O

Complications	O
included	O
acute	O
renal	B-ANAT
insufficiency	O
with	O
temporary	O
need	O
of	O
renal	B-ANAT
replacement	O
therapy	O
(	O
53	O
%),	O
bleeding	O
(	O
33	O
%),	O
critical	O
illness	O
polyneuropathy	O
(	O
66	O
%),	O
and	O
reversible	O
thrombocytopenia	O
(	O
73	O
%).	O

Due	O
to	O
multi	O
-	O
organ	B-ANAT
involvement	O
in	O
P	O
.	O
Falciparum	O
malaria	O
,	O
supportive	O
therapy	O
is	O
crucial	O
along	O
with	O
parenteral	O
antimalarial	O
to	O
improve	O
survival	O
.	O

In	O
addition	O
,	O
abdominal	B-ANAT
paracentesis	O
is	O
often	O
needed	O
for	O
pain	O
relief	O
and	O
to	O
reduce	O
the	O
pressure	O
of	O
tense	O
ascites	O
.	O

ECMO	O
TECHNIQUES	O
:	O
Two	O
types	O
of	O
ECMO	O
are	O
used	O
:	O
veno	O
-	O
venous	B-ANAT
ECMO	O
(	O
VV	O
-	O
ECMO	O
)	O
or	O
veno	O
-	O
arterial	B-ANAT
ECMO	O
(	O
VA	O
-	O
ECMO	O
).	O

Absolute	O
contraindications	O
are	O
uncontrolled	O
coagulopathy	O
and	O
severe	O
intracranial	B-ANAT
bleeding	O
,	O
which	O
precludes	O
the	O
use	O
of	O
anticoagulation	O
therapy	O
.	O

In	O
patients	O
with	O
life	O
-	O
threatening	O
haemodynamic	O
instability	O
,	O
VA	O
-	O
ECMO	O
can	O
be	O
considered	O
when	O
shock	O
persists	O
despite	O
volume	O
administration	O
,	O
inotropes	O
and	O
vasoconstrictors	O
,	O
and	O
(	O
sometimes	O
)	O
intra	O
-	O
aortic	B-ANAT
balloon	O
counterpulsation	O
.	O

A59	O
and	O
ns2	O
-	O
H126R	O
replicated	O
with	O
similar	O
kinetics	O
in	O
all	O
cell	B-ANAT
types	O
tested	O
,	O
except	O
macrophages	B-ANAT
and	O
microglia	B-ANAT
.	O

However	O
,	O
rRNA	O
degradation	O
was	O
induced	O
by	O
treatment	O
of	O
astrocytes	B-ANAT
or	O
oligodendrocytes	B-ANAT
with	O
poly	O
(	O
I	O
Â·	O
C	O
).	O

Our	O
results	O
indicate	O
that	O
a	O
dileucine	O
motif	O
in	O
the	O
endodomain	O
tail	O
(	O
218LL219	O
)	O
is	O
required	O
for	O
efficient	O
N	O
packaging	O
into	O
VLPs	B-ANAT
.	O

All	O
three	O
patients	O
had	O
severe	O
cardiac	B-ANAT
dysfunction	O
,	O
respiratory	O
failure	O
,	O
and	O
acute	O
kidney	B-ANAT
injury	O
treated	O
with	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
,	O
and	O
plasma	B-ANAT
exchange	O
.	O

Anaesthesia	O
for	O
this	O
long	O
procedure	O
involves	O
advanced	O
planning	O
for	O
airway	B-ANAT
management	O
,	O
vascular	B-ANAT
access	O
,	O
technique	O
of	O
anaesthesia	O
,	O
and	O
fluid	O
management	O
.	O

Furthermore	O
,	O
overexpression	O
of	O
ApoE3	O
and	O
ApoE4	O
isoforms	O
but	O
not	O
ApoE2	O
significantly	O
inhibited	O
the	O
ApoD	O
promoter	O
activity	O
in	O
U87	O
cells	B-ANAT
(	O
E3	O
/	O
E3	O
genotype	O
)	O
cultured	O
under	O
normal	O
or	O
different	O
stress	O
conditions	O
while	O
ApoE	O
knock	O
-	O
down	O
by	O
siRNA	O
had	O
a	O
converse	O
effect	O
.	O

This	O
negative	O
correlation	O
was	O
also	O
observed	O
for	O
cortex	B-ANAT
layers	B-ANAT
IV	O
-	O
VI	O
based	O
on	O
a	O
new	O
Transcriptomic	O
Atlas	B-ANAT
of	O
the	O
Mouse	O
Neocortical	O
Layers	B-ANAT
.	O

A	O
key	O
activity	O
of	O
the	O
protein	O
is	O
the	O
ability	O
to	O
oligomerize	O
during	O
capsid	B-ANAT
formation	O
by	O
utilizing	O
the	O
dimer	O
as	O
a	O
building	O
block	O
,	O
but	O
the	O
structural	O
and	O
mechanistic	O
bases	O
of	O
this	O
activity	O
are	O
not	O
well	O
understood	O
.	O

The	O
IBV	O
virus	O
was	O
detected	O
in	O
the	O
caecal	O
tonsils	B-ANAT
and	O
cloaca	B-ANAT
from	O
the	O
2nd	O
to	O
the	O
12th	O
day	O
PI	O
.	O

The	O
most	O
obvious	O
histopathological	O
lesions	O
were	O
found	O
in	O
the	O
trachea	B-ANAT
,	O
kidney	B-ANAT
,	O
lungs	B-ANAT
and	O
bursa	B-ANAT
of	I-ANAT
Fabricius	I-ANAT
.	O

Ultrasonographic	O
evaluation	O
of	O
the	O
abdomen	B-ANAT
did	O
not	O
identify	O
any	O
abnormalities	O
.	O

Polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
on	O
formalin	O
-	O
fixed	B-ANAT
paraffin	O
-	O
wax	B-ANAT
embedded	O
tissues	B-ANAT
was	O
positive	O
for	O
Toxoplasma	O
sp	O
.,	O
but	O
attempts	O
at	O
sequencing	O
were	O
unsuccessful	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
most	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
were	O
presciently	O
described	O
nearly	O
two	O
centuries	O
ago	O
by	O
RenÃ©	O
Laennec	O
,	O
later	O
to	O
be	O
described	O
clinically	O
in	O
the	O
1950s	O
and	O
1960s	O
.	O

This	O
study	O
demonstrated	O
that	O
hyposialylated	O
fAGP	O
down	O
-	O
regulates	O
the	O
phagocytic	O
activity	O
of	O
feline	O
neutrophils	B-ANAT
.	O

Respiratory	O
symptoms	O
rapidly	O
became	O
predominant	O
with	O
acute	O
respiratory	O
failure	O
leading	O
to	O
mechanical	O
ventilation	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

Patient	O
1	O
died	O
on	O
May	O
28	O
,	O
due	O
to	O
refractory	O
multiple	O
organ	B-ANAT
failure	O
.	O

Specific	O
CT	O
images	O
of	O
GC	O
in	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
included	O
enlarged	O
and	O
high	O
-	O
tensioned	O
gallbladder	B-ANAT
,	O
wall	O
thickening	O
,	O
lumenal	O
emphysema	O
,	O
discontinuous	O
and	O
/	O
or	O
irregular	O
enhancement	O
of	O
mucosa	B-ANAT
,	O
and	O
pericholecystic	O
effusion	B-ANAT
.	O

This	O
is	O
the	O
first	O
reported	O
use	O
of	O
immunocytochemistry	O
for	O
detection	O
of	O
feline	O
coronavirus	O
within	O
CSF	B-ANAT
macrophages	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
clinical	O
presentation	O
ofmyositis	O
ranges	O
from	O
a	O
painless	O
muscle	B-ANAT
weakness	O
to	O
significant	O
myalgia	O
with	O
muscle	B-ANAT
weakness	O
and	O
constitutional	O
symptoms	O
.	O

Along	O
with	O
muscle	B-ANAT
and	O
skin	B-ANAT
affection	O
and	O
constitutional	O
symptoms	O
,	O
the	O
disease	O
can	O
affect	O
lungs	B-ANAT
,	O
joints	B-ANAT
,	O
heart	B-ANAT
and	O
gastrointestinal	B-ANAT
system	I-ANAT
.	O

Severe	O
forms	O
of	O
the	O
disease	O
with	O
affection	O
of	O
the	O
throat	B-ANAT
and	O
respiratory	B-ANAT
muscles	I-ANAT
can	O
vitally	O
endan	O
-	O
ger	B-ANAT
patients	O
.	O

The	O
affection	O
of	O
lung	B-ANAT
can	O
sometimes	O
result	O
in	O
fatal	O
outcome	O
(	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
,	O
secondary	O
pulmonary	B-ANAT
hypertension	O
).	O

Routine	O
neurological	O
evaluation	O
,	O
including	O
computed	O
tomography	O
of	O
the	O
head	B-ANAT
,	O
was	O
within	O
normal	O
limits	O
.	O

TITLE	O
:	O
Controversial	O
treatment	O
of	O
a	O
victim	O
of	O
severe	O
head	B-ANAT
injury	O
complicated	O
by	O
septic	O
shock	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Pneumonia	O
,	O
severe	O
sepsis	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
frequent	O
complications	O
after	O
head	B-ANAT
trauma	O
.	O

RL	O
or	O
RS	O
protein	O
with	O
95	O
%	O
purity	O
was	O
obtained	O
and	O
reacted	O
positively	O
with	O
anti	O
-	O
sera	B-ANAT
from	O
mice	O
immunized	O
with	O
the	O
recombinant	O
vaccinia	O
virus	O
(	O
Tiantan	O
strain	O
)	O
in	O
which	O
HCoV	O
-	O
NL63	O
RL	O
or	O
RS	O
protein	O
was	O
expressed	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
)	O
plays	O
an	O
essential	O
structural	O
role	O
in	O
virions	B-ANAT
through	O
a	O
network	O
of	O
interactions	O
with	O
positive	O
-	O
strand	O
viral	O
genomic	O
RNA	O
,	O
the	O
envelope	B-ANAT
membrane	B-ANAT
protein	O
(	O
M	O
),	O
and	O
other	O
N	O
molecules	O
.	O

Staining	O
with	O
Hoechst	O
33	O
,	O
342	O
revealed	O
morphological	O
changes	O
in	O
the	O
nuclei	O
and	O
chromatin	B-ANAT
fragmentation	O
.	O

The	O
percentage	O
of	O
apoptotic	O
cells	B-ANAT
increased	O
with	O
the	O
incubation	O
time	O
and	O
reached	O
a	O
maximum	O
at	O
96h	O
post	O
-	O
infection	O
,	O
as	O
determined	O
using	O
flow	O
cytometry	O
and	O
fluorescence	O
microscopy	O
of	O
cells	B-ANAT
that	O
were	O
stained	O
with	O
annexin	O
V	O
-	O
FITC	O
and	O
propidium	O
iodide	O
(	O
PI	O
).	O

Moreover	O
,	O
as	O
is	O
commonly	O
observed	O
for	O
coronavirus	O
infections	O
of	O
other	O
animals	O
,	O
the	O
activities	O
of	O
the	O
effecter	O
caspase	O
,	O
caspase	O
-	O
3	O
,	O
and	O
the	O
initiator	O
caspases	O
,	O
caspase	O
-	O
8	O
and	O
caspase	O
-	O
9	O
,	O
which	O
are	O
representative	O
factors	O
in	O
the	O
death	O
receptor	O
-	O
mediated	O
apoptotic	O
pathway	O
and	O
the	O
mitochondrial	B-ANAT
apoptotic	O
pathway	O
,	O
respectively	O
,	O
were	O
increased	O
in	O
PHEV	O
-	O
infected	O
PK	O
-	O
15	O
cells	B-ANAT
.	O

Apoptotic	O
death	O
of	O
infected	O
cells	B-ANAT
is	O
detrimental	O
to	O
animals	O
because	O
it	O
causes	O
cell	B-ANAT
and	O
tissue	B-ANAT
destruction	O
.	O

The	O
complications	O
seen	O
in	O
vivax	O
malaria	O
were	O
:	O
thrombocytopenia	O
(	O
68	O
%),	O
leukopenia	O
(	O
19	O
%),	O
ARDS	O
(	O
3	O
%),	O
high	O
bilirubin	O
(	O
5	O
%),	O
acute	O
renal	B-ANAT
failure	O
(	O
3	O
.	O
5	O
%),	O
anemia	O
(	O
3	O
%),	O
mucosal	B-ANAT
bleeding	O
(	O
8	O
%),	O
cerebral	B-ANAT
malaria	O
(	O
3	O
.	O
5	O
%),	O
hypotension	O
(	O
5	O
%),	O
metabolic	O
acidosis	O
(	O
4	O
%)	O
and	O
death	O
(	O
1	O
.	O
77	O
%).	O

Within	O
all	O
MTPs	O
with	O
10	O
or	O
more	O
units	O
of	O
PRBC	O
,	O
HRR	O
was	O
not	O
a	O
predictor	O
of	O
morbidity	O
,	O
but	O
crystalloid	B-ANAT
volume	O
was	O
.	O

Although	O
exact	O
mechanisms	O
are	O
yet	O
to	O
be	O
discerned	O
,	O
vitamin	O
D	O
appears	O
to	O
impact	O
on	O
a	O
variety	O
of	O
inflammatory	O
and	O
structural	O
cells	B-ANAT
within	O
the	O
lung	B-ANAT
including	O
macrophages	B-ANAT
,	O
lymphocytes	B-ANAT
and	O
epithelial	B-ANAT
cells	I-ANAT
.	O

Stool	B-ANAT
samples	O
obtained	O
on	O
days	O
12	O
and	O
16	O
contained	O
the	O
virus	O
,	O
with	O
up	O
to	O
1031	O
RNA	O
copies	O
per	O
g	O
(	O
close	O
to	O
the	O
lowest	O
detection	O
limit	O
of	O
the	O
assay	O
).	O

To	O
our	O
surprise	O
,	O
no	O
relationship	O
was	O
observed	O
between	O
clinical	O
severity	O
and	O
sole	B-ANAT
or	O
coinfections	O
.	O

Direct	O
interactions	O
with	O
the	O
small	O
sugar	O
fragments	O
Man3	O
,	O
Man5	O
,	O
and	O
(	O
GlcNAc	O
)	O
2Man3	O
were	O
investigated	O
alongside	O
Man9GlcNAc	O
derived	O
from	O
recombinant	O
gp120	O
(	O
present	O
on	O
the	O
HIV	O
viral	B-ANAT
envelope	I-ANAT
),	O
providing	O
the	O
first	O
structural	O
data	O
for	O
DC	O
-	O
SIGNR	O
in	O
complex	O
with	O
a	O
virus	O
-	O
associated	O
ligand	O
,	O
and	O
unique	O
binding	O
modes	O
were	O
observed	O
for	O
each	O
glycan	O
.	O

Beside	O
the	O
well	O
known	O
capacity	O
to	O
act	O
as	O
plasma	B-ANAT
-	O
expander	O
,	O
HSA	O
is	O
provided	O
of	O
many	O
other	O
properties	O
which	O
are	O
unrelated	O
to	O
the	O
regulation	O
of	O
fluid	O
compartmentalization	O
,	O
including	O
binding	O
and	O
transport	O
of	O
many	O
endogenous	O
and	O
exogenous	O
substances	O
,	O
antioxidant	O
function	O
,	O
immuno	O
-	O
modulation	O
,	O
anti	O
-	O
inflammatory	O
activity	O
,	O
and	O
endothelial	B-ANAT
stabilization	O
.	O

Other	O
clinical	O
uses	O
for	O
HSA	O
administration	O
not	O
supported	O
by	O
definitive	O
scientific	O
evidence	O
are	O
long	O
-	O
term	O
treatment	O
of	O
ascites	O
,	O
nephrotic	O
syndrome	O
,	O
pancreatitis	O
,	O
abdominal	B-ANAT
surgery	O
,	O
acute	O
distress	O
respiratory	O
syndrome	O
,	O
cerebral	B-ANAT
ischemia	O
,	O
and	O
enteric	O
diseases	O
.	O

Overall	O
,	O
of	O
the	O
97	O
influenza	O
infected	O
patients	O
,	O
9	O
(	O
9	O
.	O
3	O
%)	O
needed	O
hospitalisation	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
);	O
one	O
patient	O
with	O
COPD	O
died	O
due	O
to	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
Staphylococcus	O
toxic	O
shock	O
syndrome	O
presenting	O
with	O
multiple	O
pneumatocoeles	O
in	O
the	O
chest	B-ANAT
.	O

Adverse	O
events	O
were	O
rarely	O
reported	O
but	O
included	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
ventricular	B-ANAT
fibrillation	O
,	O
and	O
hypotension	O
.	O

Adventitious	O
viruses	O
in	O
the	O
RPTEC	O
were	O
isolated	O
and	O
/	O
or	O
detected	O
and	O
identified	O
by	O
isolation	O
in	O
various	O
indicator	O
cell	B-ANAT
lines	I-ANAT
,	O
observation	O
of	O
cytopathology	O
,	O
an	O
immunoflurorescence	O
assay	O
,	O
electron	O
microscopy	O
,	O
PCR	O
,	O
and	O
sequencing	O
.	O

Whereas	O
we	O
are	O
unable	O
to	O
determine	O
whether	O
the	O
original	O
RPTEC	O
were	O
pre	O
-	O
infected	O
prior	O
to	O
their	O
separation	O
from	O
other	O
kidney	B-ANAT
cells	B-ANAT
,	O
or	O
had	O
gotten	O
contaminated	O
with	O
HCoV	O
-	O
NL63	O
from	O
an	O
ill	O
laboratory	O
worker	O
during	O
their	O
preparation	O
for	O
commercial	O
sale	O
,	O
our	O
findings	O
are	O
a	O
reminder	O
that	O
human	O
-	O
derived	O
biologicals	O
should	O
always	O
be	O
considered	O
as	O
potential	O
sources	O
of	O
infectious	O
agents	O
.	O

The	O
RT	O
-	O
RPA	B-ANAT
assay	O
was	O
significantly	O
more	O
rapid	O
than	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
.	O

The	O
BCoV	O
RT	O
-	O
RPA	B-ANAT
constitutes	O
a	O
suitable	O
accurate	O
,	O
sensitive	O
and	O
rapid	O
alternative	O
to	O
the	O
common	O
measures	O
used	O
for	O
BCoV	O
diagnosis	O
.	O

Despite	O
the	O
high	O
prevalence	O
of	O
this	O
disease	O
in	O
our	O
midst	O
,	O
there	O
has	O
been	O
no	O
report	O
on	O
the	O
clinical	O
features	O
in	O
the	O
sickle	B-ANAT
cell	I-ANAT
pediatric	O
population	O
suffering	O
from	O
malaria	O
in	O
our	O
midst	O
.	O

No	O
case	O
of	O
cerebral	B-ANAT
malaria	O
was	O
found	O
.	O

However	O
,	O
the	O
patient	O
developed	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
then	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
initiated	O
on	O
the	O
2nd	O
day	O
.	O

Sampling	O
was	O
done	O
using	O
mid	O
-	O
turbinate	B-ANAT
flocked	O
swabs	O
,	O
and	O
the	O
collected	O
samples	O
were	O
stored	O
in	O
universal	O
transport	O
medium	O
.	O

After	O
the	O
incubation	O
period	O
of	O
seven	O
days	O
standard	O
practice	O
is	O
for	O
the	O
embryos	B-ANAT
to	O
be	O
taken	O
from	O
each	O
egg	B-ANAT
and	O
examined	O
visually	O
for	O
IB	O
specific	O
lesions	O
;	O
these	O
readings	O
are	O
used	O
to	O
determine	O
an	O
end	O
-	O
point	O
in	O
viral	O
titrations	O
.	O

In	O
order	O
to	O
determine	O
end	O
-	O
points	O
in	O
the	O
titration	O
for	O
each	O
of	O
the	O
two	O
strains	O
,	O
we	O
collected	O
the	O
allantoic	O
fluids	B-ANAT
from	O
each	O
egg	B-ANAT
after	O
the	O
incubation	O
period	O
and	O
tested	O
these	O
for	O
the	O
presence	O
of	O
IB	O
H120	O
and	O
IB	O
D274	O
by	O
a	O
strain	O
specific	O
reverse	O
phase	O
PCR	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
emergent	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
can	O
cause	O
severe	O
pulmonary	B-ANAT
disease	O
in	O
humans	O
,	O
representing	O
the	O
second	O
example	O
of	O
a	O
highly	O
pathogenic	O
coronavirus	O
,	O
the	O
first	O
being	O
SARS	O
-	O
CoV	O
.	O
CD26	O
(	O
also	O
known	O
as	O
dipeptidyl	O
peptidase	O
4	O
,	O
DPP4	O
)	O
was	O
recently	O
identified	O
as	O
the	O
cellular	B-ANAT
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
The	O
engagement	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
with	O
CD26	O
mediates	O
viral	O
attachment	O
to	O
host	O
cells	B-ANAT
and	O
virus	O
-	O
cell	B-ANAT
fusion	O
,	O
thereby	O
initiating	O
infection	O
.	O

Here	O
we	O
delineate	O
the	O
molecular	O
basis	O
of	O
this	O
specific	O
interaction	O
by	O
presenting	O
the	O
first	O
crystal	B-ANAT
structures	O
of	O
both	O
the	O
free	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
and	O
its	O
complex	O
with	O
CD26	O
.	O

We	O
report	O
the	O
3	O
.	O
0	O
Ã	O
-	O
resolution	O
crystal	B-ANAT
structure	O
of	O
MERS	O
-	O
CoV	O
RBD	O
bound	O
to	O
the	O
extracellular	B-ANAT
domain	O
of	O
human	O
DPP4	O
.	O

Reporter	O
gene	O
expression	O
was	O
confirmed	O
by	O
fluorescence	O
microscopy	O
,	O
or	O
luciferase	O
activity	O
assays	O
,	O
for	O
all	O
successfully	O
rescued	O
rIBVs	O
following	O
infection	O
of	O
primary	O
chick	O
kidney	B-ANAT
(	O
CK	O
)	O
cells	B-ANAT
.	O

The	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWi	O
)	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
index	O
(	O
PVPI	O
)	O
were	O
measured	O
using	O
a	O
transpulmonary	O
thermodilution	O
method	O
for	O
three	O
consecutive	O
days	O
in	O
195	O
patients	O
with	O
an	O
EVLWi	O
of	O
â¥	O
10	O
mL	O
/	O
kg	O
and	O
who	O
fulfilled	O
the	O
Berlin	O
definition	O
of	O
ARDS	O
.	O

We	O
evaluated	O
the	O
effect	O
of	O
HFO	O
-	O
TGI	O
on	O
PaO2	O
/	O
fractional	O
inspired	O
O2	O
(	O
FiO2	O
)	O
and	O
PaCO2	O
,	O
systemic	O
hemodynamics	O
,	O
intracranial	B-ANAT
pressure	O
(	O
ICP	O
),	O
and	O
cerebral	B-ANAT
perfusion	O
pressure	O
(	O
CPP	O
)	O
in	O
patients	O
with	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
and	O
concurrent	O
severe	O
ARDS	O
.	O

RESULTS	O
:	O
Injured	O
regions	O
demonstrate	O
increased	O
pulmonary	B-ANAT
blood	B-ANAT
flow	O
in	O
association	O
with	O
reduced	O
arterial	B-ANAT
pressure	O
and	O
the	O
deterioration	O
of	O
arterial	B-ANAT
oxygenation	O
.	O

Over	O
the	O
course	O
of	O
48	O
hours	O
,	O
the	O
use	O
of	O
HFOV	O
reduced	O
the	O
oxygenation	O
index	O
[	O
38	O
(	O
31	O
-	O
50	O
)	O
vs	O
.	O
17	O
(	O
10	O
-	O
27	O
)]	O
and	O
increased	O
the	O
ratio	O
of	O
partial	O
arterial	B-ANAT
pressure	O
O2	O
and	O
fraction	O
of	O
inspired	O
O2	O
[	O
65	O
[	O
44	O
-	O
80	O
)	O
vs	O
.	O
152	O
(	O
106	O
-	O
213	O
)].	O

The	O
mean	O
airway	B-ANAT
pressure	O
ranged	O
between	O
23	O
and	O
29	O
cmH2O	O
.	O

HFOV	O
did	O
not	O
compromise	O
hemodynamics	O
,	O
and	O
a	O
reduction	O
in	O
heart	B-ANAT
rate	O
was	O
observed	O
(	O
141	O
Â±	O
32	O
vs	O
.	O
119	O
Â±	O
22	O
beats	O
/	O
min	O
),	O
whereas	O
mean	O
arterial	B-ANAT
pressure	O
(	O
66	O
Â±	O
20	O
vs	O
.	O
71	O
Â±	O
17	O
mmHg	O
)	O
and	O
inotropic	O
score	O
[	O
44	O
(	O
17	O
-	O
130	O
)	O
vs	O
.	O
20	O
(	O
16	O
-	O
75	O
)]	O
remained	O
stable	O
during	O
this	O
period	O
.	O

TITLE	O
:	O
Identification	O
of	O
two	O
ATR	O
-	O
dependent	O
phosphorylation	O
sites	O
on	O
coronavirus	O
nucleocapsid	B-ANAT
protein	O
with	O
nonessential	O
functions	O
in	O
viral	O
replication	O
and	O
infectivity	O
in	O
cultured	B-ANAT
cells	I-ANAT
.	O

Upon	O
histological	O
examination	O
,	O
intraoperative	O
muscle	B-ANAT
biopsy	O
showed	O
severe	O
muscle	B-ANAT
damage	O
.	O

We	O
also	O
introduce	O
a	O
novel	O
method	O
to	O
assess	O
the	O
degree	O
of	O
ischemic	O
injury	O
,	O
which	O
may	O
be	O
suitable	O
in	O
the	O
near	O
future	O
for	O
the	O
rapid	O
detection	O
of	O
irreversible	O
muscle	B-ANAT
injury	O
.	O

Western	O
blot	O
analysis	O
was	O
used	O
to	O
validate	O
the	O
changes	O
of	O
alpha	O
tubulin	B-ANAT
,	O
keratin	O
19	O
,	O
and	O
prohibitin	O
during	O
TGEV	O
infection	O
.	O

In	O
contrast	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
an	O
exemplar	O
of	O
an	O
acute	O
pulmonary	B-ANAT
process	O
.	O

ABSTRACT	O
:	O
Use	O
of	O
aspirin	O
(	O
acetylsalicylic	O
acid	O
[	O
ASA	O
])	O
was	O
found	O
to	O
improve	O
outcome	O
in	O
animal	O
models	O
of	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
its	O
more	O
severe	O
form	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Effect	O
of	O
a	O
fixed	B-ANAT
-	O
ratio	O
(	O
1	O
:	O
1	O
:	O
1	O
)	O
transfusion	O
protocol	O
versus	O
laboratory	O
-	O
results	O
-	O
guided	O
transfusion	O
in	O
patients	O
with	O
severe	O
trauma	O
:	O
a	O
randomized	O
feasibility	O
trial	O
.	O

We	O
randomly	O
assigned	O
them	O
to	O
either	O
the	O
fixed	B-ANAT
-	O
ratio	O
(	O
1	O
:	O
1	O
:	O
1	O
)	O
transfusion	O
protocol	O
(	O
n	O
=	O
40	O
)	O
or	O
to	O
a	O
laboratory	O
-	O
results	O
-	O
guided	O
transfusion	O
protocol	O
(	O
control	O
;	O
n	O
=	O
38	O
).	O

Nine	O
of	O
these	O
twelve	O
(	O
75	O
%)	O
were	O
successfully	O
treated	O
and	O
weaned	O
off	O
ECLS	O
and	O
8	O
patients	O
(	O
67	O
%)	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

Renal	B-ANAT
failure	O
requiring	O
some	O
form	O
of	O
continuous	O
dialysis	O
occurred	O
in	O
seven	O
patients	O
(	O
58	O
%)	O
and	O
the	O
survival	O
for	O
this	O
sub	O
-	O
set	O
of	O
patients	O
was	O
43	O
%.	O

RESULTS	O
:	O
A	O
total	O
of	O
twelve	O
patients	O
with	O
a	O
diagnosis	O
of	O
Legionella	O
pneumonia	O
were	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
(	O
VV	O
)	O
ECLS	O
over	O
this	O
time	O
period	O
.	O

TITLE	O
:	O
Microglia	B-ANAT
play	O
a	O
major	O
role	O
in	O
direct	O
viral	O
-	O
induced	O
demyelination	O
.	O

Fecal	B-ANAT
shedding	O
of	O
this	O
type	O
II	O
virus	O
in	O
the	O
effusive	O
form	O
of	O
FIP	O
can	O
be	O
detected	O
up	O
to	O
six	O
days	O
before	O
death	O
.	O

The	O
number	O
of	O
CD34KDR	O
,	O
KDRCD133	O
,	O
and	O
CD34KDRCD133	O
cells	B-ANAT
was	O
higher	O
in	O
the	O
acute	O
lung	B-ANAT
injury	O
group	O
than	O
in	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
group	O
.	O

There	O
was	O
a	O
rapid	O
release	O
of	O
endothelial	B-ANAT
progenitor	B-ANAT
cells	I-ANAT
from	O
bone	B-ANAT
marrow	I-ANAT
into	O
circulation	O
in	O
moderate	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
endothelial	B-ANAT
progenitor	B-ANAT
cell	I-ANAT
mobilization	O
was	O
impaired	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Variations	O
in	O
the	O
receptor	O
specificity	O
are	O
important	O
determinants	O
for	O
host	O
range	O
,	O
tissue	B-ANAT
tropism	O
,	O
pathogenicity	O
,	O
and	O
transmissibility	O
of	O
these	O
viruses	O
.	O

In	O
addition	O
,	O
chimeric	O
viruses	O
expressing	O
either	O
active	O
ns2	O
or	O
VP3	O
-	O
CTD	O
,	O
but	O
not	O
nonfunctional	O
equivalents	O
,	O
were	O
able	O
to	O
protect	O
ribosomal	B-ANAT
RNA	I-ANAT
from	O
RNase	O
L	O
-	O
mediated	O
degradation	O
.	O

Overstimulation	O
of	O
the	O
ovaries	B-ANAT
results	O
in	O
the	O
overproduction	O
of	O
vasoactive	O
cytokines	O
and	O
mediators	O
by	O
the	O
ovaries	B-ANAT
,	O
thereby	O
causing	O
a	O
generalized	O
capillary	B-ANAT
leak	O
and	O
acute	O
shift	O
of	O
protein	O
-	O
rich	O
fluid	O
from	O
the	O
intravascular	O
compartment	B-ANAT
into	O
the	O
third	O
space	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
syndromes	O
of	O
severe	O
respiratory	O
failure	O
that	O
are	O
associated	O
with	O
substantial	O
mortality	O
and	O
morbidity	O
.	O

The	O
following	O
adverse	O
events	O
were	O
considered	O
:	O
hypoxia	O
(	O
arterial	B-ANAT
PO2	O
<	O
80	O
mm	O
Hg	O
),	O
pneumothorax	O
(	O
any	O
air	O
leak	O
into	O
the	O
pleural	B-ANAT
space	I-ANAT
requiring	O
therapeutic	O
intervention	O
),	O
hypotension	O
(	O
systolic	O
blood	B-ANAT
pressure	O
<	O
90	O
mm	O
Hg	O
sustained	O
for	O
longer	O
than	O
two	O
minutes	O
or	O
requiring	O
treatment	O
with	O
fluids	B-ANAT
or	O
vasoactive	O
drugs	O
),	O
bradycardia	O
(	O
heart	B-ANAT
rate	O
<	O
50	O
beats	O
per	O
minute	O
sustained	O
for	O
longer	O
than	O
one	O
minute	O
or	O
requiring	O
therapeutic	O
intervention	O
)	O
and	O
cardiac	B-ANAT
arrest	O
(	O
absence	O
of	O
effective	O
cardiac	B-ANAT
output	O
).	O

We	O
describe	O
a	O
cured	O
case	O
of	O
acute	O
,	O
severe	O
gemcitabine	O
-	O
induced	O
pulmonary	B-ANAT
toxicity	O
.	O

Physicians	O
should	O
be	O
cognizant	O
of	O
the	O
possible	O
association	O
of	O
serious	O
pulmonary	B-ANAT
toxicity	O
with	O
gemcitabine	O
treatment	O
.	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhea	O
is	O
a	O
major	O
economic	O
burden	O
for	O
the	O
US	O
cattle	O
industry	O
.	O

A	O
case	O
-	O
control	O
study	O
was	O
conducted	O
to	O
assess	O
infectious	O
etiologies	O
associated	O
with	O
calf	B-ANAT
diarrhea	O
in	O
Midwest	O
cattle	O
farms	O
.	O

SPT	O
is	O
then	O
used	O
to	O
identify	O
fusion	O
intermediates	O
and	O
measure	O
membrane	B-ANAT
fusion	O
kinetics	O
for	O
FCoV	O
.	O
Overall	O
,	O
the	O
fusion	O
results	O
recapitulate	O
what	O
is	O
observed	O
in	O
vivo	O
,	O
that	O
coronavirus	O
entry	O
requires	O
binding	O
to	O
specific	O
receptors	O
,	O
a	O
low	O
-	O
pH	O
environment	O
,	O
and	O
that	O
membrane	B-ANAT
fusion	O
is	O
receptor	O
-	O
and	O
protease	O
-	O
dependent	O
.	O

ABSTRACT	O
:	O
This	O
is	O
the	O
first	O
published	O
report	O
of	O
a	O
young	O
girl	O
with	O
co	O
-	O
inherited	O
sickle	B-ANAT
cell	I-ANAT
-	O
Î²	O
+	O
thalassemia	O
and	O
cystic	O
fibrosis	O
.	O

Although	O
a	O
small	O
subset	O
of	O
patients	O
with	O
co	O
-	O
inherited	O
cystic	O
fibrosis	O
and	O
other	O
hemoglobinopathies	O
have	O
been	O
reported	O
,	O
this	O
patient	O
developed	O
early	O
hematologic	O
and	O
pulmonary	B-ANAT
complications	O
that	O
were	O
more	O
severe	O
than	O
the	O
previous	O
cases	O
.	O

Infant	O
pulmonary	B-ANAT
function	O
testing	O
data	O
demonstrated	O
moderate	O
-	O
to	O
-	O
severe	O
lower	O
airways	O
obstruction	O
,	O
moderate	O
air	O
trapping	O
,	O
and	O
no	O
evidence	O
of	O
restrictive	O
lung	B-ANAT
disease	O
.	O

All	O
patients	O
had	O
abnormal	O
findings	O
on	O
chest	B-ANAT
radiography	O
,	O
ranging	O
from	O
subtle	O
to	O
extensive	O
unilateral	O
and	O
bilateral	O
abnormalities	O
.	O

Human	O
coronavirus	O
HKU1	O
,	O
first	O
discovered	O
in	O
2005	O
,	O
has	O
a	O
worldwide	O
prevalence	O
and	O
is	O
associated	O
with	O
both	O
upper	O
and	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
disease	O
in	O
both	O
children	O
and	O
adults	O
.	O

Further	O
developments	O
in	O
digital	B-ANAT
disease	O
surveillance	O
have	O
the	O
potential	O
to	O
improve	O
sensitivity	O
and	O
specificity	O
,	O
passively	O
through	O
advances	O
in	O
machine	O
learning	O
and	O
actively	O
through	O
engagement	O
of	O
users	O
.	O

ABSTRACT	O
:	O
The	O
aims	O
of	O
this	O
study	O
are	O
(	O
1	O
)	O
to	O
investigate	O
the	O
occurrence	O
rate	O
of	O
postoperative	O
complications	O
in	O
patients	O
â¥	O
80	O
years	O
old	O
after	O
cardiac	B-ANAT
surgery	O
and	O
(	O
2	O
)	O
to	O
elucidate	O
the	O
impact	O
of	O
the	O
most	O
common	O
postoperative	O
complications	O
on	O
mortality	O
.	O

Our	O
findings	O
revealed	O
that	O
the	O
ORF4a	O
proteins	O
were	O
expressed	O
in	O
infected	O
cells	B-ANAT
and	O
localized	O
at	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
/	O
Golgi	B-ANAT
intermediate	O
compartment	B-ANAT
(	O
ERGIC	B-ANAT
).	O

ABSTRACT	O
:	O
This	O
study	O
was	O
designed	O
to	O
identify	O
factors	O
associated	O
with	O
death	O
by	O
6	O
months	O
post	O
-	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
discharge	B-ANAT
and	O
to	O
develop	O
a	O
practical	O
mortality	O
risk	O
score	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)-	O
treated	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
.	O

Clinically	O
detectable	O
hyphema	O
and	O
cytologic	O
erythrocyte	B-ANAT
number	O
were	O
correlated	O
.	O

However	O
,	O
cytologic	O
cell	B-ANAT
grades	O
and	O
clinical	O
grade	O
of	O
flare	O
or	O
cell	B-ANAT
numbers	O
within	O
the	O
anterior	B-ANAT
chamber	I-ANAT
were	O
not	O
correlated	O
.	O

These	O
observations	O
suggest	O
that	O
leukocytes	B-ANAT
from	O
FIP	O
patients	O
show	O
signs	O
of	O
systemic	O
activation	O
causing	O
them	O
to	O
extravasate	O
into	O
surrounding	O
tissues	B-ANAT
and	O
ultimately	O
contribute	O
to	O
pyogranuloma	O
formation	O
seen	O
in	O
FIP	O
.	O

Thus	O
whether	O
aPC	B-ANAT
will	O
continue	O
to	O
be	O
used	O
to	O
modulate	O
the	O
acute	O
inflammatory	O
response	O
in	O
humans	O
remains	O
uncertain	O
.	O

These	O
cell	B-ANAT
lines	I-ANAT
are	O
valuable	O
tools	O
to	O
perform	O
in	O
vitro	O
studies	O
in	O
a	O
mouse	O
cell	B-ANAT
system	O
that	O
reflects	O
the	O
species	O
used	O
for	O
in	O
vivo	O
studies	O
of	O
SARS	O
-	O
CoV	O
-	O
MA15	O
pathogenesis	O
.	O

After	O
12	O
h	O
va	O
-	O
ECMO	O
was	O
converted	O
to	O
veno	O
-	O
venoarterial	O
ECMO	O
(	O
vva	O
-	O
ECMO	O
)	O
for	O
improvement	O
of	O
pulmonary	B-ANAT
and	O
systemic	O
oxygenation	O
.	O

By	O
infecting	O
Serpine1	O
-	O
knockout	O
mice	O
,	O
we	O
showed	O
that	O
the	O
urokinase	O
pathway	O
had	O
a	O
significant	O
effect	O
on	O
both	O
lung	B-ANAT
pathology	O
and	O
overall	O
SARS	O
-	O
CoV	O
pathogenesis	O
.	O

Cohorts	O
included	O
healthy	O
young	O
adults	O
,	O
healthy	O
elderly	O
adults	O
,	O
high	O
-	O
risk	O
adults	O
with	O
underlying	O
cardiopulmonary	B-ANAT
disease	O
,	O
and	O
a	O
hospitalized	O
group	O
.	O

TITLE	O
:	O
Successful	O
application	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
due	O
to	O
pulmonary	B-ANAT
hemorrhage	O
secondary	O
to	O
granulomatosis	O
with	O
polyangiitis	O
.	O

Nevertheless	O
,	O
there	O
are	O
cases	O
of	O
successful	O
ECMO	O
application	O
in	O
patients	O
with	O
multiple	O
trauma	O
and	O
hemorrhagic	O
shock	O
or	O
head	B-ANAT
trauma	O
and	O
intracranial	B-ANAT
hemorrhage	O
.	O

ABSTRACT	O
:	O
Mice	O
that	O
are	O
transgenic	O
(	O
Tg	O
)	O
for	O
T	B-ANAT
cell	I-ANAT
receptor	O
(	O
TCR	B-ANAT
)	O
expression	O
are	O
used	O
extensively	O
to	O
analyze	O
longitudinal	O
T	B-ANAT
cell	I-ANAT
responses	O
during	O
effector	O
and	O
memory	O
phases	O
of	O
the	O
T	B-ANAT
cell	I-ANAT
response	O
.	O

50	O
of	O
50	O
(	O
100	O
%)	O
sera	B-ANAT
from	O
Omani	O
camels	O
and	O
15	O
of	O
105	O
(	O
14	O
%)	O
from	O
Spanish	O
camels	O
had	O
protein	O
-	O
specific	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
spike	O
.	O

MERS	O
-	O
CoV	O
neutralising	O
antibody	O
titres	O
varied	O
between	O
1	O
/	O
320	O
and	O
1	O
/	O
2560	O
for	O
the	O
Omani	O
camel	O
sera	B-ANAT
and	O
between	O
1	O
/	O
20	O
and	O
1	O
/	O
320	O
for	O
the	O
Spanish	O
camel	O
sera	B-ANAT
.	O

There	O
are	O
pathogen	O
-	O
specific	O
pathways	O
underlying	O
virally	O
mediated	O
ALI	O
that	O
converge	O
onto	O
a	O
common	O
end	O
pathway	O
resulting	O
in	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

In	O
terms	O
of	O
therapy	O
,	O
lung	B-ANAT
protective	O
ventilation	O
is	O
the	O
cornerstone	O
of	O
supportive	O
care	O
.	O

We	O
have	O
established	O
a	O
reverse	O
genetics	O
system	O
for	O
PEDV	O
based	O
on	O
targeted	O
RNA	O
recombination	O
that	O
allows	O
the	O
modification	O
of	O
the	O
3	O
'-	O
end	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
,	O
which	O
encodes	O
the	O
structural	O
proteins	O
and	O
the	O
ORF3	O
protein	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
),	O
like	O
other	O
positive	O
-	O
stranded	O
RNA	O
viruses	O
,	O
redirect	O
and	O
rearrange	O
host	O
cell	B-ANAT
membranes	I-ANAT
for	O
use	O
as	O
part	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
replication	O
and	O
transcription	O
machinery	O
.	O

This	O
interpretation	O
was	O
supported	O
by	O
observations	O
that	O
changes	O
in	O
mononuclear	B-ANAT
cells	I-ANAT
were	O
mirrored	O
by	O
that	O
in	O
CD3	O
(+)	O
CD44	O
(+)	O
T	B-ANAT
cell	I-ANAT
abundance	O
,	O
which	O
presumably	O
represent	O
T	O
effector	O
cells	B-ANAT
.	O

Thus	O
,	O
ACE2	O
counteracts	O
the	O
role	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
)	O
which	O
generates	O
Ang	O
II	O
from	O
Ang	O
I	O
.	O
ACE	O
and	O
ACE2	O
have	O
been	O
implicated	O
in	O
several	O
pathologies	O
such	O
as	O
cardiovascular	B-ANAT
and	O
renal	B-ANAT
disease	O
or	O
acute	O
lung	B-ANAT
injury	O
.	O

To	O
date	O
,	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
research	O
has	O
been	O
hampered	O
by	O
the	O
lack	O
of	O
susceptible	O
cell	B-ANAT
lines	I-ANAT
for	O
the	O
propagation	O
of	O
serotype	O
I	O
FCoVs	O
.	O

In	O
this	O
study	O
,	O
long	O
-	O
term	O
feline	O
intestinal	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
cultures	O
were	O
established	O
from	O
primary	O
ileocytes	O
and	O
colonocytes	O
by	O
simian	O
virus	O
40	O
(	O
SV40	O
)	O
T	O
-	O
antigen	O
-	O
and	O
human	O
Telomerase	O
Reverse	O
Transcriptase	O
(	O
hTERT	O
)-	O
induced	O
immortalization	O
.	O

TITLE	O
:	O
Production	O
and	O
characterization	O
of	O
egg	B-ANAT
yolk	B-ANAT
antibodies	O
against	O
bovine	O
alimentary	B-ANAT
tract	I-ANAT
pathogens	O
.	O

All	O
used	O
vaccines	O
induced	O
the	O
rise	O
of	O
IgY	O
antibody	O
in	O
egg	B-ANAT
yolks	O
.	O

TITLE	O
:	O
Metagenomic	O
analysis	O
of	O
the	O
ferret	O
fecal	B-ANAT
viral	O
flora	O
.	O

Non	O
-	O
invasive	O
ventilation	O
via	O
face	B-ANAT
masks	O
and	O
single	O
circuit	O
can	O
disperse	O
exhaled	B-ANAT
air	I-ANAT
from	O
0	O
.	O
4	O
to	O
1	O
m	O
.	O
Both	O
higher	O
inspiratory	O
pressures	O
and	O
use	O
of	O
whisper	O
swivel	O
device	O
(	O
to	O
facilitate	O
carbon	O
dioxide	O
removal	O
)	O
could	O
increase	O
the	O
exhaled	B-ANAT
air	I-ANAT
leakage	O
and	O
isolation	O
room	O
contamination	O
during	O
on	O
-	O
invasive	O
ventilation	O
.	O

Addition	O
of	O
a	O
viral	O
-	O
bacterial	O
filter	O
during	O
manual	O
ventilation	O
by	O
bagging	O
may	O
reduce	O
the	O
exhaled	B-ANAT
air	I-ANAT
leakage	O
forward	O
and	O
yet	O
increase	O
the	O
sideway	O
leakage	O
.	O

Our	O
results	O
demonstrated	O
that	O
the	O
generated	O
MERS	O
-	O
CoV	O
pseudovirus	O
allows	O
for	O
single	O
-	O
cycle	O
infection	O
of	O
a	O
variety	O
of	O
cells	B-ANAT
expressing	O
dipeptidyl	O
peptidase	O
-	O
4	O
(	O
DPP4	O
),	O
the	O
confirmed	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
Consistent	O
with	O
the	O
results	O
from	O
a	O
live	O
MERS	O
-	O
CoV	O
-	O
based	O
inhibition	O
assay	O
,	O
the	O
antisera	O
of	O
mice	O
vaccinated	O
with	O
a	O
recombinant	O
protein	O
containing	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
,	O
residues	O
377	O
-	O
662	O
)	O
of	O
MERS	O
-	O
CoV	O
S	O
fused	O
with	O
Fc	O
of	O
human	O
IgG	O
exhibited	O
neutralizing	O
antibody	O
response	O
against	O
infection	O
of	O
MERS	O
-	O
CoV	O
pseudovirus	O
.	O

Furthermore	O
,	O
one	O
small	O
molecule	O
HIV	O
entry	O
inhibitor	O
targeting	O
gp41	O
(	O
ADS	O
-	O
J1	O
)	O
and	O
the	O
3	O
-	O
hydroxyphthalic	O
anhydride	O
-	O
modified	O
human	O
serum	B-ANAT
albumin	O
(	O
HP	O
-	O
HSA	O
)	O
could	O
significantly	O
inhibit	O
MERS	O
-	O
CoV	O
pseudovirus	O
infection	O
.	O

Emerging	O
evidence	O
for	O
the	O
pathogenic	O
role	O
of	O
microglia	B-ANAT
and	O
the	O
activation	O
of	O
inflammatory	O
pathways	O
in	O
these	O
cells	B-ANAT
in	O
MHV	O
infection	O
supports	O
the	O
concept	O
that	O
microglia	B-ANAT
induced	O
neuroinflammation	O
is	O
an	O
amplifier	O
of	O
virus	O
-	O
induced	O
neuropathology	O
.	O

The	O
DP3	O
circuit	O
was	O
used	O
22	O
times	O
in	O
these	O
children	O
for	O
different	O
indications	O
:	O
(	O
I	O
)	O
extracorporeal	O
life	O
support	O
(	O
ECLS	O
)	O
in	O
post	O
-	O
cardiotomy	O
heart	B-ANAT
failure	O
(	O
n	O
=	O
11	O
),	O
(	O
II	O
)	O
ECLS	O
in	O
cardiopulmonary	B-ANAT
resuscitation	O
(	O
CPR	O
)	O
(	O
n	O
=	O
7	O
)	O
and	O
(	O
III	O
)	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
n	O
=	O
4	O
).	O

The	O
use	O
of	O
the	O
Deltastream	O
DP3	O
seems	O
to	O
be	O
safe	O
and	O
effective	O
for	O
MCS	B-ANAT
in	O
children	O
and	O
may	O
show	O
a	O
low	O
degree	O
of	O
haemolysis	O
.	O

However	O
,	O
investigation	O
of	O
root	B-ANAT
causes	O
revealed	O
no	O
association	O
with	O
the	O
positioning	O
therapy	O
and	O
had	O
no	O
documented	O
effect	O
on	O
the	O
outcome	O
.	O

Vaccinated	O
mice	O
produced	O
high	O
levels	O
of	O
serum	B-ANAT
antibodies	O
neutralizing	O
MERS	O
-	O
CoV	O
.	O
Thus	O
,	O
MVA	O
-	O
MERS	O
-	O
S	O
may	O
serve	O
for	O
further	O
development	O
of	O
an	O
emergency	O
vaccine	O
against	O
MERS	O
-	O
CoV	O
.	O

These	O
prominent	O
vessels	B-ANAT
appear	O
similar	O
to	O
""""	O
misaligned	O
pulmonary	B-ANAT
veins	I-ANAT
""""	O
described	O
in	O
the	O
lethal	O
form	O
of	O
congenital	O
lung	B-ANAT
disorder	O
,	O
alveolar	B-ANAT
capillary	B-ANAT
dysplasia	O
.	O

We	O
propose	O
that	O
persistence	O
or	O
expansion	O
of	O
these	O
vessels	B-ANAT
after	O
premature	O
birth	O
provides	O
the	O
anatomic	O
basis	O
for	O
intrapulmonary	O
shunt	O
and	O
hypoxemia	O
in	O
neonates	O
with	O
severe	O
bronchopulmonary	O
dysplasia	O
and	O
may	O
play	O
a	O
significant	O
role	O
in	O
the	O
morbidity	O
and	O
mortality	O
of	O
BPD	O
.	O

Variables	O
associated	O
with	O
mechanical	O
ventilation	O
in	O
multivariate	O
analysis	O
included	O
serum	B-ANAT
bicarbonates	O
less	O
than	O
20	O
mM	O
(	O
odds	O
ratio	O
,	O
4	O
.	O
9	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
22	O
.	O
7	O
];	O
p	O
=	O
0	O
.	O
041	O
),	O
serum	B-ANAT
urea	O
greater	O
than	O
10	O
mM	O
(	O
odds	O
ratio	O
,	O
7	O
.	O
0	O
[	O
95	O
%	O
CI	O
,	O
2	O
.	O
2	O
-	O
22	O
.	O
8	O
];	O
p	O
<	O
0	O
.	O
001	O
),	O
a	O
detached	O
body	B-ANAT
surface	O
area	O
between	O
10	O
%	O
and	O
29	O
%	O
(	O
odds	O
ratio	O
,	O
3	O
.	O
7	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
13	O
.	O
8	O
];	O
p	O
=	O
0	O
.	O
048	O
)	O
or	O
greater	O
than	O
or	O
equal	O
to	O
30	O
%	O
(	O
odds	O
ratio	O
,	O
19	O
.	O
7	O
[	O
95	O
%	O
CI	O
,	O
4	O
.	O
4	O
-	O
87	O
.	O
4	O
];	O
p	O
<	O
0	O
.	O
0001	O
),	O
WBCs	O
more	O
than	O
12	O
,	O
000	O
/	O
mm3	O
(	O
odds	O
ratio	O
,	O
11	O
.	O
6	O
[	O
95	O
%	O
CI	O
,	O
2	O
.	O
8	O
-	O
48	O
.	O
1	O
];	O
p	O
<	O
0	O
.	O
001	O
),	O
blood	B-ANAT
hemoglobin	O
less	O
than	O
8	O
g	O
/	O
dL	O
(	O
odds	O
ratio	O
,	O
8	O
.	O
1	O
[	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
55	O
.	O
2	O
];	O
p	O
=	O
0	O
.	O
032	O
),	O
and	O
more	O
extensive	O
pulmonary	B-ANAT
infiltrates	O
(	O
odds	O
ratio	O
,	O
9	O
.	O
7	O
[	O
95	O
%	O
CI	O
,	O
3	O
.	O
6	O
-	O
25	O
.	O
9	O
];	O
p	O
<	O
0	O
.	O
0001	O
).	O

Mechanical	O
ventilation	O
is	O
required	O
in	O
one	O
of	O
four	O
Stevens	O
-	O
Johnson	O
syndrome	O
/	O
toxic	O
epidermal	B-ANAT
necrolysis	O
patients	O
and	O
is	O
associated	O
with	O
a	O
poor	O
outcome	O
.	O

This	O
study	O
defines	O
the	O
contribution	O
of	O
interleukin	O
(	O
IL	O
)-	O
21	O
,	O
a	O
regulator	O
of	O
T	O
and	O
B	B-ANAT
cell	I-ANAT
function	O
,	O
to	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
immunity	O
.	O

These	O
data	O
demonstrate	O
a	O
critical	O
role	O
of	O
IL	O
-	O
21	O
in	O
regulating	O
CNS	B-ANAT
immunity	O
,	O
sustaining	O
viral	O
persistence	O
and	O
preventing	O
mortality	O
.	O

TITLE	O
:	O
[	O
Study	O
of	O
changes	O
in	O
extravascular	O
lung	B-ANAT
water	O
index	O
of	O
patients	O
suffered	O
from	O
H7N9	O
avian	O
influenza	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

The	O
patients	O
who	O
suffered	O
from	O
severe	O
ARDS	O
were	O
administered	O
with	O
low	O
tide	O
volume	O
ventilation	O
plus	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
),	O
namely	O
protected	O
ventilation	O
strategy	O
,	O
with	O
monitoring	O
hemodynamic	O
parameters	O
and	O
EVLWI	O
through	O
pulse	O
-	O
indicated	O
continuous	O
cardiac	B-ANAT
output	O
(	O
PiCCO	O
)	O
catheter	O
.	O

By	O
contrast	O
,	O
viral	O
pseudotypes	O
containing	O
the	O
surface	O
protein	O
GP	O
of	O
Marburg	O
virus	O
from	O
the	O
family	O
Filoviridae	O
infected	O
all	O
six	O
cell	B-ANAT
lines	I-ANAT
though	O
at	O
different	O
efficiency	O
.	O

TITLE	O
:	O
Body	B-ANAT
position	O
changes	O
redistribute	O
lung	B-ANAT
computed	O
-	O
tomographic	O
density	O
in	O
patients	O
with	O
acute	O
respiratory	O
failure	O
:	O
impact	O
and	O
clinical	O
fallout	O
through	O
the	O
following	O
20	O
years	O
.	O

The	O
final	O
result	O
of	O
proning	O
was	O
that	O
the	O
inversion	O
of	O
gravitational	O
forces	O
,	O
together	O
with	O
other	O
factors	O
such	O
as	O
lung	B-ANAT
-	O
chest	B-ANAT
wall	I-ANAT
shape	O
-	O
matching	O
and	O
the	O
heart	B-ANAT
weight	O
led	O
to	O
a	O
more	O
homogeneous	O
distribution	O
of	O
inflation	O
throughout	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
.	O

Importantly	O
,	O
the	O
coronavirus	O
is	O
thought	O
to	O
enter	O
cells	B-ANAT
via	O
two	O
distinct	O
pathways	O
,	O
one	O
mediated	O
by	O
TMPRSS2	O
at	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
the	O
other	O
mediated	O
by	O
cathepsin	O
L	O
in	O
the	O
endosome	B-ANAT
.	O

TITLE	O
:	O
Sustained	O
improvement	O
of	O
gas	O
exchange	O
and	O
lung	B-ANAT
mechanics	O
by	O
vaporized	O
perfluorocarbon	O
inhalation	O
in	O
piglet	O
acute	O
lung	B-ANAT
injury	O
model	O
.	O

ABSTRACT	O
:	O
In	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
(	O
LTRs	O
),	O
severe	O
clinical	O
complications	O
,	O
such	O
as	O
microbial	O
infections	O
of	O
the	O
lung	B-ANAT
or	O
transplant	B-ANAT
rejection	O
,	O
may	O
occur	O
.	O

Surfactant	O
protein	O
D	O
(	O
SP	O
-	O
D	O
)	O
is	O
a	O
C	O
-	O
type	O
lectin	O
that	O
is	O
mainly	O
produced	O
in	O
alveolar	B-ANAT
type	O
II	O
cells	B-ANAT
.	O

Median	O
plasma	B-ANAT
SP	O
-	O
D	O
levels	O
were	O
significantly	O
increased	O
during	O
episodes	O
of	O
microbial	O
pneumonia	O
,	O
but	O
not	O
in	O
the	O
absence	O
of	O
pathologic	O
respiratory	O
findings	O
,	O
during	O
microbial	O
colonization	O
,	O
or	O
during	O
ACR	O
up	O
to	O
grade	O
A2	O
-	O
A3	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

During	O
pneumonia	O
,	O
an	O
increased	O
plasma	B-ANAT
SP	O
-	O
D	O
level	O
was	O
detected	O
in	O
60	O
%	O
of	O
LTRs	O
and	O
this	O
was	O
further	O
associated	O
with	O
a	O
significantly	O
higher	O
risk	O
for	O
the	O
patients	O
to	O
develop	O
stage	O
III	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	O
III	O
)	O
or	O
to	O
die	O
within	O
the	O
subsequent	O
6	O
months	O
after	O
pneumonia	O
(	O
P	O
=	O
0	O
.	O
0093	O
).	O

The	O
Beta	O
-	O
Agonist	O
Lung	B-ANAT
injury	O
TrIal	O
-	O
2	O
(	O
BALTI	O
-	O
2	O
)	O
was	O
initiated	O
to	O
evaluate	O
the	O
effects	O
of	O
this	O
intervention	O
on	O
mortality	O
in	O
patients	O
with	O
ARDS	O
.	O

infusion	O
of	O
salbutamol	O
given	O
at	O
15	O
Î¼g	O
/	O
kg	O
ideal	O
body	B-ANAT
weight	O
(	O
IBW	O
)/	O
hour	O
for	O
up	O
to	O
7	O
days	O
,	O
compared	O
with	O
a	O
placebo	O
(	O
0	O
.	O
9	O
%	O
sodium	O
chloride	O
)	O
infusion	O
,	O
reduces	O
28	O
-	O
day	O
all	O
-	O
cause	O
mortality	O
and	O
other	O
clinical	O
outcomes	O
.	O

Patients	O
were	O
eligible	O
if	O
they	O
(	O
1	O
)	O
were	O
intubated	O
and	O
mechanically	O
ventilated	O
patients	O
in	O
participating	O
ICUs	O
;	O
(	O
2	O
)	O
were	O
within	O
72	O
hours	O
of	O
onset	O
of	O
ARDS	O
;	O
(	O
3	O
)	O
fulfilled	O
American	O
-	O
European	O
Consensus	O
Conference	O
definition	O
for	O
ARDS	O
{	O
acute	O
-	O
onset	O
,	O
severe	O
hypoxaemic	O
respiratory	O
failure	O
[	O
partial	O
pressure	O
of	O
oxygen	O
in	O
arterial	B-ANAT
blood	I-ANAT
/	O
fraction	O
of	O
inspired	O
oxygen	O
â¤	O
26	O
.	O
7	O
kPa	O
(	O
200	O
mmHg	O
)]	O
and	O
bilateral	O
infiltrates	O
on	O
the	O
chest	B-ANAT
radiograph	O
in	O
the	O
absence	O
of	O
clinical	O
evidence	O
of	O
left	O
atrial	B-ANAT
hypertension	O
};	O
and	O
(	O
4	O
)	O
were	O
aged	O
â¥	O
16	O
years	O
.	O

TITLE	O
:	O
Acute	O
fetal	B-ANAT
asphyxia	O
after	O
gastric	B-ANAT
rupture	O
in	O
a	O
pregnant	O
patient	O
with	O
a	O
gastric	B-ANAT
band	B-ANAT
.	O

ABSTRACT	O
:	O
Portopulmonary	O
hypertension	O
has	O
been	O
reported	O
in	O
2	O
%	O
to	O
9	O
%	O
of	O
candidates	O
for	O
liver	B-ANAT
transplantation	O
(	O
OLT	O
).	O

In	O
addition	O
,	O
LIMK1	O
or	O
SSH	O
-	O
1L	O
depletion	O
inhibited	O
RelA	O
/	O
p65	O
phosphorylation	O
at	O
Ser	B-ANAT
(	O
536	O
),	O
a	O
critical	O
event	O
conferring	O
transcriptional	O
competency	O
to	O
the	O
bound	O
NF	O
-	O
ÎºB	O
.	O
However	O
,	O
unlike	O
SSH	O
-	O
1L	O
,	O
LIMK1	O
knockdown	O
also	O
impairs	O
the	O
release	O
of	O
RelA	O
/	O
p65	O
by	O
blocking	O
IKKÎ²	O
-	O
dependent	O
phosphorylation	O
/	O
degradation	O
of	O
IÎºBÎ±	O
.	O

Both	O
are	O
enveloped	O
,	O
single	O
-	O
stranded	O
,	O
negative	O
-	O
sense	O
RNA	O
viruses	O
and	O
cause	O
similar	O
symptoms	O
,	O
ranging	O
from	O
sub	O
-	O
clinical	O
infections	O
to	O
severe	O
diseases	O
,	O
including	O
decrease	O
in	O
egg	B-ANAT
production	O
,	O
acute	O
respiratory	O
syndrome	O
,	O
and	O
high	O
mortality	O
.	O

However	O
,	O
the	O
natural	O
prevalence	O
of	O
antibodies	O
against	O
these	O
viruses	O
in	O
serum	B-ANAT
among	O
population	O
is	O
unknown	O
.	O

Of	O
794	O
blood	B-ANAT
samples	I-ANAT
tested	O
,	O
only	O
29	O
(	O
3	O
.	O
65	O
%)	O
were	O
negative	O
for	O
anti	O
-	O
S	O
IgG	O
.	O
The	O
seropositivity	O
of	O
the	O
four	O
anti	O
-	O
S	O
IgG	O
antibodies	O
was	O
>	O
70	O
%	O
within	O
the	O
general	O
population	O
.	O

Recombinant	O
IBV	O
Beaudette	O
spike	O
ectodomains	O
,	O
comprising	O
the	O
entire	O
S1	O
domain	O
and	O
the	O
S2	O
ectodomain	O
,	O
were	O
expressed	O
and	O
analyzed	O
for	O
binding	O
to	O
susceptible	O
embryonic	B-ANAT
chorio	O
-	O
allantoic	B-ANAT
membrane	I-ANAT
(	O
CAM	B-ANAT
)	O
in	O
our	O
previously	O
developed	O
spike	O
histochemistry	O
assay	O
.	O

We	O
observed	O
that	O
extension	O
of	O
the	O
S1	O
domain	O
with	O
the	O
S2	O
subunit	O
of	O
the	O
Beaudette	O
spike	O
was	O
sufficient	O
to	O
gain	O
binding	O
to	O
CAM	B-ANAT
.	O

Using	O
3c	O
-	O
stable	O
expression	O
cells	B-ANAT
,	O
the	O
replication	O
of	O
a	O
3c	O
-	O
defective	O
FCoV	O
strain	O
was	O
titrated	O
and	O
a	O
significant	O
decrease	O
in	O
replication	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
was	O
observed	O
.	O

Although	O
,	O
the	O
IL	O
-	O
33	O
levels	O
increased	O
in	O
sera	B-ANAT
of	O
viral	O
hepatitis	O
patients	O
in	O
human	O
,	O
the	O
cellular	B-ANAT
sources	O
of	O
IL	O
-	O
33	O
in	O
viral	O
hepatitis	O
remained	O
obscure	O
.	O

In	O
conclusion	O
,	O
the	O
alarmin	O
cytokine	O
IL	O
-	O
33	O
was	O
over	O
-	O
expressed	O
during	O
fulminant	O
hepatitis	O
in	O
mice	O
with	O
LSEC	O
,	O
VEC	O
and	O
hepatocytes	B-ANAT
as	O
potential	O
sources	O
of	O
IL	O
-	O
33	O
.	O

Lastly	O
,	O
expression	O
of	O
several	O
genes	O
involved	O
in	O
osteoclast	B-ANAT
or	O
bone	B-ANAT
-	O
resident	O
macrophage	B-ANAT
function	O
,	O
most	O
notably	O
TREM2	O
and	O
DAP12	O
,	O
was	O
upregulated	O
in	O
persistently	O
infected	O
mouse	B-ANAT
spinal	I-ANAT
cord	I-ANAT
.	O

It	O
is	O
known	O
that	O
the	O
surface	O
spike	O
(	O
S	O
)	O
proteins	O
of	O
coronaviruses	O
mediate	O
receptor	O
recognition	O
and	O
membrane	B-ANAT
fusion	O
,	O
thereby	O
playing	O
an	O
indispensable	O
role	O
in	O
initiating	O
infection	O
.	O

Recently	O
,	O
various	O
studies	O
in	O
critically	O
ill	O
patients	O
indicated	O
that	O
increased	O
pulmonary	B-ANAT
glucose	O
levels	O
with	O
airway	B-ANAT
/	O
blood	B-ANAT
glucose	O
threshold	O
over	O
150	O
mg	O
/	O
dl	O
lead	O
to	O
an	O
overwhelming	O
growth	O
of	O
bacteria	O
in	O
the	O
broncho	B-ANAT
-	I-ANAT
pulmonary	I-ANAT
system	O
,	O
subsequently	O
resulting	O
in	O
an	O
increased	O
risk	O
of	O
pulmonary	B-ANAT
infections	O
.	O

The	O
objective	O
of	O
this	O
double	O
-	O
blind	O
randomized	O
clinical	O
trial	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
oral	B-ANAT
inorganic	O
or	O
organic	O
zinc	O
supplementation	O
as	O
a	O
treatment	O
for	O
neonatal	O
diarrhea	O
in	O
calves	O
.	O

Calves	O
received	O
a	O
daily	O
dose	O
of	O
either	O
a	O
placebo	O
composed	O
of	O
80	O
mg	O
of	O
zinc	O
-	O
free	O
powder	O
,	O
381	O
.	O
54	O
mg	O
of	O
zinc	O
methionine	O
(	O
Met	O
)	O
(	O
equivalent	O
to	O
80	O
mg	O
of	O
zinc	O
),	O
or	O
99	O
.	O
69	O
mg	O
of	O
zinc	O
oxide	O
(	O
ZO	O
)	O
(	O
equivalent	O
to	O
80	O
mg	O
of	O
zinc	O
)	O
in	O
2L	O
of	O
a	O
zinc	O
-	O
free	O
oral	B-ANAT
rehydration	O
solution	O
(	O
ORS	O
).	O

The	O
current	O
trial	O
identified	O
clinically	O
important	O
findings	O
that	O
warrant	O
further	O
research	O
to	O
investigate	O
zinc	O
'	O
s	O
therapeutic	O
effect	O
for	O
calf	B-ANAT
diarrhea	O
.	O

Neurotropic	O
demyelinating	O
strain	O
of	O
MHV	O
(	O
MHV	O
-	O
A59	O
or	O
its	O
isogenic	O
recombinant	O
strain	O
RSA59	O
)	O
induces	O
MS	O
-	O
like	O
disease	O
in	O
mice	O
mediated	O
by	O
microglia	B-ANAT
,	O
along	O
with	O
a	O
small	O
population	O
of	O
T	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Intrapleural	B-ANAT
steroid	O
instillation	O
for	O
multiple	O
organ	B-ANAT
failure	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Despite	O
clear	O
demonstration	O
of	O
its	O
selective	O
and	O
potent	O
pulmonary	B-ANAT
vasodilator	O
properties	O
,	O
inhaled	O
NO	O
therapy	O
has	O
only	O
been	O
formally	O
approved	O
by	O
the	O
US	O
Food	O
and	O
Drug	O
Administration	O
and	O
European	O
Medicine	O
Evaluation	O
Agency	O
for	O
clinical	O
use	O
in	O
the	O
treatment	O
of	O
term	O
and	O
near	O
-	O
term	O
infants	O
with	O
severe	O
persistent	O
pulmonary	B-ANAT
hypertension	O
of	O
the	O
newborn	O
(	O
PPHN	O
)	O
with	O
acute	O
hypoxemic	O
respiratory	O
failure	O
.	O

Over	O
the	O
past	O
decades	O
,	O
inhaled	O
NO	O
remains	O
the	O
central	O
therapy	O
for	O
PPHN	O
and	O
is	O
commonly	O
used	O
for	O
acute	O
pulmonary	B-ANAT
vasoreactivity	O
testing	O
during	O
right	B-ANAT
heart	I-ANAT
catheterization	O
and	O
for	O
treating	O
pediatric	O
and	O
adult	O
patients	O
with	O
PAH	O
associated	O
with	O
postoperative	O
cardiac	B-ANAT
surgery	O
,	O
severe	O
respiratory	O
failure	O
,	O
pulmonary	B-ANAT
hypertension	O
crises	O
,	O
and	O
other	O
disorders	O
.	O

The	O
results	O
showed	O
that	O
TGEV	O
infection	O
induced	O
cell	B-ANAT
cycle	O
arrest	O
at	O
S	O
and	O
G2	O
/	O
M	O
phases	O
in	O
both	O
asynchronous	O
and	O
synchronized	O
PK	O
-	O
15	O
and	O
ST	O
cells	B-ANAT
,	O
while	O
UV	O
-	O
inactivated	O
TGEV	O
lost	O
the	O
ability	O
of	O
induction	O
of	O
cell	B-ANAT
cycle	O
arrest	O
.	O

After	O
highly	O
active	O
antiretroviral	O
treatment	O
(	O
HAART	O
)	O
was	O
introduced	O
at	O
the	O
age	O
of	O
35	O
years	O
old	O
,	O
serum	B-ANAT
level	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
was	O
not	O
detected	O
,	O
but	O
the	O
number	O
of	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
was	O
still	O
less	O
than	O
200	O
/	O
Î¼l	O
.	O

Cerebrospinal	B-ANAT
fluid	I-ANAT
(	O
CSF	B-ANAT
)	O
examination	O
showed	O
a	O
mild	O
mononuclear	O
pleocytosis	O
(	O
16	O
/	O
Î¼l	O
).	O

Oligoclonal	O
band	B-ANAT
was	O
positive	O
.	O

Exacerbation	O
of	O
both	O
COPD	O
and	O
asthma	O
,	O
which	O
are	O
basically	O
defined	O
and	O
diagnosed	O
by	O
clinical	O
symptoms	O
,	O
is	O
associated	O
with	O
a	O
rapid	O
decline	O
in	O
lung	B-ANAT
function	O
and	O
increased	O
mortality	O
.	O

In	O
summary	O
,	O
the	O
assembly	O
of	O
IBV	O
VLPs	B-ANAT
with	O
M	O
and	O
S	O
proteins	O
provided	O
a	O
simple	O
strategy	O
for	O
generating	O
VLPs	B-ANAT
for	O
coronaviruses	O
,	O
and	O
the	O
generated	O
IBV	O
VLPs	B-ANAT
laid	O
a	O
feasible	O
foundation	O
for	O
the	O
development	O
of	O
an	O
effective	O
vaccine	O
against	O
infection	O
of	O
IBV	O
in	O
the	O
future	O
.	O

Mortality	O
(	O
13	O
.	O
9	O
%	O
for	O
mild	O
ARDS	O
;	O
11	O
.	O
3	O
%	O
for	O
moderate	O
ARDS	O
;	O
25	O
%	O
for	O
severe	O
ARDS	O
,	O
p	O
=	O
0	O
.	O
04	O
)	O
and	O
the	O
composite	O
outcome	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)/	O
mortality	O
(	O
13	O
.	O
9	O
%	O
for	O
mild	O
ARDS	O
;	O
11	O
.	O
3	O
%	O
for	O
moderate	O
ARDS	O
;	O
28	O
.	O
4	O
%	O
for	O
severe	O
ARDS	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
were	O
different	O
across	O
the	O
BD	O
classes	O
,	O
whereas	O
they	O
were	O
similar	O
using	O
the	O
previous	O
definition	O
.	O

The	O
sensitivity	O
of	O
the	O
infection	O
screening	O
system	O
in	O
detecting	O
influenza	O
were	O
92	O
.	O
3	O
%,	O
which	O
was	O
higher	O
than	O
the	O
sensitivity	O
reported	O
in	O
our	O
previous	O
paper	O
(	O
88	O
.	O
0	O
%)	O
with	O
average	O
facial	B-ANAT
skin	I-ANAT
temperature	O
.	O

Patients	O
with	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
were	O
excluded	O
.	O

Spokespersons	O
of	O
health	O
and	O
medical	O
institutions	O
play	O
an	O
important	O
role	O
in	O
media	B-ANAT
relations	O
during	O
the	O
crisis	O
of	O
a	O
newly	O
emerging	O
infectious	O
disease	O
.	O

Severe	O
acute	O
respiratory	O
failure	O
that	O
did	O
not	O
respond	O
to	O
optimal	O
conventional	O
treatment	O
led	O
us	O
to	O
employ	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

From	O
2003	O
to	O
2009	O
,	O
we	O
collected	O
88	O
faecal	B-ANAT
samples	O
from	O
healthy	O
cats	O
and	O
11	O
ascitic	B-ANAT
fluids	I-ANAT
from	O
FIP	O
cats	O
.	O

Pioneer	O
studies	O
identified	O
cathepsins	O
and	O
type	O
II	O
transmembrane	B-ANAT
serine	O
proteases	O
as	O
cellular	B-ANAT
activators	O
of	O
SARS	O
-	O
CoV	O
and	O
demonstrated	O
that	O
several	O
emerging	O
viruses	O
might	O
exploit	O
these	O
enzymes	O
to	O
promote	O
their	O
spread	O
.	O

TITLE	O
:	O
Prospective	O
evaluation	O
for	O
respiratory	O
pathogens	O
in	O
children	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
and	O
acute	O
respiratory	O
illness	O
.	O

ABSTRACT	O
:	O
Human	O
rhinovirus	O
(	O
HRV	O
),	O
human	O
coronavirus	O
(	O
hCoV	O
),	O
human	O
bocavirus	O
(	O
hBoV	O
),	O
and	O
human	O
metapneumovirus	O
(	O
hMPV	O
)	O
infections	O
in	O
children	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
have	O
not	O
been	O
well	O
studied	O
.	O

HRV	O
was	O
the	O
most	O
common	O
virus	O
detected	O
in	O
children	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
and	O
acute	O
respiratory	O
illness	O
,	O
and	O
was	O
not	O
associated	O
with	O
increased	O
morbidity	O
.	O

Larger	O
prospective	O
studies	O
with	O
asymptomatic	O
controls	O
are	O
needed	O
to	O
study	O
the	O
association	O
of	O
these	O
emerging	O
respiratory	O
viruses	O
with	O
ACS	O
in	O
children	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
severe	O
malaria	O
.	O

Two	O
patients	O
survived	O
to	O
hospital	O
-	O
discharge	B-ANAT
(	O
duration	O
of	O
ECMO	O
support	O
:	O
8	O
.	O
5	O
days	O
)	O
and	O
one	O
patient	O
died	O
from	O
nosocomial	O
sepsis	O
and	O
multi	O
-	O
organ	B-ANAT
failure	O
after	O
40	O
days	O
of	O
ECMO	O
support	O
.	O

Females	O
are	O
also	O
a	O
mosaic	O
of	O
cells	B-ANAT
with	O
genes	O
from	O
either	O
paternal	O
or	O
maternal	O
X	B-ANAT
chromosome	I-ANAT
.	O

Animal	O
experiments	O
clearly	O
show	O
that	O
prone	O
positioning	O
delays	O
or	O
prevents	O
ventilation	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
likely	O
due	O
in	O
large	O
part	O
to	O
more	O
homogeneously	O
distributed	O
stress	O
and	O
strain	O
.	O

ABSTRACT	O
:	O
In	O
neonatal	O
rodents	O
,	O
a	O
loss	O
of	O
brain	B-ANAT
stem	I-ANAT
serotonin	O
[	O
5	O
-	O
hydroxytryptamine	O
(	O
5	O
-	O
HT	O
)]	O
in	O
utero	B-ANAT
or	O
at	O
birth	O
compromises	O
anoxia	O
-	O
induced	O
gasping	O
and	O
the	O
recovery	O
of	O
heart	B-ANAT
rate	O
(	O
HR	O
)	O
and	O
breathing	O
with	O
reoxygenation	O
(	O
i	O
.	O
e	O
.,	O
autoresuscitation	O
).	O

How	O
mean	O
arterial	B-ANAT
pressure	O
(	O
MAP	O
)	O
is	O
influenced	O
after	O
an	O
acute	O
loss	O
of	O
brain	B-ANAT
stem	I-ANAT
5	O
-	O
HT	O
content	O
is	O
unknown	O
.	O

These	O
data	O
may	O
help	O
explain	O
why	O
some	O
sudden	O
infant	O
death	O
syndrome	O
cases	O
die	O
from	O
what	O
appears	O
to	O
be	O
cardiovascular	B-ANAT
collapse	O
during	O
apparent	O
severe	O
hypoxia	O
.	O

Clinical	O
characteristics	O
of	O
infants	O
affected	O
by	O
BPD	O
have	O
widely	O
changed	O
in	O
the	O
last	O
decades	O
:	O
they	O
are	O
extraordinarly	O
immature	O
,	O
with	O
impaired	O
alveolar	B-ANAT
and	O
vascular	B-ANAT
lung	B-ANAT
development	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	O
generates	O
spherules	O
from	O
zippered	O
endoplasmic	B-ANAT
reticulum	I-ANAT
membranes	B-ANAT
.	O

In	O
all	O
cell	B-ANAT
types	O
,	O
structures	O
novel	O
to	O
IBV	O
infection	O
were	O
identified	O
that	O
we	O
have	O
termed	O
zippered	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
and	O
spherules	O
.	O

We	O
have	O
studied	O
the	O
membrane	B-ANAT
rearrangements	O
induced	O
by	O
an	O
important	O
poultry	O
pathogen	O
,	O
the	O
gammacoronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Here	O
,	O
we	O
characterized	O
structures	O
novel	O
to	O
IBV	O
infection	O
:	O
zippered	O
ER	O
and	O
small	O
vesicles	B-ANAT
tethered	O
to	O
the	O
zippered	O
ER	O
termed	O
spherules	O
.	O

TITLE	O
:	O
Lung	B-ANAT
injury	O
and	O
its	O
prognostic	O
significance	O
in	O
acute	O
liver	B-ANAT
failure	O
.	O

Two	O
hundred	O
acute	O
liver	B-ANAT
failure	O
patients	O
were	O
admitted	O
during	O
the	O
study	O
period	O
of	O
whom	O
148	O
,	O
median	O
age	O
39	O
years	O
(	O
16	O
-	O
74	O
yr	O
),	O
were	O
included	O
.	O

Duration	O
of	O
liver	B-ANAT
intensive	O
therapy	O
unit	O
stay	O
(	O
p	O
=	O
0	O
.	O
175	O
),	O
survival	O
(	O
p	O
=	O
0	O
.	O
877	O
),	O
inotrope	O
requirements	O
(	O
p	O
=	O
0	O
.	O
495	O
),	O
need	O
for	O
extracorporeal	O
renal	B-ANAT
support	O
(	O
p	O
=	O
0	O
.	O
565	O
),	O
and	O
severity	O
of	O
organ	B-ANAT
failure	O
scores	O
were	O
not	O
affected	O
.	O

As	O
MMPs	O
(	O
matrix	O
metalloproteinases	O
)	O
facilitate	O
migration	O
across	O
the	O
glia	B-ANAT
limitans	O
,	O
specific	O
expression	O
of	O
the	O
TIMP	O
(	O
tissue	B-ANAT
inhibitor	O
of	O
MMPs	O
)-	O
1	O
by	O
CD4	O
âº	O
T	B-ANAT
cells	I-ANAT
present	O
in	O
the	O
perivascular	O
cuffs	O
suggested	O
that	O
TIMP	O
-	O
1	O
is	O
responsible	O
for	O
stalling	O
CD4	O
âº	O
T	B-ANAT
cell	I-ANAT
migration	O
into	O
the	O
CNS	B-ANAT
parenchyma	B-ANAT
.	O

RESULTS	O
:	O
Using	O
the	O
five	O
best	O
-	O
performing	O
biomarkers	O
(	O
surfactant	O
protein	O
-	O
D	O
(	O
SP	O
-	O
D	O
),	O
receptor	O
for	O
advanced	O
glycation	O
end	O
-	O
products	O
(	O
RAGE	O
),	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
),	O
club	O
cell	B-ANAT
secretory	O
protein	O
(	O
CC	O
-	O
16	O
),	O
and	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
))	O
the	O
area	O
under	O
the	O
receiver	O
operator	O
characteristic	O
curve	O
(	O
AUC	O
)	O
was	O
0	O
.	O
75	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
7	O
to	O
0	O
.	O
84	O
)	O
for	O
the	O
diagnosis	O
of	O
ARDS	O
.	O

Compared	O
to	O
controls	O
,	O
the	O
main	O
echocardiographic	O
findings	O
in	O
patients	O
during	O
the	O
acute	O
phase	O
were	O
significantly	O
higher	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
,	O
higher	O
systolic	O
pulmonary	B-ANAT
artery	I-ANAT
pressure	O
,	O
lower	O
left	O
ventricular	B-ANAT
ejection	O
fraction	O
and	O
impaired	O
left	O
atrial	B-ANAT
myocardial	O
motion	O
.	O

In	O
a	O
majority	O
of	O
patients	O
with	O
PUUV	O
-	O
infection	O
,	O
both	O
cardiac	B-ANAT
and	O
pulmonary	B-ANAT
involvement	O
was	O
demonstrated	O
with	O
implications	O
on	O
patients	O
'	O
recovery	O
.	O

The	O
results	O
demonstrate	O
vascular	B-ANAT
leakage	O
in	O
the	O
lungs	B-ANAT
that	O
most	O
likely	O
is	O
responsible	O
for	O
impaired	O
gas	O
diffusing	O
capacity	O
and	O
increased	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
with	O
secondary	O
pulmonary	B-ANAT
hypertension	O
and	O
right	B-ANAT
heart	I-ANAT
distress	O
.	O

In	O
the	O
most	O
severe	O
cases	O
,	O
it	O
can	O
cause	O
pneumonia	O
,	O
respiratory	O
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pulmonary	B-ANAT
hypertension	O
,	O
and	O
death	O
.	O

We	O
report	O
here	O
the	O
case	O
of	O
a	O
2	O
-	O
month	O
-	O
old	O
boy	O
with	O
severe	O
respiratory	O
failure	O
and	O
pulmonary	B-ANAT
hypertension	O
who	O
satisfied	O
ECMO	O
criteria	O
but	O
was	O
successfully	O
treated	O
with	O
repeated	O
bronchoscopy	O
with	O
instillation	O
of	O
N	O
-	O
acetylcysteine	O
.	O

Usually	O
diagnosis	O
of	O
botulism	O
is	O
considered	O
in	O
patients	O
with	O
predominant	O
motor	O
symptoms	O
:	O
muscle	B-ANAT
weakness	O
with	O
intact	O
sensation	O
and	O
preserved	O
mental	O
function	O
.	O

We	O
report	O
a	O
case	O
of	O
56	O
-	O
year	O
-	O
old	O
Caucasian	O
female	O
with	O
a	O
history	O
of	O
arterial	B-ANAT
hypertension	O
,	O
who	O
presented	O
with	O
acute	O
respiratory	O
failure	O
and	O
bilateral	O
ptosis	O
misdiagnosed	O
as	O
brainstem	B-ANAT
ischemia	O
.	O

This	O
study	O
shows	O
that	O
the	O
clinical	O
features	O
of	O
GBS	O
in	O
Australia	O
are	O
similar	O
to	O
that	O
previously	O
reported	O
and	O
confirms	O
the	O
male	O
predominance	O
,	O
increased	O
incidence	O
with	O
age	O
,	O
and	O
frequent	O
evidence	O
of	O
peripheral	B-ANAT
nerve	I-ANAT
demyelination	O
as	O
features	O
of	O
GBS	O
.	O

As	O
a	O
strongly	O
dissociated	O
anion	O
(	O
pK	O
'=	O
3	O
.	O
7	O
)	O
directly	O
changing	O
the	O
strong	O
ion	O
difference	O
,	O
lactate	O
causes	O
a	O
reduction	O
in	O
the	O
dependent	O
anion	O
[	O
HCO3	O
-]	O
and	O
a	O
rise	O
in	O
[	O
H	O
+],	O
resulting	O
in	O
""""	O
metabolic	O
""""	O
acidosis	O
in	O
the	O
CSF	B-ANAT
.	O

An	O
increase	O
in	O
AQP4	O
membrane	B-ANAT
expression	O
during	O
acute	O
NMO	O
attacks	O
could	O
potentially	O
enhance	O
the	O
complement	O
-	O
mediated	O
humoral	O
immune	O
reaction	O
against	O
AQP4	O
-	O
expressing	O
astrocytes	B-ANAT
characteristic	O
for	O
NMO	O
and	O
,	O
thus	O
,	O
result	O
in	O
more	O
severe	O
astrocytic	B-ANAT
damage	O
.	O

Moreover	O
,	O
lactate	O
and	O
acidosis	O
have	O
been	O
shown	O
to	O
cause	O
astrocytic	B-ANAT
swelling	O
and	O
to	O
affect	O
astrocytic	B-ANAT
viability	O
,	O
potentially	O
rendering	O
astrocytes	B-ANAT
more	O
susceptible	O
to	O
AQP4	O
-	O
Ab	O
-	O
mediated	O
damage	O
.	O

Finally	O
,	O
increased	O
AQP4	O
expression	O
could	O
be	O
an	O
independent	O
risk	O
factor	O
in	O
NMO	O
and	O
other	O
forms	O
of	O
CNS	B-ANAT
inflammation	O
,	O
as	O
indicated	O
by	O
the	O
finding	O
of	O
grossly	O
attenuated	O
experimental	O
autoimmune	O
encephalomyelitis	O
in	O
AQP4	O
-	O
null	O
mice	O
.	O

Sixty	O
-	O
nine	O
faecal	B-ANAT
samples	O
and	O
126	O
carcasses	O
were	O
tested	O
using	O
pan	B-ANAT
-	O
coronavirus	O
RT	O
-	O
PCR	O
.	O

The	O
infectious	O
titers	O
of	O
the	O
viruses	O
during	O
the	O
first	O
10	O
passages	O
ranged	O
from	O
6	O
Ã	O
10	O
(	O
2	O
)	O
to	O
2	O
Ã	O
10	O
(	O
5	O
)	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
doses	O
(	O
TCID50	O
)/	O
ml	O
.	O

TITLE	O
:	O
Massive	O
blood	B-ANAT
transfusion	O
during	O
hospitalization	O
for	O
delivery	O
in	O
New	O
York	O
State	O
,	O
1998	O
-	O
2007	O
.	O

Risk	O
factors	O
with	O
the	O
strongest	O
independent	O
associations	O
with	O
massive	O
blood	B-ANAT
transfusion	O
included	O
abnormal	O
placentation	O
(	O
1	O
.	O
6	O
/	O
10	O
,	O
000	O
deliveries	O
,	O
adjusted	O
odds	O
ratio	O
[	O
OR	O
]	O
18	O
.	O
5	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
14	O
.	O
7	O
-	O
23	O
.	O
3	O
),	O
placental	B-ANAT
abruption	O
(	O
1	O
.	O
0	O
/	O
10	O
,	O
000	O
,	O
adjusted	O
OR	O
14	O
.	O
6	O
,	O
95	O
%	O
CI	O
11	O
.	O
2	O
-	O
19	O
.	O
0	O
),	O
severe	O
preeclampsia	O
(	O
0	O
.	O
8	O
/	O
10	O
,	O
000	O
,	O
adjusted	O
OR	O
10	O
.	O
4	O
,	O
95	O
%	O
CI	O
7	O
.	O
7	O
-	O
14	O
.	O
2	O
),	O
and	O
intrauterine	B-ANAT
fetal	B-ANAT
demise	O
(	O
0	O
.	O
7	O
/	O
10	O
,	O
000	O
,	O
adjusted	O
OR	O
5	O
.	O
5	O
,	O
95	O
%	O
CI	O
3	O
.	O
9	O
-	O
7	O
.	O
8	O
).	O

In	O
the	O
presence	O
of	O
known	O
risk	O
for	O
receipt	O
of	O
massive	O
blood	B-ANAT
transfusion	O
,	O
women	O
should	O
be	O
informed	O
of	O
this	O
possibility	O
,	O
should	O
deliver	O
in	O
a	O
well	O
-	O
resourced	O
facility	O
if	O
possible	O
,	O
and	O
should	O
receive	O
appropriate	O
blood	B-ANAT
product	O
preparation	O
and	O
venous	B-ANAT
access	O
in	O
advance	O
of	O
delivery	O
.	O

A	O
disproportionate	O
number	O
of	O
women	O
who	O
received	O
a	O
massive	O
blood	B-ANAT
transfusion	O
experienced	O
severe	O
morbidity	O
including	O
renal	B-ANAT
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
sepsis	O
,	O
and	O
in	O
-	O
hospital	O
death	O
.	O

Heart	B-ANAT
rate	O
(	O
P	O
<	O
.	O
001	O
)	O
and	O
mean	O
arterial	B-ANAT
pressure	O
(	O
P	O
<	O
.	O
001	O
)	O
increased	O
less	O
during	O
NAVA	O
than	O
during	O
PSV	O
.	O

However	O
,	O
their	O
absence	O
during	O
acute	O
infection	O
alters	O
the	O
ability	O
of	O
the	O
host	O
to	O
limit	O
tissue	B-ANAT
damage	O
.	O

A	O
recent	O
randomized	O
controlled	O
trial	O
(	O
RCT	O
)	O
comparing	O
hyperimmune	O
globulin	O
prepared	O
from	O
convalescent	O
plasma	B-ANAT
against	O
normal	O
intravenous	O
gammaglobulin	O
(	O
IVIG	O
)	O
manufactured	O
before	O
2009	O
as	O
control	O
in	O
patients	O
with	O
severe	O
A	O
(	O
H1N1	O
)	O
pdm09	O
infection	O
on	O
standard	O
antiviral	O
treatment	O
has	O
shown	O
that	O
the	O
hyperimmune	O
globulin	O
group	O
who	O
received	O
treatment	O
within	O
5	O
days	O
of	O
symptom	O
onset	O
had	O
a	O
lower	O
viral	O
load	O
and	O
reduced	O
mortality	O
compared	O
with	O
the	O
controls	O
.	O

In	O
130	O
blood	B-ANAT
donors	O
sampled	O
during	O
2012	O
in	O
Jeddah	O
and	O
226	O
slaughterhouse	O
workers	O
sampled	O
in	O
October	O
2012	O
in	O
Jeddah	O
and	O
Makkah	O
,	O
Saudi	O
Arabia	O
,	O
8	O
reactive	O
sera	B-ANAT
were	O
seen	O
in	O
IFA	O
but	O
were	O
resolved	O
to	O
be	O
specific	O
for	O
established	O
HCoVs	O
by	O
discriminative	O
testing	O
.	O

TITLE	O
:	O
Acute	O
effects	O
of	O
estradiol	O
on	O
lung	B-ANAT
inflammation	O
due	O
to	O
intestinal	B-ANAT
ischemic	O
insult	O
in	O
male	O
rats	O
.	O

To	O
reduce	O
the	O
lung	B-ANAT
inflammation	O
caused	O
by	O
intestinal	B-ANAT
I	O
/	O
R	O
,	O
we	O
have	O
acutely	O
treated	O
male	O
rats	O
with	O
estradiol	O
.	O

Leukocytes	B-ANAT
influx	O
into	O
the	O
lung	B-ANAT
and	O
microvascular	O
leakage	O
were	O
assessed	O
by	O
lung	B-ANAT
myeloperoxidase	O
activity	O
and	O
Evans	O
blue	O
dye	O
extravasation	O
,	O
respectively	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
estradiol	O
modulates	O
the	O
lung	B-ANAT
inflammatory	O
response	O
induced	O
by	O
lung	B-ANAT
injury	O
,	O
likely	O
by	O
acute	O
effects	O
.	O

Disseminated	O
blastomycosis	O
involving	O
the	O
heart	B-ANAT
is	O
exceptionally	O
rare	O
and	O
can	O
be	O
potentially	O
life	O
threatening	O
.	O

Here	O
,	O
we	O
report	O
a	O
case	O
of	O
cardiac	B-ANAT
blastomycosis	O
who	O
initially	O
presented	O
with	O
respiratory	O
failure	O
.	O

In	O
addition	O
,	O
TGEV	O
infection	O
lowered	O
mitochondrial	B-ANAT
transmembrane	B-ANAT
potential	O
in	O
PK	O
-	O
15	O
cell	B-ANAT
line	I-ANAT
,	O
which	O
could	O
be	O
inhibited	O
by	O
ROS	O
scavengers	O
,	O
pyrrolidinedithiocarbamic	O
(	O
PDTC	O
)	O
and	O
N	O
-	O
acetyl	O
-	O
l	O
-	O
cysteine	O
(	O
NAC	B-ANAT
).	O

ABSTRACT	O
:	O
The	O
type	O
II	O
transmembrane	B-ANAT
serine	O
proteases	O
TMPRSS2	O
and	O
HAT	O
can	O
cleave	O
and	O
activate	O
the	O
spike	O
protein	O
(	O
S	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
for	O
membrane	B-ANAT
fusion	O
.	O

We	O
herein	O
report	O
a	O
case	O
of	O
LAS	O
,	O
which	O
developed	O
after	O
a	O
transient	O
hypoxic	O
event	O
without	O
an	O
overt	O
cardiac	B-ANAT
arrest	O
due	O
to	O
hematoma	O
formation	O
in	O
the	O
neck	B-ANAT
after	O
partial	O
glossectomy	O
.	O

The	O
administration	O
of	O
cytoflavin	O
led	O
to	O
reduction	O
of	O
erythrocyte	B-ANAT
aggregation	O
and	O
general	O
improvements	O
in	O
rheological	O
indices	O
of	O
children	O
with	O
severe	O
forms	O
of	O
acute	O
respiratory	O
viral	O
infection	O
and	O
toxic	O
encephalopathy	O
.	O

Lung	B-ANAT
inflammation	O
in	O
ARDS	O
patients	O
may	O
have	O
deleterious	O
effects	O
on	O
remote	O
organs	B-ANAT
such	O
as	O
the	O
kidney	B-ANAT
.	O

PARP	O
and	O
NF	O
-	O
ÎºB	O
in	O
the	O
lung	B-ANAT
and	O
kidney	B-ANAT
were	O
histologically	O
examined	O
by	O
immunostaining	O
and	O
assigned	O
expression	O
scores	O
.	O

One	O
hundred	O
and	O
three	O
(	O
89	O
.	O
6	O
%)	O
of	O
115	O
patients	O
presented	O
with	O
multiple	O
organ	B-ANAT
dysfunction	O
,	O
and	O
22	O
(	O
19	O
.	O
1	O
%)	O
of	O
115	O
proceeded	O
to	O
the	O
stage	O
of	O
life	O
threatening	O
multiple	O
organ	B-ANAT
failure	O
.	O

Due	O
to	O
infection	O
with	O
a	O
novel	O
bunyavirus	O
,	O
the	O
patients	O
may	O
sufferer	O
multiple	O
organ	B-ANAT
dysfunction	O
and	O
die	O
of	O
multiple	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
The	O
lectin	O
ERGIC	B-ANAT
-	O
53	O
goes	O
viral	O
.	O

We	O
identified	O
human	O
proteins	O
that	O
interact	O
with	O
the	O
glycoproteins	O
(	O
GPs	O
)	O
of	O
a	O
prototypic	O
arenavirus	O
and	O
hantavirus	O
and	O
show	O
that	O
the	O
lectin	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)-	O
Golgi	B-ANAT
intermediate	O
compartment	B-ANAT
53	O
kDa	O
protein	O
(	O
ERGIC	B-ANAT
-	O
53	O
),	O
a	O
cargo	O
receptor	O
required	O
for	O
glycoprotein	O
trafficking	O
within	O
the	O
early	O
exocytic	O
pathway	O
,	O
associates	O
with	O
arenavirus	O
,	O
hantavirus	O
,	O
coronavirus	O
,	O
orthomyxovirus	O
,	O
and	O
filovirus	O
GPs	O
.	O

ERGIC	B-ANAT
-	O
53	O
binds	O
to	O
arenavirus	O
GPs	O
through	O
a	O
lectin	O
-	O
independent	O
mechanism	O
,	O
traffics	O
to	O
arenavirus	O
budding	O
sites	O
,	O
and	O
is	O
incorporated	O
into	O
virions	B-ANAT
.	O

Clinic	O
-	O
based	O
PCPs	O
were	O
significantly	O
less	O
prepared	O
than	O
hospital	O
-	O
based	O
PCPs	O
to	O
provide	O
N95	O
masks	O
(	O
OR	O
0	O
.	O
34	O
),	O
gowns	O
(	O
OR	O
0	O
.	O
15	O
),	O
and	O
eye	B-ANAT
protection	O
(	O
OR	O
0	O
.	O
18	O
).	O

To	O
quantify	O
lung	B-ANAT
inhomogeneities	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
patient	O
presented	O
with	O
isolated	O
respiratory	O
failure	O
with	O
profound	O
hypoxemia	O
requiring	O
oxygen	O
delivered	O
at	O
high	O
concentration	O
by	O
face	B-ANAT
mask	O
.	O

The	O
CT	O
appearance	O
of	O
the	O
lesions	O
corresponded	O
to	O
a	O
spread	O
of	O
bilateral	O
micro	O
-	O
connected	O
pulmonary	B-ANAT
nodules	B-ANAT
(	O
a	O
""""	O
tree	O
-	O
in	O
-	O
bud	B-ANAT
""""	O
pattern	O
)	O
associated	O
with	O
obstructive	O
ventilatory	O
disorder	O
.	O

ABSTRACT	O
:	O
The	O
Proteus	O
syndrome	O
is	O
a	O
rare	O
genetic	O
disease	O
which	O
is	O
characterized	O
by	O
the	O
overgrowth	O
of	O
tissues	B-ANAT
,	O
especially	O
bone	B-ANAT
,	O
connective	O
and	O
adipose	B-ANAT
tissue	I-ANAT
.	O

Severe	O
bullous	O
pulmonary	B-ANAT
emphysema	O
,	O
predominantly	O
on	O
the	O
left	O
,	O
with	O
mediastinal	B-ANAT
deviation	O
,	O
was	O
diagnosed	O
.	O

It	O
can	O
be	O
hypothesized	O
that	O
the	O
development	O
of	O
pulmonary	B-ANAT
cysts	O
leading	O
to	O
emphysema	O
may	O
share	O
the	O
same	O
AKT1	O
activation	O
pathway	O
with	O
lymphangioleiomyomatosis	O
.	O

ABSTRACT	O
:	O
To	O
combat	O
the	O
public	O
health	O
threat	O
from	O
emerging	O
coronaviruses	O
(	O
CoV	O
),	O
the	O
development	O
of	O
antiviral	O
therapies	O
with	O
either	O
virus	O
-	O
specific	O
or	O
pan	B-ANAT
-	O
coronaviral	O
activities	O
is	O
necessary	O
.	O

In	O
this	O
article	O
we	O
review	O
cell	B-ANAT
-	O
based	O
assays	O
using	O
infectious	O
virus	O
(	O
BSL	O
-	O
3	O
)	O
and	O
surrogate	O
assays	O
(	O
BSL	O
-	O
2	O
)	O
that	O
can	O
be	O
implemented	O
to	O
accelerate	O
antiviral	O
development	O
against	O
MERS	O
-	O
CoV	O
and	O
future	O
emergent	O
coronaviruses	O
.	O

TITLE	O
:	O
Akt2	O
deficiency	O
protects	O
from	O
acute	O
lung	B-ANAT
injury	O
via	O
alternative	O
macrophage	B-ANAT
activation	O
and	O
miR	O
-	O
146a	O
induction	O
in	O
mice	O
.	O

Alveolar	B-ANAT
macrophages	I-ANAT
participate	O
in	O
the	O
pathogenesis	O
of	O
ARDS	O
.	O

Acid	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
WT	O
mice	O
was	O
characterized	O
by	O
decreased	O
lung	B-ANAT
compliance	O
and	O
increased	O
protein	O
and	O
cytokine	O
concentration	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
.	O

Alveolar	B-ANAT
macrophages	I-ANAT
from	O
acid	O
-	O
injured	O
Akt2	O
(-/-)	O
mice	O
demonstrated	O
the	O
alternative	O
activation	O
phenotype	O
(	O
M2	O
).	O

In	O
the	O
cloacal	B-ANAT
swabs	O
,	O
TCoV	O
was	O
detected	O
consistently	O
at	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
12	O
days	O
postinoculation	O
(	O
DPI	O
)	O
with	O
higher	O
rates	O
of	O
detection	O
after	O
5	O
DPI	O
(>	O
90	O
%).	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
evaluate	O
the	O
extended	O
temporal	O
relationship	O
between	O
neutrophil	B-ANAT
chemotactic	O
factor	O
expression	O
and	O
influx	O
of	O
neutrophils	B-ANAT
into	O
the	O
lung	B-ANAT
after	O
intratracheal	O
administration	O
of	O
either	O
LPS	O
or	O
bleomycin	O
.	O

In	O
Vero	B-ANAT
cells	I-ANAT
,	O
the	O
virus	O
proliferates	O
as	O
its	O
parental	O
virus	O
and	O
can	O
cause	O
syncytium	B-ANAT
formation	O
.	O

Six	O
hundred	O
patients	O
with	O
systemic	O
inflammatory	O
response	O
syndrome	O
due	O
to	O
acute	O
pyelonephritis	O
,	O
acute	O
intra	O
-	O
abdominal	B-ANAT
infections	O
or	O
primary	O
Gram	O
-	O
negative	O
bacteraemia	O
were	O
enrolled	O
in	O
a	O
double	O
-	O
blind	O
,	O
randomized	O
,	O
multicentre	O
trial	O
.	O

Overall	O
28	O
day	O
mortality	O
was	O
17	O
.	O
1	O
%	O
(	O
51	O
deaths	O
)	O
in	O
the	O
placebo	O
arm	B-ANAT
and	O
18	O
.	O
5	O
%	O
(	O
56	O
deaths	O
)	O
in	O
the	O
clarithromycin	O
arm	B-ANAT
(	O
P	O
=	O
0	O
.	O
671	O
).	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
incidence	O
,	O
risk	O
factors	O
,	O
and	O
mortality	O
of	O
ARDS	O
following	O
cardiac	B-ANAT
surgery	O
.	O

Multivariate	O
regression	O
analysis	O
identified	O
previous	O
cardiac	B-ANAT
surgery	O
,	O
complex	O
cardiac	B-ANAT
surgery	O
,	O
and	O
more	O
than	O
three	O
transfusions	O
with	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
PRBC	O
)	O
were	O
independent	O
predictors	O
for	O
developing	O
ARDS	O
.	O

The	O
addition	O
of	O
MBL	O
ligands	O
to	O
the	O
IBV	O
vaccine	O
,	O
especially	O
FOS	O
,	O
enhanced	O
the	O
production	O
of	O
IBV	O
-	O
specific	O
IgG	B-ANAT
antibody	I-ANAT
production	O
in	O
L10H	O
chickens	O
,	O
but	O
not	O
L10L	O
chickens	O
after	O
the	O
second	O
vaccination	O
.	O

The	O
L10H	O
chickens	O
as	O
well	O
as	O
the	O
L10L	O
chickens	O
also	O
showed	O
an	O
increased	O
number	O
of	O
CD4	O
-	O
CD8Î±	O
-	O
Î³Î´	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
when	O
an	O
MBL	O
ligand	O
was	O
added	O
to	O
the	O
vaccine	O
,	O
most	O
pronouncedly	O
after	O
the	O
first	O
vaccination	O
.	O

The	O
serum	B-ANAT
MMP	O
-	O
9	O
,	O
CRP	O
and	O
the	O
APACHE	O
II	O
scores	O
on	O
the	O
3rd	O
,	O
5th	O
and	O
7th	O
day	O
in	O
the	O
treatment	O
group	O
were	O
lower	O
than	O
those	O
in	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

RESULTS	O
:	O
The	O
serum	B-ANAT
MMP	O
-	O
9	O
,	O
CRP	O
and	O
the	O
APACHE	O
II	O
scores	O
on	O
the	O
3rd	O
,	O
5th	O
and	O
7th	O
day	O
in	O
the	O
treatment	O
group	O
were	O
lower	O
than	O
those	O
in	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Hence	O
,	O
in	O
order	O
to	O
investigate	O
the	O
test	O
agreement	O
between	O
serum	B-ANAT
and	O
milk	O
,	O
both	O
serum	B-ANAT
and	O
milk	O
samples	O
from	O
105	O
cows	O
in	O
27	O
dairy	O
herds	O
were	O
analyzed	O
in	O
parallel	O
for	O
presence	O
of	O
immunoglobulin	O
G	O
antibodies	O
to	O
BCV	O
and	O
BRSV	O
.	O

ABSTRACT	O
:	O
The	O
infection	O
of	O
the	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
is	O
initiated	O
by	O
the	O
binding	O
of	O
the	O
spike	O
glycoprotein	O
S	O
to	O
sialic	O
acids	O
on	O
the	O
chicken	O
host	B-ANAT
cell	I-ANAT
.	O

While	O
ORF	O
4b	O
demonstrated	O
majorly	O
nuclear	O
localization	O
,	O
all	O
of	O
the	O
other	O
proteins	O
demonstrated	O
cytoplasmic	B-ANAT
localization	O
.	O

Rat	O
coronavirus	O
(	O
RCoV	O
)	O
causes	O
respiratory	O
disease	O
in	O
adult	O
rats	O
,	O
characterized	O
by	O
an	O
early	O
PMN	B-ANAT
response	O
,	O
viral	O
replication	O
and	O
inflammatory	O
lesions	O
in	O
the	O
lungs	B-ANAT
,	O
mild	O
weight	O
loss	O
and	O
effective	O
resolution	O
of	O
infection	O
.	O

Despite	O
their	O
critical	O
role	O
in	O
the	O
protection	O
from	O
severe	O
disease	O
,	O
the	O
presence	O
of	O
PMN	B-ANAT
was	O
correlated	O
with	O
haemorrhagic	O
lesions	O
,	O
epithelial	O
barrier	O
permeability	O
and	O
cellular	B-ANAT
inflammation	O
in	O
the	O
lungs	B-ANAT
.	O

Herein	O
,	O
we	O
report	O
a	O
case	O
of	O
vivax	O
malaria	O
complicated	O
by	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
that	O
was	O
successfully	O
managed	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

Genetic	O
variation	O
affecting	O
interferon	O
lambda	O
(	O
IFN	O
-	O
Î»	O
)	O
expression	O
is	O
now	O
known	O
to	O
influence	O
the	O
outcome	O
of	O
both	O
hepatitis	O
C	O
virus	O
and	O
herpes	O
simplex	B-ANAT
virus	O
type	O
1	O
infection	O
in	O
humans	O
.	O

This	O
virus	O
displayed	O
the	O
S1	O
glycoprotein	O
on	O
the	O
baculovirus	O
envelope	B-ANAT
,	O
and	O
was	O
capable	O
of	O
expressing	O
it	O
in	O
mammalian	O
cells	B-ANAT
.	O

TITLE	O
:	O
Effect	O
of	O
microtubule	B-ANAT
disruption	O
on	O
neuronal	O
spread	O
and	O
replication	O
of	O
demyelinating	O
and	O
nondemyelinating	O
strains	O
of	O
mouse	O
hepatitis	O
virus	O
in	O
vitro	O
.	O

Disruption	O
of	O
microtubules	B-ANAT
with	O
colchicine	O
and	O
vinblastine	O
significantly	O
blocks	O
neuronal	O
transport	O
and	O
reduces	O
the	O
replication	O
of	O
RSA59	O
,	O
whereas	O
RSMHV2	O
remains	O
unaffected	O
.	O

The	O
primary	O
end	O
-	O
point	O
was	O
the	O
incidence	O
(	O
with	O
reference	O
to	O
1	O
,	O
000	O
days	O
of	O
invasive	O
mechanical	O
ventilation	O
or	O
1	O
,	O
000	O
days	O
of	O
ICU	O
stay	O
)	O
of	O
new	O
patients	O
with	O
pressure	O
ulcers	O
at	O
stage	O
2	O
or	O
higher	O
from	O
randomisation	O
to	O
ICU	O
discharge	B-ANAT
.	O

The	O
incidence	O
of	O
new	O
patients	O
with	O
pressure	O
ulcers	O
from	O
randomisation	O
to	O
ICU	O
discharge	B-ANAT
was	O
20	O
.	O
80	O
and	O
14	O
.	O
26	O
/	O
1	O
,	O
000	O
days	O
of	O
invasive	O
mechanical	O
ventilation	O
(	O
P	O
=	O
0	O
.	O
061	O
)	O
and	O
13	O
.	O
92	O
and	O
7	O
.	O
72	O
/	O
1	O
,	O
000	O
of	O
ICU	O
days	O
(	O
P	O
=	O
0	O
.	O
002	O
)	O
in	O
the	O
prone	O
and	O
supine	O
groups	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
High	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
has	O
been	O
considered	O
a	O
potentially	O
ideal	O
mode	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

These	O
results	O
demonstrate	O
that	O
social	O
media	B-ANAT
could	O
be	O
a	O
useful	O
measure	O
of	O
public	O
awareness	O
and	O
reaction	O
to	O
disease	O
outbreak	O
information	O
released	O
by	O
health	O
authorities	O
.	O

For	O
organ	B-ANAT
failure	O
resolution	O
the	O
rates	O
were	O
highly	O
variable	O
.	O

For	O
organ	B-ANAT
failure	O
resolution	O
the	O
rates	O
were	O
highly	O
variable	O
.	O

Despite	O
these	O
findings	O
and	O
the	O
isolation	O
of	O
the	O
Q1	O
IB	O
virus	O
directly	O
from	O
proventricular	O
tissue	B-ANAT
,	O
further	O
studies	O
are	O
necessary	O
to	O
confirm	O
the	O
role	O
of	O
this	O
IBV	O
strain	O
in	O
the	O
development	O
of	O
proventricular	O
lesions	O
.	O

The	O
balance	O
between	O
inflammatory	O
mediators	O
is	O
key	O
for	O
the	O
outcome	O
of	O
the	O
pulmonary	B-ANAT
infection	O
;	O
elimination	O
of	O
invading	O
pathogen	O
was	O
marked	O
by	O
the	O
release	O
of	O
cytokines	O
and	O
other	O
inflammatory	O
mediators	O
from	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
glucocorticoid	O
steroids	O
(	O
GCs	O
)	O
acting	O
on	O
the	O
inflammatory	O
component	O
.	O

Despite	O
great	O
progress	O
in	O
the	O
management	O
of	O
ARDS	O
with	O
novel	O
agents	O
and	O
sophisticated	O
techniques	O
,	O
including	O
antimicrobial	O
drugs	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
prostaglandins	O
,	O
nitric	O
oxide	O
,	O
prostacyclin	O
,	O
exogenous	O
surfactant	O
administration	O
and	O
activated	O
protein	O
C	O
,	O
supportive	O
treatment	O
based	O
mostly	O
on	O
advanced	O
mechanical	O
ventilation	O
in	O
the	O
intensive	O
care	O
units	O
seems	O
to	O
be	O
the	O
most	O
important	O
for	O
the	O
prognosis	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
symptoms	O
similar	O
to	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
yet	O
involving	O
an	O
additional	O
component	O
of	O
acute	O
renal	B-ANAT
failure	O
(	O
ARF	O
)	O
according	O
to	O
several	O
published	O
case	O
reports	O
.	O

The	O
role	O
of	O
kidney	B-ANAT
infection	O
in	O
MERS	O
is	O
not	O
understood	O
.	O

Comparative	O
infection	O
experiments	O
with	O
SARS	O
-	O
and	O
MERS	O
-	O
CoV	O
in	O
primary	O
human	O
kidney	B-ANAT
cells	B-ANAT
versus	O
primary	O
human	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
showed	O
cytopathogenic	O
infection	O
only	O
in	O
kidney	B-ANAT
cells	B-ANAT
,	O
and	O
only	O
if	O
infected	O
with	O
MERS	O
-	O
CoV	O
.	O
Kidney	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
produced	O
almost	O
1000	O
-	O
fold	O
more	O
infectious	O
MERS	O
-	O
CoV	O
progeny	O
than	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
while	O
only	O
a	O
small	O
difference	O
was	O
seen	O
between	O
cell	B-ANAT
types	O
when	O
infected	O
with	O
SARS	O
-	O
CoV	O
.	O
Epidemiological	O
studies	O
should	O
analyze	O
kidney	B-ANAT
impairment	O
and	O
its	O
characteristics	O
in	O
MERS	O
-	O
CoV	O
.	O
Virus	O
replication	O
in	O
the	O
kidney	B-ANAT
with	O
potential	O
shedding	O
in	O
urine	B-ANAT
might	O
constitute	O
a	O
way	O
of	O
transmission	O
,	O
and	O
could	O
explain	O
untraceable	O
transmission	O
chains	O
leading	O
to	O
new	O
cases	O
.	O

Together	O
with	O
the	O
findings	O
that	O
early	O
renal	B-ANAT
function	O
,	O
incidence	O
of	O
ARDS	O
,	O
length	O
of	O
stay	O
,	O
and	O
mortality	O
were	O
not	O
negatively	O
influenced	O
by	O
HES	O
in	O
this	O
setting	O
,	O
balanced	O
HES	O
130	O
/	O
0	O
.	O
4	O
(	O
6	O
%)	O
plus	O
lactated	O
Ringer	O
'	O
s	O
solution	O
could	O
not	O
be	O
considered	O
superior	O
to	O
lactated	O
Ringer	O
'	O
s	O
solution	O
alone	O
.	O

Compared	O
with	O
patients	O
with	O
the	O
rs12252	O
-	O
T	O
/	O
T	O
or	O
rs12252	O
-	O
T	O
/	O
C	O
genotype	O
of	O
IFITM3	O
,	O
patients	O
with	O
the	O
C	O
/	O
C	O
genotype	O
had	O
a	O
shorter	O
time	O
from	O
disease	O
onset	O
to	O
the	O
time	O
point	O
when	O
they	O
sought	O
medical	O
aid	O
(	O
hospital	O
admission	O
or	O
antiviral	O
therapy	O
)	O
and	O
a	O
shorter	O
interval	O
to	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
stage	O
(	O
reflected	O
by	O
shorter	O
intervals	O
between	O
clinical	O
onset	O
and	O
methylprednisolone	O
treatments	O
and	O
higher	O
rates	O
of	O
mechanical	O
ventilator	O
use	O
),	O
as	O
well	O
as	O
experiencing	O
elevated	O
/	O
prolonged	O
lung	B-ANAT
virus	O
titers	O
and	O
cytokine	O
production	O
and	O
higher	O
mortality	O
.	O

This	O
might	O
account	O
for	O
the	O
different	O
effects	O
on	O
cardiovascular	B-ANAT
risk	O
factors	O
induced	O
by	O
the	O
two	O
treatments	O
.	O

The	O
HNE	O
inhibitory	O
activity	O
of	O
ursolic	O
acid	O
was	O
further	O
verified	O
using	O
a	O
mouse	O
model	O
of	O
acute	O
smoke	O
-	O
induced	O
lung	B-ANAT
inflammation	O
.	O

TITLE	O
:	O
Production	O
and	O
immunogenicity	O
of	O
chimeric	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particles	I-ANAT
containing	O
the	O
spike	O
glycoprotein	O
of	O
infectious	O
bronchitis	O
virus	O
.	O

Results	O
were	O
analysed	O
according	O
to	O
sample	O
type	O
(	O
upper	O
versus	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
)	O
and	O
age	O
group	O
.	O

ABSTRACT	O
:	O
The	O
catastrophic	O
antiphospholipid	O
syndrome	O
(	O
CAPS	O
)	O
is	O
a	O
rare	O
life	O
-	O
threatening	O
form	O
of	O
the	O
antiphospholipid	O
syndrome	O
characterized	O
by	O
disseminated	O
vascular	B-ANAT
thrombosis	O
resulting	O
in	O
multiorgan	O
failure	O
.	O

This	O
led	O
to	O
a	O
reduction	O
in	O
metabolic	O
syndrome	O
prevalence	O
for	O
the	O
AER	B-ANAT
(	O
56	O
%	O
vs	O
43	O
%)	O
and	O
AER	B-ANAT
+	O
RES	O
(	O
55	O
%	O
vs	O
46	O
%)	O
groups	O
between	O
baseline	O
and	O
follow	O
-	O
up	O
.	O

Genotypes	O
HKU1	O
A	O
and	O
B	O
were	O
both	O
isolated	O
from	O
clinical	O
specimens	O
and	O
propagated	O
on	O
primary	O
human	O
tracheal	O
-	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
cultured	O
at	O
the	O
air	O
-	O
liquid	O
interface	O
and	O
were	O
neutralized	O
in	O
vitro	O
by	O
human	O
intravenous	O
immunoglobulin	O
and	O
by	O
polyclonal	O
rabbit	O
antibodies	O
to	O
the	O
spike	O
glycoprotein	O
of	O
HKU1	O
.	O

ABSTRACT	O
:	O
Experiments	O
have	O
shown	O
that	O
anaphylaxis	O
decreases	O
cardiac	B-ANAT
output	O
;	O
increases	O
left	O
ventricular	B-ANAT
end	O
diastolic	O
pressure	O
;	O
induces	O
severe	O
early	O
acute	O
increase	O
in	O
respiratory	O
resistance	O
with	O
pulmonary	B-ANAT
interstitial	B-ANAT
edema	O
;	O
and	O
decreases	O
splanchnic	O
,	O
cerebral	B-ANAT
,	O
and	O
myocardial	O
blood	B-ANAT
flow	O
more	O
than	O
what	O
would	O
be	O
expected	O
from	O
severe	O
arterial	B-ANAT
dilation	O
and	O
hypotension	O
.	O

Although	O
the	O
mechanisms	O
of	O
anaphylactic	O
shock	O
still	O
remain	O
to	O
be	O
elucidated	O
,	O
myocardial	O
involvement	O
due	O
to	O
vasospasm	O
-	O
induced	O
coronary	B-ANAT
blood	B-ANAT
flow	O
reduction	O
manifesting	O
as	O
Kounis	O
syndrome	O
should	O
be	O
always	O
considered	O
.	O

Transmembrane	B-ANAT
serine	O
protease	O
TMPRSS2	O
catalyzed	O
the	O
cleavage	O
of	O
SARS	O
-	O
CoV	O
S	O
protein	O
,	O
but	O
not	O
the	O
counterpart	O
in	O
HCoV	O
-	O
HKU1	O
.	O

Multiple	O
infections	O
should	O
be	O
considered	O
the	O
most	O
likely	O
result	O
of	O
faecal	B-ANAT
testing	O
in	O
cats	O
,	O
and	O
case	O
management	O
needs	O
to	O
take	O
this	O
into	O
account	O
.	O

Data	O
was	O
analyzed	O
using	O
the	O
BioMark	O
digital	B-ANAT
array	O
software	O
.	O

TCID50	O
/	O
ml	O
(	O
tissue	B-ANAT
culture	O
infectious	O
dose	O
that	O
will	O
produce	O
cytopathic	O
effect	O
in	O
50	O
%	O
of	O
the	O
inoculated	O
tissue	B-ANAT
culture	O
cells	B-ANAT
)	O
was	O
found	O
for	O
treatments	O
to	O
determine	O
the	O
viral	O
loads	O
.	O

Therefore	O
Ah	O
extract	O
is	O
the	O
best	O
candidate	O
in	O
our	O
hands	B-ANAT
that	O
contains	O
potential	O
treatment	O
molecule	O
(	O
s	O
).	O

Importantly	O
,	O
cytokines	O
secreted	O
by	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
inhibit	O
JHMV	O
replication	O
in	O
NPCs	O
,	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
specifically	O
target	O
viral	O
peptide	O
-	O
pulsed	O
NPCs	O
for	O
lysis	O
.	O

Here	O
we	O
report	O
our	O
findings	O
that	O
(	O
a	O
)	O
the	O
production	O
of	O
human	O
coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
)	O
progeny	O
viruses	O
,	O
whose	O
budding	O
occurs	O
at	O
the	O
ER	B-ANAT
-	I-ANAT
Golgi	I-ANAT
intermediate	I-ANAT
compartment	I-ANAT
(	O
ERGIC	B-ANAT
),	O
markedly	O
decreases	O
in	O
the	O
presence	O
of	O
BST2	O
;	O
and	O
(	O
b	O
)	O
BST2	O
knockdown	O
expression	O
results	O
in	O
enhanced	O
HCoV	O
-	O
229E	O
virion	B-ANAT
production	O
.	O

Our	O
results	O
suggest	O
that	O
BST2	O
exerts	O
a	O
broad	O
blocking	O
effect	O
against	O
enveloped	O
virus	O
release	O
,	O
regardless	O
of	O
whether	O
budding	O
occurs	O
at	O
the	O
plasma	B-ANAT
membrane	I-ANAT
or	O
intracellular	B-ANAT
compartments	B-ANAT
.	O

Dose	O
-	O
response	O
cytotoxicity	O
curves	O
on	O
Vero	B-ANAT
cells	I-ANAT
using	O
trypan	O
blue	O
staining	O
determined	O
the	O
highest	O
non	O
-	O
cytotoxic	O
concentrations	O
of	O
each	O
plant	O
extract	O
.	O

Most	O
women	O
developed	O
pneumonia	O
in	O
the	O
3d	O
trimester	O
Risk	O
factors	O
offlu	O
complications	O
included	O
smoking	O
,	O
obesity	O
,	O
underlying	O
respiratory	O
and	O
cardiovascular	B-ANAT
diseases	O
,	O
sexually	O
transmitted	O
infections	O
.	O

Scavenging	O
of	O
superoxide	O
by	O
pretreating	O
the	O
DKO	O
mice	O
with	O
MnTMPYP	O
(	O
a	O
superoxide	O
dismutase	O
mimetic	O
)	O
restored	O
the	O
inflammatory	O
responses	O
to	O
LPS	O
challenge	O
including	O
reduced	O
lung	B-ANAT
myeloperoxidase	O
activity	O
and	O
vascular	B-ANAT
permeability	O
.	O

ABSTRACT	O
:	O
The	O
recently	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
),	O
a	O
betacoronavirus	O
,	O
is	O
associated	O
with	O
severe	O
pneumonia	O
and	O
renal	B-ANAT
failure	O
.	O

We	O
also	O
analysed	O
the	O
subcellular	O
localization	O
of	O
p4b	O
from	O
MERS	O
-	O
CoV	O
,	O
BtCoV	O
-	O
HKU4	O
and	O
BtCoV	O
-	O
HKU5	O
and	O
demonstrated	O
that	O
all	O
are	O
localized	O
to	O
the	O
nucleus	B-ANAT
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
adult	O
patients	O
with	O
hematologic	O
malignancies	O
and	O
severe	O
acute	O
respiratory	O
failure	O
.	O

Thrombocytopenia	O
occurred	O
in	O
all	O
patients	O
(	O
lowest	O
platelet	B-ANAT
count	O
was	O
20	O
(	O
11	O
to	O
21	O
)	O
G	O
/	O
L	O
).	O

ABSTRACT	O
:	O
We	O
tested	O
,	O
using	O
a	O
low	O
starting	O
dilution	O
,	O
sequential	O
serum	B-ANAT
samples	O
from	O
dromedary	O
camels	O
,	O
sheep	O
and	O
horses	O
collected	O
in	O
Dubai	O
from	O
February	O
/	O
April	O
to	O
October	O
of	O
2005	O
and	O
from	O
dromedary	O
camels	O
for	O
export	O
/	O
import	O
testing	O
between	O
Canada	O
and	O
USA	O
in	O
2000	O
-	O
2001	O
.	O

Outcomes	O
included	O
the	O
number	O
of	O
days	O
on	O
mechanical	O
ventilation	O
,	O
days	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
),	O
days	O
in	O
the	O
hospital	O
,	O
and	O
rates	O
of	O
pneumonia	O
,	O
sepsis	O
,	O
tracheostomy	O
,	O
chest	B-ANAT
tube	O
placement	O
,	O
and	O
death	O
.	O

Significant	O
head	B-ANAT
injury	O
was	O
present	O
in	O
15	O
%,	O
while	O
54	O
%	O
had	O
lung	B-ANAT
contusions	O
.	O

RESULTS	O
:	O
Flail	O
chest	B-ANAT
injury	O
was	O
identified	O
in	O
3	O
,	O
467	O
patients	O
;	O
the	O
mean	O
age	O
was	O
52	O
.	O
5	O
years	O
,	O
and	O
77	O
%	O
of	O
the	O
patients	O
were	O
male	O
.	O

We	O
used	O
the	O
Xenopus	B-ANAT
oocyte	I-ANAT
with	O
a	O
heterologously	O
expressed	O
3a	O
protein	O
as	O
a	O
model	O
system	O
to	O
test	O
the	O
efficacy	O
of	O
the	O
flavonols	O
.	O

The	O
mechanical	O
obstruction	O
,	O
along	O
with	O
the	O
direct	O
action	O
of	O
the	O
unfavorable	O
metabolic	O
and	O
hormonal	O
milieu	O
on	O
the	O
bladder	B-ANAT
neck	I-ANAT
,	O
helps	O
in	O
generating	O
LUTS	O
.	O

Complications	O
of	O
opiate	O
overdose	O
include	O
infection	O
,	O
rhabdomyolysis	O
,	O
respiratory	O
depression	O
and	O
central	O
or	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
neurological	O
complications	O
.	O

The	O
presence	O
of	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
injuries	O
may	O
portend	O
a	O
poor	O
prognosis	O
and	O
can	O
also	O
lead	O
to	O
long	O
term	O
disability	O
.	O

In	O
this	O
study	O
,	O
we	O
describe	O
the	O
development	O
of	O
a	O
reverse	O
transcription	O
isothermal	O
Recombinase	O
Polymerase	O
Amplification	O
(	O
RT	O
-	O
RPA	B-ANAT
)	O
assay	O
for	O
the	O
identification	O
of	O
MERS	O
-	O
CoV	O
.	O
A	O
partial	O
nucleocapsid	B-ANAT
gene	O
RNA	O
molecular	O
standard	O
of	O
MERS	O
-	O
coronavirus	O
was	O
used	O
to	O
determine	O
the	O
assay	O
sensitivity	O
.	O

The	O
developed	O
isothermal	O
real	O
-	O
time	O
RT	O
-	O
RPA	B-ANAT
is	O
ideal	O
for	O
rapid	O
mobile	O
molecular	O
MERS	O
-	O
CoV	O
monitoring	O
in	O
acute	O
patients	O
and	O
may	O
also	O
facilitate	O
the	O
search	O
for	O
the	O
animal	O
reservoir	O
of	O
MERS	O
-	O
CoV	O
.	O

However	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
G	O
-	O
CSF	B-ANAT
-	O
producing	O
lung	B-ANAT
cancer	O
is	O
extremely	O
rare	O
.	O

Thus	O
,	O
G	O
-	O
CSF	B-ANAT
-	O
producing	O
lung	B-ANAT
cancer	O
with	O
marked	O
leukocytosis	O
should	O
be	O
carefully	O
monitored	O
before	O
surgery	O
and	O
during	O
treatment	O
.	O

Further	O
structure	O
-	O
activity	O
relationships	O
are	O
also	O
discussed	O
,	O
demonstrating	O
for	O
the	O
first	O
time	O
that	O
the	O
same	O
changes	O
of	O
the	O
original	O
skeletons	B-ANAT
of	O
phenanthroindolizidine	O
and	O
phenanthroquinolizidine	O
exihibted	O
totally	O
different	O
antiviral	O
activities	O
results	O
,	O
providing	O
some	O
original	O
and	O
useful	O
information	O
about	O
the	O
preferential	O
conformation	O
for	O
maintaining	O
high	O
activities	O
.	O

Echocardiography	O
revealed	O
an	O
underfilled	O
,	O
hypokinetic	O
,	O
diastolic	O
dysfunctional	O
left	B-ANAT
ventricle	I-ANAT
with	O
pericardial	B-ANAT
effusion	I-ANAT
but	O
no	O
signs	O
of	O
tamponade	O
.	O

TITLE	O
:	O
Highly	O
pathogenic	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
infection	O
results	O
in	O
acute	O
lung	B-ANAT
injury	O
of	O
the	O
infected	O
pigs	O
.	O

Additionally	O
,	O
the	O
fibrosis	O
of	O
lung	B-ANAT
was	O
observed	O
in	O
the	O
HP	O
-	O
PRRSV	O
-	O
infected	O
pigs	O
.	O

Several	O
viruses	O
,	O
including	O
SARS	O
-	O
CoV	O
,	O
utilize	O
virally	O
encoded	O
2	O
'-	O
O	O
-	O
MTases	O
to	O
camouflage	O
and	O
obscure	O
their	O
viral	O
RNA	O
from	O
host	B-ANAT
cell	I-ANAT
sensing	O
machinery	O
,	O
thus	O
preventing	O
recognition	O
and	O
activation	O
of	O
cell	B-ANAT
intrinsic	O
defense	O
pathways	O
.	O

TITLE	O
:	O
Therapeutic	O
effect	O
of	O
intravenous	O
infusion	O
of	O
perfluorocarbon	O
emulsion	O
on	O
LPS	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
in	O
rats	O
.	O

TITLE	O
:	O
Mesenchymal	B-ANAT
stromal	I-ANAT
cell	I-ANAT
therapies	O
:	O
potential	O
and	O
pitfalls	O
for	O
ARDS	O
.	O

In	O
addition	O
,	O
MSCs	O
may	O
be	O
able	O
to	O
enhance	O
the	O
repair	O
and	O
resolution	O
of	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
The	O
influence	O
of	O
age	O
,	O
gender	O
and	O
treatment	O
with	O
steroids	O
on	O
the	O
incidence	O
of	O
osteonecrosis	O
of	O
the	O
femoral	B-ANAT
head	I-ANAT
during	O
the	O
management	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
a	O
retrospective	O
study	O
.	O

Moreover	O
,	O
the	O
SARS	O
-	O
CoV	O
N	O
substitutions	O
did	O
not	O
alter	O
the	O
fidelity	O
of	O
leader	O
-	O
body	B-ANAT
junction	O
formation	O
during	O
subgenomic	O
mRNA	O
synthesis	O
.	O

We	O
show	O
that	O
expression	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
PLpros	O
blocks	O
upregulation	O
of	O
cytokines	O
CCL5	O
,	O
IFN	O
-	O
Î²	O
and	O
CXCL10	O
in	O
stimulated	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Hantavirus	O
(	O
Bunyaviridae	O
)	O
cardiopulmonary	B-ANAT
syndrome	O
(	O
HCPS	O
)	O
is	O
an	O
emerging	O
health	O
problem	O
in	O
South	O
America	O
due	O
to	O
urban	O
growth	O
and	O
to	O
the	O
expansion	O
of	O
agriculture	O
and	O
cattle	O
-	O
raising	O
areas	O
into	O
ecosystems	O
containing	O
most	O
of	O
the	O
species	O
of	O
Sigmodontinae	O
rodents	O
that	O
act	O
as	O
hantavirus	O
reservoirs	O
.	O

HCPS	O
courses	O
with	O
a	O
capillary	B-ANAT
leaking	O
syndrome	O
produced	O
by	O
the	O
hantavirus	O
infecting	O
lung	B-ANAT
endothelial	B-ANAT
cells	I-ANAT
and	O
mostly	O
with	O
a	O
severe	O
inflammatory	O
process	O
associated	O
with	O
a	O
cytokine	O
storm	O
.	O

It	O
is	O
responsible	O
for	O
huge	O
economic	O
losses	O
by	O
causing	O
winter	O
dysentery	O
in	O
adult	O
dairy	O
cattle	O
and	O
respiratory	O
and	O
intestinal	B-ANAT
tract	I-ANAT
infections	O
leading	O
to	O
pneumo	O
-	O
enteritis	O
in	O
young	O
calves	O
.	O

Out	O
of	O
the	O
15	O
positive	O
fecal	B-ANAT
samples	O
,	O
virus	O
from	O
only	O
seven	O
was	O
able	O
to	O
infect	O
vero	O
cell	B-ANAT
line	I-ANAT
.	O

It	O
can	O
be	O
concluded	O
that	O
vero	O
cell	B-ANAT
line	I-ANAT
can	O
be	O
used	O
for	O
isolation	O
of	O
BCoV	O
,	O
however	O
due	O
to	O
the	O
enormous	O
stain	O
diversity	O
of	O
the	O
virus	O
it	O
is	O
possible	O
that	O
many	O
stains	O
can	O
'	O
t	O
grow	O
and	O
get	O
adapt	O
in	O
this	O
cell	B-ANAT
line	I-ANAT
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
which	O
kinases	O
and	O
cytoskeletal	B-ANAT
proteins	O
are	O
of	O
importance	O
during	O
internalisation	O
and	O
subsequent	O
intracellular	B-ANAT
transport	O
.	O

Intracellular	B-ANAT
trafficking	O
over	O
microtubules	B-ANAT
was	O
mediated	O
by	O
MLCK	O
,	O
myosin	O
1	O
and	O
a	O
small	O
actin	O
tail	O
.	O

Patients	O
with	O
cholinergic	O
syndrome	O
should	O
also	O
be	O
assessed	O
for	O
possible	O
cardiac	B-ANAT
complications	O
such	O
as	O
dysrhythmias	O
.	O

It	O
was	O
shown	O
that	O
unlike	O
the	O
pH	O
-	O
independent	O
retroviral	O
fusion	O
proteins	O
,	O
SARS	O
-	O
CoV	O
S2	O
is	O
stable	O
over	O
a	O
wide	O
pH	O
range	O
,	O
supporting	O
its	O
ability	O
to	O
fuse	O
at	O
both	O
the	O
plasma	B-ANAT
membrane	I-ANAT
and	O
endosome	B-ANAT
.	O

The	O
importance	O
of	O
the	O
C	O
-	O
terminal	O
hydrophobic	O
residues	O
led	O
us	O
to	O
identify	O
a	O
42	O
-	O
residue	O
substructure	O
on	O
the	O
central	B-ANAT
core	I-ANAT
that	O
is	O
structurally	O
conserved	O
in	O
all	O
existing	O
CoV	O
S2	O
fusion	O
proteins	O
(	O
root	B-ANAT
mean	O
squared	O
deviation	O
=	O
0	O
.	O
4	O
Ã	O
).	O

TITLE	O
:	O
[	O
The	O
prognostic	O
value	O
of	O
extravascular	O
lung	B-ANAT
water	O
index	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

These	O
results	O
validated	O
the	O
yeast	O
assay	O
system	O
for	O
inhibitor	O
screening	O
yet	O
also	O
demonstrated	O
the	O
difference	O
between	O
cell	B-ANAT
-	O
based	O
and	O
in	O
vitro	O
biochemical	O
assays	O
.	O

Glycoforms	O
of	O
serum	B-ANAT
IgG1	O
and	O
IgG2	O
were	O
determined	O
separately	O
by	O
liquid	O
chromatography	O
mass	O
spectrometry	O
.	O

IVIg	O
preparations	O
contained	O
relatively	O
high	O
levels	O
of	O
galactosylated	O
and	O
sialylated	O
IgG	O
Fc	O
glycoforms	O
compared	O
with	O
serum	B-ANAT
IgG	O
in	O
patients	O
.	O

Treatment	O
with	O
IVIg	O
resulted	O
in	O
an	O
increase	O
in	O
serum	B-ANAT
of	O
the	O
Fc	O
-	O
galactosylation	O
and	O
-	O
sialylation	O
of	O
both	O
IgG1	O
and	O
IgG2	O
.	O

We	O
found	O
that	O
TGEV	O
N	O
protein	O
suppressed	O
cell	B-ANAT
proliferation	O
by	O
causing	O
cell	B-ANAT
cycle	O
arrest	O
at	O
the	O
S	O
and	O
G2	O
/	O
M	O
phases	O
and	O
apoptosis	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
TGEV	O
N	O
gene	O
promoted	O
translocation	O
of	O
Bax	O
to	O
mitochondria	B-ANAT
,	O
which	O
in	O
turn	O
caused	O
the	O
release	O
of	O
cytochrome	O
c	O
,	O
followed	O
by	O
activation	O
of	O
caspase	O
-	O
3	O
,	O
resulting	O
in	O
cell	B-ANAT
apoptosis	O
in	O
the	O
transfected	O
PK	O
-	O
15	O
cells	B-ANAT
following	O
cell	B-ANAT
cycle	O
arrest	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
TGEV	O
N	O
protein	O
might	O
play	O
an	O
important	O
role	O
in	O
TGEV	O
infection	O
-	O
induced	O
p53	O
activation	O
and	O
cell	B-ANAT
cycle	O
arrest	O
at	O
the	O
S	O
and	O
G2	O
/	O
M	O
phases	O
and	O
apoptosis	O
occurrence	O
.	O

Cell	B-ANAT
entry	O
begins	O
with	O
virus	O
spike	O
(	O
S	O
)	O
protein	O
binding	O
to	O
DPP4	O
receptors	O
.	O

Sera	B-ANAT
from	O
noninfected	O
and	O
infected	O
pigs	O
were	O
used	O
to	O
set	O
the	O
median	O
fluorescent	O
intensity	O
(	O
MFI	O
)	O
cutoffs	O
and	O
as	O
positive	O
controls	O
,	O
respectively	O
.	O

An	O
outbreak	O
of	O
mould	O
infections	O
of	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
has	O
been	O
described	O
in	O
the	O
United	O
States	O
following	O
injection	O
of	O
contaminated	O
steroids	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
-	O
OHD	O
)	O
levels	O
at	O
the	O
onset	O
of	O
critical	O
illness	O
and	O
the	O
development	O
of	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
in	O
patients	O
with	O
sepsis	O
or	O
trauma	O
.	O

vaccination	O
,	O
including	O
neutralizing	O
antibodies	O
,	O
but	O
more	O
robust	O
systemic	O
cellular	B-ANAT
immune	O
responses	O
and	O
significantly	O
higher	O
local	O
mucosal	B-ANAT
immune	O
responses	O
in	O
mouse	O
lungs	B-ANAT
.	O

Biochemical	O
blood	B-ANAT
analyses	O
show	O
an	O
elevated	O
C	O
-	O
reactive	O
protein	O
,	O
but	O
creatine	O
kinase	O
is	O
often	O
normal	O
.	O

We	O
subsequently	O
review	O
48	O
episodes	O
of	O
diabetic	O
muscle	B-ANAT
infarction	O
previously	O
reported	O
in	O
the	O
literature	O
in	O
patients	O
with	O
end	O
-	O
stage	O
renal	B-ANAT
disease	O
.	O

We	O
also	O
determined	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
N	O
-	O
NTD	O
-	O
PJ34	O
complex	O
.	O

Selectivity	O
and	O
cytotoxicity	O
studies	O
established	O
a	O
more	O
than	O
100	O
-	O
fold	O
preference	O
for	O
the	O
coronaviral	O
enzyme	O
over	O
homologous	O
human	O
deubiquitinating	O
enzymes	O
(	O
DUBs	O
),	O
and	O
no	O
significant	O
cytotoxicity	O
in	O
Vero	O
E6	O
and	O
HEK293	B-ANAT
cell	I-ANAT
lines	O
is	O
observed	O
.	O

FECV	O
and	O
FIP	O
also	O
exhibit	O
functional	O
differences	O
,	O
since	O
FECVs	O
replicate	O
mainly	O
in	O
intestinal	B-ANAT
epithelium	I-ANAT
and	O
are	O
shed	O
in	O
feces	B-ANAT
,	O
and	O
FIPVs	O
replicate	O
efficiently	O
in	O
monocytes	B-ANAT
and	O
induce	O
systemic	O
disease	O
.	O

It	O
is	O
the	O
activation	O
of	O
monocytes	B-ANAT
and	O
macrophages	B-ANAT
that	O
directly	O
leads	O
to	O
the	O
pathologic	O
features	O
of	O
FIP	O
,	O
including	O
vasculitis	O
,	O
body	B-ANAT
cavity	I-ANAT
effusions	O
,	O
and	O
fibrinous	O
and	O
granulomatous	O
inflammatory	O
lesions	O
.	O

A	O
peripheral	B-ANAT
blood	I-ANAT
smear	O
showed	O
numerous	O
Trypanosoma	O
brucei	O
trypomastigotes	O
with	O
a	O
massive	O
parasitaemia	O
of	O
100	O
,	O
000	O
/	O
Î¼l	O
.	O

ABSTRACT	O
:	O
The	O
aim	O
of	O
this	O
research	O
was	O
to	O
investigate	O
the	O
blood	B-ANAT
coagulation	O
function	O
in	O
the	O
patients	O
with	O
avascular	O
necrosis	O
of	O
the	O
femoral	B-ANAT
head	I-ANAT
(	O
ANFH	O
)	O
after	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Therefore	O
,	O
we	O
examined	O
tonsils	B-ANAT
for	O
the	O
presence	O
of	O
respiratory	O
viruses	O
'	O
nucleic	B-ANAT
acids	O
in	O
children	O
with	O
OSA	O
,	O
and	O
in	O
children	O
without	O
OSA	O
(	O
undergoing	O
surgery	O
for	O
recurrent	O
throat	B-ANAT
infections	O
(	O
RI	O
)).	O

Respiratory	O
viruses	O
are	O
detected	O
in	O
OSA	O
hypertrophic	O
tonsils	B-ANAT
,	O
suggestive	O
of	O
their	O
role	O
in	O
the	O
evolution	O
of	O
tonsillar	B-ANAT
inflammation	O
and	O
hypertrophy	O
.	O

Consistent	O
with	O
the	O
media	B-ANAT
attention	O
generated	O
,	O
and	O
with	O
results	O
from	O
other	O
studies	O
,	O
the	O
reporting	O
rates	O
of	O
syncope	O
or	O
loss	O
of	O
consciousness	O
and	O
seizures	O
were	O
higher	O
for	O
the	O
HPV	O
vaccine	O
than	O
for	O
other	O
vaccines	O
given	O
in	O
adolescence	O
.	O

The	O
survival	O
ratio	O
showed	O
statistically	O
significant	O
differences	O
in	O
mild	O
and	O
moderate	O
ARDS	O
-	O
patients	O
treated	O
with	O
the	O
neutrophil	B-ANAT
elastase	O
inhibitor	O
.	O

TITLE	O
:	O
Prolonged	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
without	O
anticoagulation	O
:	O
a	O
case	O
of	O
Goodpasture	O
syndrome	O
-	O
related	O
pulmonary	B-ANAT
haemorrhage	O
.	O

Bilateral	O
heterogeneous	O
densities	O
were	O
seen	O
on	O
his	O
chest	B-ANAT
x	O
-	O
ray	O
film	O
.	O

Here	O
,	O
we	O
show	O
that	O
mice	O
were	O
sensitized	O
to	O
MERS	O
-	O
CoV	O
infection	O
by	O
prior	O
transduction	O
with	O
adenoviral	O
vectors	O
expressing	O
the	O
human	O
host	O
-	O
cell	B-ANAT
receptor	O
dipeptidyl	O
peptidase	O
4	O
.	O

Mice	O
developed	O
a	O
pneumonia	O
characterized	O
by	O
extensive	O
inflammatory	O
-	O
cell	B-ANAT
infiltration	O
with	O
virus	O
clearance	O
occurring	O
6	O
-	O
8	O
d	O
after	O
infection	O
.	O

Clinical	O
disease	O
and	O
histopathological	O
changes	O
were	O
more	O
severe	O
in	O
the	O
absence	O
of	O
type	O
-	O
I	O
IFN	O
signaling	O
whereas	O
the	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
response	O
was	O
required	O
for	O
virus	O
clearance	O
.	O

The	O
scar	O
above	O
the	O
suprasternal	B-ANAT
notch	I-ANAT
was	O
visibly	O
sunken	O
and	O
retracted	O
with	O
respiration	O
.	O

Continuous	O
airway	B-ANAT
pressure	O
via	O
a	O
facemask	O
restored	O
airway	B-ANAT
patency	O
and	O
improved	O
breathing	O
.	O

Four	O
main	O
mechanisms	O
leading	O
to	O
VALI	O
are	O
:	O
1	O
)	O
increased	O
stress	O
and	O
strain	O
,	O
induced	O
by	O
high	O
tidal	O
volume	O
(	O
VT	O
);	O
2	O
)	O
increased	O
shear	O
stress	O
,	O
i	O
.	O
e	O
.	O
opening	O
and	O
closing	O
,	O
of	O
previously	O
atelectatic	O
alveolar	B-ANAT
units	O
;	O
3	O
)	O
distribution	O
of	O
perfusion	O
and	O
4	O
)	O
biotrauma	O
.	O

Thirty	O
-	O
four	O
per	O
cent	O
required	O
mechanical	O
ventilation	O
and	O
22	O
%	O
required	O
renal	B-ANAT
replacement	O
therapy	O
.	O

In	O
accordance	O
,	O
biopsy	O
of	O
FH	O
patients	O
shows	O
a	O
dramatic	O
increase	O
of	O
Fgl2	O
expression	O
,	O
which	O
correlates	O
with	O
C5aR	O
up	O
-	O
regulation	O
in	O
the	O
liver	B-ANAT
.	O

Our	O
recent	O
assessment	O
of	O
mitochondrial	B-ANAT
function	O
in	O
MeCP2	O
(	O
methyl	O
-	O
CpG	O
-	O
binding	O
protein	O
2	O
)-	O
deficient	O
mouse	O
(	O
Mecp2	O
(-)	O
(/	O
y	O
))	O
hippocampus	B-ANAT
confirmed	O
early	O
metabolic	O
alterations	O
,	O
an	O
increased	O
oxidative	O
burden	O
,	O
and	O
a	O
more	O
vulnerable	O
cellular	B-ANAT
redox	O
balance	O
.	O

As	O
these	O
changes	O
may	O
contribute	O
to	O
the	O
manifestation	O
of	O
symptoms	O
and	O
disease	O
progression	O
,	O
we	O
now	O
evaluated	O
whether	O
free	O
radical	O
scavengers	O
are	O
capable	O
of	O
improving	O
neuronal	O
and	O
mitochondrial	B-ANAT
function	O
in	O
RS	O
.	O

Acute	O
hippocampal	B-ANAT
slices	O
of	O
adult	O
mice	O
were	O
incubated	O
with	O
the	O
vitamin	O
E	O
derivative	O
Trolox	O
for	O
3	O
-	O
5	O
h	O
.	O
In	O
Mecp2	O
(-)	O
(/	O
y	O
)	O
slices	O
this	O
treatment	O
dampened	O
neuronal	O
hyperexcitability	O
,	O
improved	O
synaptic	O
short	O
-	O
term	O
plasticity	O
,	O
and	O
fully	O
restored	O
synaptic	O
long	O
-	O
term	O
potentiation	O
(	O
LTP	O
).	O

TITLE	O
:	O
Depletion	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
ameliorates	O
virus	O
-	O
induced	O
disease	O
following	O
a	O
pulmonary	B-ANAT
coronavirus	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
mucosa	B-ANAT
that	O
lines	O
the	O
respiratory	O
and	O
gastrointestinal	O
(	O
GI	O
)	O
tracts	B-ANAT
is	O
an	O
important	O
portal	B-ANAT
of	O
entry	O
for	O
pathogens	O
and	O
provides	O
the	O
first	O
line	O
of	O
innate	O
immune	O
defense	O
against	O
infections	O
.	O

To	O
better	O
understand	O
the	O
replication	O
features	O
of	O
these	O
viruses	O
in	O
their	O
target	O
organs	B-ANAT
and	O
molecular	O
pathogenesis	O
of	O
these	O
different	O
viruses	O
,	O
comparative	O
proteomic	O
analysis	O
was	O
performed	O
to	O
investigate	O
the	O
proteome	O
changes	O
of	O
primary	O
target	O
organ	B-ANAT
during	O
IBV	O
,	O
NDV	O
,	O
and	O
AIV	O
H9	O
infections	O
,	O
using	O
2D	O
-	O
DIGE	O
followed	O
MALDI	O
-	O
TOF	O
/	O
TOF	O
-	O
MS	O
.	O

In	O
total	O
,	O
44	O
,	O
39	O
,	O
41	O
,	O
48	O
,	O
and	O
38	O
proteins	O
were	O
identified	O
in	O
the	O
tracheal	O
tissues	B-ANAT
of	O
the	O
chickens	O
inoculated	O
with	O
IBV	O
(	O
ck	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
,	O
H120	O
),	O
NDV	O
(	O
La	O
Sota	O
),	O
and	O
AIV	O
H9	O
,	O
and	O
between	O
ck	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
and	O
H120	O
,	O
respectively	O
.	O

Gene	O
expression	O
of	O
collagen	B-ANAT
type	I-ANAT
I	I-ANAT
,	O
but	O
not	O
collagen	B-ANAT
type	I-ANAT
V	I-ANAT
,	O
in	O
the	O
isthmus	O
and	O
CaBP	O
-	O
D28K	O
in	O
the	O
uterus	B-ANAT
was	O
decreased	O
in	O
the	O
aIBV	O
group	O
compared	O
with	O
that	O
in	O
the	O
control	O
.	O

It	O
rarely	O
causes	O
cardiac	B-ANAT
arrhythmia	O
,	O
pancreatitis	O
and	O
hepatic	B-ANAT
dysfunction	O
.	O

On	O
the	O
same	O
day	O
the	O
patient	O
also	O
developed	O
severe	O
upper	O
abdominal	B-ANAT
pain	O
along	O
with	O
nausea	O
and	O
vomiting	O
.	O

Recent	O
studies	O
link	O
deficiency	O
of	O
intersectin	O
-	O
1s	O
(	O
ITSN	O
-	O
1s	O
),	O
a	O
prosurvival	O
protein	O
of	O
lung	B-ANAT
endothelial	B-ANAT
cells	I-ANAT
,	O
to	O
endothelial	B-ANAT
barrier	O
dysfunction	O
and	O
pulmonary	B-ANAT
edema	O
as	O
well	O
as	O
to	O
the	O
repair	O
/	O
recovery	O
from	O
ALI	O
.	O

Human	O
Coronaviruses	O
(	O
HCoV	O
)	O
usually	O
infect	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
where	O
they	O
are	O
mainly	O
associated	O
with	O
common	O
colds	O
.	O

Furthermore	O
,	O
it	O
was	O
shown	O
that	O
in	O
the	O
murine	O
CNS	B-ANAT
,	O
neurons	B-ANAT
are	O
the	O
main	O
target	O
of	O
infection	O
,	O
which	O
causes	O
these	O
essential	O
cells	B-ANAT
to	O
undergo	O
degeneration	O
and	O
eventually	O
die	O
by	O
some	O
form	O
of	O
programmed	O
cell	B-ANAT
death	O
after	O
virus	O
infection	O
.	O

There	O
was	O
no	O
evidence	O
of	O
MERS	O
-	O
CoV	O
nasal	B-ANAT
carriage	O
among	O
Hajj	O
pilgrims	O
.	O

Active	O
inflammatory	O
demyelinating	O
lesions	O
induced	O
by	O
CD8	O
(+)	O
T	B-ANAT
cells	I-ANAT
or	O
by	O
innate	O
immunity	O
showed	O
macrophage	B-ANAT
and	O
microglial	B-ANAT
activation	O
together	O
with	O
the	O
expression	O
of	O
p22phox	O
,	O
but	O
low	O
or	O
absent	O
iNOS	O
reactivity	O
.	O

We	O
corroborated	O
the	O
differences	O
between	O
acute	O
CD4	O
(+)	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
experimental	O
autoimmune	O
encephalomyelitis	O
and	O
acute	O
MS	O
lesions	O
via	O
gene	O
expression	O
studies	O
.	O

Furthermore	O
,	O
age	O
-	O
dependent	O
iron	O
accumulation	O
and	O
lesion	O
-	O
associated	O
iron	O
liberation	O
,	O
as	O
occurring	O
in	O
the	O
human	O
brain	B-ANAT
,	O
were	O
only	O
minor	O
in	O
rodent	O
brains	B-ANAT
.	O

Replication	O
is	O
associated	O
with	O
multiple	O
virus	O
-	O
induced	O
membrane	B-ANAT
structures	O
that	O
evolve	O
during	O
infection	O
;	O
however	O
,	O
the	O
dynamics	O
of	O
this	O
process	O
remain	O
poorly	O
understood	O
.	O

Although	O
a	O
small	O
number	O
of	O
camels	O
have	O
been	O
found	O
to	O
have	O
positive	O
nasal	B-ANAT
swabs	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
to	O
carry	O
antibody	O
against	O
MERS	O
-	O
CoV	O
,	O
the	O
transmission	O
route	O
and	O
the	O
intermediary	O
animal	O
source	O
remain	O
uncertain	O
amongst	O
the	O
sporadic	O
primary	O
cases	O
.	O

The	O
lung	B-ANAT
injury	O
is	O
caused	O
by	O
the	O
invasion	O
of	O
the	O
respiratory	B-ANAT
epithelium	I-ANAT
,	O
whereas	O
the	O
extrarespiratory	O
manifestations	O
are	O
probably	O
due	O
to	O
immunological	O
disorders	O
.	O

Nasopharyngeal	B-ANAT
aspirate	I-ANAT
and	O
sputum	B-ANAT
samples	O
should	O
be	O
collected	O
for	O
diagnosis	O
,	O
preferably	O
using	O
reverse	O
transcriptase	O
-	O
PCR	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
infection	O
in	O
aged	O
nonhuman	O
primates	O
is	O
associated	O
with	O
modulated	O
pulmonary	B-ANAT
and	O
systemic	O
immune	O
responses	O
.	O

Serum	B-ANAT
proinflammatory	O
cytokines	O
were	O
similar	O
in	O
both	O
age	O
groups	O
,	O
whereas	O
significantly	O
lower	O
levels	O
of	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
18	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
12	O
and	O
IL	O
-	O
15	O
were	O
detected	O
in	O
the	O
lungs	B-ANAT
of	O
SARS	O
-	O
CoV	O
-	O
infected	O
aged	O
monkeys	O
at	O
either	O
5	O
or	O
10	O
days	O
post	O
infection	O
.	O

TITLE	O
:	O
Serum	B-ANAT
MMP	O
-	O
8	O
and	O
TIMP	O
-	O
1	O
in	O
critically	O
ill	O
patients	O
with	O
acute	O
respiratory	O
failure	O
:	O
TIMP	O
-	O
1	O
is	O
associated	O
with	O
increased	O
90	O
-	O
day	O
mortality	O
.	O

In	O
a	O
recent	O
study	O
,	O
high	O
matrix	O
metalloproteinases	O
(	O
MMP	O
-	O
8	O
)	O
levels	O
in	O
tracheal	O
aspirates	B-ANAT
of	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
were	O
associated	O
with	O
worse	O
outcome	O
.	O

Phylogenetic	O
analysis	O
of	O
F	O
gene	O
revealed	O
that	O
96	O
.	O
8	O
%	O
of	O
hMPV	O
detected	O
was	O
subgenotype	O
B1	O
,	O
1	O
.	O
6	O
%	O
was	O
sublineage	O
A2a	B-ANAT
,	O
and	O
1	O
.	O
6	O
%	O
was	O
A2b	B-ANAT
.	O

HPV	O
was	O
virucidal	O
for	O
structurally	O
distinct	O
viruses	O
dried	B-ANAT
on	O
surfaces	O
,	O
suggesting	O
that	O
HPV	O
can	O
be	O
considered	O
for	O
the	O
disinfection	O
of	O
virus	O
-	O
contaminated	O
surfaces	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
improve	O
the	O
analytic	O
quality	O
of	O
respiratory	O
specimens	O
collected	O
from	O
cattle	O
for	O
nucleic	B-ANAT
acid	O
-	O
based	O
diagnosis	O
,	O
a	O
study	O
was	O
undertaken	O
to	O
verify	O
realtime	O
PCR	O
efficiency	O
of	O
specimens	O
collected	O
and	O
stabilized	O
on	O
FTA	O
Cards	O
â¢,	O
filter	O
paper	O
which	O
is	O
treated	O
chemically	O
.	O

No	O
significant	O
difference	O
(	O
P	O
â¥	O
0	O
.	O
05	O
)	O
was	O
observed	O
in	O
realtime	O
PCR	O
cycle	O
threshold	O
values	O
over	O
the	O
temperature	O
range	O
and	O
time	O
storage	B-ANAT
conditions	O
for	O
Bovine	O
Viral	O
Diarrhea	O
virus	O
,	O
Bovine	O
Respiratory	O
Syncytial	O
virus	O
,	O
Bovine	O
Coronavirus	O
,	O
and	O
Bovine	O
Herpesvirus	O
I	O
.	O
The	O
four	O
viruses	O
evaluated	O
in	O
the	O
study	O
are	O
associated	O
with	O
Bovine	O
Respiratory	O
Disease	O
Complex	O
where	O
improvements	O
in	O
ease	O
and	O
reliability	O
of	O
specimen	O
collection	O
and	O
shipping	O
would	O
enhance	O
the	O
diagnostic	O
quality	O
of	O
specimens	O
collected	O
in	O
the	O
field	O
,	O
and	O
ultimately	O
improve	O
diagnostic	O
efficiency	O
.	O

Therefore	O
,	O
we	O
performed	O
time	O
course	O
experiments	O
in	O
which	O
Vero	B-ANAT
cells	I-ANAT
were	O
C	O
.	O
pecorum	O
/	O
PEDV	O
infected	O
in	O
the	O
presence	O
of	O
cycloheximide	O
(	O
CHX	O
),	O
which	O
inhibits	O
viral	O
but	O
not	O
chlamydial	O
protein	O
synthesis	O
.	O

Reovirus	O
pathogenicity	O
has	O
been	O
associated	O
with	O
virus	O
-	O
induced	O
apoptosis	O
in	O
cultured	B-ANAT
cells	I-ANAT
and	O
in	O
vivo	O
.	O

The	O
reovirus	O
outer	O
capsid	B-ANAT
protein	O
Î¼1	O
is	O
recognized	O
as	O
the	O
primary	O
determinant	O
of	O
reovirus	O
-	O
induced	O
apoptosis	O
.	O

In	O
the	O
course	O
of	O
ALI	O
/	O
ARDS	O
,	O
mediators	O
released	O
from	O
resident	O
cells	B-ANAT
,	O
such	O
as	O
alveolar	B-ANAT
macrophages	I-ANAT
,	O
may	O
act	O
as	O
chemoattractants	O
for	O
invading	O
cells	B-ANAT
and	O
stimulate	O
local	O
cells	B-ANAT
to	O
build	O
up	O
a	O
proinflammatory	O
micromilieu	O
.	O

Among	O
RCTs	O
with	O
more	O
than	O
50	O
deaths	O
in	O
at	O
least	O
one	O
treatment	O
arm	B-ANAT
(	O
n	O
=	O
21	O
),	O
two	O
showed	O
a	O
statistically	O
significant	O
mortality	O
benefit	O
of	O
the	O
intervention	O
(	O
lower	O
tidal	O
volumes	O
and	O
prone	O
positioning	O
),	O
one	O
showed	O
a	O
statistically	O
significant	O
mortality	O
benefit	O
only	O
in	O
adjusted	O
analyses	O
(	O
cisatracurium	O
),	O
and	O
one	O
(	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
)	O
showed	O
a	O
significant	O
detrimental	O
effect	O
.	O

This	O
hydrophobic	O
motif	O
has	O
been	O
reported	O
to	O
constitute	O
a	O
Golgi	B-ANAT
-	O
targeting	O
signal	O
or	O
a	O
second	O
TM	O
domain	O
.	O

Herein	O
,	O
we	O
show	O
that	O
the	O
E	O
protein	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	O
has	O
only	O
one	O
TM	O
domain	O
in	O
micelles	O
,	O
whereas	O
the	O
predicted	O
Î²	O
-	O
coil	O
-	O
Î²	O
motif	O
forms	O
a	O
short	O
membrane	B-ANAT
-	O
bound	O
Î±	O
-	O
helix	O
connected	O
by	O
a	O
disordered	O
loop	O
to	O
the	O
TM	O
domain	O
.	O

It	O
results	O
in	O
recurrent	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
and	O
bronchiectasis	O
.	O

Similarly	O
,	O
improvements	O
in	O
carbon	O
dioxide	O
(	O
CO2	O
)	O
clearance	O
,	O
pulmonary	B-ANAT
vascular	B-ANAT
pressures	O
and	O
inflammation	O
were	O
observed	O
and	O
confirmed	O
by	O
histology	O
and	O
by	O
the	O
decrease	O
in	O
lung	B-ANAT
edema	O
.	O

These	O
results	O
suggest	O
that	O
high	O
dietary	O
Zn	O
could	O
provide	O
enhanced	O
protection	O
in	O
the	O
intestinal	B-ANAT
tract	I-ANAT
and	O
stimulate	O
the	O
systemic	O
humoral	O
immune	O
response	O
against	O
TGEV	O
infection	O
.	O

All	O
surveys	O
were	O
conducted	O
using	O
questionnaire	O
-	O
based	O
telephone	O
interviews	O
,	O
with	O
random	O
digit	B-ANAT
dialing	O
to	O
recruit	O
adults	O
from	O
the	O
general	O
population	O
.	O

Tonsillar	B-ANAT
virus	O
detection	O
showed	O
a	O
strong	O
negative	O
association	O
with	O
age	O
;	O
especially	O
rhinovirus	O
or	O
parainfluenza	O
virus	O
detection	O
showed	O
positive	O
association	O
with	O
IFN	O
-	O
Î³	O
and	O
Tbet	O
expressions	O
.	O

ABSTRACT	O
:	O
A	O
toddler	O
presented	O
with	O
poor	O
appetite	O
,	O
weight	O
loss	O
and	O
frequent	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
for	O
the	O
past	O
6	O
months	O
,	O
fever	O
and	O
increasing	O
paleness	O
for	O
the	O
past	O
2	O
months	O
and	O
bilateral	O
pedal	B-ANAT
oedema	O
for	O
the	O
past	O
1	O
month	O
.	O

Possible	O
harmful	O
effects	O
of	O
further	O
viruses	O
like	O
adenovirus	O
,	O
bocavirus	O
,	O
coronavirus	O
,	O
metapneumovirus	O
,	O
parainfluenzavirus	O
on	O
the	O
lung	B-ANAT
function	O
of	O
CF	O
patients	O
are	O
discussed	O
.	O

Blast	B-ANAT
crisis	O
with	O
transformation	O
into	O
acute	O
myeloid	O
leukemia	O
occurs	O
in	O
one	O
third	O
of	O
patients	O
.	O

IMPORTANCE	O
The	O
viruses	O
that	O
cause	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
poliomyelitis	O
,	O
and	O
hepatitis	O
C	O
all	O
replicate	O
in	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
).	O

In	O
this	O
study	O
,	O
we	O
looked	O
at	O
thousands	O
of	O
infected	O
cells	B-ANAT
and	O
identified	O
two	O
coronavirus	O
mutants	O
that	O
made	O
half	O
as	O
many	O
organelles	B-ANAT
as	O
normal	O
and	O
two	O
others	O
that	O
made	O
typical	O
numbers	O
but	O
smaller	O
organelles	B-ANAT
.	O

The	O
Respiratory	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Survival	O
Prediction	O
(	O
RESP	O
)	O
score	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
an	O
established	O
method	O
of	O
treatment	O
for	O
extremely	O
severe	O
respiratory	O
failure	O
(	O
ARDS	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
),	O
for	O
mechanical	O
circulatory	O
support	O
after	O
cardiac	B-ANAT
surgery	O
as	O
well	O
as	O
advanced	O
resuscitation	O
technique	O
in	O
specific	O
cases	O
.	O

He	O
was	O
placed	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
to	O
stabilise	O
his	O
condition	O
.	O

Neutrophils	B-ANAT
exposed	O
to	O
platelet	B-ANAT
-	O
activating	O
factor	O
were	O
initially	O
retained	O
but	O
subsequently	O
released	O
such	O
that	O
only	O
14	O
%	O
remained	O
in	O
the	O
lungs	B-ANAT
at	O
40	O
min	O
.	O

Peripheral	B-ANAT
blood	I-ANAT
-	O
derived	O
macrophages	B-ANAT
were	O
stimulated	O
with	O
poly	O
I	O
:	O
C	O
,	O
simulating	O
an	O
RNA	O
virus	O
,	O
or	O
IFNÎ³	O
,	O
a	O
cytokine	O
at	O
the	O
interface	O
of	O
innate	O
and	O
adaptive	O
immunity	O
.	O

Many	O
commercial	O
herbal	O
medicines	O
containing	O
one	O
or	O
more	O
compounds	O
have	O
been	O
successfully	O
applied	O
to	O
prevent	O
and	O
treat	O
viral	O
infections	O
of	O
respiratory	B-ANAT
tract	I-ANAT
clinically	O
.	O

Many	O
commercial	O
herbal	O
medicines	O
containing	O
one	O
or	O
more	O
compounds	O
have	O
been	O
successfully	O
applied	O
to	O
prevent	O
and	O
treat	O
viral	O
infections	O
of	O
respiratory	B-ANAT
tract	I-ANAT
clinically	O
.	O

ABSTRACT	O
:	O
Liver	B-ANAT
resection	O
is	O
increasingly	O
performed	O
in	O
elderly	O
patients	O
who	O
are	O
suspected	O
of	O
increased	O
postoperative	O
morbidity	O
(	O
PM	O
)	O
and	O
reduced	O
overall	O
survival	O
(	O
OS	O
).	O

Six	O
herbal	O
extracts	O
,	O
one	O
each	O
from	O
Gentianae	O
Radix	O
(	O
lÃ³ng	O
dÇn	O
;	O
the	O
dried	B-ANAT
rhizome	O
of	O
Gentiana	O
scabra	O
),	O
Dioscoreae	O
Rhizoma	O
(	O
shÄn	O
yÃ o	O
;	O
the	O
tuber	B-ANAT
of	O
Dioscorea	O
batatas	O
),	O
Cassiae	O
Semen	B-ANAT
(	O
juÃ©	O
mÃ­ng	O
zÇ	O
;	O
the	O
dried	B-ANAT
seed	O
of	O
Cassia	O
tora	O
)	O
and	O
Loranthi	O
Ramus	O
(	O
sÄng	O
jÃ¬	O
shÄng	O
;	O
the	O
dried	B-ANAT
stem	B-ANAT
,	O
with	O
leaf	O
of	O
Taxillus	O
chinensis	O
)	O
(	O
designated	O
as	O
GSH	O
,	O
DBM	O
,	O
CTH	O
and	O
TCH	O
,	O
respectively	O
),	O
and	O
two	O
from	O
Rhizoma	O
Cibotii	O
(	O
gÇu	O
jÇ	O
;	O
the	O
dried	B-ANAT
rhizome	O
of	O
Cibotium	O
barometz	O
)	O
(	O
designated	O
as	O
CBE	O
and	O
CBM	O
),	O
were	O
found	O
to	O
be	O
potent	O
inhibitors	O
of	O
SARS	O
-	O
CoV	O
at	O
concentrations	O
between	O
25	O
and	O
200	O
Î¼g	O
/	O
ml	O
.	O

Established	O
mortality	O
risk	O
scores	O
were	O
validated	O
to	O
assess	O
their	O
usefulness	O
in	O
304	O
adult	O
patients	O
undergoing	O
vvECMO	O
for	O
refractory	O
lung	B-ANAT
failure	O
at	O
the	O
University	O
Medical	O
Center	O
Regensburg	O
from	O
2008	O
to	O
2013	O
.	O

In	O
this	O
study	O
,	O
the	O
antiviral	O
and	O
anti	O
-	O
inflammatory	O
effects	O
of	O
two	O
indirubin	O
derivatives	O
:	O
indirubin	O
-	O
3	O
'-	O
oxime	O
(	O
IM	O
)	O
and	O
E804	O
on	O
primary	O
human	O
peripherial	O
blood	B-ANAT
-	O
derived	O
macrophages	B-ANAT
and	O
type	O
-	O
I	O
like	O
pneumocytes	B-ANAT
(	O
human	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
)	O
during	O
influenza	O
A	O
(	O
H5N1	O
)	O
virus	O
infection	O
were	O
investigated	O
.	O

We	O
found	O
that	O
both	O
of	O
the	O
indirubin	O
derivatives	O
strongly	O
suppress	O
the	O
pro	O
-	O
inflammatory	O
cytokines	O
including	O
IP	O
-	O
10	O
(	O
CXCL10	O
),	O
one	O
of	O
the	O
key	O
factors	O
which	O
contribute	O
to	O
the	O
lung	B-ANAT
inflammation	O
during	O
H5N1	O
virus	O
infection	O
.	O

Here	O
,	O
we	O
have	O
produced	O
a	O
neutralizing	O
monoclonal	O
antibody	O
with	O
the	O
capacity	O
to	O
effectively	O
block	O
MERS	O
-	O
CoV	O
entry	O
into	O
permissive	O
human	O
cells	B-ANAT
.	O

Streptococcus	O
pneumoniae	O
was	O
not	O
isolated	O
in	O
this	O
girl	O
with	O
'	O
typical	O
'	O
pneumonia	O
by	O
symptomatology	O
and	O
chest	B-ANAT
radiography	O
,	O
but	O
tracheal	B-ANAT
aspirate	I-ANAT
identified	O
MP	O
instead	O
.	O

Management	O
of	O
severe	O
mycoplasma	O
infection	O
in	O
the	O
PICU	O
includes	O
general	O
cardiopulmonary	B-ANAT
support	O
and	O
specific	O
antimicrobial	O
treatment	O
.	O

For	O
the	O
patients	O
who	O
need	O
mechanical	O
ventilation	O
and	O
ECMO	O
support	O
,	O
the	O
lung	B-ANAT
protective	O
strategy	O
under	O
the	O
guidance	O
of	O
transpulmonary	O
pressure	O
may	O
be	O
helpful	O
for	O
recovering	O
the	O
lung	B-ANAT
.	O

This	O
distinction	O
was	O
mediated	O
by	O
mouse	O
phagocytic	B-ANAT
cells	I-ANAT
(	O
monocyte	B-ANAT
-	O
derived	O
infiltrating	O
macrophages	B-ANAT
and	O
partially	O
alveolar	B-ANAT
macrophages	I-ANAT
,	O
but	O
not	O
neutrophils	B-ANAT
),	O
as	O
demonstrated	O
both	O
by	O
adoptive	O
transfer	O
from	O
donors	O
and	O
by	O
immunological	O
depletion	O
of	O
selected	O
cell	B-ANAT
types	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
closely	O
resembled	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
in	O
disease	O
manifestation	O
as	O
rapidly	O
progressive	O
acute	O
pneumonia	O
with	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
.	O

Second	O
,	O
MERS	O
-	O
CoV	O
induced	O
significantly	O
higher	O
levels	O
of	O
IFN	O
-	O
Î³	O
,	O
IP	O
-	O
10	O
,	O
IL	O
-	O
12	O
,	O
and	O
RANTES	O
expression	O
than	O
SARS	O
-	O
CoV	O
.	O
Third	O
,	O
MERS	O
-	O
CoV	O
-	O
infection	O
induced	O
higher	O
surface	O
expression	O
of	O
MHC	B-ANAT
class	O
II	O
(	O
HLA	B-ANAT
-	O
DR	O
)	O
and	O
the	O
co	O
-	O
stimulatory	O
molecule	O
CD86	O
than	O
SARS	O
-	O
CoV	O
-	O
infection	O
.	O

Overall	O
,	O
our	O
data	O
suggests	O
that	O
the	O
dendritic	B-ANAT
cell	I-ANAT
can	O
serve	O
as	O
an	O
important	O
target	O
of	O
viral	O
replication	O
and	O
a	O
vehicle	O
for	O
dissemination	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
improve	O
the	O
availability	O
of	O
existing	O
nucleic	B-ANAT
acid	O
amplification	O
-	O
based	O
diagnostic	O
methods	O
for	O
MERS	O
-	O
CoV	O
infections	O
by	O
providing	O
a	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
kit	O
,	O
including	O
an	O
internal	O
control	O
and	O
two	O
target	O
regions	O
recommended	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
).	O

A	O
pathogenicity	O
study	O
in	O
2	O
-	O
week	O
-	O
old	O
chickens	O
found	O
that	O
N1	O
/	O
08	O
had	O
similar	O
pathogenicity	O
for	O
chicken	O
respiratory	O
tissues	B-ANAT
to	O
that	O
reported	O
for	O
subgroup	O
2	O
strains	O
rather	O
than	O
subgroup	O
3	O
strains	O
.	O

MV	O
dramatically	O
increased	O
lung	B-ANAT
and	O
blood	B-ANAT
cytokines	O
but	O
not	O
lung	B-ANAT
leukocyte	B-ANAT
counts	O
in	O
pneumonia	O
.	O

Interestingly	O
,	O
compound	O
4e	O
could	O
inhibit	O
not	O
only	O
HBsAg	O
and	O
HBeAg	O
secretions	B-ANAT
but	O
also	O
HBV	O
DNA	O
replication	O
with	O
SI	O
values	O
of	O
20	O
.	O
3	O
,	O
125	O
.	O
0	O
and	O
104	O
.	O
9	O
.	O

This	O
review	O
focuses	O
on	O
emerging	O
evidence	O
regarding	O
strategies	O
for	O
mechanical	O
ventilation	O
in	O
patients	O
with	O
acute	O
hypoxemic	O
respiratory	O
failure	O
including	O
:	O
low	O
tidal	O
volume	O
ventilation	O
in	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
novel	O
ventilator	O
modes	O
as	O
alternatives	O
to	O
low	O
tidal	O
volume	O
ventilation	O
,	O
adjunctive	O
strategies	O
that	O
may	O
enhance	O
recovery	O
in	O
ARDS	O
,	O
the	O
use	O
of	O
lung	B-ANAT
-	O
protective	O
strategies	O
in	O
patients	O
without	O
ARDS	O
,	O
rescue	O
therapies	O
in	O
refractory	O
hypoxemia	O
,	O
and	O
an	O
evidence	O
-	O
based	O
approach	O
to	O
weaning	O
from	O
mechanical	O
ventilation	O
.	O

There	O
is	O
also	O
emerging	O
evidence	O
that	O
a	O
lung	B-ANAT
-	O
protective	O
strategy	O
may	O
benefit	O
non	O
-	O
ARDS	O
patients	O
.	O

In	O
the	O
absence	O
of	O
contraindications	O
,	O
it	O
is	O
reasonable	O
to	O
consider	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
non	O
-	O
ARDS	O
patients	O
as	O
well	O
,	O
though	O
the	O
evidence	O
supporting	O
this	O
practice	O
is	O
less	O
conclusive	O
.	O

ABSTRACT	O
:	O
Most	O
coronaviruses	O
cause	O
respiratory	O
or	O
intestinal	B-ANAT
infections	O
in	O
their	O
animal	O
or	O
human	O
host	O
.	O

Hence	O
,	O
their	O
interaction	O
with	O
polarized	O
epithelial	B-ANAT
cells	I-ANAT
plays	O
a	O
critical	O
role	O
in	O
the	O
onset	O
and	O
outcome	O
of	O
infection	O
.	O

As	O
these	O
viruses	O
approach	O
the	O
epithelial	O
surfaces	O
from	O
the	O
apical	O
side	O
,	O
it	O
is	O
not	O
surprising	O
that	O
coronavirus	O
cell	B-ANAT
receptors	O
are	O
exposed	O
primarily	O
on	O
the	O
apical	O
domain	O
of	O
polarized	O
epithelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Effects	O
of	O
virulent	O
and	O
attenuated	O
transmissible	O
gastroenteritis	O
virus	O
on	O
the	O
ability	O
of	O
porcine	O
dendritic	B-ANAT
cells	I-ANAT
to	O
sample	O
and	O
present	O
antigen	O
.	O

A	O
cohort	O
of	O
17	O
ECLS	O
and	O
17	O
CONV	O
patients	O
matched	O
for	O
age	O
and	O
lung	B-ANAT
injury	O
severity	O
also	O
demonstrated	O
a	O
significantly	O
greater	O
survival	O
in	O
the	O
ECLS	O
group	O
(	O
adjusted	O
odds	O
ratio	O
,	O
0	O
.	O
038	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
004	O
-	O
0	O
.	O
407	O
;	O
p	O
=	O
0	O
.	O
007	O
).	O

A	O
cohort	O
of	O
17	O
ECLS	O
and	O
17	O
CONV	O
patients	O
matched	O
for	O
age	O
and	O
lung	B-ANAT
injury	O
severity	O
also	O
demonstrated	O
a	O
significantly	O
greater	O
survival	O
in	O
the	O
ECLS	O
group	O
(	O
adjusted	O
odds	O
ratio	O
,	O
0	O
.	O
038	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
004	O
-	O
0	O
.	O
407	O
;	O
p	O
=	O
0	O
.	O
007	O
).	O

We	O
hypothesize	O
that	O
flight	O
,	O
a	O
factor	O
common	O
to	O
all	O
bats	O
but	O
to	O
no	O
other	O
mammals	O
,	O
provides	O
an	O
intensive	O
selective	O
force	O
for	O
coexistence	O
with	O
viral	O
parasites	O
through	O
a	O
daily	O
cycle	O
that	O
elevates	O
metabolism	O
and	O
body	B-ANAT
temperature	O
analogous	O
to	O
the	O
febrile	O
response	O
in	O
other	O
mammals	O
.	O

Viral	O
loads	O
in	O
lachrymal	O
fluids	B-ANAT
of	O
birds	O
receiving	O
rLS	O
/	O
IBV	O
.	O
S2	O
+	O
Mass	O
showed	O
a	O
clear	O
tendency	O
of	O
improved	O
protection	O
compared	O
to	O
Mass	O
+	O
Mass	O
;	O
however	O
,	O
the	O
difference	O
did	O
not	O
achieve	O
statistical	O
significance	O
.	O

TITLE	O
:	O
The	O
YXXÎ¦	O
motif	O
within	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
3a	O
protein	O
is	O
crucial	O
for	O
its	O
intracellular	B-ANAT
transport	O
.	O

However	O
the	O
3a	O
protein	O
with	O
mutations	O
within	O
the	O
EXD	O
di	O
-	O
acidic	O
motif	O
(	O
ÎEXD	O
)	O
showed	O
an	O
intracellular	B-ANAT
distribution	O
similar	O
to	O
the	O
wild	O
type	O
protein	O
.	O

Their	O
interaction	O
with	O
receptors	O
expressed	O
on	O
cells	B-ANAT
located	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
is	O
an	O
essential	O
first	O
step	O
in	O
the	O
infection	O
.	O

Thus	O
far	O
three	O
membrane	B-ANAT
ectopeptidases	O
,	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
),	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
and	O
aminopeptidase	O
N	O
(	O
APN	O
),	O
have	O
been	O
identified	O
as	O
entry	O
receptors	O
for	O
four	O
human	O
-	O
infecting	O
coronaviruses	O
.	O

SARS	O
-	O
CoV	O
N	O
is	O
released	O
from	O
cells	B-ANAT
through	O
an	O
association	O
with	O
E	O
protein	O
-	O
containing	O
vesicles	B-ANAT
.	O

TITLE	O
:	O
Exhaled	O
breath	B-ANAT
profiling	O
for	O
diagnosing	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
contrast	O
,	O
91	O
%	O
of	O
the	O
tissue	B-ANAT
samples	O
from	O
cats	O
with	O
FIP	O
and	O
89	O
%	O
from	O
cats	O
without	O
FIP	O
had	O
a	O
leucine	O
codon	O
at	O
position	O
1058	O
,	O
consistent	O
with	O
a	O
systemic	O
form	O
of	O
FCoV	O
.	O
These	O
results	O
suggest	O
that	O
the	O
methionine	O
to	O
leucine	O
substitution	O
at	O
position	O
1058	O
in	O
the	O
FCoV	O
spike	O
protein	O
is	O
indicative	O
of	O
systemic	O
spread	O
of	O
FCoV	O
from	O
the	O
intestine	B-ANAT
,	O
rather	O
than	O
a	O
virus	O
with	O
the	O
potential	O
to	O
cause	O
FIP	O
.	O

TITLE	O
:	O
Is	O
abdomen	B-ANAT
release	O
really	O
necessary	O
for	O
prone	O
ventilation	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
?	O

TITLE	O
:	O
Noninvasive	O
ventilation	O
in	O
the	O
event	O
of	O
acute	O
respiratory	O
failure	O
in	O
patients	O
with	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
.	O

Elevated	O
plasma	B-ANAT
NT	O
-	O
proBNP	O
levels	O
at	O
the	O
time	O
of	O
ICU	O
admission	O
is	O
a	O
simple	O
clinical	O
marker	O
for	O
poor	O
NIV	O
outcome	O
.	O

Here	O
,	O
we	O
used	O
a	O
well	O
-	O
characterized	O
nonimmune	O
human	O
Ab	O
-	O
phage	O
library	O
and	O
a	O
panning	O
strategy	O
with	O
proteoliposomes	O
and	O
cells	B-ANAT
to	O
identify	O
seven	O
human	O
nAbs	O
against	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
MERS	O
-	O
CoV	O
Spike	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
pathophysiology	O
of	O
hantavirus	O
pulmonary	B-ANAT
syndrome	O
(	O
HPS	O
)	O
remains	O
unclear	O
because	O
of	O
a	O
lack	O
of	O
surrogate	O
disease	O
models	O
with	O
which	O
to	O
perform	O
pathogenesis	O
studies	O
.	O

Despite	O
establishing	O
a	O
systemic	O
infection	O
,	O
SNV	O
differentially	O
activated	O
host	O
responses	O
exclusively	O
in	O
the	O
pulmonary	B-ANAT
endothelium	B-ANAT
,	O
potentially	O
the	O
mechanism	O
leading	O
to	O
acute	O
severe	O
respiratory	O
distress	O
.	O

Here	O
,	O
we	O
report	O
recovery	O
of	O
MERS	O
-	O
CoV	O
from	O
nasal	B-ANAT
swabs	O
of	O
dromedaries	O
,	O
demonstrate	O
that	O
MERS	O
-	O
CoV	O
whole	O
-	O
genome	O
consensus	O
sequences	O
from	O
dromedaries	O
and	O
humans	O
are	O
indistinguishable	O
,	O
and	O
show	O
that	O
dromedaries	O
can	O
be	O
simultaneously	O
infected	O
with	O
more	O
than	O
one	O
MERS	O
-	O
CoV	O
.	O
Together	O
with	O
data	O
indicating	O
widespread	O
dromedary	O
infection	O
in	O
the	O
Kingdom	O
of	O
Saudi	O
Arabia	O
,	O
these	O
findings	O
support	O
the	O
plausibility	O
of	O
a	O
role	O
for	O
dromedaries	O
in	O
human	O
infection	O
.	O

All	O
these	O
key	O
cytokines	O
promote	O
the	O
progression	O
of	O
lung	B-ANAT
damage	O
and	O
ARDS	O
pathology	O
.	O

This	O
augmented	O
MHC	B-ANAT
binding	O
is	O
likely	O
to	O
increase	O
the	O
half	O
-	O
life	O
and	O
surface	O
density	O
of	O
the	O
heteroclitic	O
complex	O
,	O
but	O
precisely	O
how	O
this	O
enhanced	O
T	B-ANAT
cell	I-ANAT
response	O
occurs	O
in	O
vivo	O
is	O
not	O
known	O
.	O

We	O
also	O
identified	O
a	O
heteroclitic	O
epitope	O
(	O
RCVIFANI	O
)	O
that	O
elicited	O
a	O
T	B-ANAT
cell	I-ANAT
response	O
with	O
nearly	O
complete	O
cross	O
-	O
reactivity	O
with	O
native	O
epitope	O
and	O
demonstrated	O
increased	O
MHC	B-ANAT
/	O
peptide	O
abundance	O
compared	O
with	O
native	O
S598	O
.	O

At	O
24	O
â	O
48	O
hours	O
postinoculation	O
,	O
the	O
pigs	O
exhibited	O
severe	O
diarrhea	O
and	O
vomiting	O
,	O
fecal	B-ANAT
shedding	O
,	O
viremia	O
,	O
and	O
severe	O
atrophic	O
enteritis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
detection	O
rates	O
of	O
respiratory	O
viruses	O
from	O
nasopharyngeal	B-ANAT
swabs	O
and	O
sputum	B-ANAT
using	O
a	O
multiplex	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

TITLE	O
:	O
T	O
-	O
tube	O
drainage	B-ANAT
and	O
intercostals	B-ANAT
muscle	I-ANAT
flap	B-ANAT
reinforcement	O
for	O
the	O
management	O
of	O
intrathoracic	O
esophago	O
-	O
gastric	B-ANAT
anastomotic	O
leakage	O
with	O
pyothorax	O
:	O
a	O
case	O
report	O
.	O

After	O
an	O
irrigation	O
of	O
the	O
thoracic	B-ANAT
cavity	I-ANAT
and	O
a	O
decortication	O
of	O
the	O
pleura	B-ANAT
,	O
we	O
found	O
a	O
perforation	O
in	O
the	O
left	O
side	O
of	O
the	O
anastomosis	B-ANAT
.	O

(	O
2	O
)	O
The	O
areas	O
under	O
the	O
ROC	O
curve	O
of	O
0	O
h	O
blood	B-ANAT
lactate	O
,	O
6	O
h	O
lactate	O
clearance	O
rate	O
and	O
APACHE	O
II	O
score	O
for	O
predicting	O
death	O
were	O
0	O
.	O
699	O
Â±	O
0	O
.	O
083	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
567	O
â¼	O
0	O
.	O
892	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
0	O
.	O
871	O
Â±	O
0	O
.	O
119	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
724	O
â¼	O
0	O
.	O
980	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
0	O
.	O
836	O
Â±	O
0	O
.	O
063	O
(	O
95	O
%	O
CI	O
:	O
0	O
.	O
713	O
â¼	O
0	O
.	O
958	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

TITLE	O
:	O
Characteristics	O
and	O
outcomes	O
of	O
patients	O
hospitalized	O
following	O
pulmonary	B-ANAT
aspiration	O
.	O

Neither	O
obesity	O
nor	O
gastroesophageal	B-ANAT
reflux	O
was	O
associated	O
with	O
aspiration	O
.	O

Findings	O
from	O
this	O
study	O
may	O
facilitate	O
the	O
design	O
of	O
future	O
clinical	O
studies	O
of	O
aspiration	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

The	O
patient	O
was	O
immediately	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
after	O
evidence	O
of	O
multiple	O
organ	B-ANAT
failure	O
(	O
coma	O
,	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
etc	O
.).	O

In	O
early	O
preterm	O
neonates	O
,	O
pneumothorax	O
was	O
associated	O
with	O
mortality	O
,	O
bronchopulmonary	O
dysplasia	O
,	O
severe	O
intraventricular	B-ANAT
hemorrhage	O
,	O
and	O
prolonged	O
NICU	O
stay	O
.	O

ABSTRACT	O
:	O
Evaluation	O
of	O
:	O
Vergadi	O
E	O
,	O
Vaporidi	O
K	O
,	O
Theodorakis	O
EE	O
et	O
al	O
.	O
Akt2	O
deficiency	O
protects	O
from	O
acute	O
lung	B-ANAT
injury	O
via	O
alternative	O
macrophage	B-ANAT
activation	O
and	O
miR	O
-	O
146a	O
induction	O
in	O
mice	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
currently	O
has	O
limited	O
effective	O
treatments	O
;	O
however	O
,	O
recent	O
evidence	O
suggests	O
that	O
modulation	O
of	O
alveolar	B-ANAT
macrophage	I-ANAT
responses	O
may	O
be	O
an	O
effective	O
method	O
for	O
protection	O
or	O
repair	O
of	O
lung	B-ANAT
injury	O
.	O

Reovirus	O
and	O
HEV	B-ANAT
were	O
not	O
detected	O
in	O
this	O
survey	O
.	O

TITLE	O
:	O
Diffuse	O
alveolar	B-ANAT
damage	O
in	O
a	O
patient	O
with	O
Epstein	O
Barr	O
virus	O
(	O
EBV	O
)-	O
positive	O
diffuse	O
large	O
B	O
-	O
cell	B-ANAT
lymphoma	I-ANAT
,	O
severely	O
low	O
serum	B-ANAT
folate	O
,	O
and	O
megaloblastic	O
anemia	O
:	O
a	O
case	O
report	O
of	O
autopsy	O
.	O

The	O
differences	O
of	O
demographic	O
features	O
(	O
age	O
,	O
gender	O
,	O
history	O
of	O
atopy	O
,	O
exposure	O
of	O
smoking	O
,	O
length	O
of	O
breast	B-ANAT
-	O
feeding	O
,	O
presence	O
of	O
school	O
-	O
age	O
sibling	O
)	O
and	O
frequency	O
of	O
virus	O
detection	O
(	O
83	O
.	O
9	O
%	O
and	O
63	O
.	O
6	O
%,	O
respectively	O
)	O
between	O
the	O
patient	O
and	O
control	O
groups	O
were	O
not	O
statistically	O
significant	O
(	O
p	O
>	O
0	O
.	O
05	O
).	O

Pulmonary	B-ANAT
graphies	O
revealed	O
that	O
diffuse	O
air	O
trappings	O
were	O
more	O
common	O
in	O
virus	O
-	O
associated	O
bronchiolitis	O
(	O
36	O
/	O
52	O
;	O
69	O
.	O
2	O
%)	O
cases	O
,	O
on	O
the	O
other	O
hand	O
infiltrations	O
were	O
more	O
common	O
(	O
6	O
/	O
10	O
;	O
60	O
%)	O
in	O
patients	O
who	O
were	O
virus	O
-	O
negative	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

PCR	O
for	O
16	O
respiratory	O
viruses	O
was	O
performed	O
on	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
collected	O
during	O
77	O
paediatric	O
pulmonologist	O
-	O
defined	O
exacerbations	O
.	O

However	O
,	O
much	O
debate	O
and	O
concern	O
have	O
been	O
raised	O
regarding	O
its	O
applicability	O
in	O
adults	O
with	O
pectus	B-ANAT
excavatum	O
flail	O
chest	B-ANAT
and	O
other	O
thoratic	O
wall	O
deformities	O
,	O
as	O
compared	O
with	O
younger	O
patients	O
,	O
in	O
terms	O
of	O
complications	O
after	O
surgery	O
.	O

To	O
stabilize	O
the	O
segment	O
of	O
paradoxical	O
chest	B-ANAT
wall	I-ANAT
movement	O
we	O
performed	O
the	O
Nuss	O
operation	O
on	O
a	O
patient	O
with	O
multiple	O
myeloma	O
who	O
sustained	O
blunt	O
thoracic	B-ANAT
trauma	O
.	O

The	O
pathological	O
osteo	O
-	O
articular	B-ANAT
involvement	O
in	O
the	O
course	O
of	O
drepanocytosis	O
is	O
secondary	O
to	O
the	O
avascular	O
necrosis	O
of	O
the	O
bone	B-ANAT
marrow	I-ANAT
,	O
caused	O
by	O
vaso	O
-	O
occlusive	O
episodes	O
in	O
the	O
microcirculation	O
during	O
acute	O
painful	O
crises	O
.	O

In	O
summary	O
,	O
these	O
data	O
show	O
that	O
a	O
cellular	B-ANAT
factor	O
,	O
importin	O
-	O
Î±7	O
,	O
is	O
required	O
for	O
enhanced	O
virus	O
replication	O
in	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
,	O
resulting	O
in	O
elevated	O
cytokine	O
and	O
chemokine	O
levels	O
,	O
extensive	O
mononuclear	O
infiltration	O
,	O
and	O
thus	O
,	O
severe	O
pneumonia	O
and	O
enhanced	O
virulence	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
The	O
evidence	O
saying	O
that	O
the	O
rate	O
of	O
Systemic	O
Inflammatory	O
Response	O
Syndrome	O
(	O
SIRS	O
)	O
is	O
high	O
in	O
patients	O
with	O
advanced	O
cirrhosis	O
and	O
portal	B-ANAT
hypertension	O
,	O
this	O
could	O
have	O
negative	O
outcome	O
on	O
patients	O
prognosis	O
.	O

The	O
presence	O
of	O
SIRS	O
and	O
the	O
model	O
for	O
end	O
stage	O
liver	B-ANAT
disease	O
(	O
MELD	O
)	O
were	O
assessed	O
on	O
admission	O
and	O
during	O
the	O
hospital	O
stay	O
.	O

SIRS	O
was	O
considered	O
positive	O
if	O
patients	O
had	O
two	O
or	O
more	O
of	O
the	O
following	O
:	O
temperature	O
of	O
>	O
38ÂºC	O
or	O
<	O
36ÂºC	O
;	O
heart	B-ANAT
rate	O
>	O
90	O
beats	O
/	O
min	O
;	O
respiratory	O
rate	O
>	O
20	O
/	O
min	O
or	O
PaCO2	O
<	O
32	O
mmHg	O
or	O
the	O
use	O
of	O
mechanical	O
ventilation	O
;	O
WBC	B-ANAT
>	O
12000	O
/	O
mm	O
(	O
3	O
)	O
or	O
<	O
4000	O
/	O
mm	O
(	O
3	O
)	O
or	O
more	O
than	O
10	O
%	O
immature	O
neutrophil	B-ANAT
count	O
.	O

Hospital	O
outcome	O
was	O
defined	O
as	O
death	O
or	O
hospital	O
discharge	B-ANAT
.	O

Some	O
drugs	O
that	O
had	O
a	O
well	O
-	O
defined	O
cellular	B-ANAT
pathway	O
as	O
target	O
were	O
included	O
.	O

ABSTRACT	O
:	O
Neural	O
precursor	O
cells	B-ANAT
(	O
NPCs	O
)	O
offer	O
a	O
promising	O
approach	O
for	O
treating	O
demyelinating	O
diseases	O
.	O

Our	O
findings	O
reveal	O
focal	O
axonal	O
degeneration	O
that	O
occurs	O
in	O
the	O
ventral	O
side	O
of	O
the	O
spinal	B-ANAT
cord	I-ANAT
within	O
1	O
wk	O
following	O
intracranial	B-ANAT
instillation	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
).	O

These	O
findings	O
indicate	O
that	O
NPCs	O
transplanted	B-ANAT
into	O
an	O
inflammatory	O
demyelinating	O
microenvironment	O
participate	O
directly	O
in	O
therapeutic	O
outcome	O
through	O
the	O
wrapping	O
of	O
myelin	B-ANAT
around	O
damaged	O
neurons	B-ANAT
.	O

Interestingly	O
,	O
the	O
acute	O
phase	O
of	O
SARS	O
in	O
humans	O
is	O
associated	O
with	O
a	O
severe	O
reduction	O
in	O
the	O
number	O
of	O
T	B-ANAT
cells	I-ANAT
in	O
the	O
blood	B-ANAT
.	O

Employing	O
models	O
of	O
the	O
human	O
airway	B-ANAT
,	O
transcriptomics	O
and	O
proteomics	O
datasets	O
were	O
used	O
to	O
compare	O
ISG	O
response	O
patterns	O
following	O
highly	O
pathogenic	O
H5N1	O
avian	O
influenza	O
(	O
HPAI	O
)	O
A	O
virus	O
,	O
2009	O
pandemic	O
H1N1	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

In	O
moderate	O
and	O
severe	O
ARDS	O
tracheal	O
intubation	O
associated	O
with	O
heavy	O
sedation	O
/	O
muscle	B-ANAT
relaxation	O
allows	O
to	O
fully	O
characterize	O
the	O
patient	O
.	O

Additionally	O
,	O
microarray	O
analysis	O
showed	O
that	O
genes	O
associated	O
with	O
chemotaxis	O
,	O
eosinophil	B-ANAT
migration	O
,	O
eosinophilia	O
,	O
and	O
cell	B-ANAT
movement	O
and	O
the	O
polarization	O
of	O
Th2	B-ANAT
cells	I-ANAT
were	O
upregulated	O
in	O
UV	O
-	O
V	O
-	O
immunized	O
but	O
not	O
in	O
UV	O
-	O
V	O
+	O
TLR	O
-	O
immunized	O
mice	O
.	O

We	O
present	O
the	O
X	O
-	O
ray	O
crystal	B-ANAT
structure	O
of	O
PLpro	O
in	O
complex	O
with	O
ubiquitin	O
-	O
aldehyde	O
and	O
model	O
the	O
interaction	O
of	O
PLpro	O
with	O
other	O
ubiquitin	O
-	O
chain	O
and	O
ISG15	O
substrates	O
.	O

Rhinovirus	O
C	O
and	O
human	O
bocavirus	O
type	O
1	O
have	O
been	O
commonly	O
detected	O
in	O
infants	O
and	O
young	O
children	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
and	O
studies	O
have	O
shown	O
a	O
positive	O
correlation	O
between	O
respiratory	O
illness	O
and	O
high	O
viral	O
loads	O
,	O
mono	O
-	O
infection	O
,	O
viremia	O
,	O
and	O
/	O
or	O
serologically	O
-	O
confirmed	O
primary	O
infection	O
.	O

A	O
mechanical	O
ventilation	O
strategy	O
aiming	O
at	O
optimal	O
alveolar	B-ANAT
recruitment	O
,	O
judicious	O
use	O
of	O
positive	O
end	O
-	O
respiratory	O
pressure	O
(	O
PEEP	O
)	O
and	O
low	O
tidal	O
volumes	O
(	O
VT	O
)	O
remains	O
the	O
mainstay	O
for	O
managing	O
this	O
lung	B-ANAT
disease	O
.	O

We	O
then	O
used	O
reverse	O
-	O
transcription	O
PCR	O
to	O
look	O
for	O
the	O
coronavirus	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
in	O
fecal	B-ANAT
samples	O
collected	O
from	O
27	O
little	O
Japanese	O
horseshoe	O
bats	O
and	O
found	O
eight	O
were	O
provisionally	O
positive	O
.	O

ABSTRACT	O
:	O
Various	O
infections	O
in	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
trigger	O
B	B-ANAT
cell	I-ANAT
accumulation	O
;	O
however	O
,	O
the	O
relative	O
dynamics	O
between	O
viral	O
replication	O
and	O
alterations	O
in	O
distinct	O
B	B-ANAT
cell	I-ANAT
subsets	O
are	O
largely	O
unknown	O
.	O

Moreover	O
,	O
CNS	B-ANAT
viral	O
persistence	O
is	O
a	O
driving	O
force	O
promoting	O
differentiated	O
B	B-ANAT
cells	I-ANAT
with	O
protective	O
potential	O
.	O

Here	O
,	O
we	O
identify	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
as	O
a	O
novel	O
PEDV	O
-	O
encoded	O
interferon	O
(	O
IFN	O
)	O
antagonist	O
and	O
demonstrate	O
that	O
N	O
protein	O
antagonizes	O
IFN	O
production	O
by	O
sequestering	O
the	O
interaction	O
between	O
IRF3	O
and	O
TBK1	O
,	O
a	O
critical	O
step	O
in	O
type	O
I	O
IFN	O
signaling	O
.	O

This	O
adds	O
another	O
layer	B-ANAT
of	O
complexity	O
to	O
the	O
immune	O
evasion	O
strategies	O
evolved	O
by	O
this	O
economically	O
important	O
viral	O
pathogen	O
.	O

K22	O
-	O
resistant	O
viruses	O
contained	O
substitutions	O
in	O
non	O
-	O
structural	O
protein	O
6	O
(	O
nsp6	O
),	O
a	O
membrane	B-ANAT
-	O
spanning	O
integral	O
component	O
of	O
the	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
implicated	O
in	O
DMV	O
formation	O
,	O
corroborating	O
that	O
K22	O
targets	O
membrane	B-ANAT
bound	O
viral	O
RNA	O
synthesis	O
.	O

Knowing	O
that	O
NA	O
treatment	O
of	O
coronaviruses	O
can	O
unmask	O
viral	O
sialic	O
acid	O
binding	O
activity	O
,	O
replication	O
of	O
untreated	O
and	O
NA	O
-	O
treated	O
viruses	O
was	O
compared	O
,	O
showing	O
that	O
NA	O
treatment	O
of	O
the	O
virus	O
enhanced	O
infectivity	O
in	O
untreated	O
cells	B-ANAT
,	O
but	O
was	O
detrimental	O
in	O
NA	O
-	O
treated	O
cells	B-ANAT
.	O

In	O
conclusion	O
,	O
this	O
study	O
demonstrated	O
that	O
FECV	O
had	O
a	O
sialic	O
acid	O
binding	O
capacity	O
,	O
which	O
was	O
partially	O
masked	O
by	O
virus	O
-	O
associated	O
sialic	O
acids	O
,	O
and	O
that	O
attachment	O
to	O
sialylated	O
compounds	O
could	O
facilitate	O
enterocyte	B-ANAT
infections	O
.	O

Median	O
percentage	O
of	O
the	O
predicted	O
distance	O
covered	O
during	O
a	O
6	O
-	O
minute	O
walk	O
test	O
was	O
86	O
%	O
[	O
46	O
-	O
120	O
];	O
the	O
distance	O
was	O
negatively	O
associated	O
with	O
LDH	O
(	O
P	O
=	O
0	O
.	O
044	O
)	O
and	O
with	O
a	O
past	O
history	O
of	O
acute	O
chest	B-ANAT
syndrome	O
(	O
P	O
=	O
0	O
.	O
009	O
).	O

However	O
,	O
in	O
the	O
1980s	O
several	O
investigators	O
provided	O
novel	O
evidence	O
that	O
the	O
primary	O
mechanism	O
for	O
removal	O
of	O
alveolar	B-ANAT
edema	O
fluid	O
depended	O
on	O
active	O
ion	O
transport	O
across	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

Sodium	O
enters	O
through	O
apical	O
channels	O
,	O
primarily	O
the	O
epithelial	O
sodium	O
channel	O
,	O
and	O
is	O
pumped	O
into	O
the	O
lung	B-ANAT
interstitium	B-ANAT
by	O
basolaterally	O
located	O
Na	O
/	O
K	O
-	O
ATPase	O
,	O
thus	O
creating	O
a	O
local	O
osmotic	O
gradient	O
to	O
reabsorb	O
the	O
water	O
fraction	O
of	O
the	O
edema	O
fluid	O
from	O
the	O
airspaces	O
of	O
the	O
lungs	B-ANAT
.	O

At	O
the	O
time	O
of	O
admission	O
to	O
intensive	O
care	O
unit	O
,	O
elevated	O
serum	B-ANAT
levels	O
above	O
the	O
normal	O
range	O
for	O
respective	O
age	O
group	O
and	O
sex	O
were	O
observed	O
in	O
44	O
%	O
for	O
activin	O
A	O
,	O
57	O
%	O
for	O
activin	O
B	O
,	O
and	O
39	O
%	O
for	O
FS	O
.	O

These	O
observations	O
prompted	O
us	O
to	O
investigate	O
the	O
molecular	O
mechanisms	O
and	O
responses	O
to	O
antibody	O
-	O
mediated	O
infection	O
in	O
human	O
macrophages	B-ANAT
.	O

These	O
results	O
may	O
also	O
guide	O
future	O
acute	O
lung	B-ANAT
injury	O
preclinical	O
and	O
clinical	O
research	O
.	O

However	O
,	O
when	O
PEDV	O
,	O
TGEV	O
and	O
porcine	O
pseudorabies	O
virus	O
were	O
incubated	O
with	O
peptide	O
H	O
(	O
HVTTTFAPPPPR	O
),	O
only	O
infection	O
of	O
Vero	B-ANAT
cells	I-ANAT
by	O
PEDV	O
was	O
inhibited	O
.	O

Temperature	O
shift	O
assays	O
demonstrated	O
that	O
peptide	O
H	O
inhibited	O
pre	O
-	O
attachment	O
of	O
the	O
virus	O
to	O
the	O
cells	B-ANAT
.	O

Despite	O
increased	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
antiviral	O
function	O
in	O
IL	O
-	O
27RÎ±	O
(-/-)	O
mice	O
,	O
the	O
virus	O
persisted	O
in	O
the	O
CNS	B-ANAT
at	O
similar	O
levels	O
as	O
in	O
wild	O
-	O
type	O
mice	O
.	O

We	O
also	O
demonstrate	O
that	O
transplantation	O
of	O
allogeneic	O
NPCs	O
into	O
JHMV	O
-	O
infected	O
mice	O
resulted	O
in	O
infection	O
of	O
the	O
transplanted	B-ANAT
cells	B-ANAT
suggesting	O
that	O
these	O
cells	B-ANAT
may	O
be	O
targets	O
for	O
infection	O
.	O

Our	O
case	O
report	O
indicates	O
that	O
although	O
syndrome	O
of	O
inappropriate	O
antidiuretic	O
hormone	O
secretion	B-ANAT
and	O
autonomic	B-ANAT
dysfunction	O
are	O
rarely	O
the	O
initial	O
characteristics	O
of	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
,	O
the	O
possibility	O
of	O
postoperative	O
syndrome	O
of	O
inappropriate	O
antidiuretic	O
hormone	O
secretion	B-ANAT
should	O
be	O
kept	O
in	O
mind	O
.	O

The	O
MHV	O
spike	O
protein	O
(	O
S	O
)	O
is	O
a	O
major	O
virulence	O
determinant	O
which	O
in	O
addition	O
to	O
binding	O
to	O
cellular	B-ANAT
receptors	O
to	O
mediate	O
cell	B-ANAT
entry	O
and	O
facilitate	O
virus	O
spread	O
to	O
adjacent	O
cells	B-ANAT
by	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
,	O
also	O
is	O
a	O
molecular	O
mimic	O
of	O
the	O
FcÎ³RII	O
receptor	O
.	O

Two	O
cousins	O
of	O
PI	O
had	O
the	O
same	O
hypomorphic	O
splice	O
site	O
mutation	O
leading	O
to	O
a	O
deletion	O
of	O
27	O
amino	O
acids	O
,	O
but	O
normal	O
FOXP3	O
protein	O
expression	O
and	O
normal	O
suppressive	O
capacity	O
of	O
T	B-ANAT
reg	I-ANAT
in	O
a	O
proliferation	O
inhibition	O
assay	O
.	O

However	O
,	O
they	O
exhibited	O
typical	O
symptoms	O
such	O
as	O
eczema	O
,	O
diabetes	O
and	O
enteropathy	O
with	O
eosinophilia	O
at	O
early	O
age	O
(	O
PII	O
,	O
PIII	O
)	O
and	O
were	O
transplanted	B-ANAT
in	O
infancy	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
:	O
chest	B-ANAT
CT	O
findings	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
chest	B-ANAT
CT	O
findings	O
in	O
seven	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
investigate	O
the	O
prevalence	O
and	O
track	O
genetic	O
and	O
antigenic	O
evolutions	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
and	O
their	O
prevalence	O
in	O
Guangxi	O
,	O
China	O
since	O
1985	O
,	O
gene	O
amplification	O
and	O
sequencing	O
and	O
virus	O
neutralization	O
(	O
VN	O
)	O
test	O
on	O
chicken	O
embryo	B-ANAT
tracheal	O
organ	B-ANAT
cultures	O
were	O
used	O
in	O
genotyping	O
and	O
serotyping	O
of	O
28	O
IBV	O
isolates	O
during	O
2009	O
-	O
2011	O
in	O
Guangxi	O
.	O

They	O
are	O
the	O
cause	O
of	O
severe	O
problems	O
with	O
kidney	B-ANAT
disease	O
and	O
reproductive	O
tract	O
disorders	O
.	O

This	O
attachment	O
was	O
sialic	O
acid	O
dependent	O
,	O
indicating	O
that	O
the	O
sugar	O
binding	O
property	O
of	O
IBV	O
spike	O
proteins	O
is	O
not	O
the	O
limiting	O
factor	O
for	O
differences	O
in	O
infection	O
efficiency	O
for	O
the	O
oviduct	B-ANAT
of	O
the	O
corresponding	O
viruses	O
.	O

Among	O
42	O
intestinal	B-ANAT
samples	O
from	O
pigs	O
with	O
severe	O
watery	O
diarrhea	O
,	O
36	O
variant	O
PEDV	O
and	O
three	O
classical	O
PEDV	O
samples	O
were	O
detected	O
,	O
with	O
viral	O
loads	O
of	O
10	O
(	O
2	O
)-	O
10	O
(	O
8	O
)	O
copies	O
/	O
Î¼l	O
and	O
10	O
(	O
3	O
)-	O
10	O
(	O
5	O
)	O
copies	O
/	O
Î¼l	O
,	O
respectively	O
,	O
which	O
suggested	O
that	O
the	O
variant	O
PEDV	O
was	O
prevalent	O
in	O
China	O
.	O

A	O
subset	O
of	O
cats	O
exhibiting	O
signs	O
of	O
upper	O
respiratory	O
disease	O
or	O
diarrhea	O
had	O
been	O
tested	O
for	O
infections	O
by	O
PCR	O
and	O
fecal	B-ANAT
flotation	O
for	O
treatment	O
planning	O
.	O

TITLE	O
:	O
SOCS3	O
expression	O
correlates	O
with	O
severity	O
of	O
inflammation	O
in	O
mouse	O
hepatitis	O
virus	O
strain	O
3	O
-	O
induced	O
acute	O
liver	B-ANAT
failure	O
and	O
HBV	O
-	O
ACLF	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
role	O
of	O
SOCS3	O
in	O
the	O
development	O
of	O
mouse	O
hepatitis	O
virus	O
strain	O
3	O
(	O
MHV	O
-	O
3	O
)-	O
induced	O
acute	O
liver	B-ANAT
failure	O
and	O
its	O
expression	O
in	O
liver	B-ANAT
and	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
of	O
patients	O
with	O
HBV	O
-	O
ACLF	O
.	O

There	O
was	O
a	O
close	O
correlation	O
between	O
hepatic	B-ANAT
SOCS3	O
level	O
and	O
IL	O
-	O
6	O
,	O
and	O
the	O
severity	O
of	O
liver	B-ANAT
injury	O
defined	O
by	O
alanine	O
aminotransferase	O
(	O
ALT	O
)	O
and	O
aspartate	O
aminotransferase	O
(	O
AST	O
)	O
levels	O
,	O
respectively	O
.	O

We	O
analysed	O
the	O
prevalence	O
of	O
P	O
.	O
jirovecii	O
pneumonia	O
(	O
PCP	O
)	O
among	O
HIV	O
-	O
infected	O
and	O
HIV	O
-	O
uninfected	O
patients	O
presented	O
with	O
interstitial	B-ANAT
pneumonia	O
or	O
acute	O
respiratory	O
syndrome	O
hospitalized	O
in	O
six	O
Croatian	O
tertiary	O
care	O
hospitals	O
.	O

The	O
search	O
keywords	O
were	O
:	O
""""	O
tako	O
-	O
tsubo	O
cardiomyopathy	O
""","	O
""""	O
takotsubo	O
""","	O
""""	O
takotsubo	O
cardiomyopathy	O
""","	O
""""	O
broken	O
heart	B-ANAT
syndrome	O
""","	O
""""	O
stress	O
-	O
induced	O
cardiomyopathy	O
""","	O
""""	O
apical	O
ballooning	O
syndrome	O
""","	O
and	O
""""	O
ampulla	O
cardiomyopathy	O
in	O
combination	O
with	O
respiratory	O
diseases	O
,	O
lung	B-ANAT
,	O
pulmonary	B-ANAT
disease	O
.	O

Overall	O
,	O
31	O
patients	O
(	O
mean	O
age	O
,	O
42	O
.	O
2	O
years	O
,	O
standard	O
deviation	O
,	O
14	O
.	O
1	O
years	O
;	O
21	O
males	O
)	O
received	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
the	O
treatment	O
of	O
severe	O
respiratory	O
failure	O
.	O

Complications	O
related	O
to	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
included	O
severe	O
bleeding	O
(	O
n	O
=	O
2	O
;	O
6	O
.	O
5	O
%)	O
and	O
mechanical	O
complications	O
of	O
the	O
circuits	O
(	O
n	O
=	O
3	O
;	O
9	O
.	O
7	O
%).	O

ABSTRACT	O
:	O
Lung	B-ANAT
ultrasound	O
has	O
been	O
shown	O
to	O
identify	O
in	O
real	O
-	O
time	O
,	O
various	O
pathologies	O
of	O
the	O
lung	B-ANAT
such	O
as	O
pneumonia	O
,	O
viral	O
pneumonia	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Lung	B-ANAT
ultrasound	O
maybe	O
a	O
first	O
-	O
line	O
alternative	O
to	O
chest	B-ANAT
X	O
-	O
ray	O
and	O
CT	O
scan	O
in	O
critically	O
ill	O
patients	O
with	O
respiratory	O
failure	O
.	O

We	O
describe	O
the	O
use	O
of	O
lung	B-ANAT
ultrasound	O
imaging	O
and	O
findings	O
in	O
two	O
cases	O
of	O
severe	O
respiratory	O
failure	O
from	O
avian	O
influenza	O
A	O
(	O
H7N9	O
)	O
infection	O
.	O

In	O
addition	O
,	O
numerous	O
,	O
confluent	O
,	O
or	O
coalescing	O
B	O
-	O
lines	O
leading	O
to	O
'	O
white	O
lung	B-ANAT
'	O
with	O
corresponding	O
pleural	O
line	O
thickening	O
are	O
associated	O
with	O
ARDS	O
.	O

RESULTS	O
:	O
IN	O
BOTH	O
PATIENTS	O
,	O
CHARACTERISTIC	O
LUNG	B-ANAT
ULTRASOUND	O
FINDINGS	O
HAVE	O
BEEN	O
OBSERVED	O
AS	O
PREVIOUSLY	O
DESCRIBED	O
IN	O
VIRAL	O
PULMONARY	B-ANAT
INFECTIONS	O
:	O
subpleural	O
consolidations	O
associated	O
or	O
not	O
with	O
local	O
pleural	B-ANAT
effusion	I-ANAT
.	O

Severe	O
complications	O
like	O
significant	O
hepatomegaly	O
,	O
thrombocytopenia	O
,	O
acute	O
renal	B-ANAT
failure	O
,	O
severe	O
anaemia	O
,	O
leucopoenia	O
,	O
electrolyte	O
disturbance	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
cerebral	B-ANAT
malaria	O
,	O
multiorgan	O
dysfunction	O
,	O
hepatic	B-ANAT
dysfunction	O
,	O
pancytopenia	O
,	O
and	O
death	O
seen	O
in	O
21	O
.	O
57	O
%,	O
18	O
.	O
63	O
%,	O
11	O
.	O
76	O
%,	O
8	O
.	O
82	O
%,	O
5	O
.	O
88	O
%,	O
5	O
.	O
88	O
%,	O
3	O
.	O
92	O
%,	O
2	O
.	O
94	O
%,	O
1	O
.	O
96	O
%,	O
1	O
.	O
96	O
%,	O
0	O
.	O
98	O
%,	O
1	O
.	O
96	O
%	O
patients	O
respectively	O
.	O

TITLE	O
:	O
Surface	O
tension	O
in	O
situ	O
in	O
flooded	O
alveolus	B-ANAT
unaltered	O
by	O
albumin	O
.	O

We	O
determine	O
alveolar	B-ANAT
air	I-ANAT
pressure	O
at	O
the	O
trachea	B-ANAT
,	O
alveolar	B-ANAT
liquid	O
phase	O
pressure	O
by	O
servo	O
-	O
nulling	O
pressure	O
measurement	O
,	O
and	O
meniscus	B-ANAT
radius	B-ANAT
by	O
confocal	O
microscopy	O
,	O
and	O
we	O
calculate	O
T	O
according	O
to	O
the	O
Laplace	O
relation	O
.	O

Over	O
60	O
ventilation	O
cycles	O
,	O
application	O
of	O
maximal	O
physiologic	O
%	O
ÎA	O
to	O
alveoli	B-ANAT
flooded	O
with	O
4	O
.	O
6	O
%	O
albumin	O
solution	O
does	O
not	O
alter	O
T	O
;	O
supraphysiologic	O
%	O
ÎA	O
raise	O
T	O
,	O
transiently	O
,	O
by	O
51	O
Â±	O
4	O
%.	O

Knockdown	O
of	O
EF1A	O
impairs	O
N	O
protein	O
proliferation	O
and	O
TGEV	O
replication	O
in	O
host	B-ANAT
cell	I-ANAT
.	O

TITLE	O
:	O
[	O
Syndromic	O
surveillance	O
:	O
a	O
finger	B-ANAT
on	O
the	O
pulse	O
of	O
public	O
health	O
].	O

We	O
report	O
herein	O
a	O
patient	O
with	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
who	O
developed	O
fever	O
with	O
worsening	O
of	O
respiratory	O
symptoms	O
and	O
severe	O
hypoxemia	O
requiring	O
ventilatory	O
support	O
shortly	O
after	O
influenza	O
vaccination	O
.	O

TITLE	O
:	O
Ion	O
flux	O
in	O
the	O
lung	B-ANAT
:	O
virus	O
-	O
induced	O
inflammasome	O
activation	O
.	O

This	O
is	O
a	O
novel	O
mechanism	O
by	O
which	O
respiratory	O
viral	O
infection	O
activates	O
inflammasomes	O
,	O
and	O
identifies	O
sensing	O
of	O
disturbances	O
in	O
intracellular	B-ANAT
ionic	O
concentrations	O
as	O
a	O
novel	O
pathogen	O
-	O
recognition	O
pathway	O
in	O
the	O
lung	B-ANAT
.	O

Here	O
we	O
report	O
that	O
a	O
cellular	B-ANAT
protein	O
,	O
AKAP7	O
,	O
has	O
an	O
analogous	O
2	O
',	O
5	O
'-	O
phosphodiesterase	O
(	O
2	O
',	O
5	O
'-	O
PDE	O
)	O
domain	O
that	O
is	O
able	O
to	O
restore	O
the	O
growth	O
of	O
chimeric	O
MHV	O
expressing	O
inactive	O
ns2	O
.	O

Evidence	O
-	O
based	O
permissive	O
hypercapnia	O
strategy	O
for	O
ARDS	O
could	O
be	O
fatal	O
in	O
patients	O
with	O
intracranial	B-ANAT
hypertension	O
.	O

IBV	O
NSP6	O
also	O
limited	O
autophagosome	B-ANAT
and	O
omegasome	O
expansion	O
in	O
response	O
to	O
starvation	O
and	O
Torin1	O
and	O
could	O
therefore	O
limit	O
the	O
size	O
of	O
autophagosomes	O
induced	O
following	O
inhibition	O
of	O
MTOR	O
signaling	O
,	O
as	O
well	O
as	O
those	O
induced	O
independently	O
by	O
the	O
NSP6	O
protein	O
itself	O
.	O

This	O
may	O
favor	O
coronavirus	O
infection	O
by	O
compromising	O
the	O
ability	O
of	O
autophagosomes	O
to	O
deliver	O
viral	B-ANAT
components	I-ANAT
to	O
lysosomes	B-ANAT
for	O
degradation	O
.	O

TITLE	O
:	O
Up	O
-	O
regulation	O
of	O
MDP	O
and	O
tuftsin	O
gene	O
expression	O
in	O
Th1	O
and	O
Th17	O
cells	B-ANAT
as	O
an	O
adjuvant	O
for	O
an	O
oral	B-ANAT
Lactobacillus	O
casei	O
vaccine	O
against	O
anti	O
-	O
transmissible	O
gastroenteritis	O
virus	O
.	O

TITLE	O
:	O
Risk	O
factors	O
for	O
febrile	O
neutropenia	O
in	O
patients	O
receiving	O
docetaxel	O
chemotherapy	O
for	O
castration	O
-	O
resistant	O
prostate	B-ANAT
cancer	O
.	O

At	O
admission	O
,	O
he	O
had	O
a	O
severe	O
clinical	O
picture	O
with	O
fever	O
,	O
hypotension	O
,	O
jaundice	O
,	O
immobility	O
,	O
and	O
pain	O
in	O
leg	B-ANAT
muscles	I-ANAT
.	O

Further	O
,	O
enforced	O
expression	O
of	O
miR	O
-	O
125b	O
resulted	O
in	O
remarkable	O
reversal	O
of	O
LPS	O
-	O
induced	O
increases	O
in	O
lung	B-ANAT
permeability	O
as	O
assessed	O
by	O
reductions	O
in	O
total	O
protein	O
,	O
albumin	O
and	O
IgM	O
in	O
BAL	O
fluid	O
,	O
and	O
ameliorated	O
the	O
histopathology	O
changes	O
of	O
lung	B-ANAT
in	O
LPS	O
-	O
induced	O
ALI	O
mice	O
.	O

TITLE	O
:	O
Coronavirus	O
-	O
induced	O
demyelination	O
of	O
neural	B-ANAT
pathways	I-ANAT
triggers	O
neurogenic	O
bladder	B-ANAT
overactivity	O
in	O
a	O
mouse	O
model	O
of	O
multiple	O
sclerosis	O
.	O

One	O
week	O
after	O
inoculation	O
with	O
the	O
A59	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
,	O
mice	O
became	O
increasingly	O
sensitive	O
to	O
von	O
Frey	O
filament	B-ANAT
testing	O
with	O
responses	O
enhanced	O
by	O
45	O
%	O
(	O
n	O
=	O
8	O
,	O
P	O
â¤	O
0	O
.	O
05	O
vs	O
.	O
baseline	O
at	O
4	O
g	O
);	O
however	O
,	O
this	O
initial	O
increase	O
in	O
sensitivity	O
was	O
followed	O
by	O
gradual	O
and	O
significant	O
diminution	O
of	O
abdominal	B-ANAT
sensitivity	O
to	O
mechanical	O
stimulation	O
by	O
4	O
wk	O
postinoculation	O
.	O

Since	O
the	O
S1	O
domain	O
is	O
involved	O
in	O
a	O
specific	O
high	O
-	O
affinity	O
interaction	O
with	O
the	O
cellular	B-ANAT
receptor	O
and	O
induction	O
of	O
neutralizing	O
antibody	O
in	O
the	O
natural	O
host	O
,	O
it	O
is	O
a	O
primary	O
target	O
for	O
the	O
development	O
of	O
effective	O
vaccines	O
against	O
PEDV	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
sought	O
to	O
investigate	O
whether	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
induces	O
apoptosis	O
and	O
to	O
elucidate	O
the	O
mechanisms	O
associated	O
with	O
apoptotic	O
cell	B-ANAT
death	O
after	O
PEDV	O
infection	O
.	O

Altogether	O
,	O
our	O
results	O
indicate	O
that	O
a	O
caspase	O
-	O
independent	O
mitochondrial	B-ANAT
AIF	O
-	O
mediated	O
pathway	O
plays	O
a	O
central	O
role	O
in	O
PEDV	O
-	O
induced	O
apoptosis	O
to	O
facilitate	O
viral	O
replication	O
and	O
pathogenesis	O
.	O

Determination	O
of	O
drug	O
activity	O
was	O
based	O
on	O
achievable	O
serum	B-ANAT
levels	O
in	O
humans	O
relative	O
to	O
in	O
vitro	O
IC50	O
(	O
50	O
%	O
inhibitory	O
concentration	O
)	O
or	O
EC50	O
(	O
50	O
%	O
effective	O
concentration	O
)	O
drug	O
concentrations	O
.	O

Pulmonary	B-ANAT
findings	O
are	O
miliary	O
nodules	B-ANAT
and	O
confluent	O
parenchymal	O
opacities	O
.	O

TITLE	O
:	O
Volume	O
of	O
fluids	B-ANAT
administered	O
during	O
resuscitation	O
for	O
severe	O
sepsis	O
and	O
septic	O
shock	O
and	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
the	O
volume	O
of	O
intravenous	O
(	O
IV	O
)	O
fluids	B-ANAT
administered	O
in	O
the	O
resuscitative	O
phase	O
of	O
severe	O
sepsis	O
and	O
septic	O
shock	O
and	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

After	O
controlling	O
for	O
confounding	O
variables	O
,	O
there	O
was	O
no	O
significant	O
association	O
between	O
the	O
volume	O
of	O
IV	O
fluids	B-ANAT
administered	O
in	O
the	O
first	O
24	O
hours	O
of	O
hospitalization	O
and	O
the	O
development	O
of	O
ARDS	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
1	O
.	O
05	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
0	O
.	O
95	O
-	O
1	O
.	O
18	O
).	O

Serum	B-ANAT
albumin	O
(	O
OR	O
,	O
0	O
.	O
52	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
31	O
-	O
0	O
.	O
87	O
)	O
and	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
(	O
OR	O
,	O
1	O
.	O
08	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
04	O
-	O
1	O
.	O
13	O
)	O
on	O
admission	O
were	O
the	O
most	O
informative	O
covariates	O
for	O
the	O
development	O
of	O
ARDS	O
in	O
the	O
regression	O
model	O
.	O

Serum	B-ANAT
albumin	O
(	O
OR	O
,	O
0	O
.	O
52	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
31	O
-	O
0	O
.	O
87	O
)	O
and	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
(	O
OR	O
,	O
1	O
.	O
08	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
04	O
-	O
1	O
.	O
13	O
)	O
on	O
admission	O
were	O
the	O
most	O
informative	O
covariates	O
for	O
the	O
development	O
of	O
ARDS	O
in	O
the	O
regression	O
model	O
.	O

The	O
only	O
intervention	O
proven	O
to	O
reduce	O
mortality	O
is	O
the	O
use	O
of	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
strategies	O
,	O
although	O
such	O
a	O
strategy	O
may	O
lead	O
to	O
problematic	O
hypercapnia	O
.	O

We	O
determined	O
its	O
crystal	B-ANAT
structure	O
,	O
which	O
still	O
adopts	O
the	O
dimeric	O
structure	O
almost	O
identical	O
to	O
that	O
of	O
the	O
wild	O
-	O
type	O
(	O
WT	O
),	O
except	O
for	O
slightly	O
tighter	O
packing	O
between	O
two	O
extra	O
-	O
domains	O
.	O

TITLE	O
:	O
Does	O
form	O
meet	O
function	O
in	O
the	O
coronavirus	O
replicative	O
organelle	B-ANAT
?	O

TITLE	O
:	O
Patterns	O
of	O
detection	O
of	O
respiratory	O
viruses	O
in	O
nasal	B-ANAT
swabs	O
from	O
calves	O
in	O
Ireland	O
:	O
a	O
retrospective	O
study	O
.	O

The	O
crystal	B-ANAT
structure	O
of	O
the	O
free	O
SARS	O
coronavirus	O
M	O
(	O
pro	O
)	O
and	O
its	O
dependence	O
on	O
pH	O
is	O
discussed	O
,	O
as	O
are	O
efforts	O
to	O
design	O
inhibitors	O
on	O
the	O
basis	O
of	O
these	O
structures	O
.	O

TITLE	O
:	O
Virus	O
-	O
specific	O
memory	O
CD8	O
T	B-ANAT
cells	I-ANAT
provide	O
substantial	O
protection	O
from	O
lethal	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
infection	O
.	O

However	O
,	O
it	O
is	O
unclear	O
whether	O
MERS	O
-	O
S	O
is	O
also	O
cleaved	B-ANAT
during	O
S	O
protein	O
synthesis	O
in	O
infected	O
cells	B-ANAT
and	O
whether	O
cleavage	O
is	O
required	O
for	O
MERS	O
-	O
CoV	O
infectivity	O
.	O

Efforts	O
to	O
inhibit	O
MERS	O
-	O
CoV	O
infection	O
by	O
targeting	O
host	B-ANAT
cell	I-ANAT
proteases	O
should	O
therefore	O
focus	O
on	O
enzymes	O
that	O
process	O
MERS	O
-	O
S	O
during	O
viral	O
uptake	O
into	O
target	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Severe	O
murine	O
typhus	O
with	O
pulmonary	B-ANAT
system	I-ANAT
involvement	O
.	O

The	O
HA	O
and	O
M1	O
proteins	O
from	O
the	O
H3N2	O
influenza	O
virus	O
and	O
the	O
PRRSV	O
GP5	O
protein	O
fused	O
to	O
the	O
cytoplasmic	B-ANAT
and	O
transmembrane	B-ANAT
domains	O
of	O
the	O
NA	O
protein	O
were	O
both	O
incorporated	O
into	O
the	O
chimeric	O
VLPs	B-ANAT
.	O

TITLE	O
:	O
Bicaval	O
dual	O
-	O
lumen	B-ANAT
cannula	O
for	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
Avalon	O
Â©	O
cannula	O
in	O
childhood	O
disease	O
.	O

Specifically	O
,	O
bicaval	O
VV	O
-	O
ECMO	O
is	O
a	O
well	O
-	O
recognized	O
and	O
validated	O
therapy	O
,	O
where	O
single	O
or	O
double	O
periphery	O
venous	B-ANAT
access	O
is	O
used	O
for	O
the	O
insertion	O
of	O
two	O
differently	O
sized	O
cannulas	O
in	O
order	O
to	O
achieve	O
adequate	O
blood	B-ANAT
oxygenation	O
.	O

The	O
most	O
severely	O
ill	O
patient	O
presented	O
an	O
expression	O
of	O
the	O
virus	O
in	O
blood	B-ANAT
and	O
urine	B-ANAT
,	O
consistent	O
with	O
a	O
type	O
-	O
1	O
interferon	O
mediated	O
immunological	O
response	O
impaired	O
in	O
patient	O
1	O
,	O
but	O
developed	O
by	O
patient	O
2	O
.	O

The	O
148	O
-	O
amino	O
acid	O
nsp10	O
subunit	O
contains	O
two	O
zinc	O
fingers	B-ANAT
and	O
is	O
known	O
to	O
interact	O
with	O
both	O
nsp14	O
and	O
nsp16	O
,	O
stimulating	O
their	O
respective	O
3	O
'-	O
5	O
'	O
exoribonuclease	O
and	O
2	O
'-	O
O	O
-	O
methyltransferase	O
activities	O
.	O

Nasal	B-ANAT
/	O
Nasopharyngeal	B-ANAT
swabs	O
were	O
tested	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
),	O
HCoV	O
-	O
22E	O
,	O
HCoV	O
-	O
OC43	O
,	O
HCoV	O
-	O
NL63	O
and	O
HCoV	O
-	O
HKU1	O
using	O
Reverse	O
Transcriptase	O
Real	O
-	O
Time	O
Polymerase	O
Chain	O
Reaction	O
.	O

The	O
complex	O
crystals	B-ANAT
diffracted	O
to	O
2	O
.	O
85	O
Ã	O
resolution	O
and	O
belonged	O
to	O
space	O
group	O
P41212	O
,	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
b	O
=	O
87	O
.	O
2	O
,	O
c	O
=	O
212	O
.	O
1	O
Ã	O
.	O
Two	O
molecules	O
were	O
identified	O
per	O
asymmetric	O
unit	O
.	O

TITLE	O
:	O
Tissue	B-ANAT
microscopic	O
changes	O
and	O
artifacts	O
in	O
multi	O
-	O
phase	O
post	O
-	O
mortem	O
computed	O
tomography	O
angiography	O
in	O
a	O
hospital	O
setting	O
:	O
a	O
fatal	O
case	O
of	O
systemic	O
vasculitis	O
.	O

MPMCTA	O
revealed	O
absence	O
of	O
opacification	O
of	O
the	O
left	B-ANAT
middle	I-ANAT
cerebral	I-ANAT
artery	I-ANAT
.	O

These	O
results	O
demonstrate	O
that	O
recombinant	O
DEV	O
expressing	O
the	O
TE	O
and	O
pre	O
-	O
membrane	B-ANAT
proteins	O
is	O
protective	O
and	O
can	O
serve	O
as	O
a	O
potential	O
candidate	O
vaccine	O
to	O
prevent	O
DTMUV	O
infection	O
in	O
ducks	O
.	O

However	O
,	O
an	O
uncontrolled	O
induction	O
of	O
these	O
proinflammatory	O
cytokines	O
can	O
lead	O
to	O
pathogenesis	O
and	O
disease	O
severity	O
as	O
described	O
for	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
The	O
cellular	B-ANAT
pathways	O
mediated	O
by	O
interferon	O
regulatory	O
factor	O
(	O
IRF	O
)-	O
3	O
and	O
-	O
7	O
,	O
activating	O
transcription	O
factor	O
(	O
ATF	O
)-	O
2	O
/	O
jun	O
,	O
activator	O
protein	O
(	O
AP	O
)-	O
1	O
,	O
nuclear	O
factor	O
kappa	O
-	O
light	O
-	O
chain	O
-	O
enhancer	O
of	O
activated	O
B	B-ANAT
cells	I-ANAT
(	O
NF	O
-	O
ÎºB	O
),	O
and	O
nuclear	O
factor	O
of	O
activated	O
T	B-ANAT
cells	I-ANAT
(	O
NF	O
-	O
AT	O
),	O
are	O
the	O
main	O
drivers	O
of	O
the	O
inflammatory	O
response	O
triggered	O
after	O
viral	O
infections	O
,	O
with	O
NF	O
-	O
ÎºB	O
pathway	O
the	O
most	O
frequently	O
activated	O
.	O

Although	O
E	O
protein	O
is	O
not	O
essential	O
for	O
CoV	O
genome	O
replication	O
or	O
subgenomic	O
mRNA	O
synthesis	O
,	O
it	O
affects	O
virus	O
morphogenesis	O
,	O
budding	O
,	O
assembly	O
,	O
intracellular	B-ANAT
trafficking	O
,	O
and	O
virulence	O
.	O

ABSTRACT	O
:	O
Macropinocytosis	O
is	O
exploited	O
by	O
many	O
pathogens	O
for	O
entry	O
into	O
cells	B-ANAT
.	O

MHV	O
-	O
induced	O
macropinocytosis	O
requires	O
fusogenic	O
spike	O
protein	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
and	O
is	O
dependent	O
on	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
activation	O
.	O

We	O
engineered	O
Sindbis	O
virus	O
to	O
coexpress	O
PLpro	O
and	O
a	O
substrate	O
,	O
murine	O
interferon	O
-	O
stimulated	O
gene	O
15	O
(	O
ISG15	O
),	O
and	O
found	O
that	O
PLpro	O
mediates	O
removal	O
of	O
ISG15	O
(	O
deISGylation	O
)	O
from	O
cellular	B-ANAT
proteins	O
.	O

Mutation	O
of	O
the	O
catalytic	O
cysteine	O
residue	O
of	O
PLpro	O
or	O
addition	O
of	O
a	O
PLpro	O
inhibitor	O
blocked	O
deISGylation	O
in	O
virus	O
-	O
infected	O
cells	B-ANAT
.	O

This	O
system	O
provides	O
an	O
important	O
tool	O
to	O
rapidly	O
assess	O
the	O
efficacy	O
of	O
protease	O
inhibitors	O
targeting	O
existing	O
and	O
emerging	O
human	O
pathogens	O
,	O
as	O
well	O
as	O
other	O
enzymes	O
capable	O
of	O
removing	O
ISG15	O
from	O
cellular	B-ANAT
proteins	O
.	O

These	O
cells	B-ANAT
are	O
more	O
suppressive	O
than	O
bulk	O
Tregs	O
and	O
provide	O
a	O
targeted	O
approach	O
to	O
ameliorating	O
immunopathological	O
disease	O
in	O
infectious	O
settings	O
.	O

TITLE	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
is	O
a	O
multifunctional	O
protein	O
.	O

ABSTRACT	O
:	O
Tracheal	B-ANAT
mucosa	I-ANAT
is	O
the	O
primary	O
site	O
of	O
replication	O
of	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
which	O
leads	O
to	O
both	O
morphologic	O
and	O
immune	O
modulatory	O
changes	O
in	O
this	O
organ	B-ANAT
.	O

In	O
contrast	O
to	O
the	O
striking	O
difficulties	O
in	O
defense	O
against	O
bacterial	O
and	O
fungal	O
microorganisms	O
,	O
LAD	B-ANAT
1	O
patients	O
do	O
not	O
exhibit	O
susceptibility	O
to	O
viral	O
infections	O
and	O
neoplasias	O
.	O

Rising	O
respiratory	O
rate	O
[	O
1	O
.	O
29	O
(	O
1	O
.	O
15	O
-	O
1	O
.	O
46	O
)],	O
falling	O
systolic	O
blood	B-ANAT
pressure	O
[	O
0	O
.	O
96	O
(	O
0	O
.	O
93	O
-	O
0	O
.	O
99	O
)],	O
leucocytosis	O
[	O
12	O
.	O
87	O
(	O
1	O
.	O
43	O
-	O
115	O
.	O
93	O
)]	O
and	O
haematuria	O
[	O
59	O
.	O
36	O
(	O
13	O
.	O
51	O
-	O
260	O
.	O
81	O
)]	O
were	O
the	O
independent	O
predictors	O
of	O
severity	O
in	O
P	O
.	O
vivax	O
.	O

Nitazoxanide	O
also	O
inhibits	O
the	O
replication	O
of	O
a	O
broad	O
range	O
of	O
other	O
RNA	O
and	O
DNA	O
viruses	O
including	O
respiratory	O
syncytial	O
virus	O
,	O
parainfluenza	O
,	O
coronavirus	O
,	O
rotavirus	O
,	O
norovirus	O
,	O
hepatitis	O
B	O
,	O
hepatitis	O
C	O
,	O
dengue	O
,	O
yellow	O
fever	O
,	O
Japanese	O
encephalitis	O
virus	O
and	O
human	O
immunodeficiency	O
virus	O
in	O
cell	B-ANAT
culture	O
assays	O
.	O

Here	O
we	O
present	O
a	O
synopsis	O
of	O
the	O
challenges	O
,	O
considerations	O
,	O
and	O
potential	O
controversies	O
regarding	O
veno	O
-	O
venous	B-ANAT
ECMO	O
that	O
will	O
be	O
of	O
benefit	O
to	O
anesthesiologists	O
,	O
surgeons	O
,	O
and	O
intensivists	O
,	O
especially	O
those	O
newly	O
confronted	O
with	O
care	O
of	O
the	O
ECMO	O
patient	O
.	O

EGDT	O
and	O
the	O
Surviving	O
Sepsis	O
Campaign	O
Guidelines	O
recommend	O
targeting	O
a	O
central	O
venous	B-ANAT
pressure	O
(	O
CVP	O
)	O
>	O
8	O
mmHg	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
and	O
extracorporeal	O
CO	O
(	O
2	O
)	O
removal	O
(	O
ECCO	O
(	O
2	O
)	O
R	O
)	O
techniques	O
have	O
increasingly	O
been	O
applied	O
in	O
patients	O
with	O
severe	O
acute	O
lung	B-ANAT
injury	O
refractory	O
to	O
conventional	O
mechanical	O
ventilatory	O
support	O
.	O

The	O
clinical	O
features	O
and	O
outcomes	O
of	O
the	O
most	O
critically	O
ill	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
HAdV	O
-	O
55	O
requiring	O
invasive	O
mechanical	O
ventilation	O
(	O
IMV	O
)	O
and	O
/	O
or	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
are	O
lacking	O
.	O

Mean	O
durations	O
from	O
onset	O
to	O
a	O
single	O
-	O
lobe	B-ANAT
consolidation	O
shown	O
on	O
chest	B-ANAT
X	O
-	O
rays	O
(	O
CXRs	O
)	O
and	O
,	O
from	O
the	O
first	O
positive	O
CXR	O
to	O
bilateral	O
multilobar	O
lung	B-ANAT
infiltrates	O
,	O
were	O
2	O
days	O
and	O
4	O
.	O
8	O
days	O
,	O
respectively	O
.	O

Conversely	O
,	O
the	O
interaction	O
of	O
S	O
with	O
the	O
M	O
protein	O
,	O
essential	O
for	O
VLP	B-ANAT
incorporation	O
of	O
S	O
,	O
was	O
not	O
impaired	O
by	O
lack	O
of	O
palmitoylation	O
.	O

They	O
also	O
suggest	O
that	O
DPP4	O
-	O
recognizing	O
bat	O
coronaviruses	O
threaten	O
human	O
health	O
because	O
of	O
their	O
spikes	O
'	O
capability	O
to	O
adapt	O
to	O
human	O
cells	B-ANAT
for	O
cross	O
-	O
species	O
transmissions	O
.	O

A	O
histological	O
lung	B-ANAT
injury	O
score	O
was	O
determined	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
PEDV	O
infected	O
not	O
only	O
the	O
small	B-ANAT
intestines	I-ANAT
,	O
but	O
also	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

At	O
day	O
post	O
inoculation	O
(	O
dpi	O
)	O
0	O
,	O
NEG	O
-	O
CONTROL	O
pigs	O
were	O
sham	O
-	O
inoculated	O
,	O
PEDV	O
-	O
CONTROL	O
pigs	O
received	O
cell	B-ANAT
culture	O
propagated	O
PEDV	O
,	O
and	O
SDPP	O
-	O
CONTROL	O
pigs	O
were	O
switched	O
to	O
a	O
diet	O
with	O
5	O
%	O
SDPP	O
containing	O
5	O
.	O
1	O
Â±	O
0	O
.	O
1	O
log10	O
PEDV	O
RNA	O
copies	O
/	O
g	O
.	O

Another	O
group	O
,	O
EGG	B-ANAT
-	O
PEDV	O
,	O
was	O
orally	B-ANAT
administered	O
a	O
commercial	O
egg	B-ANAT
-	O
derived	O
liquid	O
PEDV	O
globulin	O
product	O
from	O
dpi	O
-	O
4	O
through	O
6	O
.	O

All	O
PEDV	O
-	O
CONTROL	O
pigs	O
began	O
shedding	O
PEDV	O
in	O
feces	B-ANAT
by	O
dpi	O
3	O
and	O
seroconverted	O
between	O
dpi	O
7	O
and	O
14	O
,	O
whereas	O
pigs	O
in	O
NEG	O
-	O
CONTROL	O
and	O
SDPP	O
-	O
CONTROL	O
groups	O
remained	O
PEDV	O
RNA	O
negative	O
and	O
did	O
not	O
seroconvert	O
to	O
PEDV	O
for	O
the	O
study	O
duration	O
.	O

ABSTRACT	O
:	O
The	O
type	O
II	O
transmembrane	B-ANAT
serine	O
protease	O
(	O
TTSP	O
)	O
TMPRSS2	O
cleaves	O
and	O
activates	O
the	O
influenza	O
virus	O
and	O
coronavirus	O
surface	O
proteins	O
.	O

Here	O
,	O
we	O
analyzed	O
TTSPs	O
,	O
reported	O
to	O
be	O
expressed	O
in	O
the	O
respiratory	B-ANAT
system	I-ANAT
,	O
for	O
the	O
ability	O
to	O
activate	O
influenza	O
viruses	O
and	O
coronaviruses	O
.	O

According	O
to	O
different	O
methods	O
of	O
lung	B-ANAT
RM	O
,	O
the	O
conventional	O
mechanical	O
ventilation	O
(	O
i	O
.	O
e	O
.	O
implementing	O
ventilation	O
for	O
both	O
lung	B-ANAT
by	O
using	O
a	O
ventilator	O
)	O
was	O
performed	O
as	O
control	O
group	O
;	O
the	O
individual	O
lung	B-ANAT
ventilation	O
(	O
that	O
was	O
,	O
implementing	O
ventilation	O
for	O
both	O
lung	B-ANAT
individually	O
by	O
using	O
two	O
ventilators	O
)	O
as	O
independent	O
lung	B-ANAT
ventilation	O
group	O
.	O

Along	O
with	O
the	O
increase	O
in	O
RM	O
pressure	O
,	O
the	O
PaOâ	O
/	O
FiOâ	O
of	O
independent	O
lung	B-ANAT
ventilation	O
group	O
showed	O
a	O
tendency	O
of	O
gradual	O
increase	O
,	O
and	O
that	O
at	O
40	O
cmHâO	O
and	O
60	O
cmHâO	O
were	O
significantly	O
higher	O
than	O
that	O
at	O
20	O
cmHâO	O
(	O
244	O
.	O
45	O
Â±	O
53	O
.	O
93	O
mmHg	O
,	O
270	O
.	O
05	O
Â±	O
53	O
.	O
42	O
mmHg	O
vs	O
.	O
205	O
.	O
65	O
Â±	O
31	O
.	O
33	O
mmHg	O
,	O
P	O
<	O
0	O
.	O
05	O
and	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
the	O
level	O
at	O
20	O
,	O
40	O
,	O
60	O
cmHâO	O
was	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
205	O
.	O
65	O
Â±	O
31	O
.	O
33	O
vs	O
.	O
187	O
.	O
40	O
Â±	O
21	O
.	O
66	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
244	O
.	O
45	O
Â±	O
53	O
.	O
93	O
vs	O
.	O
175	O
.	O
20	O
Â±	O
23	O
.	O
00	O
,	O
P	O
<	O
0	O
.	O
01	O
;	O
270	O
.	O
05	O
Â±	O
53	O
.	O
42	O
vs	O
.	O
126	O
.	O
40	O
Â±	O
37	O
.	O
55	O
,	O
P	O
<	O
0	O
.	O
01	O
).	O

RESULTS	O
:	O
(	O
1	O
)	O
Hemodynamics	O
parameters	O
changes	O
:	O
with	O
the	O
increase	O
in	O
RM	O
pressure	O
,	O
the	O
heart	B-ANAT
rate	O
(	O
HR	O
)	O
in	O
control	O
group	O
showed	O
a	O
tendency	O
of	O
gradual	O
increase	O
,	O
and	O
the	O
level	O
at	O
60	O
cmHâO	O
was	O
significantly	O
higher	O
than	O
that	O
at	O
20	O
cmHâO	O
(	O
192	O
.	O
65	O
Â±	O
22	O
.	O
99	O
bpm	O
vs	O
.	O
178	O
.	O
20	O
Â±	O
18	O
.	O
25	O
bpm	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

This	O
study	O
describes	O
399	O
microRNAs	O
identified	O
by	O
deep	O
sequencing	O
of	O
small	O
RNA	O
isolated	O
from	O
tissues	B-ANAT
of	O
the	O
Black	O
flying	O
fox	O
,	O
Pteropus	O
alecto	O
,	O
a	O
confirmed	O
natural	O
reservoir	O
of	O
the	O
human	O
pathogens	O
Hendra	O
virus	O
and	O
Australian	O
bat	O
lyssavirus	O
.	O

RESULTS	O
:	O
This	O
study	O
describes	O
399	O
microRNAs	O
identified	O
by	O
deep	O
sequencing	O
of	O
small	O
RNA	O
isolated	O
from	O
tissues	B-ANAT
of	O
the	O
Black	O
flying	O
fox	O
,	O
Pteropus	O
alecto	O
,	O
a	O
confirmed	O
natural	O
reservoir	O
of	O
the	O
human	O
pathogens	O
Hendra	O
virus	O
and	O
Australian	O
bat	O
lyssavirus	O
.	O

Here	O
,	O
we	O
investigated	O
282	O
tissue	B-ANAT
specimens	O
from	O
28	O
cats	O
that	O
succumbed	O
to	O
FIP	O
.	O

In	O
serum	B-ANAT
samples	O
from	O
experimentally	O
infected	O
pigs	O
(	O
n	O
=	O
35	O
),	O
anti	O
-	O
IgG	O
PEDV	O
antibodies	O
were	O
detected	O
as	O
early	O
as	O
7	O
days	O
post	O
-	O
infection	O
.	O

In	O
field	O
serum	B-ANAT
samples	O
(	O
n	O
=	O
239	O
),	O
the	O
diagnostic	O
sensitivity	O
of	O
the	O
S1	O
ELISA	O
was	O
100	O
%	O
and	O
the	O
diagnostic	O
specificity	O
was	O
94	O
%.	O

ABSTRACT	O
:	O
Cysteine	O
-	O
containing	O
peptides	O
represent	O
an	O
important	O
class	O
of	O
T	B-ANAT
cell	I-ANAT
epitopes	O
,	O
yet	O
their	O
prevalence	O
remains	O
underestimated	O
.	O

This	O
severely	O
limits	O
host	B-ANAT
cell	I-ANAT
IFN	O
responses	O
.	O

Conditioned	O
medium	O
collected	O
from	O
an	O
in	O
vitro	O
lipopolysaccharide	O
-	O
induced	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
injury	O
model	O
using	O
human	O
A549	O
alveolar	B-ANAT
cells	B-ANAT
was	O
subsequently	O
added	O
at	O
increasing	O
concentrations	O
(	O
no	O
conditioned	O
,	O
2	O
%,	O
5	O
%,	O
10	O
%,	O
15	O
%,	O
25	O
%,	O
and	O
50	O
%)	O
to	O
a	O
rat	O
mixed	O
brain	B-ANAT
cell	I-ANAT
culture	O
containing	O
both	O
astrocytes	B-ANAT
and	O
neurons	B-ANAT
.	O

Samples	O
from	O
culture	O
media	B-ANAT
and	O
cells	B-ANAT
from	O
mixed	O
brain	B-ANAT
cultures	O
were	O
collected	O
before	O
treatment	O
,	O
and	O
at	O
6	O
and	O
24	O
h	O
for	O
analysis	O
.	O

Our	O
findings	O
demonstrated	O
that	O
human	O
epithelial	O
pulmonary	B-ANAT
cells	B-ANAT
stimulated	O
with	O
bacterial	O
lipopolysaccharide	O
release	O
inflammatory	O
mediators	O
that	O
are	O
able	O
to	O
induce	O
a	O
translational	O
clinically	O
relevant	O
and	O
harmful	O
response	O
in	O
brain	B-ANAT
cells	I-ANAT
.	O

At	O
follow	O
-	O
up	O
,	O
changes	O
in	O
body	B-ANAT
mass	O
(-	O
2	O
.	O
0	O
[-	O
3	O
.	O
5	O
,	O
-	O
0	O
.	O
5	O
]	O
kg	O
;	O
P	O
=	O
0	O
.	O
010	O
),	O
body	B-ANAT
fat	I-ANAT
percentage	O
(-	O
1	O
[-	O
2	O
,	O
0	O
]%;	O
P	O
=	O
0	O
.	O
033	O
),	O
and	O
C	O
-	O
reactive	O
protein	O
(-	O
1	O
.	O
3	O
[-	O
2	O
.	O
5	O
,	O
-	O
0	O
.	O
1	O
]	O
mg	O
Â·	O
L	O
(-	O
1	O
);	O
P	O
=	O
0	O
.	O
037	O
)	O
were	O
maintained	O
and	O
exercise	O
capacity	O
was	O
further	O
improved	O
(	O
132	O
[	O
90	O
,	O
175	O
]	O
m	O
;	O
P	O
<	O
0	O
.	O
001	O
).	O

These	O
results	O
correlated	O
with	O
impaired	O
ability	O
to	O
control	O
viral	O
replication	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
within	O
the	O
CNS	B-ANAT
at	O
days	O
7	O
and	O
14	O
post	O
-	O
infection	O
,	O
which	O
was	O
associated	O
with	O
diminished	O
accumulation	O
of	O
virus	O
-	O
specific	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
(	O
P	O
<	O
0	O
.	O
05	O
)	O
into	O
the	O
CNS	B-ANAT
.	O

Here	O
,	O
we	O
report	O
that	O
inositol	O
-	O
requiring	O
protein	O
1	O
alpha	O
(	O
IRE1Î±	O
),	O
a	O
key	O
sensor	O
of	O
ER	O
stress	O
,	O
is	O
activated	O
in	O
cells	B-ANAT
infected	O
with	O
the	O
avian	O
coronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

Some	O
animals	O
were	O
also	O
viremic	O
;	O
high	O
viral	O
loads	O
were	O
detected	O
in	O
the	O
lungs	B-ANAT
of	O
all	O
infected	O
animals	O
,	O
and	O
total	O
RNAseq	O
demonstrated	O
the	O
induction	O
of	O
immune	O
and	O
inflammatory	O
pathways	O
.	O

In	O
vivo	O
,	O
acute	O
treatment	O
of	O
Mecp2	O
-	O
null	O
and	O
-	O
heterozygous	O
mutants	O
with	O
LM22A	O
-	O
4	O
completely	O
eliminated	O
spontaneous	O
apneas	O
in	O
resting	B-ANAT
animals	O
,	O
without	O
sedation	O
.	O

Such	O
an	O
approach	O
may	O
also	O
be	O
useful	O
for	O
identifying	O
patients	O
with	O
severe	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
who	O
may	O
benefit	O
from	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

TITLE	O
:	O
Lung	B-ANAT
postmortem	O
autopsy	O
revealing	O
extramedullary	O
involvement	O
in	O
multiple	O
myeloma	O
causing	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Recombinant	O
nucleocapsid	B-ANAT
protein	O
based	O
single	O
serum	B-ANAT
dilution	O
ELISA	O
for	O
the	O
detection	O
of	O
antibodies	O
to	O
infectious	O
bronchitis	O
virus	O
in	O
poultry	O
.	O

Sera	B-ANAT
from	O
a	O
cat	O
experimentally	O
infected	O
with	O
type	O
I	O
FCoV	O
was	O
unable	O
to	O
neutralize	O
type	O
II	O
CCoV	O
infection	O
,	O
indicating	O
that	O
cats	O
persistently	O
infected	O
with	O
type	O
I	O
FCoV	O
may	O
be	O
superinfected	O
with	O
type	O
II	O
CCoV	O
.	O
Our	O
previous	O
study	O
reported	O
that	O
few	O
Japanese	O
cats	O
have	O
antibody	O
against	O
type	O
II	O
FCoV	O
.	O
All	O
of	O
these	O
observations	O
suggest	O
that	O
type	O
II	O
FCoV	O
emerged	O
inside	O
the	O
cat	O
body	B-ANAT
and	O
is	O
unable	O
to	O
readily	O
spread	O
among	O
cats	O
,	O
indicating	O
that	O
these	O
recombination	O
events	O
for	O
emergence	O
of	O
pathogenic	O
coronaviruses	O
occur	O
frequently	O
.	O

Feces	B-ANAT
samples	O
from	O
82	O
diarrheic	O
dairy	O
calves	O
from	O
farms	O
around	O
Tiaret	O
(	O
Western	O
Algeria	O
)	O
were	O
collected	O
.	O

Nevertheless	O
,	O
impaired	O
virus	O
control	O
in	O
the	O
absence	O
of	O
CD4	O
T	B-ANAT
cells	I-ANAT
was	O
associated	O
with	O
gradually	O
diminished	O
CNS	B-ANAT
CD8	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
interferon	O
-	O
Î³	O
production	O
.	O

TITLE	O
:	O
Human	O
coronavirus	O
NL63	O
utilizes	O
heparan	O
sulfate	O
proteoglycans	O
for	O
attachment	O
to	O
target	B-ANAT
cells	I-ANAT
.	O

Previous	O
studies	O
showed	O
that	O
HCoV	O
-	O
NL63	O
and	O
the	O
genetically	O
distant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
employ	O
the	O
same	O
receptor	O
for	O
host	B-ANAT
cell	I-ANAT
entry	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
but	O
it	O
is	O
largely	O
unclear	O
whether	O
ACE2	O
interactions	O
are	O
sufficient	O
to	O
allow	O
HCoV	O
-	O
NL63	O
binding	O
to	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Human	O
coronavirus	O
(	O
HCoV	O
),	O
a	O
member	O
of	O
Coronaviridae	O
family	O
,	O
is	O
the	O
causative	O
agent	O
of	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
and	O
""""	O
atypical	O
pneumonia	O
"""."	O

TITLE	O
:	O
Successful	O
treatment	O
of	O
Panton	O
-	O
Valentine	O
leukocidin	O
-	O
expressing	O
Staphylococcus	O
aureus	O
-	O
associated	O
pneumonia	O
co	O
-	O
infected	O
with	O
influenza	O
using	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

She	O
had	O
a	O
medical	O
history	O
of	O
osteosarcoma	O
of	O
the	O
leg	B-ANAT
and	O
hyperthyroidism	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
failure	O
as	O
a	O
rare	O
complication	O
of	O
celiac	B-ANAT
plexus	I-ANAT
block	O
in	O
a	O
patient	O
with	O
adenocarcinoma	O
of	O
the	O
ampulla	B-ANAT
of	I-ANAT
vater	I-ANAT
.	O

To	O
compare	O
the	O
full	O
-	O
length	O
genome	O
sequences	O
of	O
the	O
Chinese	O
IBV	O
strain	O
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
and	O
its	O
embryo	B-ANAT
-	O
passaged	O
,	O
attenuated	O
level	O
to	O
identify	O
sequence	O
substitutions	O
responsible	O
for	O
the	O
attenuation	O
and	O
define	O
markers	O
of	O
attenuation	O
.	O

This	O
protein	B-ANAT
complex	I-ANAT
is	O
a	O
fascinating	O
example	O
of	O
the	O
functional	O
integration	O
of	O
RNA	O
polymerase	O
,	O
capping	O
,	O
and	O
proofreading	O
activities	O
.	O

An	O
increasing	O
body	B-ANAT
of	O
evidence	O
suggests	O
that	O
STING	O
also	O
modulates	O
responses	O
to	O
RNA	O
viruses	O
,	O
though	O
the	O
mechanisms	O
remain	O
less	O
clear	O
.	O

The	O
outcome	O
measurements	O
included	O
mortality	O
rate	O
,	O
cure	O
rate	O
,	O
resolution	O
of	O
pulmonary	B-ANAT
infiltrate	O
,	O
use	O
of	O
corticosteroid	O
,	O
and	O
time	O
to	O
defervescence	O
.	O

Interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
),	O
as	O
a	O
proinflammatory	O
mediator	O
causing	O
recruitment	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
,	O
induces	O
an	O
increase	O
in	O
oxidant	O
stress	O
mediators	O
and	O
makes	O
it	O
as	O
a	O
key	O
parameter	O
for	O
localized	O
inflammation	O
.	O

In	O
addition	O
,	O
the	O
level	O
of	O
plasma	B-ANAT
vWF	O
was	O
positively	O
correlated	O
with	O
platelet	B-ANAT
count	O
,	O
but	O
negatively	O
correlated	O
with	O
oxygen	O
index	O
.	O

Consequently	O
,	O
we	O
have	O
hypothesized	O
that	O
germline	O
antibodies	O
may	O
not	O
bind	O
to	O
the	O
HIV	O
-	O
1	O
envelope	B-ANAT
glycoprotein	O
(	O
Env	O
)	O
because	O
they	O
are	O
so	O
different	O
compared	O
to	O
the	O
highly	O
somatically	O
mutated	O
HIV	O
-	O
1	O
-	O
specific	O
bnAbs	O
.	O

However	O
,	O
guiding	O
the	O
immune	B-ANAT
system	I-ANAT
through	O
the	O
exceptionally	O
complex	O
antibody	O
maturation	O
pathways	O
to	O
elicit	O
known	O
bnAbs	O
remains	O
a	O
major	O
challenge	O
.	O

In	O
addition	O
to	O
being	O
able	O
to	O
detect	O
the	O
presence	O
of	O
IBV	O
vaccine	O
and	O
wild	O
-	O
type	O
strains	O
by	O
ARMS	B-ANAT
RT	O
-	O
PCR	O
,	O
the	O
IBV	O
Mass	O
,	O
IBV	O
H120	O
,	O
IBV	O
TW	O
-	O
I	O
,	O
and	O
IBV	O
TW	O
-	O
II	O
strains	O
were	O
distinguished	O
using	O
ARMS	B-ANAT
qRT	O
-	O
PCR	O
by	O
their	O
melting	O
temperatures	O
and	O
by	O
HRMA	O
.	O

TITLE	O
:	O
Combined	O
use	O
of	O
non	O
-	O
biological	O
artificial	O
liver	B-ANAT
treatments	O
for	O
patients	O
with	O
acute	O
liver	B-ANAT
failure	O
complicated	O
by	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

Thirty	O
-	O
one	O
patients	O
with	O
mid	O
-	O
or	O
late	O
-	O
stage	O
liver	B-ANAT
failure	O
complicated	O
by	O
MODS	O
(	O
score	O
4	O
)	O
were	O
randomly	O
divided	O
into	O
three	O
treatment	O
groups	O
:	O
plasmapheresis	O
(	O
PE	O
)	O
combined	O
with	O
hemoperfusion	O
(	O
HP	O
)	O
and	O
continuous	O
venovenous	O
hemodiafiltration	O
(	O
CVVHDF	O
),	O
PE	O
+	O
CVVHDF	O
,	O
and	O
HP	O
+	O
CVVHDF	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Apoptosis	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
(	O
AMs	O
)	O
plays	O
a	O
pathogenic	O
role	O
in	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
type	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
investigated	O
the	O
effects	O
of	O
rat	B-ANAT
bone	I-ANAT
marrow	I-ANAT
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
BMSCs	O
)	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
apoptosis	O
in	O
AMs	O
using	O
transwell	O
experiments	O
,	O
and	O
examined	O
the	O
underlying	O
mechanisms	O
LPS	O
induced	O
AMs	O
apoptosis	O
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
fashion	O
,	O
whereas	O
BMSCs	O
reduced	O
AMs	O
apoptosis	O
when	O
co	O
-	O
cultured	O
at	O
appropriate	O
ratios	O
.	O

Patients	O
having	O
more	O
than	O
three	O
days	O
history	O
of	O
fever	O
,	O
leucocytosis	O
,	O
severe	O
thrombocytopaenia	O
and	O
renal	B-ANAT
failure	O
are	O
more	O
likely	O
to	O
require	O
either	O
prolonged	O
hospitalization	O
and	O
/	O
or	O
intensive	O
care	O
.	O

At	O
the	O
calf	B-ANAT
level	O
,	O
the	O
odds	O
of	O
C	O
.	O
parvum	O
shedding	O
and	O
of	O
co	O
-	O
infection	O
with	O
any	O
combination	O
of	O
pathogens	O
were	O
greater	O
in	O
calves	O
that	O
were	O
9	O
-	O
21	O
than	O
1	O
-	O
5	O
days	O
-	O
old	O
.	O

ABSTRACT	O
:	O
WHEN	O
AN	O
ANTIVIRAL	O
IMMUNE	O
RESPONSE	O
IS	O
GENERATED	O
,	O
A	O
BALANCE	O
MUST	O
BE	O
REACHED	O
BETWEEN	O
TWO	O
OPPOSING	O
PATHWAYS	O
:	O
the	O
production	O
of	O
proinflammatory	O
and	O
cytotoxic	O
effectors	O
that	O
drive	O
a	O
robust	O
antiviral	O
immune	O
response	O
to	O
control	O
the	O
infection	O
and	O
regulators	O
that	O
function	O
to	O
limit	O
or	O
blunt	O
an	O
excessive	O
immune	O
response	O
to	O
minimize	O
immune	O
-	O
mediated	O
pathology	O
and	O
repair	O
tissue	B-ANAT
damage	O
.	O

Comparative	O
sequence	O
analyses	O
of	O
viral	O
RNA	O
extracted	O
from	O
intestinal	B-ANAT
tissues	B-ANAT
revealed	O
CCoV	O
-	O
II	O
genotype	O
in	O
9	O
out	O
of	O
11	O
puppies	O
.	O

Serum	B-ANAT
SP	O
-	O
A	O
levels	O
in	O
Baseline	O
,	O
SO	O
group	O
,	O
SAP	O
group	O
,	O
ARDS	O
group	O
,	O
and	O
non	O
-	O
ARDS	O
group	O
were	O
43	O
.	O
15	O
Â±	O
14	O
.	O
29	O
,	O
51	O
.	O
91	O
Â±	O
16	O
.	O
99	O
,	O
193	O
.	O
4	O
Â±	O
35	O
.	O
37	O
,	O
198	O
.	O
0	O
+	O
29	O
.	O
73	O
,	O
and	O
185	O
.	O
7	O
Â±	O
43	O
.	O
21	O
ug	O
/	O
ml	O
,	O
respectively	O
.	O

TITLE	O
:	O
Ca2	B-ANAT
+	I-ANAT
influx	O
and	O
ATP	O
release	O
mediated	O
by	O
mechanical	O
stretch	O
in	O
human	O
lung	B-ANAT
fibroblasts	B-ANAT
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
pulmonary	B-ANAT
support	O
procedures	O
in	O
intensive	O
care	O
medicine	O
2014	O
].	O

RESULTS	O
:	O
The	O
VV	O
-	O
ECMO	O
systems	O
may	O
be	O
indicated	O
in	O
severe	O
,	O
refractory	O
and	O
predominantly	O
hypoxemic	O
lung	B-ANAT
failure	O
(	O
pAO2	O
/	O
FIO2	O
<	O
80	O
mmHg	O
).	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
characterized	O
by	O
proteinaceous	O
pulmonary	B-ANAT
edema	O
and	O
severe	O
arterial	B-ANAT
hypoxemia	O
with	O
a	O
mortality	O
of	O
approximately	O
40	O
%.	O

In	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
insulin	O
increased	O
the	O
expression	O
of	O
Î±	O
-,	O
Î²	O
-,	O
and	O
Î³	O
-	O
ENaC	O
,	O
which	O
was	O
blocked	O
by	O
the	O
mammalian	O
target	O
of	O
rapamycin	O
complex	O
2	O
(	O
mTORC2	B-ANAT
)	O
inhibitor	O
or	O
knockdown	O
of	O
Rictor	O
(	O
a	O
necessary	O
component	O
of	O
mTORC2	B-ANAT
),	O
and	O
SGK1	O
inhibitor	O
,	O
respectively	O
.	O

The	O
data	O
revealed	O
that	O
during	O
ALI	O
,	O
insulin	O
stimulates	O
alveolar	B-ANAT
fluid	O
clearance	O
by	O
upregulating	O
the	O
expression	O
of	O
Î±	O
-,	O
Î²	O
-,	O
and	O
Î³	O
-	O
ENaC	O
at	O
the	O
cell	B-ANAT
surface	I-ANAT
,	O
which	O
was	O
,	O
at	O
least	O
,	O
partially	O
through	O
activating	O
mTROC2	O
/	O
SGK1	O
signaling	O
pathway	O
.	O

The	O
only	O
common	O
and	O
strong	O
association	O
identified	O
between	O
the	O
various	O
GWAS	O
case	O
configurations	O
was	O
for	O
the	O
34	O
.	O
7	O
-	O
45	O
.	O
8Mb	O
region	B-ANAT
of	I-ANAT
chromosome	I-ANAT
A3	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
efficacy	O
of	O
the	O
treatment	O
of	O
severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
using	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
CRRT	O
)	O
by	O
evaluating	O
the	O
effect	O
of	O
CRRT	O
on	O
respiratory	O
and	O
circulatory	O
function	O
as	O
well	O
as	O
serum	B-ANAT
cytokines	O
level	O
.	O

Peak	O
inspiratory	O
pressure	O
and	O
pulmonary	B-ANAT
compliance	O
were	O
also	O
recorded	O
.	O

Arterial	B-ANAT
oxygen	O
tension	O
(	O
PaO2	O
),	O
oxygenation	O
index	O
(	O
OI	O
)	O
as	O
well	O
as	O
dynamic	O
pulmonary	B-ANAT
compliance	O
were	O
all	O
elevated	O
significantly	O
,	O
whereas	O
peak	O
inspiratory	O
pressure	O
significantly	O
decreased	O
at	O
6h	O
,	O
12h	O
and	O
24h	O
after	O
CRRT	O
respectively	O
;	O
serum	B-ANAT
cytokine	O
level	O
and	O
CRP	O
significantly	O
decreased	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
this	O
review	O
,	O
we	O
discuss	O
the	O
importance	O
of	O
the	O
innate	O
immune	O
response	O
and	O
the	O
development	O
of	O
lung	B-ANAT
pathology	O
following	O
human	O
coronavirus	O
infection	O
.	O

The	O
established	O
method	O
had	O
a	O
good	O
linear	O
correlation	O
from	O
7	O
.	O
77	O
x	O
10	O
(	O
8	O
)	O
to	O
10	O
(	O
0	O
)	O
copies	O
/	O
microL	O
.	O
SPF	O
chickens	O
developed	O
typical	O
clinical	O
signs	O
of	O
IBV	O
at	O
the	O
4th	O
dpi	O
,	O
and	O
the	O
IBV	O
viral	O
concentration	O
of	O
tissues	B-ANAT
and	O
organs	B-ANAT
gradually	O
increased	O
with	O
a	O
peak	O
of	O
up	O
to	O
7	O
.	O
13	O
x	O
10	O
(	O
4	O
)	O
copies	O
/	O
microL	O
.	O
The	O
viral	O
concentration	O
of	O
most	O
organs	B-ANAT
decreased	O
by	O
the	O
10th	O
dpi	O
,	O
but	O
those	O
of	O
the	O
kidney	B-ANAT
,	O
trachea	B-ANAT
and	O
lung	B-ANAT
remained	O
positive	O
for	O
IBV	O
at	O
28	O
dpi	O
and	O
the	O
heart	B-ANAT
was	O
still	O
positive	O
for	O
IBV	O
at	O
>	O
35	O
dpi	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
and	O
life	O
-	O
threatening	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
that	O
is	O
caused	O
by	O
noxious	O
stimuli	O
and	O
pathogens	O
.	O

For	O
ex	O
vivo	O
experiments	O
,	O
alveolar	B-ANAT
macrophages	I-ANAT
were	O
harvested	O
from	O
untreated	O
WT	O
and	O
Spred	O
-	O
2	O
(-/-)	O
mice	O
and	O
stimulated	O
with	O
LPS	O
.	O

Specific	O
knock	O
down	O
of	O
Spred	O
-	O
2	O
augmented	O
LPS	O
-	O
induced	O
cytokine	O
and	O
chemokine	O
responses	O
in	O
RAW264	O
.	O
7	O
cells	B-ANAT
and	O
MLE	O
-	O
12	O
cells	B-ANAT
,	O
whereas	O
Spred	O
-	O
2	O
overexpression	O
decreased	O
this	O
response	O
in	O
RAW264	O
.	O
7	O
cells	B-ANAT
.	O

In	O
elderly	O
nursing	O
home	O
residents	O
,	O
high	O
CMV	O
-	O
reactive	O
CD4	O
+	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
were	O
associated	O
with	O
an	O
increased	O
risk	O
and	O
high	O
T	O
-	O
regs	O
were	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
respiratory	O
viral	O
infection	O
.	O

This	O
report	O
describes	O
timing	O
of	O
antibody	O
generation	O
and	O
disease	O
progression	O
following	O
infection	O
with	O
a	O
US	O
PEDV	O
isolate	O
by	O
assessing	O
fecal	B-ANAT
viral	O
shedding	O
,	O
morphometric	O
analysis	O
of	O
intestinal	B-ANAT
lesions	O
,	O
and	O
magnitude	O
of	O
immunohistochemical	O
staining	O
.	O

TITLE	O
:	O
Innate	O
receptors	O
and	O
cellular	B-ANAT
defense	O
against	O
pulmonary	B-ANAT
infections	O
.	O

We	O
report	O
here	O
a	O
carbohydrate	O
microarray	O
analysis	O
of	O
a	O
number	O
of	O
tumor	O
-	O
associated	O
carbohydrates	O
for	O
their	O
serum	B-ANAT
antibody	O
reactivities	O
and	O
potential	O
immunogenicity	O
in	O
humans	O
.	O

The	O
findings	O
of	O
this	O
investigation	O
,	O
as	O
well	O
as	O
associated	O
ancillary	O
studies	O
,	O
will	O
be	O
disseminated	O
in	O
the	O
form	O
of	O
oral	B-ANAT
and	O
abstract	O
presentations	O
at	O
major	O
national	O
and	O
international	O
medical	O
specialty	O
meetings	O
.	O

ABSTRACT	O
:	O
In	O
September	O
2012	O
a	O
novel	O
coronavirus	O
(	O
CoV	O
)	O
caused	O
severe	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
patients	O
from	O
The	O
Arabian	O
Peninsula	O
.	O

Analyzing	O
only	O
patients	O
with	O
severe	O
hypoxemia	O
(	O
i	O
.	O
e	O
.,	O
a	O
ratio	O
of	O
partial	O
oxygen	O
pressure	O
in	O
the	O
blood	B-ANAT
to	O
the	O
fraction	O
of	O
inspired	O
oxygen	O
<	O
100	O
mmHg	O
),	O
the	O
increased	O
cost	O
was	O
R	O
$=-	O
5	O
,	O
714	O
.	O
00	O
/	O
272	O
.	O
00	O
,	O
with	O
a	O
cost	O
per	O
six	O
-	O
month	O
quality	O
-	O
adjusted	O
life	O
-	O
year	O
gained	O
of	O
R	O
$=-	O
9	O
,	O
521	O
.	O
00	O
/	O
293	O
.	O
00	O
and	O
a	O
cost	O
of	O
R	O
$=-	O
280	O
.	O
00	O
/	O
7	O
.	O
00	O
per	O
quality	O
-	O
adjusted	O
life	O
-	O
year	O
gained	O
.	O

The	O
cost	O
-	O
utility	O
ratio	O
associated	O
with	O
the	O
use	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
Brazil	O
is	O
potentially	O
acceptable	O
according	O
to	O
this	O
hypothetical	O
study	O
.	O

Maximum	O
enrolled	O
children	O
were	O
of	O
viral	O
encephalitis	O
(	O
46	O
.	O
59	O
%)	O
and	O
rest	O
,	O
were	O
of	O
pyogenic	O
meningitis	O
,	O
tuberculosis	O
meningitis	O
and	O
cerebral	B-ANAT
malaria	O
.	O

Accumulating	O
evidence	O
has	O
shown	O
that	O
coronavirus	O
infection	O
causes	O
ER	O
stress	O
and	O
induces	O
UPR	O
in	O
the	O
infected	O
cells	B-ANAT
.	O

Demographic	O
data	O
,	O
severity	O
scores	O
,	O
clinical	O
,	O
hemodynamic	O
,	O
pulmonary	B-ANAT
,	O
metabolic	O
and	O
renal	B-ANAT
function	O
data	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
a	O
virulent	O
TGEV	O
SHXB	O
strain	O
could	O
infect	O
porcine	O
immature	B-ANAT
monocyte	I-ANAT
-	O
derived	O
dendritic	B-ANAT
cells	I-ANAT
(	O
Mo	O
-	O
DCs	O
),	O
and	O
down	O
-	O
regulate	O
cell	B-ANAT
surface	I-ANAT
markers	O
(	O
SLA	O
-	O
II	O
-	O
DR	O
,	O
CD1a	O
and	O
CD80	O
/	O
86	O
).	O

In	O
this	O
study	O
50	O
clinically	O
normal	O
and	O
50	O
cats	O
with	O
cutaneous	O
and	O
/	O
or	O
systemic	O
signs	O
that	O
lived	O
in	O
an	O
endemic	O
area	O
and	O
had	O
been	O
previously	O
examined	O
for	O
infection	O
by	O
L	O
.	O
infantum	O
using	O
PCR	O
in	O
four	O
different	O
tissues	B-ANAT
were	O
serologically	O
tested	O
for	O
the	O
presence	O
of	O
anti	O
-	O
Leishmania	O
IgG	O
(	O
IFAT	O
and	O
ELISA	O
)	O
and	O
IgM	O
(	O
IFAT	O
).	O

TITLE	O
:	O
Sustainable	O
reduction	O
of	O
nasal	B-ANAT
colonization	O
and	O
hand	O
contamination	O
with	O
Staphylococcus	O
aureus	O
in	O
food	O
handlers	O
,	O
2002	O
-	O
2011	O
.	O

In	O
2011	O
,	O
nasal	B-ANAT
carriage	O
was	O
similar	O
to	O
2003	O
(	O
22	O
Â·	O
9	O
%),	O
while	O
hand	O
contamination	O
dropped	O
further	O
to	O
3	O
Â·	O
7	O
%	O
(	O
P	O
<	O
0	O
Â·	O
001	O
).	O

It	O
causes	O
two	O
syndromes	O
:	O
hemorrhagic	O
fever	O
with	O
renal	B-ANAT
syndrome	O
(	O
HFRS	O
),	O
endemic	O
in	O
Asia	O
and	O
Europe	O
and	O
the	O
Hantavirus	O
pulmonary	B-ANAT
syndrome	O
(	O
HPS	O
),	O
found	O
in	O
the	O
American	O
continent	O
,	O
including	O
Brazil	O
,	O
with	O
high	O
mortality	O
rates	O
.	O

The	O
maximum	O
effect	O
of	O
EFS	O
was	O
not	O
significantly	O
different	O
between	O
CIE	O
and	O
control	O
bladders	B-ANAT
.	O

In	O
response	O
to	O
EFS	O
,	O
the	O
Î±	O
,	O
Î²	O
-	O
methylene	O
ATP	O
-	O
resistant	O
(	O
cholinergic	O
)	O
component	O
of	O
contraction	O
was	O
significantly	O
reduced	O
,	O
while	O
the	O
atropine	O
-	O
resistant	O
(	O
purinergic	O
)	O
component	O
was	O
significantly	O
increased	O
in	O
CIE	O
bladders	B-ANAT
.	O

Our	O
data	O
demonstrate	O
a	O
deficit	O
in	O
the	O
nerve	B-ANAT
-	O
evoked	O
cholinergic	O
component	O
of	O
contraction	O
that	O
is	O
not	O
due	O
to	O
the	O
ability	O
of	O
the	O
smooth	B-ANAT
muscle	I-ANAT
to	O
respond	O
to	O
acetylcholine	O
.	O

The	O
data	O
were	O
collected	O
by	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
interviews	O
in	O
the	O
period	O
of	O
October	O
2005	O
to	O
March	O
2006	O
.	O

Treatment	O
consisted	O
of	O
immediate	O
administration	O
of	O
intravenous	O
acyclovir	O
and	O
a	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategy	O
.	O

The	O
severity	O
form	O
of	O
the	O
disease	O
is	O
caused	O
,	O
mainly	O
by	O
P	O
.	O
falciparum	O
and	O
may	O
occur	O
together	O
with	O
cerebral	B-ANAT
,	O
kidney	B-ANAT
,	O
pulmonary	B-ANAT
,	O
hematologic	O
,	O
circulatory	O
and	O
hepatic	B-ANAT
complications	O
.	O

A	O
30	O
-	O
years	O
-	O
old	O
man	O
,	O
mulatto	O
,	O
Philippine	O
,	O
sailor	O
,	O
coming	O
from	O
a	O
ship	O
arriving	O
from	O
Nigeria	O
,	O
with	O
a	O
history	O
of	O
abdominal	B-ANAT
pain	O
on	O
the	O
right	B-ANAT
hypochondrium	I-ANAT
,	O
jaundice	O
,	O
fever	O
,	O
decreased	O
in	O
the	O
consciousness	O
.	O

Bovine	O
coronavirus	O
(	O
BCoV	O
)	O
was	O
detected	O
in	O
93	O
fecal	B-ANAT
samples	O
collected	O
from	O
46	O
calves	O
(	O
68	O
.	O
6	O
%).	O

Here	O
,	O
we	O
show	O
that	O
the	O
membrane	B-ANAT
-	O
associated	O
papain	O
-	O
like	O
protease	O
PLP2	O
(	O
PLP2	O
-	O
TM	O
)	O
of	O
coronaviruses	O
acts	O
as	O
a	O
novel	O
autophagy	O
-	O
inducing	O
protein	O
.	O

In	O
addition	O
,	O
H9N2	O
viral	O
infection	O
resulted	O
in	O
severe	O
progressive	O
hypoxemia	O
,	O
lymphopenia	O
,	O
and	O
a	O
significant	O
increase	O
in	O
interleukin	O
1	O
,	O
interleukin	O
6	O
,	O
tumor	O
necrosis	O
factor	O
,	O
and	O
interferon	O
in	O
BALF	O
and	O
serum	B-ANAT
.	O

In	O
addition	O
,	O
H9N2	O
viral	O
infection	O
resulted	O
in	O
severe	O
progressive	O
hypoxemia	O
,	O
lymphopenia	O
,	O
and	O
a	O
significant	O
increase	O
in	O
interleukin	O
1	O
,	O
interleukin	O
6	O
,	O
tumor	O
necrosis	O
factor	O
,	O
and	O
interferon	O
in	O
BALF	O
and	O
serum	B-ANAT
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
obtained	O
from	O
162	O
individuals	O
between	O
August	O
2007	O
-	O
August	O
2009	O
.	O

Survival	O
to	O
hospital	O
discharge	B-ANAT
was	O
the	O
dependent	O
variable	O
.	O

ABSTRACT	O
:	O
Toxic	O
epidermal	B-ANAT
necrosis	O
is	O
a	O
severe	O
mucocutaneous	O
disease	O
with	O
a	O
high	O
mortality	O
rate	O
.	O

The	O
intraperitoneal	O
pressure	O
measured	O
with	O
a	O
drainage	B-ANAT
catheter	O
was	O
31	O
mm	O
Hg	O
.	O

After	O
abdominal	B-ANAT
decompression	O
,	O
the	O
multiorgan	O
failure	O
was	O
reversed	O
.	O

RIP3	O
was	O
detectable	O
in	O
the	O
plasma	B-ANAT
of	O
patients	O
with	O
severe	O
sepsis	O
,	O
and	O
was	O
increased	O
with	O
blood	B-ANAT
transfusion	O
and	O
among	O
nonsurvivors	O
of	O
sepsis	O
.	O

ABSTRACT	O
:	O
The	O
systemic	O
vasculitides	O
are	O
multifocal	O
diseases	O
characterized	O
by	O
the	O
presence	O
of	O
blood	B-ANAT
vessel	I-ANAT
inflammation	O
in	O
multiple	O
organ	B-ANAT
systems	I-ANAT
.	O

TITLE	O
:	O
Proteome	O
profile	O
of	O
swine	O
testicular	O
cells	B-ANAT
infected	O
with	O
porcine	O
transmissible	O
gastroenteritis	O
coronavirus	O
.	O

ABSTRACT	O
:	O
The	O
interactions	O
occurring	O
between	O
a	O
virus	O
and	O
a	O
host	B-ANAT
cell	I-ANAT
during	O
a	O
viral	O
infection	O
are	O
complex	O
.	O

ABSTRACT	O
:	O
The	O
factors	O
influencing	O
the	O
outcome	O
of	O
infectious	O
bronchitis	O
vaccination	O
and	O
challenge	O
experiments	O
regarding	O
the	O
respiratory	O
and	O
renal	B-ANAT
systems	O
are	O
reviewed	O
.	O

Besides	O
symptoms	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
(	O
asthma	O
,	O
nasal	B-ANAT
polyps	O
,	O
eosinophilic	O
lung	B-ANAT
infiltrations	O
)	O
also	O
cardiovascular	B-ANAT
symptoms	O
,	O
gastrointestinal	B-ANAT
tract	I-ANAT
symptoms	O
,	O
as	O
well	O
as	O
skin	B-ANAT
lesions	O
and	O
kidneys	B-ANAT
involvement	O
can	O
appear	O
.	O

The	O
most	O
dangerous	O
for	O
patients	O
is	O
involvement	O
of	O
the	O
nervous	O
and	O
cardiovascular	B-ANAT
systems	I-ANAT
.	O

We	O
present	O
a	O
patient	O
with	O
asthma	O
and	O
eosinophilia	O
in	O
whom	O
EGPA	O
was	O
diagnosed	O
in	O
the	O
course	O
of	O
acute	O
recurrent	O
substernal	O
chest	B-ANAT
pain	O
,	O
with	O
subsequent	O
signs	O
of	O
cardiac	B-ANAT
insufficiency	O
.	O

ABSTRACT	O
:	O
Because	O
of	O
technological	O
advancements	O
and	O
encouraging	O
experiences	O
during	O
the	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
epidemic	O
,	O
many	O
critical	O
care	O
clinicians	O
consider	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
a	O
reasonable	O
strategy	O
for	O
managing	O
patients	O
with	O
refractory	O
hypoxemia	O
when	O
standardized	O
therapies	O
have	O
failed	O
.	O

This	O
study	O
is	O
the	O
first	O
to	O
show	O
that	O
MBL	O
expression	O
is	O
present	O
in	O
the	O
lungs	B-ANAT
of	O
healthy	O
chickens	O
and	O
that	O
the	O
expression	O
is	O
upregulated	O
at	O
days	O
3	O
postinfection	O
(	O
p	O
.	O
i	O
.)	O
in	O
L10H	O
chickens	O
.	O

Furthermore	O
,	O
at	O
week	O
3	O
p	O
.	O
i	O
.,	O
the	O
number	O
of	O
monocytes	B-ANAT
was	O
higher	O
in	O
infected	O
and	O
noninfected	O
L10H	O
chickens	O
than	O
in	O
the	O
infected	O
and	O
noninfected	O
L10L	O
chickens	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
manifestation	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
well	O
-	O
known	O
illnesses	O
.	O

Uncontrolled	O
and	O
self	O
-	O
amplified	O
pulmonary	B-ANAT
inflammation	O
lies	O
at	O
the	O
center	O
of	O
the	O
pathology	O
of	O
this	O
disease	O
.	O

After	O
72	O
h	O
of	O
LPS	O
stimulation	O
,	O
pulmonary	B-ANAT
pathological	O
changes	O
,	O
lung	B-ANAT
injury	O
scores	O
,	O
pulmonary	B-ANAT
edema	O
,	O
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
,	O
total	O
cells	B-ANAT
,	O
neutrophils	B-ANAT
,	O
macrophages	B-ANAT
,	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
1Î²	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
),	O
and	O
MCP	O
-	O
1	O
and	O
E	O
-	O
selectin	O
expression	O
were	O
notably	O
attenuated	O
by	O
emodin	O
in	O
mice	O
.	O

ABSTRACT	O
:	O
Endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)-	O
resident	O
glucosidases	O
I	O
and	O
II	O
sequentially	O
trim	O
the	O
three	O
terminal	O
glucose	O
moieties	O
on	O
the	O
N	O
-	O
linked	O
glycans	O
attached	O
to	O
nascent	O
glycoproteins	O
.	O

It	O
is	O
therefore	O
possible	O
that	O
inhibition	O
of	O
ER	O
glucosidases	O
not	O
only	O
compromises	O
virion	B-ANAT
production	O
but	O
also	O
disrupts	O
expression	O
and	O
function	O
of	O
viral	O
receptors	O
and	O
thus	O
inhibits	O
virus	O
entry	O
into	O
host	O
cells	B-ANAT
.	O

TITLE	O
:	O
Determination	O
of	O
'	O
recruited	O
volume	O
'	O
following	O
a	O
PEEP	O
step	O
is	O
not	O
a	O
measure	O
of	O
lung	B-ANAT
recruitability	O
.	O

We	O
assessed	O
baseline	O
data	O
,	O
hospital	O
mortality	O
,	O
time	O
on	O
ECMO	O
,	O
hemoglobin	O
levels	O
,	O
hematocrit	O
,	O
quantities	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
received	O
,	O
and	O
lactate	O
concentrations	O
and	O
compared	O
survivors	O
and	O
nonsurvivors	O
.	O

Patients	O
were	O
assigned	O
to	O
the	O
PCT	O
elevated	O
cohort	O
or	O
the	O
control	O
cohort	O
based	O
on	O
serum	B-ANAT
PCT	O
concentrations	O
on	O
the	O
first	O
postoperative	O
day	O
with	O
a	O
cut	O
-	O
off	O
value	O
of	O
7	O
.	O
0	O
ng	O
/	O
mL	O
.	O
Data	O
,	O
including	O
baseline	O
,	O
perioperative	O
and	O
outcome	O
data	O
,	O
were	O
collected	O
daily	O
for	O
7	O
days	O
.	O

The	O
lungs	B-ANAT
of	O
the	O
3	O
dogs	O
submitted	O
for	O
necropsy	O
were	O
diffusely	O
and	O
severely	O
reddened	O
due	O
to	O
hyperemia	O
and	O
hemorrhage	O
.	O

Protein	O
analysis	O
of	O
spinal	B-ANAT
cord	I-ANAT
extracts	O
taken	O
from	O
mice	O
6	O
days	O
post	O
-	O
inoculation	O
,	O
the	O
time	O
of	O
peak	O
inflammation	O
,	O
reveals	O
robust	O
expression	O
of	O
IFN	O
-	O
Î³	O
,	O
IL	O
-	O
12	O
and	O
mKC	O
.	O

In	O
this	O
case	O
,	O
lung	B-ANAT
recruitment	O
maneuver	O
(	O
RM	O
)	O
with	O
positive	O
end	O
-	O
expiratory	O
pressure	O
under	O
computed	O
tomography	O
guidance	O
is	O
the	O
procedure	O
of	O
choice	O
,	O
but	O
cumulative	O
ionizing	O
radiation	O
exposure	O
is	O
a	O
major	O
radiologic	O
concern	O
,	O
especially	O
in	O
infants	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
role	O
of	O
ultraprotective	O
mechanical	O
ventilation	O
(	O
UP	O
-	O
MV	O
)	O
and	O
extracorporeal	O
carbon	O
dioxide	O
removal	O
with	O
and	O
without	O
spontaneous	O
breathing	O
(	O
SB	O
)	O
to	O
improve	O
respiratory	O
function	O
and	O
lung	B-ANAT
protection	O
in	O
experimental	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

During	O
UP	O
-	O
MV	O
,	O
pressure	O
supported	O
SB	O
increased	O
lung	B-ANAT
inflammation	O
.	O

TITLE	O
:	O
Multiple	O
bilateral	O
branch	B-ANAT
retinal	B-ANAT
artery	I-ANAT
occlusions	O
in	O
a	O
patient	O
with	O
sickle	B-ANAT
cell	I-ANAT
disease	O
with	O
vancomycin	O
red	O
man	O
syndrome	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
virus	O
that	O
manifests	O
itself	O
in	O
viral	O
infection	O
with	O
fever	O
,	O
cough	O
,	O
shortness	O
of	O
breath	B-ANAT
,	O
renal	B-ANAT
failure	O
and	O
severe	O
acute	O
pneumonia	O
,	O
which	O
often	O
result	O
in	O
a	O
fatal	O
outcome	O
.	O

While	O
some	O
viruses	O
fuse	O
with	O
the	O
plasma	B-ANAT
membrane	I-ANAT
,	O
many	O
viruses	O
are	O
endocytosed	O
prior	O
to	O
fusion	O
.	O

Specific	O
cues	O
in	O
the	O
endosomal	O
microenvironment	O
induce	O
conformational	O
changes	O
in	O
the	O
viral	O
fusion	O
proteins	O
leading	O
to	O
viral	O
and	O
host	O
membrane	B-ANAT
fusion	O
.	O

Using	O
recombinant	O
MHVs	O
expressing	O
reporter	O
genes	O
as	O
well	O
as	O
a	O
novel	O
,	O
replication	O
-	O
independent	O
fusion	O
assay	O
we	O
confirmed	O
the	O
importance	O
of	O
clathrin	O
-	O
mediated	O
endocytosis	O
and	O
demonstrated	O
that	O
trafficking	O
of	O
MHV	O
to	O
lysosomes	B-ANAT
is	O
required	O
for	O
fusion	O
and	O
productive	O
entry	O
to	O
occur	O
.	O

We	O
show	O
that	O
the	O
prototypical	O
Gammacoronavirus	O
,	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
induces	O
a	O
delayed	O
activation	O
of	O
the	O
IFN	O
response	O
in	O
primary	O
renal	B-ANAT
cells	B-ANAT
,	O
tracheal	O
epithelial	B-ANAT
cells	I-ANAT
,	O
and	O
a	O
chicken	O
cell	B-ANAT
line	I-ANAT
.	O

In	O
addition	O
,	O
we	O
demonstrate	O
that	O
MDA5	O
is	O
the	O
primary	O
sensor	O
for	O
Gammacoronavirus	O
infections	O
in	O
chicken	B-ANAT
cells	I-ANAT
.	O

We	O
concluded	O
that	O
plasmoblastic	O
/	O
plasmocytoid	O
-	O
like	O
type	B-ANAT
II	I-ANAT
pneumocytes	I-ANAT
might	O
represent	O
a	O
morphologic	O
marker	O
of	O
A	O
/	O
H1N1	O
influenza	O
virus	O
infection	O
as	O
well	O
as	O
reparative	O
cellular	B-ANAT
activation	O
after	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Subsequently	O
,	O
in	O
weaned	O
animals	O
,	O
oral	B-ANAT
vaccines	O
incorporating	O
novel	O
mucosal	B-ANAT
adjuvants	O
(	O
e	O
.	O
g	O
.,	O
vitamin	O
A	O
,	O
probiotics	O
)	O
may	O
provide	O
active	O
protection	O
when	O
maternal	O
immunity	O
wanes	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
report	O
that	O
ACE2	O
could	O
mediate	O
the	O
severe	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	O
infection	O
in	O
an	O
experimental	O
mouse	O
model	O
.	O

TITLE	O
:	O
Structure	O
based	O
computational	O
assessment	O
of	O
channel	O
properties	O
of	O
assembled	O
ORF	O
-	O
8a	O
from	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
ORF	O
8a	O
is	O
a	O
short	O
39	O
amino	O
acid	O
bitopic	O
membrane	B-ANAT
protein	O
encoded	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
causing	O
corona	O
virus	O
(	O
SARS	O
-	O
CoV	O
).	O

Computational	O
models	O
of	O
a	O
pentameric	O
assembly	O
of	O
8a	O
peptides	O
are	O
generated	O
using	O
the	O
first	O
22	O
amino	O
acids	O
,	O
which	O
include	O
the	O
transmembrane	B-ANAT
domain	O
.	O

Among	O
recombinant	O
spike	O
S1	O
,	O
S2	O
,	O
S3	O
,	O
and	O
nucleocapsid	B-ANAT
N	O
protein	O
of	O
PEDV	O
,	O
S3	O
protein	O
presented	O
the	O
highest	O
antibody	O
level	O
in	O
the	O
K	O
/	O
K	O
group	O
.	O

When	O
respiratory	O
rate	O
>	O
30	O
beats	O
/	O
min	O
(	O
OR	O
=	O
3	O
.	O
305	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
910	O
-	O
5	O
.	O
721	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
heart	B-ANAT
rate	O
>	O
100	O
beats	O
/	O
min	O
(	O
OR	O
=	O
2	O
.	O
101	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
048	O
-	O
4	O
.	O
213	O
,	O
P	O
=	O
0	O
.	O
037	O
)	O
happened	O
in	O
critically	O
ill	O
patients	O
,	O
it	O
highly	O
suggested	O
ARDS	O
would	O
happen	O
.	O

Plasma	B-ANAT
levels	O
of	O
Ang	O
-	O
2	O
was	O
better	O
in	O
predicting	O
ARDS	O
than	O
APACHEII	O
score	O
,	O
SOFA	O
score	O
and	O
IL	O
-	O
6	O
.	O

RESULTS	O
:	O
Compared	O
with	O
non	O
-	O
ARDS	O
group	O
,	O
APACHEII	O
score	O
,	O
SOFA	O
score	O
,	O
LIS	O
score	O
,	O
mortality	O
were	O
significantly	O
increased	O
,	O
PaO2	O
/	O
FiO2	O
was	O
significantly	O
decreased	O
,	O
and	O
plasma	B-ANAT
Ang	O
-	O
2	O
,	O
IL	O
-	O
6	O
,	O
CRP	O
were	O
significantly	O
elevated	O
[	O
APACHEII	O
score	O
:	O
20	O
.	O
7	O
Â±	O
5	O
.	O
0	O
vs	O
.	O
14	O
.	O
1	O
Â±	O
5	O
.	O
3	O
,	O
SOFA	O
score	O
:	O
7	O
.	O
7	O
Â±	O
3	O
.	O
5	O
vs	O
.	O
3	O
.	O
5	O
Â±	O
2	O
.	O
1	O
,	O
LIS	O
score	O
:	O
1	O
.	O
69	O
Â±	O
0	O
.	O
71	O
vs	O
.	O
0	O
.	O
28	O
Â±	O
0	O
.	O
27	O
,	O
PaOâ	O
/	O
FiOâ	O
(	O
mmHg	O
,	O
1	O
mmHg	O
=	O
0	O
.	O
133	O
kPa	O
):	O
159	O
.	O
5	O
Â±	O
61	O
.	O
3	O
vs	O
.	O
394	O
.	O
0	O
Â±	O
3	O
.	O
2	O
,	O
mortality	O
:	O
45	O
.	O
3	O
%	O
(	O
24	O
/	O
53	O
)	O
vs	O
.	O
20	O
.	O
0	O
%	O
(	O
4	O
/	O
20	O
),	O
Ang	O
-	O
2	O
(	O
Î¼g	O
/	O
L	O
):	O
4	O
.	O
73	O
(	O
2	O
.	O
59	O
,	O
6	O
.	O
99	O
)	O
vs	O
.	O

ATF3	O
-	O
deficient	O
macrophages	B-ANAT
were	O
unable	O
to	O
limit	O
the	O
expression	O
of	O
pro	O
-	O
inflammatory	O
mediators	O
.	O

Despite	O
release	O
of	O
ATF3	O
-	O
dependent	O
Nrf2	O
transcriptional	O
inhibition	O
,	O
mice	O
that	O
lacked	O
ATF3	O
expression	O
in	O
resident	O
cells	B-ANAT
had	O
increased	O
Nrf2	O
protein	O
degradation	O
.	O

Finally	O
,	O
sequential	O
passage	O
of	O
MERS	O
-	O
CoV	O
in	O
permissive	O
bat	O
cells	B-ANAT
established	O
persistent	O
infection	O
with	O
concomitant	O
downregulation	O
of	O
CD26	O
/	O
DPP4	O
surface	O
expression	O
.	O

Nasopharyngeal	B-ANAT
swabs	O
and	O
sputum	B-ANAT
samples	O
were	O
assayed	O
for	O
16	O
respiratory	O
viruses	O
,	O
using	O
polymerase	O
chain	O
reaction	O
assays	O
.	O

In	O
this	O
work	O
,	O
we	O
used	O
a	O
metagenomic	O
approach	O
and	O
deep	O
sequencing	O
to	O
examine	O
respiratory	B-ANAT
samples	I-ANAT
from	O
children	O
with	O
lower	O
and	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
that	O
had	O
been	O
previously	O
found	O
negative	O
for	O
6	O
bacteria	O
and	O
15	O
respiratory	O
viruses	O
by	O
PCR	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remains	O
an	O
unsolved	O
problem	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
),	O
which	O
can	O
be	O
treated	O
with	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
-	O
ECMO	O
).	O

In	O
a	O
univariate	O
analysis	O
median	O
platelet	B-ANAT
(	O
PLT	O
)	O
count	O
at	O
ICU	O
admission	O
(	O
162	O
vs	O
.	O
97	O
Ã	O
10	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
046	O
)	O
and	O
pre	O
-	O
day	O
1	O
(	O
118	O
.	O
5	O
vs	O
.	O
62	O
.	O
5	O
Ã	O
10	O
/	O
L	O
;	O
p	O
=	O
0	O
.	O
046	O
)	O
was	O
higher	O
in	O
the	O
ECMO	O
-	O
weaned	O
group	O
than	O
those	O
in	O
the	O
weaning	O
failure	O
group	O
.	O

ABSTRACT	O
:	O
Liver	B-ANAT
abscess	O
remains	O
a	O
life	O
-	O
threatening	O
disease	O
,	O
particularly	O
when	O
it	O
results	O
in	O
systemic	O
organ	B-ANAT
failure	O
necessitating	O
intensive	O
care	O
.	O

Here	O
we	O
present	O
a	O
case	O
of	O
liver	B-ANAT
abscess	O
with	O
rapid	O
progression	O
of	O
multiple	O
organ	B-ANAT
dysfunction	O
,	O
including	O
severe	O
acute	O
respiratory	O
failure	O
on	O
admission	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
).	O

Therefore	O
,	O
partitioning	O
respiratory	B-ANAT
system	I-ANAT
between	O
lungs	B-ANAT
and	O
chest	B-ANAT
wall	I-ANAT
at	O
the	O
bedside	O
is	O
useful	O
to	O
optimize	O
ventilator	O
settings	O
.	O

This	O
prospective	O
study	O
was	O
designed	O
to	O
compare	O
EL	O
assessed	O
by	O
lung	B-ANAT
barometry	O
(	O
ELLB	O
)	O
versus	O
esophageal	O
pressure	O
(	O
ELPeso	O
).	O

TITLE	O
:	O
Gardening	O
can	O
induce	O
pulmonary	B-ANAT
failure	O
:	O
Aspergillus	O
ARDS	O
in	O
an	O
immunocompetent	O
patient	O
,	O
a	O
case	O
report	O
.	O

Owing	O
to	O
her	O
severe	O
clinical	O
condition	O
,	O
she	O
was	O
treated	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
with	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

A	O
third	O
calf	B-ANAT
from	O
another	O
herd	O
died	O
and	O
was	O
necropsied	O
.	O

However	O
,	O
the	O
adaptive	O
immune	B-ANAT
system	I-ANAT
was	O
required	O
for	O
protection	O
since	O
N1347A	O
virus	O
was	O
able	O
to	O
cause	O
lethal	O
encephalitis	O
in	O
RAG1	O
(-/-)	O
(	O
recombination	O
activation	O
gene	O
1	O
knockout	O
)	O
mice	O
although	O
disease	O
onset	O
was	O
modestly	O
delayed	O
.	O

Understanding	O
the	O
mechanism	O
used	O
by	O
this	O
enzyme	O
to	O
promote	O
viral	O
pathogenesis	O
will	O
open	O
up	O
novel	O
avenues	O
for	O
therapies	O
and	O
may	O
give	O
further	O
insight	O
into	O
the	O
role	O
of	O
macrodomain	O
proteins	O
in	O
the	O
host	B-ANAT
cell	I-ANAT
since	O
these	O
proteins	O
are	O
found	O
in	O
all	O
living	O
organisms	O
.	O

(	O
1	O
)	O
Before	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
24	O
h	O
after	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
and	O
at	O
the	O
end	O
of	O
combining	O
lung	B-ANAT
recruitment	O
maneuver	O
,	O
the	O
levels	O
of	O
PaO2	O
and	O
OI	O
of	O
patients	O
were	O
respectively	O
(	O
77	O
Â±	O
8	O
),	O
(	O
113	O
Â±	O
5	O
),	O
(	O
142	O
Â±	O
6	O
)	O
mmHg	O
,	O
and	O
(	O
128	O
Â±	O
12	O
),	O
(	O
188	O
Â±	O
8	O
),	O
(	O
237	O
Â±	O
10	O
)	O
mmHg	O
.	O

(	O
3	O
)	O
The	O
patients	O
received	O
mechanical	O
ventilation	O
at	O
2	O
to	O
72	O
h	O
after	O
burn	O
,	O
lasting	O
for	O
14	O
-	O
32	O
(	O
21	O
Â±	O
13	O
)	O
d	O
.	O
At	O
post	O
injury	O
day	O
3	O
-	O
14	O
(	O
7	O
Â±	O
5	O
)	O
d	O
,	O
lung	B-ANAT
recruitment	O
maneuver	O
was	O
applied	O
for	O
2	O
-	O
5	O
(	O
3	O
.	O
0	O
Â±	O
2	O
.	O
0	O
)	O
d	O
.	O
All	O
15	O
patients	O
recovered	O
without	O
other	O
complications	O
.	O

In	O
28	O
patients	O
(	O
97	O
%)	O
a	O
veno	O
-	O
venous	B-ANAT
bypass	O
was	O
utilized	O
,	O
while	O
in	O
one	O
case	O
(	O
3	O
%)	O
a	O
Veno	O
-	O
Arterial	B-ANAT
cannulation	O
was	O
performed	O
.	O

Tryptase	O
levels	O
are	O
seldom	O
increased	O
because	O
of	O
infant	O
anaphylaxis	O
,	O
although	O
baseline	O
tryptase	O
levels	O
can	O
be	O
increased	O
in	O
the	O
first	O
few	O
months	O
of	O
life	O
,	O
reflecting	O
mast	B-ANAT
cell	I-ANAT
burden	O
in	O
the	O
developing	O
immune	B-ANAT
system	I-ANAT
.	O

TITLE	O
:	O
Survival	O
predictors	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Organ	B-ANAT
dysfunction	O
scores	O
before	O
and	O
during	O
ECMO	O
support	O
are	O
correlated	O
with	O
survival	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
abnormalities	O
occur	O
in	O
30	O
-	O
80	O
%	O
of	O
fatalities	O
after	O
burn	O
.	O

Protein	O
-	O
rich	O
alveolar	B-ANAT
edema	O
,	O
which	O
is	O
the	O
abnormality	O
that	O
leads	O
to	O
ARDS	O
,	O
may	O
occur	O
from	O
multiple	O
causes	O
,	O
including	O
inhalation	O
injury	O
.	O

TITLE	O
:	O
Noninvasive	O
mechanical	O
ventilation	O
in	O
high	O
-	O
risk	O
pulmonary	B-ANAT
infections	O
:	O
a	O
clinical	O
review	O
.	O

ABSTRACT	O
:	O
In	O
the	O
coronavirus	O
(	O
CoV	O
),	O
the	O
envelope	B-ANAT
spike	O
(	O
S	O
)	O
glycoprotein	O
is	O
responsible	O
for	O
CoV	O
cell	B-ANAT
entry	O
and	O
host	O
-	O
to	O
-	O
host	O
transmission	O
.	O

The	O
S	O
is	O
a	O
multifunctional	O
glycoprotein	O
that	O
mediates	O
both	O
attachment	O
of	O
CoV	O
particles	O
to	O
cell	B-ANAT
surface	I-ANAT
receptor	O
molecules	O
as	O
well	O
as	O
membrane	B-ANAT
penetration	O
by	O
fusion	O
.	O

This	O
research	O
has	O
provided	O
significant	O
new	O
insight	O
into	O
functions	O
and	O
activities	O
of	O
the	O
replication	O
/	O
transcription	O
multi	O
-	O
protein	B-ANAT
complex	I-ANAT
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
),	O
a	O
novel	O
coronavirus	O
that	O
causes	O
a	O
severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
humans	O
,	O
emerged	O
in	O
the	O
Middle	O
East	O
in	O
2012	O
.	O

HCoVs	O
were	O
present	O
in	O
the	O
stools	B-ANAT
of	O
eight	O
(	O
4	O
.	O
7	O
%)	O
of	O
the	O
172	O
children	O
with	O
AGE	O
;	O
in	O
six	O
of	O
these	O
cases	O
,	O
the	O
nasal	B-ANAT
swab	O
sample	O
was	O
also	O
positive	O
for	O
the	O
respective	O
HCoV	O
.	O
Additionally	O
,	O
in	O
six	O
of	O
the	O
eight	O
cases	O
,	O
the	O
stool	B-ANAT
sample	I-ANAT
contained	O
either	O
rotavirus	O
or	O
calicivirus	O
.	O

ABSTRACT	O
:	O
Bovine	O
plasma	B-ANAT
was	O
inoculated	O
with	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
at	O
an	O
average	O
final	O
titer	O
of	O
4	O
.	O
2	O
log10	O
TCID50	O
/	O
mL	O
to	O
determine	O
the	O
effect	O
of	O
spray	O
drying	O
on	O
viral	O
inactivation	O
.	O

PEDV	O
was	O
infective	O
in	O
1	O
out	O
of	O
5	O
samples	O
stored	O
at	O
12	O
Â°	O
C	O
at	O
7	O
days	O
,	O
but	O
none	O
of	O
the	O
samples	O
stored	O
for	O
14	O
and	O
21	O
days	O
were	O
infectious	O
in	O
cell	B-ANAT
culture	O
.	O

Severity	O
and	O
further	O
characteristics	O
of	O
ALI	O
/	O
ARDS	O
may	O
be	O
detected	O
by	O
biomarkers	O
in	O
the	O
plasma	B-ANAT
and	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
or	O
tracheal	B-ANAT
aspirate	I-ANAT
)	O
of	O
patients	O
.	O

All	O
positive	O
-	O
sense	O
RNA	O
viruses	O
modify	O
host	O
cytoplasmic	B-ANAT
membranes	I-ANAT
for	O
viral	B-ANAT
replication	I-ANAT
complex	I-ANAT
formation	O
.	O

It	O
is	O
unknown	O
how	O
these	O
proteins	O
induce	O
membrane	B-ANAT
modification	O
or	O
which	O
regions	O
of	O
the	O
proteins	O
are	O
involved	O
in	O
DMV	O
formation	O
and	O
stability	O
.	O

Three	O
regions	O
of	O
the	O
S2	O
subunit	O
have	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
.	O

To	O
guide	O
fluid	O
management	O
,	O
the	O
cardiac	B-ANAT
index	O
(	O
CI	O
)	O
was	O
measured	O
to	O
assess	O
cardiac	B-ANAT
function	O
,	O
the	O
global	O
end	O
-	O
diastolic	O
volume	O
index	O
(	O
GEDVI	O
)	O
was	O
used	O
to	O
evaluate	O
cardiac	B-ANAT
preload	O
,	O
and	O
the	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWI	O
)	O
was	O
used	O
to	O
evaluate	O
the	O
pulmonary	B-ANAT
edema	O
.	O

Except	O
comprehensive	O
treatment	O
(	O
life	O
supporting	O
,	O
antibiotic	O
,	O
etc	O
.)	O
and	O
applying	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemodiafiltration	O
(	O
CVVHDF	O
)	O
to	O
remove	O
inflammatory	O
mediators	O
.	O

Three	O
respiratory	O
clinical	O
samples	O
were	O
tested	O
on	O
well	O
-	O
differentiated	O
pseudostratified	O
tracheobronchial	O
human	O
airway	B-ANAT
epithelial	O
(	O
HAE	O
)	O
cultures	O
grown	O
at	O
an	O
air	O
-	O
liquid	O
interface	O
,	O
which	O
resemble	O
the	O
airway	B-ANAT
epithelium	B-ANAT
.	O

Cells	B-ANAT
were	O
stained	O
with	O
convalescent	O
serum	B-ANAT
of	O
the	O
patients	O
to	O
identify	O
infected	O
cells	B-ANAT
and	O
apical	O
washes	O
were	O
analyzed	O
by	O
VIDISCA	O
-	O
454	O
,	O
a	O
next	O
-	O
generation	O
sequencing	O
virus	O
discovery	O
technique	O
.	O

Oral	B-ANAT
samples	O
were	O
collected	O
on	O
the	O
first	O
day	O
of	O
glandular	B-ANAT
swelling	O
in	O
53	O
patients	O
(	O
52	O
.	O
5	O
%),	O
and	O
on	O
the	O
first	O
two	O
days	O
in	O
74	O
patients	O
(	O
73	O
.	O
3	O
%).	O

The	O
crystals	B-ANAT
diffracted	O
to	O
2	O
.	O
6	O
Ã	O
resolution	O
and	O
belonged	O
to	O
space	O
group	O
P212121	O
,	O
with	O
unit	O
-	O
cell	B-ANAT
parameters	O
a	O
=	O
31	O
.	O
9	O
,	O
b	O
=	O
85	O
.	O
0	O
,	O
c	O
=	O
95	O
.	O
0	O
Ã	O
.	O
Two	O
molecules	O
were	O
identified	O
per	O
asymmetric	O
unit	O
.	O

In	O
community	O
-	O
acquired	O
pneumonia	O
,	O
NIV	O
is	O
often	O
associated	O
with	O
poor	O
response	O
,	O
with	O
better	O
response	O
in	O
patients	O
with	O
preexisting	O
cardiac	B-ANAT
or	O
respiratory	O
disease	O
.	O

In	O
addition	O
,	O
analysis	O
of	O
the	O
effects	O
of	O
specific	O
kinase	O
inhibitors	O
on	O
MERS	O
-	O
CoV	O
infection	O
in	O
tissue	B-ANAT
culture	O
models	O
confirmed	O
these	O
cellular	B-ANAT
response	O
observations	O
.	O

Incisions	O
included	O
anterolateral	O
thoracotomy	O
in	O
69	O
%	O
and	O
sternotomy	O
in	O
25	O
%;	O
73	O
%	O
required	O
pulmonary	B-ANAT
resection	O
,	O
20	O
%	O
required	O
cardiorraphy	O
,	O
and	O
9	O
%	O
had	O
major	O
vascular	B-ANAT
injuries	O
;	O
multiple	O
procedures	O
were	O
common	O
.	O

The	O
SF1	O
helicase	O
protein	O
of	O
viruses	O
classified	O
in	O
the	O
order	O
Nidovirales	O
is	O
encoded	O
in	O
replicase	O
open	O
reading	O
frame	O
1b	O
(	O
ORF1b	O
),	O
which	O
is	O
translated	O
to	O
give	O
rise	O
to	O
a	O
large	O
polyprotein	O
following	O
a	O
ribosomal	B-ANAT
frameshift	O
from	O
the	O
upstream	O
ORF1a	O
.	O

This	O
was	O
a	O
retrospective	O
study	O
of	O
adults	O
receiving	O
ECMO	O
for	O
ARDS	O
after	O
initiation	O
of	O
a	O
blood	B-ANAT
conservation	O
protocol	O
that	O
included	O
a	O
transfusion	O
trigger	O
of	O
hemoglobin	O
of	O
less	O
than	O
7	O
.	O
0	O
g	O
/	O
dL	O
,	O
use	O
of	O
low	O
-	O
dose	O
anticoagulation	O
targeting	O
an	O
activated	O
partial	O
thromboplastin	O
time	O
of	O
40	O
to	O
60	O
seconds	O
,	O
and	O
autotransfusion	O
of	O
circuit	O
blood	B-ANAT
during	O
decannulation	O
.	O

TITLE	O
:	O
Lung	B-ANAT
recruitability	O
is	O
better	O
estimated	O
according	O
to	O
the	O
Berlin	O
definition	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
at	O
standard	O
5	O
cm	O
H2O	O
rather	O
than	O
higher	O
positive	O
end	O
-	O
expiratory	O
pressure	O
:	O
a	O
retrospective	O
cohort	O
study	O
.	O

The	O
best	O
way	O
to	O
ensure	O
mechanical	O
ventilation	O
in	O
ARDS	O
patients	O
is	O
still	O
debated	O
,	O
recent	O
data	O
arguing	O
for	O
a	O
muscle	B-ANAT
paralysis	O
and	O
a	O
controlled	O
ventilation	O
whereas	O
other	O
elements	O
being	O
in	O
favor	O
of	O
a	O
preserved	O
spontaneous	O
breathing	O
.	O

This	O
may	O
simply	O
be	O
due	O
to	O
the	O
universal	O
IBV	O
qRT	O
-	O
PCR	O
assay	O
being	O
more	O
sensitive	O
than	O
virus	O
detection	O
in	O
eggs	O
or	O
to	O
the	O
assay	O
detecting	O
nucleic	B-ANAT
acid	O
from	O
nonviable	O
virus	O
.	O

The	O
nine	O
residues	O
at	O
the	O
interface	O
between	O
the	O
virus	O
spikes	O
and	O
the	O
lancets	O
4	O
and	O
5	O
of	O
host	O
DPP4	O
can	O
be	O
used	O
as	O
a	O
predictive	O
tool	O
for	O
the	O
host	O
tropism	O
and	O
virus	O
affinity	O
to	O
host	B-ANAT
cell	I-ANAT
receptors	O
.	O

The	O
STem	B-ANAT
cells	I-ANAT
for	O
ARDS	O
Treatment	O
(	O
START	O
)	O
trial	O
was	O
a	O
multicentre	O
,	O
open	O
-	O
label	O
,	O
dose	O
-	O
escalation	O
,	O
phase	O
1	O
clinical	O
trial	O
.	O

Serum	B-ANAT
antibodies	O
as	O
measured	O
by	O
indirect	O
immunofluorescence	O
appeared	O
after	O
2	O
weeks	O
p	O
.	O
i	O
.	O
and	O
correlated	O
with	O
the	O
onset	O
of	O
disease	O
signs	O
.	O

High	O
levels	O
of	O
viral	O
genomic	O
RNA	O
were	O
also	O
detected	O
in	O
whole	O
ascitic	B-ANAT
fluid	I-ANAT
,	O
with	O
the	O
cellular	B-ANAT
fraction	O
containing	O
10	O
-	O
1000	O
times	O
more	O
viral	O
RNA	O
than	O
the	O
supernatant	O
.	O

FIPV	O
genomic	O
RNA	O
was	O
also	O
found	O
to	O
be	O
highly	O
macrophage	B-ANAT
associated	O
within	O
diseased	O
tissues	B-ANAT
and	O
effusions	O
as	O
determined	O
by	O
RT	O
-	O
qPCR	O
and	O
immunohistochemistry	O
but	O
was	O
not	O
present	O
in	O
blood	B-ANAT
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
interaction	O
between	O
vimentin	B-ANAT
and	O
nucleocapsid	B-ANAT
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	O
.	O

The	O
present	O
study	O
thus	O
provides	O
protein	O
-	O
related	O
information	O
about	O
interaction	O
of	O
TGEV	O
N	O
protein	O
with	O
host	B-ANAT
cell	I-ANAT
that	O
should	O
be	O
useful	O
for	O
understanding	O
host	B-ANAT
cell	I-ANAT
response	O
to	O
coronavirus	O
pathogenesis	O
infection	O
and	O
the	O
underlying	O
mechanism	O
of	O
coronavirus	O
replication	O
.	O

Patients	O
with	O
evidence	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
were	O
excluded	O
.	O

Increased	O
levels	O
of	O
cTnI	O
are	O
an	O
independent	O
predictor	O
of	O
ICU	O
mortality	O
in	O
patients	O
hospitalized	O
with	O
severe	O
pneumonia	O
without	O
evidence	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

CT	O
scan	O
was	O
performed	O
for	O
all	O
the	O
cases	O
and	O
consolidation	O
with	O
pleural	B-ANAT
effusion	I-ANAT
were	O
shown	O
.	O

Blood	B-ANAT
MxA	O
protein	O
levels	O
were	O
measured	O
by	O
an	O
enzyme	O
immunoassay	O
and	O
PCR	O
methods	O
were	O
used	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	O
in	O
nasal	B-ANAT
swabs	O
.	O

CONCLUSIONS	O
:	O
Blood	B-ANAT
MxA	O
protein	O
levels	O
are	O
increased	O
in	O
young	O
children	O
with	O
symptomatic	O
respiratory	O
virus	O
infections	O
,	O
including	O
rhinovirus	O
infections	O
.	O

TITLE	O
:	O
Coronavirus	O
MHV	O
-	O
A59	O
infects	O
the	O
lung	B-ANAT
and	O
causes	O
severe	O
pneumonia	O
in	O
C57BL	O
/	O
6	O
mice	O
.	O

Here	O
we	O
report	O
that	O
intranasal	O
inoculation	O
of	O
sublethal	O
doses	O
of	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
A	O
-	O
59	O
(	O
MHV	O
-	O
A59	O
),	O
a	O
hepatic	B-ANAT
and	O
neuronal	O
tropic	O
coronavirus	O
,	O
can	O
induce	O
acute	O
pneumonia	O
and	O
severe	O
lung	B-ANAT
injuries	O
in	O
C57BL	O
/	O
6	O
mice	O
.	O

Under	O
hyperoxic	O
conditions	O
,	O
the	O
lungs	B-ANAT
of	O
NLRP3	O
(-/-)	O
mice	O
exhibited	O
reduced	O
inflammatory	O
responses	O
,	O
such	O
as	O
inflammatory	B-ANAT
cell	I-ANAT
infiltration	O
and	O
cytokine	O
expression	O
,	O
as	O
well	O
as	O
increased	O
and	O
decreased	O
expression	O
of	O
MMP	O
-	O
9	O
and	O
Bcl	O
-	O
2	O
,	O
respectively	O
.	O

In	O
vitro	O
experiments	O
revealed	O
that	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
neutrophils	B-ANAT
promoted	O
Stat3	O
activation	O
in	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Furthermore	O
,	O
NLRP3	O
deficiency	O
impaired	O
the	O
migration	O
of	O
neutrophils	B-ANAT
and	O
chemokine	O
expression	O
by	O
macrophages	B-ANAT
.	O

Endotoxin	O
infusion	O
increased	O
serum	B-ANAT
ET	O
-	O
1	O
,	O
and	O
INO	O
almost	O
doubled	O
the	O
ratio	O
between	O
mRNA	O
expression	O
of	O
endothelin	O
receptor	O
A	O
(	O
mediating	O
vasoconstriction	O
)	O
and	O
B	O
(	O
mediating	O
vasodilation	O
and	O
clearance	O
of	O
ET	O
-	O
1	O
)	O
(	O
ET	O
-	O
A	O
/	O
ET	O
-	O
B	O
)	O
in	O
atelectatic	O
lung	B-ANAT
regions	O
.	O

In	O
Brazil	O
,	O
patients	O
with	O
severe	O
scorpion	O
envenoming	O
have	O
mainly	O
cardiovascular	B-ANAT
events	O
,	O
including	O
acute	O
heart	B-ANAT
failure	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
shock	O
,	O
death	O
is	O
rare	O
.	O

We	O
present	O
evidence	O
that	O
both	O
viruses	O
traffic	O
late	O
into	O
the	O
endocytic	O
pathway	O
,	O
to	O
NPC1	O
(+)	O
LE	O
/	O
Lys	O
,	O
in	O
order	O
to	O
enter	O
host	O
cells	B-ANAT
,	O
and	O
that	O
they	O
do	O
so	O
to	O
access	O
high	O
levels	O
of	O
cathepsin	O
activity	O
,	O
which	O
both	O
viruses	O
use	O
in	O
their	O
fusion	O
-	O
triggering	O
mechanisms	O
.	O

TITLE	O
:	O
A	O
follow	O
-	O
up	O
study	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
survivors	O
after	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
by	O
pulmonary	B-ANAT
high	O
-	O
resolution	O
CT	O
.	O

However	O
,	O
higher	O
positive	O
end	O
-	O
expiratory	O
pressure	O
levels	O
during	O
the	O
first	O
3	O
days	O
on	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
were	O
independently	O
associated	O
with	O
improved	O
survival	O
.	O

Patients	O
who	O
progressed	O
had	O
acute	O
kidney	B-ANAT
injury	O
and	O
other	O
severe	O
maternal	O
morbidity	O
,	O
including	O
one	O
case	O
of	O
maternal	O
death	O
.	O

In	O
the	O
present	O
study	O
,	O
two	O
-	O
way	O
antigenic	O
cross	O
-	O
reactivity	O
examinations	O
between	O
the	O
prototype	O
PEDV	O
CV777	O
strain	O
,	O
three	O
distinct	O
U	O
.	O
S	O
.	O
PEDV	O
strains	O
(	O
the	O
original	O
highly	O
virulent	O
PC22A	O
,	O
S	O
indel	O
Iowa106	O
,	O
and	O
S	O
197del	O
PC177	O
),	O
and	O
two	O
representative	O
U	O
.	O
S	O
.	O
TGEV	O
strains	O
(	O
Miller	O
and	O
Purdue	O
)	O
were	O
conducted	O
by	O
cell	B-ANAT
culture	O
immunofluorescent	O
(	O
CCIF	O
)	O
and	O
viral	O
neutralization	O
(	O
VN	O
)	O
assays	O
.	O

Exchanging	O
the	O
spike	O
proteins	O
of	O
the	O
two	O
viruses	O
neither	O
increased	O
replication	O
of	O
JHM	O
.	O
SD	O
in	O
the	O
liver	B-ANAT
nor	O
attenuated	O
JHM	O
.	O
WU	O
.	O

The	O
K194R	O
polymorphism	O
has	O
no	O
effect	O
on	O
in	O
vitro	O
replication	O
but	O
influences	O
hepatotropism	O
,	O
and	O
introduction	O
of	O
R194K	O
into	O
JHM	O
.	O
SD	O
promotes	O
replication	O
in	O
the	O
liver	B-ANAT
.	O

The	O
pattern	O
of	O
respiratory	O
virus	O
seasonality	O
found	O
in	O
nasal	B-ANAT
mucosa	I-ANAT
,	O
polyps	O
,	O
and	O
paranasal	B-ANAT
sinus	I-ANAT
samples	O
in	O
patients	O
with	O
CRS	O
reinforces	O
the	O
possibility	O
of	O
asymptomatic	O
respiratory	O
viral	O
infections	O
.	O

The	O
most	O
common	O
abnormal	O
finding	O
in	O
spirometry	O
was	O
small	O
airway	B-ANAT
disease	O
(	O
20	O
.	O
3	O
%).	O
The	O
follow	O
-	O
up	O
data	O
showed	O
that	O
178	O
patients	O
(	O
45	O
.	O
2	O
%)	O
had	O
significant	O
improvement	O
clinically	O
,	O
radiologically	O
or	O
both	O
.	O

The	O
alveolar	B-ANAT
spaces	O
showed	O
fibrinous	O
exudates	B-ANAT
.	O

There	O
were	O
no	O
hyaline	B-ANAT
membranes	B-ANAT
or	O
massive	O
intraluminal	O
fibrosis	O
.	O

The	O
frequency	O
of	O
CD8	O
(+)	O
and	O
TCRÎ³Î´	O
(+)	O
T	B-ANAT
cells	I-ANAT
expression	O
was	O
examined	O
by	O
immunohistochemistry	O
,	O
followed	O
by	O
image	O
analysis	O
.	O

The	O
expression	O
of	O
the	O
genes	O
of	O
toll	O
-	O
like	O
receptor	O
7	O
(	O
TLR7	O
),	O
natural	B-ANAT
killer	I-ANAT
cell	I-ANAT
receptor	O
(	O
BNK	O
),	O
cytotoxic	O
substances	O
(	O
granzyme	O
,	O
perforin	O
),	O
and	O
cytokines	O
(	O
CXCL12	O
,	O
CX3CL1	O
,	O
and	O
IFNÎ³	O
)	O
were	O
examined	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
analysis	O
.	O

This	O
report	O
describes	O
study	O
design	O
features	O
that	O
are	O
unique	O
to	O
a	O
phase	O
1	O
trial	O
in	O
critically	O
ill	O
subjects	O
and	O
the	O
specific	O
challenges	O
of	O
implementation	O
of	O
a	O
cell	B-ANAT
-	O
based	O
therapy	O
trial	O
in	O
the	O
ICU	O
.	O

These	O
activities	O
limit	O
infection	O
in	O
cultured	B-ANAT
cells	I-ANAT
by	O
many	O
viruses	O
,	O
including	O
dengue	O
virus	O
,	O
Ebola	O
virus	O
,	O
influenza	O
A	O
virus	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
and	O
West	O
Nile	O
virus	O
.	O

TITLE	O
:	O
Androctonus	O
australis	O
hector	O
venom	O
contributes	O
to	O
the	O
interaction	O
between	O
neuropeptides	O
and	O
mast	B-ANAT
cells	I-ANAT
in	O
pulmonary	B-ANAT
hyperresponsiveness	O
.	O

TITLE	O
:	O
Proteome	O
analysis	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
.	O

In	O
this	O
study	O
,	O
LC	O
-	O
MS	O
/	O
MS	O
coupled	O
to	O
iTRAQ	O
labeling	O
was	O
used	O
to	O
quantitatively	O
identify	O
differentially	O
expressed	O
cellular	B-ANAT
proteins	O
in	O
PEDV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
A	O
case	O
of	O
a	O
30	O
year	O
-	O
old	O
man	O
presenting	O
with	O
severe	O
systemic	O
chickenpox	O
with	O
refractory	O
hypoxemia	O
,	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
vasculitis	O
and	O
anuric	O
renal	B-ANAT
failure	O
is	O
described	O
.	O

However	O
,	O
unlike	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
PLpro	O
that	O
lacks	O
blocking	O
loop	O
(	O
BL	O
)	O
1	O
of	O
deubiquitinating	O
enzymes	O
,	O
the	O
IBV	O
PLpro	O
has	O
a	O
short	O
BL1	B-ANAT
-	O
like	O
loop	O
.	O

A	O
mouse	O
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
SARS	O
-	O
CoV	O
-	O
MA15	O
)	O
lacking	O
the	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
(	O
rSARS	O
-	O
CoV	O
-	O
MA15	O
-	O
ÎE	O
)	O
is	O
attenuated	O
in	O
vivo	O
.	O

Eight	O
patients	O
had	O
ground	O
-	O
glass	O
opacity	O
(	O
53	O
%),	O
five	O
had	O
ground	O
-	O
glass	O
and	O
consolidation	O
in	O
combination	O
(	O
33	O
%),	O
five	O
had	O
pleural	B-ANAT
effusion	I-ANAT
(	O
33	O
%),	O
and	O
four	O
patients	O
had	O
interlobular	O
thickening	O
(	O
27	O
%).	O

The	O
number	O
of	O
involved	O
lung	B-ANAT
segments	I-ANAT
was	O
higher	O
in	O
group	O
1	O
.	O

The	O
lower	O
lobe	B-ANAT
was	O
more	O
commonly	O
involved	O
(	O
mean	O
,	O
12	O
.	O
2	O
segments	O
)	O
than	O
in	O
the	O
upper	O
and	O
middle	O
lobes	B-ANAT
combined	O
(	O
mean	O
,	O
6	O
.	O
3	O
segments	O
).	O

RESULTS	O
:	O
Eight	O
patients	O
had	O
ground	O
-	O
glass	O
opacity	O
(	O
53	O
%),	O
five	O
had	O
ground	O
-	O
glass	O
and	O
consolidation	O
in	O
combination	O
(	O
33	O
%),	O
five	O
had	O
pleural	B-ANAT
effusion	I-ANAT
(	O
33	O
%),	O
and	O
four	O
patients	O
had	O
interlobular	O
thickening	O
(	O
27	O
%).	O

At	O
enrollment	O
,	O
calves	O
were	O
weighed	O
,	O
clinically	O
examined	O
,	O
swabbed	O
(	O
nasal	B-ANAT
and	O
nasopharyngeal	B-ANAT
),	O
and	O
lung	B-ANAT
ultrasonography	O
was	O
performed	O
.	O

Identification	O
of	O
the	O
surfactant	O
proteins	O
,	O
lipid	O
transporters	O
,	O
and	O
transcriptional	O
networks	O
regulating	O
their	O
expression	O
has	O
provided	O
the	O
tools	O
and	O
insights	O
needed	O
to	O
discern	O
the	O
molecular	O
and	O
cellular	B-ANAT
processes	O
regulating	O
the	O
production	O
and	O
function	O
of	O
pulmonary	B-ANAT
surfactant	O
prior	O
to	O
and	O
after	O
birth	O
.	O

ABSTRACT	O
:	O
In	O
response	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
pandemic	O
of	O
2003	O
and	O
the	O
influenza	O
pandemic	O
of	O
2009	O
,	O
many	O
countries	O
instituted	O
border	B-ANAT
measures	O
as	O
a	O
means	O
of	O
stopping	O
or	O
slowing	O
the	O
spread	O
of	O
disease	O
.	O

TITLE	O
:	O
Blood	B-ANAT
values	O
of	O
captive	O
beira	O
antelope	O
(	O
Dorcatragus	O
megalotis	O
)	O
prior	O
to	O
and	O
during	O
an	O
outbreak	O
of	O
fibrinous	O
pleuropneumonia	O
syndrome	O
(	O
FPPS	O
).	O

The	O
annual	O
population	O
WBC	B-ANAT
increased	O
and	O
decreased	O
concurrently	O
with	O
the	O
population	O
size	O
,	O
with	O
a	O
significant	O
correlation	O
between	O
the	O
two	O
measures	O
(	O
R	O
=	O
0	O
.	O
92	O
;	O
P	O
=	O
0	O
.	O
001	O
).	O

No	O
cross	O
-	O
reactivity	O
was	O
observed	O
with	O
a	O
panel	O
of	O
18	O
viruses	O
associated	O
with	O
livestock	O
including	O
eight	O
other	O
pestivirus	O
strains	O
(	O
bovine	O
viral	O
diarrhoea	O
virus	O
type	O
1	O
and	O
type	O
2	O
,	O
border	B-ANAT
disease	O
virus	O
,	O
HoBi	O
atypical	O
pestivirus	O
),	O
African	O
swine	O
fever	O
virus	O
,	O
swine	O
vesicular	O
disease	O
virus	O
,	O
swine	O
influenza	O
virus	O
,	O
porcine	O
respiratory	O
and	O
reproductive	O
syndrome	O
virus	O
,	O
porcine	O
circovirus	O
1	O
,	O
porcine	O
circovirus	O
2	O
,	O
porcine	O
respiratory	O
coronavirus	O
,	O
vesicular	O
exanthema	O
of	O
swine	O
virus	O
,	O
bovine	O
herpes	O
virus	O
type	O
1	O
and	O
vesicular	O
stomatitis	O
virus	O
.	O

Even	O
though	O
there	O
was	O
an	O
increased	O
use	O
of	O
plasma	B-ANAT
and	O
platelets	B-ANAT
transfused	O
in	O
the	O
1	O
:	O
1	O
:	O
1	O
group	O
,	O
no	O
other	O
safety	O
differences	O
were	O
identified	O
between	O
the	O
2	O
groups	O
.	O

We	O
describe	O
the	O
pathologic	O
,	O
immunohistochemical	O
,	O
ultrastructural	O
,	O
and	O
molecular	O
findings	O
in	O
2	O
horses	O
and	O
1	O
donkey	O
that	O
succumbed	O
to	O
natural	O
infection	O
with	O
ECoV	O
.	O
One	O
horse	O
and	O
the	O
donkey	O
(	O
case	O
Nos	O
.	O
1	O
,	O
3	O
)	O
had	O
severe	O
diffuse	O
necrotizing	O
enteritis	O
with	O
marked	O
villous	O
attenuation	O
,	O
epithelial	B-ANAT
cell	I-ANAT
necrosis	O
at	O
the	O
tips	O
of	O
the	O
villi	O
,	O
neutrophilic	O
and	O
fibrinous	O
extravasation	O
into	O
the	O
small	B-ANAT
intestinal	I-ANAT
lumen	I-ANAT
(	O
pseudomembrane	O
formation	O
),	O
as	O
well	O
as	O
crypt	B-ANAT
necrosis	O
,	O
microthrombosis	O
,	O
and	O
hemorrhage	O
.	O

TITLE	O
:	O
Risk	O
factors	O
for	O
neonatal	O
calf	B-ANAT
diarrhoea	O
and	O
enteropathogen	O
shedding	O
in	O
New	O
Zealand	O
dairy	O
farms	O
.	O

In	O
this	O
age	O
group	O
,	O
the	O
odds	O
of	O
liquid	O
faeces	B-ANAT
were	O
smaller	O
on	O
farms	O
where	O
females	O
took	O
care	O
of	O
the	O
calves	O
,	O
compared	O
with	O
males	O
(	O
OR	O
=	O
0	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
01	O
-	O
0	O
.	O
9	O
;	O
P	O
=	O
0	O
.	O
04	O
).	O

Most	O
strikingly	O
,	O
the	O
high	O
U	O
and	O
low	O
C	O
proportions	O
are	O
quite	O
variable	O
and	O
act	O
like	O
communicating	O
vessels	B-ANAT
,	O
C	O
goes	O
down	O
when	O
U	O
goes	O
up	O
and	O
vice	O
versa	O
.	O

We	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
inhibition	O
of	O
PPV	O
replication	O
in	O
swine	O
testis	B-ANAT
(	O
ST	O
)	O
cells	B-ANAT
by	O
LiCl	O
is	O
dose	O
-	O
dependent	O
,	O
and	O
that	O
the	O
antiviral	O
effect	O
of	O
LiCl	O
occurred	O
in	O
the	O
early	O
phase	O
of	O
PPV	O
replication	O
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
syndrome	O
of	O
acute	O
respiratory	O
failure	O
associated	O
with	O
severe	O
inflammation	O
and	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

Possible	O
correlation	O
between	O
plasma	B-ANAT
sRAGE	O
levels	O
and	O
clinical	O
parameters	O
were	O
explored	O
using	O
a	O
simple	O
linear	O
model	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
plasma	B-ANAT
sRAGE	O
levels	O
between	O
survivors	O
and	O
non	O
-	O
survivors	O
(	O
P	O
=	O
0	O
.	O
34	O
).	O

As	O
deletions	O
in	O
CoV	O
accessory	O
proteins	O
have	O
already	O
been	O
involved	O
in	O
tissue	B-ANAT
or	O
host	O
switch	O
,	O
studies	O
of	O
these	O
different	O
gp3	O
proteins	O
were	O
conducted	O
in	O
canine	O
and	O
feline	O
cell	B-ANAT
.	O

All	O
proteins	O
oligomerise	O
through	O
covalent	O
bonds	O
,	O
are	O
N	O
-	O
glycosylated	O
and	O
are	O
maintained	O
in	O
the	O
ER	O
in	O
non	O
-	O
infected	O
but	O
also	O
in	O
CCoV	O
-	O
II	O
infected	O
cells	B-ANAT
,	O
without	O
any	O
specific	O
retention	O
signal	O
.	O

ABSTRACT	O
:	O
In	O
order	O
to	O
gain	O
entry	O
into	O
cells	B-ANAT
,	O
diverse	O
viruses	O
,	O
including	O
Ebola	O
virus	O
,	O
SARS	O
-	O
coronavirus	O
and	O
the	O
emerging	O
MERS	O
-	O
coronavirus	O
,	O
depend	O
on	O
activation	O
of	O
their	O
envelope	B-ANAT
glycoproteins	O
by	O
host	B-ANAT
cell	I-ANAT
proteases	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
FIP	O
in	O
an	O
African	O
lion	O
and	O
the	O
first	O
report	O
of	O
ocular	B-ANAT
FIP	O
in	O
a	O
non	O
-	O
domestic	O
felid	O
.	O

The	O
objective	O
was	O
to	O
compare	O
the	O
HR	O
-	O
QoL	O
of	O
patients	O
with	O
a	O
diagnosis	O
of	O
H1N1	O
influenza	O
who	O
were	O
mechanically	O
ventilated	O
,	O
12	O
months	O
after	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
discharge	B-ANAT
with	O
healthy	O
population	O
data	O
and	O
ICU	O
survivor	O
data	O
.	O

TITLE	O
:	O
Correction	O
:	O
Coronavirus	O
cell	B-ANAT
entry	O
occurs	O
through	O
the	O
endo	O
-/	O
lysosomal	B-ANAT
pathway	O
in	O
a	O
proteolysis	O
-	O
dependent	O
manner	O
.	O

Infection	O
involved	O
porcine	O
aminpeptidase	O
N	O
(	O
pAPN	O
),	O
a	O
reported	O
cellular	B-ANAT
receptor	O
for	O
PEDV	O
,	O
transient	O
expression	O
of	O
pAPN	O
and	O
siRNA	O
targeted	O
pAPN	O
increased	O
and	O
decreased	O
the	O
infectivity	O
of	O
PEDV	O
in	O
IECs	O
,	O
respectively	O
.	O

PEDV	O
entry	O
into	O
polarized	O
cells	B-ANAT
and	O
pAPN	O
grown	O
on	O
membrane	B-ANAT
inserts	O
occurs	O
via	O
apical	B-ANAT
membrane	I-ANAT
.	O

Properties	O
of	O
aptamers	O
allow	O
detecting	O
virus	O
infected	O
cells	B-ANAT
or	O
viruses	O
themselves	O
and	O
make	O
them	O
competitive	O
to	O
monoclonal	O
antibodies	O
.	O

The	O
second	O
child	O
developed	O
headache	O
,	O
somnolence	O
,	O
agitation	O
,	O
and	O
speech	O
dysfunction	O
following	O
an	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

The	O
structures	O
of	O
compounds	O
that	O
showed	O
potent	O
dual	O
antiviral	O
activities	O
with	O
a	O
wide	O
margin	B-ANAT
of	O
safety	O
were	O
identified	O
and	O
are	O
discussed	O
.	O

Villus	B-ANAT
atrophy	O
in	O
affected	O
piglets	O
was	O
confined	O
to	O
the	O
small	B-ANAT
intestine	I-ANAT
.	O

Samples	O
of	O
colon	B-ANAT
content	O
were	O
PCR	O
-	O
positive	O
for	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
).	O

Positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
and	O
inspiratory	O
driving	O
pressures	O
were	O
adjusted	O
with	O
the	O
aim	O
of	O
achieving	O
tidal	O
volume	O
of	O
6	O
to	O
8	O
mL	O
/	O
kg	O
based	O
on	O
ideal	O
body	B-ANAT
weight	O
(	O
IBW	O
),	O
while	O
not	O
exceeding	O
end	O
inspiratory	O
transpulmonary	O
(	O
EITP	O
)	O
pressure	O
of	O
25	O
cm	O
H2O	O
.	O

Adjustment	O
of	O
PEEP	O
and	O
inspiratory	O
driving	O
pressures	O
did	O
not	O
worsen	O
oxygenation	O
and	O
did	O
not	O
affect	O
cardiac	B-ANAT
output	O
significantly	O
.	O

Furthermore	O
,	O
2	O
recently	O
published	O
large	O
multicenter	O
trials	O
(	O
ARISE	O
and	O
ProCESS	O
)	O
have	O
discredited	O
the	O
""""	O
early	O
goal	O
-	O
directed	O
therapy	O
""""	O
approach	O
,	O
which	O
used	O
prespecified	O
targets	O
of	O
central	O
venous	B-ANAT
pressure	O
and	O
venous	B-ANAT
saturation	O
to	O
guide	O
fluid	O
and	O
vasopressor	O
administration	O
.	O

Use	O
of	O
smaller	O
volumes	O
to	O
perform	O
fluid	O
challenges	O
,	O
monitoring	O
of	O
extravascular	O
lung	B-ANAT
water	O
,	O
earlier	O
use	O
of	O
norepinephrine	O
,	O
and	O
other	O
strategies	O
can	O
help	O
further	O
reduce	O
morbidity	O
and	O
mortality	O
from	O
severe	O
sepsis	O
.	O

This	O
study	O
attempted	O
to	O
identify	O
viruses	O
from	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
in	O
adults	O
visiting	O
emergency	O
departments	O
for	O
clinically	O
suspected	O
CAP	O
.	O

Adults	O
with	O
suspected	O
CAP	O
enrolled	O
in	O
the	O
ESCAPED	O
study	O
(	O
impact	O
of	O
computed	O
tomography	O
on	O
CAP	O
diagnosis	O
)	O
had	O
prospective	O
nasopharyngeal	B-ANAT
(	O
NP	O
)	O
samples	O
studied	O
by	O
multiplex	O
PCR	O
(	O
targeting	O
15	O
viruses	O
and	O
four	O
intracellular	B-ANAT
bacteria	O
).	O

Spontaneous	O
circulation	O
had	O
earlier	O
resumed	O
after	O
brief	O
application	O
of	O
cardiopulmonary	B-ANAT
resuscitation	O
.	O

Ninety	O
-	O
three	O
mechanically	O
ventilated	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
sepsis	O
were	O
enrolled	O
for	O
subgroup	O
analysis	O
in	O
a	O
multicenter	O
,	O
prospective	O
,	O
observational	O
study	O
.	O

He	O
had	O
undergone	O
resection	O
for	O
rectal	O
cancer	O
and	O
ileal	B-ANAT
conduit	O
replacement	O
.	O

His	O
kidney	B-ANAT
function	O
recovered	O
gradually	O
after	O
continuous	O
administration	O
of	O
hemodiafiltration	O
;	O
however	O
,	O
PSP	O
continued	O
to	O
rise	O
up	O
to	O
6	O
,	O
051	O
,	O
along	O
with	O
high	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
and	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
II	O
values	O
.	O

Case	O
2	O
:	O
a	O
78	O
-	O
year	O
-	O
old	O
woman	O
with	O
CKD	O
on	O
hemodialysis	O
(	O
HD	O
)	O
was	O
admitted	O
to	O
the	O
ICU	O
after	O
cardiovascular	B-ANAT
surgery	O
.	O

Therefore	O
,	O
evaluation	O
of	O
PSP	O
in	O
kidney	B-ANAT
dysfunction	O
patients	O
will	O
be	O
difficult	O
.	O

Our	O
work	O
shows	O
that	O
fruit	O
bat	O
cells	B-ANAT
have	O
homologs	O
of	O
cathepsin	O
and	O
furin	O
proteases	O
capable	O
of	O
cleaving	O
and	O
activating	O
both	O
the	O
cathepsin	O
-	O
dependent	O
Hendra	O
virus	O
F	O
and	O
the	O
furin	O
-	O
dependent	O
parainfluenza	O
virus	O
5	O
F	O
proteins	O
.	O

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
the	O
unusual	O
role	O
of	O
cathepsin	O
proteases	O
in	O
the	O
life	O
cycle	O
of	O
bat	O
-	O
borne	O
viruses	O
is	O
not	O
due	O
to	O
the	O
lack	O
of	O
active	O
furin	O
-	O
like	O
proteases	O
in	O
these	O
natural	O
reservoir	O
species	O
;	O
however	O
,	O
differences	O
may	O
exist	O
between	O
furin	O
proteases	O
present	O
in	O
fruit	O
bats	O
compared	O
to	O
furins	O
in	O
other	O
mammalian	O
species	O
,	O
and	O
these	O
differences	O
may	O
impact	O
protease	O
usage	O
for	O
viral	B-ANAT
glycoprotein	I-ANAT
processing	O
.	O

A	O
simple	O
technique	O
for	O
the	O
preparation	O
of	O
chicken	O
tracheal	O
organ	B-ANAT
cultures	O
in	O
glass	O
test	O
tubes	O
,	O
in	O
which	O
virus	O
growth	O
and	O
ciliostasis	O
can	O
be	O
readily	O
observed	O
,	O
is	O
described	O
.	O

Within	O
the	O
family	O
Coronaviridae	O
the	O
embryonated	O
egg	B-ANAT
has	O
been	O
used	O
as	O
a	O
host	O
system	O
primarily	O
for	O
two	O
avian	O
coronaviruses	O
within	O
the	O
genus	O
Gammacoronavirus	O
,	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
and	O
turkey	O
coronavirus	O
(	O
TCoV	O
).	O

The	O
embryonated	O
egg	B-ANAT
also	O
has	O
been	O
shown	O
to	O
be	O
suitable	O
for	O
isolation	O
and	O
propagation	O
of	O
pheasant	O
coronavirus	O
,	O
a	O
proposed	O
member	O
of	O
the	O
Gammacoronavirus	O
genus	O
.	O

IBV	O
and	O
pheasant	O
coronavirus	O
replicate	O
well	O
in	O
the	O
embryonated	O
chicken	O
egg	B-ANAT
,	O
regardless	O
of	O
inoculation	O
route	O
;	O
however	O
,	O
the	O
allantoic	O
route	O
is	O
favored	O
as	O
these	O
viruses	O
replicate	O
well	O
in	O
epithelium	B-ANAT
lining	O
the	O
chorioallantoic	B-ANAT
membrane	I-ANAT
,	O
with	O
high	O
virus	O
titers	O
found	O
in	O
these	O
membranes	B-ANAT
and	O
associated	O
allantoic	O
fluids	B-ANAT
.	O

TITLE	O
:	O
Characterization	O
of	O
human	O
coronaviruses	O
on	O
well	O
-	O
differentiated	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
cultures	O
.	O

To	O
further	O
study	O
the	O
presence	O
of	O
virion	B-ANAT
proteins	O
,	O
high	O
-	O
quality	O
sample	O
preparation	O
is	O
crucial	O
to	O
ensure	O
reproducible	O
analysis	O
by	O
the	O
wide	O
variety	O
of	O
methods	O
available	O
for	O
proteomic	O
analysis	O
.	O

Infectious	O
recombinant	O
IBVs	O
are	O
generated	O
in	O
situ	O
following	O
the	O
transfection	O
of	O
vaccinia	O
virus	O
DNA	O
,	O
containing	O
the	O
modified	O
IBV	O
cDNA	O
,	O
into	O
cells	B-ANAT
infected	O
with	O
a	O
recombinant	O
fowlpox	O
virus	O
expressing	O
T7	O
DNA	O
-	O
dependent	O
RNA	O
polymerase	O
.	O

ABSTRACT	O
:	O
Protein	O
histochemistry	O
is	O
a	O
tissue	B-ANAT
-	O
based	O
technique	O
that	O
enables	O
the	O
analysis	O
of	O
viral	O
attachment	O
patterns	O
as	O
well	O
as	O
the	O
identification	O
of	O
specific	O
viral	O
and	O
host	O
determinants	O
involved	O
in	O
the	O
first	O
step	O
in	O
the	O
infection	O
of	O
a	O
host	B-ANAT
cell	I-ANAT
by	O
a	O
virus	O
.	O

Interfering	O
with	O
receptor	O
recognition	O
is	O
an	O
attractive	O
antiviral	O
therapy	O
,	O
since	O
it	O
occurs	O
before	O
the	O
viral	B-ANAT
genome	I-ANAT
has	O
reached	O
the	O
relative	O
safe	O
haven	O
within	O
the	O
cell	B-ANAT
.	O

After	O
the	O
identification	O
of	O
specific	O
cellular	B-ANAT
factors	O
interacting	O
with	O
the	O
target	O
viral	O
protein	O
using	O
the	O
yeast	O
two	O
-	O
hybrid	O
screening	O
system	O
,	O
co	O
-	O
immunoprecipitation	O
and	O
confocal	O
microscopy	O
analyses	O
are	O
often	O
used	O
to	O
verify	O
the	O
virus	O
-	O
host	O
protein	O
interactions	O
in	O
cells	B-ANAT
.	O

Here	O
,	O
we	O
present	O
a	O
yeast	O
two	O
-	O
hybrid	O
protocol	O
that	O
has	O
been	O
used	O
in	O
our	O
laboratory	O
since	O
2006	O
to	O
search	O
for	O
cellular	B-ANAT
partners	O
of	O
more	O
than	O
300	O
viral	O
proteins	O
.	O

These	O
sites	O
harbor	O
the	O
CoV	O
replication	O
-	O
transcription	O
complexes	O
(	O
RTCs	O
):	O
multi	O
-	O
protein	O
complexes	O
consisting	O
of	O
16	O
nonstructural	O
proteins	O
(	O
nsps	O
),	O
the	O
CoV	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
)	O
and	O
presumably	O
host	O
proteins	O
.	O

Compared	O
with	O
VicS	O
-	O
v	O
,	O
the	O
more	O
attenuated	O
VicS	O
-	O
del	O
strain	O
had	O
two	O
non	O
-	O
synonymous	O
changes	O
in	O
the	O
non	O
-	O
structural	O
protein	O
6	O
(	O
nsp6	O
),	O
a	O
transmembrane	B-ANAT
(	O
TM	O
)	O
domain	O
that	O
may	O
participate	O
in	O
autocatalytic	O
release	O
of	O
the	O
3	O
-	O
chymotrypsin	O
-	O
like	O
protease	O
,	O
a	O
polymorphic	O
difference	O
at	O
the	O
end	O
of	O
the	O
S2	O
gene	O
,	O
which	O
coincided	O
with	O
the	O
body	B-ANAT
transcription	O
-	O
regulating	O
sequence	O
(	O
B	O
-	O
TRS	O
)	O
of	O
mRNA	O
3	O
and	O
a	O
truncated	O
open	O
reading	O
frame	O
for	O
a	O
peptide	O
encoded	O
by	O
gene	O
4	O
(	O
4b	O
).	O

The	O
purified	O
whole	O
viral	O
antigen	O
of	O
Sczy3	O
strain	O
was	O
used	O
to	O
immunize	O
BALB	O
/	O
c	O
mice	O
to	O
produce	O
hybridoma	B-ANAT
-	O
secreting	O
anti	O
-	O
IBV	O
MAbs	O
.	O

MHV	O
was	O
genetically	O
engineered	O
with	O
a	O
tetracysteine	O
tag	O
at	O
the	O
carboxy	O
end	O
of	O
E	O
.	O
Fluorescence	O
recovery	O
after	O
photobleaching	O
(	O
FRAP	O
)	O
showed	O
that	O
E	O
is	O
mobile	O
in	O
ERGIC	B-ANAT
/	O
Golgi	B-ANAT
membranes	B-ANAT
.	O

Among	O
patients	O
treated	O
with	O
iNO	O
,	O
60	O
.	O
2	O
%	O
survived	O
to	O
discharge	B-ANAT
.	O

It	O
might	O
be	O
speculated	O
that	O
host	O
factors	O
such	O
as	O
the	O
function	O
of	O
the	O
immune	B-ANAT
system	I-ANAT
influence	O
the	O
clinical	O
outcome	O
of	O
the	O
infection	O
.	O

The	O
detection	O
limit	O
corresponds	O
to	O
a	O
cycle	O
treshold	O
value	O
of	O
â¼	O
35	O
with	O
standard	O
upE	O
real	O
time	O
PCR	O
assays	O
on	O
RNA	O
isolated	O
from	O
MERS	O
-	O
CoV	O
EMC	B-ANAT
.	O

ABSTRACT	O
:	O
Eukaryotic	O
cellular	B-ANAT
and	O
most	O
viral	O
RNAs	O
carry	O
a	O
5	O
'-	O
terminal	O
cap	O
structure	O
,	O
a	O
5	O
'-	O
5	O
'	O
triphosphate	O
linkage	O
between	O
the	O
5	O
'	O
end	O
of	O
the	O
RNA	O
and	O
a	O
guanosine	O
nucleotide	O
(	O
cap	O
-	O
0	O
).	O

TITLE	O
:	O
MERS	O
coronavirus	O
envelope	B-ANAT
protein	O
has	O
a	O
single	O
transmembrane	B-ANAT
domain	O
that	O
forms	O
pentameric	O
ion	O
channels	O
.	O

Seven	O
patients	O
were	O
successfully	O
taken	O
off	O
ECMO	O
with	O
4	O
being	O
bridged	O
to	O
recovery	O
and	O
a	O
further	O
3	O
to	O
lung	B-ANAT
transplantation	O
after	O
a	O
mean	O
of	O
11	O
(	O
range	O
,	O
9	O
-	O
18	O
)	O
days	O
.	O

However	O
,	O
hypercapnic	O
acidosis	O
resulting	O
from	O
ventilation	O
at	O
lower	O
tidal	O
volume	O
enhances	O
pulmonary	B-ANAT
hypertension	O
and	O
might	O
induce	O
right	O
ventricular	B-ANAT
(	O
RV	O
)	O
failure	O
.	O

RV	O
-	O
arterial	B-ANAT
coupling	O
was	O
derived	O
from	O
RV	O
pressure	O
-	O
volume	O
loops	O
.	O

Systolic	O
pulmonary	B-ANAT
artery	I-ANAT
pressure	O
significantly	O
increased	O
from	O
29	O
.	O
6	O
Â±	O
1	O
.	O
8	O
to	O
43	O
.	O
9	O
Â±	O
2	O
.	O
0	O
mmHg	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

Veno	O
-	O
venous	B-ANAT
CO2	O
removal	O
therapy	O
enabled	O
protective	O
ventilation	O
while	O
maintaining	O
normocarbia	O
during	O
ARDS	O
.	O

CO2	O
removal	O
decreased	O
pulmonary	B-ANAT
hypertension	O
and	O
improved	O
RV	O
function	O
.	O

CONCLUSIONS	O
:	O
Veno	O
-	O
venous	B-ANAT
CO2	O
removal	O
therapy	O
enabled	O
protective	O
ventilation	O
while	O
maintaining	O
normocarbia	O
during	O
ARDS	O
.	O

Subsequent	O
structural	O
modification	O
on	O
p	O
-	O
HAP	O
and	O
its	O
glycoside	O
led	O
to	O
the	O
synthesis	O
of	O
28	O
additional	O
derivatives	O
,	O
of	O
which	O
13	O
compounds	O
showed	O
activity	O
inhibiting	O
hepatitis	O
B	O
surface	O
antigen	O
(	O
HBsAg	O
)	O
secretion	B-ANAT
;	O
and	O
18	O
compounds	O
possessed	O
inhibition	O
on	O
HBV	O
DNA	O
replication	O
.	O

A	O
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
revealed	O
huge	O
tumours	O
that	O
occupied	O
the	O
peritoneal	B-ANAT
cavity	I-ANAT
,	O
with	O
multiple	O
lung	B-ANAT
,	O
liver	B-ANAT
,	O
and	O
para	O
-	O
aortic	B-ANAT
metastases	O
.	O

Although	O
there	O
was	O
no	O
abnormal	O
finding	O
in	O
the	O
testes	B-ANAT
,	O
serum	B-ANAT
testicular	O
tumor	O
markers	O
showed	O
marked	O
elevation	O
.	O

A	O
CT	O
-	O
guided	O
biopsy	O
for	O
the	O
peritoneal	B-ANAT
tumours	O
revealed	O
extragonadal	O
germ	B-ANAT
cell	I-ANAT
tumour	O
(	O
GCT	O
),	O
including	O
yolk	B-ANAT
sac	I-ANAT
tumour	O
and	O
choriocarcinoma	O
.	O

The	O
morning	O
after	O
the	O
beginning	O
of	O
BEP	O
,	O
the	O
patient	O
developed	O
hemorrhagic	O
shock	O
,	O
in	O
addition	O
to	O
acute	O
pulmonary	B-ANAT
and	O
renal	B-ANAT
failure	O
,	O
because	O
of	O
TLS	O
and	O
massive	O
hemorrhage	O
at	O
bilateral	O
lung	B-ANAT
metastases	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
case	O
report	O
of	O
TLS	O
and	O
CS	O
as	O
complications	O
of	O
hemorrhage	O
at	O
the	O
lung	B-ANAT
metastases	O
of	O
advanced	O
testicular	O
cancer	O
leading	O
to	O
death	O
.	O

We	O
also	O
isolated	O
PDCoV	O
[	O
OH	O
-	O
FD22	O
(	O
DC44	O
)	O
strain	O
]	O
in	O
LLC	B-ANAT
-	O
PK	O
cells	B-ANAT
from	O
intestinal	B-ANAT
contents	I-ANAT
of	O
PDCoV	O
OH	O
-	O
FD22	O
strain	O
-	O
inoculated	O
gnotobiotic	O
(	O
Gn	O
)	O
pigs	O
.	O

This	O
is	O
the	O
first	O
report	O
describing	O
cell	B-ANAT
culture	O
isolation	O
,	O
serial	O
propagation	O
,	O
and	O
biological	O
and	O
genetic	O
characterization	O
of	O
cell	B-ANAT
-	O
adapted	O
PDCoV	O
strains	O
.	O

Moreover	O
,	O
CD107a	O
mobilisation	O
was	O
analysed	O
on	O
CTL	B-ANAT
isolated	O
from	O
airways	O
of	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)-	O
infected	O
birds	O
direct	O
ex	O
vivo	O
and	O
upon	O
in	O
vitro	O
stimulation	O
.	O

Results	O
showed	O
that	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
(	O
PMA	O
)	O
in	O
combination	O
with	O
ionomycin	O
was	O
a	O
consistent	O
inducer	O
of	O
CD107a	O
cell	B-ANAT
surface	I-ANAT
mobilisation	O
on	O
chicken	O
CTL	B-ANAT
in	O
a	O
4h	O
cell	B-ANAT
culture	O
model	O
.	O

Monitoring	O
of	O
CD107a	O
cell	B-ANAT
surface	I-ANAT
mobilisation	O
may	O
thus	O
be	O
a	O
useful	O
tool	O
for	O
studies	O
of	O
chicken	O
CTL	B-ANAT
cytolytic	O
potential	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

TITLE	O
:	O
Recombinant	O
nucleocapsid	B-ANAT
protein	O
-	O
based	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
detection	O
of	O
antibody	O
to	O
turkey	O
coronavirus	O
.	O

Additionally	O
,	O
the	O
poorly	O
aerated	O
tissue	B-ANAT
presented	O
the	O
largest	O
uptake	O
concentration	O
after	O
27	O
hours	O
.	O

Pediatricians	O
should	O
keep	O
a	O
high	O
index	O
of	O
suspicion	O
for	O
scrub	O
typhus	O
in	O
any	O
febrile	O
child	O
having	O
a	O
maculopapular	O
rash	O
,	O
hepatosplenomegaly	O
,	O
tender	O
lymphadenopathy	O
,	O
thrombocytopenia	O
and	O
features	O
suggestive	O
of	O
capillary	B-ANAT
leak	O
.	O

CONCLUSIONS	O
:	O
Pediatricians	O
should	O
keep	O
a	O
high	O
index	O
of	O
suspicion	O
for	O
scrub	O
typhus	O
in	O
any	O
febrile	O
child	O
having	O
a	O
maculopapular	O
rash	O
,	O
hepatosplenomegaly	O
,	O
tender	O
lymphadenopathy	O
,	O
thrombocytopenia	O
and	O
features	O
suggestive	O
of	O
capillary	B-ANAT
leak	O
.	O

Human	O
bocavirus	O
,	O
with	O
its	O
four	O
separate	O
lineages	O
,	O
discovered	O
in	O
2005	O
,	O
has	O
been	O
linked	O
to	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
and	O
gastrointestinal	O
complications	O
.	O

The	O
APOLDLT	O
is	O
a	O
life	O
-	O
saving	O
modality	O
for	O
rescuing	O
patients	O
with	O
high	O
-	O
risk	O
acute	O
liver	B-ANAT
failure	O
following	O
HBV	O
infection	O
without	O
available	O
donor	O
and	O
hence	O
is	O
recommended	O
under	O
standardized	O
antiviral	O
therapy	O
coverage	O
as	O
stated	O
above	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
in	O
vivo	O
systemic	O
and	O
mucosal	B-ANAT
antigen	O
-	O
specific	O
immune	O
responses	O
induced	O
by	O
a	O
single	O
intramuscular	O
or	O
intragastric	O
administration	O
of	O
recombinant	O
adenoviral	O
type	O
5	O
(	O
Ad5	O
)	O
or	O
type	O
41	O
(	O
Ad41	O
)	O
-	O
based	O
vaccines	O
expressing	O
the	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
.	O

Systematic	O
checks	O
need	O
to	O
be	O
carried	O
out	O
before	O
sailing	O
to	O
ensure	O
that	O
the	O
vessel	B-ANAT
'	O
s	O
compartments	B-ANAT
are	O
airtight	O
.	O

Usually	O
,	O
we	O
would	O
stop	O
existing	O
CRRT	O
when	O
cardiac	B-ANAT
arrest	O
occurred	O
.	O

We	O
would	O
not	O
start	O
CRRT	O
for	O
the	O
complexity	O
of	O
operation	O
and	O
additional	O
loss	O
of	O
blood	B-ANAT
.	O

We	O
strongly	O
recommended	O
a	O
prolonged	O
cardiopulmonary	B-ANAT
cerebral	B-ANAT
resuscitation	O
in	O
some	O
not	O
quite	O
old	O
SAP	O
patients	O
and	O
continue	O
to	O
use	O
existing	O
CRRT	O
but	O
not	O
remove	O
it	O
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
elucidate	O
the	O
anti	O
-	O
inflammatory	O
mechanism	O
of	O
eucalyptol	O
in	O
relation	O
to	O
tissue	B-ANAT
remodelling	O
in	O
acute	O
lung	B-ANAT
inflammation	O
.	O

Aside	O
from	O
Ebola	O
,	O
other	O
trends	O
in	O
the	O
infection	O
prevention	O
and	O
control	O
literature	O
covered	O
in	O
this	O
article	O
include	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
coronavirus	O
,	O
universal	O
versus	O
targeted	O
interventions	O
,	O
faecal	B-ANAT
microbiota	O
transplantation	O
,	O
whole	O
genome	O
sequencing	O
,	O
carbapenem	O
-	O
resistant	O
Enterobacteriaceae	O
,	O
and	O
some	O
aspects	O
of	O
environmental	O
science	O
.	O

Of	O
1105	O
stool	B-ANAT
samples	O
available	O
,	O
viral	O
RNA	O
/	O
DNA	O
was	O
detected	O
in	O
247	O
(	O
26	O
.	O
2	O
%)	O
of	O
941	O
pediatric	O
samples	O
(	O
median	O
age	O
=	O
2	O
.	O
97	O
years	O
,	O
54	O
%	O
male	O
)	O
with	O
28	O
(	O
3	O
.	O
0	O
%)	O
positive	O
for	O
more	O
than	O
one	O
virus	O
.	O

Experimental	O
studies	O
on	O
ARDS	O
have	O
shown	O
that	O
inhibition	O
of	O
apoptosis	O
in	O
the	O
lungs	B-ANAT
reduces	O
lung	B-ANAT
epithelial	O
injury	O
.	O

Eight	O
-	O
to	O
11	O
-	O
week	O
-	O
old	O
female	O
C57BL	O
/	O
6OlaHsd	O
mice	O
were	O
inoculated	O
with	O
the	O
rodent	O
-	O
specific	O
pneumovirus	O
pneumonia	O
virus	O
of	O
mice	O
(	O
PVM	O
)	O
strain	O
J3666	O
and	O
received	O
multiple	O
injections	O
of	O
zVAD	O
or	O
vehicle	O
(	O
control	O
)	O
during	O
the	O
course	O
of	O
disease	O
,	O
after	O
which	O
they	O
were	O
studied	O
for	O
markers	O
of	O
apoptosis	O
,	O
inflammation	O
,	O
and	O
lung	B-ANAT
injury	O
on	O
day	O
7	O
after	O
infection	O
.	O

Furthermore	O
,	O
zVAD	O
treatment	O
led	O
to	O
higher	O
concentrations	O
of	O
several	O
proinflammatory	O
cytokines	O
in	O
the	O
lungs	B-ANAT
and	O
more	O
weight	O
loss	O
in	O
PVM	O
-	O
infected	O
mice	O
.	O

In	O
contrast	O
,	O
zVAD	O
did	O
not	O
reduce	O
apoptosis	O
of	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
did	O
not	O
affect	O
the	O
degree	O
of	O
lung	B-ANAT
injury	O
,	O
permeability	O
,	O
and	O
viral	O
titers	O
in	O
PVM	O
disease	O
.	O

We	O
conclude	O
that	O
zVAD	O
has	O
an	O
adverse	O
effect	O
in	O
severe	O
pneumovirus	O
disease	O
in	O
mice	O
by	O
enhancing	O
the	O
lung	B-ANAT
proinflammatory	O
response	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
the	O
identification	O
of	O
ST	O
cell	B-ANAT
miRNAs	O
and	O
the	O
comprehensive	O
analysis	O
of	O
the	O
miRNA	O
regulatory	O
mechanism	O
during	O
TGEV	O
infection	O
,	O
which	O
revealed	O
the	O
miRNA	O
molecular	O
regulatory	O
mechanisms	O
for	O
the	O
viral	O
infection	O
,	O
expression	O
of	O
viral	O
genes	O
and	O
the	O
expression	O
of	O
immune	O
-	O
related	O
genes	O
.	O

TITLE	O
:	O
Analysis	O
of	O
protein	O
expression	O
changes	O
of	O
the	O
Vero	O
E6	O
cells	B-ANAT
infected	O
with	O
classic	O
PEDV	O
strain	O
CV777	O
by	O
using	O
quantitative	O
proteomic	O
technique	O
.	O

Although	O
the	O
use	O
of	O
intermittent	O
positive	O
pressure	O
ventilation	O
(	O
IPPV	O
)	O
in	O
neonates	O
with	O
respiratory	O
failure	O
saves	O
lives	O
,	O
its	O
use	O
is	O
associated	O
with	O
lung	B-ANAT
injury	O
and	O
chronic	O
lung	B-ANAT
disease	O
.	O

The	O
objective	O
of	O
this	O
review	O
was	O
to	O
determine	O
the	O
effect	O
of	O
the	O
elective	O
use	O
of	O
high	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
as	O
compared	O
to	O
conventional	O
ventilation	O
(	O
CV	O
)	O
on	O
the	O
incidence	O
of	O
chronic	O
lung	B-ANAT
disease	O
(	O
CLD	O
),	O
mortality	O
and	O
other	O
complications	O
associated	O
with	O
prematurity	O
and	O
assisted	O
ventilation	O
in	O
preterm	O
infants	O
who	O
were	O
mechanically	O
ventilated	O
for	O
respiratory	O
distress	O
syndrome	O
(	O
RDS	O
).	O

Meta	O
-	O
analysis	O
was	O
performed	O
using	O
both	O
a	O
fixed	B-ANAT
-	O
effect	O
and	O
a	O
random	O
-	O
effects	O
model	O
.	O

Subgroup	O
analysis	O
by	O
HFOV	O
strategy	O
showed	O
a	O
similar	O
effect	O
in	O
trials	O
with	O
a	O
more	O
strict	O
lung	B-ANAT
volume	O
recruitment	O
strategy	O
,	O
targeting	O
a	O
very	O
low	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FiO2	O
),	O
and	O
trials	O
with	O
a	O
less	O
strict	O
lung	B-ANAT
volume	O
recruitment	O
strategy	O
and	O
with	O
a	O
somewhat	O
higher	O
or	O
unspecified	O
target	O
FiO2	O
.	O

Most	O
trials	O
did	O
not	O
find	O
a	O
significant	O
difference	O
in	O
long	O
-	O
term	O
neurodevelopmental	O
outcome	O
,	O
although	O
one	O
recent	O
trial	O
showed	O
a	O
significant	O
reduction	O
in	O
the	O
risk	O
of	O
cerebral	B-ANAT
palsy	O
and	O
poor	O
mental	O
development	O
.	O

TITLE	O
:	O
Effects	O
of	O
a	O
recruitment	O
maneuver	O
on	O
plasma	B-ANAT
levels	O
of	O
soluble	O
RAGE	O
in	O
patients	O
with	O
diffuse	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
prospective	O
randomized	O
crossover	O
study	O
.	O

Clinical	O
severity	O
may	O
be	O
related	O
to	O
MERS	O
-	O
CoV	O
'	O
s	O
ability	O
to	O
infect	O
a	O
broad	O
range	O
of	O
cells	B-ANAT
with	O
DPP4	O
expression	O
,	O
evade	O
the	O
host	O
innate	O
immune	O
response	O
,	O
and	O
induce	O
cytokine	O
dysregulation	O
.	O

Infectious	O
virus	O
,	O
however	O
,	O
was	O
excreted	O
from	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
indicating	O
a	O
potential	O
route	O
of	O
MERS	O
-	O
CoV	O
transmission	O
in	O
some	O
animal	O
species	O
.	O

We	O
recently	O
managed	O
a	O
case	O
of	O
leptospirosis	O
with	O
isolated	O
lung	B-ANAT
involvement	O
as	O
alveolar	B-ANAT
hemorrhage	O
and	O
ARDS	O
.	O

High	O
index	O
of	O
suspicion	O
should	O
be	O
kept	O
in	O
acute	O
febrile	O
illness	O
patients	O
with	O
respiratory	O
symptoms	O
and	O
alveolar	B-ANAT
hemorrhage	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
risk	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
transmission	O
from	O
camels	O
to	O
humans	O
,	O
we	O
tested	O
serum	B-ANAT
from	O
191	O
persons	O
with	O
various	O
levels	O
of	O
exposure	O
to	O
an	O
infected	O
dromedary	O
herd	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
infection	O
induces	O
NF	O
-	O
ÎºB	O
activation	O
through	O
the	O
TLR2	O
,	O
TLR3	O
and	O
TLR9	O
pathways	O
in	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

478	O
patients	O
with	O
eligible	O
criteria	O
for	O
moderate	O
(	O
100	O
<	O
PaOâ	O
/	O
FiOâ	O
â¤	O
200	O
)	O
and	O
severe	O
(	O
PaOâ	O
/	O
FiOâ	O
â¤	O
100	O
)	O
ARDS	O
and	O
followed	O
until	O
hospital	O
discharge	B-ANAT
.	O

It	O
was	O
identified	O
to	O
be	O
approximately	O
32	O
kDa	O
as	O
a	O
His	O
-	O
tagged	O
fusion	O
protein	O
and	O
can	O
bind	O
IBV	O
positive	O
serum	B-ANAT
by	O
western	O
blot	O
analysis	O
.	O

TITLE	O
:	O
Safety	O
and	O
efficacy	O
of	O
bronchoalveolar	O
lavage	O
using	O
a	O
laryngeal	B-ANAT
mask	O
airway	B-ANAT
in	O
cases	O
of	O
acute	O
hypoxaemic	O
respiratory	O
failure	O
with	O
diffuse	O
lung	B-ANAT
infiltrates	O
.	O

Isolated	O
TEMs	O
,	O
when	O
mixed	O
with	O
CoV	O
and	O
LP	O
IAV	O
pseudoparticles	O
,	O
cleaved	B-ANAT
viral	O
fusion	O
proteins	O
to	O
fusion	O
-	O
primed	O
fragments	O
and	O
potentiated	O
viral	O
transductions	O
.	O

TITLE	O
:	O
Structural	O
alteration	O
of	O
tight	O
and	O
adherens	B-ANAT
junctions	I-ANAT
in	O
villous	O
and	O
crypt	B-ANAT
epithelium	I-ANAT
of	O
the	O
small	O
and	O
large	B-ANAT
intestine	I-ANAT
of	O
conventional	O
nursing	O
piglets	O
infected	O
with	O
porcine	O
epidemic	O
diarrhea	O
virus	O
.	O

The	O
ÎTNC	O
has	O
a	O
high	O
diagnostic	O
accuracy	O
for	O
FIP	O
-	O
related	O
effusions	O
by	O
providing	O
an	O
estimate	O
of	O
precipitable	O
proteins	O
,	O
as	O
the	O
Rivalta	O
'	O
s	O
test	O
,	O
in	O
addition	O
to	O
the	O
cell	B-ANAT
count	O
.	O

Moreover	O
,	O
the	O
docking	O
study	O
of	O
all	O
synthesized	O
compounds	O
inside	O
the	O
HLA	B-ANAT
-	O
A	O
protein	O
(	O
PDB	O
ID	O
:	O
3OX8	O
)	O
active	O
site	O
were	O
carried	O
out	O
to	O
explore	O
the	O
molecular	O
interactions	O
and	O
a	O
molecular	O
target	O
for	O
activity	O
of	O
phenylpropanoid	O
derivatives	O
with	O
the	O
protein	O
using	O
a	O
moe	O
-	O
docking	O
technique	O
.	O

TITLE	O
:	O
Clinical	O
outcomes	O
associated	O
with	O
respiratory	O
virus	O
detection	O
before	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
.	O

We	O
explored	O
the	O
utility	O
of	O
simvastatin	O
in	O
a	O
mouse	O
model	O
of	O
severe	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Ventilation	O
with	O
high	O
tidal	O
volume	O
(	O
HVt	O
)	O
resulted	O
in	O
significantly	O
increased	O
lung	B-ANAT
elastance	O
by	O
3	O
-	O
fold	O
and	O
decreased	O
lung	B-ANAT
compliance	O
by	O
45	O
%	O
compared	O
to	O
low	O
tidal	O
volume	O
(	O
LVt	O
)	O
but	O
simvastatin	O
abrogated	O
lung	B-ANAT
mechanical	O
alterations	O
of	O
HVt	O
.	O

Wet	O
mount	O
microscopy	O
from	O
respiratory	B-ANAT
samples	I-ANAT
showed	O
broad	O
-	O
based	O
yeast	O
consistent	O
with	O
B	O
.	O
dermatitidis	O
.	O

In	O
all	O
four	O
cases	O
,	O
ECMO	O
decannulation	O
was	O
performed	O
(	O
7	O
-	O
23	O
days	O
),	O
mechanical	O
ventilation	O
was	O
withdrawn	O
(	O
18	O
-	O
52	O
days	O
),	O
and	O
the	O
patients	O
survived	O
to	O
hospital	O
discharge	B-ANAT
(	O
31	O
-	O
87	O
days	O
).	O

Thus	O
,	O
the	O
efficient	O
incorporation	O
of	O
viral	B-ANAT
envelope	I-ANAT
proteins	O
into	O
CoV	O
virions	B-ANAT
depends	O
on	O
protein	O
trafficking	O
and	O
protein	O
-	O
protein	O
interactions	O
near	O
the	O
ERGIC	B-ANAT
.	O

The	O
resulting	O
assays	O
could	O
detect	O
0	O
.	O
02	O
to	O
0	O
.	O
2	O
plaque	O
forming	O
units	O
(	O
PFU	O
)	O
(	O
5	O
to	O
50	O
PFU	O
/	O
ml	O
)	O
of	O
MERS	O
-	O
CoV	O
in	O
infected	O
cell	B-ANAT
culture	O
supernatants	O
within	O
30	O
to	O
50	O
min	O
and	O
did	O
not	O
cross	O
-	O
react	O
with	O
common	O
human	O
respiratory	O
pathogens	O
.	O

A	O
comparison	O
was	O
made	O
between	O
those	O
patients	O
that	O
met	O
urine	B-ANAT
SIADH	O
criteria	O
and	O
those	O
who	O
did	O
not	O
.	O

Patients	O
older	O
than	O
one	O
month	O
with	O
acute	O
moderate	O
bronchiolitis	O
and	O
urine	B-ANAT
SIADH	O
criteria	O
have	O
worse	O
clinical	O
courses	O
and	O
more	O
need	O
for	O
non	O
-	O
invasive	O
mechanical	O
ventilation	O
,	O
PICU	O
admission	O
,	O
and	O
have	O
a	O
higher	O
incidence	O
of	O
pneumonia	O
on	O
chest	B-ANAT
X	O
-	O
ray	O
.	O

This	O
review	O
charts	O
the	O
development	O
of	O
protein	O
mimics	O
based	O
on	O
cell	B-ANAT
-	O
penetrating	O
peptides	O
(	O
CPPs	O
)	O
and	O
how	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
with	O
these	O
molecules	O
and	O
their	O
protein	O
counterparts	O
ultimately	O
led	O
to	O
the	O
use	O
of	O
polymeric	O
scaffolds	O
.	O

TITLE	O
:	O
Risk	O
factors	O
for	O
transient	O
dysfunction	O
of	O
gas	O
exchange	O
after	O
cardiac	B-ANAT
surgery	O
.	O

In	O
the	O
cross	O
-	O
sectional	O
serosurvey	O
,	O
we	O
tested	O
human	O
serum	B-ANAT
samples	O
obtained	O
from	O
healthy	O
individuals	O
older	O
than	O
15	O
years	O
who	O
attended	O
primary	O
health	O
-	O
care	O
centres	O
or	O
participated	O
in	O
a	O
national	O
burden	O
-	O
of	O
-	O
disease	O
study	O
in	O
all	O
13	O
provinces	O
of	O
Saudi	O
Arabia	O
.	O

Additionally	O
,	O
we	O
tested	O
serum	B-ANAT
samples	O
from	O
shepherds	O
and	O
abattoir	O
workers	O
with	O
occupational	O
exposure	O
to	O
camels	O
.	O

At	O
48	O
h	O
post	O
-	O
transfection	O
,	O
the	O
transfected	O
Vero	B-ANAT
cells	I-ANAT
were	O
harvested	O
,	O
and	O
passaging	O
continued	O
.	O

A	O
syncytium	B-ANAT
was	O
not	O
observed	O
until	O
the	O
recombinant	O
virus	O
had	O
passed	O
through	O
four	O
passages	O
.	O

In	O
this	O
article	O
we	O
underlined	O
the	O
key	O
elements	O
of	O
the	O
new	O
definition	O
of	O
ARDS	O
,	O
diagnostic	O
criteria	O
and	O
the	O
importance	O
of	O
early	O
diagnosis	O
in	O
prehospital	O
period	O
following	O
clinical	O
feature	O
and	O
course	O
(	O
a	O
presence	O
of	O
severe	O
dyspnea	O
)	O
by	O
adding	O
chest	B-ANAT
x	O
-	O
ray	O
and	O
laboratory	O
investigations	O
.	O

IgM	B-ANAT
antibody	I-ANAT
was	O
positive	O
in	O
all	O
the	O
17	O
cases	O
,	O
which	O
included	O
9	O
male	O
cases	O
,	O
8	O
female	O
cases	O
,	O
and	O
their	O
age	O
was	O
from	O
2	O
months	O
to	O
10	O
years	O
.	O

The	O
severity	O
of	O
RDS	O
in	O
preterm	O
infants	O
seemed	O
to	O
be	O
associated	O
with	O
the	O
plasma	B-ANAT
level	O
of	O
sRAGE	O
and	O
AQP5	O
:	O
the	O
more	O
severe	O
the	O
disease	O
,	O
the	O
higher	O
the	O
plasma	B-ANAT
level	O
of	O
sRAGE	O
and	O
AQP5	O
.	O

RESULTS	O
:	O
The	O
plasma	B-ANAT
levels	O
of	O
sRAGE	O
and	O
AQP5	O
of	O
the	O
control	O
group	O
were	O
significantly	O
lower	O
than	O
that	O
of	O
experimental	O
group	O
at	O
three	O
time	O
points	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

A	O
high	O
resolution	O
computer	O
tomography	O
showed	O
severe	O
diffuse	O
parenchymal	O
lung	B-ANAT
disease	O
,	O
while	O
the	O
patient	O
'	O
s	O
pulmonary	B-ANAT
function	O
tests	O
were	O
normal	O
and	O
he	O
was	O
asymptomatic	O
.	O

The	O
father	O
suffered	O
from	O
spondylarthritis	O
,	O
and	O
apart	O
from	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
lymphopenia	O
,	O
no	O
other	O
changes	O
within	O
the	O
leukocyte	B-ANAT
pool	O
were	O
seen	O
.	O

Due	O
to	O
the	O
difficulty	O
in	O
isolating	O
and	O
growing	O
this	O
virus	O
in	O
cell	B-ANAT
culture	O
,	O
few	O
vaccine	O
studies	O
using	O
cell	B-ANAT
culture	O
propagated	O
PEDV	O
have	O
been	O
performed	O
on	O
U	O
.	O
S	O
.	O
strains	O
in	O
pigs	O
.	O

The	O
imbalance	O
between	O
CD4	O
+	O
CD25	O
+	O
Foxp3	O
+	O
regulatory	O
T	O
(	O
Treg	O
)	O
cells	B-ANAT
and	O
T	O
helper	O
(	O
Th	O
)	O
17	O
cells	B-ANAT
has	O
been	O
found	O
in	O
a	O
number	O
of	O
different	O
inflammation	O
and	O
autoimmune	O
diseases	O
,	O
while	O
the	O
role	O
of	O
the	O
Th17	O
/	O
Treg	O
balance	O
in	O
ARDS	O
remains	O
largely	O
unknown	O
.	O

Currently	O
,	O
there	O
is	O
no	O
effective	O
pharmacological	O
treatment	O
for	O
acute	O
lung	B-ANAT
injury	O
.	O

We	O
also	O
measured	O
the	O
inflammatory	O
gene	O
expression	O
in	O
human	O
pulmonary	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

In	O
vivo	O
,	O
LPS	O
significantly	O
increased	O
protein	O
concentration	O
and	O
number	O
of	O
inflammatory	B-ANAT
cells	I-ANAT
in	O
BALF	O
,	O
pulmonary	B-ANAT
edema	O
,	O
pathological	O
changes	O
of	O
lung	B-ANAT
tissue	I-ANAT
,	O
inflammatory	O
cytokines	O
in	O
serum	B-ANAT
and	O
BALF	O
,	O
macrophage	B-ANAT
infiltration	O
,	O
inflammatory	O
gene	O
expression	O
,	O
and	O
MAPKs	O
phosphorylation	O
.	O

Meanwhile	O
,	O
compound	O
c26	O
reduced	O
the	O
LPS	O
-	O
induced	O
inflammatory	O
gene	O
expression	O
in	O
human	O
pulmonary	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Sequence	O
analysis	O
indicated	O
that	O
it	O
was	O
conserved	O
in	O
the	O
5	O
'	O
and	O
3	O
'-	O
non	O
-	O
translated	O
regions	O
,	O
and	O
there	O
were	O
no	O
insertions	O
or	O
deletions	O
in	O
nonstructural	O
genes	O
,	O
such	O
as	O
ORF1a	O
,	O
ORF1b	O
,	O
ORF3a	O
,	O
ORF3b	O
,	O
and	O
ORF7	O
,	O
as	O
well	O
as	O
in	O
genes	O
encoding	O
structural	O
proteins	O
,	O
such	O
as	O
the	O
envelope	B-ANAT
(	O
E	O
),	O
membrane	B-ANAT
(	O
M	O
),	O
and	O
nucleoprotein	O
(	O
N	O
)	O
proteins	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
whether	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
an	O
emerging	O
veterinary	O
virus	O
,	O
infects	O
Vero	B-ANAT
cells	I-ANAT
by	O
attaching	O
to	O
heparan	O
sulfate	O
.	O

The	O
mortality	O
rate	O
in	O
patients	O
with	O
renal	B-ANAT
failure	O
(	O
14	O
),	O
including	O
8	O
on	O
haemodialysis	O
,	O
was	O
100	O
%.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
conducted	O
to	O
investigate	O
the	O
impacts	O
of	O
deoxynivalenol	O
(	O
DON	O
)	O
feeding	O
either	O
alone	O
or	O
in	O
combination	O
with	O
a	O
microbial	O
feed	O
additive	O
(	O
MFA	O
)	O
on	O
the	O
immune	O
response	O
to	O
a	O
viral	O
vaccine	O
and	O
serum	B-ANAT
clinical	O
chemical	O
parameters	O
.	O

Following	O
National	O
Institute	O
for	O
Health	O
Research	O
'	O
s	O
Research	O
Centre	O
(	O
London	O
,	O
United	O
Kingdom	O
)	O
approval	O
,	O
the	O
authors	O
of	O
this	O
study	O
conducted	O
a	O
survey	O
of	O
specialist	O
registrars	O
'	O
knowledge	O
of	O
the	O
respiratory	O
and	O
skin	B-ANAT
protection	O
requirements	O
needed	O
during	O
a	O
resuscitation	O
scenario	O
with	O
Advanced	O
Life	O
Support	O
.	O

A	O
total	O
of	O
98	O
specialist	O
registrars	O
(	O
in	O
Anesthesiology	O
,	O
n	O
=	O
51	O
;	O
in	O
Emergency	O
Medicine	O
(	O
EM	O
),	O
n	O
=	O
21	O
;	O
and	O
in	O
Intensive	O
Care	O
Medicine	O
(	O
ICM	B-ANAT
)	O
n	O
=	O
26	O
)	O
completed	O
hand	O
-	O
delivered	O
surveys	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
98	O
specialist	O
registrars	O
(	O
in	O
Anesthesiology	O
,	O
n	O
=	O
51	O
;	O
in	O
Emergency	O
Medicine	O
(	O
EM	O
),	O
n	O
=	O
21	O
;	O
and	O
in	O
Intensive	O
Care	O
Medicine	O
(	O
ICM	B-ANAT
)	O
n	O
=	O
26	O
)	O
completed	O
hand	O
-	O
delivered	O
surveys	O
.	O

Its	O
interaction	O
with	O
P6	O
was	O
confirmed	O
within	O
cells	B-ANAT
.	O

The	O
presence	O
of	O
coronavirus	O
in	O
the	O
left	B-ANAT
eye	I-ANAT
was	O
confirmed	O
by	O
positive	O
immunohistochemistry	O
.	O

Two	O
oropharyngeal	B-ANAT
swab	O
specimens	O
were	O
collected	O
on	O
the	O
1st	O
and	O
2nd	O
day	O
of	O
patient	O
hospitalization	O
and	O
tested	O
using	O
two	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
(	O
rRT	O
-	O
PCR	O
)	O
assays	O
targeting	O
the	O
UpE	O
and	O
Orf	O
-	O
1a	O
regions	O
of	O
the	O
MERS	O
-	O
CoV	O
genome	O
and	O
RT	O
-	O
PCR	O
and	O
partial	O
sequencing	O
of	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
nucleocapsid	B-ANAT
genes	O
.	O

Full	O
-	O
length	O
nucleocapsid	B-ANAT
and	O
spike	O
gene	O
coding	O
sequences	O
were	O
later	O
obtained	O
from	O
the	O
positive	O
swab	O
sample	O
.	O

In	O
addition	O
,	O
results	O
indicate	O
the	O
existence	O
of	O
age	O
-	O
dependent	O
changes	O
in	O
key	O
components	O
of	O
the	O
intracellular	B-ANAT
signaling	O
pathways	O
involved	O
in	O
the	O
inflammatory	O
response	O
.	O

Pulmonary	B-ANAT
inflammation	O
seems	O
relatively	O
suppressed	O
in	O
infants	O
/	O
juveniles	O
,	O
whereas	O
in	O
the	O
middle	O
aged	O
/	O
elderly	O
,	O
the	O
inflammatory	O
response	O
seems	O
delayed	O
but	O
aggravated	O
.	O

Importantly	O
,	O
platelets	B-ANAT
are	O
more	O
affected	O
by	O
vv	O
-	O
ECMO	O
compared	O
with	O
pumpless	O
iLA	O
.	O

Prone	O
positioning	O
was	O
not	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
cardiac	B-ANAT
events	O
(	O
RR	O
1	O
.	O
01	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
87	O
-	O
1	O
.	O
17	O
)	O
or	O
ventilator	O
associated	O
pneumonia	O
(	O
RR	O
0	O
.	O
88	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
71	O
-	O
1	O
.	O
09	O
),	O
but	O
it	O
was	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
pressure	O
sores	O
(	O
RR	O
1	O
.	O
23	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
07	O
-	O
1	O
.	O
41	O
)	O
and	O
endotracheal	O
dislocation	O
(	O
RR	O
1	O
.	O
33	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
02	O
-	O
1	O
.	O
74	O
).	O

Brain	B-ANAT
magnetic	O
resonant	O
imaging	O
(	O
MRI	O
)	O
revealed	O
a	O
strikingly	O
selective	O
white	B-ANAT
matter	I-ANAT
injury	O
early	O
in	O
the	O
course	O
of	O
the	O
disease	O
.	O

The	O
patient	O
remained	O
in	O
a	O
comatose	O
state	O
with	O
no	O
signs	O
of	O
neurologic	O
recovery	O
until	O
he	O
died	O
few	O
weeks	O
later	O
following	O
an	O
increase	O
in	O
the	O
brain	B-ANAT
edema	O
and	O
herniation	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
may	O
mediate	O
infection	O
by	O
binding	O
to	O
a	O
cellular	B-ANAT
neural	B-ANAT
cell	I-ANAT
adhesion	O
molecule	O
(	O
NCAM	O
).	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
human	O
coronavirus	O
(	O
HCoV	O
)-	O
NL63	O
,	O
human	O
metapneumovirus	O
(	O
hMPV	O
),	O
human	O
bocavirus	O
(	O
Boca	O
),	O
human	O
polyomavirus	O
KI	O
(	O
KIV	O
)	O
and	O
human	O
polyomavirus	O
WU	O
(	O
WUV	O
)	O
in	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTI	O
)	O
in	O
Kuwait	O
.	O

We	O
established	O
a	O
miniaturized	O
luciferase	O
gene	O
reporter	O
assay	O
in	O
A549	O
cells	B-ANAT
that	O
measures	O
IFN	O
-	O
Î²	O
induction	O
by	O
viral	O
dsRNA	O
and	O
is	O
dose	O
-	O
dependently	O
inhibited	O
by	O
VP35	O
expression	O
.	O

The	O
second	O
objective	O
was	O
to	O
determine	O
whether	O
the	O
serostatus	O
(	O
seropositive	O
/	O
seronegative	O
)	O
of	O
seven	O
respiratory	O
pathogens	O
(	O
bovine	O
respiratory	O
syncytial	O
virus	O
(	O
BRSV	O
),	O
parainfluenzavirus	O
-	O
3	O
,	O
bovine	O
coronavirus	O
(	O
BCV	O
),	O
bovine	O
herpesvirus	O
-	O
1	O
,	O
bovine	O
viral	O
diarrhea	O
virus	O
,	O
Mannheimia	O
haemolytica	O
and	O
Mycoplasma	O
bovis	O
)	O
of	O
these	O
arrival	O
serum	B-ANAT
samples	O
could	O
be	O
associated	O
with	O
the	O
risk	O
of	O
having	O
BRD	O
.	O

For	O
pathology	O
and	O
immunofluorescence	O
staining	O
for	O
Ki67	O
(	O
marker	O
for	O
crypt	B-ANAT
proliferation	O
)	O
and	O
LGR5	O
(	O
marker	O
for	O
crypt	B-ANAT
stem	B-ANAT
cell	I-ANAT
),	O
3	O
-	O
4	O
pigs	O
were	O
euthanized	O
at	O
postinoculation	O
days	O
(	O
PIDs	O
)	O
1	O
,	O
3	O
and	O
5	O
.	O

ABSTRACT	O
:	O
Seasonal	O
influenza	O
vaccination	O
is	O
recommended	O
for	O
patients	O
with	O
end	O
-	O
stage	O
renal	B-ANAT
disease	O
(	O
ESRD	O
),	O
despite	O
suggested	O
inferior	O
efficacy	O
among	O
these	O
patients	O
.	O

TITLE	O
:	O
Alterations	O
of	O
lung	B-ANAT
microbiota	O
in	O
a	O
mouse	O
model	O
of	O
LPS	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
are	O
common	O
responses	O
to	O
a	O
variety	O
of	O
infectious	O
and	O
noninfectious	O
insults	O
.	O

Additionally	O
,	O
microbiota	O
from	O
LPS	O
-	O
treated	O
mice	O
intensified	O
IL	O
-	O
6	O
-	O
induced	O
lung	B-ANAT
inflammation	O
in	O
naive	O
mice	O
.	O

ABSTRACT	O
:	O
High	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
is	O
theoretically	O
ideal	O
for	O
lung	B-ANAT
protective	O
strategy	O
ventilation	O
(	O
LPSV	O
)	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
use	O
of	O
fluid	O
resuscitation	O
is	O
an	O
important	O
treatment	O
for	O
sepsis	O
,	O
but	O
positive	O
fluid	O
balance	O
may	O
induce	O
pulmonary	B-ANAT
injury	O
.	O

We	O
found	O
that	O
hypertonic	O
saline	O
(	O
NaCl	O
7	O
.	O
5	O
%)	O
treatment	O
in	O
rat	O
model	O
of	O
LPS	O
-	O
induced	O
ARDS	O
avoided	O
pulmonary	B-ANAT
function	O
worsening	O
and	O
inhibited	O
type	O
I	O
collagen	B-ANAT
deposition	O
.	O

In	O
addition	O
,	O
hypertonic	O
saline	O
prevented	O
pulmonary	B-ANAT
injury	O
by	O
decreasing	O
metalloproteinase	O
9	O
(	O
MMP	O
-	O
9	O
)	O
activity	O
in	O
tissue	B-ANAT
.	O

Our	O
study	O
shows	O
that	O
fluid	O
resuscitation	O
with	O
hypertonic	O
saline	O
decreases	O
the	O
progression	O
of	O
LPS	O
-	O
induced	O
ARDS	O
due	O
to	O
inhibition	O
of	O
pulmonary	B-ANAT
remodeling	O
that	O
is	O
observed	O
when	O
regular	O
saline	O
is	O
used	O
.	O

This	O
technique	O
enables	O
simultaneous	O
serological	O
testing	O
against	O
multiple	O
recombinant	O
HA	O
-	O
types	O
in	O
5	O
Î¼l	O
of	O
serum	B-ANAT
.	O

Anesthesia	O
and	O
surgery	O
with	O
accompanying	O
post	O
-	O
traumatic	O
stress	O
can	O
weaken	O
patients	O
'	O
immunity	O
and	O
cause	O
susceptibility	O
to	O
severe	O
lung	B-ANAT
infections	O
.	O

TITLE	O
:	O
A	O
Single	O
Point	O
Mutation	O
Creating	O
a	O
Furin	O
Cleavage	O
Site	O
in	O
the	O
Spike	O
Protein	O
Renders	O
Porcine	O
Epidemic	O
Diarrhea	O
Coronavirus	O
Trypsin	O
Independent	O
for	O
Cell	B-ANAT
Entry	O
and	O
Fusion	O
.	O

However	O
,	O
PEDV	O
vaccine	O
research	O
has	O
been	O
hampered	O
by	O
difficulties	O
in	O
isolating	O
and	O
propagating	O
the	O
virus	O
in	O
mammalian	O
cells	B-ANAT
,	O
thereby	O
complicating	O
the	O
recovery	O
of	O
infectious	O
PEDV	O
using	O
a	O
full	O
-	O
length	O
infectious	O
clone	O
.	O

ABSTRACT	O
:	O
Phenol	O
burns	O
can	O
result	O
in	O
multiple	O
organ	B-ANAT
failure	O
.	O

TITLE	O
:	O
Mixed	O
viral	O
infections	O
circulating	O
in	O
hospitalized	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
kuwait	O
.	O

Hospitalized	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
RTI	O
)	O
were	O
investigated	O
for	O
15	O
respiratory	O
viruses	O
by	O
using	O
sensitive	O
molecular	O
techniques	O
.	O

As	O
ALI	O
developed	O
over	O
6	O
hr	O
,	O
extracellular	B-ANAT
histones	O
appeared	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluids	I-ANAT
(	O
BALF	O
).	O

We	O
did	O
not	O
detect	O
antibodies	O
against	O
Brucella	O
abortus	B-ANAT
/	O
suis	O
or	O
Brucella	O
canis	O
.	O

Intermittent	O
hemodialysis	O
is	O
the	O
preferred	O
modality	O
(	O
1D	O
),	O
although	O
hemoperfusion	O
(	O
1D	O
)	O
and	O
continuous	O
renal	B-ANAT
replacement	O
therapies	O
(	O
3D	O
)	O
are	O
acceptable	O
alternatives	O
if	O
hemodialysis	O
is	O
unavailable	O
,	O
as	O
is	O
exchange	O
transfusion	O
in	O
neonates	O
(	O
1D	O
).	O

NextGen	O
sequencing	O
of	O
ultrapurified	O
viruses	O
indicated	O
a	O
strong	O
homology	O
of	O
the	O
S1	B-ANAT
segment	I-ANAT
to	O
mammalian	O
and	O
bat	O
MRV3	O
.	O

These	O
fecal	B-ANAT
and	O
blood	B-ANAT
meal	O
isolates	O
or	O
a	O
chloroform	O
extract	O
of	O
blood	B-ANAT
meal	O
induced	O
severe	O
diarrhea	O
and	O
mortality	O
in	O
experimentally	O
infected	O
neonatal	O
pigs	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
23	O
-	O
year	O
-	O
old	O
woman	O
with	O
rapid	O
onset	O
of	O
proximal	O
and	O
distal	O
limb	B-ANAT
weakness	O
and	O
areflexia	O
,	O
associated	O
with	O
tumor	O
-	O
like	O
spinal	B-ANAT
nerve	I-ANAT
root	I-ANAT
enlargement	O
and	O
markedly	O
elevated	O
cerebrospinal	B-ANAT
fluid	I-ANAT
protein	O
.	O

Her	O
cranial	B-ANAT
nerves	I-ANAT
and	O
respiratory	O
function	O
remained	O
intact	O
.	O

Dietary	O
inclusion	O
of	O
genistein	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
lymphocytes	B-ANAT
and	O
subsequently	O
reduced	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
heterophil	B-ANAT
to	O
lymphocyte	B-ANAT
ratio	O
.	O

The	O
mechanistic	O
description	O
is	O
that	O
C5a	O
altered	O
the	O
alveolar	B-ANAT
cytokine	O
milieu	O
and	O
caused	O
significant	O
release	O
of	O
CC	O
-	O
chemokines	O
.	O

The	O
usefulness	O
of	O
this	O
block	O
has	O
been	O
discussed	O
in	O
the	O
management	O
of	O
pain	O
of	O
rib	B-ANAT
fractures	O
and	O
breast	B-ANAT
surgeries	O
.	O

Compared	O
to	O
controls	O
,	O
patients	O
with	O
respiratory	O
dysfunction	O
had	O
higher	O
values	O
for	O
the	O
Walton	O
and	O
Gardner	O
-	O
Medwin	O
score	O
(	O
6	O
.	O
1	O
Â±	O
1	O
.	O
9	O
vs	O
.	O
3	O
.	O
2	O
Â±	O
1	O
.	O
2	O
;	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
body	B-ANAT
mass	O
index	O
(	O
26	O
.	O
9	O
Â±	O
6	O
.	O
0	O
vs	O
.	O
22	O
.	O
9	O
Â±	O
4	O
.	O
0	O
kg	O
/	O
m	O
(	O
2	O
);	O
P	O
=	O
0	O
.	O
003	O
)	O
and	O
a	O
smaller	O
number	O
of	O
D4Z4	O
allele	O
repeats	O
(	O
4	O
.	O
8	O
Â±	O
1	O
.	O
6	O
vs	O
.	O
5	O
.	O
7	O
Â±	O
1	O
.	O
8	O
;	O
P	O
=	O
0	O
.	O
05	O
).	O

Respiratory	O
dysfunction	O
in	O
facioscapulohumeral	O
muscular	B-ANAT
dystrophy	O
is	O
predominantly	O
related	O
to	O
expiratory	O
muscle	B-ANAT
weakness	O
.	O

However	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
plasma	B-ANAT
TFPI	O
values	O
among	O
the	O
healthy	O
control	O
,	O
sepsis	O
and	O
severe	O
sepsis	O
groups	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Factors	O
secreted	O
from	O
dental	B-ANAT
pulp	I-ANAT
stem	B-ANAT
cells	I-ANAT
show	O
multifaceted	O
benefits	O
for	O
treating	O
acute	O
lung	B-ANAT
injury	O
in	O
mice	O
.	O

Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
scores	O
and	O
the	O
requirements	O
for	O
organ	B-ANAT
support	O
were	O
evaluated	O
throughout	O
the	O
observational	O
period	O
to	O
assess	O
organ	B-ANAT
failure	O
.	O

Alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
(	O
AECs	O
)	O
are	O
the	O
first	O
cells	B-ANAT
that	O
influenza	O
virus	O
encounters	O
upon	O
entering	O
the	O
alveolus	B-ANAT
.	O

Recently	O
,	O
TGF	O
-	O
Î±	O
/	O
EGFR	O
signaling	O
has	O
also	O
been	O
shown	O
to	O
regulate	O
innate	O
immune	O
responses	O
in	O
bronchial	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

HGF	O
secretion	B-ANAT
by	O
fibroblasts	B-ANAT
was	O
stimulated	O
by	O
AEC	O
production	O
of	O
prostaglandin	O
E2	O
during	O
influenza	O
infection	O
.	O

Consensus	O
Conference	O
of	O
experts	O
in	O
pediatric	O
acute	O
lung	B-ANAT
injury	O
.	O

Binding	O
of	O
all	O
coronaviral	O
S1	O
proteins	O
was	O
dependent	O
on	O
sialic	O
acids	O
;	O
however	O
,	O
while	O
chicken	O
CoV	O
S1	O
preferred	O
sialic	O
acids	O
type	O
I	O
lactosamine	O
(	O
Gal	O
(	O
1	O
-	O
3	O
)	O
GlcNAc	O
)	O
over	O
type	O
II	O
(	O
Gal	O
(	O
1	O
-	O
4	O
)	O
GlcNAc	O
),	O
the	O
fine	O
glycan	O
specificities	O
of	O
pigeon	O
and	O
partridge	O
CoVs	O
were	O
different	O
,	O
as	O
chicken	O
CoV	O
S1	O
-	O
specific	O
sialylglycopolymers	O
could	O
not	O
block	O
their	O
binding	O
to	O
tissues	B-ANAT
.	O

All	O
-	O
in	O
/	O
all	O
-	O
out	O
'	O
operations	O
of	O
rearing	O
along	O
with	O
good	O
biosafety	O
measures	O
forms	O
the	O
basis	O
of	O
prevention	O
,	O
whereas	O
vaccination	O
forms	O
the	O
backbone	B-ANAT
of	O
IB	O
control	O
programme	O
.	O

Interestingly	O
,	O
nine	O
putative	O
non	O
-	O
canonical	O
cleavage	O
sites	O
were	O
predicted	O
and	O
three	O
of	O
them	O
could	O
be	O
cleaved	B-ANAT
by	O
MERS	O
-	O
CoV	O
nsp5	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
outbreak	O
of	O
severe	O
respiratory	O
infections	O
associated	O
with	O
a	O
novel	O
group	O
C	O
betacoronavirus	O
(	O
HCoV	O
-	O
EMC	B-ANAT
)	O
from	O
Saudi	O
Arabia	O
has	O
drawn	O
global	O
attention	O
to	O
another	O
highly	O
probable	O
""""	O
SARS	O
-	O
like	O
""""	O
animal	O
-	O
to	O
-	O
human	O
interspecies	O
jumping	O
event	O
in	O
coronavirus	O
(	O
CoV	O
).	O

The	O
genome	O
of	O
HCoV	O
-	O
EMC	B-ANAT
is	O
most	O
closely	O
related	O
to	O
Tylonycteris	O
bat	O
coronavirus	O
HKU4	O
(	O
Ty	O
-	O
BatCoV	O
HKU4	O
)	O
and	O
Pipistrellus	O
bat	O
coronavirus	O
HKU5	O
(	O
Pi	O
-	O
BatCoV	O
HKU5	O
)	O
we	O
discovered	O
in	O
2006	O
.	O

More	O
intensive	O
surveillance	O
studies	O
in	O
bats	O
and	O
other	O
animals	O
may	O
reveal	O
the	O
natural	O
host	O
of	O
HCoV	O
-	O
EMC	B-ANAT
.	O

However	O
,	O
recent	O
studies	O
in	O
mice	O
suggest	O
the	O
importance	O
of	O
T	B-ANAT
cells	I-ANAT
in	O
viral	O
clearance	O
during	O
SARS	O
-	O
CoV	O
infection	O
.	O

Moreover	O
,	O
a	O
growing	O
number	O
of	O
studies	O
have	O
investigated	O
the	O
memory	O
T	B-ANAT
cell	I-ANAT
responses	O
in	O
recovered	O
SARS	O
patients	O
.	O

Pathway	O
analysis	O
grouped	O
subsets	O
of	O
these	O
factors	O
in	O
specific	O
cellular	B-ANAT
processes	O
,	O
including	O
the	O
innate	O
immune	O
response	O
and	O
the	O
metabolism	O
of	O
complex	O
lipids	O
,	O
which	O
appear	O
to	O
play	O
a	O
role	O
in	O
SARS	O
-	O
CoV	O
infection	O
.	O

In	O
cells	B-ANAT
depleted	O
for	O
the	O
Î²2	O
subunit	O
of	O
the	O
coatomer	B-ANAT
protein	B-ANAT
complex	I-ANAT
(	O
COPB2	O
),	O
the	O
strongest	O
proviral	O
hit	O
,	O
we	O
observed	O
reduced	O
SARS	O
-	O
CoV	O
protein	O
expression	O
and	O
a	O
>	O
2	O
-	O
log	O
reduction	O
in	O
virus	O
yield	O
.	O

Knockdown	O
of	O
the	O
COPB2	O
-	O
related	O
proteins	O
COPB1	O
and	O
Golgi	B-ANAT
-	O
specific	O
brefeldin	O
A	O
-	O
resistant	O
guanine	O
nucleotide	O
exchange	O
factor	O
1	O
(	O
GBF1	O
)	O
also	O
suggested	O
that	O
COPI	B-ANAT
-	I-ANAT
coated	I-ANAT
vesicles	I-ANAT
and	O
/	O
or	O
the	O
early	O
secretory	O
pathway	O
are	O
important	O
for	O
SARS	O
-	O
CoV	O
replication	O
.	O

Although	O
PEDV	O
is	O
known	O
to	O
use	O
the	O
pAPN	O
as	O
the	O
major	O
receptor	O
for	O
cell	B-ANAT
entry	O
,	O
the	O
crucial	O
domain	O
of	O
the	O
pAPN	O
that	O
interacts	O
with	O
the	O
PEDV	O
is	O
still	O
unknown	O
.	O

ABSTRACT	O
:	O
A	O
2	O
-	O
year	O
-	O
old	O
male	O
ferret	O
was	O
presented	O
with	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
signs	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
C5a	O
in	O
acute	O
lung	B-ANAT
injury	O
induced	O
by	O
highly	O
pathogenic	O
viral	O
infections	O
.	O

A	O
comprehensive	O
understanding	O
of	O
the	O
tropism	O
and	O
pathogenicity	O
of	O
these	O
viruses	O
explained	O
by	O
their	O
receptor	O
specificity	O
and	O
receptor	O
expression	O
on	O
tissues	B-ANAT
was	O
therefore	O
needed	O
.	O

In	O
2013	O
,	O
a	O
PEDV	O
-	O
positive	O
sample	O
from	O
a	O
sow	O
with	O
very	O
mild	O
clinical	O
sign	O
was	O
used	O
to	O
inoculate	O
in	O
Vero	B-ANAT
cells	I-ANAT
to	O
isolate	O
the	O
virus	O
.	O

TITLE	O
:	O
Effects	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
on	O
porcine	O
monocyte	B-ANAT
-	O
derived	O
dendritic	B-ANAT
cells	I-ANAT
and	O
intestinal	B-ANAT
dendritic	B-ANAT
cells	I-ANAT
.	O

DCs	O
uptake	O
and	O
present	O
viral	O
antigens	O
to	O
T	B-ANAT
cells	I-ANAT
,	O
which	O
then	O
initiate	O
a	O
distinct	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
lung	B-ANAT
support	O
is	O
currently	O
used	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
severe	O
respiratory	O
failure	O
until	O
organ	B-ANAT
recovery	O
and	O
as	O
a	O
bridge	O
to	O
further	O
therapeutic	O
modalities	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
impact	O
of	O
acute	O
kidney	B-ANAT
injury	O
on	O
outcome	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
under	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
and	O
to	O
analyze	O
the	O
association	O
between	O
prognosis	O
and	O
the	O
time	O
of	O
occurrence	O
of	O
acute	O
kidney	B-ANAT
injury	O
and	O
renal	B-ANAT
replacement	O
therapy	O
initiation	O
.	O

A	O
large	O
European	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
center	O
,	O
University	O
Medical	O
Center	O
Regensburg	O
,	O
Germany	O
.	O

However	O
,	O
the	O
necessity	O
of	O
renal	B-ANAT
replacement	O
therapy	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
was	O
not	O
an	O
independent	O
risk	O
factor	O
for	O
mortality	O
in	O
these	O
patients	O
(	O
p	O
=	O
0	O
.	O
37	O
).	O

TITLE	O
:	O
Anthrax	O
lethal	O
toxin	O
-	O
induced	O
lung	B-ANAT
injury	O
and	O
treatment	O
by	O
activating	O
MK2	O
.	O

Such	O
a	O
model	O
could	O
be	O
utilized	O
in	O
evaluating	O
and	O
developing	O
better	O
treatment	O
for	O
ALI	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
as	O
other	O
available	O
rodent	O
models	O
do	O
not	O
consistently	O
produce	O
the	O
endothelial	B-ANAT
permeability	O
that	O
is	O
a	O
major	O
component	O
of	O
ARDS	O
.	O

In	O
primary	O
cultures	O
of	O
human	O
monocytes	B-ANAT
or	O
alveolar	B-ANAT
type	O
2	O
cells	B-ANAT
,	O
the	O
uptake	O
of	O
MVs	O
was	O
mediated	O
by	O
CD44	O
receptors	O
,	O
which	O
were	O
essential	O
for	O
the	O
therapeutic	O
effects	O
.	O

To	O
characterize	O
the	O
role	O
of	O
CoV	O
in	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
among	O
HSCT	O
and	O
hematologic	O
malignancy	O
patients	O
.	O

TITLE	O
:	O
Endothelin	O
-	O
1	O
induces	O
VCAM	O
-	O
1	O
expression	O
-	O
mediated	O
inflammation	O
via	O
receptor	O
tyrosine	O
kinases	O
and	O
Elk	O
/	O
p300	O
in	O
human	O
tracheal	O
smooth	B-ANAT
muscle	I-ANAT
cells	I-ANAT
.	O

ET	O
-	O
1	O
may	O
affect	O
vessel	B-ANAT
tone	O
together	O
with	O
lung	B-ANAT
physiology	O
and	O
pathology	O
.	O

ABSTRACT	O
:	O
Novel	O
approaches	O
to	O
the	O
management	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
include	O
strategies	O
to	O
enhance	O
alveolar	B-ANAT
liquid	O
clearance	O
,	O
promote	O
epithelial	B-ANAT
cell	I-ANAT
growth	O
and	O
recovery	O
after	O
acute	O
lung	B-ANAT
injury	O
,	O
and	O
individualize	O
ventilator	O
care	O
on	O
the	O
basis	O
of	O
physiological	O
responses	O
.	O

Critical	O
illness	O
causes	O
long	O
-	O
term	O
psychological	O
and	O
function	O
sequelae	O
:	O
the	O
risk	O
of	O
a	O
new	O
psychiatric	O
diagnosis	O
and	O
severe	O
physical	O
impairment	O
is	O
significantly	O
increased	O
in	O
the	O
months	O
after	O
discharge	B-ANAT
from	O
the	O
intensive	O
care	O
unit	O
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
obtained	O
and	O
analysed	O
by	O
real	O
-	O
time	O
PCR	O
for	O
15	O
viruses	O
.	O

In	O
this	O
study	O
,	O
nasopharyngeal	B-ANAT
swab	I-ANAT
sample	O
was	O
obtained	O
from	O
1	O
326	O
patients	O
who	O
presented	O
to	O
Ege	O
University	O
,	O
Medical	O
Faculty	O
Children	O
'	O
s	O
Hospital	O
between	O
2002	O
and	O
2012	O
and	O
who	O
were	O
thought	O
to	O
have	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
.	O

Among	O
the	O
34	O
patients	O
who	O
were	O
successfully	O
weaned	O
from	O
ECMO	O
,	O
21	O
patients	O
(	O
30	O
.	O
4	O
%)	O
eventually	O
died	O
before	O
discharge	B-ANAT
from	O
the	O
hospital	O
,	O
resulting	O
in	O
13	O
hospital	O
survivors	O
(	O
18	O
.	O
8	O
%).	O

Respiratory	O
and	O
serum	B-ANAT
samples	O
from	O
all	O
contacts	O
were	O
tested	O
for	O
MERS	O
-	O
CoV	O
.	O
Of	O
61	O
identified	O
contacts	O
,	O
56	O
were	O
interviewed	O
.	O

To	O
date	O
,	O
some	O
different	O
subtypes	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
were	O
identified	O
but	O
its	O
origin	O
was	O
unclear	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
spike	O
(	O
S	O
)	O
glycoproteins	O
mediate	O
receptor	O
binding	O
,	O
membrane	B-ANAT
fusion	O
,	O
and	O
virus	O
entry	O
and	O
determine	O
host	O
range	O
.	O

Coronavirus	O
-	O
associated	O
illnesses	O
(	O
percent	O
of	O
illnesses	O
,	O
group	O
1	O
vs	O
group	O
2	O
)	O
were	O
characterized	O
by	O
myalgias	O
(	O
21	O
%	O
vs	O
68	O
%,	O
P	O
<	O
.	O
01	O
),	O
chills	O
(	O
50	O
%	O
vs	O
52	O
%),	O
dyspnea	O
(	O
71	O
%	O
vs	O
24	O
%,	O
P	O
<	O
.	O
01	O
),	O
headache	O
(	O
64	O
%	O
vs	O
72	O
%),	O
malaise	O
(	O
64	O
%	O
vs	O
84	O
%),	O
cough	O
(	O
86	O
%	O
vs	O
68	O
%),	O
sputum	B-ANAT
production	O
(	O
86	O
%	O
vs	O
60	O
%),	O
sore	O
throat	B-ANAT
(	O
64	O
%	O
vs	O
80	O
%),	O
and	O
nasal	B-ANAT
congestion	O
(	O
93	O
%	O
vs	O
96	O
%).	O

Patients	O
were	O
divided	O
into	O
4	O
groups	O
according	O
to	O
the	O
severity	O
of	O
acute	O
-	O
HCA	O
(	O
i	O
.	O
e	O
.	O
total	O
grade	O
:	O
minimal	O
,	O
1	O
;	O
mild	O
,	O
2	O
;	O
moderate	O
,	O
3	O
-	O
4	O
;	O
severe	O
,	O
5	O
-	O
6	O
)	O
or	O
IAI	O
(	O
i	O
.	O
e	O
.	O
amniotic	B-ANAT
fluid	I-ANAT
MMP	O
-	O
8	O
:	O
minimal	O
,	O
23	O
-	O
100	O
ng	O
/	O
ml	O
;	O
mild	O
,	O
100	O
-	O
400	O
ng	O
/	O
ml	O
;	O
moderate	O
,	O
400	O
-	O
800	O
ng	O
/	O
ml	O
;	O
severe	O
,	O
â¥	O
800	O
ng	O
/	O
ml	O
).	O

We	O
then	O
examined	O
the	O
effects	O
of	O
these	O
inhibitors	O
on	O
the	O
activation	O
of	O
collagen	B-ANAT
I	O
and	O
Î±	O
-	O
smooth	B-ANAT
muscle	I-ANAT
actin	O
(	O
Î±	O
-	O
SMA	O
)	O
induced	O
by	O
PDGF	O
or	O
TGFÎ²1	O
stimulation	O
.	O

The	O
RVP	O
fast	O
assay	O
identified	O
at	O
least	O
one	O
respiratory	O
virus	O
in	O
130	O
of	O
the	O
216	O
specimens	O
examined	O
(	O
60	O
.	O
2	O
%)	O
and	O
rose	O
to	O
137	O
(	O
63	O
.	O
4	O
%)	O
by	O
combining	O
the	O
results	O
of	O
cell	B-ANAT
culture	O
and	O
RVP	O
fast	O
assay	O
.	O

suPAR	O
was	O
determined	O
batchwise	O
in	O
plasma	B-ANAT
obtained	O
within	O
24	O
h	O
after	O
admission	O
.	O

Plasma	B-ANAT
suPAR	O
,	O
however	O
,	O
improves	O
the	O
net	O
reclassification	O
,	O
suggesting	O
a	O
potential	O
role	O
for	O
suPAR	O
in	O
ICU	O
mortality	O
prediction	O
models	O
.	O

TITLE	O
:	O
Immunoprophylactic	O
effect	O
of	O
chicken	O
egg	B-ANAT
yolk	B-ANAT
antibody	O
(	O
IgY	O
)	O
against	O
a	O
recombinant	O
S1	O
domain	O
of	O
the	O
porcine	O
epidemic	O
diarrhea	O
virus	O
spike	O
protein	O
in	O
piglets	O
.	O

Specific	O
chicken	O
IgY	O
against	O
the	O
S1	O
protein	O
was	O
orally	B-ANAT
administered	O
to	O
neonatal	O
piglets	O
,	O
and	O
their	O
responses	O
subsequent	O
to	O
a	O
virulent	O
PEDV	O
challenge	O
were	O
monitored	O
.	O

Likewise	O
,	O
measures	O
of	O
soluble	O
inflammatory	O
markers	O
including	O
interleukin	O
-	O
6	O
,	O
C	O
-	O
reactive	O
peptide	O
,	O
interleukin	O
-	O
8	O
,	O
and	O
soluble	O
tumor	O
necrosis	O
factor	O
receptor	O
1	O
were	O
most	O
different	O
between	O
this	O
dosing	O
arm	B-ANAT
and	O
placebo	O
.	O

Univariate	O
and	O
logistic	O
regression	O
analyses	O
identified	O
the	O
chest	B-ANAT
radiographic	O
score	O
as	O
an	O
independent	O
predictor	O
of	O
mortality	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
1	O
.	O
38	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
07	O
-	O
1	O
.	O
77	O
;	O
p	O
=	O
0	O
.	O
01	O
).	O

The	O
affected	O
cellular	B-ANAT
proteins	O
that	O
we	O
identified	O
in	O
this	O
study	O
were	O
classified	O
into	O
the	O
functional	O
groups	O
involved	O
in	O
various	O
cellular	B-ANAT
processes	O
such	O
as	O
cell	B-ANAT
division	O
,	O
metabolism	O
,	O
the	O
stress	O
response	O
,	O
protein	O
biosynthesis	O
and	O
transport	O
,	O
cytoskeleton	B-ANAT
networks	O
and	O
cell	B-ANAT
communication	O
.	O

Consistent	O
with	O
an	O
inhibition	O
of	O
viral	O
disassembly	O
,	O
5	O
-	O
NT	O
treatment	O
did	O
not	O
alter	O
infection	O
by	O
in	O
vitro	O
-	O
generated	O
infectious	O
subvirion	O
particles	O
,	O
which	O
bind	O
to	O
JAM	O
-	O
A	O
but	O
bypass	O
a	O
requirement	O
for	O
proteolytic	O
uncoating	O
in	O
endosomes	O
to	O
infect	O
cells	B-ANAT
.	O

TITLE	O
:	O
The	O
Pattern	O
of	O
Brain	B-ANAT
Microhemorrhages	O
After	O
Severe	O
Lung	B-ANAT
Failure	O
Resembles	O
the	O
One	O
Seen	O
in	O
High	O
-	O
Altitude	O
Cerebral	B-ANAT
Edema	O
.	O

TITLE	O
:	O
Decreased	O
neutralizing	O
antigenicity	O
in	O
IBV	O
S1	O
protein	O
expressed	O
from	O
mammalian	O
cells	B-ANAT
.	O

TITLE	O
:	O
Characterization	O
of	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
Isolate	O
US	O
/	O
Iowa	O
/	O
18984	O
/	O
2013	O
Infection	O
in	O
1	O
-	O
Day	O
-	O
Old	O
Cesarean	O
-	O
Derived	O
Colostrum	B-ANAT
-	O
Deprived	O
Piglets	O
.	O

One	O
piglet	O
had	O
a	O
positive	O
real	O
-	O
time	O
quantitative	O
polymerase	O
chain	O
reaction	O
test	O
on	O
rectal	B-ANAT
swab	I-ANAT
at	O
12	O
hpi	O
,	O
and	O
all	O
remaining	O
piglets	O
were	O
positive	O
thereafter	O
,	O
with	O
highest	O
viral	O
quantities	O
detected	O
at	O
24	O
and	O
36	O
hpi	O
.	O

TITLE	O
:	O
Significant	O
Transplantation	O
-	O
Related	O
Mortality	O
from	O
Respiratory	O
Virus	O
Infections	O
within	O
the	O
First	O
One	O
Hundred	O
Days	O
in	O
Children	O
after	O
Hematopoietic	B-ANAT
Stem	I-ANAT
Cell	I-ANAT
Transplantation	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viral	O
infections	O
(	O
RVI	O
)	O
are	O
important	O
in	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantations	O
(	O
HSCT	O
)	O
and	O
knowledge	O
regarding	O
incidence	O
,	O
morbidity	O
,	O
mortality	O
,	O
and	O
long	O
-	O
term	O
pulmonary	B-ANAT
complications	O
is	O
limited	O
.	O

All	O
5	O
deaths	O
were	O
directly	O
attributable	O
to	O
RVI	O
and	O
all	O
5	O
deaths	O
occurred	O
in	O
patients	O
with	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

In	O
the	O
present	O
study	O
,	O
1734	O
clinical	O
samples	O
(	O
903	O
cases	O
)	O
submitted	O
to	O
the	O
Iowa	O
State	O
University	O
Veterinary	O
Diagnostic	O
Laboratory	O
(	O
ISU	O
VDL	O
)	O
for	O
enteric	O
disease	O
diagnosis	O
between	O
October	O
2012	O
and	O
December	O
2013	O
were	O
tested	O
retrospectively	O
for	O
PDCoV	O
using	O
a	O
virus	O
-	O
specific	O
real	O
-	O
time	O
reverse	O
transcription	O
(	O
RT	O
)	O
PCR	O
targeting	O
conserved	O
region	O
of	O
the	O
membrane	B-ANAT
gene	O
.	O

PDCoV	O
genome	O
was	O
first	O
detected	O
in	O
a	O
fecal	B-ANAT
sample	O
collected	O
on	O
August	O
19th	O
2013	O
from	O
Minnesota	O
.	O

TITLE	O
:	O
Elevated	O
level	O
of	O
renal	B-ANAT
xanthine	O
oxidase	O
mRNA	O
transcription	O
after	O
nephropathogenic	O
infectious	O
bronchitis	O
virus	O
infection	O
in	O
growing	O
layers	B-ANAT
.	O

The	O
results	O
indicated	O
that	O
NIBV	O
infection	O
could	O
cause	O
the	O
increases	O
of	O
renal	B-ANAT
XOD	O
gene	O
transcription	O
and	O
serum	B-ANAT
XOD	O
activity	O
,	O
leading	O
to	O
hyperuricemia	O
and	O
reduction	O
of	O
antioxidants	O
in	O
the	O
body	B-ANAT
.	O

Our	O
data	O
show	O
that	O
high	O
DWV	O
loads	O
in	O
winter	O
bees	O
correlate	O
with	O
reduced	O
expression	O
of	O
genes	O
involved	O
in	O
the	O
cellular	B-ANAT
immune	O
response	O
and	O
physiological	O
activity	O
and	O
high	O
expression	O
of	O
humoral	O
immune	O
genes	O
involved	O
in	O
antibacterial	O
defense	O
compared	O
with	O
summer	O
bees	O
.	O

We	O
present	O
two	O
cases	O
of	O
patients	O
with	O
clinical	O
symptoms	O
of	O
brain	B-ANAT
death	O
,	O
with	O
lung	B-ANAT
pathology	O
(	O
acute	O
lung	B-ANAT
injury	O
,	O
ARDS	O
,	O
lung	B-ANAT
embolism	O
and	O
lung	B-ANAT
infection	O
),	O
in	O
whom	O
apneic	O
tests	O
for	O
recognizing	O
brain	B-ANAT
death	O
were	O
difficult	O
to	O
perform	O
.	O

A	O
common	O
cause	O
of	O
death	O
in	O
adults	O
is	O
acute	O
chest	B-ANAT
syndrome	O
(	O
AChS	O
)	O
with	O
resulting	O
hypoxemic	O
respiratory	O
failure	O
.	O

The	O
ubiquitin	O
-	O
proteasome	O
,	O
autophagy	O
,	O
and	O
calpain	O
-	O
caspase	O
pathways	O
have	O
all	O
been	O
implicated	O
in	O
early	O
-	O
phase	O
muscle	B-ANAT
dysfunction	O
.	O

In	O
all	O
three	O
cases	O
,	O
PEDV	O
was	O
confirmed	O
in	O
feces	B-ANAT
and	O
small	B-ANAT
intestines	I-ANAT
by	O
RT	O
-	O
qPCR	O
.	O

Specific	O
residues	O
in	O
the	O
HD	O
regulate	O
the	O
ion	O
-	O
conducting	O
pore	B-ANAT
formed	O
by	O
SARS	O
-	O
CoV	O
E	O
in	O
artificial	O
bilayers	O
and	O
the	O
pathogenicity	O
of	O
the	O
virus	O
during	O
infection	O
.	O

ABSTRACT	O
:	O
Myd88	O
signaling	O
is	O
critical	O
to	O
the	O
control	O
of	O
numerous	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
infections	O
by	O
promoting	O
both	O
innate	O
and	O
adaptive	O
immune	O
responses	O
.	O

However	O
,	O
a	O
contribution	O
of	O
Myd88	O
-	O
dependent	O
signals	O
to	O
CNS	B-ANAT
pathogenesis	O
has	O
not	O
been	O
assessed	O
.	O

These	O
data	O
support	O
a	O
vital	O
role	O
of	O
Myd88	O
signaling	O
in	O
protective	O
antimicrobial	O
functions	O
in	O
the	O
CNS	B-ANAT
by	O
promoting	O
proinflammatory	O
mediators	O
and	O
T	B-ANAT
cell	I-ANAT
-	O
mediated	O
IFN	O
-	O
Î³	O
production	O
.	O

TITLE	O
:	O
Methylene	O
blue	O
treatment	O
for	O
cytokine	O
release	O
syndrome	O
-	O
associated	O
vasoplegia	O
following	O
a	O
renal	B-ANAT
transplant	B-ANAT
with	O
rATG	O
infusion	O
:	O
A	O
case	O
report	O
and	O
literature	O
review	O
.	O

Following	O
the	O
protocol	O
described	O
for	O
treating	O
refractory	O
VS	O
in	O
post	O
-	O
cardiac	B-ANAT
surgery	O
patients	O
,	O
the	O
decision	O
was	O
made	O
to	O
initiate	O
the	O
patient	O
on	O
an	O
IV	O
MB	O
infusion	O
.	O

LIPS	B-ANAT
and	O
Lac	O
are	O
independent	O
risk	O
factors	O
of	O
ARDS	O
in	O
patients	O
with	O
sepsis	O
in	O
emergency	O
department	O
,	O
which	O
may	O
be	O
a	O
reference	O
for	O
the	O
early	O
clinical	O
diagnosis	O
of	O
ARDS	O
.	O

According	O
to	O
the	O
new	O
Berlin	O
standard	O
of	O
definition	O
,	O
73	O
patients	O
with	O
moderate	O
or	O
severe	O
ARDS	O
due	O
to	O
pulmonary	B-ANAT
factors	O
,	O
age	O
from	O
18	O
to	O
65	O
years	O
,	O
admitted	O
to	O
Department	O
of	O
Critical	O
Care	O
Medicine	O
of	O
Taian	O
Central	O
Hospital	O
and	O
Handan	O
Central	O
Hospital	O
were	O
enrolled	O
.	O

Using	O
MERSpv	O
-	O
St16	B-ANAT
,	O
we	O
demonstrated	O
the	O
inability	O
of	O
rat	O
DPP4	O
to	O
serve	O
as	O
a	O
functional	O
receptor	O
for	O
MERS	O
-	O
CoV	O
,	O
suggesting	O
that	O
rats	O
are	O
not	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
infection	O
.	O

PQ	O
may	O
damage	O
alveolar	B-ANAT
type	O
II	O
cells	B-ANAT
leading	O
to	O
moderate	O
to	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

More	O
importantly	O
,	O
for	O
the	O
first	O
time	O
,	O
CQ	O
was	O
found	O
to	O
improve	O
cell	B-ANAT
viability	O
of	O
PQ	O
treated	O
A549	O
cells	B-ANAT
.	O

So	O
far	O
,	O
no	O
empirical	O
virus	O
isolation	O
study	O
has	O
been	O
done	O
to	O
elucidate	O
infectious	O
virus	O
secretion	B-ANAT
or	O
serotype	O
variability	O
.	O

Here	O
,	O
we	O
used	O
51	O
respiratory	B-ANAT
samples	I-ANAT
from	O
32	O
patients	O
with	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
for	O
virus	O
isolation	O
in	O
Vero	O
B4	O
and	O
Caco	O
-	O
2	O
cells	B-ANAT
.	O

Results	O
from	O
plaque	O
reduction	O
neutralization	O
assays	O
using	O
a	O
representative	O
range	O
of	O
serum	B-ANAT
samples	O
and	O
virus	O
isolates	O
suggested	O
that	O
all	O
circulating	O
human	O
MERS	O
-	O
CoV	O
strains	O
represent	O
one	O
single	O
serotype	O
.	O

Association	O
of	O
delivery	O
route	O
with	O
complications	O
was	O
estimated	O
using	O
multivariable	O
regression	O
models	O
yielding	O
adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
controlling	O
for	O
maternal	O
age	O
,	O
race	O
,	O
body	B-ANAT
mass	O
index	O
,	O
hypertension	O
,	O
diabetes	O
,	O
preterm	O
premature	O
rupture	O
of	O
membranes	B-ANAT
,	O
preterm	O
labor	O
,	O
GA	O
,	O
and	O
hospital	O
of	O
delivery	O
.	O

The	O
frequency	O
of	O
complications	O
was	O
associated	O
with	O
delivery	O
route	O
;	O
compared	O
with	O
3	O
.	O
5	O
%	O
of	O
vaginal	B-ANAT
delivery	O
,	O
23	O
.	O
0	O
%	O
of	O
CCD	O
(	O
aRR	O
,	O
3	O
.	O
54	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
2	O
.	O
29	O
-	O
5	O
.	O
48	O
),	O
12	O
.	O
1	O
%	O
of	O
LTCD	O
(	O
aRR	O
,	O
2	O
.	O
59	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
77	O
-	O
3	O
.	O
77	O
),	O
and	O
10	O
.	O
3	O
%	O
of	O
LVCD	O
(	O
aRR	O
,	O
2	O
.	O
27	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
68	O
-	O
7	O
.	O
55	O
)	O
experienced	O
complications	O
.	O

ABSTRACT	O
:	O
To	O
gain	O
entry	O
into	O
the	O
target	B-ANAT
cell	I-ANAT
,	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
uses	O
its	O
spike	O
(	O
S	O
)	O
protein	O
S2	O
subunit	O
to	O
fuse	O
with	O
the	O
plasma	B-ANAT
or	O
endosomal	O
membrane	B-ANAT
.	O

Recruitment	O
maneuvers	O
(	O
RM	O
)	O
can	O
be	O
used	O
to	O
augment	O
other	O
methods	O
,	O
like	O
positive	O
end	O
-	O
expiratory	O
pressure	O
and	O
positioning	O
,	O
to	O
improve	O
aerated	O
lung	B-ANAT
volume	O
.	O

The	O
correlation	O
of	O
the	O
aeration	O
score	O
variation	O
(	O
ASV	O
)	O
and	O
the	O
arterial	B-ANAT
blood	I-ANAT
gas	O
indexes	O
(	O
pH	O
,	O
PaO	O
(	O
2	O
),	O
PaCO	O
(	O
2	O
),	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
))	O
were	O
recorded	O
also	O
.	O

The	O
scores	O
of	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
(	O
APACHE	O
)	O
II	O
and	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
(	O
SOFA	O
)	O
within	O
24	O
h	O
of	O
admission	O
were	O
recorded	O
.	O

ABSTRACT	O
:	O
Most	O
viral	O
infections	O
encountered	O
in	O
resource	O
-	O
rich	O
countries	O
are	O
relatively	O
trivial	O
and	O
transient	O
with	O
perhaps	O
fever	O
,	O
malaise	O
,	O
myalgia	O
,	O
rash	O
(	O
exanthema	O
)	O
and	O
sometimes	O
mucosal	B-ANAT
manifestations	O
(	O
enanthema	O
),	O
including	O
oral	B-ANAT
in	O
some	O
.	O

Apart	O
from	O
baseline	O
hematological	O
,	O
biochemical	O
,	O
and	O
metabolic	O
parameters	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
(	O
APACHE	O
II	O
),	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
and	O
III	O
(	O
SAPS	O
II	O
and	O
SAPS	O
III	O
),	O
and	O
Sequential	O
Organ	B-ANAT
Function	O
Assessment	O
(	O
SOFA	O
)	O
scores	O
were	O
calculated	O
on	O
day	O
1	O
of	O
admission	O
.	O

Band	B-ANAT
neutrophilia	O
was	O
documented	O
in	O
44	O
.	O
3	O
%	O
(	O
81	O
/	O
183	O
),	O
of	O
which	O
35	O
.	O
8	O
%	O
did	O
not	O
have	O
mature	O
neutrophilia	O
.	O

In	O
this	O
study	O
,	O
molecular	O
characterization	O
of	O
FCV	O
and	O
feline	O
norovirus	O
(	O
FNoV	O
)	O
was	O
undertaken	O
using	O
real	O
-	O
time	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
sequence	O
analysis	O
of	O
the	O
ORF1	O
region	O
in	O
fecal	B-ANAT
specimens	O
from	O
29	O
diarrheic	O
cats	O
.	O

Sepsis	O
can	O
be	O
averted	O
experimentally	O
by	O
endothelial	B-ANAT
cytoprotection	O
through	O
targeting	O
nuclear	O
signaling	O
that	O
mediates	O
inflammation	O
and	O
deranged	O
metabolism	O
.	O

We	O
found	O
that	O
Trizol	O
,	O
AVL	O
buffer	O
and	O
gamma	O
irradiation	O
were	O
effective	O
at	O
inactivating	O
MERS	O
-	O
CoV	O
,	O
that	O
formaldehyde	O
-	O
based	O
solutions	O
required	O
at	O
least	O
30	O
min	O
of	O
contact	O
time	O
in	O
a	O
cell	B-ANAT
culture	O
system	O
while	O
a	O
mixture	O
of	O
methanol	O
and	O
acetone	O
required	O
60	O
min	O
to	O
inactivate	O
MERS	O
-	O
CoV	O
.	O
Together	O
,	O
these	O
data	O
provide	O
a	O
foundation	O
for	O
safely	O
inactivating	O
MERS	O
-	O
CoV	O
,	O
and	O
potentially	O
other	O
coronaviruses	O
,	O
prior	O
to	O
removal	O
from	O
biocontainment	O
facilities	O
.	O

After	O
bleeding	O
was	O
controlled	O
by	O
operation	O
,	O
fluid	O
resuscitation	O
was	O
done	O
as	O
fast	O
as	O
possible	O
and	O
the	O
plasma	B-ANAT
was	O
transfused	O
early	O
according	O
to	O
the	O
proportion	O
of	O
plasma	B-ANAT
and	O
red	B-ANAT
cell	I-ANAT
suspension	O
(	O
2	O
U	O
:	O
1	O
U	O
-	O
3	O
U	O
:	O
2	O
U	O
).	O

Dosage	O
of	O
balanced	O
salt	O
solution	O
was	O
(	O
3	O
,	O
798	O
Â±	O
340	O
)	O
ml	O
and	O
red	B-ANAT
cell	I-ANAT
suspension	O
was	O
14	O
to	O
18	O
U	O
,	O
fresh	B-ANAT
frozen	I-ANAT
plasma	I-ANAT
(	O
FFP	B-ANAT
)	O
was	O
(	O
1	O
,	O
267	O
Â±	O
58	O
)	O
ml	O
(	O
1U	O
FFP	O
=	O
100	O
ml	O
),	O
blood	B-ANAT
platelet	I-ANAT
was	O
8	O
to	O
12	O
U	O
for	O
9	O
patients	O
.	O

CONCLUSIONS	O
:	O
Damage	O
control	O
resuscitation	O
(	O
DCR	O
)	O
integrates	O
the	O
main	O
links	O
such	O
as	O
damage	O
control	O
operation	O
and	O
allowable	O
low	O
blood	B-ANAT
pressure	O
(	O
or	O
limited	O
liquid	O
resuscitation	O
)	O
and	O
hemostatic	O
control	O
resuscitation	O
,	O
was	O
early	O
effective	O
treatment	O
measures	O
for	O
the	O
patients	O
with	O
severe	O
multiple	O
trauma	O
in	O
the	O
pelvic	B-ANAT
fractures	O
.	O

Virus	O
production	O
in	O
cell	B-ANAT
culture	O
was	O
confirmed	O
by	O
cytopathology	O
,	O
immunofluorescence	O
,	O
and	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

We	O
therefore	O
investigated	O
the	O
effects	O
of	O
stress	O
index	O
guided	O
PEEP	O
titration	O
on	O
pulmonary	B-ANAT
mechanics	O
and	O
hemodynamics	O
in	O
the	O
prone	O
position	O
in	O
a	O
piglet	O
acute	O
lung	B-ANAT
injury	O
model	O
.	O

Stress	O
-	O
index	O
PEEP	O
was	O
the	O
level	O
at	O
which	O
the	O
airway	B-ANAT
pressure	O
stress	O
index	O
was	O
1	O
,	O
and	O
open	O
-	O
lung	B-ANAT
PEEP	O
was	O
the	O
level	O
at	O
which	O
it	O
was	O
required	O
to	O
keep	O
the	O
lung	B-ANAT
open	O
according	O
to	O
computed	O
tomography	O
(	O
CT	O
)	O
scans	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
collapsed	O
lung	B-ANAT
volume	O
(	O
P	O
=	O
0	O
.	O
07	O
)	O
and	O
hyperinflation	O
lung	B-ANAT
volume	O
(	O
P	O
=	O
0	O
.	O
76	O
)	O
in	O
the	O
two	O
groups	O
.	O

RESULTS	O
:	O
Respiratory	B-ANAT
system	I-ANAT
elastance	O
and	O
lung	B-ANAT
elastance	O
were	O
improved	O
in	O
the	O
prone	O
position	O
but	O
the	O
ratio	O
of	O
chest	B-ANAT
wall	I-ANAT
elastance	O
and	O
respiratory	B-ANAT
system	I-ANAT
elastance	O
was	O
higher	O
in	O
the	O
prone	O
position	O
.	O

Endothelial	B-ANAT
tube	O
formation	O
was	O
disrupted	O
in	O
the	O
presence	O
of	O
LPS	O
-	O
activated	O
THP	O
-	O
1	O
conditioned	O
media	B-ANAT
,	O
with	O
reversal	O
of	O
the	O
effect	O
occurring	O
in	O
the	O
presence	O
of	O
0	O
.	O
1Âµg	O
/	O
ml	O
Enbrel	O
,	O
indicating	O
that	O
TNF	O
-	O
Î±	O
was	O
the	O
major	O
serum	B-ANAT
component	O
inhibiting	O
endothelial	B-ANAT
tube	O
formation	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
have	O
shown	O
neuroinvasive	O
properties	O
in	O
humans	O
and	O
animals	O
secondary	O
to	O
replication	O
in	O
peripheral	O
organs	B-ANAT
,	O
but	O
the	O
mechanism	O
of	O
neuroinvasion	O
is	O
unknown	O
.	O

Herein	O
we	O
report	O
for	O
the	O
first	O
time	O
that	O
CoVs	O
exhibit	O
the	O
ability	O
to	O
cross	O
the	O
BBB	B-ANAT
according	O
to	O
strain	O
virulence	O
.	O

Here	O
,	O
we	O
further	O
investigated	O
the	O
interplay	O
between	O
human	O
primary	O
T	B-ANAT
cells	I-ANAT
and	O
MERS	O
-	O
CoV	O
in	O
disease	O
pathogenesis	O
.	O

We	O
further	O
demonstrated	O
that	O
MERS	O
-	O
CoV	O
infection	O
induced	O
apoptosis	O
in	O
T	B-ANAT
cells	I-ANAT
,	O
which	O
involved	O
the	O
activation	O
of	O
both	O
the	O
extrinsic	O
and	O
intrinsic	O
apoptosis	O
pathways	O
.	O

Overall	O
,	O
our	O
results	O
suggested	O
that	O
the	O
unusual	O
capacity	O
of	O
MERS	O
-	O
CoV	O
to	O
infect	O
T	B-ANAT
cells	I-ANAT
and	O
induce	O
apoptosis	O
might	O
partly	O
contribute	O
to	O
the	O
high	O
pathogenicity	O
of	O
the	O
virus	O
.	O

ABSTRACT	O
:	O
Hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
enters	O
human	O
hepatocytes	B-ANAT
through	O
a	O
multistep	O
mechanism	O
involving	O
,	O
among	O
other	O
host	O
proteins	O
,	O
the	O
virus	O
receptor	O
CD81	O
.	O

SRFBP1	O
facilitates	O
host	B-ANAT
cell	I-ANAT
penetration	O
by	O
all	O
seven	O
HCV	O
genotypes	O
,	O
but	O
not	O
of	O
vesicular	O
stomatitis	O
virus	O
and	O
human	O
coronavirus	O
.	O

The	O
gut	B-ANAT
microbiota	O
may	O
play	O
a	O
critical	O
role	O
in	O
the	O
gut	B-ANAT
health	O
of	O
the	O
host	O
.	O

Most	O
commensal	O
bacteria	O
(	O
i	O
.	O
e	O
.	O
Psychrobacter	O
,	O
Prevotella	O
,	O
and	O
Faecalibacterium	O
)	O
in	O
the	O
healthy	O
gastrointestinal	B-ANAT
tract	I-ANAT
were	O
decreased	O
due	O
to	O
dysbiosis	O
induced	O
by	O
PEDV	O
infection	O
.	O

Here	O
we	O
show	O
that	O
immunogens	O
based	O
on	O
full	O
-	O
length	O
S	O
DNA	O
and	O
S1	O
subunit	O
protein	O
elicit	O
robust	O
serum	B-ANAT
-	O
neutralizing	O
activity	O
against	O
several	O
MERS	O
-	O
CoV	O
strains	O
in	O
mice	O
and	O
non	O
-	O
human	O
primates	O
.	O

Animals	O
that	O
received	O
LPS	O
showed	O
circulatory	O
failure	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
,	O
metabolic	O
acidosis	O
,	O
hyperventilation	O
,	O
lung	B-ANAT
edema	O
,	O
and	O
high	O
mortality	O
.	O

Tissue	B-ANAT
samples	O
on	O
FTA	O
cards	O
were	O
received	O
over	O
the	O
six	O
-	O
year	O
period	O
.	O

The	O
FFN	O
assay	O
allows	O
relative	O
quantitation	O
of	O
functional	O
neutralizing	O
antibodies	O
in	O
serum	B-ANAT
,	O
milk	O
or	O
colostrum	B-ANAT
samples	O
.	O

TITLE	O
:	O
Surgical	O
management	O
of	O
AAST	O
grades	O
III	O
-	O
V	O
hepatic	B-ANAT
trauma	O
by	O
Damage	O
control	O
surgery	O
with	O
perihepatic	O
packing	O
and	O
Definitive	O
hepatic	B-ANAT
repair	O
-	O
single	O
centre	O
experience	O
.	O

Non	O
-	O
survivors	O
have	O
significantly	O
higher	O
AAST	O
grade	O
of	O
liver	B-ANAT
injury	O
and	O
higher	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
)	O
(	O
p	O
=	O
0	O
.	O
000	O
;	O
p	O
=	O
0	O
.	O
0001	O
).	O

There	O
was	O
significant	O
difference	O
in	O
the	O
amount	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
RBC	B-ANAT
)	O
transfusion	O
in	O
the	O
first	O
24	O
h	O
between	O
survivors	O
and	O
non	O
-	O
survivors	O
(	O
p	O
=	O
0	O
.	O
001	O
).	O

RESULTS	O
:	O
Non	O
-	O
survivors	O
have	O
significantly	O
higher	O
AAST	O
grade	O
of	O
liver	B-ANAT
injury	O
and	O
higher	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
)	O
(	O
p	O
=	O
0	O
.	O
000	O
;	O
p	O
=	O
0	O
.	O
0001	O
).	O

Immunoadhesins	O
that	O
incorporate	O
normal	O
cellular	B-ANAT
receptors	O
for	O
viruses	O
or	O
bacterial	O
toxins	O
hold	O
great	O
,	O
but	O
as	O
yet	O
unrealized	O
,	O
potential	O
for	O
treating	O
infectious	O
disease	O
.	O

An	O
immunoadhesin	O
incorporating	O
the	O
cellular	B-ANAT
receptor	O
for	O
anthrax	O
toxin	O
,	O
CMG2	O
,	O
potently	O
blocks	O
toxin	O
activity	O
in	O
vitro	O
and	O
protects	O
animals	O
against	O
inhalational	O
anthrax	O
.	O

We	O
developed	O
and	O
validated	O
an	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
based	O
on	O
the	O
recombinant	O
membrane	B-ANAT
(	O
M	O
)	O
protein	O
of	O
PEDV	O
.	O

(	O
1	O
)	O
A	O
43	O
years	O
old	O
male	O
of	O
South	O
Korean	O
nationality	O
was	O
admitted	O
with	O
the	O
complaint	O
of	O
back	B-ANAT
ache	O
for	O
7	O
days	O
and	O
fever	O
2	O
days	O
with	O
the	O
following	O
characteristics	O
:	O
back	B-ANAT
ache	O
7	O
days	O
ago	O
,	O
without	O
fever	O
or	O
cough	O
or	O
expectoration	B-ANAT
.	O

(	O
2	O
)	O
Auxiliary	O
examination	O
:	O
3	O
copies	O
of	O
throat	B-ANAT
swab	I-ANAT
specimens	O
for	O
virus	O
nucleic	B-ANAT
acid	O
detection	O
were	O
performed	O
by	O
the	O
Disease	O
Prevention	O
Control	O
Center	O
of	O
China	O
(	O
China	O
CDC	O
),	O
and	O
they	O
were	O
positive	O
on	O
May	O
29th	O
,	O
2015	O
,	O
and	O
also	O
for	O
serum	B-ANAT
,	O
sputum	B-ANAT
and	O
stool	B-ANAT
.	O

It	O
was	O
changed	O
to	O
a	O
low	O
flow	O
oxygen	O
inhalation	O
nasal	B-ANAT
cannula	O
on	O
the	O
20th	O
day	O
,	O
and	O
oxygen	O
treatment	O
was	O
stopped	O
on	O
the	O
24th	O
day	O
.	O

Then	O
there	O
was	O
cough	O
without	O
sputum	B-ANAT
.	O

The	O
indicators	O
of	O
hemodynamics	O
and	O
pulmonary	B-ANAT
circulation	O
such	O
as	O
cardiac	B-ANAT
index	O
,	O
intrathoracic	O
blood	B-ANAT
volume	O
index	O
,	O
and	O
central	O
venous	B-ANAT
pressure	O
improved	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
the	O
APACHE	O
II	O
score	O
in	O
the	O
GS	O
+	O
UTI	O
group	O
was	O
lower	O
than	O
that	O
of	O
the	O
UTI	O
group	O
.	O

However	O
,	O
retinal	B-ANAT
hemorrhages	O
are	O
very	O
rare	O
in	O
Plasmodium	O
vivax	O
infestation	O
.	O

Antineutrophil	O
cytoplasm	B-ANAT
antibodies	O
were	O
proteinase	O
3	O
-	O
positive	O
in	O
65	O
.	O
5	O
%	O
of	O
the	O
patients	O
(	O
50	O
%	O
of	O
those	O
with	O
SGS	O
).	O
Despite	O
conventional	O
GPA	O
therapy	O
,	O
62	O
%	O
patients	O
experienced	O
â¥	O
1	O
stenosis	O
relapse	O
(	O
s	O
)	O
(	O
81	O
%	O
of	O
SGS	O
patients	O
,	O
for	O
a	O
total	O
of	O
1	O
-	O
8	O
relapses	O
per	O
patient	O
).	O

Our	O
findings	O
confirmed	O
that	O
TBSs	O
are	O
severe	O
GPA	O
manifestations	O
that	O
evolve	O
independently	O
of	O
other	O
organ	B-ANAT
involvements	O
and	O
do	O
not	O
respond	O
to	O
conventional	O
systemic	O
regimens	O
.	O

This	O
strategy	O
also	O
allowed	O
decreasing	O
airway	B-ANAT
pressures	O
while	O
maintaining	O
stable	O
PaCO2	O
levels	O
.	O

Nevertheless	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
a	O
life	O
-	O
saving	O
technology	O
in	O
patients	O
with	O
respiratory	O
failure	O
refractory	O
to	O
maximal	O
medical	O
therapy	O
.	O

BCoV	O
was	O
detected	O
in	O
78	O
.	O
8	O
%	O
of	O
fecal	B-ANAT
samples	O
from	O
symptomatic	O
cattle	O
and	O
three	O
nasal	B-ANAT
and	O
paired	O
fecal	B-ANAT
samples	O
from	O
calves	O
with	O
respiratory	O
symptoms	O
.	O

Hemodynamic	O
monitoring	O
was	O
performed	O
with	O
a	O
single	O
-	O
use	O
indwelling	O
transesophageal	O
echocardiography	O
probe	O
during	O
50	O
h	O
.	O
Initially	O
,	O
a	O
contrast	O
study	O
depicted	O
a	O
patent	O
foramen	B-ANAT
ovale	I-ANAT
with	O
a	O
right	O
-	O
to	O
-	O
left	O
shunt	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
respiratory	O
and	O
urogenital	B-ANAT
disease	O
of	O
chickens	O
caused	O
by	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

TITLE	O
:	O
Use	O
of	O
Isotope	O
-	O
Edited	O
FTIR	O
to	O
Derive	O
a	O
Backbone	B-ANAT
Structure	O
of	O
a	O
Transmembrane	B-ANAT
Protein	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
inhibits	O
dsRNA	O
-	O
induced	O
interferon	O
-	O
Î²	O
production	O
in	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
by	O
blockade	O
of	O
the	O
RIG	O
-	O
I	O
-	O
mediated	O
pathway	O
.	O

ABSTRACT	O
:	O
The	O
lack	O
of	O
optimal	O
porcine	O
cell	B-ANAT
lines	I-ANAT
has	O
severely	O
impeded	O
the	O
study	O
and	O
progress	O
in	O
elucidation	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
pathogenesis	O
.	O

In	O
vitro	O
studies	O
of	O
the	O
MSCs	O
demonstrated	O
a	O
broad	O
anti	O
-	O
inflammatory	O
capacity	O
,	O
including	O
suppression	O
of	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
and	O
induction	O
of	O
regulatory	O
phenotypes	O
in	O
T	B-ANAT
cells	I-ANAT
,	O
monocytes	B-ANAT
,	O
and	O
neutrophils	B-ANAT
.	O

This	O
article	O
describes	O
the	O
cases	O
of	O
two	O
patients	O
with	O
severe	O
refractory	O
adult	O
respiratory	O
syndrome	O
(	O
ARDS	O
)	O
who	O
failed	O
to	O
improve	O
after	O
both	O
standard	O
life	O
support	O
measures	O
,	O
including	O
mechanical	O
ventilation	O
,	O
and	O
additional	O
measures	O
,	O
including	O
extracorporeal	O
ventilation	O
(	O
i	O
.	O
e	O
.,	O
in	O
a	O
heart	B-ANAT
-	O
lung	B-ANAT
machine	O
).	O

We	O
report	O
on	O
the	O
development	O
of	O
a	O
synthetic	O
DNA	O
vaccine	O
against	O
MERS	O
-	O
CoV	O
.	O
An	O
optimized	O
DNA	O
vaccine	O
encoding	O
the	O
MERS	O
spike	O
protein	O
induced	O
potent	O
cellular	B-ANAT
immunity	O
and	O
antigen	O
-	O
specific	O
neutralizing	O
antibodies	O
in	O
mice	O
,	O
macaques	O
,	O
and	O
camels	O
.	O

Both	O
conventional	O
and	O
deep	O
-	O
sequencing	O
results	O
consistently	O
showed	O
population	O
changes	O
occurred	O
during	O
adaptation	O
to	O
CEK	O
cells	B-ANAT
.	O

CEK	O
adaptation	O
shifted	O
the	O
virus	O
population	O
towards	O
homogeneity	O
in	O
S	O
.	O
The	O
changes	O
achieved	O
in	O
the	O
S1	O
gene	O
in	O
CEKp7	O
were	O
maintained	O
after	O
a	O
back	B-ANAT
-	O
passage	O
in	O
ECE	O
.	O

We	O
also	O
found	O
that	O
the	O
Ark	O
-	O
DPI	O
and	O
Mass	O
vaccines	O
had	O
significantly	O
(	O
P	O
<	O
0	O
.	O
005	O
)	O
fewer	O
spike	O
proteins	O
per	O
virus	B-ANAT
particle	I-ANAT
when	O
compared	O
to	O
their	O
respective	O
challenge	O
viruses	O
.	O

In	O
contrast	O
to	O
peptide	O
M	O
,	O
a	O
consensus	O
motif	O
'	O
PxxY	O
'	O
was	O
identified	O
on	O
both	O
peptides	O
L	O
and	O
W	O
,	O
and	O
on	O
the	O
S1	O
protein	O
,	O
but	O
not	O
on	O
peptide	O
H	O
.	O
Peptide	O
M	O
and	O
the	O
MAb	O
-	O
5E12	O
-	O
recognizing	O
peptides	O
L	O
and	O
W	O
significantly	O
inhibited	O
the	O
adsorption	O
of	O
PEDV	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
as	O
monitored	O
through	O
plaque	O
-	O
reduction	O
assays	O
.	O

High	O
mortality	O
and	O
a	O
limited	O
spectrum	O
of	O
therapeutic	O
options	O
have	O
left	O
clinicians	O
searching	O
for	O
alternatives	O
,	O
spiking	O
interest	O
in	O
selective	O
pulmonary	B-ANAT
vasodilators	O
(	O
SPVs	O
).	O

TITLE	O
:	O
Balloon	O
-	O
Occluded	O
Retrograde	O
Transvenous	O
Obliteration	O
for	O
the	O
Treatment	O
of	O
Gastric	B-ANAT
Varices	O
:	O
Polidocanol	O
Foam	O
Versus	O
Liquid	O
Ethanolamine	O
Oleate	O
.	O

Among	O
215	O
dromedaries	O
,	O
DcAstV	O
was	O
detected	O
in	O
faecal	B-ANAT
samples	O
of	O
four	O
[	O
three	O
(	O
1	O
.	O
5	O
%)	O
adult	O
dromedaries	O
and	O
one	O
(	O
8	O
.	O
3	O
%)	O
dromedary	O
calf	B-ANAT
]	O
by	O
reverse	O
transcription	O
-	O
PCR	O
.	O

Common	O
pathophysiological	O
indicators	O
of	O
ARDS	O
in	O
mice	O
include	O
impaired	O
pulmonary	B-ANAT
gas	O
exchange	O
and	O
histological	O
evidence	O
of	O
inflammatory	O
infiltrates	O
into	O
the	O
lung	B-ANAT
.	O

Humoral	O
(	O
neutralization	O
titer	O
and	O
specific	O
IgG	O
),	O
cellular	B-ANAT
(	O
interleukin	O
-	O
4	O
,	O
Î³	O
-	O
interferon	O
,	O
and	O
peripheral	O
lymphocyte	B-ANAT
proliferation	O
),	O
and	O
mucosal	B-ANAT
(	O
sIgA	O
)	O
immune	O
responses	O
were	O
detected	O
and	O
evaluated	O
.	O

ABSTRACT	O
:	O
Nucleic	B-ANAT
acid	O
(	O
NA	O
)-	O
targeted	O
tests	O
detect	O
and	O
quantify	O
viral	O
DNA	O
and	O
RNA	O
(	O
collectively	O
xNA	O
)	O
to	O
support	O
epidemiological	O
surveillance	O
and	O
,	O
in	O
individual	O
patients	O
,	O
to	O
guide	O
therapy	O
.	O

Therefore	O
,	O
inflammation	O
in	O
lung	B-ANAT
tissue	I-ANAT
following	O
blunt	O
chest	B-ANAT
trauma	O
was	O
characterized	O
in	O
a	O
well	O
-	O
defined	O
bilateral	O
lung	B-ANAT
injury	O
model	O
.	O

Chest	B-ANAT
trauma	O
led	O
to	O
elevated	O
expression	O
levels	O
of	O
inflammatory	O
and	O
coagulatory	O
proteins	O
(	O
such	O
as	O
TNFÎ±	O
receptor	O
,	O
IL	O
-	O
1Î±	O
,	O
IL	O
-	O
1Î²	O
,	O
C3	O
,	O
NF	O
-	O
ÎºB	O
and	O
plasminogen	O
activator	O
).	O

Taken	O
together	O
,	O
the	O
provided	O
global	O
perspective	O
of	O
the	O
inflammatory	O
response	O
following	O
blunt	O
chest	B-ANAT
trauma	O
could	O
provide	O
a	O
molecular	O
framework	O
for	O
future	O
research	O
in	O
trauma	O
pathophysiology	O
.	O

TITLE	O
:	O
Effects	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
on	O
brain	B-ANAT
tissue	I-ANAT
oxygen	O
pressure	O
of	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
A	O
pilot	O
study	O
.	O

ABSTRACT	O
:	O
To	O
verify	O
whether	O
high	O
positive	O
end	O
-	O
expiratory	O
pressure	O
levels	O
can	O
increase	O
brain	B-ANAT
tissue	I-ANAT
oxygen	O
pressure	O
,	O
and	O
also	O
their	O
effects	O
on	O
pulse	O
oxygen	O
saturation	O
,	O
intracranial	B-ANAT
pressure	O
,	O
and	O
cerebral	B-ANAT
perfusion	O
pressure	O
.	O

Using	O
genome	O
-	O
wide	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
screening	O
,	O
we	O
identified	O
83	O
novel	O
genes	O
supporting	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
replication	O
in	O
human	O
cells	B-ANAT
.	O

TITLE	O
:	O
Ventilator	O
-	O
Induced	O
Lung	B-ANAT
Injury	O
(	O
VILI	O
)	O
in	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
(	O
ARDS	O
):	O
Volutrauma	O
and	O
Molecular	O
Effects	O
.	O

The	O
purpose	O
of	O
this	O
article	O
is	O
to	O
present	O
an	O
approach	O
to	O
VILI	O
pathophysiology	O
focused	O
on	O
the	O
effects	O
of	O
volutrauma	O
that	O
lead	O
to	O
lung	B-ANAT
injury	O
and	O
the	O
'	O
mechanotransduction	O
'	O
mechanism	O
.	O

This	O
is	O
a	O
substudy	O
of	O
the	O
Transfusion	O
Requirements	O
After	O
Cardiac	B-ANAT
Surgery	O
(	O
TRACS	O
)	O
randomized	O
controlled	O
trial	O
.	O

Cardiovascular	B-ANAT
risk	O
of	O
anemia	O
may	O
be	O
more	O
harmful	O
than	O
the	O
risk	O
of	O
blood	B-ANAT
transfusion	O
in	O
older	O
patients	O
.	O

RESULTS	O
:	O
Of	O
the	O
502	O
patients	O
included	O
in	O
the	O
Transfusion	O
Requirements	O
After	O
Cardiac	B-ANAT
Surgery	O
study	O
,	O
260	O
(	O
51	O
.	O
8	O
%)	O
were	O
aged	O
60	O
years	O
or	O
more	O
and	O
242	O
(	O
48	O
.	O
2	O
%)	O
were	O
aged	O
less	O
than	O
60	O
years	O
and	O
were	O
included	O
in	O
this	O
study	O
.	O

Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
Infection	O
Induced	O
the	O
Unbalance	O
of	O
Gut	B-ANAT
Microbiota	O
in	O
Piglets	O
.	O

A	O
little	O
was	O
known	O
regarding	O
the	O
status	O
of	O
gut	B-ANAT
microbiota	O
after	O
piglets	O
infected	O
by	O
PEDV	O
.	O

Confocal	O
imaging	O
revealed	O
a	O
close	O
colocalization	O
of	O
SARS	O
-	O
CoV	O
ORF6	O
protein	O
with	O
NPIPB3	O
in	O
human	O
promonocytes	B-ANAT
.	O

Crystals	B-ANAT
of	O
trimeric	O
nsp15	O
were	O
obtained	O
by	O
the	O
hanging	O
-	O
drop	O
vapour	O
-	O
diffusion	O
method	O
using	O
polyethylene	O
glycol	O
as	O
a	O
precipitant	O
and	O
diffracted	O
to	O
2	O
.	O
5	O
Ã	O
resolution	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
ultrasound	O
and	O
pulse	O
oximetry	O
versus	O
chest	B-ANAT
radiography	O
and	O
arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
for	O
the	O
diagnosis	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
pilot	O
study	O
.	O

The	O
cytopathic	O
effect	O
and	O
MTS	O
assays	O
demonstrated	O
that	O
two	O
shRNAs	O
(	O
pSilencer4	O
.	O
1	O
-	O
M1	O
and	O
pSilencer4	O
.	O
1	O
-	O
N	O
)	O
were	O
capable	O
of	O
protecting	O
cells	B-ANAT
against	O
PEDV	O
invasion	O
with	O
very	O
high	O
specificity	O
and	O
efficiency	O
.	O

Calcium	O
ions	O
together	O
with	O
pH	O
modulated	O
E	O
protein	O
pore	B-ANAT
charge	O
and	O
selectivity	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
204	O
and	O
97	O
nasopharyngeal	B-ANAT
samples	O
were	O
collected	O
in	O
the	O
GENDRES	O
and	O
UK	O
cohorts	O
,	O
respectively	O
.	O

Moreover	O
,	O
we	O
confirmed	O
the	O
anti	O
-	O
inflammatory	O
effect	O
of	O
these	O
nanoparticles	O
on	O
human	O
monocytes	B-ANAT
and	O
macrophages	B-ANAT
in	O
vitro	O
and	O
in	O
a	O
human	O
ex	O
vivo	O
lung	B-ANAT
perfusion	O
(	O
EVLP	O
)	O
model	O
of	O
lung	B-ANAT
injury	O
.	O

Specific	O
inhibition	O
of	O
complement	O
with	O
compstatin	O
down	O
-	O
regulated	O
sepsis	O
-	O
induced	O
fibrosis	O
genes	O
,	O
including	O
transforming	O
growth	O
factor	O
-	O
beta	O
(	O
TGF	O
-	O
Î²	O
),	O
connective	B-ANAT
tissue	I-ANAT
growth	O
factor	O
(	O
CTGF	O
),	O
tissue	B-ANAT
inhibitor	O
of	O
metalloproteinase	O
1	O
(	O
TIMP1	O
),	O
various	O
collagens	O
and	O
chemokines	O
responsible	O
for	O
fibrocyte	B-ANAT
recruitment	O
(	O
e	O
.	O
g	O
.	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
2	O
(	O
CCL2	O
)	O
and	O
12	O
(	O
CCL12	O
)).	O

We	O
did	O
not	O
detect	O
a	O
significant	O
association	O
between	O
blood	B-ANAT
type	O
and	O
AKI	O
risk	O
among	O
individuals	O
of	O
African	O
descent	O
in	O
either	O
cohort	O
.	O

Based	O
on	O
these	O
data	O
we	O
sought	O
to	O
compare	O
two	O
isolates	O
of	O
MERS	O
-	O
CoV	O
.	O
We	O
followed	O
disease	O
progression	O
in	O
common	O
marmosets	O
after	O
intratracheal	O
exposure	O
with	O
:	O
MERS	O
-	O
CoV	O
-	O
EMC	B-ANAT
/	O
2012	O
,	O
MERS	O
-	O
CoV	O
-	O
Jordan	O
-	O
n3	O
/	O
2012	O
,	O
media	B-ANAT
,	O
or	O
inactivated	O
virus	O
.	O

The	O
present	O
study	O
shows	O
that	O
a	O
recombinant	O
MV	O
expressing	O
MERS	O
-	O
S	O
is	O
genetically	O
stable	O
and	O
induces	O
strong	O
humoral	O
and	O
cellular	B-ANAT
immunity	O
against	O
MERS	O
-	O
CoV	O
in	O
vaccinated	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
dynamics	O
properties	O
of	O
lung	B-ANAT
tissue	I-ANAT
in	O
intensive	O
care	O
unit	O
patients	O
with	O
symptoms	O
of	O
severe	O
violations	O
of	O
restrictive	O
lung	B-ANAT
tissue	I-ANAT
being	O
on	O
ventilatory	O
support	O
.	O

Increased	O
expiratory	O
time	O
constant	O
has	O
a	O
direct	O
correlation	O
with	O
the	O
value	O
of	O
airway	B-ANAT
resistance	O
was	O
due	O
not	O
only	O
to	O
the	O
maintenance	O
of	O
optimal	O
parameters	O
for	O
MVV	O
(	O
mechanical	O
voluntary	O
ventilation	O
),	O
but	O
regular	O
lavage	O
of	O
the	O
tracheobronchial	B-ANAT
tree	I-ANAT
,	O
which	O
allows	O
to	O
maintain	O
patency	O
of	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
.	O

An	O
extreme	O
TTS	O
score	O
on	O
admission	O
accurately	O
predicts	O
the	O
occurrence	O
of	O
delayed	O
ARDS	O
in	O
blunt	O
thoracic	B-ANAT
trauma	O
patients	O
affected	O
by	O
pulmonary	B-ANAT
contusion	O
.	O

To	O
dissect	O
out	O
the	O
underlying	O
pathogenic	O
mechanism	O
of	O
virulent	O
PEDV	O
and	O
clarify	O
the	O
differences	O
between	O
virulent	O
and	O
CV777	O
vaccine	O
strain	O
-	O
like	O
PEDV	O
infections	O
,	O
we	O
performed	O
an	O
iTRAQ	O
-	O
based	O
comparative	O
quantitative	O
proteomic	O
study	O
of	O
Vero	B-ANAT
cells	I-ANAT
infected	O
with	O
both	O
PEDV	O
strains	O
.	O

ABSTRACT	O
:	O
Viral	O
fulminant	O
hepatitis	O
(	O
FH	O
)	O
is	O
a	O
severe	O
disease	O
with	O
high	O
mortality	O
resulting	O
from	O
excessive	O
inflammation	O
in	O
the	O
infected	O
liver	B-ANAT
.	O

We	O
show	O
that	O
wild	O
-	O
type	O
mice	O
infected	O
with	O
murine	O
hepatitis	O
virus	O
strain	O
-	O
3	O
(	O
MHV	O
-	O
3	O
),	O
a	O
model	O
for	O
viral	O
FH	O
,	O
manifest	O
with	O
severe	O
disease	O
and	O
high	O
mortality	O
in	O
association	O
with	O
a	O
significant	O
elevation	O
in	O
IL	O
-	O
1Î²	O
expression	O
in	O
the	O
serum	B-ANAT
and	O
liver	B-ANAT
.	O

IL	O
-	O
1R1	O
deficiency	O
appears	O
to	O
debilitate	O
the	O
virus	O
-	O
induced	O
fibrinogen	B-ANAT
-	O
like	O
protein	O
-	O
2	O
(	O
FGL2	O
)	O
production	O
in	O
macrophages	B-ANAT
and	O
CD45	O
+	O
Gr	O
-	O
1high	O
neutrophil	B-ANAT
infiltration	O
in	O
the	O
liver	B-ANAT
.	O

Further	O
experiments	O
show	O
that	O
mice	O
deficient	O
of	O
p47phox	O
,	O
a	O
nicotinamide	O
adenine	O
dinucleotide	O
phosphate	O
(	O
NADPH	O
)	O
oxidase	O
subunit	O
that	O
controls	O
acute	O
ROS	O
production	O
,	O
present	O
with	O
reductions	O
in	O
NLRP3	O
inflammasome	O
activation	O
and	O
subsequent	O
IL	O
-	O
1Î²	O
secretion	B-ANAT
during	O
viral	O
infection	O
,	O
which	O
appears	O
to	O
be	O
responsible	O
for	O
acquiring	O
resilience	O
to	O
viral	O
FH	O
.	O

The	O
potent	O
antiviral	O
activity	O
of	O
both	O
GO	O
and	O
rGO	O
can	O
be	O
attributed	O
to	O
the	O
unique	O
single	O
-	O
layer	B-ANAT
structure	O
and	O
negative	O
charge	O
.	O

Although	O
,	O
ECMO	O
is	O
a	O
time	O
-	O
limited	O
procedure	O
and	O
most	O
manufacturers	O
do	O
not	O
advise	O
more	O
than	O
14	O
days	O
of	O
use	O
,	O
the	O
situation	O
for	O
this	O
patient	O
was	O
life	O
-	O
threatening	O
and	O
ECMO	O
,	O
despite	O
the	O
dangerous	O
risks	O
listed	O
above	O
,	O
was	O
the	O
only	O
way	O
to	O
win	O
time	O
for	O
the	O
lungs	B-ANAT
to	O
recover	O
and	O
for	O
treatment	O
of	O
the	O
underlying	O
disease	O
,	O
while	O
maintaining	O
adequate	O
oxygenation	O
and	O
circulation	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
differences	O
in	O
clinical	O
and	O
laboratory	O
characteristics	O
between	O
the	O
different	O
viral	O
causes	O
of	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
in	O
preschool	O
children	O
.	O

Bone	B-ANAT
marrow	I-ANAT
stromal	O
antigen	O
2	O
(	O
BST	O
-	O
2	O
;	O
also	O
known	O
as	O
CD317	O
or	O
tetherin	O
)	O
was	O
initially	O
identified	O
to	O
be	O
a	O
pre	B-ANAT
-	I-ANAT
B	I-ANAT
-	I-ANAT
cell	I-ANAT
growth	O
promoter	O
,	O
but	O
it	O
also	O
inhibits	O
the	O
release	O
of	O
virions	B-ANAT
of	O
the	O
retrovirus	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
by	O
tethering	O
budding	O
virions	B-ANAT
to	O
the	O
host	B-ANAT
cell	I-ANAT
membrane	I-ANAT
.	O

Neutralizing	O
antibody	O
titers	O
were	O
detected	O
using	O
the	O
serum	B-ANAT
neutralization	O
test	O
(	O
SN50	O
).	O

An	O
aggregate	O
of	O
4546	O
genes	O
(	O
2229	O
down	O
-	O
regulated	O
and	O
2317	O
up	O
-	O
regulated	O
)	O
from	O
17	O
cellular	B-ANAT
process	O
,	O
11	O
molecular	O
functions	O
and	O
130	O
possible	O
biological	O
pathways	O
were	O
affected	O
by	O
FIPV	O
.	O

Few	O
renal	B-ANAT
manifestations	O
associated	O
with	O
this	O
syndrome	O
have	O
been	O
reported	O
so	O
far	O
.	O

Strikingly	O
,	O
infection	O
of	O
mice	O
lacking	O
PLA2G2D	O
expression	O
(	O
Pla2g2d	O
(-/-)	O
mice	O
)	O
converted	O
a	O
uniformly	O
lethal	O
infection	O
to	O
a	O
nonlethal	O
one	O
(>	O
80	O
%	O
survival	O
),	O
subsequent	O
to	O
development	O
of	O
enhanced	O
respiratory	O
DC	O
migration	O
to	O
the	O
draining	O
lymph	B-ANAT
nodes	I-ANAT
,	O
augmented	O
antivirus	O
T	B-ANAT
cell	I-ANAT
responses	O
,	O
and	O
diminished	O
lung	B-ANAT
damage	O
.	O

TITLE	O
:	O
New	O
Epidemiological	O
and	O
Clinical	O
Signatures	O
of	O
18	O
Pathogens	O
from	O
Respiratory	B-ANAT
Tract	I-ANAT
Infections	O
Based	O
on	O
a	O
5	O
-	O
Year	O
Study	O
.	O

To	O
determine	O
the	O
epidemiological	O
and	O
clinical	O
characteristics	O
of	O
18	O
respiratory	O
pathogens	O
,	O
we	O
analyzed	O
12	O
,	O
502	O
patients	O
with	O
acute	O
respiratory	O
infections	O
(	O
ARIs	O
)	O
by	O
performing	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
on	O
patient	O
pharyngeal	B-ANAT
swabs	O
.	O

The	O
use	O
of	O
sartorius	B-ANAT
muscle	I-ANAT
flap	I-ANAT
for	O
the	O
treatment	O
of	O
an	O
infected	O
vascular	B-ANAT
reconstructions	O
after	O
VA	O
-	O
ECMO	O
use	O
.	O

2h	O
later	O
,	O
due	O
to	O
active	O
bleeding	O
and	O
signs	O
of	O
limb	B-ANAT
ischemia	O
,	O
the	O
patient	O
was	O
referred	O
to	O
our	O
department	O
and	O
emergency	O
trombectomy	O
and	O
patch	O
angioplasty	O
with	O
PTFE	O
were	O
performed	O
.	O

Cough	O
,	O
fever	O
,	O
radiological	O
evidence	O
of	O
pneumonia	O
,	O
and	O
shortness	O
of	O
breath	B-ANAT
were	O
identified	O
as	O
significant	O
risk	O
factors	O
for	O
a	O
diagnosis	O
of	O
MER	O
-	O
CoV	O
infection	O
.	O

Improved	O
global	O
awareness	O
,	O
together	O
with	O
improved	O
hygiene	O
practices	O
in	O
healthcare	O
facilities	O
,	O
has	O
been	O
highlighted	O
as	O
key	O
strategies	O
in	O
controlling	O
the	O
spread	O
of	O
MERS	O
-	O
CoV	O
.	O
This	O
study	O
tested	O
the	O
in	O
vitro	O
efficacy	O
of	O
three	O
formulations	O
of	O
povidone	O
iodine	O
(	O
PVP	O
-	O
I	O
:	O
4	O
%	O
PVP	O
-	O
I	O
skin	B-ANAT
cleanser	O
,	O
7	O
.	O
5	O
%	O
PVP	O
-	O
I	O
surgical	O
scrub	O
,	O
and	O
1	O
%	O
PVP	O
-	O
I	O
gargle	O
/	O
mouthwash	O
)	O
against	O
a	O
reference	O
virus	O
(	O
Modified	O
vaccinia	O
virus	O
Ankara	O
,	O
MVA	O
)	O
and	O
MERS	O
-	O
CoV	O
.	O
According	O
to	O
EN14476	O
,	O
a	O
standard	O
suspension	O
test	O
was	O
used	O
to	O
assess	O
virucidal	O
activity	O
against	O
MVA	O
and	O
large	O
volume	O
plating	O
was	O
used	O
for	O
MERS	O
-	O
CoV	O
.	O
All	O
products	O
were	O
tested	O
under	O
clean	O
(	O
0	O
.	O
3	O
g	O
/	O
L	O
bovine	O
serum	B-ANAT
albumin	O
,	O
BSA	O
)	O
and	O
dirty	O
conditions	O
(	O
3	O
.	O
0	O
g	O
/	O
L	O
BSA	O
+	O
3	O
.	O
0	O
mL	O
/	O
L	O
erythrocytes	B-ANAT
),	O
with	O
application	O
times	O
of	O
15	O
,	O
30	O
,	O
and	O
60	O
s	O
for	O
MVA	O
,	O
and	O
15	O
s	O
for	O
MERS	O
-	O
CoV	O
.	O
The	O
products	O
were	O
tested	O
undiluted	O
,	O
1	O
:	O
10	O
and	O
1	O
:	O
100	O
diluted	O
against	O
MVA	O
,	O
and	O
undiluted	O
against	O
MERS	O
-	O
CoV	O
.	O
A	O
reduction	O
in	O
virus	O
titer	O
of	O
â¥	O
4	O
log10	O
(	O
corresponding	O
to	O
an	O
inactivation	O
of	O
â¥	O
99	O
.	O
99	O
%)	O
was	O
regarded	O
as	O
evidence	O
of	O
virucidal	O
activity	O
.	O

Although	O
they	O
are	O
both	O
autoimmune	O
conditions	O
that	O
benefit	O
from	O
the	O
administration	O
of	O
plasma	B-ANAT
exchange	O
or	O
IV	O
immunoglobulin	O
(	O
IVIg	O
),	O
they	O
are	O
otherwise	O
very	O
different	O
disorders	O
with	O
unique	O
features	O
and	O
distinct	O
complications	O
.	O

TITLE	O
:	O
Bioinformatics	O
Analysis	O
of	O
Proteome	O
Changes	O
in	O
Calu	O
-	O
3	O
Cell	B-ANAT
Infected	O
by	O
Influenza	O
A	O
Virus	O
(	O
H5N1	O
).	O

ABSTRACT	O
:	O
This	O
paper	O
aimed	O
to	O
identify	O
the	O
differentially	O
expressed	O
proteins	O
(	O
DEPs	O
)	O
in	O
Calu	O
-	O
3	O
cells	B-ANAT
infected	O
by	O
influenza	O
A	O
virus	O
(	O
IAV	O
)	O
subtype	O
H5N1	O
.	O

Here	O
,	O
we	O
describe	O
the	O
rapid	O
(	O
19	O
days	O
)	O
development	O
of	O
a	O
plant	O
-	O
derived	O
VLP	B-ANAT
vaccine	O
based	O
on	O
the	O
hemagglutinin	O
sequence	O
of	O
influenza	O
H7N9	O
A	O
/	O
Hangzhou	O
/	O
1	O
/	O
2013	O
.	O

Studies	O
are	O
currently	O
ongoing	O
to	O
better	O
characterize	O
the	O
immune	O
response	O
elicited	O
by	O
the	O
plant	O
-	O
derived	O
VLP	B-ANAT
vaccines	O
.	O

Pro	O
-	O
inflammatory	O
cytokine	O
profiles	O
of	O
PEDV	O
infected	O
suckling	O
pigs	O
differed	O
from	O
those	O
of	O
PEDV	O
infected	O
weaned	O
pigs	O
and	O
coincided	O
with	O
onset	O
of	O
fecal	B-ANAT
PEDV	O
RNA	O
shedding	O
and	O
serum	B-ANAT
PEDV	O
RNA	O
titers	O
.	O

The	O
infected	O
suckling	O
pigs	O
have	O
higher	O
and	O
earlier	O
increases	O
in	O
serum	B-ANAT
IFNÎ±	O
,	O
but	O
lower	O
serum	B-ANAT
IL	O
-	O
8	O
and	O
TNFÎ±	O
levels	O
compared	O
to	O
infected	O
weaned	O
pigs	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
M	O
protein	O
blocks	O
cell	B-ANAT
cycle	O
progression	O
at	O
S	O
-	O
phase	O
and	O
its	O
subcellular	O
localization	O
in	O
the	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

The	O
S	O
-	O
phase	O
arrest	O
is	O
associated	O
with	O
a	O
decrease	O
in	O
level	O
of	O
cyclin	O
A	O
.	O
Furthermore	O
,	O
our	O
results	O
revealed	O
that	O
the	O
M	O
protein	O
of	O
PEDV	O
does	O
not	O
induce	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
stress	O
and	O
does	O
not	O
activate	O
NF	O
-	O
ÎºB	O
which	O
is	O
responsible	O
for	O
IL	O
-	O
8	O
and	O
Bcl	O
-	O
2	O
expression	O
.	O

Administration	O
of	O
FTY720	O
to	O
JHMV	O
-	O
infected	O
mice	O
resulted	O
in	O
enhanced	O
migration	O
and	O
increased	O
proliferation	O
of	O
transplanted	B-ANAT
NPCs	O
after	O
spinal	B-ANAT
cord	I-ANAT
engraftment	O
.	O

TITLE	O
:	O
Opioid	O
associated	O
intravenous	O
and	O
cutaneous	O
microvascular	O
drug	O
abuse	O
(	O
skin	B-ANAT
-	O
popping	O
)	O
masquerading	O
as	O
Degos	O
disease	O
(	O
malignant	O
atrophic	O
papulosis	O
)	O
with	O
multiorgan	O
involvement	O
.	O

Herein	O
,	O
we	O
report	O
another	O
case	O
involving	O
a	O
31	O
-	O
year	O
-	O
old	O
woman	O
who	O
self	O
intravenously	O
administered	O
dissolved	O
oral	B-ANAT
oxymorphone	O
resulting	O
in	O
thrombotic	O
sequelae	O
resembling	O
Degos	O
disease	O
.	O

The	O
main	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
oral	B-ANAT
minimum	O
infectious	O
dose	O
of	O
PEDV	O
in	O
naÃ¯ve	O
conventional	O
neonatal	O
piglets	O
and	O
weaned	O
pigs	O
.	O

EIT	O
played	O
a	O
role	O
in	O
detecting	O
lung	B-ANAT
derecruitment	O
at	O
the	O
patient	O
'	O
s	O
bedside	O
.	O

Integrating	O
phenotypic	O
and	O
genetic	O
data	O
narrowed	O
this	O
region	O
to	O
a	O
single	O
gene	O
,	O
Trim55	O
,	O
an	O
E3	O
ubiquitin	O
ligase	O
with	O
a	O
role	O
in	O
muscle	B-ANAT
fiber	I-ANAT
maintenance	O
.	O

Patients	O
with	O
underlying	O
neurologic	O
diseases	O
(	O
OR	O
76	O
.	O
8	O
;	O
p	O
<	O
0	O
.	O
001	O
),	O
airway	B-ANAT
anomaly	O
(	O
OR	O
15	O
.	O
1	O
;	O
p	O
=	O
0	O
.	O
033	O
),	O
chronic	O
lung	B-ANAT
diseases	O
(	O
OR	O
12	O
.	O
5	O
;	O
p	O
=	O
0	O
.	O
047	O
),	O
weight	O
<	O
3	O
HAdV	O
infections	O
circulate	O
all	O
year	O
-	O
round	O
.	O

The	O
sera	B-ANAT
were	O
tested	O
with	O
a	O
neutralizing	O
antibody	O
test	O
.	O

This	O
work	O
provides	O
basic	O
information	O
for	O
the	O
mechanism	O
of	O
IBV	O
VLP	B-ANAT
formation	O
and	O
develops	O
a	O
platform	O
for	O
further	O
designing	O
IBV	O
VLP	B-ANAT
-	O
based	O
vaccines	O
against	O
IBV	O
or	O
other	O
viruses	O
.	O

ECMO	O
gives	O
the	O
lungs	B-ANAT
an	O
opportunity	O
to	O
rest	O
and	O
recover	O
.	O

Bleeding	O
from	O
the	O
chest	B-ANAT
tube	O
site	O
was	O
reported	O
in	O
13	O
.	O
5	O
%	O
of	O
prone	O
positioning	O
maneuvers	O
in	O
1	O
study	O
,	O
and	O
the	O
rest	O
of	O
the	O
studies	O
reported	O
no	O
evidence	O
of	O
chest	B-ANAT
tube	O
site	O
bleeding	O
.	O

Social	O
media	B-ANAT
platforms	O
,	O
including	O
Twitter	O
,	O
Facebook	O
,	O
and	O
YouTube	O
,	O
are	O
now	O
frequently	O
utilized	O
to	O
address	O
health	O
-	O
related	O
issues	O
.	O

ABSTRACT	O
:	O
Objectives	O
The	O
aim	O
of	O
the	O
study	O
was	O
to	O
determine	O
whether	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
RNA	O
in	O
effusion	B-ANAT
samples	O
can	O
be	O
used	O
as	O
a	O
diagnostic	O
marker	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
);	O
and	O
in	O
FCoV	O
RNA	O
-	O
positive	O
samples	O
to	O
examine	O
amino	O
acid	O
codons	O
in	O
the	O
FCoV	O
spike	O
protein	O
at	O
positions	O
1058	O
and	O
1060	O
where	O
leucine	O
and	O
alanine	O
,	O
respectively	O
,	O
have	O
been	O
associated	O
with	O
systemic	O
or	O
virulent	O
(	O
FIP	O
)	O
FCoV	O
infection	O
.	O

Eleven	O
out	O
of	O
38	O
PEDV	O
strains	O
were	O
isolated	O
successfully	O
on	O
Vero	B-ANAT
cells	I-ANAT
with	O
trypsin	O
treatment	O
and	O
subjected	O
to	O
genome	O
sequence	O
analysis	O
.	O

These	O
DN	O
T	B-ANAT
cells	I-ANAT
were	O
predominantly	O
consisted	O
of	O
a	O
TCRÎ±Î²	O
(+)	O
subset	O
expressing	O
high	O
levels	O
of	O
CD44	O
and	O
did	O
not	O
produce	O
cytokine	O
except	O
IL	O
-	O
2	O
.	O

Adoptive	O
transfer	O
of	O
this	O
subset	O
of	O
DN	O
T	B-ANAT
cells	I-ANAT
to	O
the	O
MHV	O
-	O
3	O
-	O
infected	O
mice	O
resulted	O
in	O
an	O
increase	O
in	O
murine	O
fibrinogen	B-ANAT
-	O
like	O
protein	O
2	O
(	O
mfgl2	O
)	O
expressions	O
in	O
association	O
with	O
massive	O
fibrin	O
deposition	O
in	O
the	O
liver	B-ANAT
.	O

However	O
,	O
under	O
this	O
condition	O
,	O
adoptive	O
transfer	O
of	O
the	O
DN	O
T	B-ANAT
cells	I-ANAT
accelerated	O
the	O
disease	O
progression	O
and	O
reversed	O
the	O
benefit	O
from	O
mfgl2	O
gene	O
silence	O
,	O
leading	O
to	O
a	O
100	O
%	O
death	O
rate	O
.	O

The	O
autopsy	O
findings	O
depicted	O
the	O
right	B-ANAT
lung	I-ANAT
agenesis	O
without	O
any	O
other	O
concomitant	O
malformation	O
.	O

Traditional	O
mass	O
media	B-ANAT
were	O
the	O
most	O
used	O
information	O
sources	O
in	O
both	O
surveys	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
Causes	O
Multiple	O
Organ	B-ANAT
Damage	O
and	O
Lethal	O
Disease	O
in	O
Mice	O
Transgenic	O
for	O
Human	O
Dipeptidyl	O
Peptidase	O
4	O
.	O

High	O
virus	O
titers	O
were	O
present	O
in	O
lung	B-ANAT
and	O
brain	B-ANAT
tissues	I-ANAT
2	O
and	O
6	O
days	O
after	O
infection	O
,	O
respectively	O
.	O

In	O
addition	O
to	O
a	O
short	O
duration	O
on	O
the	O
skin	B-ANAT
surface	I-ANAT
,	O
alcohol	O
is	O
ineffective	O
against	O
certain	O
viruses	O
such	O
as	O
norovirus	O
,	O
rabies	O
virus	O
,	O
and	O
polio	O
virus	O
.	O

These	O
results	O
suggest	O
that	O
this	O
difference	O
in	O
E1B	O
20K	O
gene	O
expression	O
during	O
Ad14p1	O
infection	O
and	O
its	O
modulating	O
effect	O
on	O
the	O
interactions	O
between	O
Ad14	O
-	O
infected	O
cells	B-ANAT
and	O
the	O
host	O
innate	O
immune	O
response	O
could	O
explain	O
the	O
increased	O
immunopathogenic	O
potential	O
and	O
associated	O
increase	O
in	O
clinical	O
illness	O
in	O
some	O
people	O
infected	O
with	O
the	O
Ad14p1	O
outbreak	O
strain	O
.	O

We	O
show	O
that	O
there	O
is	O
markedly	O
reduced	O
expression	O
of	O
E1B	O
20K	O
in	O
Ad14p1	O
-	O
infected	O
human	O
cells	B-ANAT
and	O
that	O
this	O
causes	O
an	O
increased	O
proinflammatory	O
cytokine	O
response	O
of	O
human	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
more	O
severe	O
inflammatory	O
lung	B-ANAT
disease	O
in	O
infected	O
hamsters	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
truncated	O
S1	O
gene	O
,	O
encoding	O
the	O
exterior	O
of	O
the	O
viral	O
spike	O
protein	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
was	O
subcloned	O
into	O
prokaryotic	O
expression	O
vector	O
pET32a	O
(+)	O
and	O
expressed	O
as	O
a	O
recombinant	O
protein	O
in	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
).	O

There	O
is	O
also	O
evidence	O
that	O
this	O
syndrome	O
is	O
under	O
-	O
diagnosed	O
and	O
the	O
utilization	O
of	O
lung	B-ANAT
protective	O
ventilation	O
is	O
still	O
variable	O
.	O

In	O
contrast	O
,	O
pulmonary	B-ANAT
perfusion	O
remains	O
preferentially	O
distributed	O
to	O
the	O
dorsal	O
lung	B-ANAT
regions	O
,	O
thus	O
improving	O
overall	O
alveolar	B-ANAT
ventilation	O
/	O
perfusion	O
relationships	O
.	O

Moreover	O
,	O
the	O
larger	O
tissue	B-ANAT
mass	O
suspended	O
from	O
a	O
wider	O
dorsal	O
chest	B-ANAT
wall	I-ANAT
effects	O
a	O
more	O
homogeneous	O
distribution	O
of	O
pleural	O
pressures	O
throughout	O
the	O
lung	B-ANAT
that	O
reduces	O
abnormal	O
strain	O
and	O
stress	O
development	O
.	O

While	O
it	O
is	O
impossible	O
to	O
trace	O
back	B-ANAT
the	O
modes	O
of	O
transmission	O
of	O
all	O
cases	O
in	O
a	O
large	O
-	O
scale	O
outbreak	O
,	O
case	O
-	O
by	O
-	O
case	O
tracking	O
and	O
isolation	O
of	O
infected	O
individuals	O
and	O
those	O
in	O
close	O
contact	O
with	O
them	O
is	O
important	O
in	O
preventing	O
the	O
spread	O
.	O

The	O
inhomogeneous	O
compartment	B-ANAT
with	O
high	O
[(	O
18	O
)	O
F	O
]	O
FDG	O
uptake	O
was	O
preferentially	O
located	O
in	O
the	O
dependent	O
lung	B-ANAT
(	O
21	O
Â±	O
10	O
%	O
versus	O
12	O
Â±	O
10	O
%,	O
p	O
<	O
0	O
.	O
0001	O
),	O
mostly	O
at	O
the	O
open	O
/	O
closed	O
interfaces	O
and	O
related	O
to	O
recruitability	O
(	O
r	O
(	O
2	O
)=	O
0	O
.	O
53	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O
The	O
homogeneous	O
lung	B-ANAT
compartment	B-ANAT
with	O
normal	O
inflation	O
and	O
[(	O
18	O
)	O
F	O
]	O
FDG	O
uptake	O
decreases	O
with	O
ARDS	O
severity	O
,	O
while	O
the	O
inhomogeneous	O
poorly	O
/	O
not	O
inflated	O
compartment	B-ANAT
increases	O
.	O

A	O
diffuse	O
comet	O
tail	O
sign	O
or	O
a	O
consolidation	O
score	O
â¤	O
6	O
and	O
a	O
lung	B-ANAT
ultrasound	O
score	O
<	O
25	O
were	O
observed	O
in	O
four	O
patients	O
.	O

Overall	O
,	O
149	O
subjects	O
with	O
ACS	O
(	O
namely	O
,	O
acute	O
myocardial	O
infarct	O
with	O
or	O
without	O
ST	O
-	O
segment	O
elevation	O
or	O
unstable	O
angina	O
),	O
with	O
no	O
previous	O
history	O
of	O
CHD	O
,	O
admitted	O
to	O
three	O
cardiac	B-ANAT
intensive	O
care	O
units	O
were	O
included	O
and	O
evaluated	O
by	O
the	O
Structured	O
Clinical	O
Interview	O
for	O
Complicated	O
Grief	O
(	O
SCI	O
-	O
CG	O
),	O
Hamilton	O
Depression	O
Rating	O
Scale	O
,	O
Hamilton	O
Anxiety	O
Rating	O
Scale	O
,	O
and	O
the	O
36	O
-	O
item	O
Short	O
-	O
Form	O
Health	O
Survey	O
(	O
MOS	O
-	O
SF	O
-	O
36	O
).	O

Our	O
objective	O
was	O
to	O
determine	O
whether	O
sampling	O
with	O
a	O
throat	B-ANAT
swab	I-ANAT
provides	O
incremental	O
benefit	O
-	O
when	O
used	O
in	O
conjunction	O
with	O
a	O
nasal	B-ANAT
swab	O
-	O
to	O
detect	O
respiratory	O
viruses	O
among	O
patients	O
with	O
acute	O
pharyngitis	O
in	O
the	O
outpatient	O
setting	O
.	O

The	O
flocked	O
nasal	B-ANAT
swab	O
samples	O
respiratory	O
viruses	O
well	O
,	O
even	O
among	O
patients	O
whose	O
primary	O
complaint	O
is	O
a	O
sore	O
throat	B-ANAT
.	O

Overall	O
,	O
there	O
has	O
been	O
a	O
decreasing	O
trend	O
in	O
in	O
-	O
hospital	O
and	O
1	O
-	O
year	O
mortality	O
rates	O
in	O
recent	O
years	O
,	O
likely	O
because	O
of	O
the	O
implementation	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

In	O
this	O
study	O
,	O
a	O
variant	O
PEDV	O
strain	O
YN1	O
was	O
isolated	O
,	O
serially	O
propagated	O
on	O
the	O
Vero	B-ANAT
cells	I-ANAT
and	O
was	O
characterized	O
for	O
200	O
passages	O
.	O

The	O
chimeric	O
proteins	O
generated	O
in	O
cell	B-ANAT
culture	O
increased	O
virus	O
fitness	O
in	O
vitro	O
but	O
remained	O
attenuated	O
in	O
mice	O
.	O

Pumpless	O
extracorporeal	O
lung	B-ANAT
assist	O
(	O
pECLA	O
)	O
devices	O
(	O
iLA	O
Membrane	B-ANAT
Ventilator	O
;	O
Novalung	O
,	O
Heilbronn	O
,	O
Germany	O
)	O
can	O
improve	O
decarboxylation	O
without	O
aggravation	O
associated	O
with	O
invasive	O
ventilation	O
.	O

TITLE	O
:	O
Mortality	O
Predictors	O
in	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Renal	B-ANAT
Transplant	B-ANAT
Recipients	O
With	O
ESKAPE	O
/	O
rESKAPE	O
Pneumonia	O
.	O

The	O
primary	O
diseases	O
were	O
acute	O
myeloid	O
leukemia	O
(	O
n	O
=	O
8	O
)	O
and	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
(	O
n	O
=	O
4	O
).	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
demonstrate	O
non	O
-	O
invasive	O
detection	O
of	O
lung	B-ANAT
inflammation	O
using	O
integrin	O
receptor	O
targeted	O
fluorescence	O
liposomes	O
.	O

Near	O
-	O
infrared	O
fluorescence	O
imaging	O
(	O
NIRFI	O
)	O
was	O
applied	O
for	O
visualization	O
and	O
quantitation	O
of	O
lung	B-ANAT
inflammation	O
.	O

NIRFI	O
signals	O
were	O
correlated	O
with	O
inflammatory	O
cellular	B-ANAT
and	O
biochemical	O
markers	O
of	O
lungs	B-ANAT
.	O

Non	O
-	O
invasive	O
detection	O
of	O
lung	B-ANAT
inflammation	O
was	O
demonstrated	O
using	O
a	O
combination	O
of	O
integrin	O
receptor	O
targeting	O
and	O
NIRFI	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
43	O
-	O
year	O
-	O
old	O
man	O
who	O
ingested	O
,	O
for	O
suicidal	O
purposes	O
,	O
common	O
(	O
or	O
European	O
)	O
yew	O
leaves	O
(	O
Taxus	O
baccata	O
)	O
and	O
presented	O
severe	O
hypokalemia	O
,	O
ventricular	B-ANAT
arrhythmias	O
with	O
hemodynamic	O
instability	O
accompanied	O
by	O
severe	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
including	O
respiratory	O
insufficiency	O
,	O
renal	B-ANAT
failure	O
,	O
acid	O
-	O
base	O
imbalance	O
with	O
severe	O
hypokalemia	O
,	O
hepatic	B-ANAT
dysfunction	O
and	O
coma	O
,	O
which	O
led	O
to	O
death	O
12	O
hours	O
after	O
Taxus	O
baccata	O
ingestion	O
.	O

TITLE	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
ORF3	O
gene	O
prolongs	O
S	O
-	O
phase	O
,	O
facilitates	O
formation	O
of	O
vesicles	B-ANAT
and	O
promotes	O
the	O
proliferation	O
of	O
attenuated	O
PEDV	O
.	O

However	O
,	O
its	O
influence	O
on	O
cell	B-ANAT
cycle	O
and	O
subcellular	B-ANAT
structure	I-ANAT
still	O
require	O
more	O
research	O
.	O

In	O
addition	O
,	O
the	O
ORF3	O
-	O
expressing	O
Vero	B-ANAT
cells	I-ANAT
had	O
more	O
vesicles	B-ANAT
than	O
the	O
host	O
Vero	B-ANAT
cells	I-ANAT
.	O

CONCLUSIONS	O
:	O
There	O
were	O
many	O
important	O
additions	O
to	O
the	O
critical	O
care	O
pharmacotherapy	O
literature	O
in	O
2014	O
,	O
including	O
a	O
joint	B-ANAT
guideline	O
for	O
the	O
management	O
of	O
AF	O
and	O
reports	O
of	O
clinical	O
trials	O
.	O

They	O
are	O
characterized	O
by	O
a	O
pseudocyclic	O
backbone	B-ANAT
with	O
two	O
to	O
four	O
prolines	O
and	O
three	O
disulfides	O
arranged	O
in	O
a	O
knotted	O
motif	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
complications	O
associated	O
with	O
the	O
use	O
of	O
therapeutic	O
temperature	O
modulation	O
(	O
mild	O
hypothermia	O
and	O
normothermia	O
)	O
in	O
patients	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
).	O

The	O
increase	O
in	O
end	O
-	O
expiratory	O
pressure	O
led	O
to	O
an	O
equivalent	O
increase	O
in	O
the	O
plateau	O
pressure	O
,	O
and	O
lung	B-ANAT
-	O
protective	O
ventilation	O
was	O
significantly	O
altered	O
during	O
the	O
procedure	O
.	O

The	O
conditions	O
promoting	O
or	O
stemming	O
self	O
-	O
reactive	O
(	O
SR	O
)	O
T	B-ANAT
cells	I-ANAT
following	O
viral	O
-	O
induced	O
tissue	B-ANAT
damage	O
thus	O
need	O
to	O
be	O
better	O
defined	O
.	O

While	O
both	O
the	O
CNS	B-ANAT
-	O
infiltrating	O
myeloid	O
population	O
and	O
microglia	B-ANAT
ingested	O
myelin	B-ANAT
,	O
only	O
CNS	B-ANAT
-	O
infiltrating	O
APC	B-ANAT
were	O
capable	O
of	O
presenting	O
endogenous	O
myelin	B-ANAT
antigen	O
to	O
SR	O
T	B-ANAT
cells	I-ANAT
ex	O
vivo	O
.	O

Risk	O
of	O
bias	O
,	O
although	O
acceptable	O
in	O
the	O
view	O
of	O
the	O
review	O
authors	O
,	O
was	O
inevitable	O
:	O
Blinding	O
of	O
participants	O
and	O
carers	O
to	O
treatment	O
allocation	O
was	O
not	O
possible	O
(	O
face	B-ANAT
-	O
up	O
vs	O
face	B-ANAT
-	O
down	O
).	O
Primary	O
analyses	O
of	O
short	O
-	O
and	O
longer	O
-	O
term	O
mortality	O
pooled	O
from	O
six	O
trials	O
demonstrated	O
an	O
RR	O
of	O
0	O
.	O
84	O
to	O
0	O
.	O
86	O
in	O
favour	O
of	O
the	O
prone	O
position	O
(	O
PP	O
),	O
but	O
findings	O
were	O
not	O
statistically	O
significant	O
:	O
In	O
the	O
short	O
term	O
,	O
mortality	O
for	O
those	O
ventilated	O
prone	O
was	O
33	O
.	O
4	O
%	O
(	O
363	O
/	O
1086	O
)	O
and	O
supine	O
38	O
.	O
3	O
%	O
(	O
395	O
/	O
1031	O
).	O

One	O
hundred	O
ninety	O
-	O
nine	O
LRT	B-ANAT
samples	O
collected	O
during	O
the	O
3	O
weeks	O
following	O
diagnosis	O
yielded	O
virus	O
RNA	O
in	O
93	O
%	O
of	O
tests	O
.	O

Lung	B-ANAT
volumes	O
were	O
measured	O
in	O
computed	O
tomography	O
slices	O
acquired	O
at	O
end	O
-	O
expiration	O
and	O
end	O
-	O
inspiration	O
.	O

From	O
both	O
series	O
,	O
recruited	O
volume	O
and	O
lung	B-ANAT
strain	O
(	O
total	O
,	O
dynamic	O
,	O
and	O
static	O
)	O
were	O
computed	O
.	O

These	O
structures	O
combined	O
with	O
six	O
crystal	B-ANAT
structures	O
complexed	O
with	O
a	O
series	O
of	O
related	O
ligands	O
reported	O
by	O
us	O
are	O
collectively	O
analyzed	O
.	O

[(	O
18	O
)	O
F	O
]-	O
FDG	O
uptake	O
is	O
increased	O
in	O
activated	O
immune	O
cells	B-ANAT
in	O
response	O
to	O
virus	O
entry	O
and	O
can	O
be	O
localized	O
by	O
PET	O
imaging	O
.	O

Two	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
revealed	O
alterations	O
in	O
K	O
i	O
that	O
was	O
associated	O
with	O
the	O
time	O
point	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
after	O
virus	O
exposure	O
and	O
the	O
location	O
of	O
lymphoid	B-ANAT
tissue	I-ANAT
(	O
p	O
=	O
0	O
.	O
0004	O
).	O

RESULTS	O
:	O
Three	O
patients	O
with	O
severe	O
acute	O
pancreatitis	O
requiring	O
ECMO	O
suffered	O
from	O
increased	O
intra	O
abdominal	B-ANAT
pressure	O
during	O
their	O
ICU	O
stay	O
.	O

The	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
of	O
this	O
skeleton	B-ANAT
will	O
provide	O
valuable	O
clues	O
to	O
identify	O
more	O
effective	O
adenine	O
derivatives	O
as	O
antiviral	O
drugs	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
lesions	O
in	O
non	O
-	O
effusive	O
and	O
effusive	O
cases	O
of	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
)	O
regarding	O
aspects	O
related	O
to	O
astrocytic	B-ANAT
and	O
microglial	B-ANAT
reactions	O
.	O

An	O
important	O
astrocytic	B-ANAT
response	O
in	O
many	O
areas	O
of	O
the	O
CNS	B-ANAT
of	O
all	O
cats	O
,	O
including	O
the	O
periventricular	O
areas	O
of	O
lateral	B-ANAT
ventricles	I-ANAT
and	O
fourth	B-ANAT
ventricle	I-ANAT
,	O
the	O
molecular	B-ANAT
layer	I-ANAT
of	I-ANAT
the	I-ANAT
cerebellum	I-ANAT
and	O
cerebral	B-ANAT
cortex	I-ANAT
,	O
was	O
visualized	O
.	O

A	O
microglial	B-ANAT
response	O
was	O
present	O
only	O
in	O
severe	O
lesions	O
,	O
and	O
RCA	O
-	O
I	O
expression	O
was	O
detected	O
primarily	O
in	O
gitter	O
cells	B-ANAT
and	O
resting	B-ANAT
microglia	B-ANAT
.	O

In	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
hypoxemia	O
,	O
the	O
expired	O
tidal	O
volume	O
above	O
9	O
.	O
5	O
mL	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
accurately	O
predicts	O
noninvasive	O
ventilation	O
failure	O
.	O

These	O
data	O
demonstrate	O
that	O
European	O
turkey	O
and	O
guinea	O
fowl	O
coronaviruses	O
share	O
a	O
common	O
genetic	O
backbone	B-ANAT
(	O
most	O
likely	O
an	O
ancestor	O
of	O
IBV	O
Italy	O
2005	O
)	O
and	O
suggest	O
that	O
this	O
recombined	O
in	O
two	O
separate	O
events	O
with	O
different	O
,	O
yet	O
related	O
,	O
unknown	O
avian	O
coronaviruses	O
,	O
acquiring	O
their	O
S	O
-	O
3a	O
genes	O
.	O

ABSTRACT	O
:	O
The	O
Binational	O
Border	B-ANAT
Infectious	O
Disease	O
Surveillance	O
program	O
began	O
surveillance	O
for	O
severe	O
acute	O
respiratory	O
infections	O
(	O
SARI	O
)	O
on	O
the	O
US	O
-	O
Mexico	O
border	B-ANAT
in	O
2009	O
.	O

Staff	O
completed	O
a	O
standard	O
form	O
and	O
collected	O
a	O
nasopharyngeal	B-ANAT
swab	I-ANAT
which	O
was	O
tested	O
for	O
selected	O
respiratory	O
viruses	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

Simulation	O
results	O
show	O
that	O
temperature	O
differences	O
across	O
the	O
750	O
Î¼m	O
thick	O
cavity	B-ANAT
are	O
less	O
than	O
2	O
Â°	O
C	O
and	O
0	O
.	O
2	O
Â°	O
C	O
,	O
respectively	O
,	O
at	O
94	O
Â°	O
C	O
and	O
68	O
Â°	O
C	O
.	O

Nucleic	B-ANAT
acid	O
concentrations	O
as	O
low	O
as	O
10	O
(-	O
8	O
)	O
ng	O
Î¼L	O
(-	O
1	O
)	O
(	O
2	O
DNA	O
copies	O
per	O
Î¼L	O
)	O
can	O
be	O
amplified	O
with	O
40	O
PCR	O
thermal	O
cycles	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
has	O
been	O
used	O
increasingly	O
since	O
the	O
mid	O
-	O
2000s	O
in	O
part	O
due	O
to	O
the	O
H1N1	O
epidemic	O
.	O

ABSTRACT	O
:	O
Respiratory	B-ANAT
tract	I-ANAT
infections	O
are	O
a	O
principal	O
cause	O
of	O
illness	O
and	O
mortality	O
in	O
children	O
worldwide	O
and	O
mostly	O
caused	O
by	O
viruses	O
.	O

DPP4	O
was	O
also	O
found	O
in	O
a	O
subset	O
of	O
mononuclear	B-ANAT
leukocytes	I-ANAT
and	O
in	O
serous	O
cells	B-ANAT
of	O
submucosal	O
glands	B-ANAT
.	O

In	O
the	O
parenchyma	B-ANAT
,	O
DPP4	O
was	O
found	O
principally	O
in	O
type	O
I	O
and	O
II	O
cells	B-ANAT
and	O
alveolar	B-ANAT
macrophages	I-ANAT
and	O
was	O
also	O
detected	O
in	O
vascular	B-ANAT
endothelium	I-ANAT
(	O
eg	O
,	O
lymphatics	B-ANAT
)	O
and	O
pleural	O
mesothelia	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
following	O
cardiovascular	B-ANAT
surgery	O
:	O
current	O
concepts	O
and	O
novel	O
therapeutic	O
approaches	O
.	O

In	O
the	O
future	O
also	O
new	O
approaches	O
like	O
mesenchymal	B-ANAT
cell	I-ANAT
therapy	O
,	O
activation	O
of	O
hypoxia	O
-	O
elicited	O
transcription	O
factors	O
or	O
targeting	O
of	O
purinergic	O
signaling	O
may	O
be	O
successful	O
outside	O
the	O
experimental	O
setting	O
.	O

Especially	O
,	O
use	O
of	O
low	O
tidal	O
volumes	O
,	O
avoiding	O
of	O
fluid	O
overload	O
and	O
restrictive	O
blood	B-ANAT
transfusion	O
regimes	O
may	O
help	O
to	O
prevent	O
ARDS	O
.	O

A	O
serious	O
alveolar	B-ANAT
hemorrhage	O
in	O
a	O
young	O
patient	O
should	O
raise	O
suspicion	O
of	O
silicone	O
embolism	O
syndrome	O
,	O
especially	O
if	O
there	O
are	O
cutaneous	O
lesions	O
compatible	O
with	O
injections	O
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
and	O
B	O
,	O
and	O
many	O
unrelated	O
viruses	O
including	O
rhinovirus	O
,	O
RSV	O
,	O
adenovirus	O
,	O
metapneumovirus	O
and	O
coronavirus	O
share	O
the	O
same	O
seasonality	O
,	O
since	O
these	O
viral	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
vARIs	O
)	O
are	O
much	O
more	O
common	O
in	O
winter	O
than	O
summer	O
.	O

Due	O
to	O
their	O
cytotoxic	O
and	O
proinflammatory	O
effects	O
,	O
extracellular	B-ANAT
histones	O
can	O
lead	O
to	O
excessive	O
and	O
overwhelming	O
cell	B-ANAT
damage	O
and	O
death	O
,	O
thus	O
contributing	O
to	O
the	O
pathogenesis	O
of	O
both	O
sepsis	O
and	O
ARDS	O
.	O

ABSTRACT	O
:	O
OBJECT	O
Subarachnoid	O
hemorrhage	O
(	O
SAH	O
)	O
is	O
often	O
accompanied	O
by	O
pulmonary	B-ANAT
complications	O
,	O
which	O
may	O
lead	O
to	O
poor	O
outcomes	O
and	O
death	O
.	O

This	O
study	O
investigated	O
the	O
incidence	O
and	O
cause	O
of	O
pulmonary	B-ANAT
edema	O
in	O
patients	O
with	O
SAH	O
by	O
using	O
hemodynamic	O
monitoring	O
with	O
PiCCO	O
-	O
plus	O
pulse	O
contour	O
analysis	O
.	O

In	O
the	O
delayed	O
phase	O
(	O
Days	O
6	O
-	O
14	O
after	O
SAH	O
),	O
the	O
serum	B-ANAT
C	O
-	O
reactive	O
protein	O
level	O
and	O
the	O
global	O
end	O
-	O
diastolic	O
volume	O
index	O
were	O
significantly	O
higher	O
in	O
the	O
PE	O
group	O
than	O
in	O
the	O
non	O
-	O
PE	O
group	O
,	O
whereas	O
the	O
PVPI	O
tended	O
to	O
be	O
higher	O
in	O
the	O
PE	O
group	O
.	O

Additionally	O
,	O
serum	B-ANAT
concentration	O
of	O
miR	O
-	O
449a	O
,	O
b	O
,	O
c	O
and	O
miR	O
-	O
34a	O
,	O
a	O
transient	O
upregulation	O
of	O
E	O
-	O
cadherin	O
and	O
associated	O
chromatin	B-ANAT
marks	O
in	O
PBMCs	O
indicated	O
airway	B-ANAT
epithelial	O
differentiation	O
.	O

Furthermore	O
,	O
the	O
sensitivity	O
of	O
Dembo	O
-	O
PCR	O
in	O
fecal	B-ANAT
sample	O
analysis	O
was	O
measured	O
with	O
feces	B-ANAT
spiked	O
with	O
target	O
pathogens	O
or	O
synthesized	O
DNA	O
that	O
included	O
specific	O
nucleotide	O
target	O
regions	O
.	O

TITLE	O
:	O
Assembly	O
of	O
Viral	B-ANAT
Membrane	I-ANAT
Proteins	O
.	O

TITLE	O
:	O
Multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
an	O
unusual	O
complication	O
of	O
heroin	O
intoxication	O
:	O
a	O
case	O
report	O
and	O
review	O
of	O
literature	O
.	O

This	O
study	O
provides	O
a	O
new	O
method	O
to	O
screen	O
virus	O
CTL	B-ANAT
epitopes	O
in	O
chicken	O
and	O
to	O
develop	O
poly	O
-	O
CTL	B-ANAT
-	O
epitope	O
DNA	O
vaccines	O
.	O

We	O
found	O
that	O
influenza	O
pneumonia	O
was	O
dramatically	O
attenuated	O
in	O
Card9	O
-	O
deficient	O
mice	O
,	O
which	O
showed	O
improved	O
mortality	O
with	O
reduced	O
inflammatory	O
cytokines	O
and	O
chemokines	O
in	O
the	O
infected	O
lungs	B-ANAT
.	O

Monkeys	O
were	O
challenged	O
with	O
MERS	O
-	O
CoV	O
at	O
14	O
days	O
after	O
the	O
final	O
immunisation	O
followed	O
by	O
observation	O
for	O
clinical	O
signs	O
and	O
chest	B-ANAT
X	O
-	O
rays	O
.	O

Instead	O
,	O
it	O
formed	O
a	O
unique	O
branch	B-ANAT
more	O
closely	O
related	O
to	O
other	O
MERS	O
-	O
CoV	O
strains	O
from	O
patients	O
in	O
Qatar	O
and	O
Hafr	O
-	O
Al	O
-	O
Batin	O
in	O
Saudi	O
Arabia	O
,	O
as	O
well	O
as	O
the	O
MERS	O
-	O
CoV	O
strains	O
from	O
patients	O
in	O
the	O
recent	O
Korean	O
outbreak	O
,	O
in	O
which	O
the	O
index	O
patient	O
acquired	O
the	O
infection	O
during	O
travel	O
in	O
the	O
eastern	O
part	O
of	O
the	O
Arabian	O
Peninsula	O
.	O

MERS	O
-	O
CoV	O
detection	O
for	O
all	O
other	O
254	O
dromedaries	O
in	O
this	O
closed	O
dairy	O
herd	O
was	O
negative	O
by	O
nucleocapsid	B-ANAT
protein	O
-	O
capture	O
ELISA	O
and	O
RNA	O
detection	O
.	O

To	O
determine	O
the	O
presence	O
of	O
CoVs	O
in	O
French	O
bats	O
,	O
fecal	B-ANAT
samples	O
were	O
collected	O
between	O
July	O
and	O
August	O
of	O
2014	O
from	O
four	O
bat	O
species	O
in	O
seven	O
different	O
locations	O
around	O
the	O
city	O
of	O
Bourges	O
in	O
France	O
.	O

The	O
B	O
-	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
stimulation	O
potentials	O
of	O
the	O
screened	O
epitopes	O
is	O
to	O
be	O
further	O
validated	O
for	O
their	O
efficient	O
use	O
as	O
vaccines	O
against	O
MERS	O
-	O
CoV	O
.	O
Collectively	O
,	O
this	O
study	O
provides	O
novel	O
vaccine	O
target	O
candidates	O
and	O
may	O
prompt	O
further	O
development	O
of	O
vaccines	O
against	O
MERS	O
-	O
CoV	O
and	O
other	O
emerging	O
infectious	O
diseases	O
.	O

A	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
CO2	O
removal	O
(	O
ECCO2R	O
)	O
circuit	O
was	O
initiated	O
,	O
effectively	O
eliminating	O
carbon	O
dioxide	O
while	O
improving	O
oxygenation	O
and	O
enabling	O
a	O
reduction	O
in	O
applied	O
ventilatory	O
pressures	O
.	O

In	O
lymphoid	B-ANAT
tissues	I-ANAT
,	O
viral	O
RNA	O
and	O
proteins	O
were	O
detected	O
in	O
infected	O
monocytes	B-ANAT
upon	O
differentiation	O
into	O
dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
within	O
3	O
days	O
.	O

ABSTRACT	O
:	O
Increased	O
right	B-ANAT
ventricle	I-ANAT
(	O
RV	O
)	O
afterload	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
may	O
induce	O
acute	O
cor	B-ANAT
pulmonale	O
(	O
ACP	O
).	O

Elevated	O
IIR	O
is	O
associated	O
with	O
tissue	B-ANAT
tropism	O
of	O
different	O
IBV	O
strains	O
.	O

In	O
summary	O
,	O
greater	O
levels	O
of	O
apoptosis	O
and	O
elevated	O
levels	O
of	O
TLR3	O
,	O
MDA5	O
and	O
IFN	O
-	O
Î²	O
expression	O
are	O
associated	O
with	O
increased	O
pathogenicity	O
of	O
IBV	O
strains	O
in	O
renal	B-ANAT
and	O
tracheal	O
tissues	B-ANAT
.	O

Plasma	B-ANAT
Ang	O
-	O
2	O
,	O
von	O
Willebrand	O
Factor	O
antigen	O
(	O
vWF	O
),	O
and	O
vascular	B-ANAT
endothelial	B-ANAT
growth	O
factor	O
(	O
VEGF	O
)	O
were	O
measured	O
on	O
ARDS	O
days	O
1	O
and	O
3	O
and	O
correlated	O
with	O
patient	O
outcomes	O
.	O

In	O
contrast	O
,	O
an	O
approach	O
based	O
on	O
combining	O
numerical	O
optimisation	O
methods	O
with	O
computational	O
simulation	O
allowed	O
a	O
sequence	O
of	O
tidal	O
volume	O
reductions	O
to	O
be	O
computed	O
for	O
each	O
virtual	O
patient	O
that	O
maintained	O
PaCO2	O
levels	O
while	O
significantly	O
reducing	O
peak	O
airway	B-ANAT
pressures	O
and	O
dynamic	O
alveolar	B-ANAT
strain	O
in	O
all	O
patients	O
.	O

TITLE	O
:	O
Impact	O
of	O
overlap	O
syndrome	O
on	O
severity	O
of	O
acute	O
exacerbation	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
.	O

It	O
is	O
feasible	O
that	O
severe	O
acidosis	O
,	O
hypotension	O
,	O
azotemia	O
,	O
hypoalbuminemia	O
and	O
the	O
superimposed	O
aggressive	O
intravenous	O
fluid	O
administration	O
were	O
important	O
risk	O
factors	O
for	O
the	O
development	O
of	O
cerebral	B-ANAT
edema	O
and	O
ARDS	O
in	O
the	O
index	O
patient	O
.	O

From	O
1	O
,	O
874	O
screened	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
200	O
were	O
randomized	O
:	O
99	O
to	O
open	O
lung	B-ANAT
approach	O
and	O
101	O
to	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
network	O
protocol	O
.	O

Airway	B-ANAT
driving	O
pressure	O
(	O
plateau	O
pressure	O
-	O
positive	O
end	O
-	O
expiratory	O
pressure	O
)	O
and	O
PaO2	O
/	O
FIO2	O
improved	O
significantly	O
at	O
24	O
,	O
48	O
and	O
72	O
hours	O
in	O
patients	O
in	O
open	O
lung	B-ANAT
approach	O
compared	O
with	O
patients	O
in	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
network	O
protocol	O
.	O

ABSTRACT	O
:	O
Gap	B-ANAT
junctions	I-ANAT
(	O
GJs	O
)	O
form	O
intercellular	O
channels	O
which	O
directly	O
connect	O
the	O
cytoplasm	B-ANAT
between	O
neighboring	O
cells	B-ANAT
to	O
facilitate	O
the	O
transfer	O
of	O
ions	O
and	O
small	O
molecules	O
.	O

Our	O
studies	O
demonstrated	O
that	O
MHV	O
infection	O
downregulated	O
Cx43	O
expression	O
at	O
protein	O
and	O
mRNA	O
levels	O
in	O
vitro	O
in	O
primary	O
astrocytes	B-ANAT
obtained	O
from	O
neonatal	O
mouse	O
brains	B-ANAT
.	O

After	O
infection	O
,	O
a	O
significant	O
amount	O
of	O
Cx43	O
was	O
retained	O
in	O
endoplasmic	B-ANAT
reticulum	I-ANAT
/	O
endoplasmic	B-ANAT
reticulum	I-ANAT
Golgi	B-ANAT
intermediate	O
complex	O
(	O
ER	O
/	O
ERGIC	B-ANAT
)	O
and	O
GJ	O
plaque	O
formation	O
was	O
impaired	O
at	O
the	O
cell	B-ANAT
surface	I-ANAT
,	O
as	O
evidenced	O
by	O
a	O
reduction	O
of	O
the	O
Triton	O
X	O
-	O
100	O
insoluble	B-ANAT
fraction	I-ANAT
of	O
Cx43	O
.	O

Some	O
strains	O
are	O
highly	O
similar	O
to	O
SARS	O
-	O
CoV	O
even	O
in	O
the	O
spike	O
protein	O
and	O
are	O
able	O
to	O
use	O
the	O
same	O
receptor	O
as	O
SARS	O
-	O
CoV	O
for	O
cell	B-ANAT
entry	O
.	O

MERS	O
-	O
CoV	O
can	O
also	O
effectively	O
infect	O
human	O
primary	O
T	B-ANAT
cells	I-ANAT
and	O
induce	O
massive	O
apoptosis	O
in	O
these	O
cells	B-ANAT
.	O

Here	O
,	O
we	O
describe	O
the	O
current	O
literature	O
on	O
the	O
role	O
of	O
Cdc42	O
in	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-	O
1	O
cell	B-ANAT
entry	O
,	O
which	O
represents	O
the	O
most	O
investigated	O
instance	O
of	O
Cdc42	O
function	O
in	O
viral	O
cell	B-ANAT
entry	O
processes	O
,	O
and	O
also	O
review	O
evidence	O
of	O
Cdc42	O
use	O
in	O
other	O
RNA	O
virus	O
cell	B-ANAT
entries	O
,	O
demonstrating	O
prime	O
areas	O
for	O
more	O
extensive	O
research	O
using	O
similar	O
techniques	O
.	O

Conversely	O
,	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
liver	B-ANAT
injury	O
(	O
LI	O
)	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
were	O
significantly	O
more	O
common	O
during	O
hospitalization	O
in	O
the	O
O	O
-	O
group	O
,	O
although	O
no	O
significant	O
differences	O
in	O
the	O
duration	O
of	O
hospital	O
stay	O
(	O
p	O
=	O
0	O
.	O
92	O
)	O
or	O
outcomes	O
(	O
p	O
=	O
0	O
.	O
95	O
)	O
were	O
observed	O
between	O
the	O
two	O
groups	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
increased	O
susceptibility	O
of	O
the	O
G6PD	O
-	O
knockdown	O
cells	B-ANAT
to	O
viral	O
infection	O
was	O
due	O
to	O
impaired	O
NF	O
-	O
ÎºB	O
signaling	O
and	O
antiviral	O
response	O
mediated	O
by	O
HSCARG	O
.	O

In	O
humans	O
,	O
MERS	O
is	O
mostly	O
known	O
as	O
a	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
(	O
LRT	B-ANAT
)	O
disease	O
involving	O
fever	O
,	O
cough	O
,	O
breathing	O
difficulties	O
and	O
pneumonia	O
that	O
may	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
multiorgan	O
failure	O
and	O
death	O
in	O
20	O
%	O
to	O
40	O
%	O
of	O
those	O
infected	O
.	O

Quantitative	O
real	O
-	O
time	O
PCR	O
data	O
revealed	O
the	O
inhibitory	O
effect	O
of	O
2	O
on	O
genes	O
encoding	O
essential	O
structural	O
proteins	O
(	O
GP6	O
nucleocapsid	B-ANAT
,	O
GP2	O
spike	O
,	O
and	O
GP5	O
membrane	B-ANAT
)	O
for	O
PEDV	O
replication	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

In	O
addition	O
,	O
the	O
mice	O
exhibited	O
systemic	O
inflammation	O
with	O
mild	O
to	O
severe	O
pneumonia	O
accompanied	O
by	O
the	O
injury	O
of	O
liver	B-ANAT
,	O
kidney	B-ANAT
and	O
spleen	B-ANAT
with	O
neutrophil	B-ANAT
and	O
macrophage	B-ANAT
infiltration	O
.	O

The	O
lung	B-ANAT
functions	O
of	O
the	O
patients	O
showed	O
no	O
significant	O
difference	O
as	O
compared	O
with	O
those	O
obtained	O
from	O
the	O
healthy	O
controls	O
.	O

Similar	O
comparative	O
assays	O
were	O
done	O
on	O
LLC	B-ANAT
-	O
PK	O
and	O
ST	O
cells	B-ANAT
inoculated	O
with	O
the	O
cell	B-ANAT
-	O
adapted	O
PDCoV	O
strain	O
OH	O
-	O
FD22	O
-	O
P44	O
(	O
passage	O
44	O
)	O
in	O
cell	B-ANAT
culture	O
medium	O
with	O
2	O
.	O
5	O
-	O
10	O
Î¼g	O
/	O
ml	O
of	O
trypsin	O
and	O
1	O
%	O
pancreatin	O
,	O
respectively	O
.	O

Although	O
TLS	O
has	O
been	O
reported	O
in	O
disseminated	O
ARMS	B-ANAT
,	O
this	O
singular	O
case	O
of	O
life	O
-	O
threatening	O
respiratory	O
deterioration	O
developing	O
after	O
initiation	O
of	O
chemotherapy	O
presented	O
unique	O
therapeutic	O
dilemmas	O
.	O

After	O
that	O
,	O
interactions	O
between	O
GM	O
changes	O
and	O
white	B-ANAT
matter	I-ANAT
alterations	O
were	O
investigated	O
by	O
using	O
a	O
correlation	O
analysis	O
.	O

TITLE	O
:	O
Respiratory	O
Failure	O
in	O
a	O
Child	O
Due	O
to	O
Type	O
2	O
Postobstructive	O
Pulmonary	B-ANAT
Edema	O
.	O

The	O
membrane	B-ANAT
wrap	O
around	O
the	O
nanoparticles	O
not	O
only	O
serves	O
as	O
a	O
matrix	O
to	O
incorporate	O
GM3	O
as	O
targeting	O
moiety	O
for	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
but	O
also	O
offers	O
unique	O
opportunities	O
for	O
constructing	O
a	O
biomimetic	O
surface	O
from	O
lipids	O
with	O
potentially	O
protein	O
-	O
repellent	O
properties	O
.	O

TITLE	O
:	O
Prolonged	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
in	O
a	O
Patient	O
With	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Quantitative	O
analysis	O
showed	O
significantly	O
higher	O
levels	O
of	O
pulmonary	B-ANAT
neutrophil	B-ANAT
infiltration	O
and	O
higher	O
amounts	O
of	O
pulmonary	B-ANAT
viral	O
antigen	O
in	O
marmosets	O
.	O

These	O
results	O
suggest	O
that	O
increased	O
virus	O
replication	O
and	O
the	O
local	O
immune	O
response	O
to	O
MERS	O
-	O
CoV	O
infection	O
likely	O
play	O
a	O
role	O
in	O
pulmonary	B-ANAT
pathology	O
severity	O
.	O

A	O
double	O
strand	O
probe	O
with	O
an	O
optimized	O
fluorescent	O
-	O
quencher	O
couple	O
was	O
designed	O
for	O
the	O
detection	O
of	O
different	O
lengths	O
of	O
nucleic	B-ANAT
acids	O
(	O
39	O
nt	O
and	O
100	O
nt	O
).	O

Our	O
data	O
further	O
suggest	O
that	O
myeloid	B-ANAT
cells	I-ANAT
may	O
serve	O
as	O
sentinels	O
to	O
restrict	O
viral	O
replication	O
,	O
thus	O
protecting	O
other	O
cell	B-ANAT
types	O
from	O
infection	O
.	O

After	O
hospital	O
discharge	B-ANAT
,	O
the	O
patient	O
went	O
to	O
a	O
pulmonary	B-ANAT
rehabilitation	O
facility	O
for	O
2	O
weeks	O
.	O

Furthermore	O
,	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
MERS	O
-	O
CoV	O
macro	O
domain	O
was	O
determined	O
at	O
1	O
.	O
43	O
-	O
Ã	O
resolution	O
in	O
complex	O
with	O
ADP	O
-	O
ribose	O
.	O

An	O
outbreak	O
investigation	O
was	O
conducted	O
and	O
it	O
was	O
hypothesized	O
that	O
feed	O
containing	O
spray	O
-	O
dried	B-ANAT
porcine	O
plasma	B-ANAT
contaminated	O
with	O
the	O
virus	O
was	O
a	O
risk	O
factor	O
in	O
the	O
introduction	O
and	O
spread	O
of	O
the	O
disease	O
in	O
Ontario	O
.	O

One	O
patient	O
had	O
no	O
major	O
symptoms	O
upon	O
admission	O
,	O
but	O
pneumonia	O
was	O
identified	O
upon	O
chest	B-ANAT
radiography	O
.	O

Induction	O
of	O
sepsis	O
using	O
LPS	O
is	O
a	O
known	O
experimental	O
model	O
,	O
but	O
LPS	O
treatment	O
in	O
rats	O
does	O
not	O
cause	O
the	O
severe	O
endothelial	B-ANAT
and	O
epithelial	O
injury	O
that	O
occurs	O
in	O
humans	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
It	O
has	O
proved	O
that	O
muscle	B-ANAT
paralysis	O
was	O
more	O
protective	O
for	O
injured	O
lung	B-ANAT
in	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
but	O
the	O
precise	O
mechanism	O
is	O
not	O
clear	O
.	O

TITLE	O
:	O
Adult	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
respiratory	O
failure	O
:	O
Current	O
status	O
and	O
future	O
perspectives	O
.	O

Significant	O
risk	O
factors	O
for	O
AKI	O
following	O
multivariate	O
analysis	O
were	O
:	O
age	O
1	O
-	O
5	O
,	O
PRISM	O
score	O
(>	O
10	O
)	O
at	O
admission	O
,	O
shock	O
,	O
infection	O
,	O
thrombocytopenia	O
,	O
hypo	O
-	O
albuminaemia	O
and	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
.	O

ABSTRACT	O
:	O
Leukocyte	B-ANAT
-	O
mediated	O
pulmonary	B-ANAT
inflammation	O
is	O
a	O
key	O
pathophysiological	O
mechanism	O
involved	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
therefore	O
investigated	O
the	O
potential	O
role	O
of	O
leukocyte	B-ANAT
stiffness	O
and	O
adhesiveness	O
in	O
the	O
sequestration	O
of	O
leukocytes	B-ANAT
in	O
microvessels	O
.	O

Rapid	O
and	O
strong	O
stiffening	O
of	O
primary	O
neutrophils	B-ANAT
and	O
monocytes	B-ANAT
was	O
induced	O
within	O
30	O
minutes	O
(	O
mean	O
ET	O
>	O
50	O
seconds	O
)	O
by	O
sera	B-ANAT
from	O
the	O
ARDS	O
group	O
compared	O
with	O
both	O
the	O
healthy	O
subjects	O
and	O
the	O
ACPE	O
groups	O
(	O
mean	O
ET	O
<	O
1	O
second	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Crystal	B-ANAT
structure	O
of	O
the	O
mouse	O
hepatitis	O
virus	O
ns2	O
phosphodiesterase	O
domain	O
that	O
antagonizes	O
RNase	O
L	O
activation	O
.	O

Here	O
,	O
we	O
present	O
the	O
crystal	B-ANAT
structure	O
of	O
the	O
MHV	O
ns2	O
PDE	O
domain	O
and	O
demonstrate	O
a	O
PDE	O
fold	O
similar	O
to	O
that	O
of	O
the	O
cellular	B-ANAT
protein	O
,	O
a	O
kinase	O
anchoring	O
protein	O
7	O
central	O
domain	O
(	O
AKAP7	O
(	O
CD	O
))	O
and	O
rotavirus	O
VP3	O
carboxy	O
-	O
terminal	O
domain	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
human	O
coronaviruses	O
(	O
HCoVs	O
)	O
infection	O
in	O
children	O
with	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
ALRTI	O
)	O
and	O
to	O
explore	O
the	O
clinical	O
features	O
of	O
ALRTI	O
caused	O
by	O
HCoVs	O
in	O
children	O
.	O

ABSTRACT	O
:	O
To	O
trace	O
the	O
evolution	O
of	O
canine	O
coronavirus	O
(	O
CCoV	O
),	O
201	O
stool	B-ANAT
samples	O
from	O
diarrheic	O
dogs	O
in	O
northeast	O
China	O
were	O
subjected	O
to	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reactions	O
(	O
RT	O
-	O
PCRs	O
)	O
targeting	O
the	O
partial	O
M	O
and	O
S	O
genes	O
of	O
CCoV	O
,	O
followed	O
by	O
an	O
epidemiological	O
analysis	O
.	O

ABSTRACT	O
:	O
The	O
functional	O
role	O
of	O
the	O
ELR	O
(+)	O
chemokine	O
CXCL1	O
in	O
host	O
defense	O
and	O
disease	O
following	O
infection	O
of	O
the	O
CNS	B-ANAT
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
JHMV	O
)	O
was	O
examined	O
.	O

Sustained	O
CXCL1	O
expression	O
within	O
the	O
CNS	B-ANAT
resulted	O
in	O
increased	O
mortality	O
that	O
correlated	O
with	O
elevated	O
neutrophil	B-ANAT
infiltration	O
,	O
diminished	O
numbers	O
of	O
mature	O
oligodendrocytes	B-ANAT
,	O
and	O
an	O
increase	O
in	O
the	O
severity	O
of	O
demyelination	O
.	O

PEDV	O
nsp1	O
did	O
not	O
interfere	O
the	O
IRF3	O
phosphorylation	O
and	O
nuclear	O
translocation	O
but	O
interrupted	O
the	O
enhanceosome	B-ANAT
assembly	O
of	O
IRF3	O
and	O
CREB	O
-	O
binding	O
protein	O
(	O
CBP	O
)	O
by	O
degrading	O
CBP	O
.	O

Sensitivity	O
in	O
cell	B-ANAT
-	O
free	O
body	B-ANAT
cavity	I-ANAT
effusion	B-ANAT
was	O
high	O
but	O
low	O
in	O
PBMCs	O
and	O
serum	B-ANAT
.	O

Thus	O
,	O
antibodies	O
targeting	O
the	O
HA	O
stem	B-ANAT
can	O
reduce	O
the	O
severity	O
of	O
ARDS	O
and	O
show	O
promise	O
as	O
agents	O
for	O
controlling	O
pulmonary	B-ANAT
complications	O
in	O
influenza	O
.	O

TITLE	O
:	O
Clinical	O
and	O
laboratory	O
outcomes	O
after	O
umbilical	B-ANAT
cord	I-ANAT
blood	I-ANAT
transplantation	O
in	O
a	O
patient	O
with	O
mucolipidosis	O
II	O
alpha	O
/	O
beta	O
.	O

The	O
preparative	O
regimen	O
consisted	O
of	O
fludarabine	O
,	O
cyclophosphamide	O
,	O
6	O
-	O
Gy	O
total	O
body	B-ANAT
irradiation	O
,	O
and	O
rabbit	O
antithymocyte	O
globulin	O
.	O

Although	O
HSCT	O
effects	O
on	O
the	O
clinical	O
manifestations	O
were	O
limited	O
,	O
laboratory	O
data	O
including	O
plasma	B-ANAT
lysosomal	B-ANAT
enzyme	O
activities	O
and	O
serum	B-ANAT
levels	O
of	O
immunoglobulin	O
showed	O
improvement	O
.	O

Deep	O
sequencing	O
data	O
was	O
obtained	O
from	O
the	O
nasal	B-ANAT
samples	O
of	O
three	O
camels	O
that	O
had	O
been	O
experimentally	O
infected	O
with	O
a	O
human	O
MERS	O
-	O
CoV	O
isolate	O
.	O

We	O
have	O
also	O
focused	O
on	O
the	O
involvement	O
of	O
miRNAs	O
in	O
macrophage	B-ANAT
polarization	O
,	O
which	O
play	O
a	O
critical	O
role	O
in	O
regulating	O
the	O
pathogenesis	O
of	O
ALI	O
/	O
ARDS	O
.	O

The	O
death	O
rate	O
was	O
not	O
statistically	O
significant	O
on	O
burned	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
sex	O
(	O
male	O
/	O
female	O
),	O
but	O
we	O
had	O
p	O
<	O
0	O
.	O
001	O
when	O
we	O
referred	O
to	O
the	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
,	O
and	O
p	O
<	O
0	O
.	O
05	O
when	O
we	O
took	O
into	O
account	O
the	O
degree	O
burns	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
age	O
.	O

S	O
-	O
MB	O
DATK	O
surfactant	O
showed	O
a	O
significant	O
ability	O
to	O
resist	O
inhibition	O
by	O
serum	B-ANAT
albumin	O
,	O
C16	O
:	O
0	O
lyso	O
-	O
PC	O
,	O
and	O
free	O
fatty	O
acids	O
,	O
but	O
surfactant	O
inhibition	O
was	O
mitigated	O
by	O
increasing	O
surfactant	O
concentration	O
.	O

The	O
data	O
demonstrate	O
that	O
CXCL13	O
is	O
not	O
essential	O
in	O
mounting	O
effective	O
peripheral	O
humoral	O
responses	O
,	O
but	O
specifically	O
promotes	O
CNS	B-ANAT
accumulation	O
of	O
differentiated	O
B	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
To	O
compare	O
the	O
discrepancy	O
between	O
the	O
new	O
(	O
2012	O
)	O
and	O
the	O
old	O
(	O
1992	O
)	O
Atlanta	O
classification	O
criteria	O
for	O
defining	O
severity	O
,	O
organ	B-ANAT
failure	O
and	O
local	O
complications	O
in	O
patients	O
with	O
acute	O
pancreatitis	O
(	O
AP	O
).	O

Microscopical	O
and	O
immunohistochemical	O
examination	O
showed	O
multifocal	O
infiltration	O
of	O
the	O
myocardium	B-ANAT
with	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
fewer	O
macrophages	B-ANAT
,	O
neutrophils	B-ANAT
and	O
plasma	B-ANAT
cells	I-ANAT
.	O

Nasal	B-ANAT
and	O
pharyngeal	B-ANAT
swabs	O
were	O
tested	O
using	O
the	O
PCR	O
method	O
for	O
the	O
following	O
12	O
viruses	O
:	O
influenza	O
A	O
,	O
influenza	O
B	O
,	O
respiratory	O
syncytial	O
virus	O
A	O
(	O
RSV	O
A	O
),	O
respiratory	O
syncytial	O
virus	O
B	O
(	O
RSV	O
B	O
),	O
adenovirus	O
,	O
metapneumovirus	O
,	O
coronavirus	O
229E	O
/	O
NL63	O
(	O
hCoV229	O
),	O
coronavirus	O
OC43	O
(	O
hCoVOC43	O
),	O
parainfluenza	O
virus	O
1	O
(	O
PIV	O
-	O
1	O
),	O
parainfluenza	O
virus	O
2	O
(	O
PIV	O
-	O
2	O
),	O
parainfluenza	O
virus	O
3	O
(	O
PIV	O
-	O
3	O
),	O
and	O
rhinovirus	O
A	O
/	O
B	O
.	O
Coinfections	O
were	O
detected	O
in	O
nine	O
(	O
8	O
%)	O
patients	O
.	O

A	O
direct	O
interaction	O
between	O
SARS	O
-	O
CoV	O
spike	O
protein	O
and	O
host	O
surface	O
vimentin	B-ANAT
was	O
further	O
confirmed	O
by	O
far	O
-	O
Western	O
blotting	O
.	O

Vimentin	B-ANAT
is	O
a	O
putative	O
anti	O
-	O
viral	O
drug	O
target	O
for	O
preventing	O
/	O
reducing	O
the	O
susceptibility	O
to	O
SARS	O
-	O
CoV	O
infection	O
.	O

As	O
a	O
clinical	O
sign	O
of	O
infection	O
,	O
dwarfism	O
of	O
the	O
embryo	B-ANAT
was	O
quantified	O
using	O
the	O
embryo	B-ANAT
:	O
egg	B-ANAT
(	O
EE	O
)	O
index	O
.	O

82	O
.	O
1	O
%	O
had	O
an	O
infectious	O
complication	O
,	O
mainly	O
non	O
-	O
pancreatic	B-ANAT
infection	O
(	O
66	O
.	O
7	O
%	O
on	O
moderately	O
severe	O
AP	O
vs	O
.	O
79	O
.	O
5	O
%	O
on	O
severe	O
,	O
p	O
=	O
0	O
.	O
0443	O
).	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
value	O
of	O
serum	B-ANAT
cholinesterase	O
(	O
S	O
-	O
ChE	O
)	O
levels	O
in	O
judgment	O
of	O
severity	O
and	O
prognosis	O
in	O
patients	O
with	O
severe	O
pneumonia	O
.	O

At	O
12	O
months	O
following	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
,	O
89	O
patients	O
(	O
66	O
.	O
9	O
%)	O
who	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
had	O
died	O
.	O

Only	O
7	O
of	O
133	O
acute	O
respiratory	O
distress	O
syndrome	O
cases	O
met	O
criteria	O
for	O
engraftment	O
syndrome	O
and	O
15	O
for	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
.	O

BLAST	B-ANAT
search	O
for	O
motifs	O
M1	O
-	O
M6	O
revealed	O
that	O
M3	O
-	O
M5	O
were	O
almost	O
identical	O
to	O
the	O
strain	O
ZMDZY	O
identified	O
in	O
2011	O
in	O
China	O
,	O
while	O
M1	O
and	O
M2	O
were	O
similar	O
to	O
other	O
Chinese	O
strains	O
isolated	O
in	O
2011	O
-	O
2012	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
effect	O
of	O
mehanical	O
ventilation	O
(	O
MV	O
)	O
guided	O
by	O
transpulmonary	O
pressure	O
(	O
Ptp	O
)	O
on	O
respiratory	O
mechanics	O
and	O
gas	O
exchange	O
in	O
severe	O
acute	O
pancreatitis	O
patient	O
with	O
intraabdominal	B-ANAT
hypertension	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
135	O
intubated	O
trauma	O
patients	O
with	O
pulmonary	B-ANAT
contusions	O
were	O
identified	O
over	O
the	O
study	O
period	O
.	O

ABSTRACT	O
:	O
Avian	O
infectious	O
bronchitis	O
is	O
a	O
highly	O
contagious	O
disease	O
of	O
the	O
upper	O
-	O
respiratory	B-ANAT
tract	I-ANAT
caused	O
by	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
).	O

When	O
comparing	O
IBV	O
-	O
infected	O
birds	O
between	O
the	O
two	O
lines	O
,	O
the	O
most	O
enriched	O
GO	O
terms	O
were	O
""""	O
Alpha	O
-	O
beta	O
T	B-ANAT
cell	I-ANAT
activation	O
""""	O
and	O
""""	O
Positive	O
regulation	O
of	O
leukocyte	B-ANAT
activation	O
""""	O
at	O
weeks	O
1	O
and	O
3	O
,	O
respectively	O
.	O

At	O
present	O
,	O
clinical	O
management	O
is	O
directed	O
toward	O
achieving	O
sufficient	O
oxygenation	O
while	O
minimizing	O
toxicity	O
of	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

The	O
gold	O
standard	O
remains	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
,	O
using	O
lower	O
-	O
tidal	O
volumes	O
and	O
pressure	O
-	O
limited	O
ventilator	O
titration	O
.	O

Neuromuscular	O
blockade	O
is	O
commonly	O
used	O
to	O
ease	O
tracheal	O
intubation	O
,	O
to	O
optimize	O
mechanical	O
ventilation	O
and	O
oxygenation	O
in	O
acute	O
respiratory	O
disorders	O
such	O
as	O
status	O
asthmaticus	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
to	O
prevent	O
shivering	O
during	O
therapeutic	O
hypothermia	O
,	O
and	O
also	O
in	O
patients	O
with	O
elevated	O
intracranial	B-ANAT
pressure	O
.	O

These	O
data	O
indicate	O
that	O
FECV	O
can	O
infect	O
immune	O
cells	B-ANAT
even	O
in	O
the	O
absence	O
of	O
intestinal	B-ANAT
replication	O
and	O
raise	O
the	O
hypothesis	O
that	O
the	O
gradual	O
adaptation	O
to	O
these	O
cells	B-ANAT
can	O
allow	O
non	O
-	O
enterotropic	O
mutants	O
to	O
arise	O
.	O

In	O
addition	O
,	O
we	O
report	O
a	O
25	O
-	O
year	O
-	O
old	O
pregnant	O
patient	O
with	O
hantavirus	O
cardiopulmonary	B-ANAT
syndrome	O
unresponsive	O
to	O
pressors	O
and	O
inotropes	O
.	O

ECLS	O
during	O
pregnancy	O
is	O
effective	O
and	O
relatively	O
safe	O
for	O
the	O
mother	B-ANAT
and	I-ANAT
fetus	I-ANAT
.	O

TITLE	O
:	O
Dihydro	O
-	O
Resveratrol	O
Ameliorates	O
Lung	B-ANAT
Injury	O
in	O
Rats	O
with	O
Cerulein	O
-	O
Induced	O
Acute	O
Pancreatitis	O
.	O

ABSTRACT	O
:	O
Acute	O
pancreatitis	O
is	O
an	O
inflammatory	O
process	O
originated	O
in	O
the	O
pancreas	B-ANAT
;	O
however	O
,	O
it	O
often	O
leads	O
to	O
systemic	O
complications	O
that	O
affect	O
distant	O
organs	B-ANAT
.	O

This	O
study	O
is	O
the	O
first	O
to	O
report	O
the	O
oral	B-ANAT
administration	O
of	O
dihydro	O
-	O
resveratrol	O
ameliorated	O
acute	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
via	O
an	O
inhibitory	O
modulation	O
of	O
pro	O
-	O
inflammatory	O
response	O
,	O
which	O
was	O
associated	O
with	O
a	O
suppression	O
of	O
the	O
NF	O
-	O
ÎºB	O
signaling	O
pathway	O
.	O

The	O
inflammatory	O
responses	O
indicate	O
that	O
the	O
cellular	B-ANAT
immune	O
response	O
is	O
most	O
effective	O
during	O
the	O
initial	O
stage	O
,	O
while	O
the	O
humoral	O
immune	O
response	O
is	O
more	O
significant	O
in	O
later	O
stages	O
of	O
infection	O
.	O

We	O
need	O
further	O
experience	O
and	O
improvements	O
in	O
the	O
circuit	O
system	O
used	O
in	O
the	O
veno	O
-	O
veno	O
-	O
arterial	B-ANAT
mode	O
of	O
ECMO	O
.	O

The	O
injection	O
of	O
a	O
lentiviral	O
vector	O
carrying	O
a	O
minigene	O
encoding	O
for	O
a	O
FXN	O
-	O
specific	O
short	O
hairpin	O
ribonucleic	O
acid	O
(	O
shRNA	O
)	O
into	O
the	O
mouse	O
cerebellar	B-ANAT
cortex	I-ANAT
triggers	O
a	O
FXN	O
deficit	O
which	O
is	O
accompanied	O
by	O
significant	O
apoptosis	O
of	O
granule	B-ANAT
neurons	B-ANAT
as	O
well	O
as	O
loss	O
of	O
calbindin	O
in	O
Purkinje	B-ANAT
cells	I-ANAT
.	O

These	O
data	O
demonstrate	O
the	O
potential	O
therapeutic	O
usefulness	O
of	O
neurotrophins	O
like	O
BDNF	O
to	O
protect	O
FXN	O
-	O
deficient	O
neurons	B-ANAT
from	O
degeneration	O
.	O

Therefore	O
,	O
we	O
developed	O
a	O
demonstrator	O
with	O
an	O
integrated	O
control	O
algorithm	O
to	O
keep	O
continuously	O
measured	O
peripheral	O
oxygen	O
saturation	O
and	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
constant	O
by	O
automatically	O
adjusting	O
extracorporeal	B-ANAT
blood	I-ANAT
and	O
gas	O
flow	O
.	O

Patients	O
with	O
admission	O
positive	O
Tn	O
I	O
(	O
38	O
.	O
1	O
%)	O
showed	O
higher	O
values	O
of	O
systolic	O
pulmonary	B-ANAT
hypertension	O
(	O
P	O
=	O
.	O
013	O
)	O
associated	O
with	O
significantly	O
lower	O
values	O
of	O
tricuspid	O
annular	O
plane	O
excursion	O
(	O
P	O
=	O
.	O
011	O
).	O

TITLE	O
:	O
Outcome	O
of	O
Severe	O
Dengue	O
Viral	O
Infection	O
-	O
caused	O
Acute	O
Liver	B-ANAT
Failure	O
in	O
Thai	O
Children	O
.	O

Multiorgan	O
failure	O
including	O
respiratory	O
failure	O
,	O
massive	O
bleeding	O
and	O
acute	O
kidney	B-ANAT
injury	O
occurred	O
in	O
80	O
.	O
0	O
%,	O
96	O
.	O
0	O
%	O
and	O
84	O
.	O
0	O
%	O
of	O
the	O
ALF	O
cases	O
,	O
respectively	O
,	O
with	O
an	O
overall	O
fatality	O
rate	O
of	O
68	O
.	O
3	O
%.	O

The	O
EA	O
fraction	O
of	O
H	O
.	O
cordata	O
was	O
tested	O
for	O
acute	O
oral	B-ANAT
toxicity	O
in	O
C57BL	O
/	O
6	O
mice	O
.	O

To	O
establish	O
a	O
link	O
between	O
the	O
research	O
conducted	O
in	O
animal	O
models	O
and	O
humans	O
,	O
an	O
organotypic	O
human	O
airway	B-ANAT
culture	O
system	O
,	O
that	O
recapitulates	O
the	O
human	O
airway	B-ANAT
epithelium	B-ANAT
,	O
has	O
been	O
developed	O
.	O

Finally	O
,	O
comparison	O
with	O
crystal	B-ANAT
structures	O
of	O
human	O
coronavirus	O
S	O
domains	O
allows	O
rationalization	O
of	O
the	O
molecular	O
basis	O
for	O
species	O
specificity	O
based	O
on	O
the	O
use	O
of	O
spatially	O
contiguous	O
but	O
distinct	O
domains	O
.	O

Variations	O
in	O
intrathoracic	O
pressure	O
have	O
a	O
major	O
impact	O
and	O
affect	O
systemic	O
venous	B-ANAT
return	O
,	O
right	O
ventricular	B-ANAT
preload	O
,	O
left	O
ventricular	B-ANAT
preload	O
,	O
right	O
ventricular	B-ANAT
afterload	O
,	O
left	O
ventricular	B-ANAT
afterload	O
and	O
myocardial	O
contracility	O
.	O

ABSTRACT	O
:	O
Most	O
of	O
the	O
intracellular	B-ANAT
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
reside	O
in	O
either	O
the	O
endolysosome	B-ANAT
or	O
the	O
cytoplasm	B-ANAT
to	O
sense	O
pathogen	O
-	O
derived	O
RNAs	O
,	O
DNAs	O
,	O
or	O
synthetic	O
analogs	O
of	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
),	O
such	O
as	O
poly	O
(	O
I	O
:	O
C	O
).	O

Viral	O
protein	O
can	O
serve	O
as	O
a	O
pathogen	O
-	O
associated	O
molecular	O
pattern	O
(	O
PAMP	O
)	O
that	O
is	O
usually	O
recognized	O
by	O
certain	O
pathogen	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
,	O
such	O
as	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
and	O
TLR4	O
.	O

Thus	O
,	O
the	O
results	O
indicate	O
for	O
the	O
first	O
time	O
that	O
SARS	O
-	O
CoV	O
M	O
protein	O
may	O
function	O
as	O
a	O
cytosolic	B-ANAT
PAMP	O
to	O
stimulate	O
IFN	O
-	O
Î²	O
production	O
by	O
activating	O
a	O
TLR	O
-	O
related	O
TRAF3	O
-	O
independent	O
signaling	O
cascade	O
.	O

It	O
'	O
s	O
a	O
46	O
-	O
year	O
-	O
old	O
Chinese	O
man	O
presented	O
with	O
sore	O
throat	B-ANAT
,	O
hemoptysis	O
,	O
fever	O
,	O
dyspnea	O
and	O
multiple	O
lung	B-ANAT
nodules	B-ANAT
.	O

RESULTS	O
:	O
This	O
is	O
the	O
first	O
case	O
of	O
seronegative	O
HIV	O
-	O
1	O
infection	O
with	O
presentation	O
of	O
primary	O
pulmonary	B-ANAT
KS	O
.	O

CONCLUSIONS	O
:	O
This	O
case	O
underscores	O
the	O
importance	O
of	O
plasma	B-ANAT
RNA	O
test	O
in	O
conjunction	O
with	O
HIV	O
antibody	O
test	O
for	O
some	O
rare	O
patients	O
with	O
HIV	O
infection	O
who	O
present	O
with	O
severe	O
immunodeficiency	O
and	O
opportunistic	O
infections	O
or	O
malignancy	O
.	O

ABSTRACT	O
:	O
Highly	O
pathogenic	O
human	O
respiratory	O
coronaviruses	O
cause	O
acute	O
lethal	O
disease	O
characterized	O
by	O
exuberant	O
inflammatory	O
responses	O
and	O
lung	B-ANAT
damage	O
.	O

Although	O
the	O
clinical	O
presentation	O
of	O
human	O
MERS	O
-	O
CoV	O
infection	O
has	O
been	O
documented	O
,	O
many	O
facets	B-ANAT
of	O
this	O
emerging	O
disease	O
are	O
still	O
unknown	O
and	O
could	O
be	O
studied	O
with	O
animal	O
models	O
.	O

These	O
molecules	O
are	O
able	O
to	O
directly	O
inhibit	O
many	O
viruses	O
such	O
as	O
Human	O
Immunodeficiency	O
Virus	O
(	O
HIV	O
),	O
Hepatitis	O
C	O
Virus	O
(	O
HCV	O
),	O
Dengue	O
Virus	O
,	O
Ebola	O
Virus	O
or	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	O
through	O
binding	O
to	O
envelope	B-ANAT
protein	O
N	O
-	O
glycans	O
.	O

At	O
the	O
end	O
of	O
lectin	O
exposure	O
,	O
the	O
genome	O
of	O
the	O
isolated	O
strains	O
was	O
sequenced	O
and	O
several	O
potential	O
resistance	O
mutations	O
in	O
the	O
E1E2	O
envelope	B-ANAT
glycoproteins	O
were	O
identified	O
.	O

Thus	O
,	O
our	O
results	O
suggest	O
that	O
in	O
contrast	O
to	O
HIV	O
,	O
HCV	O
resistance	O
to	O
CBAs	O
is	O
not	O
directly	O
conferred	O
by	O
mutations	O
in	O
the	O
envelope	B-ANAT
protein	O
genes	O
but	O
could	O
occur	O
through	O
an	O
indirect	O
mechanism	O
involving	O
mutations	O
in	O
other	O
viral	O
proteins	O
.	O

TITLE	O
:	O
Interactive	O
mechanism	O
between	O
avian	O
infectious	O
bronchitis	O
S1	O
protein	O
T	B-ANAT
cell	I-ANAT
peptide	O
and	O
avian	O
MHC	B-ANAT
I	O
molecule	O
.	O

These	O
data	O
suggest	O
that	O
Sp6	B-ANAT
can	O
induce	O
the	O
activated	O
avian	O
lymphocytes	B-ANAT
in	O
vitro	O
to	O
produce	O
CTL	B-ANAT
,	O
which	O
is	O
the	O
CTL	B-ANAT
epitope	O
in	O
IBV	O
S1	O
.	O

TITLE	O
:	O
[	O
Corynebacterium	O
ulcerans	O
pulmonary	B-ANAT
infection	O
].	O

Structure	O
activity	O
relationship	O
studies	O
of	O
the	O
candidate	O
compounds	O
were	O
given	O
reasonable	O
inhibitors	O
ent	B-ANAT
-	O
3	O
and	O
ent	B-ANAT
-	O
7k	O
against	O
SARS	O
3CL	O
R188I	O
mutant	O
protease	O
.	O

Falciparum	O
malaria	O
in	O
pregnancy	O
is	O
more	O
likely	O
to	O
be	O
complicated	O
:	O
the	O
placenta	B-ANAT
contains	O
high	O
levels	O
of	O
parasites	O
,	O
stillbirth	O
or	O
early	O
delivery	O
may	O
occur	O
and	O
diagnosis	O
can	O
be	O
difficult	O
if	O
parasites	O
are	O
concentrated	O
in	O
the	O
placenta	B-ANAT
and	O
scanty	O
in	O
the	O
blood	B-ANAT
.	O

Either	O
an	O
oral	B-ANAT
ACT	O
or	O
chloroquine	O
can	O
be	O
used	O
for	O
the	O
treatment	O
of	O
non	O
-	O
falciparum	O
malaria	O
.	O

In	O
unadjusted	O
logistic	O
regression	O
analyses	O
,	O
the	O
odds	O
of	O
developing	O
ARDS	O
were	O
significantly	O
associated	O
with	O
head	B-ANAT
AIS	O
score	O
(	O
odds	O
ratio	O
[	O
OR	O
],	O
1	O
.	O
8	O
;	O
p	O
=	O
0	O
.	O
018	O
),	O
male	O
sex	O
(	O
OR	O
,	O
2	O
.	O
9	O
;	O
p	O
=	O
0	O
.	O
012	O
),	O
and	O
early	O
transfusion	O
of	O
platelets	B-ANAT
(	O
OR	O
,	O
2	O
.	O
8	O
;	O
p	O
=	O
0	O
.	O
003	O
).	O

TITLE	O
:	O
Gene	O
control	O
of	O
tyrosine	O
kinase	O
TIE2	O
and	O
vascular	B-ANAT
manifestations	O
of	O
infections	O
.	O

Compared	O
with	O
wild	O
-	O
type	O
littermates	O
,	O
mice	O
possessing	O
one	O
allele	O
of	O
Tie2	O
suffered	O
more	O
severe	O
vascular	B-ANAT
leakage	O
and	O
higher	O
mortality	O
in	O
two	O
different	O
sepsis	O
models	O
.	O

RESULTS	O
:	O
At	O
least	O
one	O
respiratory	B-ANAT
tract	I-ANAT
pathogen	O
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
in	O
78	O
.	O
6	O
%	O
(	O
n	O
=	O
140	O
)	O
of	O
the	O
patients	O
:	O
influenza	O
A	O
33	O
.	O
5	O
%,	O
influenza	O
B	O
16	O
.	O
4	O
%,	O
respiratory	O
syncytial	O
virus	O
9	O
.	O
2	O
%,	O
adenovirus	O
7	O
.	O
8	O
%,	O
rhinovirus	O
7	O
.	O
1	O
%,	O
coronavirus	O
7	O
.	O
1	O
%,	O
human	O
metapneumovirus	O
5	O
.	O
7	O
%,	O
human	O
bocavirus	O
5	O
.	O
7	O
%,	O
parainfluenza	O
virus	O
3	O
.	O
5	O
%,	O
coinfection	O
2	O
.	O
8	O
%.	O

In	O
this	O
study	O
,	O
using	O
an	O
LPS	O
-	O
induced	O
ALI	O
mouse	O
model	O
,	O
we	O
found	O
intratracheal	O
(	O
i	O
.	O
t	O
.)	O
administration	O
of	O
melatonin	O
markedly	O
reduced	O
the	O
pulmonary	B-ANAT
injury	O
and	O
decreased	O
the	O
infiltration	O
of	O
macrophages	B-ANAT
and	O
neutrophils	B-ANAT
into	O
lung	B-ANAT
.	O

Here	O
we	O
report	O
that	O
the	O
MERS	O
-	O
CoV	O
receptor	O
--	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)--	O
is	O
expressed	O
in	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
epithelium	B-ANAT
of	O
camels	O
but	O
not	O
in	O
that	O
of	O
humans	O
.	O

After	O
24	O
hours	O
,	O
animals	O
were	O
weaned	O
from	O
treatment	O
for	O
recovery	O
in	O
the	O
ensuing	O
14	O
days	O
,	O
with	O
their	O
lungs	B-ANAT
assessed	O
for	O
injury	O
and	O
reparation	O
.	O

More	O
PKH26	O
-	O
labeled	O
type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
were	O
detected	O
by	O
fluorescence	O
in	O
the	O
lungs	B-ANAT
of	O
ALI	O
-	O
EC	O
-	O
T	O
than	O
in	O
CON	O
-	O
EC	O
-	O
T	O
as	O
further	O
verified	O
by	O
the	O
expression	O
of	O
messenger	O
RNA	O
of	O
sex	O
-	O
determining	O
region	O
of	O
Y	B-ANAT
chromosome	I-ANAT
.	O

Electromicroscopically	O
intact	O
type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
and	O
prominent	O
lattice	O
-	O
like	O
tubular	O
myelin	B-ANAT
were	O
also	O
found	O
in	O
ALI	O
-	O
EC	O
-	O
T	O
and	O
CON	O
-	O
MV	O
but	O
not	O
in	O
ALI	O
-	O
EC	O
.	O

Immunofluorescence	O
staining	O
of	O
FCoV	O
in	O
macrophages	B-ANAT
in	O
effusion	B-ANAT
has	O
been	O
considered	O
as	O
the	O
reference	O
standard	O
for	O
the	O
diagnosis	O
,	O
but	O
recently	O
this	O
method	O
has	O
been	O
shown	O
to	O
have	O
lower	O
specificity	O
than	O
previously	O
reported	O
.	O

In	O
addition	O
,	O
effusion	B-ANAT
samples	O
were	O
stained	O
with	O
haematoxylin	O
and	O
eosin	O
and	O
evaluated	O
cytologically	O
.	O

Based	O
on	O
the	O
results	O
of	O
the	O
present	O
study	O
,	O
however	O
,	O
ICC	O
of	O
effusion	B-ANAT
samples	O
currently	O
cannot	O
be	O
recommended	O
to	O
confirm	O
a	O
suspicion	O
of	O
FIP	O
.	O

We	O
investigated	O
Le	O
(	O
x	O
)	O
expression	O
using	O
CD11b	O
-	O
positive	O
peritoneal	B-ANAT
exudate	B-ANAT
cells	B-ANAT
(	O
PECs	O
)	O
and	O
found	O
that	O
Le	O
(	O
x	O
)	O
is	O
inducible	O
in	O
Mo	O
/	O
Mas	B-ANAT
after	O
infection	O
with	O
srr7	O
,	O
especially	O
in	O
the	O
syncytial	O
cells	B-ANAT
during	O
the	O
late	O
phase	O
of	O
infection	O
.	O

Particulate	O
substances	O
in	O
smoke	O
,	O
toxic	O
and	O
harmful	O
gas	O
,	O
and	O
chemical	O
substances	O
act	O
together	O
would	O
rapidly	O
induce	O
the	O
occurrence	O
of	O
dramatic	O
pathophysiologic	O
reaction	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
resulting	O
in	O
acute	O
injury	O
to	O
the	O
respiratory	B-ANAT
tract	I-ANAT
,	O
thus	O
inducing	O
serious	O
injury	O
to	O
it	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
leading	O
to	O
death	O
of	O
the	O
victims	O
.	O

ABSTRACT	O
:	O
A	O
clinical	O
trial	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
as	O
an	O
alternative	O
ventilator	O
tool	O
is	O
being	O
performed	O
as	O
a	O
new	O
indication	O
for	O
ECMO	O
.	O

We	O
analyzed	O
patient	O
history	O
,	O
the	O
partial	O
arterial	B-ANAT
pressure	O
of	O
oxygen	O
(	O
PaO2	O
)/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
FiO2	O
)	O
ratio	O
,	O
and	O
patient	O
outcome	O
.	O

Additionally	O
,	O
it	O
is	O
possible	O
for	O
patients	O
to	O
breathe	O
spontaneously	O
,	O
which	O
might	O
prevents	O
respiratory	B-ANAT
muscle	I-ANAT
dystrophy	O
.	O

TITLE	O
:	O
ROS	O
-	O
activated	O
calcium	O
signaling	O
mechanisms	O
regulating	O
endothelial	B-ANAT
barrier	O
function	O
.	O

ABSTRACT	O
:	O
Ebola	O
and	O
MERS	O
are	O
contagious	O
diseases	O
with	O
high	O
mortality	O
,	O
and	O
separate	O
handling	O
of	O
blood	B-ANAT
samples	I-ANAT
in	O
the	O
laboratory	O
is	O
necessary	O
.	O

Moreover	O
,	O
common	O
clinical	O
concerns	O
such	O
as	O
systemic	O
inflammatory	O
response	O
syndrome	O
and	O
multiple	O
organ	B-ANAT
dysfunction	O
remain	O
unaddressed	O
.	O

TITLE	O
:	O
Comparison	O
of	O
lentiviruses	O
pseudotyped	O
with	O
S	O
proteins	O
from	O
coronaviruses	O
and	O
cell	B-ANAT
tropisms	O
of	O
porcine	O
coronaviruses	O
.	O

Both	O
live	O
and	O
pseudoviruses	O
could	O
infected	O
Vero	O
-	O
CCL	O
-	O
81	O
(	O
monkey	O
kidney	B-ANAT
),	O
Huh	O
-	O
7	O
(	O
human	O
liver	B-ANAT
),	O
and	O
PK	O
-	O
15	O
(	O
pig	O
kidney	B-ANAT
)	O
cells	B-ANAT
efficiently	O
.	O

We	O
investigated	O
the	O
effects	O
of	O
prone	O
position	O
on	O
arterial	B-ANAT
blood	I-ANAT
gases	O
,	O
lung	B-ANAT
inflammation	O
,	O
and	O
histology	O
in	O
an	O
experimental	O
mild	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
model	O
.	O

ABSTRACT	O
:	O
Fifteen	O
years	O
have	O
passed	O
since	O
lung	B-ANAT
protective	O
strategy	O
to	O
the	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
established	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
plays	O
an	O
important	O
role	O
in	O
the	O
virus	B-ANAT
structure	I-ANAT
,	O
the	O
replication	O
,	O
and	O
the	O
transcription	O
of	O
CoV	O
.	O
This	O
protein	O
,	O
which	O
has	O
a	O
helix	O
and	O
flexible	O
structure	O
,	O
and	O
capable	O
of	O
binding	O
on	O
to	O
the	O
viral	O
genomic	O
RNA	O
,	O
is	O
a	O
non	O
-	O
structural	O
protein	O
(	O
nsp3	O
).	O

The	O
aim	O
of	O
this	O
retrospective	O
study	O
was	O
to	O
detect	O
selected	O
pathogens	O
in	O
pneumonic	O
lung	B-ANAT
tissue	I-ANAT
of	O
dogs	O
of	O
different	O
age	O
groups	O
by	O
immunohistochemistry	O
(	O
IHC	O
),	O
in	O
situ	O
hybridisation	O
(	O
ISH	O
)	O
or	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
order	O
to	O
get	O
information	O
about	O
their	O
involvement	O
in	O
pneumonia	O
formation	O
.	O

Contrary	O
to	O
expectations	O
,	O
ribosomes	B-ANAT
were	O
not	O
found	O
to	O
pause	O
at	O
the	O
ribosomal	B-ANAT
frameshift	O
site	O
.	O

Its	O
main	O
pathologic	O
mechanism	O
seems	O
to	O
result	O
from	O
increased	O
alveolar	B-ANAT
permeability	O
.	O

The	O
cornerstone	O
of	O
therapy	O
was	O
found	O
to	O
be	O
a	O
low	O
tidal	O
volume	O
strategy	O
featuring	O
volumes	O
of	O
6	O
to	O
8	O
mL	O
per	O
kg	O
of	O
ideal	O
body	B-ANAT
weight	O
that	O
has	O
been	O
shown	O
to	O
have	O
decreased	O
mortality	O
as	O
proven	O
by	O
the	O
ARDSnet	O
trials	O
.	O

We	O
did	O
not	O
detect	O
significant	O
differences	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
levels	O
of	O
sESEL	O
,	O
Ang	O
-	O
1	O
or	O
Ang	O
-	O
2	O
between	O
patients	O
with	O
ARDS	O
and	O
healthy	O
volunteers	O
.	O

In	O
this	O
review	O
,	O
we	O
will	O
analyze	O
and	O
discuss	O
new	O
evidence	O
supporting	O
an	O
important	O
role	O
for	O
the	O
CB	O
chemoreceptor	B-ANAT
in	O
the	O
progression	O
of	O
autonomic	B-ANAT
and	O
cardiorespiratory	O
alterations	O
induced	O
by	O
heart	B-ANAT
failure	O
,	O
obstructive	O
sleep	O
apnea	O
,	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
and	O
metabolic	O
syndrome	O
.	O

Sequenced	O
partial	O
RdRp	O
fragments	O
had	O
80	O
%-	O
99	O
%	O
nucleic	B-ANAT
acid	O
sequence	O
identity	O
with	O
well	O
-	O
characterized	O
Alphacoronavirus	O
species	O
,	O
including	O
BtCoV	O
HKU2	O
,	O
BtCoV	O
HKU8	O
,	O
and	O
BtCoV1	O
,	O
and	O
unassigned	O
species	O
BtCoV	O
HKU7	O
and	O
BtCoV	O
HKU10	O
.	O

ABSTRACT	O
:	O
Our	O
recent	O
investigation	O
on	O
the	O
antiviral	O
activities	O
against	O
tobacco	O
mosaic	O
virus	O
(	O
TMV	O
)	O
of	O
phenanthroindolizidine	O
alkaloid	O
analogues	O
preliminarily	O
revealed	O
that	O
the	O
basic	O
skeleton	B-ANAT
and	O
substitution	O
pattern	O
at	O
the	O
C13a	O
position	O
of	O
the	O
molecule	O
,	O
which	O
are	O
closely	O
related	O
to	O
the	O
spatial	O
arrangement	O
of	O
the	O
molecule	O
,	O
have	O
great	O
effects	O
on	O
the	O
biological	O
activity	O
.	O

We	O
assessed	O
the	O
management	O
of	O
RSV	O
and	O
other	O
non	O
-	O
influenza	O
respiratory	O
viruses	O
in	O
Midwestern	O
transplant	B-ANAT
centers	O
.	O

Amongst	O
the	O
important	O
measures	O
to	O
control	O
MERS	O
-	O
CoV	O
spread	O
are	O
strict	O
regulation	O
of	O
camel	O
movement	O
,	O
regular	O
herd	O
screening	O
and	O
isolation	O
of	O
infected	O
camels	O
,	O
use	O
of	O
personal	O
protective	O
equipment	O
by	O
camel	O
handlers	O
and	O
enforcing	O
rules	O
banning	O
all	O
consumption	O
of	O
unpasteurized	O
camel	O
milk	O
and	O
urine	B-ANAT
.	O

The	O
root	B-ANAT
of	O
the	O
HCoV	O
-	O
229E	O
tree	O
was	O
dated	O
to	O
1955	O
,	O
before	O
it	O
diverged	O
into	O
groups	O
1	O
-	O
4	O
between	O
the	O
1970s	O
and	O
1990s	O
.	O

A	O
20	O
-	O
year	O
-	O
old	O
girl	O
from	O
Pakistan	O
presented	O
for	O
acute	O
fatigue	O
,	O
fever	O
,	O
and	O
cough	O
with	O
a	O
chest	B-ANAT
X	O
-	O
ray	O
displayed	O
the	O
micronodular	O
interstitial	B-ANAT
disease	O
.	O

These	O
features	O
,	O
along	O
with	O
the	O
location	O
of	O
the	O
two	O
protease	O
sites	O
known	O
to	O
be	O
important	O
for	O
coronavirus	O
entry	O
,	O
provide	O
a	O
structural	O
basis	O
to	O
support	O
a	O
model	O
of	O
membrane	B-ANAT
fusion	O
mediated	O
by	O
progressive	O
S	O
protein	O
destabilization	O
through	O
receptor	O
binding	O
and	O
proteolytic	O
cleavage	O
.	O

CoV	O
genomes	O
encode	O
an	O
integral	O
viral	B-ANAT
component	I-ANAT
,	O
main	O
protease	O
(	O
M	O
(	O
pro	O
)),	O
which	O
is	O
essential	O
for	O
viral	O
replication	O
through	O
proteolytic	O
processing	O
of	O
RNA	O
replicase	O
machinery	O
.	O

This	O
review	O
examines	O
the	O
significance	O
of	O
viral	O
infection	O
of	O
macrophages	B-ANAT
.	O

In	O
conclusion	O
,	O
both	O
assays	O
were	O
able	O
to	O
detect	O
Mass	O
and	O
BR	O
genotypes	O
,	O
allowing	O
rapid	O
and	O
easy	O
IBV	O
molecular	O
typing	O
from	O
allantoic	O
fluids	B-ANAT
and	O
clinical	O
samples	O
.	O

TITLE	O
:	O
Memory	O
T	B-ANAT
cell	I-ANAT
responses	O
targeting	O
the	O
SARS	O
coronavirus	O
persist	O
up	O
to	O
11	O
years	O
post	O
-	O
infection	O
.	O

Coronavirus	O
RNA	O
synthesis	O
is	O
performed	O
by	O
a	O
replication	O
-	O
transcription	O
complex	O
that	O
includes	O
viral	O
and	O
cell	B-ANAT
proteins	O
that	O
recognize	O
cis	O
-	O
acting	O
RNA	O
elements	O
mainly	O
located	O
in	O
the	O
highly	O
structured	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
regions	O
.	O

Viral	O
clearance	O
and	O
resolution	O
of	O
infection	O
requires	O
a	O
complex	O
,	O
multi	O
-	O
faceted	O
response	O
initiated	O
by	O
resident	O
respiratory	B-ANAT
tract	I-ANAT
cells	B-ANAT
and	O
innate	O
immune	O
cells	B-ANAT
and	O
ultimately	O
resolved	O
by	O
adaptive	O
immune	O
cells	B-ANAT
.	O

On	O
the	O
cellular	B-ANAT
level	O
there	O
is	O
pulmonary	O
capillary	B-ANAT
endothelial	I-ANAT
cell	I-ANAT
permeability	O
and	O
fluid	O
leakage	O
into	O
the	O
pulmonary	B-ANAT
parenchyma	B-ANAT
,	O
followed	O
by	O
neutrophils	B-ANAT
,	O
cytokines	O
and	O
an	O
acute	O
inflammatory	O
response	O
.	O

We	O
also	O
showed	O
that	O
pFcRn	O
mediated	O
bidirectional	O
IgG	O
transport	O
across	O
polarized	O
IPEC	O
-	O
J2	O
cells	B-ANAT
and	O
bound	O
to	O
IgG	O
in	O
a	O
pH	O
-	O
dependent	O
manner	O
.	O

Our	O
results	O
indicate	O
that	O
pFcRn	O
-	O
dependent	O
bidirectional	O
IgG	O
transport	O
across	O
the	O
intestinal	B-ANAT
epithelium	I-ANAT
plays	O
critical	O
role	O
in	O
the	O
acquisition	O
of	O
humoral	O
immunity	O
in	O
early	O
life	O
and	O
in	O
host	O
defense	O
at	O
mucosal	B-ANAT
surfaces	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
of	O
plasma	B-ANAT
adiponectin	O
level	O
at	O
ICU	O
admission	O
with	O
ARDS	O
and	O
30	O
-	O
day	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	O
and	O
septic	O
shock	O
.	O

Plasma	B-ANAT
adiponectin	O
was	O
measured	O
at	O
the	O
time	O
of	O
ICU	O
admission	O
.	O

Both	O
LAV	O
and	O
MAS	B-ANAT
significantly	O
decreased	O
lung	B-ANAT
compliance	O
,	O
increased	O
airway	B-ANAT
resistance	O
,	O
and	O
caused	O
severe	O
hypoxemia	O
,	O
hypercarbia	O
,	O
and	O
acidosis	O
.	O

As	O
organs	B-ANAT
from	O
conventional	O
pigs	O
are	O
usually	O
too	O
large	O
,	O
those	O
from	O
minipigs	O
may	O
be	O
better	O
suited	O
.	O

HEV	B-ANAT
RNA	O
was	O
found	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
in	O
most	O
,	O
and	O
DNA	O
of	O
PCMV	O
,	O
PLHV	O
-	O
2	O
,	O
and	O
PLHV	O
-	O
3	O
was	O
found	O
by	O
PCR	O
in	O
some	O
animals	O
.	O

A	O
36	O
-	O
year	O
-	O
old	O
woman	O
,	O
G3P2002	O
,	O
presented	O
at	O
33	O
(	O
2	O
/	O
7	O
)	O
weeks	O
'	O
gestation	O
with	O
6	O
days	O
of	O
worsening	O
cough	O
,	O
fever	O
,	O
and	O
shortness	O
of	O
breath	B-ANAT
.	O

TITLE	O
:	O
Influenza	O
leaves	O
a	O
TRAIL	O
to	O
pulmonary	B-ANAT
edema	O
.	O

ABSTRACT	O
:	O
The	O
amount	O
of	O
extracorporeal	O
carbon	O
dioxide	O
removal	O
may	O
influence	O
respiratory	O
drive	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
undergoing	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

To	O
modulate	O
carbon	O
dioxide	O
extraction	O
,	O
ECMO	O
gas	O
flow	O
(	O
GF	O
)	O
was	O
decreased	O
from	O
baseline	O
resting	B-ANAT
protective	O
conditions	O
(	O
i	O
.	O
e	O
.,	O
GF100	O
%,	O
set	O
to	O
obtain	O
pressure	O
generated	O
in	O
the	O
first	O
100	O
ms	O
of	O
inspiration	O
against	O
an	O
occluded	O
airway	B-ANAT
less	O
than	O
2	O
cm	O
H2O	O
,	O
respiratory	O
rate	O
less	O
than	O
or	O
equal	O
to	O
25	O
bpm	O
,	O
tidal	O
volume	O
less	O
than	O
6	O
ml	O
/	O
kg	O
,	O
and	O
peak	O
airway	B-ANAT
pressure	O
less	O
than	O
25	O
cm	O
H2O	O
)	O
to	O
GF50	O
%-	O
GF25	O
%-	O
GF0	O
%	O
during	O
both	O
PSV	O
and	O
NAVA	O
(	O
random	O
order	O
for	O
ventilation	O
mode	O
).	O

Serial	O
blood	B-ANAT
samples	I-ANAT
for	O
endocan	O
levels	O
were	O
taken	O
in	O
the	O
perioperative	O
period	O
(	O
T0	O
:	O
baseline	O
prior	O
to	O
induction	O
,	O
T1	O
:	O
at	O
the	O
time	O
of	O
heparin	O
administration	O
,	O
T2	O
:	O
at	O
the	O
time	O
of	O
protamine	O
,	O
T2	O
,	O
T3	O
,	O
T4	O
and	O
T5	O
at	O
1	O
,	O
2	O
,	O
4	O
and	O
6h	O
following	O
protamine	O
administration	O
respectively	O
).	O

Our	O
results	O
reveal	O
that	O
an	O
initial	O
rise	O
in	O
the	O
levels	O
of	O
serum	B-ANAT
endocan	O
from	O
baseline	O
in	O
all	O
patients	O
after	O
induction	O
of	O
anaesthesia	O
.	O

The	O
baseline	O
endocan	O
concentrations	O
were	O
elevated	O
in	O
patients	O
with	O
hypertension	O
and	O
severe	O
coronary	B-ANAT
artery	I-ANAT
disease	O
.	O

Whereas	O
adult	O
rats	O
developed	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
spike	O
protein	O
after	O
intranasal	O
inoculation	O
,	O
there	O
was	O
no	O
evidence	O
of	O
viral	O
replication	O
in	O
the	O
lungs	B-ANAT
of	O
adult	O
,	O
young	O
,	O
or	O
neonatal	O
rats	O
after	O
intranasal	O
inoculation	O
with	O
MERS	O
-	O
CoV	O
.	O
In	O
addition	O
,	O
human	O
DPP4	O
-	O
expressing	O
rat	B-ANAT
kidney	I-ANAT
fibroblasts	B-ANAT
,	O
but	O
not	O
rat	O
DPP4	O
-	O
expressing	O
cells	B-ANAT
,	O
were	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
rat	O
is	O
not	O
a	O
useful	O
animal	O
model	O
for	O
studying	O
MERS	O
-	O
CoV	O
infection	O
.	O

Plasma	B-ANAT
and	O
broncho	O
-	O
alveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
serum	B-ANAT
amyloid	O
P	O
contents	O
were	O
determined	O
by	O
western	O
blot	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
broncho	O
-	O
alveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
inhibited	O
by	O
71	O
%	O
(	O
55	O
-	O
94	O
)	O
fibrocyte	B-ANAT
differentiation	O
compared	O
to	O
saline	O
control	O
.	O

The	O
aspiration	O
is	O
associated	O
with	O
possible	O
clinical	O
outcomes	O
,	O
ranging	O
from	O
mild	O
asymptomatic	O
limited	O
episodes	O
of	O
bronchial	B-ANAT
injury	O
up	O
to	O
the	O
development	O
of	O
a	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Prone	O
positioning	O
reduces	O
collapse	O
of	O
dorsal	O
lung	B-ANAT
segments	I-ANAT
with	O
subsequent	O
reduction	O
of	O
alveolar	B-ANAT
overdistension	O
of	O
ventral	O
lung	B-ANAT
segments	I-ANAT
,	O
optimizes	O
lung	B-ANAT
recruitment	O
and	O
enhances	O
drainage	B-ANAT
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
pancreatitis	O
(	O
SAP	O
)	O
can	O
often	O
be	O
complicated	O
by	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
leading	O
to	O
increased	O
mortality	O
.	O

Hyperbilirubinemia	O
(	O
Serum	B-ANAT
bilirubin	O
>	O
3mg	O
/	O
dL	O
)	O
with	O
>	O
3	O
-	O
fold	O
rise	O
in	O
serum	B-ANAT
aminotransferases	O
in	O
absence	O
of	O
a	O
different	O
explanation	O
for	O
such	O
derangement	O
was	O
considered	O
as	O
malarial	O
hepatopathy	O
.	O

TITLE	O
:	O
A	O
phase	O
trial	O
of	O
the	O
oral	B-ANAT
Lactobacillus	O
casei	O
vaccine	O
polarizes	O
Th2	B-ANAT
cell	I-ANAT
immunity	O
against	O
transmissible	O
gastroenteritis	O
coronavirus	O
infection	O
.	O

The	O
histopathological	O
examination	O
showed	O
tremendous	O
potential	O
for	O
recombinant	O
Lactobacillus	O
to	O
enable	O
rapid	O
and	O
effective	O
treatment	O
for	O
TGEV	O
with	O
an	O
intestinal	B-ANAT
tropism	O
in	O
piglets	O
.	O

TITLE	O
:	O
Characteristics	O
and	O
outcomes	O
of	O
patients	O
treated	O
with	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O

Prior	O
to	O
APRV	O
initiation	O
,	O
median	O
Murray	O
Lung	B-ANAT
Injury	O
Score	O
was	O
3	O
.	O
5	O
(	O
interquartile	O
range	O
(	O
IQR	O
)	O
2	O
.	O
5	O
-	O
3	O
.	O
9	O
)	O
and	O
PaO2	O
/	O
FiO2	O
was	O
99mmHg	O
(	O
IQR	O
73	O
-	O
137	O
).	O

Furthermore	O
,	O
MERS	O
-	O
CoV	O
mutants	O
with	O
deletion	O
of	O
genes	O
encoding	O
accessory	O
proteins	O
NS3	O
to	O
NS5	O
or	O
NS4b	O
alone	O
or	O
inactivation	O
of	O
the	O
PDE	O
can	O
activate	O
RNase	O
L	O
during	O
infection	O
of	O
Calu	O
-	O
3	O
cells	B-ANAT
.	O

This	O
dynamic	O
nature	O
of	O
coronaviruses	O
may	O
facilitate	O
cross	O
-	O
species	O
transmission	O
and	O
shifts	O
in	O
tissue	B-ANAT
or	O
cell	B-ANAT
tropism	O
in	O
a	O
host	O
,	O
resulting	O
in	O
substantial	O
change	O
in	O
virulence	O
.	O

We	O
observe	O
that	O
TGEV	O
infection	O
induce	O
mitochondrial	B-ANAT
injury	O
,	O
abnormal	O
morphology	O
,	O
complete	O
mitophagy	O
,	O
and	O
without	O
obvious	O
apoptosis	O
after	O
TGEV	O
infection	O
.	O

TITLE	O
:	O
Infection	O
site	O
is	O
predictive	O
of	O
outcome	O
in	O
acute	O
lung	B-ANAT
injury	O
associated	O
with	O
severe	O
sepsis	O
and	O
septic	O
shock	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
TGEV	O
infection	O
increased	O
the	O
number	O
of	O
autophagosome	B-ANAT
-	O
like	O
double	O
-	O
and	O
single	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
in	O
the	O
cytoplasm	B-ANAT
of	O
host	O
cells	B-ANAT
,	O
a	O
phenomenon	O
that	O
is	O
known	O
to	O
be	O
related	O
to	O
autophagy	O
.	O

The	O
disease	O
rapidly	O
progressed	O
to	O
severe	O
pneumonia	O
,	O
multiple	O
organ	B-ANAT
dysfunctions	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
the	O
patient	O
died	O
on	O
6	O
February	O
.	O

Data	O
related	O
to	O
age	O
,	O
Injury	O
Severity	O
Scores	O
(	O
ISSs	O
),	O
admission	O
lactic	O
acid	O
levels	O
,	O
base	O
deficit	O
,	O
the	O
number	O
of	O
transfused	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
units	O
within	O
the	O
first	O
24	O
hours	O
,	O
and	O
presence	O
of	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
were	O
collected	O
and	O
were	O
not	O
statistically	O
different	O
between	O
the	O
groups	O
.	O

TITLE	O
:	O
CpG	O
DNA	O
facilitate	O
the	O
inactivated	O
transmissible	O
gastroenteritis	O
virus	O
in	O
enhancing	O
the	O
local	O
and	O
systemic	O
immune	O
response	O
of	O
pigs	O
via	O
oral	B-ANAT
administration	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
oral	B-ANAT
immunization	O
of	O
ITGEV	O
plus	O
CpG	O
DNA	O
elicits	O
a	O
local	O
immune	O
response	O
.	O

Chicks	O
were	O
humanely	O
euthanized	O
at	O
3	O
,	O
6	O
,	O
9	O
,	O
12	O
,	O
15	O
,	O
21	O
and	O
28	O
days	O
post	O
infection	O
(	O
dpi	O
)	O
for	O
necropsy	O
examination	O
,	O
and	O
tissues	B-ANAT
were	O
collected	O
for	O
histopathology	O
and	O
virus	O
detection	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
).	O

Affinity	O
tagged	O
PEDV	O
S1	O
protein	O
was	O
expressed	O
in	O
a	O
secretory	O
form	O
in	O
yeast	O
,	O
insect	O
and	O
mammalian	O
cells	B-ANAT
to	O
identify	O
the	O
most	O
suitable	O
production	O
system	O
.	O

PEDV	O
-	O
specific	O
immune	O
responses	O
in	O
sera	B-ANAT
and	O
colostrum	B-ANAT
of	O
the	O
sow	O
and	O
piglets	O
were	O
assayed	O
by	O
ELISA	O
and	O
virus	O
neutralization	O
assays	O
.	O

Piglets	O
were	O
challenged	O
orally	B-ANAT
with	O
PEDV	O
,	O
and	O
clinical	O
parameters	O
were	O
monitored	O
for	O
6	O
days	O
post	O
-	O
challenge	O
.	O

Our	O
result	O
revealed	O
that	O
RAGE	O
was	O
highly	O
expressed	O
on	O
the	O
alveolar	B-ANAT
type	O
I	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
healthy	O
rat	B-ANAT
lung	I-ANAT
including	O
sRAGE	O
isoform	O
sized	O
45	O
kDa	O
.	O

Under	O
LPS	O
-	O
induced	O
injured	O
lung	B-ANAT
,	O
the	O
release	O
of	O
sRAGE	O
into	O
the	O
alveolar	B-ANAT
space	O
was	O
increased	O
,	O
whereas	O
the	O
expression	O
of	O
RAGE	O
was	O
decreased	O
with	O
alveolar	B-ANAT
disruption	O
.	O

Typical	O
clinical	O
determinations	O
are	O
:	O
arterial	B-ANAT
partial	O
pressure	O
of	O
oxygen	O
<	O
60	O
mmHg	O
and	O
/	O
or	O
arterial	B-ANAT
oxygenation	O
<	O
88	O
%	O
and	O
/	O
or	O
the	O
ratio	O
of	O
PaO2	O
/	O
FIO2	O
<	O
100	O
.	O

For	O
mechanical	O
ventilation	O
specific	O
settings	O
are	O
recommended	O
:	O
limitation	O
of	O
tidal	O
volume	O
(	O
6	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
),	O
adequate	O
high	O
PEEP	O
(>	O
12	O
cmH2O	O
),	O
a	O
recruitment	O
manoeuvre	O
in	O
special	O
situations	O
,	O
and	O
a	O
'	O
balanced	O
'	O
respiratory	O
rate	O
(	O
20	O
-	O
30	O
/	O
min	O
).	O

An	O
advanced	O
infection	O
management	O
/	O
control	O
includes	O
early	O
diagnosis	O
of	O
bacterial	O
,	O
atypical	O
,	O
viral	O
and	O
fungal	O
specimen	O
(	O
blood	B-ANAT
culture	O
,	O
bronchoalveolar	O
lavage	O
),	O
and	O
of	O
infection	O
sources	O
by	O
CT	O
scan	O
,	O
followed	O
by	O
administration	O
of	O
broad	O
-	O
spectrum	O
anti	O
-	O
infectives	O
.	O

CONCLUSIONS	O
:	O
With	O
respect	O
to	O
results	O
advanced	O
in	O
pre	O
hospital	O
,	O
medical	O
and	O
surgical	O
care	O
for	O
the	O
decrease	O
in	O
mortality	O
rates	O
of	O
Head	B-ANAT
trauma	O
(	O
HT	O
),	O
the	O
use	O
of	O
trauma	O
triage	O
tools	O
and	O
strict	O
enforcement	O
of	O
traffic	O
rules	O
are	O
necessary	O
.	O

In	O
the	O
present	O
work	O
,	O
the	O
influence	O
of	O
single	O
-	O
site	O
low	O
-	O
flow	O
veno	O
-	O
venous	B-ANAT
ECLS	O
(	O
LFVV	O
-	O
ECLS	O
)	O
on	O
hemodynamic	O
monitoring	O
by	O
transpulmonary	O
thermodilution	O
(	O
TPTD	O
)	O
was	O
prospectively	O
investigated	O
.	O

For	O
single	O
-	O
site	O
LFVV	O
-	O
ECLS	O
,	O
a	O
22	O
Fr	O
twin	O
-	O
port	O
double	O
-	O
lumen	B-ANAT
cannula	O
was	O
inserted	O
percutaneously	O
into	O
the	O
right	O
jugular	B-ANAT
vein	I-ANAT
.	O

Each	O
treatment	O
was	O
designed	O
to	O
achieve	O
a	O
different	O
level	O
of	O
circulating	O
anti	O
-	O
PEDV	O
antibody	O
via	O
intraperitoneally	O
administration	O
of	O
concentrated	O
serum	B-ANAT
antibody	O
.	O

Specifically	O
,	O
antibody	O
-	O
positive	O
groups	O
returned	O
to	O
normal	O
body	B-ANAT
temperature	O
faster	O
and	O
demonstrated	O
a	O
higher	O
rate	O
of	O
survivability	O
than	O
piglets	O
without	O
PEDV	O
antibody	O
.	O

TITLE	O
:	O
A	O
Case	O
Report	O
of	O
a	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Survivor	O
with	O
Kidney	B-ANAT
Biopsy	O
Results	O
.	O

The	O
isotope	O
dilution	O
mass	O
spectrometry	O
traceable	O
serum	B-ANAT
creatinine	O
level	O
increased	O
to	O
3	O
.	O
0	O
mg	O
/	O
dL	O
.	O
We	O
performed	O
a	O
kidney	B-ANAT
biopsy	O
8	O
weeks	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

Acute	O
tubular	O
necrosis	O
was	O
the	O
main	O
finding	O
,	O
and	O
proteinaceous	O
cast	B-ANAT
formation	O
and	O
acute	O
tubulointerstitial	O
nephritis	O
were	O
found	O
.	O

TITLE	O
:	O
Acute	O
ischemic	O
optic	B-ANAT
neuropathy	O
with	O
extended	O
prone	O
position	O
ventilation	O
in	O
a	O
lung	B-ANAT
transplant	B-ANAT
recipient	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
42	O
-	O
year	O
-	O
old	O
Caucasian	O
man	O
who	O
presented	O
with	O
severe	O
ARDS	O
from	O
Bordetella	O
pertussis	O
,	O
5	O
years	O
after	O
bilateral	O
sequential	O
lung	B-ANAT
transplant	B-ANAT
for	O
cystic	O
fibrosis	O
.	O

Since	O
his	O
discharge	B-ANAT
from	O
the	O
ICU	O
6	O
months	O
ago	O
,	O
his	O
FEV1	O
has	O
recovered	O
to	O
47	O
%	O
predicted	O
compared	O
to	O
his	O
pre	O
-	O
ICU	O
peak	O
FEV1	O
of	O
85	O
%	O
predicted	O
,	O
suggesting	O
recovery	O
of	O
lung	B-ANAT
function	O
.	O

Research	O
has	O
recently	O
reemphasized	O
the	O
importance	O
to	O
well	O
known	O
physiology	O
of	O
the	O
venous	B-ANAT
return	O
which	O
is	O
a	O
contributor	O
of	O
RV	O
preload	O
.	O

Recent	O
works	O
have	O
also	O
demonstrated	O
the	O
crucial	O
impact	O
of	O
lung	B-ANAT
inflation	O
and	O
driving	O
pressure	O
on	O
RV	O
afterload	O
,	O
and	O
have	O
confirmed	O
the	O
deleterious	O
effect	O
of	O
severe	O
RV	O
failure	O
,	O
described	O
as	O
acute	O
cor	B-ANAT
pulmonale	O
.	O

Electromyographic	O
analysis	O
of	O
the	O
diaphragm	B-ANAT
clearly	O
showed	O
improved	O
triggering	O
of	O
both	O
the	O
start	O
and	O
the	O
end	O
of	O
spontaneous	O
inspiration	O
.	O

TITLE	O
:	O
The	O
Ratio	O
of	O
Partial	O
Pressure	O
Arterial	B-ANAT
Oxygen	O
and	O
Fraction	O
of	O
Inspired	O
Oxygen	O
1	O
Day	O
After	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Onset	O
Can	O
Predict	O
the	O
Outcomes	O
of	O
Involving	O
Patients	O
.	O

ABSTRACT	O
:	O
The	O
effect	O
of	O
alcohol	O
consumption	O
on	O
inflammatory	O
state	O
and	O
outcome	O
in	O
brain	B-ANAT
-	O
injured	O
patients	O
remains	O
controversial	O
.	O

Patients	O
with	O
an	O
Injury	O
Severity	O
Score	O
(	O
ISS	O
)	O
at	O
least	O
16	O
and	O
Abbreviated	O
Injury	O
Scale	O
of	O
head	B-ANAT
(	O
AIS	O
-	O
head	B-ANAT
)	O
at	O
least	O
3	O
were	O
included	O
upon	O
arrival	O
in	O
the	O
emergency	O
room	O
and	O
grouped	O
according	O
to	O
positive	O
BAC	O
(>	O
0	O
.	O
5	O
â°,	O
BAC	O
)	O
vs	O
.	O
less	O
than	O
0	O
.	O
5	O
â°	O
alcohol	O
(	O
no	O
BAC	O
).	O

Inhospital	O
complications	O
,	O
including	O
single	O
/	O
multiple	O
organ	B-ANAT
failure	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
,	O
sepsis	O
,	O
pneumonia	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
showed	O
no	O
significant	O
differences	O
.	O

TITLE	O
:	O
Suspected	O
drug	O
-	O
induced	O
infiltrative	O
lung	B-ANAT
disease	O
culminating	O
in	O
acute	O
respiratory	O
failure	O
in	O
a	O
dog	O
treated	O
with	O
cytarabine	O
and	O
prednisone	O
.	O

No	O
significant	O
differences	O
in	O
apparent	O
ileal	B-ANAT
digestibility	O
(	O
AID	O
)	O
were	O
detected	O
between	O
virus	O
challenges	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
porcine	O
reproductive	O
and	O
respiratory	O
syndrome	O
virus	O
and	O
porcine	O
epidemic	O
diarrhea	O
virus	O
challenge	O
on	O
growing	O
pigs	O
II	O
:	O
Intestinal	B-ANAT
integrity	O
and	O
function	O
.	O

TITLE	O
:	O
Interdisciplinary	O
Peripartum	O
Management	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
with	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
-	O
a	O
Case	O
Report	O
and	O
Literature	O
Review	O
.	O

Advances	O
in	O
treatment	O
modalities	O
including	O
lung	B-ANAT
protective	O
ventilation	O
,	O
prone	O
positioning	O
,	O
use	O
of	O
neuromuscular	O
blockade	O
,	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
have	O
improved	O
the	O
outcome	O
over	O
recent	O
decades	O
,	O
nevertheless	O
,	O
the	O
mortality	O
rate	O
still	O
remains	O
high	O
.	O

ABSTRACT	O
:	O
All	O
eukaryotic	O
positive	O
-	O
stranded	O
RNA	O
(+	O
RNA	O
)	O
viruses	O
appropriate	O
host	O
cell	B-ANAT
membranes	I-ANAT
and	O
transform	O
them	O
into	O
replication	O
organelles	B-ANAT
,	O
specialized	O
micro	O
-	O
environments	O
that	O
are	O
thought	O
to	O
support	O
viral	O
RNA	O
synthesis	O
.	O

Arterivirus	O
-	O
induced	O
DMVs	O
appear	O
to	O
be	O
closed	O
compartments	B-ANAT
that	O
are	O
continuous	O
with	O
endoplasmic	B-ANAT
reticulum	I-ANAT
membranes	B-ANAT
,	O
thus	O
forming	O
an	O
extensive	O
reticulovesicular	O
network	O
(	O
RVN	O
)	O
of	O
intriguing	O
complexity	O
.	O

TITLE	O
:	O
A	O
comparison	O
of	O
clinical	O
efficacy	O
between	O
high	O
frequency	O
oscillatory	O
ventilation	O
and	O
conventional	O
ventilation	O
with	O
lung	B-ANAT
volume	O
recruitment	O
in	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
A	O
randomized	O
controlled	O
trial	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
efficacy	O
of	O
lung	B-ANAT
volume	O
recruitment	O
maneuver	O
(	O
LVRM	O
)	O
with	O
high	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
on	O
oxygenation	O
,	O
hemodynamic	O
alteration	O
,	O
and	O
clinical	O
outcomes	O
when	O
compared	O
to	O
conventional	O
mechanical	O
ventilation	O
(	O
CV	O
)	O
in	O
children	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
shift	O
of	O
inflammation	O
may	O
become	O
prominent	O
when	O
the	O
colon	B-ANAT
is	O
removed	O
after	O
colectomy	O
and	O
independent	O
of	O
the	O
bowel	B-ANAT
disease	O
activity	O
;	O
pulmonary	B-ANAT
involvement	O
may	O
be	O
exarbecated	O
.	O

We	O
represent	O
a	O
5	O
-	O
year	O
-	O
old	O
CD	O
patient	O
with	O
previous	O
bronchiolitis	O
episodes	O
that	O
might	O
have	O
resulted	O
from	O
CD	O
-	O
associated	O
pulmonary	B-ANAT
involvement	O
;	O
whom	O
later	O
developed	O
severe	O
pneumonia	O
resulting	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
bronchiectasia	O
following	O
a	O
colectomy	O
operation	O
.	O

We	O
retrospectively	O
reviewed	O
all	O
lung	B-ANAT
transplants	B-ANAT
at	O
our	O
center	O
from	O
January	O
1	O
,	O
2000	O
through	O
August	O
31	O
,	O
2012	O
(	O
n	O
=	O
562	O
),	O
comparing	O
the	O
SSc	O
group	O
(	O
n	O
=	O
35	O
)	O
to	O
the	O
following	O
lung	B-ANAT
transplant	B-ANAT
diagnostic	O
subsets	O
:	O
all	O
non	O
-	O
SSc	O
(	O
n	O
=	O
527	O
),	O
non	O
-	O
SSc	O
diffuse	O
fibrotic	O
lung	B-ANAT
disease	O
(	O
n	O
=	O
264	O
),	O
and	O
a	O
non	O
-	O
SSc	O
matched	O
group	O
(	O
n	O
=	O
109	O
).	O

In	O
addition	O
,	O
we	O
defined	O
severe	O
esophageal	O
dysfunction	O
using	O
esophageal	O
manometry	O
and	O
esophageal	O
morphometry	O
criteria	O
on	O
the	O
basis	O
of	O
chest	B-ANAT
computed	O
tomography	O
images	O
.	O

Esophageal	O
dysfunction	O
rarely	O
precluded	O
active	O
listing	O
for	O
lung	B-ANAT
transplantation	O
.	O

TITLE	O
:	O
Retinoic	O
acid	O
facilitates	O
inactivated	O
transmissible	O
gastroenteritis	O
virus	O
induction	O
of	O
CD8	O
(+)	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
migration	O
to	O
the	O
porcine	O
gut	B-ANAT
.	O

The	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
(	O
RAS	O
),	O
one	O
of	O
the	O
primary	O
cardiovascular	B-ANAT
regulatory	O
systems	O
,	O
has	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
lung	B-ANAT
disease	O
.	O

There	O
are	O
a	O
vast	O
number	O
of	O
pathophysiological	O
causes	O
of	O
lung	B-ANAT
failure	O
and	O
the	O
optimal	O
treatment	O
highly	O
depends	O
on	O
the	O
underlying	O
pathology	O
;	O
therefore	O
,	O
no	O
standard	O
algorithm	O
exists	O
.	O

When	O
organ	B-ANAT
dysfunction	O
occurs	O
,	O
the	O
primary	O
clinical	O
management	O
of	O
critically	O
ill	O
patients	O
is	O
based	O
on	O
support	O
/	O
replacement	O
of	O
organ	B-ANAT
function	O
until	O
recovery	O
.	O

The	O
current	O
US	O
PDCoV	O
strains	O
are	O
enteropathogenic	O
and	O
infect	O
villous	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
entire	O
small	O
and	O
large	O
intestines	B-ANAT
although	O
the	O
jejunum	B-ANAT
and	O
ileum	B-ANAT
are	O
the	O
primary	O
sites	O
of	O
infection	O
.	O

TC	O
-	O
PDCoV	O
strains	O
will	O
be	O
useful	O
to	O
develop	O
serologic	O
assays	O
and	O
to	O
evaluate	O
if	O
serial	O
cell	B-ANAT
-	O
culture	O
passage	O
attenuates	O
TC	O
-	O
PDCoV	O
as	O
a	O
potential	O
vaccine	O
candidate	O
strain	O
.	O

TITLE	O
:	O
Personal	O
protective	O
equipment	O
for	O
preventing	O
highly	O
infectious	O
diseases	O
due	O
to	O
exposure	O
to	O
contaminated	O
body	B-ANAT
fluids	I-ANAT
in	O
healthcare	O
staff	O
.	O

There	O
were	O
no	O
studies	O
on	O
goggles	O
versus	O
face	B-ANAT
shields	O
,	O
on	O
long	O
-	O
versus	O
short	O
-	O
sleeved	O
gloves	O
,	O
or	O
on	O
the	O
use	O
of	O
taping	O
PPE	O
parts	O
together	O
.	O

TITLE	O
:	O
Lung	B-ANAT
complications	O
are	O
common	O
in	O
intensive	O
care	O
treated	O
patients	O
with	O
pelvis	B-ANAT
fractures	O
:	O
a	O
retrospective	O
cohort	O
study	O
.	O

Plasma	B-ANAT
was	O
sampled	O
from	O
the	O
healthy	O
as	O
controls	O
or	O
patients	O
with	O
SP	O
infected	O
with	O
bacteria	O
or	O
infection	O
-	O
associated	O
SP	O
-	O
ARDS	O
on	O
the	O
day	O
of	O
admission	O
,	O
day	O
3	O
,	O
and	O
day	O
7	O
.	O

BCX4430	O
is	O
active	O
in	O
vitro	O
against	O
many	O
RNA	O
viral	O
pathogens	O
,	O
including	O
the	O
filoviruses	O
and	O
emerging	O
infectious	O
agents	O
such	O
as	O
MERS	O
-	O
CoV	O
and	O
SARS	O
-	O
CoV	O
.	O
In	O
vivo	O
,	O
BCX4430	O
is	O
active	O
after	O
intramuscular	O
,	O
intraperitoneal	O
,	O
and	O
oral	B-ANAT
administration	O
in	O
a	O
variety	O
of	O
experimental	O
infections	O
.	O

Nitazoxanide	O
also	O
suppresses	O
production	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
in	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
and	O
suppresses	O
interleukin	O
6	O
production	O
in	O
mice	O
.	O

Due	O
to	O
high	O
risk	O
of	O
bleeding	O
,	O
thrombotic	O
complications	O
present	O
in	O
this	O
context	O
are	O
particularly	O
difficult	O
to	O
manage	O
and	O
usually	O
require	O
insertion	O
of	O
an	O
inferior	B-ANAT
vena	I-ANAT
cava	I-ANAT
filter	O
to	O
prevent	O
embolism	O
from	O
the	O
distal	O
veins	B-ANAT
to	O
the	O
pulmonary	B-ANAT
circulation	O
.	O

TITLE	O
:	O
Diminished	O
COX	O
-	O
2	O
/	O
PGE2	O
-	O
Mediated	O
Antiviral	O
Response	O
Due	O
to	O
Impaired	O
NOX	O
/	O
MAPK	O
Signaling	O
in	O
G6PD	O
-	O
Knockdown	O
Lung	B-ANAT
Epithelial	B-ANAT
Cells	I-ANAT
.	O

It	O
was	O
previously	O
shown	O
that	O
a	O
major	O
determinant	O
of	O
PS	O
recognition	O
is	O
the	O
second	O
of	O
the	O
two	O
RNA	O
-	O
binding	O
domains	O
of	O
the	O
viral	B-ANAT
nucleocapsid	I-ANAT
(	O
N	O
)	O
protein	O
.	O

This	O
study	O
reveals	O
the	O
important	O
role	O
of	O
macrophages	B-ANAT
in	O
the	O
inflammatory	O
response	O
of	O
ferrets	O
against	O
the	O
virus	O
and	O
the	O
variable	O
proportions	O
of	O
leukocytes	B-ANAT
among	O
different	O
types	O
of	O
lesions	O
,	O
indicating	O
their	O
variable	O
age	O
.	O

Nasal	B-ANAT
swabs	O
were	O
collected	O
from	O
114	O
cattle	O
on	O
initial	O
BRD	O
treatment	O
.	O

SAIBK2	O
causes	O
severe	O
kidney	B-ANAT
lesions	O
and	O
results	O
in	O
50	O
%	O
mortality	O
in	O
30	O
-	O
day	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	O
(	O
with	O
a	O
dose	O
of	O
10	O
(	O
5	O
)	O
EID50	O
/	O
0	O
.	O
1	O
mL	O
SAIBK2	O
per	O
chicken	O
).	O

We	O
determined	O
the	O
kinetics	O
of	O
antibody	O
(	O
IgG	O
and	O
IgM	O
)	O
and	O
neutralizing	O
antibodies	O
against	O
MERS	O
-	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
in	O
this	O
case	O
before	O
discharge	B-ANAT
.	O

Moreover	O
,	O
no	O
seroconversion	O
was	O
found	O
among	O
53	O
close	O
contacts	O
by	O
anti	O
-	O
MERS	O
IgG	B-ANAT
antibody	I-ANAT
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
of	O
paired	O
serum	B-ANAT
samples	O
.	O

We	O
reanalyzed	O
the	O
effect	O
of	O
acute	O
blood	B-ANAT
volume	O
variations	O
on	O
intrapulmonary	O
shunt	O
(	O
shunt	O
),	O
arterial	B-ANAT
oxygenation	O
(	O
PaO2	O
:	O
FiO2	O
),	O
global	O
oxygen	O
delivery	O
(	O
DO2	O
)	O
and	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
(	O
Crs	O
).	O

There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
factors	O
before	O
therapy	O
(	O
all	O
P	O
>	O
0	O
.	O
05	O
),	O
except	O
pH	O
,	O
heart	B-ANAT
rate	O
(	O
HR	O
)	O
and	O
mean	O
arterial	B-ANAT
pressure	O
(	O
MAP	O
)	O
between	O
the	O
ECMO	O
survival	O
group	O
and	O
the	O
ECMO	O
non	O
-	O
survival	O
group	O
.	O

TITLE	O
:	O
Formation	O
of	O
fibroblastic	O
reticular	O
network	O
in	O
the	O
brain	B-ANAT
after	O
infection	O
with	O
neurovirulent	O
murine	O
coronavirus	O
.	O

Early	O
VV	O
ECLS	O
can	O
be	O
used	O
for	O
salvage	O
of	O
patients	O
with	O
traumatic	O
lung	B-ANAT
injury	O
.	O

The	O
recombinant	O
VP8	O
-	O
S2	O
protein	O
was	O
purified	O
by	O
Ni	O
-	O
NTA	O
chromatography	O
column	B-ANAT
.	O

This	O
protein	O
was	O
expressed	O
by	O
induction	O
of	O
IPTG	O
at	O
concentration	O
of	O
1mM	O
and	O
it	O
was	O
confirmed	O
by	O
Ni	O
-	O
NTA	O
column	B-ANAT
,	O
dot	O
-	O
blotting	O
analysis	O
and	O
SDS	O
-	O
PAGE	O
electrophoresis	O
.	O

The	O
Eastern	O
bent	O
-	O
wing	B-ANAT
bat	O
Miniopterus	O
fuliginosus	O
is	O
distributed	O
extensively	O
throughout	O
China	O
.	O

U	O
.	O
S	O
.	O
adult	O
critical	O
care	O
physicians	O
predominantly	O
employ	O
lung	B-ANAT
-	O
protective	O
ventilation	O
for	O
severe	O
hypoxemia	O
.	O

Here	O
,	O
we	O
present	O
the	O
crystal	B-ANAT
structures	O
of	O
PEDV	O
3CL	O
(	O
pro	O
)	O
and	O
a	O
molecular	O
complex	O
between	O
an	O
inactive	O
PEDV	O
3CL	O
(	O
pro	O
)	O
variant	O
C144A	O
bound	O
to	O
a	O
peptide	O
substrate	O
.	O

A	O
43	O
-	O
year	O
old	O
male	O
was	O
admitted	O
to	O
negative	O
pressure	O
isolation	O
intensive	O
care	O
unit	O
with	O
the	O
complaint	O
of	O
back	B-ANAT
ache	O
for	O
7	O
days	O
and	O
fever	O
for	O
2	O
days	O
.	O

Oxygen	O
inhalation	O
(	O
6	O
L	O
/	O
min	O
)	O
was	O
given	O
immediately	O
after	O
admission	O
,	O
but	O
the	O
condition	O
of	O
patient	O
worsened	O
with	O
the	O
following	O
symptoms	O
:	O
frequent	O
cough	O
and	O
obvious	O
shortness	O
of	O
breath	B-ANAT
.	O

Shortness	O
of	O
breath	B-ANAT
of	O
the	O
patient	O
was	O
improved	O
on	O
the	O
7th	O
day	O
of	O
admission	O
after	O
the	O
application	O
of	O
HFNC	O
.	O

RESULTS	O
:	O
A	O
43	O
-	O
year	O
old	O
male	O
was	O
admitted	O
to	O
negative	O
pressure	O
isolation	O
intensive	O
care	O
unit	O
with	O
the	O
complaint	O
of	O
back	B-ANAT
ache	O
for	O
7	O
days	O
and	O
fever	O
for	O
2	O
days	O
.	O

In	O
the	O
late	O
group	O
,	O
it	O
was	O
shown	O
by	O
single	O
factor	O
analysis	O
that	O
the	O
age	O
,	O
the	O
case	O
history	O
of	O
chronic	O
disease	O
,	O
infection	O
sites	O
,	O
WBC	B-ANAT
,	O
pH	O
value	O
,	O
Lac	O
,	O
and	O
ScvOâ	O
before	O
treatment	O
,	O
6	O
-	O
hour	O
urine	B-ANAT
output	O
after	O
treatment	O
,	O
the	O
number	O
of	O
organ	B-ANAT
with	O
failure	O
,	O
the	O
use	O
of	O
antibiotics	O
within	O
1	O
hour	O
,	O
and	O
incidence	O
of	O
AKI	O
or	O
ALI	O
/	O
ARDS	O
within	O
24	O
hours	O
were	O
risk	O
factors	O
of	O
28	O
-	O
day	O
death	O
(	O
P	O
<	O
0	O
.	O
05	O
or	O
P	O
<	O
0	O
.	O
01	O
).	O

The	O
urine	B-ANAT
output	O
in	O
both	O
reaching	O
standard	O
of	O
EGDT	O
groups	O
was	O
more	O
than	O
0	O
.	O
5	O
mL	O
Â·	O
h	O
â»	O
Â¹	O
Â·	O
kg	O
â»	O
Â¹	O
without	O
statistically	O
different	O
significance	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
presents	O
as	O
hypoxia	O
and	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
on	O
chest	B-ANAT
imaging	O
in	O
the	O
absence	O
of	O
heart	B-ANAT
failure	O
sufficient	O
to	O
account	O
for	O
this	O
clinical	O
state	O
.	O

This	O
assay	O
successfully	O
differentiated	O
three	O
PEDV	O
strains	O
:	O
PC22A	O
(	O
the	O
original	O
US	O
virulent	O
),	O
Iowa106	O
(	O
S	O
-	O
INDEL	O
),	O
and	O
PC177	O
(	O
S	O
-	O
197DEL	O
)	O
that	O
was	O
derived	O
from	O
cell	B-ANAT
culture	O
adaptation	O
and	O
has	O
a	O
197	O
amino	O
acid	O
-	O
deletion	O
in	O
the	O
S1	O
domain	O
.	O

The	O
presence	O
of	O
human	O
herpes	O
simplex	B-ANAT
virus	O
1	O
,	O
human	O
cytomegalovirus	O
and	O
Epstein	O
-	O
Barr	O
virus	O
in	O
respiratory	B-ANAT
samples	I-ANAT
of	O
critically	O
ill	O
patients	O
is	O
increasingly	O
reported	O
even	O
without	O
canonical	O
immunosuppression	O
.	O

In	O
conclusion	O
,	O
these	O
results	O
indicate	O
that	O
herpesviruses	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
,	O
which	O
occurs	O
more	O
frequently	O
following	O
influenza	O
virus	O
infection	O
,	O
can	O
be	O
a	O
negative	O
prognostic	O
marker	O
.	O

We	O
defined	O
lung	B-ANAT
protective	O
ventilation	O
as	O
a	O
tidal	O
volume	O
of	O
less	O
than	O
or	O
equal	O
to	O
8	O
mL	O
/	O
kg	O
of	O
predicted	O
body	B-ANAT
weight	O
and	O
compared	O
outcomes	O
for	O
patients	O
ventilated	O
with	O
lung	B-ANAT
protective	O
vs	O
non	O
-	O
lung	B-ANAT
protective	O
ventilation	O
,	O
including	O
inhospital	O
mortality	O
,	O
ventilator	O
days	O
,	O
intensive	O
care	O
unit	O
length	O
of	O
stay	O
,	O
and	O
hospital	O
length	O
of	O
stay	O
.	O

Our	O
analyses	O
show	O
:	O
1	O
)	O
28	O
potential	O
recombinant	O
sequences	O
were	O
detected	O
and	O
they	O
can	O
be	O
classified	O
into	O
seven	O
potential	O
recombinant	O
types	O
;	O
2	O
)	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
MERS	O
-	O
CoV	O
was	O
under	O
strong	O
positive	O
selection	O
when	O
MERS	O
-	O
CoV	O
transmitted	O
from	O
their	O
natural	O
host	O
to	O
human	O
;	O
3	O
)	O
Six	O
out	O
of	O
nine	O
positive	O
selection	O
sites	O
detected	O
in	O
spike	O
(	O
S	O
)	O
protein	O
are	O
located	O
in	O
its	O
receptor	O
-	O
binding	O
domain	O
which	O
is	O
in	O
direct	O
contact	O
with	O
host	O
cells	B-ANAT
;	O
4	O
)	O
MERS	O
-	O
CoV	O
frequently	O
transmitted	O
back	B-ANAT
and	O
forth	O
between	O
human	O
and	O
camel	O
after	O
it	O
had	O
acquired	O
the	O
human	O
-	O
camel	O
infection	O
capability	O
.	O

Intracellular	B-ANAT
trafficking	O
and	O
indirect	O
immunofluorescence	O
analysis	O
suggested	O
that	O
when	O
M	O
protein	O
was	O
present	O
,	O
wild	O
-	O
type	O
S	O
protein	O
(	O
wtS	O
)	O
could	O
be	O
retained	O
in	O
the	O
pre	O
-	O
and	O
post	O
-	O
medial	B-ANAT
Golgi	I-ANAT
compartments	B-ANAT
intracellularly	O
and	O
co	O
-	O
localized	O
with	O
M	O
protein	O
in	O
the	O
Golgi	B-ANAT
.	O

Moreover	O
,	O
the	O
intracellular	B-ANAT
accumulation	O
of	O
mutant	O
S	O
protein	O
,	O
particularly	O
at	O
the	O
post	O
-	O
medial	B-ANAT
Golgi	I-ANAT
compartment	B-ANAT
,	O
was	O
significantly	O
reduced	O
compared	O
with	O
wtS	O
.	O
A	O
VLP	B-ANAT
assay	O
suggested	O
that	O
wtS	O
that	O
reached	O
the	O
post	O
-	O
medial	O
compartment	B-ANAT
could	O
be	O
returned	O
to	O
the	O
ERGIC	B-ANAT
for	O
subsequent	O
incorporation	O
into	O
VLPs	B-ANAT
,	O
while	O
mutant	O
S	O
protein	O
could	O
not	O
.	O

TITLE	O
:	O
Serum	B-ANAT
antibody	O
responses	O
to	O
vaccinal	O
antigens	O
in	O
lean	O
and	O
obese	O
geriatric	O
dogs	O
.	O

The	O
mainstay	O
of	O
treatment	O
for	O
ARDS	O
is	O
lung	B-ANAT
protective	O
ventilation	O
with	O
low	O
tidal	O
volumes	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
sufficient	O
for	O
alveolar	B-ANAT
recruitment	O
.	O

In	O
this	O
study	O
,	O
we	O
utilized	O
viral	O
metagenomic	O
sequencing	O
to	O
explore	O
the	O
virome	O
of	O
nasal	B-ANAT
swab	O
samples	O
obtained	O
from	O
feedlot	O
cattle	O
with	O
acute	O
BRD	O
and	O
asymptomatic	O
pen	O
-	O
mates	O
at	O
six	O
and	O
four	O
feedlots	O
in	O
Mexico	O
and	O
the	O
USA	O
,	O
respectively	O
,	O
in	O
April	O
-	O
October	O
2015	O
.	O

TLR7	O
agonist	O
(	O
imiquimod	O
(	O
IMQ	O
))	O
concentration	O
-	O
dependently	O
induced	O
activation	O
of	O
ISRE	O
-,	O
NF	O
-	O
ÎºB	O
-	O
and	O
AP	O
-	O
1	O
-	O
luciferase	O
reporters	O
,	O
as	O
well	O
as	O
the	O
production	O
of	O
IFN	O
-	O
Î±	O
,	O
IFN	O
-	O
Î²	O
,	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
human	O
promonocyte	B-ANAT
cells	B-ANAT
.	O

ABSTRACT	O
:	O
In	O
chickens	O
,	O
the	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
often	O
causes	O
respiratory	O
distress	O
,	O
a	O
decrease	O
in	O
egg	B-ANAT
production	O
,	O
poor	O
egg	B-ANAT
quality	O
,	O
and	O
occasional	O
nephritis	O
.	O

During	O
infection	O
of	O
target	B-ANAT
cell	I-ANAT
,	O
MERS	O
-	O
CoV	O
S	O
protein	O
S1	O
subunit	O
binds	O
to	O
the	O
cellular	B-ANAT
receptor	O
(	O
DPP4	O
),	O
and	O
its	O
S2	O
subunit	O
HR1	O
and	O
HR2	O
regions	O
intact	O
with	O
each	O
other	O
to	O
form	O
a	O
stable	O
six	O
-	O
helix	O
bundle	O
to	O
mediate	O
the	O
fusion	O
between	O
virus	O
and	O
target	O
cell	B-ANAT
membranes	I-ANAT
.	O

TITLE	O
:	O
End	O
-	O
Expiratory	O
Lung	B-ANAT
Volume	O
in	O
Patients	O
with	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
A	O
Time	O
Course	O
Analysis	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
a	O
ronivirus	O
,	O
gill	B-ANAT
-	O
associated	O
virus	O
(	O
GAV	O
),	O
encodes	O
the	O
2	O
'-	O
O	O
-	O
MTase	O
activity	O
,	O
although	O
we	O
could	O
not	O
detect	O
2	O
'-	O
O	O
-	O
MTase	O
activity	O
for	O
the	O
homologous	O
protein	O
of	O
a	O
torovirus	O
,	O
equine	O
torovirus	O
,	O
which	O
is	O
more	O
closely	O
related	O
to	O
coronaviruses	O
.	O

Organ	B-ANAT
failure	O
(	O
s	O
)	O
is	O
defined	O
by	O
the	O
Chronic	O
Liver	B-ANAT
Failure	O
-	O
Sequential	O
Organ	B-ANAT
Failure	O
(	O
CLIF	O
-	O
SOFA	O
)	O
score	O
or	O
by	O
its	O
simplified	O
version	O
Chronic	O
Liver	B-ANAT
Failure	O
-	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
CLIF	O
-	O
OF	O
)	O
score	O
.	O

TITLE	O
:	O
Qingfei	O
Xiaoyan	O
Wan	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
formula	O
,	O
ameliorates	O
Pseudomonas	O
aeruginosa	O
-	O
induced	O
acute	O
lung	B-ANAT
inflammation	O
by	O
regulation	O
of	O
PI3K	O
/	O
AKT	O
and	O
Ras	O
/	O
MAPK	O
pathways	O
.	O

His	O
peripheral	B-ANAT
blood	I-ANAT
smear	O
revealed	O
ring	O
-	O
formed	O
trophozoites	O
and	O
banana	O
-	O
shaped	O
gametocytes	O
of	O
P	O
.	O
falciparum	O
.	O

With	O
the	O
availability	O
of	O
a	O
cell	B-ANAT
culture	O
-	O
propagated	O
PEDV	O
strain	O
,	O
we	O
are	O
able	O
to	O
explore	O
vaccination	O
and	O
challenge	O
studies	O
on	O
pigs	O
.	O

CONCLUSIONS	O
:	O
Infection	O
-	O
related	O
mortality	O
in	O
kidney	B-ANAT
transplant	I-ANAT
patients	O
with	O
ARDS	O
was	O
associated	O
with	O
high	O
serum	B-ANAT
creatinine	O
level	O
and	O
severe	O
ARDS	O
.	O

In	O
LPS	O
-	O
induced	O
severe	O
ARDS	O
,	O
RIP3	O
knock	O
-	O
out	O
alleviated	O
the	O
hypothermia	O
symptom	O
,	O
increased	O
survival	O
rate	O
and	O
ameliorated	O
the	O
lung	B-ANAT
tissue	I-ANAT
injury	O
RIP3	O
depletion	O
also	O
attenuated	O
LPS	O
-	O
induced	O
increase	O
in	O
IL	O
-	O
1Î±	O
/	O
Î²	O
,	O
IL	O
-	O
6	O
and	O
HMGB1	O
release	O
,	O
decreased	O
tissue	B-ANAT
MPO	O
activity	O
,	O
and	O
reduced	O
neutrophil	B-ANAT
influx	O
and	O
total	O
protein	O
concentration	O
in	O
BALF	O
in	O
severe	O
ARDS	O
.	O

Further	O
,	O
RIP3	O
depletion	O
reduced	O
the	O
necrotic	O
cells	B-ANAT
in	O
the	O
lung	B-ANAT
and	O
decreased	O
the	O
expression	O
of	O
MLKL	O
,	O
but	O
had	O
no	O
impact	O
on	O
cleaved	B-ANAT
caspase	O
-	O
3	O
in	O
LPS	O
-	O
induced	O
ARDS	O
.	O

Physical	O
examination	O
revealed	O
a	O
black	O
eschar	O
on	O
her	O
right	B-ANAT
leg	I-ANAT
,	O
making	O
us	O
suspect	O
rickettsial	O
infection	O
since	O
Kobe	O
City	O
is	O
not	O
an	O
area	O
predisposed	O
to	O
Japanese	O
spotted	O
fever	O
.	O

ABSTRACT	O
:	O
Î³	O
-	O
Hydroxybutyrate	O
(	O
GHB	O
)	O
is	O
a	O
common	O
drug	O
of	O
abuse	O
and	O
poses	O
important	O
health	O
risks	O
to	O
users	O
in	O
the	O
form	O
of	O
respiratory	O
,	O
cardiovascular	B-ANAT
,	O
mental	O
,	O
or	O
traumatic	O
adverse	O
events	O
.	O

These	O
viruses	O
infect	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
small	B-ANAT
intestine	I-ANAT
and	O
cause	O
watery	O
diarrhea	O
,	O
dehydration	O
,	O
and	O
a	O
high	O
mortality	O
in	O
neonatal	O
piglets	O
.	O

This	O
review	O
describes	O
the	O
recent	O
understanding	O
on	O
the	O
immune	O
evasion	O
strategies	O
of	O
porcine	O
enteric	O
coronaviruses	O
and	O
the	O
role	O
of	O
different	O
types	O
of	O
IFNs	O
for	O
intestinal	B-ANAT
antiviral	O
innate	O
immunity	O
.	O

TITLE	O
:	O
Detection	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
-	O
Like	O
,	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Like	O
Bat	O
Coronaviruses	O
and	O
Group	O
H	O
Rotavirus	O
in	O
Faeces	B-ANAT
of	O
Korean	O
Bats	O
.	O

However	O
,	O
independent	O
treatments	O
with	O
either	O
SAPK	O
inhibitor	O
did	O
not	O
inhibit	O
PEDV	O
-	O
induced	O
apoptotic	O
cell	B-ANAT
death	O
mediated	O
by	O
activation	O
of	O
mitochondrial	B-ANAT
apoptosis	O
-	O
inducing	O
factor	O
(	O
AIF	O
)	O
suggesting	O
that	O
SAPKs	O
are	O
irrelevant	O
to	O
the	O
apoptosis	O
pathway	O
during	O
PEDV	O
infection	O
.	O

ABSTRACT	O
:	O
Equine	O
coronavirus	O
(	O
EqCoV	O
)	O
infection	O
has	O
been	O
documented	O
in	O
most	O
reports	O
through	O
quantitative	O
qPCR	O
analysis	O
of	O
feces	B-ANAT
and	O
viral	B-ANAT
genome	I-ANAT
sequencing	O
.	O

We	O
developed	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
targeting	O
antibodies	O
to	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
EqCoV	O
and	O
validated	O
its	O
use	O
,	O
using	O
acute	O
and	O
convalescent	O
sera	B-ANAT
from	O
83	O
adult	O
horses	O
involved	O
in	O
6	O
outbreaks	O
.	O

The	O
computationally	O
designed	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
validated	O
using	O
169	O
field	O
sera	B-ANAT
,	O
whose	O
statuses	O
were	O
determined	O
by	O
a	O
PEDV	O
-	O
specific	O
immunofluorescence	O
assay	O
.	O

Therefore	O
,	O
the	O
described	O
approach	O
is	O
useful	O
in	O
reducing	O
the	O
development	O
time	O
for	O
serological	O
assays	O
in	O
the	O
face	B-ANAT
of	O
an	O
infectious	O
disease	O
outbreak	O
.	O

Dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
are	O
highly	O
effective	O
antigen	B-ANAT
-	I-ANAT
presenting	I-ANAT
cells	I-ANAT
to	O
uptake	O
and	O
present	O
viral	O
antigens	O
to	O
T	B-ANAT
cells	I-ANAT
,	O
which	O
then	O
initiate	O
a	O
distinct	O
immune	O
response	O
.	O

This	O
review	O
describes	O
the	O
synthesis	O
,	O
bioactivities	O
and	O
SARs	O
of	O
indole	O
-	O
based	O
agents	O
targeting	O
tubulin	B-ANAT
polymerization	O
during	O
the	O
past	O
decade	O
.	O

Demographic	O
and	O
epidemiologic	O
data	O
were	O
obtained	O
from	O
enrolled	O
patients	O
after	O
which	O
nasopharyngeal	B-ANAT
and	O
oropharyngeal	B-ANAT
swabs	O
were	O
collected	O
,	O
and	O
processed	O
by	O
molecular	O
methods	O
for	O
the	O
presence	O
of	O
influenza	O
viruses	O
.	O

Pressure	O
support	O
or	O
inspiratory	O
positive	O
airway	B-ANAT
pressure	O
(	O
IPAP	O
),	O
external	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
or	O
expiratory	O
positive	O
airway	B-ANAT
pressure	O
(	O
EPAP	O
)	O
levels	O
were	O
titrated	O
to	O
achieve	O
an	O
expiratory	O
tidal	O
volume	O
of	O
8	O
to	O
10	O
ml	O
/	O
kg	O
according	O
to	O
ideal	O
body	B-ANAT
weight	O
,	O
SpO2	O
>	O
90	O
%	O
and	O
respiratory	O
rate	O
below	O
25	O
/	O
min	O
.	O

There	O
was	O
no	O
impairment	O
in	O
arterial	B-ANAT
blood	I-ANAT
gas	O
and	O
cardiopulmonary	B-ANAT
parameters	O
after	O
FOB	O
.	O

The	O
latter	O
two	O
are	O
involved	O
in	O
the	O
suppression	O
of	O
the	O
antiviral	O
innate	O
immune	O
response	O
of	O
the	O
host	B-ANAT
cell	I-ANAT
.	O

To	O
contribute	O
to	O
an	O
understanding	O
of	O
this	O
process	O
,	O
we	O
present	O
here	O
the	O
X	O
-	O
ray	O
crystal	B-ANAT
structure	O
of	O
a	O
complex	O
between	O
MERS	O
-	O
CoV	O
PL	O
(	O
pro	O
)	O
and	O
human	O
ubiquitin	O
(	O
Ub	O
)	O
that	O
is	O
devoid	O
of	O
any	O
covalent	O
linkage	O
between	O
the	O
two	O
proteins	O
.	O

ABSTRACT	O
:	O
Eukaryotic	O
mRNAs	O
possess	O
a	O
methylated	O
5	O
'-	O
guanosine	O
cap	O
that	O
is	O
required	O
for	O
RNA	O
stability	O
,	O
efficient	O
translation	O
,	O
and	O
protection	O
from	O
cell	B-ANAT
-	O
intrinsic	O
defenses	O
.	O

Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
(	O
APACHE	O
II	O
),	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
(	O
SAPS	O
II	O
),	O
and	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
SOFA	O
)	O
scores	O
were	O
lower	O
in	O
survivors	O
.	O

Our	O
previous	O
work	O
showed	O
that	O
in	O
addition	O
to	O
the	O
conserved	O
coronavirus	O
double	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
),	O
Beau	O
-	O
R	O
,	O
an	O
apathogenic	O
strain	O
of	O
avian	O
Gammacoronavirus	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
),	O
induces	O
regions	O
of	O
ER	O
that	O
are	O
zippered	O
together	O
and	O
tethered	O
open	O
-	O
necked	O
double	O
membrane	B-ANAT
spherules	O
that	O
resemble	O
replication	O
organelles	B-ANAT
induced	O
by	O
other	O
+	O
RNA	O
viruses	O
.	O

However	O
,	O
coronavirus	O
replicative	O
apparatus	B-ANAT
clearly	O
has	O
the	O
plasticity	O
to	O
function	O
in	O
different	O
structural	O
contexts	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
a	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
with	O
bilateral	O
chest	B-ANAT
X	O
-	O
ray	O
opacities	O
and	O
reduction	O
in	O
lung	B-ANAT
compliance	O
,	O
and	O
the	O
hallmark	O
of	O
the	O
syndrome	O
is	O
hypoxemia	O
refractory	O
to	O
oxygen	O
therapy	O
.	O

Severe	O
ARDS	O
patients	O
should	O
receive	O
a	O
holistic	O
framework	O
of	O
respiratory	O
and	O
hemodynamic	O
support	O
aimed	O
to	O
ensure	O
adequate	O
gas	O
exchange	O
while	O
minimizing	O
the	O
risk	O
of	O
VILI	O
,	O
by	O
promoting	O
lung	B-ANAT
recruitment	O
and	O
setting	O
protective	O
mechanical	O
ventilation	O
.	O

TITLE	O
:	O
The	O
proteome	O
of	O
the	O
infectious	O
bronchitis	O
virus	O
Beau	O
-	O
R	O
virion	B-ANAT
.	O

TITLE	O
:	O
Production	O
of	O
soluble	O
truncated	O
spike	O
protein	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
from	O
inclusion	B-ANAT
bodies	I-ANAT
of	O
Escherichia	O
coli	O
through	O
refolding	O
.	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
a	O
contagious	O
intestinal	B-ANAT
disease	O
caused	O
by	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
that	O
characterized	O
by	O
vomiting	O
,	O
diarrhea	O
,	O
and	O
dehydration	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
if	O
a	O
hypersensitive	O
-	O
type	O
lung	B-ANAT
pathology	O
might	O
occur	O
when	O
mice	O
were	O
given	O
an	O
inactivated	O
MERS	O
-	O
CoV	O
vaccine	O
and	O
challenged	O
with	O
infectious	O
virus	O
as	O
was	O
seen	O
with	O
SARS	O
-	O
CoV	O
vaccines	O
,	O
we	O
prepared	O
and	O
vaccinated	O
mice	O
with	O
an	O
inactivated	O
MERS	O
-	O
CoV	O
vaccine	O
.	O

Inactivated	O
MERS	O
-	O
CoV	O
vaccine	O
appears	O
to	O
carry	O
a	O
hypersensitive	O
-	O
type	O
lung	B-ANAT
pathology	O
risk	O
from	O
MERS	O
-	O
CoV	O
infection	O
that	O
is	O
similar	O
to	O
that	O
found	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
vaccines	O
from	O
SARS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Low	O
Blood	B-ANAT
Arterial	I-ANAT
Oxygenation	O
During	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
:	O
Proposal	O
for	O
a	O
Rational	O
Algorithm	O
-	O
Based	O
Management	O
.	O

The	O
first	O
step	O
is	O
to	O
obtain	O
adequate	O
pump	O
flow	O
,	O
the	O
main	O
determinant	O
of	O
oxygenation	O
,	O
by	O
eliminating	O
a	O
mechanical	O
problem	O
or	O
inadequate	O
venous	B-ANAT
drainage	B-ANAT
.	O

Primary	O
and	O
secondary	B-ANAT
bronchi	I-ANAT
,	O
epithelial	O
hyperplasia	O
and	O
mononuclear	O
inflammatory	B-ANAT
cell	I-ANAT
infiltrate	I-ANAT
of	O
the	O
lamina	B-ANAT
propria	I-ANAT
were	O
also	O
observed	O
.	O

CONCLUSIONS	O
:	O
The	O
results	O
demonstrated	O
that	O
the	O
three	O
strains	O
Italy02	O
genotype	O
emerging	O
in	O
Moroccan	O
poultry	O
farms	O
have	O
a	O
wide	O
distribution	O
for	O
respiratory	B-ANAT
system	I-ANAT
,	O
without	O
kidney	B-ANAT
damage	O
and	O
without	O
causing	O
mortality	O
.	O

Serum	B-ANAT
samples	O
from	O
swine	O
herds	O
with	O
recent	O
documentation	O
of	O
PDCoV	O
infection	O
and	O
samples	O
from	O
expected	O
naÃ¯ve	O
herds	O
were	O
used	O
for	O
initial	O
assay	O
optimization	O
.	O

An	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
test	O
was	O
also	O
developed	O
using	O
cell	B-ANAT
culture	O
adapted	O
PDCoV	O
for	O
comparative	O
purposes	O
.	O

The	O
standard	O
McMaster	O
flotation	O
technique	O
was	O
used	O
to	O
detect	O
eggs	O
and	O
oocysts	O
in	O
feces	B-ANAT
.	O

TITLE	O
:	O
Airway	B-ANAT
Memory	O
CD4	O
(+)	O
T	B-ANAT
Cells	I-ANAT
Mediate	O
Protective	O
Immunity	O
against	O
Emerging	O
Respiratory	O
Coronaviruses	O
.	O

Serum	B-ANAT
IgG	O
results	O
declined	O
slowly	O
over	O
the	O
monitoring	O
period	O
,	O
with	O
60	O
%	O
of	O
serum	B-ANAT
samples	O
positive	O
(	O
S	O
/	O
P	O
â¥	O
0	O
.	O
80	O
)	O
at	O
the	O
final	O
sampling	O
on	O
111	O
DPE	O
.	O

Therefore	O
,	O
the	O
objectives	O
of	O
this	O
study	O
were	O
to	O
characterize	O
anti	O
-	O
PEDV	O
neutralizing	O
activity	O
in	O
mammary	B-ANAT
secretions	B-ANAT
.	O

This	O
review	O
highlights	O
recent	O
studies	O
using	O
coronavirus	O
-	O
induced	O
neurologic	O
disease	O
as	O
a	O
model	O
to	O
determine	O
how	O
neutrophils	B-ANAT
affect	O
effective	O
control	O
of	O
viral	O
replication	O
as	O
well	O
as	O
demyelination	O
.	O

We	O
compared	O
the	O
antigenicity	O
of	O
the	O
vaccine	O
type	O
strain	O
and	O
newly	O
isolated	O
strains	O
by	O
means	O
of	O
a	O
neutralization	O
test	O
using	O
sera	B-ANAT
from	O
a	O
number	O
of	O
pigs	O
from	O
various	O
farms	O
;	O
the	O
results	O
revealed	O
that	O
they	O
are	O
antigenically	O
similar	O
.	O

Providers	O
should	O
include	O
Salmonella	O
Typhi	O
in	O
the	O
differential	O
diagnosis	O
of	O
the	O
pediatric	O
patient	O
with	O
fever	O
,	O
severe	O
abdominal	B-ANAT
pain	O
,	O
and	O
enteritis	O
,	O
and	O
be	O
aware	O
of	O
its	O
potentially	O
severe	O
complications	O
and	O
the	O
limited	O
data	O
on	O
safety	O
and	O
efficacy	O
of	O
adjunctive	O
therapies	O
that	O
can	O
be	O
considered	O
in	O
addition	O
to	O
antibiotics	O
.	O

Serum	B-ANAT
was	O
analyzed	O
for	O
BCoV	O
antibodies	O
.	O

Two	O
weeks	O
after	O
gene	O
transfer	O
,	O
animals	O
received	O
LPS	O
(	O
7	O
.	O
5	O
mg	O
/	O
Kg	O
)	O
injection	O
alone	O
or	O
in	O
combination	O
with	O
Mas	B-ANAT
receptor	O
antagonist	O
A779	O
(	O
10	O
Î¼g	O
/	O
Kg	O
)	O
or	O
ACE2	O
inhibitor	O
MLN	O
-	O
4760	O
(	O
1	O
mg	O
/	O
Kg	O
)	O
pretreatment	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
the	O
clinical	O
manifestations	O
of	O
severe	O
lung	B-ANAT
damage	O
and	O
respiratory	O
failure	O
.	O

Another	O
promising	O
new	O
therapeutic	O
strategy	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
ALI	O
/	O
ARDS	O
is	O
the	O
activation	O
of	O
autophagy	O
,	O
a	O
bulk	O
protein	O
and	O
organelle	B-ANAT
degradation	O
pathway	O
.	O

Cellular	B-ANAT
entry	O
of	O
this	O
enveloped	O
virus	O
is	O
mediated	O
by	O
the	O
large	O
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
trimers	O
of	O
which	O
mediate	O
virus	O
attachment	O
to	O
the	O
target	B-ANAT
cell	I-ANAT
and	O
subsequent	O
membrane	B-ANAT
fusion	O
.	O

Moreover	O
,	O
we	O
summarize	O
the	O
recent	O
progress	O
on	O
the	O
proteolytic	O
activation	O
of	O
PEDV	O
S	O
proteins	O
,	O
and	O
discuss	O
factors	O
that	O
may	O
determine	O
tissue	B-ANAT
tropism	O
of	O
PEDV	O
in	O
vivo	O
.	O

Serological	O
results	O
from	O
archived	O
camel	O
sera	B-ANAT
provide	O
evidence	O
for	O
circulation	O
of	O
MERS	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
among	O
dromedary	O
camels	O
in	O
the	O
Greater	B-ANAT
Horn	I-ANAT
of	O
Africa	O
as	O
far	O
back	B-ANAT
as	O
1983	O
and	O
in	O
Saudi	O
Arabia	O
as	O
far	O
back	B-ANAT
as	O
1992	O
.	O

Independent	O
covariates	O
related	O
to	O
significant	O
decreases	O
of	O
linezolid	O
concentrations	O
included	O
higher	O
weight	O
,	O
creatinine	O
clearance	O
rates	O
,	O
and	O
fibrinogen	B-ANAT
and	O
antithrombin	O
concentrations	O
,	O
lower	O
concentrations	O
of	O
lactate	O
,	O
and	O
the	O
presence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Linezolid	O
clearance	O
was	O
increased	O
in	O
ARDS	O
patients	O
(	O
by	O
82	O
%)	O
and	O
in	O
patients	O
with	O
elevated	O
fibrinogen	B-ANAT
or	O
decreased	O
lactate	O
concentrations	O
.	O

RESULTS	O
:	O
The	O
leading	O
maternal	O
complications	O
associated	O
with	O
HELLP	O
syndrome	O
were	O
the	O
following	O
:	O
severe	O
preeclampsia	O
,	O
eclampsia	O
,	O
placental	B-ANAT
abruption	O
,	O
acute	O
pulmonary	B-ANAT
edema	O
,	O
acute	O
kidney	B-ANAT
failure	O
,	O
disseminated	O
intravascular	O
coagulation	O
syndrome	O
,	O
and	O
immediate	O
maternal	O
death	O
.	O

There	O
was	O
a	O
significant	O
improvement	O
in	O
partial	O
oxygen	O
pressure	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
PaO2	O
/	O
FiO2	O
)	O
24	O
hours	O
after	O
CRRT	O
onset	O
compared	O
with	O
baseline	O
(	O
median	O
change	O
=	O
51	O
.	O
5	O
;	O
range	O
=	O
-	O
19	O
to	O
450	O
.	O
5	O
;	O
P	O
<	O
.	O
001	O
)	O
as	O
well	O
as	O
decreases	O
in	O
FiO2	O
,	O
peak	O
inspiratory	O
pressure	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
and	O
mean	O
airway	B-ANAT
pressure	O
(	O
P	O
<	O
.	O
05	O
).	O

PaO2	O
/	O
FiO2	O
was	O
higher	O
in	O
ARDS	O
patients	O
with	O
extrapulmonary	O
etiology	O
than	O
in	O
those	O
with	O
pulmonary	B-ANAT
etiology	O
(	O
P	O
<	O
.	O
05	O
).	O

Plasma	B-ANAT
leptin	O
levels	O
in	O
ambulatory	O
subjects	O
(	O
NHANES	O
)	O
correlated	O
positively	O
with	O
annual	O
risk	O
of	O
respiratory	O
infection	O
independent	O
of	O
BMI	O
.	O

HealthMap	O
accumulates	O
and	O
assesses	O
outbreak	O
data	O
from	O
a	O
range	O
of	O
sources	O
,	O
this	O
includes	O
news	O
media	B-ANAT
(	O
Google	O
News	O
(	O
Arabic	O
)),	O
validated	O
official	O
alerts	O
(	O
WHO	O
)	O
and	O
expert	O
-	O
curated	O
accounts	O
(	O
ProMED	O
).	O

HSCs	O
were	O
stably	O
transduced	O
with	O
the	O
miRNA	O
-	O
expressing	O
lentivirus	O
vector	O
that	O
produced	O
the	O
most	O
effective	O
viral	O
inhibition	O
in	O
a	O
feline	O
cell	B-ANAT
line	I-ANAT
.	O

The	O
assessment	O
of	O
virus	O
replication	O
inhibition	O
was	O
determined	O
via	O
titration	O
of	O
extracellular	B-ANAT
virus	O
using	O
the	O
TCID	O

Suggestive	O
lesions	O
of	O
acute	O
infection	O
with	O
PEDV	O
were	O
detected	O
in	O
histological	O
sections	O
of	O
the	O
small	O
and	O
large	O
bowels	B-ANAT
;	O
specifically	O
,	O
multiple	O
virus	B-ANAT
particles	I-ANAT
with	O
visible	O
crown	B-ANAT
-	O
shaped	O
projections	O
were	O
observed	O
using	O
electron	O
microscopy	O
and	O
negative	O
staining	O
.	O

It	O
is	O
clear	O
from	O
the	O
current	O
evidence	O
that	O
,	O
in	O
certain	O
patients	O
,	O
OPCAB	O
offers	O
advantages	O
over	O
conventional	O
Coronary	B-ANAT
Artery	I-ANAT
Bypass	O
Grafting	B-ANAT
(	O
CABG	O
).	O

We	O
evaluated	O
the	O
following	O
three	O
sputum	B-ANAT
-	O
homogenization	O
methods	O
:	O
proteinase	O
K	O
and	O
DNase	O
I	O
(	O
PK	O
-	O
DNase	O
)	O
treatment	O
,	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
treatment	O
,	O
and	O
N	O
-	O
acetyl	O
-	O
L	O
-	O
cysteine	O
and	O
sodium	O
citrate	O
(	O
NALC	O
)	O
treatment	O
.	O

In	O
the	O
first	O
group	O
(	O
APRV	O
)	O
the	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
was	O
used	O
;	O
the	O
second	O
group	O
(	O
SIMV	O
)	O
was	O
ventilated	O
using	O
synchronized	O
intermittent	O
mandatory	O
ventilation	O
mode	O
and	O
positive	O
end	O
expiratory	O
pressure	O
(	O
PEEP	O
).	O

TNF	O
-	O
a	O
and	O
IL	O
-	O
10	O
levels	O
in	O
alveolar	B-ANAT
lavage	O
were	O
also	O
measured	O
.	O

Oxygenation	O
index	O
was	O
increased	O
,	O
airway	B-ANAT
peak	O
pressure	O
(	O
Ppeak	O
)	O
was	O
reduced	O
,	O
the	O
lung	B-ANAT
dynamic	O
compliance	O
improved	O
,	O
extravascular	O
lung	B-ANAT
water	O
was	O
relieved	O
,	O
functional	O
residual	O
capacity	O
increased	O
and	O
Murray	O
score	O
was	O
improved	O
.	O

The	O
close	O
association	O
of	O
coronavirus	O
replication	O
with	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	B-ANAT
)	O
results	O
in	O
the	O
ER	B-ANAT
stress	O
responses	O
,	O
which	O
impose	O
a	O
challenge	O
to	O
the	O
viruses	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
STAT1	O
expression	O
was	O
markedly	O
reduced	O
in	O
PEDV	O
-	O
infected	O
cells	B-ANAT
and	O
that	O
this	O
reduction	O
was	O
not	O
due	O
to	O
inhibition	O
of	O
STAT1	O
transcription	O
.	O

The	O
patient	O
subsequently	O
developed	O
fever	O
,	O
severe	O
stomatitis	O
,	O
and	O
oropharyngeal	B-ANAT
ulcers	O
,	O
which	O
persisted	O
even	O
after	O
discontinuing	O
ATRA	O
.	O

Therefore	O
,	O
hypercytokinemia	O
with	O
DS	O
might	O
have	O
induced	O
BehÃ§et	O
'	O
s	O
disease	O
-	O
like	O
symptoms	O
,	O
including	O
stomatitis	O
and	O
ileocecal	O
perforation	O
,	O
complications	O
that	O
are	O
particularly	O
observed	O
in	O
patients	O
with	O
HLA	B-ANAT
-	O
B51	O
.	O

Less	O
is	O
known	O
about	O
NIV	O
failure	O
in	O
patients	O
with	O
acute	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
(	O
ACPE	O
)	O
and	O
obesity	O
hypoventilation	O
syndrome	O
(	O
OHS	O
).	O

Plasma	B-ANAT
levels	O
of	O
Presepsin	O
were	O
useful	O
for	O
the	O
diagnosis	O
of	O
SS	O
,	O
SSh	O
and	O
sCAP	O
and	O
may	O
predict	O
ICU	O
mortality	O
in	O
these	O
patients	O
.	O

ABSTRACT	O
:	O
In	O
patients	O
with	O
acute	O
lung	B-ANAT
injury	O
and	O
/	O
or	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
prone	O
positioning	O
is	O
a	O
therapeutic	O
intervention	O
to	O
improve	O
oxygenation	O
.	O

ABSTRACT	O
:	O
In	O
July	O
2009	O
,	O
some	O
farms	O
of	O
breeding	O
Muscovy	O
ducks	O
on	O
the	O
peak	O
of	O
egg	B-ANAT
laying	O
suffered	O
the	O
decrease	O
of	O
hatching	O
rate	O
and	O
the	O
quality	O
of	O
the	O
eggs	O
showing	O
low	O
mortality	O
and	O
no	O
evident	O
respiratory	O
symptoms	O
.	O

To	O
this	O
end	O
,	O
host	B-ANAT
cell	I-ANAT
signaling	O
pathways	O
influencing	O
porcine	O
CoV	O
virulence	O
should	O
be	O
identified	O
.	O

In	O
addition	O
,	O
novel	O
antiviral	O
drugs	O
may	O
be	O
developed	O
once	O
the	O
host	B-ANAT
cell	I-ANAT
pathways	O
and	O
the	O
molecular	O
mechanism	O
affecting	O
porcine	O
CoV	O
replication	O
and	O
virulence	O
are	O
known	O
.	O

IBV	O
mainly	O
causes	O
respiratory	O
disease	O
but	O
can	O
also	O
result	O
in	O
reduced	O
weight	O
gain	O
,	O
reduced	O
egg	B-ANAT
production	O
,	O
increased	O
frequency	O
of	O
abnormal	O
eggs	O
and	O
increased	O
rates	O
of	O
mortality	O
.	O

We	O
documented	O
cases	O
of	O
MERS	O
-	O
CoV	O
infection	O
,	O
confirmed	O
by	O
real	O
-	O
time	O
PCR	O
testing	O
of	O
sputum	B-ANAT
samples	O
.	O

ABSTRACT	O
:	O
Bedside	O
goal	O
-	O
directed	O
ultrasound	O
is	O
a	O
powerful	O
tool	O
for	O
rapid	O
differential	O
diagnosis	O
and	O
monitoring	O
of	O
cardiopulmonary	B-ANAT
disease	O
in	O
the	O
critically	O
ill	O
patient	O
population	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
feasibility	O
of	O
conducting	O
a	O
randomized	O
controlled	O
trial	O
(	O
RCT	O
)	O
of	O
convalescent	O
plasma	B-ANAT
therapy	O
for	O
MERS	O
-	O
CoV	O
-	O
infected	O
patients	O
by	O
using	O
MERS	O
-	O
CoV	O
-	O
specific	O
convalescent	O
plasma	B-ANAT
obtained	O
from	O
previously	O
recovered	O
patients	O
.	O

The	O
questionnaire	O
was	O
modified	O
for	O
this	O
study	O
to	O
include	O
26	O
items	O
that	O
were	O
divided	O
into	O
three	O
main	O
domains	O
of	O
interest	O
:	O
(	O
1	O
)	O
the	O
ability	O
to	O
care	O
for	O
critically	O
ill	O
MERS	O
-	O
CoV	O
patients	O
;	O
(	O
2	O
)	O
laboratory	O
capacity	O
to	O
diagnose	O
MERS	O
-	O
CoV	O
and	O
blood	B-ANAT
bank	O
ability	O
to	O
prepare	O
convalescent	O
plasma	B-ANAT
;	O
and	O
(	O
3	O
),	O
research	O
capacity	O
to	O
conduct	O
randomized	O
controlled	O
trials	O
.	O

ABSTRACT	O
:	O
Noninvasive	O
positive	O
pressure	O
ventilation	O
(	O
NIPPV	O
)	O
delivered	O
by	O
nasal	B-ANAT
route	O
or	O
facemask	O
is	O
increasingly	O
being	O
used	O
in	O
the	O
management	O
of	O
patients	O
with	O
acute	O
respiratory	O
failure	O
.	O

Initial	O
resting	B-ANAT
arterial	B-ANAT
blood	I-ANAT
gases	O
showed	O
mean	O
arterial	B-ANAT
oxygen	O
tension	O
(	O
PaO2	O
)	O
61	O
mmHg	O
(	O
range	O
45	O
to	O
78	O
mmHg	O
),	O
mean	O
arterial	B-ANAT
carbon	O
dioxide	O
tension	O
(	O
PaCO2	O
)	O
75	O
.	O
2	O
mmHg	O
(	O
range	O
32	O
to	O
127	O
mmHg	O
)	O
and	O
mean	O
arterial	B-ANAT
pH	O
-	O
7	O
.	O
26	O
(	O
range	O
7	O
.	O
03	O
to	O
7	O
.	O
45	O
).	O

It	O
causes	O
a	O
wide	O
spectrum	O
of	O
clinical	O
features	O
in	O
human	O
beings	O
ranging	O
from	O
mild	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
to	O
a	O
fatal	O
pneumonia	O
leading	O
to	O
multi	O
organ	B-ANAT
system	I-ANAT
failure	O
.	O

Although	O
considerable	O
translational	O
challenges	O
,	O
such	O
as	O
concerns	O
regarding	O
cell	B-ANAT
manufacture	O
scale	O
-	O
up	O
and	O
issues	O
regarding	O
cell	B-ANAT
potency	O
and	O
batch	O
variability	O
,	O
must	O
be	O
overcome	O
,	O
MSCs	O
constitute	O
a	O
highly	O
promising	O
potential	O
therapy	O
for	O
ARDS	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ECMO	O
should	O
be	O
considered	O
one	O
of	O
the	O
treatment	O
options	O
for	O
the	O
management	O
of	O
ARDS	O
due	O
to	O
severe	O
pulmonary	B-ANAT
tuberculosis	O
.	O

We	O
prospectively	O
followed	O
143	O
patients	O
with	O
haematological	O
malignancies	O
,	O
and	O
whose	O
lungs	B-ANAT
were	O
mechanically	O
ventilated	O
for	O
more	O
than	O
24	O
h	O
,	O
over	O
a	O
5	O
-	O
y	O
period	O
.	O

Placing	O
AEGIS	O
components	O
in	O
the	O
stems	B-ANAT
of	O
molecular	O
beacons	O
is	O
shown	O
to	O
lower	O
noise	O
by	O
preventing	O
unwanted	O
stem	B-ANAT
invasion	O
by	O
adventitious	O
natural	O
xNA	O
.	O

Whole	O
exome	O
sequencing	O
revealed	O
biallelic	O
missense	O
mutations	O
in	O
the	O
NSMCE3	O
(	O
also	O
known	O
as	O
NDNL2	O
)	O
gene	O
,	O
which	O
encodes	O
a	O
subunit	O
of	O
the	O
SMC5	O
/	O
6	O
complex	O
that	O
is	O
essential	O
for	O
DNA	O
damage	O
response	O
and	O
chromosome	B-ANAT
segregation	O
.	O

Patient	O
cells	B-ANAT
showed	O
chromosome	B-ANAT
rearrangements	O
,	O
micronuclei	B-ANAT
,	O
sensitivity	O
to	O
replication	O
stress	O
and	O
DNA	O
damage	O
,	O
and	O
defective	O
homologous	O
recombination	O
.	O

Little	O
is	O
known	O
about	O
the	O
role	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
management	O
in	O
this	O
setting	O
.	O

TITLE	O
:	O
Usefulness	O
of	O
acute	O
phase	O
proteins	O
in	O
differentiating	O
between	O
feline	O
infectious	O
peritonitis	O
and	O
other	O
diseases	O
in	O
cats	O
with	O
body	B-ANAT
cavity	I-ANAT
effusions	O
.	O

Interstitial	B-ANAT
lung	B-ANAT
disease	O
(	O
ILD	O
)	O
is	O
the	O
main	O
pulmonary	B-ANAT
manifestation	O
and	O
may	O
be	O
severe	O
thereby	O
determining	O
the	O
prognosis	O
.	O

TITLE	O
:	O
Role	O
of	O
Complement	O
C5	O
in	O
Experimental	O
Blunt	O
Chest	B-ANAT
Trauma	O
-	O
Induced	O
Septic	O
Acute	O
Lung	B-ANAT
Injury	O
(	O
ALI	O
).	O

We	O
suggest	O
that	O
noncanonical	O
autophagy	O
,	O
which	O
is	O
sensitive	O
to	O
treatment	O
with	O
brefeldin	O
A	O
,	O
may	O
converge	O
with	O
the	O
infectious	O
cycles	O
of	O
certain	O
DNA	O
and	O
RNA	O
viruses	O
that	O
utilize	O
membrane	B-ANAT
from	O
the	O
ER	O
and	O
cis	O
-	O
Golgi	B-ANAT
.	O

A	O
secondary	O
analysis	O
of	O
data	O
from	O
331	O
patients	O
gathered	O
during	O
the	O
Beta	O
Agonists	O
Lung	B-ANAT
Injury	O
Prevention	O
Trial	O
was	O
undertaken	O
.	O

RESULTS	O
:	O
ARDS	O
was	O
associated	O
with	O
more	O
non	O
-	O
respiratory	B-ANAT
organ	I-ANAT
failure	O
(	O
early	O
44	O
.	O
1	O
%,	O
late	O
75	O
.	O
0	O
%,	O
no	O
ARDS	O
27	O
.	O
6	O
%	O
P	O
<	O
0	O
.	O
001	O
),	O
longer	O
ICU	O
stay	O
(	O
mean	O
early	O
12	O
.	O
1	O
,	O
late	O
20	O
.	O
2	O
,	O
no	O
ARDS	O
7	O
.	O
3	O
days	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
longer	O
hospital	O
stay	O
(	O
mean	O
early	O
18	O
.	O
1	O
,	O
late	O
24	O
.	O
5	O
,	O
no	O
ARDS	O
14	O
.	O
2	O
days	O
P	O
<	O
0	O
.	O
001	O
)	O
but	O
no	O
difference	O
in	O
mortality	O
or	O
quality	O
of	O
life	O
.	O

We	O
sought	O
to	O
evaluate	O
the	O
incidence	O
and	O
factors	O
associated	O
with	O
severe	O
T	O
(	O
platelet	B-ANAT
count	O
â¤	O
50	O
,	O
000	O
/	O
Î¼l	O
)	O
in	O
adults	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
managed	O
with	O
or	O
without	O
ECMO	O
.	O

Eligible	O
patients	O
will	O
be	O
randomly	O
allocated	O
to	O
two	O
arms	B-ANAT
:	O
(	O
i	O
)	O
conventional	O
treatment	O
without	O
dexamethasone	O
,	O
(	O
ii	O
)	O
conventional	O
treatment	O
plus	O
dexamethasone	O
.	O

Since	O
the	O
development	O
of	O
the	O
first	O
viral	O
infectious	O
clone	O
system	O
for	O
the	O
poliovirus	O
,	O
novel	O
strategies	O
of	O
viral	B-ANAT
genome	I-ANAT
construction	O
have	O
allowed	O
for	O
the	O
assembly	O
of	O
viral	O
genomes	O
across	O
the	O
identified	O
viral	O
families	O
.	O

ABSTRACT	O
:	O
A	O
new	O
family	O
of	O
IFNs	O
called	O
type	O
III	O
IFN	O
or	O
IFN	O
-	O
Î»	O
has	O
been	O
described	O
,	O
and	O
shown	O
to	O
induce	O
antiviral	O
activity	O
against	O
several	O
viruses	O
in	O
the	O
cell	B-ANAT
culture	O
.	O

ABSTRACT	O
:	O
Parenchymal	O
lung	B-ANAT
involvement	O
(	O
PLI	O
)	O
in	O
adult	O
-	O
onset	O
Still	O
'	O
s	O
disease	O
(	O
AOSD	O
)	O
has	O
seldom	O
,	O
if	O
ever	O
,	O
been	O
studied	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
spike	O
proteins	O
mediate	O
host	O
-	O
cell	B-ANAT
-	O
attachment	O
and	O
virus	O
entry	O
.	O

Virus	O
replication	O
takes	O
place	O
within	O
the	O
host	B-ANAT
cell	I-ANAT
cytosol	I-ANAT
,	O
whereas	O
assembly	O
and	O
budding	O
occur	O
at	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
-	I-ANAT
Golgi	I-ANAT
intermediate	I-ANAT
compartment	I-ANAT
.	O

These	O
data	O
demonstrate	O
that	O
interaction	O
of	O
Alphacoronavirus	O
spike	O
proteins	O
with	O
tubulin	B-ANAT
supports	O
S	O
protein	O
transport	O
and	O
incorporation	O
into	O
virus	B-ANAT
particles	I-ANAT
.	O

TITLE	O
:	O
Viral	O
RNA	O
in	O
Blood	B-ANAT
as	O
Indicator	O
of	O
Severe	O
Outcome	O
in	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
Infection	O
.	O

Influenza	O
virus	O
is	O
the	O
most	O
likely	O
pathogen	O
in	O
ILI	O
/	O
ARI	O
when	O
CRP	O
â¥	O
5	O
mg	O
/	O
L	O
.	O
This	O
might	O
be	O
explained	O
by	O
tissue	B-ANAT
destruction	O
.	O

Convalescent	O
plasma	B-ANAT
therapy	O
has	O
shown	O
some	O
efficacy	O
among	O
patients	O
refractory	O
to	O
antiviral	O
drugs	O
if	O
administered	O
within	O
2	O
weeks	O
of	O
the	O
onset	O
of	O
the	O
disease	O
.	O

In	O
this	O
prospective	O
study	O
,	O
conducted	O
in	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
from	O
2009	O
through	O
2012	O
,	O
we	O
compared	O
two	O
groups	O
-	O
SLED	O
(	O
n	O
=	O
19	O
)	O
and	O
SLEDf	O
(	O
n	O
=	O
20	O
)-	O
evaluating	O
demographic	O
,	O
clinical	O
,	O
and	O
biochemical	O
parameters	O
,	O
as	O
well	O
as	O
serum	B-ANAT
levels	O
of	O
interleukins	O
,	O
up	O
to	O
the	O
third	O
day	O
after	O
admission	O
.	O

We	O
identified	O
the	O
following	O
risk	O
factors	O
(	O
sensitivities	O
/	O
specificities	O
)	O
for	O
mortality	O
in	O
severe	O
leptospirosis	O
:	O
age	O
â¥	O
55	O
years	O
(	O
67	O
%/	O
91	O
%);	O
serum	B-ANAT
urea	O
â¥	O
204	O
mg	O
/	O
dl	O
(	O
100	O
%/	O
70	O
%);	O
creatinine	O
â¥	O
5	O
.	O
2	O
mg	O
/	O
dl	O
(	O
100	O
%/	O
58	O
%);	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
score	O
â¥	O
39	O
.	O
5	O
(	O
67	O
%/	O
88	O
%);	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
score	O
â¥	O
20	O
.	O
5	O
(	O
67	O
%/	O
85	O
%);	O
and	O
inspiratory	O
pressure	O
â¥	O
31	O
mmHg	O
(	O
84	O
%/	O
85	O
%).	O

We	O
provide	O
evidence	O
that	O
TLR2	O
activation	O
of	O
LSCEs	O
by	O
MHV3	O
is	O
an	O
aggravating	O
factor	O
of	O
hepatic	B-ANAT
inflammation	O
and	O
correlates	O
with	O
the	O
severity	O
of	O
hepatitis	O
.	O

Using	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
infections	O
as	O
animal	O
models	O
of	O
viral	O
hepatitis	O
,	O
we	O
report	O
for	O
the	O
first	O
time	O
that	O
in	O
vitro	O
and	O
in	O
vivo	O
infection	O
of	O
LSECs	O
by	O
the	O
pathogenic	O
MHV3	O
serotype	O
leads	O
to	O
a	O
reversion	O
of	O
their	O
intrinsic	O
anti	O
-	O
inflammatory	O
phenotype	O
toward	O
a	O
proinflammatory	O
profile	O
as	O
well	O
to	O
as	O
disorders	O
in	O
vascular	B-ANAT
factors	O
,	O
correlating	O
with	O
the	O
severity	O
of	O
hepatitis	O
.	O

TITLE	O
:	O
Carcinoembryonic	O
Antigen	O
-	O
Related	O
Cell	B-ANAT
Adhesion	O
Molecule	O
5	O
Is	O
an	O
Important	O
Surface	O
Attachment	O
Factor	O

Disrupting	O
the	O
interaction	O
between	O
CEACAM5	O
and	O
MERS	O
-	O
CoV	O
spike	O
with	O
anti	O
-	O
CEACAM5	O
antibody	O
,	O
recombinant	O
CEACAM5	O
protein	O
,	O
or	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
knockdown	O
of	O
CEACAM5	O
significantly	O
inhibited	O
the	O
entry	O
of	O
MERS	O
-	O
CoV	O
.	O
Recombinant	O
expression	O
of	O
CEACAM5	O
did	O
not	O
render	O
nonpermissive	O
baby	O
hamster	O
kidney	B-ANAT
(	O
BHK21	O
)	O
cells	B-ANAT
susceptible	O
to	O
MERS	O
-	O
CoV	O
infection	O
.	O

The	O
disease	O
progressed	O
to	O
severe	O
pneumonia	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Up	O
to	O
70	O
%	O
of	O
coronary	B-ANAT
artery	I-ANAT
bypass	O
graft	B-ANAT
(	O
CABG	B-ANAT
)	O
recipients	O
had	O
an	O
AHI	O
â¥	O
15	O
/	O
h	O
versus	O
33	O
%	O
of	O
those	O
who	O
had	O
not	O
undergone	O
CABG	B-ANAT
.	O

69	O
.	O
5	O
%	O
were	O
male	O
,	O
78	O
%	O
had	O
acute	O
coronary	B-ANAT
syndrome	O
,	O
and	O
22	O
%	O
had	O
stable	O
CAD	O
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
PDCoV	O
in	O
this	O
region	O
and	O
compare	O
its	O
activity	O
to	O
other	O
enteric	O
disease	O
of	O
swine	O
caused	O
by	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
transmissible	O
gastroenteritis	O
coronavirus	O
(	O
TGEV	O
),	O
and	O
porcine	O
rotavirus	O
group	O
C	O
(	O
Rota	O
C	O
),	O
390	O
fecal	B-ANAT
samples	O
were	O
collected	O
from	O
swine	O
of	O
various	O
ages	O
from	O
15	O
swine	O
farms	O
with	O
reported	O
diarrhea	O
.	O

We	O
conducted	O
a	O
histologic	O
analysis	O
and	O
measured	O
HMGB1	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
1Î²	O
,	O
and	O
TNF	O
-	O
Î±	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
on	O
day	O
3	O
after	O
pneumonectomy	O
.	O

The	O
level	O
of	O
HMGB1	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
1Î²	O
,	O
and	O
TNF	O
-	O
Î±	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
was	O
significantly	O
increased	O
by	O
LPS	O
administration	O
after	O
pneumonectomy	O
and	O
significantly	O
decreased	O
by	O
rTM	O
administration	O
with	O
LPS	O
and	O
pneumonectomy	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

RESULTS	O
:	O
On	O
histologic	O
analysis	O
,	O
left	O
pneumonectomy	O
followed	O
by	O
LPS	O
administration	O
induced	O
both	O
severe	O
inflammatory	O
cellular	B-ANAT
infiltration	O
and	O
alveolar	B-ANAT
wall	I-ANAT
congestion	O
with	O
hemorrhage	O
.	O

Leptospirosis	O
presenting	O
as	O
Weil	O
'	O
s	O
disease	O
is	O
a	O
common	O
cause	O
of	O
renal	B-ANAT
and	O
hyperbilirubinemia	O
in	O
endemic	O
areas	O
.	O

ABSTRACT	O
:	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
the	O
predominant	O
component	O
of	O
the	O
outer	B-ANAT
membrane	I-ANAT
of	O
Gram	O
-	O
negative	O
bacteria	O
,	O
which	O
can	O
cause	O
severe	O
inflammation	O
in	O
the	O
body	B-ANAT
.	O

Hematoxylin	O
â	O
eosin	O
staining	O
,	O
reverse	O
transcription	O
â	O
quantitative	O
polymerase	O
chain	O
reaction	O
analysis	O
,	O
western	O
blot	O
analysis	O
and	O
thin	O
layer	B-ANAT
chromatography	O
were	O
used	O
to	O
investigate	O
the	O
mechanism	O
of	O
SMS	O
in	O
ALI	O
.	O

A	O
total	O
of	O
23	O
Saudi	O
patients	O
with	O
severe	O
MERS	O
-	O
CoV	O
infection	O
were	O
typed	O
for	O
HLA	B-ANAT
class	O
II	O
,	O
results	O
were	O
compared	O
with	O
those	O
of	O
161	O
healthy	O
controls	O
.	O

Based	O
on	O
our	O
results	O
,	O
in	O
the	O
second	O
group	O
,	O
IBV	O
vaccine	O
strain	O
(	O
4	O
/	O
91	O
)	O
at	O
all	O
titration	O
and	O
M41	O
in	O
10	O
(-	O
2	O
)	O
and	O
10	O
(-	O
3	O
)	O
titration	O
and	O
in	O
the	O
third	O
group	O
both	O
variants	O
of	O
virus	O
the	O
embryonic	B-ANAT
Index	O
(	O
EI	O
)	O
was	O
significantly	O
increased	O
.	O

The	O
IgG	O
concentration	O
in	O
the	O
bloodand	O
colostral	O
serum	B-ANAT
was	O
determined	O
using	O
radial	O
immuno	O
diffusion	O
test	O
(	O
RID	O
).	O

in	O
bovine	O
feces	B-ANAT
(	O
bio	O
-	O
X	O
Diagnostics	O
Â®,	O
Belgium	O
).	O

RESULTS	O
:	O
We	O
included	O
162	O
subjects	O
[	O
24	O
%	O
female	O
,	O
age	O
48	O
(	O
35	O
-	O
60	O
),	O
%	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
(	O
TBSA	O
)	O
burn	O
28	O
(	O
19	O
-	O
40	O
),	O
%	O
body	B-ANAT
surface	O
area	O
(	O
BSA	O
)	O
full	O
thickness	O
(	O
FT	O
)	O
burn	O
13	O
(	O
0	O
-	O
30	O
),	O
and	O
62	O
%	O
with	O
inhalation	O
injury	O
].	O

ABSTRACT	O
:	O
Metabolite	O
-	O
responsive	O
RNA	O
pseudoknots	O
derived	O
from	O
prokaryotic	O
riboswitches	O
have	O
been	O
shown	O
to	O
stimulate	O
-	O
1	O
programmed	O
ribosomal	B-ANAT
frameshifting	O
(	O
PRF	O
),	O
suggesting	O
-	O
1	O
PRF	O
as	O
a	O
promising	O
gene	O
expression	O
platform	O
to	O
extend	O
riboswitch	O
applications	O
in	O
higher	O
eukaryotes	O
.	O

In	O
particular	O
,	O
the	O
extra	O
stem	B-ANAT
of	O
SARS	O
-	O
PK	O
was	O
replaced	O
by	O
an	O
RNA	O
aptamer	O
of	O
theophylline	O
and	O
designed	O
to	O
couple	O
theophylline	O
binding	O
with	O
the	O
stimulation	O
of	O
-	O
1	O
PRF	O
.	O

In	O
addition	O
,	O
CCE	O
precisely	O
depicts	O
the	O
consequences	O
of	O
pulmonary	B-ANAT
vascular	B-ANAT
lesions	O
on	O
right	O
ventricular	B-ANAT
function	O
and	O
helps	O
in	O
adjusting	O
the	O
ventilator	O
settings	O
in	O
patients	O
sustaining	O
moderate	O
-	O
to	O
-	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

PEDV	O
positive	O
samples	O
were	O
distributed	O
throughout	O
the	O
mainland	O
of	O
South	O
Korea	O
,	O
clustering	O
at	O
the	O
northern	O
border	B-ANAT
adjacent	O
to	O
the	O
Demilitarized	O
Zone	O
(	O
DMZ	O
)	O
and	O
in	O
mountainous	O
regions	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
study	O
the	O
effect	O
of	O
ROS	O
produced	O
by	O
hypoxanthine	O
-	O
xanthine	O
oxidase	O
(	O
Hx	O
-	O
XO	O
)	O
on	O
the	O
adhesion	O
of	O
human	O
umbilical	B-ANAT
vein	I-ANAT
endothelial	B-ANAT
cells	I-ANAT
(	O
HUVEC	O
)	O
and	O
on	O
the	O
signaling	O
pathways	O
involved	O
.	O

Activation	O
of	O
the	O
pro	O
-	O
inflammatory	O
transcription	O
factor	O
nuclear	O
factor	O
-	O
ÎºB	O
(	O
NF	O
-	O
ÎºB	O
)	O
results	O
in	O
muscle	B-ANAT
wasting	O
during	O
disuse	O
-	O
induced	O
skeletal	B-ANAT
muscle	I-ANAT
atrophy	O
(	O
ICU	O
bed	O
rest	O
)	O
and	O
septic	O
shock	O
.	O

Extrapolating	O
data	O
from	O
the	O
adult	O
population	O
to	O
the	O
pediatric	O
population	O
is	O
complicated	O
as	O
we	O
know	O
that	O
physiology	O
and	O
the	O
body	B-ANAT
'	O
s	O
response	O
to	O
disease	O
can	O
be	O
different	O
between	O
adult	O
and	O
pediatric	O
patients	O
.	O

TITLE	O
:	O
Feasibility	O
of	O
Using	O
Convalescent	O
Plasma	B-ANAT
Immunotherapy	O
for	O
MERS	O
-	O
CoV	O
Infection	O
,	O
Saudi	O
Arabia	O
.	O

TITLE	O
:	O
Identification	O
of	O
Nafamostat	O
as	O
a	O
Potent	O
Inhibitor	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
S	O
Protein	O
-	O
Mediated	O
Membrane	B-ANAT
Fusion	O
Using	O
the	O
Split	O
-	O
Protein	O
-	O
Based	O
Cell	B-ANAT
-	O
Cell	B-ANAT
Fusion	O
Assay	O
.	O

Following	O
removal	O
of	O
free	O
proteins	O
,	O
antigen	O
-	O
laden	O
particles	O
were	O
recovered	O
and	O
showed	O
morphological	O
semblance	O
to	O
natural	O
viral	B-ANAT
particles	I-ANAT
under	O
nanoparticle	O
tracking	O
analysis	O
and	O
transmission	O
electron	O
microscopy	O
.	O

The	O
PI3K	O
/	O
Akt	O
pathway	O
is	O
an	O
important	O
cellular	B-ANAT
pathway	O
that	O
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
virus	O
replication	O
.	O

Clinical	O
presentations	O
included	O
pain	O
abdomen	B-ANAT
(	O
42	O
,	O
42	O
%),	O
nausea	O
and	O
vomiting	O
(	O
35	O
,	O
35	O
%),	O
jaundice	O
(	O
34	O
,	O
34	O
%),	O
oliguria	O
(	O
24	O
,	O
24	O
%),	O
altered	O
sensorium	O
(	O
24	O
,	O
24	O
%),	O
breathing	O
difficulty	O
(	O
10	O
,	O
10	O
%),	O
and	O
seizures	O
(	O
5	O
,	O
5	O
%).	O

Manifestations	O
of	O
severe	O
falciparum	O
malaria	O
included	O
hepatopathy	O
(	O
38	O
%),	O
renal	B-ANAT
failure	O
(	O
28	O
%),	O
shock	O
(	O
9	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
7	O
%),	O
hypoglycemia	O
(	O
3	O
%),	O
and	O
severe	O
anemia	O
(	O
1	O
%).	O

Critical	O
to	O
this	O
discovery	O
process	O
was	O
the	O
employment	O
of	O
an	O
ex	O
vivo	O
cardiovascular	B-ANAT
(	O
CV	B-ANAT
)	O
model	O
which	O
served	O
to	O
identify	O
compounds	O
that	O
,	O
like	O
2	O
,	O
were	O
free	O
of	O
the	O
CV	B-ANAT
liabilities	O
that	O
resulted	O
in	O
the	O
discontinuation	O
of	O
BMS	O
-	O
605339	O
(	O
1	O
)	O
from	O
clinical	O
trials	O
.	O

I	O
further	O
discuss	O
the	O
evolution	O
of	O
these	O
two	O
critical	O
functions	O
of	O
coronavirus	O
spike	O
proteins	O
,	O
receptor	O
recognition	O
and	O
membrane	B-ANAT
fusion	O
,	O
in	O
the	O
context	O
of	O
the	O
corresponding	O
functions	O
from	O
other	O
viruses	O
and	O
host	O
cells	B-ANAT
.	O

Mesenteric	B-ANAT
lymph	I-ANAT
node	I-ANAT
and	O
small	B-ANAT
intestine	I-ANAT
were	O
the	O
primary	O
sites	O
of	O
antigen	O
detection	O
by	O
immunohistochemistry	O
,	O
and	O
virus	O
RNA	O
was	O
detected	O
in	O
these	O
tissues	B-ANAT
to	O
the	O
end	O
of	O
the	O
study	O
.	O

Virus	O
RNA	O
was	O
detectable	O
in	O
piglet	O
fecal	B-ANAT
swabs	O
to	O
21	O
dpi	O
,	O
and	O
dams	O
to	O
14	O
-	O
35	O
dpi	O
.	O

Alternatively	O
,	O
melphalan	O
at	O
5	O
mg	O
and	O
PSL	O
at	O
32	O
mg	O
were	O
administered	O
,	O
with	O
no	O
amelioration	O
,	O
while	O
serum	B-ANAT
IgA	O
-	O
Î»	O
monoclonal	O
protein	O
diminished	O
,	O
and	O
IgM	O
-	O
Î»	O
M	O
protein	O
positivity	O
was	O
continuously	O
observed	O
.	O

TITLE	O
:	O
Synbiotics	O
suppress	O
the	O
release	O
of	O
lactate	O
dehydrogenase	O
,	O
promote	O
non	O
-	O
specific	O
immunity	O
and	O
integrity	O
of	O
jejunum	B-ANAT
mucosa	I-ANAT
in	O
piglets	O
.	O

The	O
maternal	O
mortality	O
ratio	O
was	O
32	O
.	O
5	O
%,	O
incidence	O
of	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
was	O
71	O
%,	O
and	O
pregnancy	O
loss	O
was	O
43	O
.	O
5	O
%.	O

The	O
results	O
showed	O
higher	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
plasma	B-ANAT
glucose	O
and	O
total	O
protein	O
in	O
birds	O
under	O
CF	O
.	O

(	O
6	O
)	O
The	O
median	O
of	O
survival	O
table	O
of	O
children	O
with	O
normal	O
pancreas	B-ANAT
was	O
75	O
days	O
,	O
the	O
median	O
of	O
survival	O
table	O
of	O
children	O
with	O
elevated	O
amylase	O
or	O
lipase	O
was	O
24	O
days	O
.(	O
7	O
)	O

However	O
,	O
owing	O
to	O
existing	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
which	O
is	O
associated	O
with	O
a	O
considerable	O
risk	O
of	O
peri	O
-	O
interventional	O
hypoxia	O
,	O
a	O
temporary	O
bridging	O
concept	O
using	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
was	O
implemented	O
successfully	O
.	O

Microscopic	O
lesions	O
were	O
observed	O
on	O
the	O
ovary	B-ANAT
post	O
-	O
infection	O
,	O
but	O
were	O
restricted	O
to	O
the	O
acute	O
infection	O
period	O
.	O

Nasopharyngeal	B-ANAT
(	O
NP	O
)	O
and	O
oropharyngeal	B-ANAT
(	O
OP	O
)	O
swabs	O
were	O
collected	O
from	O
all	O
participants	O
.	O

To	O
determine	O
the	O
impact	O
of	O
miR	O
-	O
155	O
on	O
trafficking	O
,	O
T	B-ANAT
cells	I-ANAT
from	O
infected	O
WT	O
or	O
miR	O
-	O
155	O
(-/-)	O
mice	O
were	O
adoptively	O
transferred	O
into	O
RAG1	O
(-/-)	O
mice	O
,	O
and	O
T	B-ANAT
cell	I-ANAT
accumulation	O
into	O
the	O
CNS	B-ANAT
was	O
assessed	O
using	O
flow	O
cytometry	O
.	O

Compared	O
to	O
WT	O
mice	O
,	O
JHMV	O
-	O
infected	O
miR	O
-	O
155	O
(-/-)	O
mice	O
developed	O
exacerbated	O
disease	O
concomitant	O
with	O
increased	O
morbidity	O
/	O
mortality	O
and	O
an	O
inability	O
to	O
control	O
viral	O
replication	O
within	O
the	O
CNS	B-ANAT
.	O

Both	O
IFN	O
-	O
Î³	O
secretion	B-ANAT
and	O
trafficking	O
were	O
impaired	O
in	O
miR	O
-	O
155	O
(-/-)	O
,	O
virus	O
-	O
specific	O
CD4	O
(+)	O
T	B-ANAT
cells	I-ANAT
;	O
however	O
,	O
expression	O
of	O
the	O
chemokine	O
homing	O
receptors	O
analyzed	O
on	O
CD4	O
(+)	O
cells	B-ANAT
was	O
not	O
affected	O
.	O

For	O
patients	O
with	O
a	O
respiratory	B-ANAT
system	I-ANAT
compliance	O
above	O
40	O
mL	O
/	O
cm	O
H2O	O
or	O
patients	O
with	O
a	O
BMI	O
above	O
35	O
kg	O
/	O
m	O
(	O
2	O
),	O
we	O
found	O
a	O
trend	O
towards	O
reduced	O
mortality	O
with	O
higher	O
PEEP	O
,	O
but	O
there	O
is	O
very	O
weak	O
statistical	O
confidence	O
in	O
these	O
findings	O
.	O

A	O
phylogenetic	O
tree	O
based	O
on	O
partial	O
S1	O
sequences	O
of	O
the	O
detected	O
AvCoV	O
-	O
IBVs	O
(	O
including	O
isolates	O
)	O
revealed	O
that	O
1	O
)	O
viruses	O
detected	O
in	O
five	O
broiler	O
flocks	O
were	O
similar	O
to	O
the	O
IBV	O
vaccines	O
Ma5	O
,	O
H120	O
,	O
M41	O
;	O
2	O
)	O
viruses	O
detected	O
in	O
24	O
broiler	O
flocks	O
were	O
similar	O
to	O
those	O
previously	O
reported	O
from	O
Turkey	O
and	O
to	O
Israel	O
variant	O
-	O
2	O
strains	O
;	O
3	O
)	O
viruses	O
detected	O
in	O
seven	O
layer	B-ANAT
flocks	O
were	O
different	O
from	O
those	O
found	O
in	O
any	O
of	O
the	O
broiler	O
flocks	O
but	O
similar	O
to	O
viruses	O
previously	O
reported	O
from	O
Iran	O
,	O
India	O
,	O
and	O
China	O
(	O
similar	O
to	O
Israel	O
variant	O
-	O
1	O
and	O
4	O
/	O
91	O
serotypes	O
);	O
and	O
4	O
)	O
that	O
the	O
AVCoV	O
-	O
IBV	O
,	O
Israeli	O
variant	O
-	O
2	O
strain	O
,	O
found	O
to	O
be	O
circulating	O
in	O
Turkey	O
appears	O
to	O
be	O
undergoing	O
molecular	O
evolution	O
.	O

Additional	O
investigations	O
,	O
including	O
a	O
cell	B-ANAT
-	O
free	O
haemoglobin	O
of	O
10	O
.	O
2	O
Ã	O
10	O
(	O
5	O
)	O
ng	O
/	O
mL	O
and	O
an	O
undetectable	O
haptoglobin	O
,	O
confirmed	O
intravascular	O
haemolysis	O
.	O

The	O
patient	O
continued	O
on	O
intravenous	O
artesunate	O
for	O
a	O
total	O
of	O
48	O
h	O
prior	O
to	O
substitution	O
with	O
artemether	O
-	O
lumefantrine	O
,	O
and	O
made	O
a	O
good	O
recovery	O
with	O
resolution	O
of	O
his	O
haemoglobinuria	O
and	O
improvement	O
of	O
his	O
kidney	B-ANAT
function	O
by	O
day	O
3	O
.	O

ABSTRACT	O
:	O
During	O
a	O
severe	O
outbreak	O
of	O
diarrhoea	O
and	O
vomiting	O
in	O
a	O
pig	O
herd	O
in	O
Central	O
Eastern	O
Europe	O
,	O
faecal	B-ANAT
samples	O
were	O
tested	O
positive	O
for	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
(	O
PEDV	O
)	O
and	O
negative	O
for	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
using	O
a	O
commercial	O
RT	O
-	O
qPCR	O
assay	O
that	O
can	O
detect	O
both	O
of	O
these	O
coronaviruses	O
.	O

The	O
most	O
common	O
clinical	O
manifestations	O
included	O
fever	O
,	O
irritability	O
,	O
rash	O
,	O
hyperalgesia	O
syndrome	O
,	O
diffuse	O
limb	B-ANAT
edema	O
,	O
meningoencephalitis	O
,	O
and	O
bullous	O
dermatitis	O
.	O

Leukocytosis	O
with	O
neutrophilia	O
and	O
normal	O
or	O
increased	O
platelets	B-ANAT
was	O
a	O
common	O
finding	O
,	O
and	O
in	O
those	O
with	O
signs	O
of	O
meningeal	O
involvement	O
,	O
moderate	O
lymphocytic	O
pleocytosis	O
with	O
normal	O
glucose	O
and	O
protein	O
levels	O
was	O
typical	O
.	O

The	O
most	O
common	O
complications	O
were	O
liver	B-ANAT
dysfunction	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
encephalopathy	O
,	O
pleural	B-ANAT
effusion	I-ANAT
,	O
ascites	O
,	O
myocarditis	O
,	O
myositis	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
and	O
disseminated	O
intravascular	O
coagulopathy	O
.	O

Using	O
antibodies	O
from	O
SARS	O
patients	O
,	O
we	O
identified	O
and	O
characterized	O
SARS	O
-	O
CoV	O
B	B-ANAT
-	I-ANAT
cell	I-ANAT
peptide	O
epitopes	O
with	O
disparate	O
functions	O
.	O

Plasma	B-ANAT
markers	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IL	O
-	O
10	O
are	O
associated	O
with	O
ARDS	O
in	O
patients	O
with	O
severe	O
TBI	O
.	O

ABSTRACT	O
:	O
Initial	O
success	O
with	O
chimeric	O
antigen	O
receptor	O
-	O
modified	O
T	B-ANAT
cell	I-ANAT
therapy	O
for	O
relapsed	O
/	O
refractory	O
acute	O
lymphoblastic	B-ANAT
leukemia	O
is	O
leading	O
to	O
expanded	O
use	O
through	O
multicenter	O
trials	O
.	O

ABSTRACT	O
:	O
Legionnaires	O
'	O
disease	O
is	O
a	O
bacterial	O
disease	O
of	O
the	O
respiratory	B-ANAT
system	I-ANAT
caused	O
by	O
a	O
gram	O
-	O
negative	O
germ	O
whose	O
clinical	O
manifestation	O
can	O
be	O
benign	O
limiting	O
to	O
flu	O
-	O
like	O
syndrome	O
or	O
can	O
be	O
more	O
severe	O
being	O
characterized	O
by	O
pneumonia	O
which	O
may	O
be	O
complicated	O
by	O
multisystem	O
disease	O
that	O
can	O
lead	O
to	O
death	O
.	O

ABSTRACT	O
:	O
To	O
clarify	O
the	O
possible	O
association	O
between	O
the	O
Zika	O
virus	O
(	O
ZIKV	O
)	O
and	O
microcephaly	O
and	O
understand	O
where	O
we	O
are	O
in	O
terms	O
of	O
research	O
and	O
the	O
debate	O
on	O
the	O
causation	O
between	O
mild	O
maternal	O
clinical	O
features	O
and	O
severe	O
fetal	B-ANAT
microcephaly	O
.	O

RESULTS	O
:	O
We	O
emphasize	O
the	O
diagnosis	O
of	O
ZIKV	O
infection	O
,	O
including	O
maternal	O
clinical	O
manifestations	O
,	O
maternal	O
and	O
fetal	B-ANAT
laboratory	O
confirmation	O
,	O
and	O
possible	O
autopsy	O
if	O
need	O
.	O

TITLE	O
:	O
Radiologic	O
manifestations	O
of	O
pulmonary	B-ANAT
tuberculosis	O
in	O
patients	O
of	O
intensive	O
care	O
units	O
.	O

ARDS	O
-	O
like	O
(	O
64	O
.	O
5	O
%)	O
manifestations	O
on	O
CT	O
and	O
miliary	O
TB	O
(	O
85	O
.	O
5	O
%)	O
had	O
the	O
highest	O
mortality	O
rates	O
among	O
other	O
pulmonary	B-ANAT
manifestations	O
.	O

Dexmedetomidine	O
as	O
a	O
secondary	O
sedative	O
usual	O
care	O
patients	O
(	O
n	O
=	O
280	O
;	O
23	O
%)	O
included	O
more	O
children	O
with	O
severe	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
organ	B-ANAT
failure	O
.	O

All	O
pigs	O
were	O
euthanized	O
7	O
days	O
after	O
challenge	O
exposure	O
;	O
fresh	B-ANAT
tissues	B-ANAT
were	O
collected	O
and	O
used	O
for	O
PCR	O
assay	O
,	O
histologic	O
examination	O
,	O
and	O
immunohistochemical	O
analysis	O
.	O

Survival	O
to	O
discharge	B-ANAT
was	O
100	O
%.	O

And	O
out	O
of	O
all	O
the	O
investigations	O
WBC	B-ANAT
,	O
neutrophil	B-ANAT
counts	O
,	O
AST	O
and	O
ALT	O
values	O
have	O
some	O
predictive	O
utility	O
.	O

These	O
findings	O
suggested	O
that	O
the	O
virus	O
had	O
a	O
strong	O
tropism	O
for	O
CNS	B-ANAT
,	O
in	O
this	O
way	O
,	O
inducing	O
nonsuppurative	O
encephalitis	O
as	O
the	O
cause	O
of	O
death	O
in	O
piglets	O
.	O

Twenty	O
-	O
four	O
hours	O
after	O
acute	O
respiratory	O
distress	O
syndrome	O
onset	O
,	O
the	O
presence	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
using	O
either	O
Berlin	O
or	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
)	O
was	O
associated	O
with	O
nearly	O
50	O
%	O
mortality	O
.	O

Herein	O
,	O
we	O
identified	O
a	O
novel	O
coronavirus	O
,	O
provisionally	O
designated	O
Rousettus	O
bat	O
coronavirus	O
GCCDC1	O
(	O
Ro	O
-	O
BatCoV	O
GCCDC1	O
),	O
in	O
the	O
rectal	B-ANAT
swab	I-ANAT
samples	O
of	O
Rousettus	O
leschenaulti	O
bats	O
by	O
using	O
pan	B-ANAT
-	O
coronavirus	O
RT	O
-	O
PCR	O
and	O
next	O
-	O
generation	O
sequencing	O
.	O

To	O
determine	O
whether	O
neutrophils	B-ANAT
influence	O
alveolar	B-ANAT
epithelial	O
repair	O
in	O
vivo	O
,	O
we	O
developed	O
a	O
unilateral	O
acid	O
injury	O
model	O
that	O
creates	O
a	O
severe	O
yet	O
survivable	O
injury	O
with	O
features	O
similar	O
to	O
ARDS	O
.	O

To	O
approach	O
the	O
mechanisms	O
,	O
we	O
employed	O
an	O
unbiased	O
protein	O
analysis	O
of	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
from	O
neutrophil	B-ANAT
-	O
depleted	O
and	O
neutrophil	B-ANAT
-	O
replete	O
mice	O
12	O
h	O
after	O
inducing	O
lung	B-ANAT
injury	O
.	O

Symptoms	O
include	O
sepsis	O
,	O
pain	O
,	O
and	O
/	O
or	O
swelling	O
in	O
the	O
throat	B-ANAT
or	O
neck	B-ANAT
,	O
as	O
well	O
as	O
respiratory	O
symptoms	O
.	O

Laboratory	O
findings	O
show	O
elevated	O
infectious	O
parameters	O
and	O
radiological	O
findings	O
show	O
thrombosis	O
of	O
the	O
internal	B-ANAT
jugular	I-ANAT
vein	I-ANAT
and	O
emboli	O
in	O
the	O
lungs	B-ANAT
or	O
other	O
organs	B-ANAT
.	O

Although	O
feces	B-ANAT
and	O
intestines	B-ANAT
collected	O
at	O
42	O
dpi	O
were	O
PEDV	O
negative	O
by	O
PCR	O
and	O
immunohistochemistry	O
,	O
respectively	O
,	O
small	B-ANAT
intestines	I-ANAT
from	O
70	O
%	O
of	O
group	O
A	O
pigs	O
were	O
PCR	O
positive	O
.	O

Markedly	O
elevated	O
serum	B-ANAT
ferritin	O
levels	O
(>	O
1	O
,	O
500	O
Âµg	O
/	O
ml	O
)	O
were	O
identified	O
in	O
all	O
patients	O
.	O

ABSTRACT	O
:	O
A	O
role	O
for	O
pulmonary	B-ANAT
endothelial	B-ANAT
cells	I-ANAT
in	O
the	O
orchestration	O
of	O
cytokine	O
production	O
and	O
leukocyte	B-ANAT
recruitment	O
during	O
influenza	O
virus	O
infection	O
,	O
leading	O
to	O
severe	O
lung	B-ANAT
damage	O
,	O
has	O
been	O
recently	O
identified	O
.	O

In	O
this	O
model	O
,	O
immune	O
-	O
mediated	O
demyelination	O
is	O
associated	O
with	O
induction	O
of	O
SR	O
T	B-ANAT
cells	I-ANAT
after	O
viral	O
control	O
.	O

Serum	B-ANAT
cytokine	O
and	O
chemokine	O
levels	O
in	O
serial	O
serum	B-ANAT
samples	O
were	O
measured	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

In	O
the	O
second	O
week	O
of	O
illness	O
,	O
the	O
severe	O
group	O
had	O
higher	O
serum	B-ANAT
levels	O
of	O
IL	O
-	O
6	O
(	O
54	O
vs	O
.	O
4	O
pg	O
/	O
mL	O
,	O
P	O
=	O
0	O
.	O
006	O
)	O
and	O
CXCL	O
-	O
10	O
(	O
2	O
,	O
642	O
vs	O
.	O
382	O
pg	O
/	O
mL	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Coronavirus	O
replication	O
is	O
known	O
to	O
affect	O
cellular	B-ANAT
translation	O
,	O
involving	O
activation	O
of	O
stress	O
-	O
induced	O
signaling	O
pathways	O
,	O
and	O
employing	O
viral	O
proteins	O
that	O
affect	O
cellular	B-ANAT
mRNA	O
translation	O
and	O
RNA	O
stability	O
.	O

We	O
also	O
review	O
the	O
current	O
classification	O
of	O
FCoVs	O
into	O
distinct	O
serotypes	O
and	O
biotypes	O
,	O
cellular	B-ANAT
receptors	O
of	O
FCoVs	O
and	O
their	O
presumed	O
role	O
in	O
viral	O
virulence	O
,	O
and	O
discuss	O
other	O
aspects	O
of	O
FIPV	O
-	O
induced	O
pathogenesis	O
.	O

TITLE	O
:	O
Prevalence	O
and	O
Risk	O
Factors	O
of	O
Respiratory	O
Viral	O
Infections	O
in	O
Exacerbations	O
of	O
Chronic	O
Obstructive	O
Pulmonary	B-ANAT
Disease	O
.	O

ABSTRACT	O
:	O
Airway	B-ANAT
obstruction	O
due	O
to	O
enlargement	O
of	O
tonsils	B-ANAT
and	I-ANAT
adenoids	I-ANAT
is	O
a	O
common	O
pediatric	O
problem	O
resulting	O
in	O
sleep	O
disordered	O
breathing	O
.	O

Viruses	O
were	O
detected	O
in	O
70	O
.	O
9	O
%	O
of	O
tonsils	B-ANAT
and	O
94	O
.	O
7	O
%	O
of	O
adenoids	B-ANAT
,	O
p	O
<	O
0	O
.	O
001	O
.	O

Many	O
enveloped	O
viruses	O
enter	O
cells	B-ANAT
through	O
endocytosis	O
.	O

They	O
were	O
also	O
significantly	O
higher	O
in	O
patients	O
with	O
versus	O
without	O
organ	B-ANAT
failure	O
(	O
p	O
<	O
0	O
.	O
05	O
for	O
all	O
).	O

The	O
Î±1	O
-	O
microglobulin	O
/	O
creatinine	O
ratio	O
upon	O
admission	O
predicted	O
organ	B-ANAT
failure	O
[	O
adjusted	O
odds	O
ratio	O
1	O
.	O
286	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
1	O
.	O
024	O
-	O
1	O
.	O
614	O
]	O
with	O
similar	O
accuracy	O
(	O
AUROC	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
0	O
.	O
69	O
-	O
0	O
.	O
94	O
)	O
as	O
the	O
more	O
complex	O
APACHE	O
II	O
score	O
(	O
AUROC	O
0	O
.	O
86	O
,	O
95	O
%	O
CI	O
0	O
.	O
70	O
-	O
1	O
.	O
00	O
).	O

ABSTRACT	O
:	O
Gastroenteritis	O
represents	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
the	O
most	O
common	O
infectious	O
disease	O
syndrome	O
of	O
humans	O
in	O
developing	O
countries	O
.	O

This	O
study	O
suggests	O
that	O
the	O
demonstrated	O
T	B-ANAT
lymphocyte	I-ANAT
activation	O
is	O
in	O
part	O
due	O
to	O
antigen	O
presentation	O
by	O
the	O
macrophages	B-ANAT
as	O
well	O
as	O
cytokine	O
release	O
by	O
the	O
infected	O
macrophages	B-ANAT
,	O
with	O
B2	O
haplotypes	O
showing	O
stronger	O
activation	O
.	O

Insights	O
from	O
the	O
LUNG	B-ANAT
SAFE	O
Study	O
.	O

Non	O
-	O
modifiable	O
factors	O
associated	O
with	O
worsened	O
outcome	O
from	O
ARDS	O
included	O
older	O
age	O
,	O
active	O
neoplasm	O
,	O
hematologic	O
neoplasm	O
,	O
and	O
chronic	O
liver	B-ANAT
failure	O
.	O

In	O
endemic	O
areas	O
,	O
good	O
understanding	O
and	O
familiarity	O
with	O
the	O
various	O
radiologic	O
findings	O
of	O
scrub	O
typhus	O
are	O
essential	O
in	O
identifying	O
pulmonary	B-ANAT
complications	O
.	O

Patients	O
admitted	O
to	O
a	O
tertiary	O
care	O
center	O
with	O
scrub	O
typhus	O
between	O
October	O
2012	O
and	O
September	O
2013	O
and	O
had	O
a	O
chest	B-ANAT
X	O
ray	O
done	O
were	O
included	O
in	O
the	O
analysis	O
.	O

Almost	O
half	O
of	O
the	O
patients	O
(	O
49	O
.	O
4	O
%)	O
had	O
normal	O
chest	B-ANAT
radiographs	O
.	O

Patients	O
with	O
an	O
abnormal	O
chest	B-ANAT
X	O
-	O
ray	O
had	O
a	O
higher	O
requirement	O
of	O
noninvasive	O
ventilation	O
(	O
odds	O
ratio	O
[	O
OR	O
]:	O
13	O
.	O
98	O
;	O
95	O
%	O
confidence	O
interval	O
CI	O
:	O
5	O
.	O
89	O
-	O
33	O
.	O
16	O
),	O
invasive	O
ventilation	O
(	O
OR	O
:	O
18	O
.	O
07	O
;	O
95	O
%	O
CI	O
:	O
6	O
.	O
42	O
-	O
50	O
.	O
88	O
),	O
inotropes	O
(	O
OR	O
:	O
8	O
.	O
76	O
;	O
95	O
%	O
CI	O
:	O
4	O
.	O
35	O
-	O
17	O
.	O
62	O
),	O
higher	O
involvement	O
of	O
other	O
organ	B-ANAT
systems	I-ANAT
,	O
longer	O
duration	O
of	O
hospital	O
stay	O
(	O
3	O
.	O
18	O
Â±	O
3	O
vs	O
.	O
7	O
.	O
27	O
Â±	O
5	O
.	O
58	O
days	O
;	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
higher	O
mortality	O
(	O
OR	O
:	O
4	O
.	O
63	O
;	O
95	O
%	O
CI	O
:	O
1	O
.	O
54	O
-	O
13	O
.	O
85	O
).	O

CONCLUSIONS	O
:	O
Almost	O
half	O
of	O
the	O
patients	O
with	O
scrub	O
typhus	O
have	O
abnormal	O
chest	B-ANAT
radiographs	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
characterized	O
by	O
inflammatory	O
injury	O
to	O
the	O
alveolar	B-ANAT
and	O
capillary	B-ANAT
barriers	O
that	O
results	O
in	O
impaired	O
gas	O
exchange	O
and	O
severe	O
acute	O
respiratory	O
failure	O
.	O

These	O
results	O
indicated	O
that	O
Nur77	O
decreases	O
ET	O
-	O
1	O
expression	O
by	O
suppressing	O
NF	O
-	O
ÎºB	O
and	O
p38	O
MAPK	O
in	O
LPS	O
-	O
stimulated	O
A549	O
cells	B-ANAT
in	O
vitro	O
,	O
and	O
,	O
in	O
an	O
LPS	O
-	O
induced	O
ARDS	O
rat	O
model	O
,	O
CsnB	O
reduced	O
ET	O
-	O
1	O
expression	O
and	O
lung	B-ANAT
injury	O
in	O
ARDS	O
rats	O
.	O

ABSTRACT	O
:	O
Hemolytic	O
uremic	O
syndrome	O
(	O
HUS	O
)	O
is	O
a	O
thrombotic	O
microangiopathy	O
defined	O
by	O
thrombocytopenia	O
,	O
non	O
-	O
immune	O
microangiopathic	O
hemolytic	O
anemia	O
and	O
acute	O
renal	B-ANAT
failure	O
.	O

For	O
the	O
aHUS	O
the	O
initial	O
management	O
is	O
supportive	O
and	O
similar	O
to	O
the	O
approach	O
for	O
STEC	O
-	O
HUS	O
;	O
currently	O
we	O
have	O
moved	O
from	O
the	O
historic	O
plasma	B-ANAT
therapy	O
to	O
new	O
therapeutic	O
approaches	O
,	O
first	O
of	O
all	O
eculizumab	O
,	O
a	O
monoclonal	O
antibody	O
that	O
blocks	O
the	O
C5	O
cascade	O
.	O

The	O
development	O
of	O
new	O
,	O
more	O
effective	O
vaccines	O
has	O
been	O
hampered	O
by	O
difficulties	O
in	O
isolating	O
strains	O
and	O
viral	B-ANAT
genome	I-ANAT
manipulation	O
.	O

TITLE	O
:	O
Amiodarone	O
-	O
Induced	O
Pulmonary	B-ANAT
Toxicity	O
-	O
A	O
Frequently	O
Missed	O
Complication	O
.	O

Several	O
pulmonary	B-ANAT
diseases	O
can	O
manifest	O
including	O
interstitial	B-ANAT
pneumonitis	O
,	O
organizing	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
,	O
pulmonary	B-ANAT
nodules	B-ANAT
or	O
masses	O
,	O
and	O
pleural	B-ANAT
effusion	I-ANAT
.	O

APT	O
occurs	O
via	O
cytotoxic	B-ANAT
T	I-ANAT
cells	I-ANAT
and	O
indirectly	O
by	O
immunological	O
reaction	O
.	O

Infiltrates	O
with	O
a	O
'	O
ground	O
-	O
glass	O
'	O
appearance	O
appreciated	O
on	O
HRCT	O
are	O
more	O
definitive	O
than	O
chest	B-ANAT
x	O
-	O
ray	O
.	O

Pulmonary	B-ANAT
nodules	B-ANAT
can	O
be	O
seen	O
,	O
frequently	O
in	O
the	O
upper	O
lobes	B-ANAT
.	O

Mycobacterial	O
liquid	O
culture	O
and	O
Xpert	O
MTB	B-ANAT
/	O
RIF	O
was	O
performed	O
on	O
2	O
induced	O
sputa	O
obtained	O
from	O
each	O
participant	O
.	O

Ventilation	O
with	O
low	O
tidal	O
volumes	O
and	O
pressure	O
limitation	O
at	O
30cmH	O
Demographic	O
data	O
,	O
risk	O
factors	O
and	O
severity	O
of	O
ARDS	O
,	O
APACHE	O
II	O
and	O
SOFA	O
scores	O
,	O
daily	O
Lung	B-ANAT
Injury	O
Score	O
,	O
ventilatory	O
measurements	O
,	O
ICU	O
and	O
hospital	O
stay	O
,	O
organ	B-ANAT
failure	O
and	O
mortality	O
at	O
day	O
28	O
and	O
90	O
after	O
inclusion	O
.	O

The	O
median	O
lung	B-ANAT
injury	O
score	O
was	O
9	O
(	O
8	O
-	O
10	O
).	O

Regional	O
analysis	O
showed	O
a	O
homogeneous	O
time	O
course	O
of	O
lung	B-ANAT
inflation	O
during	O
inspiration	O
,	O
indicating	O
no	O
tendency	O
to	O
atelectasis	O
after	O
the	O
introduction	O
of	O
NMB	O
.	O

NMB	O
decreased	O
the	O
mean	O
airway	B-ANAT
pressure	O
(	O
p	O
=	O
0	O
.	O
039	O
)	O
and	O
OI	O
(	O
p	O
=	O
0	O
.	O
039	O
)	O
in	O
all	O
patients	O
.	O

Upon	O
detecting	O
viral	O
dsRNA	O
,	O
PKR	O
phosphorylates	O
eIF2Î±	O
,	O
leading	O
to	O
the	O
inhibition	O
of	O
cellular	B-ANAT
and	O
viral	O
translation	O
and	O
the	O
formation	O
of	O
stress	O
granules	O
(	O
SGs	O
),	O
which	O
are	O
increasingly	O
recognized	O
as	O
platforms	O
for	O
antiviral	O
signaling	O
pathways	O
.	O

Additionally	O
,	O
infections	O
with	O
typical	O
bacteria	O
were	O
more	O
common	O
in	O
patients	O
with	O
chronic	O
lung	B-ANAT
disease	O
(	O
p	O
=	O
0	O
.	O
029	O
),	O
and	O
typical	O
bacterial	O
infections	O
showed	O
a	O
trend	O
towards	O
a	O
higher	O
prevalence	O
with	O
older	O
age	O
(	O
p	O
=	O
0	O
.	O
001	O
).	O

Additionally	O
,	O
infections	O
with	O
typical	O
bacteria	O
were	O
more	O
common	O
in	O
patients	O
with	O
chronic	O
lung	B-ANAT
disease	O
(	O
p	O
=	O
0	O
.	O
029	O
),	O
and	O
typical	O
bacterial	O
infections	O
showed	O
a	O
trend	O
towards	O
a	O
higher	O
prevalence	O
with	O
older	O
age	O
(	O
p	O
=	O
0	O
.	O
001	O
).	O

These	O
mutations	O
severely	O
compromised	O
MERS	O
-	O
CoV	O
infection	O
into	O
human	O
lung	B-ANAT
-	O
derived	O
cells	B-ANAT
,	O
but	O
had	O
little	O
effect	O
on	O
infection	O
into	O
several	O
other	O
cell	B-ANAT
types	O
.	O

Given	O
that	O
the	O
strain	O
OC43	O
is	O
neurovirulent	O
in	O
mice	O
and	O
induces	O
neuronal	O
cell	B-ANAT
death	O
,	O
we	O
explored	O
the	O
neuronal	O
response	O
to	O
infection	O
by	O
characterizing	O
the	O
activation	O
of	O
RCD	O
.	O

Our	O
results	O
revealed	O
that	O
classical	O
apoptosis	O
associated	O
with	O
the	O
Bax	O
protein	O
does	O
not	O
play	O
a	O
significant	O
role	O
in	O
HCoV	O
-	O
OC43	O
-	O
induced	O
neuronal	O
cell	B-ANAT
death	O
and	O
that	O
RIP1	O
and	O
MLKL	O
,	O
two	O
cellular	B-ANAT
proteins	O
usually	O
associated	O
with	O
necroptosis	O
(	O
an	O
RCD	O
back	B-ANAT
-	O
up	O
system	O
when	O
apoptosis	O
is	O
not	O
adequately	O
induced	O
),	O
both	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
process	O
.	O

Aiming	O
for	O
the	O
establishment	O
of	O
baseline	O
data	O
on	O
the	O
presence	O
of	O
potential	O
pathogens	O
in	O
this	O
species	O
,	O
a	O
comprehensive	O
health	O
assessment	O
(	O
blood	B-ANAT
smear	O
examination	O
,	O
haematology	O
,	O
biochemistry	O
and	O
serology	O
)	O
was	O
conducted	O
on	O
samples	O
obtained	O
from	O
578	O
African	O
penguins	O
at	O
11	O
breeding	O
colonies	O
and	O
a	O
rehabilitation	O
centre	O
.	O

Babesia	O
-	O
infected	O
individuals	O
had	O
a	O
regenerative	O
response	O
of	O
the	O
erythrocytic	B-ANAT
lineage	O
,	O
an	O
active	O
inflammatory	O
response	O
and	O
hepatic	B-ANAT
function	O
impairment	O
.	O

TITLE	O
:	O
Lung	B-ANAT
remodeling	O
associated	O
with	O
recovery	O
from	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
critical	O
pathophysiological	O
processes	O
in	O
ARDS	O
are	O
alveolar	B-ANAT
barrier	O
dysfunction	O
and	O
overwhelming	O
inflammation	O
.	O

We	O
found	O
that	O
regions	O
of	O
intrinsic	O
disorder	O
are	O
rarely	O
conserved	O
among	O
different	O
coronavirus	O
protein	O
families	O
,	O
with	O
the	O
primary	O
exception	O
of	O
the	O
nucleocapsid	B-ANAT
.	O

In	O
screening	O
children	O
with	O
acute	O
undifferentiated	O
febrile	O
illness	O
in	O
a	O
school	O
cohort	O
in	O
rural	O
Haiti	O
,	O
we	O
identified	O
HCoV	O
-	O
NL63	O
in	O
blood	B-ANAT
samples	I-ANAT
from	O
four	O
children	O
.	O

TITLE	O
:	O
Molecular	O
Detection	O
of	O
Circovirus	O
and	O
Adenovirus	O
in	O
Feces	B-ANAT
of	O
Fur	O
Seals	O
(	O
Arctocephalus	O
spp	O
.).	O

The	O
Mirasol	O
Pathogen	O
Reduction	O
Technology	O
System	O
uses	O
riboflavin	O
and	O
ultraviolet	O
(	O
UV	O
)	O
light	O
to	O
render	O
blood	B-ANAT
-	O
borne	O
pathogens	O
noninfectious	O
while	O
maintaining	O
blood	B-ANAT
product	O
quality	O
.	O

Here	O
,	O
we	O
report	O
on	O
the	O
efficacy	O
of	O
riboflavin	O
and	O
UV	O
light	O
against	O
MERS	O
-	O
CoV	O
when	O
tested	O
in	O
human	O
plasma	B-ANAT
.	O

The	O
infectious	O
titers	O
of	O
MERS	O
-	O
CoV	O
in	O
the	O
samples	O
before	O
and	O
after	O
treatment	O
were	O
determined	O
by	O
plaque	O
assay	O
on	O
Vero	B-ANAT
cells	I-ANAT
.	O

The	O
mean	O
log	O
reductions	O
in	O
the	O
viral	O
titers	O
were	O
â¥	O
4	O
.	O
07	O
and	O
â¥	O
4	O
.	O
42	O
for	O
the	O
pooled	O
and	O
individual	O
donor	O
plasma	B-ANAT
,	O
respectively	O
.	O

CONCLUSIONS	O
:	O
Riboflavin	O
and	O
UV	O
light	O
effectively	O
reduced	O
the	O
titer	O
of	O
MERS	O
-	O
CoV	O
in	O
human	O
plasma	B-ANAT
products	I-ANAT
to	O
below	O
the	O
limit	O
of	O
detection	O
,	O
suggesting	O
that	O
the	O
treatment	O
process	O
may	O
reduce	O
the	O
risk	O
of	O
transfusion	O
transmission	O
of	O
MERS	O
-	O
CoV	O
.	O

As	O
blood	B-ANAT
contact	O
with	O
the	O
membrane	B-ANAT
oxygenator	O
surface	O
leads	O
to	O
adverse	O
effects	O
due	O
to	O
insufficient	O
biocompatibility	O
partly	O
caused	O
by	O
activation	O
of	O
platelets	B-ANAT
,	O
coagulation	O
factors	O
and	O
leucocytes	B-ANAT
,	O
we	O
hypothesized	O
that	O
these	O
adverse	O
effects	O
would	O
be	O
amplified	O
if	O
septic	O
blood	B-ANAT
in	O
a	O
preactivated	O
state	O
came	O
into	O
contact	O
with	O
the	O
membrane	B-ANAT
oxygenator	O
.	O

At	O
the	O
beginning	O
of	O
the	O
mock	O
loop	O
experiments	O
,	O
the	O
septic	O
blood	B-ANAT
showed	O
significantly	O
increased	O
thrombin	O
-	O
antithrombin	O
complexes	O
(	O
76	O
.	O
9	O
vs	O
27	O
.	O
7	O
Âµg	O
/	O
l	O
),	O
D	O
-	O
dimers	O
(	O
1	O
.	O
2	O
vs	O
0	O
.	O
3	O
mg	O
/	O
l	O
)	O
and	O
fibrinogen	B-ANAT
concentration	O
(	O
1	O
.	O
8	O
vs	O
1	O
.	O
5	O
g	O
/	O
l	O
),	O
as	O
well	O
as	O
elevated	O
extrinsic	O
coagulation	O
activity	O
(	O
shorter	O
EXTEM	O
-	O
CT	O
:	O
44	O
.	O
2	O
vs	O
57	O
s	O
)	O
and	O
higher	O
lactate	O
(	O
3	O
.	O
4	O
vs	O
1	O
.	O
5	O
mmol	O
/	O
l	O
)	O
and	O
cytokine	O
levels	O
(	O
interleukin	O
-	O
6	O
:	O
827	O
vs	O
31	O
pg	O
/	O
ml	O
)	O
when	O
compared	O
with	O
the	O
blood	B-ANAT
from	O
healthy	O
animals	O
.	O

Intense	O
research	O
efforts	O
are	O
now	O
focusing	O
on	O
defining	O
viral	O
characteristics	O
that	O
confer	O
a	O
growth	O
advantage	O
,	O
pathogenicity	O
,	O
or	O
cell	B-ANAT
adaptability	O
in	O
order	O
to	O
better	O
understand	O
the	O
PEDV	O
life	O
cycle	O
and	O
identify	O
suitable	O
targets	O
for	O
antiviral	O
or	O
vaccine	O
development	O
.	O

GILZ	O
was	O
expressed	O
in	O
about	O
Â¾	O
of	O
the	O
corticosteroid	O
-	O
treated	O
patients	O
and	O
its	O
expression	O
could	O
also	O
occur	O
independently	O
of	O
corticosteroids	O
,	O
suggesting	O
that	O
inflammatory	O
signals	O
may	O
also	O
induce	O
neutrophil	B-ANAT
GILZ	O
expression	O
in	O
vivo	O
.	O

GILZ	O
was	O
expressed	O
in	O
about	O
Â¾	O
of	O
the	O
corticosteroid	O
-	O
treated	O
patients	O
and	O
its	O
expression	O
could	O
also	O
occur	O
independently	O
of	O
corticosteroids	O
,	O
suggesting	O
that	O
inflammatory	O
signals	O
may	O
also	O
induce	O
neutrophil	B-ANAT
GILZ	O
expression	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Hyponatremia	O
is	O
commonly	O
noted	O
with	O
cardiovascular	B-ANAT
disorders	O
,	O
but	O
its	O
role	O
in	O
infective	O
endocarditis	O
(	O
IE	O
)	O
is	O
limited	O
to	O
being	O
a	O
marker	O
of	O
increased	O
morbidity	O
in	O
IE	O
patients	O
with	O
intravenous	O
drug	O
use	O
.	O

An	O
increase	O
in	O
the	O
post	O
-	O
LPS	O
inflammatory	O
cytokine	O
mRNA	O
levels	O
coincided	O
with	O
the	O
in	O
vivo	O
neutrophil	B-ANAT
aggregation	O
in	O
the	O
swim	O
bladder	B-ANAT
.	O

Blood	B-ANAT
and	O
bronchial	B-ANAT
alveolar	I-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BAL	O
)	O
from	O
humans	O
(	O
n	O
=	O
10	O
-	O
13	O
)	O
with	O
ARDS	O
and	O
controls	O
(	O
n	O
=	O
5	O
-	O
10	O
)	O
as	O
well	O
as	O
a	O
murine	O
model	O
of	O
ARDS	O
(	O
n	O
=	O
5	O
-	O
6	O
)	O
with	O
controls	O
(	O
n	O
=	O
6	O
-	O
7	O
)	O
were	O
studied	O
.	O

BAL	O
fluid	O
from	O
mice	O
with	O
ARDS	O
dampens	O
the	O
TNF	O
-	O
Î±	O
production	O
compared	O
to	O
cells	B-ANAT
cultured	I-ANAT
with	O
BAL	O
lacking	O
sPD	O
-	O
1	O
(	O
2	O
.	O
7	O
pg	O
/	O
mL	O
(	O
SD	O
3	O
.	O
8	O
)	O
vs	O
.	O
52	O
.	O
38	O
pg	O
/	O
mL	O
(	O
SD	O
25	O
.	O
1	O
),	O
p	O
=	O
0	O
.	O
002	O
).	O

The	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
)	O
is	O
the	O
associated	O
histological	O
pattern	O
and	O
the	O
most	O
severe	O
end	O
-	O
stage	O
of	O
the	O
disease	O
.	O

TITLE	O
:	O
Alisporivir	O
inhibits	O
MERS	O
-	O
and	O
SARS	O
-	O
coronavirus	O
replication	O
in	O
cell	B-ANAT
culture	O
,	O
but	O
not	O
SARS	O
-	O
coronavirus	O
infection	O
in	O
a	O
mouse	O
model	O
.	O

Emergent	O
coronary	B-ANAT
artery	I-ANAT
surgery	O
was	O
planned	O
,	O
but	O
the	O
platelet	B-ANAT
count	O
before	O
surgery	O
was	O
2	O
K	O
/	O
uL	O
.	O
Eptifibatide	O
was	O
discontinued	O
,	O
surgery	O
was	O
postponed	O
,	O
and	O
acute	O
coronary	B-ANAT
syndrome	O
was	O
treated	O
with	O
intraaortic	O
balloon	O
counterpulsation	O
.	O

For	O
every	O
centimeter	O
H	O
Our	O
results	O
suggest	O
that	O
PEEP	O
can	O
be	O
applied	O
safely	O
in	O
patients	O
with	O
acute	O
brain	B-ANAT
injury	O
as	O
it	O
does	O
not	O
have	O
a	O
clinically	O
significant	O
effect	O
on	O
ICP	O
or	O
CPP	O
.	O

METHODS	O
:	O
Retrospective	O
data	O
were	O
collected	O
from	O
341	O
patients	O
with	O
severe	O
acute	O
brain	B-ANAT
injury	O
admitted	O
to	O
the	O
ICU	O
between	O
2008	O
and	O
2015	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
is	O
a	O
coronavirus	O
that	O
causes	O
villus	B-ANAT
atrophy	O
,	O
followed	O
by	O
crypt	B-ANAT
hyperplasia	O
,	O
reduces	O
the	O
activities	O
of	O
intestinal	B-ANAT
digestive	O
enzymes	O
,	O
and	O
disrupts	O
the	O
absorption	O
of	O
intestinal	B-ANAT
nutrients	O
.	O

There	O
are	O
concerns	O
that	O
the	O
use	O
of	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
in	O
patients	O
with	O
brain	B-ANAT
injury	O
may	O
potentially	O
elevate	O
intracranial	B-ANAT
pressure	O
(	O
ICP	O
).	O

This	O
study	O
is	O
a	O
prospective	O
,	O
single	O
-	O
centre	O
,	O
physiological	O
study	O
in	O
patients	O
with	O
severe	O
brain	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
porcine	O
islets	O
to	O
replace	O
insulin	O
-	O
producing	O
islet	O
Î²	O
-	O
cells	B-ANAT
,	O
destroyed	O
during	O
the	O
diabetogenic	O
disease	O
process	O
,	O
presents	O
distinct	O
challenges	O
if	O
this	O
option	O
is	O
to	O
become	O
a	O
therapeutic	O
reality	O
for	O
the	O
treatment	O
of	O
type	O
1	O
diabetes	O
.	O

The	O
results	O
do	O
not	O
differ	O
much	O
in	O
immunocompetent	O
patients	O
supported	O
by	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

ABSTRACT	O
:	O
CHARGE	O
(	O
coloboma	O
,	O
heart	B-ANAT
defect	O
,	O
atresia	O
choanae	B-ANAT
,	O
retarded	O
growth	O
and	O
development	O
,	O
genital	B-ANAT
hypoplasia	O
,	O
and	O
ear	B-ANAT
anomalies	O
/	O
deafness	O
)	O
syndrome	O
is	O
a	O
rare	O
genetic	O
disorder	O
caused	O
by	O
CHD7	O
mutation	O
and	O
is	O
related	O
to	O
immunodeficiency	O
.	O

Animal	O
challenge	O
experiments	O
exhibited	O
strong	O
respiratory	O
and	O
renal	B-ANAT
pathogenicity	O
for	O
3575	O
/	O
08	O
.	O

In	O
acute	O
asthma	O
,	O
IL	O
-	O
17	O
expression	O
,	O
like	O
most	O
other	O
clinical	O
measures	O
,	O
was	O
similar	O
among	O
lean	O
,	O
overweight	O
and	O
obese	O
groups	O
,	O
but	O
was	O
higher	O
in	O
acute	O
versus	O
stable	O
asthma	O
subjects	O
,	O
with	O
sputum	B-ANAT
IL	O
-	O
17	O
correlating	O
positively	O
with	O
sputum	B-ANAT
neutrophils	B-ANAT
and	O
negatively	O
with	O
FEV	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
a	O
highly	O
lethal	O
pulmonary	B-ANAT
infection	O
caused	O
by	O
a	O
coronavirus	O
(	O
CoV	O
),	O
MERS	O
-	O
CoV	O
.	O
With	O
the	O
continuing	O
spread	O
of	O
MERS	O
-	O
CoV	O
,	O
prophylactic	O
and	O
therapeutic	O
treatments	O
are	O
urgently	O
needed	O
.	O

ABSTRACT	O
:	O
Viral	B-ANAT
membrane	I-ANAT
fusion	O
is	O
an	O
orchestrated	O
process	O
triggered	O
by	O
membrane	B-ANAT
-	O
anchored	O
viral	O
fusion	O
glycoproteins	O
.	O

DSC	O
data	O
showed	O
the	O
peptides	O
strongly	O
perturb	O
the	O
structural	O
integrity	O
of	O
anionic	O
vesicles	B-ANAT
and	O
support	O
the	O
hypothesis	O
that	O
the	O
peptides	O
generate	O
opposing	O
curvature	O
stresses	O
on	O
phosphatidylethanolamine	O
membranes	B-ANAT
.	O

Serial	O
MERS	O
-	O
CoV	O
passage	O
in	O
these	O
engineered	O
mice	O
was	O
then	O
used	O
to	O
generate	O
a	O
mouse	O
-	O
adapted	O
virus	O
that	O
replicated	O
efficiently	O
within	O
the	O
lungs	B-ANAT
and	O
evoked	O
symptoms	O
indicative	O
of	O
severe	O
ARDS	O
,	O
including	O
decreased	O
survival	O
,	O
extreme	O
weight	O
loss	O
,	O
decreased	O
pulmonary	B-ANAT
function	O
,	O
pulmonary	B-ANAT
haemorrhage	O
and	O
pathological	O
signs	O
indicative	O
of	O
end	O
-	O
stage	O
lung	B-ANAT
disease	O
.	O

According	O
to	O
the	O
ratio	O
of	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
P	O
/	O
F	O
ratio	O
)	O
at	O
7	O
days	O
,	O
patients	O
were	O
classified	O
into	O
PPP	O
-	O
positive	O
(	O
P	O
/	O
F	O
ratio	O
>	O
300	O
)	O
and	O
PPP	O
-	O
negative	O
groups	O
;	O
also	O
,	O
the	O
patients	O
were	O
classified	O
into	O
survival	O
and	O
nonsurvival	O
groups	O
according	O
to	O
28	O
-	O
day	O
mortality	O
.	O

As	O
an	O
alternative	O
to	O
chicks	O
,	O
this	O
study	O
used	O
an	O
in	O
vitro	O
infection	O
model	O
to	O
identify	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
within	O
the	O
part	O
-	O
S1	O
gene	O
of	O
two	O
live	O
infectious	O
bronchitis	O
virus	O
vaccine	O
strains	O
(	O
793B	O
and	O
Massachusetts	O
)	O
following	O
single	O
or	O
dual	O
inoculation	O
onto	O
tracheal	O
organ	B-ANAT
cultures	O
.	O

The	O
Hemolung	O
is	O
a	O
new	O
,	O
low	O
-	O
flow	O
,	O
venovenous	O
,	O
minimally	O
invasive	O
,	O
partial	O
ECCOR	O
device	O
that	O
has	O
recently	O
been	O
introduced	O
to	O
clinical	O
practice	O
to	O
aid	O
in	O
avoiding	O
invasive	O
ventilation	O
or	O
to	O
facilitate	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

In	O
the	O
remaining	O
10	O
patients	O
,	O
the	O
strategy	O
of	O
instituting	O
lung	B-ANAT
-	O
protective	O
ventilation	O
was	O
successful	O
.	O

Pooled	O
data	O
from	O
clinical	O
trials	O
have	O
signaled	O
a	O
renal	B-ANAT
safety	O
warning	O
for	O
iNO	O
therapy	O
,	O
but	O
the	O
significance	O
of	O
these	O
findings	O
in	O
daily	O
clinical	O
practice	O
is	O
unclear	O
.	O

ABSTRACT	O
:	O
The	O
coordinated	O
recognition	O
of	O
virus	O
-	O
derived	O
T	B-ANAT
cell	I-ANAT
epitopes	O
and	O
MHC	B-ANAT
molecules	O
by	O
T	B-ANAT
cells	I-ANAT
plays	O
a	O
pivotal	O
role	O
in	O
cellular	B-ANAT
immunity	O
-	O
mediated	O
virus	O
clearance	O
.	O

ABSTRACT	O
:	O
Bronchitis	O
is	O
a	O
common	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
of	O
humans	O
mainly	O
caused	O
by	O
influenza	O
virus	O
,	O
rhinovirus	O
,	O
adenovirus	O
,	O
coronavirus	O
and	O
respiratory	O
syncytial	O
virus	O
.	O

Cholinesterase	O
inhibitors	O
should	O
be	O
discontinued	O
,	O
but	O
resumed	O
prior	O
to	O
extubation	O
,	O
and	O
steroid	O
dosage	O
could	O
be	O
increased	O
once	O
the	O
airway	B-ANAT
is	O
secured	O
.	O

Here	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
treatment	O
on	O
the	O
formation	O
of	O
arterivirus	O
-	O
induced	O
membrane	B-ANAT
structures	O
.	O

Strikingly	O
,	O
we	O
also	O
observed	O
abundant	O
stretches	O
of	O
double	O
-	O
membrane	B-ANAT
sheets	O
(	O
a	O
proposed	O
intermediate	O
of	O
DMV	O
formation	O
)	O
in	O
IFN	O
-	O
Î²	O
-	O
treated	O
samples	O
,	O
suggesting	O
the	O
disruption	O
of	O
DMV	O
biogenesis	O
.	O

Three	O
interferon	O
-	O
stimulated	O
gene	O
products	O
,	O
two	O
of	O
which	O
have	O
been	O
reported	O
to	O
target	O
the	O
hepatitis	O
C	O
virus	O
replication	O
structures	O
,	O
were	O
tested	O
for	O
their	O
possible	O
involvement	O
,	O
but	O
none	O
of	O
them	O
affected	O
membrane	B-ANAT
structure	I-ANAT
formation	O
.	O

We	O
also	O
observed	O
that	O
the	O
parasites	O
Plasmodium	O
falciparum	O
and	O
PbA	O
induced	O
the	O
formation	O
of	O
neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
(	O
NETs	O
)	O
ex	O
vivo	O
,	O
which	O
were	O
associated	O
with	O
inflammation	O
and	O
tissue	B-ANAT
injury	O
.	O

Real	O
-	O
time	O
PCR	O
results	O
demonstrated	O
variant	O
-	O
2	O
tropism	O
for	O
respiratory	B-ANAT
tract	I-ANAT
,	O
digestive	B-ANAT
system	I-ANAT
and	O
renal	B-ANAT
tissue	I-ANAT
that	O
is	O
due	O
to	O
its	O
epitheliotropic	O
nature	O
.	O

Seventeen	O
patients	O
with	O
genetically	O
proven	O
late	O
-	O
onset	O
Pompe	O
disease	O
(	O
50	O
Â±	O
18	O
years	O
,	O
11	O
male	O
)	O
and	O
18	O
age	O
-	O
and	O
gender	O
-	O
matched	O
healthy	O
controls	O
(	O
44	O
Â±	O
10	O
year	O
,	O
12	O
male	O
)	O
underwent	O
comprehensive	O
cardiovascular	B-ANAT
magnetic	O
resonance	O
(	O
CMR	O
)	O
including	O
conventional	O
and	O
advanced	O
techniques	O
:	O
cine	O
and	O
feature	O
tracking	O
-	O
based	O
strain	O
imaging	O
for	O
depiction	O
of	O
(	O
even	O
subtle	O
)	O
systolic	O
LV	O
dysfunction	O
as	O
well	O
as	O
late	O
gadolinium	O
enhancement	O
(	O
LGE	O
)	O
and	O
myocardial	O
extracellular	B-ANAT
volume	O
fraction	O
(	O
ECV	O
)	O
quantification	O
for	O
focal	O
and	O
diffuse	O
fibrosis	O
detection	O
.	O

All	O
patients	O
had	O
normal	O
left	O
ventricular	B-ANAT
(	O
LV	B-ANAT
)	O
and	O
right	O
ventricular	B-ANAT
(	O
RV	B-ANAT
)	O
volumes	O
and	O
normal	O
LV	B-ANAT
and	O
RV	B-ANAT
ejection	O
fraction	O
.	O

The	O
observed	O
structural	O
abnormalities	O
seem	O
to	O
result	O
from	O
an	O
interplay	O
between	O
the	O
storage	B-ANAT
disease	O
and	O
other	O
comorbidities	O
and	O
they	O
did	O
not	O
affect	O
short	O
-	O
term	O
to	O
mid	O
-	O
term	O
prognosis	O
in	O
adult	O
Pompe	O
patients	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
ability	O
of	O
five	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISAs	O
)	O
to	O
detect	O
antibodies	O
against	O
different	O
PEDV	O
strains	O
in	O
pig	O
serum	B-ANAT
.	O

Cells	B-ANAT
with	O
the	O
phenotype	O
,	O
morphology	O
and	O
functional	O
features	O
of	O
monocyte	B-ANAT
-	O
derived	O
DC	O
,	O
bona	O
fide	O
DC	O
or	O
macrophages	B-ANAT
were	O
obtained	O
in	O
GM	O
-	O
CSF	B-ANAT
/	O
IL4	O
,	O
FLT3L	O
or	O
CSF	B-ANAT
-	O
1	O
cultures	O
,	O
respectively	O
.	O

TITLE	O
:	O
Inter	O
-	O
laboratory	O
study	O
to	O
characterize	O
the	O
detection	O
of	O
serum	B-ANAT
antibodies	O
against	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
.	O

Pregnant	O
multiparous	O
sows	O
and	O
their	O
litters	O
were	O
allocated	O
to	O
one	O
of	O
3	O
treatment	O
groups	O
:	O
Group	O
1	O
-	O
6	O
serum	B-ANAT
antibody	O
-	O
negative	O
sows	O
and	O
a	O
subset	O
(	O
n	O
=	O
11	O
)	O
of	O
their	O
piglets	O
.	O

Piglets	O
were	O
monitored	O
daily	O
for	O
clinical	O
signs	O
,	O
body	B-ANAT
weight	O
,	O
and	O
body	B-ANAT
temperature	O
through	O
day	O
post	O
-	O
inoculation	O
(	O
DPI	O
)	O
12	O
(	O
Groups	O
2	O
and	O
3	O
)	O
or	O
14	O
(	O
Group	O
1	O
).	O

Our	O
aim	O
was	O
to	O
investigate	O
the	O
relationships	O
between	O
ARDS	O
diagnosis	O
and	O
plasma	B-ANAT
concentrations	O
of	O
tissue	B-ANAT
factor	O
(	O
TF	O
),	O
tissue	B-ANAT
plasminogen	O
activator	O
(	O
t	O
-	O
PA	O
),	O
and	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
)	O
in	O
mechanically	O
ventilated	O
patients	O
at	O
increased	O
risk	O
of	O
developing	O
ARDS	O
.	O

TITLE	O
:	O
Channel	O
-	O
Inactivating	O
Mutations	O
and	O
Their	O
Revertant	O
Mutants	O
in	O
the	O
Envelope	B-ANAT
Protein	O
of	O
Infectious	O
Bronchitis	O
Virus	O
.	O

TITLE	O
:	O
Association	O
of	O
Heme	O
Oxygenase	O
1	O
with	O
Lung	B-ANAT
Protection	O
in	O
Malaria	O
-	O
Associated	O
ALI	O
/	O
ARDS	O
.	O

TITLE	O
:	O
Hepatitis	O
E	O
Virus	O
Infection	O
after	O
Platelet	B-ANAT
Transfusion	O
in	O
an	O
Immunocompetent	O
Trauma	O
Patient	O
.	O

In	O
all	O
the	O
subjects	O
groups	O
,	O
the	O
patient	O
-	O
related	O
independent	O
clinical	O
risk	O
factors	O
for	O
the	O
early	O
complication	O
rate	O
were	O
coronary	B-ANAT
atherosclerotic	O
heart	B-ANAT
disease	O
(	O
B	O
=	O
1	O
.	O
545	O
,	O
P	O
=	O
0	O
.	O
006	O
,	O
OR	O
=	O
4	O
.	O
686	O
,	O
95	O
%	O
CI	O
1	O
.	O
568	O
-	O
14	O
.	O
006	O
),	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
B	O
=	O
1	O
.	O
037	O
,	O
P	O
=	O
0	O
.	O
049	O
,	O
OR	O
=	O
2	O
.	O
820	O
,	O
95	O
%	O
CI	O
1	O
.	O
675	O
-	O
11	O
.	O
790	O
),	O
and	O
current	O
smoking	O
status	O
(	O
B	O
=	O
1	O
.	O
412	O
,	O
P	O
=	O
0	O
.	O
032	O
,	O
OR	O
=	O
4	O
.	O
139	O
,	O
95	O
%	O
CI	O
1	O
.	O
134	O
-	O
15	O
.	O
109	O
);	O
for	O
the	O
newly	O
respiratory	O
failure	O
rates	O
were	O
coronary	B-ANAT
atherosclerotic	O
heart	B-ANAT
disease	O
(	O
B	O
=	O
2	O
.	O
207	O
,	O
P	O
=	O
0	O
.	O
004	O
,	O
OR	O
=	O
9	O
.	O
087	O
,	O
95	O
%	O
CI	O
2	O
.	O
028	O
-	O
40	O
.	O
714	O
),	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
B	O
=	O
1	O
.	O
646	O
,	O
P	O
=	O
0	O
.	O
048	O
,	O
OR	O
=	O
5	O
.	O
188	O
,	O
95	O
%	O
CI	O
1	O
.	O
783	O
-	O
34	O
.	O
375	O
),	O
and	O
lesions	O
involving	O
three	O
central	O
airways	O
(	O
B	O
=	O
1	O
.	O
899	O
,	O
P	O
=	O
0	O
.	O
032	O
,	O
OR	O
=	O
6	O
.	O
680	O
,	O
95	O
%	O
CI	O
1	O
.	O
182	O
-	O
37	O
.	O
740	O
).	O

It	O
is	O
crucial	O
that	O
the	O
field	O
of	O
epidemic	O
science	O
matures	O
to	O
place	O
patients	O
at	O
the	O
heart	B-ANAT
of	O
the	O
response	O
.	O

Sphingosine	O
-	O
1	O
-	O
phosphate	O
(	O
S1P	O
)	O
is	O
able	O
to	O
enhance	O
the	O
resistance	O
of	O
endothelial	B-ANAT
cell	I-ANAT
barrier	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
risk	O
factors	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
children	O
receiving	O
surgeries	O
for	O
critical	O
and	O
complex	O
congenital	O
heart	B-ANAT
disease	O
(	O
CCHD	O
).	O

ABSTRACT	O
:	O
Griffithsin	O
(	O
GRFT	O
)	O
is	O
a	O
red	O
alga	O
-	O
derived	O
lectin	O
with	O
demonstrated	O
broad	O
spectrum	O
antiviral	O
activity	O
against	O
enveloped	O
viruses	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
Coronavirus	O
(	O
SARS	O
-	O
CoV	O
),	O
Japanese	O
encephalitis	O
virus	O
(	O
JEV	O
),	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
),	O
and	O
herpes	O
simplex	B-ANAT
virus	O
-	O
2	O
(	O
HSV	O
-	O
2	O
).	O

However	O
,	O
cathepsin	O
and	O
trypsin	O
-	O
like	O
protease	O
activation	O
were	O
retained	O
,	O
albeit	O
with	O
much	O
reduced	O
efficiency	O
compared	O
with	O
the	O
prototypical	O
EMC	B-ANAT
/	O
2012	O
human	O
strain	O
.	O

Overall	O
,	O
the	O
introduced	O
models	O
represent	O
meaningful	O
and	O
robust	O
methods	O
to	O
investigate	O
principles	O
of	O
pathogen	O
-	O
host	O
interaction	O
in	O
original	O
human	O
lung	B-ANAT
tissue	I-ANAT
.	O

Moreover	O
,	O
we	O
show	O
that	O
the	O
coumarin	O
-	O
labeled	O
inhibitor	O
can	O
be	O
used	O
to	O
image	O
PI4KB	O
in	O
cells	B-ANAT
using	O
fluorescence	O
-	O
lifetime	O
imaging	O
microscopy	O
(	O
FLIM	O
)	O
microscopy	O
.	O

ABSTRACT	O
:	O
Viral	O
pseudotyped	O
particles	O
(	O
pp	O
)	O
are	O
enveloped	O
virus	B-ANAT
particles	I-ANAT
,	O
typically	O
derived	O
from	O
retroviruses	O
or	O
rhabdoviruses	O
,	O
that	O
harbor	O
heterologous	O
envelope	B-ANAT
glycoproteins	O
on	O
their	O
surface	O
and	O
a	O
genome	O
lacking	O
essential	O
genes	O
.	O

TITLE	O
:	O
Prognostic	O
evaluation	O
by	O
oxygenation	O
with	O
positive	O
end	O
-	O
expiratory	O
pressure	O
in	O
acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
:	O
A	O
retrospective	O
cohort	O
study	O
.	O

TITLE	O
:	O
The	O
Effectiveness	O
of	O
Corticosteroid	O
Usage	O
in	O
Complex	O
Therapy	O
for	O
Severe	O
Sepsis	O
and	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Cases	O
of	O
Severe	O
Traumatic	O
Brain	B-ANAT
Injury	O
.	O

Our	O
hypothesis	O
was	O
that	O
this	O
method	O
is	O
reasonable	O
if	O
tissue	B-ANAT
hypoxia	O
is	O
avoided	O
.	O

MRI	O
showed	O
no	O
changes	O
related	O
to	O
cerebral	B-ANAT
hypoxia	O
.	O

ABSTRACT	O
:	O
Hosts	O
and	O
pathogens	O
are	O
locked	O
in	O
an	O
evolutionary	O
arms	B-ANAT
race	O
.	O

Noninvasive	O
ventilation	O
failure	O
in	O
ARDS	O
patients	O
with	O
malignancies	O
is	O
frequent	O
and	O
related	O
to	O
ARDS	O
severity	O
,	O
SOFA	O
score	O
,	O
and	O
pulmonary	B-ANAT
infection	O
-	O
related	O
ARDS	O
.	O

CONCLUSIONS	O
:	O
Noninvasive	O
ventilation	O
failure	O
in	O
ARDS	O
patients	O
with	O
malignancies	O
is	O
frequent	O
and	O
related	O
to	O
ARDS	O
severity	O
,	O
SOFA	O
score	O
,	O
and	O
pulmonary	B-ANAT
infection	O
-	O
related	O
ARDS	O
.	O

IFN	O
-	O
Î³	O
,	O
IL	O
-	O
4	O
and	O
IL	O
-	O
2	O
secreting	O
cells	B-ANAT
induced	O
by	O
the	O
RBD	O
were	O
detected	O
in	O
the	O
splenocytes	O
of	O
vaccinated	O
mice	O
by	O
ELISpot	O
.	O

Interestingly	O
,	O
N	O
protein	O
importation	O
into	O
the	O
nucleolus	B-ANAT
is	O
independent	O
of	O
the	O
ability	O
of	O
NPM1	O
to	O
shuttle	O
between	O
the	O
nucleus	B-ANAT
and	O
the	O
cytoplasm	B-ANAT
.	O

In	O
the	O
face	B-ANAT
of	O
a	O
novel	O
and	O
highly	O
contagious	O
disease	O
such	O
as	O
MERS	O
,	O
the	O
government	O
must	O
deploy	O
a	O
response	O
system	O
that	O
includes	O
provision	O
and	O
dissemination	O
of	O
reliable	O
information	O
and	O
inhibits	O
online	O
diffusion	O
of	O
false	O
information	O
.	O

Furthermore	O
,	O
fever	O
with	O
cough	O
and	O
shortness	O
of	O
breath	B-ANAT
(	O
SOB	B-ANAT
)	O
(	O
n	O
=	O
39	O
;	O
20	O
.	O
5	O
%),	O
fever	O
with	O
cough	O
(	O
n	O
=	O
29	O
;	O
15	O
.	O
3	O
%),	O
fever	O
(	O
n	O
=	O
18	O
;	O
9	O
.	O
5	O
%),	O
and	O
fever	O
with	O
SOB	B-ANAT
(	O
n	O
=	O
13	O
;	O
6	O
.	O
8	O
%),	O
were	O
the	O
most	O
common	O
clinical	O
manifestations	O
associated	O
with	O
confirmed	O
MERS	O
-	O
CoV	O
cases	O
.	O

TITLE	O
:	O
Widespread	O
Virus	O
Replication	O
in	O
Alveoli	B-ANAT
Drives	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Aerosolized	O
H5N1	O
Influenza	O
Infection	O
of	O
Macaques	O
.	O

TITLE	O
:	O
Roles	O
of	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
and	O
IL	O
-	O
10	O
in	O
virus	O
-	O
induced	O
demyelination	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
exposure	O
to	O
the	O
plant	O
toxin	O
ricin	O
leads	O
to	O
respiratory	O
insufficiency	O
and	O
death	O
.	O

ABSTRACT	O
:	O
A	O
pandemic	O
of	O
obesity	O
is	O
sweeping	O
all	O
across	O
the	O
globe	B-ANAT
and	O
the	O
Middle	O
East	O
region	O
also	O
does	O
not	O
remain	O
untouched	O
by	O
this	O
prevailing	O
pandemic	O
.	O

Since	O
the	O
resulting	O
morphology	O
closely	O
resembles	O
the	O
3	O
-	O
dimensional	O
fibrous	O
network	O
of	O
an	O
extracellular	B-ANAT
matrix	I-ANAT
(	O
ECM	B-ANAT
),	O
the	O
capability	O
of	O
the	O
TMV	O
assemblies	O
to	O
support	O
the	O
adhesion	O
of	O
NIH	O
-	O
3T3	O
fibroblast	B-ANAT
cells	B-ANAT
was	O
investigated	O
,	O
demonstrating	O
potential	O
utility	O
in	O
regenerative	O
medicine	O
.	O

However	O
,	O
our	O
recent	O
cellular	B-ANAT
studies	O
reveal	O
that	O
removing	O
the	O
Ubl2	O
domain	O
from	O
MERS	O
PLpro	O
has	O
no	O
effect	O
on	O
its	O
ability	O
to	O
process	O
the	O
viral	O
polyprotein	O
or	O
act	O
as	O
an	O
interferon	O
antagonist	O
,	O
which	O
involves	O
deubiquitinating	O
and	O
deISGylating	O
cellular	B-ANAT
proteins	O
.	O

TITLE	O
:	O
Mixed	O
Connective	B-ANAT
Tissue	I-ANAT
Disorder	O
Complicated	O
by	O
Polymyositis	O
,	O
Sjogren	O
'	O
s	O
Syndrome	O
,	O
Pleural	B-ANAT
Effusion	I-ANAT
and	O
Pericarditis	O
.	O

She	O
presented	O
to	O
the	O
emergency	O
room	O
with	O
severe	O
chest	B-ANAT
pain	O
,	O
chest	B-ANAT
tightness	O
,	O
and	O
shortness	O
of	O
breath	B-ANAT
following	O
an	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
.	O

It	O
was	O
relieved	O
by	O
sitting	O
up	O
straight	O
and	O
did	O
not	O
radiate	O
to	O
her	O
left	B-ANAT
arm	I-ANAT
or	O
jaw	B-ANAT
.	O

We	O
conducted	O
a	O
randomized	O
,	O
double	O
-	O
blinded	O
,	O
placebo	O
-	O
controlled	O
pilot	O
clinical	O
trial	O
to	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
ARMS	B-ANAT
-	O
I	O
â¢	O
(	O
currently	O
marketed	O
as	O
Halo	O
â¢)	O
in	O
the	O
prevention	O
of	O
URIs	O
.	O

Moreover	O
,	O
frequency	O
of	O
post	O
-	O
treatment	O
exit	O
visits	O
was	O
reduced	O
by	O
55	O
%	O
in	O
ARMS	B-ANAT
-	O
I	O
compared	O
to	O
the	O
placebo	O
group	O
(	O
N	O
=	O
4	O
and	O
2	O
,	O
respectively	O
).	O

ARMS	B-ANAT
-	O
I	O
was	O
safe	O
,	O
well	O
tolerated	O
,	O
had	O
high	O
acceptability	O
and	O
high	O
adherence	O
to	O
medication	O
use	O
.	O

Based	O
on	O
these	O
experimental	O
results	O
,	O
we	O
believe	O
that	O
MPLEx	O
will	O
facilitate	O
systems	O
biology	O
studies	O
of	O
infectious	O
samples	O
by	O
enabling	O
simultaneous	O
pathogen	O
inactivation	O
and	O
multi	O
-	O
omics	O
measurements	O
from	O
a	O
single	O
specimen	O
with	O
high	O
success	O
for	O
pathogens	O
with	O
exposed	O
lipid	O
membranes	B-ANAT
.	O

His	O
serum	B-ANAT
adenovirus	O
load	O
was	O
markedly	O
elevated	O
.	O

Although	O
his	O
initial	O
response	O
to	O
antimicrobial	O
therapy	O
was	O
optimal	O
,	O
he	O
became	O
symptomatic	O
again	O
in	O
spite	O
of	O
continuation	O
of	O
antibiotics	O
as	O
he	O
developed	O
severe	O
paradoxical	O
IRIS	B-ANAT
3	O
weeks	O
after	O
starting	O
a	O
new	O
highly	O
active	O
anti	O
-	O
retroviral	O
therapy	O
(	O
HAART	O
).	O

TITLE	O
:	O
Bedside	O
Contribution	O
of	O
Electrical	O
Impedance	O
Tomography	O
to	O
Setting	O
Positive	O
End	O
-	O
Expiratory	O
Pressure	O
for	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
-	O
treated	O
Patients	O
with	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Anti	O
-	O
CoV	O
IgM	O
antibodies	O
were	O
detected	O
in	O
22	O
/	O
183	O
(	O
12	O
.	O
02	O
%)	O
and	O
26	O
/	O
236	O
(	O
11	O
.	O
02	O
%)	O
patients	O
with	O
acute	O
encephalitis	O
-	O
like	O
syndrome	O
and	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
,	O
respectively	O
.	O

Additionally	O
,	O
the	O
serum	B-ANAT
level	O
of	O
granulocyte	B-ANAT
macrophage	B-ANAT
colony	O
-	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	B-ANAT
)	O
was	O
significantly	O
higher	O
in	O
CoV	O
-	O
CNS	B-ANAT
infection	O
than	O
in	O
CoV	O
-	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
.	O

CONCLUSIONS	O
:	O
To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
showing	O
a	O
high	O
incidence	O
of	O
CoV	O
infection	O
in	O
hospitalized	O
children	O
,	O
especially	O
with	O
CNS	B-ANAT
illness	O
.	O

While	O
research	O
has	O
mainly	O
focused	O
on	O
virus	O
associated	O
autoimmune	O
activation	O
,	O
less	O
is	O
known	O
about	O
prevention	O
of	O
autoimmunity	O
,	O
especially	O
following	O
resolving	O
infections	O
associated	O
with	O
CNS	B-ANAT
tissue	B-ANAT
damage	O
.	O

In	O
addition	O
,	O
rpIFN	O
-	O
L1	O
exhibited	O
greater	O
antiviral	O
activity	O
against	O
PEDV	O
infection	O
of	O
IPEC	O
-	O
J2	O
cells	B-ANAT
than	O
that	O
of	O
porcine	O
IFN	O
-	O
alpha	O
.	O

Moreover	O
,	O
we	O
show	O
that	O
activation	O
of	O
IFN	O
responses	O
induced	O
by	O
poly	O
(	O
I	O
:	O
C	O
)	O
could	O
inhibit	O
viral	O
replication	O
in	O
the	O
early	O
infection	O
stage	O
,	O
but	O
failed	O
in	O
the	O
late	O
infection	O
stage	O
in	O
IPEC	O
-	O
J2	O
cells	B-ANAT
.	O

Taken	O
together	O
,	O
this	O
study	O
provides	O
a	O
preliminary	O
analysis	O
of	O
an	O
interaction	O
between	O
TGEV	O
and	O
IFN	O
-	O
Î²	O
responses	O
of	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Blood	B-ANAT
and	O
urine	B-ANAT
analyses	O
and	O
histopathology	O
were	O
also	O
performed	O
.	O

Cecal	B-ANAT
infarction	O
cases	O
were	O
then	O
compared	O
to	O
controls	O
using	O
a	O
retrospective	O
matched	O
case	O
-	O
control	O
study	O
design	O
.	O

In	O
this	O
study	O
,	O
we	O
successfully	O
isolated	O
a	O
PEDV	O
isolate	O
(	O
strain	O
NJ	O
)	O
from	O
clinical	O
samples	O
collected	O
during	O
a	O
recent	O
outbreak	O
of	O
diarrhea	O
in	O
piglets	O
in	O
China	O
,	O
using	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
(	O
IEC	O
).	O

Retrospective	O
propensity	O
-	O
score	O
analyses	O
also	O
suggest	O
that	O
LDC	O
administered	O
in	O
severe	O
septic	O
shock	O
or	O
in	O
septic	O
shock	O
due	O
to	O
community	O
-	O
acquired	O
pneumonia	O
or	O
intestinal	B-ANAT
perforation	O
may	O
improve	O
survival	O
.	O

A	O
set	O
of	O
six	O
LAMP	O
primers	O
[	O
F3	O
,	O
B3	O
,	O
FIP	O
,	O
BIP	O
,	O
LF	O
(	O
Loop	O
-	O
F	O
),	O
and	O
LB	O
(	O
Loop	O
-	O
B	O
)]	O
were	O
designed	O
using	O
the	O
sequence	O
of	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
with	O
optimized	O
RT	O
-	O
LAMP	O
enzyme	O
conditions	O
:	O
100	O
U	O
M	O
-	O
MLV	O
RTase	O
and	O
4	O
U	O

These	O
results	O
imply	O
the	O
involvement	O
of	O
a	O
co	O
-	O
receptor	O
because	O
cells	B-ANAT
expressing	O
the	O
internalization	O
-	O
deficient	O
mutants	O
could	O
still	O
be	O
infected	O
.	O

Despite	O
recent	O
advances	O
in	O
defining	O
many	O
aspects	O
of	O
the	O
pathogenesis	O
of	O
sepsis	O
-	O
related	O
MOD	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
there	O
are	O
currently	O
no	O
effective	O
pharmacological	O
or	O
cell	B-ANAT
-	O
based	O
treatments	O
for	O
the	O
disease	O
.	O

The	O
potential	O
beneficial	O
effect	O
of	O
anticoagulation	O
on	O
outcome	O
is	O
unconvincing	O
in	O
clinical	O
studies	O
,	O
however	O
,	O
and	O
these	O
discrepancies	O
may	O
arise	O
from	O
the	O
multiple	O
and	O
sometimes	O
opposing	O
actions	O
of	O
thrombosis	O
on	O
the	O
pulmonary	B-ANAT
endothelium	B-ANAT
following	O
sepsis	O
.	O

Among	O
people	O
with	O
CF	O
,	O
these	O
viruses	O
are	O
associated	O
with	O
prolonged	O
respiratory	O
illness	O
and	O
show	O
a	O
clear	O
association	O
with	O
pulmonary	B-ANAT
exacerbations	O
which	O
in	O
turn	O
are	O
associated	O
with	O
lung	B-ANAT
function	O
decline	O
and	O
risk	O
of	O
death	O
.	O

We	O
highlight	O
the	O
significant	O
role	O
that	O
respiratory	O
viruses	O
play	O
in	O
CF	O
lung	B-ANAT
disease	O
and	O
argue	O
that	O
these	O
pathogens	O
represent	O
an	O
under	O
-	O
exploited	O
target	O
in	O
the	O
battle	O
to	O
control	O
patients	O
'	O
symptoms	O
and	O
disease	O
progression	O
.	O

TITLE	O
:	O
Spontaneous	O
intracranial	B-ANAT
hemorrhage	O
in	O
a	O
patient	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	O
virus	O
.	O

Computed	O
angiogram	O
of	O
the	O
brain	B-ANAT
did	O
not	O
reveal	O
any	O
aneurysm	O
or	O
structural	O
defects	O
.	O

The	O
literature	O
search	O
identified	O
eight	O
articles	O
for	O
review	O
that	O
reported	O
on	O
paramedic	O
exposure	O
trends	O
;	O
the	O
lack	O
of	O
reported	O
blood	B-ANAT
-	O
borne	O
infections	O
contracted	O
,	O
such	O
as	O
hepatitis	O
B	O
,	O
hepatitis	O
C	O
,	O
and	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
);	O
instances	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infections	O
;	O
and	O
the	O
higher	O
prevalence	O
of	O
methicillin	O
-	O
resistant	O
staphylococcus	O
aureus	O
(	O
MRSA	O
)	O
nasal	B-ANAT
infections	O
amongst	O
paramedics	O
.	O

The	O
etiology	O
of	O
respiratory	O
failure	O
was	O
multifactorial	O
in	O
31	O
(	O
39	O
%)	O
patients	O
,	O
with	O
features	O
of	O
pneumonia	O
in	O
61	O
(	O
77	O
%)	O
patients	O
,	O
severe	O
sepsis	O
or	O
septic	O
shock	O
in	O
33	O
(	O
42	O
%)	O
patients	O
,	O
and	O
pulmonary	B-ANAT
edema	O
in	O
24	O
(	O
30	O
%)	O
patients	O
.	O

These	O
two	O
diagnoses	O
should	O
be	O
promptly	O
investigated	O
and	O
systematically	O
treated	O
in	O
lung	B-ANAT
transplant	B-ANAT
recipients	O
.	O

However	O
,	O
other	O
internal	O
organs	B-ANAT
,	O
such	O
as	O
the	O
respiratory	B-ANAT
tract	I-ANAT
and	O
gastrointestinal	B-ANAT
tract	I-ANAT
,	O
can	O
be	O
affected	O
.	O

Many	O
strains	O
of	O
the	O
murine	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
have	O
distinct	O
,	O
S	O
-	O
dependent	O
organ	B-ANAT
and	O
tissue	B-ANAT
tropisms	O
despite	O
using	O
a	O
common	O
receptor	O
,	O
suggesting	O
that	O
they	O
employ	O
different	O
cellular	B-ANAT
proteases	O
for	O
fusion	O
.	O

The	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
protein	O
)	O
of	O
SARS	O
-	O
CoV	O
plays	O
an	O
important	O
role	O
in	O
inhibition	O
of	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
production	O
via	O
an	O
unknown	O
mechanism	O
.	O

In	O
macrophages	B-ANAT
we	O
found	O
immediate	O
induction	O
of	O
IFN	O
-	O
I	O
expression	O
and	O
RNase	O
L	O
-	O
mediated	O
breakdown	O
of	O
ribosomal	B-ANAT
RNA	I-ANAT
.	O

Collectively	O
our	O
results	O
demonstrate	O
that	O
the	O
coronavirus	O
EndoU	O
efficiently	O
prevents	O
simultaneous	O
activation	O
of	O
host	B-ANAT
cell	I-ANAT
dsRNA	O
sensors	O
,	O
such	O
as	O
Mda5	O
,	O
OAS	O
and	O
PKR	O
.	O

ABSTRACT	O
:	O
Polymerase	O
chain	O
reaction	O
-	O
based	O
diagnosis	O
has	O
become	O
the	O
standard	O
for	O
viral	O
pneumonia	O
and	O
other	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

ABSTRACT	O
:	O
Intestinal	B-ANAT
goblet	B-ANAT
cells	I-ANAT
secret	O
mucins	O
to	O
form	O
mucus	B-ANAT
layers	B-ANAT
critical	O
for	O
maintaining	O
the	O
integrity	O
of	O
the	O
intestinal	B-ANAT
epithelium	I-ANAT
.	O

TITLE	O
:	O
A	O
17	O
-	O
Year	O
-	O
Old	O
With	O
Chest	B-ANAT
Pain	O
.	O

Median	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
before	O
ECMO	O
was	O
15	O
(	O
range	O
,	O
12	O
to	O
17	O
),	O
predicting	O
a	O
mortality	O
rate	O
greater	O
than	O
80	O
%.	O

Most	O
research	O
has	O
been	O
focused	O
on	O
isolation	O
,	O
genome	O
sequencing	O
,	O
pathogenicity	O
,	O
and	O
virulence	O
of	O
these	O
viruses	O
,	O
but	O
there	O
is	O
little	O
information	O
on	O
long	O
-	O
term	O
growth	O
performance	O
and	O
tissue	B-ANAT
accretion	O
of	O
pigs	O
inoculated	O
with	O
PEDV	O
or	O
PDCoV	O
.	O
Therefore	O
,	O
our	O
objective	O
was	O
to	O
determine	O
the	O
effect	O
of	O
PEDV	O
or	O
PDCoV	O
infection	O
on	O
growth	O
performance	O
and	O
tissue	B-ANAT
accretion	O
over	O
42	O
d	O
following	O
inoculation	O
.	O

Multiple	O
clinical	O
variables	O
were	O
recorded	O
and	O
analyzed	O
,	O
including	O
arterial	B-ANAT
oxygenation	O
,	O
cardiac	B-ANAT
output	O
,	O
peripheral	O
oxygen	O
delivery	O
and	O
alveolar	B-ANAT
strain	O
.	O

Reduced	O
cardiac	B-ANAT
output	O
in	O
the	O
moderate	O
and	O
mild	O
in	O
silico	O
ARDS	O
patients	O
produced	O
significant	O
drops	O
in	O
oxygen	O
delivery	O
during	O
the	O
RM	O
(	O
average	O
decrease	O
of	O
423	O
ml	O
min	O

Univariate	O
correlation	O
analysis	O
demonstrated	O
that	O
APACHE	O
II	O
score	O
(	O
r	O
=-	O
0	O
.	O
463	O
,	O
p	O
=	O
0	O
.	O
03	O
),	O
acute	O
kidney	B-ANAT
injury	O
(	O
r	O
=-	O
0	O
.	O
574	O
,	O
p	O
=	O
0	O
.	O
005	O
),	O
membrane	B-ANAT
oxygenator	O
replacement	O
(	O
r	O
=-	O
0	O
.	O
516	O
,	O
p	O
=	O
0	O
.	O
014	O
)	O
and	O
total	O
length	O
of	O
hospital	O
stay	O
(	O
r	O
=	O
0	O
.	O
526	O
,	O
p	O
=	O
0	O
.	O
012	O
)	O
were	O
significantly	O
correlated	O
with	O
survival	O
to	O
hospital	O
discharge	B-ANAT
,	O
and	O
that	O
the	O
evolution	O
of	O
the	O
levels	O
of	O
urea	O
nitrogen	O
,	O
platelet	B-ANAT
,	O
and	O
fibrinogen	B-ANAT
may	O
help	O
to	O
determine	O
patient	O
prognosis	O
.	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
HCoV	O
)	O
are	O
RNA	O
viruses	O
that	O
cause	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
with	O
viral	O
replication	O
of	O
limited	O
duration	O
.	O

In	O
severe	O
pancreatitis	O
,	O
necrosis	O
of	O
pancreas	B-ANAT
and	O
surrounding	O
tissues	B-ANAT
may	O
occur	O
.	O

ABSTRACT	O
:	O
Lungs	B-ANAT
are	O
easily	O
damaged	O
by	O
the	O
inflammatory	O
responses	O
induced	O
after	O
extensive	O
burns	O
.	O

In	O
the	O
second	O
experiment	O
,	O
another	O
two	O
groups	O
were	O
established	O
by	O
transfusion	O
with	O
either	O
mtDNA	B-ANAT
(	O
mtDNA	B-ANAT
group	O
)	O
or	O
phosphate	O
-	O
buffered	O
saline	O
(	O
phosphate	O
-	O
buffered	O
saline	O
group	O
).	O

The	O
plasma	B-ANAT
concentrations	O
of	O
mtDNA	B-ANAT
and	O
inflammatory	O
mediators	O
were	O
significantly	O
decreased	O
after	O
the	O
administration	O
of	O
EGCG	O
(	O
P	O
<	O
.	O
05	O
).	O

Intravenous	O
administration	O
of	O
mtDNA	B-ANAT
significantly	O
increased	O
concentrations	O
of	O
inflammatory	O
mediators	O
and	O
caused	O
severe	O
ARDS	O
(	O
P	O
<	O
.	O
05	O
).	O

RESULTS	O
:	O
The	O
univariate	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
patients	O
with	O
hemoglobin	O
<	O
90	O
g	O
/	O
L	O
,	O
plasma	B-ANAT
albumin	O
<	O
30	O
g	O
/	O
L	O
,	O
C	O
-	O
reactive	O
protein	O
>	O
30	O
mg	O
/	O
L	O
,	O
procalcitonin	O
>	O
10	O
ng	O
/	O
mL	O
,	O
alanine	O
aminotransferase	O
>	O
100	O
U	O
/	O
L	O
,	O
or	O
aspartate	O
aminotransferase	O
>	O
100	O
U	O
/	O
L	O
had	O
poor	O
prognosis	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
that	O
those	O
with	O
congenital	O
dysplasia	O
of	O
the	O
airway	B-ANAT
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
circulatory	O
complications	O
,	O
electrolyte	O
and	O
acid	O
-	O
base	O
disturbance	O
,	O
or	O
more	O
than	O
three	O
complications	O
also	O
had	O
poor	O
prognosis	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Doxycycline	O
Induces	O
Mitophagy	O
and	O
Suppresses	O
Production	O
of	O
Interferon	O
-	O
Î²	O
in	O
IPEC	O
-	O
J2	O
Cells	B-ANAT
.	O

Sensitivity	O
and	O
negative	O
predictive	O
value	O
were	O
higher	O
for	O
the	O
modified	O
ÎTNC	O
(	O
84	O
.	O
2	O
%	O
and	O
83	O
.	O
3	O
%,	O
respectively	O
,	O
at	O
the	O
cutoff	O
of	O
1	O
.	O
7	O
;	O
78	O
.	O
9	O
%	O
and	O
78	O
.	O
9	O
%,	O
respectively	O
,	O
at	O
the	O
cutoff	O
of	O
3	O
.	O
4	O
)	O
than	O
for	O
the	O
ÎTNC	O
on	O
fresh	B-ANAT
samples	O
(	O
78	O
.	O
6	O
%	O
and	O
81	O
.	O
3	O
%,	O
respectively	O
,	O
at	O
the	O
cutoff	O
of	O
1	O
.	O
7	O
;	O
57	O
.	O
1	O
%	O
and	O
68	O
.	O
4	O
%,	O
respectively	O
,	O
at	O
the	O
cutoff	O
of	O
3	O
.	O
4	O
).	O

Renal	B-ANAT
biopsy	O
showed	O
TMA	O
.	O

Clinical	O
trial	O
design	O
for	O
diseases	O
with	O
high	O
mortality	O
rates	O
and	O
/	O
or	O
high	O
morbidity	O
in	O
the	O
face	B-ANAT
of	O
a	O
global	O
perception	O
of	O
immediate	O
need	O
and	O
the	O
factors	O
that	O
drive	O
design	O
in	O
the	O
face	B-ANAT
of	O
a	O
changing	O
epidemiology	O
are	O
presented	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
lethal	O
disease	O
in	O
humans	O
,	O
which	O
is	O
characterized	O
by	O
exacerbated	O
inflammatory	O
response	O
and	O
extensive	O
lung	B-ANAT
pathology	O
.	O

Antagomir	O
-	O
mediated	O
inhibition	O
of	O
svRNA	O
-	O
N	O
significantly	O
reduced	O
in	O
vivo	O
lung	B-ANAT
pathology	O
and	O
pro	O
-	O
inflammatory	O
cytokine	O
expression	O
.	O

The	O
host	O
factors	O
associated	O
with	O
high	O
CFR	O
were	O
pre	O
-	O
existing	O
pneumonia	O
,	O
smoking	O
history	O
,	O
an	O
incubation	O
period	O
of	O
less	O
than	O
5	O
days	O
,	O
leukocytosis	O
,	O
abnormal	O
renal	B-ANAT
function	O
at	O
diagnosis	O
,	O
and	O
respiratory	O
symptoms	O
such	O
as	O
sputum	B-ANAT
and	O
dyspnea	O
.	O

The	O
control	O
group	O
was	O
given	O
conventional	O
supportive	O
therapy	O
,	O
while	O
the	O
experimental	O
group	O
was	O
given	O
continuous	O
veno	O
-	O
venous	B-ANAT
hemofiltration	O
therapy	O
.	O

The	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
-	O
Î±	O
),	O
interleukin	O
6	O
(	O
IL	O
-	O
6	O
),	O
and	O
IL	O
-	O
10	O
in	O
serum	B-ANAT
and	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
)	O
were	O
measured	O
using	O
the	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

CBP	O
treatment	O
cleared	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
6	O
,	O
and	O
IL	O
-	O
10	O
partially	O
from	O
serum	B-ANAT
and	O
BALF	O
.	O

The	O
pathological	O
examination	O
of	O
the	O
heart	B-ANAT
,	O
lung	B-ANAT
,	O
and	O
kidney	B-ANAT
tissues	B-ANAT
revealed	O
that	O
the	O
injury	O
was	O
less	O
severe	O
in	O
the	O
experimental	O
group	O
.	O

The	O
present	O
study	O
is	O
the	O
first	O
to	O
examine	O
the	O
prevalence	O
of	O
DogCV	O
in	O
faeces	B-ANAT
of	O
dogs	O
from	O
Germany	O
and	O
other	O
European	O
countries	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
presence	O
of	O
viruses	O
and	O
bacteria	O
in	O
middle	B-ANAT
ear	I-ANAT
and	O
adenoids	B-ANAT
of	O
patients	O
with	O
and	O
without	O
otitis	O
media	B-ANAT
with	O
effusion	B-ANAT
(	O
OME	O
).	O

Although	O
total	O
virus	O
detection	O
was	O
not	O
statistically	O
different	O
from	O
controls	O
at	O
the	O
middle	B-ANAT
ear	I-ANAT
washes	O
(	O
p	O
=	O
0	O
.	O
065	O
),	O
adenovirus	O
was	O
detected	O
in	O
higher	O
proportions	O
in	O
adenoid	B-ANAT
samples	O
of	O
OME	O
patients	O
than	O
controls	O
(	O
p	O
=	O
0	O
.	O
019	O
).	O

Despite	O
both	O
OME	O
and	O
control	O
patients	O
presented	O
similar	O
rates	O
of	O
viruses	O
and	O
bacteria	O
at	O
the	O
adenoid	B-ANAT
,	O
children	O
with	O
OME	O
presented	O
higher	O
prevalence	O
of	O
S	O
.	O
pneumonia	O
,	O
M	O
.	O
catarrhalis	O
in	O
middle	B-ANAT
ear	I-ANAT
and	O
adenovirus	O
in	O
adenoids	B-ANAT
when	O
compared	O
to	O
controls	O
.	O

The	O
first	O
prone	O
session	O
significantly	O
increased	O
PaO	O
CONCLUSIONS	O
:	O
Prone	O
position	O
of	O
ARDS	O
patients	O
after	O
abdominal	B-ANAT
surgery	O
was	O
not	O
associated	O
with	O
an	O
increased	O
rate	O
of	O
surgical	O
complication	O
.	O

TITLE	O
:	O
Viral	O
rewiring	O
of	O
cellular	B-ANAT
lipid	O
metabolism	O
to	O
create	O
membranous	B-ANAT
replication	O
compartments	B-ANAT
.	O

ABSTRACT	O
:	O
Concern	O
regarding	O
functioning	O
and	O
effectiveness	O
of	O
joint	B-ANAT
health	O
and	O
safety	O
committees	O
(	O
JHSCs	O
)	O
in	O
Ontario	O
hospitals	O
was	O
raised	O
following	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
outbreak	O
in	O
2003	O
.	O

Eight	O
proinflammatory	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
were	O
measured	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
day	O
1	O
and	O
correlated	O
with	O
mortality	O
,	O
ICU	O
morbidity	O
as	O
measured	O
by	O
survivor	O
Pediatric	O
Logistic	O
Organ	B-ANAT
Dysfunction	O
score	O
,	O
and	O
biomarkers	O
of	O
endothelial	B-ANAT
injury	O
,	O
including	O
angiopoietin	O
-	O
2	O
,	O
von	O
Willebrand	O
Factor	O
,	O
and	O
soluble	O
thrombomodulin	O
.	O

In	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
are	O
strongly	O
associated	O
with	O
mortality	O
,	O
ICU	O
morbidity	O
,	O
and	O
biochemical	O
evidence	O
of	O
endothelial	B-ANAT
injury	O
.	O

TITLE	O
:	O
A	O
Quantile	O
Analysis	O
of	O
Plateau	O
and	O
Driving	O
Pressures	O
:	O
Effects	O
on	O
Mortality	O
in	O
Patients	O
With	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Receiving	O
Lung	B-ANAT
-	O
Protective	O
Ventilation	O
.	O

We	O
assessed	O
the	O
risk	O
of	O
hospital	O
death	O
based	O
on	O
quantiles	O
of	O
tidal	O
volume	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
,	O
plateau	O
pressure	O
,	O
and	O
driving	O
pressure	O
evaluated	O
at	O
24	O
hours	O
after	O
acute	O
respiratory	O
distress	O
syndrome	O
diagnosis	O
while	O
ventilated	O
with	O
standardized	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

Besides	O
,	O
variations	O
of	O
all	O
sagittal	B-ANAT
-	O
lung	B-ANAT
CT	O
measurements	O
were	O
significantly	O
larger	O
in	O
patients	O
with	O
ACOS	O
than	O
in	O
patients	O
with	O
pure	O
COPD	O
(	O
P	O
values	O
all	O
<	O
0	O
.	O
001	O
)	O
and	O
showed	O
high	O
performance	O
in	O
differentiating	O
these	O
two	O
kinds	O
of	O
patient	O
,	O
with	O
diagnostic	O
sensitivities	O
ranging	O
from	O
76	O
.	O
4	O
to	O
97	O
.	O
2	O
%,	O
specificities	O
ranging	O
from	O
86	O
.	O
2	O
to	O
100	O
.	O
0	O
%,	O
and	O
accuracies	O
ranging	O
from	O
80	O
.	O
9	O
to	O
90	O
.	O
7	O
%.	O

TITLE	O
:	O
Pitfalls	O
in	O
interpretation	O
of	O
CT	O
-	O
values	O
of	O
RT	O
-	O
PCR	O
in	O
children	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

Studying	O
the	O
bacterial	O
flora	O
of	O
both	O
tonsils	B-ANAT
in	O
study	O
II	O
,	O
we	O
found	O
almost	O
perfect	O
concordance	O
between	O
the	O
bacterial	O
findings	O
of	O
the	O
tonsillar	B-ANAT
core	O
at	O
the	O
side	O
of	O
the	O
abscess	O
and	O
contralaterally	O
.	O

Frozen	O
brain	B-ANAT
was	O
submitted	O
to	O
PCR	O
amplification	O
and	O
220	O
bp	O
multiple	O
sequence	O
alignment	O
was	O
analysed	O
by	O
Bayesian	O
phylogenetic	O
analysis	O
.	O

However	O
,	O
the	O
macropinocytosis	O
inhibitors	O
could	O
not	O
impede	O
virus	O
replication	O
once	O
the	O
virus	O
had	O
entered	O
host	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Up	O
to	O
80	O
%	O
of	O
sore	O
throats	B-ANAT
are	O
caused	O
by	O
viruses	O
.	O

TITLE	O
:	O
Guillain	O
-	O
BarrÃ©	O
Syndrome	O
Presenting	O
with	O
Sinus	B-ANAT
Node	I-ANAT
Dysfunction	O
and	O
Refractory	O
Shock	O
.	O

The	O
patient	O
eventually	O
died	O
of	O
multi	O
-	O
organ	B-ANAT
failure	O
.	O

Among	O
non	O
-	O
immune	O
compromised	O
adults	O
,	O
hPIV	O
infection	O
typically	O
causes	O
mild	O
disease	O
manifested	O
as	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
and	O
is	O
infrequently	O
associated	O
with	O
severe	O
croup	O
or	O
pneumonia	O
.	O

There	O
were	O
no	O
significant	O
differences	O
between	O
groups	O
in	O
comorbidities	O
,	O
baseline	O
characteristics	O
or	O
arterial	B-ANAT
blood	I-ANAT
gases	O
at	O
inclusion	O
.	O

It	O
remains	O
to	O
be	O
determined	O
if	O
primary	O
closure	O
and	O
subsequent	O
tensioning	O
or	O
scar	O
tissue	B-ANAT
of	O
the	O
GE	O
mucosa	B-ANAT
results	O
in	O
further	O
complications	O
related	O
to	O
restricted	O
epiglottic	B-ANAT
movement	O
.	O

The	O
causes	O
of	O
death	O
were	O
multi	O
-	O
system	B-ANAT
organ	I-ANAT
failure	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
Autophagy	O
is	O
a	O
basic	O
biological	O
metabolic	O
process	O
involving	O
in	O
intracellular	B-ANAT
membrane	I-ANAT
transport	O
pathways	O
that	O
recycle	O
cellular	B-ANAT
components	O
and	O
eliminate	O
intracellular	B-ANAT
microorganisms	O
within	O
the	O
lysosome	B-ANAT
.	O

This	O
study	O
explores	O
the	O
mechanism	O
of	O
autophagy	O
induction	O
by	O
porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
in	O
Neuro	O
-	O
2a	O
cells	B-ANAT
,	O
and	O
examines	O
the	O
role	O
of	O
autophagy	O
in	O
PHEV	O
replication	O
.	O

Here	O
,	O
we	O
describe	O
the	O
development	O
of	O
a	O
bacterial	O
artificial	O
chromosome	B-ANAT
(	O
BAC	O
)	O
reverse	O
genetics	O
system	O
for	O
PEDV	O
based	O
on	O
two	O
recent	O
Chinese	O
field	O
isolates	O
,	O
namely	O
CHM2013	O
and	O
BJ2011C	O
.	O

In	O
model	O
organisms	O
,	O
intravenously	O
injected	O
PELs	O
strongly	O
concentrate	O
drugs	O
in	O
alveoli	B-ANAT
,	O
even	O
in	O
animal	O
models	O
displaying	O
severe	O
,	O
spatially	O
heterogeneous	O
pathology	O
similar	O
to	O
severe	O
ARDS	O
.	O

Furthermore	O
,	O
the	O
IBV	O
replicase	O
-	O
encoded	O
PLP	O
,	O
including	O
the	O
downstream	O
transmembrane	B-ANAT
(	O
TM	O
)	O
domain	O
,	O
is	O
a	O
DUB	O
enzyme	O
and	O
dramatically	O
reduced	O
the	O
level	O
of	O
Ub	O
-	O
conjugated	O
proteins	O
,	O
while	O
processing	O
both	O
K48	O
-	O
and	O
K63	O
-	O
linked	O
polyubiquitin	O
chains	O
.	O

In	O
addition	O
,	O
the	O
brain	B-ANAT
parenchymal	O
cells	B-ANAT
that	O
produce	O
interferon	O
Î²	O
after	O
infection	O
in	O
spite	O
of	O
their	O
residence	O
away	O
from	O
the	O
sites	O
of	O
viral	O
invasion	O
were	O
surrounded	O
by	O
ERfibs	O
,	O
which	O
were	O
closely	O
associated	O
with	O
astrocytic	B-ANAT
fibers	O
.	O

These	O
findings	O
indicate	O
that	O
astrocytes	B-ANAT
play	O
a	O
central	O
role	O
in	O
forming	O
the	O
astrocytic	B-ANAT
reticular	O
network	O
(	O
ARN	O
)	O
in	O
the	O
brain	B-ANAT
parenchyma	B-ANAT
,	O
as	O
FRCs	O
do	O
to	O
form	O
FRN	O
in	O
the	O
lymphoid	B-ANAT
organs	I-ANAT
.	O

The	O
median	O
lung	B-ANAT
injury	O
score	O
was	O
3	O
.	O
0	O
(	O
IQR	O
,	O
2	O
.	O
50	O
-	O
3	O
.	O
25	O
),	O
and	O
the	O
median	O
level	O
of	O
NT	O
-	O
proBNP	O
was	O
2011	O
pg	O
/	O
ml	O
(	O
IQR	O
,	O
579	O
-	O
7216	O
).	O

In	O
this	O
study	O
,	O
we	O
solved	O
the	O
crystal	B-ANAT
structures	O
of	O
the	O
N	O
-	O
and	O
C	O
-	O
terminal	O
domains	O
(	O
NTD	O
,	O
residues	O
10	O
to	O
140	O
,	O
and	O
CTD	O
,	O
residues	O
221	O
to	O
340	O
,	O
respectively	O
)	O
of	O
the	O
N	O
protein	O
of	O
HCoV	O
-	O
NL63	O
,	O
both	O
at	O
a	O
1	O
.	O
5	O
-	O
Ã	O
resolution	O
.	O

Overall	O
,	O
this	O
study	O
expands	O
our	O
understanding	O
of	O
the	O
initial	O
steps	O
of	O
N	O
protein	O
-	O
nucleic	B-ANAT
acid	O
interaction	O
and	O
may	O
facilitate	O
future	O
efforts	O
to	O
control	O
the	O
associated	O
infections	O
.	O

Oseltamivir	O
(	O
75	O
mg	O
)	O
was	O
orally	B-ANAT
administered	O
on	O
Day	O
1	O
and	O
Day	O
8	O
,	O
and	O
dexamethasone	O
(	O
1	O
.	O
5	O
mg	O
)	O
was	O
administered	O
once	O
daily	O
from	O
Day	O
3	O
to	O
Day	O
8	O
.	O

In	O
February	O
2014	O
,	O
an	O
assessment	O
was	O
made	O
of	O
the	O
suitability	O
and	O
sensitivity	O
of	O
different	O
types	O
of	O
sample	O
for	O
the	O
detection	O
of	O
MERSCoV	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
for	O
three	O
gene	O
targets	O
:	O
UpE	O
(	O
upstream	O
of	O
the	O
E	O
gene	O
),	O
the	O
N	O
(	O
nucleocapsid	B-ANAT
)	O
gene	O
and	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
1a	O
.	O

A	O
total	O
of	O
1	O
,	O
031	O
sera	B-ANAT
,	O
1	O
,	O
078	O
nasal	B-ANAT
swabs	O
,	O
13	O
rectal	O
swabs	O
,	O
and	O
38	O
milk	O
samples	O
were	O
collected	O
from	O
1	O
,	O
078	O
camels	O
in	O
different	O
types	O
of	O
sites	O
.	O

Serum	B-ANAT
IP	O
-	O
10	O
concentrations	O
were	O
measured	O
by	O
ELISA	O
(	O
R	O
&	O
D	O
Systems	O
,	O
Inc	O
.,	O
Quantikine	O
ELISA	O
,	O
Minneapolis	O
,	O
MN	O
).	O

TITLE	O
:	O
The	O
answer	O
is	O
blowing	O
in	O
the	O
wind	O
:	O
an	O
uncommon	O
cause	O
for	O
severe	O
ARDS	O
accompanied	O
by	O
circulatory	O
insufficiency	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

A	O
small	O
animal	O
model	O
that	O
develops	O
progressive	O
pulmonary	B-ANAT
manifestations	O
when	O
infected	O
with	O
MERS	O
-	O
CoV	O
would	O
advance	O
the	O
field	O
.	O

Whole	O
-	O
genome	O
sequencing	O
of	O
a	O
new	O
isolate	O
(	O
F46	O
)	O
from	O
a	O
rectal	B-ANAT
swab	I-ANAT
from	O
a	O
least	O
horseshoe	O
bat	O
showed	O
that	O
it	O
contained	O
29	O
699	O
nucleotides	O
,	O
excluding	O
the	O
poly	O
(	O
A	O
)	O
tail	O
,	O
with	O
13	O
open	O
reading	O
frames	O
(	O
ORFs	O
).	O

The	O
data	O
revealed	O
that	O
,	O
in	O
HCoV	O
-	O
infected	O
(	O
but	O
not	O
IL	O
-	O
1	O
-	O
treated	O
)	O
cells	B-ANAT
,	O
an	O
extensive	O
set	O
of	O
genes	O
was	O
activated	O
without	O
inducible	O
p65	O
NF	O
-	O
ÎºB	O
being	O
recruited	O
.	O

Plasma	B-ANAT
cortisol	O
levels	O
during	O
treatment	O
were	O
measured	O
by	O
immunoassay	O
.	O

In	O
multiple	O
regression	O
analyses	O
,	O
younger	O
age	O
,	O
female	O
sex	O
,	O
higher	O
severity	O
of	O
illness	O
,	O
fewer	O
steroid	O
treatment	O
days	O
,	O
and	O
GM	O
-	O
CSF	B-ANAT
treatment	O
were	O
all	O
independently	O
associated	O
with	O
more	O
severe	O
psychiatric	O
symptoms	O
on	O
at	O
least	O
one	O
scale	O
.	O

ABSTRACT	O
:	O
Ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
)	O
is	O
a	O
severe	O
complication	O
of	O
mechanical	O
ventilation	O
that	O
can	O
lead	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Available	O
lung	B-ANAT
-	O
protective	O
ventilator	O
strategies	O
offer	O
only	O
a	O
modest	O
benefit	O
in	O
preventing	O
VILI	O
because	O
they	O
cannot	O
impede	O
alveolar	B-ANAT
overdistension	O
and	O
concomitant	O
epithelial	O
barrier	O
dysfunction	O
in	O
the	O
inflamed	O
lung	B-ANAT
regions	O
.	O

There	O
are	O
currently	O
no	O
effective	O
biochemical	O
therapies	O
to	O
mitigate	O
injury	O
to	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

Interaction	O
of	O
the	O
viral	O
spike	O
(	O
S	O
)	O
surface	O
glycoprotein	O
-	O
through	O
its	O
S1	O
subunit	O
-	O
with	O
the	O
host	B-ANAT
cell	I-ANAT
receptor	O
is	O
the	O
first	O
step	O
in	O
infection	O
and	O
the	O
main	O
determinant	O
for	O
virus	O
tropism	O
.	O

However	O
,	O
genetic	O
ablation	O
of	O
APN	O
expression	O
had	O
no	O
effect	O
on	O
their	O
infectability	O
by	O
PEDV	O
,	O
demonstrating	O
that	O
APN	O
is	O
not	O
essential	O
for	O
PEDV	O
cell	B-ANAT
entry	O
.	O

CONCLUSIONS	O
:	O
Usage	O
of	O
extended	O
criteria	O
donors	O
seems	O
a	O
successful	O
strategy	O
to	O
overcome	O
shortage	O
of	O
donor	O
lungs	B-ANAT
by	O
the	O
increasing	O
number	O
of	O
lung	B-ANAT
transplant	B-ANAT
candidates	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
pneumonia	O
have	O
a	O
great	O
impact	O
on	O
the	O
treatment	O
regimen	O
of	O
polytraumatized	O
patients	O
with	O
severe	O
chest	B-ANAT
trauma	O
.	O

With	O
regard	O
to	O
ARDS	O
,	O
initial	O
levels	O
of	O
cytokeratin	O
fragment	O
21	O
-	O
1	O
,	O
the	O
soluble	O
fragment	O
of	O
cytokeratin	O
19	O
(	O
CYFRA21	O
-	O
1	O
)	O
and	O
of	O
the	O
club	O
cell	B-ANAT
protein	O
16	O
(	O
CC16	O
)	O
provided	O
significant	O
results	O
in	O
each	O
statistical	O
analysis	O
.	O

CYFRA21	O
-	O
1	O
levels	O
exceeding	O
cut	O
-	O
off	O
value	O
of	O
1	O
.	O
85	O
ng	O
/	O
ml	O
and	O
2	O
.	O
49	O
ng	O
/	O
ml	O
in	O
the	O
serum	B-ANAT
shortly	O
after	O
multiple	O
injury	O
occurred	O
may	O
identify	O
polytraumatized	O
patients	O
at	O
risk	O
for	O
ARDS	O
and	O
pneumonia	O
,	O
respectively	O
.	O

However	O
,	O
if	O
either	O
PEDV	O
dose	O
of	O
inoculated	O
feed	O
was	O
pelleted	O
at	O
any	O
of	O
the	O
9	O
tested	O
conditioning	O
time	O
Ã	O
temperature	O
combinations	O
,	O
no	O
PEDV	O
RNA	O
was	O
detected	O
in	O
fecal	B-ANAT
swabs	O
or	O
cecum	B-ANAT
content	O
.	O

To	O
systematically	O
investigate	O
the	O
genetic	O
diversity	O
of	O
RVAs	O
,	O
547	O
bat	O
anal	B-ANAT
swabs	O
or	O
gut	B-ANAT
samples	O
along	O
with	O
448	O
bat	O
sera	B-ANAT
were	O
collected	O
from	O
five	O
South	O
Chinese	O
provinces	O
.	O

TITLE	O
:	O
Cell	B-ANAT
Attachment	I-ANAT
Domains	O
of	O
the	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
Spike	O
Protein	O
Are	O
Key	O
Targets	O
of	O
Neutralizing	O
Antibodies	O
.	O

These	O
findings	O
suggest	O
that	O
media	B-ANAT
content	O
affected	O
the	O
public	O
'	O
s	O
perception	O
of	O
MERS	O
risk	O
and	O
that	O
perception	O
of	O
a	O
high	O
level	O
of	O
risk	O
led	O
to	O
overreaction	O
.	O

The	O
phylogenetic	O
relationship	O
of	O
BR	O
-	O
UEL11	O
with	O
Brazilian	O
BCoV	O
,	O
which	O
is	O
associated	O
with	O
calf	B-ANAT
diarrhea	O
and	O
winter	O
dysentery	O
(	O
enteric	O
,	O
BECoV	O
;	O
respiratory	O
,	O
BRCoV	O
),	O
and	O
classical	O
reference	O
prototypes	O
was	O
analyzed	O
.	O

In	O
addition	O
,	O
an	O
increase	O
in	O
the	O
expression	O
of	O
the	O
above	O
cytokines	O
as	O
well	O
as	O
GM	O
-	O
CSF	B-ANAT
and	O
IFNÎ³	O
was	O
also	O
detected	O
in	O
the	O
PBMC	O
,	O
serum	B-ANAT
,	O
and	O
peritoneal	B-ANAT
effusions	I-ANAT
of	O
FCoV	O
-	O
positive	O
cats	O
.	O

ABSTRACT	O
:	O
Many	O
survivors	O
of	O
the	O
2003	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
developed	O
residual	O
pulmonary	B-ANAT
fibrosis	O
with	O
increased	O
severity	O
seen	O
in	O
older	O
patients	O
.	O

ABSTRACT	O
:	O
Cell	B-ANAT
surface	I-ANAT
aminopeptidase	O
N	O
(	O
APN	O
)	O
is	O
a	O
membrane	B-ANAT
-	O
bound	O
ectoenzyme	O
that	O
hydrolyzes	O
proteins	O
and	O
peptides	O
and	O
regulates	O
numerous	O
cell	B-ANAT
functions	O
.	O

APN	O
participates	O
in	O
tumor	B-ANAT
cell	I-ANAT
expansion	O
and	O
motility	O
,	O
and	O
is	O
a	O
target	O
for	O
cancer	O
therapies	O
.	O

ABSTRACT	O
:	O
Infections	O
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
can	O
be	O
caused	O
by	O
a	O
diversity	O
of	O
pathogens	O
,	O
both	O
viral	O
and	O
bacterial	O
.	O

Using	O
mouse	O
models	O
of	O
SARS	O
-	O
CoV	O
pathogenesis	O
,	O
we	O
have	O
identified	O
that	O
the	O
wound	O
repair	O
pathway	O
,	O
controlled	O
by	O
the	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
(	O
EGFR	O
),	O
is	O
critical	O
to	O
recovery	O
from	O
SARS	O
-	O
CoV	O
-	O
induced	O
tissue	B-ANAT
damage	O
.	O

Our	O
data	O
demonstrate	O
a	O
key	O
role	O
of	O
EGFR	O
in	O
the	O
host	O
response	O
to	O
SARS	O
-	O
CoV	O
and	O
how	O
it	O
may	O
be	O
implicated	O
in	O
lung	B-ANAT
disease	O
induced	O
by	O
other	O
highly	O
pathogenic	O
respiratory	O
viruses	O
.	O

We	O
hypothesized	O
that	O
lower	O
airway	B-ANAT
symptoms	O
in	O
ENS	O
could	O
be	O
explained	O
by	O
HVS	O
.	O

Three	O
-	O
week	O
-	O
old	O
barrows	O
were	O
inoculated	O
intragastrically	O
with	O
5	O
mL	O
of	O
PEDV	O
-	O
negative	O
feces	B-ANAT
for	O
the	O
negative	O
control	O
,	O
5	O
mL	O
of	O
untreated	O
PEDV	O
-	O
positive	O
feces	B-ANAT
for	O
the	O
positive	O
control	O
,	O
and	O
5	O
mL	O
or	O
10	O
mL	O
of	O
PEDV	O
-	O
positive	O
feces	B-ANAT
that	O
was	O
subjected	O
to	O
treatment	O
with	O
a	O
1	O
:	O
16	O
or	O
1	O
:	O
32	O
concentrations	O
of	O
accelerated	O
hydrogen	O
peroxide	O
disinfectant	O
for	O
a	O
contact	O
time	O
of	O
30	O
min	O
at	O
20	O
Â°	O
C	O
.	O

Our	O
approach	O
to	O
phenotype	O
categorization	O
remains	O
hypothetical	O
,	O
and	O
the	O
phenotypes	O
identified	O
need	O
to	O
be	O
confirmed	O
in	O
multicenter	O
studies	O
of	O
pediatric	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
.	O

ABSTRACT	O
:	O
To	O
enter	O
into	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
,	O
influenza	O
,	O
parainfluenza	O
-	O
and	O
coronaviruses	O
rely	O
on	O
host	B-ANAT
cell	I-ANAT
proteases	O
for	O
activation	O
of	O
the	O
viral	O
protein	O
involved	O
in	O
membrane	B-ANAT
fusion	O
.	O

Since	O
the	O
catalytic	O
sites	O
of	O
the	O
diverse	O
serine	O
proteases	O
linked	O
to	O
influenza	O
,	O
parainfluenza	O
-	O
and	O
coronavirus	O
activation	O
are	O
structurally	O
similar	O
,	O
active	O
site	O
inhibitors	O
of	O
these	O
airway	B-ANAT
proteases	O
could	O
have	O
broad	O
therapeutic	O
applicability	O
against	O
multiple	O
respiratory	O
viruses	O
.	O

The	O
main	O
contraindications	O
are	O
a	O
gestational	O
age	O
under	O
34	O
weeks	O
or	O
birth	O
weight	O
under	O
2kg	O
,	O
severe	O
underlying	O
pulmonary	B-ANAT
disease	O
,	O
severe	O
immune	O
deficiency	O
,	O
a	O
neurodegenerative	O
disease	O
and	O
hereditary	O
disease	O
of	O
hemostasis	O
.	O

More	O
importantly	O
,	O
CCL2	O
deficiency	O
ameliorated	O
H7N9	O
-	O
induced	O
ALI	O
in	O
mice	O
as	O
determined	O
by	O
weight	O
loss	O
,	O
survival	O
rate	O
,	O
the	O
wet	O
:	O
dry	O
ratio	O
of	O
the	O
lung	B-ANAT
,	O
and	O
pathology	O
.	O

The	O
patient	O
was	O
44	O
years	O
old	O
and	O
had	O
symptoms	O
including	O
high	O
fever	O
,	O
dry	O
cough	O
with	O
a	O
little	O
phlegm	B-ANAT
,	O
and	O
shortness	O
of	O
breath	B-ANAT
,	O
which	O
are	O
roughly	O
consistent	O
with	O
those	O
associated	O
with	O
MERS	O
,	O
and	O
had	O
had	O
close	O
contact	O
with	O
individuals	O
with	O
confirmed	O
cases	O
of	O
MERS	O
.	O
After	O
one	O
month	O
of	O
therapy	O
with	O
antiviral	O
,	O
anti	O
-	O
infection	O
,	O
and	O
immune	O
-	O
enhancing	O
agents	O
,	O
the	O
patient	O
recovered	O
in	O
the	O
hospital	O
and	O
was	O
discharged	O
.	O

A	O
nasopharyngeal	B-ANAT
swab	I-ANAT
sample	O
was	O
collected	O
for	O
direct	O
sequencing	O
,	O
which	O
revealed	O
two	O
deletion	O
variants	O
of	O
MERS	O
CoV	O
.	O
Deletions	O
of	O
414	O
and	O
419	O
nt	O
occurred	O
between	O
ORF5	O
and	O
the	O
E	O
protein	O
,	O
resulting	O
in	O
a	O
partial	O
protein	O
fusion	O
or	O
truncation	O
of	O
ORF5	O
and	O
the	O
E	O
protein	O
.	O

The	O
animals	O
received	O
intravenous	O
recombinant	O
human	O
IL	O
-	O
6	O
(	O
rHuIL	O
-	O
6	O
)	O
or	O
vehicle	O
followed	O
by	O
intratracheal	O
lipopolysaccharide	O
(	O
LPS	O
)	O
or	O
saline	O
before	O
undergoing	O
low	O
tidal	O
volume	O
mechanical	O
ventilation	O
(	O
MV	O
)	O
for	O
5	O
h	O
.	O
Before	O
sacrifice	O
,	O
right	O
ventricular	B-ANAT
systolic	O
pressure	O
and	O
cardiac	B-ANAT
output	O
were	O
measured	O
and	O
total	O
pulmonary	B-ANAT
resistance	O
was	O
calculated	O
.	O

Conclusions	O
and	O
relevance	O
FCoV	O
viremia	O
and	O
peripheral	B-ANAT
blood	I-ANAT
replication	O
in	O
healthy	O
shelter	O
cats	O
have	O
a	O
low	O
prevalence	O
and	O
do	O
not	O
correlate	O
with	O
later	O
development	O
of	O
FIP	O
in	O
this	O
study	O
population	O
,	O
but	O
larger	O
case	O
-	O
control	O
studies	O
evaluating	O
the	O
prognostic	O
accuracy	O
of	O
the	O
qRT	O
-	O
PCR	O
assays	O
are	O
needed	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
improved	O
outcomes	O
in	O
solid	B-ANAT
organ	I-ANAT
transplantation	O
with	O
regard	O
to	O
prevention	O
of	O
rejection	O
and	O
increased	O
patient	O
and	O
graft	B-ANAT
survival	O
,	O
infection	O
remains	O
a	O
common	O
cause	O
of	O
morbidity	O
and	O
mortality	O
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
System	O
selection	O
,	O
(	O
contra	O
)	O
indications	O
,	O
and	O
management	O
].	O

pentosaceus	O
77F	O
)	O
from	O
pig	O
feces	B-ANAT
were	O
well	O
-	O
characterized	O
as	O
high	O
potential	O
probiotics	O
.	O

Two	O
groups	O
of	O
4	O
animals	O
each	O
received	O
a	O
2	O
-	O
hour	O
infusion	O
of	O
LPS	O
through	O
the	O
external	B-ANAT
jugular	I-ANAT
vein	I-ANAT
.	O

Airway	B-ANAT
pressures	O
and	O
blood	B-ANAT
gases	O
were	O
recorded	O
for	O
calculation	O
of	O
dynamic	O
lung	B-ANAT
compliance	O
and	O
partial	O
pressure	O
of	O
oxygen	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
ratios	O
.	O

The	O
EVLP	O
group	O
demonstrated	O
significant	O
improvements	O
hour	O
1	O
to	O
hour	O
4	O
in	O
oxygenation	O
(	O
365	O
.	O
8	O
Â±	O
53	O
.	O
0	O
vs	O
584	O
.	O
4	O
Â±	O
21	O
.	O
0	O
mm	O
Hg	O
,	O
p	O
=	O
0	O
.	O
02	O
)	O
and	O
dynamic	O
compliance	O
(	O
9	O
.	O
0	O
Â±	O
2	O
.	O
8	O
vs	O
15	O
.	O
0	O
Â±	O
3	O
.	O
6	O
,	O
p	O
=	O
0	O
.	O
02	O
mL	O
/	O
cm	O
H	O
EVLP	O
successfully	O
rehabilitated	O
LPS	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
this	O
preclinical	O
porcine	O
model	O
and	O
may	O
thus	O
provide	O
a	O
means	O
to	O
rehabilitate	O
many	O
types	O
of	O
acute	O
lung	B-ANAT
injury	O
.	O

We	O
report	O
three	O
patients	O
presenting	O
with	O
common	O
dermatological	O
and	O
haematological	O
features	O
leading	O
to	O
the	O
diagnosis	O
of	O
GATA2	O
deficiency	O
,	O
but	O
also	O
with	O
skin	B-ANAT
manifestations	O
that	O
have	O
not	O
been	O
previously	O
described	O
:	O
gingival	B-ANAT
hypertrophy	O
,	O
macroglossitis	O
and	O
glossitis	O
and	O
granulomatous	O
lupoid	O
facial	B-ANAT
lesions	O
.	O

ABSTRACT	O
:	O
Plastic	O
bronchitis	O
is	O
used	O
to	O
designate	O
endobronchial	O
plugs	O
of	O
rubber	O
-	O
like	O
consistency	O
that	O
form	O
into	O
bronchial	B-ANAT
trees	O
.	O

It	O
has	O
been	O
described	O
in	O
several	O
diseases	O
like	O
asthma	O
,	O
cystic	O
fibrosis	O
,	O
pulmonary	B-ANAT
infection	O
,	O
cyanotic	O
congenital	O
heart	B-ANAT
disease	O
and	O
in	O
few	O
young	O
children	O
with	O
homozygous	O
sickle	B-ANAT
cell	I-ANAT
disease	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
is	O
characterized	O
by	O
diffuse	O
inflammatory	O
lung	B-ANAT
injury	O
and	O
is	O
classified	O
as	O
mild	O
,	O
moderate	O
,	O
and	O
severe	O
.	O

Among	O
the	O
direct	O
causes	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
chlorine	O
inhalation	O
is	O
an	O
uncommon	O
cause	O
,	O
generating	O
mucosal	B-ANAT
and	O
airway	B-ANAT
irritation	O
in	O
most	O
cases	O
.	O

TITLE	O
:	O
Plasminogen	O
Activator	O
Inhibitor	O
-	O
1	O
Is	O
Critical	O
in	O
Alcohol	O
-	O
Enhanced	O
Acute	O
Lung	B-ANAT
Injury	O
in	O
Mice	O
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
alcohol	O
sensitizes	O
the	O
lung	B-ANAT
to	O
development	O
of	O
this	O
disease	O
are	O
poorly	O
understood	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
TGEV	O
infection	O
activates	O
transcription	O
factors	O
NF	O
-	O
ÎºB	O
,	O
IRF3	O
and	O
AP	O
-	O
1	O
in	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
manner	O
in	O
porcine	O
kidney	B-ANAT
cells	B-ANAT
.	O

TITLE	O
:	O
An	O
Official	O
American	O
Thoracic	B-ANAT
Society	O
/	O
European	O
Society	O
of	O
Intensive	O
Care	O
Medicine	O
/	O
Society	O
of	O
Critical	O
Care	O
Medicine	O
Clinical	O
Practice	O
Guideline	O
:	O
Mechanical	O
Ventilation	O
in	O
Adult	O
Patients	O
with	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

RESULTS	O
:	O
For	O
all	O
patients	O
with	O
ARDS	O
,	O
the	O
recommendation	O
is	O
strong	O
for	O
mechanical	O
ventilation	O
using	O
lower	O
tidal	O
volumes	O
(	O
4	O
-	O
8	O
ml	O
/	O
kg	O
predicted	O
body	B-ANAT
weight	O
)	O
and	O
lower	O
inspiratory	O
pressures	O
(	O
plateau	O
pressure	O
<	O
30	O
cm	O
H	O

In	O
a	O
6	O
hour	O
pilot	O
study	O
,	O
we	O
analyzed	O
the	O
use	O
of	O
the	O
combination	O
of	O
both	O
stem	B-ANAT
cell	I-ANAT
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
strategies	O
to	O
prevent	O
or	O
treat	O
severe	O
lung	B-ANAT
injury	O
.	O

In	O
a	O
cohort	O
of	O
82	O
VV	O
-	O
ECMO	O
patients	O
(	O
PRedicting	O
dEath	O
for	O
SEvere	O
ARDS	O
on	O
VV	O
-	O
ECMO	O
[	O
PRESERVE	O
]	O
score	O
:	O
4	O
,	O
Interquartile	O
range	O
[	O
IQR	O
]:	O
3	O
-	O
5	O
,	O
Respiratory	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Survival	O
Prediction	O
[	O
RESP	O
]	O
score	O
:	O
2	O
,	O
IQR	O
:	O
2	O
-	O
4	O
),	O
76	O
(	O
92	O
.	O
7	O
%)	O
patients	O
received	O
at	O
least	O
1	O
unit	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
PRBCs	O
)	O
during	O
the	O
intensive	O
care	O
unit	O
stay	O
related	O
to	O
ECMO	O
(	O
median	O
PRBC	O
/	O
d	O
156	O
mL	O
,	O
IQR	O
:	O
93	O
-	O
218	O
;	O
median	O
ECMO	O
duration	O
14	O
days	O
,	O
IQR	O
:	O
8	O
-	O
22	O
).	O

Acute	O
respiratory	O
failure	O
was	O
a	O
common	O
indicator	O
for	O
pulmonary	B-ANAT
manifestation	O
(	O
87	O
%).	O

While	O
,	O
chest	B-ANAT
CT	O
findings	O
frequently	O
showed	O
ground	O
-	O
glass	O
opacity	O
(	O
GGO	O
)	O
in	O
89	O
%	O
of	O
patients	O
.	O

Chest	B-ANAT
X	O
-	O
ray	O
findings	O
in	O
HS	O
/	O
DS	O
cases	O
frequently	O
showed	O
diffuse	O
shadows	O
,	O
and	O
the	O
combination	O
of	O
GGO	O
and	O
interlobular	O
septal	O
thickening	O
in	O
chest	B-ANAT
CT	O
was	O
common	O
in	O
HS	O
/	O
DS	O
,	O
regardless	O
of	O
accompanying	O
pulmonary	B-ANAT
manifestations	O
.	O

By	O
combining	O
these	O
substrate	O
profiling	O
and	O
structural	O
data	O
,	O
we	O
were	O
able	O
to	O
design	O
a	O
selective	O
peptide	O
inhibitor	O
of	O
APN	O
that	O
was	O
an	O
effective	O
therapeutic	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
against	O
APN	O
-	O
expressing	O
prostate	B-ANAT
cancer	O
models	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
concisely	O
describe	O
the	O
current	O
standards	O
of	O
care	O
,	O
major	O
recent	O
advances	O
,	O
common	O
beliefs	O
that	O
have	O
been	O
contradicted	O
by	O
recent	O
trials	O
,	O
areas	O
of	O
uncertainty	O
,	O
and	O
clinical	O
studies	O
that	O
need	O
to	O
be	O
performed	O
over	O
the	O
next	O
decade	O
and	O
their	O
expected	O
outcomes	O
with	O
regard	O
to	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

ABSTRACT	O
:	O
The	O
ORF3	O
accessory	O
protein	O
has	O
been	O
shown	O
to	O
impede	O
reverse	O
genetics	O
of	O
cell	B-ANAT
-	O
culture	O
-	O
adapted	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
).	O

It	O
is	O
generally	O
associated	O
with	O
reduced	O
lung	B-ANAT
volume	O
with	O
increased	O
atelectasis	O
,	O
decreased	O
lung	B-ANAT
and	O
chest	B-ANAT
wall	I-ANAT
compliance	O
,	O
increased	O
airway	B-ANAT
resistance	O
,	O
and	O
moderate	O
to	O
severe	O
hypoxemia	O
.	O

It	O
may	O
ameliorate	O
obesity	O
-	O
related	O
comorbidities	O
,	O
counteract	O
upper	O
airway	B-ANAT
obstruction	O
,	O
reduce	O
hypoventilation	O
and	O
atelectasis	O
,	O
improve	O
gas	O
exchange	O
and	O
respiratory	O
function	O
,	O
relieve	O
dyspnea	O
,	O
and	O
decrease	O
breathing	O
effort	O
in	O
obese	O
patients	O
in	O
the	O
perioperative	O
period	O
.	O

ABSTRACT	O
:	O
Unilateral	O
anterior	B-ANAT
spinal	I-ANAT
artery	I-ANAT
(	O
ASA	O
)	O
occlusion	O
resulting	O
in	O
bilateral	O
medullary	B-ANAT
pyramidal	O
(	O
BMP	O
)	O
infarction	O
is	O
a	O
rare	O
and	O
devastating	O
stroke	O
subtype	O
.	O

Blood	B-ANAT
cultures	O
from	O
6	O
of	O
9	O
animals	O
in	O
the	O
SS	O
group	O
were	O
positive	O
for	O
MRSA	O
.	O

Respiratory	O
failure	O
,	O
caused	O
by	O
ARDS	O
as	O
the	O
severe	O
presentation	O
of	O
anastomotic	O
leak	O
,	O
is	O
the	O
most	O
common	O
organ	B-ANAT
failure	O
.	O

Clinical	O
data	O
were	O
collected	O
from	O
the	O
patients	O
'	O
electronic	O
medical	O
records	O
,	O
including	O
their	O
clinically	O
hematological	O
examination	O
,	O
drainage	B-ANAT
fluid	O
cultures	O
,	O
and	O
sputum	B-ANAT
culture	O
.	O

The	O
viral	B-ANAT
genome	I-ANAT
shares	O
75	O
.	O
4	O
%	O
nucleotide	O
identity	O
with	O
a	O
prototypic	O
EVG	O
strain	O
(	O
PEV9	O
UKG	O
/	O
410	O
/	O
73	O
).	O

Within	O
7	O
days	O
postinoculation	O
,	O
TC	O
-	O
PC177	O
caused	O
mild	O
diarrhea	O
and	O
lower	O
fecal	B-ANAT
viral	O
RNA	O
shedding	O
,	O
with	O
no	O
mortality	O
,	O
whereas	O
PC21A	O
caused	O
severe	O
clinical	O
signs	O
and	O
55	O
%	O
mortality	O
.	O

The	O
apoptosis	O
in	O
the	O
pyramidal	O
neurons	B-ANAT
is	O
accompanied	O
by	O
various	O
types	O
of	O
proinflammatory	O
cytokines	O
depending	O
on	O
the	O
causative	O
agents	O
.	O

Immunocytochemistry	O
was	O
positive	O
in	O
16	O
of	O
25	O
cats	O
with	O
FIP	O
and	O
2	O
of	O
11	O
control	O
cats	O
(	O
one	O
cat	O
with	O
lymphoma	O
,	O
one	O
with	O
pulmonary	B-ANAT
adenocarcinoma	O
).	O

The	O
pathogenesis	O
of	O
viral	O
FH	O
includes	O
virus	O
-	O
induced	O
immune	O
activation	O
,	O
inflammation	O
,	O
and	O
subsequent	O
hepatic	B-ANAT
apoptosis	O
and	O
necrosis	O
.	O

The	O
Hellevad	O
chickens	O
were	O
found	O
to	O
have	O
higher	O
body	B-ANAT
weight	O
at	O
the	O
end	O
of	O
the	O
experiment	O
(	O
17	O
weeks	O
of	O
age	O
)	O
than	O
the	O
other	O
two	O
lines	O
.	O

However	O
,	O
despite	O
initially	O
similar	O
Bmem	O
and	O
ASC	O
accumulation	O
,	O
Bmem	O
prevailed	O
in	O
the	O
brain	B-ANAT
,	O
but	O
were	O
lower	O
than	O
ASC	O
in	O
the	O
spinal	B-ANAT
cord	I-ANAT
during	O
persistence	O
.	O

The	O
optimal	O
mechanical	O
ventilator	O
management	O
and	O
lung	B-ANAT
recruitment	O
strategy	O
of	O
a	O
pediatric	O
patient	O
requiring	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
not	O
known	O
.	O

The	O
severity	O
of	O
his	O
illness	O
and	O
pertussis	O
infection	O
-	O
associated	O
intraluminal	O
bronchiole	B-ANAT
obstruction	O
made	O
medical	O
management	O
challenging	O
.	O

Second	O
,	O
there	O
was	O
a	O
trend	O
that	O
individuals	O
with	O
a	O
poor	O
body	B-ANAT
condition	O
had	O
a	O
higher	O
probability	O
of	O
shedding	O
astroviruses	O
in	O
their	O
feces	B-ANAT
.	O

An	O
iTRAQ	O
-	O
based	O
comparative	O
quantitative	O
proteomic	O
study	O
of	O
IPEC	O
-	O
J2	O
cells	B-ANAT
infected	O
with	O
YC2014	O
and	O
a	O
classical	O
CV777	O
strain	O
(	O
CV777	O
)	O
was	O
performed	O
to	O
determine	O
the	O
differences	O
between	O
pandemic	O
and	O
classical	O
PEDV	O
strain	O
infection	O
.	O

The	O
results	O
indicated	O
that	O
the	O
PEDV	O
suppressed	O
protein	O
synthesis	O
of	O
IPEC	O
-	O
J2	O
cells	B-ANAT
through	O
down	O
-	O
regulation	O
of	O
the	O
PI3K	O
-	O
AKT	O
/	O
mTOR	O
signaling	O
pathways	O
.	O

Migration	O
of	O
fibroblasts	B-ANAT
toward	O
the	O
fibrotic	O
lesions	O
plays	O
an	O
important	O
role	O
in	O
pulmonary	B-ANAT
fibrosis	O
.	O

Fibrotic	O
tissue	B-ANAT
in	O
the	O
lung	B-ANAT
is	O
much	O
stiffer	O
than	O
normal	O
lung	B-ANAT
tissue	I-ANAT
.	O

Expression	O
of	O
GPC3	O
leads	O
to	O
an	O
increased	O
apoptosis	O
response	O
in	O
human	O
lung	B-ANAT
carcinoma	O
tumor	B-ANAT
cells	I-ANAT
,	O
and	O
is	O
considered	O
to	O
be	O
a	O
candidate	O
lung	B-ANAT
tumor	O
suppressor	O
gene	O
.	O

Glypican	O
-	O
3	O
could	O
be	O
considered	O
as	O
a	O
clinically	O
useful	O
biomarker	O
in	O
hepatocellular	O
carcinoma	O
,	O
lung	B-ANAT
carcinoma	O
,	O
and	O
ARDS	O
,	O
but	O
further	O
research	O
is	O
needed	O
to	O
confirm	O
and	O
expand	O
on	O
these	O
findings	O
.	O

Here	O
,	O
we	O
report	O
that	O
miR	O
-	O
142	O
-	O
5p	O
is	O
localized	O
to	O
neurons	B-ANAT
and	O
negatively	O
regulates	O
neuronal	O
morphogenesis	O
in	O
porcine	O
hemagglutinating	O
encephalomyelitis	O
(	O
PHE	O
).	O

This	O
phenotype	O
was	O
mediated	O
by	O
miR	O
-	O
142	O
-	O
5p	O
inhibition	O
of	O
an	O
mRNA	O
encoding	O
unc	O
-	O
51	O
-	O
like	O
-	O
kinase1	O
(	O
Ulk1	O
),	O
which	O
controls	O
axon	B-ANAT
outgrowth	O
and	O
dendrite	B-ANAT
formation	O
.	O

ABSTRACT	O
:	O
The	O
study	O
aim	O
was	O
to	O
investigate	O
the	O
prevalence	O
and	O
clinical	O
relevance	O
of	O
viral	O
findings	O
by	O
multiplex	O
PCR	O
from	O
the	O
nasopharynx	B-ANAT
of	O
clinically	O
septic	O
patients	O
during	O
a	O
winter	O
season	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
lung	B-ANAT
epithelium	B-ANAT
,	O
specifically	O
alveolar	B-ANAT
type	O
II	O
cells	B-ANAT
,	O
is	O
the	O
predominant	O
site	O
of	O
LIF	O
transcript	O
induction	O
in	O
pneumonic	O
mouse	O
lungs	B-ANAT
.	O

Reciprocal	O
bone	B-ANAT
marrow	I-ANAT
chimera	O
studies	O
demonstrated	O
that	O
LIF	O
deficiency	O
in	O
the	O
nonhematopoietic	O
compartment	B-ANAT
,	O
but	O
not	O
LIF	O
deficiency	O
in	O
hematopoietic	O
cells	B-ANAT
,	O
eliminated	O
LIF	O
induction	O
during	O
pneumonia	O
.	O

Overall	O
,	O
our	O
data	O
suggest	O
a	O
signaling	O
axis	B-ANAT
whereby	O
activation	O
of	O
NF	O
-	O
ÎºB	O
RelA	O
in	O
myeloid	B-ANAT
cells	I-ANAT
promotes	O
epithelial	O
LIF	O
induction	O
during	O
lung	B-ANAT
infections	O
,	O
representing	O
a	O
means	O
through	O
which	O
these	O
two	O
cell	B-ANAT
types	O
collaborate	O
to	O
improve	O
tissue	B-ANAT
resilience	O
during	O
pneumonia	O
.	O

Five	O
days	O
after	O
challenge	O
,	O
the	O
tissue	B-ANAT
samples	O
from	O
the	O
trachea	B-ANAT
,	O
lungs	B-ANAT
and	O
kidneys	B-ANAT
were	O
taken	O
to	O
evaluate	O
cilliary	O
activity	O
,	O
viral	O
load	O
(	O
quantitative	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
),	O
and	O
histopathological	O
evaluation	O
.	O

ABSTRACT	O
:	O
Type	O
II	O
transmembrane	B-ANAT
serine	O
proteases	O
(	O
TTSPs	O
)	O
facilitate	O
the	O
spread	O
and	O
replication	O
of	O
viruses	O
such	O
as	O
influenza	O
and	O
human	O
coronaviruses	O
,	O
although	O
it	O
remains	O
unclear	O
whether	O
TTSPs	O
play	O
a	O
role	O
in	O
the	O
progression	O
of	O
animal	O
coronavirus	O
infections	O
,	O
such	O
as	O
that	O
by	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
).	O

TITLE	O
:	O
Antiviral	O
escin	O
derivatives	O
from	O
the	O
seeds	O
of	O
Aesculus	O
turbinata	O
Blume	O
(	O
Japanese	O
horse	O
chestnut	B-ANAT
).	O

Compounds	O
1	O
-	O
7	O
had	O
no	O
cytotoxicity	O
at	O
20Î¼M	O
on	O
VERO	B-ANAT
cells	I-ANAT
,	O
while	O
compounds	O
8	O
-	O
10	O
showed	O
strong	O
cytotoxicity	O
at	O
similar	O
concentrations	O
on	O
PEDV	O
.	O

Neonatal	O
complications	O
resulting	O
from	O
meconium	B-ANAT
aspiration	O
syndrome	O
(	O
MAS	B-ANAT
)	O
and	O
sepsis	O
were	O
more	O
common	O
in	O
the	O
non	O
-	O
obstetric	O
causes	O
group	O
;	O
however	O
,	O
neurological	O
development	O
impairment	O
was	O
more	O
common	O
in	O
the	O
obstetric	O
causes	O
group	O
.	O

TITLE	O
:	O
Evaluation	O
and	O
Comparison	O
of	O
the	O
Pathogenicity	O
and	O
Host	O
Immune	O
Responses	O
Induced	O
by	O
a	O
G2b	O
Taiwan	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
(	O
Strain	O
Pintung	O
52	O
)	O
and	O
Its	O
Highly	O
Cell	B-ANAT
-	O
Culture	O
Passaged	O
Strain	O
in	O
Conventional	O
5	O
-	O
Week	O
-	O
Old	O
Pigs	O
.	O

TITLE	O
:	O
Clinicopathological	O
spectrum	O
of	O
snake	O
bite	O
-	O
induced	O
acute	O
kidney	B-ANAT
injury	O
from	O
India	O
.	O

In	O
patients	O
subjected	O
to	O
kidney	B-ANAT
biopsy	O
,	O
the	O
findings	O
of	O
histopathological	O
examination	O
of	O
the	O
kidney	B-ANAT
biopsies	O
were	O
also	O
analyzed	O
.	O

The	O
U	O
.	O
angolensis	O
stem	B-ANAT
bark	O
methanol	O
extract	O
inhibit	O
both	O
HIV	O
-	O
1	O
RNase	O
H	O
function	O
and	O
RDDP	O
activity	O
with	O
IC	O

She	O
developed	O
severe	O
acute	O
kidney	B-ANAT
injury	O
with	O
acute	O
tubular	O
necrosis	O
,	O
subnephrotic	O
ranged	O
proteinuria	O
and	O
tubulointerstitial	O
nephritis	O
for	O
which	O
she	O
underwent	O
haemodialysis	O
three	O
times	O
along	O
with	O
other	O
measures	O
of	O
resuscitation	O
.	O

Organ	B-ANAT
dysfunction	O
was	O
assessed	O
via	O
daily	O
Pediatric	O
Logistic	O
Organ	B-ANAT
Dysfunction	O
-	O
2	O
scores	O
for	O
7	O
days	O
preceding	O
death	O
with	O
an	O
increase	O
greater	O
than	O
or	O
equal	O
to	O
5	O
defined	O
as	O
worsening	O
organ	B-ANAT
dysfunction	O
.	O

In	O
recent	O
years	O
,	O
there	O
has	O
been	O
a	O
significant	O
increase	O
in	O
extracorporeal	O
life	O
support	O
as	O
a	O
substitute	O
for	O
cardiac	B-ANAT
function	O
(	O
VA	O
-	O
ECMO	O
)	O
and	O
lung	B-ANAT
function	O
(	O
VV	O
-	O
ECMO	O
)	O
in	O
light	O
of	O
technological	O
improvements	O
and	O
the	O
experience	O
of	O
the	O
medical	O
teams	O
.	O

Therefore	O
,	O
this	O
treatment	O
option	O
for	O
patients	O
with	O
severe	O
respiratory	O
and	O
/	O
or	O
cardiac	B-ANAT
insufficiency	O
should	O
be	O
considered	O
as	O
a	O
therapeutic	O
option	O
in	O
appropriate	O
situations	O
.	O

TITLE	O
:	O
A	O
Role	O
for	O
Neutrophils	B-ANAT
in	O
Viral	O
Respiratory	O
Disease	O
.	O

ABSTRACT	O
:	O
Neutrophils	B-ANAT
are	O
immune	O
cells	B-ANAT
that	O
are	O
well	O
known	O
to	O
be	O
present	O
during	O
many	O
types	O
of	O
lung	B-ANAT
diseases	O
associated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
may	O
contribute	O
to	O
acute	O
lung	B-ANAT
injury	O
.	O

Therefore	O
,	O
in	O
acute	O
cases	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
when	O
rapid	O
diagnostics	O
of	O
the	O
causative	O
agent	O
are	O
not	O
readily	O
available	O
,	O
an	O
antiviral	O
drug	O
with	O
properties	O
like	O
FA	O
-	O
613	O
could	O
prove	O
to	O
be	O
very	O
valuable	O
.	O

Outcomes	O
were	O
modeled	O
with	O
multivariable	O
regressions	O
adjusted	O
for	O
baseline	O
covariates	O
,	O
age	O
,	O
sex	O
,	O
race	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
III	O
(	O
APACHE	O
III	O
),	O
vasopressor	O
use	O
,	O
modified	O
lung	B-ANAT
injury	O
score	O
,	O
diabetes	O
mellitus	O
,	O
cancer	O
status	O
,	O
body	B-ANAT
mass	O
index	O
,	O
pre	O
-	O
ICU	O
location	O
,	O
ICU	O
location	O
,	O
and	O
study	O
.	O

ABSTRACT	O
:	O
Intracellular	B-ANAT
trafficking	O
and	O
localization	O
studies	O
of	O
spike	O
protein	O
from	O
SARS	O
and	O
OC43	O
showed	O
that	O
SARS	O
spike	O
protein	O
is	O
localized	O
in	O
the	O
ER	O
or	O
ERGIC	B-ANAT
compartment	B-ANAT
and	O
OC43	O
spike	O
protein	O
is	O
predominantly	O
localized	O
in	O
the	O
lysosome	B-ANAT
.	O

The	O
sequence	O
alignment	O
using	O
Clustal	O
W	O
shows	O
that	O
the	O
signal	O
sequence	O
present	O
at	O
the	O
cytoplasmic	B-ANAT
tail	I-ANAT
plays	O
an	O
important	O
role	O
in	O
spike	O
protein	O
localization	O
.	O

This	O
study	O
sheds	O
some	O
light	O
on	O
the	O
role	O
of	O
cytoplasmic	B-ANAT
tail	I-ANAT
of	O
spike	O
protein	O
in	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
fusion	O
,	O
coronavirus	O
host	B-ANAT
cell	I-ANAT
fusion	O
and	O
subsequent	O
pathogenicity	O
.	O

In	O
order	O
to	O
identify	O
potential	O
serological	O
markers	O
that	O
distinguish	O
HFRS	O
and	O
HPS	O
,	O
serum	B-ANAT
samples	O
collected	O
during	O
early	O
and	O
late	O
phases	O
of	O
the	O
disease	O
were	O
analyzed	O
for	O
48	O
analytes	O
using	O
multiplex	O
magnetic	O
bead	O
-	O
based	O
assays	O
.	O

TITLE	O
:	O
Recurrent	O
elevated	O
liver	B-ANAT
transaminases	O
and	O
acute	O
liver	B-ANAT
failure	O
in	O
two	O
siblings	O
with	O
novel	O
bi	O
-	O
allelic	O
mutations	O
of	O
NBAS	O
.	O

Patient	O
1	O
had	O
mild	O
facial	B-ANAT
dysmorphism	O
and	O
died	O
during	O
the	O
second	O
ELT	O
crisis	O
at	O
3	O
-	O
11	O
/	O
12	O
years	O
of	O
age	O
.	O

MVA	O
MERS	O
with	O
mH5	O
or	O
F11	O
promoter	O
induced	O
similar	O
antibody	O
levels	O
;	O
however	O
,	O
F11	O
promoter	O
enhanced	O
the	O
cellular	B-ANAT
immunogenicity	O
of	O
MVA	O
MERS	O
to	O
significantly	O
higher	O
magnitudes	O
.	O

The	O
protein	O
contains	O
a	O
frataxin	O
fold	O
or	O
double	O
-	O
wing	B-ANAT
motif	O
,	O
which	O
is	O
an	O
Î±	O
+	O
Î²	O
fold	O
that	O
is	O
associated	O
with	O
protein	O
/	O
protein	O
interactions	O
,	O
DNA	O
binding	O
,	O
and	O
metal	O
ion	O
binding	O
.	O

In	O
this	O
study	O
,	O
we	O
collected	O
1004	O
samples	O
involving	O
10	O
bat	O
species	O
from	O
7	O
sites	O
from	O
April	O
2015	O
to	O
May	O
2016	O
,	O
and	O
examined	O
the	O
presence	O
of	O
viruses	O
using	O
nucleic	B-ANAT
acid	O
-	O
based	O
methods	O
.	O

Herein	O
,	O
the	O
genomic	O
part	O
coding	O
for	O
the	O
spike	O
glycoprotein	O
ectodomain	O
was	O
replaced	O
by	O
that	O
of	O
the	O
coronavirus	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
allowing	O
for	O
the	O
selection	O
and	O
propagation	O
of	O
recombinant	O
mIBV	O
in	O
murine	O
cells	B-ANAT
.	O

ARDS	O
is	O
defined	O
as	O
an	O
acute	O
disorder	O
that	O
starts	O
within	O
7	O
days	O
of	O
the	O
inciting	O
event	O
and	O
is	O
characterized	O
by	O
bilateral	O
lung	B-ANAT
infiltrates	O
and	O
severe	O
progressive	O
hypoxemia	O
in	O
the	O
absence	O
of	O
any	O
evidence	O
of	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
.	O

ABSTRACT	O
:	O
Human	O
coronaviruses	O
(	O
CoV	O
)	O
have	O
been	O
long	O
recognized	O
as	O
a	O
common	O
cause	O
of	O
respiratory	B-ANAT
tract	I-ANAT
disease	O
including	O
severe	O
respiratory	B-ANAT
tract	I-ANAT
illness	O
.	O

Virus	O
infection	O
experiments	O
showed	O
that	O
SD	O
caused	O
high	O
mortality	O
with	O
strong	O
respiratory	O
and	O
renal	B-ANAT
pathogenicity	O
in	O
chickens	O
,	O
whereas	O
SZ	O
caused	O
milder	O
lesions	O
by	O
comparison	O
.	O

She	O
was	O
intubated	O
and	O
managed	O
with	O
intravenous	O
antibiotics	O
and	O
blood	B-ANAT
transfusion	O
.	O

In	O
this	O
study	O
,	O
the	O
PEDV	O
strain	O
85	O
-	O
7	O
could	O
be	O
proliferated	O
effectively	O
in	O
MARC	O
-	O
145	O
cells	B-ANAT
,	O
and	O
caused	O
a	O
distinct	O
inhibition	O
of	O
the	O
expression	O
of	O
interferon	O
-	O
Î²	O
(	O
IFN	O
-	O
Î²	O
,	O
encoded	O
by	O
IFNB1	O
),	O
which	O
suggested	O
that	O
a	O
full	O
understanding	O
how	O
this	O
virus	O
manipulates	O
the	O
host	O
immune	O
responses	O
is	O
critical	O
in	O
the	O
fight	O
against	O
the	O
spread	O
of	O
PEDV	O
.	O

Isolating	O
PEDV	O
neutralizing	O
antibodies	O
from	O
porcine	O
B	B-ANAT
cells	I-ANAT
is	O
critical	O
to	O
elucidate	O
the	O
development	O
of	O
PEDV	O
neutralizing	O
antibodies	O
and	O
the	O
protective	O
mechanism	O
of	O
PEDV	O
infection	O
.	O

TITLE	O
:	O
Optimal	O
right	B-ANAT
heart	I-ANAT
filling	O
pressure	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
determined	O
by	O
strain	O
echocardiography	O
.	O

While	O
preload	O
optimization	O
is	O
crucial	O
in	O
its	O
management	O
,	O
dynamic	O
fluid	O
responsiveness	O
indices	O
lack	O
reliability	O
,	O
and	O
there	O
is	O
no	O
consensus	O
on	O
target	O
central	O
venous	B-ANAT
pressure	O
(	O
CVP	O
).	O

ABSTRACT	O
:	O
Controlled	O
hypoventilation	O
while	O
accepting	O
hypercapnia	O
has	O
been	O
advocated	O
to	O
reduce	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
collected	O
for	O
analysis	O
of	O
oxidative	O
parameters	O
and	O
specific	O
antibody	O
titers	O
,	O
and	O
splenocytes	O
were	O
prepared	O
for	O
lymphocyte	B-ANAT
proliferative	O
assay	O
.	O

To	O
develop	O
a	O
radiological	O
metric	O
of	O
injurious	O
inflation	O
derived	O
from	O
matched	O
inspiratory	O
and	O
expiratory	O
CT	O
scans	O
,	O
calibrate	O
it	O
in	O
a	O
model	O
of	O
experimental	O
lung	B-ANAT
injury	O
,	O
and	O
test	O
it	O
in	O
patients	O
with	O
ARDS	O
.	O

A	O
single	O
set	O
of	O
superimposed	O
inspiratory	O
-	O
expiratory	O
CT	O
scans	O
may	O
predict	O
progression	O
of	O
lung	B-ANAT
injury	O
and	O
outcome	O
in	O
ARDS	O
;	O
if	O
these	O
preliminary	O
results	O
are	O
validated	O
,	O
this	O
could	O
facilitate	O
clinical	O
trial	O
recruitment	O
and	O
individualised	O
care	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
HKU15	O
is	O
a	O
deltacoronavirus	O
that	O
was	O
discovered	O
in	O
fecal	B-ANAT
samples	O
of	O
pigs	O
in	O
Hong	O
Kong	O
in	O
2012	O
.	O

Throat	B-ANAT
or	O
nasopharyngeal	B-ANAT
swabs	O
were	O
obtained	O
from	O
36	O
patient	O
and	O
analyzed	O
for	O
the	O
presence	O
of	O
Influenza	O
virus	O
by	O
quantitative	O
PCR	O
.	O

In	O
addition	O
,	O
other	O
modalities	O
,	O
such	O
as	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
,	O
may	O
further	O
complicate	O
dosing	O
strategies	O
.	O

The	O
protocol	O
below	O
regards	O
exclusively	O
veno	O
-	O
venous	B-ANAT
ECMO	O
treatment	O
as	O
a	O
support	O
for	O
blood	B-ANAT
gas	O
conditioning	O
by	O
means	O
of	O
extracorporeal	O
circuit	O
in	O
adult	O
patients	O
with	O
severe	O
ARDS	O
.	O

Rapamycin	O
adjuvant	O
suppressed	O
influenza	O
hemagglutinin	O
antigen	O
-	O
specific	O
T	B-ANAT
cell	I-ANAT
immunity	O
and	O
impaired	O
virus	O
clearance	O
from	O
the	O
lungs	B-ANAT
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
resveratrol	O
and	O
pterostilbene	O
completely	O
block	O
HIV	O
-	O
1	O
infection	O
at	O
a	O
low	O
micromolar	O
dose	O
in	O
resting	B-ANAT
CD4	O
T	B-ANAT
cells	I-ANAT
,	O
primarily	O
at	O
the	O
reverse	O
transcription	O
step	O
.	O

The	O
investigation	O
of	O
the	O
cardiac	B-ANAT
murmur	O
disclosed	O
AS	O
.	O

However	O
,	O
the	O
aortic	B-ANAT
valve	I-ANAT
replacement	O
was	O
prioritized	O
.	O

While	O
awaiting	O
cardiac	B-ANAT
surgery	O
,	O
the	O
patient	O
died	O
because	O
of	O
respiratory	O
insufficiency	O
.	O

Imaging	O
studies	O
showed	O
bilateral	O
diaphragmatic	B-ANAT
paralysis	O
,	O
and	O
electromyography	O
(	O
EMG	O
)	O
confirmed	O
neuropathy	O
of	O
both	O
phrenic	B-ANAT
nerves	I-ANAT
.	O

The	O
patient	O
received	O
nocturnal	O
ventilation	O
support	O
via	O
nasal	B-ANAT
high	O
flow	O
oxygen	O
therapy	O
.	O

We	O
show	O
that	O
a	O
nucleotide	O
prodrug	O
,	O
GS	O
-	O
5734	O
,	O
currently	O
in	O
clinical	O
development	O
for	O
treatment	O
of	O
Ebola	O
virus	O
disease	O
,	O
can	O
inhibit	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
replication	O
in	O
multiple	O
in	O
vitro	O
systems	O
,	O
including	O
primary	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
cultures	O
with	O
submicromolar	O
IC	O

The	O
massive	O
inflammatory	O
reaction	O
that	O
follows	O
deep	O
burn	O
injury	O
,	O
compounded	O
by	O
episodes	O
of	O
sepsis	O
and	O
organ	B-ANAT
dysfunction	O
,	O
predisposes	O
patients	O
to	O
the	O
development	O
of	O
ARDS	O
.	O

Computed	O
tomography	O
revealed	O
subarachnoid	O
hemorrhage	O
and	O
cerebral	B-ANAT
angiography	O
showed	O
a	O
right	O
vertebral	B-ANAT
dissecting	O
aneurysm	O
involving	O
the	O
posterior	B-ANAT
inferior	I-ANAT
cerebellar	I-ANAT
artery	I-ANAT
.	O

Demographic	O
and	O
clinical	O
characteristics	O
were	O
similar	O
among	O
the	O
2	O
groups	O
except	O
for	O
a	O
lower	O
median	O
(	O
interquartile	O
range	O
[	O
IQR	O
])	O
body	B-ANAT
mass	O
index	O
(	O
BMI	O
;	O
27	O
[	O
22	O
.	O
67	O
-	O
31	O
.	O
60	O
]	O
versus	O
30	O
.	O
8	O
[	O
24	O
.	O
55	O
-	O
40	O
.	O
06	O
],	O
Among	O
institutions	O
with	O
a	O
tracheostomy	O
team	O
,	O
the	O
practice	O
of	O
tracheostomy	O
with	O
concomitant	O
PEG	O
placement	O
may	O
be	O
considered	O
as	O
feasible	O
as	O
delayed	O
PEG	O
in	O
carefully	O
selected	O
neurocritically	O
ill	O
patients	O
with	O
possible	O
advantages	O
of	O
overall	O
shorter	O
NCCU	O
and	O
hospital	O
LOS	O
,	O
higher	O
predischarge	O
prealbumin	O
,	O
and	O
lower	O
hospital	O
costs	O
.	O

Moreover	O
,	O
in	O
a	O
bleomycin	O
-	O
based	O
model	O
of	O
acute	O
lung	B-ANAT
injury	O
,	O
megalin	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
and	O
Pulmonary	B-ANAT
Tuberculosis	O
Coinfection	O
:	O
Implications	O
for	O
Infection	O
Control	O
.	O

This	O
study	O
was	O
conducted	O
to	O
develop	O
a	O
drug	O
delivery	O
system	O
using	O
lipid	O
-	O
core	O
nanocapsules	O
(	O
LNCs	O
)	O
to	O
improve	O
the	O
anti	O
-	O
inflammatory	O
effects	O
of	O
orally	B-ANAT
administered	O
Î±	O
-	O
bis	O
.	O

The	O
serum	B-ANAT
levels	O
of	O
interferon	O
(	O
IFN	O
)-	O
Î³	O
and	O
the	O
IFN	O
-	O
Î³	O
/	O
interleukin	O
(	O
IL	O
)-	O
10	O
ratio	O
were	O
higher	O
in	O
non	O
-	O
survivors	O
.	O

Skin	B-ANAT
and	O
soft	B-ANAT
tissue	I-ANAT
infections	O
were	O
diagnosed	O
in	O
14	O
patients	O
(	O
26	O
.	O
9	O
%),	O
14	O
(	O
26	O
.	O
9	O
%)	O
pneumonias	O
,	O
12	O
(	O
23	O
.	O
1	O
%)	O
bones	B-ANAT
and	O
joints	B-ANAT
infections	O
,	O
10	O
(	O
19	O
.	O
2	O
%)	O
SSTS	O
,	O
6	O
(	O
11	O
.	O
5	O
%)	O
occult	O
bacteremia	O
,	O
4	O
(	O
7	O
.	O
7	O
%)	O
meningitis	O
and	O
2	O
(	O
3	O
.	O
8	O
%)	O
sepsis	O
.	O

Skin	B-ANAT
and	O
soft	B-ANAT
tissue	I-ANAT
infections	O
,	O
and	O
pleuroneumonia	O
were	O
the	O
most	O
common	O
forms	O
of	O
ID	O
.	O

In	O
these	O
patients	O
,	O
ECCO	O
CONCLUSIONS	O
:	O
Optimized	O
use	O
of	O
NIV	O
and	O
lung	B-ANAT
-	O
protective	O
ventilation	O
remains	O
standard	O
of	O
care	O
in	O
the	O
management	O
of	O
hypercapnic	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Effect	O
of	O
feeding	O
three	O
lysine	O
to	O
energy	O
diets	O
on	O
growth	O
,	O
body	B-ANAT
composition	O
and	O
age	O
at	O
puberty	O
in	O
replacement	O
gilts	O
.	O

ABSTRACT	O
:	O
This	O
study	O
evaluated	O
the	O
effect	O
of	O
diets	O
differing	O
in	O
standard	O
ileal	B-ANAT
digestible	O
(	O
SID	O
)	O
lysine	O
on	O
lysine	O
intake	O
,	O
growth	O
rate	O
,	O
body	B-ANAT
composition	O
and	O
age	O
at	O
puberty	O
on	O
maternal	O
line	O
gilts	O
.	O

Body	B-ANAT
weight	O
(	O
BW	O
),	O
backfat	O
thickness	O
(	O
BF	O
),	O
and	O
loin	B-ANAT
depth	O
(	O
LD	O
)	O
were	O
recorded	O
every	O
28days	O
.	O

RESULTS	O
:	O
Arrived	O
on	O
16th	O
December	O
2012	O
,	O
mostly	O
stayed	O
at	O
daughter	O
'	O
s	O
house	O
,	O
visited	O
by	O
relatives	O
,	O
on	O
19th	O
January	O
,	O
left	O
for	O
KSA	O
accompanied	O
by	O
daughter	O
,	O
developed	O
fever	O
with	O
chills	O
and	O
body	B-ANAT
aches	O
on	O
23rd	O
January	O
.	O

We	O
examined	O
sera	B-ANAT
from	O
100	O
wild	O
raccoons	O
in	O
Japan	O
for	O
antibodies	O
to	O
six	O
canine	O
viruses	O
with	O
veterinary	O
significance	O
to	O
assess	O
their	O
potential	O
as	O
reservoirs	O
.	O

In	O
the	O
present	O
study	O
using	O
porcine	O
epithelial	B-ANAT
cells	I-ANAT
,	O
we	O
showed	O
that	O
PEDV	O
inhibited	O
both	O
NF	O
-	O
ÎºB	O
and	O
proinflammatory	O
cytokines	O
.	O

Human	O
and	O
camel	O
sera	B-ANAT
were	O
tested	O
for	O
anti	O
-	O
MERS	O
-	O
CoV	O
IgG	O
using	O
a	O
commercial	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
test	O
.	O

Treating	O
that	O
with	O
steroids	O
compromised	O
her	O
immune	B-ANAT
system	I-ANAT
beyond	O
her	O
pre	O
-	O
existing	O
primary	O
immunodeficiency	O
status	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
role	O
of	O
the	O
protein	O
C	O
system	O
,	O
endothelial	B-ANAT
protein	O
C	O
receptor	O
(	O
EPCR	O
)	O
and	O
thrombomodulin	O
(	O
TM	O
)	O
in	O
the	O
pathogenesis	O
of	O
malaria	O
-	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
relation	O
to	O
hemozoin	O
and	O
proinflammatory	O
cytokines	O
-	O
induced	O
type	B-ANAT
II	I-ANAT
pneumocyte	I-ANAT
injury	O
and	O
-	O
aggravated	O
pulmonary	B-ANAT
resolution	O
.	O

The	O
loss	O
of	O
EPCR	O
and	O
TM	O
was	O
primarily	O
identified	O
in	O
ARDS	O
patients	O
and	O
was	O
related	O
to	O
the	O
level	O
of	O
hemozoin	O
,	O
parasitized	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
(	O
PRBC	O
)	O
and	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
accumulation	O
in	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Extracorporeal	O
Life	O
Support	O
as	O
a	O
Bridge	O
to	O
Lung	B-ANAT
Transplantation	O
in	O
Patients	O
With	O
Acute	O
Respiratory	O
Failure	O
.	O

Our	O
findings	O
support	O
the	O
view	O
that	O
well	O
-	O
selected	O
candidates	O
with	O
acutely	O
decompensated	O
end	O
-	O
stage	O
lung	B-ANAT
disease	O
may	O
be	O
safely	O
bridged	O
until	O
a	O
suitable	O
donor	O
is	O
identified	O
.	O

In	O
addition	O
,	O
we	O
revealed	O
that	O
the	O
nsp3	O
-	O
nsp4	O
interaction	O
is	O
not	O
sufficient	O
to	O
induce	O
membrane	B-ANAT
rearrangement	O
,	O
suggesting	O
the	O
participation	O
of	O
other	O
factors	O
such	O
as	O
host	O
proteins	O
.	O

TITLE	O
:	O
SARS	O
,	O
MERS	O
and	O
other	O
Viral	O
Lung	B-ANAT
Infections	O
ABSTRACT	O
:	O
Respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
infection	O
has	O
an	O
estimated	O
global	O
incidence	O
of	O
33	O
million	O
cases	O
in	O
children	O
younger	O
than	O
5	O
years	O
,	O
with	O
10	O
%	O
requiring	O
hospital	O
admission	O
and	O
up	O
to	O
199	O
,	O
000	O
dying	O
of	O
the	O
disease	O
.	O

For	O
the	O
most	O
promising	O
ELISA	O
,	O
i	O
.	O
e	O
.,	O
the	O
SP4	B-ANAT
ELISA	O
,	O
the	O
correlation	O
coefficient	O
(	O
r	O
)	O
and	O
the	O
area	O
under	O
curve	O
(	O
AUC	O
)	O
were	O
determined	O
to	O
be	O
0	O
.	O
6113	O
and	O
0	O
.	O
8538	O
,	O
respectively	O
.	O

Thus	O
,	O
we	O
conclude	O
that	O
SP4	B-ANAT
is	O
a	O
promising	O
serological	O
testing	O
protein	O
for	O
use	O
in	O
the	O
field	O
.	O

ABSTRACT	O
:	O
Prone	O
position	O
ventilation	O
(	O
PPV	O
)	O
has	O
been	O
shown	O
to	O
improve	O
oxygenation	O
and	O
decrease	O
pulmonary	B-ANAT
vascular	B-ANAT
resistance	O
and	O
mortality	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

This	O
experience	O
shows	O
the	O
feasibility	O
and	O
effectiveness	O
of	O
ECMO	O
support	O
in	O
liver	B-ANAT
transplant	B-ANAT
recipients	O
with	O
poor	O
respiratory	O
functions	O
.	O

Three	O
survivors	O
were	O
discharged	O
without	O
any	O
ECMO	O
-	O
related	O
complications	O
or	O
pulmonary	B-ANAT
sequelae	O
after	O
one	O
year	O
of	O
follow	O
up	O
.	O

In	O
the	O
present	O
study	O
,	O
a	O
virulent	O
Korean	O
pandemic	O
PEDV	O
strain	O
,	O
KNU	O
-	O
141112	O
,	O
was	O
serially	O
propagated	O
in	O
Vero	B-ANAT
cells	I-ANAT
for	O
up	O
to	O
100	O
passages	O
.	O

To	O
evaluate	O
the	O
importance	O
of	O
these	O
complexes	O
in	O
an	O
in	O
vivo	O
CoV	O
infection	O
model	O
,	O
we	O
used	O
recombinant	O
Adenovirus	O
5	O
(	O
rAd5	O
)	O
vectors	O
to	O
express	O
human	O
DPP4	O
in	O
mouse	O
lungs	B-ANAT
,	O
thereby	O
sensitizing	O
the	O
animals	O
to	O
MERS	O
-	O
CoV	O
infection	O
.	O

Furthermore	O
,	O
the	O
S	O
proteins	O
of	O
virulent	O
mouse	O
-	O
adapted	O
MERS	O
-	O
CoVs	O
acquired	O
a	O
CD9	O
-	O
dependent	O
cell	B-ANAT
entry	O
character	O
,	O
suggesting	O
that	O
CD9	O
is	O
a	O
selective	O
agent	O
in	O
the	O
evolution	O
of	O
CoV	O
virulence	O
.	O

Although	O
it	O
is	O
known	O
that	O
macrophage	B-ANAT
numbers	O
are	O
elevated	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
of	O
IBV	O
infected	O
chickens	O
,	O
the	O
role	O
played	O
by	O
macrophages	B-ANAT
in	O
IBV	O
infection	O
,	O
particularly	O
as	O
a	O
target	B-ANAT
cell	I-ANAT
for	O
viral	O
replication	O
,	O
is	O
unknown	O
.	O

This	O
in	O
vivo	O
observation	O
was	O
substantiated	O
by	O
demonstrating	O
IBV	O
antigens	O
in	O
macrophages	B-ANAT
following	O
in	O
vitro	O
IBV	O
infection	O
.	O

No	O
serum	B-ANAT
/	O
plasma	B-ANAT
samples	O
were	O
positive	O
for	O
FIPV	O
.	O

However	O
,	O
there	O
was	O
a	O
higher	O
expression	O
of	O
CD4	O
+	O
and	O
CD8	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
,	O
CD83	O
+	O
dendritic	B-ANAT
cells	I-ANAT
,	O
granzyme	O
A	O
+	O
and	O
natural	O
killer	O
+	O
cell	B-ANAT
density	O
in	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
of	O
the	O
H1N1	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Recovery	O
from	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
is	O
associated	O
with	O
antibody	O
and	O
T	B-ANAT
-	I-ANAT
cell	I-ANAT
responses	O
.	O

Thoracoscopic	O
approach	O
to	O
esophagectomy	O
significantly	O
reduced	O
PPC	O
frequency	O
with	O
minimal	O
additional	O
effect	O
from	O
laparoscopic	O
gastric	B-ANAT
mobilization	O
.	O

CONCLUSIONS	O
:	O
Thoracoscopic	O
approach	O
to	O
esophagectomy	O
significantly	O
reduced	O
PPC	O
frequency	O
with	O
minimal	O
additional	O
effect	O
from	O
laparoscopic	O
gastric	B-ANAT
mobilization	O
.	O

TITLE	O
:	O
Retrospective	O
use	O
of	O
next	O
-	O
generation	O
sequencing	O
reveals	O
the	O
presence	O
of	O
Enteroviruses	O
in	O
acute	O
influenza	O
-	O
like	O
illness	O
respiratory	B-ANAT
samples	I-ANAT
collected	O
in	O
South	O
/	O
South	O
-	O
East	O
Asia	O
during	O
2010	O
-	O
2013	O
.	O

The	O
Armed	O
Forces	O
Research	O
Institute	O
of	O
Medical	O
Sciences	O
(	O
AFRIMS	O
)	O
collected	O
12	O
,	O
865	O
nasopharyngeal	B-ANAT
specimens	O
from	O
acute	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
)	O
patients	O
in	O
five	O
countries	O
in	O
South	O
/	O
South	O
East	O
Asia	O
during	O
2010	O
-	O
2013	O
.	O

The	O
supernatant	O
of	O
these	O
CPE	O
positive	O
cell	B-ANAT
cultures	O
were	O
grouped	O
in	O
32	O
pools	O
containing	O
2	O
-	O
26	O
supernatants	O
per	O
pool	O
.	O

Ciliary	O
activity	O
of	O
the	O
epithelial	B-ANAT
cells	I-ANAT
in	O
the	O
bronchus	B-ANAT
of	O
precision	O
-	O
cut	O
lung	B-ANAT
slices	O
was	O
measured	O
.	O

TITLE	O
:	O
Periurban	O
outbreaks	O
of	O
bovine	O
calf	B-ANAT
scours	O
in	O
Northern	O
India	O
caused	O
by	O
Cryptosporidium	O
in	O
association	O
with	O
other	O
enteropathogens	O
.	O

In	O
the	O
present	O
study	O
,	O
faecal	B-ANAT
samples	O
from	O
100	O
diarrhoeic	O
calves	O
randomly	O
picked	O
up	O
out	O
of	O
17	O
outbreaks	O
of	O
bovine	O
calf	B-ANAT
diarrhoea	O
in	O
periurban	O
Ludhiana	O
,	O
Punjab	O
in	O
Northern	O
India	O
were	O
subjected	O
to	O
conventional	O
(	O
microscopy	O
,	O
modified	O
Zeihl	O
-	O
Neelsen	O
(	O
mZN	O
)	O
staining	O
)	O
and	O
immunological	O
and	O
molecular	O
techniques	O
(	O
faecal	B-ANAT
antigen	O
capture	O
ELISA	O
and	O
PCR	O
)	O
for	O
detection	O
of	O
primary	O
Cryptosporidium	O
parvum	O
infection	O
as	O
well	O
as	O
other	O
frequently	O
reported	O
concurrent	O
pathogens	O
,	O
viz	O
.	O

An	O
important	O
finding	O
of	O
the	O
study	O
was	O
that	O
C	O
.	O
parvum	O
alone	O
was	O
found	O
in	O
only	O
10	O
%	O
of	O
the	O
diarrhoeic	O
faecal	B-ANAT
samples	O
,	O
whereas	O
,	O
majority	O
of	O
the	O
samples	O
(	O
90	O
%)	O
showed	O
mixed	O
infections	O
ranging	O
from	O
a	O
combination	O
of	O
two	O
to	O
five	O
agents	O
.	O

The	O
lack	O
of	O
distinguishing	O
clinical	O
features	O
,	O
the	O
need	O
to	O
rely	O
on	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
from	O
respiratory	B-ANAT
samples	I-ANAT
,	O
variability	O
in	O
viral	O
shedding	O
duration	O
,	O
lack	O
of	O
effective	O
therapy	O
,	O
and	O
high	O
mortality	O
represent	O
substantial	O
clinical	O
challenges	O
and	O
help	O
guide	O
ongoing	O
clinical	O
research	O
efforts	O
.	O

TITLE	O
:	O
Persistent	O
Transmissible	O
Gastroenteritis	O
Virus	O
Infection	O
Enhances	O
Enterotoxigenic	O
Escherichia	O
coli	O
K88	O
Adhesion	O
by	O
Promoting	O
Epithelial	O
-	O
Mesenchymal	O
Transition	O
in	O
Intestinal	B-ANAT
Epithelial	B-ANAT
Cells	I-ANAT
.	O

Pulmonary	B-ANAT
infiltrations	O
were	O
nearly	O
vanished	O
in	O
a	O
CT	O
-	O
scan	O
few	O
days	O
later	O
and	O
completely	O
disappeared	O
in	O
follow	O
up	O
examinations	O
.	O

Tissues	B-ANAT
were	O
infected	O
with	O
RV	O
-	O
A55	O
,	O
RV	O
-	O
A49	O
,	O
RV	O
-	O
B48	O
,	O
RV	O
-	O
C8	O
,	O
and	O
RV	O
-	O
C15	O
;	O
respiratory	O
EV	O
-	O
D68	O
;	O
influenza	O
virus	O
H3N2	O
;	O
RSV	O
-	O
B	O
;	O
and	O
human	O
coronavirus	O
(	O
HCoV	O
)-	O
OC43	O
.	O

Replication	O
kinetics	O
,	O
cell	B-ANAT
tropism	O
,	O
effect	O
on	O
tissue	B-ANAT
integrity	O
,	O
and	O
cytokine	O
secretion	B-ANAT
were	O
compared	O
.	O

Viral	O
adaptation	O
and	O
tissue	B-ANAT
response	O
were	O
assessed	O
through	O
RNA	O
sequencing	O
.	O

RVs	O
,	O
RSV	O
-	O
B	O
,	O
and	O
HCoV	O
-	O
OC43	O
infected	O
ciliated	O
cells	B-ANAT
and	O
caused	O
no	O
major	O
cell	B-ANAT
death	O
,	O
whereas	O
H3N2	O
and	O
EV	O
-	O
D68	O
induced	O
ciliated	B-ANAT
cell	I-ANAT
loss	O
and	O
tissue	B-ANAT
integrity	O
disruption	O
.	O

ABSTRACT	O
:	O
Acute	O
neuromuscular	O
paralysis	O
(	O
ANMP	O
)	O
is	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
rapid	O
onset	O
muscle	B-ANAT
weakness	O
progressing	O
to	O
maximum	O
severity	O
within	O
several	O
days	O
to	O
weeks	O
(	O
less	O
than	O
4	O
wk	O
).	O

These	O
findings	O
suggest	O
that	O
lipidations	O
localize	O
antiviral	O
peptides	O
to	O
protease	O
-	O
rich	O
sites	O
of	O
CoV	O
fusion	O
,	O
thereby	O
protecting	O
cells	B-ANAT
from	O
diverse	O
CoVs	O
.	O

He	O
developed	O
refractory	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
was	O
commenced	O
on	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

TITLE	O
:	O
Clinical	O
phenotype	O
of	O
South	O
-	O
East	O
Asian	O
temporomandibular	O
disorder	O
patients	O
with	O
upper	O
airway	B-ANAT
resistance	O
syndrome	O
.	O

Patients	O
with	O
persistent	O
TMD	O
and	O
/	O
or	O
reporting	O
SB	O
should	O
be	O
screened	O
for	O
UARS	O
and	O
chronic	O
nasal	B-ANAT
obstruction	O
,	O
especially	O
when	O
they	O
also	O
present	O
with	O
FHP	O
.	O

The	O
structures	O
reveal	O
that	O
G4	O
recognizes	O
a	O
glycosylated	O
loop	O
that	O
is	O
variable	O
among	O
coronaviruses	O
and	O
they	O
define	O
four	O
conformational	O
states	O
of	O
the	O
trimer	O
wherein	O
each	O
receptor	O
-	O
binding	O
domain	O
is	O
either	O
tightly	O
packed	O
at	O
the	O
membrane	B-ANAT
-	O
distal	O
apex	O
or	O
rotated	O
into	O
a	O
receptor	O
-	O
accessible	O
conformation	O
.	O

A	O
series	O
of	O
other	O
viruses	O
were	O
tested	O
by	O
the	O
RT	O
-	O
RPA	B-ANAT
.	O
Thirty	O
-	O
two	O
field	O
samples	O
were	O
further	O
tested	O
by	O
RT	O
-	O
RPA	B-ANAT
,	O
and	O
the	O
resuts	O
were	O
compared	O
with	O
those	O
obtained	O
by	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Pharmacological	O
modulation	O
of	O
C	O
-	O
X	O
-	O
C	O
motif	O
chemokine	O
receptor	O
4	O
influences	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
lung	B-ANAT
ischaemia	O
-	O
reperfusion	O
injury	O
.	O

Thus	O
,	O
we	O
studied	O
whether	O
blockade	O
and	O
activation	O
of	O
CXCR4	O
influences	O
development	O
of	O
ARDS	O
in	O
a	O
unilateral	O
lung	B-ANAT
ischaemia	O
-	O
reperfusion	O
injury	O
rat	O
model	O
.	O

In	O
this	O
study	O
,	O
APS	O
were	O
employed	O
as	O
an	O
adjuvant	O
for	O
an	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
vaccine	O
,	O
and	O
its	O
effects	O
on	O
the	O
cellular	B-ANAT
immune	O
and	O
humoral	O
immune	O
responses	O
to	O
vaccination	O
in	O
chicken	O
were	O
investigated	O
.	O

Data	O
show	O
no	O
significant	O
differences	O
between	O
treatment	O
groups	O
for	O
our	O
primary	O
outcomes	O
:	O
proportion	O
of	O
children	O
(	O
n	O
=	O
249	O
)	O
who	O
had	O
persistent	O
symptoms	O
at	O
follow	O
-	O
up	O
(	O
odds	O
ratio	O
(	O
OR	O
)	O
0	O
.	O
69	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
37	O
to	O
1	O
.	O
28	O
;	O
fixed	B-ANAT
-	O
effect	O
model	O
);	O
and	O
number	O
of	O
children	O
(	O
n	O
=	O
240	O
)	O
rehospitalised	O
with	O
respiratory	O
illness	O
within	O
six	O
months	O
(	O
OR	O
0	O
.	O
54	O
,	O
95	O
%	O
CI	O
0	O
.	O
05	O
to	O
6	O
.	O
21	O
;	O
random	O
-	O
effects	O
model	O
).	O

As	O
compared	O
to	O
healthy	O
controls	O
,	O
metabolomic	O
analyses	O
identified	O
significant	O
differences	O
in	O
the	O
serum	B-ANAT
metabolomes	O
of	O
SARS	O
survivors	O
.	O

Cerebrospinal	B-ANAT
fluid	I-ANAT
was	O
analysed	O
in	O
11	O
cases	O
;	O
all	O
demonstrated	O
a	O
marked	O
increase	O
in	O
total	O
protein	O
concentration	O
and	O
total	O
nucleated	B-ANAT
cell	I-ANAT
count	O
.	O

The	O
present	O
case	O
highlights	O
the	O
need	O
for	O
physicians	O
to	O
consider	O
periorbital	B-ANAT
edema	O
as	O
an	O
unusual	O
predominant	O
manifestation	O
of	O
pituitary	B-ANAT
tumor	O
apoplexy	O
.	O

Infection	O
of	O
these	O
mice	O
with	O
rJ	O
-	O
Cre	O
resulted	O
in	O
expression	O
of	O
tdTomato	O
in	O
host	O
cells	B-ANAT
.	O

Most	O
notably	O
,	O
interneurons	B-ANAT
in	O
the	O
olfactory	B-ANAT
bulb	I-ANAT
,	O
which	O
are	O
known	O
to	O
be	O
inhibitory	O
,	O
represented	O
a	O
large	O
fraction	O
of	O
the	O
surviving	O
cells	B-ANAT
.	O

Osteomyelitis	O
of	O
C1	O
/	O
C2	O
and	O
severe	O
muscle	B-ANAT
wasting	O
required	O
a	O
prolonged	O
hospital	O
stay	O
.	O

CONCLUSIONS	O
AND	O
CLINICAL	O
RELEVANCE	O
Results	O
indicated	O
that	O
serum	B-ANAT
anti	O
-	O
BCV	O
antibody	O
abundance	O
as	O
determined	O
with	O
ELISA	O
were	O
not	O
associated	O
with	O
BCV	O
shedding	O
or	O
risk	O
of	O
BRD	O
in	O
individual	O
beef	O
calves	O
from	O
birth	O
through	O
the	O
first	O
5	O
weeks	O
after	O
feedlot	O
entry	O
.	O

ABSTRACT	O
:	O
Recent	O
data	O
suggest	O
that	O
human	O
coronavirus	O
(	O
HCoV	O
)	O
pneumonia	O
is	O
associated	O
with	O
significant	O
mortality	O
in	O
hematopoietic	B-ANAT
cell	I-ANAT
transplant	B-ANAT
(	O
HCT	O
)	O
recipients	O
.	O

No	O
differences	O
in	O
demographics	O
,	O
etiology	O
of	O
acute	O
pancreatitis	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
scores	O
,	O
or	O
development	O
of	O
pancreatic	B-ANAT
necrosis	O
were	O
seen	O
between	O
patients	O
with	O
isolated	O
RF	O
Among	O
patients	O
with	O
SAP	O
per	O
the	O
Revised	O
Atlanta	O
Classification	O
,	O
approximately	O
15	O
%	O
develop	O
isolated	O
RF	O
.	O

TITLE	O
:	O
Rapamycin	O
-	O
induced	O
autophagy	O
restricts	O
porcine	O
epidemic	O
diarrhea	O
virus	O
infectivity	O
in	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Moreover	O
,	O
alleviation	O
of	O
PEDV	O
-	O
induced	O
cell	B-ANAT
death	O
in	O
IPEC	O
-	O
J2	O
cells	B-ANAT
pretreated	O
with	O
rapamycin	O
demonstrates	O
a	O
protective	O
effect	O
of	O
rapamycin	O
against	O
PEDV	O
-	O
induced	O
epithelial	B-ANAT
cell	I-ANAT
death	O
.	O

Macrophage	B-ANAT
subsets	O
in	O
the	O
lung	B-ANAT
were	O
identified	O
by	O
flow	O
cytometry	O
.	O

After	O
MP	O
treatment	O
,	O
the	O
number	O
of	O
M1	O
decreased	O
and	O
M2	O
increased	O
in	O
the	O
lung	B-ANAT
.	O

SIV	O
,	O
RESULTS	O
:	O
According	O
to	O
the	O
pathology	O
and	O
bacteriology	O
of	O
the	O
lung	B-ANAT
samples	O
,	O
APP	O
and	O

ABSTRACT	O
:	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
inhibits	O
the	O
host	O
typeâ interferon	O
and	O
cellular	B-ANAT
antiviral	O
response	O
,	O
but	O
its	O
inhibition	O
mechanism	O
is	O
unclear	O
,	O
and	O
the	O
roles	O
of	O
PEDV	O
nonstructural	O
proteins	O
in	O
regulating	O
typeâ interferon	O
responses	O
have	O
been	O
seldom	O
studied	O
.	O

The	O
Medline	O
database	O
was	O
searched	O
using	O
combinations	O
and	O
variations	O
of	O
terms	O
,	O
including	O
'	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
',	O
'	O
MERS	O
-	O
CoV	O
',	O
'	O
SARS	O
',	O
'	O
therapy	O
',	O
'	O
molecular	O
',	O
'	O
vaccine	O
',	O
'	O
prophylactic	O
',	O
'	O
S	O
protein	O
',	O
'	O
DPP4	O
',	O
'	O
heptad	O
repeat	O
',	O
'	O
protease	O
',	O
'	O
inhibitor	O
',	O
'	O
anti	O
-	O
viral	O
',	O
'	O
broad	O
-	O
spectrum	O
',	O
'	O
interferon	O
',	O
'	O
convalescent	O
plasma	B-ANAT
',	O
'	O
lopinavir	O
ritonavir	O
',	O
'	O
antibodies	O
',	O
'	O
antiviral	O
peptides	O
'	O
and	O
'	O
live	O
attenuated	O
viruses	O
'.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
explore	O
and	O
define	O
the	O
spectrum	O
of	O
histological	O
and	O
ultrastructural	O
pathological	O
changes	O
affecting	O
various	O
organs	B-ANAT
in	O
a	O
patient	O
with	O
MERS	O
-	O
CoV	O
infection	O
and	O
represent	O
a	O
base	O
of	O
MERS	O
-	O
CoV	O
histopathology	O
.	O

The	O
results	O
highlight	O
the	O
pulmonary	B-ANAT
and	O
extrapulmonary	O
pathological	O
changes	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
provide	O
the	O
first	O
evidence	O
of	O
the	O
viral	O
presence	O
in	O
human	O
renal	B-ANAT
tissue	I-ANAT
,	O
which	O
suggests	O
tissue	B-ANAT
trophism	O
for	O
MERS	O
-	O
CoV	O
in	O
kidney	B-ANAT
.	O

CONCLUSIONS	O
:	O
The	O
results	O
highlight	O
the	O
pulmonary	B-ANAT
and	O
extrapulmonary	O
pathological	O
changes	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
provide	O
the	O
first	O
evidence	O
of	O
the	O
viral	O
presence	O
in	O
human	O
renal	B-ANAT
tissue	I-ANAT
,	O
which	O
suggests	O
tissue	B-ANAT
trophism	O
for	O
MERS	O
-	O
CoV	O
in	O
kidney	B-ANAT
.	O

In	O
early	O
phase	O
pneumonia	O
,	O
protective	O
ventilation	O
with	O
lower	O
tidal	O
volume	O
and	O
higher	O
end	O
expiratory	O
pressure	O
has	O
the	O
potential	O
to	O
reduce	O
the	O
pulmonary	B-ANAT
bacterial	O
burden	O
and	O
the	O
development	O
of	O
lung	B-ANAT
injury	O
.	O

The	O
control	O
group	O
deteriorated	O
in	O
arterial	B-ANAT
oxygen	O
tension	O
/	O
inspired	O
oxygen	O
fraction	O
,	O
whereas	O
the	O
protective	O
group	O
was	O
unchanged	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

ABSTRACT	O
:	O
To	O
characterize	O
sedation	O
,	O
analgesia	O
,	O
delirium	O
,	O
and	O
mobilization	O
practices	O
in	O
patients	O
supported	O
with	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
acute	O
respiratory	O
failure	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
medical	O
directors	O
and	O
program	O
coordinators	O
.	O

ABSTRACT	O
:	O
Sickle	O
-	O
cell	B-ANAT
disease	O
(	O
SCD	O
)	O
affects	O
millions	O
worldwide	O
.	O

Patients	O
with	O
SCA	B-ANAT
were	O
more	O
likely	O
to	O
develop	O
pneumonia	O
,	O
respiratory	O
failure	O
,	O
and	O
acute	O
renal	B-ANAT
failure	O
,	O
and	O
require	O
mechanical	O
ventilation	O
,	O
hemodialysis	O
for	O
acute	O
renal	B-ANAT
failure	O
and	O
blood	B-ANAT
transfusion	O
.	O

In	O
total	O
,	O
450	O
nurses	O
attended	O
the	O
Nasopharyngeal	B-ANAT
Skills	O
Day	O
and	O
1000	O
nurses	O
received	O
training	O
.	O

Two	O
testing	O
methods	O
are	O
currently	O
used	O
for	O
MERS	O
-	O
CoV	O
diagnostics	O
:	O
nucleic	B-ANAT
acid	O
detection	O
(	O
the	O
gold	O
standard	O
)	O
and	O
serological	O
analysis	O
.	O

After	O
a	O
full	O
recovery	O
of	O
MERS	O
,	O
the	O
patient	O
manifested	O
abrupt	O
vaginal	B-ANAT
bleeding	O
with	O
rupture	O
of	O
membrane	B-ANAT
.	O

Most	O
rash	O
illnesses	O
exhibited	O
a	O
generalized	O
maculopapular	O
pattern	O
involving	O
the	O
trunk	B-ANAT
and	O
limbs	B-ANAT
,	O
and	O
were	O
more	O
likely	O
associated	O
with	O
HPeV4	O
compared	O
to	O
other	O
syndrome	O
groups	O
(	O
36	O
.	O
4	O
%	O
vs	O
.	O
3	O
.	O
1	O
%,	O
p	O
=	O
0	O
.	O
011	O
).	O

A	O
total	O
of	O
321	O
patients	O
(	O
mean	O
age	O
72	O
.	O
4	O
Â±	O
9	O
.	O
3	O
years	O
old	O
,	O
74	O
.	O
5	O
%	O
male	O
,	O
mean	O
Society	O
of	O
Thoracic	B-ANAT
Surgeons	O
predicted	O
risk	O
of	O
mortality	O
3	O
.	O
8	O
Â±	O
1	O
.	O
9	O
%,	O
mean	O
forced	O
expiratory	O
volume	O
1	O
:	O
59	O
Â±	O
13	O
%)	O
were	O
included	O
in	O
the	O
analysis	O
.	O

As	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
Is	O
Being	O
Considered	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
and	O
critical	O
care	O
physicians	O
must	O
be	O
facile	O
in	O
recognition	O
and	O
management	O
of	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

This	O
article	O
provides	O
a	O
basic	O
understanding	O
of	O
the	O
evolution	O
of	O
ARDS	O
to	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
,	O
recognizing	O
benefits	O
and	O
limits	O
of	O
rescue	O
therapies	O
,	O
indications	O
and	O
contraindications	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
and	O
coordination	O
of	O
care	O
for	O
severe	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Cytomegalovirus	O
associated	O
severe	O
pneumonia	O
,	O
multi	O
-	O
organ	B-ANAT
failure	O
and	O
Ganciclovir	O
associated	O
arrhythmia	O
in	O
immunocompetent	O
child	O
.	O

TITLE	O
:	O
Concurrent	O
Acute	O
Glomerulonephritis	O
and	O
Retropharyngeal	B-ANAT
Abscess	O
in	O
10	O
Year	O
Boy	O
:	O
A	O
Case	O
Report	O
.	O

The	O
next	O
day	O
,	O
he	O
subsequently	O
developed	O
haematuria	O
and	O
oliguria	O
with	O
borderline	O
raised	O
blood	B-ANAT
pressure	O
.	O

He	O
had	O
a	O
remarkable	O
improvement	O
on	O
injectable	O
broad	O
spectrum	O
antibiotics	O
with	O
complete	O
resolution	O
of	O
fever	O
and	O
neck	B-ANAT
symptoms	O
.	O

MERS	O
is	O
caused	O
by	O
a	O
coronavirus	O
known	O
as	O
MERS	O
-	O
CoV	O
,	O
which	O
attacks	O
the	O
respiratory	B-ANAT
system	I-ANAT
.	O

In	O
addition	O
,	O
the	O
genetic	O
alterations	O
in	O
the	O
S1	O
gene	O
of	O
these	O
isolates	O
were	O
not	O
able	O
to	O
change	O
their	O
tissue	B-ANAT
tropism	O
and	O
pathogenicity	O
,	O
but	O
did	O
seem	O
to	O
negatively	O
influence	O
the	O
effectiveness	O
of	O
the	O
host	O
immune	O
responses	O
against	O
these	O
viruses	O
,	O
and	O
favour	O
viral	O
persistence	O
.	O

In	O
this	O
study	O
,	O
we	O
performed	O
metagenomic	O
sequencing	O
analysis	O
on	O
nasopharyngeal	B-ANAT
swab	I-ANAT
samples	O
from	O
108	O
MERS	O
-	O
CoV	O
-	O
positive	O
dromedary	O
camels	O
from	O
a	O
live	O
animal	O
market	O
in	O
Abu	O
Dhabi	O
,	O
United	O
Arab	O
Emirates	O
.	O

This	O
study	O
provides	O
a	O
comprehensive	O
survey	O
of	O
viruses	O
in	O
the	O
virome	O
of	O
upper	O
respiratory	B-ANAT
samples	I-ANAT
in	O
camels	O
that	O
have	O
extensive	O
contact	O
with	O
the	O
human	O
population	O
.	O

Here	O
,	O
we	O
rationally	O
designed	O
a	O
novel	O
fusion	O
inhibitor	O
named	O
MERS	O
-	O
five	O
-	O
helix	O
bundle	O
(	O
MERS	O
-	O
5HB	O
)	O
derived	O
from	O
the	O
six	O
-	O
helix	O
bundle	O
(	O
MERS	O
-	O
6HB	O
)	O
which	O
was	O
formed	O
by	O
the	O
process	O
of	O
membrane	B-ANAT
fusion	O
.	O

Fecal	B-ANAT
(	O
n	O
=	O
28	O
)	O
and	O
nasal	B-ANAT
(	O
n	O
=	O
8	O
)	O
samples	O
from	O
diarrheic	O
calves	O
were	O
tested	O
for	O
the	O
presence	O
of	O
BCoV	O
by	O
both	O
the	O
PanCoV	O
-	O
RT	O
-	O
PCR	O
and	O
a	O
specific	O
BCoV	O
-	O
RT	O
-	O
PCR	O
assays	O
.	O

Serum	B-ANAT
IgA	O
titers	O
in	O
rSPV	O
-	O
St	O
-	O
vaccinated	O
animals	O
were	O
significantly	O
higher	O
than	O
in	O
those	O
immunized	O
with	O
inactivated	O
vaccines	O
.	O

Here	O
,	O
we	O
report	O
a	O
nanoparticle	O
-	O
enabled	O
blood	B-ANAT
test	O
that	O
can	O
help	O
overcome	O
this	O
major	O
challenge	O
.	O

This	O
new	O
blood	B-ANAT
test	O
can	O
provide	O
critical	O
clinical	O
information	O
needed	O
to	O
optimize	O
further	O
treatment	O
and	O
/	O
or	O
to	O
determine	O
if	O
further	O
quarantining	O
should	O
be	O
continued	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
targets	O
the	O
epithelial	B-ANAT
cells	I-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
both	O
in	O
humans	O
and	O
in	O
its	O
natural	O
host	O
,	O
the	O
dromedary	O
camel	O
.	O

Pooled	O
analysis	O
showed	O
that	O
NAC	B-ANAT
did	O
not	O
contribute	O
to	O
reduce	O
short	O
-	O
term	O
mortality	O
[	O
risk	O
ratio	O
(	O
RR	O
)=	O
0	O
.	O
73	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
0	O
.	O
50	O
-	O
1	O
.	O
07	O
;	O
P	O
=	O
0	O
.	O
10	O
]	O
or	O
30	O
-	O
day	O
mortality	O
(	O
RR	O
=	O
0	O
.	O
72	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
44	O
-	O
1	O
.	O
19	O
;	O
P	O
=	O
0	O
.	O
20	O
)	O
when	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
.	O

A	O
novel	O
sgmRNA	O
(	O
M	O
-	O
1	O
)	O
was	O
identified	O
as	O
a	O
short	O
version	O
of	O
membrane	B-ANAT
(	O
M	O
)	O
gene	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
some	O
of	O
the	O
recent	O
findings	O
of	O
host	B-ANAT
cell	I-ANAT
factors	O
that	O
might	O
be	O
exploited	O
by	O
HCoVs	O
to	O
facilitate	O
their	O
own	O
replication	O
cycle	O
.	O

Immediate	O
interruption	O
of	O
sedation	O
in	O
critically	O
ill	O
postoperative	O
patients	O
with	O
organ	B-ANAT
dysfunction	O
who	O
were	O
admitted	O
to	O
the	O
ICU	O
after	O
abdominal	B-ANAT
surgery	O
improved	O
outcomes	O
compared	O
with	O
usual	O
sedation	O
care	O
.	O

The	O
task	O
force	O
was	O
unable	O
to	O
reach	O
agreement	O
on	O
a	O
single	O
test	O
that	O
can	O
reliably	O
diagnose	O
CIRCI	O
,	O
although	O
delta	O
cortisol	O
(	O
change	O
in	O
baseline	O
cortisol	O
at	O
60	O
min	O
of	O
<	O
9	O
Î¼g	O
/	O
dL	O
)	O
after	O
cosyntropin	O
(	O
250	O
Î¼g	O
)	O
administration	O
and	O
a	O
random	O
plasma	B-ANAT
cortisol	O
of	O
<	O
10	O
Î¼g	O
/	O
dL	O
may	O
be	O
used	O
by	O
clinicians	O
.	O

RESULTS	O
:	O
The	O
task	O
force	O
was	O
unable	O
to	O
reach	O
agreement	O
on	O
a	O
single	O
test	O
that	O
can	O
reliably	O
diagnose	O
CIRCI	O
,	O
although	O
delta	O
cortisol	O
(	O
change	O
in	O
baseline	O
cortisol	O
at	O
60	O
min	O
of	O
<	O
9	O
Î¼g	O
/	O
dL	O
)	O
after	O
cosyntropin	O
(	O
250	O
Î¼g	O
)	O
administration	O
and	O
a	O
random	O
plasma	B-ANAT
cortisol	O
of	O
<	O
10	O
Î¼g	O
/	O
dL	O
may	O
be	O
used	O
by	O
clinicians	O
.	O

She	O
initially	O
presented	O
to	O
an	O
urgent	O
care	O
centre	O
with	O
a	O
classic	O
HZ	O
rash	O
localised	O
to	O
her	O
neck	B-ANAT
,	O
and	O
upper	O
respiratory	O
symptoms	O
and	O
was	O
treated	O
with	O
prednisone	O
and	O
cephalexin	O
.	O

TITLE	O
:	O
Vitamin	O
D	O
alleviates	O
lipopolysaccharide	O
â	O
induced	O
acute	O
lung	B-ANAT
injury	O
via	O
regulation	O
of	O
the	O
renin	O
â	O
angiotensin	O
system	O
.	O

We	O
report	O
here	O
the	O
first	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
in	O
the	O
Kingdom	O
of	O
Bahrain	O
in	O
a	O
Saudi	O
gentleman	O
who	O
was	O
admitted	O
electively	O
for	O
coronary	B-ANAT
bypass	O
surgery	O
,	O
postoperatively	O
developed	O
an	O
acute	O
respiratory	O
illness	O
,	O
and	O
tested	O
positive	O
for	O
MERS	O
-	O
CoV	O
.	O
40	O
close	O
contacts	O
,	O
all	O
healthcare	O
workers	O
,	O
were	O
traced	O
and	O
followed	O
with	O
no	O
documented	O
secondary	O
cases	O
.	O

We	O
present	O
a	O
case	O
of	O
the	O
successful	O
use	O
of	O
ECMO	O
to	O
treat	O
acute	O
respiratory	O
failure	O
secondary	O
to	O
staphylococcal	O
sepsis	O
in	O
an	O
adolescent	O
CF	O
patient	O
with	O
previously	O
normal	O
lung	B-ANAT
function	O
.	O

The	O
4	O
cases	O
in	O
moderate	O
and	O
severe	O
group	O
had	O
delayed	O
impairment	O
of	O
liver	B-ANAT
functions	O
after	O
the	O
accident	O
.	O

Chest	B-ANAT
CT	O
scan	O
showed	O
diffuse	O
ground	O
-	O
glass	O
opacities	O
that	O
were	O
suggestive	O
of	O
alveolar	B-ANAT
hemorrhage	O
.	O

ABSTRACT	O
:	O
Porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
is	O
a	O
highly	O
neurovirulent	O
coronavirus	O
that	O
invades	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
in	O
piglets	O
.	O

We	O
analyzed	O
and	O
compared	O
immunologic	O
responses	O
and	O
the	O
effect	O
of	O
challenge	O
by	O
measuring	O
viral	O
load	O
,	O
IgG	O
and	O
IgA	O
humoral	O
responses	O
,	O
histopathology	O
and	O
histomorphometry	O
,	O
clinical	O
signs	O
,	O
and	O
immune	O
cell	B-ANAT
populations	O
in	O
the	O
different	O
MHC	B-ANAT
B	O
haplotype	O
lines	O
.	O

Three	O
selected	O
isolates	O
were	O
identified	O
as	O
IBV	O
using	O
a	O
real	O
-	O
time	O
reverse	O
transcriptase	O
-	O
PCR	O
assay	O
targeted	O
the	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
and	O
further	O
characterized	O
by	O
partial	O
spike	O
(	O
S	O
)	O
gene	O
sequence	O
analysis	O
.	O

In	O
final	O
step	O
,	O
we	O
removed	O
the	O
inspiratory	O
pause	O
and	O
titrated	O
PEEP	O
,	O
after	O
lung	B-ANAT
recruitment	O
,	O
with	O
the	O
aid	O
of	O
electrical	O
impedance	O
tomography	O
.	O

ABSTRACT	O
:	O
Knowledge	O
of	O
the	O
blood	B-ANAT
-	O
feeding	O
patterns	O
exhibited	O
by	O
arthropod	O
vectors	O
is	O
essential	O
for	O
understanding	O
the	O
complex	O
dynamics	O
of	O
vector	O
-	O
borne	O
disease	O
transmission	O
.	O

This	O
review	O
focuses	O
on	O
the	O
current	O
treatment	O
options	O
for	O
pulmonary	B-ANAT
ricin	O
intoxication	O
using	O
anti	O
-	O
ricin	O
antibodies	O
,	O
disease	O
-	O
modifying	O
countermeasures	O
,	O
anti	O
-	O
ricin	O
small	O
molecules	O
and	O
their	O
various	O
combinations	O
.	O

The	O
Intraoperative	O
Norepinephrine	O
to	O
Control	O
Arterial	B-ANAT
Pressure	O
(	O
INPRESS	O
)	O
study	O
was	O
a	O
multicenter	O
,	O
randomized	O
,	O
parallel	O
-	O
group	O
clinical	O
trial	O
conducted	O
in	O
9	O
French	O
university	O
and	O
nonuniversity	O
hospitals	O
.	O

Sixty	O
-	O
eight	O
patients	O
(	O
46	O
.	O
3	O
%)	O
in	O
the	O
individualized	O
treatment	O
group	O
and	O
92	O
(	O
63	O
.	O
4	O
%)	O
in	O
the	O
standard	O
treatment	O
group	O
had	O
postoperative	O
organ	B-ANAT
dysfunction	O
by	O
day	O
30	O
(	O
adjusted	O
hazard	O
ratio	O
,	O
0	O
.	O
66	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
52	O
to	O
0	O
.	O
84	O
;	O
P	O
=	O
.	O
001	O
).	O

ABSTRACT	O
:	O
Polytraumatised	O
patients	O
with	O
haemorrhagic	O
shock	O
are	O
prone	O
to	O
develop	O
systemic	O
complications	O
,	O
such	O
as	O
SIRS	O
(	O
systemic	O
inflammatory	O
response	O
syndrome	O
),	O
ARDS	O
(	O
acute	O
respiratory	O
distress	O
syndrome	O
)	O
and	O
MOF	O
(	O
multiple	O
organ	B-ANAT
failure	O
).	O

Twelve	O
pigs	O
(	O
German	O
Landrace	O
)	O
underwent	O
femur	B-ANAT
fracture	O
,	O
liver	B-ANAT
laceration	O
,	O
blunt	O
chest	B-ANAT
trauma	O
,	O
and	O
haemorrhagic	O
shock	O
under	O
standard	O
anaesthesia	O
and	O
intensive	O
care	O
monitoring	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
10	O
patients	O
received	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
H1N1	O
influenza	O
between	O
January	O
2013	O
and	O
March	O
2014	O
.	O

The	O
median	O
arterial	B-ANAT
oxygen	O
partial	O
pressure	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
ratio	O
was	O
62	O
.	O
5	O
,	O
and	O
the	O
median	O
RESP	O
score	O
was	O
6	O
.	O

Our	O
experience	O
shows	O
that	O
even	O
a	O
relatively	O
new	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
program	O
can	O
play	O
an	O
important	O
role	O
in	O
that	O
capacity	O
and	O
provide	O
excellent	O
outcomes	O
for	O
the	O
sickest	O
patients	O
.	O

If	O
high	O
plateau	O
,	O
driving	O
or	O
mean	O
airway	B-ANAT
pressures	O
are	O
observed	O
,	O
prone	O
positioning	O
or	O
ultraprotective	O
ventilation	O
may	O
be	O
indicated	O
to	O
improve	O
oxygenation	O
without	O
additional	O
stress	O
and	O
strain	O
in	O
the	O
lung	B-ANAT
.	O

TITLE	O
:	O
Management	O
of	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
using	O
pumped	O
extracorporeal	O
carbon	O
dioxide	O
removal	O
device	O
.	O

ABSTRACT	O
:	O
The	O
effects	O
of	O
a	O
high	O
carbon	O
dioxide	O
on	O
cerebral	B-ANAT
perfusion	O
and	O
intracranial	B-ANAT
pressure	O
are	O
well	O
known	O
.	O

Here	O
we	O
present	O
a	O
novel	O
reverse	O
genetics	O
system	O
for	O
MERS	O
-	O
CoV	O
that	O
involves	O
maintenance	O
of	O
the	O
full	O
-	O
length	O
viral	B-ANAT
genome	I-ANAT
as	O
a	O
cDNA	O
copy	O
inserted	O
in	O
a	O
bacterial	O
artificial	O
chromosome	B-ANAT
amenable	O
to	O
manipulation	O
by	O
homologue	O
recombination	O
,	O
based	O
on	O
the	O
bacteriophage	O
Î»	O
Red	O
recombination	O
system	O
.	O

The	O
resulting	O
reporter	O
virus	O
achieved	O
titres	O
nearly	O
identical	O
to	O
the	O
wild	O
-	O
type	O
virus	O
48	O
h	O
after	O
infection	O
of	O
Vero	B-ANAT
cells	I-ANAT
at	O
m	O
.	O
o	O
.	O
i	O
.	O

The	O
N	O
-	O
terminus	O
of	O
S2	O
subunit	O
of	O
SARS	O
-	O
CoV	O
reported	O
to	O
be	O
active	O
in	O
cell	B-ANAT
fusion	O
whereby	O
FPs	O
have	O
been	O
identified	O
.	O

Atomic	O
-	O
resolution	O
structure	O
of	O
FPs	O
derived	O
either	O
in	O
model	O
membranes	B-ANAT
or	O
in	O
membrane	B-ANAT
mimic	O
environment	O
would	O
glean	O
insights	O
toward	O
viral	O
cell	B-ANAT
fusion	O
mechanism	O
.	O

MERS	O
-	O
CoV	O
RNA	O
from	O
infected	O
camels	O
was	O
not	O
detected	O
beyond	O
2	O
weeks	O
after	O
the	O
first	O
positive	O
result	O
was	O
detected	O
in	O
nasal	B-ANAT
swabs	O
obtained	O
from	O
infected	O
camels	O
.	O

Patients	O
in	O
the	O
orthopaedic	O
cohort	O
were	O
further	O
examined	O
for	O
pulmonary	B-ANAT
complications	O
and	O
death	O
.	O

We	O
provide	O
evidence	O
that	O
DPP4	O
is	O
upregulated	O
in	O
the	O
lungs	B-ANAT
of	O
smokers	O
and	O
COPD	O
patients	O
,	O
which	O
could	O
partially	O
explain	O
why	O
these	O
individuals	O
are	O
more	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Nanoparticulate	O
vacuolar	B-ANAT
ATPase	O
blocker	O
exhibits	O
potent	O
host	O
-	O
targeted	O
antiviral	O
activity	O
against	O
feline	O
coronavirus	O
.	O

In	O
light	O
of	O
the	O
pathogenic	O
mechanism	O
of	O
feline	O
coronavirus	O
that	O
relies	O
on	O
endosomal	O
acidification	O
for	O
cytoplasmic	B-ANAT
entry	O
,	O
a	O
novel	O
vacuolar	B-ANAT
ATPase	O
blocker	O
,	O
diphyllin	O
,	O
and	O
its	O
nanoformulation	O
are	O
herein	O
investigated	O
for	O
their	O
antiviral	O
activity	O
against	O
the	O
type	O
II	O
feline	O
infectious	O
peritonitis	O
virus	O
(	O
FIPV	O
).	O

Malarial	O
complications	O
are	O
the	O
main	O
cause	O
of	O
death	O
and	O
include	O
cerebral	B-ANAT
malaria	O
and	O
malaria	O
-	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
MA	O
-	O
ARDS	O
).	O

To	O
determine	O
whether	O
cigarette	O
smoking	O
contributes	O
to	O
ARDS	O
development	O
after	O
trauma	O
by	O
altering	O
community	O
composition	O
of	O
the	O
lung	B-ANAT
microbiota	O
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
,	O
several	O
studies	O
based	O
on	O
the	O
interaction	O
of	O
self	O
-	O
assembling	O
short	O
peptides	O
derived	O
from	O
viroporins	O
with	O
model	O
membranes	B-ANAT
,	O
have	O
improved	O
our	O
understanding	O
of	O
the	O
molecular	O
mechanism	O
of	O
corona	O
virus	O
(	O
CoV	O
)	O
infection	O
under	O
physiological	O
conditions	O
.	O

Challenges	O
to	O
successful	O
development	O
include	O
incomplete	O
understanding	O
of	O
viral	O
transmission	O
,	O
pathogenesis	O
and	O
immune	O
response	O
(	O
in	O
particular	O
at	O
the	O
mucosal	B-ANAT
level	O
),	O
no	O
optimal	O
animal	O
challenge	O
models	O
,	O
lack	O
of	O
standardized	O
immunological	O
assays	O
,	O
and	O
insufficient	O
sustainable	O
funding	O
.	O

In	O
this	O
study	O
,	O
we	O
discovered	O
that	O
CD59	O
was	O
downregulated	O
in	O
IBV	O
-	O
infected	O
cells	B-ANAT
and	O
was	O
associated	O
with	O
IBV	O
virions	B-ANAT
.	O

Because	O
no	O
considerable	O
change	O
in	O
IBV	O
N	O
protein	O
and	O
viral	O
RNA	O
levels	O
was	O
detected	O
in	O
total	O
cell	B-ANAT
lysates	O
prepared	O
from	O
the	O
overexpression	O
,	O
knockdown	O
or	O
cleavage	O
of	O
CD59	O
groups	O
,	O
our	O
data	O
indicated	O
that	O
CD59	O
was	O
involved	O
in	O
IBV	O
particle	O
release	O
and	O
that	O
IBV	O
had	O
evolved	O
a	O
mechanism	O
to	O
utilize	O
CD59	O
to	O
evade	O
complement	O
-	O
mediated	O
destruction	O
.	O

Thirty	O
-	O
nine	O
PEDV	O
naÃ¯ve	O
pigs	O
were	O
randomly	O
divided	O
into	O
five	O
groups	O
:	O
EXP	O
-	O
IM	O
-	O
1b	O
(	O
intramuscular	O
G1b	O
exposure	O
;	O
G2b	O
challenge	O
),	O
EXP	O
-	O
ORAL	B-ANAT
-	O
1b	O
(	O
oral	B-ANAT
G1b	O
exposure	O
;	O
G2b	O
challenge	O
),	O
VAC	O
-	O
IM	O
-	O
2b	O
(	O
intramuscular	O
commercial	O
inactivated	O
G2b	O
vaccination	O
;	O
G2b	O
challenge	O
),	O
POS	O
-	O
CONTROL	O
(	O
sham	O
-	O
vaccination	O
;	O
G2b	O
challenge	O
)	O
and	O
NEG	O
-	O
CONTROL	O
(	O
sham	O
-	O
vaccination	O
;	O
sham	O
-	O
challenge	O
).	O

It	O
is	O
extremely	O
important	O
to	O
optimally	O
adjust	O
ventilator	O
setting	O
to	O
current	O
condition	O
of	O
lungs	B-ANAT
,	O
while	O
providing	O
all	O
other	O
therapeutic	O
measures	O
in	O
the	O
treatment	O
of	O
sepsis	O
,	O
severe	O
sepsis	O
and	O
septic	O
shock	O
.	O

One	O
hundred	O
and	O
sixty	O
consecutive	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
refractory	O
to	O
conventional	O
treatment	O
requiring	O
veno	O
-	O
venous	B-ANAT
(	O
VV	O
)-	O
ECMO	O
.	O

In	O
the	O
spleen	B-ANAT
,	O
and	O
in	O
the	O
combined	O
data	O
set	O
of	O
the	O
shell	B-ANAT
gland	I-ANAT
and	O
spleen	B-ANAT
,	O
the	O
two	O
most	O
stable	O
and	O
the	O
two	O
least	O
stable	O
reference	O
genes	O
were	O
TBP	O
and	O
YWHAZ	O
,	O
and	O
ribosomal	B-ANAT
protein	O
L4	O
(	O
RPL4	O
)	O
and	O
ALB	O
,	O
respectively	O
.	O

ChAd	O
vectors	O
are	O
safe	O
and	O
induce	O
antigen	O
-	O
specific	O
cellular	B-ANAT
and	O
humoral	O
immunity	O
in	O
all	O
age	O
groups	O
,	O
as	O
well	O
as	O
circumventing	O
the	O
problem	O
of	O
pre	O
-	O
existing	O
immunity	O
encountered	O
with	O
human	O
Ad	O
vectors	O
.	O

Primary	O
outcome	O
was	O
change	O
in	O
normalized	O
IL	O
-	O
6	O
-	O
serum	B-ANAT
concentrations	O
during	O
study	O
day	O
1	O
and	O
7	O
.	O

We	O
were	O
not	O
able	O
to	O
detect	O
differences	O
in	O
systemic	O
plasma	B-ANAT
IL	O
-	O
6	O
levels	O
between	O
the	O
two	O
groups	O
(	O
n	O
=	O
75	O
;	O
p	O
=	O
0	O
.	O
15	O
).	O

Cytokines	O
(	O
interleukin	O
[	O
IL	O
]	O
6	O
,	O
IL8	O
and	O
tissue	B-ANAT
necrosis	O
factor	O
[	O
TNF	O
]	O
A	O
total	O
of	O
262	O
adult	O
patients	O
undergoing	O
VV	O
ECMO	O
were	O
analysed	O
.	O

Lung	B-ANAT
parenchyma	I-ANAT
and	O
airways	O
were	O
assessed	O
for	O
consolidation	O
,	O
ground	O
-	O
glass	O
opacity	O
(	O
GGO	O
),	O
nodular	O
opacity	O
and	O
reticular	O
opacity	O
(	O
i	O
.	O
e	O
.,	O
fibrosis	O
).	O

Follow	O
-	O
up	O
chest	B-ANAT
radiographs	O
were	O
also	O
evaluated	O
for	O
pleural	O
thickening	O
,	O
pleural	B-ANAT
effusion	I-ANAT
,	O
pneumothorax	O
and	O
lymphadenopathy	O
.	O

At	O
month	O
6	O
after	O
ICU	O
admission	O
,	O
estimated	O
glomerular	B-ANAT
filtration	O
rate	O
was	O
24	O
mL	O
/	O
min	O
/	O
1	O
.	O
73m	O
<	O
sup	O
>	O
2	O
</	O
sup	O
>.	O
Compelling	O
evidence	O
obtained	O
from	O
in	O
-	O
vitro	O
and	O
animal	O
studies	O
suggest	O
that	O
vitamin	O
C	O
,	O
a	O
circulating	O
antioxidant	O
,	O
may	O
be	O
a	O
valuable	O
adjunctive	O
therapy	O
in	O
critically	O
-	O
ill	O
patients	O
.	O

They	O
utilize	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
anchored	O
in	O
the	O
viral	B-ANAT
envelope	I-ANAT
to	O
mediate	O
host	O
attachment	O
and	O
fusion	O
of	O
the	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
to	O
initiate	O
infection	O
.	O

In	O
this	O
study	O
,	O
we	O
successfully	O
isolated	O
and	O
attenuated	O
the	O
PEDV	O
epidemic	O
strain	O
Zhejiang08	O
,	O
which	O
was	O
characterized	O
by	O
good	O
cell	B-ANAT
adaptation	O
and	O
high	O
-	O
titer	O
production	O
48	O
h	O
post	O
infection	O
in	O
Vero	O
E6	O
cells	B-ANAT
.	O

At	O
2	O
,	O
5	O
,	O
7	O
,	O
and	O
14days	O
post	O
inoculation	O
(	O
dpi	O
),	O
4	O
pigs	O
per	O
treatment	O
were	O
euthanized	O
and	O
jejunum	B-ANAT
sections	O
collected	O
.	O

PEDV	O
-	O
specific	O
IgG	O
and	O
IgA	B-ANAT
antibody	I-ANAT
titers	O
were	O
enhanced	O
in	O
pregnant	O
sows	O
immunized	O
with	O
PLGA	O
-	O
KAg	O
relative	O
to	O
the	O
titers	O
in	O
sows	O
inoculated	O
with	O
KAg	O
.	O

TITLE	O
:	O
VSIG4	O
inhibits	O
proinflammatory	O
macrophage	B-ANAT
activation	O
by	O
reprogramming	O
mitochondrial	B-ANAT
pyruvate	O
metabolism	O
.	O

ABSTRACT	O
:	O
Exacerbation	O
of	O
macrophage	B-ANAT
-	O
mediated	O
inflammation	O
contributes	O
to	O
pathogenesis	O
of	O
various	O
inflammatory	O
diseases	O
,	O
but	O
the	O
immunometabolic	O
programs	O
underlying	O
regulation	O
of	O
macrophage	B-ANAT
activation	O
are	O
unclear	O
.	O

Further	O
,	O
in	O
order	O
to	O
understand	O
the	O
influence	O
of	O
quasispecies	O
of	O
these	O
viruses	O
in	O
relation	O
to	O
biology	O
,	O
techniques	O
for	O
deep	O
-	O
sequence	O
and	O
full	O
-	O
length	O
viral	B-ANAT
genome	I-ANAT
analysis	O
are	O
needed	O
.	O

CSF	B-ANAT
antibody	O
was	O
detected	O
in	O
28	O
cats	O
,	O
which	O
were	O
divided	O
into	O
2	O
groups	O
;	O
15	O
with	O
CSF	B-ANAT
titer	O
of	O
1	O
:	O
80	O
or	O
lower	O
and	O
13	O
with	O
CSF	B-ANAT
titer	O
of	O
1	O
:	O
640	O
or	O
higher	O
.	O

The	O
inhibition	O
of	O
virus	O
replication	O
has	O
been	O
documented	O
in	O
cell	B-ANAT
culture	O
against	O
multiple	O
viruses	O
by	O
RNAi	O
approach	O
.	O

Although	O
more	O
severe	O
lung	B-ANAT
damage	O
with	O
fibroproliferation	O
was	O
observed	O
in	O
patients	O
with	O
drug	O
-	O
associated	O
ARDS	O
,	O
ventilator	O
weaning	O
was	O
earlier	O
,	O
and	O
their	O
prognosis	O
was	O
better	O
than	O
the	O
others	O
.	O

This	O
report	O
supplies	O
useful	O
clinical	O
information	O
on	O
the	O
treatment	O
of	O
severe	O
mamushi	O
bite	O
cases	O
,	O
and	O
severe	O
abdominal	B-ANAT
symptoms	O
,	O
such	O
as	O
ileus	O
and	O
melena	O
,	O
may	O
be	O
a	O
lethal	O
sign	O
.	O

TITLE	O
:	O
Healthcare	O
worker	O
infected	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
during	O
cardiopulmonary	B-ANAT
resuscitation	O
in	O
Korea	O
,	O
2015	O
.	O

She	O
suggested	O
that	O
she	O
was	O
contaminated	O
with	O
the	O
MERS	O
patient	O
'	O
s	O
body	B-ANAT
fluids	I-ANAT
by	O
wiping	O
away	O
the	O
sweat	B-ANAT
from	O
her	O
face	B-ANAT
during	O
the	O
CPR	O
.	O

Infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
is	O
one	O
of	O
the	O
most	O
important	O
infectious	O
agents	O
in	O
chickens	O
,	O
and	O
in	O
chicken	B-ANAT
cells	I-ANAT
,	O
it	O
can	O
be	O
recognized	O
by	O
MDA5	O
to	O
activate	O
interferon	O
production	O
.	O

Here	O
,	O
we	O
showed	O
that	O
chicken	B-ANAT
cells	I-ANAT
transfected	O
with	O
domestic	O
goose	O
RIG	O
-	O
I	O
(	O
dgRIG	O
-	O
I	O
)	O
exhibited	O
increased	O
IFN	O
-	O
Î²	O
activity	O
after	O
IBV	O
infection	O
.	O

RESULTS	O
:	O
Here	O
,	O
we	O
showed	O
that	O
chicken	B-ANAT
cells	I-ANAT
transfected	O
with	O
domestic	O
goose	O
RIG	O
-	O
I	O
(	O
dgRIG	O
-	O
I	O
)	O
exhibited	O
increased	O
IFN	O
-	O
Î²	O
activity	O
after	O
IBV	O
infection	O
.	O

Acute	O
kidney	B-ANAT
injury	O
,	O
liver	B-ANAT
dysfunction	O
,	O
thrombocytopenia	O
,	O
disseminated	O
intravascular	O
coagulopathy	O
(	O
DIC	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
are	O
also	O
common	O
in	O
severe	O
malaria	O
.	O

Patients	O
with	O
cervical	B-ANAT
fracture	O
were	O
isolated	O
.	O

TITLE	O
:	O
Platelet	B-ANAT
aggregation	O
after	O
blunt	O
trauma	O
is	O
associated	O
with	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
altered	O
by	O
cigarette	O
smoke	O
exposure	O
.	O

Plasma	B-ANAT
cotinine	O
was	O
measured	O
to	O
assess	O
cigarette	O
smoke	O
exposure	O
.	O

ABSTRACT	O
:	O
To	O
clarify	O
the	O
effect	O
of	O
single	O
-	O
session	O
multivessel	O
percutaneous	O
coronary	B-ANAT
intervention	O
(	O
PCI	O
)	O
strategy	O
relative	O
to	O
the	O
staged	O
multivessel	O
strategy	O
on	O
clinical	O
outcomes	O
in	O
patients	O
with	O
stable	O
coronary	B-ANAT
artery	I-ANAT
disease	O
(	O
CAD	O
)	O
or	O
non	O
-	O
ST	O
-	O
elevation	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
lung	B-ANAT
disease	O
,	O
with	O
an	O
associated	O
mortality	O
rate	O
exceeding	O
60	O
%	O
for	O
the	O
most	O
severe	O
forms	O
of	O
the	O
disease	O
.	O

TITLE	O
:	O
Anaphylactic	O
shock	O
with	O
methylprednisolone	O
sodium	O
succinate	O
in	O
a	O
child	O
with	O
short	O
bowel	B-ANAT
syndrome	O
and	O
cow	O
'	O
s	O
milk	O
allergy	O
.	O

Children	O
who	O
are	O
highly	O
sensitive	O
to	O
milk	O
may	O
have	O
severe	O
allergic	O
reactions	O
also	O
after	O
exposure	O
to	O
CMP	O
through	O
a	O
different	O
administration	O
route	O
than	O
the	O
oral	B-ANAT
one	O
.	O

CONCLUSIONS	O
:	O
Children	O
who	O
are	O
highly	O
sensitive	O
to	O
milk	O
may	O
have	O
severe	O
allergic	O
reactions	O
also	O
after	O
exposure	O
to	O
CMP	O
through	O
a	O
different	O
administration	O
route	O
than	O
the	O
oral	B-ANAT
one	O
.	O

ABSTRACT	O
:	O
To	O
observe	O
the	O
clinical	O
efficacy	O
of	O
noninvasive	O
ventilation	O
(	O
NIV	O
)	O
on	O
the	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
severe	O
pneumonia	O
after	O
kidney	B-ANAT
transplantation	O
.	O

We	O
describe	O
the	O
case	O
of	O
a	O
25	O
-	O
year	O
-	O
old	O
male	O
who	O
developed	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
an	O
uneventful	O
laparoscopic	O
appendectomy	O
for	O
a	O
perforated	O
appendix	B-ANAT
,	O
requiring	O
mechanical	O
ventilation	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

Introduction	O
of	O
a	O
mobile	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
program	O
designed	O
to	O
facilitate	O
the	O
implementation	O
of	O
ECMO	O
at	O
outside	O
hospitals	O
in	O
patients	O
too	O
unstable	O
for	O
transport	O
for	O
ECMO	O
.	O

In	O
the	O
context	O
of	O
permanently	O
wheelchair	O
bound	O
and	O
on	O
mechanical	O
ventilation	O
(	O
MV	O
)	O
patients	O
,	O
the	O
clinical	O
presentation	O
of	O
acute	O
heart	B-ANAT
failure	O
(	O
AHF	O
)	O
syndrome	O
may	O
be	O
atypical	O
.	O

In	O
adult	O
DMD	O
and	O
BMD	O
patients	O
with	O
severe	O
ejection	O
fraction	O
alteration	O
and	O
on	O
HMV	O
,	O
admitted	O
for	O
AHF	O
,	O
right	O
cardiac	B-ANAT
signs	O
are	O
frequent	O
.	O

Since	O
MSR1	O
expression	O
was	O
upregulated	O
in	O
the	O
livers	B-ANAT
of	O
patients	O
with	O
fulminant	O
hepatitis	O
(	O
FH	O
),	O
we	O
investigated	O
the	O
functional	O
mechanism	O
of	O
Msr1	O
in	O
FH	O
pathogenesis	O
.	O

Enhanced	O
levels	O
of	O
macrophage	B-ANAT
scavenger	O
receptor	O
1	O
(	O
Msr1	O
)	O
in	O
the	O
liver	B-ANAT
of	O
patients	O
with	O
FH	O
and	O
of	O
murine	O
experimental	O
FH	O
indicated	O
Msr1	O
plays	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
FH	O
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
(	O
CPE	O
)	O
are	O
both	O
characterized	O
by	O
an	O
increase	O
in	O
lung	B-ANAT
edema	O
that	O
can	O
be	O
measured	O
by	O
computed	O
tomography	O
(	O
CT	O
).	O

Lung	B-ANAT
CT	O
was	O
performed	O
at	O
a	O
mean	O
positive	O
end	O
-	O
expiratory	O
pressure	O
level	O
of	O
5	O
cm	O
H	O
A	O
total	O
of	O
60	O
patients	O
with	O
ARDS	O
(	O
20	O
mild	O
,	O
20	O
moderate	O
,	O
20	O
severe	O
)	O
and	O
20	O
patients	O
with	O
CPE	O
were	O
enrolled	O
.	O

Moving	O
from	O
the	O
nondependent	O
to	O
the	O
dependent	O
lung	B-ANAT
regions	O
,	O
the	O
not	O
inflated	O
lung	B-ANAT
tissue	I-ANAT
significantly	O
increased	O
,	O
while	O
the	O
well	O
inflated	O
tissue	B-ANAT
decreased	O
(	O
Ï	O
=	O
0	O
.	O
96	O
-	O
1	O
.	O
00	O
,	O

These	O
are	O
transformed	O
into	O
double	O
-	O
membrane	B-ANAT
vesicles	B-ANAT
(	O
DMVs	O
)	O
containing	O
viral	O
double	O
-	O
stranded	O
RNA	O
and	O
into	O
other	O
membranous	B-ANAT
elements	O
such	O
as	O
convoluted	O
membranes	B-ANAT
,	O
together	O
forming	O
a	O
reticulovesicular	O
network	O
.	O

ABSTRACT	O
:	O
Gastrointestinal	O
(	O
GI	O
)	O
symptoms	O
,	O
such	O
as	O
diarrhea	O
,	O
vomiting	O
,	O
abdominal	B-ANAT
pain	O
and	O
nausea	O
are	O
not	O
an	O
uncommon	O
manifestation	O
of	O
an	O
acute	O
respiratory	O
infection	O
(	O
ARI	O
).	O

The	O
latter	O
provide	O
a	O
structural	O
scaffold	O
for	O
viral	O
replication	O
/	O
transcription	O
complexes	O
(	O
RTCs	O
)	O
and	O
help	O
to	O
sequester	O
RTC	O
components	O
from	O
recognition	O
by	O
cellular	B-ANAT
factors	O
involved	O
in	O
antiviral	O
host	O
responses	O
.	O

The	O
SOPs	O
validated	O
by	O
the	O
SPILF	O
and	O
its	O
affiliates	O
were	O
disseminated	O
to	O
a	O
wide	O
range	O
of	O
key	O
stakeholders	O
through	O
various	O
media	B-ANAT
including	O
workshops	O
and	O
the	O
SPILF	O
'	O
s	O
website	O
.	O

TITLE	O
:	O
Astragalus	B-ANAT
polysaccharides	O
inhibit	O
avian	O
infectious	O
bronchitis	O
virus	O
infection	O
by	O
regulating	O
viral	O
replication	O
.	O

IBV	O
titers	O
in	O
infected	O
CEK	O
cells	B-ANAT
treated	O
with	O
APS	O
were	O
significantly	O
reduced	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
indicating	O
that	O
APS	O
inhibited	O
IBV	O
replication	O
in	O
vitro	O
.	O

These	O
findings	O
,	O
together	O
with	O
sophisticated	O
molecular	O
structure	O
analyses	O
,	O
omics	O
tools	O
and	O
computer	O
-	O
based	O
models	O
,	O
have	O
helped	O
delineate	O
the	O
interaction	O
between	O
respiratory	O
viruses	O
and	O
the	O
host	O
immune	B-ANAT
system	I-ANAT
,	O
which	O
will	O
facilitate	O
the	O
development	O
of	O
novel	O
treatment	O
strategies	O
and	O
vaccines	O
with	O
enhanced	O
efficacy	O
.	O

The	O
nephropathogenic	O
IBV	O
strains	O
cause	O
nephritis	O
and	O
kidney	B-ANAT
lesions	O
intrinsically	O
and	O
the	O
pathogenic	O
mechanism	O
is	O
still	O
unclear	O
.	O

Gene	O
Ontology	O
(	O
GO	O
)	O
and	O
KEGG	O
pathway	O
enrichment	O
analysis	O
on	O
SCDY2	O
group	O
displayed	O
that	O
the	O
up	O
-	O
regulated	O
DE	O
genes	O
were	O
mainly	O
involved	O
in	O
cell	B-ANAT
apoptosis	O
,	O
and	O
the	O
down	O
-	O
regulated	O
genes	O
were	O
involved	O
in	O
metabolic	O
processes	O
and	O
DNA	O
replication	O
.	O

In	O
addition	O
,	O
the	O
number	O
of	O
apoptotic	O
cells	B-ANAT
detected	O
experimentally	O
in	O
kidney	B-ANAT
tissue	B-ANAT
were	O
very	O
different	O
among	O
the	O
three	O
virus	O
inoculated	O
groups	O
and	O
were	O
positively	O
accordant	O
with	O
the	O
viral	O
titer	O
,	O
kidney	B-ANAT
lesions	O
and	O
viral	O
virulence	O
of	O
each	O
group	O
.	O

Taken	O
all	O
together	O
,	O
the	O
present	O
study	O
revealed	O
that	O
virulent	O
nephropathogenic	O
IBV	O
infection	O
modified	O
a	O
number	O
of	O
gene	O
expression	O
and	O
induction	O
of	O
apoptosis	O
in	O
kidney	B-ANAT
cells	B-ANAT
may	O
be	O
a	O
major	O
pathogenic	O
determinant	O
for	O
virulent	O
nephropathogenic	O
IBV	O
.	O

Recent	O
experimental	O
studies	O
have	O
illustrated	O
how	O
several	O
regulatory	O
circuits	O
interact	O
during	O
pulmonary	B-ANAT
inflammation	O
,	O
including	O
the	O
resolution	O
of	O
inflammation	O
,	O
the	O
inflammasome	O
,	O
autophagy	O
and	O
apoptosis	O
.	O

The	O
results	O
showed	O
that	O
higher	O
anti	O
-	O
PEDV	O
serum	B-ANAT
IgG	O
and	O
mucosal	B-ANAT
SIgA	B-ANAT
antibody	I-ANAT
responses	O
were	O
induced	O
in	O
mice	O
orally	B-ANAT
immunized	O
with	O
strain	O
pPG	O
-	O
COE	O
-	O
Co1	O
/	O
L393	O
as	O
compared	O
to	O
the	O
mice	O
immunized	O
with	O
strain	O
L393	O
expressing	O
COE	O
alone	O
or	O
carrying	O
the	O
empty	O
plasmid	O
.	O

RESULTS	O
:	O
BAL	O
IL	O
-	O
6	O
and	O
tumor	O
necrosis	O
factor	O
as	O
well	O
as	O
plasma	B-ANAT
IL	O
-	O
6	O
were	O
significantly	O
lower	O
in	O
the	O
animals	O
administered	O
VPA	O
within	O
3	O
h	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
but	O
not	O
when	O
administered	O
later	O
(	O
4	O
,	O
6	O
,	O
9	O
h	O
).	O

By	O
using	O
real	O
-	O
time	O
data	O
sources	O
,	O
a	O
digital	B-ANAT
syndromic	O
surveillance	O
system	O
can	O
overcome	O
the	O
limitation	O
of	O
time	O
-	O
delay	O
in	O
traditional	O
surveillance	O
systems	O
.	O

A	O
digital	B-ANAT
surveillance	O
system	O
that	O
uses	O
Internet	O
resources	O
has	O
enormous	O
potential	O
to	O
monitor	O
disease	O
outbreaks	O
in	O
the	O
early	O
phase	O
.	O

TITLE	O
:	O
Acute	O
phase	O
proteins	O
and	O
stress	O
markers	O
in	O
the	O
immediate	O
response	O
to	O
a	O
combined	O
vaccination	O
against	O
Newcastle	O
disease	O
and	O
infectious	O
bronchitis	O
viruses	O
in	O
specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
layer	B-ANAT
chicks	O
.	O

Serum	B-ANAT
IFNÎ³	O
was	O
detected	O
in	O
mice	O
infected	O
with	O
MHV	O
-	O
A59	O
and	O
its	O
concentration	O
increased	O
after	O
MAb	O
anti	O
-	O
IL	O
-	O
17A	O
administration	O
.	O

PEDV	O
nsp1	O
blocked	O
the	O
nuclear	O
translocation	O
of	O
IRF1	O
and	O
reduced	O
the	O
number	O
of	O
peroxisomes	B-ANAT
to	O
suppress	O
IRF1	O
-	O
mediated	O
type	O
III	O
IFNs	O
.	O

However	O
,	O
the	O
irreversibility	O
of	O
the	O
patient	O
'	O
s	O
lung	B-ANAT
status	O
should	O
be	O
considered	O
.	O

One	O
15	O
.	O
24	O
X	O
15	O
.	O
24	O
X	O
2	O
.	O
54	O
cm	O
aluminum	O
coupon	O
,	O
contaminated	O
with	O
swine	O
feces	B-ANAT
,	O
and	O
randomly	O
matched	O
to	O
one	O
pig	O
was	O
the	O
experimental	O
unit	O
.	O

Following	O
60	O
episodes	O
of	O
repeated	O
head	B-ANAT
shakings	O
,	O
the	O
pups	O
demonstrated	O
apnea	O
and	O
/	O
or	O
bradycardia	O
immediately	O
after	O
injury	O
.	O

TITLE	O
:	O
Etiology	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
the	O
community	O
and	O
clinic	O
in	O
Ilorin	O
,	O
Nigeria	O
.	O

These	O
results	O
suggest	O
that	O
circulating	O
HCoVs	O
in	O
the	O
field	O
generally	O
use	O
cell	B-ANAT
-	O
surface	O
TMPRSS2	O
for	O
cell	B-ANAT
entry	O
,	O
not	O
endosomal	O
cathepsins	O
,	O
in	O
human	O
airway	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
microRNA	O
-	O
4331	O
Promotes	O
Transmissible	O
Gastroenteritis	O
Virus	O
(	O
TGEV	O
)-	O
induced	O
Mitochondrial	B-ANAT
Damage	O
Via	O
Targeting	O
RB1	O
,	O
Upregulating	O
Interleukin	O
-	O
1	O
Receptor	O
Accessory	O
Protein	O
(	O
IL1RAP	O
),	O
and	O
Activating	O
p38	O
MAPK	O
Pathway	O
ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
),	O
a	O
member	O
of	O
the	O
coronaviridae	O
family	O
,	O
could	O
cause	O
fatal	O
diarrhea	O
of	O
piglets	O
and	O
result	O
in	O
numerous	O
economic	O
losses	O
.	O

To	O
explore	O
the	O
potential	O
role	O
of	O
miR	O
-	O
4331	O
in	O
mitochondrial	B-ANAT
damage	O
,	O
we	O
adopted	O
a	O
strategy	O
consisting	O
of	O
quantitative	O
proteomic	O
analysis	O
of	O
porcine	O
kidney	B-ANAT
(	O
PK	O
-	O
15	O
)	O
cells	B-ANAT
in	O
response	O
to	O
miR	O
-	O
4331	O
and	O
TGEV	O
infection	O
.	O

Using	O
estimated	O
sensitivity	O
and	O
specificity	O
values	O
from	O
cutoffs	O
determined	O
with	O
the	O
ROC	O
analysis	O
(	O
cutoff	O
level	O
:	O
ST2	B-ANAT
,	O
21	O
ng	O
/	O
mL	O
;	O
IL	O
-	O
6	O
,	O
61	O
pg	O
/	O
mL	O
;	O
TNFR1	O
,	O
3421	O
pg	O
/	O
mL	O
),	O
we	O
calculated	O
positive	O
predictive	O
values	O
(	O
PPV	O
)	O
for	O
a	O
range	O
of	O
estimated	O
population	O
prevalence	O
values	O
of	O
IPS	O
.	O

We	O
conclude	O
that	O
a	O
prospective	O
validation	O
study	O
is	O
warranted	O
to	O
determine	O
whether	O
a	O
plasma	B-ANAT
biomarker	O
panel	O
can	O
aid	O
the	O
noninvasive	O
diagnosis	O
and	O
prognosis	O
of	O
IPS	O
.	O

In	O
a	O
multivariate	O
analysis	O
,	O
history	O
of	O
autologous	O
stem	B-ANAT
cell	I-ANAT
transplantation	O
(	O
HR	O
,	O
31	O
.	O
151	O
;	O
95	O
%	O
CI	O
,	O
5	O
.	O
447	O
-	O
178	O
.	O
145	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
tachypnea	O
at	O
ED	O
(	O
HR	O
,	O
4	O
.	O
392	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
402	O
-	O
13	O
.	O
761	O
;	O
P	O
=	O
0	O
.	O
011	O
)	O
were	O
significantly	O
associated	O
with	O
MERS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
The	O
significance	O
of	O
changes	O
in	O
platelet	B-ANAT
concentration	O
during	O
the	O
early	O
phase	O
after	O
severe	O
burn	O
injury	O
in	O
a	O
Chinese	O
mass	O
casualty	O
.	O

We	O
analyzed	O
the	O
platelet	B-ANAT
concentration	O
of	O
the	O
two	O
groups	O
using	O
The	O
group	O
with	O
successful	O
resuscitation	O
had	O
higher	O
platelet	B-ANAT
concentration	O
than	O
the	O
failure	O
group	O
on	O
day	O
3	O
and	O
day	O
5	O
.	O

The	O
patients	O
who	O
suffered	O
from	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
)	O
and	O
septic	O
shock	O
had	O
a	O
lower	O
platelet	B-ANAT
concentration	O
than	O
non	O
-	O
sufferers	O
on	O
day	O
3	O
and	O
day	O
5	O
.	O

Seven	O
-	O
days	O
-	O
ovariectomized	O
rats	O
were	O
subjected	O
to	O
intestinal	B-ANAT
IR	O
by	O
occlusion	O
of	O
the	O
superior	B-ANAT
mesenteric	I-ANAT
artery	I-ANAT
for	O
45	O
min	O
.	O

RESULTS	O
:	O
We	O
observed	O
a	O
significant	O
increase	O
in	O
serum	B-ANAT
levels	O
of	O
IL	O
-	O
10	O
,	O
CINC	O
-	O
1	O
,	O
uric	O
acid	O
and	O
circulating	O
,	O
but	O
not	O
bone	B-ANAT
marrow	I-ANAT
,	O
leukocyte	B-ANAT
numbers	O
.	O

In	O
ALI	O
,	O
the	O
lack	O
of	O
viable	O
ATII	O
favors	O
progression	O
to	O
more	O
severe	O
lung	B-ANAT
injury	O
.	O

In	O
this	O
study	O
ATII	O
cells	B-ANAT
(	O
2	O
.	O
5	O
Ã	O
10	O
ATII	O
cell	B-ANAT
transplantation	O
promoted	O
recovery	O
of	O
lung	B-ANAT
function	O
,	O
decrease	O
mortality	O
and	O
lung	B-ANAT
inflammation	O
of	O
the	O
animals	O
with	O
ALI	O
.	O

In	O
summary	O
,	O
CPMV	O
and	O
eVLPs	O
can	O
be	O
considered	O
promising	O
nanocarriers	O
for	O
applications	O
requiring	O
oral	B-ANAT
delivery	O
,	O
given	O
their	O
chemical	O
,	O
physical	O
and	O
colloidal	O
stability	O
and	O
lack	O
of	O
protein	O
adsorption	O
from	O
the	O
environment	O
in	O
most	O
of	O
the	O
tested	O
conditions	O
.	O

Outcomes	O
included	O
hospital	O
mortality	O
,	O
duration	O
of	O
mechanical	O
ventilation	O
,	O
ICU	O
and	O
hospital	O
duration	O
,	O
and	O
discharge	B-ANAT
location	O
.	O

RNA	O
viruses	O
,	O
including	O
PEDV	O
,	O
can	O
interact	O
with	O
a	O
large	O
number	O
of	O
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
in	O
the	O
intestinal	B-ANAT
mucosa	I-ANAT
,	O
including	O
toll	O
-	O
like	O
receptors	O
(	O
TLRs	O
)	O
and	O
RIG	O
-	O
I	O
-	O
like	O
receptors	O
(	O
RLRs	O
).	O

It	O
provides	O
a	O
description	O
of	O
key	O
epidemiologic	O
events	O
and	O
news	O
released	O
from	O
a	O
prime	O
daily	O
newspaper	O
and	O
main	O
Emergency	O
Risk	O
Communication	O
(	O
ERC	B-ANAT
)	O
actions	O
that	O
were	O
undertaken	O
by	O
public	O
health	O
authorities	O
.	O

Using	O
the	O
Crisis	O
and	O
Emergency	O
Risk	O
Communication	O
(	O
CERC	O
)	O
theoretical	O
framework	O
,	O
the	O
study	O
analyzes	O
how	O
the	O
performed	O
ERC	B-ANAT
strategies	O
during	O
the	O
first	O
days	O
of	O
the	O
outbreak	O
might	O
have	O
contributed	O
to	O
the	O
outbreak	O
management	O
.	O

Both	O
samples	O
resulted	O
positive	O
to	O
the	O
pan	B-ANAT
-	O
coronavirus	O
RT	O
-	O
PCR	O
(	O
IT	O
-	O
batCoVs	O
)	O
and	O
their	O
genome	O
organization	O
showed	O
identical	O
pattern	O
of	O
MERS	O
CoV	O
.	O
Phylogenetic	O
analysis	O
showed	O
a	O
monophyletic	O
group	O
placed	O
in	O
the	O
Beta2c	O
clade	O
formed	O
by	O
MERS	O
-	O
CoV	O
sequences	O
originating	O
from	O
humans	O
and	O
camels	O
and	O
bat	O
-	O
related	O
sequences	O
from	O
Africa	O
,	O
Italy	O
and	O
China	O
.	O

TITLE	O
:	O
Possible	O
therapeutic	O
effect	O
of	O
orally	B-ANAT
administered	O
ribavirin	O
for	O
respiratory	O
syncytial	O
virus	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
an	O
immunocompetent	O
patient	O
:	O
a	O
case	O
report	O
.	O

We	O
report	O
a	O
case	O
of	O
respiratory	O
syncytial	O
virus	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
occurring	O
in	O
a	O
previously	O
healthy	O
man	O
successfully	O
treated	O
with	O
orally	B-ANAT
administered	O
ribavirin	O
.	O

CONCLUSIONS	O
:	O
This	O
case	O
demonstrates	O
the	O
potential	O
usefulness	O
of	O
orally	B-ANAT
administered	O
ribavirin	O
as	O
a	O
therapeutic	O
option	O
for	O
severe	O
respiratory	O
syncytial	O
virus	O
infection	O
,	O
at	O
least	O
in	O
an	O
immunocompetent	O
host	O
.	O

Evaluation	O
revealed	O
evidence	O
of	O
bilateral	O
central	B-ANAT
retinal	I-ANAT
artery	I-ANAT
occlusion	O
and	O
bilateral	O
ischemic	O
optic	B-ANAT
neuropathy	O
.	O

A	O
serial	O
multiple	O
mediator	O
model	O
finds	O
that	O
interpersonal	O
communication	O
and	O
higher	O
perceived	O
concern	O
indirectly	O
influence	O
the	O
effects	O
of	O
media	B-ANAT
coverage	O
on	O
the	O
engagement	O
in	O
preventive	O
actions	O
.	O

In	O
a	O
continuing	O
effort	O
to	O
decipher	O
the	O
molecular	O
mechanism	O
underlying	O
IFITM	O
differential	O
modulation	O
of	O
HCoV	O
entry	O
,	O
we	O
investigated	O
the	O
roles	O
of	O
structural	O
motifs	O
important	O
for	O
IFITM	O
protein	O
posttranslational	O
modifications	O
,	O
intracellular	B-ANAT
trafficking	O
,	O
and	O
oligomerization	O
in	O
modulating	O
the	O
entry	O
of	O
five	O
HCoVs	O
.	O

As	O
part	O
of	O
her	O
pre	O
-	O
HCT	O
conditioning	O
regimen	O
,	O
the	O
patient	O
received	O
myeloablative	O
treatment	O
with	O
cyclophosphamide	O
and	O
12	O
Gy	O
total	O
body	B-ANAT
irradiation	O
.	O

TITLE	O
:	O
Attenuated	O
accumulation	O
of	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
and	O
reduced	O
production	O
of	O
interleukin	O
10	O
lead	O
to	O
the	O
exacerbation	O
of	O
tissue	B-ANAT
injury	O
in	O
a	O
mouse	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

We	O
have	O
established	O
a	O
mouse	O
model	O
of	O
severe	O
ARDS	O
,	O
developed	O
by	O
intratracheal	O
injection	O
of	O
Î±	O
-	O
galactosylceramide	O
(	O
Î±	O
-	O
GalCer	O
),	O
an	O
activator	O
of	O
natural	O
killer	O
T	O
(	O
NKT	O
)	O
cells	B-ANAT
,	O
followed	O
by	O
LPS	O
.	O

Compared	O
with	O
severe	O
pneumonia	O
without	O
ARDS	O
development	O
,	O
patients	O
with	O
ARDS	O
development	O
had	O
shorter	O
disease	O
duration	O
before	O
admission	O
,	O
higher	O
lung	B-ANAT
injury	O
score	O
(	O
LIS	O
),	O
serum	B-ANAT
fibrinogen	B-ANAT
(	O
FiB	O
),	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
),	O
lower	O
Marshall	O
score	O
,	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
score	O
and	O
proportion	O
of	O
cardiovascular	B-ANAT
and	O
gastrointestinal	O
diseases	O
,	O
but	O
similar	O
mortality	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
represents	O
the	O
longest	O
reported	O
use	O
of	O
the	O
Impella	O
Cardiac	B-ANAT
Power	O
device	O
for	O
the	O
management	O
of	O
cardiogenic	O
shock	O
in	O
a	O
patient	O
with	O
takotsubo	O
syndrome	O
and	O
severe	O
sepsis	O
.	O

This	O
report	O
also	O
highlights	O
the	O
importance	O
of	O
considering	O
a	O
ventricular	B-ANAT
assist	O
device	O
in	O
the	O
management	O
of	O
takotsubo	O
syndrome	O
cardiogenic	O
shock	O
with	O
severe	O
sepsis	O
which	O
is	O
unresponsive	O
to	O
maximal	O
medical	O
therapy	O
.	O

ABSTRACT	O
:	O
The	O
effectiveness	O
of	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
in	O
the	O
pediatric	O
hematopoietic	B-ANAT
cell	I-ANAT
transplant	B-ANAT
patient	O
has	O
not	O
been	O
established	O
.	O

ACS	O
is	O
associated	O
with	O
prolonged	O
hospitalization	O
,	O
increased	O
risk	O
of	O
respiratory	O
failure	O
,	O
and	O
the	O
potential	O
for	O
developing	O
chronic	O
lung	B-ANAT
disease	O
.	O

The	O
patient	O
subsequently	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
followed	O
by	O
rash	O
and	O
acute	O
interstitial	B-ANAT
nephritis	O
.	O

CONCLUSIONS	O
:	O
This	O
is	O
the	O
first	O
case	O
to	O
report	O
pulmonary	B-ANAT
manifestation	O
as	O
the	O
initial	O
symptom	O
in	O
vancomycin	O
induced	O
DRESS	O
syndrome	O
.	O

The	O
use	O
of	O
nasal	B-ANAT
high	O
-	O
flow	O
therapy	O
(	O
nHFT	O
)	O
has	O
been	O
more	O
recently	O
introduced	O
into	O
the	O
NICUs	O
as	O
a	O
non	O
-	O
invasive	O
respiratory	O
(	O
NIV	O
)	O
support	O
.	O

Secondary	O
outcomes	O
were	O
rate	O
of	O
bronchopulmonary	O
dysplasia	O
(	O
BDP	O
),	O
air	O
leaks	O
,	O
nasal	B-ANAT
injury	O
,	O
late	O
onset	O
sepsis	O
(	O
LOS	O
),	O
intraventricular	B-ANAT
hemorrhage	O
(	O
IVH	O
),	O
retinopathy	O
(	O
ROP	O
),	O
necrotizing	O
enterocolitis	O
(	O
NEC	O
),	O
hemodynamically	O
-	O
significant	O
patent	O
ductus	B-ANAT
arteriosus	I-ANAT
(	O
PDA	B-ANAT
)	O
and	O
death	O
.	O

RPA	B-ANAT
primers	O
and	O
LF	O
probes	O
were	O
designed	O
by	O
targeting	O
the	O
specific	O
G	O
gene	O
,	O
and	O
the	O
amplification	O
product	O
can	O
be	O
visualized	O
on	O
a	O
simple	O
lateral	O
flow	O
dipstick	O
with	O
the	O
naked	O
eyes	B-ANAT
.	O

The	O
RPA	B-ANAT
combined	O
with	O
LFD	O
assay	O
probably	O
provides	O
a	O
rapid	O
and	O
sensitive	O
alternative	O
for	O
diagnosis	O
of	O
BEFV	O
infections	O
outbreak	O
.	O

ABSTRACT	O
:	O
Using	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
and	O
limited	O
dilution	O
methods	O
to	O
screen	O
and	O
clone	O
antigen	O
-	O
specific	O
hybridoma	B-ANAT
cells	B-ANAT
is	O
extremely	O
time	O
-	O
consuming	O
and	O
labor	O
-	O
intensive	O
.	O

In	O
this	O
assay	O
,	O
antigens	O
are	O
first	O
anchored	O
to	O
the	O
hybridoma	B-ANAT
cell	B-ANAT
surface	I-ANAT
through	O
a	O
dual	O
-	O
functioning	O
molecular	O
Oleyl	O
-	O
PEG4000	O
-	O
NHS	O
.	O

Using	O
this	O
method	O
,	O
positive	O
hybridoma	B-ANAT
clones	O
against	O
both	O
malachite	O
green	O
and	O
porcine	O
epidemic	O
diarrhea	O
virus	O
are	O
selected	O
with	O
high	O
efficiency	O
.	O

The	O
model	O
consisted	O
of	O
three	O
separate	O
houses	O
and	O
four	O
swine	O
populations	O
framed	O
in	O
a	O
standard	O
commercial	O
farrow	O
-	O
to	O
-	O
finish	O
swine	O
operation	O
in	O
Japan	O
,	O
with	O
a	O
special	O
focus	O
on	O
the	O
role	O
of	O
indirect	O
transmission	O
via	O
the	O
on	O
-	O
farm	O
environment	O
contaminated	O
by	O
feces	B-ANAT
of	O
infected	O
pigs	O
.	O

Next	O
,	O
we	O
determined	O
the	O
anti	O
-	O
PRRSV	O
capacity	O
of	O
compounds	O
2	O
and	O
3	O
in	O
MARC	O
-	O
145	O
cells	B-ANAT
and	O
obtained	O
EC	O

This	O
study	O
indicates	O
that	O
there	O
are	O
tremendous	O
differences	O
in	O
pathogenicity	O
and	O
tissue	B-ANAT
tropism	O
between	O
the	O
QX	O
-	O
like	O
strain	O
and	O
Mass	O
-	O
type	O
strain	O
.	O

ABSTRACT	O
:	O
The	O
incidence	O
and	O
long	O
-	O
term	O
outcomes	O
of	O
acute	O
kidney	B-ANAT
injury	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
due	O
to	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	O
(	O
pH1N1	O
)	O
have	O
not	O
been	O
examined	O
.	O

This	O
inhomogeneity	O
is	O
normally	O
caused	O
by	O
the	O
presence	O
of	O
lung	B-ANAT
edema	O
and	O
/	O
or	O
anatomical	O
variations	O
,	O
and	O
is	O
deeply	O
influenced	O
by	O
the	O
gravitational	O
forces	O
.	O

In	O
severe	O
ARDS	O
,	O
the	O
ventilatable	O
parenchyma	B-ANAT
is	O
strongly	O
reduced	O
in	O
size	O
('	O
baby	O
lung	B-ANAT
');	O
its	O
resting	B-ANAT
volume	O
could	O
be	O
as	O
low	O
as	O
300	O
mL	O
,	O
and	O
the	O
total	O
inspiratory	O
capacity	O
could	O
be	O
reached	O
with	O
a	O
tidal	O
volume	O
of	O
750	O
-	O
900	O
mL	O
,	O
thus	O
generating	O
lethal	O
stress	O
and	O
strain	O
in	O
the	O
lung	B-ANAT
.	O

Although	O
most	O
of	O
the	O
literature	O
on	O
VILI	O
concentrates	O
on	O
the	O
possible	O
dangers	O
of	O
tidal	O
volume	O
,	O
mechanical	O
ventilation	O
in	O
fact	O
delivers	O
mechanical	O
power	O
(	O
i	O
.	O
e	O
.,	O
energy	O
per	O
unit	O
of	O
time	O
)	O
to	O
the	O
lung	B-ANAT
parenchyma	I-ANAT
,	O
which	O
reacts	O
to	O
it	O
according	O
to	O
its	O
anatomical	B-ANAT
structure	I-ANAT
and	O
pathophysiological	O
status	O
.	O

We	O
previously	O
determined	O
the	O
immunogenicity	O
of	O
a	O
novel	O
dendritic	B-ANAT
cell	I-ANAT
(	O
DC	O
)-	O
targeted	O
PEDV	O
S1	O
protein	O
-	O
based	O
subunit	O
vaccine	O
in	O
weaned	O
piglets	O
in	O
which	O
the	O
PEDV	O
antigen	O
was	O
targeted	O
to	O
DCs	O
through	O
a	O
porcine	O
Langerin	O
-	O
specific	O
antibody	O
.	O

A	O
recently	O
published	O
international	O
standard	O
indicates	O
that	O
regions	O
medially	O
adjacent	O
to	O
the	O
inner	O
canthi	O
provide	O
accurate	O
estimates	O
of	O
core	O
body	B-ANAT
temperature	O
and	O
are	O
preferred	O
sites	O
for	O
fever	O
screening	O
.	O

When	O
comparing	O
radial	O
versus	O
femoral	B-ANAT
,	O
there	O
was	O
no	O
significant	O
interaction	O
for	O
MACCE	O
and	O
NACE	O
stratified	O
by	O
sex	O
(	O
p	O
Women	O
showed	O
a	O
higher	O
risk	O
of	O
severe	O
bleeding	O
and	O
access	O
site	O
complications	O
,	O
and	O
radial	O
access	O
was	O
an	O
effective	O
method	O
to	O
reduce	O
these	O
complications	O
as	O
well	O
as	O
composite	O
ischemic	O
and	O
ischemic	O
or	O
bleeding	O
endpoints	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
an	O
association	O
between	O
mitochondrial	B-ANAT
dysfunction	O
and	O
apoptosis	O
following	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
infection	O
,	O
HD11	O
avian	O
macrophage	B-ANAT
cells	B-ANAT
were	O
infected	O
with	O
the	O
Massachusetts	O
41	O
(	O
M41	O
)	O
strain	O
.	O

TITLE	O
:	O
Differential	O
induction	O
of	O
malaria	O
liver	B-ANAT
pathology	O
in	O
mice	O
infected	O
with	O
Plasmodium	O
chabaudi	O
AS	O
or	O
Plasmodium	O
berghei	O
NK65	O
.	O

Moreover	O
,	O
in	O
P	O
.	O
berghei	O
NK65	O
infected	O
mice	O
,	O
increased	O
lipid	O
peroxidation	O
,	O
accumulation	O
of	O
triglycerides	O
,	O
impairment	O
of	O
anti	O
-	O
oxidant	O
enzymes	O
and	O
higher	O
collagen	B-ANAT
deposition	O
were	O
detected	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
multiple	O
injuries	O
are	O
particularly	O
susceptible	O
to	O
accidental	O
hypothermia	O
which	O
is	O
correlated	O
with	O
an	O
increased	O
risk	O
of	O
post	O
-	O
traumatic	O
complications	O
and	O
mortality	O
;	O
however	O
,	O
its	O
impact	O
on	O
neurological	O
outcome	O
in	O
cases	O
where	O
there	O
is	O
concomitant	O
traumatic	O
brain	B-ANAT
injury	O
is	O
underexplored	O
.	O

We	O
analyzed	O
severely	O
injured	O
patients	O
(	O
ISS	O
â¥	O
16	O
)	O
including	O
a	O
moderate	O
-	O
to	O
-	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
(	O
AIS	O
We	O
analyzed	O
278	O
patients	O
(	O
M	O
age	O
=	O
43	O
years	O
,	O
SD	O
19	O
;	O
M	O
ISS	O
=	O
32	O
.	O
8	O
,	O
SD	O
10	O
.	O
7	O
).	O

Two	O
patients	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

Regional	O
histology	O
(	O
rabbit	O
),	O
inflammation	O
(	O
positron	O
emission	B-ANAT
tomography	O
;	O
pig	O
),	O
regional	O
inspiratory	O
Ppl	O
(	O
intrabronchial	O
balloon	O
manometry	O
),	O
and	O
stretch	O
(	O
electrical	O
impedance	O
tomography	O
;	O
pig	O
)	O
were	O
measured	O
.	O

In	O
contrast	O
,	O
high	O
PEEP	O
minimized	O
lung	B-ANAT
injury	O
by	O
more	O
uniformly	O
distributing	O
negative	O
Ppl	O
,	O
and	O
lowering	O
the	O
magnitude	O
of	O
spontaneous	O
effort	O
(	O
i	O
.	O
e	O
.,	O
deflection	O
in	O
esophageal	O
pressure	O
observed	O
in	O
rabbits	O
,	O
pigs	O
,	O
and	O
patients	O
).	O

The	O
greater	O
number	O
of	O
CFs	O
in	O
the	O
ALI	O
/	O
ARDS	O
group	O
implied	O
higher	O
degree	O
of	O
lung	B-ANAT
injury	O
and	O
more	O
severe	O
pulmonary	B-ANAT
fibrosis	O
.	O

During	O
PSV	O
,	O
PEEP	O
of	O
5	O
cmH2O	O
,	O
but	O
not	O
a	O
PEEP	O
of	O
2	O
cmH2O	O
,	O
reduced	O
lung	B-ANAT
damage	O
and	O
inflammatory	O
markers	O
while	O
maintaining	O
epithelial	B-ANAT
cell	I-ANAT
integrity	O
.	O

RESULTS	O
:	O
In	O
both	O
PCV	O
and	O
PSV	O
,	O
peak	O
transpulmonary	O
pressure	O
was	O
lower	O
,	O
whereas	O
E	O
-	O
cadherin	O
tissue	B-ANAT
expression	O
,	O
which	O
is	O
related	O
to	O
epithelial	O
integrity	O
,	O
was	O
higher	O
at	O
PEEP	O
=	O
5	O
cmH2O	O
than	O
at	O
PEEP	O
=	O
2	O
cmH2O	O
.	O

Neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
(	O
NETs	O
)	O
can	O
be	O
induced	O
by	O
pathogens	O
and	O
are	O
responsible	O
for	O
immune	O
tissue	B-ANAT
damage	O
.	O

We	O
investigated	O
NET	O
production	O
in	O
plasma	B-ANAT
and	O
supernatant	O
of	O
cultured	O
neutrophils	B-ANAT
by	O
measuring	O
cell	B-ANAT
-	O
free	O
deoxyribonucleic	O
acid	O
(	O
DNA	O
)	O
and	O
myeloperoxidase	O
(	O
MPO	O
)-	O
DNA	O
complexes	O
with	O
PicoGreen	O
dye	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
methods	O
,	O
respectively	O
.	O

Fibroblasts	B-ANAT
in	O
the	O
meninges	B-ANAT
together	O
with	O
the	O
basal	B-ANAT
lamina	I-ANAT
and	O
the	O
astrocyte	B-ANAT
endfeet	O
forms	O
the	O
glial	B-ANAT
limitans	O
superficialis	O
as	O
part	O
of	O
the	O
blood	B-ANAT
-	I-ANAT
brain	I-ANAT
barrier	I-ANAT
(	O
BBB	B-ANAT
).	O

Alteration	O
of	O
glial	B-ANAT
-	O
pial	O
gap	B-ANAT
junction	I-ANAT
intercellular	O
communication	O
(	O
GJIC	O
)	O
in	O
MHV	O
infection	O
has	O
the	O
potential	O
to	O
affect	O
the	O
integrity	O
of	O
BBB	B-ANAT
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
MHV	O
infection	O
on	O
Cx43	O
localization	O
and	O
function	O
in	O
mouse	B-ANAT
brain	I-ANAT
meningeal	O
cells	B-ANAT
and	O
primary	O
meningeal	O
fibroblasts	B-ANAT
.	O

This	O
regulation	O
is	O
carried	O
out	O
by	O
spike	O
'	O
s	O
major	O
functions	O
:	O
receptor	O
binding	O
and	O
virus	O
-	O
cell	B-ANAT
membrane	I-ANAT
fusion	O
.	O

TITLE	O
:	O
Supplementing	O
dietary	O
rosemary	O
(	O
Rosmarinus	O
officinalis	O
L	O
.)	O
powder	O
and	O
vitamin	O
E	O
in	O
broiler	O
chickens	O
:	O
evaluation	O
of	O
humoral	O
immune	O
response	O
,	O
lymphoid	B-ANAT
organs	I-ANAT
,	O
and	O
blood	B-ANAT
proteins	O
.	O

Blood	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
birds	O
1	O
week	O
after	O
each	O
vaccination	O
to	O
determine	O
antibody	O
titers	O
.	O

Neither	O
antibody	O
titers	O
against	O
viruses	O
nor	O
lymphoid	B-ANAT
tissues	I-ANAT
weight	O
were	O
affected	O
by	O
RP	O
and	O
/	O
or	O
VE	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
treatments	O
.	O

Kidney	B-ANAT
biopsy	O
was	O
done	O
in	O
13	O
patients	O
.	O

During	O
two	O
animal	O
infection	O
experiments	O
,	O
swabs	O
were	O
collected	O
from	O
personnel	O
(	O
nasal	B-ANAT
mucosa	I-ANAT
)	O
and	O
their	O
clothes	O
,	O
boots	O
and	O
equipment	O
after	O
contact	O
with	O
calves	O
shedding	O
either	O
virus	O
.	O

Live	O
attenuated	O
viruses	O
are	O
widely	O
used	O
in	O
both	O
the	O
broiler	O
and	O
layer	B-ANAT
industry	O
because	O
of	O
their	O
efficacy	O
and	O
ability	O
to	O
be	O
mass	O
applied	O
.	O

These	O
assumptions	O
include	O
the	O
effects	O
of	O
the	O
chest	B-ANAT
wall	I-ANAT
on	O
lung	B-ANAT
-	O
surface	O
pressure	O
,	O
its	O
topographical	O
distribution	O
,	O
and	O
the	O
effects	O
of	O
non	O
-	O
uniform	O
tissue	B-ANAT
properties	O
on	O
local	O
parenchymal	O
stresses	O
.	O

Understanding	O
both	O
the	O
assumptions	O
of	O
lung	B-ANAT
mechanics	O
and	O
the	O
scope	O
of	O
injury	O
mechanisms	O
operating	O
during	O
ARDS	O
is	O
necessary	O
to	O
interpret	O
the	O
results	O
of	O
clinical	O
trials	O
that	O
inform	O
prevailing	O
ventilator	O
-	O
management	O
guidelines	O
.	O

For	O
each	O
case	O
,	O
data	O
were	O
extracted	O
pertaining	O
to	O
age	O
,	O
sex	O
,	O
type	O
of	O
medication	O
associated	O
with	O
the	O
disease	O
,	O
time	O
from	O
the	O
onset	O
of	O
symptoms	O
to	O
diagnosis	O
,	O
eosinophil	B-ANAT
counts	O
in	O
the	O
blood	B-ANAT
,	O
eosinophil	B-ANAT
fractions	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
,	O
initial	O
chest	B-ANAT
radiograph	O
and	O
computed	O
tomography	O
results	O
,	O
use	O
of	O
mechanical	O
ventilation	O
,	O
and	O
use	O
of	O
steroid	O
treatment	O
and	O
recurrence	O
.	O

In	O
wild	O
-	O
type	O
virus	O
infected	O
cells	B-ANAT
,	O
4b	O
localized	O
to	O
the	O
nucleus	B-ANAT
,	O
while	O
NF	O
-	O
ÎºB	O
was	O
retained	O
in	O
the	O
cytoplasm	B-ANAT
.	O

In	O
particular	O
,	O
4b	O
had	O
a	O
strong	O
preference	O
for	O
binding	O
karyopherin	O
-	O
Î±4	O
(	O
KPNA4	O
),	O
which	O
is	O
known	O
to	O
translocate	O
the	O
NF	O
-	O
ÎºB	O
protein	B-ANAT
complex	I-ANAT
into	O
the	O
nucleus	B-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
exacerbation	O
(	O
s	O
)	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
AECOPD	O
)	O
tend	O
to	O
be	O
critical	O
and	O
debilitating	O
events	O
leading	O
to	O
poorer	O
outcomes	O
in	O
relation	O
to	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
treatment	O
modalities	O
,	O
and	O
contribute	O
to	O
a	O
higher	O
and	O
earlier	O
mortality	O
rate	O
in	O
COPD	O
patients	O
.	O

Here	O
,	O
we	O
used	O
an	O
inhibitor	O
of	O
colony	O
-	O
stimulating	O
factor	O
1	O
receptor	O
(	O
CSF1R	O
)	O
that	O
depletes	O
microglia	B-ANAT
to	O
examine	O
the	O
specific	O
roles	O
of	O
microglia	B-ANAT
in	O
response	O
to	O
infection	O
with	O
the	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
a	O
neurotropic	O
coronavirus	O
.	O

These	O
results	O
reveal	O
nonredundant	O
,	O
critical	O
roles	O
for	O
microglia	B-ANAT
in	O
the	O
early	O
innate	O
and	O
virus	O
-	O
specific	O
T	B-ANAT
cell	I-ANAT
responses	O
and	O
for	O
subsequent	O
host	O
protection	O
from	O
viral	O
encephalitis	O
.	O

ABSTRACT	O
:	O
Group	O
A	O
Streptococcus	O
(	O
GAS	O
)	O
are	O
pathogenic	O
bacteria	O
of	O
the	O
genus	O
Streptococcus	O
and	O
cause	O
severe	O
invasive	O
infections	O
that	O
comprise	O
a	O
wide	O
range	O
of	O
diverse	O
diseases	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
renal	B-ANAT
failure	O
,	O
toxic	O
shock	O
-	O
like	O
syndrome	O
,	O
sepsis	O
,	O
cellulitis	O
and	O
necrotizing	O
fasciitis	O
.	O

In	O
this	O
period	O
,	O
we	O
found	O
a	O
moderate	O
but	O
statistically	O
significant	O
decline	O
of	O
overall	O
anti	O
-	O
HEV	B-ANAT
IgG	O
prevalence	O
from	O
18	O
.	O
6	O
%	O
to	O
15	O
.	O
3	O
%.	O

However	O
,	O
the	O
energy	O
and	O
nutrients	O
needed	O
to	O
recover	O
the	O
epithelium	B-ANAT
may	O
be	O
originating	O
from	O
available	O
luminal	O
nutrients	O
instead	O
of	O
muscle	B-ANAT
proteolysis	O
and	O
gluconeogenesis	O
.	O

After	O
the	O
last	O
immunization	O
,	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
(	O
PBMCs	O
)	O
were	O
isolated	O
from	O
the	O
whole	B-ANAT
blood	I-ANAT
and	O
total	O
RNA	O
was	O
extracted	O
.	O

RESULTS	O
:	O
Although	O
all	O
nasopharyngeal	B-ANAT
samples	O
were	O
negative	O
,	O
MERS	O
CoV	O
infection	O
was	O
confirmed	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
of	O
the	O
E	O
gene	O
(	O
UpE	O
)	O
and	O
open	O
reading	O
frame	O
(	O
ORF1b	O
)	O
on	O
sputum	B-ANAT
samples	O
.	O

The	O
diagnosis	O
is	O
often	O
challenging	O
and	O
not	O
all	O
of	O
the	O
diagnostic	O
criteria	O
may	O
be	O
present	O
at	O
the	O
same	O
time	O
;	O
this	O
case	O
shows	O
how	O
complex	O
the	O
diagnosis	O
could	O
be	O
,	O
how	O
hematic	O
ferritin	O
levels	O
could	O
help	O
in	O
following	O
the	O
course	O
of	O
the	O
disease	O
,	O
and	O
the	O
possibility	O
of	O
severe	O
pulmonary	B-ANAT
complication	O
either	O
due	O
to	O
the	O
disease	O
itself	O
and	O
to	O
possible	O
sovra	O
infections	O
.	O

Patients	O
with	O
BAIT	O
generally	O
present	O
with	O
acute	O
ocular	B-ANAT
pain	O
,	O
photophobia	O
,	O
and	O
red	O
eyes	B-ANAT
.	O

ABSTRACT	O
:	O
Human	B-ANAT
embryo	I-ANAT
lung	B-ANAT
cellular	B-ANAT
protein	O
interacting	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	O
nonstructural	O
protein	O
-	O
10	O
(	O
HEPIS	O
)	O
is	O
a	O
novel	O
transcriptional	O
repressor	O
,	O
the	O
expression	O
profile	O
and	O
promoter	O
activity	O
of	O
which	O
have	O
not	O
been	O
well	O
studied	O
.	O

ABSTRACT	O
:	O
Pancreatitis	O
is	O
a	O
condition	O
characterized	O
by	O
parenchymal	O
inflammation	O
of	O
the	O
pancreas	B-ANAT
,	O
which	O
is	O
often	O
associated	O
with	O
lung	B-ANAT
injury	O
due	O
to	O
low	O
level	O
of	O
oxygen	O
and	O
the	O
condition	O
is	O
termed	O
as	O
acute	O
pancreatitis	O
-	O
associated	O
lung	B-ANAT
injury	O
(	O
APALI	O
).	O

Acute	O
lung	B-ANAT
injury	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
acute	O
pancreatitis	O
remains	O
an	O
unsolved	O
issue	O
and	O
needs	O
more	O
research	O
and	O
resources	O
to	O
develop	O
effective	O
treatments	O
and	O
therapies	O
.	O

Secondary	O
outcomes	O
included	O
the	O
number	O
of	O
non	O
-	O
pulmonary	B-ANAT
organ	B-ANAT
failure	O
-	O
free	O
days	O
to	O
day	O
28	O
,	O
mortality	O
and	O
safety	O
.	O

Preliminary	O
data	O
using	O
saliva	B-ANAT
samples	O
spiked	O
with	O
ZIKV	O
showed	O
that	O
our	O
diagnostic	O
system	O
detects	O
ZIKV	O
RNA	O
in	O
saliva	B-ANAT
.	O

Comorbidities	O
were	O
diabetes	O
mellitus	O
(	O
87	O
%),	O
chronic	O
respiratory	O
failure	O
(	O
57	O
%),	O
and	O
chronic	O
renal	B-ANAT
failure	O
(	O
29	O
%).	O

For	O
diagnostic	O
investigations	O
in	O
the	O
affected	O
farms	O
,	O
real	O
time	O
RT	O
-	O
PCR	O
was	O
performed	O
to	O
detect	O
PEDV	O
RNA	O
in	O
individually	O
taken	O
fecal	B-ANAT
samples	O
,	O
and	O
two	O
commercial	O
ELISA	O
kits	O
,	O
both	O
based	O
on	O
the	O
N	O
protein	O
of	O
PEDV	O
,	O
were	O
used	O
to	O
detect	O
IgG	O
in	O
serum	B-ANAT
samples	O
of	O
pigs	O
experiencing	O
acute	O
signs	O
of	O
the	O
disease	O
.	O

Then	O
,	O
the	O
effects	O
of	O
PGE2	O
on	O
the	O
expression	O
of	O
innate	O
antiviral	O
factors	O
in	O
cultured	O
uterine	B-ANAT
mucosal	B-ANAT
cells	B-ANAT
were	O
examined	O
.	O

TITLE	O
:	O
Peptide	O
-	O
Based	O
Membrane	B-ANAT
Fusion	O
Inhibitors	O
Targeting	O
HCoV	O
-	O
229E	O
Spike	O
Protein	O
HR1	O
and	O
HR2	O
Domains	O
.	O

Here	O
we	O
reported	O
the	O
design	O
,	O
synthesis	O
and	O
characterization	O
of	O
two	O
peptide	O
-	O
based	O
membrane	B-ANAT
fusion	O
inhibitors	O
targeting	O
HCoV	O
-	O
229E	O
spike	O
protein	O
heptad	O
repeat	O
1	O
(	O
HR1	O
)	O
and	O
heptad	O
repeat	O
2	O
(	O
HR2	O
)	O
domains	O
,	O
229E	O
-	O
HR1P	O
and	O
229E	O
-	O
HR2P	O
,	O
respectively	O
.	O

Neutrophil	B-ANAT
extracellular	B-ANAT
traps	O
(	O
NETs	O
)	O
have	O
been	O
proposed	O
as	O
an	O
innate	O
defense	O
mechanism	O
responsible	O
for	O
pathogen	O
clearance	O
,	O
but	O
there	O
are	O
concerns	O
that	O
NETs	O
may	O
induce	O
collateral	B-ANAT
damage	O
to	O
host	O
tissues	B-ANAT
.	O

Most	O
deaths	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
are	O
not	O
directly	O
related	O
to	O
lung	B-ANAT
damage	O
but	O
to	O
extrapulmonary	O
multisystem	O
organ	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
Rehabilitation	O
is	O
an	O
integral	O
component	O
of	O
care	O
for	O
patients	O
affected	O
by	O
either	O
acute	O
or	O
chronic	O
pulmonary	B-ANAT
diseases	O
.	O

However	O
,	O
only	O
the	O
recruitment	O
of	O
macrophages	B-ANAT
in	O
the	O
lung	B-ANAT
correlated	O
with	O
IBV	O
genome	O
loads	O
in	O
this	O
tissue	B-ANAT
.	O

In	O
conclusion	O
,	O
the	O
present	O
study	O
demonstrates	O
that	O
recruitment	O
of	O
macrophages	B-ANAT
and	O
the	O
production	O
of	O
IL	O
-	O
1Î²	O
originating	O
from	O
macrophages	B-ANAT
,	O
as	O
well	O
as	O
other	O
sources	O
,	O
occur	O
following	O
IBV	O
infection	O
in	O
the	O
respiratory	B-ANAT
tract	I-ANAT
suggesting	O
potential	O
roles	O
of	O
these	O
mediators	O
in	O
the	O
host	O
responses	O
to	O
IBV	O
infection	O
.	O

To	O
meet	O
the	O
pressing	O
need	O
of	O
developing	O
a	O
safe	O
and	O
cost	O
-	O
efficient	O
PED	O
maternal	O
vaccine	O
,	O
we	O
generated	O
three	O
PED	O
subunit	O
vaccine	O
candidates	O
,	O
using	O
recombined	O
Salmonella	O
flagellin	O
(	O
rSF	O
)	O
as	O
a	O
mucosal	B-ANAT
molecular	O
adjuvant	O
.	O

Specific	O
primers	O
and	O
probe	O
were	O
designed	O
and	O
synthesized	O
based	O
on	O
the	O
conserved	O
region	O
within	O
the	O
N	O
gene	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
.	O

In	O
this	O
review	O
we	O
will	O
describe	O
some	O
pathophysiological	O
aspects	O
of	O
heart	B-ANAT
-	O
lung	B-ANAT
interactions	O
during	O
the	O
ventilatory	O
support	O
of	O
ARDS	O
,	O
its	O
clinical	O
assessment	O
and	O
discuss	O
therapeutic	O
interventions	O
to	O
prevent	O
the	O
occurrence	O
and	O
progression	O
of	O
PVD	O
and	O
RV	O
failure	O
.	O

ABSTRACT	O
:	O
A	O
50	O
-	O
year	O
-	O
old	O
man	O
with	O
acute	O
myelogenous	O
leukemia	O
underwent	O
allogeneic	O
bone	B-ANAT
-	O
marrow	O
transplantation	O
(	O
BMT	O
).	O

His	O
clinical	O
course	O
and	O
the	O
findings	O
of	O
a	O
nerve	B-ANAT
conduction	O
study	O
fulfilled	O
the	O
criteria	O
for	O
diagnosis	O
of	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
(	O
GBS	O
).	O

To	O
explore	O
this	O
possibility	O
,	O
we	O
investigated	O
the	O
timing	O
that	O
events	O
occurred	O
in	O
each	O
treatment	O
arm	B-ANAT
during	O
active	O
treatment	O
intervention	O
(	O
efficacy	O
)	O
and	O
after	O
stopping	O
therapy	O
.	O

ABSTRACT	O
:	O
Respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
infection	O
is	O
common	O
and	O
may	O
be	O
severe	O
among	O
patients	O
with	O
preexisting	O
cardiac	B-ANAT
anomalies	O
,	O
but	O
direct	O
involvement	O
of	O
myocardial	O
damage	O
is	O
not	O
common	O
in	O
those	O
patients	O
.	O

Evoked	O
serious	O
complications	O
include	O
rhabdomyolysis	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
ultimately	O
,	O
sepsis	O
and	O
disseminated	O
intravascular	O
coagulation	O
.	O

He	O
also	O
had	O
paroxysmal	O
ventricular	B-ANAT
tachycardia	O
treated	O
with	O
prophylactic	O
propranolol	O
.	O

ABSTRACT	O
:	O
Continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
is	O
an	O
effective	O
treatment	O
for	O
obstructive	O
sleep	O
apnoea	O
(	O
OSA	O
),	O
but	O
an	O
evaluation	O
of	O
CPAP	O
adherence	O
is	O
rarely	O
carried	O
out	O
among	O
patients	O
with	O
acute	O
coronary	B-ANAT
syndrome	O
(	O
ACS	O
).	O

In	O
vitro	O
,	O
pneumolysin	O
enhanced	O
endothelial	B-ANAT
angiopoietin	O
-	O
2	O
release	O
,	O
angiopoietin	O
-	O
2	O
increased	O
endothelial	B-ANAT
permeability	O
,	O
and	O
angiopoietin	O
-	O
1	O
reduced	O
pneumolysin	O
-	O
evoked	O
endothelial	B-ANAT
permeability	O
.	O

TITLE	O
:	O
Aetiology	O
of	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
in	O
adults	O
in	O
primary	O
care	O
:	O
a	O
prospective	O
study	O
in	O
11	O
European	O
countries	O
.	O

Electrocardiography	O
and	O
laryngofiberscopy	O
indicated	O
the	O
absence	O
of	O
acute	O
coronary	B-ANAT
syndrome	O
and	O
airway	B-ANAT
obstruction	O
,	O
respectively	O
.	O

An	O
arterial	B-ANAT
blood	I-ANAT
gas	O
determination	O
showed	O
pH	O
7	O
.	O
63	O
,	O
PaCO	O
HVS	O
can	O
occur	O
after	O
emergence	O
from	O
general	O
anesthesia	O
,	O
and	O
dexmedetomidine	O
infusion	O
was	O
effective	O
for	O
HVS	O
.	O

The	O
severe	O
inflammatory	O
cascades	O
impaired	O
the	O
regulation	O
of	O
vascular	B-ANAT
endothelial	B-ANAT
barrier	O
and	O
vascular	B-ANAT
permeability	O
.	O

Juveniles	O
(	O
forearm	B-ANAT
length	O
â¤	O
136	O
mm	O
)	O
were	O
found	O
with	O
more	O
CoV	O
infection	O
than	O
adults	O
at	O
all	O
three	O
sites	O
;	O
S1	O
(	O
9	O
/	O
24	O
,	O
37	O
.	O
5	O
%	O
vs	O
2	O
/	O
20	O
,	O
10	O
%),	O
S2	O
(	O
22	O
/	O
49	O
,	O
44	O
.	O
9	O
%	O
vs	O
13	O
/	O
50	O
,	O
26	O
.	O
0	O
%),	O
and	O
S3	O
(	O
10	O
/	O
30	O
,	O
33	O
.	O
3	O
%	O
vs	O
12	O
/	O
194	O
,	O
6	O
.	O
2	O
%).	O

TITLE	O
:	O
Delivery	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
support	O
of	O
pregnant	O
woman	O
with	O
severe	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
influenza	O
:	O
a	O
case	O
report	O
and	O
review	O
of	O
the	O
literature	O
.	O

RESULTS	O
:	O
Our	O
data	O
reveals	O
that	O
two	O
macrophage	B-ANAT
populations	O
corresponding	O
to	O
M1	O
(	O
classically	O
activated	O
)	O
and	O
M2	O
(	O
alternatively	O
activated	O
)	O
macrophage	B-ANAT
subtypes	O
respond	O
distinctly	O
to	O
H5N1	O
virus	O
infection	O
when	O
compared	O
to	O
H1N1	O
virus	O
or	O
mock	O
infection	O
,	O
a	O
distinction	O
that	O
could	O
not	O
be	O
made	O
from	O
previous	O
microarray	O
studies	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
activation	O
of	O
a	O
disintergrin	O
and	O
metalloprotease	O
17	O
(	O
ADAM17	O
)	O
induced	O
the	O
decrease	O
of	O
PEDV	O
infection	O
in	O
HEK293	O
and	O
IPEC	O
-	O
J2	O
cells	B-ANAT
and	O
the	O
downregulation	O
of	O
cell	B-ANAT
surface	I-ANAT
aminopeptidase	O
N	O
(	O
APN	O
)	O
expression	O
,	O
an	O
important	O
entry	O
factor	O
for	O
PEDV	O
infection	O
.	O

Furthermore	O
,	O
overexpression	O
of	O
ADAM17	O
suppressed	O
PEDV	O
infection	O
in	O
HEK293	O
and	O
IPEC	O
-	O
J2	O
cells	B-ANAT
,	O
whereas	O
ablation	O
of	O
ADAM17	O
expression	O
using	O
ADAM17	O
specific	O
siRNA	O
resulted	O
in	O
a	O
corresponding	O
increase	O
of	O
PEDV	O
infection	O
and	O
an	O
upregulation	O
of	O
cell	B-ANAT
surface	I-ANAT
APN	O
expression	O
.	O

TITLE	O
:	O
A	O
Conserved	O
Distal	O
Lung	B-ANAT
Regenerative	O
Pathway	O
in	O
Acute	O
Lung	B-ANAT
Injury	O
.	O

TITLE	O
:	O
Upper	B-ANAT
arm	I-ANAT
anthropometrics	O
versus	O
DXA	O
scan	O
in	O
survivors	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Short	O
time	O
from	O
symptom	O
onset	O
to	O
hospital	O
admission	O
(	O
less	O
than	O
7	O
days	O
),	O
bulbar	B-ANAT
(	O
odds	O
ratio	O
[	O
OR	O
],	O
9	O
.	O
0	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
94	O
-	O
20	O
.	O
6	O
;	O
P	O
<	O
0	O
.	O
001	O
)	O
or	O
neck	B-ANAT
weakness	O
(	O
OR	O
,	O
6	O
.	O
36	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
32	O
-	O
17	O
.	O
5	O
;	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
severe	O
muscle	B-ANAT
weakness	O
at	O
hospital	O
admission	O
were	O
associated	O
with	O
increased	O
risk	O
of	O
intubation	O
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
distinct	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
resident	O
cells	B-ANAT
to	O
protective	O
alpha	O
/	O
beta	O
interferon	O
(	O
IFN	O
-	O
Î±	O
/	O
Î²	O
)	O
function	O
following	O
viral	O
infections	O
is	O
poorly	O
understood	O
.	O

TITLE	O
:	O
Impact	O
and	O
safety	O
of	O
open	O
lung	B-ANAT
biopsy	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
an	O
inflammatory	O
lung	B-ANAT
disorder	O
,	O
and	O
its	O
pathological	O
hallmark	O
is	O
diffuse	O
alveolar	B-ANAT
damage	O
(	O
DAD	O
).	O

Given	O
that	O
open	O
lung	B-ANAT
biopsy	O
(	O
OLB	O
)	O
can	O
sometimes	O
result	O
in	O
severe	O
side	O
effects	O
,	O
it	O
is	O
rarely	O
performed	O
in	O
patients	O
with	O
ARDS	O
.	O

DAD	O
was	O
defined	O
by	O
the	O
presence	O
of	O
a	O
hyaline	B-ANAT
membrane	B-ANAT
plus	O
at	O
least	O
one	O
of	O
the	O
following	O
:	O
intra	O
-	O
alveolar	B-ANAT
edema	O
,	O
alveolar	B-ANAT
type	B-ANAT
I	I-ANAT
cell	I-ANAT
necrosis	O
,	O
alveolar	B-ANAT
type	I-ANAT
II	I-ANAT
cell	I-ANAT
(	O
cuboidal	B-ANAT
cells	I-ANAT
)	O
proliferation	O
progressively	O
covering	O
the	O
denuded	O
alveolar	B-ANAT
-	O
capillary	B-ANAT
membrane	B-ANAT
,	O
interstitial	B-ANAT
proliferation	O
of	O
fibroblasts	B-ANAT
and	O
myofibroblasts	B-ANAT
,	O
or	O
organizing	O
interstitial	B-ANAT
fibrosis	O
.	O

Patients	O
were	O
followed	O
-	O
up	O
until	O
death	O
or	O
hospital	O
discharge	B-ANAT
.	O

TITLE	O
:	O
Aminopeptidase	O
-	O
N	O
-	O
independent	O
entry	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
into	O
Vero	O
or	O
porcine	O
small	B-ANAT
intestine	I-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

We	O
found	O
that	O
endogenous	O
expression	O
of	O
Vero	O
-	O
APN	O
was	O
undetectable	O
in	O
the	O
mRNA	O
and	O
the	O
protein	O
levels	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

Studies	O
conducted	O
over	O
the	O
past	O
three	O
decades	O
indicate	O
that	O
MIT	O
and	O
Virus	O
Isolation	O
in	O
Cell	B-ANAT
Culture	O
(	O
VICC	O
)	O
can	O
provide	O
the	O
same	O
effectiveness	O
,	O
the	O
latter	O
being	O
considered	O
superior	O
in	O
bioethics	O
and	O
animal	O
welfare	O
.	O

Importantly	O
,	O
combining	O
RBD	O
-	O
and	O
non	O
-	O
RBD	O
MAbs	O
delayed	O
the	O
emergence	O
of	O
escape	O
mutations	O
in	O
a	O
cell	B-ANAT
-	O
based	O
virus	O
escape	O
assay	O
.	O

Finally	O
,	O
the	O
H209A	O
mutation	O
significantly	O
increased	O
the	O
thermostability	O
of	O
S	O
protein	O
in	O
its	O
prefusion	O
conformation	O
,	O
which	O
may	O
raise	O
the	O
energy	O
barrier	O
for	O
conformational	O
change	O
of	O
S	O
protein	O
required	O
for	O
membrane	B-ANAT
fusion	O
and	O
lead	O
to	O
a	O
decrease	O
in	O
virus	O
fitness	O
in	O
cell	B-ANAT
culture	O
.	O

A	O
generalized	O
estimating	O
equation	O
tested	O
for	O
an	O
association	O
between	O
the	O
level	O
of	O
inflammation	O
and	O
the	O
prevalence	O
of	O
these	O
cell	B-ANAT
types	O
.	O

TITLE	O
:	O
[	O
Application	O
of	O
early	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
in	O
the	O
bundle	O
treatment	O
of	O
severe	O
pneumonia	O
].	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
serum	B-ANAT
PCT	O
,	O
IL	O
-	O
6	O
,	O
TNF	O
-	O
Î±	O
or	O
CD4	O

The	O
exacerbation	O
of	O
general	O
and	O
respiratory	O
clinical	O
signs	O
has	O
been	O
attributed	O
not	O
only	O
to	O
an	O
efficient	O
replication	O
(	O
virulence	O
)	O
but	O
also	O
to	O
the	O
ability	O
to	O
dysregulate	O
viral	O
recognition	O
and	O
induce	O
mechanisms	O
of	O
immune	O
evasion	O
or	O
immune	O
enhancement	O
of	O
humoral	O
and	O
cellular	B-ANAT
anti	O
-	O
viral	O
responses	O
differently	O
from	O
non	O
-	O
HP	O
PRRSV	O
isolates	O
in	O
terms	O
of	O
intensity	O
and	O
temporal	O
onset	O
.	O

The	O
present	O
study	O
aims	O
at	O
addressing	O
the	O
modulation	O
of	O
relevant	O
immune	O
cell	B-ANAT
subsets	O
by	O
flow	O
cytometry	O
in	O
the	O
blood	B-ANAT
of	O
4	O
-	O
week	O
-	O
old	O
pigs	O
experimentally	O
infected	O
with	O
the	O
recently	O
discovered	O
PR40	O
/	O
2014	O
HP	O
PRRSV	O
-	O
1	O
.	O
1	O
strain	O
phenotypically	O
characterized	O
in	O
Canelli	O
et	O
al	O
.	O
(	O
2017	O
)	O
compared	O
to	O
pigs	O
infected	O
with	O
a	O
non	O
-	O
HP	O
PRRSV	O
isolate	O
(	O
PR11	O
/	O
2014	O
)	O
and	O
uninfected	O
controls	O
.	O

In	O
addition	O
,	O
PR40	O
infection	O
showed	O
an	O
early	O
depletion	O
of	O
activated	O
CD4	O
+	O
CD25	O
+	O
T	B-ANAT
lymphocytes	I-ANAT
and	O
Tregs	O
together	O
with	O
an	O
intense	O
and	O
lasting	O
depletion	O
of	O
CD21	O
+	O
B	B-ANAT
lymphocytes	I-ANAT
.	O

In	O
this	O
study	O
we	O
have	O
examined	O
the	O
subcellular	O
localization	O
and	O
other	O
functions	O
of	O
TGEV	O
nsp7	O
protein	O
through	O
analysis	O
of	O
its	O
effects	O
on	O
cell	B-ANAT
growth	O
,	O
cell	B-ANAT
cycle	O
progression	O
,	O
interleukin	O
8	O
(	O
IL	O
-	O
8	O
)	O
expression	O
,	O
and	O
NF	O
-	O
ÎºB	O
activation	O
.	O

Further	O
studies	O
showed	O
that	O
TGEV	O
nsp7	O
protein	O
had	O
no	O
effect	O
on	O
GRP78	O
expression	O
,	O
could	O
not	O
induce	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
stress	O
and	O
activate	O
NF	O
-	O
ÎºB	O
activity	O
.	O

Interestingly	O
,	O
the	O
IECs	O
expressing	O
nsp7	O
protein	O
secreted	O
lower	O
levels	O
of	O
IL	O
-	O
8	O
than	O
control	O
cells	B-ANAT
.	O

We	O
sought	O
to	O
determine	O
whether	O
NMB	O
attenuates	O
biomarkers	O
of	O
epithelial	O
and	O
endothelial	B-ANAT
lung	B-ANAT
injury	O
and	O
systemic	O
inflammation	O
in	O
ARDS	O
patients	O
,	O
and	O
whether	O
the	O
association	O
is	O
dependent	O
on	O
tidal	O
volume	O
size	O
and	O
the	O
initial	O
degree	O
of	O
hypoxemia	O
.	O

An	O
18	O
-	O
year	O
-	O
old	O
African	O
American	O
male	O
with	O
SCD	O
was	O
admitted	O
after	O
multiple	O
days	O
of	O
fever	O
and	O
severe	O
generalized	O
body	B-ANAT
pain	O
.	O

A	O
source	O
of	O
infection	O
was	O
not	O
readily	O
identified	O
,	O
but	O
treatment	O
was	O
initiated	O
with	O
continuous	O
intravenous	O
fluids	B-ANAT
and	O
empiric	O
antibiotics	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
belongs	O
to	O
the	O
family	O
Coronaviridae	O
,	O
and	O
is	O
named	O
for	O
the	O
crown	B-ANAT
-	O
like	O
spikes	O
on	O
its	O
surface	O
.	O

A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
in	O
oncology	O
wards	O
and	O
outpatient	O
clinics	O
by	O
using	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
interviews	O
with	O
the	O
participants	O
.	O

The	O
use	O
of	O
CAM	B-ANAT
,	O
including	O
camel	O
products	O
,	O
is	O
highly	O
prevalent	O
among	O
cancer	O
patients	O
in	O
the	O
Middle	O
East	O
,	O
but	O
these	O
patients	O
do	O
not	O
necessarily	O
divulge	O
their	O
CAM	B-ANAT
use	O
to	O
their	O
treating	O
physicians	O
and	O
nurses	O
.	O

Co	O
-	O
immunoprecipitation	O
(	O
CO	O
-	O
IP	O
)	O
results	O
clearly	O
demonstrated	O
that	O
PEDV	O
N	O
protein	O
could	O
bind	O
to	O
human	O
hnRNP	B-ANAT
A1	O
.	O

Replication	O
of	O
PEDV	O
was	O
inhibited	O
by	O
silencing	O
the	O
expression	O
of	O
hnRNP	B-ANAT
A1	O
in	O
CCL	O
-	O
81	O
cells	B-ANAT
,	O
suggesting	O
the	O
positive	O
effect	O
of	O
hnRNP	B-ANAT
A1	O
on	O
PEDV	O
infection	O
.	O

Multivariable	O
logistic	O
regression	O
models	O
revealed	O
that	O
age	O
was	O
independently	O
associated	O
with	O
increased	O
risk	O
for	O
a	O
pulmonary	B-ANAT
complication	O
(	O
odds	O
ratio	O
,	O
1	O
.	O
24	O
[	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
02	O
-	O
1	O
.	O
51	O
])	O
and	O
that	O
receipt	O
of	O
an	O
intestine	B-ANAT
/	O
multivisceral	O
transplant	B-ANAT
was	O
associated	O
with	O
increased	O
risk	O
of	O
all	O
-	O
cause	O
death	O
(	O
odds	O
ratio	O
,	O
24	O
.	O
54	O
[	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
69	O
-	O
327	O
.	O
96	O
]).	O

All	O
cases	O
underwent	O
autopsy	O
,	O
histopathology	O
and	O
immunohistochemistry	O
(	O
IHC	O
)	O
for	O
FCoV	O
.	O
Furthermore	O
,	O
a	O
genotype	O
-	O
discriminating	O
quantitative	O
reverse	O
transcriptase	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
was	O
performed	O
on	O
shavings	O
of	O
paraffin	O
-	O
embedded	O
tissues	B-ANAT
to	O
discriminate	O
between	O
cats	O
with	O
FIP	O
and	O
controls	O
,	O
and	O
the	O
sensitivity	O
and	O
specificity	O
of	O
this	O
discriminating	O
RT	O
-	O
qPCR	O
were	O
calculated	O
using	O
95	O
%	O
confidence	O
intervals	O
(	O
CIs	O
).	O

During	O
pneumococcal	O
infection	O
,	O
CS	O
-	O
exposed	O
mice	O
had	O
greater	O
survival	O
than	O
air	O
-	O
exposed	O
mice	O
,	O
in	O
association	O
with	O
reduced	O
systemic	O
spread	O
of	O
bacteria	O
from	O
the	O
lungs	B-ANAT
.	O

The	O
results	O
indicate	O
that	O
acute	O
CS	O
exposure	O
enhances	O
the	O
recruitment	O
of	O
immune	O
cells	B-ANAT
to	O
the	O
lung	B-ANAT
during	O
bacterial	O
pneumonia	O
,	O
an	O
effect	O
that	O
may	O
provide	O
microbiological	O
benefit	O
but	O
simultaneously	O
exposes	O
the	O
mice	O
to	O
more	O
severe	O
inflammatory	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Hemolytic	O
uremic	O
syndrome	O
(	O
HUS	O
)	O
is	O
a	O
clinical	O
syndrome	O
characterized	O
by	O
hemolytic	O
anemia	O
,	O
thrombocytopenia	O
,	O
and	O
acute	O
kidney	B-ANAT
injury	O
.	O

Drawing	O
on	O
media	B-ANAT
dependency	O
theory	O
and	O
source	O
credibility	O
research	O
as	O
our	O
primary	O
theoretical	O
framework	O
,	O
we	O
tested	O
how	O
credibility	O
of	O
information	O
from	O
PHOs	O
is	O
associated	O
with	O
people	O
'	O
s	O
reliance	O
on	O
a	O
particular	O
communication	O
channel	O
in	O
the	O
context	O
of	O
the	O
2015	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
outbreak	O
in	O
South	O
Korea	O
.	O

Even	O
if	O
failed	O
transfer	O
of	O
passive	O
immunity	O
(	O
FTPI	O
)	O
is	O
commonly	O
recognized	O
as	O
a	O
main	O
factor	O
affecting	O
calf	B-ANAT
health	O
and	O
survival	O
,	O
conflicting	O
results	O
are	O
reported	O
in	O
literature	O
about	O
the	O
association	O
between	O
passive	O
immunity	O
(	O
PI	O
)	O
and	O
calf	B-ANAT
health	O
,	O
especially	O
regarding	O
enteric	O
diseases	O
.	O

Calves	O
that	O
suffered	O
from	O
diarrhea	O
or	O
died	O
within	O
the	O
first	O
month	O
of	O
life	O
had	O
lower	O
serum	B-ANAT
Ig	O
concentrations	O
than	O
those	O
that	O
remained	O
healthy	O
or	O
survived	O
(	O
P	O
<	O
.	O
05	O
).	O

In	O
this	O
study	O
,	O
the	O
PI	O
level	O
influenced	O
the	O
occurrence	O
of	O
enteric	O
diseases	O
and	O
mortality	O
in	O
calves	O
under	O
one	O
month	O
of	O
age	O
,	O
confirming	O
the	O
importance	O
of	O
a	O
proper	O
colostrum	B-ANAT
provision	O
to	O
calf	B-ANAT
health	O
and	O
,	O
consequently	O
,	O
to	O
the	O
reduction	O
of	O
antimicrobial	O
use	O
in	O
dairy	O
farming	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
clinical	O
features	O
of	O
patients	O
with	O
avian	O
influenza	O
A	O
(	O
H7N9	O
)	O
and	O
influenza	O
A	O
(	O
H1N1	O
)	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O
The	O
clinical	O
data	O
of	O
18	O
cases	O
of	O
H7N9	O
and	O
26	O
cases	O
of	O
H1N1	O
with	O
ARDS	O
were	O
collected	O
and	O
compared	O
in	O
the	O
respiratory	O
intensive	O
care	O
unit	O
(	O
RICU	O
)	O
of	O
Fuzhou	O
Pulmonary	B-ANAT
Hospital	O
of	O
Fujian	O
from	O
March	O
2014	O
to	O
December	O
2016	O
.	O
Patients	O
with	O
H7N9	O
had	O
a	O
higher	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
-	O
II	O
score	O
(	O
P	O
<	O
.	O
05	O
)	O
and	O
lung	B-ANAT
injury	O
score	O
(	O
P	O
<	O
.	O
05	O
).	O

We	O
have	O
determined	O
that	O
EV	O
-	O
D68	O
induces	O
autophagic	O
signaling	O
and	O
membrane	B-ANAT
formation	O
.	O

TITLE	O
:	O
Splenic	B-ANAT
Rupture	O
as	O
the	O
First	O
Manifestation	O
of	O
Babesia	O
Microti	O
Infection	O
:	O
Report	O
of	O
a	O
Case	O
and	O
Review	O
of	O
Literature	O
.	O

She	O
was	O
transfused	O
with	O
3	O
units	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
(	O
PRBC	O
)	O
and	O
underwent	O
emergent	O
splenectomy	O
.	O

We	O
report	O
the	O
cases	O
of	O
three	O
young	O
patients	O
who	O
developed	O
extensive	O
myocardial	O
calcifications	O
on	O
prolonged	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
septic	O
cardiomyopathy	O
,	O
postresuscitation	O
cardiogenic	O
shock	O
,	O
and	O
septic	O
shock	O
complicating	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
immunosuppression	O
from	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
have	O
been	O
traditionally	O
considered	O
poor	O
candidates	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
because	O
of	O
high	O
in	O
-	O
hospital	O
mortality	O
and	O
poor	O
long	O
-	O
term	O
survival	O
.	O

Areas	O
covered	O
:	O
Several	O
mechanisms	O
of	O
VILI	O
have	O
been	O
described	O
,	O
such	O
as	O
:	O
inspiratory	O
and	O
/	O
or	O
expiratory	O
stress	O
inducing	O
overdistension	O
(	O
volutrauma	O
);	O
interfaces	O
between	O
collapsed	O
or	O
edema	O
-	O
filled	O
alveoli	B-ANAT
with	O
surrounding	O
open	O
alveoli	B-ANAT
,	O
acting	O
as	O
stress	O
raisers	O
;	O
alveoli	B-ANAT
that	O
repetitively	O
open	O
and	O
close	O
during	O
tidal	O
breathing	O
(	O
atelectrauma	O
);	O
and	O
peripheral	O
airway	B-ANAT
dynamics	O
.	O

TITLE	O
:	O
DYSFUNCTION	O
OF	O
VARIOUS	O
ORGAN	B-ANAT
SYSTEMS	I-ANAT
INDUCED	O
BY	O
SEPSIS	O
WITH	O
UNDERLYING	O
SEVERE	O
MYELOMIC	O
DISEASES	O
AND	O
PROSTATE	B-ANAT
CANCER	O
(	O
CASE	O
REPORT	O
).	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
a	O
20	O
-	O
year	O
-	O
old	O
male	O
patient	O
suffering	O
from	O
motorcycle	O
accident	O
complicated	O
by	O
rapid	O
development	O
of	O
severe	O
refractory	O
hypoxemia	O
and	O
hypercapnia	O
due	O
to	O
serious	O
bilateral	O
lung	B-ANAT
contusions	O
and	O
lacerations	O
.	O

Despite	O
considerable	O
areas	O
of	O
nonaerated	O
tissue	B-ANAT
on	O
computed	O
tomography	O
prior	O
to	O
the	O
disconnection	O
from	O
mechanical	O
ventilation	O
,	O
almost	O
total	O
functional	O
recovery	O
of	O
lungs	B-ANAT
was	O
eventually	O
achieved	O
.	O

Here	O
,	O
we	O
measured	O
the	O
concentration	O
of	O
sDPP4	O
in	O
the	O
plasma	B-ANAT
and	O
sputa	O
of	O
14	O
MERS	O
-	O
CoV	O
-	O
infected	O
patients	O
of	O
various	O
degrees	O
of	O
disease	O
severity	O
.	O

The	O
concentration	O
of	O
sDPP4	O
in	O
the	O
plasma	B-ANAT
of	O
MERS	O
patients	O
(	O
474	O
.	O
76	O
Â±	O
108	O
.	O
06	O
ng	O
/	O
ml	O
)	O
was	O
significantly	O
lower	O
than	O
those	O
of	O
healthy	O
controls	O
(	O
703	O
.	O
42	O
Â±	O
169	O
.	O
96	O
ng	O
/	O
ml	O
),	O
but	O
there	O
were	O
no	O
significant	O
differences	O
among	O
the	O
patient	O
groups	O
.	O

TITLE	O
:	O
Nucleated	B-ANAT
red	I-ANAT
blood	I-ANAT
cells	I-ANAT
as	O
predictors	O
of	O
mortality	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
):	O
an	O
observational	O
study	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
interstitial	B-ANAT
pneumonia	O
associated	O
with	O
anti	O
-	O
PL	O
-	O
7	O
antibody	O
in	O
a	O
patient	O
with	O
rheumatoid	O
arthritis	O
.	O

ABSTRACT	O
:	O
A	O
65	O
-	O
year	O
-	O
old	O
female	O
had	O
been	O
treated	O
rheumatoid	O
arthritis	O
(	O
RA	O
),	O
interstitial	B-ANAT
pneumonia	O
(	O
IP	O
)	O
and	O
nephrotic	O
syndrome	O
with	O
prednisolone	O
and	O
cyclosporine	O
.	O

Chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
showed	O
new	O
diffuse	O
ground	O
-	O
glass	O
opacities	O
(	O
GGOs	O
)	O
with	O
slight	O
consolidations	O
along	O
with	O
bronchovascular	B-ANAT
bundle	I-ANAT
were	O
observed	O
in	O
addition	O
to	O
pre	O
-	O
existing	O
reticular	O
shadows	O
in	O
both	O
lungs	B-ANAT
with	O
lower	O
lobe	B-ANAT
-	O
predominance	O
.	O

Acute	O
cor	B-ANAT
pulmonale	O
is	O
common	O
in	O
severe	O
ARDS	O
.	O

TITLE	O
:	O
Capturing	O
the	O
multifactorial	O
nature	O
of	O
ARDS	O
-	O
""""	O
Two	O
-	O
hit	O
""""	O
approach	O
to	O
model	O
murine	O
acute	O
lung	B-ANAT
injury	O
.	O

LPS	O
prior	O
to	O
VILI	O
showed	O
significantly	O
increased	O
inflammatory	O
lung	B-ANAT
injury	O
compared	O
to	O
animals	O
that	O
underwent	O
i	O
.	O
t	O
.	O

CONCLUSIONS	O
:	O
Heightening	O
education	O
of	O
infectious	O
outbreaks	O
through	O
appropriate	O
media	B-ANAT
to	O
the	O
young	O
and	O
less	O
educated	O
could	O
increase	O
awareness	O
.	O

TITLE	O
:	O
PCR	O
array	O
profiling	O
of	O
antiviral	O
genes	O
in	O
human	O
embryonic	B-ANAT
kidney	B-ANAT
cells	B-ANAT
expressing	O
human	O
coronavirus	O
OC43	O
structural	O
and	O
accessory	O
proteins	O
.	O

In	O
2015	O
,	O
an	O
IBV	O
with	O
the	O
TC07	O
-	O
2	O
genotype	O
(	O
designated	O
KrD1515	O
)	O
was	O
isolated	O
from	O
layer	B-ANAT
chickens	O
with	O
severe	O
respiratory	O
symptoms	O
in	O
Korea	O
.	O

In	O
addition	O
,	O
its	O
infection	O
leads	O
to	O
reduced	O
fertility	O
and	O
hatchability	O
in	O
layer	B-ANAT
birds	O
.	O

In	O
addition	O
,	O
all	O
piglets	O
inoculated	O
with	O
the	O
Japanese	O
PDCoV	O
exhibited	O
virus	O
shedding	O
at	O
high	O
level	O
in	O
faeces	B-ANAT
and	O
viremia	O
corresponding	O
to	O
their	O
clinical	O
symptoms	O
.	O

Staphylococcal	O
protein	O
A	O
and	O
rabbit	O
anti	O
-	O
N	O
protein	O
IgG	O
were	O
blotted	O
on	O
a	O
nitrocellulose	O
membrane	B-ANAT
for	O
the	O
test	O
and	O
control	O
lines	O
,	O
respectively	O
.	O

Severe	O
hypoxemia	O
unresponsive	O
to	O
conventional	O
lung	B-ANAT
-	O
protective	O
mechanical	O
ventilation	O
could	O
also	O
occur	O
in	O
the	O
operating	O
room	O
from	O
severe	O
bronchospasm	O
,	O
pulmonary	B-ANAT
contusions	O
,	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Here	O
,	O
we	O
report	O
the	O
effect	O
of	O
R	O
-	O
848	O
when	O
adjuvanted	O
with	O
live	O
or	O
inactivated	O
avian	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
vaccines	O
with	O
special	O
emphasis	O
on	O
mucosal	B-ANAT
immunity	O
.	O

The	O
concentration	O
of	O
multiple	O
plasma	B-ANAT
lipids	O
is	O
associated	O
with	O
mortality	O
in	O
this	O
group	O
of	O
critically	O
ill	O
patients	O
with	O
ARDS	O
.	O

However	O
,	O
treatment	O
with	O
APN	O
-	O
specific	O
antibody	O
and	O
inhibitors	O
did	O
not	O
completely	O
block	O
PDCoV	O
infection	O
in	O
IPI	O
-	O
2I	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Alveolar	B-ANAT
macrophage	I-ANAT
polarization	O
and	O
role	O
on	O
alveolar	B-ANAT
repair	O
during	O
human	O
acute	O
respiratory	O
distress	O
syndrome	O
remain	O
unclear	O
.	O

Modulation	O
of	O
macrophage	B-ANAT
polarization	O
was	O
studied	O
in	O
vitro	O
using	O
phenotypic	O
and	O
functional	O
readouts	O
.	O

Accordingly	O
,	O
early	O
acute	O
respiratory	O
distress	O
syndrome	O
-	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
drives	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
-	O
specific	O
anti	O
-	O
inflammatory	O
macrophage	B-ANAT
polarization	O
in	O
vitro	O
,	O
close	O
to	O
that	O
induced	O
by	O
recombinant	O
interleukin	O
-	O
10	O
.	O

Finally	O
,	O
hepatocyte	B-ANAT
growth	O
factor	O
and	O
soluble	O
form	O
of	O
CD163	O
concentrations	O
expressed	O
relatively	O
to	O
macrophage	B-ANAT
count	O
were	O
higher	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
from	O
acute	O
respiratory	O
distress	O
syndrome	O
survivors	O
.	O

TITLE	O
:	O
Inactivated	O
infectious	O
bronchitis	O
virus	O
vaccine	O
encapsulated	O
in	O
chitosan	O
nanoparticles	O
induces	O
mucosal	B-ANAT
immune	O
responses	O
and	O
effective	O
protection	O
against	O
challenge	O
.	O

The	O
mucosa	B-ANAT
of	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
,	O
specially	O
the	O
trachea	B-ANAT
,	O
is	O
the	O
primary	O
replication	O
site	O
for	O
this	O
virus	O
.	O

Among	O
those	O
contacts	O
,	O
9	O
out	O
of	O
107	O
health	O
care	O
workers	O
(	O
5	O
nurses	O
,	O
3	O
physicians	O
,	O
and	O
1	O
paramedic	O
)	O
and	O
7	O
out	O
of	O
13	O
patients	O
tested	O
positive	O
for	O
MERS	O
-	O
CoV	O
.	O
This	O
hospital	O
outbreak	O
demonstrated	O
the	O
difficulties	O
in	O
diagnosing	O
pneumonia	O
in	O
patients	O
with	O
renal	B-ANAT
and	O
cardiac	B-ANAT
failure	O
,	O
which	O
leads	O
to	O
delayed	O
suspicion	O
of	O
MERS	O
-	O
CoV	O
and	O
hence	O
delay	O
in	O
applying	O
the	O
proper	O
infection	O
control	O
procedures	O
.	O

This	O
study	O
was	O
conducted	O
to	O
determine	O
the	O
incidence	O
,	O
clinical	O
presentation	O
,	O
renal	B-ANAT
injury	O
and	O
clinical	O
outcome	O
in	O
snakebite	O
victims	O
who	O
developed	O
acute	O
kidney	B-ANAT
injury	O
(	O
AKI	O
).	O

Twelve	O
patients	O
were	O
in	O
stage	O
III	O
kidney	B-ANAT
disease	O
and	O
needed	O
haemodialysis	O
.	O

Only	O
fecal	B-ANAT
score	O
and	O
breed	O
size	O
had	O
an	O
effect	O
on	O
fecal	B-ANAT
S100A12	O
concentrations	O
in	O
multivariate	O
analysis	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

ABSTRACT	O
:	O
Dairy	O
calf	B-ANAT
rearing	O
unit	O
is	O
a	O
management	O
system	O
that	O
is	O
only	O
recently	O
being	O
implemented	O
by	O
some	O
milk	O
producer	O
'	O
s	O
cooperatives	O
in	O
southern	O
Brazil	O
.	O

However	O
,	O
entrapped	O
patients	O
are	O
prone	O
to	O
sustain	O
more	O
severe	O
trauma	O
to	O
the	O
extremities	B-ANAT
.	O

The	O
clinical	O
features	O
associated	O
with	O
MERS	O
-	O
CoV	O
infection	O
are	O
not	O
MERS	O
-	O
specific	O
and	O
are	O
similar	O
to	O
other	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

Specifically	O
,	O
among	O
different	O
genera	O
,	O
the	O
two	O
domains	O
of	O
S1	O
,	O
the	O
N	O
-	O
terminal	O
domain	O
(	O
S1	O
-	O
NTD	O
)	O
and	O
C	O
-	O
terminal	O
domain	O
(	O
S1	O
-	O
CTD	O
),	O
diverge	O
from	O
simpler	O
tertiary	O
structures	O
and	O
quaternary	O
packing	O
to	O
more	O
complex	O
ones	O
,	O
leading	O
to	O
different	O
functions	O
of	O
the	O
spikes	O
in	O
receptor	O
usage	O
and	O
membrane	B-ANAT
fusion	O
.	O

In	O
addition	O
to	O
SARS	O
,	O
other	O
respiratory	O
pathogens	O
have	O
also	O
emerged	O
recently	O
,	O
contributing	O
to	O
the	O
high	O
burden	O
of	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
-	O
related	O
morbidity	O
and	O
mortality	O
.	O

A	O
total	O
of	O
114	O
faecal	B-ANAT
samples	O
from	O
beef	O
and	O
dairy	O
calves	O
with	O
or	O
without	O
clinical	O
symptoms	O
of	O
diarrhoea	O
from	O
five	O
Brazilian	O
states	O
(	O
SÃ£o	O
Paulo	O
,	O
Minas	O
Gerais	O
,	O
Santa	O
Catarina	O
,	O
Mato	O
Grosso	O
and	O
Bahia	O
)	O
were	O
evaluated	O
between	O
2008	O
and	O
2015	O
by	O
technique	O
of	O
Semi	O
-	O
nested	O
RT	O
-	O
PCR	O
for	O
gene	O
N	O
and	O
genealogical	O
analysis	O
.	O

Furthermore	O
,	O
compared	O
with	O
the	O
sham	O
treatment	O
control	O
,	O
apoptosis	O
of	O
splenic	B-ANAT
cells	B-ANAT
was	O
less	O
pronounced	O
in	O
the	O
splenic	B-ANAT
white	I-ANAT
pulp	I-ANAT
of	O
treated	O
mice	O
,	O
and	O
greater	O
number	O
of	O
proliferating	O
splenic	B-ANAT
cells	B-ANAT
,	O
particularly	O
in	O
the	O
red	B-ANAT
pulp	I-ANAT
,	O
was	O
observed	O
.	O

These	O
data	O
indicate	O
that	O
(	O
1	O
)	O
dysregulated	O
host	O
immune	O
responses	O
contribute	O
to	O
the	O
severe	O
outcome	O
of	O
MERS	O
;	O
(	O
2	O
)	O
excessive	O
complement	O
activation	O
,	O
triggered	O
by	O
MERS	O
-	O
CoV	O
infection	O
,	O
promote	O
such	O
dysregulation	O
;	O
and	O
(	O
3	O
)	O
blockade	O
of	O
the	O
C5a	O
-	O
C5aR	O
axis	B-ANAT
lead	O
to	O
the	O
decreased	O
tissue	B-ANAT
damage	O
induced	O
by	O
MERS	O
-	O
CoV	O
infection	O
,	O
as	O
manifested	O
by	O
reduced	O
apoptosis	O
and	O
T	B-ANAT
cell	I-ANAT
regeneration	O
in	O
the	O
spleen	B-ANAT
.	O

In	O
the	O
present	O
study	O
,	O
we	O
were	O
able	O
to	O
isolate	O
and	O
cultivate	O
a	O
Korean	O
PDCoV	O
strain	O
(	O
KNU16	O
-	O
07	O
)	O
in	O
cell	B-ANAT
culture	O
and	O
investigate	O
its	O
pathogenicity	O
.	O

The	O
scenario	O
includes	O
all	O
critical	O
stages	O
:	O
hospital	O
identification	O
(	O
Regional	O
Department	O
of	O
Intensive	O
Care	O
)	O
-	O
inclusion	O
and	O
exclusion	O
criteria	O
matching	O
using	O
an	O
authorship	O
protocol	O
;	O
ECMO	O
team	O
transport	O
;	O
therapy	O
confirmation	O
;	O
veno	O
-	O
venous	B-ANAT
cannulation	O
of	O
mannequin	O
'	O
s	O
artificial	O
vessels	B-ANAT
and	O
implementation	O
of	O
perfusion	O
therapy	O
and	O
transport	O
with	O
ECMO	O
to	O
another	O
hospital	O
in	O
a	O
provincial	O
city	O
(	O
Clinical	O
Department	O
of	O
Intensive	O
Care	O
),	O
where	O
the	O
VV	O
ECMO	O
therapy	O
was	O
performed	O
in	O
the	O
next	O
48	O
h	O
,	O
as	O
training	O
platform	O
.	O

RESULTS	O
:	O
The	O
total	O
time	O
,	O
by	O
definition	O
,	O
means	O
the	O
time	O
from	O
the	O
first	O
contact	O
with	O
the	O
mannequin	O
to	O
the	O
cannulation	O
of	O
artificial	O
vessels	B-ANAT
and	O
starting	O
VV	O
perfusion	O
on	O
ECMO	O
,	O
did	O
not	O
exceed	O
3	O
h	O
-	O
including	O
75	O
min	O
of	O
transport	O
(	O
the	O
total	O
time	O
of	O
simulation	O
with	O
first	O
call	O
from	O
provincial	O
hospital	O
to	O
admission	O
to	O
the	O
Clinical	O
Intensive	O
Care	O
department	O
was	O
5	O
h	O
).	O

Only	O
seventy	O
-	O
nine	O
(	O
12	O
%)	O
were	O
admitted	O
with	O
a	O
COPD	O
exacerbation	O
,	O
27	O
(	O
4	O
%)	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
78	O
(	O
12	O
%)	O
had	O
pneumonia	O
,	O
78	O
(	O
12	O
%)	O
had	O
sepsis	O
,	O
and	O
312	O
(	O
47	O
%)	O
had	O
other	O
causes	O
of	O
respiratory	O
failure	O
,	O
including	O
pulmonary	B-ANAT
embolism	O
,	O
pneumothorax	O
,	O
etc	O
.	O

A	O
discharge	B-ANAT
home	O
at	O
the	O
time	O
of	O
index	O
admission	O
was	O
associated	O
an	O
increased	O
overall	O
survival	O
compared	O
with	O
any	O
other	O
discharge	B-ANAT
location	O
(	O
P	O
<	O
.	O
001	O
).	O
We	O
report	O
good	O
early	O
outcomes	O
,	O
but	O
significant	O
long	O
-	O
term	O
morbidity	O
in	O
patients	O
with	O
severe	O
COPD	O
requiring	O
invasive	O
mechanical	O
ventilation	O
for	O
acute	O
respiratory	O
failure	O
.	O

A	O
higher	O
APACHE	O
score	O
and	O
presence	O
of	O
active	O
malignancy	O
are	O
associated	O
with	O
a	O
decrease	O
in	O
ICU	O
survival	O
,	O
whereas	O
a	O
discharge	B-ANAT
home	O
is	O
associated	O
with	O
an	O
increase	O
in	O
the	O
overall	O
survival	O
.	O

TITLE	O
:	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
to	O
Prolong	O
Pregnancy	O
:	O
A	O
Case	O
Report	O
.	O

Sterilization	O
using	O
a	O
chemical	O
reactor	O
with	O
plasma	B-ANAT
assisted	O
catalytic	O
technology	O
(	O
PACT	O
)	O
was	O
investigated	O
.	O

The	O
actual	O
hospital	O
discharge	B-ANAT
survival	O
rate	O
without	O
ECMO	O
was	O
56	O
%.	O

Both	O
THERAFLEX	O
UV	O
-	O
Platelets	B-ANAT
(	O
UVC	O
)	O
and	O
THERAFLEX	O
MB	O
-	O
Plasma	B-ANAT
(	O
MB	O
/	O
light	O
)	O
effectively	O
reduce	O
EBOV	O
and	O
MERS	O
-	O
CoV	O
infectivity	O
in	O
platelets	B-ANAT
and	O
plasma	B-ANAT
,	O
respectively	O
.	O

With	O
the	O
increasing	O
use	O
of	O
advanced	O
treatments	O
such	O
as	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
prone	O
positioning	O
,	O
and	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
the	O
necessity	O
to	O
transport	O
these	O
patients	O
to	O
specialized	O
hospitals	O
will	O
correspondingly	O
increase	O
.	O

RESULTS	O
:	O
DTI	O
quantified	O
diffusion	O
alterations	O
in	O
the	O
corpus	B-ANAT
callosum	I-ANAT
and	O
corona	B-ANAT
radiata	I-ANAT
(	O
MD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
chronic	O
axonal	O
injury	O
in	O
the	O
corpus	B-ANAT
callosum	I-ANAT
,	O
corona	B-ANAT
radiata	I-ANAT
,	O
internal	B-ANAT
capsule	I-ANAT
,	O
external	B-ANAT
capsule	I-ANAT
,	O
posterior	B-ANAT
thalamic	I-ANAT
radiation	I-ANAT
,	O
sagittal	B-ANAT
stratum	O
,	O
and	O
superior	B-ANAT
longitudinal	I-ANAT
fasciculus	I-ANAT
(	O
AD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Cardiopulmonary	B-ANAT
arrest	O
occurred	O
within	O
3	O
days	O
after	O
the	O
onset	O
of	O
symptoms	O
,	O
which	O
included	O
cough	O
and	O
high	O
fever	O
.	O

Real	O
-	O
time	O
PCR	O
analysis	O
of	O
>	O
240	O
tissue	B-ANAT
samples	O
detected	O
MVA	O
-	O
DNA	O
predominantly	O
at	O
the	O
injection	O
site	O
and	O
in	O
the	O
draining	O
lymph	B-ANAT
nodes	I-ANAT
,	O
and	O
suggested	O
continuous	O
clearance	O
of	O
the	O
candidate	O
vaccine	O
during	O
the	O
observation	O
period	O
.	O

TITLE	O
:	O
Early	O
Pulmonary	B-ANAT
Interstitial	B-ANAT
Emphysema	O
in	O
Preterm	O
Neonates	O
-	O
Respiratory	O
Management	O
and	O
Case	O
Report	O
in	O
Nonventilated	O
Very	O
Low	O
Birth	O
Weight	O
Twins	O
.	O

Herein	O
,	O
we	O
report	O
on	O
very	O
low	O
birth	O
weight	O
twins	O
who	O
developed	O
early	O
pulmonary	B-ANAT
interstitial	B-ANAT
emphysema	O
during	O
noninvasive	O
respiratory	O
support	O
.	O

We	O
further	O
review	O
the	O
current	O
evidence	O
from	O
the	O
literature	O
,	O
specifically	O
addressing	O
on	O
possible	O
preventive	O
measures	O
and	O
the	O
respiratory	O
management	O
options	O
of	O
this	O
acute	O
pulmonary	B-ANAT
disease	O
in	O
high	O
-	O
risk	O
neonates	O
.	O

Eleven	O
plasma	B-ANAT
biomarkers	O
of	O
inflammation	O
,	O
lung	B-ANAT
epithelial	O
and	O
endothelial	B-ANAT
injury	O
were	O
measured	O
in	O
a	O
derivation	O
cohort	O
of	O
439	O
severe	O
trauma	O
patients	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
replication	O
is	O
closely	O
associated	O
with	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
),	O
the	O
primary	O
cellular	B-ANAT
organelle	B-ANAT
for	O
protein	O
synthesis	O
,	O
folding	O
,	O
and	O
modification	O
.	O

Western	O
blotting	O
detected	O
specific	O
anti	O
-	O
FalCoV	O
UAE	O
-	O
HKU27	O
antibodies	O
in	O
33	O
(	O
75	O
%)	O
of	O
44	O
falcon	O
serum	B-ANAT
samples	O
,	O
supporting	O
genuine	O
infection	O
in	O
falcons	O
after	O
virus	O
acquisition	O
.	O

The	O
extent	O
to	O
which	O
different	O
alveolar	B-ANAT
macrophage	I-ANAT
(	O
AM	O
)	O
polarization	O
states	O
exist	O
in	O
homeostasis	O
or	O
in	O
the	O
setting	O
of	O
severe	O
injury	O
such	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
largely	O
unknown	O
.	O

In	O
the	O
present	O
study	O
,	O
FCoVs	O
were	O
analyzed	O
for	O
the	O
frequency	O
and	O
location	O
of	O
mutations	O
in	O
the	O
S	O
and	O
3c	O
genes	O
from	O
faecal	B-ANAT
samples	O
of	O
cats	O
in	O
an	O
animal	O
shelter	O
and	O
the	O
faeces	B-ANAT
,	O
effusions	O
,	O
and	O
tissues	B-ANAT
of	O
cats	O
that	O
were	O
referred	O
to	O
veterinary	O
hospitals	O
.	O

ABSTRACT	O
:	O
CD26	O
is	O
a	O
110	O
kDa	O
surface	O
glycoprotein	O
with	O
intrinsic	O
dipeptidyl	O
peptidase	O
IV	O
activity	O
that	O
is	O
expressed	O
on	O
numerous	O
cell	B-ANAT
types	O
and	O
has	O
a	O
multitude	O
of	O
biological	O
functions	O
.	O

We	O
determined	O
that	O
GS	O
-	O
441524	O
was	O
non	O
-	O
toxic	O
in	O
feline	O
cells	B-ANAT
at	O
concentrations	O
as	O
high	O
as	O
100	O
uM	O
and	O
effectively	O
inhibited	O
FIPV	O
replication	O
in	O
cultured	O
CRFK	O
cells	B-ANAT
and	O
in	O
naturally	O
infected	O
feline	O
peritoneal	B-ANAT
macrophages	I-ANAT
at	O
concentrations	O
as	O
low	O
as	O
1	O
uM	O
.	O
We	O
determined	O
the	O
pharmacokinetics	O
of	O
GS	O
-	O
441524	O
in	O
cats	O
in	O
vivo	O
and	O
established	O
a	O
dosage	O
that	O
would	O
sustain	O
effective	O
blood	B-ANAT
levels	O
for	O
24	O
h	O
.	O
In	O
an	O
experimental	O
FIPV	O
infection	O
of	O
cats	O
,	O
GS	O
-	O
441524	O
treatment	O
caused	O
a	O
rapid	O
reversal	O
of	O
disease	O
signs	O
and	O
return	O
to	O
normality	O
with	O
as	O
little	O
as	O
two	O
weeks	O
of	O
treatment	O
in	O
10	O
/	O
10	O
cats	O
and	O
with	O
no	O
apparent	O
toxicity	O
.	O

Fecal	B-ANAT
pathogen	O
shedding	O
at	O
d	O
14	O
,	O
respiratory	O
disease	O
at	O
d	O
56	O
,	O
and	O
antibiotic	O
usage	O
were	O
compared	O
using	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
chi	O
-	O
squared	O
test	O
.	O

Three	O
colostrum	B-ANAT
-	O
deprived	O
Holstein	O
calves	O
were	O
housed	O
separately	O
in	O
individual	O
rooms	O
of	O
a	O
high	O
-	O
containment	O
facility	O
and	O
inoculated	O
with	O
the	O
BCoV	O
strain	O
Kumamoto	O
/	O
1	O
/	O
07	O
.	O

Acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
can	O
trigger	O
persistent	O
lung	B-ANAT
inflammation	O
and	O
fibrosis	O
through	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	O
and	O
subsequent	O
secretion	B-ANAT
of	O
mature	O
IL	O
-	O
1Î²	O
,	O
suggesting	O
that	O
the	O
NLRP3	O
inflammasome	O
is	O
a	O
potential	O
therapeutic	O
target	O
for	O
ALI	O
,	O
for	O
which	O
new	O
therapeutic	O
approaches	O
are	O
needed	O
.	O

Mice	O
were	O
administered	O
pirfenidone	O
by	O
oral	B-ANAT
gavage	O
throughout	O
the	O
entire	O
experimental	O
course	O
.	O

The	O
mouse	B-ANAT
macrophage	I-ANAT
cell	B-ANAT
line	I-ANAT
(	O
J774	O
A	O
.	O
1	O
)	O
was	O
incubated	O
with	O
LPS	O
and	O
ATP	O
,	O
with	O
or	O
without	O
PFD	O
pre	O
-	O
treatment	O
.	O

We	O
demonstrated	O
that	O
PFD	O
remarkably	O
ameliorated	O
LPS	O
-	O
induced	O
pulmonary	B-ANAT
inflammation	O
and	O
fibrosis	O
and	O
reduced	O
IL	O
-	O
1Î²	O
and	O
TGF	O
-	O
Î²1	O
levels	O
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
).	O

In	O
vitro	O
,	O
the	O
experiments	O
revealed	O
that	O
PFD	O
significantly	O
suppressed	O
LPS	O
/	O
ATP	O
-	O
induced	O
production	O
of	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
decreased	O
caspase	O
-	O
1	O
activation	O
and	O
the	O
level	O
of	O
IL	O
-	O
1Î²	O
in	O
J774	O
A	O
.	O
1	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
Extracorporeal	O
life	O
support	O
(	O
ECLS	O
)	O
is	O
a	O
mainstay	O
of	O
current	O
practice	O
in	O
severe	O
respiratory	O
,	O
circulatory	O
or	O
cardiac	B-ANAT
failure	O
refractory	O
to	O
conventional	O
management	O
.	O

A	O
focused	O
set	O
of	O
thienyl	O
chalcone	O
derivaties	O
II	O
-	O
VI	O
was	O
screened	O
for	O
selected	O
viruses	O
Hepatitis	O
B	O
virus	O
(	O
HBV	O
),	O
Herpes	O
simplex	B-ANAT
virus	O
1	O
(	O
HSV	O
-	O
1	O
),	O
Human	O
cytomegalovirus	O
(	O
HCMV	O
),	O
Dengue	O
virus	O
2	O
(	O
DENV2	O
),	O
Influenza	O
A	O
(	O
H1N1	O
)	O
virus	O
,	O
MERS	O
coronavirus	O
,	O
Poliovirus	O
1	O
(	O
PV	O
1	O
),	O
Rift	O
Valley	O
fever	O
(	O
RVF	O
),	O
Tacaribe	O
virus	O
(	O
TCRV	O
),	O
Venezuelan	O
equine	O
encephalitis	O
virus	O
(	O
VEE	O
)	O
and	O
Zika	O
virus	O
(	O
ZIKV	O
)	O
using	O
the	O
National	O
Institute	O
of	O
Allergy	O
and	O
Infectious	O
Diseases	O
(	O
NIAID	O
)'	O
s	O
Division	O
of	O
Microbiology	O
and	O
Infectious	O
Diseases	O
(	O
DMID	O
)	O
antiviral	O
screening	O
program	O
.	O

Additionally	O
,	O
cyclopropylquinoline	O
derivative	O
IV	O
has	O
shown	O
strong	O
growth	O
inhibitory	O
activity	O
towards	O
three	O
major	O
cancers	O
(	O
colon	B-ANAT
,	O
breast	B-ANAT
,	O
and	O
leukemia	O
)	O
cell	B-ANAT
lines	I-ANAT
and	O
moderate	O
growth	O
inhibition	O
shown	O
towards	O
other	O
cancer	B-ANAT
cell	I-ANAT
lines	O
screened	O
.	O

Additionally	O
,	O
cyclopropylquinoline	O
derivative	O
IV	O
has	O
shown	O
strong	O
growth	O
inhibitory	O
activity	O
towards	O
three	O
major	O
cancers	O
(	O
colon	B-ANAT
,	O
breast	B-ANAT
,	O
and	O
leukemia	O
)	O
cell	B-ANAT
lines	I-ANAT
and	O
moderate	O
growth	O
inhibition	O
shown	O
towards	O
other	O
cancer	B-ANAT
cell	I-ANAT
lines	O
screened	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
consists	O
of	O
a	O
positive	O
-	O
sense	O
,	O
single	O
-	O
stranded	O
RNA	O
genome	O
and	O
four	O
structural	O
proteins	O
:	O
the	O
spike	O
,	O
envelope	B-ANAT
,	O
membrane	B-ANAT
,	O
and	O
nucleocapsid	B-ANAT
protein	O
.	O

ABSTRACT	O
:	O
The	O
quick	O
Sequential	O
(	O
Sepsis	O
-	O
Related	O
)	O
Organ	B-ANAT
Failure	O
Assessment	O
(	O
qSOFA	O
)	O
score	O
has	O
not	O
been	O
well	O
-	O
evaluated	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
(	O
LMICs	O
).	O

The	O
results	O
demonstrated	O
that	O
PEDV	O
infection	O
induces	O
cell	B-ANAT
cycle	O
arrest	O
at	O
G0	O
/	O
G1	O
phase	O
in	O
Vero	B-ANAT
cells	I-ANAT
,	O
while	O
UV	O
-	O
inactivated	O
PEDV	O
does	O
not	O
cause	O
cell	B-ANAT
cycle	O
arrest	O
.	O

The	O
advancements	O
of	O
sequencing	O
technology	O
have	O
made	O
it	O
possible	O
to	O
characterize	O
the	O
entire	O
microbiome	O
of	O
different	O
body	B-ANAT
sites	O
for	O
any	O
host	O
.	O

The	O
lower	O
left	O
esophageal	B-ANAT
wall	I-ANAT
was	O
perforated	O
in	O
all	O
patients	O
.	O

Younger	O
children	O
and	O
the	O
elderly	O
are	O
considered	O
vulnerable	O
to	O
developing	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infections	O
(	O
LRTIs	O
).	O

She	O
needed	O
immediate	O
oxygen	O
supply	O
,	O
while	O
ABGs	O
deteriorated	O
and	O
chest	B-ANAT
imaging	O
and	O
PaO	O

Whole	O
genome	O
sequence	O
(	O
PEDV	O
1842	O
/	O
2016	O
)	O
was	O
also	O
obtained	O
by	O
next	O
generation	O
sequencing	O
straight	O
from	O
RNA	O
purified	O
from	O
one	O
fecal	B-ANAT
sample	O
.	O

ABSTRACT	O
:	O
Mechanical	O
ventilation	O
is	O
a	O
life	O
-	O
saving	O
intervention	O
that	O
maintains	O
gas	O
exchange	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
);	O
however	O
,	O
it	O
is	O
associated	O
with	O
high	O
mortality	O
and	O
it	O
may	O
augment	O
,	O
or	O
even	O
initiate	O
,	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
past	O
decade	O
,	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
vvECMO	O
)	O
has	O
been	O
increasingly	O
utilized	O
in	O
respiratory	O
failure	O
in	O
patients	O
.	O

Sczy3C100	O
effectively	O
reduced	O
the	O
morbidity	O
,	O
mortality	O
,	O
mean	O
lesion	O
scores	O
(	O
MLSs	O
),	O
and	O
viral	O
load	O
of	O
trachea	B-ANAT
of	O
chickens	O
challenged	O
by	O
GI	O
-	O
19	O
/	O
QX	O
and	O
GI	O
-	O
7	O
/	O
TWI	O
strains	O
.	O

TITLE	O
:	O
Efficacy	O
of	O
statin	O
therapy	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
/	O
acute	O
lung	B-ANAT
injury	O
:	O
a	O
systematic	O
review	O
and	O
meta	O
-	O
analysis	O
.	O

ABSTRACT	O
:	O
Approximately	O
7	O
.	O
5	O
%	O
of	O
patients	O
admitted	O
to	O
Intensive	O
Care	O
Unit	O
(	O
ICU	O
)	O
of	O
hospitals	O
are	O
likely	O
diagnosed	O
with	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
),	O
and	O
more	O
than	O
one	O
-	O
third	O
of	O
the	O
affected	O
patients	O
die	O
with	O
this	O
disease	O
.	O

The	O
HEV	B-ANAT
(+)-	O
strand	O
RNA	O
genome	O
contains	O
a	O
5	O
'-	O
capped	O
,	O
short	O
5	O
'-	O
UTR	O
.	O

Acute	O
lung	B-ANAT
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
is	O
one	O
of	O
the	O
main	O
clinical	O
complications	O
of	O
severe	O
malaria	O
;	O
it	O
is	O
characterized	O
by	O
a	O
high	O
mortality	O
rate	O
and	O
can	O
even	O
occur	O
after	O
antimalarial	O
treatment	O
when	O
parasitemia	O
is	O
not	O
detected	O
.	O

Here	O
we	O
describe	O
a	O
few	O
general	O
methods	O
to	O
isolate	O
and	O
study	O
the	O
VNP	O
-	O
protein	O
corona	O
complexes	O
,	O
in	O
order	O
to	O
evaluate	O
the	O
impact	O
of	O
protein	O
corona	O
on	O
molecular	O
recognition	O
of	O
VNPs	O
by	O
target	B-ANAT
cells	I-ANAT
,	O
and	O
clearance	O
by	O
phagocytes	B-ANAT
.	O

Fecal	B-ANAT
samples	O
from	O
482	O
cats	O
,	O
approximately	O
half	O
of	O
the	O
cats	O
with	O
normal	O
fecal	B-ANAT
consistency	O
and	O
half	O
with	O
diarrhea	O
,	O
were	O
tested	O
by	O
zinc	O
sulfate	O
centrifugation	O
and	O
by	O
real	O
-	O
time	O
PCR	O
for	O
a	O
panel	O
of	O
enteropathogens	O
.	O

ABSTRACT	O
:	O
The	O
nasal	B-ANAT
mucosa	I-ANAT
is	O
an	O
important	O
component	O
of	O
mucosal	B-ANAT
immunity	O
.	O

Here	O
,	O
we	O
showed	O
that	O
nasal	B-ANAT
inoculation	O
of	O
murine	O
coronavirus	O
(	O
CoV	O
)	O
in	O
the	O
absence	O
of	O
direct	O
lung	B-ANAT
infection	O
primes	O
the	O
lung	B-ANAT
immune	O
environment	O
by	O
recruiting	O
activated	O
monocytes	B-ANAT
(	O
Ly6C	O
+	O
inflammatory	O
monocytes	B-ANAT
)	O
and	O
NK	B-ANAT
cells	I-ANAT
into	O
the	O
lungs	B-ANAT
.	O

Unlike	O
infiltration	O
of	O
these	O
cells	B-ANAT
into	O
directly	O
infected	O
lungs	B-ANAT
,	O
a	O
process	O
that	O
requires	O
type	O
I	O
IFN	O
signaling	O
,	O
nasally	O
induced	O
infiltration	O
of	O
Ly6C	O
+	O
inflammatory	O
monocytes	B-ANAT
into	O
the	O
lungs	B-ANAT
is	O
IFN	O
-	O
I	O
independent	O
.	O

ABSTRACT	O
:	O
A	O
68	O
-	O
year	O
-	O
old	O
man	O
presented	O
to	O
our	O
ED	O
with	O
shortness	O
of	O
breath	B-ANAT
,	O
weakness	O
,	O
and	O
a	O
25	O
-	O
lb	O
unintentional	O
weight	O
loss	O
.	O

He	O
had	O
undergone	O
bilateral	O
lung	B-ANAT
transplantation	O
(	O
cytomegalovirus	O
[	O
CMV	O
]:	O
donor	O
+,	O
recipient	O
+;	O
Epstein	O
-	O
Barr	O
virus	O
:	O
donor	O
+;	O
recipient	O
+)	O
for	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
IPF	O
)	O
18	O
months	O
prior	O
.	O

Inhalation	O
injury	O
was	O
present	O
in	O
56	O
.	O
6	O
%	O
of	O
the	O
cases	O
,	O
and	O
mouth	B-ANAT
and	O
nose	B-ANAT
burn	O
was	O
present	O
in	O
30	O
.	O
2	O
%.	O

TITLE	O
:	O
Development	O
of	O
sandwich	O
Enzyme	O
-	O
Linked	O
Immunosorbent	O
Assay	O
for	O
the	O
detection	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
in	O
fecal	B-ANAT
samples	O
.	O

The	O
plasmid	O
was	O
transferred	O
into	O
Escherichia	O
coli	O
BL21	B-ANAT
(	O
DE3	O
).	O

We	O
performed	O
a	O
post	O
hoc	O
analysis	O
on	O
the	O
cohort	O
of	O
immunocompromised	O
patients	O
enrolled	O
in	O
the	O
Large	O
Observational	O
Study	O
to	O
Understand	O
the	O
Global	O
Impact	O
of	O
Severe	O
Acute	O
Respiratory	O
Failure	O
(	O
LUNG	B-ANAT
SAFE	O
)	O
study	O
.	O

Venous	B-ANAT
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
VV	O
-	O
ECMO	O
)	O
has	O
been	O
implemented	O
in	O
various	O
cases	O
of	O
ARDS	O
to	O
provide	O
support	O
and	O
allow	O
for	O
protective	O
lung	B-ANAT
ventilation	O
strategies	O
.	O

The	O
cause	O
of	O
ARDS	O
in	O
these	O
patients	O
included	O
inhalation	O
injury	O
,	O
airway	B-ANAT
trauma	O
and	O
bacterial	O
pneumonia	O
.	O

Ten	O
of	O
the	O
14	O
patients	O
survived	O
to	O
decanulation	O
from	O
ECMO	O
(	O
71	O
%)	O
and	O
eight	O
of	O
14	O
patients	O
(	O
57	O
%)	O
survived	O
to	O
hospital	O
discharge	B-ANAT
.	O

Spine	B-ANAT
magnetic	O
resonance	O
imaging	O
showed	O
abnormal	O
enhancement	O
of	O
the	O
conus	B-ANAT
medullaris	I-ANAT
with	O
thick	O
enhanced	O
cauda	B-ANAT
equina	I-ANAT
nerve	B-ANAT
roots	I-ANAT
,	O
consistent	O
with	O
a	O
possible	O
case	O
of	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
.	O

The	O
results	O
showed	O
that	O
TGEV	O
N	O
protein	O
localised	O
in	O
the	O
cytoplasm	B-ANAT
,	O
inhibited	O
IEC	O
growth	O
,	O
prolonged	O
the	O
S	O
-	O
phase	O
cell	B-ANAT
cycle	O
by	O
down	O
-	O
regulating	O
cell	B-ANAT
cycle	O
protein	O
cyclin	O
A	O
,	O
and	O
was	O
mainly	O
degraded	O
through	O
the	O
proteasome	O
pathway	O
.	O

TITLE	O
:	O
Immunohistochemical	O
detection	O
of	O
the	O
vomiting	O
-	O
inducing	O
monoamine	O
neurotransmitter	O
serotonin	O
and	O
enterochromaffin	B-ANAT
cells	I-ANAT
in	O
the	O
intestines	B-ANAT
of	O
conventional	O
or	O
gnotobiotic	O
(	O
Gn	O
)	O
pigs	O
infected	O
with	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
and	O
serum	B-ANAT
cytokine	O
responses	O
of	O
Gn	O
pigs	O
to	O
acute	O
PEDV	O
infection	O
.	O

Histological	O
analyses	O
showed	O
that	O
TGEV	O
infection	O
led	O
to	O
villi	O
atrophy	O
,	O
and	O
reduced	O
villous	O
height	O
and	O
crypt	B-ANAT
depth	O
.	O

In	O
most	O
areas	O
of	O
Africa	O
,	O
P	O
.	O
vivax	O
infection	O
is	O
essentially	O
absent	O
because	O
of	O
the	O
inherited	O
lack	O
of	O
Duffy	O
antigen	O
receptor	O
for	O
chemokines	O
on	O
the	O
surface	O
of	O
red	B-ANAT
blood	I-ANAT
cells	I-ANAT
that	O
is	O
involved	O
in	O
the	O
parasite	O
invasion	O
of	O
erythrocytes	B-ANAT
.	O

Although	O
,	O
P	O
.	O
vivax	O
infection	O
has	O
long	O
been	O
considered	O
to	O
be	O
benign	O
,	O
recent	O
studies	O
have	O
reported	O
life	O
-	O
threatening	O
consequences	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
cerebral	B-ANAT
malaria	O
,	O
multi	O
-	O
organ	B-ANAT
failure	O
,	O
dyserythropoiesis	O
and	O
anaemia	O
.	O

TITLE	O
:	O
[	O
The	O
incidences	O
of	O
organ	B-ANAT
dysfunction	O
in	O
the	O
early	O
resuscitation	O
of	O
severe	O
sepsis	O
and	O
septic	O
shock	O
patients	O
:	O
a	O
retrospective	O
analysis	O
].	O

Donor	O
plasma	B-ANAT
with	O
a	O
PRNT	O
titre	O
1	O
:	O
80	O
demonstrated	O
meaningful	O
serological	O
response	O
after	O
CP	O
infusion	O
,	O
while	O
that	O
with	O
a	O
PRNT	O
titre	O
1	O
:	O
40	O
did	O
not	O
.	O

In	O
the	O
latter	O
two	O
trials	O
,	O
only	O
one	O
reported	O
a	O
difference	O
in	O
the	O
lowest	O
peripheral	O
capillary	B-ANAT
oxygen	O
saturation	O
between	O
NIV	O
+	O
HFNC	O
versus	O
the	O
NIV	O
group	O
during	O
intubation	O
[	O
100	O
%	O
(	O
interquartile	O
range	O
:	O
95	O
-	O
100	O
)	O
vs	O
.	O
96	O
%	O
(	O
interquartile	O
range	O
:	O
92	O
-	O
99	O
);	O
P	O
=	O
0	O
.	O
029	O
].	O

Oropharyngeal	B-ANAT
swabs	O
were	O
subjected	O
to	O
virus	O
isolation	O
and	O
tested	O
for	O
canine	O
parainfluenza	O
virus	O
(	O
CPIV	O
),	O
canine	O
adenovirus	O
(	O
CAdV	O
)	O
2	O
,	O
canine	O
herpesvirus	O
(	O
CHV	O
),	O
canine	O
respiratory	O
coronavirus	O
(	O
CRCoV	O
),	O
canine	O
influenza	O
virus	O
(	O
CIV	O
),	O
canine	O
distemper	O
virus	O
(	O
CDV	O
),	O
Bordetella	O
bronchiseptica	O
,	O
Streptococcus	O
equi	O
subsp	O
.	O

Making	O
use	O
of	O
our	O
already	O
described	O
animal	O
model	O
of	O
HCoV	O
neuropathogenesis	O
,	O
we	O
describe	O
the	O
route	O
of	O
neuropropagation	O
from	O
the	O
nasal	B-ANAT
cavity	I-ANAT
to	O
the	O
olfactory	B-ANAT
bulb	I-ANAT
and	O
piriform	B-ANAT
cortex	I-ANAT
and	O
then	O
the	O
brain	B-ANAT
stem	I-ANAT
.	O

However	O
,	O
the	O
mechanisms	O
of	O
the	O
dimerization	O
and	O
nucleic	B-ANAT
acid	O
binding	O
of	O
nsp9	O
remain	O
elusive	O
.	O

Our	O
results	O
show	O
that	O
the	O
diverse	O
dimerization	O
forms	O
of	O
coronavirus	O
nsp9	O
proteins	O
enhance	O
their	O
nucleic	B-ANAT
acid	O
binding	O
affinity	O
.	O

TITLE	O
:	O
Prolonged	O
Evolution	O
of	O
Virus	O
-	O
Specific	O
Memory	O
T	B-ANAT
Cell	I-ANAT
Immunity	O
after	O
Severe	O
Avian	O
Influenza	O
A	O
(	O
H7N9	O
)	O
Virus	O
Infection	O
.	O

CONCLUSIONS	O
:	O
The	O
application	O
of	O
epidemiological	O
methods	O
and	O
ecological	O
theory	O
to	O
respiratory	B-ANAT
tract	I-ANAT
samples	O
has	O
yielded	O
novel	O
insights	O
into	O
the	O
factors	O
that	O
drive	O
microbial	O
community	O
composition	O
.	O

With	O
a	O
multidisciplinary	O
translational	O
approach	O
,	O
we	O
studied	O
EVs	O
from	O
the	O
blood	B-ANAT
of	O
33	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
ARDS	O
.	O

Hence	O
,	O
the	O
differential	O
macrophage	B-ANAT
infection	O
phenotype	O
is	O
caused	O
by	O
the	O
cooperative	O
effect	O
of	O
five	O
mutations	O
,	O
which	O
occur	O
in	O
five	O
functionally	O
different	O
domains	O
of	O
the	O
spike	O
fusion	O
subunit	O
S2	O
.	O

The	O
sample	O
types	O
included	O
nasopharyngeal	B-ANAT
swabs	O
(	O
n	O
=	O
677	O
),	O
expectorated	O
deep	O
cough	B-ANAT
sputum	I-ANAT
(	O
n	O
=	O
32	O
),	O
induced	B-ANAT
sputum	I-ANAT
(	O
n	O
=	O
17	O
),	O
and	O
tracheal	O
aspirates	B-ANAT
(	O
n	O
=	O
23	O
).	O

TITLE	O
:	O
[	O
Alcohol	O
consumption	O
and	O
lung	B-ANAT
damage	O
:	O
Dangerous	O
relationships	O
].	O

Chronic	O
alcohol	O
exposure	O
alters	O
the	O
adaptative	O
immune	O
response	O
to	O
pathogens	O
(	O
decreasing	O
the	O
phagocytic	O
function	O
of	O
macrophages	B-ANAT
)	O
and	O
leads	O
to	O
an	O
inflammatory	O
response	O
(	O
pro	O
-	O
inflammatory	O
cytokines	O
).	O

However	O
,	O
the	O
relative	O
contributions	O
of	O
BMDM	O
and	O
microglia	B-ANAT
to	O
demyelinating	O
pathology	O
are	O
unclear	O
,	O
as	O
their	O
identification	O
in	O
MS	O
tissue	B-ANAT
is	O
difficult	O
due	O
to	O
similar	O
morphology	O
and	O
indistinguishable	O
surface	O
markers	O
when	O
activated	O
.	O

Respiratory	O
viruses	O
were	O
analysed	O
in	O
tonsils	B-ANAT
and	O
nasopharynx	B-ANAT
by	O
PCR	O
.	O

Of	O
the	O
studied	O
cytokines	O
,	O
only	O
newly	O
discovered	O
anti	O
-	O
inflammatory	O
cytokine	O
IL	O
-	O
37	O
,	O
was	O
independently	O
associated	O
with	O
tonsillar	B-ANAT
hypertrophy	O
showing	O
slightly	O
stronger	O
anti	O
-	O
inflammatory	O
response	O
in	O
these	O
patients	O
.	O

To	O
assess	O
the	O
association	O
of	O
IL1RA	O
gene	O
polymorphism	O
on	O
serum	B-ANAT
levels	O
of	O
IL1RA	O
and	O
with	O
AO	O
in	O
children	O
under	O
5	O
years	O
of	O
age	O
hospitalized	O
with	O
WHO	O
-	O
defined	O
severe	O
CAP	O
.	O

This	O
is	O
the	O
first	O
report	O
describing	O
IBV	O
spike	O
S2	O
epitopes	O
located	O
in	O
the	O
proximity	O
of	O
the	O
fusion	O
peptide	O
,	O
and	O
it	O
is	O
suggested	O
that	O
the	O
spike	O
fusion	O
machinery	O
of	O
IBV	O
may	O
differ	O
from	O
that	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
,	O
or	O
,	O
alternatively	O
,	O
IBV	O
may	O
have	O
another	O
mechanism	O
to	O
penetrate	O
the	O
cell	B-ANAT
membrane	I-ANAT
.	O

TITLE	O
:	O
Effects	O
of	O
dietary	O
yeast	O
nucleotides	O
supplementation	O
on	O
intestinal	B-ANAT
barrier	O
function	O
,	O
intestinal	B-ANAT
microbiota	O
,	O
and	O
humoral	O
immunity	O
in	O
specific	O
pathogen	O
-	O
free	O
chickens	O
.	O

There	O
was	O
a	O
significant	O
increased	O
ileal	B-ANAT
villus	B-ANAT
height	O
and	O
villus	B-ANAT
height	O
to	O
crypt	B-ANAT
depth	O
ratio	O
in	O
group	O
2	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

In	O
the	O
current	O
study	O
,	O
tissues	B-ANAT
of	O
eight	O
dromedaries	O
receiving	O
inoculation	O
of	O
MERS	O
-	O
Coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
after	O
recombinant	O
Modified	O
-	O
Vaccinia	O
-	O
Virus	O
-	O
Ankara	O
(	O
MVA	O
-	O
S	O
)-	O
vaccination	O
(	O
n	O
=	O
4	O
),	O
MVA	O
-	O
vaccination	O
(	O
mock	O
vaccination	O
,	O
n	O
=	O
2	O
)	O
and	O
PBS	O
application	O
(	O
mock	O
vaccination	O
,	O
n	O
=	O
2	O
),	O
respectively	O
,	O
were	O
investigated	O
.	O

MERS	O
-	O
CoV	O
infection	O
in	O
mock	O
-	O
vaccinated	O
dromedaries	O
revealed	O
high	O
numbers	O
of	O
MERS	O
-	O
CoV	O
-	O
nucleocapsid	B-ANAT
positive	O
cells	B-ANAT
,	O
T	B-ANAT
cells	I-ANAT
,	O
and	O
macrophages	B-ANAT
within	O
nasal	B-ANAT
turbinates	I-ANAT
and	O
trachea	B-ANAT
at	O
day	O
four	O
post	O
infection	O
.	O

ABSTRACT	O
:	O
A	O
central	O
goal	O
for	O
reintroduced	O
populations	O
of	O
threatened	O
wood	O
bison	O
(	O
Bison	O
bison	O
athabascae	O
)	O
is	O
to	O
maintain	O
them	O
free	O
of	O
diseases	O
of	O
concern	O
,	O
particularly	O
bovine	O
tuberculosis	O
(	O
caused	O
by	O
Mycobacterium	O
bovis	O
)	O
and	O
brucellosis	O
(	O
caused	O
by	O
Brucella	O
abortus	B-ANAT
).	O

We	O
seek	O
to	O
provide	O
a	O
further	O
understanding	O
of	O
this	O
process	O
,	O
with	O
the	O
report	O
of	O
a	O
case	O
of	O
splenic	B-ANAT
rupture	O
followed	O
by	O
a	O
systematic	O
review	O
of	O
the	O
current	O
literature	O
.	O

RESULTS	O
:	O
Among	O
24	O
patients	O
,	O
9	O
(	O
37	O
.	O
5	O
%)	O
additionally	O
had	O
at	O
least	O
one	O
of	O
the	O
MAAs	O
examined	O
in	O
this	O
study	O
:	O
1	O
patient	O
was	O
positive	O
for	O
ANA	O
,	O
5	O
for	O
anti	O
-	O
CCP	O
,	O
5	O
for	O
either	O
anti	O
-	O
SSA	O
or	O
anti	O
-	O
SSB	B-ANAT
,	O
1	O
for	O
anti	O
-	O
cardiolipin	O
,	O
and	O
1	O
for	O
anti	O
-	O
Scl	O
-	O
70	O
.	O

In	O
the	O
present	O
study	O
,	O
to	O
mimic	O
the	O
native	O
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
a	O
stable	B-ANAT
cell	I-ANAT
line	I-ANAT
producing	O
the	O
trimeric	O
ectodomain	O
of	O
S	O
glycoprotein	O
of	O
the	O
PEDV	O
Pintung	O
-	O
52	O
(	O
PEDV	O
-	O
PT	O
)	O
strain	O
was	O
successfully	O
established	O
by	O
incorporating	O
T4	O
bacteriophage	O
foldon	O
sequence	O
of	O
fibritin	O
trimerization	O
domains	O
at	O
the	O
C	O
-	O
terminal	O
end	O
and	O
replacing	O
the	O
signal	O
peptide	O
of	O
S	O
protein	O
with	O
the	O
tissue	B-ANAT
plasminogen	O
activator	O
signal	O
peptide	O
sequence	O
at	O
the	O
N	O
terminal	O
end	O
.	O

The	O
detection	O
was	O
specific	O
for	O
MERS	O
-	O
CoV	O
.	O
In	O
validation	O
using	O
clinical	O
samples	O
,	O
pharyngeal	B-ANAT
swabs	O
from	O
Shanghai	O
patients	O
were	O
detected	O
as	O
negative	O
,	O
while	O
swabs	O
from	O
the	O
first	O
imported	O
MERS	O
case	O
in	O
China	O
were	O
detected	O
as	O
positive	O
.	O

ABSTRACT	O
:	O
OBJECTIVE	O
To	O
characterize	O
and	O
investigate	O
potential	O
associations	O
between	O
causes	O
of	O
pleural	B-ANAT
effusion	I-ANAT
and	O
various	O
clinical	O
factors	O
in	O
a	O
large	O
cohort	O
of	O
affected	O
cats	O
.	O

ANIMALS	O
380	O
client	O
-	O
owned	O
cats	O
with	O
a	O
diagnosis	O
of	O
pleural	B-ANAT
effusion	I-ANAT
from	O
January	O
1	O
,	O
2009	O
,	O
through	O
July	O
14	O
,	O
2014	O
,	O
for	O
which	O
the	O
cause	O
of	O
pleural	B-ANAT
effusion	I-ANAT
had	O
been	O
fully	O
investigated	O
.	O

Cats	O
with	O
CHF	O
had	O
a	O
significantly	O
lower	O
rectal	O
temperature	O
at	O
hospital	O
admission	O
(	O
mean	O
Â±	O
SD	O
,	O
36	O
.	O
9	O
Â±	O
1	O
.	O
2	O
Â°	O
C	O
[	O
98	O
.	O
4	O
Â±	O
2	O
.	O
2	O
Â°	O
F	O
])	O
than	O
did	O
cats	O
with	O
pleural	B-ANAT
effusion	I-ANAT
from	O
other	O
causes	O
(	O
37	O
.	O
9	O
Â±	O
1	O
.	O
2	O
Â°	O
C	O
[	O
100	O
.	O
2	O
Â±	O
2	O
.	O
2	O
Â°	O
F	O
]).	O

Age	O
and	O
hypothermia	O
may	O
be	O
helpful	O
to	O
raise	O
the	O
index	O
of	O
suspicion	O
for	O
certain	O
underlying	O
causes	O
of	O
pleural	B-ANAT
effusion	I-ANAT
in	O
cats	O
.	O

The	O
patient	O
was	O
diagnosed	O
with	O
bilateral	O
pneumonia	O
,	O
pulmonary	B-ANAT
sepsis	O
and	O
underwent	O
invasive	O
mechanical	O
ventilation	O
.	O

A	O
60	O
-	O
year	O
old	O
Caucasian	O
male	O
,	O
diagnosed	O
with	O
a	O
stage	O
IIIA	O
left	B-ANAT
lung	I-ANAT
tumor	O
underwent	O
a	O
left	O
pneumonectomy	O
.	O

All	O
infected	O
pigs	O
shed	O
virus	O
in	O
faeces	B-ANAT
regardless	O
of	O
PEDV	O
strain	O
with	O
9	O
of	O
30	O
pigs	O
showing	O
intermittent	O
faecal	B-ANAT
shedding	O
.	O

She	O
had	O
severe	O
dyspnea	O
and	O
a	O
chest	B-ANAT
X	O
-	O
ray	O
showed	O
bilateral	O
infiltration	O
without	O
findings	O
of	O
heart	B-ANAT
failure	O
.	O

RESULTS	O
:	O
No	O
significant	O
differences	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
were	O
observed	O
with	O
respect	O
to	O
average	O
daily	O
feed	O
intake	O
,	O
body	B-ANAT
weight	O
gain	O
and	O
feed	O
conversion	O
ratio	O
among	O
the	O
experimental	O
groups	O
during	O
the	O
entire	O
study	O
period	O
(	O
1	O
-	O
70	O
days	O
).	O

CONCLUSIONS	O
:	O
FVW	O
at	O
the	O
6	O
%	O
level	O
can	O
be	O
used	O
as	O
a	O
potential	O
phytogenic	O
feed	O
stuff	O
in	O
growing	O
layer	B-ANAT
hen	O
rations	O
with	O
respect	O
to	O
improving	O
the	O
immune	O
response	O
without	O
affecting	O
normal	O
weight	O
gain	O
.	O

Strains	O
K1	O
/	O
ST23	B-ANAT
(	O
n	O
=	O
5	O
)	O
and	O
K2	O
/	O
ST86	O
(	O
n	O
=	O
5	O
)	O
predominated	O
.	O

ABSTRACT	O
:	O
EU	O
Decision	O
1082	O
/	O
2013	O
/	O
EU	O
on	O
serious	O
cross	O
-	O
border	B-ANAT
health	O
threats	O
provides	O
a	O
legal	O
basis	O
for	O
collaboration	O
between	O
EU	O
Member	O
States	O
,	O
and	O
between	O
international	O
and	O
European	O
level	O
institutions	O
on	O
preparedness	O
,	O
prevention	O
,	O
and	O
mitigation	O
in	O
the	O
event	O
of	O
a	O
public	O
health	O
emergency	O
.	O

The	O
type	O
II	O
transmembrane	B-ANAT
serine	O
protease	O
(	O
TTSP	O
)	O
TMPRSS2	O
has	O
been	O
identified	O
as	O
an	O
HA	O
activator	O
in	O
cell	B-ANAT
culture	O
and	O
in	O
the	O
infected	O
host	O
.	O

Our	O
results	O
suggest	O
that	O
TMPRSS11A	O
could	O
promote	O
FLUAV	O
spread	O
in	O
target	B-ANAT
cells	I-ANAT
and	O
that	O
HA	O
-	O
activating	O
TTSPs	O
exhibit	O
differential	O
sensitivity	O
to	O
blockade	O
by	O
cellular	B-ANAT
serine	O
protease	O
inhibitors	O
.	O

TITLE	O
:	O
Inhaled	O
nitric	O
oxide	O
mitigates	O
need	O
for	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
a	O
patient	O
with	O
refractory	O
acute	O
hypoxemic	O
respiratory	O
failure	O
due	O
to	O
cardiac	B-ANAT
and	O
pulmonary	B-ANAT
shunts	O
.	O

PDCoV	O
antigen	O
was	O
detected	O
in	O
the	O
cells	B-ANAT
showing	O
CPE	O
.	O

By	O
double	O
IF	O
and	O
TUNEL	O
staining	O
,	O
most	O
PDCoV	O
antigen	O
-	O
positive	O
IPEC	O
-	O
J2	O
cells	B-ANAT
failed	O
to	O
show	O
TUNEL	O
-	O
positive	O
signals	O
,	O
indicating	O
that	O
PDCoV	O
-	O
infected	O
IPEC	O
-	O
J2	O
cells	B-ANAT
may	O
not	O
undergo	O
apoptosis	O
,	O
but	O
rather	O
necrosis	O
,	O
similar	O
to	O
necrotic	O
cell	B-ANAT
death	O
of	O
infected	O
enterocytes	B-ANAT
in	O
vivo	O
.	O

TITLE	O
:	O
Prone	O
positioning	O
before	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
A	O
retrospective	O
multicenter	O
study	O
.	O

TITLE	O
:	O
N	O
-	O
terminal	O
Domain	O
of	O
the	O
Spike	O
Protein	O
of	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
as	O
a	O
New	O
Candidate	O
Molecule	O
for	O
a	O
Mucosal	B-ANAT
Vaccine	O
.	O

However	O
,	O
an	O
effective	O
mucosal	B-ANAT
vaccine	O
against	O
the	O
currently	O
prevalent	O
PEDV	O
strain	O
is	O
not	O
available	O
.	O

These	O
data	O
reveal	O
a	O
link	O
between	O
the	O
gut	B-ANAT
flora	O
composition	O
and	O
the	O
development	O
of	O
antibody	O
-	O
mediated	O
TRALI	O
in	O
mice	O
.	O

Moreover	O
,	O
ARDS	O
RCTs	O
strictly	O
adhere	O
to	O
lung	B-ANAT
-	O
protective	O
strategies	O
,	O
while	O
ARDS	O
observational	O
studies	O
continually	O
demonstrate	O
variable	O
compliance	O
.	O

Fat	O
embolism	O
syndrome	O
is	O
a	O
rare	O
but	O
serious	O
complication	O
of	O
long	B-ANAT
bone	I-ANAT
fractures	O
.	O

Such	O
binding	O
resulted	O
in	O
the	O
folding	O
of	O
the	O
Î²5	O
-	O
Î²6	O
loop	O
toward	O
a	O
shallow	O
groove	B-ANAT
on	O
the	O
RBD	O
interface	O
critical	O
for	O
accommodating	O
DPP4	O
.	O

An	O
MCC	B-ANAT
tree	O
based	O
on	O
relative	O
synonymous	O
codon	O
usage	O
(	O
RSCU	O
)	O
data	O
integrating	O
data	O
from	O
both	O
viruses	O
and	O
hosts	O
into	O
a	O
same	O
analysis	O
indicated	O
three	O
putative	O
host	O
/	O
virus	O
contact	O
dates	O
ranging	O
from	O
1	O
.	O
54E8	O
to	O
2	O
.	O
44E5	O
years	O
ago	O
,	O
suggesting	O
that	O
an	O
ancestor	O
coronavirus	O
might	O
have	O
followed	O
human	O
evolution	O
.	O

Molecular	O
diagnostics	O
offer	O
an	O
advantage	O
to	O
the	O
current	O
serological	O
and	O
culture	O
-	O
based	O
methods	O
in	O
terms	O
of	O
sensitivity	O
,	O
coverage	O
,	O
hands	B-ANAT
-	O
on	O
time	O
,	O
and	O
time	O
to	O
results	O
.	O

ABSTRACT	O
:	O
Xylometazoline	O
hydrochloride	O
(	O
HCl	O
)	O
is	O
a	O
nasal	B-ANAT
decongestant	O
that	O
causes	O
vasoconstriction	O
in	O
the	O
nasal	B-ANAT
submucosa	B-ANAT
.	O

Similarly	O
,	O
lung	B-ANAT
ER	O
stress	O
-	O
related	O
genes	O
'	O
(	O
PERK	O
,	O
eIF2	B-ANAT
-	O
ER	O
stress	O
was	O
activated	O
during	O
CLP	O
-	O
induced	O
ALI	O
,	O
which	O
may	O
represent	O
a	O
mechanism	O
by	O
which	O
CLP	O
induces	O
ALI	O
.	O

HO	O
-	O
1	O
activation	O
could	O
inhibit	O
CLP	O
-	O
induced	O
lung	B-ANAT
ER	O
stress	O
and	O
attenuate	O
CLP	O
-	O
induced	O
ALI	O
.	O

The	O
data	O
analyzed	O
refer	O
to	O
the	O
patient	O
,	O
event	O
,	O
type	O
of	O
resuscitation	O
performed	O
,	O
and	O
clinical	O
situation	O
after	O
resuscitation	O
and	O
at	O
arrival	O
to	O
the	O
PICU	O
;	O
results	O
of	O
additional	O
tests	O
;	O
and	O
clinical	O
evolution	O
and	O
neurological	O
status	O
at	O
discharge	B-ANAT
from	O
the	O
PICU	O
(	O
categorized	O
as	O
death	O
,	O
severe	O
encephalopathy	O
,	O
or	O
normal	O
).	O

In	O
this	O
group	O
,	O
there	O
was	O
also	O
a	O
higher	O
incidence	O
of	O
seizures	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
hemodynamic	O
compromise	O
,	O
and	O
acute	O
renal	B-ANAT
failure	O
.	O

Furthermore	O
,	O
a	O
virus	O
cell	B-ANAT
entry	O
assay	O
and	O
a	O
cell	B-ANAT
-	O
cell	B-ANAT
fusion	O
assay	O
provided	O
no	O
evidence	O
that	O
the	O
S	O
protein	O
was	O
activated	O
by	O
exogenous	O
furin	O
.	O

In	O
a	O
retrospective	O
study	O
of	O
182	O
patients	O
with	O
severe	O
isolated	O
TBI	O
,	O
we	O
measured	O
TIMP	O
-	O
3	O
in	O
plasma	B-ANAT
obtained	O
on	O
emergency	O
department	O
arrival	O
.	O

Our	O
findings	O
reveal	O
a	O
comprehensive	O
CD81	O
network	O
in	O
human	O
liver	B-ANAT
cells	I-ANAT
and	O
show	O
that	O
HCV	O
and	O
Plasmodium	O
highjack	O
selective	O
CD81	O
interactions	O
,	O
including	O
CAPN5	O
and	O
CBLB	O
for	O
HCV	O
,	O
to	O
invade	O
cells	B-ANAT
.	O

However	O
,	O
the	O
increased	O
airway	B-ANAT
pressures	O
resulting	O
from	O
the	O
recruitment	O
maneuver	O
may	O
induce	O
cardiac	B-ANAT
dysfunction	O
,	O
limiting	O
the	O
benefit	O
of	O
this	O
maneuver	O
.	O

Thus	O
,	O
combination	O
therapy	O
with	O
ET	O
and	O
PSL	O
that	O
targets	O
inflammatory	B-ANAT
cells	I-ANAT
has	O
the	O
potential	O
to	O
attenuate	O
fatal	O
ARDS	O
.	O

HCoV	O
-	O
OC43	O
structural	O
(	O
membrane	B-ANAT
M	O
and	O
nucleocapsid	B-ANAT
N	O
)	O
and	O
accessory	O
proteins	O
(	O
ns2a	O
and	O
ns5a	O
)	O
were	O
expressed	O
individually	O
in	O
human	O
embryonic	B-ANAT
kidney	B-ANAT
293	O
(	O
HEK	O
-	O
293	O
)	O
cells	B-ANAT
.	O

The	O
transcriptional	O
activity	O
of	O
ISRE	O
,	O
IFN	O
-	O
Î²	O
promoter	O
,	O
and	O
NF	O
-	O
ÎºB	O
-	O
RE	O
was	O
significantly	O
reduced	O
in	O
the	O
presence	O
of	O
HCoV	O
-	O
OC43	O
ns2a	O
,	O
ns5a	O
,	O
M	O
,	O
or	O
N	O
protein	O
,	O
following	O
the	O
challenge	O
of	O
cells	B-ANAT
with	O
Sendai	O
virus	O
,	O
IFN	O
-	O
Î±	O
or	O
tumor	O
necrosis	O
factor	O
-	O
Î±	O
.	O

Finally	O
,	O
we	O
also	O
discuss	O
some	O
of	O
the	O
risks	O
and	O
challenges	O
for	O
the	O
long	O
-	O
term	O
use	O
of	O
ambulatory	O
miniaturized	O
bioartificial	O
lungs	B-ANAT
.	O

The	O
addition	O
of	O
exogenous	O
cholesterol	O
to	O
MÎ²CD	O
-	O
treated	O
cells	B-ANAT
or	O
virions	B-ANAT
moderately	O
restored	O
PDCoV	O
infectivity	O
.	O

Furthermore	O
,	O
the	O
pharmacological	O
sequestration	O
of	O
cellular	B-ANAT
or	O
viral	O
cholesterol	O
efficiently	O
blocked	O
both	O
virus	O
attachment	O
and	O
internalization	O
.	O

ABSTRACT	O
:	O
Severe	O
complications	O
after	O
reperfusion	O
therapy	O
for	O
acute	O
major	O
vessel	B-ANAT
occlusion	O
are	O
not	O
well	O
described	O
.	O

Virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
were	O
examined	O
by	O
intracellular	B-ANAT
cytokine	O
staining	O
after	O
stimulation	O
of	O
peripheral	B-ANAT
blood	I-ANAT
mononuclear	I-ANAT
cells	I-ANAT
with	O
overlapping	O
peptides	O
spanning	O
whole	O
virus	O
structural	O
proteins	O
.	O

At	O
the	O
acute	O
phase	O
of	O
infection	O
,	O
elevated	O
levels	O
of	O
plasma	B-ANAT
proinflammatory	O
cytokines	O
/	O
chemokines	O
were	O
detected	O
in	O
proportion	O
to	O
the	O
severity	O
of	O
the	O
disease	O
.	O

These	O
T	B-ANAT
cells	I-ANAT
belonged	O
to	O
the	O
T	O
-	O
helper	O
1	O
or	O
type	O
1	O
cytotoxic	B-ANAT
T	I-ANAT
cell	I-ANAT
subtypes	O
.	O

While	O
CD8	O
+	O
T	B-ANAT
cells	I-ANAT
responded	O
preferentially	O
to	O
the	O
viral	O
S	O
protein	O
compared	O
with	O
E	O
/	O
M	O
/	O
N	O
proteins	O
,	O
especially	O
at	O
the	O
acute	O
stage	O
,	O
slightly	O
more	O
CD4	O
+	O
T	B-ANAT
cells	I-ANAT
recognized	O
E	O
/	O
M	O
/	O
N	O
proteins	O
compared	O
with	O
S	O
protein	O
at	O
the	O
convalescent	O
phase	O
.	O

Interestingly	O
,	O
ORF3	O
with	O
the	O
N	O
-	O
terminal	O
Flag	O
tag	O
was	O
also	O
detected	O
on	O
the	O
cell	B-ANAT
surface	I-ANAT
concomitant	O
with	O
the	O
spike	O
(	O
S	O
)	O
protein	O
as	O
determined	O
by	O
flow	O
cytometry	O
and	O
confocal	O
microscopy	O
.	O

ORF3	O
and	O
S	O
proteins	O
were	O
also	O
co	O
-	O
localized	O
at	O
perinuclear	O
compartments	B-ANAT
and	O
in	O
the	O
vesicle	B-ANAT
-	O
like	O
structures	O
in	O
transfected	O
and	O
infected	O
cells	B-ANAT
.	O

ABSTRACT	O
:	O
GSK3532795	O
,	O
formerly	O
known	O
as	O
BMS	O
-	O
955176	O
(	O
1	O
),	O
is	O
a	O
potent	O
,	O
orally	B-ANAT
active	O
,	O
second	O
-	O
generation	O
HIV	O
-	O
1	O
maturation	O
inhibitor	O
(	O
MI	O
)	O
that	O
advanced	O
through	O
phase	O
IIb	O
clinical	O
trials	O
.	O

The	O
age	O
-	O
allied	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
was	O
highest	O
amongst	O
elderly	O
people	O
with	O
chronic	O
debilitating	O
diseases	O
such	O
as	O
pulmonary	B-ANAT
diseases	O
,	O
end	O
-	O
stage	O
renal	B-ANAT
illness	O
,	O
diabetes	O
mellitus	O
and	O
malignancy	O
.	O

The	O
optimal	O
immunization	O
regimen	O
for	O
the	O
nasal	B-ANAT
spray	O
H7N9	O
vaccine	O
was	O
determined	O
to	O
be	O
a	O
21	O
-	O
day	O
interval	O
between	O
the	O
primary	O
immunization	O
and	O
booster	O
,	O
with	O
a	O
dose	O
of	O
4	O
.	O
5	O
Î¼g	O
hemagglutinin	O
per	O
mouse	O
.	O

ABSTRACT	O
:	O
Porcine	O
hemagglutinating	O
encephalomyelitis	O
virus	O
(	O
PHEV	O
)	O
is	O
a	O
member	O
of	O
the	O
genus	O
betacoronavirus	O
within	O
the	O
family	O
coronaviridae	O
,	O
which	O
invades	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
via	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
and	O
causes	O
encephalomyelitis	O
or	O
vomiting	O
and	O
wasting	O
disease	O
(	O
VWD	O
)	O
in	O
sucking	O
piglets	O
.	O

Differential	O
mRNA	O
expression	O
analysis	O
identified	O
5621	O
genes	O
as	O
deregulated	O
in	O
peritoneal	B-ANAT
cells	B-ANAT
from	O
FIPV	O
infected	O
versus	O
normal	O
cats	O
;	O
956	O
genes	O
showed	O
>	O
2	O
.	O
0	O
Log	O

When	O
HBD	O
2	O
-	O
conjugated	O
S	O
RBD	O
was	O
used	O
to	O
treat	O
THP	O
-	O
1	O
human	O
monocytic	B-ANAT
cells	B-ANAT
,	O
the	O
expression	O
levels	O
of	O
antiviral	O
(	O
IFN	O
-	O
Î²	O
,	O
IFN	O
-	O
Î³	O
,	O
MxA	O
,	O
PKR	O
,	O
and	O
RNaseL	O
)	O
and	O
primary	O
immune	O
-	O
inducing	O
(	O
NOD2	O
,	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
1Î²	O
,	O
and	O
IL	O
-	O
6	O
)	O
molecules	O
were	O
enhanced	O
compared	O
to	O
those	O
expressed	O
after	O
treatment	O
with	O
S	O
RBD	O
only	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
increasingly	O
used	O
in	O
the	O
management	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

During	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
,	O
all	O
patients	O
were	O
able	O
to	O
maintain	O
a	O
normal	O
respiratory	O
rate	O
and	O
experienced	O
steady	O
improvements	O
in	O
vital	O
capacities	O
.	O

Mean	O
(Â±	O
SD	O
)	O
ICU	O
length	O
of	O
stay	O
was	O
10	O
.	O
43	O
(Â±	O
2	O
.	O
64	O
)	O
days	O
,	O
while	O
all	O
patients	O
survived	O
to	O
hospital	O
discharge	B-ANAT
and	O
at	O
90	O
days	O
.	O

ABSTRACT	O
:	O
The	O
trimeric	O
SARS	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
surface	O
spike	O
(	O
S	O
)	O
glycoprotein	O
consisting	O
of	O
three	O
S1	O
-	O
S2	O
heterodimers	O
binds	O
the	O
cellular	B-ANAT
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
and	O
mediates	O
fusion	O
of	O
the	O
viral	O
and	O
cellular	B-ANAT
membranes	B-ANAT
through	O
a	O
pre	O
-	O
to	O
postfusion	O
conformation	O
transition	O
.	O

Here	O
,	O
we	O
report	O
the	O
structure	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
in	O
complex	O
with	O
its	O
host	B-ANAT
cell	I-ANAT
receptor	O
ACE2	O
revealed	O
by	O
cryo	O
-	O
electron	O
microscopy	O
(	O
cryo	O
-	O
EM	O
).	O

Here	O
,	O
we	O
present	O
a	O
novel	O
arch	B-ANAT
-	O
shaped	O
multiple	O
-	O
target	O
sensor	O
capable	O
of	O
rapid	O
pathogen	O
identification	O
using	O
direct	O
amplification	O
in	O
clinical	O
samples	O
.	O

Virus	O
-	O
specific	O
T	B-ANAT
cells	I-ANAT
are	O
recruited	O
to	O
the	O
CNS	B-ANAT
,	O
and	O
control	O
viral	O
replication	O
through	O
release	O
of	O
antiviral	O
cytokines	O
and	O
cytolytic	O
activity	O
.	O

Chemokines	O
are	O
expressed	O
and	O
contribute	O
to	O
defense	O
as	O
well	O
as	O
chronic	O
disease	O
by	O
attracting	O
targeted	O
populations	O
of	O
leukocytes	B-ANAT
to	O
the	O
CNS	B-ANAT
.	O

In	O
293	O
-	O
derived	O
cells	B-ANAT
,	O
the	O
three	O
viruses	O
accumulated	O
similar	O
levels	O
of	O
nsp1	O
and	O
major	O
viral	O
structural	O
proteins	O
and	O
did	O
not	O
induce	O

The	O
subsequent	O
diagnosis	O
of	O
antisynthetase	O
syndrome	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
unusual	O
,	O
even	O
more	O
so	O
when	O
a	O
veino	O
-	O
veinous	O
(	O
VV	O
)	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
required	O
.	O

Pediatric	O
patients	O
with	O
ARDS	O
have	O
specific	O
plasma	B-ANAT
MMP	O
profiles	O
associated	O
with	O
inflammation	O
,	O
endothelial	B-ANAT
injury	O
,	O
morbidity	O
,	O
and	O
mortality	O
.	O

Overall	O
,	O
17	O
patients	O
(	O
68	O
%)	O
died	O
on	O
ECMO	O
,	O
whereas	O
5	O
patients	O
survived	O
to	O
hospital	O
discharge	B-ANAT
(	O
20	O
%).	O

RESULTS	O
:	O
25	O
patients	O
,	O
11	O
of	O
whom	O
underwent	O
haematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplantation	O
(	O
SCT	O
),	O
were	O
analysed	O
.	O

Within	O
PPs	O
,	O
Dendritic	B-ANAT
cells	I-ANAT
(	O
DCs	O
)	O
can	O
uptake	O
antigens	O
from	O
the	O
gut	B-ANAT
lumen	I-ANAT
by	O
extending	O
dendrites	B-ANAT
into	O
epithelium	B-ANAT
,	O
and	O
process	O
it	O
and	O
then	O
present	O
to	O
lymphocytes	B-ANAT
,	O
which	O
effectively	O
antigen	O
produces	O
an	O
immune	O
response	O
.	O

In	O
this	O
study	O
,	O
for	O
the	O
first	O
time	O
we	O
investigated	O
the	O
role	O
of	O
DCs	O
in	O
porcine	O
PPs	O
after	O
oral	B-ANAT
administration	O
inactivated	O
PEDV	O
.	O

RESULTS	O
:	O
In	O
this	O
study	O
,	O
for	O
the	O
first	O
time	O
we	O
investigated	O
the	O
role	O
of	O
DCs	O
in	O
porcine	O
PPs	O
after	O
oral	B-ANAT
administration	O
inactivated	O
PEDV	O
.	O

This	O
is	O
a	O
secondary	O
analysis	O
of	O
LUNG	B-ANAT
-	O
SAFE	O
,	O
an	O
international	O
,	O
multicenter	O
,	O
prospective	O
cohort	O
study	O
of	O
patients	O
receiving	O
invasive	O
or	O
noninvasive	O
ventilation	O
in	O
50	O
countries	O
spanning	O
5	O
continents	O
.	O

ABSTRACT	O
:	O
Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
can	O
be	O
a	O
lifesaving	O
therapy	O
for	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

This	O
is	O
characterized	O
by	O
bilateral	O
pulmonary	B-ANAT
infiltrates	O
and	O
severe	O
hypoxemia	O
.	O

We	O
hypothesize	O
that	O
SES	O
is	O
caused	O
by	O
an	O
infectious	O
bronchitis	O
virus	O
(	O
IBV	O
)	O
strain	O
since	O
it	O
is	O
known	O
that	O
IBV	O
replicates	O
in	O
the	O
shell	B-ANAT
gland	I-ANAT
causing	O
various	O
eggshell	O
abnormalities	O
.	O

This	O
indirect	O
ELISA	O
was	O
compared	O
to	O
indirect	O
immunoinfluscent	O
assay	O
(	O
IFA	O
),	O
and	O
the	O
overall	O
coincidence	O
rate	O
was	O
96	O
.	O
74	O
%	O
based	O
on	O
testing	O
368	O
clinical	O
serum	B-ANAT
samples	O
with	O
different	O
PEDV	O
antibody	O
levels	O
.	O

Appropriate	O
media	B-ANAT
should	O
be	O
used	O
for	O
bacterial	O
isolation	O
,	O
and	O
the	O
role	O
of	O
additional	O
contributing	O
factors	O
and	O
/	O
or	O
complicating	O
agents	O
should	O
be	O
investigated	O
in	O
cases	O
of	O
infectious	O
coryza	O
.	O

There	O
are	O
many	O
potential	O
causes	O
of	O
ARDS	O
;	O
however	O
,	O
alveolar	B-ANAT
injury	O
associated	O
with	O
mechanical	O
ventilation	O
,	O
termed	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
(	O
VILI	O
),	O
remains	O
a	O
well	O
-	O
recognized	O
contributor	O
.	O

Based	O
on	O
our	O
published	O
preliminary	O
data	O
,	O
we	O
hypothesized	O
that	O
the	O
endoplasmic	B-ANAT
reticulum	I-ANAT
(	O
ER	O
)	O
stress	O
response	O
molecule	O
Protein	O
Kinase	O
R	O
-	O
like	O
Endoplasmic	B-ANAT
Reticulum	I-ANAT
Kinase	O
(	O
PERK	O
)	O
plays	O
a	O
role	O
in	O
transmitting	O
mechanosensory	O
signals	O
the	O
alveolar	B-ANAT
epithelium	I-ANAT
.	O

To	O
explore	O
the	O
effect	O
of	O
PERK	O
inhibition	O
on	O
VILI	O
,	O
we	O
ventilated	O
live	O
rats	O
and	O
compared	O
lung	B-ANAT
injury	O
parameters	O
to	O
non	O
-	O
ventilated	O
controls	O
.	O

In	O
this	O
study	O
,	O
we	O
constructed	O
scIAV	O
-	O
S	O
,	O
a	O
single	O
-	O
cycle	O
influenza	O
A	O
virus	O
pseudotyped	O
with	O
the	O
spike	O
protein	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
),	O
and	O
demonstrated	O
that	O
this	O
virus	O
could	O
infect	O
cultured	B-ANAT
cells	I-ANAT
and	O
trigger	O
massive	O
syncytium	B-ANAT
formation	O
.	O

Tracheal	O
and	O
cloacal	B-ANAT
swabs	O
were	O
collected	O
from	O
3	O
,	O
5	O
,	O
7	O
,	O
10	O
,	O
12	O
,	O
and	O
15	O
day	O
'	O
s	O
old	O
chicks	O
from	O
all	O
groups	O
in	O
experiment	O
1	O
and	O
21	O
,	O
23	O
,	O
25	O
,	O
and	O
28	O
days	O
old	O
from	O
all	O
groups	O
in	O
experiment	O
2	O
.	O

Cloacal	B-ANAT
swabs	O
and	O
the	O
positive	O
rRT	O
-	O
PCR	O
tracheal	O
swabs	O
were	O
inoculated	O
in	O
10	O
-	O
day	O
-	O
old	O
SPF	O
embryonated	O
chicken	O
eggs	O
(	O
ECE	O
)	O
to	O
confirm	O
rRT	O
-	O
PCR	O
results	O
.	O

ABSTRACT	O
:	O
Tracheal	O
swabs	O
and	O
different	O
organs	B-ANAT
are	O
collected	O
from	O
17	O
chicken	O
farms	O
showing	O
respiratory	O
signs	O
and	O
variable	O
mortalities	O
in	O
different	O
governorates	O
.	O

We	O
report	O
a	O
case	O
of	O
profound	O
,	O
long	O
-	O
lasting	O
unexplained	O
hypotension	O
during	O
and	O
after	O
anaesthesia	O
in	O
a	O
patient	O
presented	O
for	O
emergency	O
vocal	B-ANAT
cord	I-ANAT
surgery	O
(	O
cordectomy	O
).	O

Serum	B-ANAT
cortisol	O
level	O
was	O
sent	O
postoperatively	O
in	O
intensive	O
care	O
unit	O
that	O
was	O
found	O
extremely	O
low	O
.	O

The	O
main	O
pulmonary	B-ANAT
side	O
effects	O
are	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
essentially	O
caused	O
by	O
crizotinib	O
,	O
respiratory	O
infections	O
,	O
pneumothorax	O
,	O
and	O
alveolar	B-ANAT
hemorrhage	O
.	O

Valid	O
data	O
were	O
collected	O
from	O
140	O
males	O
,	O
which	O
showed	O
83	O
.	O
5	O
%	O
of	O
HPV	O
infection	O
of	O
the	O
external	B-ANAT
genitalia	I-ANAT
,	O
including	O
60	O
cases	O
of	O
HPV6	O
(	O
43	O
.	O
2	O
%),	O
27	O
cases	O
of	O
HPV16	O
(	O
19	O
.	O
4	O
%),	O
14	O
cases	O
of	O
HPV39	O
(	O
10	O
.	O
1	O
%),	O
13	O
cases	O
of	O
HPV18	O
(	O
9	O
.	O
4	O
%),	O
13	O
cases	O
of	O
HPV58	O
(	O
9	O
.	O
4	O
%),	O
and	O
13	O
cases	O
of	O
HPV52	O
(	O
9	O
.	O
4	O
%).	O

Men	O
who	O
have	O
the	O
female	O
partners	O
with	O
positive	O
cervical	B-ANAT
HPV	O
are	O
at	O
high	O
risk	O
of	O
HPV	O
infection	O
and	O
therefore	O
need	O
to	O
be	O
screened	O
and	O
treated	O
so	O
as	O
to	O
reduce	O
HPV	O
infection	O
in	O
both	O
sexes	O
.	O

In	O
addition	O
,	O
lactate	O
dehydrogenase	O
(	O
LDH	O
)	O
>	O
246	O
IU	O
/	O
L	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7	O
.	O
06	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
2	O
.	O
15	O
-	O
23	O
.	O
2	O
,	O
P	O
=	O
0	O
.	O
001	O
],	O
and	O
serum	B-ANAT
calcium	O
<	O
2	O
.	O
18	O
mmol	O
/	O
L	O
(	O
OR	O
=	O
6	O
.	O
67	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
42	O
-	O
31	O
.	O
3	O
,	O
P	O
=	O
0	O
.	O
016	O
)	O
were	O
associated	O
with	O
death	O
.	O

Both	O
viruses	O
establish	O
an	O
infection	O
in	O
porcine	O
enterocytes	B-ANAT
in	O
the	O
small	B-ANAT
intestine	I-ANAT
,	O
and	O
their	O
spike	O
(	O
S	O
)	O
proteins	O
play	O
a	O
key	O
role	O
in	O
the	O
virus	O
-	O
cell	B-ANAT
binding	O
process	O
under	O
unfavorable	O
conditions	O
when	O
the	O
intestine	B-ANAT
with	O
a	O
low	O
pH	O
is	O
filled	O
with	O
a	O
thick	O
layer	B-ANAT
of	O
mucus	B-ANAT
and	O
proteases	O
.	O

From	O
week	O
4	O
to	O
8	O
of	O
training	O
,	O
proper	O
neck	B-ANAT
extension	O
,	O
positive	O
pressure	O
ventilation	O
(	O
PPV	O
)	O
with	O
chest	B-ANAT
rise	O
,	O
and	O
assessment	O
of	O
heart	B-ANAT
rate	O
increased	O
by	O
14	O
%,	O
19	O
%,	O
and	O
12	O
%	O
respectively	O
(	O
all	O
p	O
â¤	O
0	O
.	O
01	O
).	O

TITLE	O
:	O
Novel	O
coronavirus	O
-	O
like	O
particles	O
targeting	O
cells	B-ANAT
lining	I-ANAT
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

In	O
this	O
study	O
we	O
describe	O
for	O
the	O
first	O
time	O
the	O
generation	O
of	O
HCoV	O
-	O
NL63	O
VLPs	B-ANAT
using	O
baculovirus	O
system	O
.	O

Major	O
structural	O
proteins	O
of	O
HCoV	O
-	O
NL63	O
have	O
been	O
expressed	O
in	O
tagged	O
or	O
native	O
form	O
,	O
and	O
their	O
assembly	O
to	O
form	O
VLPs	B-ANAT
was	O
evaluated	O
.	O

Additionally	O
,	O
a	O
novel	O
procedure	O
for	O
chromatography	O
purification	O
of	O
HCoV	O
-	O
NL63	O
VLPs	B-ANAT
was	O
developed	O
.	O

While	O
previously	O
implicated	O
in	O
a	O
non	O
-	O
inflammatory	O
apoptotic	O
cell	B-ANAT
death	O
pathway	O
,	O
here	O
we	O
extend	O
the	O
range	O
of	O
SARS	O
3a	O
pathophysiologic	O
targets	O
by	O
examining	O
its	O
effects	O
on	O
necrotic	O
cell	B-ANAT
death	O
pathways	O
.	O

We	O
show	O
that	O
SARS	O
3a	O
interacts	O
with	O
Receptor	O
Interacting	O
Protein	O
3	O
(	O
Rip3	O
),	O
which	O
augments	O
the	O
oligomerization	O
of	O
SARS	O
3a	O
helping	O
drive	O
necrotic	O
cell	B-ANAT
death	O
.	O

In	O
addition	O
,	O
by	O
inserting	O
into	O
lysosomal	B-ANAT
membranes	B-ANAT
SARS	O
3a	O
triggers	O
lysosomal	B-ANAT
damage	O
and	O
dysfunction	O
.	O

TITLE	O
:	O
DPP4	O
inhibition	O
by	O
sitagliptin	O
attenuates	O
LPS	O
-	O
induced	O
lung	B-ANAT
injury	O
in	O
mice	O
.	O

Several	O
reports	O
have	O
described	O
lung	B-ANAT
injury	O
caused	O
by	O
waterproofing	O
spray	O
inhalation	O
;	O
however	O
,	O
severe	O
cases	O
that	O
progress	O
to	O
ARDS	O
are	O
rare	O
.	O

Immediately	O
after	O
the	O
first	O
cerulein	O
injection	O
,	O
phosphate	O
-	O
buffered	O
saline	O
,	O
human	O
serum	B-ANAT
albumin	O
(	O
20	O
mg	O
/	O
kg	O
),	O
or	O
HRG	O
(	O
20	O
mg	O
/	O
kg	O
)	O
was	O
intravenously	O
injected	O
.	O

We	O
observed	O
significantly	O
decreased	O
plasma	B-ANAT
HRG	O
levels	O
in	O
an	O
acute	O
pancreatitis	O
mouse	O
model	O
.	O

Virus	O
entry	O
of	O
HCoV	O
-	O
229E	O
is	O
mediated	O
by	O
its	O
spike	O
(	O
S	O
)	O
protein	O
,	O
where	O
the	O
S1	O
domain	O
facilitates	O
attachment	O
to	O
host	O
cells	B-ANAT
and	O
the	O
S2	O
domain	O
is	O
involved	O
in	O
subsequent	O
fusion	O
of	O
the	O
virus	O
and	O
host	O
membranes	B-ANAT
.	O

We	O
hypothesized	O
that	O
HFO	O
strategies	O
aimed	O
at	O
averting	O
/	O
attenuating	O
hypercapnia	O
,	O
such	O
as	O
""""	O
low	O
-	O
frequency	O
""""	O
(	O
i	O
.	O
e	O
.,	O
4	O
Hz	O
)	O
HFO	O
and	O
4	O
-	O
Hz	O
HFO	O
with	O
tracheal	O
-	O
gas	O
insufflation	O
(	O
HFO	O
-	O
TGI	O
),	O
may	O
result	O
in	O
an	O
improved	O
RV	O
function	O
relative	O
to	O
""""	O
high	O
-	O
frequency	O
""""	O
(	O
i	O
.	O
e	O
.,	O
7	O
Hz	O
)	O
HFO	O
(	O
which	O
may	O
promote	O
hypercapnia	O
)	O
and	O
similar	O
RV	O
function	O
relative	O
to	O
lung	B-ANAT
protective	O
CV	O
.	O

ABSTRACT	O
:	O
Anti	O
-	O
synthetase	O
(	O
AS	O
)	O
and	O
dermato	O
-	O
pulmonary	B-ANAT
associated	O
with	O
anti	O
-	O
MDA	O
-	O
5	O
antibodies	O
(	O
aMDA	O
-	O
5	O
)	O
syndromes	O
are	O
near	O
one	O
of	O
the	O
other	O
autoimmune	O
inflammatory	O
myopathies	O
potentially	O
responsible	O
for	O
severe	O
acute	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
.	O

Seventeen	O
of	O
them	O
(	O
36	O
%)	O
had	O
no	O
extra	O
-	O
pulmonary	B-ANAT
manifestations	O
.	O

Forty	O
-	O
two	O
patients	O
(	O
89	O
%)	O
had	O
ARDS	O
,	O
which	O
was	O
severe	O
in	O
86	O
%,	O
with	O
a	O
rate	O
of	O
17	O
%	O
(	O
n	O
=	O
8	O
/	O
47	O
)	O
of	O
extra	O
-	O
corporeal	O
membrane	B-ANAT
oxygenation	O
requirement	O
.	O

TITLE	O
:	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
After	O
Uterine	B-ANAT
Artery	I-ANAT
Embolization	O
.	O

TITLE	O
:	O
Characterizing	O
replication	O
kinetics	O
and	O
plaque	O
production	O
of	O
type	O
I	O
feline	O
infectious	O
peritonitis	O
virus	O
in	O
three	O
feline	O
cell	B-ANAT
lines	I-ANAT
.	O

ABSTRACT	O
:	O
Investigating	O
type	O
I	O
feline	O
coronaviruses	O
(	O
FCoVs	O
)	O
in	O
tissue	B-ANAT
culture	O
is	O
critical	O
for	O
understanding	O
the	O
basic	O
virology	O
,	O
pathogenesis	O
,	O
and	O
virus	O
-	O
host	O
interactome	O
of	O
these	O
important	O
veterinary	O
pathogens	O
.	O

Here	O
we	O
characterize	O
replication	O
kinetics	O
and	O
plaque	O
formation	O
of	O
a	O
model	O
type	O
I	O
strain	O
FIPV	O
Black	O
in	O
Fcwf	O
-	O
4	O
cells	B-ANAT
established	O
at	O
Cornell	O
University	O
(	O
Fcwf	O
-	O
4	O
CU	O
).	O

ABSTRACT	O
:	O
In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
roles	O
of	O
interactions	O
among	O
the	O
poly	O
(	O
A	O
)	O
tail	O
,	O
coronavirus	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
,	O
and	O
poly	O
(	O
A	O
)-	O
binding	O
protein	O
(	O
PABP	O
)	O
in	O
the	O
regulation	O
of	O
coronavirus	O
gene	O
expression	O
.	O

Current	O
ongoing	O
trials	O
include	O
the	O
use	O
of	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
,	O
vitamin	O
C	O
,	O
re	O
-	O
evaluation	O
of	O
neuromuscular	O
blockade	O
,	O
and	O
extracorporeal	O
carbon	O
dioxide	O
removal	O
.	O

All	O
patients	O
completed	O
induction	O
therapy	O
with	O
addition	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
,	O
with	O
two	O
patients	O
dying	O
secondary	O
to	O
their	O
acute	O
leukemia	O
and	O
the	O
other	O
two	O
surviving	O
to	O
allogeneic	O
hematopoietic	B-ANAT
stem	I-ANAT
cell	I-ANAT
transplant	B-ANAT
.	O

The	O
position	O
of	O
the	O
drainage	B-ANAT
cannula	O
was	O
varied	O
among	O
the	O
right	B-ANAT
atrium	I-ANAT
,	O
the	O
upper	O
inferior	B-ANAT
vena	I-ANAT
cava	I-ANAT
,	O
and	O
the	O
lower	O
inferior	B-ANAT
vena	I-ANAT
cava	I-ANAT
,	O
whereas	O
the	O
position	O
of	O
the	O
return	O
cannula	O
was	O
fixed	B-ANAT
in	O
the	O
superior	B-ANAT
vena	I-ANAT
cava	I-ANAT
.	O

Small	B-ANAT
intestinal	I-ANAT
and	O
lung	B-ANAT
washings	O
were	O
collected	O
on	O
30th	O
and	O
47th	O
day	O
after	O
the	O
second	O
immunization	O
to	O
measure	O
PEDV	O
-	O
specific	O
IgA	O
levels	O
,	O
and	O
SP	O
immunohistochemical	O
method	O
staining	O
was	O
employed	O
to	O
analyze	O
the	O
deviations	O
of	O
IgA	O
+	O
positive	O
cells	B-ANAT
in	O
the	O
small	B-ANAT
intestinal	I-ANAT
of	O
the	O
immunized	O
mice	O
.	O

Moreover	O
,	O
our	O
findings	O
verified	O
the	O
significantly	O
enhanced	O
PEDV	O
-	O
specific	O
IgA	B-ANAT
antibody	I-ANAT
titers	O
in	O
small	B-ANAT
intestinal	I-ANAT
and	O
lung	B-ANAT
in	O
the	O
mice	O
immunized	O
with	O
PEDV	O
vaccine	O
and	O
CVC1303	O
.	O

In	O
this	O
study	O
,	O
the	O
antiviral	O
activity	O
of	O
a	O
cationic	O
amphibian	O
antimicrobial	O
peptide	O
Caerin1	O
.	O
1	O
against	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
was	O
evaluated	O
by	O
an	O
in	O
vitro	O
system	O
using	O
Vero	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Neurotropic	O
strains	O
of	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
)	O
induce	O
acute	O
inflammation	O
and	O
chronic	O
demyelination	O
in	O
the	O
spinal	B-ANAT
cord	I-ANAT
and	O
optic	B-ANAT
nerves	I-ANAT
mediated	O
by	O
axonal	O
spread	O
following	O
intracranial	B-ANAT
inoculation	O
in	O
mice	O
,	O
with	O
pathologic	O
features	O
similar	O
to	O
the	O
human	O
demyelinating	O
disease	O
multiple	O
sclerosis	O
.	O

These	O
studies	O
suggest	O
that	O
MHV	O
does	O
not	O
selectively	O
concentrate	O
in	O
optic	B-ANAT
nerve	I-ANAT
and	O
retina	B-ANAT
to	O
sufficient	O
levels	O
to	O
induce	O
demyelination	O
following	O
intranasal	O
inoculation	O
.	O

Its	O
use	O
in	O
patients	O
with	O
obstructive	O
pulmonary	B-ANAT
diseases	O
has	O
been	O
rare	O
since	O
obstructions	O
could	O
not	O
be	O
monitored	O
on	O
a	O
regional	O
level	O
at	O
the	O
bedside	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
impact	O
of	O
TGEV	O
infection	O
on	O
arginine	O
uptake	O
using	O
the	O
porcine	O
small	B-ANAT
intestinal	I-ANAT
epithelial	B-ANAT
cell	I-ANAT
line	O
IPEC	O
-	O
J2	O
as	O
a	O
model	O
system	O
.	O

TGEV	O
infection	O
induced	O
activation	O
of	O
phospho	O
-	O
protein	O
kinase	O
C	O
Î±	O
(	O
p	O
-	O
PKC	O
Î±	O
),	O
phospho	O
-	O
epidermal	B-ANAT
growth	O
factor	O
receptor	O
(	O
p	O
-	O
EGFR	O
),	O
and	O
enhanced	O
the	O
expression	O
of	O
caveolin	O
-	O
1	O
,	O
all	O
of	O
which	O
appear	O
to	O
be	O
involved	O
in	O
down	O
-	O
regulating	O
arginine	O
uptake	O
and	O
CAT	O
-	O
1	O
expression	O
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
virus	O
(	O
IAV	O
)	O
causes	O
severe	O
respiratory	O
infections	O
and	O
alveolar	B-ANAT
epithelial	O
damage	O
resulting	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

TITLE	O
:	O
Overexpression	O
of	O
the	O
nucleocapsid	B-ANAT
protein	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
up	O
-	O
regulates	O
CXCL10	O
.	O

TITLE	O
:	O
Oral	B-ANAT
administration	O
of	O
coated	O
PEDV	O
-	O
loaded	O
microspheres	O
elicited	O
PEDV	O
-	O
specific	O
immunity	O
in	O
weaned	O
piglets	O
.	O

Weaned	O
piglets	O
orally	B-ANAT
immunized	O
with	O
coated	O
PEDV	O
-	O
loaded	O
microspheres	O
developed	O
higher	O
levels	O
of	O
PEDV	O
-	O
specific	O
antibodies	O
(	O
IgG	O
and	O
IgA	O
)	O
in	O
their	O
sera	B-ANAT
and	O
saliva	B-ANAT
than	O
those	O
negative	O
control	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
or	O
p	O
<	O
0	O
.	O
01	O
).	O

Severe	O
respiratory	O
failure	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
may	O
present	O
with	O
refractory	O
hypoxemia	O
,	O
severe	O
respiratory	O
acidosis	O
,	O
or	O
elevated	O
plateau	O
airway	B-ANAT
pressures	O
despite	O
lung	B-ANAT
-	O
protective	O
ventilation	O
according	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
Network	O
protocol	O
.	O

TITLE	O
:	O
Burden	O
of	O
exposure	O
to	O
infectious	O
bursal	O
disease	O
virus	O
,	O
infectious	O
bronchitis	O
virus	O
,	O
Newcastle	O
disease	O
virus	O
,	O
Mycoplasma	O
gallisepticum	O
,	O
and	O
intestinal	B-ANAT
parasites	O
in	O
introduced	O
broiler	O
chickens	O
on	O
the	O
Galapagos	O
.	O

Prone	O
positioning	O
with	O
longer	O
duration	O
and	O
lung	B-ANAT
-	O
protective	O
strategies	O
might	O
reduce	O
the	O
mortality	O
level	O
in	O
ARDS	O
.	O

hDPP4	O
+/+	O
mice	O
were	O
unexpectedly	O
more	O
resistant	O
than	O
hDPP4	O
+/-	O
mice	O
to	O
MERS	O
-	O
CoV	O
infection	O
,	O
as	O
judged	O
by	O
increased	O
LD50	O
,	O
reduced	O
lung	B-ANAT
viral	O
infection	O
,	O
attenuated	O
morbidity	O
and	O
mortality	O
,	O
and	O
reduced	O
histopathology	O
.	O

Moreover	O
,	O
purified	O
lysosomal	B-ANAT
extracts	O
from	O
bat	O
cells	B-ANAT
cleave	O
cell	B-ANAT
surface	I-ANAT
-	O
expressed	O
coronavirus	O
spikes	O
more	O
efficiently	O
than	O
their	O
counterparts	O
from	O
human	O
cells	B-ANAT
.	O

Overall	O
,	O
our	O
study	O
suggests	O
that	O
different	O
lysosomal	B-ANAT
protease	O
activities	O
from	O
different	O
host	O
species	O
and	O
tissue	B-ANAT
cells	B-ANAT
are	O
an	O
important	O
determinant	O
of	O
the	O
species	O
and	O
tissue	B-ANAT
tropism	O
of	O
coronaviruses	O
.	O

Histopathological	O
and	O
immunohistochemical	O
analyses	O
of	O
the	O
cutaneous	O
nodule	O
revealed	O
pyogranulomatous	O
dermatitis	O
with	O
intralesional	O
macrophages	B-ANAT
laden	O
with	O
feline	O
coronavirus	O
(	O
FCoV	O
)	O
antigen	O
.	O

ORF	O
3a	O
is	O
predicted	O
to	O
contain	O
DNA	O
-	O
binding	O
and	O
transcription	O
activator	O
domains	O
,	O
and	O
it	O
is	O
localised	O
in	O
the	O
nucleus	B-ANAT
and	O
in	O
the	O
cytoplasm	B-ANAT
.	O

Both	O
type	O
I	O
and	O
II	O
FCoV	O
can	O
replicate	O
in	O
Felis	O
catus	O
whole	O
fetus	B-ANAT
(	O
fcwf	O
)-	O
4	O
cells	B-ANAT
,	O
but	O
the	O
replicability	O
of	O
type	O
I	O
FCoV	O
in	O
feline	O
cell	B-ANAT
lines	I-ANAT
is	O
lower	O
than	O
that	O
of	O
type	O
II	O
FCoV	O
,	O
the	O
reason	O
for	O
which	O
is	O
unclear	O
.	O

TITLE	O
:	O
Hepatopulmonary	O
syndrome	O
-	O
attributed	O
extreme	O
hypoxemia	O
and	O
polycythemia	O
revealing	O
liver	B-ANAT
cirrhosis	O
.	O

Since	O
pig	O
small	B-ANAT
intestinal	I-ANAT
epithelial	B-ANAT
cells	I-ANAT
(	O
IECs	O
)	O
are	O
target	B-ANAT
cells	I-ANAT
of	O
PEDV	O
infection	O
,	O
IEC	O
cells	B-ANAT
were	O
utilized	O
as	O
a	O
model	O
for	O
studying	O
changes	O
in	O
cellular	B-ANAT
activities	O
post	O
-	O
PEDV	O
infection	O
.	O

Chlordecone	O
also	O
accelerated	O
the	O
death	O
of	O
mice	O
infected	O
by	O
murine	O
hepatitis	O
virus	O
and	O
enhanced	O
the	O
entry	O
of	O
the	O
virus	O
into	O
the	O
cervical	B-ANAT
spinal	I-ANAT
cord	I-ANAT
in	O
infected	O
mice	O
,	O
leading	O
to	O
considerable	O
neurological	O
damage	O
.	O

We	O
tested	O
sera	B-ANAT
by	O
an	O
indirect	O
fluorescence	O
antibody	O
test	O
for	O
antibodies	O
to	O
canine	O
distemper	O
virus	O
(	O
CDV	O
),	O
canine	O
coronavirus	O
(	O
CCV	O
),	O
canine	O
parvovirus	O
type	O
2	O
(	O
CPV	O
-	O
2	O
),	O
canine	O
adenovirus	O
,	O
canine	O
parainfluenza	O
virus	O
type	O
2	O
(	O
CPIV	O
-	O
2	O
),	O
and	O
canine	O
herpesvirus	O
type	O
1	O
(	O
CHV	O
-	O
1	O
).	O

Both	O
patients	O
had	O
Coccidioides	O
immitis	O
cultured	O
from	O
respiratory	B-ANAT
samples	I-ANAT
.	O

We	O
compared	O
three	O
lung	B-ANAT
-	O
ultrasound	O
(	O
L	O
-	O
US	O
)	O
techniques	O
against	O
the	O
reference	O
-	O
standard	O
transpulmonary	O
thermodilution	O
(	O
TPTD	O
)	O
technique	O
to	O
access	O
EVLW	O
.	O

We	O
reviewed	O
epidemiologic	O
and	O
medical	O
chart	O
data	O
and	O
analyzed	O
viral	B-ANAT
genome	I-ANAT
sequences	O
from	O
respiratory	O
specimens	O
of	O
MERS	O
-	O
CoV	O
cases	O
.	O

In	O
early	O
2016	O
,	O
sera	B-ANAT
and	O
standardized	O
interviews	O
were	O
obtained	O
from	O
MERS	O
-	O
CoV	O
cases	O
and	O
their	O
contacts	O
.	O

Our	O
study	O
presents	O
clear	O
evidence	O
for	O
the	O
biological	O
importance	O
of	O
the	O
NMD	O
pathway	O
in	O
controlling	O
the	O
stability	O
of	O
mRNAs	O
and	O
the	O
efficiency	O
of	O
replication	O
of	O
a	O
cytoplasmic	B-ANAT
RNA	O
virus	O
.	O

As	O
compared	O
to	O
the	O
survival	O
group	O
,	O
the	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
,	O
serum	B-ANAT
bilirubin	O
,	O
aspartate	O
aminotransferase	O
,	O
alanine	O
aminotransferase	O
,	O
creatine	O
kinase	O
,	O
and	O
lactate	O
dehydrogenase	O
were	O
significantly	O
higher	O
,	O
and	O
serum	B-ANAT
albumin	O
levels	O
were	O
significantly	O
lower	O
in	O
patients	O
who	O
died	O
.	O

Independent	O
of	O
the	O
cell	B-ANAT
system	O
,	O
the	O
truncation	O
of	O
ORF8	O
(	O
29	O
nt	O
deletion	O
)	O
decreased	O
replication	O
up	O
to	O
23	O
-	O
fold	O
.	O

Of	O
the	O
camel	O
nasal	B-ANAT
swabs	O
,	O
22	O
were	O
found	O
to	O
be	O
positive	O
by	O
RT	O
-	O
qPCR	O
though	O
with	O
high	O
Ct	O
values	O
.	O

Moreover	O
,	O
2	O
,	O
409	O
human	O
serum	B-ANAT
samples	O
were	O
also	O
collected	O
from	O
four	O
provinces	O
of	O
Pakistan	O
during	O
2016	O
-	O
2017	O
.	O

Venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
or	O
standard	O
lung	B-ANAT
protective	O
ventilation	O
.	O

Last	O
,	O
the	O
PEDV	O
CV777	O
Vero	O
adapted	O
and	O
non	O
-	O
adapted	O
(	O
fecal	B-ANAT
suspension	O
)	O
strains	O
could	O
infect	O
co	O
-	O
cultured	O
ileocytes	O
but	O
not	O
colonocytes	O
.	O

ABSTRACT	O
:	O
The	O
alphacoronaviruses	O
,	O
transmissible	O
gastroenteritis	O
virus	O
(	O
TGEV	O
)	O
and	O
Porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
are	O
sources	O
of	O
high	O
morbidity	O
and	O
mortality	O
in	O
neonatal	O
pigs	O
,	O
a	O
consequence	O
of	O
dehydration	O
caused	O
by	O
the	O
infection	O
and	O
necrosis	O
of	O
enterocytes	B-ANAT
.	O

Immunohistochemistry	O
confirmed	O
the	O
presence	O
of	O
PEDV	O
reactivity	O
and	O
absence	O
of	O
TGEV	O
reactivity	O
in	O
the	O
enterocytes	B-ANAT
lining	O
the	O
ileum	B-ANAT
in	O
ANPEP	O
null	O
pigs	O
.	O

TITLE	O
:	O
Early	O
initiation	O
of	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
a	O
mechanically	O
ventilated	O
patient	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

ABSTRACT	O
:	O
A	O
49	O
-	O
year	O
-	O
old	O
man	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
acute	O
-	O
onset	O
dyspnoea	O
and	O
hypoxaemia	O
1	O
day	O
following	O
nasal	B-ANAT
surgery	O
for	O
obstructive	O
sleep	O
apnoea	O
.	O

Our	O
results	O
show	O
that	O
NF	O
-	O
ÎºB	O
was	O
activated	O
in	O
swine	O
testicular	O
(	O
ST	O
)	O
cells	B-ANAT
and	O
intestinal	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
lines	O
J2	O
(	O
IPEC	O
-	O
J2	O
)	O
cells	B-ANAT
infected	O
with	O
TGEV	O
,	O
which	O
is	O
consistent	O
with	O
the	O
up	O
-	O
regulation	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
.	O

Takotsubo	O
cardiomyopathy	O
(	O
TTC	O
),	O
which	O
is	O
typically	O
triggered	O
by	O
psychological	O
or	O
physical	O
stress	O
,	O
is	O
characterized	O
by	O
transient	O
myocardial	O
dysfunction	O
affecting	O
the	O
left	O
ventricular	B-ANAT
apex	O
.	O

Immunohistochemically	O
,	O
FIPV	O
antigens	O
were	O
detected	O
in	O
the	O
inflammatory	O
foci	O
of	O
the	O
leptomeninges	B-ANAT
,	O
choroid	B-ANAT
plexus	I-ANAT
and	O
ventricles	B-ANAT
in	O
3	O
of	O
the	O
4	O
cats	O
.	O

Individualized	O
vancomycin	O
dosing	O
regimens	O
and	O
therapeutic	O
drug	O
monitoring	O
are	O
necessary	O
for	O
critically	O
ill	O
patients	O
receiving	O
CVVH	O
and	O
ECMO	O
to	O
ensure	O
that	O
the	O
target	O
serum	B-ANAT
vancomycin	O
levels	O
are	O
reached	O
to	O
adequately	O
treat	O
the	O
infection	O
and	O
avoid	O
nephrotoxicity	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
a	O
patient	O
with	O
AIDS	O
successfully	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
:	O
a	O
case	O
report	O
and	O
literature	O
review	O
.	O

A	O
47	O
-	O
year	O
-	O
old	O
man	O
was	O
admitted	O
with	O
progressive	O
shortness	O
of	O
breath	B-ANAT
.	O

ABSTRACT	O
:	O
Previous	O
research	O
has	O
suggested	O
that	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
vvECMO	O
)	O
is	O
useful	O
for	O
patients	O
refractory	O
to	O
conventional	O
therapy	O
.	O

ABSTRACT	O
:	O
Most	O
indications	O
for	O
performing	O
echocardiography	O
focus	O
on	O
the	O
evaluation	O
of	O
properties	O
intrinsic	O
to	O
the	O
heart	B-ANAT
.	O

This	O
may	O
result	O
in	O
dilatation	O
of	O
the	O
right	B-ANAT
ventricle	I-ANAT
and	O
,	O
in	O
severe	O
cases	O
,	O
concomitant	O
early	O
diastolic	O
septal	O
collapse	O
into	O
the	O
left	B-ANAT
ventricle	I-ANAT
.	O

Positive	O
pressure	O
ventilation	O
affects	O
preload	O
,	O
afterload	O
,	O
and	O
compliance	O
of	O
both	O
ventricles	B-ANAT
.	O

Moreover	O
,	O
EC	O
-	O
specific	O
PHD2	O
inducible	O
knockout	O
mice	O
exhibit	O
improved	O
adherens	B-ANAT
junction	I-ANAT
integrity	O
and	O
endothelial	B-ANAT
barrier	O
function	O
.	O

Data	O
indicate	O
that	O
PHD2	O
depletion	O
prevents	O
the	O
formation	O
of	O
leaky	O
vessels	B-ANAT
and	O
edema	O
by	O
regulating	O
endothelial	B-ANAT
barrier	O
function	O
.	O

Here	O
,	O
we	O
tested	O
the	O
prediction	O
that	O
little	O
brown	O
bats	O
(	O
Myotis	O
lucifugus	O
)	O
co	O
-	O
infected	O
with	O
the	O
M	O
.	O
lucifugus	O
coronavirus	O
(	O
Myl	O
-	O
CoV	O
)	O
and	O
with	O
Pseudogymnoascus	O
destructans	O
(	O
Pd	O
),	O
the	O
fungus	O
that	O
causes	O
bat	O
white	O
-	O
nose	B-ANAT
syndrome	O
(	O
WNS	O
),	O
exhibit	O
different	O
disease	O
severity	O
,	O
viral	O
shedding	O
and	O
molecular	O
responses	O
than	O
bats	O
infected	O
with	O
only	O
Myl	O
-	O
CoV	O
or	O
only	O
P	O
.	O
destructans	O
.	O

Additionally	O
,	O
the	O
intestines	B-ANAT
of	O
bats	O
infected	O
with	O
fungus	O
exhibited	O
different	O
expression	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
pathway	O
and	O
cytokine	O
related	O
transcripts	O
,	O
irrespective	O
of	O
viral	O
presence	O
.	O

A	O
post	O
hoc	O
Bayesian	O
analysis	O
of	O
data	O
from	O
an	O
RCT	O
(	O
ECMO	O
to	O
Rescue	O
Lung	B-ANAT
Injury	O
in	O
Severe	O
ARDS	O
[	O
EOLIA	O
])	O
that	O
included	O
249	O
patients	O
with	O
very	O
severe	O
ARDS	O
who	O
had	O
been	O
randomized	O
to	O
receive	O
early	O
ECMO	O
(	O
n	O
=	O
124	O
;	O
mortality	O
at	O
60	O
days	O
,	O
35	O
%)	O
vs	O
initial	O
conventional	O
lung	B-ANAT
-	O
protective	O
ventilation	O
with	O
the	O
option	O
for	O
rescue	O
ECMO	O
(	O
n	O
=	O
125	O
,	O
mortality	O
at	O
60	O
days	O
,	O
46	O
%).	O

All	O
horses	O
maintained	O
total	O
white	B-ANAT
cell	I-ANAT
counts	O
within	O
normal	O
limits	O
,	O
but	O
3	O
horses	O
developed	O
transient	O
lymphopenia	O
.	O

Experimental	O
infection	O
of	O
adult	O
horses	O
with	O
ECoV	O
was	O
associated	O
with	O
mild	O
and	O
self	O
-	O
limiting	O
clinical	O
signs	O
,	O
transient	O
lymphopenia	O
,	O
and	O
fecal	B-ANAT
shedding	O
of	O
ECoV	O
,	O
which	O
mimics	O
natural	O
infection	O
.	O

These	O
results	O
demonstrate	O
that	O
rIBVs	O
are	O
able	O
to	O
express	O
S1	O
subunits	O
from	O
genetically	O
diverse	O
strains	O
of	O
IBV	O
,	O
which	O
will	O
enable	O
the	O
rational	O
design	O
of	O
a	O
future	O
generation	O
of	O
IBV	O
vaccines	O
that	O
may	O
be	O
grown	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
uses	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
to	O
recognize	O
and	O
enter	O
target	B-ANAT
cells	I-ANAT
.	O

The	O
evaluation	O
of	O
viral	O
nucleic	B-ANAT
acid	O
extraction	O
efficiency	O
is	O
different	O
between	O
NGS	O
and	O
qRT	O
-	O
PCR	O
analysis	O
.	O

ICU	O
mortality	O
(	O
25	O
%)	O
and	O
ICU	O
LOS	O
(	O
median	O
[	O
interquartile	O
range	O
],	O
5	O
[	O
2	O
-	O
12	O
]	O
days	O
)	O
were	O
not	O
different	O
when	O
stratified	O
by	O
ABO	O
blood	B-ANAT
type	O
(	O
ICU	O
mortality	O
,	O
overall	O
p	O
value	O
=	O
0	O
.	O
905	O
;	O
ICU	O
LOS	O
,	O
overall	O
p	O
value	O
=	O
0	O
.	O
609	O
).	O

QX	O
genotype	O
causes	O
permanent	O
damage	O
to	O
the	O
oviduct	B-ANAT
in	O
layer	B-ANAT
and	O
breeder	O
flock	O
if	O
it	O
occurs	O
in	O
the	O
early	O
life	O
cycle	O
.	O

Interestingly	O
,	O
high	O
titers	O
of	O
virus	O
-	O
neutralizing	O
antibodies	O
in	O
sera	B-ANAT
were	O
detected	O
at	O
21	O
DPI	O
.	O

The	O
individual	O
shedding	O
duration	O
of	O
PEDV	O
in	O
feces	B-ANAT
was	O
estimated	O
around	O
20	O
days	O
for	O
pigs	O
of	O
different	O
ages	O
.	O

ABSTRACT	O
:	O
Fibroproliferative	O
repair	O
phase	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
followed	O
by	O
a	O
restitutio	O
ad	O
integrum	O
of	O
lung	B-ANAT
parenchyma	I-ANAT
or	O
by	O
an	O
irreversible	O
lung	B-ANAT
fibrosis	O
and	O
patients	O
'	O
death	O
.	O

Neuromuscular	O
blocking	O
agents	O
(	O
NMBAs	O
)	O
have	O
been	O
prescribed	O
to	O
patients	O
with	O
ARDS	O
as	O
they	O
are	O
thought	O
to	O
decrease	O
inflammation	O
,	O
oxygen	O
consumption	O
,	O
and	O
cardiac	B-ANAT
output	O
and	O
help	O
facilitate	O
ventilator	O
synchrony	O
.	O

TITLE	O
:	O
Healthcare	O
workers	O
'	O
views	O
on	O
the	O
use	O
of	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
(	O
CPAP	O
)	O
in	O
neonates	O
:	O
a	O
qualitative	O
study	O
in	O
Andhra	O
Pradesh	O
,	O
India	O
.	O

Overexpression	O
of	O
S1	O
Spike	O
protein	O
of	O
PEDV	O
SM98	O
strain	O
effectively	O
induced	O
host	B-ANAT
cell	I-ANAT
apoptosis	O
,	O
while	O
the	O
expression	O
of	O
the	O
other	O
non	O
-	O
structure	O
proteins	O
(	O
Nsp1	O
-	O
16	O
)	O
and	O
structural	O
proteins	O
(	O
M	O
,	O
N	O
,	O
E	O
,	O
S2	O
and	O
ORF3	O
)	O
has	O
no	O
or	O
less	O
effect	O
on	O
cell	B-ANAT
apoptosis	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
the	O
S1	O
proteins	O
from	O
various	O
coronavirus	O
family	O
members	O
such	O
as	O
TGEV	O
,	O
IBV	O
,	O
CCoV	O
,	O
SARS	O
and	O
MERS	O
could	O
also	O
induce	O
Vero	O
-	O
E6	O
cells	B-ANAT
apoptosis	O
.	O

ATD	O
is	O
an	O
autosomal	B-ANAT
recessive	O
genetic	O
disorder	O
.	O

TITLE	O
:	O
Elevated	O
IL	O
-	O
33	O
promotes	O
expression	O
of	O
MMP2	O
and	O
MMP9	O
via	O
activating	O
STAT3	O
in	O
alveolar	B-ANAT
macrophages	I-ANAT
during	O
LPS	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
.	O

The	O
expression	O
and	O
secretion	B-ANAT
of	O
MMPs	O
were	O
respectively	O
detected	O
using	O
quantitative	O
PCR	O
,	O
Western	O
blotting	O
and	O
ELISA	O
assays	O
.	O

The	O
levels	O
of	O
IL	O
-	O
33	O
and	O
MMP2	O
/	O
9	O
in	O
BALF	O
increased	O
in	O
all	O
the	O
ALI	O
rats	O
with	O
severe	O
lung	B-ANAT
injury	O
.	O

The	O
IL	O
-	O
33	O
/	O
STAT3	O
/	O
MMP2	O
/	O
9	O
regulatory	O
pathway	O
is	O
activated	O
in	O
alveolar	B-ANAT
macrophages	I-ANAT
during	O
acute	O
lung	B-ANAT
injury	O
,	O
which	O
may	O
exacerbate	O
the	O
pulmonary	B-ANAT
inflammation	O
.	O

ABSTRACT	O
:	O
Central	B-ANAT
Nervous	I-ANAT
System	I-ANAT
(	O
CNS	B-ANAT
)	O
infections	O
are	O
one	O
of	O
the	O
most	O
critical	O
problems	O
in	O
public	O
health	O
,	O
as	O
frequently	O
patients	O
exhibit	O
neurologic	O
sequelae	O
.	O

To	O
study	O
the	O
effects	O
of	O
halogenated	O
agents	O
on	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
under	O
""""	O
physiologic	O
""""	O
conditions	O
,	O
we	O
describe	O
an	O
easy	O
system	O
to	O
culture	O
cells	B-ANAT
at	O
the	O
air	O
-	O
liquid	O
interface	O
and	O
expose	O
them	O
to	O
halogenated	O
agents	O
to	O
provide	O
precise	O
controlled	O
""""	O
air	O
""""	O
fractions	O
and	O
""""	O
medium	O
""""	O
concentrations	O
for	O
these	O
agents	O
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
analyzed	O
with	O
semiquantitative	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
tests	O
for	O
HCoV	O
subtypes	O
OC43	O
,	O
229E	O
,	O
NL63	O
,	O
and	O
HKU1	O
,	O
and	O
13	O
other	O
respiratory	O
pathogens	O
.	O

The	O
role	O
of	O
these	O
hormones	O
in	O
coordinating	O
maternal	O
immunotolerance	O
in	O
uterine	B-ANAT
tissue	B-ANAT
and	O
cellular	B-ANAT
subsets	O
has	O
been	O
well	O
researched	O
;	O
however	O
,	O
these	O
hormones	O
have	O
wide	O
-	O
ranging	O
effects	O
outside	O
the	O
uterus	B-ANAT
in	O
modulating	O
the	O
immune	O
response	O
to	O
disease	O
.	O

In	O
patients	O
who	O
present	O
with	O
severe	O
mycoplasma	O
pneumonia	O
with	O
respiratory	O
failure	O
,	O
nasal	B-ANAT
high	O
-	O
flow	O
oxygen	O
therapy	O
can	O
help	O
reduce	O
the	O
needs	O
for	O
ventilator	O
management	O
including	O
intubation	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
removal	O
of	O
carbon	O
dioxide	O
in	O
patients	O
experiencing	O
severe	O
hypercapnia	O
due	O
to	O
lung	B-ANAT
protective	O
mechanical	O
ventilation	O
was	O
first	O
described	O
over	O
four	O
decades	O
ago	O
.	O

Patients	O
with	O
chronic	O
renal	B-ANAT
impairment	O
represented	O
a	O
particularly	O
high	O
-	O
risk	O
group	O
that	O
should	O
receive	O
extra	O
caution	O
during	O
suspected	O
or	O
confirmed	O
MERS	O
cases	O
clinical	O
care	O
assignment	O
and	O
during	O
outbreaks	O
.	O

Wild	O
-	O
type	O
(	O
wt	O
)	O
and	O
RAG2	O
In	O
wt	O
mice	O
,	O
lung	B-ANAT
mechanics	O
,	O
body	B-ANAT
weight	O
and	O
body	B-ANAT
temperature	O
deteriorated	O
in	O
the	O
LPS	O
-	O
group	O
during	O
the	O
early	O
phase	O
(	O
up	O
to	O
d4	O
);	O
these	O
alterations	O
were	O
accompanied	O
by	O
increased	O
leukocyte	B-ANAT
numbers	O
and	O
inflammatory	O
cytokine	O
levels	O
in	O
the	O
BALF	O
.	O

The	O
compliance	O
rates	O
for	O
the	O
entire	O
3	O
-	O
h	O
bundle	O
,	O
measurement	O
of	O
central	O
venous	B-ANAT
pressure	O
,	O
and	O
assessment	O
of	O
central	O
venous	B-ANAT
oxygen	O
saturation	O
were	O
64	O
%,	O
26	O
%,	O
and	O
7	O
%,	O
respectively	O
.	O

Among	O
the	O
EBOVencoded	O
proteins	O
,	O
the	O
Viral	O
Proteins	O
35	O
(	O
VP35	O
)	O
and	O
24	O
(	O
VP24	O
)	O
are	O
responsible	O
for	O
the	O
EBOV	O
extreme	O
virulence	O
,	O
representing	O
the	O
core	O
of	O
such	O
inhibitory	O
function	O
through	O
which	O
EBOV	O
determines	O
its	O
very	O
effective	O
shield	O
to	O
the	O
cellular	B-ANAT
immune	O
defenses	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
lncRNA	O
expression	O
profiles	O
during	O
PEDV	O
infection	O
in	O
intestinal	B-ANAT
porcine	O
epithelial	B-ANAT
cell	I-ANAT
-	O
jejunum	B-ANAT
2	O
(	O
IPEC	O
-	O
J2	O
)	O
cell	B-ANAT
lines	I-ANAT
by	O
next	O
-	O
generation	O
sequencing	O
and	O
identified	O
6188	O
novel	O
lncRNAs	O
.	O

Both	O
strains	O
could	O
cause	O
severe	O
respiratory	O
distress	O
and	O
renal	B-ANAT
lesions	O
,	O
with	O
a	O
mortality	O
rate	O
were	O
approximately	O
20	O
%.	O

The	O
GD	O
strain	O
persisted	O
for	O
a	O
longer	O
duration	O
and	O
caused	O
extensive	O
damages	O
to	O
the	O
tracheas	B-ANAT
and	O
lungs	B-ANAT
.	O

Furthermore	O
,	O
exogenous	O
IFN	O
-	O
Î²	O
and	O
polyinosinic	O
-	O
polycytidylic	O
acid	O
(	O
poly	O
(	O
I	O
:	O
C	O
))	O
treatment	O
markedly	O
inhibited	O
the	O
mRNA	O
levels	O
of	O
TGEV	O
gRNA	O
,	O
N	O
and	O
ORF7	O
in	O
WT	O
PK	O
-	O
15	O
cells	B-ANAT
and	O
p53	O
-/-	O
PK	O
-	O
15	O
cells	B-ANAT
compared	O
to	O
control	O
.	O

An	O
empirical	O
systemic	O
anticoagulation	O
protocol	O
(	O
heparin	O
intravenous	O
infusion	O
)	O
was	O
initiated	O
when	O
autopsy	O
of	O
patients	O
with	O
severe	O
hypoxemia	O
confirmed	O
multiple	O
primary	O
pulmonary	B-ANAT
thrombi	O
and	O
emboli	O
.	O

Critically	O
ill	O
patients	O
with	O
H1N1	O
ARDS	O
have	O
increased	O
risk	O
of	O
venous	B-ANAT
thrombotic	O
complications	O
,	O
particularly	O
pulmonary	B-ANAT
thromboembolism	O
.	O

We	O
performed	O
chi	O
-	O
square	O
feature	O
selection	O
and	O
identified	O
the	O
top	O
20	O
keywords	O
that	O
were	O
most	O
unique	O
to	O
each	O
corpus	B-ANAT
.	O

TITLE	O
:	O
Muse	O
Cells	B-ANAT
and	O
Ischemia	O
-	O
Reperfusion	O
Lung	B-ANAT
Injury	O
.	O

TITLE	O
:	O
Outcomes	O
of	O
Patients	O
Presenting	O
with	O
Mild	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
Insights	O
from	O
the	O
LUNG	B-ANAT
SAFE	O
Study	O
.	O

This	O
study	O
analyzed	O
patients	O
from	O
the	O
international	O
prospective	O
Large	O
Observational	O
Study	O
to	O
Understand	O
the	O
Global	O
Impact	O
of	O
Severe	O
Acute	O
Respiratory	O
Failure	O
(	O
LUNG	B-ANAT
SAFE	O
)	O
who	O
had	O
initial	O
mild	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
the	O
first	O
day	O
of	O
inclusion	O
.	O

On	O
the	O
outer	O
surface	O
,	O
virus	O
has	O
spike	O
like	O
glycoprotein	O
which	O
is	O
responsible	O
for	O
the	O
attachment	O
and	O
entrance	O
inside	O
host	O
cells	B-ANAT
.	O

in	O
any	O
tissue	B-ANAT
by	O
IHC	O
.	O

TITLE	O
:	O
A	O
Single	O
-	O
Step	O
Gold	O
Nanoparticle	O
-	O
Blood	B-ANAT
Serum	I-ANAT
Interaction	O
Assay	O
Reveals	O
Humoral	O
Immunity	O
Development	O
and	O
Immune	O
Status	O
of	O
Animals	O
from	O
Neonates	O
to	O
Adults	O
.	O

TITLE	O
:	O
Risk	O
factors	O
and	O
the	O
associated	O
limit	O
values	O
for	O
abnormal	O
elevation	O
of	O
extravascular	O
lung	B-ANAT
water	O
in	O
severely	O
burned	O
adults	O
.	O

The	O
extravascular	O
lung	B-ANAT
water	O
index	O
(	O
EVLWI	O
),	O
which	O
reflects	O
the	O
degree	O
of	O
EVLW	O
in	O
an	O
individual	O
,	O
increases	O
in	O
the	O
fluid	O
reabsorption	O
stage	O
rather	O
than	O
the	O
initial	O
resuscitation	O
stage	O
in	O
severe	O
burn	O
cases	O
.	O

Demographic	O
data	O
were	O
collected	O
,	O
and	O
transpulmonary	O
thermodilution	O
(	O
TPTD	O
)	O
measurements	O
and	O
blood	B-ANAT
biochemistry	O
tests	O
were	O
performed	O
upon	O
admission	O
and	O
up	O
to	O
day	O
(	O
PBD	O
)	O
9	O
.	O

The	O
limit	O
values	O
for	O
predicting	O
a	O
supranormal	O
EVLWI	O
in	O
those	O
patients	O
are	O
65	O
.	O
5	O
%	O
TBSA	O
for	O
burn	O
size	O
and	O
845ml	O
/	O
m	O
METHODS	O
:	O
This	O
prospective	O
,	O
single	O
-	O
center	O
study	O
included	O
only	O
adults	O
with	O
burn	O
sizes	O
â¥	O
50	O
%	O
of	O
the	O
total	B-ANAT
body	I-ANAT
surface	I-ANAT
area	O
(	O
TBSA	O
)	O
who	O
were	O
admitted	O
within	O
24h	O
after	O
burn	O
.	O

Tripartite	O
motif	O
8	O
(	O
TRIM8	O
)	O
contains	O
an	O
N	O
-	O
terminal	O
RING	B-ANAT
finger	I-ANAT
,	O
which	O
is	O
followed	O
by	O
two	O
B	O
-	O
boxes	O
and	O
a	O
coiled	O
-	O
coil	O
domain	O
,	O
belonging	O
to	O
the	O
TRIM	O
/	O
RBCC	O
family	O
and	O
playing	O
significant	O
role	O
in	O
meditating	O
inflammation	O
,	O
oxidative	O
stress	O
and	O
apoptosis	O
.	O

His	O
delivery	O
was	O
complicated	O
by	O
the	O
breech	O
presentation	O
with	O
difficult	O
head	B-ANAT
extraction	O
.	O

TITLE	O
:	O
Replication	O
of	O
MERS	O
and	O
SARS	O
coronaviruses	O
in	O
bat	O
cells	B-ANAT
offers	O
insights	O
to	O
their	O
ancestral	O
origins	O
.	O

After	O
chest	B-ANAT
X	O
-	O
ray	O
and	O
diagnostic	O
bronchoscopy	O
,	O
she	O
was	O
diagnosed	O
with	O
diffuse	O
alveolar	B-ANAT
hemorrhage	O
.	O

Arterial	B-ANAT
blood	I-ANAT
gases	O
were	O
drawn	O
to	O
verify	O
the	O
PaO2	O
and	O
the	O
SpO2	O
/	O
SaO2	O
correlation	O
.	O

RESULTS	O
:	O
Experiment	O
1	O
showed	O
that	O
the	O
O2	O
bolus	O
injected	O
into	O
the	O
ventilator	O
circuit	O
300	O
ms	O
before	O
breath	B-ANAT
delivery	O
produced	O
the	O
highest	O
PaO2	O
.	O

Both	O
the	O
CTL	B-ANAT
and	O
HTL	O
MEVs	O
molecular	O
models	O
have	O
shown	O
to	O
have	O
stable	O
binding	O
and	O
complex	O
formation	O
propensity	O
with	O
toll	O
-	O
like	O
receptor	O
3	O
.	O

TITLE	O
:	O
Point	O
-	O
of	O
-	O
care	O
lung	B-ANAT
ultrasound	O
for	O
the	O
detection	O
of	O
pulmonary	B-ANAT
manifestations	O
of	O
malaria	O
and	O
sepsis	O
:	O
An	O
observational	O
study	O
.	O

ABSTRACT	O
:	O
Single	O
photon	O
emission	B-ANAT
computed	O
tomography	O
(	O
SPECT	O
)	O
is	O
frequently	O
used	O
in	O
oncology	O
and	O
cardiology	O
to	O
evaluate	O
disease	O
progression	O
and	O
/	O
or	O
treatment	O
efficacy	O
.	O

We	O
report	O
a	O
case	O
of	O
acute	O
severe	O
left	O
ventricular	B-ANAT
dysfunction	O
in	O
a	O
pregnant	O
woman	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
on	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
managed	O
with	O
short	O
-	O
term	O
IV	O
T3	O
.	O

TITLE	O
:	O
Undiagnosed	O
hypertrophic	O
obstructive	O
cardiomyopathy	O
during	O
transcatheter	O
aortic	B-ANAT
valve	I-ANAT
replacement	O
:	O
a	O
case	O
report	O
.	O

Intraoperative	O
transesophageal	O
echocardiography	O
was	O
performed	O
and	O
hypertrophic	O
obstructive	O
cardiomyopathy	O
with	O
systolic	O
anterior	O
motion	O
of	O
the	O
mitral	B-ANAT
valve	I-ANAT
was	O
discovered	O
as	O
an	O
underlying	O
pathology	O
,	O
undetected	O
on	O
preoperative	O
imaging	O
.	O

This	O
review	O
will	O
provide	O
a	O
comprehensive	O
outline	O
of	O
the	O
cytokine	O
-	O
mediated	O
exacerbation	O
of	O
disease	O
and	O
tissue	B-ANAT
damage	O
in	O
NHP	O
models	O
of	O
viral	O
infections	O
and	O
therapeutic	O
strategies	O
that	O
can	O
aid	O
in	O
prevention	O
/	O
treatment	O
of	O
the	O
disease	O
syndromes	O
.	O

TITLE	O
:	O
Muscle	B-ANAT
weakness	O
associated	O
with	O
H7N9	O
infection	O
:	O
report	O
of	O
two	O
cases	O
.	O

Where	O
conventional	O
ventilator	O
maneuvers	O
may	O
prove	O
ineffective	O
,	O
the	O
implementation	O
of	O
VV	O
-	O
ECMO	O
should	O
be	O
considered	O
as	O
a	O
therapeutic	O
option	O
in	O
limited	O
,	O
short	O
-	O
lived	O
acute	O
pulmonary	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
Several	O
viruses	O
cause	O
pulmonary	B-ANAT
infections	O
due	O
to	O
their	O
shared	O
tropism	O
with	O
cells	B-ANAT
of	O
the	O
respiratory	B-ANAT
tract	I-ANAT
.	O

Several	O
nucleic	B-ANAT
acid	O
-	O
based	O
technologies	O
such	O
as	O
short	O
interfering	O
RNAs	O
(	O
siRNA	O
),	O
antisense	O
oligonucleotides	O
,	O
aptamers	O
,	O
deoxyribozymes	O
(	O
DNAzymes	O
),	O
and	O
ribozymes	O
have	O
been	O
studied	O
and	O
used	O
against	O
management	O
of	O
respiratory	O
viruses	O
.	O

Flail	O
chest	B-ANAT
was	O
defined	O
as	O
segment	O
fracture	O
of	O
at	O
least	O
three	O
consecutive	O
ribs	B-ANAT
on	O
at	O
least	O
one	O
side	O
.	O

Flail	O
chest	B-ANAT
had	O
no	O
independent	O
influence	O
in	O
addition	O
to	O
injury	O
severity	O
on	O
post	O
-	O
traumatic	O
morbidity	O
and	O
mortality	O
in	O
multiply	O
injured	O
patients	O
with	O
blunt	O
thoracic	B-ANAT
trauma	O
.	O

Seroepidemiologic	O
studies	O
have	O
found	O
that	O
the	O
serum	B-ANAT
of	O
nearly	O
everyone	O
older	O
than	O
2	O
to	O
5	O
years	O
contains	O
anti	O
-	O
EV	O
-	O
D68	O
neutralizing	O
antibodies	O
,	O
which	O
suggests	O
that	O
EV	O
-	O
D68	O
is	O
a	O
ubiquitous	O
pathogen	O
of	O
childhood	O
.	O

Moreover	O
,	O
The	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHE	O
II	O
),	O
CT	O
severity	O
index	O
(	O
CTSI	O
),	O
multiple	O
organ	B-ANAT
failure	O
(	O
MOF	O
)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
incidence	O
,	O
mortality	O
and	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
),	O
white	B-ANAT
blood	I-ANAT
cell	I-ANAT
count	O
(	O
WBC	B-ANAT
),	O
procalcitonin	O
(	O
PCT	O
)	O
and	O
immature	O
granulocytes	B-ANAT
in	O
persistent	O
SIRS	O
group	O
were	O
further	O
higher	O
than	O
those	O
in	O
the	O
temporary	O
SIRS	O
group	O
[	O
APACHE	O
II	O
:	O
9	O
(	O
6	O
,	O
12	O
)	O
vs	O
.	O
5	O
(	O
3	O
,	O
7	O
),	O
CTSI	O
:	O
6	O
(	O
4	O
,	O
6	O
)	O
vs	O
.	O
4	O
(	O
3	O
,	O
6	O
),	O
MOF	O
incidence	O
:	O
92	O
.	O
0	O
%	O
vs	O
.	O
32	O
.	O
8	O
%,	O
ARDS	O
incidence	O
:	O
39	O
.	O
9	O
%	O
vs	O
.	O
10	O
.	O
1	O
%,	O
morbidity	O
:	O
11	O
.	O
1	O
%	O
vs	O
.	O
4	O
.	O
2	O
%,	O
CRP	O
(	O
mg	O
/	O
L	O
):	O
25	O
.	O
00	O
(	O
0	O
.	O
80	O
,	O
212	O
.	O
25	O
)	O
vs	O
.	O
0	O
.	O
80	O
(	O
0	O
.	O
80	O
,	O
123	O
.	O
50	O
),	O
WBC	B-ANAT
(Ã	O
10	O
Immature	B-ANAT
granulocyte	I-ANAT
in	O
peripheral	B-ANAT
blood	I-ANAT
is	O
a	O
potential	O
indicator	O
for	O
persistent	O
SIRS	O
in	O
AP	O
patients	O
.	O

ABSTRACT	O
:	O
PEDV	O
is	O
mainly	O
transmitted	O
by	O
the	O
oro	O
-	O
fecal	B-ANAT
route	O
although	O
PEDV	O
shedding	O
in	O
semen	B-ANAT
has	O
already	O
been	O
shown	O
for	O
an	O
S	O
-	O
non	O
-	O
InDel	O
PEDV	O
strain	O
infection	O
.	O

Additionally	O
,	O
viral	O
replication	O
was	O
compared	O
in	O
Vero	O
and	O
IPEC	O
-	O
DQ	O
cells	B-ANAT
at	O
the	O
presence	O
of	O
bovine	O
mucin	O
(	O
BM	O
),	O
porcine	O
gastric	B-ANAT
mucin	O
(	O
PGM	O
),	O
swine	O
bile	B-ANAT
and	O
bile	B-ANAT
acids	O
during	O
inoculation	O
.	O

Twenty	O
-	O
four	O
conventional	O
5	O
-	O
day	O
-	O
old	O
suckling	O
piglets	O
were	O
randomly	O
divided	O
into	O
four	O
groups	O
and	O
were	O
inoculated	O
orally	B-ANAT
,	O
intranasally	O
(	O
I	O
.	O
N	O
.),	O
intramuscularly	O
(	O
I	O
.	O
M	O
.)	O
with	O
PEDV	O
or	O
DMEM	O
(	O
mock	O
).	O

Blood	B-ANAT
samples	I-ANAT
were	O
collected	O
at	O
7	O
,	O
14	O
,	O
21	O
days	O
post	O
infection	O
(	O
dpi	O
)	O
and	O
subjected	O
for	O
the	O
analyses	O
of	O
serum	B-ANAT
antibody	O
production	O
,	O
T	B-ANAT
cell	I-ANAT
and	O
natural	O
killer	O
(	O
NK	O
)	O
cell	B-ANAT
frequencies	O
,	O
NK	O
cytotoxicity	O
and	O
serum	B-ANAT
cytokine	O
levels	O
.	O

Serum	B-ANAT
IL	O
-	O
10	O
levels	O
were	O
induced	O
drastically	O
in	O
orally	B-ANAT
infected	O
pigs	O
at	O
7	O
dpi	O
and	O
then	O
gradually	O
declined	O
.	O

Serum	B-ANAT
IL	O
-	O
12	O
levels	O
followed	O
a	O
similar	O
pattern	O
while	O
the	O
fold	O
-	O
change	O
was	O
much	O
lower	O
.	O

The	O
patient	O
arrived	O
there	O
on	O
August	O
16	O
,	O
2018	O
,	O
developed	O
watery	O
diarrhea	O
on	O
August	O
28	O
(	O
day	O
0	O
),	O
and	O
came	O
back	B-ANAT
to	O
Korea	O
on	O
September	O
7	O
(	O
day	O
10	O
)	O
as	O
his	O
condition	O
worsened	O
.	O

The	O
etiology	O
of	O
the	O
pulmonary	B-ANAT
complications	O
is	O
complex	O
,	O
as	O
these	O
are	O
caused	O
by	O
the	O
agents	O
that	O
induced	O
the	O
acute	O
kidney	B-ANAT
injury	O
in	O
the	O
first	O
place	O
,	O
most	O
frequently	O
by	O
septic	O
shock	O
.	O

Multivariate	O
analysis	O
identified	O
low	O
blood	B-ANAT
pH	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
6	O
.	O
580	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1	O
.	O
12	O
-	O
38	O
.	O
51	O
),	O
high	O
serum	B-ANAT
lactate	O
level	O
(	O
OR	O
1	O
.	O
041	O
,	O
95	O
%	O
CI	O
1	O
.	O
01	O
-	O
1	O
.	O
07	O
),	O
high	O
ISS	O
(	O
OR	O
1	O
.	O
109	O
,	O
95	O
%	O
CI	O
1	O
.	O
06	O
-	O
1	O
.	O
16	O
),	O
high	O
APACHE	O
II	O
score	O
(	O
OR	O
1	O
.	O
189	O
,	O
95	O
%	O
CI	O
1	O
.	O
07	O
-	O
1	O
.	O
33	O
),	O
traumatic	O
brain	B-ANAT
injury	O
(	O
TBI	O
)	O
(	O
OR	O
4	O
.	O
358	O
,	O
95	O
%	O
CI	O
0	O
.	O
76	O
-	O
24	O
.	O
86	O
),	O
severe	O
hemorrhage	O
(	O
OR	O
5	O
.	O
314	O
,	O
95	O
%	O
CI	O
1	O
.	O
07	O
-	O
26	O
.	O
49	O
),	O
and	O
coagulopathy	O
(	O
OR	O
5	O
.	O
916	O
,	O
95	O
%	O
CI	O
1	O
.	O
17	O
-	O
29	O
.	O
90	O
)	O
as	O
useful	O
predictors	O
of	O
acute	O
in	O
-	O
hospital	O
mortality	O
.	O

High	O
ISS	O
(	O
OR	O
1	O
.	O
047	O
,	O
95	O
%	O
CI	O
1	O
.	O
02	O
-	O
1	O
.	O
08	O
),	O
TBI	O
(	O
OR	O
8	O
.	O
922	O
,	O
95	O
%	O
CI	O
2	O
.	O
57	O
-	O
31	O
.	O
00	O
),	O
sepsis	O
(	O
OR	O
4	O
.	O
956	O
,	O
95	O
%	O
CI	O
1	O
.	O
99	O
-	O
12	O
.	O
36	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
(	O
OR	O
8	O
.	O
036	O
,	O
95	O
%	O
CI	O
1	O
.	O
85	O
-	O
34	O
.	O
84	O
),	O
respiratory	O
failure	O
(	O
OR	O
9	O
.	O
630	O
,	O
95	O
%	O
CI	O
2	O
.	O
64	O
-	O
35	O
.	O
14	O
),	O
renal	B-ANAT
failure	O
(	O
OR	O
74	O
.	O
803	O
,	O
95	O
%	O
CI	O
11	O
.	O
34	O
-	O
493	O
.	O
43	O
),	O
and	O
multiple	O
organ	B-ANAT
failure	O
[	O
MOF	O
]	O
(	O
OR	O
10	O
.	O
415	O
,	O
95	O
%	O
CI	O
4	O
.	O
48	O
-	O
24	O
.	O
24	O
)	O
were	O
risk	O
factors	O
for	O
late	O
in	O
-	O
hospital	O
mortality	O
.	O

TITLE	O
:	O
Alterations	O
in	O
sialic	O
-	O
acid	O
O	O
-	O
acetylation	O
glycoforms	O
during	O
murine	O
erythrocyte	B-ANAT
development	O
.	O

The	O
sialic	O
acid	O
glyco	O
-	O
epitope	O
recognized	O
by	O
TER	B-ANAT
-	O
119	O
on	O
erythrocytes	B-ANAT
was	O
sensitive	O
to	O
the	O
sialic	O
acid	O
O	O
-	O
acetyl	O
esterase	O
activity	O
of	O
the	O
hemagglutinin	O
-	O
esterase	O
from	O
bovine	O
coronavirus	O
but	O
not	O
to	O
the	O
corresponding	O
enzyme	O
from	O
the	O
influenza	O
C	O
virus	O
.	O

As	O
erythrocytes	B-ANAT
mature	O
,	O
the	O
surfaces	O
of	O
Ery	O
-	O
C	O
cells	B-ANAT
and	O
mature	O
erythrocytes	B-ANAT
also	O
acquire	O
an	O
additional	O
distinct	O
CASD1	O
-	O
dependent	O
9	O
-	O
O	O
-	O
acetyl	O
sialic	O
acid	O
moiety	O
that	O
can	O
be	O
recognized	O
by	O
virolectins	O
from	O
both	O
influenza	O
C	O
and	O
bovine	O
coronavirus	O
.	O

By	O
using	O
chemical	O
inhibitors	O
,	O
RNA	O
interference	O
,	O
and	O
dominant	O
negative	O
mutants	O
,	O
we	O
observed	O
that	O
lipid	B-ANAT
rafts	I-ANAT
and	O
low	O
pH	O
was	O
indeed	O
required	O
for	O
virus	O
entry	O
;	O
IBV	O
mainly	O
utilized	O
the	O
clathrin	O
mediated	O
endocytosis	O
(	O
CME	O
)	O
for	O
entry	O
;	O
GTPase	O
dynamin	O
1	O
was	O
involved	O
in	O
virus	O
containing	O
vesicle	B-ANAT
scission	O
;	O
and	O
the	O
penetration	O
of	O
IBV	O
into	O
cells	B-ANAT
led	O
to	O
active	O
cytoskeleton	B-ANAT
rearrangement	O
.	O

in	O
late	B-ANAT
endosome	I-ANAT
/	O
lysosome	B-ANAT
.	O

Our	O
patient	O
is	O
a	O
56	O
-	O
year	O
-	O
old	O
Caucasian	O
male	O
with	O
a	O
recent	O
diagnosis	O
of	O
grade	O
2	O
-	O
3a	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
who	O
presented	O
to	O
our	O
emergency	O
department	O
with	O
shortness	O
of	O
breath	B-ANAT
and	O
dark	O
discoloration	O
of	O
urine	B-ANAT
.	O

On	O
further	O
evaluation	O
,	O
patient	O
was	O
found	O
to	O
have	O
severe	O
anemia	O
with	O
hemolytic	O
picture	O
,	O
hyperkalemia	O
and	O
acute	O
kidney	B-ANAT
injury	O
.	O

He	O
also	O
had	O
a	O
discrepancy	O
of	O
the	O
transcutaneous	O
saturation	O
(	O
75	O
%)	O
and	O
the	O
saturation	O
in	O
an	O
arterial	B-ANAT
blood	I-ANAT
gas	O
value	O
(	O
99	O
%).	O

He	O
was	O
also	O
given	O
vitamin	O
C	O
and	O
8	O
units	O
of	O
packed	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
throughout	O
his	O
stay	O
in	O
the	O
hospital	O
.	O

Patient	O
'	O
s	O
hospital	O
course	O
was	O
complicated	O
by	O
ARDS	O
needed	O
to	O
be	O
on	O
mechanical	O
ventilation	O
support	O
for	O
4	O
days	O
and	O
acute	O
renal	B-ANAT
failure	O
secondary	O
to	O
pigment	O
nephropathy	O
and	O
acute	O
tubular	O
necrosis	O
which	O
required	O
a	O
hemodialysis	O
support	O
.	O

However	O
,	O
the	O
main	O
clinical	O
devastating	O
effects	O
are	O
caused	O
by	O
endothelial	B-ANAT
dysfunction	O
,	O
thought	O
to	O
be	O
the	O
main	O
mechanism	O
leading	O
to	O
pulmonary	B-ANAT
oedema	O
,	O
respiratory	O
failure	O
and	O
cardiovascular	B-ANAT
collapse	O
.	O

TITLE	O
:	O
Extra	O
corporeal	O
membrane	B-ANAT
oxygenation	O
in	O
the	O
critical	O
trauma	O
patient	O
.	O

ECMO	O
can	O
be	O
considered	O
as	O
a	O
safe	O
rescue	O
therapy	O
even	O
in	O
trauma	O
patients	O
,	O
including	O
neurological	O
injury	O
,	O
chest	B-ANAT
trauma	O
as	O
well	O
as	O
burns	O
.	O

TITLE	O
:	O
Volumetric	O
but	O
Not	O
Time	O
Capnography	O
Detects	O
Ventilation	O
/	O
Perfusion	O
Mismatch	O
in	O
Injured	O
Rabbit	O
Lung	B-ANAT
.	O

In	O
high	O
-	O
risk	O
patients	O
,	O
pre	O
-	O
emptive	O
treatment	O
with	O
antivirals	O
for	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
URTI	O
)	O
to	O
decrease	O
progression	O
to	O
LRTI	O
is	O
a	O
common	O
strategy	O
.	O

Heterozygous	O
deletion	O
of	O
Poldip2	O
was	O
found	O
to	O
reduce	O
LPS	O
-	O
induced	O
mortality	O
within	O
20	O
h	O
,	O
lung	B-ANAT
inflammatory	O
signaling	O
,	O
and	O
leukocyte	B-ANAT
infiltration	O
.	O

TITLE	O
:	O
Depletion	O
of	O
RIPK1	O
in	O
hepatocytes	B-ANAT
exacerbates	O
liver	B-ANAT
damage	O
in	O
fulminant	O
viral	O
hepatitis	O
.	O

ABSTRACT	O
:	O
The	O
protein	O
kinase	O
RIPK1	O
plays	O
a	O
crucial	O
role	O
at	O
the	O
crossroad	O
of	O
stress	O
-	O
induced	O
signaling	O
pathways	O
that	O
affects	O
cell	B-ANAT
'	O
s	O
decision	O
to	O
live	O
or	O
die	O
.	O

In	O
this	O
study	O
,	O
we	O
applied	O
site	O
-	O
specific	O
editing	O
pAPN	O
which	O
is	O
effective	O
in	O
swine	O
testis	B-ANAT
(	O
ST	O
)	O
cells	B-ANAT
.	O

We	O
studied	O
1	O
,	O
200	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
managed	O
with	O
lung	B-ANAT
-	O
protective	O
ventilation	O
.	O

The	O
primary	O
outcome	O
we	O
evaluated	O
was	O
postpartum	O
hemorrhage	O
(	O
defined	O
as	O
a	O
loss	O
of	O
>	O
500	O
ml	O
following	O
a	O
vaginal	B-ANAT
delivery	O
or	O
>	O
1000	O
ml	O
after	O
cesarean	O
section	O
)	O
or	O
maternal	O
and	O
neonatal	O
morbidity	O
and	O
mortality	O
.	O

Only	O
one	O
woman	O
required	O
platelet	B-ANAT
transfusion	O
.	O

On	O
day	O
5	O
or	O
7	O
postinoculation	O
,	O
lungs	B-ANAT
of	O
adult	O
Tg	O
mice	O
contained	O
higher	O
levels	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
associated	O
with	O
migration	O
of	O
macrophages	B-ANAT
.	O

At	O
discharge	B-ANAT
,	O
major	O
improvements	O
were	O
observed	O
for	O
upper	B-ANAT
limb	I-ANAT
activities	O
.	O

ABSTRACT	O
:	O
Viruses	O
are	O
obligate	O
intracellular	B-ANAT
microbes	O
that	O
exploit	O
the	O
host	O
metabolic	O
machineries	O
to	O
meet	O
their	O
biosynthetic	O
demands	O
,	O
making	O
these	O
host	O
pathways	O
potential	O
therapeutic	O
targets	O
.	O

The	O
mechanism	O
of	O
Griffithsin	O
'	O
s	O
action	O
against	O
PEDV	O
involved	O
both	O
preventing	O
viral	O
attachment	O
to	O
host	O
cells	B-ANAT
and	O
disrupting	O
cell	B-ANAT
-	O
to	O
-	O
cell	B-ANAT
transmission	O
;	O
its	O
dual	O
mode	O
of	O
action	O
distinguished	O
Griffithsin	O
from	O
most	O
other	O
antiviral	O
drugs	O
.	O

The	O
VP7	O
protein	O
is	O
the	O
main	O
coat	B-ANAT
protein	O
of	O
PoRV	O
,	O
and	O
the	O
S	O
protein	O
is	O
the	O
main	O
structural	O
protein	O
of	O
PEDV	O
,	O
which	O
are	O
capable	O
of	O
inducing	O
neutralizing	O
antibodies	O
in	O
vivo	O
.	O

Electrophysiological	O
studies	O
were	O
completed	O
in	O
57	O
;	O
of	O
whom	O
20	O
had	O
acute	O
inflammatory	O
demyelinating	O
polyneuropathy	O
(	O
AIDP	O
);	O
19	O
had	O
acute	O
motor	O
axonal	O
neuropathy	O
(	O
AMAN	O
);	O
12	O
had	O
non	O
-	O
reactive	O
nerves	B-ANAT
;	O
five	O
were	O
unclassifiable	O
;	O
1	O
had	O
acute	O
motor	O
sensory	O
axonal	O
neuropathy	O
(	O
AMSAN	O
).	O

We	O
investigated	O
the	O
impact	O
of	O
tidal	O
volume	O
on	O
mortality	O
and	O
probability	O
of	O
extubation	O
in	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
using	O
ideal	O
body	B-ANAT
weight	O
-	O
adjusted	O
tidal	O
volume	O
.	O

Tidal	O
volume	O
was	O
calculated	O
based	O
on	O
actual	O
body	B-ANAT
weight	O
and	O
two	O
different	O
formulations	O
of	O
ideal	O
body	B-ANAT
weight	O
.	O

We	O
comparatively	O
evaluated	O
the	O
antigenicity	O
,	O
pathogenicity	O
,	O
and	O
affinity	O
of	O
the	O
four	O
recombinant	O
viruses	O
and	O
their	O
deduced	O
parental	O
strains	O
in	O
the	O
trachea	B-ANAT
and	O
kidneys	B-ANAT
.	O

ABSTRACT	O
:	O
Acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
AE	O
-	O
IPF	O
)	O
is	O
a	O
severe	O
condition	O
with	O
limited	O
treatment	O
strategies	O
.	O

Both	O
patients	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
acute	O
respiratory	O
distress	O
and	O
were	O
previously	O
diagnosed	O
with	O
idiopathic	O
pulmonary	B-ANAT
fibrosis	O
(	O
IPF	O
).	O

Pretreatment	O
(	O
exclusion	O
assay	O
),	O
coincubation	O
(	O
competition	O
assay	O
),	O
and	O
post	O
-	O
treatment	O
(	O
displacement	O
assay	O
)	O
of	O
PEDV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
with	O
the	O
S	B-ANAT
-	I-ANAT
layer	I-ANAT
protein	O
was	O
examined	O
.	O

Structural	O
information	O
about	O
the	O
proteins	O
that	O
constitute	O
the	O
viral	B-ANAT
particle	I-ANAT
is	O
scarce	O
.	O

Piglets	O
orally	B-ANAT
administered	O
scFvs	O
showed	O
no	O
to	O
mild	O
clinical	O
symptoms	O
,	O
significantly	O
less	O
viral	O
shedding	O
,	O
no	O
mortality	O
and	O
no	O
intestinal	B-ANAT
lesions	O
.	O

Our	O
results	O
revealed	O
that	O
glycerophospholipids	O
and	O
fatty	O
acids	O
(	O
FAs	O
)	O
were	O
significantly	O
elevated	O
in	O
the	O
HCoV	O
-	O
229E	O
-	O
infected	O
cells	B-ANAT
and	O
the	O
linoleic	O
acid	O
(	O
LA	O
)	O
to	O
arachidonic	O
acid	O
(	O
AA	O
)	O
metabolism	O
axis	B-ANAT
was	O
markedly	O
perturbed	O
upon	O
HCoV	O
-	O
229E	O
infection	O
.	O

An	O
important	O
group	O
of	O
AEs	O
were	O
oedema	O
reported	O
as	O
being	O
located	O
in	O
the	O
head	B-ANAT
,	O
neck	B-ANAT
or	O
respiratory	B-ANAT
tract	I-ANAT
.	O

The	O
mAbs	O
were	O
prepared	O
by	O
using	O
PEDV	O
positive	O
hybridoma	B-ANAT
cells	B-ANAT
that	O
were	O
selected	O
by	O
using	O
cell	B-ANAT
surface	I-ANAT
fluorescence	O
immunosorbent	O
assay	O
(	O
CSFIA	O
).	O

The	O
optimal	O
mAb	O
4A11	O
was	O
coated	O
on	O
NC	O
membrane	B-ANAT
as	O
the	O
capturing	O
reagent	O
and	O
the	O
mAb	O
A11H7	O
was	O
coupled	O
to	O
gold	O
nanoparticles	O
(	O
AuNPs	O
)	O
as	O
detection	O
reagent	O
for	O
the	O
new	O
ICA	O
.	O

Patients	O
with	O
greater	O
than	O
2	O
organ	B-ANAT
failures	O
had	O
higher	O
plasma	B-ANAT
sVE	O
-	O
cadherin	O
levels	O
than	O
patients	O
with	O
2	O
or	O
fewer	O
organ	B-ANAT
failures	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

CONCLUSIONS	O
:	O
Shedding	O
of	O
sVE	O
-	O
cadherin	O
is	O
associated	O
with	O
severe	O
acute	O
kidney	B-ANAT
injury	O
and	O
with	O
more	O
severe	O
organ	B-ANAT
dysfunction	O
in	O
patients	O
with	O
sepsis	O
,	O
suggesting	O
that	O
breakdown	O
of	O
endothelial	B-ANAT
adherens	B-ANAT
junctions	I-ANAT
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
organ	B-ANAT
dysfunction	O
in	O
sepsis	O
.	O

The	O
developed	O
ELISAs	O
were	O
evaluated	O
using	O
large	O
number	O
of	O
confirmed	O
seropositive	O
(	O
79	O
samples	O
)	O
and	O
seronegative	O
(	O
274	O
samples	O
)	O
MERS	O
-	O
CoV	O
human	O
serum	B-ANAT
samples	O
.	O

Biomarkers	O
of	O
particular	O
interest	O
have	O
included	O
interleukins	O
(	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
),	O
interferon	O
gamma	O
(	O
IFN	O
-	O
Î³	O
),	O
surfactant	O
proteins	O
(	O
SPD	O
and	O
SPB	B-ANAT
),	O
von	O
Willebrand	O
factor	O
antigen	O
,	O
angiopoietin	O
1	O
/	O
2	O
and	O
plasminogen	O
activator	O
inhibitor	O
-	O
1	O
(	O
PAI	O
-	O
1	O
).	O

Compared	O
with	O
oral	B-ANAT
infection	O
,	O
intramuscular	O
infection	O
could	O
also	O
cause	O
typical	O
clinical	O
signs	O
but	O
with	O
a	O
slightly	O
delayed	O
onset	O
,	O
confirming	O
that	O
the	O
variant	O
PEDV	O
isolate	O
FJzz1	O
was	O
highly	O
pathogenic	O
to	O
suckling	O
piglets	O
.	O

Occupational	O
risk	O
for	O
customs	O
officers	O
also	O
includes	O
noise	O
-	O
induced	O
hearing	O
loss	O
,	O
exposure	O
to	O
diesel	O
engine	O
emission	B-ANAT
and	O
stored	O
tobacco	O
and	O
occupational	O
stress	O
due	O
to	O
their	O
increased	O
time	O
-	O
schedule	O
and	O
decision	O
-	O
making	O
duties	O
.	O

A	O
blood	B-ANAT
sample	I-ANAT
was	O
taken	O
at	O
admission	O
and	O
CBC	B-ANAT
parameters	O
were	O
examined	O
.	O

A	O
total	O
of	O
219	O
samples	O
of	O
nasopharyngeal	B-ANAT
aspirates	B-ANAT
and	O
blood	B-ANAT
were	O
analyzed	O
.	O

Acute	O
lymphoblastic	B-ANAT
leukemia	O
(	O
48	O
.	O
1	O
%)	O
was	O
the	O
most	O
prevalent	O
disease	O
.	O

ABSTRACT	O
:	O
To	O
estimate	O
the	O
burden	O
of	O
genital	B-ANAT
warts	O
(	O
GW	O
)	O
in	O
Mexico	O
.	O

An	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
based	O
on	O
rS1	O
(	O
rS1	O
-	O
ELISA	O
)	O
was	O
then	O
developed	O
and	O
optimized	O
by	O
checkerboard	O
assays	O
with	O
serial	O
dilutions	O
of	O
antigen	O
and	O
serum	B-ANAT
.	O

TITLE	O
:	O
[	O
Bilateral	O
diaphragmatic	B-ANAT
palsy	O
due	O
to	O
Lyme	O
neuroborreliosis	O
].	O

CONCLUSIONS	O
:	O
In	O
the	O
presence	O
of	O
unilateral	O
or	O
bilateral	O
diaphragmatic	B-ANAT
paralysis	O
of	O
undetermined	O
aetiology	O
,	O
it	O
seems	O
relevant	O
to	O
perform	O
Lyme	O
serology	O
in	O
the	O
blood	B-ANAT
and	O
,	O
in	O
positive	O
cases	O
,	O
to	O
follow	O
up	O
with	O
a	O
lumbar	B-ANAT
puncture	O
in	O
order	O
to	O
detect	O
intrathecal	B-ANAT
IgG	O
synthesis	O
.	O

TITLE	O
:	O
Development	O
and	O
Evaluation	O
of	O
a	O
Multiplexed	O
Immunoassay	O
for	O
Simultaneous	O
Detection	O
of	O
Serum	B-ANAT
IgG	O
Antibodies	O
to	O
Six	O
Human	O
Coronaviruses	O
.	O

Disk	B-ANAT
diffusion	O
technique	O
and	O
PCR	O
were	O
used	O
as	O
methodologies	O
.	O

Only	O
isolates	O
(	O
30	O
%-	O
9	O
/	O
30	O
)	O
from	O
diarrheic	O
calves	O
were	O
also	O
positive	O
for	O
fimbriae	B-ANAT
,	O
specifically	O
16	O
.	O
7	O
%	O
(	O
5	O
/	O
30	O
)	O
for	O
F5	O
and	O
13	O
.	O
3	O
%	O
(	O
4	O
/	O
30	O
)	O
for	O
F18	O
.	O

Only	O
isolates	O
(	O
30	O
%-	O
9	O
/	O
30	O
)	O
from	O
diarrheic	O
calves	O
were	O
also	O
positive	O
for	O
fimbriae	B-ANAT
,	O
specifically	O
16	O
.	O
7	O
%	O
(	O
5	O
/	O
30	O
)	O
for	O
F5	O
and	O
13	O
.	O
3	O
%	O
(	O
4	O
/	O
30	O
)	O
for	O
F18	O
.	O

However	O
,	O
early	O
,	O
short	O
-	O
term	O
use	O
of	O
neuromuscular	O
blockade	O
appears	O
to	O
improve	O
survival	O
,	O
and	O
spontaneous	O
effort	O
has	O
been	O
shown	O
to	O
potentiate	O
lung	B-ANAT
injury	O
in	O
animal	O
and	O
clinical	O
studies	O
.	O

Future	O
studies	O
are	O
needed	O
to	O
determine	O
ventilator	O
strategies	O
that	O
minimize	O
injury	O
but	O
maintaining	O
some	O
diaphragm	B-ANAT
activity	O
.	O

ResPlex	O
II	O
assays	O
and	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
assays	O
were	O
used	O
to	O
detect	O
viral	O
pathogens	O
in	O
nasal	B-ANAT
wash	O
samples	O
,	O
and	O
survival	O
analyses	O
were	O
performed	O
to	O
determine	O
whether	O
infection	O
with	O
particular	O
viruses	O
conferred	O
short	O
-	O
lived	O
relative	O
cross	O
-	O
protection	O
against	O
FRI	O
.	O

Understanding	O
and	O
use	O
of	O
blood	B-ANAT
gas	O
analysis	O
enables	O
providers	O
to	O
interpret	O
respiratory	O
,	O
circulatory	O
and	O
metabolic	O
disorders	O
.	O

[	O
1	O
]	O
A	O
""""	O
blood	B-ANAT
gas	O
analysis	O
""""	O
can	O
be	O
performed	O
on	O
blood	B-ANAT
obtained	O
from	O
anywhere	O
in	O
the	O
circulatory	B-ANAT
system	I-ANAT
(	O
artery	B-ANAT
,	O
vein	B-ANAT
,	O
or	O
capillary	B-ANAT
).	O

Arterial	B-ANAT
blood	I-ANAT
gas	O
analysis	O
assesses	O
a	O
patient	O
â	O
s	O
partial	O
pressure	O
of	O
oxygen	O
(	O
PaO2	O
),	O
providing	O
information	O
on	O
the	O
oxygenation	O
status	O
;	O
the	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
(	O
PaCO2	O
),	O
providing	O
information	O
on	O
the	O
ventilation	O
status	O
(	O
chronic	O
or	O
acute	O
respiratory	O
failure	O
,	O
and	O
is	O
changed	O
by	O
hyperventilation	O
(	O
rapid	O
or	O
deep	O
breathing	O
)	O
and	O
hypoventilation	O
(	O
slow	O
or	O
shallow	O
breathing	O
);	O
and	O
acid	O
-	O
base	O
status	O
.	O

The	O
measured	O
HCO3	O
uses	O
a	O
strong	O
alkali	O
that	O
liberates	O
all	O
CO2	O
in	O
serum	B-ANAT
,	O
including	O
dissolved	O
CO2	O
,	O
carbamino	O
compounds	O
,	O
and	O
carbonic	O
acid	O
.	O

In	O
this	O
case	O
,	O
the	O
patient	O
experienced	O
a	O
left	O
main	O
bronchial	B-ANAT
rupture	O
,	O
bilateral	O
traumatic	O
wet	O
lung	B-ANAT
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
because	O
of	O
severe	O
thoracic	B-ANAT
trauma	O
.	O

Here	O
,	O
we	O
asked	O
if	O
the	O
EndoU	O
activity	O
of	O
porcine	O
epidemic	O
diarrhea	O
coronavirus	O
(	O
PEDV	O
),	O
which	O
causes	O
acute	O
diarrhea	O
in	O
swine	O
,	O
plays	O
a	O
role	O
in	O
antagonizing	O
the	O
innate	O
response	O
in	O
porcine	O
epithelial	B-ANAT
cells	I-ANAT
and	O
macrophages	B-ANAT
,	O
the	O
sites	O
of	O
viral	O
replication	O
.	O

These	O
results	O
demonstrate	O
that	O
EndoU	O
activity	O
is	O
not	O
required	O
for	O
PEDV	O
replication	O
in	O
immortalized	O
,	O
IFN	O
-	O
deficient	O
Vero	B-ANAT
cells	I-ANAT
,	O
but	O
is	O
important	O
for	O
suppressing	O
the	O
IFN	O
response	O
in	O
epithelial	B-ANAT
cells	I-ANAT
and	O
macrophages	B-ANAT
,	O
which	O
facilitates	O
replication	O
,	O
shedding	O
,	O
and	O
pathogenesis	O

<	O
strong	O
>	O
MATERIAL	O
AND	O
METHODS	O
</	O
strong	O
>	O
We	O
used	O
an	O
LPS	O
-	O
induced	O
mouse	O
acute	O
lung	B-ANAT
injury	O
(	O
ALI	O
)	O
model	O
to	O
investigate	O
the	O
possible	O
role	O
of	O
HIPK1	O
in	O
ALI	O
pathophysiology	O
.	O

A	O
clinical	O
evaluation	O
using	O
intestinal	B-ANAT
tissue	B-ANAT
and	O
fecal	B-ANAT
samples	O
from	O
piglets	O
suffering	O
from	O
diarrhea	O
at	O
different	O
pig	O
farms	O
in	O
China	O
revealed	O
that	O
the	O
singular	O
infection	O
rates	O
of	O
PEDV	O
and	O
PCV3	O
were	O
43	O
.	O
94	O
%	O
(	O
29	O
/	O
66	O
)	O
and	O
16	O
.	O
67	O
%	O
(	O
11	O
/	O
66	O
),	O
respectively	O
,	O
while	O
the	O
co	O
-	O
infection	O
rate	O
of	O
PCV3	O
with	O
PEDV	O
was	O
27	O
.	O
27	O
%	O
(	O
18	O
/	O
66	O
).	O

This	O
article	O
reviews	O
neuromuscular	O
emergencies	O
by	O
localization	O
in	O
the	O
peripheral	B-ANAT
nervous	I-ANAT
system	I-ANAT
of	O
the	O
underlying	O
disorder	O
,	O
as	O
well	O
as	O
the	O
identification	O
and	O
management	O
of	O
neuromuscular	O
respiratory	O
failure	O
.	O

Multivariate	O
analyses	O
revealed	O
that	O
elevated	O
blood	B-ANAT
lactate	O
level	O
(â¥	O
2	O
.	O
0	O
mmol	O
/	O
L	O
)	O
and	O
increased	O
HRCT	O
scores	O
were	O
significantly	O
associated	O
with	O
weaning	O
failure	O
and	O
30	O
-	O
day	O
mortality	O
of	O
the	O
patients	O
with	O
ARDS	O
.	O

Medical	O
practitioners	O
should	O
be	O
vigilant	O
in	O
its	O
diagnosis	O
since	O
septic	O
jugular	B-ANAT
vein	I-ANAT
thrombophlebitis	O
could	O
be	O
misdiagnosed	O
as	O
neck	B-ANAT
lymphadenitis	O
.	O

TITLE	O
:	O
Kaempferol	O
reduces	O
K63	O
-	O
linked	O
polyubiquitination	O
to	O
inhibit	O
nuclear	O
factor	O
-	O
ÎºB	O
and	O
inflammatory	O
responses	O
in	O
acute	O
lung	B-ANAT
injury	O
in	O
mice	O
.	O

We	O
combined	O
personal	O
information	O
with	O
weekly	O
nasal	B-ANAT
swab	O
collection	O
to	O
investigate	O
the	O
prevalence	O
of	O
18	O
respiratory	O
viruses	O
among	O
different	O
age	O
groups	O
and	O
to	O
assess	O
risk	O
factors	O
associated	O
with	O
infection	O
susceptibility	O
.	O

TITLE	O
:	O
Absence	O
of	O
neutralizing	O
activity	O
in	O
serum	B-ANAT
1	O
year	O
after	O
successful	O
treatment	O
with	O
antivirals	O
and	O
recovery	O
from	O
MERS	O
in	O
South	O
Korea	O
.	O

At	O
28	O
days	O
,	O
33	O
of	O
102	O
patients	O
(	O
32	O
.	O
4	O
%)	O
assigned	O
to	O
PES	B-ANAT
-	O
guided	O
PEEP	O
and	O
30	O
of	O
98	O
patients	O
(	O
30	O
.	O
6	O
%)	O
assigned	O
to	O
empirical	O
PEEP	O
-	O
Fio2	O
died	O
(	O
risk	O
difference	O
,	O
1	O
.	O
7	O
%	O
[	O
95	O
%	O
CI	O
,	O
-	O
11	O
.	O
1	O
%	O
to	O
14	O
.	O
6	O
%];	O
P	O
=	O
.	O
88	O
).	O

Patients	O
assigned	O
to	O
PES	B-ANAT
-	O
guided	O
PEEP	O
were	O
significantly	O
less	O
likely	O
to	O
receive	O
rescue	O
therapy	O
(	O
4	O
/	O
102	O
[	O
3	O
.	O
9	O
%]	O
vs	O
12	O
/	O
98	O
[	O
12	O
.	O
2	O
%];	O
risk	O
difference	O
,	O
-	O
8	O
.	O
3	O
%	O
[	O
95	O
%	O
CI	O
,	O
-	O
15	O
.	O
8	O
%	O
to	O
-	O
0	O
.	O
8	O
%];	O
P	O
=	O
.	O
04	O
).	O

Adverse	O
events	O
included	O
gross	O
barotrauma	O
,	O
which	O
occurred	O
in	O
6	O
patients	O
with	O
PES	B-ANAT
-	O
guided	O
PEEP	O
and	O
5	O
patients	O
with	O
empirical	O
PEEP	O
-	O
Fio2	O
.	O

We	O
created	O
decision	O
trees	O
to	O
model	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
from	O
ICU	O
admission	O
through	O
death	O
(	O
societal	O
perspective	O
)	O
and	O
hospital	O
discharge	B-ANAT
(	O
hospital	O
perspective	O
).	O

If	O
hospitals	O
were	O
willing	O
to	O
pay	O
$	O
100	O
,	O
000	O
per	O
survival	O
-	O
to	O
-	O
discharge	B-ANAT
,	O
any	O
intervention	O
costing	O
less	O
than	O
$	O
5	O
,	O
140	O
per	O
patient	O
would	O
represent	O
good	O
value	O
.	O

The	O
plasma	B-ANAT
metabolites	O
were	O
detected	O
with	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
(	O
GC	O
-	O
MS	O
),	O
and	O
the	O
relevant	O
metabolic	O
pathways	O
were	O
predicted	O
using	O
the	O
Kyoto	O
Encyclopedia	O
of	O
Genes	O
and	O
Genomes	O
(	O
KEGG	O
)	O
database	O
.	O

Plasma	B-ANAT
metabolomics	O
may	O
improve	O
our	O
understanding	O
of	O
ARDS	O
biology	O
.	O

Cloacal	B-ANAT
/	O
throat	B-ANAT
double	O
swabs	O
were	O
collected	O
from	O
60	O
birds	O
at	O
each	O
farm	O
according	O
to	O
a	O
random	O
sampling	O
method	O
.	O

CONCLUSIONS	O
:	O
Black	O
women	O
were	O
more	O
likely	O
(	O
1	O
)	O
to	O
be	O
readmitted	O
postpartum	O
,	O
(	O
2	O
)	O
to	O
suffer	O
severe	O
maternal	O
morbidity	O
during	O
readmission	O
,	O
and	O
(	O
3	O
)	O
to	O
suffer	O
life	O
threatening	O
complications	O
such	O
as	O
pulmonary	B-ANAT
edema	O
/	O
acute	O
heart	B-ANAT
failure	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
impact	O
of	O
body	B-ANAT
temperature	O
on	O
disease	O
severity	O
,	O
implementation	O
of	O
sepsis	O
bundles	O
,	O
and	O
outcomes	O
in	O
severe	O
sepsis	O
patients	O
.	O

Compliance	O
with	O
the	O
bundles	O
proposed	O
in	O
the	O
Surviving	O
Sepsis	O
Campaign	O
Guidelines	O
2012	O
,	O
in	O
-	O
hospital	O
mortality	O
,	O
disposition	O
after	O
discharge	B-ANAT
,	O
and	O
the	O
number	O
of	O
ICU	O
and	O
ventilator	O
-	O
free	O
days	O
were	O
evaluated	O
.	O

Patients	O
with	O
hypothermia	O
were	O
significantly	O
older	O
than	O
those	O
with	O
a	O
body	B-ANAT
temperature	O
of	O
36	O
-	O
38	O
Â°	O
C	O
or	O
greater	O
than	O
38	O
Â°	O
C	O
and	O
had	O
a	O
lower	B-ANAT
body	I-ANAT
mass	O
index	O
and	O
higher	O
prevalence	O
of	O
septic	O
shock	O
than	O
those	O
with	O
body	B-ANAT
temperature	O
greater	O
than	O
38	O
Â°	O
C	O
.	O

The	O
odds	O
ratio	O
for	O
in	O
-	O
hospital	O
mortality	O
relative	O
to	O
the	O
reference	O
range	O
of	O
body	B-ANAT
temperature	O
greater	O
than	O
38	O
Â°	O
C	O
was	O
1	O
.	O
760	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
134	O
-	O
2	O
.	O
732	O
)	O
in	O
the	O
group	O
with	O
hypothermia	O
.	O

Moderate	O
cytostatic	O
activity	O
against	O
cervix	B-ANAT
carcinoma	O
(	O
HeLa	B-ANAT
),	O
murine	O
leukemia	O
(	O
L1210	O
)	O
and	O
human	O
lymphocyte	B-ANAT
(	O
CEM	O
)	O
tumor	B-ANAT
cell	I-ANAT
lines	I-ANAT
was	O
displayed	O
by	O
the	O
protected	O
3	O
Î-	O
deoxy	O
derivatives	O
12b	O
,	O
12c	O
,	O
12d	O
,	O
and	O
the	O
3	O
Î-	O
deoxy	O
-	O
3	O
Î-	O
methyl	O
18a	O
,	O
18b	O
,	O
18c	O
.	O

Recombinase	O
polymerase	O
amplification	O
(	O
RPA	B-ANAT
)	O
is	O
an	O
isothermal	O
amplification	O
method	O
which	O
has	O
been	O
widely	O
used	O
for	O
virus	O
detection	O
.	O

A	O
probe	O
-	O
based	O
reverse	O
transcription	O
RPA	B-ANAT
(	O
RT	O
-	O
RPA	B-ANAT
)	O
assay	O
was	O
developed	O
for	O
real	O
-	O
time	O
detection	O
of	O
PDCoV	O
.	O
The	O
amplification	O
can	O
be	O
finished	O
in	O
20	O
min	O
and	O
fluorescence	O
monitoring	O
was	O
performed	O
by	O
a	O
portable	O
device	O
.	O

The	O
coincidence	O
rate	O
of	O
the	O
detection	O
results	O
for	O
clinical	O
samples	O
between	O
RT	O
-	O
RPA	B-ANAT
and	O
RT	O
-	O
qPCR	O
was	O
97	O
.	O
2	O
%.	O

ABSTRACT	O
:	O
Evaluation	O
of	O
the	O
thermal	O
and	O
physical	O
conditions	O
for	O
inactivation	O
of	O
adenovirus	O
(	O
AdV	O
),	O
porcine	O
sapelovirus	O
1	O
(	O
PSV1	O
)	O
and	O
the	O
economically	O
important	O
viruses	O
porcine	O
epidemic	O
diarrhoea	O
virus	O
(	O
PEDV	O
)	O
and	O
porcine	O
circovirus	O
2	O
(	O
PCV2	O
)	O
in	O
the	O
production	O
of	O
spray	O
-	O
dried	B-ANAT
porcine	O
plasma	B-ANAT
(	O
SDPP	O
).	O

Citrate	O
-	O
treated	O
porcine	O
plasma	B-ANAT
of	O
pH	O
7	O
Â·	O
5	O
,	O
9	O
Â·	O
8	O
and	O
10	O
Â·	O
2	O
(	O
8	O
Â·	O
5	O
%	O
dry	O
-	O
matter	O
)	O
was	O
spiked	O
with	O
PEDV	O
,	O
PSV1	O
,	O
PCV2	O
and	O
AdV	O
and	O
incubated	O
at	O
3	O
Â°	O
C	O
for	O
maximum	O
24	O
h	O
,	O
and	O
at	O
44	O
or	O
48	O
Â°	O
C	O
for	O
maximum	O
10	O
min	O
(	O
Experiment	O
1	O
).	O

Spiked	O
citrate	O
-	O
treated	O
concentrated	O
plasma	B-ANAT
of	O
pH	O
7	O
Â·	O
5	O
and	O
9	O
Â·	O
8	O
(	O
24	O
%	O
dry	O
-	O
matter	O
)	O
was	O
spray	O
dried	B-ANAT
in	O
a	O
laboratory	O
scale	O
apparatus	B-ANAT
(	O
Experiment	O
2	O
).	O

TITLE	O
:	O
P53	O
:	O
The	O
endothelium	B-ANAT
defender	O
.	O

ABSTRACT	O
:	O
P53	O
represents	O
the	O
paradigm	O
of	O
a	O
multitalented	O
transcription	O
factor	O
,	O
responsible	O
for	O
the	O
cellular	B-ANAT
defense	O
against	O
a	O
plethora	O
of	O
potentially	O
harmful	O
stimuli	O
.	O

Endothelium	B-ANAT
hyperpermeability	O
is	O
considered	O
the	O
hallmark	O
of	O
severe	O
lung	B-ANAT
inflammation	O
,	O
and	O
the	O
cardinal	O
feature	O
of	O
the	O
lethal	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

An	O
emerging	O
body	B-ANAT
of	O
evidence	O
suggests	O
a	O
strategic	O
role	O
of	O
P53	O
towards	O
vascular	B-ANAT
barrier	O
integrity	O
.	O

ABSTRACT	O
:	O
These	O
updated	O
guidelines	O
from	O
the	O
Infectious	O
Diseases	O
Community	O
of	O
Practice	O
of	O
the	O
American	O
Society	O
of	O
Transplantation	O
review	O
the	O
diagnosis	O
,	O
prevention	O
,	O
and	O
management	O
of	O
RNA	O
respiratory	O
viral	O
infections	O
in	O
the	O
pre	O
-	O
and	O
post	O
-	O
transplant	B-ANAT
period	O
.	O

ABSTRACT	O
:	O
Despite	O
recent	O
advances	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
remains	O
a	O
severe	O
and	O
often	O
fatal	O
disease	O
for	O
which	O
there	O
is	O
no	O
therapy	O
able	O
to	O
reduce	O
the	O
underlying	O
excessive	O
lung	B-ANAT
inflammation	O
or	O
enhance	O
resolution	O
of	O
injury	O
.	O

Due	O
to	O
their	O
high	O
metabolic	O
needs	O
,	O
neutrophils	B-ANAT
,	O
macrophages	B-ANAT
,	O
and	O
lymphocytes	B-ANAT
rely	O
upon	O
glutamine	O
metabolism	O
to	O
support	O
activation	O
and	O
function	O
.	O

Multiplex	O
PCR	O
assays	O
were	O
performed	O
on	O
nasopharyngeal	B-ANAT
swabs	O
to	O
detect	O
respiratory	O
viruses	O
during	O
routine	O
visits	O
and	O
when	O
symptomatic	O
.	O

Future	O
investigations	O
examining	O
longitudinal	O
relationships	O
between	O
viral	O
infections	O
,	O
airway	B-ANAT
microbiome	O
,	O
and	O
antibiotic	O
use	O
will	O
allow	O
us	O
to	O
elucidate	O
the	O
interplay	O
between	O
these	O
factors	O
in	O
young	O
children	O
with	O
CF	O
.	O

TITLE	O
:	O
[	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
acute	O
phosgene	O
poisoning	O
:	O
a	O
report	O
of	O
4	O
cases	O
].	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
protective	O
effect	O
and	O
curative	O
effect	O
of	O
early	O
treatment	O
with	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
in	O
severe	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
acute	O
phosgene	O
poisoning	O
.	O

The	O
distribution	O
of	O
NOX	O
family	O
proteins	O
in	O
lung	B-ANAT
tissue	I-ANAT
is	O
cell	B-ANAT
type	I-ANAT
dependent	O
.	O

Alveolar	B-ANAT
macrophages	I-ANAT
underwent	O
functional	O
polarization	O
in	O
acutely	O
infected	O
macaques	O
,	O
demonstrating	O
simultaneously	O
both	O
proinflammatory	O
and	O
wound	O
-	O
healing	O
characteristics	O
.	O

The	O
second	O
outcomes	O
were	O
to	O
determine	O
the	O
risk	O
factors	O
of	O
mortality	O
of	O
ARDS	O
in	O
leptospirosis	O
and	O
to	O
describe	O
the	O
cases	O
requiring	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
(	O
ECMO	O
).	O

Protection	O
in	O
alpaca	O
correlates	O
with	O
high	O
serum	B-ANAT
neutralizing	O
antibody	O
titers	O
.	O

Lower	O
titers	O
of	O
serum	B-ANAT
neutralizing	O
antibodies	O
correlate	O
with	O
delayed	O
and	O
significantly	O
reduced	O
shedding	O
in	O
the	O
nasal	B-ANAT
turbinates	I-ANAT
of	O
dromedary	O
camels	O
.	O

TITLE	O
:	O
The	O
crystal	B-ANAT
structure	O
of	O
main	O
protease	O
from	O
mouse	O
hepatitis	O
virus	O
A59	O
in	O
complex	O
with	O
an	O
inhibitor	O
.	O

ABSTRACT	O
:	O
Mouse	O
hepatitis	O
virus	O
A59	O
(	O
MHV	O
-	O
A59	O
)	O
is	O
a	O
representative	O
member	O
of	O
the	O
genus	O
betacoronavirus	O
within	O
the	O
subfamily	O
Coronavirinae	O
,	O
which	O
infects	O
the	O
liver	B-ANAT
,	O
brain	B-ANAT
and	O
respiratory	B-ANAT
tract	I-ANAT
.	O

We	O
restructure	O
the	O
original	O
data	O
into	O
run	O
-	O
off	O
triangle	O
data	O
,	O
where	O
the	O
cells	B-ANAT
contain	O
the	O
numbers	O
of	O
cured	O
patients	O
,	O
deceased	O
patients	O
,	O
and	O
patients	O
still	O
having	O
the	O
disease	O
at	O
a	O
given	O
combination	O
of	O
calendar	O
and	O
disease	O
-	O
duration	O
times	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
ability	O
of	O
PEDV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
in	O
improving	O
viral	O
yields	O
in	O
cell	B-ANAT
culture	O
systems	O
.	O

The	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
according	O
to	O
pre	O
-	O
ECMO	O
arterial	B-ANAT
blood	I-ANAT
gas	O
:	O
an	O
extended	O
group	O
(	O
n	O
=	O
14	O
)	O
and	O
a	O
conventional	O
group	O
(	O
n	O
=	O
48	O
).	O

Subsequently	O
,	O
SARS	O
-	O
related	O
CoVs	O
(	O
SARSr	O
-	O
CoVs	O
)	O
were	O
found	O
in	O
palm	B-ANAT
civets	O
from	O
live	O
animal	O
markets	O
in	O
Guangdong	O
and	O
in	O
various	O
horseshoe	O
bat	O
species	O
,	O
which	O
were	O
believed	O
to	O
be	O
the	O
ultimate	O
reservoir	O
of	O
SARSr	O
-	O
CoV	O
.	O
Till	O
November	O
2018	O
,	O
339	O
SARSr	O
-	O
CoV	O
genomes	O
have	O
been	O
sequenced	O
,	O
including	O
274	O
from	O
human	O
,	O
18	O
from	O
civets	O
and	O
47	O
from	O
bats	O
[	O
mostly	O
from	O
Chinese	O
horseshoe	O
bats	O
(	O
Rhinolophus	O
sinicus	O
),	O
n	O
=	O
30	O
;	O
and	O
greater	O
horseshoe	O
bats	O
(	O
Rhinolophus	O
ferrumequinum	O
),	O
n	O
=	O
9	O
].	O

In	O
turn	O
,	O
the	O
mRNA	O
levels	O
of	O
IFIT	O
family	O
members	O
(	O
IFIT1	O
,	O
IFIT2	O
,	O
IFIT3	O
)	O
was	O
inhibited	O
in	O
cells	B-ANAT
overexpressing	O
nsp16	O
.	O

Feces	B-ANAT
were	O
tested	O
for	O
ECoV	O
and	O
nasal	B-ANAT
secretions	B-ANAT
for	O
common	O
respiratory	O
pathogens	O
(	O
equine	O
herpesvirus	O
(	O
EHV	O
)-	O
1	O
,	O
EHV	O
-	O
4	O
,	O
equine	O
influenza	O
virus	O
(	O
EIV	O
),	O
equine	O
rhinitis	O
viruses	O
(	O
ERVs	O
)	O
and	O
The	O
total	O
number	O
of	O
horses	O
testing	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
feces	B-ANAT
was	O
20	O
(	O
7	O
.	O
2	O
%),	O
4	O
of	O
which	O
also	O
tested	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
nasal	B-ANAT
secretions	B-ANAT
.	O

In	O
the	O
same	O
population	O
9	O
.	O
0	O
%	O
of	O
horses	O
tested	O
qPCR	O
-	O
positive	O
for	O
EHV	O
-	O
4	O
,	O
6	O
.	O
1	O
%	O
for	O
EIV	O
,	O
4	O
.	O
3	O
%	O
for	O
The	O
present	O
study	O
results	O
showed	O
that	O
7	O
.	O
2	O
%	O
of	O
horses	O
with	O
acute	O
onset	O
of	O
fever	O
tested	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
feces	B-ANAT
,	O
highlighting	O
the	O
importance	O
of	O
testing	O
such	O
horses	O
for	O
ECoV	O
in	O
feces	B-ANAT
.	O

Logistic	O
regression	O
analysis	O
revealed	O
that	O
a	O
high	O
tidal	O
volume	O
(	O
odds	O
ratio	O
=	O
1	O
.	O
448	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
033	O
-	O
2	O
.	O
030	O
;	O
p	O
=	O
0	O
.	O
032	O
)	O
and	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
(	O
SOFA	O
)	O
score	O
(	O
odds	O
ratio	O
=	O
1	O
.	O
233	O
,	O
95	O
%	O
CI	O
=	O
1	O
.	O
029	O
-	O
1	O
.	O
478	O
;	O
p	O
=	O
0	O
.	O
023	O
)	O
were	O
the	O
risk	O
factors	O
of	O
hospital	O
mortality	O
.	O

The	O
ability	O
to	O
evade	O
,	O
circumvent	O
or	O
subvert	O
the	O
host	O
'	O
s	O
first	O
line	O
of	O
defense	O
,	O
namely	O
the	O
innate	O
immune	B-ANAT
system	I-ANAT
,	O
is	O
the	O
key	O
determinant	O
for	O
pathogen	O
virulence	O
,	O
survival	O
,	O
and	O
the	O
establishment	O
of	O
successful	O
infection	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
incidence	O
of	O
cannula	O
-	O
related	O
thrombosis	O
and	O
its	O
risk	O
factors	O
after	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

After	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
weaning	O
,	O
duplex	O
sonography	O
or	O
CT	O
was	O
conducted	O
to	O
detect	O
cannula	O
-	O
related	O
thrombosis	O
.	O

The	O
incidence	O
of	O
thrombosis	O
was	O
correlated	O
with	O
risk	O
factors	O
such	O
as	O
coagulation	O
variables	O
(	O
mean	O
activated	O
partial	O
thromboplastin	O
time	O
â¤	O
50	O
s	O
,	O
international	O
normalized	O
ratio	O
antithrombin	O
III	O
,	O
fibrinogen	B-ANAT
,	O
plasma	B-ANAT
-	O
free	O
hemoglobin	O
,	O
platelets	B-ANAT
,	O
and	O
decline	O
in	O
D	O
-	O
dimer	O
â¤	O
50	O
%	O
the	O
day	O
after	O
decannulation	O
),	O
cannula	O
size	O
,	O
time	O
on	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
renal	B-ANAT
failure	O
,	O
and	O
underlying	O
malignant	O
disease	O
.	O

ABSTRACT	O
:	O
Viral	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
are	O
frequent	O
among	O
Hajj	O
pilgrims	O
.	O

This	O
review	O
is	O
unique	O
because	O
we	O
focused	O
on	O
antisynthetase	O
syndrome	O
that	O
initially	O
manifested	O
with	O
lung	B-ANAT
symptoms	O
rather	O
than	O
myositis	O
or	O
skin	B-ANAT
changes	O
.	O

For	O
example	O
,	O
microorganisms	O
such	O
as	O
hepatitis	O
B	O
virus	O
and	O
HIV	O
-	O
1	O
can	O
be	O
transmitted	O
by	O
a	O
contaminated	O
blood	B-ANAT
transfusion	O
from	O
an	O
infected	O
individual	O
to	O
a	O
recipient	O
and	O
cause	O
disease	O
that	O
can	O
lead	O
to	O
chronic	O
hepatitis	O
and	O
acquired	O
immunodeficiency	O
syndrome	O
respectively	O
.	O

Diagnosis	O
was	O
confirmed	O
by	O
the	O
detection	O
of	O
(	O
1	O
)	O
O	O
.	O
tsutsugamushi	O
-	O
specific	O
DNA	O
in	O
blood	B-ANAT
or	O
eschar	O
samples	O
with	O
a	O
polymerase	O
chain	O
reaction	O
assay	O
,	O
(	O
2	O
)	O
a	O
fourfold	O
rise	O
in	O
immunoglobulin	O
M	O
(	O
IgM	O
)	O
titer	O
to	O
â¥	O
1	O
:	O
3200	O
in	O
paired	O
plasma	B-ANAT
samples	O
with	O
an	O
indirect	O
immunofluorescence	O
assay	O
(	O
IFA	O
),	O
or	O
(	O
3	O
)	O
a	O
single	O
IgM	O
titer	O
of	O
â¥	O
1	O
:	O
3200	O
in	O
an	O
acute	O
plasma	B-ANAT
sample	I-ANAT
with	O
an	O
IFA	O
.	O

Nosocomial	O
infections	O
are	O
possible	O
from	O
contamination	O
by	O
infected	O
blood	B-ANAT
.	O

bilateral	O
upper	O
half	O
-	O
body	B-ANAT
irradiation	O
(	O
UHBI	O
);	O
and	O
4	O
.	O

Here	O
,	O
IBV	O
S1	O
and	O
the	O
ectodomain	O
of	O
NDV	O
F	O
proteins	O
were	O
separately	O
linked	O
with	O
the	O
trans	O
-	O
membrane	B-ANAT
and	O
carboxy	O
-	O
terminal	O
domain	O
of	O
IBV	O
S	O
protein	O
(	O
S	O

The	O
following	O
parameters	O
were	O
associated	O
with	O
increased	O
mortality	O
,	O
age	O
,	O
WBC	B-ANAT
,	O
neutrophil	B-ANAT
count	O
,	O
serum	B-ANAT
albumin	O
level	O
,	O
use	O
of	O
a	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
(	O
CRRT	O
)	O
and	O
corticosteroid	O
use	O
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
common	O
cause	O
of	O
respiratory	O
failure	O
in	O
critically	O
ill	O
patients	O
and	O
is	O
defined	O
by	O
the	O
acute	O
onset	O
of	O
noncardiogenic	O
pulmonary	B-ANAT
oedema	O
,	O
hypoxaemia	O
and	O
the	O
need	O
for	O
mechanical	O
ventilation	O
.	O

Treatment	O
focuses	O
on	O
lung	B-ANAT
-	O
protective	O
ventilation	O
;	O
no	O
specific	O
pharmacotherapies	O
have	O
been	O
identified	O
.	O

TITLE	O
:	O
Quality	O
of	O
Life	O
and	O
Lung	B-ANAT
Function	O
in	O
Survivors	O
of	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
for	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Despite	O
more	O
severe	O
respiratory	O
failure	O
at	O
admission	O
,	O
1	O
-	O
yr	O
survival	O
of	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
was	O
not	O
different	O
from	O
that	O
of	O
non	O
-	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
;	O
each	O
group	O
had	O
almost	O
full	O
recovery	O
of	O
lung	B-ANAT
function	O
,	O
but	O
non	O
-	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
patients	O
had	O
greater	O
impairment	O
of	O
health	O
-	O
related	O
quality	O
of	O
life	O
.	O

TITLE	O
:	O
Fulminant	O
Tritrichomonas	O
foetus	B-ANAT
'	O
feline	O
genotype	O
'	O
infection	O
in	O
a	O
3	O
-	O
month	O
old	O
kitten	O
associated	O
with	O
viral	O
co	O
-	O
infection	O
.	O

Preemptive	O
therapy	O
,	O
which	O
included	O
liposomal	O
amphotericin	O
B	O
and	O
posaconazole	O
,	O
was	O
adminstered	O
when	O
voriconazole	O
proved	O
to	O
be	O
unhelpful	O
and	O
before	O
histologic	O
reports	O
of	O
gastric	B-ANAT
mucormycosis	O
.	O

TITLE	O
:	O
Dynamic	O
changes	O
of	O
pulmonary	B-ANAT
arterial	B-ANAT
pressure	O
in	O
perinatal	O
neonates	O
with	O
pulmonary	B-ANAT
and	O
extrapulmonary	O
acute	O
lung	B-ANAT
injury	O
/	O
respiratory	O
distress	O
syndrome	O
.	O

A	O
limitation	O
of	O
the	O
methodology	O
is	O
that	O
it	O
can	O
only	O
recapitulate	O
virus	O
entry	O
steps	O
mediated	O
by	O
the	O
envelope	B-ANAT
protein	O
being	O
investigated	O
.	O

The	O
other	O
patient	O
suffered	O
hemothorax	O
,	O
thoracic	B-ANAT
aorta	I-ANAT
dissection	O
,	O
and	O
liver	B-ANAT
rupture	O
.	O

Patients	O
who	O
were	O
managed	O
with	O
NIV	O
initially	O
had	O
lower	O
baseline	O
SOFA	O
score	O
and	O
less	O
extensive	O
infiltrates	O
on	O
chest	B-ANAT
radiograph	O
compared	O
with	O
patients	O
managed	O
with	O
invasive	O
MV	O
.	O

TITLE	O
:	O
A	O
Single	O
V672F	O
Substitution	O
in	O
the	O
Spike	O
Protein	O
of	O
Field	O
-	O
Isolated	O
PEDV	O
Promotes	O
Cell	B-ANAT
â»	I-ANAT
Cell	I-ANAT
Fusion	O
and	O
Replication	O
in	O
VeroE6	O
Cells	B-ANAT
.	O

Moreover	O
,	O
recombinant	O
PEDV	O
viruses	O
bearing	O
S	O
of	O
the	O
G2	O
strain	O
with	O
the	O
single	O
V672F	O
substitution	O
could	O
induce	O
extensive	O
syncytium	B-ANAT
formation	O
and	O
replicate	O
efficiently	O
in	O
VeroE6	O
cells	B-ANAT
stably	O
expressing	O
porcine	O
aminopeptidase	O
N	O
(	O
VeroE6	O
-	O
APN	O
).	O

Interestingly	O
,	O
we	O
also	O
demonstrated	O
that	O
while	O
the	O
V672F	O
mutation	O
is	O
critical	O
for	O
the	O
syncytium	B-ANAT
formation	O
in	O
VeroE6	O
-	O
APN	O
cells	B-ANAT
,	O
it	O
exerts	O
a	O
minimal	O
effect	O
in	O
Huh	O
-	O
7	O
cells	B-ANAT
,	O
thereby	O
suggesting	O
the	O
difference	O
in	O
receptor	O
preference	O
of	O
PEDV	O
among	O
host	O
cells	B-ANAT
.	O

A	O
total	O
of	O
1	O
,	O
362	O
respiratory	B-ANAT
samples	I-ANAT
were	O
collected	O
from	O
733	O
(	O
53	O
.	O
8	O
%)	O
male	O
and	O
629	O
(	O
46	O
.	O
2	O
%)	O
female	O
patients	O
with	O
ARI	O
who	O
visited	O
the	O
SKSH	O
between	O
November	O
2015	O
and	O
February	O
2018	O
.	O

TITLE	O
:	O
Glycosylation	O
of	O
the	O
viral	O
attachment	O
protein	O
of	O
avian	O
coronavirus	O
is	O
essential	O
for	O
host	B-ANAT
cell	I-ANAT
and	O
receptor	O
binding	O
.	O

Although	O
lung	B-ANAT
contusion	O
shows	O
similarities	O
to	O
blast	B-ANAT
injury	O
of	O
the	O
lung	B-ANAT
with	O
respect	O
to	O
clinical	O
consequences	O
,	O
other	O
factors	O
play	O
a	O
role	O
in	O
its	O
aetiology	O
and	O
pathology	O
.	O

Generally	O
,	O
it	O
can	O
be	O
declared	O
that	O
besides	O
high	O
energy	O
,	O
blunt	O
injuries	O
affecting	O
the	O
trunk	B-ANAT
,	O
lung	B-ANAT
contusion	O
,	O
has	O
been	O
an	O
often	O
neglected	O
additional	O
radiological	O
finding	O
attached	O
to	O
the	O
main	O
report	O
,	O
despite	O
the	O
fact	O
,	O
that	O
its	O
late	O
consequences	O
crucially	O
determine	O
the	O
prospects	O
of	O
the	O
injured	O
.	O

TITLE	O
:	O
Development	O
of	O
solitary	O
chemosensory	O
cells	B-ANAT
in	O
the	O
distal	O
lung	B-ANAT
after	O
severe	O
influenza	O
injury	O
.	O

Incorporation	O
of	O
CD40L	O
into	O
rAd5	O
-	O
based	O
MERS	O
-	O
CoV	O
S1	O
vaccine	O
targeting	O
molecule	O
and	O
molecular	O
adjuvants	O
not	O
only	O
enhances	O
immunogenicity	O
and	O
efficacy	O
but	O
also	O
prevents	O
inadvertent	O
pulmonary	B-ANAT
pathology	O
after	O
viral	O
challenge	O
,	O
thereby	O
offering	O
a	O
promising	O
strategy	O
to	O
enhance	O
safety	O
and	O
potency	O
of	O
vaccines	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
an	O
increasingly	O
accepted	O
means	O
of	O
supporting	O
those	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

clinical	O
studies	O
,	O
abstracts	O
,	O
studies	O
in	O
which	O
the	O
model	O
of	O
ARDS	O
and	O
ECMO	O
has	O
been	O
reported	O
previously	O
,	O
and	O
studies	O
not	O
employing	O
veno	O
-	O
venous	B-ANAT
,	O
veno	O
-	O
arterial	B-ANAT
,	O
or	O
central	O
ECMO	O
.	O

Cranial	B-ANAT
nerve	I-ANAT
palsies	O
are	O
frequent	O
in	O
Guillain	O
-	O
BarrÃ©	O
syndrome	O
.	O

Adsorption	O
therapy	O
was	O
able	O
to	O
facilitate	O
long	O
-	O
term	O
regain	O
of	O
balance	O
between	O
inflammatory	O
process	O
,	O
cytokine	O
production	O
and	O
bilirubin	O
turnover	O
in	O
the	O
liver	B-ANAT
.	O

Twenty	O
-	O
eight	O
consecutive	O
surviving	O
polytraumatized	O
patients	O
suffering	O
thoracic	B-ANAT
trauma	O
,	O
age	O
â¥	O
18	O
years	O
,	O
Injury	O
Severity	O
Score	O
â¥	O
16	O
,	O
and	O
directly	O
admitted	O
to	O
our	O
level	O
I	O
trauma	O
center	O
were	O
enrolled	O
in	O
this	O
prospective	O
study	O
.	O

Whole	O
blood	B-ANAT
samples	I-ANAT
were	O
obtained	O
for	O
pharmacokinetic	O
analysis	O
of	O
ketamine	O
during	O
ECMO	O
.	O

Delayed	O
initiation	O
of	O
proper	O
treatment	O
allowed	O
our	O
patient	O
'	O
s	O
mycoplasma	O
pneumonia	O
to	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
acute	O
kidney	B-ANAT
injury	O
.	O

The	O
British	O
Thoracic	B-ANAT
Society	O
does	O
not	O
recommend	O
blanket	O
empiric	O
treatment	O
of	O
mycoplasma	O
pneumonia	O
,	O
although	O
other	O
European	O
and	O
American	O
guidelines	O
do	O
,	O
and	O
so	O
it	O
is	O
important	O
to	O
consider	O
this	O
organism	O
in	O
high	O
-	O
risk	O
groups	O
to	O
prevent	O
severe	O
complications	O
.	O

We	O
also	O
found	O
that	O
PDCoV	O
could	O
be	O
detected	O
in	O
sows	O
faeces	B-ANAT
and	O
sera	B-ANAT
while	O
the	O
sows	O
showed	O
mild	O
,	O
self	O
-	O
limited	O
diarrhea	O
in	O
clinic	O
.	O

From	O
June	O
15	O
,	O
2017	O
to	O
May	O
14	O
,	O
2018	O
,	O
we	O
collected	O
nasopharyngeal	B-ANAT
swabs	O
from	O
600	O
patients	O
of	O
all	O
ages	O
older	O
than	O
1	O
month	O
hospitalized	O
with	O
pneumonia	O
at	O
Sibu	O
and	O
Kapit	O
Hospitals	O
.	O

A	O
medium	O
dose	O
significantly	O
attenuated	O
lung	B-ANAT
injury	O
,	O
and	O
reduced	O
proinflammatory	O
cytokine	O
production	O
and	O
neutrophil	B-ANAT
infiltration	O
into	O
alveoli	B-ANAT
.	O

The	O
normalization	O
of	O
ccf	O
-	O
gDNA	O
and	O
ccf	O
-	O
mtDNA	B-ANAT
was	O
significantly	O
delayed	O
in	O
HD	O
patients	O
compared	O
with	O
the	O
response	O
in	O
the	O
medical	O
staff	O
.	O

Plasma	B-ANAT
cell	I-ANAT
-	O
free	O
DNA	O
and	O
PTX	O
-	O
3	O
seems	O
to	O
be	O
good	O
indicators	O
of	O
stress	O
and	O
quality	O
of	O
care	O
in	O
HD	O
patients	O
.	O

At	O
the	O
nadir	O
of	O
illness	O
,	O
the	O
most	O
frequent	O
diagnosis	O
in	O
H	O
.	O
influenzae	O
-	O
related	O
cases	O
was	O
""""	O
pure	O
FS	O
""""	O
without	O
limb	B-ANAT
weakness	O
or	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
involvement	O
(	O
71	O
%),	O
in	O
C	O
.	O
jejuni	O
-	O
related	O
cases	O
""""	O
incomplete	O
FS	O
""""	O
such	O
as	O
acute	O
ophthalmoparesis	O
with	O
or	O
without	O
ataxia	O
(	O
60	O
%),	O
and	O
in	O
CMV	O
-	O
related	O
cases	O
(	O
50	O
%)	O
advanced	O
conditions	O
such	O
as	O
GBS	O
overlap	O
and	O
Bickerstaff	O
brainstem	B-ANAT
encephalitis	O
.	O

Pregnant	O
sows	O
were	O
primed	O
orally	B-ANAT
with	O
an	O
S	O
DEL5	O
/	O
ORF3	O
live	O
vaccine	O
and	O
boosted	O
intramuscularly	O
twice	O
with	O
a	O
commercial	O
killed	O
vaccine	O
at	O
2	O
-	O
week	O
intervals	O
prior	O
to	O
parturition	O
.	O

Furthermore	O
,	O
strong	O
antibody	O
responses	O
to	O
PEDV	O
were	O
verified	O
in	O
the	O
sera	B-ANAT
and	O
colostrum	B-ANAT
of	O
immunized	O
sows	O
with	O
the	O
prime	O
-	O
boost	O
treatment	O
and	O
their	O
offspring	O
.	O

In	O
our	O
study	O
,	O
using	O
a	O
number	O
of	O
techniques	O
,	O
we	O
showed	O
that	O
all	O
three	O
viruses	O
are	O
indeed	O
able	O
to	O
bind	O
to	O
sialic	O
acids	O
to	O
a	O
different	O
extent	O
,	O
but	O
these	O
molecules	O
render	O
the	O
cells	B-ANAT
permissive	O
only	O
for	O
the	O
clinical	O
strain	O
of	O
HCoV	O
-	O
OC43	O
,	O
while	O
for	O
others	O
they	O
serve	O
only	O
as	O
attachment	O
receptors	O
.	O

Furthermore	O
,	O
we	O
identified	O
heparan	O
sulfate	O
as	O
an	O
alternative	O
attachment	O
factor	O
,	O
but	O
this	O
may	O
be	O
related	O
to	O
the	O
cell	B-ANAT
culture	O
adaptation	O
,	O
as	O
in	O
ex	O
vivo	O
conditions	O
,	O
it	O
does	O
not	O
seem	O
to	O
play	O
a	O
significant	O
role	O
.	O

The	O
remaining	O
64	O
patients	O
experienced	O
aspiration	O
of	O
liquid	O
material	O
,	O
and	O
they	O
often	O
went	O
unrecognized	O
with	O
complete	O
recovery	O
.[	O
1	O
]	O
Through	O
his	O
animal	O
model	O
,	O
Mendelson	O
replicated	O
the	O
gastric	B-ANAT
acid	I-ANAT
in	O
the	O
respiratory	O
distress	O
syndrome	O
he	O
witnessed	O
in	O
human	O
patients	O
.	O

Following	O
aspiration	O
,	O
the	O
initial	O
clinical	O
course	O
was	O
severe	O
including	O
massive	O
atelectasis	O
with	O
cyanosis	O
,	O
dyspnea	O
,	O
mediastinal	B-ANAT
shift	O
,	O
and	O
radiographic	O
signs	O
of	O
lung	B-ANAT
injury	O
.	O

However	O
,	O
there	O
are	O
no	O
reports	O
of	O
delayed	O
retroperitoneal	B-ANAT
hemorrhage	O
,	O
which	O
develops	O
a	O
few	O
days	O
after	O
ECMO	O
initiation	O
and	O
is	O
unrelated	O
to	O
the	O
ECMO	O
cannulation	O
.	O

Delayed	O
retroperitoneal	B-ANAT
hemorrhage	O
can	O
develop	O
during	O
VV	O
-	O
ECMO	O
management	O
a	O
few	O
days	O
after	O
its	O
initiation	O
.	O

To	O
determine	O
whether	O
Fc	O
fusion	O
affects	O
the	O
immunogenicity	O
of	O
MERS	O
-	O
CoV	O
antigen	O
,	O
we	O
constructed	O
a	O
Fcassociated	O
MERS	O
-	O
CoV	O
spike	O
protein	O
(	O
eS770	O
-	O
Fc	O
,	O
110	O
kDa	O
),	O
whereby	O
human	O
IgG4	B-ANAT
Fc	O
domain	O
was	O
fused	O
to	O
MERS	O
-	O
CoV	O
spike	O
protein	O
(	O
eS770	O
)	O
via	O
a	O
Gly	O
/	O
Pro	O
linker	O
using	O
baculovirus	O
as	O
the	O
expression	O
system	O
.	O

An	O
increase	O
of	O
serum	B-ANAT
visfatin	O
was	O
discovered	O
in	O
ALI	O
patients	O
compared	O
to	O
normal	O
controls	O
.	O

TITLE	O
:	O
Exposure	O
to	O
Atmospheric	O
Ultrafine	O
Particles	O
Induces	O
Severe	O
Lung	B-ANAT
Inflammatory	O
Response	O
and	O
Tissue	B-ANAT
Remodeling	O
in	O
Mice	O
.	O

Histological	O
analyses	O
revealed	O
that	O
about	O
50	O
%	O
of	O
lung	B-ANAT
tissues	I-ANAT
were	O
damaged	O
in	O
mice	O
exposed	O
to	O
UFP	O
for	O
three	O
months	O
versus	O
only	O
35	O
%	O
in	O
FF	O
-	O
exposed	O
mice	O
.	O

These	O
injuries	O
were	O
characterized	O
by	O
alveolar	B-ANAT
wall	I-ANAT
thickening	O
,	O
macrophage	B-ANAT
infiltrations	O
,	O
and	O
cystic	O
lesions	O
.	O

This	O
single	O
-	O
center	O
,	O
retrospective	O
study	O
examined	O
15	O
years	O
of	O
data	O
from	O
a	O
quality	O
assurance	O
program	O
that	O
monitored	O
the	O
use	O
of	O
lung	B-ANAT
-	O
protective	O
ventilation	O
in	O
ARDS	O
.	O

Nonpulmonary	O
organ	B-ANAT
dysfunction	O
was	O
present	O
in	O
at	O
least	O
1	O
system	O
at	O
ARDS	O
onset	O
that	O
increased	O
with	O
severity	O
:	O
80	O
%	O
(	O
mild	O
),	O
83	O
%	O
(	O
moderate	O
),	O
and	O
90	O
%	O
(	O
severe	O
).	O

Multivariate	O
logistic	O
regression	O
modeling	O
revealed	O
that	O
the	O
Berlin	O
definition	O
of	O
severe	O
ARDS	O
was	O
independently	O
associated	O
with	O
mortality	O
,	O
as	O
were	O
cutoff	O
values	O
for	O
renal	B-ANAT
and	O
hepatic	B-ANAT
function	O
as	O
well	O
as	O
acidemia	O
.	O

TITLE	O
:	O
[	O
Severe	O
pneumonia	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
Implication	O
of	O
unconventional	O
T	B-ANAT
cells	I-ANAT
].	O

To	O
address	O
this	O
,	O
""""	O
unconventional	O
T	B-ANAT
-	I-ANAT
cells	I-ANAT
(	O
UTC	O
")"""	O
-	O
Î³Î´T	O
,	O
NKT	O
and	O
MAIT	O
cells	B-ANAT
-	O
appear	O
to	O
be	O
relevant	O
targets	O
due	O
to	O
their	O
key	O
role	O
in	O
orchestrating	O
anti	O
-	O
microbial	O
immune	O
response	O
in	O
the	O
lung	B-ANAT
.	O

Thus	O
,	O
using	O
an	O
experimental	O
and	O
translational	O
approach	O
,	O
we	O
test	O
the	O
hypothesis	O
that	O
a	O
tight	O
regulation	O
of	O
UTC	O
is	O
mandatory	O
to	O
fine	O
-	O
tune	O
host	O
response	O
,	O
and	O
,	O
subsequently	O
to	O
prevent	O
emergence	O
of	O
an	O
aberrant	O
response	O
leading	O
to	O
excessive	O
tissue	B-ANAT
damages	O
,	O
and	O
eventually	O
,	O
ARDS	O
.	O

Acute	O
coronary	B-ANAT
syndrome	O
was	O
excluded	O
by	O
normal	O
coronary	B-ANAT
angiograms	O
.	O

A	O
further	O
nasal	B-ANAT
swab	O
was	O
collected	O
by	O
research	O
staff	O
during	O
a	O
clinic	O
visit	O
at	O
the	O
conclusion	O
of	O
the	O
study	O
.	O

Many	O
strains	O
of	O
type	O
I	O
FIPV	O
do	O
not	O
cause	O
FIP	O
by	O
inoculation	O
through	O
the	O
oral	B-ANAT
route	O
in	O
cats	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
rabbits	O
to	O
further	O
characterize	O
the	O
transmission	O
potential	O
of	O
MERS	O
-	O
CoV	O
.	O
In	O
line	O
with	O
the	O
presence	O
of	O
MERS	O
-	O
CoV	O
receptor	O
in	O
the	O
rabbit	O
nasal	B-ANAT
epithelium	I-ANAT
,	O
high	O
levels	O
of	O
viral	O
RNA	O
were	O
shed	O
from	O
the	O
nose	B-ANAT
following	O
virus	O
inoculation	O
.	O

TITLE	O
:	O
Porcine	O
Epidemic	O
Diarrhea	O
Virus	O
(	O
PEDV	O
)	O
ORF3	O
Interactome	O
Reveals	O
Inhibition	O
of	O
Virus	O
Replication	O
by	O
Cellular	B-ANAT
VPS36	O
Protein	O
.	O

TITLE	O
:	O
P53	O
supports	O
endothelial	B-ANAT
barrier	O
function	O
via	O
APE1	O
/	O
Ref1	O
suppression	O
.	O

Ongoing	O
investigations	O
suggest	O
that	O
P53	O
exerts	O
a	O
prominent	O
strategic	O
role	O
in	O
crucial	O
signaling	O
cascades	O
,	O
in	O
charge	O
of	O
both	O
the	O
maintenance	O
and	O
defense	O
of	O
pulmonary	B-ANAT
endothelium	B-ANAT
against	O
toxic	O
intruders	O
.	O

The	O
current	O
study	O
employs	O
human	O
and	O
bovine	O
lung	B-ANAT
microvascular	O
cells	B-ANAT
,	O
as	O
well	O
as	O
pharmacologic	O
and	O
genetic	O
P53	O
modulators	O
to	O
demonstrate	O
the	O
negative	O
regulation	O
of	O
APE1	O
/	O
Ref1	O
by	O
P53	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
immunogenicities	O
of	O
five	O
different	O
forms	O
of	O
the	O
MERS	O
-	O
CoV	O
S	O
glycoprotein	O
were	O
compared	O
:	O
the	O
full	O
-	O
length	O
S	O
glycoprotein	O
,	O
the	O
full	O
-	O
length	O
S	O
glycoprotein	O
with	O
the	O
transmembrane	B-ANAT
domain	O
of	O
the	O
G	O
glycoprotein	O
of	O
VSV	O
(	O
S	O
-	O
G	O
),	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
S	O
glycoprotein	O
,	O
the	O
membrane	B-ANAT
-	O
fused	O
RBD	O
(	O
the	O
RBD	O
fused	O
with	O
the	O
transmembrane	B-ANAT
domain	O
of	O
the	O
VSV	O
G	O
glycoprotein	O
(	O
RBD	O
-	O
G	O
)),	O
and	O
the	O
RBD	O
fused	O
with	O
Fc	O
of	O
human	O
IgG1	O
(	O
RBD	O
-	O
Fc	O
).	O

Excessive	O
activation	O
of	O
fibroblast	B-ANAT
during	O
the	O
fibroproliferative	O
phase	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
prognosis	O
of	O
ARDS	O
.	O

In	O
vitro	O
,	O
LPS	O
activated	O
NIH3T3	O
cells	B-ANAT
,	O
which	O
was	O
suppressed	O
by	O
VIP	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Extracorporeal	O
life	O
support	O
can	O
provide	O
adequate	O
oxygenation	O
while	O
allowing	O
the	O
lungs	B-ANAT
to	O
rest	O
and	O
heal	O
,	O
which	O
might	O
be	O
an	O
ideal	O
therapy	O
in	O
this	O
patient	O
group	O
,	O
although	O
long	O
-	O
term	O
clinical	O
and	O
radiological	O
outcomes	O
are	O
not	O
known	O
.	O

In	O
this	O
study	O
,	O
the	O
pro	O
-	O
apoptotic	O
effect	O
of	O
PEDV	O
was	O
examined	O
in	O
Vero	B-ANAT
cells	I-ANAT
and	O
we	O
observed	O
that	O
PEDV	O
infection	O
increased	O
MDM2	O
and	O
CBP	O
,	O
promoted	O
p53	O
phosphorylation	O
at	O
serine	O
20	O
and	O
,	O
promoted	O
p53	O
nuclear	O
translocation	O
,	O
leading	O
to	O
p53	O
activation	O
in	O
Vero	B-ANAT
cells	I-ANAT
.	O

ABSTRACT	O
:	O
Testicular	O
germ	B-ANAT
cell	I-ANAT
tumors	O
(	O
TGCTs	O
)	O
represent	O
the	O
most	O
common	O
solid	O
tumor	O
in	O
young	O
men	O
and	O
is	O
a	O
model	O
of	O
curable	O
cancer	O
.	O

TITLE	O
:	O
Inhaled	O
Nitric	O
Oxide	O
as	O
an	O
Adjunct	O
to	O
Thrombolytic	O
Therapy	O
in	O
a	O
Patient	O
with	O
Submassive	O
Pulmonary	B-ANAT
Embolism	O
and	O
Severe	O
Hypoxemia	O
.	O

ABSTRACT	O
:	O
Inhaled	O
nitric	O
oxide	O
(	O
iNO	O
)	O
is	O
a	O
selective	O
pulmonary	B-ANAT
vasodilator	O
with	O
limited	O
indications	O
in	O
adults	O
.	O

Chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
revealed	O
a	O
large	O
embolus	O
in	O
the	O
right	B-ANAT
main	I-ANAT
pulmonary	I-ANAT
artery	I-ANAT
and	O
transthoracic	O
echocardiogram	O
(	O
TTE	O
)	O
reported	O
new	O
right	O
ventricular	B-ANAT
dilatation	O
with	O
decreased	O
right	O
ventricular	B-ANAT
function	O
.	O

The	O
dexterity	O
of	O
the	O
robotic	O
instruments	O
aid	O
in	O
performing	O
a	O
more	O
extensive	O
nodal	O
dissection	O
and	O
the	O
precision	O
and	O
detailed	O
vision	O
of	O
the	O
robotic	O
system	O
potentially	O
improves	O
staging	O
,	O
oncological	O
outcomes	O
and	O
reduces	O
complications	O
(	O
i	O
.	O
e	O
.,	O
recurrent	O
nerve	B-ANAT
palsy	O
).	O

Radicality	O
rate	O
(	O
R0	O
resection	O
)	O
was	O
98	O
%	O
and	O
the	O
average	O
lymph	B-ANAT
node	I-ANAT
yield	O
was	O
24	O
(	O
range	O
,	O
9	O
-	O
57	O
).	O

ORF3a	O
interacted	O
with	O
TRAF3	O
and	O
ASC	O
,	O
colocalized	O
with	O
them	O
in	O
discrete	O
punctate	O
structures	O
in	O
the	O
cytoplasm	B-ANAT
,	O
and	O
facilitated	O
ASC	O
speck	O
formation	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
frequency	O
of	O
infections	O
caused	O
by	O
Influenza	O
viruses	O
,	O
i	O
.	O
e	O
.	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
,	O
Influenza	O
A	O
(	O
H3N2	O
)	O
and	O
Influenza	O
B	O
in	O
patients	O
presenting	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
,	O
i	O
.	O
e	O
.	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
)	O
and	O
severe	O
acute	O
respiratory	O
illness	O
(	O
SARI	O
).	O

A	O
total	O
of	O
624	O
samples	O
from	O
patients	O
with	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
both	O
ILI	O
and	O
SARI	O
)	O
were	O
included	O
in	O
the	O
study	O
.	O

In	O
the	O
quest	O
of	O
new	O
RSV	O
inhibitors	O
,	O
in	O
this	O
work	O
we	O
evaluated	O
the	O
antiviral	O
activity	O
of	O
a	O
series	O
of	O
variously	O
substituted	O
5	O
,	O
6	O
-	O
dichloro	O
-	O
1	O
-	O
phenyl	O
-	O
1	O
(	O
2	O
)	O
H	O
-	O
benzo	O
[	O
d	O
][	O
1	O
,	O
2	O
,	O
3	O
]	O
triazole	O
derivatives	O
in	O
cell	B-ANAT
-	O
based	O
assays	O
.	O

Differential	O
expression	O
of	O
the	O
genes	O
was	O
observed	O
at	O
different	O
time	O
-	O
points	O
of	O
egg	B-ANAT
-	O
shell	B-ANAT
formation	O
.	O

Peptide	O
4934	O
reacted	O
equally	O
with	O
positive	O
sera	B-ANAT
from	O
healthy	O
cats	O
and	O
cats	O
with	O
feline	O
infectious	O
peritonitis	O
(	O
FIP	O
),	O
while	O
peptide	O
16433	O
was	O
recognized	O
predominantly	O
by	O
FIP	O
-	O
affected	O
cats	O
.	O

Conclusions	O
:	O
Changes	O
in	O
antioxidant	O
system	O
happend	O
due	O
to	O
the	O
activation	O
of	O
lipid	O
peroxidation	O
,	O
and	O
because	O
of	O
the	O
inability	O
to	O
neutralize	O
toxic	O
metabolites	O
in	O
the	O
children	O
`	O
body	B-ANAT
the	O
intoxication	O
syndrome	O
developed	O
.	O

The	O
most	O
common	O
use	O
of	O
this	O
tool	O
is	O
to	O
determine	O
whether	O
acute	O
coronary	B-ANAT
syndrome	O
(	O
ACS	O
)	O
is	O
occurring	O
,	O
but	O
other	O
differentials	O
include	O
cardiomyopathy	O
,	O
pulmonary	B-ANAT
embolism	O
,	O
and	O
even	O
acute	O
heart	B-ANAT
failure	O
.	O

Lung	B-ANAT
protection	O
can	O
probably	O
be	O
further	O
enhanced	O
by	O
scaling	O
target	O
tidal	O
volumes	O
to	O
the	O
specific	O
respiratory	O
mechanics	O
of	O
individual	O
patients	O
.	O

TITLE	O
:	O
Mechanical	O
power	O
normalized	O
to	O
predicted	O
body	B-ANAT
weight	O
as	O
a	O
predictor	O
of	O
mortality	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Multivariate	O
statistical	O
models	O
using	O
hedgehog	O
case	O
history	O
data	O
,	O
faecal	B-ANAT
specimen	O
descriptions	O
and	O
post	O
-	O
mortem	O
examination	O
findings	O
found	O
no	O
significant	O
associations	O
indicative	O
of	O
disease	O
associated	O
with	O
EriCoV	O
in	O
hedgehogs	O
.	O

ABSTRACT	O
:	O
Beyond	O
retrieval	O
and	O
management	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
an	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
center	O
also	O
encompasses	O
several	O
other	O
actions	O
,	O
such	O
as	O
on	O
-	O
call	O
consultations	O
,	O
advice	O
,	O
and	O
counseling	O
,	O
to	O
the	O
physicians	O
at	O
the	O
peripheral	O
centers	O
,	O
but	O
few	O
data	O
are	O
available	O
on	O
this	O
topic	O
.	O

In	O
medical	O
sepsis	O
,	O
resource	O
-	O
limited	O
region	O
,	O
hospital	O
-	O
acquired	O
infection	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
at	O
sepsis	O
recognition	O
,	O
higher	O
Pediatric	O
Index	O
of	O
Mortality	O
-	O
3	O
score	O
,	O
and	O
malignancy	O
were	O
independent	O
risk	O
factors	O
for	O
death	O
.	O

In	O
medical	O
sepsis	O
,	O
resource	O
-	O
limited	O
region	O
,	O
hospital	O
-	O
acquired	O
infection	O
,	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
at	O
sepsis	O
recognition	O
,	O
higher	O
Pediatric	O
Index	O
of	O
Mortality	O
-	O
3	O
score	O
,	O
and	O
malignancy	O
were	O
independent	O
risk	O
factors	O
for	O
death	O
.	O

Full	O
-	O
length	O
spike	O
,	O
hemagglutinin	O
/	O
esterase	O
(	O
HE	O
),	O
nucleocapsid	B-ANAT
and	O
transmembrane	B-ANAT
genes	O
were	O
simultaneously	O
cloned	O
from	O
13	O
clinical	O
samples	O
(	O
eight	O
farms	O
in	O
four	O
provinces	O
),	O
and	O
most	O
of	O
the	O
BCoV	O
strains	O
showed	O
a	O
unique	O
evolutionary	O
pattern	O
based	O
on	O
the	O
phylogenetic	O
analysis	O
of	O
these	O
genes	O
.	O

In	O
order	O
to	O
determine	O
the	O
prevalence	O
of	O
IBV	O
serotype	O
(	O
s	O
)	O
in	O
the	O
flock	O
,	O
serum	B-ANAT
samples	O
were	O
screened	O
by	O
hemagglutination	O
-	O
inhibition	O
(	O
HI	O
)	O
test	O
using	O
IBV	O
antigens	O
and	O
antisera	O
(	O
Arkansas	O
,	O
Connecticut	O
,	O
and	O
Massachusetts	O
).	O

TITLE	O
:	O
Oxygen	O
delivery	O
,	O
carbon	O
dioxide	O
removal	O
,	O
energy	O
transfer	O
to	O
lungs	B-ANAT
and	O
pulmonary	B-ANAT
hypertension	O
behavior	O
during	O
venous	B-ANAT
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
support	O
:	O
a	O
mathematical	O
modeling	O
approach	O
.	O

RESULTS	O
:	O
The	O
transition	O
from	O
protective	O
ventilation	O
to	O
ultraprotective	O
ventilation	O
in	O
a	O
patient	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
a	O
static	O
respiratory	O
compliance	O
of	O
20mL	O
/	O
cm	O
H2O	O
reduced	O
the	O
energy	O
transfer	O
from	O
the	O
ventilator	O
to	O
the	O
lungs	B-ANAT
from	O
35	O
.	O
3	O
to	O
2	O
.	O
6	O
joules	O
/	O
minute	O
.	O

ABSTRACT	O
:	O
Avian	O
Influenza	O
A	O
(	O
H5N6	O
)	O
Virus	O
causes	O
severe	O
influenza	O
disease	O
in	O
humans	O
and	O
is	O
manifested	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
multi	O
-	O
organ	B-ANAT
failure	O
,	O
and	O
high	O
mortality	O
rates	O
.	O

FCoV	O
is	O
incredibly	O
contagious	O
and	O
transmission	O
is	O
via	O
the	O
faecal	B-ANAT
-	O
oral	B-ANAT
route	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
developed	O
and	O
the	O
patient	O
was	O
oxygenated	O
via	O
veno	O
-	O
venous	B-ANAT
ECMO	O
due	O
to	O
the	O
failure	O
of	O
mechanical	O
ventilation	O
.	O

Fatal	O
H7N9	O
pneumonia	O
complicated	O
with	O
severe	O
ARDS	O
,	O
pulmonary	B-ANAT
bullae	O
,	O
and	O
refractory	O
pneumothorax	O
.	O

TITLE	O
:	O
Venovenous	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
in	O
a	O
Gravid	O
Patient	O
with	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
A	O
Case	O
Report	O
.	O

In	O
this	O
study	O
,	O
a	O
series	O
of	O
heptad	O
repeat	O
1	O
(	O
HR1	O
)	O
peptide	O
inhibitors	O
have	O
been	O
developed	O
to	O
inhibit	O
HR1	O
/	O
HR2	O
-	O
mediated	O
membrane	B-ANAT
fusion	O
between	O
MERS	O
-	O
CoV	O
and	O
host	O
cells	B-ANAT
,	O
which	O
is	O
the	O
major	O
pathway	O
of	O
MERS	O
-	O
CoV	O
-	O
induced	O
host	O
infections	O
.	O

The	O
purpose	O
of	O
the	O
study	O
was	O
the	O
investigation	O
of	O
endogenous	O
CO	O
production	O
in	O
the	O
body	B-ANAT
of	O
patients	O
with	O
polytrauma	O
by	O
determining	O
the	O
percentage	O
of	O
carboxylated	O
hemoglobin	O
(	O
HbCO	O
%)	O
in	O
the	O
blood	B-ANAT
using	O
photoplethysmometric	O
technology	O
,	O
as	O
well	O
as	O
determining	O
the	O
degree	O
of	O
danger	O
of	O
the	O
specified	O
products	O
to	O
the	O
body	B-ANAT
of	O
patients	O
.	O

36	O
patients	O
manifested	O
the	O
syndrome	O
of	O
acute	O
respiratory	O
failure	O
on	O
the	O
background	O
of	O
a	O
chest	B-ANAT
injury	O
with	O
a	O
lung	B-ANAT
contusion	O
.	O

In	O
patients	O
with	O
lower	O
respiratory	O
symptoms	O
,	O
development	O
of	O
respiratory	O
insufficiency	O
should	O
trigger	O
rapid	O
and	O
thorough	O
clinical	O
evaluation	O
,	O
in	O
particular	O
in	O
cases	O
of	O
suspected	O
ARDS	O
,	O
including	O
electrocardiography	O
and	O
echocardiography	O
to	O
exclude	O
cardiac	B-ANAT
dysfunction	O
,	O
arrhythmias	O
and	O
ischaemia	O
.	O

The	O
management	O
algorithm	O
should	O
comprise	O
bronchoalveolar	O
lavage	O
,	O
CT	O
imaging	O
,	O
sophisticated	O
ventilator	O
-	O
management	O
,	O
rescue	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
,	O
and	O
antifungal	O
and	O
antiviral	O
therapy	O
.	O

The	O
convoluted	O
membranes	B-ANAT
structures	O
described	O
in	O
alpha	O
-	O
and	O
beta	O
-	O
coronavirus	O
were	O
not	O
observed	O
.	O

TITLE	O
:	O
[	O
Effect	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
phagocytosis	O
on	O
prognosis	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
abdominal	B-ANAT
infection	O
:	O
a	O
multicenter	O
study	O
].	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
effects	O
of	O
alveolar	B-ANAT
macrophage	I-ANAT
phagocytosis	O
on	O
prognosis	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
abdominal	B-ANAT
infection	O
.	O

The	O
gender	O
,	O
age	O
,	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
II	O
(	O
APACHE	O
II	O
)	O
within	O
24	O
hours	O
of	O
admission	O
,	O
neutral	O
red	O
phagocytosis	O
and	O
alkaline	O
phosphatase	O
activity	O
of	O
macrophages	B-ANAT
in	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
,	O
the	O
length	O
of	O
ICU	O
stay	O
,	O
total	O
hospitalization	O
time	O
,	O
hospitalization	O
expenses	O
,	O
and	O
prognosis	O
were	O
recorded	O
.	O

Compared	O
with	O
the	O
survival	O
group	O
,	O
the	O
death	O
group	O
was	O
older	O
(	O
years	O
old	O
:	O
58	O
.	O
50	O
Â±	O
14	O
.	O
86	O
vs	O
.	O
46	O
.	O
67	O
Â±	O
13	O
.	O
40	O
),	O
APACHE	O
II	O
score	O
was	O
higher	O
(	O
21	O
.	O
50	O
Â±	O
3	O
.	O
93	O
vs	O
.	O
13	O
.	O
58	O
Â±	O
4	O
.	O
12	O
),	O
neutral	O
red	O
phagocytosis	O
ability	O
and	O
alkaline	O
phosphatase	O
activity	O
of	O
alveolar	B-ANAT
macrophages	I-ANAT
were	O
significantly	O
decreased	O
(	O
A	O
value	O
:	O
0	O
.	O
265	O
Â±	O
0	O
.	O
050	O
vs	O
.	O
0	O
.	O
338	O
Â±	O
0	O
.	O
016	O
;	O
Î¼mol	O
/	O
L	O
:	O
12	O
.	O
06	O
Â±	O
1	O
.	O
24	O
vs	O
.	O
17	O
.	O
96	O
Â±	O
3	O
.	O
90	O
),	O
and	O
the	O
length	O
of	O
ICU	O
stay	O
was	O
significantly	O
longer	O
(	O
days	O
:	O
22	O
.	O
00	O
Â±	O
14	O
.	O
59	O
vs	O
.	O
11	O
.	O
50	O
Â±	O
3	O
.	O
17	O
),	O
hospitalization	O
cost	O
was	O
significantly	O
increased	O
(	O
10	O
thousand	O
Yuan	O
:	O
24	O
.	O
17	O
Â±	O
11	O
.	O
02	O
vs	O
.	O
13	O
.	O
44	O
Â±	O
3	O
.	O
53	O
),	O
the	O
total	O
hospitalization	O
time	O
was	O
shorter	O
(	O
days	O
:	O
25	O
.	O
25	O
Â±	O
15	O
.	O
01	O
vs	O
.	O
35	O
.	O
67	O
Â±	O
8	O
.	O
58	O
),	O
and	O
the	O
difference	O
was	O
statistically	O
significant	O
(	O
all	O
P	O
<	O
0	O
.	O
05	O
).	O

ROC	O
curve	O
analysis	O
showed	O
that	O
the	O
AUC	O
of	O
neutral	O
red	O
phagocytosis	O
ability	O
for	O
prognosis	O
of	O
ARDS	O
patients	O
caused	O
by	O
abdominal	B-ANAT
infection	O
was	O
0	O
.	O
948	O
,	O
and	O
the	O
sensitivity	O
and	O
specificity	O
were	O
91	O
.	O
7	O
%	O
and	O
87	O
.	O
5	O
%	O
when	O
the	O
off	O
-	O
cut	O
value	O
was	O
0	O
.	O
317	O
.	O

In	O
this	O
study	O
,	O
blood	B-ANAT
samples	I-ANAT
from	O
627	O
malaria	O
patients	O
were	O
analyzed	O
for	O
infected	O
parasite	O
species	O
,	O
clinical	O
conditions	O
,	O
platelet	B-ANAT
levels	O
,	O
and	O
key	O
cytokines	O
that	O
are	O
produced	O
in	O
response	O
to	O
infection	O
;	O
samples	O
from	O
176	O
uninfected	O
healthy	O
individuals	O
were	O
used	O
as	O
controls	O
.	O

Diagnosis	O
of	O
mercury	O
poisoning	O
was	O
confirmed	O
by	O
blood	B-ANAT
levels	O
,	O
and	O
despite	O
treatment	O
with	O
dimercaprol	O
(	O
mercury	O
chelator	O
)	O
and	O
high	O
-	O
frequency	O
ventilation	O
,	O
the	O
child	O
subsequently	O
succumbed	O
within	O
26	O
hours	O
.	O

The	O
study	O
objective	O
was	O
to	O
document	O
case	O
management	O
of	O
ECoV	O
in	O
adult	O
horses	O
presented	O
to	O
a	O
referral	O
hospital	O
and	O
compare	O
to	O
a	O
cohort	O
of	O
horses	O
that	O
tested	O
negative	O
for	O
ECoV	O
.	O
A	O
retrospective	O
case	O
series	O
was	O
performed	O
based	O
on	O
positive	O
real	O
-	O
time	O
quantitative	O
PCR	O
results	O
for	O
ECoV	O
on	O
faeces	B-ANAT
from	O
horses	O
treated	O
at	O
the	O
UC	O
Davis	O
Veterinary	O
Medical	O
Teaching	O
Hospital	O
from	O
1	O
March	O
2012	O
to	O
31	O
March	O
2018	O
.	O

Molecular	O
diagnostic	O
testing	O
found	O
BCV	O
and	O
Histophilus	O
somni	O
in	O
nasal	B-ANAT
swabs	O
taken	O
at	O
the	O
time	O
of	O
BRD	O
treatment	O
.	O

Cats	O
that	O
survived	O
primary	O
infection	O
were	O
challenged	O
a	O
second	O
time	O
to	O
pathogenic	O
FIPV	O
and	O
tested	O
for	O
antiviral	O
T	B-ANAT
cell	I-ANAT
responses	O
over	O
a	O
four	O
week	O
period	O
.	O

RESULTS	O
:	O
Differences	O
in	O
disease	O
outcome	O
provided	O
an	O
opportunity	O
to	O
investigate	O
the	O
role	O
of	O
T	B-ANAT
cell	I-ANAT
immunity	O
to	O
FIP	O
determined	O
by	O
T	B-ANAT
cell	I-ANAT
subset	I-ANAT
proliferation	O
after	O
stimulation	O
with	O
different	O
viral	O
antigens	O
.	O

TITLE	O
:	O
Veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
should	O
the	O
EOLIA	O
Study	O
results	O
change	O
our	O
clinical	O
approach	O
?	O

Passive	O
transfer	O
of	O
immune	O
sera	B-ANAT
to	O
naÃ¯ve	O
hDPP4	O
-	O
KI	O
mice	O
also	O
provided	O
survival	O
advantages	O
from	O
lethal	O
MERS	O
-	O
CoV	O
-	O
MA	O
challenge	O
.	O

TITLE	O
:	O
[	O
Investigation	O
of	O
viral	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
agents	O
by	O
multiplex	O
PCR	O
method	O
in	O
autopsy	O
cases	O
:	O
A	O
five	O
-	O
year	O
study	O
].	O

TITLE	O
:	O
Coronavirus	O
envelope	B-ANAT
protein	O
:	O
current	O
knowledge	O
.	O

Recent	O
studies	O
have	O
expanded	O
on	O
its	O
structural	O
motifs	O
and	O
topology	O
,	O
its	O
functions	O
as	O
an	O
ion	O
-	O
channelling	O
viroporin	O
,	O
and	O
its	O
interactions	O
with	O
both	O
other	O
CoV	O
proteins	O
and	O
host	B-ANAT
cell	I-ANAT
proteins	O
.	O

I	O
and	O
II	O
)	O
or	O
sow	O
'	O
s	O
colostrum	B-ANAT
(	O
in	O
exp	O
.	O

ABSTRACT	O
:	O
A	O
47	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
recent	O
history	O
of	O
wading	O
in	O
floodwaters	O
presented	O
with	O
a	O
1	O
-	O
week	O
history	O
of	O
cough	O
,	O
myalgia	O
,	O
conjunctival	O
suffusion	O
and	O
decreasing	O
urine	B-ANAT
output	O
.	O

Oxygenation	O
and	O
lung	B-ANAT
compliance	O
improved	O
,	O
and	O
serum	B-ANAT
creatinine	O
levels	O
continued	O
to	O
normalise	O
with	O
improved	O
urine	B-ANAT
output	O
.	O

ABSTRACT	O
:	O
We	O
aimed	O
to	O
assess	O
the	O
profile	O
of	O
respiratory	O
viruses	O
in	O
young	O
children	O
hospitalized	O
for	O
acute	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
(	O
ALRI	O
)	O
and	O
its	O
association	O
with	O
disease	O
severity	O
,	O
defined	O
as	O
need	O
for	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	O
)	O
admission	O
.	O

Nasopharyngeal	B-ANAT
aspirates	B-ANAT
were	O
collected	O
from	O
patients	O
from	O
June	O
1st	O
,	O
2008	O
to	O
May	O
31st	O
,	O
2009within	O
the	O
first	O
48	O
hours	O
of	O
hospitalization	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
cause	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
in	O
humans	O
and	O
outbreaks	O
of	O
deadly	O
pneumonia	O
worldwide	O
.	O

The	O
primary	O
outcome	O
was	O
hospital	O
mortality	O
,	O
whereas	O
secondary	O
outcomes	O
included	O
prevalence	O
of	O
acute	O
kidney	B-ANAT
injury	O
and	O
characterization	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
risk	O
factors	O
and	O
illness	O
severity	O
patterns	O
,	O
in	O
patients	O
with	O
acute	O
kidney	B-ANAT
injury	O
versus	O
no	O
acute	O
kidney	B-ANAT
injury	O
.	O

One	O
-	O
thousand	O
nine	O
-	O
hundred	O
seventy	O
-	O
four	O
patients	O
met	O
inclusion	O
criteria	O
:	O
1	O
,	O
209	O
(	O
61	O
%)	O
with	O
no	O
acute	O
kidney	B-ANAT
injury	O
,	O
468	O
(	O
24	O
%)	O
with	O
mild	O
-	O
moderate	O
acute	O
kidney	B-ANAT
injury	O
,	O
and	O
297	O
(	O
15	O
%)	O
with	O
severe	O
acute	O
kidney	B-ANAT
injury	O
.	O

Integrin	O
Î±5Î²1	O
is	O
a	O
transmembrane	B-ANAT
macromolecular	O
that	O
closely	O
related	O
to	O
neurological	O
function	O
.	O

The	O
small	B-ANAT
intestines	I-ANAT
,	O
particularly	O
the	O
jejunum	B-ANAT
and	O
ileum	B-ANAT
,	O
are	O
the	O
most	O
common	O
targets	O
of	O
these	O
four	O
CoVs	O
in	O
vivo	O
,	O
and	O
co	O
-	O
infections	O
by	O
these	O
CoVs	O
are	O
frequently	O
observed	O
in	O
clinically	O
infected	O
pigs	O
.	O

This	O
study	O
was	O
conducted	O
to	O
investigate	O
the	O
susceptibility	O
of	O
the	O
porcine	O
ileum	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
line	O
,	O
IPI	O
-	O
2I	O
,	O
to	O
different	O
swine	O
enteric	O
CoVs	O
.	O

We	O
found	O
that	O
IPI	O
-	O
2I	O
cells	B-ANAT
are	O
highly	O
susceptible	O
to	O
TGEV	O
,	O
PDCoV	O
,	O
and	O
PEAV	O
,	O
as	O
demonstrated	O
by	O
cytopathic	O
effect	O
and	O
virus	O
multiplication	O
.	O

However	O
,	O
only	O
a	O
small	O
number	O
of	O
cells	B-ANAT
could	O
be	O
infected	O
by	O
PEDV	O
,	O
possibly	O
due	O
to	O
the	O
heterogeneity	O
of	O
IPI	O
-	O
2I	O
cells	B-ANAT
.	O

These	O
findings	O
detail	O
the	O
maternal	O
autonomic	B-ANAT
response	O
to	O
buprenorphine	O
administration	O
but	O
also	O
illustrate	O
the	O
significant	O
effect	O
of	O
concurrent	O
cigarette	O
use	O
on	O
maternal	O
autonomic	B-ANAT
regulation	O
.	O

RESULTS	O
:	O
Buprenorphine	O
administration	O
accelerated	O
maternal	O
heart	B-ANAT
rate	O
and	O
reduced	O
variability	O
at	O
two	O
gestational	O
ages	O
(	O
24	O
and	O
36	O
weeks	O
)	O
and	O
suppressed	O
sympathetic	O
(	O
electrodermal	O
)	O
activation	O
at	O
24	O
,	O
28	O
and	O
32	O
weeks	O
at	O
times	O
of	O
peak	O
maternal	O
medication	O
levels	O
.	O

Currently	O
more	O
than	O
60	O
million	O
donations	O
per	O
year	O
are	O
NAT	O
tested	O
worldwide	O
and	O
the	O
remaining	O
residual	O
risk	O
of	O
virus	O
transmission	O
by	O
blood	B-ANAT
components	I-ANAT
and	O
products	O
could	O
be	O
reduced	O
to	O
almost	O
zero	O
.	O

Mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
(	O
MSCs	O
)	O
are	O
able	O
to	O
modulate	O
proliferation	O
,	O
activation	O
,	O
and	O
effector	O
function	O
of	O
all	O
immune	O
cells	B-ANAT
that	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
acute	O
and	O
chronic	O
inflammatory	O
lung	B-ANAT
diseases	O
.	O

Chest	B-ANAT
imaging	O
may	O
reveal	O
a	O
peripheral	O
distribution	O
of	O
bilateral	O
infiltrates	O
with	O
no	O
evidence	O
of	O
excessive	O
pulmonary	B-ANAT
vasculature	I-ANAT
congestion	O
or	O
cardiomegaly	O
.	O

The	O
scope	O
of	O
noncardiogenic	O
pulmonary	B-ANAT
edema	O
is	O
much	O
broader	O
than	O
ARDS	O
and	O
includes	O
other	O
etiologies	O
which	O
include	O
high	O
altitude	O
pulmonary	B-ANAT
edema	O
,	O
neurogenic	O
pulmonary	B-ANAT
edema	O
,	O
opioid	O
overdose	O
,	O
salicylate	O
toxicity	O
,	O
pulmonary	B-ANAT
embolism	O
,	O
reexpansion	O
pulmonary	B-ANAT
edema	O
,	O
reperfusion	O
pulmonary	B-ANAT
edema	O
,	O
and	O
transfusion	O
-	O
related	O
acute	O
lung	B-ANAT
injury	O
(	O
TRALI	O
).	O

TITLE	O
:	O
[	O
Current	O
status	O
of	O
spleen	B-ANAT
-	O
mediated	O
inflammatory	O
response	O
in	O
traumatic	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

The	O
spleen	B-ANAT
is	O
the	O
largest	O
peripheral	O
immune	O
organ	B-ANAT
of	O
the	O
body	B-ANAT
,	O
containing	O
a	O
large	O
number	O
of	O
immune	O
cells	B-ANAT
and	O
secreting	O
inflammatory	O
factors	O
.	O

Therefore	O
,	O
the	O
research	O
status	O
of	O
spleen	B-ANAT
-	O
mediated	O
inflammatory	O
response	O
in	O
traumatic	O
ARDS	O
is	O
of	O
great	O
significance	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
traumatic	O
ARDS	O
.	O

This	O
article	O
reports	O
the	O
spleen	B-ANAT
-	O
mediated	O
systemic	O
inflammatory	O
response	O
,	O
the	O
role	O
of	O
inflammatory	O
mediators	O
in	O
the	O
development	O
of	O
ARDS	O
,	O
and	O
the	O
current	O
state	O
of	O
research	O
on	O
ARDS	O
treatment	O
to	O
explore	O
new	O
approaches	O
to	O
the	O
prevention	O
and	O
treatment	O
of	O
traumatic	O
ARDS	O
.	O

He	O
had	O
burst	O
fracture	O
of	O
5th	O
lumbar	B-ANAT
vertebra	I-ANAT
with	O
canal	B-ANAT
compromise	O
along	O
with	O
other	O
fractures	O
.	O

Failing	O
conventional	O
ventilation	O
,	O
the	O
patient	O
was	O
placed	O
in	O
prone	O
position	O
taking	O
proper	O
precautions	O
in	O
positioning	O
giving	O
due	O
consideration	O
to	O
his	O
unstable	O
lumbar	B-ANAT
spine	I-ANAT
.	O

Chicken	O
sera	B-ANAT
were	O
screened	O
for	O
anti	O
-	O
NDV	O
antibodies	O
by	O
ELISA	O
.	O

Moreover	O
,	O
DNA	O
of	O
the	O
generally	O
chicken	O
-	O
specific	O
CAV	O
was	O
detected	O
in	O
oral	B-ANAT
/	O
tracheal	O
swabs	O
of	O
chickens	O
(	O
18	O
.	O
1	O
%)	O
and	O
,	O
sporadically	O
,	O
of	O
ducks	O
(	O
2	O
.	O
4	O
%).	O

Environmental	O
factors	O
(	O
e	O
.	O
g	O
.,	O
drug	O
use	O
,	O
occupational	O
chemical	O
exposure	O
,	O
infectious	O
agents	O
,	O
and	O
irradiation	O
)	O
could	O
account	O
for	O
chromosome	B-ANAT
changes	O
.	O

Mechanistically	O
,	O
ORF8b	O
interacts	O
directly	O
with	O
the	O
Leucine	O
Rich	O
Repeat	O
domain	O
of	O
NLRP3	O
and	O
localizes	O
with	O
NLRP3	O
and	O
ASC	O
in	O
cytosolic	B-ANAT
dot	O
-	O
like	O
structures	O
.	O

ORF8b	O
triggers	O
cell	B-ANAT
death	O
consistent	O
with	O
pyroptotic	O
cell	B-ANAT
death	O
in	O
macrophages	B-ANAT
.	O

While	O
in	O
those	O
cells	B-ANAT
lacking	O
NLRP3	O
accumulating	O
ORF8b	O
cytosolic	B-ANAT
aggregates	O
cause	O
ER	O
stress	O
,	O
mitochondrial	B-ANAT
dysfunction	O
,	O
and	O
caspase	O
-	O
independent	O
cell	B-ANAT
death	O
.	O

To	O
further	O
investigate	O
the	O
endogenous	O
apoptosis	O
induced	O
by	O
PDCoV	O
,	O
cytochrome	O
C	O
and	O
apoptosis	O
-	O
inducing	O
factors	O
in	O
cytoplasm	B-ANAT
and	O
mitochondria	B-ANAT
were	O
detected	O
.	O

In	O
addition	O
,	O
the	O
trial	O
registers	O
to	O
be	O
searched	O
will	O
include	O
:	O
World	O
Health	O
Organization	O
International	O
Clinical	O
Trials	O
Registry	O
Platform	O
(	O
ICTRP	O
),	O
U	O
.	O
S	O
.	O
National	O
Library	O
of	O
Medicine	O
Drug	O
Information	O
Portal	B-ANAT
and	O
ClinicalTrials	O
.	O
gov	O
.	O

In	O
this	O
work	O
,	O
we	O
performed	O
a	O
head	B-ANAT
-	O
to	O
-	O
head	B-ANAT
comparison	O
to	O
evaluate	O
the	O
multiplex	O
-	O
PCR	O
yields	O
between	O
two	O
samples	O
,	O
sputum	B-ANAT
and	O
flocked	O
oropharyngeal	B-ANAT
swabs	O
(	O
OPS	O
).	O

RESULTS	O
:	O
From	O
January	O
to	O
June	O
2018	O
,	O
440	O
children	O
with	O
paired	O
OPS	O
and	O
sputum	B-ANAT
were	O
tested	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
identified	O
PEPCK	O
-	O
M	O
(	O
encoded	O
by	O
the	O
Pck2	O
gene	O
)	O
to	O
be	O
highly	O
up	O
-	O
regulated	O
in	O
skeletal	B-ANAT
muscle	I-ANAT
of	O
pigs	O
treated	O
with	O
Ractopamine	O
,	O
an	O
anabolic	O
beta	O
-	O
adrenergic	O
receptor	O
agonist	O
.	O

To	O
determine	O
whether	O
PEPCK	O
-	O
M	O
had	O
a	O
causative	O
role	O
in	O
modulating	O
the	O
skeletal	B-ANAT
muscle	I-ANAT
growth	O
response	O
to	O
Ractopamine	O
,	O
we	O
used	O
adeno	O
-	O
associated	O
virus	O
1	O
(	O
AAV1	O
)	O
to	O
over	O
-	O
express	O
Pck2	O
(	O
AAV	O
-	O
Pck2	O
)	O
in	O
murine	O
skeletal	B-ANAT
muscle	I-ANAT
.	O

However	O
AAV	O
-	O
Pck2	O
overexpression	O
reduced	O
TA	O
muscle	B-ANAT
weights	O
(	O
p	O
=	O
0	O
.	O
0434	O
),	O
particularly	O
in	O
the	O
Control	O
(	O
vehicle	O
treated	O
)	O
mice	O
(	O
p	O
=	O
0	O
.	O
059	O
for	O
AAV	O
x	O
Clenbuterol	O
interaction	O
)	O
and	O
increased	O
the	O
expression	O
of	O
Seryl	O
-	O
tRNA	O
Synthetase	O
(	O
Sars	O
)	O
mRNA	O
(	O
p	O
=	O
0	O
.	O
0477	O
).	O

We	O
used	O
a	O
combat	O
relevant	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
due	O
to	O
SII	O
to	O
study	O
temporal	O
changes	O
in	O
ventilation	O
-	O
perfusion	O
(	O
V	O
/	O
Q	O
)	O
matching	O
,	O
computed	O
tomography	O
(	O
CT	O
)	O
scan	O
data	O
,	O
and	O
histopathology	O
and	O
hypothesized	O
that	O
SII	O
leads	O
to	O
increase	O
in	O
shunt	O
(	O
Qshunt	O
),	O
V	O
/	O
Q	O
mismatch	O
,	O
lung	B-ANAT
consolidation	O
,	O
and	O
diffuse	O
alveolar	B-ANAT
damage	O
.	O

TITLE	O
:	O
NETs	O
promote	O
ALI	O
/	O
ARDS	O
inflammation	O
by	O
regulating	O
alveolar	B-ANAT
macrophage	I-ANAT
polarization	O
.	O

Regardless	O
of	O
LPS	O
pre	O
-	O
stimulation	O
,	O
significant	O
secretion	B-ANAT
of	O
proinflammatory	O
cytokines	O
and	O
upregulated	O
M1	O
markers	O
were	O
detected	O
from	O
bone	B-ANAT
marrow	I-ANAT
-	I-ANAT
derived	I-ANAT
macrophages	I-ANAT
(	O
M0	O
and	O
M2	O
)	O
cocultured	O
with	O
high	O
concentrations	O
of	O
NETs	O
;	O
conversely	O
,	O
M2	O
markers	O
were	O
downregulated	O
.	O

Alterations	O
to	O
PPE	O
design	O
may	O
lead	O
to	O
less	O
contamination	O
such	O
as	O
added	O
tabs	O
to	O
grab	O
masks	O
(	O
RR	O
0	O
.	O
33	O
;	O
95	O
%	O
CI	O
0	O
.	O
14	O
to	O
0	O
.	O
80	O
)	O
or	O
gloves	O
(	O
RR	O
0	O
.	O
22	O
95	O
%	O
CI	O
0	O
.	O
15	O
to	O
0	O
.	O
31	O
),	O
a	O
sealed	O
gown	O
and	O
glove	O
combination	O
(	O
RR	O
0	O
.	O
27	O
;	O
95	O
%	O
CI	O
0	O
.	O
09	O
to	O
0	O
.	O
78	O
),	O
or	O
a	O
better	O
fitting	O
gown	O
around	O
the	O
neck	B-ANAT
,	O
wrists	B-ANAT
and	O
hands	B-ANAT
(	O
RR	O
0	O
.	O
08	O
;	O
95	O
%	O
CI	O
0	O
.	O
01	O
to	O
0	O
.	O
55	O
)	O
compared	O
to	O
standard	O
PPE	O
.	O
Different	O
methods	O
of	O
donning	O
and	O
doffing	O
proceduresDouble	O
gloving	O
may	O
lead	O
to	O
less	O
contamination	O
compared	O
to	O
single	O
gloving	O
(	O
RR	O
0	O
.	O
36	O
;	O
95	O
%	O
CI	O
0	O
.	O
16	O
to	O
0	O
.	O
78	O
).	O
Following	O
CDC	O
recommendations	O
for	O
doffing	O
may	O
lead	O
to	O
less	O
contamination	O
compared	O
to	O
no	O
guidance	O
(	O
MD	O
small	O
patches	O
-	O
5	O
.	O
44	O
;	O
95	O
%	O
CI	O
-	O
7	O
.	O
43	O
to	O
-	O
3	O
.	O
45	O
).	O
Alcohol	O
-	O
based	O
hand	O
rub	O
used	O
during	O
the	O
doffing	O
process	O
may	O
not	O
lead	O
to	O
less	O
contamination	O
than	O
the	O
use	O
of	O
a	O
hypochlorite	O
based	O
solution	O
(	O
MD	O
4	O
.	O
00	O
;	O
95	O
%	O
CI	O
0	O
.	O
47	O
to	O
34	O
.	O
24	O
).	O
Additional	O
spoken	O
instruction	O
may	O
lead	O
to	O
fewer	O
errors	O
in	O
doffing	O
(	O
MD	O
-	O
0	O
.	O
9	O
,	O
95	O
%	O
CI	O
-	O
1	O
.	O
4	O
to	O
-	O
0	O
.	O
4	O
).	O
Different	O
types	O
of	O
trainingThe	O
use	O
of	O
additional	O
computer	O
simulation	O
may	O
lead	O
to	O
fewer	O
errors	O
in	O
doffing	O
(	O
MD	O
-	O
1	O
.	O
2	O
,	O
95	O
%	O
CI	O
-	O
1	O
.	O
6	O
to	O
-	O
0	O
.	O
7	O
).	O
A	O
video	O
lecture	O
on	O
donning	O
PPE	O
may	O
lead	O
to	O
better	O
skills	O
scores	O
(	O
MD	O
30	O
.	O
70	O
;	O
95	O
%	O
CI	O
20	O
.	O
14	O
,	O
41	O
.	O
26	O
)	O
than	O
a	O
traditional	O
lecture	O
.	O

The	O
respiratory	B-ANAT
system	I-ANAT
was	O
the	O
most	O
common	O
organ	B-ANAT
system	I-ANAT
in	O
which	O
dysfunction	O
was	O
observed	O
(	O
76	O
.	O
7	O
%)	O
as	O
well	O
as	O
the	O
most	O
frequently	O
infected	O
site	O
(	O
37	O
.	O
6	O
%).	O

Eighty	O
-	O
six	O
percent	O
of	O
patients	O
had	O
multiple	O
organ	B-ANAT
dysfunction	O
syndrome	O
at	O
the	O
point	O
at	O
which	O
severe	O
sepsis	O
was	O
recognized	O
,	O
and	O
31	O
%	O
had	O
underlying	O
conditions	O
.	O

A	O
total	O
of	O
445	O
nasopharyngeal	B-ANAT
swabs	O
specimens	O
from	O
patients	O
with	O
AFRS	O
were	O
analyzed	O
using	O
the	O
RespiFinderSmart22kit	O
(	O
PathoFinder	O
BV	O
,	O
Netherlands	O
)	O
and	O
the	O
LightCycler	O
480	O
real	O
-	O
time	O
PCR	O
system	O
.	O

We	O
aimed	O
to	O
evaluate	O
clinical	O
characteristics	O
and	O
mortality	O
of	O
CA	O
-	O
RVI	O
except	O
seasonal	O
influenza	O
A	O
/	O
B	O
in	O
transplant	B-ANAT
recipients	O
and	O
non	O
-	O
transplant	B-ANAT
critically	O
ill	O
patients	O
in	O
ICU	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
and	O
compare	O
nebulizing	O
heparin	O
versus	O
streptokinase	O
for	O
reversing	O
alveolar	B-ANAT
collapse	O
nonresponsive	O
to	O
recruitment	O
.	O

The	O
primary	O
outcome	O
was	O
the	O
change	O
in	O
PaO	O
Inhaled	O
streptokinase	O
serves	O
as	O
rescue	O
therapy	O
in	O
patients	O
with	O
severe	O
ARDS	O
with	O
improving	O
oxygenation	O
and	O
lung	B-ANAT
mechanics	O
more	O
quickly	O
than	O
heparin	O
or	O
conventional	O
management	O
.	O

In	O
the	O
clinical	O
sample	O
study	O
,	O
mRT	B-ANAT
-	O
LAMP	O
-	O
LFD	O
performed	O
the	O
best	O
among	O
these	O
assays	O
.	O

TITLE	O
:	O
Effects	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
infection	O
on	O
tight	B-ANAT
junction	I-ANAT
protein	O
gene	O
expression	O
and	O
morphology	O
of	O
the	O
intestinal	B-ANAT
mucosa	I-ANAT
in	O
pigs	O
.	O

The	O
expression	O
of	O
six	O
tight	B-ANAT
junction	I-ANAT
protein	O
genes	O
was	O
lower	O
in	O
PEDV	O
-	O
infected	O
piglets	O
than	O
in	O
the	O
normal	O
animals	O
.	O

TITLE	O
:	O
Effect	O
of	O
lung	B-ANAT
recruitment	O
and	O
titrated	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
ABSTRACT	O
:	O
Setting	O
a	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
on	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
receiving	O
mechanical	O
ventilation	O
has	O
been	O
an	O
issue	O
of	O
great	O
contention	O
.	O

Complications	O
(	O
i	O
.	O
e	O
.	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
and	O
pneumonia	O
)	O
were	O
documented	O
by	O
a	O
review	O
of	O
the	O
medical	O
records	O
.	O

Fraxin	O
might	O
inhibit	O
the	O
increase	O
in	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
and	O
malondialdehyde	O
(	O
MDA	O
),	O
a	O
product	O
of	O
lipid	O
peroxidation	O
in	O
lung	B-ANAT
tissues	I-ANAT
.	O

Fraxin	O
might	O
inhibit	O
the	O
increase	O
in	O
pulmonary	B-ANAT
vascular	B-ANAT
permeability	O
and	O
relieve	O
pulmonary	B-ANAT
edema	O
.	O

ABSTRACT	O
:	O
The	O
DcCoV	O
UAE	O
-	O
HKU23	O
coronavirus	O
is	O
a	O
newly	O
-	O
found	O
betacoronavirus	O
(	O
betaCoV	O
)	O
that	O
can	O
infect	O
human	O
cells	B-ANAT
.	O

An	O
inadequate	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
output	O
flow	O
was	O
observed	O
,	O
possibly	O
because	O
of	O
severe	O
polycythemia	O
and	O
hyperviscosity	O
.	O

TITLE	O
:	O
Plasma	B-ANAT
Midkine	O
Is	O
Associated	O
With	O
28	O
-	O
Day	O
Mortality	O
and	O
Organ	B-ANAT
Function	O
in	O
Sepsis	O
.	O

Plasma	B-ANAT
midkine	O
levels	O
were	O
significantly	O
elevated	O
in	O
the	O
nonsurvivor	O
group	O
compared	O
with	O
the	O
survivors	O
(	O
ng	O
/	O
L	O
,	O
763	O
.	O
6	O
[	O
404	O
.	O
7	O
-	O
1305	O
],	O
268	O
.	O
5	O
[	O
147	O
.	O
8	O
-	O
511	O
.	O
4	O
];	O

In	O
this	O
study	O
,	O
we	O
screened	O
seven	O
human	O
cell	B-ANAT
lines	I-ANAT
and	O
found	O
that	O
the	O
human	O
monocytic	B-ANAT
cell	B-ANAT
U937	O
supports	O
the	O
replication	O
of	O
different	O
subtypes	O
of	O
influenza	O
viruses	O
as	O
well	O
as	O
the	O
production	O
of	O
the	O
important	O
pro	O
-	O
inflammatory	O
cytokines	O
and	O
was	O
selected	O
to	O
develop	O
the	O
cell	B-ANAT
-	O
based	O
model	O
.	O

Gene	O
Ontology	O
analysis	O
suggested	O
that	O
cellular	B-ANAT
macromolecule	O
and	O
protein	B-ANAT
location	I-ANAT
(	O
GO	O
-	O
BP	O
)	O
and	O
transcription	O
factor	O
binding	O
(	O
GO	O
-	O
MF	O
)	O
were	O
abundant	O
in	O
IBV	O
-	O
stimulated	O
avian	O
DCs	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
high	O
fat	O
diet	O
induced	O
obesity	O
increases	O
the	O
severity	O
of	O
hyperoxic	O
acute	O
lung	B-ANAT
injury	O
in	O
mice	O
in	O
part	O
by	O
altering	O
fatty	O
acid	O
synthase	O
(	O
FASN	O
)	O
levels	O
in	O
the	O
lung	B-ANAT
.	O

Depletion	O
of	O
FASN	O
in	O
type	O
II	O
alveolar	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
resulted	O
in	O
altered	O
mitochondrial	B-ANAT
bioenergetics	O
and	O
more	O
severe	O
lung	B-ANAT
injury	O
with	O
hyperoxic	O
exposure	O
,	O
even	O
upon	O
the	O
administration	O
of	O
a	O
60	O
%	O
fat	O
diet	O
.	O

The	O
effect	O
of	O
systemic	O
administration	O
of	O
recombinant	O
human	O
endocan	O
was	O
assessed	O
in	O
a	O
model	O
of	O
acute	O
lung	B-ANAT
inflammation	O
in	O
BALB	O
/	O
c	O
mice	O
.	O

ABSTRACT	O
:	O
Introducing	O
mathematically	O
derived	O
variability	O
(	O
MVV	O
)	O
into	O
the	O
otherwise	O
monotonous	O
conventional	O
mechanical	O
ventilation	O
has	O
been	O
suggested	O
to	O
improve	O
lung	B-ANAT
recruitment	O
and	O
gas	O
exchange	O
.	O

A	O
strong	O
positive	O
correlation	O
was	O
found	O
among	O
serum	B-ANAT
ACE	O
levels	O
and	O
Thoracic	B-ANAT
Trauma	O
Severity	O
Score	O
(	O
TTSS	O
).	O

Additionally	O
,	O
anti	O
-	O
canine	O
respiratory	O
coronavirus	O
antibody	O
concentrations	O
were	O
measured	O
in	O
paired	O
blood	B-ANAT
samples	I-ANAT
from	O
30	O
acutely	O
diseased	O
dogs	O
.	O

Canine	O
coronavirus	O
-	O
specific	O
nucleic	B-ANAT
acid	O
was	O
detected	O
in	O
4	O
.	O
0	O
%	O
of	O
healthy	O
dogs	O
.	O

Canine	O
coronavirus	O
-	O
specific	O
nucleic	B-ANAT
acid	O
was	O
detected	O
in	O
4	O
.	O
0	O
%	O
of	O
healthy	O
dogs	O
.	O

TITLE	O
:	O
Screening	O
and	O
treatment	O
of	O
obstructive	O
sleep	O
apnea	O
in	O
acute	O
coronary	B-ANAT
syndrome	O
.	O

Eligible	O
patients	O
were	O
randomized	O
into	O
(	O
1	O
)	O
SGMT	O
,	O
comprised	O
a	O
sleep	O
study	O
during	O
the	O
index	O
admission	O
and	O
continuous	O
positive	O
airway	B-ANAT
pressure	O
and	O
behavioral	O
therapy	O
for	O
those	O
with	O
at	O
least	O
mild	O
OSA	O
or	O
(	O
2	O
)	O
standard	O
therapy	O
.	O

Porcine	O
epidemic	O
diarrhea	O
virus	O
infection	O
increased	O
the	O
proportion	O
of	O
harmful	O
bacteria	O
and	O
decreased	O
the	O
proportion	O
of	O
beneficial	O
bacteria	O
in	O
the	O
cecal	B-ANAT
mucosa	I-ANAT
and	O
contents	O
of	O
suckling	O
piglets	O
.	O

Farms	O
that	O
fixed	B-ANAT
the	O
hours	O
staff	O
worked	O
in	O
farrowing	O
barn	O
had	O
lower	O
DP	O
/	O
S	O
than	O
the	O
other	O
farms	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
addition	O
,	O
CXCL5	O
neutralizing	O
antibody	O
effectively	O
alleviated	O
inflammatory	O
response	O
,	O
diffuse	O
alveolar	B-ANAT
damage	O
,	O
and	O
pulmonary	B-ANAT
edema	O
,	O
and	O
decreased	O
the	O
expression	O
levels	O
of	O
MMP2	O
and	O
MMP9	O
compared	O
to	O
LPS	O
-	O
induced	O
ARDS	O
.	O

Electromyography	O
showed	O
peripheral	B-ANAT
nerve	I-ANAT
injury	O
(	O
mainly	O
in	O
axon	B-ANAT
).	O

After	O
treatment	O
with	O
intravenous	O
immunoglobulin	O
and	O
plasma	B-ANAT
exchange	O
followed	O
by	O
antiviral	O
therapy	O
by	O
direct	O
-	O
acting	O
antiviral	O
agent	O
,	O
patient	O
showed	O
progressive	O
recovery	O
and	O
was	O
transferred	O
3	O
months	O
after	O
his	O
first	O
admission	O
to	O
a	O
rehabilitation	O
center	O
.	O

Here	O
,	O
we	O
examined	O
the	O
intermediate	O
conformation	O
of	O
the	O
murine	O
coronavirus	O
fusion	O
protein	O
,	O
called	O
the	O
spike	O
protein	O
,	O
which	O
must	O
be	O
cleaved	B-ANAT
by	O
a	O
cellular	B-ANAT
protease	O
following	O
receptor	O
binding	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
show	O
that	O
the	O
membrane	B-ANAT
protein	O
(	O
M	O
)	O
of	O
HCoV	O
-	O
NL63	O
mediates	O
this	O
attachment	O
.	O

The	O
decreased	O
levels	O
of	O
the	O
fibrinogen	B-ANAT
and	O
antithrombin	O
activity	O
were	O
significantly	O
associated	O
with	O
an	O
increase	O
in	O
mortality	O
(	O
P	O
=	O
0	O
.	O
011	O
and	O
0	O
.	O
002	O
,	O
respectively	O
).	O

On	O
day	O
1	O
,	O
2	O
-	O
3	O
and	O
4	O
-	O
5	O
after	O
admission	O
the	O
following	O
pituitary	B-ANAT
axes	O
were	O
assessed	O
:	O
hypothalamic	B-ANAT
-	O
pituitary	B-ANAT
-	O
adrenal	O
,	O
hypothalamic	B-ANAT
-	O
pituitary	B-ANAT
-	O
thyroid	B-ANAT
,	O
somatotroph	B-ANAT
,	O
prolactin	O
and	O
copeptin	O
.	O

The	O
activation	O
of	O
the	O
hypothalamic	B-ANAT
pituitary	I-ANAT
adrenal	I-ANAT
axis	I-ANAT
was	O
a	O
strong	O
predictor	O
of	O
ICU	O
mortality	O
.	O

All	O
these	O
administration	O
routes	O
exhibited	O
neutralizing	O
effects	O
in	O
the	O
serum	B-ANAT
.	O

We	O
performed	O
an	O
analysis	O
of	O
literature	O
and	O
a	O
systematic	O
review	O
of	O
our	O
post	O
-	O
bariatric	O
patients	O
who	O
underwent	O
body	B-ANAT
contouring	O
procedures	O
which	O
required	O
general	O
anaesthesia	O
from	O
2013	O
to	O
2018	O
and	O
divided	O
them	O
in	O
two	O
groups	O
:	O
OAGB	O
-	O
MGB	O
group	O
and	O
other	O
bariatric	O
procedures	O
in	O
order	O
to	O
compare	O
the	O
rate	O
of	O
aspiration	O
/	O
pneumonia	O
occurred	O
in	O
time	O
.	O

TITLE	O
:	O
An	O
Elusive	O
Case	O
of	O
Acute	O
Interstitial	B-ANAT
Pneumonia	O
.	O

It	O
can	O
be	O
caused	O
by	O
more	O
than	O
75	O
different	O
gene	O
mutations	O
,	O
of	O
nuclear	O
and	O
mitochondrial	B-ANAT
origin	O
,	O
involving	O
all	O
respiratory	B-ANAT
chain	I-ANAT
complexes	O
,	O
with	O
less	O
than	O
25	O
%	O
of	O
Leigh	O
syndrome	O
having	O
mitochondrial	B-ANAT
DNA	I-ANAT
mutations	O
.	O

In	O
ARDS	O
patients	O
on	O
ECMO	O
,	O
temporal	O
trends	O
of	O
specific	O
physiologic	O
parameters	O
differentiate	O
survivors	O
from	O
non	O
-	O
survivors	O
and	O
could	O
be	O
used	O
to	O
monitor	O
the	O
evolution	O
of	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
incidence	O
,	O
outcomes	O
,	O
and	O
risk	O
factors	O
of	O
postoperative	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
patients	O
undergoing	O
surgical	O
repair	O
for	O
acute	O
type	O
A	O
aortic	B-ANAT
dissection	O
.	O

This	O
study	O
has	O
particular	O
significance	O
to	O
the	O
early	O
prevention	O
of	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
and	O
pulmonary	B-ANAT
fibrosis	O
in	O
patients	O
with	O
ARDS	O
receiving	O
mechanical	O
ventilation	O
.	O

TITLE	O
:	O
Unfolded	O
protein	O
response	O
regulates	O
P53	O
expression	O
in	O
the	O
pulmonary	B-ANAT
endothelium	B-ANAT
.	O

The	O
bovine	O
cells	B-ANAT
that	O
were	O
exposed	O
to	O
the	O
UPR	O
inductors	O
brefeldin	O
A	O
,	O
dithiothreitol	O
,	O
and	O
thapsigargin	O
;	O
demonstrated	O
elevated	O
expression	O
levels	O
of	O
P53	O
compared	O
to	O
the	O
vehicle	O
-	O
treated	O
cells	B-ANAT
.	O

The	O
complete	O
blood	B-ANAT
count	O
is	O
the	O
most	O
ordered	O
clinical	O
test	O
in	O
the	O
United	O
States	O
serving	O
as	O
the	O
cornerstone	O
of	O
clinical	O
medicine	O
and	O
differential	O
diagnosis	O
.	O

Major	O
leukocyte	B-ANAT
populations	O
were	O
modulated	O
before	O
weight	O
loss	O
was	O
observed	O
.	O

While	O
one	O
out	O
of	O
four	O
patients	O
showed	O
pneumococcal	O
coinfection	O
,	O
plasma	B-ANAT
procalcitonin	O
helped	O
to	O
implement	O
antimicrobial	O
stewardship	O
.	O

In	O
comparison	O
with	O
post	O
-	O
weaned	O
calves	O
with	O
diarrhea	O
,	O
in	O
diarrhea	O
-	O
recovered	O
calves	O
,	O
the	O
lymphocyte	B-ANAT
count	O
was	O
significantly	O
higher	O
(	O
P	O
=	O
0	O
.	O
018	O
),	O
and	O
the	O
monocyte	B-ANAT
count	O
was	O
significantly	O
lower	O
(	O
P	O
=	O
0	O
.	O
001	O
);	O
however	O
,	O
the	O
number	O
of	O
monocytes	B-ANAT
was	O
still	O
high	O
.	O

At	O
week	O
60	O
,	O
vaccine	O
-	O
induced	O
humoral	O
and	O
cellular	B-ANAT
responses	O
were	O
detected	O
in	O
51	O
(	O
77	O
%)	O
of	O
66	O
participants	O
and	O
42	O
(	O
64	O
%)	O
of	O
66	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
delayed	O
IFN	O
-	O
Î²	O
treatment	O
failed	O
to	O
effectively	O
inhibit	O
virus	O
replication	O
,	O
increased	O
infiltration	O
and	O
activation	O
of	O
monocytes	B-ANAT
,	O
macrophages	B-ANAT
,	O
and	O
neutrophils	B-ANAT
in	O
the	O
lungs	B-ANAT
,	O
and	O
enhanced	O
proinflammatory	O
cytokine	O
expression	O
,	O
resulting	O
in	O
fatal	O
pneumonia	O
in	O
an	O
otherwise	O
sublethal	O
infection	O
.	O

As	O
a	O
last	O
resort	O
of	O
treatment	O
,	O
we	O
decided	O
to	O
apply	O
nanomembrane	O
-	O
based	O
apheresis	O
to	O
cleanse	O
his	O
plasma	B-ANAT
from	O
the	O
harmful	O
inflammatory	O
mediators	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
mortality	O
between	O
two	O
groups	O
after	O
90	O
days	O
of	O
discharge	B-ANAT
(	O
p	O
=	O
0	O
.	O
306	O
).	O

The	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
using	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
an	O
example	O
of	O
these	O
considerations	O
.	O

On	O
the	O
one	O
hand	O
,	O
OSA	O
in	O
patients	O
with	O
ACS	O
may	O
worsen	O
prognosis	O
;	O
on	O
the	O
other	O
hand	O
,	O
OSA	O
-	O
related	O
hypoxaemia	O
could	O
favour	O
the	O
development	O
of	O
coronary	B-ANAT
collaterals	O
,	O
thereby	O
exerting	O
a	O
protective	O
effect	O
.	O

An	O
algorithm	O
based	O
on	O
machine	O
learning	O
,	O
principal	O
component	O
analysis	O
(	O
PCA	B-ANAT
),	O
and	O
linear	O
discriminant	O
analysis	O
(	O
LDA	B-ANAT
)	O
was	O
developed	O
.	O

The	O
aim	O
of	O
the	O
study	O
is	O
to	O
assess	O
the	O
effect	O
of	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
in	O
pediatric	O
patients	O
with	O
severe	O
sepsis	O
and	O
the	O
impact	O
this	O
therapy	O
may	O
have	O
on	O
their	O
mortality	O
.	O

The	O
patients	O
were	O
divided	O
into	O
the	O
continuous	O
renal	B-ANAT
replacement	O
therapy	O
group	O
and	O
the	O
conventional	O
(	O
noncontinuous	O
renal	B-ANAT
replacement	O
therapy	O
)	O
group	O
.	O

ABSTRACT	O
:	O
Venous	B-ANAT
air	O
embolism	O
(	O
VAE	O
)	O
is	O
a	O
rare	O
but	O
,	O
frequently	O
,	O
fatal	O
complication	O
that	O
can	O
occur	O
during	O
surgery	O
.	O

A	O
41	O
-	O
year	O
-	O
old	O
man	O
had	O
undergone	O
cervical	B-ANAT
laminoplasty	O
for	O
ossification	O
of	O
the	O
posterior	B-ANAT
longitudinal	I-ANAT
ligament	I-ANAT
and	O
thoracic	B-ANAT
laminectomy	O
for	O
ossification	O
of	O
the	O
posterior	B-ANAT
longitudinal	I-ANAT
ligament	I-ANAT
and	O
ossification	O
of	O
the	O
ligamentum	B-ANAT
flavum	I-ANAT
in	O
the	O
prone	O
position	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
also	O
the	O
first	O
report	O
of	O
intraoperative	O
VAE	O
in	O
a	O
patient	O
with	O
extensive	O
ossification	O
of	O
the	O
spinal	O
ligaments	B-ANAT
.	O

The	O
reported	O
isolate	O
was	O
identified	O
by	O
a	O
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
assay	O
targeting	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
gene	O
and	O
,	O
further	O
characterized	O
by	O
full	O
-	O
length	O
spike	O
(	O
S1	O
)	O
gene	O
sequencing	O
.	O

Among	O
the	O
supportive	O
measures	O
for	O
the	O
management	O
of	O
DS	O
,	O
furosemide	O
(	O
in	O
87	O
%	O
of	O
patients	O
)	O
and	O
dialysis	O
(	O
12	O
%	O
of	O
patients	O
)	O
are	O
used	O
to	O
manage	O
acute	O
renal	B-ANAT
failure	O
,	O
peripheral	O
and	O
pulmonary	B-ANAT
edema	O
.	O

Unexpectedly	O
,	O
we	O
found	O
that	O
G29	O
was	O
critical	O
for	O
the	O
conformational	O
changes	O
of	O
the	O
S	O
protein	O
triggered	O
by	O
either	O
receptor	O
binding	O
or	O
high	O
pH	O
.	O
Replacement	O
of	O
G29	O
with	O
A	O
,	O
D	O
,	O
F	O
,	O
K	O
,	O
M	O
,	O
and	O
T	O
,	O
to	O
different	O
extents	O
,	O
caused	O
spontaneous	O
dissociation	O
of	O
S1	O
from	O
the	O
S	O
protein	O
,	O
resulting	O
in	O
an	O
enhancement	O
of	O
high	O
-	O
pH	O
-	O
triggered	O
receptor	O
-	O
independent	O
syncytium	B-ANAT
(	O
RIS	O
)	O
formation	O
in	O
HEK293T	O
cells	B-ANAT
,	O
compared	O
to	O
the	O
wild	O
type	O
(	O
WT	O
).	O

Tissue	B-ANAT
culture	O
-	O
adapted	O
type	O
I	O
FCoV	O
shows	O
reduced	O
FIP	O
induction	O
in	O
experimental	O
infections	O
,	O
which	O
complicates	O
the	O
understanding	O
of	O
FIP	O
pathogenesis	O
caused	O
by	O
type	O
I	O
FCoV	O
.	O
We	O
previously	O
found	O
that	O
the	O
type	O
I	O
FCoV	O
strain	O
C3663	O
efficiently	O
induces	O
FIP	O
in	O
specific	O
-	O
pathogen	O
-	O
free	O
cats	O
through	O
the	O
naturally	O
infectious	O
route	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
A72	O
cells	B-ANAT
derived	O
from	O
canine	O
fibroblasts	B-ANAT
permitted	O
FCoV	O
replication	O
without	O
apparent	O
cytopathic	O
effects	O
.	O

ABSTRACT	O
:	O
The	O
highly	O
virulent	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
variants	O
cause	O
the	O
death	O
of	O
mainly	O
neonatal	O
piglets	O
,	O
but	O
how	O
the	O
viruses	O
spread	O
within	O
the	O
gastro	B-ANAT
-	O
intestinal	B-ANAT
tract	I-ANAT
in	O
a	O
temporal	O
and	O
spatial	O
manner	O
has	O
remained	O
poorly	O
characterized	O
but	O
is	O
critical	O
to	O
understand	O
the	O
viral	O
pathogenesis	O
.	O

Interestingly	O
,	O
the	O
viral	O
RNAs	O
were	O
not	O
detectable	O
by	O
RNAscope	O
in	O
large	O
intestines	B-ANAT
although	O
tissue	B-ANAT
damages	O
could	O
be	O
discerned	O
by	O
H	O
&	O
E	O
staining	O
.	O

Overall	O
,	O
our	O
results	O
provide	O
useful	O
information	O
about	O
spread	O
dynamics	O
and	O
tissue	B-ANAT
preference	O
of	O
PEDV	O
epidemic	O
strain	O
BJ2011C	O
.	O

TITLE	O
:	O
Human	O
leukocyte	B-ANAT
antigen	O
-	O
associated	O
severe	O
cutaneous	O
adverse	O
drug	O
reactions	O
:	O
from	O
bedside	O
to	O
bench	O
and	O
beyond	O
.	O

TITLE	O
:	O
Time	O
-	O
course	O
of	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
viral	O
infection	O
and	O
COPD	O
exacerbation	O
.	O

Here	O
,	O
we	O
found	O
miR	O
-	O
150	O
expression	O
was	O
significantly	O
reduced	O
in	O
the	O
serum	B-ANAT
of	O
patients	O
with	O
ARDS	O
,	O
and	O
negatively	O
associated	O
with	O
the	O
disease	O
severity	O
and	O
28	O
-	O
day	O
survival	O
of	O
ARDS	O
.	O

In	O
-	O
vitro	O
assays	O
demonstrated	O
that	O
miR	O
-	O
150	O
alleviated	O
LPS	O
-	O
induced	O
A549	O
cell	B-ANAT
apoptosis	O
,	O
autophagy	O
,	O
and	O
release	O
of	O
inflammatory	O
cytokines	O
.	O

TITLE	O
:	O
Personalised	O
mechanical	O
ventilation	O
tailored	O
to	O
lung	B-ANAT
morphology	O
versus	O
low	O
positive	O
end	O
-	O
expiratory	O
pressure	O
for	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
France	O
(	O
the	O
LIVE	O
study	O
):	O
a	O
multicentre	O
,	O
single	O
-	O
blind	O
,	O
randomised	O
controlled	O
trial	O
.	O

TITLE	O
:	O
Dose	O
-	O
response	O
and	O
transmission	O
:	O
the	O
nexus	B-ANAT
between	O
reservoir	O
hosts	O
,	O
environment	O
and	O
recipient	O
hosts	O
.	O

Extracorporeal	O
life	O
support	O
is	O
now	O
an	O
acceptable	O
form	O
of	O
organ	B-ANAT
support	O
in	O
clinical	O
practice	O
.	O

We	O
used	O
a	O
prospective	O
nationwide	O
cohort	O
targeting	O
consecutive	O
adult	O
severe	O
sepsis	O
patients	O
in	O
59	O
intensive	O
care	O
units	O
in	O
Japan	O
to	O
assess	O
associations	O
between	O
anticoagulant	O
therapy	O
and	O
in	O
-	O
hospital	O
mortality	O
according	O
to	O
DIC	O
(	O
International	O
Society	O
on	O
Thrombosis	O
and	O
Haemostasis	O
[	O
ISTH	O
]	O
overt	O
and	O
Japanese	O
Association	O
for	O
Acute	O
Medicine	O
DIC	O
scores	O
)	O
and	O
disease	O
severity	O
(	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
[	O
APACHE	O
II	O
]	O
and	O
Sequential	O
Organ	B-ANAT
Failure	O
Assessment	O
scores	O
).	O

Consideration	O
of	O
various	O
differential	O
diagnoses	O
and	O
finally	O
narrowing	O
down	O
to	O
that	O
of	O
stress	O
-	O
induced	O
reversible	O
cardiomyopathy	O
(	O
Takotsubo	O
syndrome	O
)	O
following	O
his	O
intracranial	B-ANAT
bleed	O
,	O
versus	O
that	O
of	O
coexisting	O
dual	O
pathology	O
-	O
acute	O
brain	B-ANAT
injury	O
with	O
concomitant	O
acute	O
viral	O
myocarditis	O
,	O
deepened	O
our	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
each	O
disease	O
process	O
,	O
and	O
how	O
it	O
possibly	O
interlinks	O
between	O
different	O
organ	B-ANAT
systems	I-ANAT
.	O

We	O
found	O
that	O
the	O
serum	B-ANAT
immunoglobulin	O
levels	O
were	O
in	O
the	O
normal	O
range	O
in	O
70	O
%	O
of	O
the	O
children	O
.	O

Several	O
non	O
-	O
feline	O
coronaviruses	O
have	O
been	O
reported	O
to	O
infect	O
feline	O
cells	B-ANAT
as	O
well	O
as	O
cats	O
after	O
experimental	O
infection	O
,	O
supported	O
by	O
their	O
ability	O
to	O
engage	O
the	O
feline	O
receptor	O
ortholog	O
for	O
cell	B-ANAT
entry	O
.	O

Using	O
fluorescent	O
reporters	O
for	O
fluorescence	O
-	O
activated	O
cell	B-ANAT
sorting	O
(	O
FACS	O
)-	O
based	O
sorting	O
,	O
we	O
generated	O
homogenously	O
fluorescent	O
hAEC	O
cultures	O
that	O
differentiate	O
normally	O
after	O
lentiviral	O
transduction	O
.	O

Combined	O
,	O
these	O
results	O
validate	O
our	O
newly	O
established	O
protocol	O
for	O
the	O
genetic	O
modification	O
of	O
hAEC	O
cultures	O
,	O
thereby	O
unlocking	O
a	O
unique	O
potential	O
for	O
detailed	O
molecular	O
characterization	O
of	O
virus	O
-	O
host	O
interactions	O
in	O
human	O
respiratory	B-ANAT
epithelium	I-ANAT
.	O

The	O
mean	O
(	O
standard	O
deviation	O
)	O
sequential	O
organ	B-ANAT
failure	O
assessment	O
(	O
SOFA	O
)	O
score	O
was	O
9	O
.	O
5	O
(	O
3	O
.	O
4	O
)	O
in	O
non	O
-	O
survivors	O
and	O
7	O
.	O
4	O
(	O
3	O
.	O
4	O
)	O
in	O
survivors	O
(	O
p	O
=	O
0	O
.	O
002	O
).	O

TITLE	O
:	O
Lung	B-ANAT
Recruitability	O
in	O
Severe	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Requiring	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
.	O

Patients	O
with	O
potential	O
for	O
lung	B-ANAT
recruitment	O
above	O
the	O
median	O
had	O
significantly	O
shorter	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
duration	O
(	O
8	O
vs	O
13	O
d	O
;	O
p	O
=	O
0	O
.	O
013	O
)	O
and	O
shorter	O
ICU	O
stay	O
(	O
15	O
vs	O
22	O
d	O
;	O
p	O
=	O
0	O
.	O
028	O
),	O
but	O
mortality	O
was	O
not	O
statistically	O
different	O
(	O
24	O
%	O
vs	O
46	O
%;	O
p	O
=	O
0	O
.	O
159	O
).	O

Four	O
antibodies	O
against	O
the	O
SeACoV	O
spike	O
,	O
membrane	B-ANAT
,	O
nucleocapsid	B-ANAT
and	O
nonstructural	O
protein	O
3	O
capable	O
of	O
reacting	O
with	O
viral	O
antigens	O
in	O
SeACoV	O
-	O
infected	O
Vero	B-ANAT
cells	I-ANAT
were	O
generated	O
.	O

Early	O
use	O
of	O
gamma	O
globulin	O
or	O
plasma	B-ANAT
exchange	O
was	O
recommended	O
internationally	O
,	O
but	O
recently	O
some	O
new	O
ideas	O
,	O
to	O
some	O
extent	O
,	O
of	O
significance	O
on	O
GBS	O
treatment	O
emerged	O
.	O

We	O
present	O
an	O
unusual	O
case	O
of	O
left	B-ANAT
upper	I-ANAT
limb	I-ANAT
acute	O
arterial	B-ANAT
thrombosis	O
with	O
purpura	O
fulminans	O
like	O
skin	B-ANAT
lesions	O
precipitated	O
by	O
swine	O
flu	O
(	O
H1N1	O
)	O
infection	O
with	O
adult	O
respiratory	O
distress	O
syndrome	O
subsequently	O
developing	O
acute	O
renal	B-ANAT
failure	O
,	O
retinal	B-ANAT
infarcts	O
,	O
multiple	O
acute	O
cerebral	B-ANAT
infarcts	O
,	O
cardiac	B-ANAT
valvular	O
vegetations	O
and	O
hemolytic	O
anemia	O
with	O
recurrent	O
bleeding	O
episodes	O
.	O

TITLE	O
:	O
Case	O
report	O
:	O
Detection	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	O
virus	O
(	O
MERS	O
-	O
CoV	O
)	O
in	O
nasal	B-ANAT
secretions	B-ANAT
of	O
a	O
dead	O
human	O
.	O

We	O
describe	O
how	O
to	O
forecast	O
an	O
epidemic	O
based	O
on	O
the	O
premise	O
that	O
the	O
observed	O
coarse	O
-	O
scale	O
incidence	O
can	O
be	O
decomposed	O
into	O
overlapping	O
sub	O
-	O
epidemics	O
at	O
finer	O
scales	B-ANAT
.	O

We	O
aimed	O
to	O
establish	O
the	O
incidence	O
,	O
mortality	O
rate	O
,	O
and	O
factors	O
related	O
to	O
mortality	O
in	O
adult	O
patients	O
with	O
severe	O
burn	O
injury	O
and	O
AKI	O
with	O
renal	B-ANAT
replacement	O
therapy	O
(	O
RRT	O
)	O
in	O
Singapore	O
.	O

RESULTS	O
:	O
The	O
four	O
endemic	O
human	O
CoVs	O
(	O
HCoV	O
-	O
NL63	O
,	O
HCoV	O
-	O
229E	O
,	O
HCoV	O
-	O
OC43	O
and	O
HCoV	O
-	O
HKU1	O
)	O
mainly	O
cause	O
mild	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
.	O

Currently	O
,	O
there	O
are	O
no	O
effective	O
treatments	O
or	O
vaccines	O
available	O
to	O
control	O
PDCoV	O
.	O
To	O
study	O
the	O
potential	O
of	O
RNA	O
interference	O
(	O
RNAi	O
)	O
as	O
a	O
strategy	O
against	O
PDCoV	O
infection	O
,	O
two	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)-	O
expressing	O
plasmids	O
(	O
pGenesil	O
-	O
M	O
and	O
pGenesil	O
-	O
N	O
)	O
that	O
targeted	O
the	O
M	O
and	O
N	O
genes	O
of	O
PDCoV	O
were	O
constructed	O
and	O
transfected	O
separately	O
into	O
swine	O
testicular	O
(	O
ST	O
)	O
cells	B-ANAT
,	O
which	O
were	O
then	O
infected	O
with	O
PDCoV	O
strain	O
HB	O
-	O
BD	O
.	O

The	O
50	O
%	O
tissue	B-ANAT
culture	O
infective	O
dose	O
showed	O
that	O
the	O
PDCoV	O
titers	O
in	O
ST	O
cells	B-ANAT
treated	O
with	O
pGenesil	O
-	O
M	O
and	O
pGenesil	O
-	O
N	O
were	O
reduced	O
13	O
.	O
2	O
-	O
and	O
32	O
.	O
4	O
-	O
fold	O
,	O
respectively	O
.	O

TITLE	O
:	O
Postoperative	O
acute	O
respiratory	O
failure	O
in	O
cardiac	B-ANAT
surgery	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
incidence	O
,	O
causes	O
and	O
outcomes	O
of	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
in	O
patients	O
after	O
cardiac	B-ANAT
and	O
aortic	B-ANAT
surgery	O
.	O

Hypothermia	O
was	O
defined	O
as	O
body	B-ANAT
core	O
temperature	O
<	O
35	O
Â°	O
C	O
.	O

The	O
results	O
show	O
that	O
the	O
majority	O
of	O
participants	O
only	O
wash	O
their	O
hands	B-ANAT
after	O
using	O
the	O
toilet	O
(	O
87	O
%)	O
or	O
handling	O
vomitus	B-ANAT
or	O
faecal	B-ANAT
matter	O
(	O
91	O
%).	O

The	O
areas	O
of	O
the	O
hand	O
most	O
neglected	O
during	O
handwashing	O
were	O
the	O
fingertips	O
(	O
48	O
.	O
1	O
%),	O
medial	O
area	O
(	O
30	O
.	O
5	O
%),	O
and	O
back	B-ANAT
of	O
the	O
hand	O
(	O
28	O
%).	O

The	O
use	O
of	O
plasmapheresis	O
is	O
considered	O
useful	O
in	O
acute	O
anti	O
-	O
glomerular	B-ANAT
basement	I-ANAT
membrane	I-ANAT
(	O
GBM	B-ANAT
)	O
disease	O
(	O
Goodpasture	O
'	O
s	O
syndrome	O
)	O
or	O
catastrophic	O
antiphospholipid	O
antibody	O
syndrome	O
(	O
APS	O
).	O

PDCoV	O
antigen	O
was	O
detected	O
in	O
the	O
basal	B-ANAT
layer	I-ANAT
of	O
jejunum	B-ANAT
and	O
ileum	B-ANAT
by	O
IHC	O
.	O

A	O
key	O
step	O
in	O
the	O
MERS	O
-	O
CoV	O
replication	O
cycle	O
is	O
the	O
fusion	O
of	O
the	O
virus	O
and	O
host	O
cell	B-ANAT
membranes	I-ANAT
mediated	O
by	O
the	O
virus	O
spike	O
protein	O
,	O
S	O
.	O
The	O
location	O
of	O
the	O
fusion	O
peptide	O
within	O
the	O
MERS	O
S	O
protein	O
has	O
not	O
been	O
precisely	O
mapped	O
.	O

MERS	O
-	O
CoV	O
has	O
been	O
detected	O
in	O
the	O
nasal	B-ANAT
and	O
rectal	O
secretions	B-ANAT
of	O
infected	O
camels	O
,	O
and	O
MERS	O
-	O
CoV	O
of	O
this	O
origin	O
has	O
full	O
capacity	O
to	O
infect	O
human	O
airway	B-ANAT
epithelium	B-ANAT
in	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
.	O

Notably	O
,	O
the	O
features	O
of	O
bat	O
MHC	B-ANAT
I	O
may	O
be	O
shared	O
by	O
MHC	B-ANAT
I	O
from	O
various	O
marsupials	O
.	O

ABSTRACT	O
:	O
Myocardial	O
calcification	O
,	O
a	O
rare	O
disease	O
that	O
leads	O
to	O
chronic	O
or	O
acute	O
heart	B-ANAT
failure	O
and	O
with	O
a	O
poor	O
prognosis	O
,	O
occurs	O
in	O
patients	O
with	O
abnormal	O
calcium	O
-	O
phosphorus	O
metabolism	O
.	O

On	O
the	O
cut	O
surface	O
of	O
the	O
heart	B-ANAT
,	O
the	O
left	B-ANAT
ventricle	I-ANAT
was	O
dilated	O
,	O
and	O
patchy	O
yellowish	O
-	O
brown	O
areas	O
were	O
present	O
in	O
the	O
epicardial	O
-	O
side	O
of	O
the	O
myocardium	B-ANAT
and	O
spread	O
through	O
the	O
circumferential	O
wall	O
of	O
the	O
left	B-ANAT
ventricle	I-ANAT
and	O
interventricular	B-ANAT
septum	I-ANAT
.	O

The	O
drastic	O
increase	O
in	O
the	O
serum	B-ANAT
phosphorus	O
level	O
caused	O
by	O
tumor	O
lysis	O
syndrome	O
seemed	O
to	O
be	O
associated	O
with	O
myocardial	O
calcification	O
.	O

High	O
dose	O
corticosteroid	O
therapy	O
and	O
lung	B-ANAT
-	O
protective	O
ventilation	O
strategies	O
may	O
help	O
for	O
complete	O
recovery	O
of	O
lung	B-ANAT
function	O
.	O

The	O
earliest	O
IgG	B-ANAT
antibody	I-ANAT
response	O
was	O
observed	O
in	O
the	O
one	O
-	O
week	O
-	O
old	O
piglets	O
,	O
with	O
similar	O
antibody	O
ontogeny	O
and	O
patterns	O
of	O
seroconversion	O
for	O
S1	O
,	O
ORF3C	O
,	O
E	O
,	O
and	O
WV	O
antigens	O
.	O

ABSTRACT	O
:	O
Our	O
Cooling	O
to	O
Help	O
Injured	O
Lungs	B-ANAT
(	O
CHILL	O
)	O
trial	O
of	O
therapeutic	O
hypothermia	O
in	O
ARDS	O
includes	O
neuromuscular	O
blockade	O
(	O
NMB	O
)	O
as	O
an	O
inclusion	O
criterion	O
to	O
avoid	O
shivering	O
.	O

A	O
delay	O
in	O
antibiotic	O
treatment	O
resulted	O
in	O
ongoing	O
inflammation	O
and	O
renal	B-ANAT
and	O
hepatic	B-ANAT
dysfunction	O
despite	O
effective	O
bacterial	O
killing	O
.	O

These	O
data	O
have	O
demonstrated	O
that	O
non	O
-	O
influenza	O
CARVs	O
independently	O
contribute	O
to	O
morbidity	O
and	O
mortality	O
of	O
transplant	B-ANAT
patients	O
.	O

TITLE	O
:	O
A	O
rare	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
use	O
of	O
gadolinium	O
-	O
based	O
magnetic	O
resonance	O
imaging	O
contrast	O
media	B-ANAT
.	O

TITLE	O
:	O
Spontaneous	O
breathing	O
during	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
treatment	O
of	O
sickle	B-ANAT
cell	I-ANAT
disease	O
acute	O
chest	B-ANAT
syndrome	O
.	O

,	O
the	O
goal	O
of	O
personal	O
protective	O
equipment	O
(	O
PPE	O
)	O
is	O
to	O
protect	O
healthcare	O
personnel	O
(	O
HCP	O
)	O
and	O
patients	O
from	O
body	B-ANAT
fluids	I-ANAT
and	O
infectious	O
organisms	O
via	O
contact	O
,	O
droplet	O
,	O
or	O
airborne	O
transmission	O
.	O

In	O
the	O
current	O
study	O
,	O
eight	O
human	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
with	O
neutralizing	O
and	O
non	O
-	O
neutralizing	O
capabilities	O
,	O
directed	O
against	O
different	O
epitopes	O
of	O
the	O
MERS	O
-	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
spike	O
(	O
MERS	O
-	O
S	O
)	O
protein	O
,	O
were	O
investigated	O
with	O
regard	O
to	O
their	O
ability	O
to	O
immunohistochemically	O
detect	O
respective	O
epitopes	O
on	O
formalin	O
-	O
fixed	B-ANAT
paraffin	O
-	O
embedded	O
(	O
FFPE	O
)	O
nasal	B-ANAT
tissue	B-ANAT
sections	O
of	O
MERS	O
-	O
CoV	O
experimentally	O
infected	O
alpacas	O
.	O

The	O
most	O
intense	O
immunoreaction	O
was	O
detected	O
using	O
a	O
neutralizing	O
antibody	O
directed	O
against	O
the	O
receptor	O
binding	O
domain	O
S1B	O
of	O
the	O
MERS	O
-	O
S	O
protein	O
,	O
which	O
produced	O
an	O
immunosignal	O
in	O
the	O
cytoplasm	B-ANAT
of	O
ciliated	O
respiratory	B-ANAT
epithelium	I-ANAT
and	O
along	O
the	O
apical	O
membranous	B-ANAT
region	O
.	O

Five	O
mAbs	O
lacked	O
immunoreactivity	O
for	O
MERS	O
-	O
CoV	O
antigen	O
on	O
FFPE	O
tissue	B-ANAT
,	O
even	O
though	O
they	O
belong	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
same	O
epitope	O
group	O
.	O

Curcumin	O
exhibits	O
potent	O
anti	O
-	O
inflammatory	O
properties	O
but	O
has	O
poor	O
solubility	O
and	O
rapid	O
plasma	B-ANAT
clearance	O
.	O

To	O
overcome	O
these	O
physiochemical	O
limitations	O
and	O
uncover	O
the	O
full	O
therapeutic	O
potential	O
of	O
curcumin	O
in	O
lung	B-ANAT
inflammation	O
,	O
in	O
this	O
study	O
we	O
utilized	O
a	O
novel	O
water	O
-	O
soluble	O
curcumin	O
formulation	O
(	O
CDC	O
)	O
and	O
delivered	O
it	O
directly	O
into	O
the	O
lungs	B-ANAT
of	O
C57BL	O
/	O
6	O
mice	O
inoculated	O
with	O
a	O
lethal	O
dose	O
of	O

Cresol	O
intoxication	O
can	O
be	O
fatal	O
,	O
and	O
cause	O
a	O
respiratory	O
failure	O
with	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
hepatic	B-ANAT
,	O
and	O
renal	B-ANAT
injury	O
.	O

The	O
radiographs	O
showed	O
bilateral	O
widespread	O
interstitial	B-ANAT
shadowing	O
.	O

The	O
prevalence	O
of	O
pulmonary	B-ANAT
embolism	O
in	O
severe	O
respiratory	O
failure	O
has	O
important	O
clinical	O
implications	O
for	O
both	O
short	O
and	O
long	O
-	O
term	O
anticoagulation	O
strategies	O
.	O

There	O
was	O
no	O
difference	O
in	O
survival	O
rates	O
between	O
cohorts	O
with	O
PE	O
versus	O
no	O
PE	O
(	O
ECMO	O
survival	O
to	O
discharge	B-ANAT
P	O
=	O
.	O
56	O
;	O
conventional	O
ventilation	O
survival	O
to	O
discharge	B-ANAT
P	O
=	O
.	O
21	O
).	O

We	O
report	O
that	O
polyclonal	O
cell	B-ANAT
populations	O
and	O
a	O
clonal	B-ANAT
isolate	O
,	O
termed	O
Fcwf	O
-	O
4	O
IRN	O
,	O
exhibited	O
significantly	O
diminished	O
IFN	O
-	O
responsiveness	O
and	O
allowed	O
FIPV	O
replication	O
kinetics	O
comparable	O
to	O
parental	O
cells	B-ANAT
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
replication	O
of	O
FIPV	O
is	O
enhanced	O
by	O
ectopic	O
expression	O
of	O
a	O
host	O
serine	O
protease	O
,	O
TMPRSS2	O
,	O
in	O
these	O
cells	B-ANAT
.	O

The	O
study	O
investigated	O
the	O
antiviral	O
activity	O
of	O
Sambucus	O
FormosanaNakai	O
stem	B-ANAT
ethanol	O
extract	O
and	O
some	O
phenolic	O
acid	O
constituents	O
against	O
HCoV	O
-	O
NL63	O
.	O

A	O
total	O
of	O
1236	O
cloacal	B-ANAT
/	O
fecal	B-ANAT
swabs	O
collected	O
during	O
the	O
period	O
2015	O
-	O
2018	O
were	O
tested	O
for	O
Î³	O
-	O
and	O
Î´	O
-	O
CoVs	O
using	O
genus	O
-	O
specific	O
reverse	O
transcription	O
-	O
PCR	O
assays	O
.	O

TITLE	O
:	O
Activation	O
of	O
C	O
-	O
Type	O
Lectin	O
Receptor	O
and	O
(	O
RIG	O
)-	O
I	O
-	O
Like	O
Receptors	O
Contributes	O
to	O
Proinflammatory	O
Response	O
in	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
-	O
Infected	O
Macrophages	B-ANAT
.	O

Significant	O
FECV	O
-	O
specific	O
mucosal	B-ANAT
T	B-ANAT
cell	I-ANAT
IFNÎ³	O
responses	O
were	O
not	O
detected	O
in	O
any	O
of	O
the	O
three	O
groups	O
.	O

Together	O
,	O
the	O
results	O
suggest	O
that	O
control	O
of	O
FECV	O
is	O
mediated	O
by	O
humoral	O
mucosal	B-ANAT
and	O
systemic	O
responses	O
and	O
that	O
perturbations	O
in	O
the	O
primary	O
reservoir	O
organ	B-ANAT
(	O
colon	B-ANAT
)	O
are	O
minimal	O
.	O

TITLE	O
:	O
Quantitative	O
Proteomics	O
of	O
Uukuniemi	O
Virus	O
-	O
host	B-ANAT
Cell	I-ANAT
Interactions	O
Reveals	O
GBF1	O
as	O
Proviral	O
Host	O
Factor	O
for	O
Phleboviruses	O
.	O

Data	O
was	O
collected	O
by	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
interview	O
using	O
standardised	O
questionnaire	O
,	O
and	O
analyzed	O
using	O
SPSS	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
our	O
findings	O
on	O
identifying	O
the	O
alterations	O
of	O
host	B-ANAT
cell	I-ANAT
innate	O
immune	O
response	O
affected	O
by	O
PDCoV	O
infection	O
and	O
exploring	O
the	O
gene	O
expression	O
profiles	O
of	O
PK	O
-	O
15	O
cells	B-ANAT
at	O
0	O
,	O
24	O
,	O
and	O
36	O
h	O
PDCoV	O
post	O
infection	O
by	O
RNA	O
sequencing	O
.	O

Here	O
,	O
we	O
propagated	O
a	O
virulent	O
strain	O
SADS	O
-	O
CoV	O
/	O
CN	O
/	O
GDWT	O
/	O
2017	O
in	O
Vero	B-ANAT
cells	I-ANAT
for	O
up	O
to	O
83	O
passages	O
.	O

Patients	O
were	O
randomly	O
assigned	O
(	O
2	O
:	O
1	O
)	O
using	O
an	O
interactive	O
web	O
response	O
system	O
to	O
receive	O
either	O
two	O
units	O
(	O
or	O
paediatric	O
equivalent	O
)	O
of	O
high	O
-	O
titre	O
plasma	B-ANAT
(	O
high	O
-	O
titre	O
group	O
)	O
or	O
low	O
-	O
titre	O
plasma	B-ANAT
(	O
low	O
-	O
titre	O
group	O
),	O
and	O
were	O
followed	O
up	O
for	O
28	O
days	O
from	O
randomisation	O
.	O

TITLE	O
:	O
Integrin	O
Î±vÎ²3	O
enhances	O
replication	O
of	O
porcine	O
epidemic	O
diarrhea	O
virus	O
on	O
Vero	O
E6	O
and	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

Integrin	O
Î±vÎ²3	O
significantly	O
enhanced	O
the	O
replication	O
of	O
the	O
classical	O
and	O
variant	O
strains	O
of	O
PEDV	O
in	O
Vero	O
E6	O
cells	B-ANAT
and	O
IECs	O
.	O

TITLE	O
:	O
Circular	O
RNA	O
CircEZH2	O
Suppresses	O
Transmissible	O
Gastroenteritis	O
Coronavirus	O
-	O
induced	O
Opening	O
of	O
Mitochondrial	B-ANAT
Permeability	O
Transition	O
Pore	B-ANAT
via	O
Targeting	O
MiR	O
-	O
22	O
in	O
IPEC	O
-	O
J2	O
.	O

TITLE	O
:	O
An	O
in	O
vivo	O
cell	B-ANAT
-	O
based	O
assay	O
for	O
investigating	O
the	O
specific	O
interaction	O
between	O
the	O
SARS	O
-	O
CoV	O
N	O
-	O
protein	O
and	O
its	O
viral	O
RNA	O
packaging	O
sequence	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
-	O
CoV	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
protein	O
serves	O
multiple	O
functions	O
in	O
viral	O
replication	O
,	O
transcription	O
,	O
and	O
assembly	O
of	O
the	O
viral	B-ANAT
genome	I-ANAT
complex	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
Group	O
A	O
streptococcal	O
infection	O
-	O
induced	O
toxic	O
shock	O
syndrome	O
(	O
GAS	O
-	O
TSS	O
)	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
successfully	O
treated	O
with	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
V	O
-	O
A	O
ECMO	O
).	O

Nucleic	B-ANAT
acids	O
were	O
extracted	O
from	O
samples	O
collected	O
in	O
winter	O
period	O
of	O
2016	O
and	O
subjected	O
to	O
HTS	O
.	O

TITLE	O
:	O
Preparation	O
of	O
virus	B-ANAT
-	I-ANAT
like	I-ANAT
particle	I-ANAT
mimetic	O
nanovesicles	O
displaying	O
the	O
S	O
protein	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
using	O
insect	O
cells	B-ANAT
.	O

By	O
surfactant	O
treatment	O
and	O
mechanical	O
extrusion	O
using	O
S	O
protein	O
-	O
or	O
three	O
structural	O
protein	O
-	O
expressing	O
Bm5	O
cells	B-ANAT
,	O
S	O
protein	O
-	O
displaying	O
nanovesicles	O
with	O
diameters	O
of	O
approximately	O
100	O
-	O
200	O
nm	O
were	O
prepared	O
and	O
confirmed	O
by	O
immuno	O
-	O
TEM	O
.	O

The	O
mechanical	O
extrusion	O
method	O
is	O
favorable	O
for	O
obtaining	O
uniform	O
recombinant	O
protein	O
-	O
displaying	O
nanovesicles	O
from	O
cultured	B-ANAT
cells	I-ANAT
.	O

The	O
purified	O
SÎTM	O
from	O
silkworm	O
larvae	O
and	O
S	O
protein	O
-	O
displaying	O
nanovesicles	O
from	O
Bm5	O
cells	B-ANAT
may	O
lead	O
to	O
the	O
development	O
of	O
nanoparticle	O
-	O
based	O
vaccines	O
against	O
MERS	O
-	O
CoV	O
and	O
the	O
diagnostic	O
detection	O
of	O
MERS	O
-	O
CoV	O
.	O

Sequence	O
and	O
/	O
or	O
phylogenetic	O
analysis	O
showed	O
that	O
nucleocapsid	B-ANAT
,	O
spike	O
and	O
p12	O
.	O
7	O
genes	O
were	O
highly	O
conserved	O
and	O
were	O
closely	O
related	O
to	O
ECoVs	O
identified	O
in	O
other	O
countries	O
.	O

She	O
developed	O
very	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
which	O
was	O
treated	O
with	O
rescue	O
high	O
-	O
frequency	O
oscillation	O
),	O
hemodynamic	O
instability	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
rhabdomyolysis	O
,	O
and	O
remained	O
comatose	O
with	O
a	O
Glasgow	O
Coma	O
Scale	O
score	O
of	O
3	O
and	O
gasping	O
respirations	O
for	O
67	O
hours	O
(	O
when	O
the	O
Glasgow	O
Coma	O
Scale	O
score	O
improved	O
to	O
6	O
,	O
with	O
tachypnea	O
to	O
Paco	O

The	O
study	O
included	O
48	O
patients	O
diagnosed	O
with	O
primary	O
acquired	O
nasolacrimal	B-ANAT
duct	I-ANAT
obstruction	O
undergoing	O
dacryocystorhinostomy	O
surgery	O
.	O

However	O
,	O
considering	O
the	O
profibrotic	O
characteristics	O
of	O
specific	O
viruses	O
such	O
as	O
respiratory	O
syncytial	O
virus	O
and	O
adenovirus	O
,	O
viral	O
infections	O
may	O
be	O
one	O
of	O
the	O
many	O
predisposing	O
factors	O
of	O
primary	O
acquired	O
nasolacrimal	B-ANAT
duct	I-ANAT
obstruction	O
.	O

TITLE	O
:	O
GILT	O
restricts	O
the	O
cellular	B-ANAT
entry	O
mediated	O
by	O
the	O
envelope	B-ANAT
glycoproteins	O
of	O
SARS	O
-	O
CoV	O
,	O
Ebola	O
virus	O
and	O
Lassa	O
fever	O
virus	O
.	O

We	O
report	O
herein	O
that	O
gamma	O
-	O
interferon	O
-	O
inducible	O
lysosomal	B-ANAT
thiol	O
reductase	O
(	O
GILT	O
),	O
a	O
lysosome	B-ANAT
-	O
associated	O
ISG	O
,	O
restricts	O
the	O
infectious	O
entry	O
of	O
selected	O
enveloped	O
RNA	O
viruses	O
.	O

TITLE	O
:	O
Extracorporeal	O
membrane	B-ANAT
oxygenation	O
as	O
rescue	O
therapy	O
for	O
severe	O
hypoxemic	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Bedside	O
troubleshooting	O
during	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
).	O

TITLE	O
:	O
Waking	O
Up	O
Blind	O
in	O
the	O
ICU	O
:	O
A	O
Case	O
Report	O
of	O
Ischemic	O
Optic	B-ANAT
Neuropathy	O
in	O
a	O
Burn	O
Patient	O
.	O

TITLE	O
:	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Following	O
Pediatric	O
Trauma	O
:	O
Application	O
of	O
Pediatric	O
Acute	O
Lung	B-ANAT
Injury	O
Consensus	O
Conference	O
Criteria	O
.	O

Cause	O
of	O
death	O
was	O
neurologic	O
in	O
60	O
.	O
0	O
%	O
and	O
multiple	O
organ	B-ANAT
failure	O
in	O
34	O
.	O
3	O
%	O
of	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
nonsurvivors	O
versus	O
neurologic	O
in	O
85	O
.	O
4	O
%	O
of	O
nonsurvivors	O
without	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
p	O
=	O
0	O
.	O
001	O
).	O

Echocardiography	O
showed	O
left	O
ventricular	B-ANAT
hypertrophy	O
and	O
bilateral	O
atrial	B-ANAT
enlargement	O
.	O

Three	O
cases	O
of	O
enteritis	O
caused	O
by	O
BRoV	O
showed	O
the	O
hallmark	O
lesions	O
of	O
the	O
shortening	O
and	O
fusion	O
of	O
villi	O
,	O
denudation	O
and	O
infiltration	O
of	O
mononuclear	B-ANAT
cells	I-ANAT
in	O
the	O
lamina	B-ANAT
propria	I-ANAT
.	O

We	O
reviewed	O
hospital	O
records	O
of	O
confirmed	O
cases	O
(	O
detection	O
of	O
virus	O
by	O
polymerase	O
chain	O
reaction	O
from	O
respiratory	B-ANAT
tract	I-ANAT
samples	O
)	O
of	O
MERS	O
-	O
CoV	O
patients	O
(	O
n	O
=	O
63	O
)	O
admitted	O
to	O
Buraidah	O
Central	O
Hospital	O
in	O
Al	O
-	O
Qassim	O
,	O
Saudi	O
Arabia	O
between	O
2014	O
and	O
2017	O
.	O

TITLE	O
:	O
LiverTox	O
:	O
Clinical	O
and	O
Research	O
Information	O
on	O
Drug	O
-	O
Induced	O
Liver	B-ANAT
Injury	O
ABSTRACT	O
:	O
The	O
opioids	O
are	O
a	O
large	O
class	O
of	O
medications	O
related	O
in	O
structure	O
to	O
the	O
natural	O
plant	O
alkaloids	O
found	O
in	O
opium	O
that	O
are	O
derived	O
from	O
the	O
resin	O
of	O
the	O
opium	O
poppy	O
,	O
Papaver	O
somniferum	O
.	O

Engagement	O
of	O
the	O
opiate	O
receptors	O
generates	O
a	O
series	O
of	O
intracellular	B-ANAT
signals	O
,	O
including	O
inhibition	O
of	O
adenylate	O
cyclase	O
,	O
decreased	O
opening	O
of	O
calcium	O
channels	O
,	O
increased	O
potassium	O
currents	O
and	O
activation	O
of	O
protein	O
kinase	O
C	O
(	O
PKC	O
).	O

The	O
major	O
effect	O
of	O
these	O
pathways	O
is	O
reduction	O
in	O
cell	B-ANAT
excitability	O
and	O
neurotransmission	O
.	O

Opioids	O
also	O
have	O
direct	O
cardiovascular	B-ANAT
effects	O
,	O
decreasing	O
blood	B-ANAT
pressure	O
,	O
causing	O
vasodilation	O
and	O
decreasing	O
cardiac	B-ANAT
work	O
.	O

Amoxicillin	O
/	O
clavulanate	O
is	O
one	O
of	O
the	O
most	O
frequent	O
causes	O
of	O
drug	O
induced	O
liver	B-ANAT
disease	O
,	O
but	O
the	O
liver	B-ANAT
injury	O
is	O
usually	O
attributed	O
to	O
the	O
clavulanate	O
rather	O
than	O
the	O
aminopenicillin	O
,	O
and	O
the	O
pattern	O
of	O
injury	O
may	O
be	O
slightly	O
different	O
than	O
that	O
described	O
with	O
penicillin	O
,	O
ampicillin	O
and	O
amoxicillin	O
alone	O
.	O

There	O
is	O
no	O
evidence	O
on	O
use	O
of	O
'	B-ANAT
airway	I-ANAT
pressure	O
release	O
ventilation	O
'	O
mode	O
in	O
children	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
complicated	O
by	O
pneumothorax	O
.	O

To	O
study	O
the	O
respiratory	O
virome	O
in	O
nasopharyngeal	B-ANAT
samples	O
during	O
COPD	O
exacerbations	O
using	O
mNGS	O
.	O

RESULTS	O
:	O
Pathogenicity	O
experiments	O
using	O
P120	O
in	O
piglets	O
revealed	O
significant	O
reductions	O
in	O
clinical	O
symptoms	O
,	O
histopathological	O
lesions	O
,	O
and	O
intestinal	B-ANAT
PEDV	O
antigen	O
distribution	O
;	O
the	O
piglet	O
survival	O
rate	O
in	O
the	O
P120	O
group	O
was	O
100	O
%.	O

We	O
performed	O
a	O
systematic	O
review	O
of	O
literature	O
from	O
the	O
PubMed	O
database	O
and	O
selected	O
cases	O
of	O
definite	O
DRESS	O
syndrome	O
as	O
defined	O
by	O
the	O
European	O
Registry	O
of	O
Severe	O
Cutaneous	O
Adverse	O
Reactions	O
(	O
RegiSCAR	O
)	O
with	O
a	O
score	O
of	O
6	O
or	O
more	O
who	O
also	O
had	O
pulmonary	B-ANAT
involvement	O
.	O

Demographic	O
data	O
,	O
pattern	O
of	O
lung	B-ANAT
involvement	O
,	O
culprit	O
medication	O
,	O
latency	O
period	O
,	O
laboratory	O
findings	O
,	O
therapy	O
,	O
and	O
outcome	O
were	O
described	O
and	O
compared	O
with	O
the	O
literature	O
.	O

The	O
most	O
common	O
pulmonary	B-ANAT
radiographic	O
findings	O
in	O
DRESS	O
were	O
interstitial	B-ANAT
infiltrates	O
in	O
50	O
%	O
of	O
cases	O
,	O
followed	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
31	O
%.	O

Pulmonary	B-ANAT
manifestations	O
may	O
be	O
a	O
presenting	O
sign	O
of	O
DRESS	O
,	O
and	O
timely	O
recognition	O
is	O
important	O
in	O
order	O
to	O
stop	O
offending	O
medication	O
and	O
decrease	O
morbidity	O
and	O
mortality	O
.	O

Personnel	O
in	O
the	O
ED	O
exhibited	O
higher	O
rates	O
of	O
compliance	O
with	O
routine	O
infection	O
-	O
prevention	O
methods	O
as	O
observed	O
objectively	O
:	O
93	O
%	O
wore	O
a	O
surgical	O
mask	O
and	O
95	O
.	O
6	O
%	O
washed	O
their	O
hands	B-ANAT
.	O

TITLE	O
:	O
Metagenomic	O
Nanopore	O
Sequencing	O
of	O
Influenza	O
Virus	O
Direct	O
from	O
Clinical	O
Respiratory	B-ANAT
Samples	I-ANAT
.	O

As	O
a	O
result	O
,	O
HF	O
burns	O
are	O
often	O
severe	O
even	O
if	O
they	O
involve	O
a	O
small	O
area	O
of	O
the	O
skin	B-ANAT
.	O

TITLE	O
:	O
Protostemonine	O
alleviates	O
heat	O
-	O
killed	O
methicillin	O
-	O
resistant	O
Staphylococcus	O
aureus	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
through	O
MAPK	O
and	O
NF	O
-	O
ÎºB	O
signaling	O
pathways	O
.	O

In	O
addition	O
,	O
PSN	O
decreased	O
the	O
content	O
of	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
1Î²	O
,	O
IL	O
-	O
6	O
and	O
the	O
expression	O
of	O
iNOS	O
,	O
as	O
well	O
as	O
the	O
production	O
of	O
NO	O
in	O
HKMRSA	O
-	O
induced	O
bone	B-ANAT
marrow	I-ANAT
derived	I-ANAT
macrophages	I-ANAT
(	O
BMDMs	O
).	O

We	O
demonstrated	O
that	O
overexpression	O
of	O
duck	O
MDA5	O
significantly	O
upregulated	O
expression	O
of	O
interferon	O
(	O
IFN	O
)-	O
stimulated	O
genes	O
,	O
including	O
myxovirus	O
resistance	O
protein	O
(	O
Mx	O
),	O
IFN	O
-	O
induced	O
oligodenylate	O
synthetase	O
-	O
like	O
(	O
OASL	O
),	O
IFN	O
-	O
induced	O
transmembrane	B-ANAT
protein	O
1	O
(	O
IFITM1	O
)	O
and	O
IFN	O
-	O
Î²	O
.	O

In	O
this	O
study	O
,	O
the	O
next	O
-	O
generation	O
sequencing	O
(	O
NGS	O
)	O
technology	O
was	O
used	O
to	O
analyze	O
the	O
profiles	O
of	O
lncRNAs	O
in	O
Mock	O
and	O
TGEV	O
-	O
infected	O
porcine	O
intestinal	B-ANAT
epithelial	B-ANAT
cell	I-ANAT
-	O
jejunum	B-ANAT
2	O
(	O
IPEC	O
-	O
J2	O
)	O
cell	B-ANAT
line	I-ANAT
.	O

On	O
day	O
7	O
after	O
treatment	O
,	O
TNF	O
-	O
Î±	O
,	O
IL	O
-	O
6	O
,	O
CRP	O
and	O
CD8	O
CONCLUSIONS	O
:	O
EFR	O
can	O
effectively	O
eliminate	O
inflammatory	O
factors	O
,	O
improve	O
immune	O
function	O
,	O
maintain	O
the	O
stability	O
of	O
blood	B-ANAT
components	I-ANAT
,	O
reduce	O
the	O
incidences	O
of	O
ARDS	O
and	O
MODS	O
,	O
and	O
elevate	O
the	O
successful	O
rescue	O
rate	O
in	O
patients	O
with	O
SPF	O
.	O

The	O
most	O
common	O
pathogens	O
in	O
dogs	O
with	O
UMRD	O
were	O
canine	O
distemper	O
virus	O
,	O
canine	O
coronavirus	O
,	O
canine	O
parvovirus	O
2	O
,	O
and	O
Detection	O
of	O
nucleic	B-ANAT
acids	O
from	O
selected	O
cardiotropic	O
pathogens	O
in	O
myocardial	B-ANAT
tissue	I-ANAT
from	O
dogs	O
with	O
UMRD	O
suggested	O
a	O
possible	O
association	O
between	O
the	O
2	O
.	O

In	O
this	O
unconventional	O
approach	O
,	O
a	O
fine	O
-	O
tuning	O
of	O
the	O
dihedral	O
angle	O
between	O
the	O
C4	O
phenyl	O
and	O
the	O
dihydropyrimidine	O
core	O
of	O
the	O
heteroaryldihydropyrimidine	O
(	O
HAP	O
)	O
class	O
of	O
capsid	B-ANAT
inhibitors	O
successfully	O
altered	O
the	O
structure	O
-	O
activity	O
-	O
relationships	O
(	O
SARs	O
)	O
of	O
the	O
unwanted	O
CYP3A4	O
induction	O
and	O
the	O
desired	O
HBV	O
capsid	B-ANAT
inhibition	O
to	O
more	O
favorable	O
values	O
.	O

TITLE	O
:	O
Gold	O
nanoparticle	O
-	O
adjuvanted	O
S	O
protein	O
induces	O
a	O
strong	O
antigen	O
-	O
specific	O
IgG	O
response	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
related	O
coronavirus	O
infection	O
,	O
but	O
fails	O
to	O
induce	O
protective	O
antibodies	O
and	O
limit	O
eosinophilic	O
infiltration	O
in	O
lungs	B-ANAT
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
coronavirus	O
,	O
which	O
binds	O
to	O
cellular	B-ANAT
receptors	O
and	O
mediates	O
membrane	B-ANAT
fusion	O
for	O
cell	B-ANAT
entry	O
,	O
is	O
a	O
candidate	O
vaccine	O
target	O
for	O
blocking	O
coronavirus	O
infection	O
.	O

Herein	O
we	O
report	O
a	O
case	O
of	O
methadone	O
poisoning	O
with	O
rhabdomyolysis	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
and	O
persistent	O
hearing	O
loss	O
documented	O
by	O
a	O
2	O
year	O
follow	O
up	O
.	O

Our	O
patient	O
simultaneously	O
had	O
kidney	B-ANAT
failure	O
,	O
rhabdomyolysis	O
,	O
and	O
permanent	O
hearing	O
loss	O
following	O
methadone	O
poisoning	O
.	O

TITLE	O
:	O
Three	O
Amino	O
Acid	O
Changes	O
in	O
Avian	O
Coronavirus	O
Spike	O
Protein	O
Allow	O
Binding	O
to	O
Kidney	B-ANAT
Tissue	B-ANAT
.	O

While	O
removal	O
of	O
sialic	O
acids	O
from	O
tissues	B-ANAT
prevented	O
binding	O
of	O
all	O
proteins	O
to	O
all	O
tissues	B-ANAT
,	O
binding	O
of	O
QX	O
-	O
RBD	O
to	O
trachea	B-ANAT
and	O
kidney	B-ANAT
could	O
not	O
be	O
blocked	O
by	O
preincubation	O
with	O
synthetic	O
alpha	O
-	O
2	O
,	O
3	O
-	O
linked	O
sialic	O
acids	O
.	O

Here	O
,	O
we	O
show	O
that	O
AhR	O
is	O
activated	O
in	O
cells	B-ANAT
infected	O
with	O
mouse	O
hepatitis	O
virus	O
(	O
MHV	O
),	O
a	O
coronavirus	O
(	O
CoV	O
),	O
and	O
contributes	O
to	O
the	O
upregulation	O
of	O
downstream	O
effector	O
TCDD	O
-	O
inducible	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
(	O
TiPARP	O
)	O
during	O
infection	O
.	O

Amotosalen	O
and	O
UVA	O
light	O
treatment	O
of	O
MERS	O
-	O
CoV	O
-	O
spiked	O
platelet	B-ANAT
concentrates	O
efficiently	O
and	O
completely	O
inactivated	O
MERS	O
-	O
CoV	O
infectivity	O
(>	O
4	O
logs	O
),	O
suggesting	O
that	O
such	O
treatment	O
could	O
minimise	O
the	O
risk	O
of	O
transfusion	O
-	O
related	O
MERS	O
-	O
CoV	O
transmission	O
.	O

RESULTS	O
:	O
Complete	O
inactivation	O
of	O
MERS	O
-	O
CoV	O
in	O
spiked	O
platelet	B-ANAT
units	O
was	O
achieved	O
by	O
treatment	O
with	O
Amotosalen	O
/	O
UVA	O
light	O
with	O
a	O
mean	O
log	O
reduction	O
of	O
4	O
Â·	O
48	O
Â±	O
0	O
Â·	O
3	O
.	O

CONCLUSIONS	O
:	O
Amotosalen	O
and	O
UVA	O
light	O
treatment	O
of	O
MERS	O
-	O
CoV	O
-	O
spiked	O
platelet	B-ANAT
concentrates	O
efficiently	O
and	O
completely	O
inactivated	O
MERS	O
-	O
CoV	O
infectivity	O
(>	O
4	O
logs	O
),	O
suggesting	O
that	O
such	O
treatment	O
could	O
minimise	O
the	O
risk	O
of	O
transfusion	O
-	O
related	O
MERS	O
-	O
CoV	O
transmission	O
.	O

ABSTRACT	O
:	O
Capillary	B-ANAT
leak	O
syndrome	O
can	O
be	O
severe	O
in	O
children	O
after	O
open	O
-	O
heart	B-ANAT
surgery	O
which	O
may	O
hinder	O
sternum	B-ANAT
closure	O
and	O
described	O
as	O
mediastinal	B-ANAT
tamponade	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	O
(	O
MERS	O
-	O
COV	O
)	O
is	O
the	O
main	O
cause	O
of	O
lung	B-ANAT
and	O
kidney	B-ANAT
infections	O
in	O
developing	O
countries	O
such	O
as	O
Saudi	O
Arabia	O
and	O
South	O
Korea	O
.	O

Additionally	O
,	O
we	O
monitored	O
the	O
spatial	O
and	O
temporal	O
progression	O
of	O
HCoV	O
-	O
OC43	O
through	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
)	O
of	O
live	O
BALB	O
/	O
c	O
mice	O
after	O
intranasal	O
or	O
intracerebral	O
inoculation	O
with	O
rOC43	O
-	O
ns2DelRluc	O
.	O

Drug	O
-	O
induced	O
lymphocyte	B-ANAT
stimulation	O
test	O
performed	O
six	O
months	O
after	O
withdrawing	O
methylprednisolone	O
was	O
positive	O
for	O
Sai	O
-	O
rei	O
-	O
to	O
.	O

Cryptosporidium	O
spp	O
.	O
may	O
cause	O
asymptomatic	O
infection	O
,	O
mild	O
diarrheal	O
disease	O
or	O
severe	O
diarrhea	O
with	O
high	O
volume	O
,	O
which	O
may	O
be	O
accompanied	O
by	O
nausea	O
,	O
vomiting	O
,	O
abdominal	B-ANAT
pain	O
and	O
fever	O
,	O
following	O
a	O
1	O
-	O
7	O
day	O
incubation	O
period	O
.	O

Male	O
patients	O
with	O
higher	O
ISS	O
,	O
lactate	O
level	O
,	O
and	O
red	B-ANAT
blood	I-ANAT
cell	I-ANAT
transfusion	O
should	O
be	O
cared	O
for	O
with	O
caution	O
.	O

He	O
was	O
weaned	O
from	O
ECMO	O
successfully	O
and	O
has	O
been	O
able	O
to	O
run	O
without	O
difficulty	O
for	O
the	O
2	O
years	O
since	O
discharge	B-ANAT
.	O

ABSTRACT	O
:	O
Majeed	O
syndrome	O
is	O
a	O
rare	O
,	O
autosomal	B-ANAT
recessive	O
autoinflammatory	O
disorder	O
first	O
described	O
in	O
1989	O
.	O

ABSTRACT	O
:	O
Pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
PARDS	O
)	O
is	O
a	O
heterogenous	O
process	O
resulting	O
in	O
a	O
severe	O
acute	O
lung	B-ANAT
injury	O
.	O

TITLE	O
:	O
Assessment	O
of	O
respiratory	O
drive	O
with	O
esophageal	O
diaphragmatic	B-ANAT
electromyography	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
treated	O
with	O
prone	O
position	O
ventilation	O
.	O

TITLE	O
:	O
Altered	O
Pharmacokinetics	O
and	O
Dosing	O
of	O
Liposomal	O
Amphotericin	O
B	O
and	O
Isavuconazole	O
during	O
Extracorporeal	O
Membrane	B-ANAT
Oxygenation	O
.	O

The	O
use	O
of	O
therapeutic	O
drug	O
monitoring	O
for	O
patients	O
receiving	O
antimicrobial	O
therapy	O
with	O
concurrent	O
ECMO	O
may	O
facilitate	O
appropriate	O
drug	O
dosing	O
to	O
achieve	O
adequate	O
serum	B-ANAT
concentrations	O
and	O
optimize	O
favorable	O
patient	O
outcomes	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
have	O
utilized	O
steady	O
-	O
state	O
and	O
time	O
-	O
resolved	O
fluorescence	O
spectroscopy	O
in	O
tandem	O
with	O
circular	O
dichroism	O
spectroscopy	O
to	O
elucidate	O
the	O
binding	O
,	O
oligomeric	O
status	O
,	O
and	O
secondary	O
structure	O
of	O
the	O
fusion	O
peptide	O
and	O
its	O
impact	O
on	O
the	O
depth	O
-	O
dependent	O
membrane	B-ANAT
organization	O
and	O
dynamics	O
.	O

We	O
have	O
further	O
evaluated	O
the	O
effect	O
of	O
membrane	B-ANAT
cholesterol	O
on	O
the	O
binding	O
and	O
organization	O
of	O
the	O
peptide	O
and	O
the	O
impact	O
of	O
peptide	O
binding	O
on	O
the	O
depth	O
-	O
dependent	O
physical	O
properties	O
of	O
the	O
membrane	B-ANAT
at	O
various	O
cholesterol	O
concentrations	O
.	O

TITLE	O
:	O
Sepsis	O
outcomes	O
in	O
solid	O
organ	B-ANAT
transplant	I-ANAT
recipients	O
.	O

Sepsis	O
in	O
solid	O
organ	B-ANAT
transplants	I-ANAT
and	O
non	O
-	O
solid	O
organ	B-ANAT
transplant	I-ANAT
patients	O
have	O
similar	O
mortality	O
;	O
however	O
,	O
the	O
subset	O
of	O
heart	B-ANAT
and	I-ANAT
lung	I-ANAT
transplant	B-ANAT
recipients	O
with	O
sepsis	O
has	O
a	O
higher	O
rate	O
of	O
mortality	O
compared	O
with	O
the	O
non	O
-	O
solid	O
organ	B-ANAT
transplant	I-ANAT
recipients	O
.	O

TITLE	O
:	O
Early	O
signs	O
of	O
right	O
ventricular	B-ANAT
systolic	O
and	O
diastolic	O
dysfunction	O
in	O
acute	O
severe	O
respiratory	O
failure	O
:	O
the	O
importance	O
of	O
diastolic	O
restrictive	O
pattern	O
.	O

Recently	O
,	O
sacubitril	O
/	O
valsartan	O
-	O
an	O
angiotensin	O
receptor	O
blocker	O
-	O
neprilysin	O
inhibitor	O
-	O
has	O
been	O
added	O
in	O
clinical	O
practice	O
as	O
a	O
standard	O
therapy	O
for	O
heart	B-ANAT
failure	O
.	O

To	O
our	O
knowledge	O
,	O
there	O
are	O
no	O
data	O
on	O
sacubitril	O
/	O
valsartan	O
'	O
s	O
effects	O
on	O
cardiovascular	B-ANAT
outcomes	O
in	O
patients	O
with	O
Marfan	O
syndrome	O
.	O

TITLE	O
:	O
Attenuation	O
and	O
characterization	O
of	O
porcine	O
enteric	O
alphacoronavirus	O
strain	O
GDS04	O
via	O
serial	O
cell	B-ANAT
passage	O
.	O

However	O
,	O
viral	O
distribution	O
and	O
viral	O
shedding	O
showed	O
that	O
the	O
viral	O
loads	O
of	O
rIBYZ	O
-	O
ScAUG3a	O
were	O
lower	O
than	O
those	O
of	O
rIBYZ	O
in	O
tissue	B-ANAT
samples	O
and	O
swab	O
specimens	O
.	O

We	O
collected	O
nasopharyngeal	B-ANAT
specimens	O
from	O
282	O
children	O
aged	O
â¤	O
5	O
years	O
with	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infection	O
(	O
ARI	O
)	O
during	O
2005	O
to	O
2006	O
in	O
one	O
of	O
the	O
largest	O
Brazilian	O
slums	O
.	O

Physical	O
examination	O
revealed	O
oliguria	O
,	O
suppurated	O
tonsils	B-ANAT
,	O
poor	O
hemoglobin	O
saturation	O
,	O
alert	O
consciousness	O
,	O
normal	O
neurological	O
signs	O
and	O
reflexes	O
,	O
hypertension	O
,	O
and	O
tachypnea	O
.	O

High	O
levels	O
of	O
acylcarnitine	O
in	O
the	O
serum	B-ANAT
confirmed	O
the	O
diagnosis	O
of	O
CPT	O
II	O
deficiency	O
.	O

Given	O
the	O
direct	O
antiviral	O
effects	O
of	O
type	O
I	O
interferons	O
(	O
IFNs	O
)	O
in	O
inhibiting	O
the	O
replication	O
of	O
both	O
DNA	O
and	O
RNA	O
viruses	O
at	O
different	O
stages	O
of	O
their	O
replicative	O
cycles	O
,	O
and	O
the	O
effects	O
of	O
type	O
I	O
IFNs	O
on	O
activating	O
immune	O
cell	B-ANAT
populations	O
to	O
clear	O
virus	O
infections	O
,	O
IFNs	O
-	O
Î±	O
/	O
Î²	O
present	O
as	O
ideal	O
candidate	O
broad	O
-	O
spectrum	O
antivirals	O
.	O

Fecal	B-ANAT
samples	O
collected	O
from	O
the	O
rectum	B-ANAT
were	O
examined	O
for	O
causative	O
agents	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
or	O
real	O
-	O
time	O
PCR	O
and	O
the	O
number	O
of	O
oocysts	O
were	O
counted	O
.	O

The	O
demise	O
occurs	O
due	O
to	O
progressive	O
pulmonary	B-ANAT
hypoxia	O
and	O
multi	O
-	O
organ	B-ANAT
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
with	O
severe	O
inflammation	O
.	O

If	O
complement	O
regulatory	O
protein	O
such	O
as	O
endothelial	B-ANAT
CD59	O
is	O
underexpressed	O
,	O
MAC	B-ANAT
may	O
also	O
cause	O
pulmonary	B-ANAT
vascular	B-ANAT
injury	O
to	O
the	O
innocent	O
bystander	O
endothelial	B-ANAT
cell	I-ANAT
of	O
host	O
and	O
provokes	O
endotheliopathy	O
that	O
causes	O
inflammation	O
and	O
pulmonary	B-ANAT
vascular	B-ANAT
microthrombosis	O
,	O
leading	O
to	O
ARDS	O
.	O

No	O
differences	O
was	O
observed	O
in	O
age	O
,	O
family	O
history	O
for	O
atopy	O
and	O
/	O
or	O
asthma	O
,	O
clinical	O
presentations	O
,	O
chest	B-ANAT
X	O
-	O
ray	O
,	O
or	O
laboratory	O
findings	O
in	O
children	O
with	O
HBoV	O
alone	O
vs	O
.	O
multiple	O
viral	O
detection	O
.	O

When	O
compared	O
with	O
HBoV	O
detection	O
alone	O
,	O
the	O
co	O
-	O
detection	O
of	O
RSV	O
and	O
HBoV	O
was	O
associated	O
with	O
male	O
sex	O
(	O
P	O
=	O
0	O
.	O
013	O
),	O
younger	O
age	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
and	O
lower	O
blood	B-ANAT
neutrophil	B-ANAT
count	O
(	O
P	O
=	O
0	O
.	O
032	O
).	O

ABSTRACT	O
:	O
Influenza	O
virus	O
infection	O
is	O
responsible	O
for	O
significant	O
morbidity	O
and	O
mortality	O
in	O
the	O
pediatric	O
and	O
pregnant	O
women	O
populations	O
,	O
with	O
deaths	O
frequently	O
caused	O
by	O
severe	O
influenza	O
-	O
associated	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

A	O
single	O
cardiac	B-ANAT
surgical	O
institution	O
.	O

ABSTRACT	O
:	O
The	O
autoimmune	O
polyglandular	O
syndromes	O
(	O
APS	O
)	O
are	O
rare	O
immune	O
-	O
mediated	O
endocrinopathies	O
causing	O
destruction	O
of	O
multiple	O
endocrine	O
and	O
non	O
-	O
endocrine	B-ANAT
organs	I-ANAT
.	O

TITLE	O
:	O
Anesthesia	O
Management	O
for	O
a	O
Patient	O
Undergoing	O
Pulmonary	B-ANAT
Endarterctomy	O
without	O
Cardiopulmonary	B-ANAT
Bypass	O
.	O

ABSTRACT	O
:	O
Acute	O
hypoxic	O
respiratory	O
failure	O
can	O
be	O
caused	O
by	O
severe	O
pneumonia	O
,	O
cardiogenic	O
pulmonary	B-ANAT
edema	O
(	O
CPE	O
),	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Lung	B-ANAT
ultrasound	O
(	O
LUS	O
)	O
evaluation	O
of	O
acute	O
respiratory	O
failure	O
has	O
been	O
developed	O
and	O
adopted	O
only	O
recently	O
.	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
to	O
rescue	O
patients	O
with	O
severe	O
hypoxemic	O
and	O
hypercapnic	O
respiratory	O
failure	O
refractory	O
to	O
optimal	O
therapy	O
and	O
extracorporeal	O
carbon	O
dioxide	O
removal	O
(	O
ECCO2R	O
)	O
supports	O
hypercapnic	O
respiratory	O
failure	O
and	O
allows	O
very	O
low	O
tidal	O
volume	O
ventilation	O
to	O
minimize	O
the	O
risk	O
of	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
.	O

Laryngoscopy	O
should	O
be	O
performed	O
if	O
glottis	B-ANAT
edema	O
is	O
suspected	O
.	O

Mechanical	O
ventilation	O
with	O
continuous	O
-	O
positive	O
-	O
airway	B-ANAT
-	O
pressure	O
or	O
intubation	O
/	O
tracheotomy	O
with	O
high	O
positive	O
-	O
end	O
-	O
expiratory	O
-	O
pressure	O
may	O
be	O
necessary	O
.	O

Moreover	O
,	O
compound	O
5	O
also	O
inhibited	O
HIV	O
-	O
1	O
RNase	O
H	O
function	O
,	O
classifying	O
this	O
molecule	O
as	O
a	O
dual	O
HIV	O
-	O
1	O
IN	O
and	O
RNase	O
H	O
inhibitor	O
able	O
to	O
impair	O
the	O
HIV	O
-	O
1	O
virus	O
replication	O
in	O
cell	B-ANAT
culture	O
.	O

Experimental	O
and	O
clinical	O
data	O
indicate	O
that	O
vigorous	O
spontaneous	O
effort	O
may	O
worsen	O
lung	B-ANAT
injury	O
,	O
whereas	O
,	O
at	O
the	O
same	O
time	O
,	O
the	O
intensity	O
of	O
spontaneous	O
effort	O
seems	O
difficult	O
to	O
control	O
when	O
lung	B-ANAT
injury	O
is	O
severe	O
.	O

Experimental	O
studies	O
found	O
that	O
higher	O
PEEP	O
strategy	O
can	O
be	O
effective	O
to	O
reduce	O
lung	B-ANAT
injury	O
from	O
spontaneous	O
effort	O
while	O
maintaining	O
some	O
muscle	B-ANAT
activity	O
.	O

Survivors	O
had	O
more	O
stable	O
respiratory	O
rate	O
and	O
heart	B-ANAT
rate	O
after	O
extubation	O
when	O
compared	O
to	O
the	O
non	O
-	O
survivors	O
.	O

In	O
the	O
trachea	B-ANAT
,	O
viral	O
RNA	O
replication	O
and	O
protein	O
expression	O
were	O
comparable	O
in	O
both	O
groups	O
.	O

Coronavirus	O
spike	O
protein	O
mediates	O
viral	O
entry	O
into	O
cells	B-ANAT
by	O
first	O
binding	O
to	O
a	O
receptor	O
on	O
the	O
host	B-ANAT
cell	I-ANAT
surface	I-ANAT
and	O
then	O
fusing	O
viral	O
and	O
host	O
membranes	B-ANAT
.	O

TITLE	O
:	O
Surface	O
-	O
displayed	O
porcine	O
IFN	O
-	O
Î»3	O
in	O
ABSTRACT	O
:	O
Interferon	O
(	O
IFN	O
)-	O
Î»	O
plays	O
an	O
essential	O
role	O
in	O
mucosal	B-ANAT
cells	B-ANAT
which	O
exhibit	O
strong	O
antiviral	O
activity	O
.	O

Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
multiplication	O
results	O
in	O
reduced	O
BECN1	O
levels	O
and	O
blocks	O
the	O
fusion	O
of	O
autophagosomes	O
and	O
lysosomes	B-ANAT
.	O

For	O
a	O
few	O
decades	O
now	O
,	O
data	O
reported	O
in	O
the	O
scientific	O
literature	O
has	O
also	O
demonstrated	O
that	O
several	O
respiratory	O
viruses	O
have	O
neuroinvasive	O
capacities	O
,	O
since	O
they	O
can	O
spread	O
from	O
the	O
respiratory	B-ANAT
tract	I-ANAT
to	O
the	O
central	B-ANAT
nervous	I-ANAT
system	I-ANAT
(	O
CNS	B-ANAT
).	O

Herein	O
,	O
we	O
present	O
a	O
global	O
portrait	O
of	O
some	O
of	O
the	O
most	O
prevalent	O
or	O
emerging	O
human	O
respiratory	O
viruses	O
that	O
have	O
been	O
associated	O
with	O
possible	O
pathogenic	O
processes	O
in	O
CNS	B-ANAT
infection	O
,	O
with	O
a	O
special	O
emphasis	O
on	O
human	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Interleukin	O
-	O
11	O
(	O
IL	O
-	O
11	O
),	O
a	O
well	O
-	O
known	O
anti	O
-	O
inflammatory	O
factor	O
,	O
provides	O
protection	O
from	O
intestinal	B-ANAT
epithelium	I-ANAT
damage	O
caused	O
by	O
physical	O
or	O
chemical	O
factors	O
.	O

In	O
this	O
study	O
,	O
IL	O
-	O
11	O
expression	O
at	O
mRNA	O
and	O
protein	O
levels	O
were	O
found	O
to	O
be	O
high	O
in	O
Vero	B-ANAT
cells	I-ANAT
and	O
the	O
jejunum	B-ANAT
of	O
piglets	O
during	O
porcine	O
epidemic	O
diarrhea	O
virus	O
(	O
PEDV	O
)	O
infection	O
,	O
while	O
IL	O
-	O
11	O
expression	O
was	O
found	O
to	O
be	O
positively	O
correlated	O
with	O
the	O
level	O
of	O
viral	O
infection	O
.	O

Furthermore	O
,	O
pIL	O
-	O
11	O
was	O
found	O
to	O
inhibit	O
viral	O
infection	O
by	O
preventing	O
PEDV	O
-	O
mediated	O
apoptosis	O
of	O
cells	B-ANAT
by	O
activating	O
the	O
IL	O
-	O
11	O
/	O
STAT3	O
signaling	O
pathway	O
.	O

Our	O
data	O
suggest	O
that	O
IL	O
-	O
11	O
is	O
a	O
newfound	O
PEDV	O
-	O
inducible	O
cytokine	O
,	O
and	O
its	O
production	O
enhances	O
the	O
anti	O
-	O
apoptosis	O
ability	O
of	O
epithelial	B-ANAT
cells	I-ANAT
against	O
PEDV	O
infection	O
.	O

Nine	O
(	O
81	O
.	O
8	O
%)	O
pregnant	O
women	O
had	O
pneumonia	O
(	O
six	O
had	O
interstitial	B-ANAT
and	O
three	O
had	O
bacterial	O
pneumonia	O
).	O

In	O
one	O
of	O
them	O
fetal	B-ANAT
death	O
occurred	O
one	O
day	O
before	O
she	O
died	O
.	O

A	O
total	O
of	O
30	O
lung	B-ANAT
samples	O
from	O
swine	O
showing	O
respiratory	O
symptoms	O
on	O
six	O
farms	O
were	O
tested	O
by	O
the	O
Dempo	O
-	O
PCR	O
to	O
validate	O
the	O
assay	O
'	O
s	O
clinical	O
performance	O
.	O

TITLE	O
:	O
Overexpression	O
of	O
MALAT1	O
Relates	O
to	O
Lung	B-ANAT
Injury	O
through	O
Sponging	O
miR	O
-	O
425	O
and	O
Promoting	O
Cell	B-ANAT
Apoptosis	O
during	O
ARDS	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
severe	O
form	O
of	O
acute	O
lung	B-ANAT
injury	O
during	O
which	O
severe	O
inflammatory	O
responses	O
induce	O
cell	B-ANAT
apoptosis	O
,	O
necrosis	O
,	O
and	O
fibrosis	O
.	O

TITLE	O
:	O
Herpes	O
simplex	B-ANAT
virus	O
and	O
Cytomegalovirus	O
reactivation	O
among	O
severe	O
ARDS	O
patients	O
under	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

During	O
a	O
5	O
-	O
year	O
period	O
,	O
123	O
non	O
-	O
immunocompromised	O
patients	O
with	O
a	O
severe	O
ARDS	O
requiring	O
a	O
veno	O
-	O
venous	B-ANAT
ECMO	O
were	O
included	O
.	O

A	O
cardiac	B-ANAT
MRI	O
showed	O
generalised	O
oedema	O
with	O
a	O
subtle	O
wall	O
motion	O
abnormality	O
in	O
basal	O
inferior	O
/	O
inferolateral	O
wall	O
,	O
and	O
subendocardial	O
high	O
signal	O
on	O
late	O
gadolinium	O
enhancement	O
suggesting	O
a	O
localised	O
myocardial	O
infarction	O
.	O

Other	O
measures	O
to	O
improve	O
survival	O
are	O
prone	O
position	O
ventilation	O
(	O
PPV	O
)	O
and	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Here	O
,	O
we	O
describe	O
methods	O
for	O
in	O
vitro	O
serial	O
passaging	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
to	O
select	O
for	O
mutations	O
which	O
increase	O
replication	O
on	O
semi	O
-	O
permissive	O
cell	B-ANAT
lines	I-ANAT
as	O
described	O
in	O
Letko	O
et	O
al	O
.,	O
Cell	B-ANAT
Rep	O
24	O
,	O
1730	O
-	O
1737	O
,	O
2018	O
.	O

The	O
virus	O
can	O
bind	O
host	O
-	O
cell	B-ANAT
carbohydrates	O
as	O
well	O
as	O
proteinaceous	O
receptors	O
.	O

In	O
this	O
chapter	O
,	O
we	O
describe	O
the	O
isolation	O
,	O
amplification	O
,	O
and	O
titration	O
of	O
MERS	O
-	O
CoV	O
,	O
as	O
well	O
as	O
detailed	O
MN	O
assay	O
to	O
measure	O
nAb	O
levels	O
in	O
sera	B-ANAT
from	O
different	O
mammalian	O
species	O
.	O

ABSTRACT	O
:	O
Pseudotyped	O
viral	B-ANAT
particle	I-ANAT
production	O
has	O
been	O
used	O
extensively	O
and	O
broadly	O
for	O
many	O
viruses	O
to	O
evaluate	O
levels	O
of	O
neutralizing	O
antibodies	O
,	O
viral	O
entry	O
inhibitors	O
and	O
vaccine	O
immunogenicity	O
.	O

Precise	O
molecular	O
engineering	O
of	O
mouse	O
DPP4	O
(	O
mDPP4	O
)	O
with	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
(	O
CRISPR	O
)/	O
Cas9	O
technology	O
maintained	O
inherent	O
expression	O
profiles	O
,	O
and	O
limited	O
MERS	O
-	O
CoV	O
susceptibility	O
to	O
tissues	B-ANAT
that	O
naturally	O
express	O
mDPP4	O
,	O
notably	O
the	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
wherein	O
MERS	O
-	O
CoV	O
elicits	O
severe	O
pulmonary	B-ANAT
pathology	O
.	O

The	O
resultant	O
human	O
DPP4	O
KI	O
mice	O
are	O
permissive	O
to	O
MERS	O
-	O
CoV	O
(	O
HCoV	O
-	O
EMC	B-ANAT
/	O
2012	O
strain	O
)	O
infection	O
but	O
develop	O
no	O
disease	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
Activation	O
and	O
Inflammatory	O
Activity	O
of	O
Myeloid	B-ANAT
Cells	I-ANAT
During	O
Pathogenic	O
Human	O
Coronavirus	O
Infection	O
.	O

Following	O
virus	O
infection	O
,	O
the	O
beneficial	O
or	O
deleterious	O
role	O
of	O
infiltrating	O
neutrophils	B-ANAT
and	O
monocyte	B-ANAT
-	O
macrophages	B-ANAT
is	O
determined	O
largely	O
by	O
their	O
ability	O
to	O
secrete	O
inflammatory	O
cytokines	O
and	O
chemokines	O
.	O

Lung	B-ANAT
infection	O
is	O
a	O
common	O
clinical	O
feature	O
and	O
contributes	O
to	O
disease	O
severity	O
as	O
well	O
as	O
viral	O
transmission	O
.	O

Use	O
of	O
immunostaining	O
allows	O
detection	O
of	O
presumed	O
viral	O
receptors	O
and	O
viral	O
tropism	O
for	O
cells	B-ANAT
can	O
be	O
evaluated	O
to	O
correlate	O
with	O
lesions	O
.	O

In	O
the	O
lung	B-ANAT
,	O
lesions	O
and	O
immunostaining	O
can	O
be	O
qualitatively	O
described	O
to	O
define	O
the	O
cell	B-ANAT
types	O
,	O
microanatomic	O
location	O
,	O
and	O
type	O
of	O
changes	O
seen	O
.	O

Foreign	O
body	B-ANAT
(	O
FB	O
)	O
aspiration	O
is	O
a	O
risk	O
factor	O
for	O
pneumonia	O
,	O
and	O
therefore	O
,	O
ARDS	O
.	O

ABSTRACT	O
:	O
Severe	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
infection	O
caused	O
by	O
adenovirus	O
is	O
well	O
described	O
in	O
immunocompromised	O
hosts	O
and	O
can	O
cause	O
significant	O
morbidity	O
and	O
mortality	O
.	O

According	O
to	O
our	O
previous	O
study	O
,	O
type	O
I	O
FCoV	O
infection	O
is	O
inhibited	O
by	O
compounds	O
inducing	O
intracellular	B-ANAT
cholesterol	O
accumulation	O
,	O
whereas	O
type	O
II	O
FCoV	O
infection	O
is	O
not	O
inhibited	O
.	O

Her	O
medical	O
history	O
included	O
bipolar	O
disorder	O
on	O
quetiapine	O
and	O
sertraline	O
,	O
as	O
well	O
as	O
a	O
previous	O
ICU	O
admission	O
,	O
approximately	O
2	O
years	O
prior	O
,	O
for	O
non	O
-	O
cirrhotic	O
hyperammonaemic	O
encephalopathy	O
that	O
was	O
complicated	O
by	O
prolonged	O
post	O
discharge	B-ANAT
anxiety	O
and	O
post	O
-	O
traumatic	O
stress	O
disorder	O
-	O
like	O
symptoms	O
,	O
consistent	O
with	O
post	O
-	O
intensive	O
-	O
care	O
syndrome	O
.	O

ABSTRACT	O
:	O
In	O
many	O
developing	O
countries	O
,	O
acute	O
respiratory	B-ANAT
tract	I-ANAT
infections	O
(	O
ARTIs	O
)	O
are	O
the	O
main	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
young	O
children	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
tumor	O
thrombotic	O
microangiopathy	O
of	O
hepatocellular	O
carcinoma	O
:	O
A	O
case	O
report	O
and	O
review	O
of	O
literature	O
.	O

ABSTRACT	O
:	O
Pulmonary	B-ANAT
tumor	O
thrombotic	O
microangiopathy	O
(	O
PTTM	O
)	O
is	O
a	O
rare	O
condition	O
in	O
patients	O
with	O
hepatocellular	O
carcinoma	O
(	O
HCC	O
);	O
to	O
date	O
,	O
few	O
cases	O
have	O
been	O
reported	O
.	O

TITLE	O
:	O
Leptospirosis	O
manifested	O
with	O
severe	O
pulmonary	B-ANAT
haemorrhagic	O
syndrome	O
successfully	O
treated	O
with	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Preoperative	O
high	O
-	O
resolution	O
computed	O
tomography	O
(	O
HRCT	O
)	O
showed	O
37	O
(	O
53	O
.	O
6	O
%)	O
cases	O
presented	O
with	O
usual	O
interstitial	B-ANAT
pneumonia	O
(	O
UIP	O
)	O
and	O
possible	O
UIP	O
pattern	O
.	O

Overall	O
,	O
89	O
.	O
9	O
%	O
were	O
diagnosed	O
as	O
idiopathic	O
interstitial	B-ANAT
pneumonias	O
;	O
UIP	O
was	O
found	O
in	O
48	O
patients	O
(	O
69	O
.	O
6	O
%).	O

The	O
overall	O
survival	O
rate	O
at	O
3	O
years	O
was	O
41	O
.	O
8	O
%	O
of	O
the	O
total	O
and	O
47	O
.	O
2	O
%	O
of	O
cases	O
with	O
clinical	O
stage	O
I	O
.	O
Perioperative	O
use	O
of	O
sivelestat	O
and	O
low	O
-	O
dose	O
methylprednisolone	O
in	O
patients	O
with	O
anatomical	O
lung	B-ANAT
resection	O
was	O
safe	O
but	O
did	O
not	O
prove	O
to	O
be	O
a	O
prophylactic	O
effect	O
for	O
AE	O
-	O
IP	O
.	O

TITLE	O
:	O
An	O
integrated	O
vitamin	O
E	O
-	O
coated	O
polymer	O
hybrid	O
nanoplatform	O
:	O
A	O
lucrative	O
option	O
for	O
an	O
enhanced	O
in	O
vitro	O
macrophage	B-ANAT
retention	O
for	O
an	O
anti	O
-	O
hepatitis	O
B	O
therapeutic	O
prospect	O
.	O

However	O
,	O
the	O
total	O
elimination	O
of	O
the	O
hepatitis	O
B	O
virus	O
from	O
the	O
body	B-ANAT
requires	O
prolonged	O
therapy	O
.	O

A	O
modulated	O
lipidic	O
corona	O
,	O
as	O
well	O
as	O
,	O
an	O
additional	O
coat	B-ANAT
with	O
vitamin	O
E	O
were	O
used	O
to	O
extend	O
the	O
drug	O
release	O
enhance	O
the	O
macrophage	B-ANAT
uptake	O
.	O

ABSTRACT	O
:	O
Calf	B-ANAT
diarrhea	O
causes	O
severe	O
economic	O
losses	O
in	O
the	O
cattle	O
industry	O
worldwide	O
.	O

Interestingly	O
,	O
the	O
HEV	B-ANAT
5	O
'-	O
UTR	O
conferred	O
sensitivity	O
towards	O
Silvestrol	O
but	O
not	O
to	O
CR	O
-	O
31	O
-	O
B	O
(-).	O

Patients	O
underwent	O
SAVR	O
using	O
the	O
Trifecta	O
valve	B-ANAT
at	O
a	O
single	O
institution	O
.	O

Freedom	O
at	O
8	O
years	O
from	O
all	O
-	O
cause	O
mortality	O
,	O
valve	B-ANAT
-	O
related	O
mortality	O
,	O
reoperation	O
for	O
SVD	O
(	O
redo	O
SAVR	O
or	O
V	O
-	O
in	O
-	O
V	O
TAVI	O
),	O
and	O
endocarditis	O
were	O
78	O
.	O
4	O
%,	O
98	O
.	O
0	O
%,	O
93	O
.	O
3	O
%,	O
and	O
96	O
.	O
5	O
%,	O
respectively	O
.	O

Patients	O
'	O
blood	B-ANAT
samples	I-ANAT
were	O
extracted	O
.	O

TITLE	O
:	O
Lipopolysaccharides	O
increase	O
Kir2	O
.	O
1	O
expression	O
in	O
lung	B-ANAT
endothelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Risk	O
modifiers	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
patients	O
with	O
non	O
-	O
pulmonary	B-ANAT
sepsis	O
:	O
a	O
retrospective	O
analysis	O
of	O
the	O
FORECAST	O
study	O
.	O

Septic	O
shock	O
was	O
diagnosed	O
in	O
80	O
%	O
of	O
patients	O
with	O
ARDS	O
and	O
66	O
%	O
of	O
those	O
without	O
ARDS	O
(	O
Soft	B-ANAT
tissue	I-ANAT
infection	O
,	O
ICU	O
admission	O
from	O
an	O
emergency	O
department	O
,	O
and	O
a	O
higher	O
APACHE	O
II	O
score	O
appear	O
to	O
be	O
the	O
risk	O
modifiers	O
of	O
ARDS	O
in	O
patients	O
with	O
non	O
-	O
pulmonary	B-ANAT
sepsis	O
.	O

TITLE	O
:	O
The	O
characteristics	O
of	O
hDPP4	O
transgenic	O
mice	O
subjected	O
to	O
aerosol	O
MERS	O
coronavirus	O
infection	O
via	O
an	O
animal	O
nose	B-ANAT
-	O
only	O
exposure	O
device	O
.	O

Disease	O
,	O
lung	B-ANAT
lesion	O
,	O
and	O
viral	O
replication	O
progressions	O
were	O
slower	O
in	O
the	O
MERS	O
-	O
CoV	O
aerosol	O
-	O
infected	O
mice	O
than	O
in	O
the	O
MERS	O
-	O
CoV	O
instillation	O
-	O
inoculated	O
mice	O
.	O

ABSTRACT	O
:	O
Respiratory	B-ANAT
tract	I-ANAT
viral	O
infection	O
caused	O
by	O
viruses	O
or	O
bacteria	O
is	O
one	O
of	O
the	O
most	O
common	O
diseases	O
in	O
human	O
worldwide	O
,	O
while	O
those	O
caused	O
by	O
emerging	O
viruses	O
,	O
such	O
as	O
the	O
novel	O
coronavirus	O
,	O
2019	O
-	O
nCoV	O
that	O
caused	O
the	O
pneumonia	O
outbreak	O
in	O
Wuhan	O
,	O
China	O
most	O
recently	O
,	O
have	O
posed	O
great	O
threats	O
to	O
global	O
public	O
health	O
.	O

With	O
the	O
development	O
of	O
modern	O
technologies	O
,	O
new	O
diagnostic	O
strategies	O
,	O
including	O
multiplex	O
nucleic	B-ANAT
acid	O
amplification	O
and	O
microarray	O
-	O
based	O
assays	O
,	O
are	O
emerging	O
.	O

Spike	O
glycoprotein	O
(	O
S	O
)	O
of	O
MERS	O
-	O
CoV	O
is	O
a	O
key	O
target	O
for	O
vaccines	O
and	O
therapeutics	O
because	O
S	O
mediates	O
viral	O
entry	O
and	O
membrane	B-ANAT
-	O
fusion	O
to	O
host	O
cells	B-ANAT
.	O

TITLE	O
:	O
Influence	O
of	O
a	O
temporary	O
stabilization	O
device	O
on	O
respiratory	O
status	O
in	O
patients	O
with	O
severe	O
trauma	O
with	O
a	O
femoral	B-ANAT
shaft	I-ANAT
fracture	O
treated	O
by	O
damage	O
control	O
strategy	O
.	O

Therefore	O
,	O
our	O
findings	O
suggest	O
that	O
EF	O
is	O
preferable	O
to	O
ST	O
in	O
the	O
DCO	O
setting	O
for	O
femoral	B-ANAT
shaft	I-ANAT
fracture	O
,	O
especially	O
in	O
trauma	O
patients	O
at	O
high	O
risk	O
of	O
developing	O
delayed	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
Novel	O
Linear	O
B	B-ANAT
-	I-ANAT
Cell	I-ANAT
Epitope	O
on	O
the	O
Nucleocapsid	B-ANAT
Protein	O
of	O
Porcine	O
Deltacoronavirus	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
association	O
of	O
plasma	B-ANAT
suPAR	O
expression	O
with	O
disease	O
risk	O
and	O
severity	O
as	O
well	O
as	O
prognosis	O
of	O
sepsis	O
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Extracorporeal	O
membrane	B-ANAT
oxygenation	O
reduced	O
the	O
need	O
for	O
renal	B-ANAT
replacement	O
therapy	O
,	O
with	O
a	O
RR	O
of	O
0	O
.	O
88	O
(	O
95	O
%	O
CI	O
0	O
.	O
77	O
-	O
0	O
.	O
99	O
).	O

The	O
recombination	O
may	O
occurred	O
within	O
the	O
viral	O
spike	O
glycoprotein	O
,	O
which	O
recognizes	O
a	O
cell	B-ANAT
surface	I-ANAT
receptor	O
.	O

All	O
the	O
12	O
serum	B-ANAT
samples	O
that	O
were	O
positive	O
with	O
the	O
neutralization	O
antibody	O
test	O
were	O
also	O
positive	O
for	O
the	O
S	O
-	O
ELISA	O
.	O

In	O
present	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
gga	O
-	O
miR	O
-	O
30d	O
in	O
the	O
process	O
of	O
IBV	O
infection	O
of	O
HD11	O
cell	B-ANAT
line	I-ANAT
in	O
vitro	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
usefulness	O
of	O
intestinal	B-ANAT
biomarkers	O
in	O
determining	O
the	O
presence	O
of	O
intestinal	B-ANAT
epithelial	O
damage	O
in	O
neonatal	O
calves	O
with	O
diarrhea	O
caused	O
by	O
4	O
etiologic	O
agents	O
.	O

We	O
defined	O
persistent	O
severe	O
ARDS	O
as	O
a	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
ratio	O
(	O
PaO2	O
:	O
FiO2	O
)	O
of	O
equal	O
to	O
or	O
less	O
than	O
100	O
mmHg	O
on	O
the	O
second	O
study	O
day	O
following	O
enrollment	O
.	O

PaO2	O
:	O
FiO2	O
,	O
FiO2	O
,	O
hepatic	B-ANAT
failure	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
at	O
enrollment	O
were	O
useful	O
predictive	O
variables	O
.	O

PaO2	O
:	O
FiO2	O
,	O
FiO2	O
,	O
hepatic	B-ANAT
failure	O
and	O
positive	O
end	O
-	O
expiratory	O
pressure	O
at	O
enrollment	O
were	O
useful	O
predictive	O
variables	O
.	O

Five	O
family	O
members	O
(	O
aged	O
36	O
-	O
66	O
years	O
)	O
presented	O
with	O
fever	O
,	O
upper	O
or	O
lower	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
symptoms	O
,	O
or	O
diarrhoea	O
,	O
or	O
a	O
combination	O
of	O
these	O
3	O
-	O
6	O
days	O
after	O
exposure	O
.	O

Complications	O
included	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
12	O
[	O
29	O
%]),	O
RNAaemia	O
(	O
six	O
[	O
15	O
%]),	O
acute	O
cardiac	B-ANAT
injury	O
(	O
five	O
[	O
12	O
%])	O
and	O
secondary	O
infection	O
(	O
four	O
[	O
10	O
%]).	O

Second	O
,	O
several	O
critical	O
residues	O
in	O
2019	O
-	O
nCoV	O
RBM	O
(	O
particularly	O
Gln493	O
)	O
provide	O
favorable	O
interactions	O
with	O
human	O
ACE2	O
,	O
consistent	O
with	O
2019	O
-	O
nCoV	O
'	O
s	O
capacity	O
for	O
human	O
cell	B-ANAT
infection	O
.	O

Factors	O
associated	O
with	O
mortality	O
were	O
positive	O
blood	B-ANAT
culture	O
,	O
multiorgan	O
dysfunction	O
,	O
late	O
hospital	O
admissions	O
,	O
severe	O
acute	O
malnutrition	O
,	O
and	O
requirement	O
of	O
supportive	O
care	O
(	O
P	O
values	O
-<	O
0	O
.	O
0001	O
,	O
<	O
0	O
.	O
0001	O
,	O
0	O
.	O
03	O
,	O
<	O
0	O
.	O
0001	O
and	O
<	O
0	O
.	O
0001	O
,	O
respectively	O
).	O

TITLE	O
:	O
Heparin	O
-	O
free	O
veno	O
-	O
venous	B-ANAT
extracorporeal	O
membrane	B-ANAT
oxygenation	O
in	O
a	O
multiple	O
trauma	O
patient	O
:	O
A	O
case	O
report	O
.	O

Even	O
in	O
cases	O
in	O
which	O
life	O
-	O
threatening	O
hypoxemia	O
and	O
severe	O
hypercapnia	O
/	O
acidosis	O
last	O
for	O
>	O
1	O
hours	O
during	O
CPR	O
for	O
cardiac	B-ANAT
arrest	O
,	O
VV	O
-	O
ECMO	O
could	O
be	O
considered	O
a	O
potential	O
lifesaving	O
treatment	O
.	O

The	O
CURE	O
RCT	O
compares	O
two	O
groups	O
of	O
patients	O
requiring	O
invasive	O
MV	O
with	O
a	O
partial	O
pressure	O
of	O
arterial	B-ANAT
oxygen	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
(	O
PaO2	O
/	O
FiO2	O
)	O
ratio	O
â¤	O
200	O
;	O
one	O
criterion	O
of	O
the	O
Berlin	O
consensus	O
definition	O
of	O
moderate	O
(â¤	O
200	O
)	O
or	O
severe	O
(â¤	O
100	O
)	O
ARDS	O
.	O

17	O
(	O
17	O
%)	O
patients	O
developed	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
,	O
among	O
them	O
,	O
11	O
(	O
11	O
%)	O
patients	O
worsened	O
in	O
a	O
short	O
period	O
of	O
time	O
and	O
died	O
of	O
multiple	O
organ	B-ANAT
failure	O
.	O

He	O
was	O
soon	O
liberated	O
from	O
mechanical	O
ventilation	O
and	O
improved	O
to	O
hospital	O
discharge	B-ANAT
.	O

Moreover	O
,	O
VAS2870	O
proved	O
to	O
inhibit	O
Nox2	O
expression	O
,	O
reduce	O
ROS	O
generation	O
,	O
restore	O
epithelium	B-ANAT
barrier	O
integrity	O
,	O
and	O
preserve	O
cell	B-ANAT
viability	O
in	O
LPS	O
-	O
induced	O
A549	O
cells	B-ANAT
.	O

Due	O
to	O
the	O
severe	O
impairment	O
of	O
the	O
respiratory	O
mechanics	O
,	O
the	O
fibrotic	O
lung	B-ANAT
is	O
at	O
high	O
risk	O
of	O
developing	O
ventilator	O
-	O
induced	O
lung	B-ANAT
injury	O
,	O
regardless	O
of	O
the	O
lung	B-ANAT
fibrosis	O
etiology	O
.	O

Here	O
,	O
we	O
highlight	O
the	O
use	O
of	O
a	O
low	O
-	O
input	O
metagenomic	O
next	O
-	O
generation	O
sequencing	O
(	O
mNGS	O
)	O
approach	O
on	O
RNA	O
extracted	O
from	O
bronchoalveolar	B-ANAT
lavage	I-ANAT
fluid	I-ANAT
(	O
BALF	O
).	O

TITLE	O
:	O
[	O
Suggestions	O
for	O
prevention	O
of	O
2019	O
novel	O
coronavirus	O
infection	O
in	O
otolaryngology	O
head	B-ANAT
and	I-ANAT
neck	I-ANAT
surgery	O
medical	O
staff	O
].	O

The	O
novel	O
coronavirus	O
has	O
the	O
characteristics	O
of	O
rapid	O
transmission	O
,	O
atypical	O
clinical	O
symptoms	O
,	O
and	O
easy	O
to	O
affect	O
both	O
lungs	B-ANAT
,	O
leading	O
to	O
missed	O
diagnosis	O
and	O
misdiagnosis	O
,	O
as	O
well	O
as	O
difficult	O
to	O
detection	O
and	O
assessment	O
at	O
early	O
stage	O
.	O

Forty	O
-	O
four	O
of	O
51	O
(	O
86	O
%)	O
patients	O
had	O
bilateral	O
lung	B-ANAT
involvement	O
,	O
while	O
41	O
of	O
51	O
(	O
80	O
%)	O
involved	O
the	O
posterior	O
part	O
of	O
the	O
lungs	B-ANAT
and	O
44	O
of	O
51	O
(	O
86	O
%)	O
were	O
peripheral	O
.	O

The	O
cause	O
of	O
death	O
was	O
identified	O
as	O
pulmonary	B-ANAT
embolism	O
(	O
PE	O
)	O
based	O
on	O
the	O
laboratory	O
data	O
and	O
echocardiography	O
findings	O
,	O
and	O
a	O
literature	O
search	O
suggested	O
rapidly	O
progressive	O
hemolysis	O
-	O
induced	O
PE	O
.	O

In	O
all	O
three	O
cases	O
,	O
nasopharyngeal	B-ANAT
samples	O
confirmed	O
influenza	O
A	O
(	O
H1N1	O
)	O
infection	O
by	O
antigen	O
test	O
and	O
multiplex	O
PCR	O
detection	O
.	O

Oseltamivir	O
and	O
supportive	O
treatment	O
including	O
extra	O
-	O
corporeal	O
membrane	B-ANAT
oxygenation	O
(	O
ECMO	O
)	O
failed	O
.	O

TITLE	O
:	O
[	O
Suggestions	O
for	O
disinfection	O
of	O
ophthalmic	B-ANAT
examination	O
equipment	O
and	O
protection	O
of	O
ophthalmologist	O
against	O
2019	O
novel	O
coronavirus	O
infection	O
].	O

TITLE	O
:	O
Ruscogenin	O
alleviates	O
LPS	O
-	O
induced	O
pulmonary	B-ANAT
endothelial	B-ANAT
cell	I-ANAT
apoptosis	O
by	O
suppressing	O
TLR4	O
signaling	O
.	O

Ruscogenin	O
(	O
RUS	O
)	O
has	O
been	O
found	O
to	O
exert	O
significant	O
protective	O
effect	O
on	O
ALI	O
induced	O
by	O
lipopolysaccharides	O
(	O
LPS	O
),	O
but	O
there	O
is	O
little	O
information	O
about	O
its	O
role	O
in	O
LPS	O
-	O
induced	O
pulmonary	B-ANAT
endothelial	B-ANAT
cell	I-ANAT
apoptosis	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
underlying	O
mechanism	O
in	O
which	O
RUS	O
attenuates	O
LPS	O
-	O
induced	O
pulmonary	B-ANAT
endothelial	B-ANAT
cell	I-ANAT
apoptosis	O
.	O

And	O
we	O
observed	O
that	O
RUS	O
inhibited	O
the	O
activation	O
of	O
TLR4	O
/	O
MYD88	O
/	O
NF	O
-	O
ÎºB	O
pathway	O
in	O
pulmonary	B-ANAT
endothelium	B-ANAT
after	O
LPS	O
treatment	O
.	O

In	O
murine	O
lung	B-ANAT
vascular	B-ANAT
endothelial	I-ANAT
cells	I-ANAT
(	O
MLECs	O
)	O
we	O
further	O
confirmed	O
that	O
RUS	O
(	O
1	O
Î¼mol	O
/	O
L	O
)	O
markedly	O
ameliorated	O
MLECs	O
apoptosis	O
by	O
suppressing	O
TLR4	O
signaling	O
.	O

ABSTRACT	O
:	O
Coronavirus	O
(	O
CoV	O
)	O
envelope	B-ANAT
(	O
E	O
)	O
protein	O
is	O
a	O
small	O
structural	O
protein	O
critical	O
for	O
virion	B-ANAT
morphogenesis	O
and	O
release	O
.	O

TITLE	O
:	O
Transmissible	O
Gastroenteritis	O
Virus	O
Infection	O
Up	O
-	O
Regulates	O
FcRn	O
Expression	O
via	O
Nucleocapsid	B-ANAT
Protein	O
and	O
Secretion	B-ANAT
of	O
TGF	O
-	O
Î²	O
in	O
Porcine	O
Intestinal	B-ANAT
Epithelial	B-ANAT
Cells	I-ANAT
.	O

Along	O
with	O
decompensation	O
of	O
cirrhosis	O
,	O
the	O
concept	O
of	O
acute	O
-	O
on	O
-	O
chronic	O
liver	B-ANAT
failure	O
(	O
ACLF	O
)	O
has	O
emerged	O
.	O

Extrahepatic	O
complications	O
often	O
include	O
renal	B-ANAT
,	O
cardiovascular	B-ANAT
,	O
and	O
respiratory	O
failures	O
.	O

TITLE	O
:	O
Respiratory	O
parameters	O
and	O
acute	O
kidney	B-ANAT
injury	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
causal	O
inference	O
study	O
.	O

ABSTRACT	O
:	O
Assess	O
the	O
respiratory	O
-	O
related	O
parameters	O
associated	O
with	O
subsequent	O
severe	O
acute	O
kidney	B-ANAT
injury	O
in	O
mechanically	O
ventilated	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Major	O
initial	O
symptoms	O
included	O
fever	O
(	O
112	O
/	O
137	O
,	O
81	O
.	O
8	O
%),	O
coughing	O
(	O
66	O
/	O
137	O
,	O
48	O
.	O
2	O
%),	O
and	O
muscle	B-ANAT
pain	O
or	O
fatigue	O
(	O
44	O
/	O
137	O
,	O
32	O
.	O
1	O
%),	O
with	O
other	O
,	O
less	O
typical	O
initial	O
symptoms	O
observed	O
at	O
low	O
frequency	O
,	O
including	O
heart	B-ANAT
palpitations	O
,	O
diarrhea	O
,	O
and	O
headache	O
.	O

These	O
results	O
favored	O
a	O
two	O
-	O
step	O
process	O
in	O
which	O
viruses	O
first	O
adhere	O
to	O
sialic	O
acids	O
and	O
then	O
require	O
subsequent	O
engagement	O
with	O
protein	O
receptors	O
during	O
infectious	O
cell	B-ANAT
entry	O
.	O

Saliva	B-ANAT
is	O
a	O
promising	O
non	O
-	O
invasive	O
specimen	O
for	O
diagnosis	O
,	O
monitoring	O
,	O
and	O
infection	O
control	O
in	O
patients	O
with	O
2019	O
-	O
nCoV	O
infection	O
.	O

Age	O
,	O
viral	O
load	O
,	O
lung	B-ANAT
injury	O
score	O
,	O
and	O
blood	B-ANAT
biochemistry	O
indexes	O
,	O
albumin	O
(	O
ALB	O
),	O
CRP	O
,	O
LDH	O
,	O
LYM	O
(%),	O
LYM	O
,	O
and	O
NEU	O
(%),	O
may	O
be	O
predictors	O
of	O
disease	O
severity	O
.	O

In	O
this	O
report	O
,	O
we	O
present	O
chest	B-ANAT
CT	O
findings	O
from	O
five	O
patients	O
with	O
2019	O
-	O
nCoV	O
infection	O
who	O
had	O
initial	O
negative	O
RT	O
-	O
PCR	O
results	O
.	O

In	O
order	O
to	O
assess	O
the	O
potential	O
of	O
the	O
Wuhan	O
2019	O
-	O
nCoV	O
to	O
cause	O
maternal	O
,	O
fetal	B-ANAT
and	O
neonatal	O
morbidity	O
and	O
other	O
poor	O
obstetrical	O
outcomes	O
,	O
this	O
communication	O
reviews	O
the	O
published	O
data	O
addressing	O
the	O
epidemiological	O
and	O
clinical	O
effects	O
of	O
SARS	O
,	O
MERS	O
,	O
and	O
other	O
coronavirus	O
infections	O
on	O
pregnant	O
women	O
and	O
their	O
infants	O
.	O

A	O
few	O
cases	O
have	O
progressed	O
rapidly	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
/	O
or	O
multiple	O
organ	B-ANAT
function	O
failure	O
.	O

Anti	O
-	O
PDCoV	O
IgA	O
antibodies	O
in	O
152	O
serum	B-ANAT
samples	O
and	O
65	O
milk	O
samples	O
collected	O
from	O
six	O
farms	O
that	O
had	O
experienced	O
diarrhea	O
outbreaks	O
within	O
previous	O
last	O
two	O
years	O
were	O
detected	O
by	O
this	O
assay	O
,	O
and	O
62	O
.	O
5	O
%	O
of	O
the	O
serum	B-ANAT
samples	O
and	O
100	O
%	O
of	O
the	O
milk	O
samples	O
were	O
positive	O
for	O
PDCoV	O
.	O
The	O
indirect	O
ELISA	O
method	O
established	O
in	O
this	O
study	O
will	O
provide	O
a	O
convenient	O
tool	O
for	O
measurement	O
of	O
serum	B-ANAT
and	O
milk	O
IgA	O
levels	O
against	O
PDCoV	O
in	O
pig	O
herds	O
,	O
rapid	O
detection	O
of	O
PDCoV	O
infection	O
in	O
pigs	O
,	O
and	O
evaluation	O
of	O
the	O
immunogenicity	O
of	O
vaccines	O
.	O

Conclusion	O
In	O
patients	O
recovering	O
from	O
COVID	O
-	O
19	O
pneumonia	O
(	O
without	O
severe	O
respiratory	O
distress	O
during	O
the	O
disease	O
course	O
),	O
lung	B-ANAT
abnormalities	O
on	O
chest	B-ANAT
CT	O
showed	O
greatest	O
severity	O
approximately	O
10	O
days	O
after	O
initial	O
onset	O
of	O
symptoms	O
.	O

A	O
better	O
understanding	O
of	O
the	O
Ebola	O
virus	O
disease	O
clinical	O
syndrome	O
has	O
led	O
to	O
the	O
appreciation	O
of	O
a	O
central	O
role	O
for	O
critical	O
care	O
clinicians	O
-	O
over	O
50	O
%	O
of	O
patients	O
have	O
life	O
-	O
threatening	O
complications	O
,	O
including	O
hypotension	O
,	O
severe	O
electrolyte	O
imbalance	O
,	O
acute	O
kidney	B-ANAT
injury	O
,	O
metabolic	O
acidosis	O
and	O
respiratory	O
failure	O
.	O

The	O
mean	O
number	O
of	O
affected	O
lobes	B-ANAT
was	O
3	O
.	O
3	O
Â±	O
1	O
.	O
8	O
.	O

Patients	O
were	O
screened	O
for	O
picornavirus	O
,	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
),	O
coronavirus	O
,	O
human	O
metapneumovirus	O
,	O
adenovirus	O
,	O
bocavirus	O
,	O
parainfluenza	O
virus	O
,	O
and	O
influenza	O
,	O
by	O
PCR	O
on	O
nasopharyngeal	B-ANAT
samples	O
.	O

ACE2	O
plays	O
an	O
important	O
role	O
in	O
the	O
RAS	O
,	O
and	O
the	O
imbalance	O
between	O
ACE	O
/	O
Ang	O
II	O
/	O
AT1R	O
pathway	O
and	O
ACE2	O
/	O
Ang	O
(	O
1	O
-	O
7	O
)/	O
Mas	B-ANAT
receptor	O
pathway	O
in	O
the	O
RAS	O
system	O
will	O
lead	O
to	O
multi	O
-	O
system	O
inflammation	O
.	O

Finally	O
,	O
we	O
intranasally	O
infected	O
C3H	O
mice	O
with	O
TC	O
-	O
83	O
,	O
the	O
live	O
attenuated	O
vaccine	O
strain	O
of	O
VEEV	O
,	O
and	O
demonstrated	O
that	O
NT	O
particles	O
could	O
substantially	O
increase	O
the	O
detection	O
of	O
VEEV	O
capsid	B-ANAT
in	O
infected	O
blood	B-ANAT
incubated	O
up	O
to	O
72	O
h	O
at	O
40	O
Â°	O
C	O
.	O

Using	O
data	O
collected	O
during	O
the	O
2015	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
)	O
outbreak	O
in	O
South	O
Korea	O
,	O
this	O
study	O
explores	O
the	O
relationships	O
among	O
social	O
media	B-ANAT
use	O
,	O
risk	O
perception	O
,	O
and	O
preventive	O
behaviors	O
by	O
examining	O
the	O
mediating	O
role	O
of	O
two	O
self	O
-	O
relevant	O
emotions	O
:	O
fear	O
and	O
anger	O
.	O

The	O
use	O
of	O
CM	O
to	O
prevent	O
epidemics	O
of	O
infectious	O
diseases	O
was	O
traced	O
back	B-ANAT
to	O
ancient	O
Chinese	O
practice	O
cited	O
in	O
Huangdi	O
'	O
s	O
Internal	O
Classic	O
(	O
Huang	O
Di	O
Nei	O
Jing	O
)	O
where	O
preventive	O
effects	O
were	O
recorded	O
.	O

ABSTRACT	O
:	O
A	O
child	O
with	O
pre	O
-	O
B	O
acute	O
lymphoblastic	B-ANAT
leukaemia	O
(	O
ALL	O
)	O
developed	O
fatal	O
encephalitis	O
associated	O
with	O
human	O
coronavirus	O
OC43	O
(	O
HCoV	O
-	O
OC43	O
).	O

Patients	O
allocated	O
to	O
the	O
driving	O
pressure	O
-	O
limited	O
strategy	O
were	O
ventilated	O
with	O
volume	O
-	O
controlled	O
or	O
pressure	O
support	O
ventilation	O
modes	O
,	O
tidal	O
volume	O
titrated	O
to	O
4	O
-	O
8	O
mL	O
/	O
kg	O
of	O
predicted	O
body	B-ANAT
weight	O
(	O
PBW	O
),	O
aiming	O
a	O
driving	O
pressure	O
of	O
10	O
cmH20	O
,	O
or	O
the	O
lowest	O
possible	O
.	O

We	O
present	O
a	O
case	O
of	O
a	O
26	O
-	O
year	O
-	O
old	O
female	O
with	O
laryngeal	B-ANAT
papillomatosis	O
and	O
laryngospasm	O
after	O
direct	O
laryngoscopy	O
,	O
who	O
developed	O
severe	O
NPPE	O
refractory	O
to	O
mechanical	O
ventilator	O
support	O
,	O
which	O
was	O
successfully	O
treated	O
with	O
veno	O
-	O
venous	B-ANAT
ECMO	O
.	O

Dietary	O
taurine	O
,	O
creatine	O
,	O
carnosine	O
,	O
anserine	O
and	O
4	O
-	O
hydroxyproline	O
are	O
beneficial	O
for	O
preventing	O
and	O
treating	O
obesity	O
,	O
cardiovascular	B-ANAT
dysfunction	O
,	O
and	O
ageing	O
-	O
related	O
disorders	O
,	O
as	O
well	O
as	O
inhibiting	O
tumorigenesis	O
,	O
improving	O
skin	B-ANAT
and	O
bone	B-ANAT
health	O
,	O
ameliorating	O
neurological	O
abnormalities	O
,	O
and	O
promoting	O
well	O
being	O
in	O
infants	O
,	O
children	O
and	O
adults	O
.	O

Transcatheter	O
arterial	B-ANAT
embolization	O
for	O
hemostasis	O
is	O
an	O
alternative	O
choice	O
for	O
gastrointestinal	O
tumor	O
with	O
bleeding	O
.	O

Blood	B-ANAT
eosinophil	I-ANAT
counts	O
correlate	O
positively	O
with	O
lymphocyte	B-ANAT
counts	O
in	O
severe	O
(	O
r	O
=	O
.	O
486	O
,	O
P	O
<	O
.	O
001	O
)	O
and	O
nonsevere	O
(	O
r	O
=	O
.	O
469	O
,	O
P	O
<	O
.	O
001	O
)	O
patients	O
after	O
hospital	O
admission	O
.	O

Due	O
to	O
the	O
systemic	O
immunosuppressive	O
of	O
lung	B-ANAT
cancer	O
patients	O
caused	O
by	O
the	O
malignancy	O
and	O
anticancer	O
treatments	O
,	O
lung	B-ANAT
cancer	O
patients	O
are	O
more	O
susceptible	O
to	O
infection	O
than	O
healthy	O
individuals	O
.	O

During	O
the	O
COVID	O
-	O
19	O
outbreak	O
period	O
,	O
it	O
should	O
be	O
carefully	O
differentiated	O
for	O
fever	O
and	O
respiratory	O
symptoms	O
for	O
lung	B-ANAT
cancer	O
patients	O
receiving	O
anti	O
-	O
tumor	O
treatment	O
,	O
in	O
order	O
to	O
evaluate	O
the	O
risk	O
of	O
COVID	O
-	O
19	O
.	O

TITLE	O
:	O
Pulmonary	B-ANAT
edema	O
following	O
diuretic	O
therapy	O
:	O
A	O
case	O
report	O
.	O

To	O
date	O
,	O
the	O
clinical	O
phenomenon	O
of	O
inappropriate	O
use	O
of	O
diuretics	O
leading	O
to	O
acute	O
pulmonary	B-ANAT
edema	O
remains	O
unexplored	O
and	O
unrecognized	O
.	O

We	O
report	O
the	O
first	O
case	O
of	O
pulmonary	B-ANAT
edema	O
following	O
diuretic	O
therapy	O
to	O
stress	O
the	O
need	O
of	O
physicians	O
to	O
follow	O
guidelines	O
of	O
clinical	O
practice	O
.	O

Coronavirus	O
was	O
confirmed	O
with	O
spherical	O
particle	O
having	O
a	O
fringe	O
reminiscent	O
of	O
crown	B-ANAT
on	O
transmission	O
electron	O
microscopy	O
.	O

In	O
addition	O
,	O
there	O
is	O
up	O
regulation	O
of	O
inflammatory	O
factors	O
in	O
patients	O
with	O
severe	O
NCP	O
,	O
but	O
the	O
effect	O
of	O
renal	B-ANAT
replacement	O
therapy	O
needs	O
to	O
be	O
further	O
confirmed	O
by	O
clinical	O
research	O
.	O

TITLE	O
:	O
[	O
Cor	B-ANAT
pulmonale	O
].	O

Clinically	O
these	O
patients	O
are	O
dyspnoeic	O
with	O
signs	O
of	O
chronic	O
right	B-ANAT
heart	I-ANAT
failure	O
.	O

TITLE	O
:	O
Patterns	O
of	O
use	O
of	O
adjunctive	O
therapies	O
in	O
patients	O
with	O
early	O
moderate	O
-	O
severe	O
Acute	O
Respiratory	O
Distress	O
syndrome	O
:	O
Insights	O
from	O
the	O
LUNG	B-ANAT
SAFE	O
Study	O
.	O

TITLE	O
:	O
Grade	O
4	O
Pneumonitis	O
in	O
a	O
Patient	O
Treated	O
with	O
a	O
Combination	O
of	O
Gemcitabine	O
and	O
Docetaxel	O
for	O
Recurrent	O
Leiomyosarcoma	O
of	O
the	O
Uterus	B-ANAT
.	O

Although	O
they	O
are	O
generally	O
well	O
-	O
tolerated	O
agents	O
,	O
they	O
can	O
also	O
cause	O
severe	O
and	O
life	O
-	O
threatening	O
pulmonary	B-ANAT
toxicities	O
.	O

SADS	O
-	O
CoV	O
-	O
infected	O
cells	B-ANAT
showed	O
evidence	O
of	O
apoptosis	O

TITLE	O
:	O
Chlamydia	O
abortus	B-ANAT
in	O
Pregnant	O
Woman	O
with	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

Correlation	O
analysis	O
showed	O
that	O
the	O
PII	O
value	O
was	O
significantly	O
correlated	O
with	O
the	O
values	O
of	O
lymphocyte	B-ANAT
count	O
,	O
monocyte	B-ANAT
count	O
,	O
C	O
-	O
reactive	O
protein	O
,	O
procalcitonin	O
,	O
days	O
from	O
illness	O
onset	O
and	O
body	B-ANAT
temperature	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

CONCLUSIONS	O
:	O
The	O
common	O
chest	B-ANAT
CT	O
findings	O
of	O
COVID	O
-	O
19	O
are	O
multiple	O
GGO	O
,	O
consolidation	O
and	O
interlobular	O
septal	O
thickening	O
in	O
both	O
lungs	B-ANAT
,	O
which	O
are	O
mostly	O
distributed	O
under	O
the	O
pleura	B-ANAT
.	O

ABSTRACT	O
:	O
Coronavirus	O
229E	O
(	O
HCoV	O
-	O
229E	O
),	O
one	O
of	O
the	O
causes	O
of	O
the	O
common	O
cold	O
,	O
exacerbates	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
(	O
COPD	O
)	O
and	O
bronchial	B-ANAT
asthma	O
.	O

Treatment	O
of	O
the	O
cells	B-ANAT
with	O
the	O
CD13	O
inhibitor	O
2	O
'	O
2	O
'-	O
dipyridyl	O
decreased	O
viral	O
titers	O
.	O

These	O
findings	O
suggest	O
that	O
glycopyrronium	O
,	O
formoterol	O
,	O
and	O
a	O
combination	O
of	O
glycopyrronium	O
,	O
formoterol	O
,	O
and	O
budesonide	O
inhibit	O
HCoV	O
-	O
229E	O
replication	O
partly	O
by	O
inhibiting	O
receptor	O
expression	O
and	O
/	O
or	O
endosomal	O
function	O
and	O
that	O
these	O
drugs	O
modulate	O
infection	O
-	O
induced	O
inflammation	O
in	O
the	O
airway	B-ANAT
.	O

Here	O
,	O
we	O
co	O
-	O
expressed	O
the	O
MERS	O
-	O
CoV	O
nonstructural	O
proteins	O
nsp5	O
,	O
nsp7	O
,	O
nsp8	O
,	O
and	O
nsp12	O
(	O
RdRp	O
)	O
in	O
insect	O
cells	B-ANAT
as	O
a	O
part	O
a	O
polyprotein	O
to	O
study	O
the	O
mechanism	O
of	O
inhibition	O
of	O
MERS	O
-	O
CoV	O
RdRp	O
by	O
RDV	O
.	O

ABSTRACT	O
:	O
It	O
has	O
been	O
reported	O
that	O
ACE2	O
is	O
the	O
main	O
host	B-ANAT
cell	I-ANAT
receptor	O
of	O
2019	O
-	O
nCoV	O
and	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
entry	O
of	O
virus	O
into	O
the	O
cell	B-ANAT
to	O
cause	O
the	O
final	O
infection	O
.	O

Preliminarily	O
,	O
those	O
findings	O
have	O
explained	O
the	O
basic	O
mechanism	O
that	O
the	O
oral	B-ANAT
cavity	I-ANAT
is	O
a	O
potentially	O
high	O
risk	O
for	O
2019	O
-	O
nCoV	O
infectious	O
susceptibility	O
and	O
provided	O
a	O
piece	O
of	O
evidence	O
for	O
the	O
future	O
prevention	O
strategy	O
in	O
dental	O
clinical	O
practice	O
as	O
well	O
as	O
daily	O
life	O
.	O

Here	O
,	O
we	O
developed	O
an	O
approach	O
to	O
rapidly	O
screen	O
lineage	O
B	O
betacoronaviruses	O
,	O
such	O
as	O
SARS	O
-	O
CoV	O
and	O
the	O
recent	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
for	O
receptor	O
usage	O
and	O
their	O
ability	O
to	O
infect	O
cell	B-ANAT
types	O
from	O
different	O
species	O
.	O

The	O
obvious	O
shadows	O
infiltrating	O
the	O
lungs	B-ANAT
were	O
shown	O
on	O
CT	O
images	O
in	O
50	O
cases	O
,	O
for	O
other	O
2	O
cases	O
there	O
was	O
no	O
abnormal	O
changes	O
in	O
the	O
lungs	B-ANAT
during	O
the	O
first	O
CT	O
examination	O
.	O

RESULTS	O
:	O
The	O
obvious	O
shadows	O
infiltrating	O
the	O
lungs	B-ANAT
were	O
shown	O
on	O
CT	O
images	O
in	O
50	O
cases	O
,	O
for	O
other	O
2	O
cases	O
there	O
was	O
no	O
abnormal	O
changes	O
in	O
the	O
lungs	B-ANAT
during	O
the	O
first	O
CT	O
examination	O
.	O

Sputum	B-ANAT
was	O
observed	O
with	O
the	O
highest	O
positive	O
rate	O
of	O
RT	O
-	O
PCR	O
results	O
.	O

We	O
also	O
isolated	O
alive	O
viral	O
strains	O
from	O
feces	B-ANAT
,	O
indicating	O
potential	O
infectiousness	O
of	O
feces	B-ANAT
.	O

The	O
artificial	O
liver	B-ANAT
blood	B-ANAT
purification	O
system	O
could	O
rapidly	O
remove	O
inflammatory	O
mediators	O
and	O
block	O
cytokine	O
storm	O
.	O

Some	O
patients	O
with	O
COVID	O
-	O
19	O
showed	O
intestinal	B-ANAT
microbialdysbiosis	O
with	O
decreasedprobiotics	O
such	O
as	O

This	O
virus	O
causes	O
acute	O
lung	B-ANAT
symptoms	O
,	O
leading	O
to	O
a	O
condition	O
that	O
has	O
been	O
named	O
as	O
""""	O
coronavirus	O
disease	O
2019	O
""""	O
(	O
COVID	O
-	O
19	O
).	O

In	O
total	O
,	O
77	O
pulmonary	B-ANAT
lesions	O
were	O
found	O
,	O
including	O
patchy	O
lesions	O
(	O
39	O
%),	O
large	O
confluent	O
lesions	O
(	O
13	O
%),	O
and	O
small	O
nodular	O
lesions	O
(	O
48	O
%).	O

A	O
considerable	O
proportion	O
of	O
patients	O
with	O
COVID	O
-	O
19	O
pneumonia	O
had	O
normal	O
chest	B-ANAT
radiographs	O
.	O

Patchy	O
to	O
confluent	O
lesions	O
were	O
primarily	O
distributed	O
in	O
the	O
lower	O
lobes	B-ANAT
(	O
CONCLUSIONS	O
:	O
COVID	O
-	O
19	O
pneumonia	O
in	O
Korea	O
primarily	O
manifested	O
as	O
pure	O
to	O
mixed	O
ground	O
-	O
glass	O
opacities	O
with	O
a	O
patchy	O
to	O
confluent	O
or	O
nodular	O
shape	O
in	O
the	O
bilateral	O
peripheral	O
posterior	O
lungs	B-ANAT
.	O

Unexpectedly	O
,	O
the	O
2109	O
-	O
nCoV	O
RNA	O
was	O
readily	O
detected	O
in	O
the	O
blood	B-ANAT
(	O
6	O
of	O
57	O
patients	O
)	O
and	O
the	O
anal	B-ANAT
swabs	O
(	O
11	O
of	O
28	O
patients	O
).	O

For	O
patients	O
with	O
normal	O
airway	B-ANAT
,	O
awake	O
intubation	O
should	O
be	O
avoided	O
and	O
modified	O
rapid	O
sequence	O
induction	O
is	O
strongly	O
recommended	O
.	O

Although	O
the	O
virus	O
(	O
SARS	O
-	O
Cov	O
-	O
2	O
)	O
nucleic	B-ANAT
acid	O
RT	O
-	O
PCR	O
test	O
has	O
become	O
the	O
standard	O
method	O
for	O
diagnosis	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
,	O
these	O
real	O
-	O
time	O
PCR	O
test	O
kits	O
have	O
many	O
limitations	O
.	O

We	O
have	O
developed	O
a	O
rapid	O
and	O
simple	O
point	O
-	O
of	O
-	O
care	O
lateral	O
flow	O
immunoassay	O
which	O
can	O
detect	O
IgM	O
and	O
IgG	O
antibodies	O
simultaneously	O
against	O
SARS	O
-	O
CoV	O
-	O
2	O
virus	O
in	O
human	O
blood	B-ANAT
within	O
15	O
minutes	O
which	O
can	O
detect	O
patients	O
at	O
different	O
infection	O
stages	O
.	O

The	O
mean	O
number	O
of	O
involved	O
lung	B-ANAT
segments	I-ANAT
was	O
10	O
Â·	O
5	O
(	O
SD	O
6	O
Â·	O
4	O
)	O
overall	O
,	O
2	O
Â·	O
8	O
(	O
3	O
Â·	O
3	O
)	O
in	O
group	O
1	O
,	O
11	O
Â·	O
1	O
(	O
5	O
Â·	O
4	O
)	O
in	O
group	O
2	O
,	O
13	O
Â·	O
0	O
(	O
5	O
Â·	O
7	O
)	O
in	O
group	O
3	O
,	O
and	O
12	O
Â·	O
1	O
(	O
5	O
Â·	O
9	O
)	O
in	O
group	O
4	O
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
gain	O
insights	O
for	O
vaccine	O
design	O
against	O
SARS	O
-	O
CoV	O
-	O
2	O
by	O
considering	O
the	O
high	O
genetic	O
similarity	O
between	O
SARS	O
-	O
CoV	O
-	O
2	O
and	O
SARS	O
-	O
CoV	O
,	O
which	O
caused	O
the	O
outbreak	O
in	O
2003	O
,	O
and	O
leveraging	O
existing	O
immunological	O
studies	O
of	O
SARS	O
-	O
CoV	O
.	O
By	O
screening	O
the	O
experimentally	O
-	O
determined	O
SARS	O
-	O
CoV	O
-	O
derived	O
B	B-ANAT
cell	I-ANAT
and	O
T	B-ANAT
cell	I-ANAT
epitopes	O
in	O
the	O
immunogenic	O
structural	O
proteins	O
of	O
SARS	O
-	O
CoV	O
,	O
we	O
identified	O
a	O
set	O
of	O
B	B-ANAT
cell	I-ANAT
and	O
T	B-ANAT
cell	I-ANAT
epitopes	O
derived	O
from	O
the	O
spike	O
(	O
S	O
)	O
and	O
nucleocapsid	B-ANAT
(	O
N	O
)	O
proteins	O
that	O
map	O
identically	O
to	O
SARS	O
-	O
CoV	O
-	O
2	O
proteins	O
.	O

CONCLUSIONS	O
:	O
Fever	O
and	O
cough	O
are	O
the	O
most	O
common	O
symptoms	O
in	O
patients	O
with	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
,	O
and	O
most	O
of	O
these	O
patients	O
have	O
abnormal	O
chest	B-ANAT
CT	O
examination	O
.	O

Next	O
,	O
we	O
chose	O
13	O
Major	B-ANAT
Histocompatibility	I-ANAT
Complex	I-ANAT
-(	O
MHC	B-ANAT
)	O
I	O
and	O
3	O
MHC	B-ANAT
-	O
II	O
epitopes	O
,	O
having	O
antigenic	O
properties	O
.	O

TITLE	O
:	O
[	O
Discussion	O
on	O
diagnosis	O
and	O
treatment	O
of	O
hepatobiliary	B-ANAT
malignancies	O
during	O
the	O
outbreak	O
of	O
novel	O
coronavirus	O
pneumonia	O
].	O

Notably	O
,	O
infected	O
patients	O
may	O
be	O
falsely	O
excluded	O
based	O
on	O
two	O
consecutively	O
negative	O
respiratory	O
pathogenic	O
nucleic	B-ANAT
acid	O
test	O
results	O
.	O

CT	O
imaging	O
presentations	O
of	O
NCP	O
are	O
mostly	O
patchy	O
ground	O
glass	O
opacities	O
in	O
the	O
peripheral	O
areas	O
under	O
the	O
pleura	B-ANAT
with	O
partial	O
consolidation	O
which	O
will	O
be	O
absorbed	O
with	O
formation	O
of	O
fibrotic	O
stripes	O
if	O
improved	O
.	O

ABSTRACT	O
:	O
The	O
treatment	O
of	O
critically	O
ill	O
patients	O
with	O
coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
faces	B-ANAT
compelling	O
challenges	O
.	O

Under	O
the	O
current	O
epidemic	O
situation	O
,	O
convalescent	O
plasma	B-ANAT
can	O
only	O
be	O
used	O
empirically	O
,	O
indications	O
need	O
to	O
be	O
strictly	O
screened	O
,	O
the	O
blood	B-ANAT
transfusion	O
process	O
should	O
be	O
closely	O
monitored	O
and	O
the	O
curative	O
effect	O
should	O
be	O
dynamically	O
evaluated	O
.	O

ABSTRACT	O
:	O
Several	O
recent	O
case	O
reports	O
have	O
described	O
common	O
early	O
chest	B-ANAT
imaging	O
findings	O
of	O
lung	B-ANAT
pathology	O
caused	O
by	O
2019	O
novel	O
Coronavirus	O
(	O
SARS	O
-	O
COV2	O
)	O
which	O
appear	O
to	O
be	O
similar	O
to	O
those	O
seen	O
previously	O
in	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
infected	O
patients	O
.	O

Finally	O
,	O
the	O
pulmonary	B-ANAT
vessels	B-ANAT
enlargement	O
in	O
areas	O
where	O
new	O
lung	B-ANAT
infiltrates	O
develop	O
in	O
the	O
follow	O
-	O
up	O
CT	O
scan	O
,	O
could	O
describe	O
an	O
early	O
predictor	O
radiological	O
sign	O
of	O
lung	B-ANAT
impairment	O
.	O

ABSTRACT	O
:	O
Bovine	O
respiratory	O
disease	O
complex	O
is	O
the	O
most	O
common	O
disease	O
requiring	O
the	O
use	O
of	O
antimicrobials	O
in	O
industrial	O
calf	B-ANAT
production	O
worldwide	O
.	O

Test	O
efficiencies	O
of	O
the	O
qPCR	O
assays	O
,	O
based	O
on	O
nucleic	B-ANAT
acid	O
dilution	O
series	O
of	O
target	O
bacteria	O
and	O
viruses	O
,	O
were	O
93	O
-	O
106	O
%	O
and	O
91	O
-	O
104	O
%,	O
respectively	O
,	O
with	O
assay	O
detection	O
limits	O
of	O
10	O
-	O
50	O
copies	O
of	O
nucleic	B-ANAT
acids	O
.	O

ABSTRACT	O
:	O
Cases	O
of	O
vaporizer	O
-	O
induced	O
acute	O
lung	B-ANAT
injury	O
are	O
increasing	O
in	O
frequency	O
as	O
the	O
use	O
of	O
these	O
recreational	O
products	O
have	O
become	O
more	O
popular	O
.	O

Ten	O
patients	O
with	O
COVID	O
-	O
19	O
and	O
30	O
patients	O
with	O
other	O
viral	O
pneumonia	O
(	O
non	O
-	O
COVID	O
-	O
19	O
)	O
admitted	O
to	O
Shanghai	O
Jiao	O
Tong	O
University	O
Affiliated	O
Sixth	O
People	O
'	O
s	O
Hospital	O
and	O
Jinshan	O
Branch	B-ANAT
Hospital	O
from	O
January	O
22	O
to	O
February	O
17	O
,	O
2020	O
were	O
enrolled	O
in	O
this	O
study	O
.	O

Lung	B-ANAT
cancer	O
patients	O
are	O
difficult	O
to	O
differentiate	O
from	O
patients	O
with	O
COVID	O
-	O
19	O
in	O
terms	O
of	O
clinical	O
symptoms	O
,	O
which	O
will	O
bring	O
great	O
trouble	O
to	O
the	O
clinical	O
work	O
and	O
physical	O
and	O
mental	O
health	O
of	O
lung	B-ANAT
cancer	O
patients	O
.	O

CT	O
findings	O
of	O
consolidation	O
,	O
linear	O
opacities	O
,	O
crazy	O
-	O
paving	O
pattern	O
,	O
bronchial	B-ANAT
wall	I-ANAT
thickening	O
,	O
high	O
CT	O
scores	O
and	O
extrapulmonary	O
lesions	O
were	O
features	O
of	O
severe	O
/	O
critical	O
COVID	O
-	O
19	O
pneumonia	O
.	O

RESULTS	O
:	O
Compared	O
with	O
the	O
ordinary	O
patients	O
,	O
the	O
severe	O
/	O
critical	O
patients	O
had	O
older	O
ages	O
,	O
higher	O
incidence	O
of	O
comorbidities	O
,	O
cough	O
,	O
expectoration	B-ANAT
,	O
chest	B-ANAT
pain	O
and	O
dyspnea	O
.	O

By	O
February	O
10	O
,	O
2020	O
,	O
11	O
convalescent	O
patients	O
(	O
16	O
.	O
7	O
%)	O
still	O
tested	O
positive	O
for	O
viral	O
RNA	O
from	O
stool	B-ANAT
specimens	O
and	O
the	O
other	O
55	O
patients	O
'	O
stool	B-ANAT
specimens	O
were	O
negative	O
for	O
2019	O
-	O
nCoV	O
following	O
a	O
median	O
duration	O
of	O
11	O
.	O
0	O
(	O
9	O
.	O
0	O
-	O
16	O
.	O
0	O
)	O
days	O
after	O
symptom	O
onset	O
.	O

Among	O
these	O
55	O
patients	O
,	O
43	O
had	O
a	O
longer	O
duration	O
until	O
stool	B-ANAT
specimens	O
were	O
negative	O
for	O
viral	O
RNA	O
than	O
for	O
throat	B-ANAT
swabs	O
,	O
with	O
a	O
median	O
delay	O
of	O
2	O
.	O
0	O
(	O
1	O
.	O
0	O
-	O
4	O
.	O
0	O
)	O
days	O
.	O

The	O
duration	O
of	O
RNA	O
detection	O
may	O
relate	O
to	O
host	B-ANAT
cell	I-ANAT
immunity	O
.	O

Patients	O
tested	O
positive	O
for	O
the	O
COVID	O
-	O
19	O
based	O
on	O
nucleic	B-ANAT
acid	O
detection	O
were	O
included	O
in	O
this	O
study	O
.	O

Several	O
factors	O
that	O
led	O
to	O
the	O
progression	O
of	O
COVID	O
-	O
19	O
pneumonia	O
were	O
identified	O
,	O
including	O
age	O
,	O
history	O
of	O
smoking	O
,	O
maximum	O
body	B-ANAT
temperature	O
on	O
admission	O
,	O
respiratory	O
failure	O
,	O
albumin	O
,	O
C	O
-	O
reactive	O
protein	O
.	O

However	O
,	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
is	O
associated	O
with	O
a	O
coagulopathy	O
characterized	O
by	O
thromboembolic	O
and	O
hemorrhagic	O
complications	O
.	O

One	O
patient	O
per	O
group	O
(	O
venovenous	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
or	O
venoarterial	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
)	O
had	O
surgery	O
before	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
.	O

Blood	B-ANAT
was	O
sampled	O
before	O
,	O
and	O
1	O
,	O
24	O
,	O
and	O
48	O
hours	O
after	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
implantation	O
.	O

Point	O
-	O
of	O
-	O
care	O
tests	O
(	O
thrombelastometry	O
/	O
platelet	B-ANAT
aggregometry	O
),	O
conventional	O
coagulation	O
tests	O
,	O
whole	B-ANAT
blood	I-ANAT
counts	O
,	O
and	O
platelet	B-ANAT
flow	O
cytometry	O
were	O
performed	O
.	O

The	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
-	O
associated	O
coagulopathy	O
is	O
a	O
multifactorial	O
and	O
quickly	O
developing	O
syndrome	O
.	O

Therapy	O
protocols	O
for	O
treating	O
extracorporeal	O
membrane	B-ANAT
oxygenation	O
-	O
associated	O
coagulopathy	O
should	O
be	O
further	O
validated	O
in	O
large	O
-	O
scale	O
prospective	O
clinical	O
investigations	O
.	O

pulmonary	B-ANAT
rehabilitation	O
is	O
an	O
important	O
intervention	O
for	O
clinical	O
patients	O
as	O
well	O
as	O
cure	O
patients	O
.	O

During	O
the	O
epidemic	O
period	O
,	O
cancer	O
patients	O
with	O
low	O
immunity	O
levels	O
face	B-ANAT
the	O
double	O
ordeals	O
of	O
disease	O
and	O
epidemic	O
situation	O
.	O

In	O
the	O
absence	O
of	O
a	O
proven	O
clinical	O
FcR	O
blocker	O
,	O
the	O
use	O
of	O
intravenous	O
immunoglobulin	O
to	O
block	O
FcR	O
activation	O
may	O
be	O
a	O
viable	O
option	O
for	O
the	O
urgent	O
treatment	O
of	O
pulmonary	B-ANAT
inflammation	O
to	O
prevent	O
severe	O
lung	B-ANAT
injury	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
experience	O
with	O
airway	B-ANAT
pressure	O
release	O
ventilation	O
(	O
APRV	O
)	O
in	O
children	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
refractory	O
to	O
conventional	O
low	O
tidal	O
volume	O
ventilation	O
.	O

Only	O
patients	O
who	O
met	O
all	O
of	O
the	O
following	O
criteria	O
were	O
included	O
in	O
this	O
analysis	O
:	O
sustained	O
blunt	O
injuries	O
,	O
presented	O
with	O
severe	O
traumatic	O
brain	B-ANAT
injury	O
,	O
sustained	O
an	O
associated	O
SDH	O
,	O
presented	O
with	O
an	O
initial	O
Glasgow	O
Coma	O
Scale	O
(	O
GCS	O
)	O
score	O
â¤	O
8	O
and	O
an	O
Abbreviated	O
Injury	O
Scale	O
score	O
of	O
head	B-ANAT
â¥	O
3	O
,	O
and	O
underwent	O
a	O
CO	O
or	O
DC	O
within	O
4	O
hours	O
of	O
hospital	O
arrival	O
.	O

We	O
performed	O
a	O
15	O
-	O
year	O
follow	O
-	O
up	O
on	O
the	O
lung	B-ANAT
and	O
bone	B-ANAT
conditions	O
of	O
SARS	O
patients	O
.	O

We	O
evaluated	O
the	O
recovery	O
from	O
lung	B-ANAT
damage	O
and	O
femoral	B-ANAT
head	I-ANAT
necrosis	O
in	O
an	O
observational	O
cohort	O
study	O
of	O
SARS	O
patients	O
using	O
pulmonary	B-ANAT
CT	O
scans	O
,	O
hip	B-ANAT
joint	I-ANAT
MRI	O
examinations	O
,	O
pulmonary	B-ANAT
function	O
tests	O
and	O
hip	B-ANAT
joint	I-ANAT
function	O
questionnaires	O
.	O

Disposable	O
in	O
-	O
line	O
filters	O
must	O
be	O
used	O
during	O
pulmonary	B-ANAT
function	O
testing	O
.	O

ABSTRACT	O
:	O
A	O
better	O
understanding	O
of	O
the	O
complex	O
interactions	O
between	O
the	O
immune	B-ANAT
system	I-ANAT
and	O
tumour	B-ANAT
cells	I-ANAT
from	O
different	O
origins	O
has	O
opened	O
the	O
possibility	O
to	O
design	O
novel	O
procedures	O
of	O
antitumoral	O
immunotherapy	O
.	O

One	O
of	O
these	O
novel	O
approaches	O
is	O
based	O
on	O
the	O
use	O
of	O
autologous	O
or	O
allogeneic	O
natural	O
killer	O
(	O
NK	O
)	O
cells	B-ANAT
to	O
treat	O
cancer	O
.	O

More	O
so	O
,	O
the	O
FPASSA	O
-	O
ANFIS	O
model	O
is	O
compared	O
to	O
several	O
existing	O
models	O
,	O
and	O
it	O
showed	O
better	O
performance	O
in	O
terms	O
of	O
Mean	O
Absolute	O
Percentage	O
Error	O
(	O
MAPE	O
),	O
Root	B-ANAT
Mean	O
Squared	O
Relative	O
Error	O
(	O
RMSRE	O
),	O
Root	B-ANAT
Mean	O
Squared	O
Relative	O
Error	O
(	O
RMSRE	O
),	O
coefficient	O
of	O
determination	O
(	O
R	O
2	O
),	O
and	O
computing	O
time	O
.	O

Consolidation	O
with	O
surrounding	O
halo	O
sign	O
was	O
observed	O
in	O
10	O
patients	O
(	O
10	O
/	O
20	O
,	O
50	O
%),	O
ground	O
-	O
glass	O
opacities	O
were	O
observed	O
in	O
12	O
patients	O
(	O
12	O
/	O
20	O
,	O
60	O
%),	O
fine	O
mesh	O
shadow	O
was	O
observed	O
in	O
4	O
patients	O
(	O
4	O
/	O
20	O
,	O
20	O
%),	O
and	O
tiny	O
nodules	B-ANAT
were	O
observed	O
in	O
3	O
patients	O
(	O
3	O
/	O
20	O
,	O
15	O
%).	O

The	O
C	O
-	O
reactive	O
protein	O
,	O
erythrocyte	B-ANAT
sedimentation	O
rate	O
and	O
lactate	O
dehydrogenase	O
showed	O
significantly	O
positive	O
correlation	O
with	O
the	O
severity	O
of	O
pneumonia	O
assessed	O
on	O
initial	O
CT	O
(	O
R	O
range	O
0	O
.	O
36	O
-	O
0	O
.	O
75	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

Global	O
health	O
authorities	O
should	O
take	O
immediate	O
measures	O
to	O
prevent	O
the	O
outbreaks	O
of	O
such	O
emerging	O
and	O
reemerging	O
pathogens	O
across	O
the	O
globe	B-ANAT
to	O
minimize	O
the	O
disease	O
burden	O
locally	O
and	O
globally	O
.	O

TITLE	O
:	O
SARS	O
-	O
CoV	O
-	O
2	O
Cell	B-ANAT
Entry	O
Depends	O
on	O
ACE2	O
and	O
TMPRSS2	O
and	O
Is	O
Blocked	O
by	O
a	O
Clinically	O
Proven	O
Protease	O
Inhibitor	O
.	O

Clade	O
1	O
consisted	O
of	O
a	O
group	O
of	O
conserved	O
proteins	O
in	O
Orthocoronavirinae	O
comprising	O
Orf1ab	O
polyprotein	O
,	O
Nucleocapsid	B-ANAT
protein	O
,	O
Spike	O
glycoprotein	O
,	O
and	O
Membrane	B-ANAT
protein	O
.	O

As	O
a	O
result	O
,	O
none	O
of	O
the	O
24	O
asymptomatic	O
cases	O
presented	O
any	O
obvious	O
symptoms	O
while	O
nucleic	B-ANAT
acid	O
screening	O
.	O

A	O
new	O
case	O
of	O
clarithromycin	O
-	O
associated	O
ALF	O
is	O
reported	O
with	O
hepatic	B-ANAT
histopathology	O
and	O
exclusion	O
of	O
other	O
etiologies	O
by	O
extensive	O
workup	O
,	O
and	O
the	O
syndrome	O
of	O
clarithromycin	O
-	O
associated	O
ALF	O
is	O
better	O
characterized	O
by	O
systematic	O
review	O
.	O

A	O
60	O
-	O
year	O
-	O
old	O
nonalcoholic	O
man	O
,	O
with	O
normal	O
baseline	O
liver	B-ANAT
function	O
tests	O
,	O
was	O
admitted	O
with	O
diffuse	O
abdominal	B-ANAT
pain	O
and	O
AST	O
=	O
499	O
U	O
/	O
L	O
and	O
ALT	O
=	O
539	O
U	O
/	O
L	O
,	O
six	O
days	O
after	O
completing	O
a	O
7	O
-	O
day	O
course	O
of	O
clarithromycin	O
500	O
mg	O
twice	O
daily	O
for	O
suspected	O
upper	O
respiratory	O
infection	O
.	O

Autopsy	O
revealed	O
a	O
golden	O
-	O
brown	O
heavy	O
liver	B-ANAT
with	O
massive	O
hepatic	B-ANAT
necrosis	O
and	O
sinusoidal	O
congestion	O
.	O

The	O
virus	O
replicated	O
in	O
Vero	B-ANAT
cells	I-ANAT
and	O
cytopathic	O
effects	O
were	O
observed	O
.	O

The	O
early	O
symptoms	O
were	O
fever	O
,	O
sore	O
throat	B-ANAT
,	O
cough	O
or	O
sputum	B-ANAT
production	O
,	O
chills	O
,	O
and	O
muscle	B-ANAT
ache	O
.	O

Enhanced	O
expression	O
of	O
p53	O
due	O
to	O
DNA	O
damage	O
is	O
seen	O
in	O
irradiated	O
lung	B-ANAT
tissue	I-ANAT
.	O

Respiratory	B-ANAT
tract	I-ANAT
infections	O
are	O
a	O
major	O
cause	O
of	O
morbidity	O
in	O
pilgrims	O
attending	O
mass	O
gathering	O
events	O
.	O

Based	O
on	O
PBPK	O
models	O
results	O
,	O
a	O
loading	O
dose	O
of	O
400	O
mg	O
twice	O
daily	O
of	O
hydroxychloroquine	O
sulfate	O
given	O
orally	B-ANAT
,	O
followed	O
by	O
a	O
maintenance	O
dose	O
of	O
200	O
mg	O
given	O
twice	O
daily	O
for	O
4	O
days	O
is	O
recommended	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
,	O
as	O
it	O
reached	O
three	O
times	O
the	O
potency	O
of	O
chloroquine	O
phosphate	O
when	O
given	O
500	O
mg	O
twice	O
daily	O
5	O
days	O
in	O
advance	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
and	O
intrauterine	B-ANAT
vertical	O
transmission	O
potential	O
of	O
COVID	O
-	O
19	O
infection	O
in	O
nine	O
pregnant	O
women	O
:	O
a	O
retrospective	O
review	O
of	O
medical	O
records	O
.	O

This	O
article	O
makes	O
a	O
brief	O
analysis	O
and	O
reflection	O
on	O
the	O
relevant	O
legal	O
issues	O
faced	O
and	O
raised	O
by	O
oral	B-ANAT
medical	O
institutions	O
and	O
practioners	O
,	O
taking	O
cases	O
from	O
the	O
emergent	O
crisis	O
caused	O
by	O
COVID	O
-	O
19	O
in	O
China	O
since	O
December	O
2019	O
,	O
with	O
the	O
hope	O
to	O
provide	O
legal	O
help	O
and	O
guidance	O
to	O
the	O
oral	B-ANAT
medical	O
industry	O
in	O
dealing	O
with	O
public	O
health	O
emergencies	O
.	O

Based	O
on	O
these	O
considerations	O
,	O
the	O
COPD	O
Group	O
of	O
the	O
Chinese	O
Thoracic	B-ANAT
Society	O
(	O
CTS	O
)	O
and	O
the	O
COPD	O
working	O
Committee	O
of	O
the	O
Chinese	O
Association	O
of	O
Chest	B-ANAT
Physicians	O
(	O
CACP	O
)	O
altogether	O
drafted	O
the	O
instruction	O
for	O
medical	O
management	O
and	O
prevention	O
of	O
COPD	O
during	O
the	O
COVID	O
-	O
19	O
epidemic	O
period	O
for	O
the	O
healthcare	O
practitioner	O
and	O
patients	O
.	O

Purpose	O
To	O
assess	O
the	O
performance	O
of	O
United	O
States	O
(	O
U	O
.	O
S	O
.)	O
and	O
Chinese	O
radiologists	O
in	O
differentiating	O
COVID	O
-	O
19	O
from	O
viral	O
pneumonia	O
on	O
chest	B-ANAT
CT	O
.	O

Results	O
For	O
all	O
chest	B-ANAT
CTs	O
,	O
three	O
Chinese	O
radiologists	O
correctly	O
differentiated	O
COVID	O
-	O
19	O
from	O
non	O
-	O
COVID	O
-	O
19	O
pneumonia	O
83	O
%	O
(	O
350	O
/	O
424	O
),	O
80	O
%	O
(	O
338	O
/	O
424	O
),	O
and	O
60	O
%	O
(	O
255	O
/	O
424	O
)	O
of	O
the	O
time	O
,	O
respectively	O
.	O

Chest	B-ANAT
computed	O
tomography	O
offers	O
fast	O
and	O
convenient	O
evaluation	O
of	O
patients	O
with	O
suspected	O
2019	O
-	O
novel	O
coronavirus	O
pneumonia	O
.	O

The	O
genome	O
composition	O
,	O
nucleotide	O
analysis	O
,	O
codon	O
usage	O
indices	O
,	O
relative	O
synonymous	O
codons	O
usage	O
,	O
and	O
effective	O
number	O
of	O
codons	O
(	O
ENc	O
)	O
were	O
analyzed	O
in	O
the	O
four	O
structural	O
genes	O
;	O
Spike	O
(	O
S	O
),	O
Envelope	B-ANAT
(	O
E	O
),	O
membrane	B-ANAT
(	O
M	O
),	O
and	O
Nucleocapsid	B-ANAT
(	O
N	O
)	O
genes	O
,	O
and	O
two	O
of	O
the	O
most	O
important	O
nonstructural	O
genes	O
comprising	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
main	O
protease	O
(	O
Mpro	O
)	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
Beta	O
-	O
CoV	O
from	O
pangolins	O
,	O
bat	O
SARS	O
,	O
MERS	O
,	O
and	O
SARS	O
CoVs	O
.	O

Both	O
helper	B-ANAT
T	I-ANAT
cells	I-ANAT
and	O
suppressor	O
T	B-ANAT
cells	I-ANAT
in	O
patients	O
with	O
COVID	O
-	O
19	O
were	O
below	O
normal	O
levels	O
,	O
and	O
lower	O
level	O
of	O
helper	B-ANAT
T	I-ANAT
cells	I-ANAT
in	O
severe	O
group	O
.	O

The	O
novel	O
coronavirus	O
might	O
mainly	O
act	O
on	O
lymphocytes	B-ANAT
,	O
especially	O
T	B-ANAT
lymphocytes	I-ANAT
.	O

Patients	O
with	O
COVID	O
-	O
19	O
also	O
have	O
lower	O
level	O
of	O
regulatory	B-ANAT
T	I-ANAT
cells	I-ANAT
,	O
and	O
more	O
obviously	O
damaged	O
in	O
severe	O
cases	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
eligible	O
studies	O
that	O
summarized	O
the	O
prevalence	O
of	O
cardiovascular	B-ANAT
metabolic	O
diseases	O
in	O
COVID	O
-	O
19	O
and	O
compared	O
the	O
incidences	O
of	O
the	O
comorbidities	O
in	O
ICU	O
/	O
severe	O
and	O
non	O
-	O
ICU	O
/	O
severe	O
patients	O
was	O
performed	O
.	O

To	O
describe	O
chest	B-ANAT
CT	O
findings	O
in	O
children	O
with	O
COVID	O
-	O
19	O
.	O

Drugs	O
are	O
possibly	O
effective	O
for	O
2019	O
-	O
nCoV	O
include	O
:	O
remdesivir	O
,	O
lopinavir	O
/	O
ritonavir	O
,	O
lopinavir	O
/	O
ritonavir	O
combined	O
with	O
interferon	O
-	O
Î²	O
,	O
convalescent	O
plasma	B-ANAT
,	O
and	O
monoclonal	O
antibodies	O
.	O

The	O
disease	O
is	O
mild	O
in	O
most	O
people	O
;	O
in	O
some	O
(	O
usually	O
the	O
elderly	O
and	O
those	O
with	O
comorbidities	O
),	O
it	O
may	O
progress	O
to	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
multi	O
organ	B-ANAT
dysfunction	O
.	O

The	O
computerized	O
tomographic	O
chest	B-ANAT
scan	O
is	O
usually	O
abnormal	O
even	O
in	O
those	O
with	O
no	O
symptoms	O
or	O
mild	O
disease	O
.	O

TITLE	O
:	O
[	O
Which	O
sampling	O
method	O
for	O
the	O
upper	B-ANAT
respiratory	I-ANAT
tract	I-ANAT
specimen	O
should	O
be	O
taken	O
to	O
diagnose	O
patient	O
with	O
COVID	O
-	O
19	O
?]	O
ABSTRACT	O
:	O
Coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
raging	O
in	O
China	O
,	O
especially	O
in	O
Hubei	O
Province	O
,	O
which	O
has	O
resulted	O
great	O
dangers	O
in	O
people	O
'	O
s	O
life	O
and	O
national	O
economy	O
.	O

Travel	O
restrictions	O
and	O
border	B-ANAT
control	O
measures	O
have	O
been	O
enforced	O
in	O
China	O
and	O
other	O
countries	O
to	O
limit	O
the	O
spread	O
of	O
the	O
outbreak	O
.	O

This	O
is	O
a	O
consensus	O
of	O
Chinese	O
experts	O
on	O
protective	O
measures	O
and	O
advice	O
on	O
hand	O
-	O
cleaning	O
-	O
and	O
medical	O
-	O
glove	O
-	O
related	O
hand	O
protection	O
,	O
mask	O
-	O
and	O
goggles	O
-	O
related	O
face	B-ANAT
protection	O
,	O
UV	O
-	O
related	O
protection	O
,	O
eye	B-ANAT
protection	O
,	O
nasal	B-ANAT
and	O
oral	B-ANAT
mucosa	I-ANAT
protection	O
,	O
outer	B-ANAT
ear	I-ANAT
and	O
hair	B-ANAT
protection	O
.	O

TITLE	O
:	O
Liver	B-ANAT
injury	O
during	O
highly	O
pathogenic	O
human	O
coronavirus	O
infections	O
.	O

Similarly	O
,	O
previous	O
studies	O
have	O
shown	O
that	O
liver	B-ANAT
damage	O
was	O
common	O
in	O
the	O
patients	O
infected	O
by	O
the	O
other	O
two	O
highly	O
pathogenic	O
coronavirus	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
(	O
SARS	O
-	O
CoV	O
)	O
and	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	O
(	O
MERS	O
-	O
CoV	O
),	O
and	O
associated	O
with	O
the	O
severity	O
of	O
diseases	O
.	O

191	O
patients	O
(	O
135	O
from	O
Jinyintan	O
Hospital	O
and	O
56	O
from	O
Wuhan	O
Pulmonary	B-ANAT
Hospital	O
)	O
were	O
included	O
in	O
this	O
study	O
,	O
of	O
whom	O
137	O
were	O
discharged	O
and	O
54	O
died	O
in	O
hospital	O
.	O

We	O
prospectively	O
collect	O
blood	B-ANAT
coagulation	O
data	O
in	O
these	O
patients	O
and	O
in	O
40	O
healthy	O
controls	O
during	O
the	O
same	O
period	O
.	O

However	O
,	O
searches	O
for	O
handwashing	O
were	O
gradually	O
increased	O
in	O
period	O
of	O
face	B-ANAT
masks	O
shortage	O
.	O

CONCLUSIONS	O
:	O
We	O
assessed	O
the	O
prevalence	O
of	O
comorbidities	O
in	O
the	O
COVID	O
-	O
19	O
infection	O
patients	O
and	O
found	O
underlying	O
disease	O
,	O
including	O
hypertension	O
,	O
respiratory	B-ANAT
system	I-ANAT
disease	O
and	O
cardiovascular	B-ANAT
,	O
may	O
be	O
a	O
risk	O
factor	O
for	O
severe	O
patients	O
compared	O
with	O
Non	O
-	O
severe	O
patients	O
.	O

TITLE	O
:	O
Patients	O
of	O
COVID	O
-	O
19	O
may	O
benefit	O
from	O
sustained	O
lopinavir	O
-	O
combined	O
regimen	O
and	O
the	O
increase	O
of	O
eosinophil	B-ANAT
may	O
predict	O
the	O
outcome	O
of	O
COVID	O
-	O
19	O
progression	O
.	O

Viral	O
load	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
,	O
radiography	O
and	O
eosinophil	B-ANAT
improved	O
continuously	O
in	O
3	O
-	O
14	O
,	O
6	O
-	O
8	O
and	O
7	O
-	O
9	O
days	O
,	O
respectively	O
.	O

Compared	O
with	O
general	O
COVID	O
-	O
19	O
patients	O
(	O
45	O
.	O
2	O
%),	O
refractory	O
patients	O
had	O
an	O
older	O
age	O
,	O
male	O
sex	O
,	O
more	O
underlying	O
comorbidities	O
,	O
lower	O
incidence	O
of	O
fever	O
,	O
higher	O
levels	O
of	O
maximum	O
temperature	O
among	O
fever	O
cases	O
,	O
higher	O
incidence	O
of	O
breath	B-ANAT
shortness	O
and	O
anorexia	O
,	O
severer	O
disease	O
assessment	O
on	O
admission	O
,	O
high	O
levels	O
of	O
neutrophil	B-ANAT
,	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
lactate	O
dehydrogenase	O
(	O
LDH	O
)	O
and	O
C	O
-	O
reactive	O
protein	O
,	O
lower	O
levels	O
of	O
platelets	B-ANAT
and	O
albumin	O
,	O
and	O
higher	O
incidence	O
of	O
bilateral	O
pneumonia	O
and	O
pleural	B-ANAT
effusion	I-ANAT
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Can	O
the	O
Coronavirus	O
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
Affect	O
the	O
Eyes	B-ANAT
?	O

However	O
,	O
CoVs	O
have	O
been	O
known	O
to	O
cause	O
various	O
ocular	B-ANAT
infections	O
in	O
animals	O
.	O

10	O
(	O
27	O
%)	O
patients	O
had	O
chronic	O
medical	O
illnesses	O
,	O
including	O
4	O
(	O
11	O
%)	O
with	O
diabetes	O
,	O
8	O
(	O
22	O
%)	O
with	O
hypertension	O
,	O
and	O
8	O
(	O
22	O
%)	O
with	O
digestive	B-ANAT
system	I-ANAT
disease	O
.	O

Fourteen	O
of	O
the	O
patients	O
underwent	O
continuous	O
epidural	B-ANAT
anesthesia	O
with	O
12	O
experiencing	O
significant	O
intraoperative	O
hypotension	O
.	O

Importantly	O
,	O
and	O
similar	O
to	O
pregnancies	O
with	O
SARS	O
and	O
MERS	O
,	O
there	O
were	O
no	O
confirmed	O
cases	O
of	O
intrauterine	B-ANAT
transmission	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
from	O
mothers	O
with	O
COVID	O
-	O
19	O
to	O
their	O
fetuses	B-ANAT
.	O

Among	O
the	O
structural	O
proteins	O
,	O
the	O
spike	O
protein	O
(	O
S	O
-	O
protein	O
),	O
the	O
envelope	B-ANAT
protein	O
(	O
E	O
-	O
protein	O
),	O
and	O
the	O
nucleocapsid	B-ANAT
protein	O
(	O
N	O
-	O
protein	O
)	O
can	O
be	O
constructed	O
based	O
on	O
the	O
crystal	B-ANAT
structures	O
of	O
the	O
proteins	O
from	O
SARS	O
-	O
CoV	O
.	O
It	O
is	O
known	O
that	O
PL	O
-	O
Pro	O
,	O
3CL	O
-	O
Pro	O
,	O
and	O
RdRp	O
are	O
important	O
targets	O
for	O
design	O
antiviral	O
drugs	O
against	O
2019	O
-	O
nCoV	O
.	O
And	O
S	O
protein	O
is	O
critical	O
target	O
candidate	O
for	O
inhibitor	O
screening	O
or	O
vaccine	O
design	O
against	O
2019	O
-	O
nCoV	O
because	O
coronavirus	O
replication	O
is	O
initiated	O
by	O
the	O
binding	O
of	O
S	O
protein	O
to	O
cell	B-ANAT
surface	I-ANAT
receptors	O
.	O

In	O
severe	O
novel	O
coronavirus	O
pneumonia	O
cases	O
,	O
the	O
number	O
of	O
platelets	B-ANAT
,	O
their	O
dynamic	O
changes	O
during	O
the	O
treatment	O
,	O
platelet	B-ANAT
-	O
to	O
-	O
lymphocyte	B-ANAT
ratio	O
(	O
PLR	O
)	O
were	O
a	O
concern	O
.	O

The	O
patient	O
with	O
markedly	O
elevated	O
platelets	B-ANAT
and	O
longer	O
average	O
hospitalization	O
day	O
may	O
be	O
related	O
to	O
the	O
cytokine	O
storm	O
.	O

We	O
report	O
here	O
the	O
clinical	O
features	O
and	O
therapeutic	O
course	O
of	O
the	O
first	O
reported	O
renal	B-ANAT
transplant	B-ANAT
recipient	O
with	O
confirmed	O
COVID	O
-	O
19	O
pneumonia	O
.	O

Therefore	O
,	O
this	O
paper	O
proposes	O
a	O
novel	O
multi	O
-	O
objective	O
multi	O
-	O
period	O
mixed	O
integer	O
program	O
for	O
reverse	O
logistics	O
network	O
design	O
in	O
epidemic	O
outbreaks	O
,	O
which	O
aims	O
at	O
determining	O
the	O
best	O
locations	O
of	O
temporary	O
facilities	O
and	O
the	O
transportation	O
strategies	O
for	O
effective	O
management	O
of	O
the	O
exponentially	O
increased	O
medical	B-ANAT
waste	I-ANAT
within	O
a	O
very	O
short	O
period	O
.	O

TITLE	O
:	O
Post	O
-	O
discharge	B-ANAT
surveillance	O
and	O
positive	O
virus	O
detection	O
in	O
two	O
medical	O
staff	O
recovered	O
from	O
coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
China	O
,	O
January	O
to	O
February	O
2020	O
.	O

ACE2	O
receptors	O
serve	O
as	O
binding	O
sites	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
virions	B-ANAT
in	O
the	O
lungs	B-ANAT
.	O

The	O
result	O
of	O
this	O
phase	O
I	O
clinical	O
trial	O
showed	O
that	O
a	O
single	O
-	O
dose	O
IV	O
infusion	O
of	O
human	O
umbilical	B-ANAT
cord	I-ANAT
-	O
derived	O
mesenchymal	B-ANAT
stem	I-ANAT
cells	I-ANAT
was	O
safe	O
with	O
favorable	O
outcome	O
in	O
nine	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

The	O
child	O
evolved	O
to	O
refractory	O
hypoxemia	O
and	O
hypercapnia	O
,	O
requiring	O
high	O
parameters	O
of	O
mechanical	O
pulmonary	B-ANAT
ventilation	O
and	O
use	O
of	O
vasoactive	O
agents	O
.	O

We	O
used	O
transcriptomics	O
approaches	O
to	O
compare	O
the	O
scope	O
and	O
kinetics	O
of	O
the	O
host	O
response	O
to	O
the	O
wild	O
-	O
type	O
,	O
DUBmut	O
,	O
and	O
EndoUmut	O
viruses	O
in	O
infected	O
macrophages	B-ANAT
.	O

Unlike	O
other	O
acute	O
infectious	O
diseases	O
progressing	O
to	O
sepsis	O
,	O
the	O
severe	O
courses	O
of	O
COVID19	O
seemingly	O
show	O
prolonged	O
progression	O
from	O
onset	O
of	O
first	O
symptoms	O
to	O
life	O
-	O
threatening	O
deterioration	O
of	O
(	O
primarily	O
)	O
lung	B-ANAT
function	O
.	O

We	O
predict	O
that	O
these	O
individuals	O
are	O
""""	O
primed	O
""""	O
to	O
be	O
at	O
higher	O
risk	O
because	O
nicotine	O
can	O
directly	O
impact	O
the	O
putative	O
receptor	O
for	O
the	O
virus	O
(	O
ACE2	O
)	O
and	O
lead	O
to	O
deleterious	O
signaling	O
in	O
lung	B-ANAT
epithelial	B-ANAT
cells	I-ANAT
.	O

TITLE	O
:	O
Artificial	O
Intelligence	O
Distinguishes	O
COVID	O
-	O
19	O
from	O
Community	O
Acquired	O
Pneumonia	O
on	O
Chest	B-ANAT
CT	O
.	O

In	O
this	O
article	O
we	O
describe	O
cerebral	B-ANAT
malaria	O
caused	O
by	O
the	O
Plasmodium	O
falciparum	O
in	O
a	O
45	O
-	O
year	O
-	O
old	O
Polish	O
patient	O
,	O
who	O
traveled	O
to	O
Cameroon	O
without	O
any	O
malaria	O
prophylaxis	O
.	O

The	O
patient	O
underwent	O
nasopharyngeal	B-ANAT
swab	I-ANAT
for	O
a	O
respiratory	O
pathogen	O
panel	O
as	O
well	O
as	O
SARS	O
-	O
CoV	O
-	O
2	O
RT	O
-	O
PCR	O
.	O

RESULTS	O
:	O
Six	O
patients	O
(	O
8	O
%)	O
were	O
diagnosed	O
as	O
mild	O
type	O
pneumonia	O
;	O
these	O
patients	O
had	O
no	O
obvious	O
abnormal	O
CT	O
findings	O
or	O
manifested	O
mild	O
changes	O
of	O
lung	B-ANAT
infection	O
.	O

In	O
order	O
to	O
provide	O
healthcare	O
workers	O
with	O
updated	O
recommendations	O
on	O
the	O
management	O
of	O
patients	O
in	O
the	O
perioperative	O
setting	O
as	O
well	O
as	O
for	O
emergency	O
airway	B-ANAT
management	O
outside	O
of	O
the	O
operating	O
room	O
,	O
the	O
two	O
largest	O
anesthesia	O
societies	O
,	O
the	O
Chinese	O
Society	O
of	O
Anesthesiology	O
(	O
CSA	O
)	O
and	O
the	O
Chinese	O
Association	O
of	O
Anesthesiologists	O
(	O
CAA	O
)	O
have	O
formed	O
a	O
task	O
force	O
to	O
produce	O
the	O
recommendations	O
.	O

Finally	O
,	O
fluorescence	O
intensity	O
analyses	O
of	O
two	O
populations	O
of	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
(	O
nAb	O
-	O
producing	O
and	O
non	O
-	O
nAb	O
-	O
producing	O
hybridoma	B-ANAT
cell	B-ANAT
lines	I-ANAT
)	O
successfully	O
discriminated	O
between	O
the	O
two	O
populations	O
.	O

HCQ	O
is	O
likely	O
to	O
attenuate	O
the	O
severe	O
progression	O
of	O
COVID	O
-	O
19	O
,	O
inhibiting	O
the	O
cytokine	O
storm	O
by	O
suppressing	O
T	B-ANAT
cell	I-ANAT
activation	O
.	O

Nasopharyngeal	B-ANAT
specimens	O
may	O
miss	O
some	O
infections	O
;	O
a	O
deeper	O
specimen	O
may	O
need	O
to	O
be	O
obtained	O
by	O
bronchoscopy	O
.	O

CONCLUSIONS	O
:	O
Currently	O
,	O
there	O
is	O
no	O
clear	O
evidence	O
regarding	O
optimal	O
delivery	O
timing	O
,	O
the	O
safety	O
of	O
vaginal	B-ANAT
delivery	O
,	O
or	O
whether	O
cesarean	O
delivery	O
prevents	O
vertical	O
transmission	O
at	O
the	O
time	O
of	O
delivery	O
;	O
therefore	O
,	O
route	O
of	O
delivery	O
and	O
delivery	O
timing	O
should	O
be	O
individualized	O
based	O
on	O
obstetrical	O
indications	O
and	O
maternal	O
-	O
fetal	B-ANAT
status	O
.	O

Cases	O
with	O
a	O
pre	O
-	O
existing	O
condition	O
of	O
chronic	O
obstructive	O
pulmonary	B-ANAT
disease	O
or	O
complicated	O
with	O
a	O
secondary	O
bacterial	O
pneumonia	O
were	O
more	O
severe	O
.	O

Therefore	O
,	O
we	O
reinvestigated	O
published	O
data	O
from	O
pangolin	O
lung	B-ANAT
samples	O
from	O
which	O
SARS	O
-	O
CoV	O
-	O
like	O

COVID	O
-	O
19	O
and	O
pneumonia	O
was	O
diagnosed	O
based	O
on	O
the	O
positive	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
tests	O
for	O
oropharyngeal	B-ANAT
swab	O
samples	O
and	O
the	O
presence	O
of	O
anti	O
-	O
SARS	O
-	O
COV	O
-	O
2	O
IgG	O
starting	O
from	O
the	O
illness	O
day	O
11	O
and	O
post	O
-	O
exposure	O
18	O
-	O
21	O
days	O
.	O

The	O
median	O
duration	O
of	O
IgM	O
and	O
IgA	B-ANAT
antibody	I-ANAT
detection	O
were	O
5	O
days	O
(	O
IQR	O
3	O
-	O
6	O
),	O
while	O
IgG	O
was	O
detected	O
on	O
14	O
days	O
(	O
IQR	O
10	O
-	O
18	O
)	O
after	O
symptom	O
onset	O
,	O
with	O
a	O
positive	O
rate	O
of	O
85	O
.	O
4	O
%,	O
92	O
.	O
7	O
%	O
and	O
77	O
.	O
9	O
%	O
respectively	O
.	O

TITLE	O
:	O
Prepare	O
to	O
adapt	O
:	O
Blood	B-ANAT
supply	O
and	O
transfusion	O
support	O
during	O
the	O
first	O
2	O
weeks	O
of	O
the	O
2019	O
Novel	O
Coronavirus	O
(	O
COVID	O
-	O
19	O
)	O
pandemic	O
affecting	O
Washington	O
State	O
.	O

In	O
the	O
second	O
week	O
,	O
blood	B-ANAT
donations	O
recovered	O
,	O
and	O
the	O
hospital	O
postponed	O
elective	O
procedures	O
to	O
ensure	O
staff	O
and	O
personal	O
protective	O
equipment	O
were	O
appropriate	O
for	O
the	O
care	O
of	O
critical	O
patients	O
.	O

Compared	O
with	O
the	O
mild	O
cases	O
,	O
the	O
severe	O
cases	O
had	O
lower	O
lymphocyte	B-ANAT
counts	O
and	O
higher	O
plasma	B-ANAT
levels	O
of	O
Pt	O
,	O
APTT	O
,	O
D	O
-	O
dimer	O
,	O
LDH	O
,	O
PCT	O
,	O
ALB	O
,	O
CRP	O
,	O
and	O
AST	O
.	O

I	O
felt	O
my	O
heart	B-ANAT
skip	O
a	O
beat	O
as	O
I	O
took	O
off	O
my	O
lead	O
gown	O
,	O
preparing	O
to	O
put	O
in	O
my	O
post	O
-	O
operative	O
orders	O
.	O

TITLE	O
:	O
[	O
When	O
COVID	O
-	O
19	O
encounters	O
interstitial	B-ANAT
lung	B-ANAT
disease	O
:	O
challenges	O
and	O
management	O
].	O

Intriguingly	O
,	O
we	O
found	O
that	O
the	O
candidate	O
co	O
-	O
receptors	O
,	O
manifesting	O
the	O
most	O
similar	O
expression	O
patterns	O
with	O
ACE2	O
across	O
13	O
human	B-ANAT
tissues	I-ANAT
,	O
are	O
all	O
peptidases	O
,	O
including	O
ANPEP	O
,	O
DPP4	O
and	O
ENPEP	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
characteristics	O
and	O
clinical	O
value	O
of	O
chest	B-ANAT
computed	O
tomography	O
(	O
CT	O
)	O
images	O
of	O
novel	O
coronavirus	O
pneumonia	O
(	O
NCP	O
).	O

The	O
lesions	O
in	O
each	O
lung	B-ANAT
segment	O
of	O
the	O
patient	O
'	O
s	O
chest	B-ANAT
CT	O
images	O
were	O
characterised	O
.	O

A	O
total	O
of	O
1	O
,	O
702	O
scored	O
lesions	O
were	O
found	O
in	O
the	O
first	O
chest	B-ANAT
CT	O
images	O
of	O
80	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
that	O
started	O
in	O
Wuhan	O
,	O
Hubei	O
province	O
,	O
China	O
in	O
December	O
2019	O
has	O
now	O
extended	O
across	O
the	O
globe	B-ANAT
with	O
>	O
100	O
,	O
000	O
cases	O
and	O
3	O
,	O
000	O
deaths	O
reported	O
in	O
93	O
countries	O
as	O
of	O
7	O
March	O
2020	O
.	O

Second	O
,	O
infection	O
has	O
been	O
associated	O
with	O
multiple	O
direct	O
and	O
indirect	O
cardiovascular	B-ANAT
complications	O
including	O
acute	O
myocardial	O
injury	O
,	O
myocarditis	O
,	O
arrhythmias	O
and	O
venous	B-ANAT
thromboembolism	O
.	O

TITLE	O
:	O
Renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
in	O
human	O
coronavirus	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
On	O
December	O
31	O
,	O
2019	O
,	O
from	O
the	O
Chinese	O
city	O
of	O
Wuhan	O
,	O
Hubei	O
,	O
comes	O
the	O
first	O
case	O
of	O
""""	O
atypcal	O
ARDS	O
/	O
interstitial	B-ANAT
pneumonia	O
"""."	O

Based	O
on	O
our	O
collective	O
experience	O
,	O
we	O
discuss	O
mitigation	O
strategies	O
such	O
as	O
donor	O
screening	O
,	O
resource	O
planning	O
and	O
a	O
staged	O
approach	O
to	O
transplant	B-ANAT
volume	O
considerations	O
as	O
local	O
resource	O
issues	O
demand	O
.	O

In	O
this	O
study	O
,	O
we	O
cloned	O
the	O
genes	O
encoding	O
feIFN	O
-	O
Ïa	O
and	O
feIFN	O
-	O
Ïb	O
from	O
cat	O
spleen	B-ANAT
lymphocytes	B-ANAT
.	O

TITLE	O
:	O
[	O
Clinical	O
features	O
and	O
chest	B-ANAT
CT	O
findings	O
of	O
coronavirus	O
disease	O
2019	O
in	O
infants	O
and	O
young	O
children	O
].	O

ABSTRACT	O
:	O
To	O
study	O
the	O
clinical	O
features	O
and	O
chest	B-ANAT
CT	O
findings	O
of	O
coronavirus	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
infants	O
and	O
young	O
children	O
.	O

Among	O
the	O
9	O
children	O
,	O
6	O
had	O
an	O
increase	O
in	O
lymphocyte	B-ANAT
count	O
and	O
2	O
had	O
an	O
increase	O
in	O
leukocyte	B-ANAT
count	O
.	O

CT	O
examination	O
showed	O
that	O
among	O
the	O
9	O
children	O
,	O
8	O
had	O
pulmonary	B-ANAT
inflammation	O
located	O
below	O
the	O
pleura	B-ANAT
or	O
near	O
the	O
interlobar	O
fissure	B-ANAT
and	O
3	O
had	O
lesions	O
distributed	O
along	O
the	O
bronchovascular	O
bundles	O
.	O

Infants	O
and	O
young	O
children	O
with	O
COVID	O
-	O
19	O
tend	O
to	O
have	O
mild	O
clinical	O
symptoms	O
and	O
imaging	O
findings	O
not	O
as	O
typical	O
as	O
those	O
of	O
adults	O
,	O
and	O
therefore	O
,	O
the	O
diagnosis	O
of	O
COVID	O
-	O
19	O
should	O
be	O
made	O
based	O
on	O
imaging	O
findings	O
along	O
with	O
epidemiological	O
history	O
and	O
nucleic	B-ANAT
acid	O
detection	O
.	O

Two	O
chest	B-ANAT
radiologists	O
independently	O
evaluated	O
the	O
imaging	O
in	O
terms	O
of	O
distribution	O
,	O
ground	O
-	O
glass	O
opacity	O
(	O
GGO	O
),	O
consolidation	O
,	O
air	O
bronchogram	O
,	O
stripe	O
,	O
enlarged	O
mediastinal	B-ANAT
lymph	I-ANAT
node	I-ANAT
,	O
and	O
pleural	B-ANAT
effusion	I-ANAT
.	O

Under	O
eTCB	O
,	O
checkpoint	O
hand	O
disinfection	O
and	O
donning	O
of	O
face	B-ANAT
masks	O
are	O
now	O
required	O
of	O
all	O
visitors	O
who	O
seek	O
to	O
enter	O
hospitals	O
.	O

Pro	O
-	O
inflammatory	O
cytokine	O
expression	O
levels	O
upon	O
SARS	O
-	O
CoV	O
-	O
2	O
infection	O
in	O
Huh	O
-	O
7	O
cells	B-ANAT
were	O
measured	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
assays	O
.	O

Furthermore	O
,	O
LH	O
treatment	O
resulted	O
in	O
abnormal	O
particle	O
morphology	O
of	O
virion	B-ANAT
in	O
cells	B-ANAT
.	O

Rapid	O
viral	O
detection	O
was	O
performed	O
on	O
sputum	B-ANAT
and	O
nasopharyngeal	B-ANAT
samples	O
.	O

RESULTS	O
:	O
Excluding	O
72	O
patients	O
with	O
normal	O
images	O
,	O
230	O
of	O
573	O
patients	O
affected	O
more	O
than	O
two	O
lobes	B-ANAT
.	O

TITLE	O
:	O
How	O
to	O
perform	O
lung	B-ANAT
ultrasound	O
in	O
pregnant	O
women	O
with	O
suspected	O
COVID	O
-	O
19	O
infection	O
.	O

TITLE	O
:	O
Mediastinal	B-ANAT
Emphysema	O
,	O
Giant	O
Bulla	O
,	O
and	O
Pneumothorax	O
Developed	O
during	O
the	O
Course	O
of	O
COVID	O
-	O
19	O
Pneumonia	O
.	O

We	O
report	O
a	O
case	O
where	O
serial	O
follow	O
-	O
up	O
chest	B-ANAT
computed	O
tomography	O
revealed	O
progression	O
of	O
pulmonary	B-ANAT
lesions	O
into	O
confluent	O
bilateral	O
consolidation	O
with	O
lower	O
lung	B-ANAT
predominance	O
,	O
thereby	O
confirming	O
COVID	O
-	O
19	O
pneumonia	O
.	O

Mobilize	O
research	O
platforms	O
for	O
patient	O
needs	O
:	O
Leverage	O
our	O
relationships	O
with	O
participants	O
and	O
rapidly	O
deploy	O
novel	O
clinical	O
engagement	O
techniques	O
such	O
as	O
digital	B-ANAT
tools	O
to	O
intervene	O
remotely	O
to	O
reduce	O
the	O
negative	O
effects	O
of	O
social	O
isolation	O
on	O
our	O
participants	O
.	O

RESULTS	O
:	O
Implement	O
technology	O
now	O
:	O
Minimize	O
face	B-ANAT
-	O
to	O
-	O
face	B-ANAT
contact	O
with	O
participants	O
by	O
utilizing	O
digital	B-ANAT
tools	O
,	O
such	O
as	O
shifting	O
to	O
electronic	O
informed	O
consent	O
and	O
digital	B-ANAT
HIPAA	O
-	O
compliant	O
tools	O
like	O
emailed	O
surveys	O
or	O
telehealth	O
assessments	O
.	O

However	O
,	O
their	O
PCR	O
result	O
in	O
stool	B-ANAT
showed	O
longer	O
time	O
than	O
their	O
families	O
.	O

ACE2	O
in	O
its	O
full	O
-	O
length	O
form	O
is	O
a	O
membrane	B-ANAT
-	O
bound	O
enzyme	O
,	O
whereas	O
its	O
shorter	O
(	O
soluble	O
)	O
form	O
circulates	O
in	O
blood	B-ANAT
at	O
very	O
low	O
levels	O
.	O

In	O
summary	O
,	O
based	O
on	O
the	O
currently	O
available	O
evidence	O
,	O
treatment	O
with	O
renin	B-ANAT
-	I-ANAT
angiotensin	I-ANAT
system	I-ANAT
blockers	O
should	O
not	O
be	O
discontinued	O
because	O
of	O
concerns	O
with	O
coronavirus	O
infection	O
.	O

Neutralising	O
antibody	O
response	O
appeared	O
within	O
9	O
days	O
along	O
with	O
specific	O
IgM	O
and	O
IgG	O
response	O
,	O
targeting	O
particularly	O
nucleocapsid	B-ANAT
and	O
spike	O
proteins	O
.	O

Patients	O
in	O
the	O
death	O
group	O
exhibited	O
significantly	O
lower	O
lymphocyte	B-ANAT
count	O
(	O
0	O
.	O
63	O
[	O
0	O
.	O
40	O
,	O
0	O
.	O
79	O
]	O
Ã	O
10	O
/	O
L	O
vs	O
.	O
1	O
.	O
00	O
[	O
0	O
.	O
72	O
,	O
1	O
.	O
27	O
]	O
Ã	O
10	O
/	O
L	O
,	O
Z	O
=	O
8	O
.	O
037	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
lymphocyte	B-ANAT
/	O
WBC	B-ANAT
ratio	O
(	O
7	O
.	O
10	O
[	O
4	O
.	O
45	O
,	O
12	O
.	O
73	O
]%	O
vs	O
.	O
23	O
.	O
5	O
[	O
15	O
.	O
27	O
,	O
31	O
.	O
25	O
]%,	O
Z	O
=	O
10	O
.	O
315	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
on	O
admission	O
,	O
and	O
the	O
lymphocyte	B-ANAT
/	O
WBC	B-ANAT
ratio	O
continue	O
to	O
decrease	O
during	O
hospitalization	O
(	O
7	O
.	O
10	O
[	O
4	O
.	O
45	O
,	O
12	O
.	O
73	O
]%	O
vs	O
.	O
2	O
.	O
91	O
[	O
1	O
.	O
79	O
,	O
6	O
.	O
13	O
]%,	O
Z	O
=	O
5	O
.	O
242	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
patients	O
in	O
the	O
death	O
group	O
had	O
more	O
complications	O
such	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
89	O
.	O
9	O
%	O
vs	O
.	O
7	O
.	O
6	O
%,	O
Ï	O
=	O
148	O
.	O
105	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
acute	O
cardiac	B-ANAT
injury	O
(	O
59	O
.	O
6	O
%	O
vs	O
.	O
0	O
.	O
8	O
%,	O
Ï	O
=	O
93	O
.	O
222	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
acute	O
kidney	B-ANAT
injury	O
(	O
18	O
.	O
3	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
23	O
.	O
257	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
shock	O
(	O
11	O
.	O
9	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
14	O
.	O
618	O
,	O
P	O
<	O
0	O
.	O
001	O
),	O
and	O
disseminated	O
intravascular	O
coagulation	O
(	O
DIC	O
)	O
(	O
6	O
.	O
4	O
%	O
vs	O
.	O
0	O
,	O
Ï	O
=	O
7	O
.	O
655	O
,	O
P	O
=	O
0	O
.	O
006	O
).	O

Microscopic	O
analysis	O
revealed	O
diffuse	O
filamentous	O
fungi	O
throughout	O
the	O
lungs	B-ANAT
,	O
heart	B-ANAT
,	O
stomach	B-ANAT
,	O
thyroid	B-ANAT
gland	I-ANAT
,	O
and	O
the	O
pulmonary	B-ANAT
embolus	O
,	O
which	O
were	O
identified	O
as	O
Invasive	O
aspergillosis	O
should	O
also	O
be	O
considered	O
in	O
immunocompetent	O
patients	O
with	O
severe	O
respiratory	O
failure	O
after	O
non	O
-	O
fatal	O
drowning	O
who	O
do	O
not	O
respond	O
to	O
broad	O
-	O
spectrum	O
antibiotics	O
.	O

COVID	O
-	O
19	O
status	O
was	O
confirmed	O
by	O
PCR	O
testing	O
of	O
sputum	B-ANAT
,	O
nasopharyngeal	B-ANAT
swabs	O
or	O
throat	B-ANAT
swabs	O
.	O

Patients	O
with	O
cardiac	B-ANAT
injury	O
had	O
higher	O
mortality	O
than	O
those	O
without	O
cardiac	B-ANAT
injury	O
(	O
42	O
of	O
82	O
[	O
51	O
.	O
2	O
%]	O
vs	O
15	O
of	O
334	O
[	O
4	O
.	O
5	O
%];	O
P	O
<	O
.	O
001	O
).	O

The	O
presence	O
of	O
coexisting	O
medical	O
condition	O
was	O
significantly	O
higher	O
in	O
older	O
patients	O
compared	O
with	O
younger	O
patients	O
(	O
55	O
.	O
15	O
%	O
vs	O
21	O
.	O
93	O
%,	O
P	O
<	O
0	O
.	O
001	O
),	O
including	O
the	O
rate	O
of	O
hypertension	O
,	O
diabetes	O
,	O
heart	B-ANAT
diseases	O
and	O
COPD	O
.	O

